canonical_smiles,pchembl_value,assay_description,standard_type,standard_value,standard_units,standard_relation,assay_chembl_id,assay_type,molecule_chembl_id,target_organism,target_chembl_id,document_chembl_id
O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,6.16,"Inhibition of human recombinant EGF-R expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting",IC50,690.0,nM,=,CHEMBL1961280,B,CHEMBL6246,Homo sapiens,CHEMBL203,CHEMBL1955824
C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,6.47,Binding constant for EGFR(E746-A750del) kinase domain,Kd,340.0,nM,=,CHEMBL1061143,B,CHEMBL10,Homo sapiens,CHEMBL203,CHEMBL1150977
CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1,5.33,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,4655.0,nM,=,CHEMBL1909203,B,CHEMBL7002,Homo sapiens,CHEMBL203,CHEMBL1909046
COc1cc2c(cc1OC)Nc1ncnc(O)c1C2,4.12,Inhibition of epidermal growth factor receptor (EGFR),IC50,75000.0,nM,=,CHEMBL843057,B,CHEMBL414013,Homo sapiens,CHEMBL203,CHEMBL1128884
COC(=O)Cn1cc(-c2cccc(Cl)c2)c(=O)c2c(O)cc(OC)cc21,7.19,Inhibition of Epidermal growth factor receptor,IC50,64.0,nM,=,CHEMBL677887,B,CHEMBL7866,Homo sapiens,CHEMBL203,CHEMBL1132606
O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12,6.22,Inhibition of EGFR (unknown origin),IC50,600.0,nM,=,CHEMBL5131965,B,CHEMBL44,Homo sapiens,CHEMBL203,CHEMBL5131376
COc1cc(O)c2c(=O)c(-c3cccc(Cl)c3)cn(CCc3ccccc3)c2c1,5.82,Inhibition of Epidermal growth factor receptor-dependent phosphorylation,IC50,1500.0,nM,=,CHEMBL677889,B,CHEMBL7810,Homo sapiens,CHEMBL203,CHEMBL1132606
O=C1NC(=O)c2cc(Nc3ccccc3)c(Nc3ccccc3)cc21,6.80,Competitive inhibition of ATP binding to EGF-R,Ki,160.0,nM,=,CHEMBL642000,B,CHEMBL268868,Homo sapiens,CHEMBL203,CHEMBL1127678
COc1cc(O)c2c(=O)c(-c3cccc(Cl)c3)coc2c1,5.90,Inhibition of Epidermal growth factor receptor,IC50,1270.0,nM,=,CHEMBL677887,B,CHEMBL7339,Homo sapiens,CHEMBL203,CHEMBL1132606
O=c1c(-c2cccc(Cl)c2)coc2cc(O)ccc12,4.23,Inhibition of Epidermal growth factor receptor,IC50,58800.0,nM,=,CHEMBL677887,B,CHEMBL7699,Homo sapiens,CHEMBL203,CHEMBL1132606
O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21,6.16,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),IC50,700.0,nM,=,CHEMBL679549,B,CHEMBL7939,Homo sapiens,CHEMBL203,CHEMBL1127678
Oc1cc(O)c2c(O)c(-c3cccc(Cl)c3)cnc2c1,8.10,Inhibition of Epidermal growth factor receptor,IC50,8.0,nM,=,CHEMBL677887,B,CHEMBL266995,Homo sapiens,CHEMBL203,CHEMBL1132606
COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC,9.51,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,0.31,nM,=,CHEMBL680017,B,CHEMBL7917,Homo sapiens,CHEMBL203,CHEMBL1129291
O=c1c(-c2cccc(Cl)c2)coc2cc(O)cc(O)c12,7.02,Inhibition of Epidermal growth factor receptor,IC50,95.0,nM,=,CHEMBL677887,B,CHEMBL7827,Homo sapiens,CHEMBL203,CHEMBL1132606
CN(c1ccccc1)c1cc2c(cc1Nc1ccccc1)C(=O)NC2=O,5.06,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),IC50,8700.0,nM,=,CHEMBL679549,B,CHEMBL7775,Homo sapiens,CHEMBL203,CHEMBL1127678
Cc1ccc(Nc2cc3c(cc2Nc2ccc(C)cc2)C(=O)NC3=O)cc1,5.60,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),IC50,2500.0,nM,=,CHEMBL679549,B,CHEMBL7914,Homo sapiens,CHEMBL203,CHEMBL1127678
COc1cc(O)c2c(=O)c(-c3cccc(Cl)c3)cn(C)c2c1,6.77,Inhibition of Epidermal growth factor receptor,IC50,170.0,nM,=,CHEMBL677887,B,CHEMBL7819,Homo sapiens,CHEMBL203,CHEMBL1132606
COc1cc(O)c2c(O)c(-c3cccc(Cl)c3)cnc2c1,7.42,Inhibition of Epidermal growth factor receptor,IC50,38.0,nM,=,CHEMBL677887,B,CHEMBL440453,Homo sapiens,CHEMBL203,CHEMBL1132606
CCN(CC)c1ccc(Nc2cc3c(cc2Nc2ccc(N(CC)CC)cc2)C(=O)NC3=O)cc1,4.30,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),IC50,50000.0,nM,=,CHEMBL679549,B,CHEMBL8223,Homo sapiens,CHEMBL203,CHEMBL1127678
O=C1NC(=O)c2cc(Nc3ccc(O)cc3)c(Nc3ccc(O)cc3)cc21,5.60,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),IC50,2500.0,nM,=,CHEMBL679549,B,CHEMBL267019,Homo sapiens,CHEMBL203,CHEMBL1127678
COc1ccc(Nc2cc3c(cc2Nc2ccccc2)C(=O)NC3=O)cc1,5.70,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),IC50,2000.0,nM,=,CHEMBL679549,B,CHEMBL8095,Homo sapiens,CHEMBL203,CHEMBL1127678
O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,6.05,Inhibition of EGFR,IC50,900.0,nM,=,CHEMBL1029460,B,CHEMBL50,Homo sapiens,CHEMBL203,CHEMBL1158361
C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O,5.28,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,5228.0,nM,=,CHEMBL1909203,B,CHEMBL459,Homo sapiens,CHEMBL203,CHEMBL1909046
O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21,5.27,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,5385.9,nM,=,CHEMBL1909203,B,CHEMBL58,Homo sapiens,CHEMBL203,CHEMBL1909046
CC(C)=CC[C@@H](O)C1=CC(=O)c2c(O)ccc(O)c2C1=O,6.86,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,IC50,139.2,nM,=,CHEMBL4410222,B,CHEMBL9470,Homo sapiens,CHEMBL203,CHEMBL4406881
CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,5.53,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,2947.0,nM,=,CHEMBL1909203,B,CHEMBL479,Homo sapiens,CHEMBL203,CHEMBL1909046
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,4.54,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,28868.0,nM,=,CHEMBL1909203,B,CHEMBL71,Homo sapiens,CHEMBL203,CHEMBL1909046
CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,5.45,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,3553.0,nM,=,CHEMBL1909203,B,CHEMBL83,Homo sapiens,CHEMBL203,CHEMBL1909046
Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl,6.13,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,748.6,nM,=,CHEMBL1909203,B,CHEMBL496,Homo sapiens,CHEMBL203,CHEMBL1909046
Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1,4.53,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,29256.0,nM,=,CHEMBL1909203,B,CHEMBL91,Homo sapiens,CHEMBL203,CHEMBL1909046
Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O,6.25,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,564.0,nM,=,CHEMBL1909203,B,CHEMBL12131,Homo sapiens,CHEMBL203,CHEMBL1909046
O=C(CCCCCCC(=O)Nc1ccccc1)NO,7.92,Inhibition of EGFR (unknown origin),IC50,12.0,nM,=,CHEMBL5215094,B,CHEMBL98,Homo sapiens,CHEMBL203,CHEMBL5214883
Cc1ccc2c(-c3ccccc3)nc(=O)n(C(C)C)c2c1,8.70,Inhibition of EGFR (unknown origin),IC50,2.0,nM,=,CHEMBL5215227,B,CHEMBL268501,Homo sapiens,CHEMBL203,CHEMBL5214889
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C,5.52,Inhibition of EGFR,IC50,3000.0,nM,=,CHEMBL996040,B,CHEMBL13485,Homo sapiens,CHEMBL203,CHEMBL1156432
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Br)cc32)c1C,5.00,Inhibition of epidermal growth factor receptor (EGF-R),IC50,10000.0,nM,=,CHEMBL677212,B,CHEMBL13629,Homo sapiens,CHEMBL203,CHEMBL1136732
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,7.50,"Inhibition of EGFR (unknown origin) using Poly (Glu, Tyr) 4:1 as substrate preincubated with substrate followed by enzyme challenge for 1 hr by ELISA",IC50,31.8,nM,=,CHEMBL4398934,B,CHEMBL535,Homo sapiens,CHEMBL203,CHEMBL4396905
Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1,4.16,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,69421.0,nM,=,CHEMBL1909203,B,CHEMBL104,Homo sapiens,CHEMBL203,CHEMBL1909046
Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1S,6.00,Rate constant for inactivation of erbB-1 receptor of A431 human epidermoid carcinoma cells,Kd,1000.0,nM,=,CHEMBL673785,B,CHEMBL14326,Homo sapiens,CHEMBL203,CHEMBL1130008
CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,6.28,Binding constant for EGFR(G719C) kinase domain,Kd,520.0,nM,=,CHEMBL1908695,B,CHEMBL428690,Homo sapiens,CHEMBL203,CHEMBL1908390
O=C(NCCCCOc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1)C(F)(F)F,7.13,Inhibitory activity against epidermal growth factor receptor,IC50,74.0,nM,=,CHEMBL674106,B,CHEMBL14627,Homo sapiens,CHEMBL203,CHEMBL1146682
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CCOCC1,8.00,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,10.0,nM,=,CHEMBL677210,B,CHEMBL14699,Homo sapiens,CHEMBL203,CHEMBL1134804
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,9.70,Inhibition of wild type EGFR by HTRF assay,IC50,0.2,nM,=,CHEMBL1105216,B,CHEMBL553,Homo sapiens,CHEMBL203,CHEMBL1156950
CS(=O)(=O)CCNCCCOc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,6.98,Inhibitory activity against epidermal growth factor receptor,IC50,104.0,nM,=,CHEMBL674106,B,CHEMBL14952,Homo sapiens,CHEMBL203,CHEMBL1146682
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,9.70,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 15 mins by HTRF assay,IC50,0.2,nM,=,CHEMBL4670930,B,CHEMBL554,Homo sapiens,CHEMBL203,CHEMBL4665812
CN(CCCOc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1)CCS(C)(=O)=O,6.08,Inhibitory activity against epidermal growth factor receptor,IC50,830.0,nM,=,CHEMBL674106,B,CHEMBL14874,Homo sapiens,CHEMBL203,CHEMBL1146682
C=CCOc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,7.10,Inhibitory activity against epidermal growth factor receptor,IC50,79.0,nM,=,CHEMBL674106,B,CHEMBL540701,Homo sapiens,CHEMBL203,CHEMBL1146682
Oc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,7.01,Inhibitory activity against epidermal growth factor receptor,IC50,98.0,nM,=,CHEMBL674106,B,CHEMBL14932,Homo sapiens,CHEMBL203,CHEMBL1146682
COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,7.17,Inhibitory activity against epidermal growth factor receptor,IC50,68.0,nM,=,CHEMBL674106,B,CHEMBL15202,Homo sapiens,CHEMBL203,CHEMBL1146682
CS(=O)(=O)CCN(CCCCOc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1)C(=O)C(F)(F)F,6.63,Inhibition of human recombinant EGFR,IC50,234.42,nM,=,CHEMBL944276,B,CHEMBL273789,Homo sapiens,CHEMBL203,CHEMBL1140899
CS(=O)(=O)CCNCCCCOc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,7.13,Inhibitory activity against epidermal growth factor receptor,IC50,74.0,nM,=,CHEMBL674106,B,CHEMBL15346,Homo sapiens,CHEMBL203,CHEMBL1146682
Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C,4.25,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,55629.0,nM,=,CHEMBL1909203,B,CHEMBL584,Homo sapiens,CHEMBL203,CHEMBL1909046
Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,6.68,Binding constant for EGFR(E746-A750del) kinase domain,Kd,210.0,nM,=,CHEMBL1061143,B,CHEMBL278041,Homo sapiens,CHEMBL203,CHEMBL1150977
CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,5.45,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,3566.0,nM,=,CHEMBL1909203,B,CHEMBL17157,Homo sapiens,CHEMBL203,CHEMBL1909046
COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12,5.24,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,5751.0,nM,=,CHEMBL1909203,B,CHEMBL603,Homo sapiens,CHEMBL203,CHEMBL1909046
CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1,4.62,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,23981.0,nM,=,CHEMBL1909203,B,CHEMBL18797,Homo sapiens,CHEMBL203,CHEMBL1909046
O=C1NC(=O)c2c1c1c3cccc(O)c3[nH]c1c1[nH]c3c(O)cccc3c21,4.54,In vitro activity against Epidermal growth factor receptor (using poly(Glu4Tyr1) as a substrate),IC50,29000.0,nM,=,CHEMBL675381,B,CHEMBL279481,Homo sapiens,CHEMBL203,CHEMBL1131686
CNN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O,4.00,In vitro activity against Epidermal growth factor receptor (using poly(Glu4Tyr1) as a substrate),IC50,100000.0,nM,=,CHEMBL675381,B,CHEMBL277667,Homo sapiens,CHEMBL203,CHEMBL1131686
O=C(Nc1ccccc1)NN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O,4.02,In vitro activity against Epidermal growth factor receptor (using poly(Glu4Tyr1) as a substrate),IC50,95000.0,nM,=,CHEMBL675381,B,CHEMBL19978,Homo sapiens,CHEMBL203,CHEMBL1131686
Cc1ccc(N(C)C(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1,4.31,Inhibition of tyrosine kinase Epidermal growth factor receptor,IC50,49000.0,nM,=,CHEMBL676151,B,CHEMBL278287,Homo sapiens,CHEMBL203,CHEMBL1159186
O=C1NC(=O)c2c1c1c3cccc(O)c3[nH]c1c1c2c2cccc(O)c2n1C1OC(CO)C(O)C(O)C1O,4.05,In vitro activity against Epidermal growth factor receptor (using poly(Glu4Tyr1) as a substrate),IC50,90000.0,nM,=,CHEMBL675381,B,CHEMBL21108,Homo sapiens,CHEMBL203,CHEMBL1131686
CCCNN1C(=O)c2c(c3c4cccc(O)c4n(C4OC(CO)C(O)C(O)C4O)c3c3[nH]c4c(O)cccc4c23)C1=O,4.23,In vitro activity against Epidermal growth factor receptor (using poly(Glu4Tyr1) as a substrate),IC50,59000.0,nM,=,CHEMBL675381,B,CHEMBL21096,Homo sapiens,CHEMBL203,CHEMBL1131686
O=C(O)c1ccc(NN2C(=O)c3c(c4c5cccc(O)c5n(C5OC(CO)C(O)C(O)C5O)c4c4[nH]c5c(O)cccc5c34)C2=O)cc1,4.05,In vitro activity against Epidermal growth factor receptor (using poly(Glu4Tyr1) as a substrate),IC50,90000.0,nM,=,CHEMBL675381,B,CHEMBL279035,Homo sapiens,CHEMBL203,CHEMBL1131686
Cc1ccc(N(C(=O)c2ccccc2)C(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1,4.12,Inhibition of tyrosine kinase Epidermal growth factor receptor,IC50,75000.0,nM,=,CHEMBL676151,B,CHEMBL277430,Homo sapiens,CHEMBL203,CHEMBL1159186
Cc1ccc(NC(=O)c2ccccc2)cc1Nc1nccc(-c2cccnc2)n1,4.19,Inhibition of the epidermal growth factor receptor.,IC50,65000.0,nM,=,CHEMBL675386,B,CHEMBL20926,Homo sapiens,CHEMBL203,CHEMBL1130562
O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O,5.53,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,2987.0,nM,=,CHEMBL1909203,B,CHEMBL24944,Homo sapiens,CHEMBL203,CHEMBL1909046
CN1CCC(O)(c2nc(-c3ccc(F)cc3)c(-c3ccncc3)o2)CC1,6.10,Inhibition of EGFR kinase,IC50,797.0,nM,=,CHEMBL674025,B,CHEMBL22978,Homo sapiens,CHEMBL203,CHEMBL1132910
COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,5.06,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 μL of the test compounds and 10 μL solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 μL solution containing 20 mM HEPES, 2 mM MnCl2, 100 μM Na3VO4, 1 mM DTT buffer, and 20 μL of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 μL anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%−[(negative control)/(positive control−negative control)].",IC50,8650.0,nM,=,CHEMBL3888815,B,CHEMBL140,Homo sapiens,CHEMBL203,CHEMBL3886845
COc1cc2c(Nc3ccc(C)cc3F)ncnc2cc1OCC1CCNCC1,6.30,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,500.0,nM,=,CHEMBL677388,B,CHEMBL428534,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3c(F)cc(Cl)cc3F)ncnc2cc1OCC1CCNCC1,6.30,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,500.0,nM,=,CHEMBL677388,B,CHEMBL25450,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3c(F)cc(Cl)cc3F)ncnc2cc1OCC1CCN(C)CC1,6.35,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,450.0,nM,=,CHEMBL677388,B,CHEMBL422758,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCN1CCOCC1,7.00,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,100.0,nM,=,CHEMBL677388,B,CHEMBL24137,Homo sapiens,CHEMBL203,CHEMBL1135889
COCCOc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC,7.00,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,100.0,nM,=,CHEMBL677388,B,CHEMBL286160,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(C)cc3F)ncnc2cc1OCC1CCN(C)CC1,6.00,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,1000.0,nM,=,CHEMBL677388,B,CHEMBL281990,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3c(F)cc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,6.52,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,300.0,nM,=,CHEMBL677388,B,CHEMBL416191,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(C#N)cc3F)ncnc2cc1OC/C=C/CN1CCCC1,6.10,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,800.0,nM,=,CHEMBL677388,B,CHEMBL24026,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCC1CCN(C)CC1,6.52,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,300.0,nM,=,CHEMBL677388,B,CHEMBL25425,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3c(F)cc(Br)cc3F)ncnc2cc1OCC1CCNCC1,6.35,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,450.0,nM,=,CHEMBL677388,B,CHEMBL279459,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,9.30,Inhibition of EGFR (unknown origin),IC50,0.5,nM,=,CHEMBL5151930,B,CHEMBL24828,Homo sapiens,CHEMBL203,CHEMBL5150004
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1,6.40,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,400.0,nM,=,CHEMBL677388,B,CHEMBL281872,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN1CCOCC1,6.40,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,400.0,nM,=,CHEMBL677388,B,CHEMBL25610,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN1CCN(C)CC1,6.70,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,200.0,nM,=,CHEMBL677388,B,CHEMBL283088,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCC1CCN(C)CC1,6.70,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,200.0,nM,=,CHEMBL677388,B,CHEMBL24979,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN(C)c1ccncc1,6.52,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,300.0,nM,=,CHEMBL677388,B,CHEMBL25579,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCC1CCNCC1,6.70,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,200.0,nM,=,CHEMBL677388,B,CHEMBL26641,Homo sapiens,CHEMBL203,CHEMBL1135889
Oc1ccccc1O,4.58,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,26043.0,nM,=,CHEMBL1909203,B,CHEMBL280998,Homo sapiens,CHEMBL203,CHEMBL1909046
CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H](O)C1,5.34,Inhibition of Epidermal growth factor receptor,IC50,4600.0,nM,=,CHEMBL674692,B,CHEMBL418203,Homo sapiens,CHEMBL203,CHEMBL1135924
OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,4.40,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,40107.0,nM,=,CHEMBL1909203,B,CHEMBL726,Homo sapiens,CHEMBL203,CHEMBL1909046
Cc1nc(O)c2c(ccc3[nH]c(Nc4c(Cl)cccc4Cl)nc32)c1C,4.00,Inhibition of Epidermal growth factor receptor,IC50,100000.0,nM,=,CHEMBL677529,B,CHEMBL27085,Homo sapiens,CHEMBL203,CHEMBL1135526
COc1cc2ncnc(Nc3cccc(SC)c3)c2cc1OC,6.90,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,IC50,126.7,nM,=,CHEMBL2341281,B,CHEMBL29641,Homo sapiens,CHEMBL203,CHEMBL2331141
COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC,8.59,Inhibition of human EGFR in presence of 1 uM ATP,IC50,2.6,nM,=,CHEMBL892951,B,CHEMBL29197,Homo sapiens,CHEMBL203,CHEMBL1147965
C=CC(=O)Nc1cc2c(Nc3cccc(C)c3)ncnc2cc1OCCCN1CCOCC1,8.82,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,1.5,nM,=,CHEMBL674020,B,CHEMBL27688,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCCCN1CCN(C)CC1,8.77,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,1.7,nM,=,CHEMBL674020,B,CHEMBL32844,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCCCn1ccnc1,8.52,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,3.0,nM,=,CHEMBL674020,B,CHEMBL286343,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1CCCCN1CCOCC1,8.57,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,2.7,nM,=,CHEMBL674020,B,CHEMBL281543,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1/C=C/CCN1CCOCC1,9.80,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,0.16,nM,=,CHEMBL674020,B,CHEMBL417478,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2n1,9.12,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,0.75,nM,=,CHEMBL674020,B,CHEMBL28418,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1ccc2ncnc(Nc3cccc(C)c3)c2c1,9.38,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,0.42,nM,=,CHEMBL674020,B,CHEMBL31815,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,9.02,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,0.95,nM,=,CHEMBL674020,B,CHEMBL31816,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCOCCCCO,8.77,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,1.7,nM,=,CHEMBL674020,B,CHEMBL32079,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,9.96,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,0.11,nM,=,CHEMBL3790712,B,CHEMBL31965,Homo sapiens,CHEMBL203,CHEMBL3785081
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,9.12,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,0.75,nM,=,CHEMBL674020,B,CHEMBL31373,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)N(C)c1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,7.70,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,20.0,nM,=,CHEMBL674020,B,CHEMBL31630,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCCCCN(C)C,8.41,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,3.9,nM,=,CHEMBL674020,B,CHEMBL31588,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1SCCCN(CC)CC,9.11,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,0.78,nM,=,CHEMBL674020,B,CHEMBL31326,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCCCN1CCOCC1,8.44,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,3.6,nM,=,CHEMBL674020,B,CHEMBL31419,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.15,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,0.7,nM,=,CHEMBL673925,B,CHEMBL285063,Homo sapiens,CHEMBL203,CHEMBL1134843
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(OCCN(C)C)c(Br)c3)c2c1,7.57,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,27.0,nM,=,CHEMBL674020,B,CHEMBL31369,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(CN(C)C)c(Br)c3)c2c1,7.35,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,45.0,nM,=,CHEMBL674020,B,CHEMBL283201,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1,8.18,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,6.6,nM,=,CHEMBL674020,B,CHEMBL284326,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Br)c3)ncnc2cc1OCCCN1CCOCC1,8.74,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,1.8,nM,=,CHEMBL674020,B,CHEMBL27685,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Br)c3)c2c1,9.16,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,0.69,nM,=,CHEMBL674020,B,CHEMBL280757,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,8.82,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,1.5,nM,=,CHEMBL674020,B,CHEMBL31656,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1nc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCOC,9.01,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,0.97,nM,=,CHEMBL674020,B,CHEMBL31570,Homo sapiens,CHEMBL203,CHEMBL1133162
C=CC(=O)Nc1cc2c(Nc3cccc(C)c3)ncnc2cc1OCCCN1CCN(C)CC1,8.70,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,IC50,2.0,nM,=,CHEMBL674020,B,CHEMBL31622,Homo sapiens,CHEMBL203,CHEMBL1133162
CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1,9.00,Inhibition of EGF receptor,IC50,1.0,nM,=,CHEMBL675238,B,CHEMBL30432,Homo sapiens,CHEMBL203,CHEMBL1134080
C=CC(=O)Nc1ccc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1,8.01,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,IC50,9.7,nM,=,CHEMBL677385,B,CHEMBL281300,Homo sapiens,CHEMBL203,CHEMBL1147619
CC#CC(=O)Nc1ccc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2c1,6.48,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,IC50,330.2,nM,=,CHEMBL677385,B,CHEMBL31876,Homo sapiens,CHEMBL203,CHEMBL1147619
CC#CC(=O)Nc1ccc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1,6.59,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,IC50,258.9,nM,=,CHEMBL677385,B,CHEMBL283682,Homo sapiens,CHEMBL203,CHEMBL1147619
CN(C)C/C=C/C(=O)Nc1ccc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1,7.43,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,IC50,37.2,nM,=,CHEMBL677385,B,CHEMBL30973,Homo sapiens,CHEMBL203,CHEMBL1147619
CC#CC(=O)Nc1cnc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1,5.20,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,IC50,6266.2,nM,=,CHEMBL677385,B,CHEMBL31745,Homo sapiens,CHEMBL203,CHEMBL1147619
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3cccc(Br)c3)c(C#N)cnc2cn1,8.72,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,IC50,1.9,nM,=,CHEMBL677385,B,CHEMBL31276,Homo sapiens,CHEMBL203,CHEMBL1147619
CC#CC(=O)Nc1cnc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2c1,5.42,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,IC50,3762.4,nM,=,CHEMBL677385,B,CHEMBL287022,Homo sapiens,CHEMBL203,CHEMBL1147619
CN(C)C/C=C/C(=O)Nc1cnc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1,5.69,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,IC50,2043.6,nM,=,CHEMBL677385,B,CHEMBL441518,Homo sapiens,CHEMBL203,CHEMBL1147619
C=CC(=O)Nc1cnc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1,6.43,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,IC50,374.8,nM,=,CHEMBL677385,B,CHEMBL281467,Homo sapiens,CHEMBL203,CHEMBL1147619
Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O,6.21,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,614.0,nM,=,CHEMBL1909203,B,CHEMBL290106,Homo sapiens,CHEMBL203,CHEMBL1909046
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1,5.50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,3197.0,nM,=,CHEMBL1909203,B,CHEMBL787,Homo sapiens,CHEMBL203,CHEMBL1909046
Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,4.49,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,32404.0,nM,=,CHEMBL1909203,B,CHEMBL808,Homo sapiens,CHEMBL203,CHEMBL1909046
OCC(O)Cn1ccc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,8.80,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,1.6,nM,=,CHEMBL677389,B,CHEMBL416611,Homo sapiens,CHEMBL203,CHEMBL1130030
CN(C)CCn1ccc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,7.39,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,41.0,nM,=,CHEMBL677389,B,CHEMBL37373,Homo sapiens,CHEMBL203,CHEMBL1130030
Cn1ccc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,9.10,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,0.8,nM,=,CHEMBL677389,B,CHEMBL36727,Homo sapiens,CHEMBL203,CHEMBL1130030
Brc1cccc(Nc2ncnc3cc4[nH]cc(CN5CCOCC5)c4cc23)c1,8.32,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,4.8,nM,=,CHEMBL677389,B,CHEMBL36967,Homo sapiens,CHEMBL203,CHEMBL1130030
O=C(O)Cn1ncc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,7.28,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,53.0,nM,=,CHEMBL677389,B,CHEMBL36819,Homo sapiens,CHEMBL203,CHEMBL1130030
CN(C)CCN(C)Cc1c[nH]c2cc3ncnc(Nc4cccc(Br)c4)c3cc12,8.12,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,7.5,nM,=,CHEMBL677389,B,CHEMBL39811,Homo sapiens,CHEMBL203,CHEMBL1130030
c1ccc(Nc2ncnc3ccccc23)cc1,6.46,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,346.0,nM,=,CHEMBL677389,B,CHEMBL289959,Homo sapiens,CHEMBL203,CHEMBL1130030
Brc1cccc(Nc2ncnc3cc4c(cnn4CCN4CCOCC4)cc23)c1,8.43,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,3.7,nM,=,CHEMBL677389,B,CHEMBL38199,Homo sapiens,CHEMBL203,CHEMBL1130030
Brc1cccc(Nc2ncnc3cc4[nH]ccc4cc23)c1,9.41,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,0.39,nM,=,CHEMBL679944,B,CHEMBL40734,Homo sapiens,CHEMBL203,CHEMBL1132555
Brc1cccc(Nc2ncnc3cc4c(cnn4CCCN4CCOCC4)cc23)c1,8.06,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,8.8,nM,=,CHEMBL677389,B,CHEMBL39355,Homo sapiens,CHEMBL203,CHEMBL1130030
Brc1cccc(Nc2ncnc3cc4c(ccn4CCN4CCOCC4)cc23)c1,8.43,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,3.7,nM,=,CHEMBL677389,B,CHEMBL40130,Homo sapiens,CHEMBL203,CHEMBL1130030
COc1cccc2c(Nc3cccc(Br)c3)ncnc12,6.01,Inhibition of Epidermal growth factor receptor from A431 cells,IC50,974.0,nM,=,CHEMBL677205,B,CHEMBL289787,Homo sapiens,CHEMBL203,CHEMBL1128536
OCC(O)Cn1ncc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,7.92,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,12.0,nM,=,CHEMBL677389,B,CHEMBL37543,Homo sapiens,CHEMBL203,CHEMBL1130030
CN(C)CCCn1ccc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,7.68,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,21.0,nM,=,CHEMBL677389,B,CHEMBL287289,Homo sapiens,CHEMBL203,CHEMBL1130030
CN(C)Cc1c[nH]c2cc3ncnc(Nc4cccc(Br)c4)c3cc12,8.59,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,2.6,nM,=,CHEMBL677389,B,CHEMBL287007,Homo sapiens,CHEMBL203,CHEMBL1130030
OCCN(CCO)Cc1c[nH]c2cc3ncnc(Nc4cccc(Br)c4)c3cc12,8.46,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,3.5,nM,=,CHEMBL677389,B,CHEMBL36164,Homo sapiens,CHEMBL203,CHEMBL1130030
O=C(O)Cn1ccc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,8.29,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,5.1,nM,=,CHEMBL677389,B,CHEMBL289162,Homo sapiens,CHEMBL203,CHEMBL1130030
Brc1cccc(Nc2ncnc3ccccc23)c1,7.57,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,27.0,nM,=,CHEMBL677389,B,CHEMBL290096,Homo sapiens,CHEMBL203,CHEMBL1130030
CN(CC(=O)O)Cc1c[nH]c2cc3ncnc(Nc4cccc(Br)c4)c3cc12,9.14,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,0.72,nM,=,CHEMBL677389,B,CHEMBL289213,Homo sapiens,CHEMBL203,CHEMBL1130030
COC(=O)CN(C)Cc1c[nH]c2cc3ncnc(Nc4cccc(Br)c4)c3cc12,8.47,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,3.4,nM,=,CHEMBL677389,B,CHEMBL39715,Homo sapiens,CHEMBL203,CHEMBL1130030
CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC,11.22,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,0.006,nM,=,CHEMBL677389,B,CHEMBL35820,Homo sapiens,CHEMBL203,CHEMBL1130030
Brc1cccc(Nc2ccnc3ccccc23)c1,5.26,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,5500.0,nM,=,CHEMBL677389,B,CHEMBL37346,Homo sapiens,CHEMBL203,CHEMBL1130030
Brc1cccc(Nc2ncnc3cc4[nH]ncc4cc23)c1,9.36,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,0.44,nM,=,CHEMBL677389,B,CHEMBL39337,Homo sapiens,CHEMBL203,CHEMBL1130030
CN(C)CCn1ncc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,7.40,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,40.0,nM,=,CHEMBL677389,B,CHEMBL287832,Homo sapiens,CHEMBL203,CHEMBL1130030
Cn1ncc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,9.43,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,IC50,0.37,nM,=,CHEMBL677389,B,CHEMBL39320,Homo sapiens,CHEMBL203,CHEMBL1130030
COc1cc(/C=C(\C#N)C(N)=O)cc(Sc2nc3ccccc3s2)c1O,6.46,Inhibition of c-erbB2 receptor,IC50,350.0,nM,=,CHEMBL821544,B,CHEMBL290389,Homo sapiens,CHEMBL203,CHEMBL1133720
CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21,6.32,Inhibition of EGFR,IC50,480.0,nM,=,CHEMBL940057,B,CHEMBL406845,Homo sapiens,CHEMBL203,CHEMBL1145498
COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,7.75,Binding constant for EGFR(E746-A750del) kinase domain,Kd,18.0,nM,=,CHEMBL1908694,B,CHEMBL288441,Homo sapiens,CHEMBL203,CHEMBL1908390
COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,5.22,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,6057.0,nM,=,CHEMBL1909203,B,CHEMBL296419,Homo sapiens,CHEMBL203,CHEMBL1909046
O=CN/C=C/c1ccc(O)c(O)c1,5.16,Inhibition of Epidermal growth factor receptor,IC50,7000.0,nM,=,CHEMBL674699,B,CHEMBL46946,Homo sapiens,CHEMBL203,CHEMBL1153680
Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,5.50,Inhibition of Epidermal growth factor receptor,IC50,3200.0,nM,=,CHEMBL679674,B,CHEMBL47940,Homo sapiens,CHEMBL203,CHEMBL1132739
O=CN/C=C/c1cc(O)ccc1O,5.52,Inhibition of Epidermal growth factor receptor,IC50,3000.0,nM,=,CHEMBL674699,B,CHEMBL47986,Homo sapiens,CHEMBL203,CHEMBL1153680
N#C/C(=C\c1cc(O)ccc1O)C(N)=O,5.00,Inhibition of Epidermal growth factor receptor,IC50,10000.0,nM,=,CHEMBL674699,B,CHEMBL47660,Homo sapiens,CHEMBL203,CHEMBL1153680
N#C/C(=C\c1ccc(O)c(O)c1)C(N)=O,5.46,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Ki,3500.0,nM,=,CHEMBL675636,B,CHEMBL296407,Homo sapiens,CHEMBL203,CHEMBL1124610
O=C1Nc2ccccc2/C1=C/c1ccc(-c2cccs2)s1,5.00,Inhibition of recombinant human EGFR using peptide as substrate by fluorimetric analysis,IC50,10100.0,nM,=,CHEMBL4231196,B,CHEMBL47173,Homo sapiens,CHEMBL203,CHEMBL4229349
CC(C)c1ccc(/C=C2/C(=O)Nc3ccccc32)cc1,4.73,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).,IC50,18500.0,nM,=,CHEMBL676159,B,CHEMBL48760,Homo sapiens,CHEMBL203,CHEMBL1131018
CN1CCC(c2c(O)cc(O)c3c2O/C(=C\c2ccccc2Cl)C3=O)CC1,5.78,Inhibition of Epidermal growth factor receptor,IC50,1680.0,nM,=,CHEMBL674692,B,CHEMBL48614,Homo sapiens,CHEMBL203,CHEMBL1135924
Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(N)nc21,5.25,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,5600.0,nM,=,CHEMBL680019,B,CHEMBL49596,Homo sapiens,CHEMBL203,CHEMBL1131066
CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1,5.06,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,8700.0,nM,=,CHEMBL680019,B,CHEMBL299194,Homo sapiens,CHEMBL203,CHEMBL1131066
Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)nc21,7.11,Inhibition of human epidermal growth factor receptor,IC50,78.0,nM,=,CHEMBL683042,B,CHEMBL301612,Homo sapiens,CHEMBL203,CHEMBL1131506
CCN(CC)CCCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)(C)C)nc2n1,6.62,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,240.0,nM,=,CHEMBL675521,B,CHEMBL45827,Homo sapiens,CHEMBL203,CHEMBL1130094
CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1,6.46,Inhibition of human epidermal growth factor receptor,IC50,350.0,nM,=,CHEMBL683042,B,CHEMBL49120,Homo sapiens,CHEMBL203,CHEMBL1131506
CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)NCc4ccccc4)nc3n2)CC1,6.01,Inhibition of human epidermal growth factor receptor,IC50,980.0,nM,=,CHEMBL683042,B,CHEMBL51485,Homo sapiens,CHEMBL203,CHEMBL1131506
CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)NC4CCCCC4)nc3n2)CC1,6.06,Inhibition of human epidermal growth factor receptor,IC50,880.0,nM,=,CHEMBL683042,B,CHEMBL51028,Homo sapiens,CHEMBL203,CHEMBL1131506
COc1ccc(NC(=O)Nc2nc3nc(NCCCN4CCN(C)CC4)ncc3cc2-c2c(Cl)cccc2Cl)cc1,6.14,Inhibition of human epidermal growth factor receptor,IC50,720.0,nM,=,CHEMBL683042,B,CHEMBL298679,Homo sapiens,CHEMBL203,CHEMBL1131506
COc1cc(OC)cc(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1,4.30,Inhibition of Epidermal growth factor receptor,IC50,50000.0,nM,=,CHEMBL677885,B,CHEMBL299763,Homo sapiens,CHEMBL203,CHEMBL1130533
CCN(CC)CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1,5.87,Inhibition of human epidermal growth factor receptor,IC50,1350.0,nM,=,CHEMBL683042,B,CHEMBL50470,Homo sapiens,CHEMBL203,CHEMBL1131506
O=C(NCc1ccccc1)c1cc2ccc(O)c(O)c2cn1,5.85,Inhibition of epidermal growth factor receptor (EGFR),IC50,1400.0,nM,=,CHEMBL873595,B,CHEMBL48436,Homo sapiens,CHEMBL203,CHEMBL1126211
C[S+]([O-])CCCCN=C=S,5.05,Inhibition of EGFR-TK in human A431 cell lysate assessed as reduction in EGF stimulated kinase activity after 60 mins using biotinylated peptide substrate by ELISA,IC50,9000.0,nM,=,CHEMBL3813356,B,CHEMBL48802,Homo sapiens,CHEMBL203,CHEMBL3808338
O=C(Nc1ccccc1)c1cc2ccc(O)c(O)c2cn1,5.11,Inhibition of epidermal growth factor receptor (EGFR),IC50,7700.0,nM,=,CHEMBL873595,B,CHEMBL48650,Homo sapiens,CHEMBL203,CHEMBL1126211
O=C(NCCc1ccccc1)c1cc2ccc(O)c(O)c2cn1,5.85,Inhibition of epidermal growth factor receptor (EGFR),IC50,1400.0,nM,=,CHEMBL873595,B,CHEMBL49350,Homo sapiens,CHEMBL203,CHEMBL1126211
O=C(Nc1ccccc1)c1cc2cc(O)c(O)cc2cn1,5.25,Inhibition of epidermal growth factor receptor (EGFR),IC50,5600.0,nM,=,CHEMBL873595,B,CHEMBL50415,Homo sapiens,CHEMBL203,CHEMBL1126211
Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(CC(=O)O)cc3)nc21,6.66,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,220.0,nM,=,CHEMBL680019,B,CHEMBL50647,Homo sapiens,CHEMBL203,CHEMBL1131066
O=C(NCc1ccccc1)c1cc2cc(O)c(O)cc2cn1,5.51,Inhibition of epidermal growth factor receptor (EGFR),IC50,3100.0,nM,=,CHEMBL873595,B,CHEMBL296582,Homo sapiens,CHEMBL203,CHEMBL1126211
C=CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2n1,8.96,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),IC50,1.1,nM,=,CHEMBL674018,B,CHEMBL296168,Homo sapiens,CHEMBL203,CHEMBL1132213
C=CC(=O)Nc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,9.27,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),IC50,0.54,nM,=,CHEMBL674018,B,CHEMBL49986,Homo sapiens,CHEMBL203,CHEMBL1132213
C=CC(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.04,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,0.91,nM,=,CHEMBL673925,B,CHEMBL51659,Homo sapiens,CHEMBL203,CHEMBL1134843
C=CC(=O)Nc1cc2c(Nc3cccc(C)c3)ncnc2cn1,9.32,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),IC50,0.48,nM,=,CHEMBL674018,B,CHEMBL54088,Homo sapiens,CHEMBL203,CHEMBL1132213
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Br)c3)ncnc2cn1,9.14,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),IC50,0.72,nM,=,CHEMBL674018,B,CHEMBL54091,Homo sapiens,CHEMBL203,CHEMBL1132213
C=CC(=O)Nc1ccc2ncnc(N3CCc4ccc(Br)cc43)c2c1,9.40,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),IC50,0.4,nM,=,CHEMBL674018,B,CHEMBL51741,Homo sapiens,CHEMBL203,CHEMBL1132213
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Br)c3)c2n1,8.92,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),IC50,1.2,nM,=,CHEMBL674018,B,CHEMBL53665,Homo sapiens,CHEMBL203,CHEMBL1132213
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,9.11,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),IC50,0.77,nM,=,CHEMBL674018,B,CHEMBL53555,Homo sapiens,CHEMBL203,CHEMBL1132213
C=CC(=O)Nc1ccc2c(Nc3cccc(Br)c3)ncnc2c1,9.60,Inhibition of human recombinant EGFR,IC50,0.2512,nM,=,CHEMBL944276,B,CHEMBL443523,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1,9.04,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),IC50,0.91,nM,=,CHEMBL856168,B,CHEMBL53690,Homo sapiens,CHEMBL203,CHEMBL1132213
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1,8.44,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),IC50,3.6,nM,=,CHEMBL856168,B,CHEMBL430571,Homo sapiens,CHEMBL203,CHEMBL1132213
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2c1,8.32,Inhibition of EGF-stimulated autophosphorylation of Epidermal growth factor receptor in A431 cells,IC50,4.8,nM,=,CHEMBL679550,B,CHEMBL53203,Homo sapiens,CHEMBL203,CHEMBL1132213
C=CC(=O)Nc1ccc2c(Nc3cccc(C)c3)ncnc2c1,8.80,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),IC50,1.6,nM,=,CHEMBL856168,B,CHEMBL297968,Homo sapiens,CHEMBL203,CHEMBL1132213
C=CC(=O)Nc1ccc2c(Nc3cccc(Cl)c3)ncnc2c1,9.60,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),IC50,0.25,nM,=,CHEMBL856168,B,CHEMBL52913,Homo sapiens,CHEMBL203,CHEMBL1132213
C=CC(=O)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,8.80,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),IC50,1.6,nM,=,CHEMBL856168,B,CHEMBL53637,Homo sapiens,CHEMBL203,CHEMBL1132213
Brc1cccc(Nc2ncnc3cnc(NCCCN4CCOCC4)nc23)c1,8.53,Inhibition of EGFR,IC50,2.951,nM,=,CHEMBL952131,B,CHEMBL417420,Homo sapiens,CHEMBL203,CHEMBL1143196
Brc1cccc(Nc2ncnc3cnc(NCCN4CCOCC4)nc23)c1,9.09,Inhibition of EGFR,IC50,0.8128,nM,=,CHEMBL952131,B,CHEMBL294475,Homo sapiens,CHEMBL203,CHEMBL1143196
CNc1ncc2ncnc(Nc3cccc(C)c3)c2n1,8.36,Inhibition of EGFR,IC50,4.365,nM,=,CHEMBL952131,B,CHEMBL52591,Homo sapiens,CHEMBL203,CHEMBL1143196
Cc1cccc(Nc2ncnc3cnc(N)nc23)c1,7.76,Inhibition of EGFR,IC50,17.38,nM,=,CHEMBL952131,B,CHEMBL298931,Homo sapiens,CHEMBL203,CHEMBL1143196
Cc1cccc(Nc2ncnc3cnc(NCCc4c[nH]cn4)nc23)c1,8.52,Inhibition of EGFR,IC50,3.02,nM,=,CHEMBL952131,B,CHEMBL416307,Homo sapiens,CHEMBL203,CHEMBL1143196
Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.11,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,0.78,nM,=,CHEMBL680017,B,CHEMBL52765,Homo sapiens,CHEMBL203,CHEMBL1129291
Cc1cccc(Nc2ncnc3cnc(Cl)nc23)c1,6.42,Inhibition of EGFR,IC50,380.19,nM,=,CHEMBL952131,B,CHEMBL52823,Homo sapiens,CHEMBL203,CHEMBL1143196
COc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.52,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,30.0,nM,=,CHEMBL680017,B,CHEMBL52197,Homo sapiens,CHEMBL203,CHEMBL1129291
Cc1cccc(Nc2ncnc3cnc(NCCN4CCOCC4)nc23)c1,8.63,Inhibition of EGFR,IC50,2.344,nM,=,CHEMBL952131,B,CHEMBL299881,Homo sapiens,CHEMBL203,CHEMBL1143196
Cc1cccc(Nc2ncnc3cnc(N(C)C)nc23)c1,8.39,Inhibition of EGFR,IC50,4.074,nM,=,CHEMBL952131,B,CHEMBL52829,Homo sapiens,CHEMBL203,CHEMBL1143196
Brc1cccc(Nc2ncnc3cnc(NCCc4c[nH]cn4)nc23)c1,9.60,Inhibition of EGFR,IC50,0.2512,nM,=,CHEMBL952131,B,CHEMBL53426,Homo sapiens,CHEMBL203,CHEMBL1143196
Nc1ncc2ncnc(Nc3cccc(Br)c3)c2n1,8.82,Inhibition of EGFR,IC50,1.514,nM,=,CHEMBL952131,B,CHEMBL53831,Homo sapiens,CHEMBL203,CHEMBL1143196
CN(C)c1ncc2ncnc(Nc3cccc(Br)c3)c2n1,9.02,Inhibition of EGFR,IC50,0.955,nM,=,CHEMBL952131,B,CHEMBL53777,Homo sapiens,CHEMBL203,CHEMBL1143196
CNc1ncc2ncnc(Nc3ccccc3)c2n1,7.88,Inhibition of EGFR,IC50,13.18,nM,=,CHEMBL952131,B,CHEMBL53310,Homo sapiens,CHEMBL203,CHEMBL1143196
Clc1ncc2ncnc(Nc3cccc(Br)c3)c2n1,7.08,Inhibition of EGFR,IC50,83.18,nM,=,CHEMBL952131,B,CHEMBL53311,Homo sapiens,CHEMBL203,CHEMBL1143196
Nc1ccc2ncnc(Nc3cccc(Br)c3)c2n1,8.12,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,7.6,nM,=,CHEMBL680021,B,CHEMBL300217,Homo sapiens,CHEMBL203,CHEMBL1129564
CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,7.82,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,IC50,15.0,nM,=,CHEMBL677215,B,CHEMBL53753,Homo sapiens,CHEMBL203,CHEMBL1129564
CN(C)c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.08,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,84.0,nM,=,CHEMBL680017,B,CHEMBL52015,Homo sapiens,CHEMBL203,CHEMBL1129291
CN(C)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,7.68,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,IC50,21.0,nM,=,CHEMBL677215,B,CHEMBL53711,Homo sapiens,CHEMBL203,CHEMBL1129564
CNc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.40,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,4.0,nM,=,CHEMBL680017,B,CHEMBL50344,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1ccc(CNc2cc3c(Nc4cccc(Br)c4)ncnc3cn2)cc1,8.64,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,2.3,nM,=,CHEMBL680021,B,CHEMBL53299,Homo sapiens,CHEMBL203,CHEMBL1129564
COc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.59,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,2.6,nM,=,CHEMBL680021,B,CHEMBL53062,Homo sapiens,CHEMBL203,CHEMBL1129564
CN(C)c1ccc2cncnc2c1,7.96,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,11.0,nM,=,CHEMBL680021,B,CHEMBL52784,Homo sapiens,CHEMBL203,CHEMBL1129564
COc1ccc2ncnc(Nc3cccc(Br)c3)c2n1,8.37,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,4.3,nM,=,CHEMBL680021,B,CHEMBL50519,Homo sapiens,CHEMBL203,CHEMBL1129564
CNc1ccc2ncnc(Nc3cccc(Br)c3)c2n1,8.51,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,3.1,nM,=,CHEMBL680021,B,CHEMBL53156,Homo sapiens,CHEMBL203,CHEMBL1129564
COc1ccc2cncnc2c1,8.00,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,10.0,nM,=,CHEMBL680021,B,CHEMBL300491,Homo sapiens,CHEMBL203,CHEMBL1129564
CN(C)c1ccc2ncnc(Nc3cccc(Br)c3)c2n1,8.02,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,9.6,nM,=,CHEMBL680021,B,CHEMBL53796,Homo sapiens,CHEMBL203,CHEMBL1129564
Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.89,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,0.13,nM,=,CHEMBL674648,B,CHEMBL51853,Homo sapiens,CHEMBL203,CHEMBL1131301
COc1ncc2ncnc(Nc3cccc(Br)c3)c2n1,8.42,Inhibition of EGFR,IC50,3.802,nM,=,CHEMBL952131,B,CHEMBL51854,Homo sapiens,CHEMBL203,CHEMBL1143196
CNc1ncc2ncnc(Nc3cccc(Br)c3)c2n1,9.11,Inhibition of EGFR,IC50,0.7762,nM,=,CHEMBL952131,B,CHEMBL299622,Homo sapiens,CHEMBL203,CHEMBL1143196
Fc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,6.91,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,124.0,nM,=,CHEMBL680021,B,CHEMBL53121,Homo sapiens,CHEMBL203,CHEMBL1129564
Clc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,7.40,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,40.0,nM,=,CHEMBL680021,B,CHEMBL296377,Homo sapiens,CHEMBL203,CHEMBL1129564
Brc1cccc(Nc2ncnc3cnccc23)c1,7.29,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,51.0,nM,=,CHEMBL680021,B,CHEMBL51265,Homo sapiens,CHEMBL203,CHEMBL1129564
c1ccc(CNc2ncnc3cnccc23)cc1,5.69,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,2030.0,nM,=,CHEMBL680021,B,CHEMBL51320,Homo sapiens,CHEMBL203,CHEMBL1129564
CNc1ccc2c(Nc3cccc(Br)c3)ncnc2n1,7.28,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,52.0,nM,=,CHEMBL680021,B,CHEMBL298637,Homo sapiens,CHEMBL203,CHEMBL1129564
Fc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,7.89,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,13.0,nM,=,CHEMBL680021,B,CHEMBL51707,Homo sapiens,CHEMBL203,CHEMBL1129564
c1ccc(CNc2ncnc3cccnc23)cc1,6.22,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,603.0,nM,=,CHEMBL680021,B,CHEMBL53552,Homo sapiens,CHEMBL203,CHEMBL1129564
COc1ccc2c(Nc3cccc(Br)c3)ncnc2n1,6.58,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,263.0,nM,=,CHEMBL680021,B,CHEMBL301549,Homo sapiens,CHEMBL203,CHEMBL1129564
CN(C)c1ccc2c(Nc3cccc(Br)c3)ncnc2n1,6.49,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,324.0,nM,=,CHEMBL680021,B,CHEMBL50245,Homo sapiens,CHEMBL203,CHEMBL1129564
Brc1cccc(Nc2ncnc3cccnc23)c1,7.47,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,34.0,nM,=,CHEMBL680021,B,CHEMBL54805,Homo sapiens,CHEMBL203,CHEMBL1129564
COc1ccc2ncncc2c1,7.52,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,30.0,nM,=,CHEMBL680021,B,CHEMBL52472,Homo sapiens,CHEMBL203,CHEMBL1129564
Brc1cccc(Nc2ncnc3ccncc23)c1,7.46,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,35.0,nM,=,CHEMBL680021,B,CHEMBL52665,Homo sapiens,CHEMBL203,CHEMBL1129564
Nc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,8.00,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,10.0,nM,=,CHEMBL677387,B,CHEMBL52076,Homo sapiens,CHEMBL203,CHEMBL1130246
CC(=O)Nc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,7.54,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,29.0,nM,=,CHEMBL680021,B,CHEMBL52418,Homo sapiens,CHEMBL203,CHEMBL1129564
Nc1cc2ncnc(NCc3ccccc3)c2cn1,6.24,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,578.0,nM,=,CHEMBL680021,B,CHEMBL300083,Homo sapiens,CHEMBL203,CHEMBL1129564
CNc1cc2c(Nc3ccccc3)ncnc2cn1,8.05,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,9.0,nM,=,CHEMBL674648,B,CHEMBL53940,Homo sapiens,CHEMBL203,CHEMBL1131301
CC(=O)Nc1cc2ncnc(NCc3ccccc3)c2cn1,7.00,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,100.0,nM,=,CHEMBL680021,B,CHEMBL53404,Homo sapiens,CHEMBL203,CHEMBL1129564
CNc1ccc2ncncc2c1,8.15,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,7.0,nM,=,CHEMBL680021,B,CHEMBL53850,Homo sapiens,CHEMBL203,CHEMBL1129564
Nc1ccc2ncncc2c1,9.10,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,0.79,nM,=,CHEMBL680021,B,CHEMBL53300,Homo sapiens,CHEMBL203,CHEMBL1129564
CN(C)c1ccc2ncncc2c1,6.92,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,120.0,nM,=,CHEMBL680021,B,CHEMBL55150,Homo sapiens,CHEMBL203,CHEMBL1129564
COc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,7.41,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,39.0,nM,=,CHEMBL680021,B,CHEMBL53375,Homo sapiens,CHEMBL203,CHEMBL1129564
CN(C)c1cc2ncnc(Nc3cccc(Br)c3)c2cn1,7.85,Inhibition of epidermal growth factor receptor (EGFR) autophosphorylation in A431 cells,IC50,14.0,nM,=,CHEMBL673451,B,CHEMBL53428,Homo sapiens,CHEMBL203,CHEMBL1130246
c1ccc2ncncc2c1,7.57,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,27.0,nM,=,CHEMBL680021,B,CHEMBL301359,Homo sapiens,CHEMBL203,CHEMBL1129564
CNC1=CC2N=CN(C)/C(=N\c3cccc(Br)c3)C2C=N1,8.51,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,3.1,nM,=,CHEMBL680021,B,CHEMBL52882,Homo sapiens,CHEMBL203,CHEMBL1129564
Clc1ccc2ncnc(Nc3cccc(Br)c3)c2n1,7.75,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,18.0,nM,=,CHEMBL680021,B,CHEMBL291496,Homo sapiens,CHEMBL203,CHEMBL1129564
Nc1ccc2cncnc2c1,10.00,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,0.1,nM,=,CHEMBL680021,B,CHEMBL55729,Homo sapiens,CHEMBL203,CHEMBL1129564
Fc1ccc2ncnc(Nc3cccc(Br)c3)c2n1,7.36,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,44.0,nM,=,CHEMBL680021,B,CHEMBL54788,Homo sapiens,CHEMBL203,CHEMBL1129564
CNc1ccc2cncnc2c1,8.40,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,4.0,nM,=,CHEMBL680021,B,CHEMBL295961,Homo sapiens,CHEMBL203,CHEMBL1129564
Fc1ccc2c(Nc3cccc(Br)c3)ncnc2n1,6.17,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,684.0,nM,=,CHEMBL680021,B,CHEMBL291701,Homo sapiens,CHEMBL203,CHEMBL1129564
CNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,9.89,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,0.13,nM,=,CHEMBL677387,B,CHEMBL54400,Homo sapiens,CHEMBL203,CHEMBL1130246
c1ccc(CNc2ncnc3ccncc23)cc1,5.84,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,1460.0,nM,=,CHEMBL680021,B,CHEMBL54784,Homo sapiens,CHEMBL203,CHEMBL1129564
Nc1ccc2c(Nc3cccc(Br)c3)ncnc2n1,6.03,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,940.0,nM,=,CHEMBL680021,B,CHEMBL54474,Homo sapiens,CHEMBL203,CHEMBL1129564
Brc1cccc(Nc2ncnc3ncccc23)c1,6.16,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,688.0,nM,=,CHEMBL680021,B,CHEMBL54475,Homo sapiens,CHEMBL203,CHEMBL1129564
CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1,5.26,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,5551.0,nM,=,CHEMBL1909203,B,CHEMBL926,Homo sapiens,CHEMBL203,CHEMBL1909046
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccccc1,6.00,Inhibition of EGFR in human A431 cells,IC50,1000.0,nM,=,CHEMBL941404,B,CHEMBL56132,Homo sapiens,CHEMBL203,CHEMBL1150213
Cc1ccc(C(=O)/C(C#N)=C/c2ccc(O)c(O)c2)cc1,6.06,Inhibition of polyGAT phosphorylation,IC50,880.0,nM,=,CHEMBL763200,B,CHEMBL54471,Homo sapiens,CHEMBL203,CHEMBL1125266
COc1ccc(NC(=O)/C(C#N)=C/c2ccc(O)c(O)c2)c(OC)c1,5.77,Inhibition of polyGAT phosphorylation,IC50,1700.0,nM,=,CHEMBL763200,B,CHEMBL57251,Homo sapiens,CHEMBL203,CHEMBL1125266
COc1ccc(CCNC(=O)/C(C#N)=C/c2ccc(O)c(O)c2)cc1OC,5.77,Inhibition of polyGAT phosphorylation,IC50,1700.0,nM,=,CHEMBL763200,B,CHEMBL56455,Homo sapiens,CHEMBL203,CHEMBL1125266
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NC1CCCCC1,5.80,Inhibition of polyGAT phosphorylation,IC50,1600.0,nM,=,CHEMBL763200,B,CHEMBL417941,Homo sapiens,CHEMBL203,CHEMBL1125266
CCOC(=O)C(Cc1ccccc1)NC(=O)/C(C#N)=C/c1ccc(O)c(O)c1,5.82,Inhibition of polyGAT phosphorylation,IC50,1530.0,nM,=,CHEMBL763200,B,CHEMBL56319,Homo sapiens,CHEMBL203,CHEMBL1125266
Cc1cccc(C)c1NC(=O)/C(C#N)=C/c1ccc(O)c(O)c1,5.29,Inhibition of polyGAT phosphorylation,IC50,5100.0,nM,=,CHEMBL763200,B,CHEMBL55360,Homo sapiens,CHEMBL203,CHEMBL1125266
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)N1CCN(c2ccccc2)CC1,5.37,Inhibition of polyGAT phosphorylation,IC50,4300.0,nM,=,CHEMBL763200,B,CHEMBL291986,Homo sapiens,CHEMBL203,CHEMBL1125266
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)N1CCc2ccccc21,5.68,Inhibition of polyGAT phosphorylation,IC50,2100.0,nM,=,CHEMBL763200,B,CHEMBL56542,Homo sapiens,CHEMBL203,CHEMBL1125266
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,7.00,Inhibition of Epidermal growth factor receptor autophosphorylation,IC50,100.0,nM,=,CHEMBL674104,B,CHEMBL56543,Homo sapiens,CHEMBL203,CHEMBL1132364
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccc(O)c(O)c1,6.43,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,370.0,nM,=,CHEMBL677831,B,CHEMBL56393,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1Cl,5.96,Inhibition of polyGAT phosphorylation,IC50,1100.0,nM,=,CHEMBL763200,B,CHEMBL56219,Homo sapiens,CHEMBL203,CHEMBL1125266
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCCc1ccccc1,5.96,Inhibition of polyGAT phosphorylation,IC50,1100.0,nM,=,CHEMBL763200,B,CHEMBL440298,Homo sapiens,CHEMBL203,CHEMBL1125266
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCc1ccccc1,6.21,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,616.6,nM,=,CHEMBL676067,B,CHEMBL293749,Homo sapiens,CHEMBL203,CHEMBL1136802
N#CC(C#N)=C1C(=O)Nc2ccc([N+](=O)[O-])cc21,4.40,Inhibition of polyGAT phosphorylation,IC50,40000.0,nM,=,CHEMBL763200,B,CHEMBL291313,Homo sapiens,CHEMBL203,CHEMBL1125266
N#CC(C#N)=C1CCc2cc(O)c(O)cc21,6.30,Inhibition of polyGAT phosphorylation,IC50,500.0,nM,=,CHEMBL763200,B,CHEMBL293584,Homo sapiens,CHEMBL203,CHEMBL1125266
COc1cc2c(cc1O)NC(=O)C2=C(C#N)C#N,4.22,Inhibition of polyGAT phosphorylation,IC50,60000.0,nM,=,CHEMBL763200,B,CHEMBL56964,Homo sapiens,CHEMBL203,CHEMBL1125266
N#CC(C#N)=C1C(=O)Nc2ccc(O)cc21,5.00,Inhibition of EGFR,IC50,10000.0,nM,=,CHEMBL941412,B,CHEMBL55748,Homo sapiens,CHEMBL203,CHEMBL1150213
N#CC(C#N)=C1CCc2c1ccc(O)c2O,5.16,Inhibition of polyGAT phosphorylation,IC50,7000.0,nM,=,CHEMBL763200,B,CHEMBL57300,Homo sapiens,CHEMBL203,CHEMBL1125266
N#CC(C#N)=C1C(=O)Nc2cc(O)c(O)cc21,5.60,Inhibition of polyGAT phosphorylation,IC50,2500.0,nM,=,CHEMBL763200,B,CHEMBL57462,Homo sapiens,CHEMBL203,CHEMBL1125266
CN1C(=O)C(=C(C#N)C#N)c2cc(O)ccc21,4.58,Inhibition of polyGAT phosphorylation,IC50,26000.0,nM,=,CHEMBL763200,B,CHEMBL56201,Homo sapiens,CHEMBL203,CHEMBL1125266
N#CC(C#N)=Cc1cc[n+]([O-])cc1,2.89,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,IC50,1300000.0,nM,=,CHEMBL674643,B,CHEMBL57712,Homo sapiens,CHEMBL203,CHEMBL1124610
N#CC(C#N)=C(N)/C(C#N)=C/c1ccc2[nH]ccc2c1,3.09,Inhibition of polyGAT phosphorylation,IC50,820000.0,nM,=,CHEMBL763200,B,CHEMBL59150,Homo sapiens,CHEMBL203,CHEMBL1125266
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccc(F)cc1,6.25,Inhibition of polyGAT phosphorylation,IC50,560.0,nM,=,CHEMBL763200,B,CHEMBL55204,Homo sapiens,CHEMBL203,CHEMBL1125266
CC(NC(=O)/C(C#N)=C/c1ccc(O)c(O)c1)c1ccccc1,6.40,Inhibition of polyGAT phosphorylation,IC50,400.0,nM,=,CHEMBL763200,B,CHEMBL55979,Homo sapiens,CHEMBL203,CHEMBL1125266
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCNC(C)(CO)CO,7.16,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,69.0,nM,=,CHEMBL677210,B,CHEMBL56027,Homo sapiens,CHEMBL203,CHEMBL1134804
O=[N+]([O-])c1cccc(Nc2nccc(-c3cccnc3)n2)c1,4.00,Inhibition of the epidermal growth factor receptor.,IC50,100000.0,nM,=,CHEMBL675386,B,CHEMBL56081,Homo sapiens,CHEMBL203,CHEMBL1130562
COc1ccccc1C(=O)Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1,4.00,Inhibition of the epidermal growth factor receptor.,IC50,100000.0,nM,=,CHEMBL675386,B,CHEMBL299707,Homo sapiens,CHEMBL203,CHEMBL1130562
NCCCNC(=O)c1cccc(Nc2nccc(-c3cccnc3)n2)c1,4.35,Inhibition of the epidermal growth factor receptor.,IC50,45000.0,nM,=,CHEMBL675386,B,CHEMBL59099,Homo sapiens,CHEMBL203,CHEMBL1130562
FC(F)C(F)(F)Oc1cccc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c1,5.75,Inhibition of the epidermal growth factor receptor.,IC50,1800.0,nM,=,CHEMBL675386,B,CHEMBL55379,Homo sapiens,CHEMBL203,CHEMBL1130562
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCc1ccccc1,6.16,Inhibition of Epidermal growth factor receptor autophosphorylation,IC50,700.0,nM,=,CHEMBL674104,B,CHEMBL53898,Homo sapiens,CHEMBL203,CHEMBL1132364
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1,6.16,Inhibition of polyGAT phosphorylation,IC50,700.0,nM,=,CHEMBL763200,B,CHEMBL56731,Homo sapiens,CHEMBL203,CHEMBL1125266
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccccc1Cl,5.81,Inhibition of polyGAT phosphorylation,IC50,1540.0,nM,=,CHEMBL763200,B,CHEMBL59145,Homo sapiens,CHEMBL203,CHEMBL1125266
Cc1cc(C)c(C(=O)/C(C#N)=C/c2ccc(O)c(O)c2)c(C)c1,4.97,Inhibition of polyGAT phosphorylation,IC50,10700.0,nM,=,CHEMBL763200,B,CHEMBL55993,Homo sapiens,CHEMBL203,CHEMBL1125266
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1cccs1,5.51,Inhibition of polyGAT phosphorylation,IC50,3100.0,nM,=,CHEMBL763200,B,CHEMBL55994,Homo sapiens,CHEMBL203,CHEMBL1125266
CNCC(O)COc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,8.30,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,5.0,nM,=,CHEMBL677210,B,CHEMBL56266,Homo sapiens,CHEMBL203,CHEMBL1134804
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCC(O)CN,8.22,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,6.0,nM,=,CHEMBL677210,B,CHEMBL56502,Homo sapiens,CHEMBL203,CHEMBL1134804
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CCCCC1,7.01,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,98.0,nM,=,CHEMBL677210,B,CHEMBL56142,Homo sapiens,CHEMBL203,CHEMBL1134804
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN(C)C,7.31,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,49.0,nM,=,CHEMBL677210,B,CHEMBL57990,Homo sapiens,CHEMBL203,CHEMBL1134804
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccc([N+](=O)[O-])cc1,5.70,Inhibition of EGFR in human A431 cells,IC50,2000.0,nM,=,CHEMBL941404,B,CHEMBL56879,Homo sapiens,CHEMBL203,CHEMBL1150213
c1ccc(Nc2nccc(-c3cccnc3)n2)cc1,4.00,Inhibition of the epidermal growth factor receptor.,IC50,100000.0,nM,=,CHEMBL675386,B,CHEMBL57690,Homo sapiens,CHEMBL203,CHEMBL1130562
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCC(O)CN(CCO)CCO,8.30,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,5.0,nM,=,CHEMBL677210,B,CHEMBL299893,Homo sapiens,CHEMBL203,CHEMBL1134804
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,9.82,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,IC50,0.15,nM,=,CHEMBL3999845,B,CHEMBL939,Homo sapiens,CHEMBL203,CHEMBL3997839
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN(C)C,8.15,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,7.0,nM,=,CHEMBL677210,B,CHEMBL57759,Homo sapiens,CHEMBL203,CHEMBL1134804
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCn1ccnc1,7.22,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,IC50,60.2,nM,=,CHEMBL2341281,B,CHEMBL294034,Homo sapiens,CHEMBL203,CHEMBL2331141
CNCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,8.10,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,8.0,nM,=,CHEMBL677210,B,CHEMBL293090,Homo sapiens,CHEMBL203,CHEMBL1134804
COCCNCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,8.10,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,8.0,nM,=,CHEMBL677210,B,CHEMBL56912,Homo sapiens,CHEMBL203,CHEMBL1134804
CCN(CC)CCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,7.24,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,57.0,nM,=,CHEMBL677210,B,CHEMBL55425,Homo sapiens,CHEMBL203,CHEMBL1134804
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCNCCN(C)C,8.70,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,2.0,nM,=,CHEMBL677210,B,CHEMBL56936,Homo sapiens,CHEMBL203,CHEMBL1134804
NCCCn1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)C(F)F)c4)n3)cccc21,6.28,Inhibition of the epidermal growth factor receptor.,IC50,530.0,nM,=,CHEMBL675386,B,CHEMBL293991,Homo sapiens,CHEMBL203,CHEMBL1130562
COc1cc2ncnc(Nc3cccc(C)c3)c2cc1OC,8.34,Inhibition of human recombinant EGFR,IC50,4.6,nM,=,CHEMBL944276,B,CHEMBL56802,Homo sapiens,CHEMBL203,CHEMBL1140899
CCN(CC)CCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,7.03,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,93.0,nM,=,CHEMBL677210,B,CHEMBL293064,Homo sapiens,CHEMBL203,CHEMBL1134804
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CCCC1,7.06,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,87.0,nM,=,CHEMBL677210,B,CHEMBL57758,Homo sapiens,CHEMBL203,CHEMBL1134804
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CCN(C)CC1,8.00,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,10.0,nM,=,CHEMBL677210,B,CHEMBL300791,Homo sapiens,CHEMBL203,CHEMBL1134804
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCNC(C)C,6.51,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,310.0,nM,=,CHEMBL677210,B,CHEMBL55794,Homo sapiens,CHEMBL203,CHEMBL1134804
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCCCC1,7.10,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,79.0,nM,=,CHEMBL677210,B,CHEMBL291514,Homo sapiens,CHEMBL203,CHEMBL1134804
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCCC1,7.15,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,71.0,nM,=,CHEMBL677210,B,CHEMBL299672,Homo sapiens,CHEMBL203,CHEMBL1134804
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCNC(C)(C)C,7.00,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,100.0,nM,=,CHEMBL677210,B,CHEMBL57892,Homo sapiens,CHEMBL203,CHEMBL1134804
COCCN(CCOC)CCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,7.21,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,61.0,nM,=,CHEMBL677210,B,CHEMBL294395,Homo sapiens,CHEMBL203,CHEMBL1134804
c1cc(Nc2nccc(-c3cccnc3)n2)cc(OCCn2ccnc2)c1,5.15,Inhibition of the epidermal growth factor receptor.,IC50,7100.0,nM,=,CHEMBL675386,B,CHEMBL58436,Homo sapiens,CHEMBL203,CHEMBL1130562
Nc1cccc(Nc2nccc(-c3cccnc3)n2)c1,4.30,Inhibition of the epidermal growth factor receptor.,IC50,50000.0,nM,=,CHEMBL675386,B,CHEMBL57553,Homo sapiens,CHEMBL203,CHEMBL1130562
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCC(O)Cn1ccnc1,8.10,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,8.0,nM,=,CHEMBL677210,B,CHEMBL60826,Homo sapiens,CHEMBL203,CHEMBL1134804
CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl,6.35,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,450.0,nM,=,CHEMBL675521,B,CHEMBL57366,Homo sapiens,CHEMBL203,CHEMBL1130094
Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,9.96,Inhibition of EGFR (unknown origin) incubated for 1 hr in presence of ATP by Kinase-Glo Plus luminescence kinase assay,IC50,0.11,nM,=,CHEMBL5216306,B,CHEMBL941,Homo sapiens,CHEMBL203,CHEMBL5214926
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN(CCO)CCO,7.46,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,35.0,nM,=,CHEMBL677210,B,CHEMBL56505,Homo sapiens,CHEMBL203,CHEMBL1134804
Cc1cc(C)c(C)c(-c2cc3cnc(N)nc3nc2NC(=O)NC(C)(C)C)c1C,5.17,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,6680.0,nM,=,CHEMBL675521,B,CHEMBL56236,Homo sapiens,CHEMBL203,CHEMBL1130094
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC,9.00,Inhibition of EGFR by virtual HTS assay,IC50,1.0,nM,=,CHEMBL964945,B,CHEMBL301018,Homo sapiens,CHEMBL203,CHEMBL1153282
Cc1cccc(C)c1-c1cc2cnc(N)nc2nc1NC(=O)NC(C)(C)C,6.21,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,610.0,nM,=,CHEMBL675521,B,CHEMBL57323,Homo sapiens,CHEMBL203,CHEMBL1130094
CCN(CC)CCCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)Nc3ccccc3)nc2n1,6.00,Inhibition of epidermal growth factor receptor,IC50,1000.0,nM,=,CHEMBL677382,B,CHEMBL56983,Homo sapiens,CHEMBL203,CHEMBL1134497
CCNC(=O)Nc1nc2nc(NCCCCN(CC)CC)ncc2cc1-c1c(Cl)cccc1Cl,5.90,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,1260.0,nM,=,CHEMBL675521,B,CHEMBL301483,Homo sapiens,CHEMBL203,CHEMBL1130094
CCN(CC)CCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(NC(=O)NC(C)(C)C)nc2n1,5.21,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,6200.0,nM,=,CHEMBL675521,B,CHEMBL299026,Homo sapiens,CHEMBL203,CHEMBL1130094
CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(NC(=O)NC(C)(C)C)nc3n2)CC1,6.82,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,150.0,nM,=,CHEMBL675521,B,CHEMBL57347,Homo sapiens,CHEMBL203,CHEMBL1130094
CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1,5.98,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,1050.0,nM,=,CHEMBL1909203,B,CHEMBL954,Homo sapiens,CHEMBL203,CHEMBL1909046
Cn1c(SSc2c(C(=O)Nc3ccccc3)c3ccccc3n2C)c(C(=O)Nc2ccccc2)c2ccccc21,5.00,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,10000.0,nM,=,CHEMBL677391,B,CHEMBL304414,Homo sapiens,CHEMBL203,CHEMBL1127560
Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc(Br)ccc3n2C)c(C(=O)Nc2ccccc2)c2cc(Br)ccc21,4.94,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,11400.0,nM,=,CHEMBL677391,B,CHEMBL293251,Homo sapiens,CHEMBL203,CHEMBL1127560
Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc(O)ccc3n2C)c(C(=O)Nc2ccccc2)c2cc(O)ccc21,4.39,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,40500.0,nM,=,CHEMBL677391,B,CHEMBL293250,Homo sapiens,CHEMBL203,CHEMBL1127560
Cn1c(SSc2c(C(=O)Nc3ccccc3)c3ccc(O)cc3n2C)c(C(=O)Nc2ccccc2)c2ccc(O)cc21,4.36,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,44000.0,nM,=,CHEMBL677391,B,CHEMBL293913,Homo sapiens,CHEMBL203,CHEMBL1127560
CC(=O)Oc1cccc2c(C(=O)Nc3ccccc3)c(SSc3c(C(=O)Nc4ccccc4)c4cccc(OC(C)=O)c4n3C)n(C)c12,5.00,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,9900.0,nM,=,CHEMBL677391,B,CHEMBL291359,Homo sapiens,CHEMBL203,CHEMBL1127560
COc1cccc2c(C(=O)Nc3ccccc3)c(SSc3c(C(=O)Nc4ccccc4)c4cccc(OC)c4n3C)n(C)c12,5.19,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,6500.0,nM,=,CHEMBL677391,B,CHEMBL292323,Homo sapiens,CHEMBL203,CHEMBL1127560
CC(=O)Oc1cccc2c1c(C(=O)Nc1ccccc1)c(SSc1c(C(=O)Nc3ccccc3)c3c(OC(C)=O)cccc3n1C)n2C,4.70,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,20000.0,nM,=,CHEMBL677391,B,CHEMBL59812,Homo sapiens,CHEMBL203,CHEMBL1127560
Cn1c(SSc2c(C(=O)Nc3ccccc3)c3c(Cl)cccc3n2C)c(C(=O)Nc2ccccc2)c2c(Cl)cccc21,4.00,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,100000.0,nM,=,CHEMBL677391,B,CHEMBL293986,Homo sapiens,CHEMBL203,CHEMBL1127560
COc1ccc2c(C(=O)Nc3ccccc3)c(SSc3c(C(=O)Nc4ccccc4)c4ccc(OC)cc4n3C)n(C)c2c1,5.44,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,3600.0,nM,=,CHEMBL677391,B,CHEMBL60472,Homo sapiens,CHEMBL203,CHEMBL1127560
Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc(C#N)ccc3n2C)c(C(=O)Nc2ccccc2)c2cc(C#N)ccc21,4.27,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,54100.0,nM,=,CHEMBL677391,B,CHEMBL291979,Homo sapiens,CHEMBL203,CHEMBL1127560
O=C(CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)NCc2ccccc2)[nH]c2ccccc12)NCc1ccccc1,6.07,Inhibition of human epidermal growth factor receptor (EGFR),IC50,850.0,nM,=,CHEMBL677390,B,CHEMBL293261,Homo sapiens,CHEMBL203,CHEMBL1127560
Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc([N+](=O)[O-])ccc3n2C)c(C(=O)Nc2ccccc2)c2cc([N+](=O)[O-])ccc21,5.30,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,5000.0,nM,=,CHEMBL677391,B,CHEMBL64430,Homo sapiens,CHEMBL203,CHEMBL1127560
CC(=O)Oc1ccc2c(c1)c(C(=O)Nc1ccccc1)c(SSc1c(C(=O)Nc3ccccc3)c3cc(OC(C)=O)ccc3n1C)n2C,5.28,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,5300.0,nM,=,CHEMBL677391,B,CHEMBL61119,Homo sapiens,CHEMBL203,CHEMBL1127560
Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cc(Cl)ccc3n2C)c(C(=O)Nc2ccccc2)c2cc(Cl)ccc21,5.37,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,4300.0,nM,=,CHEMBL677391,B,CHEMBL293889,Homo sapiens,CHEMBL203,CHEMBL1127560
CN1C(=S)C(C(=O)Nc2ccccc2)c2ccccc21,6.00,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,1000.0,nM,=,CHEMBL677391,B,CHEMBL62176,Homo sapiens,CHEMBL203,CHEMBL1127560
CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-],6.33,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,473.0,nM,=,CHEMBL1909203,B,CHEMBL64894,Homo sapiens,CHEMBL203,CHEMBL1909046
Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cccnc3n2C)c(C(=O)Nc2ccccc2)c2cccnc21,4.65,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,22300.0,nM,=,CHEMBL677391,B,CHEMBL62701,Homo sapiens,CHEMBL203,CHEMBL1127560
Cn1c(SSc2c(C(=O)Nc3ccccc3)c3cccc(O)c3n2C)c(C(=O)Nc2ccccc2)c2cccc(O)c21,4.00,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,IC50,100000.0,nM,=,CHEMBL677391,B,CHEMBL62843,Homo sapiens,CHEMBL203,CHEMBL1127560
Nc1ncnc2c1ncn2-c1ccccc1,4.82,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,15000.0,nM,=,CHEMBL677832,B,CHEMBL62756,Homo sapiens,CHEMBL203,CHEMBL1130217
Nc1ncnc2c1cnn2-c1ccccc1,5.57,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,2700.0,nM,=,CHEMBL677832,B,CHEMBL65063,Homo sapiens,CHEMBL203,CHEMBL1130217
Brc1cccc(Nc2ncnc3cc4[nH]cnc4cc23)c1,11.10,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,IC50,0.008,nM,=,CHEMBL683040,B,CHEMBL66031,Homo sapiens,CHEMBL203,CHEMBL1129035
C#Cc1cc(Nc2ncnc3cc(OC)c(OC)cc23)ccc1F,8.40,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,IC50,4.0,nM,=,CHEMBL678292,B,CHEMBL65250,Homo sapiens,CHEMBL203,CHEMBL1135760
Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1Cl,8.19,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,6.5,nM,=,CHEMBL680017,B,CHEMBL63469,Homo sapiens,CHEMBL203,CHEMBL1129291
C#Cc1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1,9.26,Binding affinity to wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by Kinomescan method,Kd,0.55,nM,=,CHEMBL4394506,B,CHEMBL304929,Homo sapiens,CHEMBL203,CHEMBL4393671
COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1[N+](=O)[O-],7.82,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,15.0,nM,=,CHEMBL680017,B,CHEMBL65038,Homo sapiens,CHEMBL203,CHEMBL1129291
O=[N+]([O-])c1cc2c(Nc3cccc(Br)c3)ncnc2cc1Cl,7.60,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,25.0,nM,=,CHEMBL680017,B,CHEMBL66409,Homo sapiens,CHEMBL203,CHEMBL1129291
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCNC(=O)/C(C#N)=C/c1ccc(O)c(O)c1,6.40,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,400.0,nM,=,CHEMBL677831,B,CHEMBL67535,Homo sapiens,CHEMBL203,CHEMBL1129590
Oc1cc2cc(-c3cccnc3)cnc2cc1O,6.30,Concentration required to inhibit phosphorylation of isolated human epidermal growth factor tyrosine kinase receptor by 50%,IC50,500.0,nM,=,CHEMBL679946,B,CHEMBL63356,Homo sapiens,CHEMBL203,CHEMBL1127568
COc1ccc(/C=C/c2cnc3cc(OC)c(OC)cc3c2)cc1,4.70,Concentration required to inhibit phosphorylation of isolated human epidermal growth factor tyrosine kinase receptor by 50%,IC50,20000.0,nM,=,CHEMBL679946,B,CHEMBL66101,Homo sapiens,CHEMBL203,CHEMBL1127568
COc1ccc(/C=C(\C#N)c2cccnc2)cc1OC,6.16,Concentration required to inhibit phosphorylation of isolated human epidermal growth factor tyrosine kinase receptor by 50%,IC50,700.0,nM,=,CHEMBL679946,B,CHEMBL67027,Homo sapiens,CHEMBL203,CHEMBL1127568
Cc1cc(C(=O)N2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc4c(c3)CCC4)c21,5.85,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,1410.0,nM,=,CHEMBL674637,B,CHEMBL65848,Homo sapiens,CHEMBL203,CHEMBL1134862
CCN(CC)CCNC(=O)c1cc(C)c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(Cl)cc4F)c32)[nH]1,6.35,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,450.0,nM,=,CHEMBL674637,B,CHEMBL308672,Homo sapiens,CHEMBL203,CHEMBL1134862
C#Cc1cccc(Nc2ncnc3c2/C(=C/c2[nH]c(C(=O)NCCN4CCOCC4)cc2C)C(=O)N3)c1,7.75,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,18.0,nM,=,CHEMBL674637,B,CHEMBL69966,Homo sapiens,CHEMBL203,CHEMBL1134862
CCN(CC)CC(O)CNC(=O)c1cc(C)c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)[nH]1,9.35,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,0.45,nM,=,CHEMBL674637,B,CHEMBL304271,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1cc(CCC(=O)O)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21,8.33,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,4.7,nM,=,CHEMBL674637,B,CHEMBL308645,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1cc(C)c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)[nH]1,7.39,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,41.0,nM,=,CHEMBL674637,B,CHEMBL68920,Homo sapiens,CHEMBL203,CHEMBL1134862
CCN(CC)CCNC(=O)c1cc(C)c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)[nH]1,8.92,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,1.2,nM,=,CHEMBL674637,B,CHEMBL69358,Homo sapiens,CHEMBL203,CHEMBL1134862
CCN1CCN(C(=O)c2cc(C)c(/C=C3\C(=O)Nc4ncnc(Nc5ccc(F)c(Cl)c5)c43)[nH]2)CC1,7.89,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,13.0,nM,=,CHEMBL674637,B,CHEMBL66570,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1cc(C(=O)N2CCN(C)CC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21,8.55,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,2.8,nM,=,CHEMBL674637,B,CHEMBL305246,Homo sapiens,CHEMBL203,CHEMBL1134862
O=C1Nc2ncnc(Nc3ccc(F)c(Cl)c3)c2/C1=C/c1ccc(C(=O)NCCN2CCOCC2)[nH]1,7.66,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,22.0,nM,=,CHEMBL674637,B,CHEMBL302552,Homo sapiens,CHEMBL203,CHEMBL1134862
CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)c1C,6.70,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,200.0,nM,=,CHEMBL674637,B,CHEMBL432903,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1cc(C(=O)NCCN2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc4c(ccn4Cc4ccccc4)c3)c21,8.96,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,1.1,nM,=,CHEMBL674637,B,CHEMBL264382,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1cc(C(=O)N2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c21,8.74,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,1.8,nM,=,CHEMBL674637,B,CHEMBL67003,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1cc(C(=O)N2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc4c(ccn4Cc4ccccc4)c3)c21,8.35,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,4.5,nM,=,CHEMBL674637,B,CHEMBL67057,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1cc(C(=O)NCCN2CCOCC2)[nH]c1/C=C1\C(=O)N(C)c2ncnc(Nc3ccc(F)c(Cl)c3)c21,5.28,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,5310.0,nM,=,CHEMBL674637,B,CHEMBL443268,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1cc(C(=O)NCCN2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21,8.19,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,6.5,nM,=,CHEMBL674637,B,CHEMBL69629,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1cc(C(=O)N2CC(C)NC(C)C2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21,8.23,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,5.9,nM,=,CHEMBL674637,B,CHEMBL69071,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1cc(C(=O)N2CCOCC2)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21,6.77,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,170.0,nM,=,CHEMBL674637,B,CHEMBL69960,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1[nH]c(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)c(C)c1CCC(=O)O,6.75,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,180.0,nM,=,CHEMBL674637,B,CHEMBL305782,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1cc(C(=O)O)[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21,7.54,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,29.0,nM,=,CHEMBL674637,B,CHEMBL305194,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1c(C(=O)N2CCN(C)CC2)c[nH]c1/C=C1\C(=O)Nc2ncnc(Nc3ccc(F)c(Cl)c3)c21,6.39,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,410.0,nM,=,CHEMBL674637,B,CHEMBL304971,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1cc(/C=C2\C(=O)Nc3ncnc(Nc4ccc(F)c(Cl)c4)c32)[nH]c1C(=O)N1CCN(C)CC1,6.68,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,IC50,210.0,nM,=,CHEMBL674637,B,CHEMBL69964,Homo sapiens,CHEMBL203,CHEMBL1134862
Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1,6.70,Inhibition of EGFR,Ki,199.53,nM,=,CHEMBL2065348,B,CHEMBL306380,Homo sapiens,CHEMBL203,CHEMBL2062478
CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,6.25,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,559.1,nM,=,CHEMBL1909203,B,CHEMBL305660,Homo sapiens,CHEMBL203,CHEMBL1909046
N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O,5.54,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,2880.0,nM,=,CHEMBL1909203,B,CHEMBL1009,Homo sapiens,CHEMBL203,CHEMBL1909046
CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,5.49,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,3276.9,nM,=,CHEMBL1909203,B,CHEMBL1016,Homo sapiens,CHEMBL203,CHEMBL1909046
c1ccc(Nc2ncnc3[nH]c4c(c23)CCCC4)cc1,6.51,In vitro inhibitory activity against epidermal growth factor receptor,IC50,310.0,nM,=,CHEMBL677880,B,CHEMBL433305,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(Oc3cccc(Cl)c3)c2c1C,5.60,In vitro inhibitory activity against epidermal growth factor receptor,IC50,2500.0,nM,=,CHEMBL677880,B,CHEMBL76116,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(Nc3ccc(F)cc3)c2c1C,6.25,In vitro inhibitory activity against epidermal growth factor receptor,IC50,560.0,nM,=,CHEMBL677880,B,CHEMBL73710,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(Nc3cccc(C(=O)O)c3)c2c1C,4.79,In vitro inhibitory activity against epidermal growth factor receptor,IC50,16300.0,nM,=,CHEMBL677880,B,CHEMBL431001,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1C,5.72,In vitro inhibitory activity against epidermal growth factor receptor,IC50,1900.0,nM,=,CHEMBL677880,B,CHEMBL306029,Homo sapiens,CHEMBL203,CHEMBL1129072
COc1cccc(Nc2ncnc3[nH]c(C)c(C)c23)c1,5.92,In vitro inhibitory activity against epidermal growth factor receptor,IC50,1200.0,nM,=,CHEMBL677880,B,CHEMBL73301,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1ccc(Nc2ncnc3[nH]c4c(c23)CCCC4)cc1,6.96,In vitro inhibitory activity against epidermal growth factor receptor,IC50,110.0,nM,=,CHEMBL677880,B,CHEMBL74481,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(Nc3cc(Cl)cc(Cl)c3)c2c1C,6.77,In vitro inhibitory activity against epidermal growth factor receptor,IC50,170.0,nM,=,CHEMBL677880,B,CHEMBL73406,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(Nc3ccccc3Cl)c2c1C,4.12,In vitro inhibitory activity against epidermal growth factor receptor,IC50,75100.0,nM,=,CHEMBL677880,B,CHEMBL73625,Homo sapiens,CHEMBL203,CHEMBL1129072
Oc1cccc(Nc2ncnc3[nH]c4c(c23)CCCC4)c1,6.38,In vitro inhibitory activity against epidermal growth factor receptor,IC50,420.0,nM,=,CHEMBL677880,B,CHEMBL72322,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(NCc3ccccc3)c2c1C,5.97,In vitro inhibitory activity against epidermal growth factor receptor,IC50,1080.0,nM,=,CHEMBL677880,B,CHEMBL421686,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(N(C)c3cccc(Cl)c3)c2c1C,6.30,In vitro inhibitory activity against epidermal growth factor receptor,IC50,500.0,nM,=,CHEMBL677880,B,CHEMBL76444,Homo sapiens,CHEMBL203,CHEMBL1129072
Clc1cccc(Nc2ncnc3[nH]c(-c4ccccc4)c(-c4ccccc4)c23)c1,7.02,In vitro inhibitory activity against epidermal growth factor receptor,IC50,96.0,nM,=,CHEMBL677880,B,CHEMBL307209,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(Nc3cccc(Cl)c3)c2c1-c1ccccc1,6.64,In vitro inhibitory activity against epidermal growth factor receptor,IC50,230.0,nM,=,CHEMBL677880,B,CHEMBL308593,Homo sapiens,CHEMBL203,CHEMBL1129072
CCc1ccc(Nc2ncnc3[nH]c(C)c(C)c23)cc1,4.11,In vitro inhibitory activity against epidermal growth factor receptor,IC50,77500.0,nM,=,CHEMBL677880,B,CHEMBL309937,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1ccc(Nc2ncnc3[nH]c(C)c(C)c23)cc1,5.68,In vitro inhibitory activity against epidermal growth factor receptor,IC50,2100.0,nM,=,CHEMBL677880,B,CHEMBL307599,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(Nc3cccc(C#N)c3)c2c1C,6.70,In vitro inhibitory activity against epidermal growth factor receptor,IC50,200.0,nM,=,CHEMBL677880,B,CHEMBL75208,Homo sapiens,CHEMBL203,CHEMBL1129072
Clc1cccc(Nc2ncnc3[nH]c4c(c23)CCCC4)c1,7.54,In vitro inhibitory activity against epidermal growth factor receptor,IC50,29.0,nM,=,CHEMBL677880,B,CHEMBL75177,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1cccc(Nc2ncnc3[nH]c4c(c23)CCCC4)c1,6.09,In vitro inhibitory activity against epidermal growth factor receptor,IC50,820.0,nM,=,CHEMBL677880,B,CHEMBL307062,Homo sapiens,CHEMBL203,CHEMBL1129072
Clc1cccc(Nc2ncnc3[nH]c4ccccc4c23)c1,8.22,In vitro inhibitory activity against epidermal growth factor receptor,IC50,6.0,nM,=,CHEMBL677880,B,CHEMBL306315,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1c(-c2ccccc2)[nH]c2ncnc(Nc3cccc(Cl)c3)c12,8.00,In vitro inhibitory activity against epidermal growth factor receptor,IC50,10.0,nM,=,CHEMBL677880,B,CHEMBL311129,Homo sapiens,CHEMBL203,CHEMBL1129072
Brc1cccc(Nc2ncnc3[nH]c4c(c23)CCCC4)c1,7.34,In vitro inhibitory activity against epidermal growth factor receptor,IC50,46.0,nM,=,CHEMBL677880,B,CHEMBL72393,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(Nc3cccc(Cl)c3)c2c1C,7.57,In vitro inhibitory activity against epidermal growth factor receptor,IC50,27.0,nM,=,CHEMBL677880,B,CHEMBL306081,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(Nc3cccc(F)c3)c2c1C,6.26,In vitro inhibitory activity against epidermal growth factor receptor,IC50,550.0,nM,=,CHEMBL677880,B,CHEMBL308582,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1cccc(Nc2ncnc3[nH]c(C)c(C)c23)c1,6.24,In vitro inhibitory activity against epidermal growth factor receptor,IC50,570.0,nM,=,CHEMBL677880,B,CHEMBL307026,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(Nc3ccccc3)c2c1C,5.72,In vitro inhibitory activity against epidermal growth factor receptor,IC50,1900.0,nM,=,CHEMBL677880,B,CHEMBL75049,Homo sapiens,CHEMBL203,CHEMBL1129072
COc1cccc(Nc2ncnc3[nH]c4c(c23)CCCC4)c1,6.07,In vitro inhibitory activity against epidermal growth factor receptor,IC50,860.0,nM,=,CHEMBL677880,B,CHEMBL431191,Homo sapiens,CHEMBL203,CHEMBL1129072
O=C(O)c1cccc(Nc2ncnc3[nH]c4c(c23)CCCC4)c1,4.59,In vitro inhibitory activity against epidermal growth factor receptor,IC50,25700.0,nM,=,CHEMBL677880,B,CHEMBL74645,Homo sapiens,CHEMBL203,CHEMBL1129072
FC(F)(F)c1cccc(Nc2ncnc3[nH]c4c(c23)CCCC4)c1,6.44,In vitro inhibitory activity against epidermal growth factor receptor,IC50,360.0,nM,=,CHEMBL677880,B,CHEMBL440873,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(Nc3cccc(Br)c3)c2c1C,7.60,In vitro inhibitory activity against epidermal growth factor receptor,IC50,25.0,nM,=,CHEMBL677880,B,CHEMBL74722,Homo sapiens,CHEMBL203,CHEMBL1129072
Cc1[nH]c2ncnc(Nc3cccc(O)c3)c2c1C,5.90,In vitro inhibitory activity against epidermal growth factor receptor,IC50,1250.0,nM,=,CHEMBL677880,B,CHEMBL74778,Homo sapiens,CHEMBL203,CHEMBL1129072
CCNC(=O)Nc1nc2nc(N)ncc2cc1-c1c(Cl)cccc1Cl,5.87,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,1360.0,nM,=,CHEMBL675521,B,CHEMBL432738,Homo sapiens,CHEMBL203,CHEMBL1130094
C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,5.83,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,1485.2,nM,=,CHEMBL1909203,B,CHEMBL75880,Homo sapiens,CHEMBL203,CHEMBL1909046
Cc1cc(C)c(C)c(-c2cc3cnc(NCCCN4CCN(C)CC4)nc3nc2NC(=O)NC(C)(C)C)c1C,5.16,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,7000.0,nM,=,CHEMBL675521,B,CHEMBL75188,Homo sapiens,CHEMBL203,CHEMBL1130094
CC(C)(C)NC(=O)Nc1nc2nc(N)ncc2cc1-c1ccccc1,5.26,Inhibition of epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,5530.0,nM,=,CHEMBL675380,B,CHEMBL76599,Homo sapiens,CHEMBL203,CHEMBL1130094
Oc1cccc(O)c1O,5.91,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,1230.0,nM,=,CHEMBL1909203,B,CHEMBL307145,Homo sapiens,CHEMBL203,CHEMBL1909046
CC(C)(C)NC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1,5.89,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,1300.0,nM,=,CHEMBL674640,B,CHEMBL78206,Homo sapiens,CHEMBL203,CHEMBL1125600
N#CC(C#N)=C(N)/C(C#N)=C/c1cc(O)c(O)c(O)c1,6.10,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,IC50,800.0,nM,=,CHEMBL674643,B,CHEMBL78257,Homo sapiens,CHEMBL203,CHEMBL1124610
CC(C)(C)OC(=O)NCCNC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1,6.00,Inhibition of EGFR in human A431 cells,IC50,1000.0,nM,=,CHEMBL941404,B,CHEMBL418906,Homo sapiens,CHEMBL203,CHEMBL1150213
CNC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C(\C)[N+](=O)[O-])cc2OC)cc1,5.40,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,4000.0,nM,=,CHEMBL674640,B,CHEMBL78280,Homo sapiens,CHEMBL203,CHEMBL1125600
O=C(O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1,6.00,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,1000.0,nM,=,CHEMBL674640,B,CHEMBL76958,Homo sapiens,CHEMBL203,CHEMBL1125600
O=C(O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1O,7.30,Inhibition of EGFR in human A431 cells,IC50,50.0,nM,=,CHEMBL941404,B,CHEMBL449093,Homo sapiens,CHEMBL203,CHEMBL1150213
C[C@@H](NC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1)C(=O)N[C@H](C)C(=O)NCCN,4.77,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,17000.0,nM,=,CHEMBL674640,B,CHEMBL309392,Homo sapiens,CHEMBL203,CHEMBL1125600
C[C@@H](NC(=O)[C@@H](C)NC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1)C(=O)O,5.16,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,7000.0,nM,=,CHEMBL674640,B,CHEMBL311133,Homo sapiens,CHEMBL203,CHEMBL1125600
O=[N+]([O-])/C=C/c1ccc(O)cc1,5.00,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,10100.0,nM,=,CHEMBL674640,B,CHEMBL307481,Homo sapiens,CHEMBL203,CHEMBL1125600
CNC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1,6.40,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,400.0,nM,=,CHEMBL674640,B,CHEMBL74432,Homo sapiens,CHEMBL203,CHEMBL1125600
NCCNC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1,5.27,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,5400.0,nM,=,CHEMBL674640,B,CHEMBL309075,Homo sapiens,CHEMBL203,CHEMBL1125600
O=C(O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)c(O)c1,6.52,Inhibition of EGFR in human A431 cells,IC50,300.0,nM,=,CHEMBL941404,B,CHEMBL77688,Homo sapiens,CHEMBL203,CHEMBL1150213
COc1cc(/C=C/[N+](=O)[O-])ccc1OS(=O)(=O)c1ccc(C(=O)O)cc1,5.55,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,2800.0,nM,=,CHEMBL674640,B,CHEMBL418907,Homo sapiens,CHEMBL203,CHEMBL1125600
O=[N+]([O-])/C=C/c1ccc(O)c(O)c1,5.06,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,8800.0,nM,=,CHEMBL674640,B,CHEMBL78224,Homo sapiens,CHEMBL203,CHEMBL1125600
COc1cc(/C=C/[N+](=O)[O-])ccc1O,5.10,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,7900.0,nM,=,CHEMBL674640,B,CHEMBL309016,Homo sapiens,CHEMBL203,CHEMBL1125600
C/C(=C\c1ccc(O)c(O)c1)[N+](=O)[O-],5.05,Inhibition of EGFR in human A431 cells,IC50,9000.0,nM,=,CHEMBL941404,B,CHEMBL78049,Homo sapiens,CHEMBL203,CHEMBL1150213
COC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1,5.82,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,1500.0,nM,=,CHEMBL674640,B,CHEMBL77401,Homo sapiens,CHEMBL203,CHEMBL1125600
COC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1O,5.75,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,1800.0,nM,=,CHEMBL674640,B,CHEMBL76929,Homo sapiens,CHEMBL203,CHEMBL1125600
CCCCNC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1,5.32,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,4800.0,nM,=,CHEMBL674640,B,CHEMBL77100,Homo sapiens,CHEMBL203,CHEMBL1125600
COc1cc(C=C(C#N)C#N)ccc1O,4.17,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Ki,67000.0,nM,=,CHEMBL675636,B,CHEMBL77869,Homo sapiens,CHEMBL203,CHEMBL1124610
N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1,7.00,Inhibition of EGFR in human A431 cells,IC50,100.0,nM,=,CHEMBL941404,B,CHEMBL76589,Homo sapiens,CHEMBL203,CHEMBL1150213
C[C@@H](NC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1)C(=O)N[C@H](C)C(=O)OC(C)(C)C,4.40,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,40000.0,nM,=,CHEMBL674640,B,CHEMBL312451,Homo sapiens,CHEMBL203,CHEMBL1125600
N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)c(O)c1,5.60,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,IC50,2500.0,nM,=,CHEMBL674643,B,CHEMBL309334,Homo sapiens,CHEMBL203,CHEMBL1124610
N#CC(C#N)=C(N)/C(C#N)=C/c1cc(O)c(O)c(Br)c1,6.30,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,IC50,500.0,nM,=,CHEMBL674643,B,CHEMBL77803,Homo sapiens,CHEMBL203,CHEMBL1124610
N#C/C(=C/c1cc(O)ccc1O)C(=O)O,4.62,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Ki,24000.0,nM,=,CHEMBL675636,B,CHEMBL76642,Homo sapiens,CHEMBL203,CHEMBL1124610
COc1cc(/C=C(\C#N)C(N)=C(C#N)C#N)cc(O)c1O,6.00,Inhibition of EGFR in human A431 cells,IC50,1000.0,nM,=,CHEMBL941404,B,CHEMBL80745,Homo sapiens,CHEMBL203,CHEMBL1150213
N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)c([N+](=O)[O-])c1,4.22,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,IC50,60000.0,nM,=,CHEMBL674643,B,CHEMBL309625,Homo sapiens,CHEMBL203,CHEMBL1124610
COc1cc(/C=C(\C)[N+](=O)[O-])ccc1OS(=O)(=O)c1ccc(C(=O)O)cc1,5.60,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,2500.0,nM,=,CHEMBL674640,B,CHEMBL77397,Homo sapiens,CHEMBL203,CHEMBL1125600
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)O,4.60,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,IC50,25000.0,nM,=,CHEMBL674643,B,CHEMBL73820,Homo sapiens,CHEMBL203,CHEMBL1124610
N#C/C(=C\c1ccc(O)c(O)c1)C(N)=S,6.07,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Ki,850.0,nM,=,CHEMBL675636,B,CHEMBL77030,Homo sapiens,CHEMBL203,CHEMBL1124610
CCCCc1cc(/C=C(\C#N)C(N)=O)cc(CCCC)c1O,4.26,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,IC50,55000.0,nM,=,CHEMBL674643,B,CHEMBL77243,Homo sapiens,CHEMBL203,CHEMBL1124610
N#CC(C#N)=Cc1cc(O)c(O)c(O)c1,6.00,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Ki,1000.0,nM,=,CHEMBL675636,B,CHEMBL310798,Homo sapiens,CHEMBL203,CHEMBL1124610
COc1cc(C=C(C#N)C#N)cc(O)c1O,5.66,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Ki,2200.0,nM,=,CHEMBL675636,B,CHEMBL80155,Homo sapiens,CHEMBL203,CHEMBL1124610
N#CC(C#N)=Cc1ccc(O)c(O)c1,4.96,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Ki,11000.0,nM,=,CHEMBL675636,B,CHEMBL76904,Homo sapiens,CHEMBL203,CHEMBL1124610
N#CC(C#N)=Cc1cc(O)cc(O)c1,5.00,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Ki,10000.0,nM,=,CHEMBL675636,B,CHEMBL76905,Homo sapiens,CHEMBL203,CHEMBL1124610
N#CC(C#N)=Cc1ccc(C=O)cc1,4.70,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Ki,20000.0,nM,=,CHEMBL675636,B,CHEMBL311119,Homo sapiens,CHEMBL203,CHEMBL1124610
N#CC(C#N)=Cc1cc(O)ccc1[N+](=O)[O-],4.62,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Ki,24000.0,nM,=,CHEMBL675636,B,CHEMBL77085,Homo sapiens,CHEMBL203,CHEMBL1124610
N#CC(C#N)=Cc1ccc(O)c([N+](=O)[O-])c1,4.31,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Ki,49000.0,nM,=,CHEMBL675636,B,CHEMBL308134,Homo sapiens,CHEMBL203,CHEMBL1124610
COc1cc(C=C(C#N)C#N)cc(Br)c1O,4.30,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Ki,50000.0,nM,=,CHEMBL675636,B,CHEMBL77298,Homo sapiens,CHEMBL203,CHEMBL1124610
COc1cc(C=C(C#N)C#N)cc([N+](=O)[O-])c1O,4.26,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Ki,55000.0,nM,=,CHEMBL675636,B,CHEMBL307179,Homo sapiens,CHEMBL203,CHEMBL1124610
N#CC(C#N)=C(O)c1cc(O)c(O)c(O)c1,5.35,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,Ki,4500.0,nM,=,CHEMBL675636,B,CHEMBL309598,Homo sapiens,CHEMBL203,CHEMBL1124610
N#C/C(=C\c1ccc(C=O)cc1)C(=O)O,4.33,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,IC50,47000.0,nM,=,CHEMBL674643,B,CHEMBL76985,Homo sapiens,CHEMBL203,CHEMBL1124610
N#C/C(=C\c1ccc(O)cc1)C(N)=O,3.10,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,IC50,800000.0,nM,=,CHEMBL674643,B,CHEMBL308048,Homo sapiens,CHEMBL203,CHEMBL1124610
Cc1cc2cc(Nc3ccnc4cc(-c5ccc(CN6CCOCC6)cc5)sc34)ccc2[nH]1,5.90,Inhibitory activity against epidermal growth factor receptor,IC50,1250.0,nM,=,CHEMBL674107,B,CHEMBL311111,Homo sapiens,CHEMBL203,CHEMBL1146693
Cc1cc2cc(Nc3ccnc4cc(-c5ccc(CNCCO)cc5)sc34)ccc2[nH]1,6.00,Inhibitory activity against epidermal growth factor receptor,IC50,1000.0,nM,=,CHEMBL674107,B,CHEMBL80164,Homo sapiens,CHEMBL203,CHEMBL1146693
Cc1cc2cc(Nc3ccnc4cc(-c5ccc(CNCCOCCO)cc5)sc34)ccc2[nH]1,6.18,Inhibitory activity against epidermal growth factor receptor,IC50,657.0,nM,=,CHEMBL674107,B,CHEMBL77342,Homo sapiens,CHEMBL203,CHEMBL1146693
O=C(c1ccccc1)c1cc2ncnc(Nc3ccc4[nH]ccc4c3)c2s1,8.05,Inhibitory activity against epidermal growth factor receptor,IC50,9.0,nM,=,CHEMBL674107,B,CHEMBL81712,Homo sapiens,CHEMBL203,CHEMBL1146693
CC(C)(CO)NCc1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1,9.00,Inhibitory activity against epidermal growth factor receptor,IC50,1.0,nM,=,CHEMBL674107,B,CHEMBL308498,Homo sapiens,CHEMBL203,CHEMBL1146693
c1ccc(CCCN(c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)n2ccnc2)cc1,9.00,Inhibitory activity against epidermal growth factor receptor,IC50,1.0,nM,=,CHEMBL674107,B,CHEMBL312818,Homo sapiens,CHEMBL203,CHEMBL1146693
OCCNCc1ccc(-c2cc3nccc(Nc4ccc5[nH]ccc5c4)c3s2)cc1,8.70,Inhibitory activity against epidermal growth factor receptor,IC50,2.0,nM,=,CHEMBL674107,B,CHEMBL310740,Homo sapiens,CHEMBL203,CHEMBL1146693
c1ccc(NCCN(c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)n2cccc2)cc1,9.00,Inhibitory activity against epidermal growth factor receptor,IC50,1.0,nM,=,CHEMBL674107,B,CHEMBL79215,Homo sapiens,CHEMBL203,CHEMBL1146693
OCCOCCNCc1ccc(-c2cc3nccc(Nc4ccc5[nH]ccc5c4)c3s2)cc1,8.40,Inhibitory activity against epidermal growth factor receptor,IC50,4.0,nM,=,CHEMBL674107,B,CHEMBL421326,Homo sapiens,CHEMBL203,CHEMBL1146693
OCCCNCc1ccc(-c2cc3nccc(Nc4ccc5[nH]ccc5c4)c3s2)cc1,8.05,Inhibitory activity against epidermal growth factor receptor,IC50,9.0,nM,=,CHEMBL674107,B,CHEMBL77452,Homo sapiens,CHEMBL203,CHEMBL1146693
OCc1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1,9.00,Inhibitory activity against epidermal growth factor receptor,IC50,1.0,nM,=,CHEMBL674107,B,CHEMBL312753,Homo sapiens,CHEMBL203,CHEMBL1146693
c1csc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)c1,9.00,Inhibitory activity against epidermal growth factor receptor,IC50,1.0,nM,=,CHEMBL674107,B,CHEMBL76751,Homo sapiens,CHEMBL203,CHEMBL1146693
c1cc(Nc2ccc3[nH]ccc3c2)c2sc(-c3ccc(CNCCN4CCNCC4)cc3)cc2n1,8.52,Inhibitory activity against epidermal growth factor receptor,IC50,3.0,nM,=,CHEMBL674107,B,CHEMBL80540,Homo sapiens,CHEMBL203,CHEMBL1146693
NC(=O)C1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc6[nH]ccc6c5)c4s3)cc2)CC1,8.15,Inhibitory activity against epidermal growth factor receptor,IC50,7.0,nM,=,CHEMBL674107,B,CHEMBL311109,Homo sapiens,CHEMBL203,CHEMBL1146693
CC(=O)NCCNCc1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1,8.30,Inhibitory activity against epidermal growth factor receptor,IC50,5.0,nM,=,CHEMBL674107,B,CHEMBL80809,Homo sapiens,CHEMBL203,CHEMBL1146693
CN(CCO)Cc1ccc(-c2cc3nccc(Nc4ccc5[nH]ccc5c4)c3s2)cc1,8.52,Inhibitory activity against epidermal growth factor receptor,IC50,3.0,nM,=,CHEMBL674107,B,CHEMBL79206,Homo sapiens,CHEMBL203,CHEMBL1146693
c1nc(Nc2ccc3[nH]ccc3c2)c2sccc2n1,6.22,Inhibitory activity against epidermal growth factor receptor,IC50,600.0,nM,=,CHEMBL674107,B,CHEMBL442749,Homo sapiens,CHEMBL203,CHEMBL1146693
CC(=O)NCCNCc1ccc(-c2cc3nccc(Nc4ccc5[nH]ccc5c4)c3s2)cc1,8.70,Inhibitory activity against epidermal growth factor receptor,IC50,2.0,nM,=,CHEMBL674107,B,CHEMBL418909,Homo sapiens,CHEMBL203,CHEMBL1146693
c1csc(-c2cc3nccc(Nc4ccc5[nH]ccc5c4)c3s2)c1,9.00,Inhibitory activity against epidermal growth factor receptor,IC50,1.0,nM,=,CHEMBL674107,B,CHEMBL310853,Homo sapiens,CHEMBL203,CHEMBL1146693
NCc1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1,8.40,Inhibitory activity against epidermal growth factor receptor,IC50,4.0,nM,=,CHEMBL674107,B,CHEMBL78018,Homo sapiens,CHEMBL203,CHEMBL1146693
CN(C)CCc1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1,8.30,Inhibitory activity against epidermal growth factor receptor,IC50,5.0,nM,=,CHEMBL674107,B,CHEMBL77782,Homo sapiens,CHEMBL203,CHEMBL1146693
CN(C)c1ccc(Nc2ncnc3cc(-c4ccccc4)sc23)cc1,7.03,Inhibitory activity against epidermal growth factor receptor,IC50,94.0,nM,=,CHEMBL674107,B,CHEMBL306732,Homo sapiens,CHEMBL203,CHEMBL1146693
c1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1,8.52,Inhibitory activity against epidermal growth factor receptor,IC50,3.0,nM,=,CHEMBL674107,B,CHEMBL76432,Homo sapiens,CHEMBL203,CHEMBL1146693
NC(=O)C1CCN(Cc2ccc(-c3cc4nccc(Nc5ccc6[nH]ccc6c5)c4s3)cc2)CC1,9.00,Inhibitory activity against epidermal growth factor receptor,IC50,1.0,nM,=,CHEMBL674107,B,CHEMBL431977,Homo sapiens,CHEMBL203,CHEMBL1146693
Cc1c[nH]c2ccc(Nc3ncnc4cc(-c5ccccc5)sc34)cc12,8.30,Inhibitory activity against epidermal growth factor receptor,IC50,5.0,nM,=,CHEMBL674107,B,CHEMBL310827,Homo sapiens,CHEMBL203,CHEMBL1146693
Cc1cc2cc(Nc3ncnc4cc(-c5ccccc5)sc34)ccc2[nH]1,7.00,Inhibitory activity against epidermal growth factor receptor,IC50,100.0,nM,=,CHEMBL674107,B,CHEMBL80302,Homo sapiens,CHEMBL203,CHEMBL1146693
c1ccc(-c2cc3ncnc(Nc4ccc5[nH]ncc5c4)c3s2)cc1,5.80,Inhibitory activity against epidermal growth factor receptor,IC50,1600.0,nM,=,CHEMBL674107,B,CHEMBL78685,Homo sapiens,CHEMBL203,CHEMBL1146693
Cc1cc2cc(Nc3ccnc4cc(-c5ccc(CNCCCO)cc5)sc34)ccc2[nH]1,6.30,Inhibitory activity against epidermal growth factor receptor,IC50,500.0,nM,=,CHEMBL674107,B,CHEMBL78700,Homo sapiens,CHEMBL203,CHEMBL1146693
Cc1cc2cc(Nc3ccnc4cc(-c5ccc(CN(C)CCO)cc5)sc34)ccc2[nH]1,6.85,Inhibitory activity against epidermal growth factor receptor,IC50,140.0,nM,=,CHEMBL674107,B,CHEMBL81375,Homo sapiens,CHEMBL203,CHEMBL1146693
c1cc(Nc2ccc3[nH]ccc3c2)c2sc(-c3ccc(CN4CCOCC4)cc3)cc2n1,7.52,Inhibitory activity against epidermal growth factor receptor,IC50,30.0,nM,=,CHEMBL674107,B,CHEMBL312482,Homo sapiens,CHEMBL203,CHEMBL1146693
Cc1cc2cc(Nc3ccnc4cc(-c5ccc(CNCCN6CCNCC6)cc5)sc34)ccc2[nH]1,6.60,Inhibitory activity against epidermal growth factor receptor,IC50,250.0,nM,=,CHEMBL674107,B,CHEMBL79060,Homo sapiens,CHEMBL203,CHEMBL1146693
N#CC(Cc1ccc(O)c(O)c1)C(=N)S,4.16,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,70000.0,nM,=,CHEMBL677209,B,CHEMBL78249,Homo sapiens,CHEMBL203,CHEMBL1128740
C=C(CN(C)C)C(=O)c1ccc(OS(=O)(=O)c2ccc(C(=O)O)c(O)c2)cc1,6.33,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,470.0,nM,=,CHEMBL677209,B,CHEMBL310580,Homo sapiens,CHEMBL203,CHEMBL1128740
C=C(CN(C)C)C(=O)c1ccc(OS(=O)(=O)c2ccc(C(=O)O)cc2)cc1,6.64,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,230.0,nM,=,CHEMBL677209,B,CHEMBL80030,Homo sapiens,CHEMBL203,CHEMBL1128740
O=C(O)CCC1C(S)=Nc2ccccc21,5.79,Displacement of 32P-labeled ATP from EGFR derived from human A-431 cell membrane vesicles using copolymer of Glu/Ala/Tyr as substrate incubated for 10 mins by scintillation counting method,IC50,1620.0,nM,=,CHEMBL5138015,B,CHEMBL309276,Homo sapiens,CHEMBL203,CHEMBL5136983
COc1cc2ncc(C#N)c(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC,8.13,Binding affinity to wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by Kinomescan method,Kd,7.4,nM,=,CHEMBL4394506,B,CHEMBL81073,Homo sapiens,CHEMBL203,CHEMBL4393671
Cc1cccc2c(CCC(=O)O)c(SSc3[nH]c4c(C)cccc4c3CCC(=O)O)[nH]c12,5.82,Displacement of 32P-labeled ATP from EGFR derived from human A-431 cell membrane vesicles using copolymer of Glu/Ala/Tyr as substrate incubated for 10 mins by scintillation counting method,IC50,1500.0,nM,=,CHEMBL5138015,B,CHEMBL81664,Homo sapiens,CHEMBL203,CHEMBL5136983
O=C(O)CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)O)[nH]c2ccccc12,5.38,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,4200.0,nM,=,CHEMBL677470,B,CHEMBL79704,Homo sapiens,CHEMBL203,CHEMBL1128344
COC(=O)CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)OC)[nH]c2ccccc12,4.68,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,21000.0,nM,=,CHEMBL673450,B,CHEMBL79808,Homo sapiens,CHEMBL203,CHEMBL1127622
COc1cc2nccc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC,6.39,Binding affinity to wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by Kinomescan method,Kd,410.0,nM,=,CHEMBL4394506,B,CHEMBL311959,Homo sapiens,CHEMBL203,CHEMBL4393671
COc1cc2ncnc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC,7.66,Binding affinity to wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by Kinomescan method,Kd,22.0,nM,=,CHEMBL4394506,B,CHEMBL309682,Homo sapiens,CHEMBL203,CHEMBL4393671
COc1ccc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)cc1OC,4.30,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,50118.72,nM,=,CHEMBL1798351,B,CHEMBL83228,Homo sapiens,CHEMBL203,CHEMBL1795334
Oc1c(I)cc(I)c2cccnc12,5.72,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,1889.0,nM,=,CHEMBL1909203,B,CHEMBL86754,Homo sapiens,CHEMBL203,CHEMBL1909046
COc1c(Br)cc(/C=C2\C(=O)Nc3ccccc32)cc1C(C)(C)C,4.72,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).,IC50,19000.0,nM,=,CHEMBL676159,B,CHEMBL87746,Homo sapiens,CHEMBL203,CHEMBL1131018
CC(C)c1cc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc(C(C)C)c1O,5.02,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).,IC50,9500.0,nM,=,CHEMBL676159,B,CHEMBL89723,Homo sapiens,CHEMBL203,CHEMBL1131018
COc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1C(C)(C)C,4.71,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).,IC50,19300.0,nM,=,CHEMBL676159,B,CHEMBL86326,Homo sapiens,CHEMBL203,CHEMBL1131018
CC(C)c1cc(/C=C2\C(=O)Nc3ccccc32)cc(C(C)C)c1O,6.40,Inhibition of EGFR,IC50,400.0,nM,=,CHEMBL941412,B,CHEMBL85021,Homo sapiens,CHEMBL203,CHEMBL1150213
CCc1ccc(/C=C2\C(=O)Nc3ccccc32)s1,4.36,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).,IC50,44000.0,nM,=,CHEMBL676159,B,CHEMBL314146,Homo sapiens,CHEMBL203,CHEMBL1131018
CC(C)(C)c1cc(/C=C2\C(=O)Nc3ccccc32)cc(C(C)(C)C)c1O,5.10,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).,IC50,7900.0,nM,=,CHEMBL676159,B,CHEMBL89505,Homo sapiens,CHEMBL203,CHEMBL1131018
Oc1cc2cc(-c3ccncc3)cnc2cc1O,5.30,Inhibition of Epidermal growth factor receptor tyrosine kinase,IC50,5000.0,nM,=,CHEMBL676154,B,CHEMBL87084,Homo sapiens,CHEMBL203,CHEMBL1127615
NS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)CCCC3)C(=O)N2,4.54,Evaluated for inhibitory activity towards tyrosine kinase Epidermal growth factor receptor,IC50,29100.0,nM,=,CHEMBL679949,B,CHEMBL86531,Homo sapiens,CHEMBL203,CHEMBL1133768
O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(C(=O)O)cc32)[nH]c2c1CCCC2,4.25,Evaluated for inhibitory activity towards tyrosine kinase Epidermal growth factor receptor,IC50,56500.0,nM,=,CHEMBL679949,B,CHEMBL431996,Homo sapiens,CHEMBL203,CHEMBL1133768
COc1cccc(-c2ccc3c(c2)NC(=O)/C3=C\c2[nH]c3c(c2CCC(=O)O)CCCC3)c1,5.05,Evaluated for inhibitory activity towards tyrosine kinase Epidermal growth factor receptor,IC50,8880.0,nM,=,CHEMBL679949,B,CHEMBL432941,Homo sapiens,CHEMBL203,CHEMBL1133768
CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,5.29,Binding constant for EGFR(E746-A750del) kinase domain,Kd,5100.0,nM,=,CHEMBL1908694,B,CHEMBL91829,Homo sapiens,CHEMBL203,CHEMBL1908390
COc1cc2ncnc(NCc3cccc(C)c3)c2cc1OC,6.77,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,170.0,nM,=,CHEMBL680029,B,CHEMBL93173,Homo sapiens,CHEMBL203,CHEMBL1129210
COc1cc2ncnc(NNc3ccc(F)c(Cl)c3)c2cc1OC,6.37,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,430.0,nM,=,CHEMBL680029,B,CHEMBL422066,Homo sapiens,CHEMBL203,CHEMBL1129210
COc1cc2ncnc(/N=N/c3ccc(F)c(Cl)c3)c2cc1OC,6.14,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,730.0,nM,=,CHEMBL680029,B,CHEMBL92006,Homo sapiens,CHEMBL203,CHEMBL1129210
COc1cc2ncnc(NC3CC3c3ccccc3)c2cc1O,6.41,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,390.0,nM,=,CHEMBL680029,B,CHEMBL93423,Homo sapiens,CHEMBL203,CHEMBL1129210
COc1cc2ncnc(NC3CC3c3ccccc3)c2cc1OC(C)=O,7.08,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,84.0,nM,=,CHEMBL680029,B,CHEMBL90540,Homo sapiens,CHEMBL203,CHEMBL1129210
COc1cc2ncnc(Nc3nnc4ccccc4n3)c2cc1OC,6.09,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,820.0,nM,=,CHEMBL680029,B,CHEMBL90541,Homo sapiens,CHEMBL203,CHEMBL1129210
COc1cc2ncnc(NC3CC3c3ccccc3)c2cc1OCCN1CCOCC1,6.52,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,300.0,nM,=,CHEMBL680029,B,CHEMBL420059,Homo sapiens,CHEMBL203,CHEMBL1129210
COC[C@H]1CCCN1C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.07,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,85.0,nM,=,CHEMBL680018,B,CHEMBL419501,Homo sapiens,CHEMBL203,CHEMBL1134561
COc1cc2ncnc(Nc3cnc4ccccc4n3)c2cc1OC,6.11,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,780.0,nM,=,CHEMBL680029,B,CHEMBL330668,Homo sapiens,CHEMBL203,CHEMBL1129210
COc1cc2ncnc(NC3CCc4ccccc43)c2cc1OC,6.04,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,910.0,nM,=,CHEMBL680029,B,CHEMBL94019,Homo sapiens,CHEMBL203,CHEMBL1129210
COc1cc2ncnc(Nc3cc4ccccc4cn3)c2cc1OC,6.18,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,660.0,nM,=,CHEMBL680029,B,CHEMBL91428,Homo sapiens,CHEMBL203,CHEMBL1129210
COc1cc2ncnc(NC3CC3c3ccccc3)c2cc1OC,8.00,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,10.0,nM,=,CHEMBL680029,B,CHEMBL419137,Homo sapiens,CHEMBL203,CHEMBL1129210
COc1cc2ncnc(Nc3cncc4ccccc34)c2cc1OC,8.19,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,6.4,nM,=,CHEMBL680029,B,CHEMBL329867,Homo sapiens,CHEMBL203,CHEMBL1129210
COc1cc2ncnc(Nc3nccc4ccccc34)c2cc1OC,6.70,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,200.0,nM,=,CHEMBL680029,B,CHEMBL330323,Homo sapiens,CHEMBL203,CHEMBL1129210
COc1cc2ncnc(N3CCc4ccccc43)c2cc1OC,6.09,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,820.0,nM,=,CHEMBL680029,B,CHEMBL328277,Homo sapiens,CHEMBL203,CHEMBL1129210
CN(C)C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.66,Inhibition of EGFR,IC50,0.22,nM,=,CHEMBL978648,B,CHEMBL94061,Homo sapiens,CHEMBL203,CHEMBL1157167
O=C(C#CCO)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.70,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,2.0,nM,=,CHEMBL680018,B,CHEMBL94062,Homo sapiens,CHEMBL203,CHEMBL1134561
COCCOCC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.19,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,65.0,nM,=,CHEMBL680018,B,CHEMBL327838,Homo sapiens,CHEMBL203,CHEMBL1134561
COc1cc2ncnc(NC3CC3c3ccccc3)c2cc1OCCCN(C)C,7.57,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,IC50,27.0,nM,=,CHEMBL680029,B,CHEMBL91484,Homo sapiens,CHEMBL203,CHEMBL1129210
COCC1CCCN1CC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.19,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,65.0,nM,=,CHEMBL680018,B,CHEMBL93784,Homo sapiens,CHEMBL203,CHEMBL1134561
COCC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.05,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,9.0,nM,=,CHEMBL680018,B,CHEMBL91009,Homo sapiens,CHEMBL203,CHEMBL1134561
CCN1CCN(CC#CC(=O)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)CC1,7.19,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,65.0,nM,=,CHEMBL680018,B,CHEMBL92356,Homo sapiens,CHEMBL203,CHEMBL1134561
O=C(/C=C/Cn1cccn1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,5.95,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,1124.0,nM,=,CHEMBL680018,B,CHEMBL93754,Homo sapiens,CHEMBL203,CHEMBL1134561
O=C(C#CCN1CCSCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.02,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,95.0,nM,=,CHEMBL680018,B,CHEMBL328977,Homo sapiens,CHEMBL203,CHEMBL1134561
COC/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,5.95,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,1132.0,nM,=,CHEMBL680018,B,CHEMBL92882,Homo sapiens,CHEMBL203,CHEMBL1134561
O=C(/C=C/CN1CCC(N2CCCCC2)CC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.17,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,68.0,nM,=,CHEMBL680018,B,CHEMBL94109,Homo sapiens,CHEMBL203,CHEMBL1134561
CN1CCC=C(C(=O)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)C1,6.94,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,115.0,nM,=,CHEMBL680018,B,CHEMBL92902,Homo sapiens,CHEMBL203,CHEMBL1134561
CN(C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)CCO,7.85,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,14.0,nM,=,CHEMBL680018,B,CHEMBL93783,Homo sapiens,CHEMBL203,CHEMBL1134561
COCCN(C)C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.21,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,62.0,nM,=,CHEMBL680018,B,CHEMBL442754,Homo sapiens,CHEMBL203,CHEMBL1134561
O=C(C#CCN1CCOCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.70,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,20.0,nM,=,CHEMBL680018,B,CHEMBL93386,Homo sapiens,CHEMBL203,CHEMBL1134561
CCCN(C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)CCC,7.05,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,90.0,nM,=,CHEMBL680018,B,CHEMBL92731,Homo sapiens,CHEMBL203,CHEMBL1134561
CCN(CC)C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.14,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,73.0,nM,=,CHEMBL680018,B,CHEMBL91925,Homo sapiens,CHEMBL203,CHEMBL1134561
CC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.70,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,0.2,nM,=,CHEMBL862512,B,CHEMBL91867,Homo sapiens,CHEMBL203,CHEMBL1138126
CC(C)N(CC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)C(C)C,7.01,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,97.0,nM,=,CHEMBL680018,B,CHEMBL92961,Homo sapiens,CHEMBL203,CHEMBL1134561
CC(C)N(C)CC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.07,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,85.0,nM,=,CHEMBL680018,B,CHEMBL91811,Homo sapiens,CHEMBL203,CHEMBL1134561
C=CCN(C)CC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.15,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,71.0,nM,=,CHEMBL680018,B,CHEMBL414220,Homo sapiens,CHEMBL203,CHEMBL1134561
CN(C)CC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.22,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,6.0,nM,=,CHEMBL680018,B,CHEMBL329856,Homo sapiens,CHEMBL203,CHEMBL1134561
CCCN(CC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)CCC,7.21,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,62.0,nM,=,CHEMBL680018,B,CHEMBL328245,Homo sapiens,CHEMBL203,CHEMBL1134561
O=C(C#CCN1CCCCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.24,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,57.0,nM,=,CHEMBL680018,B,CHEMBL90595,Homo sapiens,CHEMBL203,CHEMBL1134561
O=C(/C=C/CN1CCCCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.97,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,106.0,nM,=,CHEMBL680018,B,CHEMBL94068,Homo sapiens,CHEMBL203,CHEMBL1134561
O=C(/C=C/CN1CCOCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.13,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,74.0,nM,=,CHEMBL680018,B,CHEMBL316127,Homo sapiens,CHEMBL203,CHEMBL1134561
CCN(CC)CC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.92,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,12.0,nM,=,CHEMBL680018,B,CHEMBL328704,Homo sapiens,CHEMBL203,CHEMBL1134561
O=C(/C=C/N1CCOCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.67,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,215.0,nM,=,CHEMBL680018,B,CHEMBL94123,Homo sapiens,CHEMBL203,CHEMBL1134561
O=C(/C=C/CN1CCSCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.69,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,203.0,nM,=,CHEMBL680018,B,CHEMBL93537,Homo sapiens,CHEMBL203,CHEMBL1134561
CN(C)/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.60,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,250.0,nM,=,CHEMBL680018,B,CHEMBL91748,Homo sapiens,CHEMBL203,CHEMBL1134561
COCOCC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.23,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,59.0,nM,=,CHEMBL680018,B,CHEMBL93049,Homo sapiens,CHEMBL203,CHEMBL1134561
C=C(C)C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.92,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,1.2,nM,=,CHEMBL673925,B,CHEMBL92086,Homo sapiens,CHEMBL203,CHEMBL1134843
C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.26,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,0.55,nM,=,CHEMBL673925,B,CHEMBL93464,Homo sapiens,CHEMBL203,CHEMBL1134843
C=C(CN1CCOCC1)C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.97,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,107.0,nM,=,CHEMBL680018,B,CHEMBL94066,Homo sapiens,CHEMBL203,CHEMBL1134561
C/C=C\C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.57,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,269.0,nM,=,CHEMBL680018,B,CHEMBL329642,Homo sapiens,CHEMBL203,CHEMBL1134561
CCNc1ccc2c(Nc3cccc(Br)c3)ncnc2c1,7.92,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,12.0,nM,=,CHEMBL680017,B,CHEMBL420254,Homo sapiens,CHEMBL203,CHEMBL1129291
Nc1ccc2c(Nc3ccccc3)ncnc2c1,7.00,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,100.0,nM,=,CHEMBL680017,B,CHEMBL330224,Homo sapiens,CHEMBL203,CHEMBL1129291
Nc1ccc2c(Nc3cccc(I)c3)ncnc2c1,9.46,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,0.35,nM,=,CHEMBL680017,B,CHEMBL91980,Homo sapiens,CHEMBL203,CHEMBL1129291
Nc1ccc2c(Nc3cccc(Br)c3)ncnc2c1,10.00,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,0.1,nM,=,CHEMBL677387,B,CHEMBL420624,Homo sapiens,CHEMBL203,CHEMBL1130246
Nc1ccc2c(Nc3cccc(Cl)c3)ncnc2c1,9.60,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,0.25,nM,=,CHEMBL680017,B,CHEMBL328955,Homo sapiens,CHEMBL203,CHEMBL1129291
O=[N+]([O-])c1ccc2c(Nc3cccc(I)c3)ncnc2c1,6.27,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,540.0,nM,=,CHEMBL680017,B,CHEMBL93284,Homo sapiens,CHEMBL203,CHEMBL1129291
Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N,9.92,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,0.12,nM,=,CHEMBL677204,B,CHEMBL328216,Homo sapiens,CHEMBL203,CHEMBL1128536
CN(C)c1ccc2c(Nc3cccc(Br)c3)ncnc2c1,7.96,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,11.0,nM,=,CHEMBL680017,B,CHEMBL90013,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1ccc2c(Nc3ccccc3)ncnc2c1,6.92,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,120.0,nM,=,CHEMBL680017,B,CHEMBL92398,Homo sapiens,CHEMBL203,CHEMBL1129291
Nc1ccc2ncnc(Nc3ccccc3)c2c1,6.11,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,770.0,nM,=,CHEMBL680017,B,CHEMBL89940,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1ccc2c(Nc3cccc(Br)c3)ncnc2c1,8.00,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,10.0,nM,=,CHEMBL677204,B,CHEMBL93181,Homo sapiens,CHEMBL203,CHEMBL1128536
O=[N+]([O-])c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.05,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,897.0,nM,=,CHEMBL677204,B,CHEMBL329161,Homo sapiens,CHEMBL203,CHEMBL1128536
O=[N+]([O-])c1ccc2ncnc(Nc3ccccc3)c2c1,5.30,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,5000.0,nM,=,CHEMBL680017,B,CHEMBL328295,Homo sapiens,CHEMBL203,CHEMBL1129291
Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1,6.24,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,574.0,nM,=,CHEMBL680017,B,CHEMBL328244,Homo sapiens,CHEMBL203,CHEMBL1129291
O=[N+]([O-])c1ccc2c(Nc3ccccc3)ncnc2c1,4.92,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,12000.0,nM,=,CHEMBL680017,B,CHEMBL91914,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1cc2ncnc(Nc3ccccc3)c2cc1OC,7.54,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,29.0,nM,=,CHEMBL680017,B,CHEMBL94191,Homo sapiens,CHEMBL203,CHEMBL1129291
O=[N+]([O-])c1ccc2c(Nc3cccc(Br)c3)ncnc2c1,6.00,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,1000.0,nM,=,CHEMBL677204,B,CHEMBL94275,Homo sapiens,CHEMBL203,CHEMBL1128536
Nc1ccc2c(Nc3cccc(C(F)(F)F)c3)ncnc2c1,8.48,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,3.3,nM,=,CHEMBL680017,B,CHEMBL433205,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1ccc2ncnc(Nc3ccccc3)c2c1,7.26,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,55.0,nM,=,CHEMBL680017,B,CHEMBL328879,Homo sapiens,CHEMBL203,CHEMBL1129291
FC(F)(F)c1cccc(Nc2ncnc3ccccc23)c1,6.24,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,577.0,nM,=,CHEMBL677204,B,CHEMBL92824,Homo sapiens,CHEMBL203,CHEMBL1128536
Ic1cccc(Nc2ncnc3ccccc23)c1,7.10,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,80.0,nM,=,CHEMBL677204,B,CHEMBL92825,Homo sapiens,CHEMBL203,CHEMBL1128536
O=[N+]([O-])c1ccc2c(Nc3cccc(Cl)c3)ncnc2c1,6.09,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,810.0,nM,=,CHEMBL680017,B,CHEMBL93635,Homo sapiens,CHEMBL203,CHEMBL1129291
O=[N+]([O-])c1ccc2c(Nc3cccc(F)c3)ncnc2c1,5.21,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,6100.0,nM,=,CHEMBL680017,B,CHEMBL329183,Homo sapiens,CHEMBL203,CHEMBL1129291
Oc1cc2ncnc(Nc3cccc(Br)c3)c2cc1O,9.77,Inhibition of Epidermal growth factor receptor from A431 cells,IC50,0.17,nM,=,CHEMBL677205,B,CHEMBL93032,Homo sapiens,CHEMBL203,CHEMBL1128536
Clc1cccc(Nc2ncnc3ccccc23)c1,7.64,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,23.0,nM,=,CHEMBL679944,B,CHEMBL329672,Homo sapiens,CHEMBL203,CHEMBL1132555
CNc1ccc2c(Nc3cccc(Br)c3)ncnc2c1,8.40,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,4.0,nM,=,CHEMBL677387,B,CHEMBL92812,Homo sapiens,CHEMBL203,CHEMBL1130246
CCCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCCC,9.77,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,0.17,nM,=,CHEMBL680017,B,CHEMBL418967,Homo sapiens,CHEMBL203,CHEMBL1129291
CCCCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCCCC,6.98,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,105.0,nM,=,CHEMBL680017,B,CHEMBL318736,Homo sapiens,CHEMBL203,CHEMBL1129291
Fc1cccc(Nc2ncnc3ccccc23)c1,7.25,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,56.0,nM,=,CHEMBL680017,B,CHEMBL92985,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1ccc2ncnc(Nc3cccc(Br)c3)c2c1OC,5.86,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,1367.0,nM,=,CHEMBL680017,B,CHEMBL96627,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N,8.42,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,3.8,nM,=,CHEMBL680017,B,CHEMBL96780,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1cc2ncnc(Nc3cc(Br)cc(Br)c3)c2cc1OC,6.95,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,113.0,nM,=,CHEMBL680017,B,CHEMBL92709,Homo sapiens,CHEMBL203,CHEMBL1129291
Oc1ccc2c(Nc3cccc(Br)c3)ncnc2c1,8.33,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,4.7,nM,=,CHEMBL680017,B,CHEMBL93302,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1cc2ncnc(Nc3ccc(Br)c(Br)c3)c2cc1OC,10.14,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,0.072,nM,=,CHEMBL680017,B,CHEMBL327307,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1cc2nc(N)nc(Nc3cccc(Br)c3)c2cc1OC,6.33,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,463.0,nM,=,CHEMBL680017,B,CHEMBL93295,Homo sapiens,CHEMBL203,CHEMBL1129291
COC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.92,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,12.0,nM,=,CHEMBL680017,B,CHEMBL328691,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1cc2ncnc(Nc3cccc(C(F)(F)F)c3)c2cc1OC,9.62,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,0.24,nM,=,CHEMBL680017,B,CHEMBL316064,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1cc2ncnc(Nc3cccc(Br)c3)c2c(OC)c1OC,9.17,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,0.67,nM,=,CHEMBL680017,B,CHEMBL317925,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1cc2ncnc(Nc3cccc(I)c3)c2cc1OC,9.05,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,0.89,nM,=,CHEMBL680017,B,CHEMBL96065,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1cc2ncnc(Nc3cccc(F)c3)c2cc1OC,8.42,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,3.8,nM,=,CHEMBL680017,B,CHEMBL94431,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1cc2ncnc(Nc3ccccc3Br)c2cc1OC,6.89,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,128.0,nM,=,CHEMBL680017,B,CHEMBL92174,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1cc2ncnc(N(C)c3cccc(Br)c3)c2cc1OC,6.82,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,152.0,nM,=,CHEMBL680017,B,CHEMBL447230,Homo sapiens,CHEMBL203,CHEMBL1129291
COc1cc2ncnc(Nc3ccc(Br)cc3)c2cc1OC,9.02,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,0.96,nM,=,CHEMBL680017,B,CHEMBL328106,Homo sapiens,CHEMBL203,CHEMBL1129291
CN(C)c1cc2ncnc(Nc3cccc(Br)c3)c2cc1N,6.80,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,159.0,nM,=,CHEMBL680017,B,CHEMBL96489,Homo sapiens,CHEMBL203,CHEMBL1129291
CNc1cc2ncnc(Nc3cccc(Br)c3)c2cc1[N+](=O)[O-],7.17,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,68.0,nM,=,CHEMBL680017,B,CHEMBL92936,Homo sapiens,CHEMBL203,CHEMBL1129291
Brc1cccc(Nc2ncnc3cc4c(cc23)OCO4)c1,7.82,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,15.0,nM,=,CHEMBL680017,B,CHEMBL93051,Homo sapiens,CHEMBL203,CHEMBL1129291
Nc1ccc2c(Nc3cccc(F)c3)ncnc2c1,8.70,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,2.0,nM,=,CHEMBL680017,B,CHEMBL93966,Homo sapiens,CHEMBL203,CHEMBL1129291
CC(=O)Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1[N+](=O)[O-],7.55,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,28.0,nM,=,CHEMBL680017,B,CHEMBL93734,Homo sapiens,CHEMBL203,CHEMBL1129291
CN(C)c1cc2ncnc(Nc3cccc(Br)c3)c2cc1[N+](=O)[O-],5.70,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,2000.0,nM,=,CHEMBL680017,B,CHEMBL93544,Homo sapiens,CHEMBL203,CHEMBL1129291
Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1[N+](=O)[O-],7.28,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,53.0,nM,=,CHEMBL680017,B,CHEMBL93545,Homo sapiens,CHEMBL203,CHEMBL1129291
CNc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N,9.16,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,0.69,nM,=,CHEMBL680017,B,CHEMBL92937,Homo sapiens,CHEMBL203,CHEMBL1129291
CC(=O)Nc1ccc2c(Nc3cccc(Br)c3)ncnc2c1,7.40,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,IC50,40.0,nM,=,CHEMBL680017,B,CHEMBL93461,Homo sapiens,CHEMBL203,CHEMBL1129291
Cc1c(C)n(-c2ccccc2)c2ncnc(N)c12,5.57,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,2710.0,nM,=,CHEMBL677832,B,CHEMBL319540,Homo sapiens,CHEMBL203,CHEMBL1130217
COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1,7.08,Inhibition of EGFR kinase,IC50,83.0,nM,=,CHEMBL674026,B,CHEMBL97162,Homo sapiens,CHEMBL203,CHEMBL1134743
COc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,5.98,Inhibition of Epidermal Growth Factor Receptor (EGFR) autophosphorylation,IC50,1040.0,nM,=,CHEMBL683041,B,CHEMBL99024,Homo sapiens,CHEMBL203,CHEMBL1135208
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cc1OCCCN1CCOCC1,7.10,Inhibition of Epidermal Growth Factor Receptor (EGFR) autophosphorylation,IC50,80.0,nM,=,CHEMBL683041,B,CHEMBL95774,Homo sapiens,CHEMBL203,CHEMBL1135208
C#Cc1cccc(Nc2c(C#N)cnc3cc(OCCOC)c(OCCOC)cc23)c1,6.07,Inhibition of Epidermal Growth Factor Receptor (EGFR) autophosphorylation,IC50,850.0,nM,=,CHEMBL683041,B,CHEMBL95320,Homo sapiens,CHEMBL203,CHEMBL1135208
CC(O)C(/N=C1/C=C(O)/C(=N\C(C(=O)O)C(C)O)C=C1O)C(=O)O,4.36,Inhibition of Epidermal growth factor receptor,IC50,44000.0,nM,=,CHEMBL674103,B,CHEMBL327725,Homo sapiens,CHEMBL203,CHEMBL1145828
COc1cc2nccc(Nc3cccc(Br)c3)c2cc1OC,7.24,Binding affinity to wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by Kinomescan method,Kd,58.0,nM,=,CHEMBL4394506,B,CHEMBL98248,Homo sapiens,CHEMBL203,CHEMBL4393671
COc1cc2ncnc(Oc3cccc(Br)c3)c2cc1OC,5.12,Inhibition of human EGFR-mediated poly(Glu4Tyr) phosphorylation after 1 hr,IC50,7600.0,nM,=,CHEMBL1763554,B,CHEMBL98798,Homo sapiens,CHEMBL203,CHEMBL1759979
Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,6.34,Inhibition of human EGFR in presence of 1 uM ATP,IC50,457.7,nM,=,CHEMBL892951,B,CHEMBL101253,Homo sapiens,CHEMBL203,CHEMBL1147965
O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1,5.14,Inhibition of Epidermal growth factor receptor,IC50,7300.0,nM,=,CHEMBL674695,B,CHEMBL101683,Homo sapiens,CHEMBL203,CHEMBL1136193
COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCOCC5)cc4)ccc23)c(Cl)cc1Cl,5.52,Inhibition of Epidermal growth factor receptor,IC50,3000.0,nM,=,CHEMBL674698,B,CHEMBL322395,Homo sapiens,CHEMBL203,CHEMBL1134917
O=C(O)c1cc(CCc2cc(O)ccc2O)ccc1O,5.48,Inhibition of EGF-R Tyrosine kinase (TK),IC50,3300.0,nM,=,CHEMBL674642,B,CHEMBL103860,Homo sapiens,CHEMBL203,CHEMBL1127418
O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O,5.39,Inhibition of EGF-R Tyrosine kinase (TK),IC50,4100.0,nM,=,CHEMBL674642,B,CHEMBL103552,Homo sapiens,CHEMBL203,CHEMBL1127418
O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O,5.54,Inhibition of EGF-R Tyrosine kinase (TK),IC50,2900.0,nM,=,CHEMBL674642,B,CHEMBL319620,Homo sapiens,CHEMBL203,CHEMBL1127418
Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,5.62,Binding constant for EGFR(T790M) kinase domain,Kd,2400.0,nM,=,CHEMBL1908704,B,CHEMBL103667,Homo sapiens,CHEMBL203,CHEMBL1908390
C[C@@H](Nc1[nH]cnc2nc(-c3ccccc3)cc1-2)c1ccccc1,8.48,Inhibition of EGFR by Z-LYTE assay,IC50,3.3,nM,=,CHEMBL1920033,B,CHEMBL105053,Homo sapiens,CHEMBL203,CHEMBL1914342
c1ccc(CNc2ncnc3ccccc23)cc1,6.50,Inhibition of Epidermal growth factor receptor from A431 cells,IC50,320.0,nM,=,CHEMBL677205,B,CHEMBL102726,Homo sapiens,CHEMBL203,CHEMBL1128536
COc1cccc(-c2cn(-c3ccc(CCN(C)CCO)cc3)c3ncnc(N)c23)c1,6.52,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,300.0,nM,=,CHEMBL674015,B,CHEMBL105436,Homo sapiens,CHEMBL203,CHEMBL1133080
O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1,6.00,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,1005.0,nM,=,CHEMBL1909203,B,CHEMBL319244,Homo sapiens,CHEMBL203,CHEMBL1909046
COc1cc2ncc(N[C@H]3CC[C@H](O)CC3)nc2cc1OC,5.43,Inhibition of Epidermal growth factor receptor,IC50,3700.0,nM,=,CHEMBL674697,B,CHEMBL104466,Homo sapiens,CHEMBL203,CHEMBL1136216
COc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1,6.66,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,220.0,nM,=,CHEMBL680019,B,CHEMBL104153,Homo sapiens,CHEMBL203,CHEMBL1131066
Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccncc3)nc21,6.04,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,910.0,nM,=,CHEMBL680019,B,CHEMBL104779,Homo sapiens,CHEMBL203,CHEMBL1131066
CN1CCN(CCCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1,6.68,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,210.0,nM,=,CHEMBL680019,B,CHEMBL104244,Homo sapiens,CHEMBL203,CHEMBL1131066
CN1CCN(CCCCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1,5.35,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,4500.0,nM,=,CHEMBL680019,B,CHEMBL106232,Homo sapiens,CHEMBL203,CHEMBL1131066
CNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1,5.12,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,7500.0,nM,=,CHEMBL680019,B,CHEMBL107472,Homo sapiens,CHEMBL203,CHEMBL1131066
CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,8.60,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,2.5,nM,=,CHEMBL4013155,B,CHEMBL321494,Homo sapiens,CHEMBL203,CHEMBL4011631
COCCOc1cc2ncc(C#N)c(Nc3cccc(Br)c3)c2cc1OCCOC,5.96,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,1096.48,nM,=,CHEMBL1798351,B,CHEMBL109515,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cc(Cl)ccc3O)c2cc1OC,4.77,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,16982.44,nM,=,CHEMBL1798351,B,CHEMBL326445,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C(N)=O)c(Nc3cccc(Br)c3)c2cc1OC,4.82,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,15135.61,nM,=,CHEMBL1798351,B,CHEMBL114446,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(SC)c3)c2cc1OC,6.12,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,758.58,nM,=,CHEMBL1798351,B,CHEMBL114496,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cc(Cl)c(O)c(Cl)c3)c2cc1OC,5.50,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,3162.28,nM,=,CHEMBL1798351,B,CHEMBL419185,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3ccc(C)c(Br)c3)c2cc1OC,5.75,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,1778.28,nM,=,CHEMBL1798351,B,CHEMBL111307,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1OC,6.27,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,537.03,nM,=,CHEMBL1798351,B,CHEMBL109372,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3ccc(O)c(Cl)c3)c2cc1OC,5.04,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,9120.11,nM,=,CHEMBL1798351,B,CHEMBL110945,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3ccc(Cl)cc3F)c2cc1OC,4.86,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,13803.84,nM,=,CHEMBL1798351,B,CHEMBL111664,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc([N+](=O)[O-])c3)c2cc1OC,6.06,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,870.96,nM,=,CHEMBL1798351,B,CHEMBL111520,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(C(N)=O)c3)c2cc1OC,5.11,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,7762.47,nM,=,CHEMBL1798351,B,CHEMBL323970,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(C(C)=O)c3)c2cc1OC,5.13,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,7413.1,nM,=,CHEMBL1798351,B,CHEMBL325760,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3ccc(C)cc3)c2cc1OC,5.56,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,2754.23,nM,=,CHEMBL1798351,B,CHEMBL109476,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(O)c3)c2cc1OC,5.20,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,6309.57,nM,=,CHEMBL1798351,B,CHEMBL110577,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(N(C)C)c3)c2cc1OC,6.07,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,851.14,nM,=,CHEMBL1798351,B,CHEMBL110035,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(N)c3)c2cc1OC,6.09,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,812.83,nM,=,CHEMBL1798351,B,CHEMBL110036,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3ccc(F)cc3)c2cc1OC,4.32,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,47863.01,nM,=,CHEMBL1798351,B,CHEMBL432396,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(C#N)c3)c2cc1OC,4.85,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,14125.38,nM,=,CHEMBL1798351,B,CHEMBL111033,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(Br)c3)c2cc1OC,8.62,Binding affinity to wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by Kinomescan method,Kd,2.4,nM,=,CHEMBL4394506,B,CHEMBL111038,Homo sapiens,CHEMBL203,CHEMBL4393671
COCOc1cc2ncc(C#N)c(Nc3cccc(Br)c3)c2cc1OCOC,5.17,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,6760.83,nM,=,CHEMBL1798351,B,CHEMBL111222,Homo sapiens,CHEMBL203,CHEMBL1795334
N#Cc1cnc2cc(O)c(O)cc2c1Nc1cccc(Br)c1,6.46,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,346.74,nM,=,CHEMBL1798351,B,CHEMBL111586,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2c(C#N)cnc(Nc3cccc(Br)c3)c2cc1OC,4.15,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,70794.58,nM,=,CHEMBL1798351,B,CHEMBL324439,Homo sapiens,CHEMBL203,CHEMBL1795334
N#Cc1cnc2cc3c(cc2c1Nc1cccc(Br)c1)OCCCO3,5.29,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,5128.61,nM,=,CHEMBL1798351,B,CHEMBL325981,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3ccc(Br)c(C)c3)c2cc1OC,6.21,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,616.6,nM,=,CHEMBL1798351,B,CHEMBL110055,Homo sapiens,CHEMBL203,CHEMBL1795334
N#Cc1cnc2cc3c(cc2c1Nc1cccc(Br)c1)OCO3,5.17,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,6760.83,nM,=,CHEMBL1798351,B,CHEMBL110062,Homo sapiens,CHEMBL203,CHEMBL1795334
CCOc1cc2ncc(C#N)c(Nc3cccc(Br)c3)c2cc1OC,4.67,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,21379.62,nM,=,CHEMBL1798351,B,CHEMBL111443,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3ccc(Br)cc3)c2cc1OC,5.18,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,6606.93,nM,=,CHEMBL1798351,B,CHEMBL323900,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C(=O)O)c(Nc3cccc(Br)c3)c2cc1OC,5.06,Inhibition of EGFR after 50 mins by HTRF assay,IC50,8719.0,nM,=,CHEMBL1949352,B,CHEMBL541988,Homo sapiens,CHEMBL203,CHEMBL1944591
COc1cc2ncc(C=O)c(Nc3cccc(Br)c3)c2cc1OC,5.47,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,3388.44,nM,=,CHEMBL1798351,B,CHEMBL109332,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3ccccc3Br)c2cc1OC,5.38,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,4168.69,nM,=,CHEMBL1798351,B,CHEMBL109575,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(C(C)C)c3)c2cc1OC,4.21,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,61659.5,nM,=,CHEMBL1798351,B,CHEMBL109625,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(N=[N+]=[N-])c3)c2cc1OC,5.66,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,2187.76,nM,=,CHEMBL1798351,B,CHEMBL113535,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3ccc(C)c(Cl)c3)c2cc1OC,5.83,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,1479.11,nM,=,CHEMBL1798351,B,CHEMBL109355,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3ccc(C(C)C)cc3)c2cc1OC,6.64,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,229.09,nM,=,CHEMBL1798351,B,CHEMBL323424,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(Cl)c3)c2cc1OC,6.74,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,181.97,nM,=,CHEMBL1798351,B,CHEMBL109428,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3ccccc3C(C)C)c2cc1OC,6.44,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,363.08,nM,=,CHEMBL1798351,B,CHEMBL112096,Homo sapiens,CHEMBL203,CHEMBL1795334
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1OCC,6.01,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,977.24,nM,=,CHEMBL1798351,B,CHEMBL324045,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(C(F)(F)F)c3)c2cc1OC,5.84,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,1445.44,nM,=,CHEMBL1798351,B,CHEMBL109503,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(F)c3)c2cc1OC,6.13,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,741.31,nM,=,CHEMBL1798351,B,CHEMBL320479,Homo sapiens,CHEMBL203,CHEMBL1795334
CCOc1cc2ncc(C#N)c(Nc3cccc(Br)c3)c2cc1OCC,6.38,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,416.87,nM,=,CHEMBL1798351,B,CHEMBL109212,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2c(C#N)cnc(Nc3cccc(Cl)c3)c2cc1OC,4.05,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,89125.09,nM,=,CHEMBL1798351,B,CHEMBL109259,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(Br)c3C)c2cc1OC,6.08,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,831.76,nM,=,CHEMBL1798351,B,CHEMBL112225,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3ccc(F)c(C(F)(F)F)c3)c2cc1OC,6.80,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,158.49,nM,=,CHEMBL1798351,B,CHEMBL111688,Homo sapiens,CHEMBL203,CHEMBL1795334
CCOc1cc2c(Nc3cccc(Br)c3)c(C#N)cnc2cc1OC,4.48,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,33113.11,nM,=,CHEMBL1798351,B,CHEMBL110065,Homo sapiens,CHEMBL203,CHEMBL1795334
COc1cc2ncc(C#N)c(Nc3cccc(NC(C)=O)c3)c2cc1OC,4.16,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,69183.1,nM,=,CHEMBL1798351,B,CHEMBL324399,Homo sapiens,CHEMBL203,CHEMBL1795334
CCn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccccc3)nc21,6.70,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,200.0,nM,=,CHEMBL680019,B,CHEMBL322298,Homo sapiens,CHEMBL203,CHEMBL1131066
COc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cn1,5.89,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,1300.0,nM,=,CHEMBL680019,B,CHEMBL111365,Homo sapiens,CHEMBL203,CHEMBL1131066
Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccnc3)nc21,6.29,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,510.0,nM,=,CHEMBL680019,B,CHEMBL325589,Homo sapiens,CHEMBL203,CHEMBL1131066
CCOC(=O)CCCc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1,6.16,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,700.0,nM,=,CHEMBL680019,B,CHEMBL419022,Homo sapiens,CHEMBL203,CHEMBL1131066
Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(O)c3)nc21,6.82,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,150.0,nM,=,CHEMBL680019,B,CHEMBL321193,Homo sapiens,CHEMBL203,CHEMBL1131066
COc1cc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc(OC)c1,6.48,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,330.0,nM,=,CHEMBL680019,B,CHEMBL324926,Homo sapiens,CHEMBL203,CHEMBL1131066
COc1ccccc1Nc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1,7.18,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,66.0,nM,=,CHEMBL680019,B,CHEMBL320705,Homo sapiens,CHEMBL203,CHEMBL1131066
COc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1C,6.60,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,250.0,nM,=,CHEMBL680019,B,CHEMBL113023,Homo sapiens,CHEMBL203,CHEMBL1131066
Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(CO)c3)nc21,7.09,Inhibition of EGFR,IC50,82.0,nM,=,CHEMBL1060165,B,CHEMBL327127,Homo sapiens,CHEMBL203,CHEMBL1150972
Cc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1,6.32,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,480.0,nM,=,CHEMBL680019,B,CHEMBL111339,Homo sapiens,CHEMBL203,CHEMBL1131066
COc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1,7.52,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,30.0,nM,=,CHEMBL680019,B,CHEMBL111197,Homo sapiens,CHEMBL203,CHEMBL1131066
Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(Br)c3)nc21,6.17,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,670.0,nM,=,CHEMBL680019,B,CHEMBL111434,Homo sapiens,CHEMBL203,CHEMBL1131066
CCn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccncc3)nc21,6.31,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,490.0,nM,=,CHEMBL680019,B,CHEMBL448154,Homo sapiens,CHEMBL203,CHEMBL1131066
Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(CCCC(=O)O)cc3)nc21,7.10,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,80.0,nM,=,CHEMBL680019,B,CHEMBL113070,Homo sapiens,CHEMBL203,CHEMBL1131066
CCCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1,5.36,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,4400.0,nM,=,CHEMBL680019,B,CHEMBL332269,Homo sapiens,CHEMBL203,CHEMBL1131066
Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3cccc(C(=O)O)c3)nc21,6.72,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,190.0,nM,=,CHEMBL680019,B,CHEMBL109631,Homo sapiens,CHEMBL203,CHEMBL1131066
Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCCCCC(=O)O)nc21,6.00,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,1000.0,nM,=,CHEMBL680019,B,CHEMBL113863,Homo sapiens,CHEMBL203,CHEMBL1131066
CCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1,5.35,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,IC50,4500.0,nM,=,CHEMBL680019,B,CHEMBL109296,Homo sapiens,CHEMBL203,CHEMBL1131066
Nc1ccc(-c2cc(=O)c3cc(N)ccc3o2)cc1,5.06,Inhibition of in vitro activity of EGFr enzyme from A431 cells in presence of 5 uM ATP,IC50,8700.0,nM,=,CHEMBL674638,B,CHEMBL112925,Homo sapiens,CHEMBL203,CHEMBL1127357
COc1cc(Nc2nccc(-c3ccc(N4CCNCC4)nc3)n2)cc(OC)c1OC,5.77,Inhibition of Epidermal growth factor receptor (EGFr),IC50,1704.0,nM,=,CHEMBL674700,B,CHEMBL322066,Homo sapiens,CHEMBL203,CHEMBL1131898
COc1cc(Nc2nccc(-c3ccc(NCCN)nc3)n2)cc(OC)c1OC,5.29,Inhibition of Epidermal growth factor receptor (EGFr),IC50,5100.0,nM,=,CHEMBL674700,B,CHEMBL113185,Homo sapiens,CHEMBL203,CHEMBL1131898
Nc1cccc(-c2cc(=O)c3c(N)c(O)c(N)cc3o2)c1,5.11,Inhibition of in vitro activity of EGFr enzyme from A431 cells in presence of 5 uM ATP,IC50,7800.0,nM,=,CHEMBL674638,B,CHEMBL325949,Homo sapiens,CHEMBL203,CHEMBL1127357
Nc1ccc(-c2cc(=O)c3cc(N)c(O)cc3o2)cc1,4.85,Inhibition of in vitro activity of EGFr enzyme from A431 cells in presence of 5 uM ATP,IC50,14100.0,nM,=,CHEMBL674638,B,CHEMBL432416,Homo sapiens,CHEMBL203,CHEMBL1127357
COc1cc2ncc(C#N)c(Nc3cccc(Br)c3)c2cc1NC(=O)/C=C/CN1CCOCC1,5.42,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,3830.0,nM,=,CHEMBL680028,B,CHEMBL332497,Homo sapiens,CHEMBL203,CHEMBL1145020
COc1cc2ncc(C#N)c(Nc3cccc(Br)c3)c2cc1NC(=O)/C=C/CN(C)C,6.10,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,790.0,nM,=,CHEMBL680028,B,CHEMBL263788,Homo sapiens,CHEMBL203,CHEMBL1145020
C=C(CN(C)C)C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cc1OCC,6.25,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,560.0,nM,=,CHEMBL680028,B,CHEMBL117326,Homo sapiens,CHEMBL203,CHEMBL1145020
C=C(CN1CCOCC1)C(=O)Nc1ccc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2c1,5.57,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,2700.0,nM,=,CHEMBL680028,B,CHEMBL114392,Homo sapiens,CHEMBL203,CHEMBL1145020
C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cc1OCC,5.12,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,7500.0,nM,=,CHEMBL680028,B,CHEMBL113902,Homo sapiens,CHEMBL203,CHEMBL1145020
C/C=C/C(=O)Nc1ccc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1,5.79,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,1620.0,nM,=,CHEMBL680028,B,CHEMBL326811,Homo sapiens,CHEMBL203,CHEMBL1145020
C=CC(=O)Nc1cc2c(Nc3cccc(Br)c3)c(C#N)cnc2cc1OC,6.09,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,810.0,nM,=,CHEMBL680028,B,CHEMBL324718,Homo sapiens,CHEMBL203,CHEMBL1145020
COc1cc2ncc(C#N)c(Nc3cccc(Br)c3)c2cc1NC(=O)C#CCN(C)C,7.05,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,90.0,nM,=,CHEMBL680028,B,CHEMBL116853,Homo sapiens,CHEMBL203,CHEMBL1145020
COCC#CC(=O)Nc1cc2c(Nc3cccc(Br)c3)c(C#N)cnc2cc1OC,6.10,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,790.0,nM,=,CHEMBL680028,B,CHEMBL326280,Homo sapiens,CHEMBL203,CHEMBL1145020
CC#CC(=O)Nc1cc2c(Nc3cccc(Br)c3)c(C#N)cnc2cc1OC,6.04,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,910.0,nM,=,CHEMBL680028,B,CHEMBL116525,Homo sapiens,CHEMBL203,CHEMBL1145020
COc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/C(C)N1CCOCC1,4.98,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,10471.29,nM,=,CHEMBL1798351,B,CHEMBL114073,Homo sapiens,CHEMBL203,CHEMBL1795334
CCOc1cc2ncc(C#N)c(Nc3cccc(Br)c3)c2cc1NC(=O)/C=C/CN(C)C,5.80,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,1600.0,nM,=,CHEMBL680028,B,CHEMBL114728,Homo sapiens,CHEMBL203,CHEMBL1145020
CCN(CC)C(C)/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cc1OC,5.32,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,4840.0,nM,=,CHEMBL680028,B,CHEMBL325156,Homo sapiens,CHEMBL203,CHEMBL1145020
CC(C)N(CC#CC(=O)Nc1ccc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1)C(C)C,6.60,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,250.0,nM,=,CHEMBL680028,B,CHEMBL113900,Homo sapiens,CHEMBL203,CHEMBL1145020
COc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/C(C)N(C)C,5.28,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,5220.0,nM,=,CHEMBL680028,B,CHEMBL113901,Homo sapiens,CHEMBL203,CHEMBL1145020
CCOc1cc2ncc(C#N)c(Nc3cccc(Br)c3)c2cc1NC(=O)/C=C/CN1CCOCC1,4.99,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,10320.0,nM,=,CHEMBL680028,B,CHEMBL116012,Homo sapiens,CHEMBL203,CHEMBL1145020
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cc1OC(F)(F)F,5.58,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,2640.0,nM,=,CHEMBL680028,B,CHEMBL421047,Homo sapiens,CHEMBL203,CHEMBL1145020
COc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCOCC1,4.87,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,13570.0,nM,=,CHEMBL680028,B,CHEMBL113996,Homo sapiens,CHEMBL203,CHEMBL1145020
CCN(CC)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cc1OC,5.72,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,1910.0,nM,=,CHEMBL680028,B,CHEMBL424252,Homo sapiens,CHEMBL203,CHEMBL1145020
COc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,5.63,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,2320.0,nM,=,CHEMBL680028,B,CHEMBL114490,Homo sapiens,CHEMBL203,CHEMBL1145020
N#Cc1cnc2ccc(NC(=O)C#CCN3CCSCC3)cc2c1Nc1cccc(Br)c1,6.26,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,550.0,nM,=,CHEMBL680028,B,CHEMBL327023,Homo sapiens,CHEMBL203,CHEMBL1145020
COc1cc(NC(=O)/C=C/CN2CCOCC2)cc2c(Nc3cccc(Br)c3)c(C#N)cnc12,5.27,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,5390.0,nM,=,CHEMBL680028,B,CHEMBL113985,Homo sapiens,CHEMBL203,CHEMBL1145020
N#Cc1cnc2ccc(NC(=O)/C=C/CN3CCOCC3)cc2c1Nc1ccc(F)c(Cl)c1,5.64,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,2290.0,nM,=,CHEMBL680028,B,CHEMBL118000,Homo sapiens,CHEMBL203,CHEMBL1145020
CN(C)C/C=C/C(=O)Nc1ccc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2c1,6.19,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,650.0,nM,=,CHEMBL680028,B,CHEMBL323630,Homo sapiens,CHEMBL203,CHEMBL1145020
COc1cc(NC(=O)/C=C/CN(C)C)cc2c(Nc3cccc(Br)c3)c(C#N)cnc12,5.54,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,2880.0,nM,=,CHEMBL680028,B,CHEMBL116857,Homo sapiens,CHEMBL203,CHEMBL1145020
COCCOCC#CC(=O)Nc1ccc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1,6.03,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,930.0,nM,=,CHEMBL680028,B,CHEMBL115440,Homo sapiens,CHEMBL203,CHEMBL1145020
CCCN(CC#CC(=O)Nc1ccc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1)CCC,6.89,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,130.0,nM,=,CHEMBL680028,B,CHEMBL115187,Homo sapiens,CHEMBL203,CHEMBL1145020
COCOCC#CC(=O)Nc1ccc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1,6.48,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,331.13,nM,=,CHEMBL1798351,B,CHEMBL441279,Homo sapiens,CHEMBL203,CHEMBL1795334
COCC#CC(=O)Nc1ccc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1,6.02,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,960.0,nM,=,CHEMBL680028,B,CHEMBL114593,Homo sapiens,CHEMBL203,CHEMBL1145020
COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,5.07,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,8600.0,nM,=,CHEMBL2318907,B,CHEMBL116438,Homo sapiens,CHEMBL203,CHEMBL2311310
CN(c1ccccc1)c1ncnc2ccccc12,4.00,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,100000.0,nM,=,CHEMBL677204,B,CHEMBL324371,Homo sapiens,CHEMBL203,CHEMBL1128536
c1ccc(CCNc2ncnc3ccccc23)cc1,5.39,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,4100.0,nM,=,CHEMBL677204,B,CHEMBL117804,Homo sapiens,CHEMBL203,CHEMBL1128536
O=[N+]([O-])c1cccc2ncnc(Nc3cccc(Br)c3)c12,6.45,Inhibition of Epidermal growth factor receptor from A431 cells,IC50,355.0,nM,=,CHEMBL677205,B,CHEMBL116308,Homo sapiens,CHEMBL203,CHEMBL1128536
O=[N+]([O-])c1ccc2c(NCc3ccccc3)ncnc2c1,5.23,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,5900.0,nM,=,CHEMBL677204,B,CHEMBL116748,Homo sapiens,CHEMBL203,CHEMBL1128536
COc1ccc2ncnc(NCc3ccccc3)c2c1,6.70,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,200.0,nM,=,CHEMBL677204,B,CHEMBL332938,Homo sapiens,CHEMBL203,CHEMBL1128536
Brc1cccc(Oc2ncnc3ccccc23)c1,6.12,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,756.0,nM,=,CHEMBL677204,B,CHEMBL117710,Homo sapiens,CHEMBL203,CHEMBL1128536
Nc1ccc2ncnc(NCc3ccccc3)c2c1,6.29,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,508.0,nM,=,CHEMBL677833,B,CHEMBL332096,Homo sapiens,CHEMBL203,CHEMBL1145114
Cc1cccc(Nc2ncnc3ccccc23)c1,6.04,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,910.0,nM,=,CHEMBL677204,B,CHEMBL441083,Homo sapiens,CHEMBL203,CHEMBL1128536
COc1cc2c(NCc3ccccc3)ncnc2cc1O,6.23,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,588.0,nM,=,CHEMBL677204,B,CHEMBL333851,Homo sapiens,CHEMBL203,CHEMBL1128536
COc1cc2ncnc(NCc3ccccc3)c2cc1OC,8.00,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,10.0,nM,=,CHEMBL677204,B,CHEMBL325245,Homo sapiens,CHEMBL203,CHEMBL1128536
COc1cc2ncnc(NCc3ccccc3)c2cc1O,7.25,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,56.0,nM,=,CHEMBL677204,B,CHEMBL115745,Homo sapiens,CHEMBL203,CHEMBL1128536
COc1cccc(Nc2ncnc3ccccc23)c1,6.08,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,842.0,nM,=,CHEMBL677204,B,CHEMBL117697,Homo sapiens,CHEMBL203,CHEMBL1128536
COc1ccc(CNc2ncnc3ccccc23)cc1,5.00,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,10000.0,nM,=,CHEMBL677204,B,CHEMBL116919,Homo sapiens,CHEMBL203,CHEMBL1128536
Clc1ccc(CNc2ncnc3ccccc23)cc1,5.16,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,7000.0,nM,=,CHEMBL677204,B,CHEMBL117554,Homo sapiens,CHEMBL203,CHEMBL1128536
O=[N+]([O-])c1cccc2ncnc(NCc3ccccc3)c12,5.10,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,8000.0,nM,=,CHEMBL677204,B,CHEMBL119708,Homo sapiens,CHEMBL203,CHEMBL1128536
Nc1cccc2ncnc(Nc3cccc(Br)c3)c12,6.36,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,439.0,nM,=,CHEMBL677204,B,CHEMBL333418,Homo sapiens,CHEMBL203,CHEMBL1128536
COc1cccc2ncnc(NCc3ccccc3)c12,5.31,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,4900.0,nM,=,CHEMBL677204,B,CHEMBL330882,Homo sapiens,CHEMBL203,CHEMBL1128536
Nc1cccc2c(Nc3cccc(Br)c3)ncnc12,6.98,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,105.0,nM,=,CHEMBL677204,B,CHEMBL333082,Homo sapiens,CHEMBL203,CHEMBL1128536
COc1ccc2c(NCc3ccccc3)ncnc2c1,7.24,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,58.0,nM,=,CHEMBL677204,B,CHEMBL326596,Homo sapiens,CHEMBL203,CHEMBL1128536
COc1cccc2ncnc(Nc3cccc(Br)c3)c12,6.86,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,IC50,139.0,nM,=,CHEMBL677204,B,CHEMBL119033,Homo sapiens,CHEMBL203,CHEMBL1128536
CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-],5.46,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,3472.0,nM,=,CHEMBL1909203,B,CHEMBL334255,Homo sapiens,CHEMBL203,CHEMBL1909046
COc1cc(/C=C(\C#N)C(=O)c2ccc(O)c(O)c2)cc(CSCc2ccccc2)c1O,6.12,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,IC50,750.0,nM,=,CHEMBL677392,B,CHEMBL116547,Homo sapiens,CHEMBL203,CHEMBL1126897
COc1cc(/C=C(\C#N)C(N)=O)cc(CSCc2ccccc2Cl)c1O,6.00,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,1000.0,nM,=,CHEMBL676067,B,CHEMBL326100,Homo sapiens,CHEMBL203,CHEMBL1136802
COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O,6.40,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,398.11,nM,=,CHEMBL676067,B,CHEMBL116595,Homo sapiens,CHEMBL203,CHEMBL1136802
COc1cc(/C=C(\C#N)C(N)=O)cc(CSC2=NCCS2)c1O,5.06,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,8709.64,nM,=,CHEMBL676067,B,CHEMBL324030,Homo sapiens,CHEMBL203,CHEMBL1136802
COc1cc(C=C(C#N)C#N)cc(CSc2ccccc2C(=O)O)c1O,5.10,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,7943.28,nM,=,CHEMBL676067,B,CHEMBL118321,Homo sapiens,CHEMBL203,CHEMBL1136802
COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccn2)c1O,5.47,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,3388.44,nM,=,CHEMBL676067,B,CHEMBL119156,Homo sapiens,CHEMBL203,CHEMBL1136802
N#C/C(=C\c1cc(O)c(O)c(CSc2nc3ccccc3s2)c1)C(N)=O,5.50,Inhibitory concentration against EGF receptor by autophosphorylation,IC50,3200.0,nM,=,CHEMBL677393,B,CHEMBL333553,Homo sapiens,CHEMBL203,CHEMBL1126897
COc1cc(/C=C(\C#N)C(N)=O)cc(CSCCCC(=O)O)c1O,4.32,Inhibitory concentration against EGF receptor by autophosphorylation,IC50,48000.0,nM,=,CHEMBL677393,B,CHEMBL326044,Homo sapiens,CHEMBL203,CHEMBL1126897
COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2C(=O)O)c1O,6.15,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,707.95,nM,=,CHEMBL676067,B,CHEMBL119987,Homo sapiens,CHEMBL203,CHEMBL1136802
COc1cc(C=C(C#N)C#N)cc(C)c1O,4.06,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,87096.36,nM,=,CHEMBL676067,B,CHEMBL120564,Homo sapiens,CHEMBL203,CHEMBL1136802
COc1cc(C=C(C#N)C#N)cc(CS(=O)(=O)c2ccc(C)cc2)c1O,4.64,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,22908.68,nM,=,CHEMBL676067,B,CHEMBL334032,Homo sapiens,CHEMBL203,CHEMBL1136802
Cc1cc(C=C(C#N)C#N)cc(O)c1O,5.25,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,IC50,5600.0,nM,=,CHEMBL677392,B,CHEMBL116423,Homo sapiens,CHEMBL203,CHEMBL1126897
COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccc(O)cc2)c1O,5.60,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,IC50,2500.0,nM,=,CHEMBL677392,B,CHEMBL419047,Homo sapiens,CHEMBL203,CHEMBL1126897
COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2nc3cc(Cl)ccc3s2)c1O,5.36,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,IC50,4400.0,nM,=,CHEMBL677392,B,CHEMBL115519,Homo sapiens,CHEMBL203,CHEMBL1126897
COc1cc(/C=C(\C#N)C(N)=O)cc(CSCc2ccccc2)c1O,6.05,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,891.25,nM,=,CHEMBL676067,B,CHEMBL326318,Homo sapiens,CHEMBL203,CHEMBL1136802
N#C/C(=C\c1cc(O)c(O)c(CSCc2ccccc2)c1)C(N)=O,6.19,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,645.65,nM,=,CHEMBL676067,B,CHEMBL432428,Homo sapiens,CHEMBL203,CHEMBL1136802
COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2NC(C)=O)c1O,5.25,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,IC50,5600.0,nM,=,CHEMBL677392,B,CHEMBL115895,Homo sapiens,CHEMBL203,CHEMBL1126897
COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2nc3ccccc3s2)c1O,4.73,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,IC50,18600.0,nM,=,CHEMBL677392,B,CHEMBL118109,Homo sapiens,CHEMBL203,CHEMBL1126897
COc1cc(C=C(C#N)C#N)cc(CSc2ccccc2)c1O,5.17,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,6760.83,nM,=,CHEMBL676067,B,CHEMBL122522,Homo sapiens,CHEMBL203,CHEMBL1136802
COc1cc(/C=C(\C#N)C(N)=O)cc(CSCc2ccc(Cl)cc2)c1O,4.83,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,IC50,14800.0,nM,=,CHEMBL677392,B,CHEMBL119923,Homo sapiens,CHEMBL203,CHEMBL1126897
COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2nc3ccccc3[nH]2)c1O,4.84,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,14454.4,nM,=,CHEMBL676067,B,CHEMBL331026,Homo sapiens,CHEMBL203,CHEMBL1136802
COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2nc3ccccc3o2)c1O,5.28,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,5248.07,nM,=,CHEMBL676067,B,CHEMBL118205,Homo sapiens,CHEMBL203,CHEMBL1136802
COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccc(C)cc2)c1O,5.76,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,1737.8,nM,=,CHEMBL676067,B,CHEMBL333454,Homo sapiens,CHEMBL203,CHEMBL1136802
COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccc3ccccc3c2)c1O,5.77,Inhibitory concentration against EGF receptor by autophosphorylation,IC50,1700.0,nM,=,CHEMBL677393,B,CHEMBL330879,Homo sapiens,CHEMBL203,CHEMBL1126897
COc1cc(C=C(C#N)C#N)cc(CSCC(=O)O)c1O,4.27,Inhibitory concentration against EGF receptor by autophosphorylation,IC50,54000.0,nM,=,CHEMBL677393,B,CHEMBL120719,Homo sapiens,CHEMBL203,CHEMBL1126897
CN1CCN(c2ccc3c(n2)nc(-c2ccc(F)cc2)n3-c2ccnc(NC3CCCC3)n2)CC1,5.06,Inhibition of human epidermal growth factor receptor,IC50,8700.0,nM,=,CHEMBL683039,B,CHEMBL120185,Homo sapiens,CHEMBL203,CHEMBL1147483
Nc1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1,8.30,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,5.0,nM,=,CHEMBL677832,B,CHEMBL332612,Homo sapiens,CHEMBL203,CHEMBL1130217
COc1ccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1,7.02,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,96.0,nM,=,CHEMBL677832,B,CHEMBL332971,Homo sapiens,CHEMBL203,CHEMBL1130217
Nc1[nH]cnc2nnc(Nc3cccc(Cl)c3)c1-2,6.80,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,160.0,nM,=,CHEMBL677832,B,CHEMBL121190,Homo sapiens,CHEMBL203,CHEMBL1130217
Clc1cccc(Nc2[nH]nc3ncnc(Nc4ccccc4)c23)c1,7.08,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,84.0,nM,=,CHEMBL677832,B,CHEMBL121260,Homo sapiens,CHEMBL203,CHEMBL1130217
Oc1cccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1,7.58,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,26.0,nM,=,CHEMBL677832,B,CHEMBL331906,Homo sapiens,CHEMBL203,CHEMBL1130217
OC1(c2nc(-c3ccc(F)cc3)c(-c3ccnc(NC4CCCCC4)c3)o2)CCNCC1,5.96,Inhibition of human epidermal growth factor receptor,IC50,1100.0,nM,=,CHEMBL683039,B,CHEMBL121405,Homo sapiens,CHEMBL203,CHEMBL1147483
Clc1cccc(Nc2[nH]cnc3nnc(-c4ccccc4)c2-3)c1,7.72,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,19.0,nM,=,CHEMBL677832,B,CHEMBL119977,Homo sapiens,CHEMBL203,CHEMBL1130217
COc1ccc(CNc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1,8.15,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,7.0,nM,=,CHEMBL677832,B,CHEMBL122245,Homo sapiens,CHEMBL203,CHEMBL1130217
COc1cccc(CNc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1,8.10,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,8.0,nM,=,CHEMBL677832,B,CHEMBL123189,Homo sapiens,CHEMBL203,CHEMBL1130217
Clc1cccc(CNc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1,7.58,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,26.0,nM,=,CHEMBL677832,B,CHEMBL333231,Homo sapiens,CHEMBL203,CHEMBL1130217
CC(C)(C)OC(=O)Nc1ccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1,6.57,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,270.0,nM,=,CHEMBL677832,B,CHEMBL420885,Homo sapiens,CHEMBL203,CHEMBL1130217
Nc1cccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1,8.30,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,5.0,nM,=,CHEMBL677832,B,CHEMBL332882,Homo sapiens,CHEMBL203,CHEMBL1130217
O=[N+]([O-])c1cccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1,6.57,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,270.0,nM,=,CHEMBL677832,B,CHEMBL118904,Homo sapiens,CHEMBL203,CHEMBL1130217
Oc1ccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1,8.22,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,6.0,nM,=,CHEMBL677832,B,CHEMBL118130,Homo sapiens,CHEMBL203,CHEMBL1130217
c1ccc(Nc2nc[nH]c3nnc(Nc4ccccc4)c2-3)cc1,7.24,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,58.0,nM,=,CHEMBL677832,B,CHEMBL332333,Homo sapiens,CHEMBL203,CHEMBL1130217
Nc1ncnc2c1c(-c1ccccc1)nn2-c1ccccc1,6.10,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,800.0,nM,=,CHEMBL677832,B,CHEMBL122243,Homo sapiens,CHEMBL203,CHEMBL1130217
Nc1nc(N)c2c(Nc3cccc(Cl)c3)[nH]nc2n1,6.66,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,220.0,nM,=,CHEMBL677832,B,CHEMBL122068,Homo sapiens,CHEMBL203,CHEMBL1130217
Clc1cccc(Nc2[nH]cnc3nnc(NCc4ccccc4)c2-3)c1,8.15,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,7.0,nM,=,CHEMBL677832,B,CHEMBL121796,Homo sapiens,CHEMBL203,CHEMBL1130217
CN(C)c1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1,7.54,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,29.0,nM,=,CHEMBL677832,B,CHEMBL332765,Homo sapiens,CHEMBL203,CHEMBL1130217
Clc1cccc(Nc2[nH]nc3ncnc(Oc4cccc(Cl)c4)c23)c1,4.62,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,24200.0,nM,=,CHEMBL677832,B,CHEMBL334026,Homo sapiens,CHEMBL203,CHEMBL1130217
Nc1ccc(-c2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1,8.70,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,2.0,nM,=,CHEMBL677832,B,CHEMBL332906,Homo sapiens,CHEMBL203,CHEMBL1130217
Oc1cccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1,9.00,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,1.0,nM,=,CHEMBL677832,B,CHEMBL121954,Homo sapiens,CHEMBL203,CHEMBL1130217
COc1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1,7.52,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,30.0,nM,=,CHEMBL677832,B,CHEMBL122411,Homo sapiens,CHEMBL203,CHEMBL1130217
Cc1cccc(Nc2[nH]cnc3nnc(Nc4cccc(Cl)c4)c2-3)c1,6.89,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,130.0,nM,=,CHEMBL677832,B,CHEMBL120069,Homo sapiens,CHEMBL203,CHEMBL1130217
COc1cccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)c1,8.10,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,8.0,nM,=,CHEMBL677832,B,CHEMBL120979,Homo sapiens,CHEMBL203,CHEMBL1130217
Oc1ccc(Nc2[nH]nc3ncnc(Nc4cccc(Cl)c4)c23)cc1,8.10,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,8.0,nM,=,CHEMBL677832,B,CHEMBL122182,Homo sapiens,CHEMBL203,CHEMBL1130217
Clc1cccc(Nc2[nH]nc3ncnc(Nc4cccc(Br)c4)c23)c1,6.89,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,130.0,nM,=,CHEMBL677832,B,CHEMBL120319,Homo sapiens,CHEMBL203,CHEMBL1130217
Clc1cccc(Nc2nc[nH]c3nnc(Nc4cccc(Cl)c4)c2-3)c1,6.48,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,330.0,nM,=,CHEMBL677832,B,CHEMBL333038,Homo sapiens,CHEMBL203,CHEMBL1130217
COc1ccc(C#CC(C)(C)N)cc1C(=O)c1ccc(Nc2ccc(F)cc2F)cc1,5.36,Inhibition of human Epidermal growth factor receptor,IC50,4400.0,nM,=,CHEMBL683038,B,CHEMBL419409,Homo sapiens,CHEMBL203,CHEMBL1147484
Clc1cccc(Nc2[nH]nc3ncnc(NCc4ccccc4)c23)c1,6.06,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,IC50,870.0,nM,=,CHEMBL677832,B,CHEMBL119982,Homo sapiens,CHEMBL203,CHEMBL1130217
CNC(=O)c1cc(NCc2cc(O)ccc2O)ccc1O,5.01,Displacement of [gamma-32P]-ATP from Epidermal growth factor receptor in A431 cell-free extracts,IC50,9700.0,nM,=,CHEMBL677211,B,CHEMBL122260,Homo sapiens,CHEMBL203,CHEMBL1159167
CCCCCCNC(=O)c1cc(NCc2cc(O)ccc2O)ccc1O,6.05,Displacement of [gamma-32P]-ATP from Epidermal growth factor receptor in A431 cell-free extracts,IC50,900.0,nM,=,CHEMBL677211,B,CHEMBL122397,Homo sapiens,CHEMBL203,CHEMBL1159167
O=S(=O)(O)c1cc(NCc2cc(O)ccc2O)ccc1O,4.99,Displacement of [gamma-32P]-ATP from Epidermal growth factor receptor in A431 cell-free extracts,IC50,10300.0,nM,=,CHEMBL677211,B,CHEMBL122785,Homo sapiens,CHEMBL203,CHEMBL1159167
CCCCCCCCCCCCCCNC(=O)c1cc(NCc2cc(O)ccc2O)ccc1O,4.57,Displacement of [gamma-32P]-ATP from Epidermal growth factor receptor in A431 cell-free extracts,IC50,27200.0,nM,=,CHEMBL677211,B,CHEMBL122721,Homo sapiens,CHEMBL203,CHEMBL1159167
O=[N+]([O-])c1cc(NCc2cc(O)ccc2O)ccc1O,5.27,Displacement of [gamma-32P]-ATP from Epidermal growth factor receptor in A431 cell-free extracts,IC50,5400.0,nM,=,CHEMBL677211,B,CHEMBL123045,Homo sapiens,CHEMBL203,CHEMBL1159167
Oc1ccc(NCc2cc(O)ccc2O)cc1,4.38,Displacement of [gamma-32P]-ATP from Epidermal growth factor receptor in A431 cell-free extracts,IC50,41900.0,nM,=,CHEMBL677211,B,CHEMBL123046,Homo sapiens,CHEMBL203,CHEMBL1159167
COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,6.68,Binding constant for EGFR(G719C) kinase domain,Kd,210.0,nM,=,CHEMBL1061068,B,CHEMBL124660,Homo sapiens,CHEMBL203,CHEMBL1150977
Nc1cc2ncnc(Nc3ccccc3N)c2cn1,5.27,Inhibition of EGFR,IC50,5370.32,nM,=,CHEMBL952131,B,CHEMBL124618,Homo sapiens,CHEMBL203,CHEMBL1143196
CCOc1cc2ncnc(Nc3cccc(-c4ccco4)c3)c2cc1OCC,8.52,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,IC50,3.0,nM,=,CHEMBL678292,B,CHEMBL125086,Homo sapiens,CHEMBL203,CHEMBL1135760
CCOc1cc2ncnc(Nc3cccc(-c4csc(C)n4)c3)c2cc1OCC,5.32,Inhibition of Epidermal growth factor receptor,IC50,4800.0,nM,=,CHEMBL678293,B,CHEMBL126456,Homo sapiens,CHEMBL203,CHEMBL1135760
CCOc1cc2ncnc(Nc3cccc(-c4cncnc4)c3)c2cc1OCC,5.96,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,IC50,1100.0,nM,=,CHEMBL678292,B,CHEMBL126974,Homo sapiens,CHEMBL203,CHEMBL1135760
CCOc1cc2ncnc(Nc3cccc(-c4nc[nH]n4)c3)c2cc1OCC,6.41,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,IC50,390.0,nM,=,CHEMBL678292,B,CHEMBL127367,Homo sapiens,CHEMBL203,CHEMBL1135760
CCOc1cc2ncnc(Nc3cccc(-c4cc[nH]n4)c3)c2cc1OCC,7.96,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,IC50,11.0,nM,=,CHEMBL678292,B,CHEMBL125920,Homo sapiens,CHEMBL203,CHEMBL1135760
CCOc1cc2ncnc(Nc3cccc(-c4cocn4)c3)c2cc1OCC,6.14,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,IC50,720.0,nM,=,CHEMBL678292,B,CHEMBL126996,Homo sapiens,CHEMBL203,CHEMBL1135760
CCOc1cc2ncnc(Nc3cccc(-c4cncs4)c3)c2cc1OCC,7.96,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,IC50,11.0,nM,=,CHEMBL678292,B,CHEMBL340862,Homo sapiens,CHEMBL203,CHEMBL1135760
CCOc1cc2nc(CC)nc(Nc3cccc(-c4csc(C)n4)c3)c2cc1OCC,5.03,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,IC50,9300.0,nM,=,CHEMBL678292,B,CHEMBL126483,Homo sapiens,CHEMBL203,CHEMBL1135760
CCOc1cc2nc(C)nc(Nc3cccc(-c4csc(C)n4)c3)c2cc1OCC,5.05,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,IC50,9000.0,nM,=,CHEMBL678292,B,CHEMBL128027,Homo sapiens,CHEMBL203,CHEMBL1135760
CCOc1cc2ncnc(Nc3cccc(-c4nccs4)c3)c2cc1OCC,8.70,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,IC50,2.0,nM,=,CHEMBL678292,B,CHEMBL126192,Homo sapiens,CHEMBL203,CHEMBL1135760
CCOc1cc2ncnc(Nc3cccc(-c4csc(N)n4)c3)c2cc1OCC,6.25,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,IC50,560.0,nM,=,CHEMBL678292,B,CHEMBL340660,Homo sapiens,CHEMBL203,CHEMBL1135760
CCOc1cc2ncnc(Nc3cccc(-c4cscn4)c3)c2cc1OCC,7.75,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,IC50,18.0,nM,=,CHEMBL678292,B,CHEMBL127223,Homo sapiens,CHEMBL203,CHEMBL1135760
OCCNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,9.62,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,0.24,nM,=,CHEMBL677387,B,CHEMBL127041,Homo sapiens,CHEMBL203,CHEMBL1130246
O=C(/C=C/c1ccc(O)c(O)c1)c1ccc(O)cc1O,5.10,Inhibition of EGFR,IC50,8000.0,nM,=,CHEMBL970971,B,CHEMBL128000,Homo sapiens,CHEMBL203,CHEMBL1157216
CN(C)CCNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,7.35,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,45.0,nM,=,CHEMBL677387,B,CHEMBL128432,Homo sapiens,CHEMBL203,CHEMBL1130246
CN(CC(O)C(O)C(O)C(O)CO)c1cc2ncnc(Nc3cccc(Br)c3)c2cn1,8.49,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,3.2,nM,=,CHEMBL677387,B,CHEMBL127611,Homo sapiens,CHEMBL203,CHEMBL1130246
OCCN(CCO)c1cc2ncnc(Nc3cccc(Br)c3)c2cn1,7.92,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,12.0,nM,=,CHEMBL677387,B,CHEMBL128759,Homo sapiens,CHEMBL203,CHEMBL1130246
CN(CC(O)CO)c1cc2ncnc(Nc3cccc(Br)c3)c2cn1,8.49,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,3.2,nM,=,CHEMBL677387,B,CHEMBL340700,Homo sapiens,CHEMBL203,CHEMBL1130246
Brc1cccc(Nc2ncnc3cc(NCCCn4ccnc4)ncc23)c1,9.29,Inhibition of epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,0.51,nM,=,CHEMBL677386,B,CHEMBL126791,Homo sapiens,CHEMBL203,CHEMBL1130246
CN(CCO)c1cc2ncnc(Nc3cccc(Br)c3)c2cn1,8.59,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,2.6,nM,=,CHEMBL677387,B,CHEMBL341319,Homo sapiens,CHEMBL203,CHEMBL1130246
OCCN(CCO)CCCNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,8.92,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,1.2,nM,=,CHEMBL677387,B,CHEMBL127058,Homo sapiens,CHEMBL203,CHEMBL1130246
OCCN(CCO)CCNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,8.04,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,9.2,nM,=,CHEMBL677387,B,CHEMBL435993,Homo sapiens,CHEMBL203,CHEMBL1130246
Cc1cccc(Nc2ncnc3cc(NCCCN4CCN(C)CC4)ncc23)c1,8.25,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,5.6,nM,=,CHEMBL677387,B,CHEMBL341522,Homo sapiens,CHEMBL203,CHEMBL1130246
CN1CCN(CCCNc2cc3ncnc(Nc4cccc(Br)c4)c3cn2)CC1,8.31,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,4.9,nM,=,CHEMBL677387,B,CHEMBL340484,Homo sapiens,CHEMBL203,CHEMBL1130246
[O-][N+]1(CCCNc2cc3ncnc(Nc4cccc(Br)c4)c3cn2)CCOCC1,9.13,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,0.74,nM,=,CHEMBL677387,B,CHEMBL339416,Homo sapiens,CHEMBL203,CHEMBL1130246
Brc1cccc(Nc2ncnc3cc(NCCCN4CCOCC4)ncc23)c1,8.72,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,1.9,nM,=,CHEMBL677387,B,CHEMBL126623,Homo sapiens,CHEMBL203,CHEMBL1130246
Brc1cccc(Nc2ncnc3cc(NCCN4CCOCC4)ncc23)c1,8.49,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,3.2,nM,=,CHEMBL677387,B,CHEMBL128987,Homo sapiens,CHEMBL203,CHEMBL1130246
O=C(O)CNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,8.82,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,1.5,nM,=,CHEMBL677387,B,CHEMBL338175,Homo sapiens,CHEMBL203,CHEMBL1130246
Cc1cccc(Nc2ncnc3cc(NCCc4c[nH]cn4)ncc23)c1,8.14,Inhibition of epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,7.2,nM,=,CHEMBL677386,B,CHEMBL340399,Homo sapiens,CHEMBL203,CHEMBL1130246
CNc1cc2ncnc(Nc3cccc(C)c3)c2cn1,8.85,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,1.4,nM,=,CHEMBL677387,B,CHEMBL127082,Homo sapiens,CHEMBL203,CHEMBL1130246
Cc1cccc(Nc2ncnc3cc(NCCCN4CCOCC4)ncc23)c1,8.03,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,9.3,nM,=,CHEMBL677387,B,CHEMBL129509,Homo sapiens,CHEMBL203,CHEMBL1130246
Cc1cccc(Nc2ncnc3cc(NCCCCN(C)C)ncc23)c1,8.27,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,5.4,nM,=,CHEMBL677387,B,CHEMBL338215,Homo sapiens,CHEMBL203,CHEMBL1130246
O=S(=O)(O)CCNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,8.85,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,1.4,nM,=,CHEMBL677387,B,CHEMBL128467,Homo sapiens,CHEMBL203,CHEMBL1130246
O=C(O)CCCNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,9.55,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,0.28,nM,=,CHEMBL677387,B,CHEMBL128468,Homo sapiens,CHEMBL203,CHEMBL1130246
Cc1cccc(Nc2ncnc3cc(NCCCn4ccnc4)ncc23)c1,8.46,Inhibition of epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,3.5,nM,=,CHEMBL677386,B,CHEMBL340898,Homo sapiens,CHEMBL203,CHEMBL1130246
CN(C)CCN(C)c1cc2ncnc(Nc3cccc(Br)c3)c2cn1,7.40,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,40.0,nM,=,CHEMBL677387,B,CHEMBL126137,Homo sapiens,CHEMBL203,CHEMBL1130246
CN(C)CCCCCNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,8.08,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,8.4,nM,=,CHEMBL677387,B,CHEMBL129824,Homo sapiens,CHEMBL203,CHEMBL1130246
CN(C)CCCCNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,8.13,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,7.4,nM,=,CHEMBL677387,B,CHEMBL129825,Homo sapiens,CHEMBL203,CHEMBL1130246
CN(CC(=O)O)c1cc2ncnc(Nc3cccc(Br)c3)c2cn1,7.80,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,16.0,nM,=,CHEMBL677387,B,CHEMBL126903,Homo sapiens,CHEMBL203,CHEMBL1130246
O=C(O)CCNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,9.22,Inhibition of human recombinant EGFR,IC50,0.6026,nM,=,CHEMBL944276,B,CHEMBL127086,Homo sapiens,CHEMBL203,CHEMBL1140899
CN(C)CCCNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,8.06,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,8.8,nM,=,CHEMBL677387,B,CHEMBL126893,Homo sapiens,CHEMBL203,CHEMBL1130246
OCC(O)C(O)C(O)C(O)CNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,8.32,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,4.8,nM,=,CHEMBL677387,B,CHEMBL129579,Homo sapiens,CHEMBL203,CHEMBL1130246
OCC(O)CNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,9.04,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,0.92,nM,=,CHEMBL677387,B,CHEMBL126372,Homo sapiens,CHEMBL203,CHEMBL1130246
OCC(CO)Nc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,7.85,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,14.0,nM,=,CHEMBL677387,B,CHEMBL125568,Homo sapiens,CHEMBL203,CHEMBL1130246
Brc1cccc(Nc2ncnc3cc(NCCc4c[nH]cn4)ncc23)c1,9.04,Inhibition of epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,IC50,0.91,nM,=,CHEMBL677386,B,CHEMBL338114,Homo sapiens,CHEMBL203,CHEMBL1130246
NNc1cc2ncnc(Nc3cccc(Br)c3)c2cn1,8.15,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,7.1,nM,=,CHEMBL677387,B,CHEMBL340508,Homo sapiens,CHEMBL203,CHEMBL1130246
Brc1cccc(Nc2ncnc3cc(NCCCCN4CCOCC4)ncc23)c1,8.27,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,IC50,5.4,nM,=,CHEMBL677387,B,CHEMBL126384,Homo sapiens,CHEMBL203,CHEMBL1130246
Cc1cccc(Cl)c1NC(=O)c1cnc(NC(=O)C2CC2)s1,5.00,Inhibitory activity against HER1 kinase,IC50,10000.0,nM,=,CHEMBL674105,B,CHEMBL131577,Homo sapiens,CHEMBL203,CHEMBL1136358
CO[C@H]1[C@@H](N(C)Cc2ccccc2)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,6.04,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,910.0,nM,=,CHEMBL677890,B,CHEMBL131193,Homo sapiens,CHEMBL203,CHEMBL1127758
COC(=O)CN(C)[C@H]1C[C@@H]2O[C@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.89,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,1300.0,nM,=,CHEMBL677890,B,CHEMBL444337,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)CCC#N)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.96,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,1100.0,nM,=,CHEMBL677890,B,CHEMBL131426,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)C(=O)c2ccc(Cl)cc2)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.16,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,7000.0,nM,=,CHEMBL677890,B,CHEMBL131715,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)C(=O)CNC(=O)OC(C)(C)C)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.46,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,3500.0,nM,=,CHEMBL677890,B,CHEMBL335931,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)C(=O)C(F)(F)F)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.19,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,6400.0,nM,=,CHEMBL677890,B,CHEMBL335932,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)S(C)(=O)=O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.96,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,1100.0,nM,=,CHEMBL677890,B,CHEMBL131020,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)C(=O)CCC(=O)O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,6.80,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,160.0,nM,=,CHEMBL677890,B,CHEMBL337027,Homo sapiens,CHEMBL203,CHEMBL1127758
CN[C@H]1C[C@@H]2O[C@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4=O,6.70,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,200.0,nM,=,CHEMBL677890,B,CHEMBL337026,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)C(=O)c2ccc(C(=O)O)cc2)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,6.96,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,110.0,nM,=,CHEMBL677890,B,CHEMBL435809,Homo sapiens,CHEMBL203,CHEMBL1127758
COC(=O)c1ccc(C(=O)N(C)[C@H]2C[C@@H]3O[C@](C)([C@H]2OC)n2c4ccccc4c4c5c(c6c7ccccc7n3c6c42)C(=O)NC5)cc1,5.13,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,7400.0,nM,=,CHEMBL677890,B,CHEMBL336192,Homo sapiens,CHEMBL203,CHEMBL1127758
COc1ccc(C(=O)N(C)[C@H]2C[C@@H]3O[C@](C)([C@H]2OC)n2c4ccccc4c4c5c(c6c7ccccc7n3c6c42)C(=O)NC5)cc1,5.44,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,3600.0,nM,=,CHEMBL677890,B,CHEMBL132169,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)C(=O)c2cccnc2)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.09,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,8180.0,nM,=,CHEMBL677890,B,CHEMBL335012,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)C(=O)c2ccccc2)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.72,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,1900.0,nM,=,CHEMBL677890,B,CHEMBL338448,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)C(=O)OC(C)(C)C)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,4.87,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,13500.0,nM,=,CHEMBL677890,B,CHEMBL338449,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)C(=O)c2cccc(Cl)c2)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.34,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,4600.0,nM,=,CHEMBL677890,B,CHEMBL338944,Homo sapiens,CHEMBL203,CHEMBL1127758
CNC(=S)N(C)[C@H]1C[C@@H]2O[C@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,4.90,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,12500.0,nM,=,CHEMBL677890,B,CHEMBL337035,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)C(=O)c2ccccc2Cl)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.33,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,4700.0,nM,=,CHEMBL677890,B,CHEMBL131590,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)C(=O)c2cnccn2)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.09,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,8180.0,nM,=,CHEMBL677890,B,CHEMBL337297,Homo sapiens,CHEMBL203,CHEMBL1127758
COC(=O)N(C)[C@H]1C[C@@H]2O[C@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.62,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,2400.0,nM,=,CHEMBL677890,B,CHEMBL130049,Homo sapiens,CHEMBL203,CHEMBL1127758
CCCCC(O)CN(C)[C@H]1C[C@@H]2O[C@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.89,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,1300.0,nM,=,CHEMBL677890,B,CHEMBL335718,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)C(=O)c2cccc([N+](=O)[O-])c2)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.32,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,4800.0,nM,=,CHEMBL677890,B,CHEMBL130208,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)C(C)=O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,5.58,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,2600.0,nM,=,CHEMBL677890,B,CHEMBL130163,Homo sapiens,CHEMBL203,CHEMBL1127758
CN[C@H]1C[C@@H]2O[C@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)[C@H](O)NC4=O,6.58,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,260.0,nM,=,CHEMBL677890,B,CHEMBL338155,Homo sapiens,CHEMBL203,CHEMBL1127758
CN[C@H]1C[C@@H]2O[C@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@@H]4O,7.77,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,17.0,nM,=,CHEMBL677890,B,CHEMBL338049,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)C(=O)CN)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,6.66,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,220.0,nM,=,CHEMBL677890,B,CHEMBL338935,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H](N(C)CC(=O)O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,7.51,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,31.0,nM,=,CHEMBL677890,B,CHEMBL132348,Homo sapiens,CHEMBL203,CHEMBL1127758
CO[C@H]1[C@@H]([N+](C)(C)C)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,7.72,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,19.0,nM,=,CHEMBL677890,B,CHEMBL335648,Homo sapiens,CHEMBL203,CHEMBL1127758
CCN(C)[C@H]1C[C@@H]2O[C@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,6.48,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,330.0,nM,=,CHEMBL677890,B,CHEMBL129946,Homo sapiens,CHEMBL203,CHEMBL1127758
CC[N+](C)(C)[C@H]1C[C@@H]2O[C@](C)([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,7.37,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,IC50,43.0,nM,=,CHEMBL677890,B,CHEMBL340611,Homo sapiens,CHEMBL203,CHEMBL1127758
COC(=O)c1cc(NCc2cc(O)ccc2O)ccc1O,4.61,Inhibition of EGF-R Tyrosine kinase (TK),IC50,24400.0,nM,=,CHEMBL674642,B,CHEMBL131653,Homo sapiens,CHEMBL203,CHEMBL1127418
COc1cc2ncnc(Oc3cccc(Cl)c3)c2cc1OC,7.70,Inhibition of Epidermal growth factor receptor autophosphorylation.,IC50,20.0,nM,=,CHEMBL676160,B,CHEMBL135853,Homo sapiens,CHEMBL203,CHEMBL1129839
COc1cc2ncnc(Sc3cccc(Cl)c3)c2cc1OC,8.00,Inhibition of Epidermal growth factor receptor autophosphorylation.,IC50,10.0,nM,=,CHEMBL676160,B,CHEMBL135902,Homo sapiens,CHEMBL203,CHEMBL1129839
N[C@H](Cc1c([Se][Se]c2[nH]c3ccccc3c2C[C@H](N)C(=O)NCc2ccccc2)[nH]c2ccccc12)C(=O)NCc1ccccc1,6.05,Inhibition of epidermal growth factor receptor (EGFr),IC50,900.0,nM,=,CHEMBL677206,B,CHEMBL336409,Homo sapiens,CHEMBL203,CHEMBL1129933
O=C(NCc1ccccc1)[C@H](Cc1c([Se][Se]c2[nH]c3ccccc3c2C[C@@H](NC(=O)C(F)(F)F)C(=O)NCc2ccccc2)[nH]c2ccccc12)NC(=O)C(F)(F)F,5.16,Inhibition of epidermal growth factor receptor (EGFr),IC50,7000.0,nM,=,CHEMBL677206,B,CHEMBL336410,Homo sapiens,CHEMBL203,CHEMBL1129933
COc1cc2cc3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3cc2cc1OC,4.75,Inhibition of epidermal growth factor receptor (EGFR),IC50,18000.0,nM,=,CHEMBL675388,B,CHEMBL132466,Homo sapiens,CHEMBL203,CHEMBL1136058
CCN(CC)CCNC(=O)c1c([Se][Se]c2c(C(=O)NCCN(CC)CC)c3ccccc3n2C)n(C)c2ccccc12,5.33,Inhibition of epidermal growth factor receptor (EGFr),IC50,4700.0,nM,=,CHEMBL677206,B,CHEMBL263666,Homo sapiens,CHEMBL203,CHEMBL1129933
CCN(CC)CCNC(=O)c1c([Se][Se]c2[nH]c3ccccc3c2C(=O)NCCN(CC)CC)[nH]c2ccccc12,5.34,Inhibition of epidermal growth factor receptor (EGFr),IC50,4600.0,nM,=,CHEMBL677206,B,CHEMBL135577,Homo sapiens,CHEMBL203,CHEMBL1129933
CNC(=O)c1c([Se][Se]c2[nH]c3ccccc3c2C(=O)NC)[nH]c2ccccc12,4.89,Inhibition of epidermal growth factor receptor (EGFr),IC50,13000.0,nM,=,CHEMBL677206,B,CHEMBL135861,Homo sapiens,CHEMBL203,CHEMBL1129933
CNC(=O)c1c([Se][Se]c2c(C(=O)NC)c3ccccc3n2C)n(C)c2ccccc12,5.51,Inhibition of epidermal growth factor receptor (EGFr) using ATP substrate,Ki,3100.0,nM,=,CHEMBL674574,B,CHEMBL137422,Homo sapiens,CHEMBL203,CHEMBL1129933
NC(Cc1c(SSc2[nH]c3ccccc3c2CC(N)C(=O)NCc2ccccc2)[nH]c2ccccc12)C(=O)NCc1ccccc1,5.48,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,3300.0,nM,=,CHEMBL677470,B,CHEMBL336174,Homo sapiens,CHEMBL203,CHEMBL1128344
CCN(CC)CCn1c([Se][Se]c2c(C(=O)NC)c3ccccc3n2CCN(CC)CC)c(C(=O)NC)c2ccccc21,5.16,Inhibition of epidermal growth factor receptor (EGFr),IC50,6900.0,nM,=,CHEMBL677206,B,CHEMBL334439,Homo sapiens,CHEMBL203,CHEMBL1129933
CNC(=O)c1c(SSc2c(C(=O)NC)c3ccccc3n2C)n(C)c2ccccc12,5.75,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,1800.0,nM,=,CHEMBL677470,B,CHEMBL342929,Homo sapiens,CHEMBL203,CHEMBL1128344
Cn1c([Se][Se]c2c(C(=O)O)c3ccccc3n2C)c(C(=O)O)c2ccccc21,5.46,Inhibition of epidermal growth factor receptor (EGFr),IC50,3500.0,nM,=,CHEMBL677206,B,CHEMBL334915,Homo sapiens,CHEMBL203,CHEMBL1129933
Brc1cccc(Nc2ncnc3ccc(N/N=N/Cc4ccccn4)cc23)c1,6.62,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,238.0,nM,=,CHEMBL677833,B,CHEMBL138125,Homo sapiens,CHEMBL203,CHEMBL1145114
COCC/N=N/Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.15,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,71.0,nM,=,CHEMBL677833,B,CHEMBL136674,Homo sapiens,CHEMBL203,CHEMBL1145114
CN(C)CC/N=N/Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.42,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,38.0,nM,=,CHEMBL677833,B,CHEMBL137534,Homo sapiens,CHEMBL203,CHEMBL1145114
CN(c1ccccc1)c1ncnc2ccc(N/N=N/Cc3ccccn3)cc12,5.03,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,9300.0,nM,=,CHEMBL677833,B,CHEMBL137635,Homo sapiens,CHEMBL203,CHEMBL1145114
C/N=N/Nc1ccc2ncnc(N(C)c3ccccc3)c2c1,5.10,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,8000.0,nM,=,CHEMBL677833,B,CHEMBL135592,Homo sapiens,CHEMBL203,CHEMBL1145114
Brc1cccc(Nc2ncnc3ccc(N/N=N/CCN4CCOCC4)cc23)c1,7.19,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,64.0,nM,=,CHEMBL677833,B,CHEMBL137364,Homo sapiens,CHEMBL203,CHEMBL1145114
Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,8.47,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,IC50,3.38,nM,=,CHEMBL3999845,B,CHEMBL343352,Homo sapiens,CHEMBL203,CHEMBL3997839
C/N=N/Nc1ccc2ncnc(Nc3cccc(C)c3)c2c1,6.70,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,200.0,nM,=,CHEMBL677833,B,CHEMBL137189,Homo sapiens,CHEMBL203,CHEMBL1145114
Cc1cccc(Nc2ncnc3ccc(N)cc23)c1,6.00,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,1000.0,nM,=,CHEMBL677833,B,CHEMBL336113,Homo sapiens,CHEMBL203,CHEMBL1145114
Brc1cccc(Nc2ncnc3ccc(N/N=N/Cc4ccccc4)cc23)c1,7.60,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,25.0,nM,=,CHEMBL677833,B,CHEMBL424093,Homo sapiens,CHEMBL203,CHEMBL1145114
CN(C)/N=N/c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.96,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,11.0,nM,=,CHEMBL677833,B,CHEMBL134312,Homo sapiens,CHEMBL203,CHEMBL1145114
Cc1cccc(Nc2ncnc3ccc(/N=N/N(C)C)cc23)c1,7.62,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,24.0,nM,=,CHEMBL677833,B,CHEMBL133023,Homo sapiens,CHEMBL203,CHEMBL1145114
C/N=N/Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,7.00,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,100.0,nM,=,CHEMBL677833,B,CHEMBL133024,Homo sapiens,CHEMBL203,CHEMBL1145114
C/N=N/Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.41,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,39.0,nM,=,CHEMBL677833,B,CHEMBL137617,Homo sapiens,CHEMBL203,CHEMBL1145114
CN(C)/N=N/c1ccc2ncnc(NCc3ccccc3)c2c1,6.32,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,482.0,nM,=,CHEMBL677833,B,CHEMBL137027,Homo sapiens,CHEMBL203,CHEMBL1145114
C/N=N/Nc1ccc2ncnc(NCc3ccccc3)c2c1,6.47,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,335.0,nM,=,CHEMBL677833,B,CHEMBL137788,Homo sapiens,CHEMBL203,CHEMBL1145114
CN(C)/N=N/c1ccc2ncnc(N(C)c3ccccc3)c2c1,4.88,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,13350.0,nM,=,CHEMBL677833,B,CHEMBL344652,Homo sapiens,CHEMBL203,CHEMBL1145114
CN(C)/N=N/c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,7.85,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,14.0,nM,=,CHEMBL677833,B,CHEMBL136491,Homo sapiens,CHEMBL203,CHEMBL1145114
CN(c1ccccc1)c1ncnc2ccc(N)cc12,5.08,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,IC50,8400.0,nM,=,CHEMBL677833,B,CHEMBL136492,Homo sapiens,CHEMBL203,CHEMBL1145114
C=C=CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.80,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,1.6,nM,=,CHEMBL673925,B,CHEMBL343722,Homo sapiens,CHEMBL203,CHEMBL1134843
C=C/C=C/C(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.96,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,1.1,nM,=,CHEMBL673925,B,CHEMBL139044,Homo sapiens,CHEMBL203,CHEMBL1134843
O=C(/C=C/C(F)(F)F)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.76,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,1.75,nM,=,CHEMBL673925,B,CHEMBL135142,Homo sapiens,CHEMBL203,CHEMBL1134843
C=CC(=O)N(CCCN1CCOCC1)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.57,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,2.7,nM,=,CHEMBL673925,B,CHEMBL137082,Homo sapiens,CHEMBL203,CHEMBL1134843
C=CC(=O)N(CCN(C)C)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.38,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,4.2,nM,=,CHEMBL673925,B,CHEMBL138691,Homo sapiens,CHEMBL203,CHEMBL1134843
C/C=C/C(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.30,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,0.5,nM,=,CHEMBL673925,B,CHEMBL136404,Homo sapiens,CHEMBL203,CHEMBL1134843
C=C[S+]([O-])c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.34,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,4.6,nM,=,CHEMBL673925,B,CHEMBL345077,Homo sapiens,CHEMBL203,CHEMBL1134843
O=C(/C=C/Cl)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.16,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,0.69,nM,=,CHEMBL673925,B,CHEMBL344177,Homo sapiens,CHEMBL203,CHEMBL1134843
C=CS(=O)(=O)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.37,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,0.43,nM,=,CHEMBL673925,B,CHEMBL336264,Homo sapiens,CHEMBL203,CHEMBL1134843
O=C(/C=C/C(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1)NCCCn1ccnc1,9.25,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,0.56,nM,=,CHEMBL673925,B,CHEMBL342828,Homo sapiens,CHEMBL203,CHEMBL1134843
O=C(/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1)NCCCN1CCOCC1,9.22,Inhibition of human recombinant EGFR,IC50,0.6026,nM,=,CHEMBL944276,B,CHEMBL138940,Homo sapiens,CHEMBL203,CHEMBL1140899
CN(C)CCCNC(=O)/C=C/C(=O)N(C)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.84,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,1.45,nM,=,CHEMBL673925,B,CHEMBL136102,Homo sapiens,CHEMBL203,CHEMBL1134843
CCN(CC)CCCNC(=O)/C=C/C(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.14,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,0.73,nM,=,CHEMBL673925,B,CHEMBL434827,Homo sapiens,CHEMBL203,CHEMBL1134843
O=S(=O)(CCO)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,7.03,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,93.5,nM,=,CHEMBL673925,B,CHEMBL335440,Homo sapiens,CHEMBL203,CHEMBL1134843
C=CS(=O)(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.85,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,1.4,nM,=,CHEMBL673925,B,CHEMBL136511,Homo sapiens,CHEMBL203,CHEMBL1134843
O=C(/C=C/C(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1)NCCCN1CCOCC1,9.09,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,0.81,nM,=,CHEMBL673925,B,CHEMBL136058,Homo sapiens,CHEMBL203,CHEMBL1134843
CN(C)CCCNC(=O)/C=C/C(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.96,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,1.1,nM,=,CHEMBL673925,B,CHEMBL334801,Homo sapiens,CHEMBL203,CHEMBL1134843
O=C(/C=C/c1ccccc1)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.04,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,9.1,nM,=,CHEMBL673925,B,CHEMBL434828,Homo sapiens,CHEMBL203,CHEMBL1134843
CCOC(=O)/C=C/C(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.82,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,1.5,nM,=,CHEMBL673925,B,CHEMBL422292,Homo sapiens,CHEMBL203,CHEMBL1134843
CN(C)CCCNC(=O)/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.36,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,0.44,nM,=,CHEMBL673925,B,CHEMBL345109,Homo sapiens,CHEMBL203,CHEMBL1134843
C=CC(=O)N(CCCN1CCOCC1)c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.48,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,3.3,nM,=,CHEMBL673925,B,CHEMBL139307,Homo sapiens,CHEMBL203,CHEMBL1134843
O=C(O)/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.43,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,0.37,nM,=,CHEMBL673925,B,CHEMBL134371,Homo sapiens,CHEMBL203,CHEMBL1134843
CC(=O)/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.92,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,1.2,nM,=,CHEMBL673925,B,CHEMBL136178,Homo sapiens,CHEMBL203,CHEMBL1134843
CN(C)CCCOC(=O)/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.62,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,2.4,nM,=,CHEMBL673925,B,CHEMBL140561,Homo sapiens,CHEMBL203,CHEMBL1134843
C=CC(=O)N(C)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.77,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,0.17,nM,=,CHEMBL673925,B,CHEMBL334697,Homo sapiens,CHEMBL203,CHEMBL1134843
C=C(C)C(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.80,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,1.6,nM,=,CHEMBL673925,B,CHEMBL138363,Homo sapiens,CHEMBL203,CHEMBL1134843
CCOC(=O)/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.57,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,2.7,nM,=,CHEMBL673925,B,CHEMBL344486,Homo sapiens,CHEMBL203,CHEMBL1134843
C=CS(=O)(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.12,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,0.76,nM,=,CHEMBL673925,B,CHEMBL139095,Homo sapiens,CHEMBL203,CHEMBL1134843
COc1cc(/C=C(\C#N)C(N)=O)cc(CSc2cccc3ccccc23)c1O,5.77,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,1698.24,nM,=,CHEMBL676067,B,CHEMBL143212,Homo sapiens,CHEMBL203,CHEMBL1136802
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccc(O)cc1,5.52,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,3019.95,nM,=,CHEMBL676067,B,CHEMBL143805,Homo sapiens,CHEMBL203,CHEMBL1136802
COc1cc(/C=C(/C#N)C(N)=O)cc(CSCc2ccc(Cl)cc2)c1O,4.80,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,15848.93,nM,=,CHEMBL676067,B,CHEMBL141175,Homo sapiens,CHEMBL203,CHEMBL1136802
Cc1cc(C)c(NC(=O)/C(C#N)=C/c2ccc(O)c(O)c2)c(C)c1,4.72,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,19054.61,nM,=,CHEMBL676067,B,CHEMBL141238,Homo sapiens,CHEMBL203,CHEMBL1136802
COC(=O)c1ccc(-c2ccc(-c3ccccc3)cc2O)cc1,4.85,In vitro inhibition of intrinsic tyrosine protein kinase activity of the Epidermal growth factor receptor using tripeptide RR-Src,IC50,14000.0,nM,=,CHEMBL677207,B,CHEMBL358092,Homo sapiens,CHEMBL203,CHEMBL1128699
N#C/C(=C\c1cc(O)c(O)c(Br)c1)C(=O)NCCCNC(=O)/C(C#N)=C/c1cc(O)c(O)c(Br)c1,6.47,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,340.0,nM,=,CHEMBL677831,B,CHEMBL144770,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1cc(O)c(O)c(O)c1)C(=O)NCCCCNC(=O)/C(C#N)=C/c1cc(O)c(O)c(O)c1,6.22,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,600.0,nM,=,CHEMBL677831,B,CHEMBL358746,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCNC(=O)/C(C#N)=C/c1ccc(O)c(O)c1,6.30,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,500.0,nM,=,CHEMBL677831,B,CHEMBL144908,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCCCCNC(=O)/C(C#N)=C/c1ccc(O)c(O)c1,6.16,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,700.0,nM,=,CHEMBL677831,B,CHEMBL144760,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCCCNC(=O)/C(C#N)=C/c1ccc(O)c(O)c1,6.16,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,700.0,nM,=,CHEMBL677831,B,CHEMBL144842,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCCNC(=O)/C(C#N)=C/c1ccc(O)c(O)c1,6.22,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,600.0,nM,=,CHEMBL677831,B,CHEMBL144589,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1cccc(CNC(=O)/C(C#N)=C/c2ccc(O)c(O)c2)c1,5.80,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,1600.0,nM,=,CHEMBL677831,B,CHEMBL144159,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCCCCCCCCNC(=O)/C(C#N)=C/c1ccc(O)c(O)c1,5.89,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,1300.0,nM,=,CHEMBL677831,B,CHEMBL424302,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCN1CCN(C(=O)/C(C#N)=C/c2ccc(O)c(O)c2)CC1,5.66,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,2200.0,nM,=,CHEMBL677831,B,CHEMBL343887,Homo sapiens,CHEMBL203,CHEMBL1129590
COc1cc(/C=C(\C#N)S(=O)(=O)/C(C#N)=C/c2cc(O)c(O)c(OC)c2)cc(O)c1O,6.03,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,940.0,nM,=,CHEMBL677831,B,CHEMBL342792,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCC1CCCC(CNC(=O)/C(C#N)=C/c2ccc(O)c(O)c2)C1,5.75,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,1800.0,nM,=,CHEMBL677831,B,CHEMBL357161,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1ccc(O)c(O)c1)S(=O)(=O)/C(C#N)=C/c1ccc(O)c(O)c1,6.42,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,380.0,nM,=,CHEMBL677831,B,CHEMBL356324,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCCCCCCCCNC(=O)/C(C#N)=C/c1ccc(O)c(O)c1,5.66,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,2200.0,nM,=,CHEMBL677831,B,CHEMBL279138,Homo sapiens,CHEMBL203,CHEMBL1129590
COc1cc(/C=C(\C#N)C(=O)NCCCCNC(=O)/C(C#N)=C/c2cc(OC)c(O)c([N+](=O)[O-])c2)cc([N+](=O)[O-])c1O,4.72,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,IC50,19000.0,nM,=,CHEMBL679672,B,CHEMBL145266,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NC1CCCC[C@@H]1NC(=O)/C(C#N)=C/c1ccc(O)c(O)c1,5.68,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,2100.0,nM,=,CHEMBL677831,B,CHEMBL144778,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1ccc(O)c(O)c1)C(=O)N1CCN(C(=O)/C(C#N)=C/c2ccc(O)c(O)c2)CC1,5.40,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,4000.0,nM,=,CHEMBL677831,B,CHEMBL358494,Homo sapiens,CHEMBL203,CHEMBL1129590
N#C/C(=C\c1cc(O)c(O)c(Br)c1)S(=O)(=O)/C(C#N)=C/c1cc(O)c(O)c(Br)c1,6.07,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",IC50,850.0,nM,=,CHEMBL677831,B,CHEMBL144791,Homo sapiens,CHEMBL203,CHEMBL1129590
CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1,4.96,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,10896.0,nM,=,CHEMBL1909203,B,CHEMBL434063,Homo sapiens,CHEMBL203,CHEMBL1909046
Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c(C)c1CCC(=O)O,4.07,Inhibitory activity against Epidermal growth factor receptor,IC50,84800.0,nM,=,CHEMBL677830,B,CHEMBL150177,Homo sapiens,CHEMBL203,CHEMBL1132535
CO.Nc1cccc2c1sc1c(Nc3cccc(Br)c3)ncnc12,8.57,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,2.7,nM,=,CHEMBL679944,B,CHEMBL151593,Homo sapiens,CHEMBL203,CHEMBL1132555
Nc1nc(Nc2cccc(Br)c2)c2c(n1)[nH]c1ccccc12,6.83,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,147.0,nM,=,CHEMBL679944,B,CHEMBL345988,Homo sapiens,CHEMBL203,CHEMBL1132555
CCN(CC)CCn1c2ccc(OC)cc2c2c(Nc3cccc(Br)c3)ncnc21,5.37,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,4270.0,nM,=,CHEMBL679944,B,CHEMBL153518,Homo sapiens,CHEMBL203,CHEMBL1132555
COc1ccc2[nH]c3ncnc(Nc4cccc(Br)c4)c3c2c1,8.92,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,1.2,nM,=,CHEMBL679944,B,CHEMBL153206,Homo sapiens,CHEMBL203,CHEMBL1132555
Nc1ccc2sc3c(Nc4cccc(C(F)(F)F)c4)ncnc3c2c1,7.33,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,47.0,nM,=,CHEMBL679944,B,CHEMBL347282,Homo sapiens,CHEMBL203,CHEMBL1132555
Brc1cccc(Nc2ncnc3c2sc2ccccc23)c1,8.74,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,1.8,nM,=,CHEMBL679944,B,CHEMBL356850,Homo sapiens,CHEMBL203,CHEMBL1132555
Brc1cccc(Nc2ncnc3ccsc23)c1,7.96,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,11.0,nM,=,CHEMBL679944,B,CHEMBL345294,Homo sapiens,CHEMBL203,CHEMBL1132555
CN(C)c1ccc2sc3c(Nc4cccc(Br)c4)ncnc3c2c1,7.70,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,19.8,nM,=,CHEMBL679944,B,CHEMBL153739,Homo sapiens,CHEMBL203,CHEMBL1132555
c1ccc(Nc2[nH]cnc3nc4ccccc4c2-3)cc1,6.58,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,264.0,nM,=,CHEMBL679944,B,CHEMBL150280,Homo sapiens,CHEMBL203,CHEMBL1132555
Cc1cccc(Nc2cc(NCCO)ncn2)c1,9.00,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,1.0,nM,=,CHEMBL679944,B,CHEMBL415738,Homo sapiens,CHEMBL203,CHEMBL1132555
Brc1cccc(Nc2ncnc3sccc23)c1,7.46,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,35.0,nM,=,CHEMBL679944,B,CHEMBL355982,Homo sapiens,CHEMBL203,CHEMBL1132555
c1ccc(CNc2ncnc3c2sc2ccccc23)cc1,6.72,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,191.0,nM,=,CHEMBL679944,B,CHEMBL153419,Homo sapiens,CHEMBL203,CHEMBL1132555
CCO.CNc1ccc2sc3c(Nc4cccc(Br)c4)ncnc3c2c1,8.96,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,1.1,nM,=,CHEMBL679944,B,CHEMBL358934,Homo sapiens,CHEMBL203,CHEMBL1132555
Cc1cccc(Nc2ncnc3c2sc2ccc(N)cc23)c1,8.68,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,2.1,nM,=,CHEMBL679944,B,CHEMBL155278,Homo sapiens,CHEMBL203,CHEMBL1132555
COc1ccc2c(c1)sc1c(Nc3cccc(Br)c3)ncnc12,7.10,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,80.0,nM,=,CHEMBL679944,B,CHEMBL346846,Homo sapiens,CHEMBL203,CHEMBL1132555
CCNc1cc2sc3c(Nc4cccc(Br)c4)ncnc3c2cc1F.CCO,8.10,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,7.9,nM,=,CHEMBL679944,B,CHEMBL357570,Homo sapiens,CHEMBL203,CHEMBL1132555
Nc1cc2sc3c(Nc4cccc(Br)c4)ncnc3c2cc1F,9.00,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,1.0,nM,=,CHEMBL679944,B,CHEMBL153573,Homo sapiens,CHEMBL203,CHEMBL1132555
c1ccc(CNc2[nH]cnc3c4ccccc4nc2-3)cc1,6.34,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,460.0,nM,=,CHEMBL679944,B,CHEMBL357097,Homo sapiens,CHEMBL203,CHEMBL1132555
CCN(CC)CCn1c2ccccc2c2c(Nc3cccc(Br)c3)ncnc21,5.39,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,4100.0,nM,=,CHEMBL679944,B,CHEMBL448730,Homo sapiens,CHEMBL203,CHEMBL1132555
CCO.Nc1ccc2sc3c(Nc4ccccc4)ncnc3c2c1,8.03,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,9.4,nM,=,CHEMBL679944,B,CHEMBL357367,Homo sapiens,CHEMBL203,CHEMBL1132555
Cn1c2ccccc2c2c(Nc3cccc(Br)c3)ncnc21,6.13,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,742.0,nM,=,CHEMBL679944,B,CHEMBL152984,Homo sapiens,CHEMBL203,CHEMBL1132555
Brc1cccc(Nc2[nH]cnc3nc4ccccc4c2-3)c1,7.51,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,31.0,nM,=,CHEMBL679944,B,CHEMBL423224,Homo sapiens,CHEMBL203,CHEMBL1132555
Nc1ccc2sc3c(Nc4cccc(Br)c4)ncnc3c2c1,9.57,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,0.27,nM,=,CHEMBL679944,B,CHEMBL152905,Homo sapiens,CHEMBL203,CHEMBL1132555
Brc1cccc(Nc2ncnc3c2ccc2[nH]cnc23)c1,6.57,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,272.0,nM,=,CHEMBL679944,B,CHEMBL155100,Homo sapiens,CHEMBL203,CHEMBL1132555
Brc1cccc(Nc2ncnc3ccc4cc[nH]c4c23)c1,8.91,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,1.24,nM,=,CHEMBL679944,B,CHEMBL153525,Homo sapiens,CHEMBL203,CHEMBL1132555
Brc1cccc(Nc2ncnc3ccc4[nH]cnc4c23)c1,7.54,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,29.0,nM,=,CHEMBL679944,B,CHEMBL153170,Homo sapiens,CHEMBL203,CHEMBL1132555
Brc1cccc(Nc2ncnc3c2oc2ccccc23)c1,6.13,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,740.0,nM,=,CHEMBL679944,B,CHEMBL149512,Homo sapiens,CHEMBL203,CHEMBL1132555
Brc1cccc(Nc2ncnc3c2sc2ncsc23)c1.CO,7.40,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,40.0,nM,=,CHEMBL679944,B,CHEMBL346863,Homo sapiens,CHEMBL203,CHEMBL1132555
Brc1cccc(Nc2ncnc3c2sc2ncccc23)c1,6.13,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,732.0,nM,=,CHEMBL679944,B,CHEMBL153409,Homo sapiens,CHEMBL203,CHEMBL1132555
O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1,4.98,"In vitro inhibition of Epidermal growth factor receptor (HER-1,ErbB) expressed in baculovirus",IC50,10400.0,nM,=,CHEMBL677883,B,CHEMBL153843,Homo sapiens,CHEMBL203,CHEMBL1135689
C=CC(=O)c1ccc2ccccc2c1,5.00,Inhibition of Epidermal growth factor receptor,IC50,10000.0,nM,=,CHEMBL857165,B,CHEMBL154580,Homo sapiens,CHEMBL203,CHEMBL1133428
O=C(CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)NCc2ccc(C(=O)O)c(O)c2)[nH]c2ccccc12)NCc1ccc(C(=O)O)c(O)c1,5.07,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,8500.0,nM,=,CHEMBL673450,B,CHEMBL347668,Homo sapiens,CHEMBL203,CHEMBL1127622
O=C(Cc1c(SSc2[nH]c3ccccc3c2CC(=O)NCc2ccccc2)[nH]c2ccccc12)NCc1ccccc1,4.42,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,38000.0,nM,=,CHEMBL673450,B,CHEMBL435831,Homo sapiens,CHEMBL203,CHEMBL1127622
O=C(CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)Nc2ccccc2)[nH]c2ccccc12)Nc1ccccc1,6.07,Inhibition of EGFR derived from human A-431 cell membrane vesicles using copolymer of Glu/Ala/Tyr as substrate by scintillation counting method,IC50,850.0,nM,=,CHEMBL5138016,B,CHEMBL156797,Homo sapiens,CHEMBL203,CHEMBL5136983
CNC(=O)CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)NC)[nH]c2ccccc12,5.03,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,9400.0,nM,=,CHEMBL673450,B,CHEMBL345203,Homo sapiens,CHEMBL203,CHEMBL1127622
O=[N+]([O-])CCc1c(SSc2[nH]c3ccccc3c2CC[N+](=O)[O-])[nH]c2ccccc12,4.05,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,89000.0,nM,=,CHEMBL673450,B,CHEMBL158119,Homo sapiens,CHEMBL203,CHEMBL1127622
CN(C)C(=O)CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)N(C)C)[nH]c2ccccc12,4.92,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,12000.0,nM,=,CHEMBL673450,B,CHEMBL422531,Homo sapiens,CHEMBL203,CHEMBL1127622
CC(=O)NC(Cc1c(SSc2[nH]c3ccccc3c2CC(NC(C)=O)C(=O)NCc2ccccc2)[nH]c2ccccc12)C(=O)NCc1ccccc1,4.29,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,51000.0,nM,=,CHEMBL673450,B,CHEMBL346716,Homo sapiens,CHEMBL203,CHEMBL1127622
CONC(=O)CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)NOC)[nH]c2ccccc12,4.17,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,68000.0,nM,=,CHEMBL673450,B,CHEMBL154969,Homo sapiens,CHEMBL203,CHEMBL1127622
NC(=O)CCc1c(SSc2[nH]c3ccccc3c2CCC(N)=O)[nH]c2ccccc12,4.80,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,16000.0,nM,=,CHEMBL673450,B,CHEMBL157021,Homo sapiens,CHEMBL203,CHEMBL1127622
COC(=O)c1ccc(CNC(=O)CCc2c(SSc3[nH]c4ccccc4c3CCC(=O)NCc3ccc(C(=O)OC)cc3)[nH]c3ccccc23)cc1,4.36,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,44000.0,nM,=,CHEMBL673450,B,CHEMBL154080,Homo sapiens,CHEMBL203,CHEMBL1127622
COC(=O)c1ccc(CNC(=O)CCc2c(SSc3[nH]c4ccccc4c3CCC(=O)NCc3ccc(C(=O)OC)c(O)c3)[nH]c3ccccc23)cc1O,4.00,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,100000.0,nM,=,CHEMBL673450,B,CHEMBL154822,Homo sapiens,CHEMBL203,CHEMBL1127622
O=C(CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)NCCc2ccccc2)[nH]c2ccccc12)NCCc1ccccc1,4.62,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,24000.0,nM,=,CHEMBL673450,B,CHEMBL154260,Homo sapiens,CHEMBL203,CHEMBL1127622
O=C(CCc1c(SSc2[nH]c3ccccc3c2CCC(=O)NCc2ccc(C(=O)O)cc2)[nH]c2ccccc12)NCc1ccc(C(=O)O)cc1,5.13,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,7400.0,nM,=,CHEMBL673450,B,CHEMBL155293,Homo sapiens,CHEMBL203,CHEMBL1127622
O=C(CCC1C(S)=Nc2ccccc21)NCc1ccccc1,4.00,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,100000.0,nM,=,CHEMBL673450,B,CHEMBL154911,Homo sapiens,CHEMBL203,CHEMBL1127622
NC(=O)CCC1C(S)=Nc2ccccc21,4.66,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,22000.0,nM,=,CHEMBL673450,B,CHEMBL155607,Homo sapiens,CHEMBL203,CHEMBL1127622
O=C(CC1C(S)=Nc2ccccc21)NCc1ccccc1,4.00,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,100000.0,nM,=,CHEMBL673450,B,CHEMBL155389,Homo sapiens,CHEMBL203,CHEMBL1127622
N#CCc1c(SSc2[nH]c3ccccc3c2CC#N)[nH]c2ccccc12,4.50,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,32000.0,nM,=,CHEMBL673450,B,CHEMBL348116,Homo sapiens,CHEMBL203,CHEMBL1127622
O=C(CCCc1c(SSc2[nH]c3ccccc3c2CCCC(=O)NCc2ccccc2)[nH]c2ccccc12)NCc1ccccc1,4.00,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,100000.0,nM,=,CHEMBL673450,B,CHEMBL156555,Homo sapiens,CHEMBL203,CHEMBL1127622
N#CCCc1c(SSc2[nH]c3ccccc3c2CCC#N)[nH]c2ccccc12,4.33,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,47000.0,nM,=,CHEMBL673450,B,CHEMBL157304,Homo sapiens,CHEMBL203,CHEMBL1127622
O=C(NCc1ccccc1)C(O)Cc1c(SSc2[nH]c3ccccc3c2CC(O)C(=O)NCc2ccccc2)[nH]c2ccccc12,4.85,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,14000.0,nM,=,CHEMBL673450,B,CHEMBL157952,Homo sapiens,CHEMBL203,CHEMBL1127622
CC(=O)OC(Cc1c(SSc2[nH]c3ccccc3c2CC(OC(C)=O)C(=O)NCc2ccccc2)[nH]c2ccccc12)C(=O)NCc1ccccc1,4.55,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),IC50,28000.0,nM,=,CHEMBL673450,B,CHEMBL348146,Homo sapiens,CHEMBL203,CHEMBL1127622
COCC1CCCN1CC#CC(=O)Nc1ccc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1,6.82,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,150.0,nM,=,CHEMBL680028,B,CHEMBL157128,Homo sapiens,CHEMBL203,CHEMBL1145020
COCOC#CC(=O)Nc1ccc2ncc(C#N)c(Nc3cccc(Br)c3)c2c1,6.48,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,IC50,330.0,nM,=,CHEMBL680028,B,CHEMBL414631,Homo sapiens,CHEMBL203,CHEMBL1145020
CS(=O)(=O)CCNc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cs1,8.00,Inhibition of EGFR,IC50,10.0,nM,=,CHEMBL680015,B,CHEMBL155761,Homo sapiens,CHEMBL203,CHEMBL1136583
CS(=O)(=O)CCNc1nc(-c2ccc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3c2)cs1,7.15,Inhibition of EGFR,IC50,71.0,nM,=,CHEMBL680015,B,CHEMBL160303,Homo sapiens,CHEMBL203,CHEMBL1136583
CS(=O)(=O)CCNc1nc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)cs1,8.10,Inhibition of EGFR,IC50,8.0,nM,=,CHEMBL680015,B,CHEMBL160846,Homo sapiens,CHEMBL203,CHEMBL1136583
CS(=O)(=O)CCNc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1,7.46,Inhibition of EGFR,IC50,35.0,nM,=,CHEMBL680015,B,CHEMBL157084,Homo sapiens,CHEMBL203,CHEMBL1136583
CS(=O)(=O)CCNc1nc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)cs1,7.09,Inhibition of EGFR,IC50,82.0,nM,=,CHEMBL680015,B,CHEMBL422347,Homo sapiens,CHEMBL203,CHEMBL1136583
CS(=O)(=O)CCNc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1,6.27,Inhibition of EGFR,IC50,540.0,nM,=,CHEMBL680015,B,CHEMBL269620,Homo sapiens,CHEMBL203,CHEMBL1136583
O=C(Nc1ccccc1)c1c(SSc2[nH]c3ccccc3c2C(=O)Nc2ccccc2)[nH]c2ccccc12,4.00,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,100000.0,nM,=,CHEMBL677470,B,CHEMBL345641,Homo sapiens,CHEMBL203,CHEMBL1128344
c1ccc(-c2c(SSc3[nH]c4ccccc4c3-c3ccccc3)[nH]c3ccccc23)cc1,4.00,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,100000.0,nM,=,CHEMBL677470,B,CHEMBL422540,Homo sapiens,CHEMBL203,CHEMBL1128344
Cn1c(SSc2c(C(=O)NCC(O)CO)c3ccccc3n2C)c(C(=O)NCC(O)CO)c2ccccc21,4.37,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,43000.0,nM,=,CHEMBL677470,B,CHEMBL158797,Homo sapiens,CHEMBL203,CHEMBL1128344
Cn1c(SSc2c(C(=O)NCC(=O)O)c3ccccc3n2C)c(C(=O)NCC(=O)O)c2ccccc21,5.00,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,10000.0,nM,=,CHEMBL677470,B,CHEMBL345211,Homo sapiens,CHEMBL203,CHEMBL1128344
COC(=O)c1ccc(CNC(=O)c2c(SSc3c(C(=O)NCc4ccc(C(=O)OC)cc4)c4ccccc4n3C)n(C)c3ccccc23)cc1,4.89,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,13000.0,nM,=,CHEMBL677470,B,CHEMBL347659,Homo sapiens,CHEMBL203,CHEMBL1128344
CC(=O)c1c(SSc2c(C(C)=O)c3ccccc3n2C)n(C)c2ccccc12,5.25,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,5600.0,nM,=,CHEMBL677470,B,CHEMBL351920,Homo sapiens,CHEMBL203,CHEMBL1128344
Cn1c(SSc2c(C(=O)NCc3ccc(C(=O)O)cc3)c3ccccc3n2C)c(C(=O)NCc2ccc(C(=O)O)cc2)c2ccccc21,5.28,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,5300.0,nM,=,CHEMBL677470,B,CHEMBL158805,Homo sapiens,CHEMBL203,CHEMBL1128344
Cn1c(SSc2c(C(=O)NCc3ccccc3)c3ccccc3n2C)c(C(=O)NCc2ccccc2)c2ccccc21,5.77,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,1700.0,nM,=,CHEMBL677470,B,CHEMBL158275,Homo sapiens,CHEMBL203,CHEMBL1128344
CN(C)CCNC(=O)c1c(SSc2c(C(=O)NCCN(C)C)c3ccccc3n2C)n(C)c2ccccc12,4.76,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,17500.0,nM,=,CHEMBL677470,B,CHEMBL348554,Homo sapiens,CHEMBL203,CHEMBL1128344
Cn1c(SSc2c(C(=O)c3ccco3)c3ccccc3n2C)c(C(=O)c2ccco2)c2ccccc21,5.11,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,7700.0,nM,=,CHEMBL677470,B,CHEMBL160935,Homo sapiens,CHEMBL203,CHEMBL1128344
O=C(NCc1ccccc1)c1c(SSc2[nH]c3ccccc3c2C(=O)NCc2ccccc2)[nH]c2ccccc12,4.82,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,15000.0,nM,=,CHEMBL677470,B,CHEMBL347160,Homo sapiens,CHEMBL203,CHEMBL1128344
CN(C)C(=O)c1c(SSc2c(C(=O)N(C)C)c3ccccc3n2C)n(C)c2ccccc12,4.67,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,21200.0,nM,=,CHEMBL677470,B,CHEMBL160207,Homo sapiens,CHEMBL203,CHEMBL1128344
Cc1ccc(S(=O)(=O)c2c(SSc3[nH]c4ccccc4c3S(=O)(=O)c3ccc(C)cc3)[nH]c3ccccc23)cc1,4.54,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,28700.0,nM,=,CHEMBL677470,B,CHEMBL347854,Homo sapiens,CHEMBL203,CHEMBL1128344
Cn1c(SSc2c(C(=O)Nc3ccc(C(=O)O)cc3)c3ccccc3n2C)c(C(=O)Nc2ccc(C(=O)O)cc2)c2ccccc21,4.77,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,16900.0,nM,=,CHEMBL677470,B,CHEMBL347161,Homo sapiens,CHEMBL203,CHEMBL1128344
Cn1c(SSc2c(C(=O)Nc3cccc(C(=O)O)c3)c3ccccc3n2C)c(C(=O)Nc2cccc(C(=O)O)c2)c2ccccc21,4.92,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,12000.0,nM,=,CHEMBL677470,B,CHEMBL345837,Homo sapiens,CHEMBL203,CHEMBL1128344
Cn1c(SSc2c(C(=O)Nc3ccccc3C(=O)O)c3ccccc3n2C)c(C(=O)Nc2ccccc2C(=O)O)c2ccccc21,4.33,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,47000.0,nM,=,CHEMBL677470,B,CHEMBL345862,Homo sapiens,CHEMBL203,CHEMBL1128344
COC(=O)c1ccc(C(=O)c2c(SSc3c(C(=O)c4ccc(C(=O)OC)cc4)c4ccccc4n3C)n(C)c3ccccc23)cc1,5.21,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,6100.0,nM,=,CHEMBL677470,B,CHEMBL346553,Homo sapiens,CHEMBL203,CHEMBL1128344
Cn1c(SSc2c(C(=O)c3ccc(C(=O)O)cc3)c3ccccc3n2C)c(C(=O)c2ccc(C(=O)O)cc2)c2ccccc21,5.26,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,5500.0,nM,=,CHEMBL677470,B,CHEMBL346770,Homo sapiens,CHEMBL203,CHEMBL1128344
Cn1c(SSc2c(C#N)c3ccccc3n2C)c(C#N)c2ccccc21,5.16,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,6900.0,nM,=,CHEMBL677470,B,CHEMBL160566,Homo sapiens,CHEMBL203,CHEMBL1128344
Cn1c(SSc2c(C(=O)Nc3ccccn3)c3ccccc3n2C)c(C(=O)Nc2ccccn2)c2ccccc21,4.33,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,47000.0,nM,=,CHEMBL677470,B,CHEMBL435054,Homo sapiens,CHEMBL203,CHEMBL1128344
Cn1c(SSc2c(C(N)=O)c3ccccc3n2C)c(C(N)=O)c2ccccc21,5.33,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,4700.0,nM,=,CHEMBL677470,B,CHEMBL157807,Homo sapiens,CHEMBL203,CHEMBL1128344
CNC(=O)c1c(SSc2[nH]c3ccccc3c2C(=O)NC)[nH]c2ccccc12,5.21,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,IC50,6100.0,nM,=,CHEMBL677470,B,CHEMBL161226,Homo sapiens,CHEMBL203,CHEMBL1128344
OCCNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.72,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,0.19,nM,=,CHEMBL674648,B,CHEMBL165864,Homo sapiens,CHEMBL203,CHEMBL1131301
Brc1cccc(Nc2ncnc3cnc(NCCCN4CCOCC4)cc23)c1,9.00,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,1.0,nM,=,CHEMBL674648,B,CHEMBL165574,Homo sapiens,CHEMBL203,CHEMBL1131301
CN(C)CCN(C)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.09,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,8.1,nM,=,CHEMBL674648,B,CHEMBL162053,Homo sapiens,CHEMBL203,CHEMBL1131301
OCCN(CCO)CCCNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.46,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,0.35,nM,=,CHEMBL674648,B,CHEMBL163369,Homo sapiens,CHEMBL203,CHEMBL1131301
Brc1cccc(Nc2ncnc3cnc(NCCN4CCOCC4)cc23)c1,9.19,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,0.65,nM,=,CHEMBL674648,B,CHEMBL162622,Homo sapiens,CHEMBL203,CHEMBL1131301
CN(CC(O)CO)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.25,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,0.56,nM,=,CHEMBL674648,B,CHEMBL165547,Homo sapiens,CHEMBL203,CHEMBL1131301
OCC(O)CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.74,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,0.18,nM,=,CHEMBL674648,B,CHEMBL166093,Homo sapiens,CHEMBL203,CHEMBL1131301
CN(C)CCCCNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.74,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,1.8,nM,=,CHEMBL674648,B,CHEMBL349070,Homo sapiens,CHEMBL203,CHEMBL1131301
CN(C)CCNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.96,Inhibition of tyrosine/glutamic acid copolymer phosphorylation by epidermal growth factor receptor prepared of human A431,IC50,1.1,nM,=,CHEMBL676074,B,CHEMBL162034,Homo sapiens,CHEMBL203,CHEMBL1131301
CN(C)CCCNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.92,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,1.2,nM,=,CHEMBL674648,B,CHEMBL166358,Homo sapiens,CHEMBL203,CHEMBL1131301
CN1CCN(NCCCNc2cc3c(Nc4cccc(Br)c4)ncnc3cn2)CC1,8.41,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,3.9,nM,=,CHEMBL674648,B,CHEMBL166307,Homo sapiens,CHEMBL203,CHEMBL1131301
OCCN(CCO)CCNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.03,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,0.93,nM,=,CHEMBL674648,B,CHEMBL165630,Homo sapiens,CHEMBL203,CHEMBL1131301
Brc1cccc(Nc2ncnc3cnc(NCc4cccnc4)cc23)c1,8.82,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,1.5,nM,=,CHEMBL674648,B,CHEMBL165508,Homo sapiens,CHEMBL203,CHEMBL1131301
Brc1cccc(Nc2ncnc3cnc(NCCCn4ccnc4)cc23)c1,8.77,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,1.7,nM,=,CHEMBL674648,B,CHEMBL162981,Homo sapiens,CHEMBL203,CHEMBL1131301
Brc1cccc(Nc2ncnc3cnc(NCCc4c[nH]cn4)cc23)c1,9.11,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,0.78,nM,=,CHEMBL674648,B,CHEMBL162142,Homo sapiens,CHEMBL203,CHEMBL1131301
Brc1cccc(Nc2ncnc3cnc(NCCc4ccccn4)cc23)c1,8.92,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,1.2,nM,=,CHEMBL674648,B,CHEMBL162223,Homo sapiens,CHEMBL203,CHEMBL1131301
CNc1cc2c(Nc3cccc(C(F)(F)F)c3)ncnc2cn1,8.96,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,1.1,nM,=,CHEMBL674648,B,CHEMBL165788,Homo sapiens,CHEMBL203,CHEMBL1131301
Cc1cccc(Nc2ncnc3cnc(NCCCN4CCOCC4)cc23)c1,8.74,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,1.8,nM,=,CHEMBL674648,B,CHEMBL162508,Homo sapiens,CHEMBL203,CHEMBL1131301
Cc1cccc(Nc2ncnc3cnc(NCCc4c[nH]cn4)cc23)c1,8.89,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,1.3,nM,=,CHEMBL674648,B,CHEMBL161895,Homo sapiens,CHEMBL203,CHEMBL1131301
Cc1cccc(Nc2ncnc3cnc(N)cc23)c1,8.51,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,3.1,nM,=,CHEMBL674648,B,CHEMBL165495,Homo sapiens,CHEMBL203,CHEMBL1131301
CCN(CC)CC(O)CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.34,Inhibition of tyrosine/glutamic acid copolymer phosphorylation by epidermal growth factor receptor prepared of human A431,IC50,4.6,nM,=,CHEMBL676233,B,CHEMBL433520,Homo sapiens,CHEMBL203,CHEMBL1131301
Cc1nc(Nc2cccc(Br)c2)c2cc(NCCN3CCOCC3)ncc2n1,6.93,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,117.0,nM,=,CHEMBL674648,B,CHEMBL165228,Homo sapiens,CHEMBL203,CHEMBL1131301
CN(CCO)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.66,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,0.22,nM,=,CHEMBL674648,B,CHEMBL161956,Homo sapiens,CHEMBL203,CHEMBL1131301
CN1CCN(c2cc3c(Nc4cccc(Br)c4)ncnc3cn2)CC1,8.19,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,6.4,nM,=,CHEMBL674648,B,CHEMBL162719,Homo sapiens,CHEMBL203,CHEMBL1131301
CN(CCO)CCNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.77,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,1.7,nM,=,CHEMBL674648,B,CHEMBL166255,Homo sapiens,CHEMBL203,CHEMBL1131301
CNc1cc2c(Nc3cccc(Cl)c3)ncnc2cn1,9.72,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,0.19,nM,=,CHEMBL674648,B,CHEMBL166154,Homo sapiens,CHEMBL203,CHEMBL1131301
O=C(O)CCNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,7.57,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,27.0,nM,=,CHEMBL674648,B,CHEMBL163168,Homo sapiens,CHEMBL203,CHEMBL1131301
CN(CC(=O)O)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.36,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,0.44,nM,=,CHEMBL674648,B,CHEMBL351629,Homo sapiens,CHEMBL203,CHEMBL1131301
O=C(O)CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.55,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,0.28,nM,=,CHEMBL674648,B,CHEMBL355816,Homo sapiens,CHEMBL203,CHEMBL1131301
CNc1cc2c(Nc3cccc(C)c3)ncnc2cn1,9.35,Inhibition of tyrosine/glutamic acid copolymer phosphorylation by epidermal growth factor receptor prepared of human A431,IC50,0.45,nM,=,CHEMBL676233,B,CHEMBL162821,Homo sapiens,CHEMBL203,CHEMBL1131301
Cc1cccc(Nc2ncnc3cnc(NCCN4CCOCC4)cc23)c1,8.82,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,1.5,nM,=,CHEMBL674648,B,CHEMBL165731,Homo sapiens,CHEMBL203,CHEMBL1131301
Cc1cccc(Nc2ncnc3cnc(N(C)C)cc23)c1,8.55,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,IC50,2.8,nM,=,CHEMBL674648,B,CHEMBL163188,Homo sapiens,CHEMBL203,CHEMBL1131301
CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,8.53,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,2.96,nM,=,CHEMBL3756968,B,CHEMBL1336,Homo sapiens,CHEMBL203,CHEMBL3751776
Nc1ncnc2c1c(-c1ccccc1)cn2C(CO)Cc1ccc(O)cc1,4.88,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,13200.0,nM,=,CHEMBL674693,B,CHEMBL170438,Homo sapiens,CHEMBL203,CHEMBL1134829
COc1ccc(CC(CO)n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)cc1,5.01,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,9700.0,nM,=,CHEMBL674693,B,CHEMBL168555,Homo sapiens,CHEMBL203,CHEMBL1134829
Nc1ncnc2c1c(-c1ccc(O)cc1)cn2C1CCC1,6.22,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,600.0,nM,=,CHEMBL674693,B,CHEMBL166765,Homo sapiens,CHEMBL203,CHEMBL1134829
Nc1ncnc2c1c(-c1ccccc1)cn2C1CCC1,6.14,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,730.0,nM,=,CHEMBL674693,B,CHEMBL166766,Homo sapiens,CHEMBL203,CHEMBL1134829
COc1cccc(-c2cn(C3CCN(CC(N)=O)C3)c3ncnc(N)c23)c1,6.36,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,440.0,nM,=,CHEMBL677878,B,CHEMBL355322,Homo sapiens,CHEMBL203,CHEMBL1134003
COC(=O)CN1CCC(n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)C1,6.08,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,830.0,nM,=,CHEMBL677878,B,CHEMBL355891,Homo sapiens,CHEMBL203,CHEMBL1134003
NC(=O)CN1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)C1,6.40,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,400.0,nM,=,CHEMBL677878,B,CHEMBL408683,Homo sapiens,CHEMBL203,CHEMBL1134003
COC(=O)CN1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)C1,6.13,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,740.0,nM,=,CHEMBL677878,B,CHEMBL355019,Homo sapiens,CHEMBL203,CHEMBL1134003
COc1cccc(-c2cn(C3CCCC3)c3ncnc(N)c23)c1,6.34,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,460.0,nM,=,CHEMBL674693,B,CHEMBL168382,Homo sapiens,CHEMBL203,CHEMBL1134829
COc1ccc(-c2cn(C3CCCC3)c3ncnc(N)c23)cc1,6.24,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,570.0,nM,=,CHEMBL674693,B,CHEMBL170724,Homo sapiens,CHEMBL203,CHEMBL1134829
Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCCC1,7.10,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,80.0,nM,=,CHEMBL674693,B,CHEMBL169390,Homo sapiens,CHEMBL203,CHEMBL1134829
Nc1ncnc2c1c(-c1ccc(O)cc1)cn2C1CCCC1,6.60,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,250.0,nM,=,CHEMBL674693,B,CHEMBL169570,Homo sapiens,CHEMBL203,CHEMBL1134829
COc1ccc(CC(CO)n2cc(-c3cccc(O)c3)c3c(N)ncnc32)cc1,5.47,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,3400.0,nM,=,CHEMBL674693,B,CHEMBL169467,Homo sapiens,CHEMBL203,CHEMBL1134829
COc1cccc(-c2cn(C3CC(CO)C3)c3ncnc(N)c23)c1,6.38,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,420.0,nM,=,CHEMBL674693,B,CHEMBL352801,Homo sapiens,CHEMBL203,CHEMBL1134829
Nc1ncnc2c1c(-c1ccccc1)cn2C1CC(O)C1,5.55,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,2820.0,nM,=,CHEMBL674693,B,CHEMBL168266,Homo sapiens,CHEMBL203,CHEMBL1134829
Nc1ncnc2c1c(-c1ccccc1)cn2C1CCC(O)C1,6.10,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,790.0,nM,=,CHEMBL674693,B,CHEMBL168285,Homo sapiens,CHEMBL203,CHEMBL1134829
Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCC1,6.52,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,300.0,nM,=,CHEMBL674693,B,CHEMBL355330,Homo sapiens,CHEMBL203,CHEMBL1134829
COC(=O)CN1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)CC1,6.10,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,800.0,nM,=,CHEMBL677878,B,CHEMBL262276,Homo sapiens,CHEMBL203,CHEMBL1134003
COc1cccc(-c2cn(C3CCC3)c3ncnc(N)c23)c1,6.35,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,450.0,nM,=,CHEMBL674693,B,CHEMBL355191,Homo sapiens,CHEMBL203,CHEMBL1134829
Nc1ncnc2c1c(-c1ccc(O)cc1)cn2C1CCNC1,5.57,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,2670.0,nM,=,CHEMBL677878,B,CHEMBL354033,Homo sapiens,CHEMBL203,CHEMBL1134003
Nc1ncnc2c1c(-c1ccccc1)cn2C1CCNC1,4.87,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,13400.0,nM,=,CHEMBL677878,B,CHEMBL168829,Homo sapiens,CHEMBL203,CHEMBL1134003
CC(C)(C)OC(=O)N1CCC(n2cc(-c3ccccc3)c3c(N)ncnc32)C1,5.08,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,8300.0,nM,=,CHEMBL677878,B,CHEMBL353823,Homo sapiens,CHEMBL203,CHEMBL1134003
COc1cccc(-c2cn(C3CCN(CCN(C)CCO)CC3)c3ncnc(N)c23)c1,6.53,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,295.0,nM,=,CHEMBL677878,B,CHEMBL168661,Homo sapiens,CHEMBL203,CHEMBL1134003
COc1cccc(-c2cn(C3CC(CNCCO)C3)c3ncnc(N)c23)c1,6.31,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,490.0,nM,=,CHEMBL674693,B,CHEMBL168550,Homo sapiens,CHEMBL203,CHEMBL1134829
Nc1ncnc2c1c(-c1ccccc1)cn2C1CCCC1,6.30,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,500.0,nM,=,CHEMBL674693,B,CHEMBL352954,Homo sapiens,CHEMBL203,CHEMBL1134829
Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1,6.30,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,500.0,nM,=,CHEMBL674015,B,CHEMBL169757,Homo sapiens,CHEMBL203,CHEMBL1133080
COc1cccc(-c2cn(C3CC(C(=O)NCCO)C3)c3ncnc(N)c23)c1,6.48,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,330.0,nM,=,CHEMBL674693,B,CHEMBL354310,Homo sapiens,CHEMBL203,CHEMBL1134829
COCCN(C)CCN1CCC(n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)CC1,6.03,Inhibition of epidermal growth factor receptor (EGF-R),IC50,930.0,nM,=,CHEMBL677879,B,CHEMBL274732,Homo sapiens,CHEMBL203,CHEMBL1134003
COc1ccc(CC(CO)n2cc(-c3ccccc3)c3c(N)ncnc32)cc1,4.84,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,14400.0,nM,=,CHEMBL674693,B,CHEMBL171256,Homo sapiens,CHEMBL203,CHEMBL1134829
Nc1ncnc2c1c(-c1ccccc1)cn2C(CO)Cc1ccccc1,6.36,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,IC50,440.0,nM,=,CHEMBL674693,B,CHEMBL171311,Homo sapiens,CHEMBL203,CHEMBL1134829
COCCNCCN1CCC(n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)CC1,6.51,Inhibition of epidermal growth factor receptor (EGF-R),IC50,310.0,nM,=,CHEMBL677879,B,CHEMBL172514,Homo sapiens,CHEMBL203,CHEMBL1134003
CN(C)C(=O)CN1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)CC1,6.30,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,500.0,nM,=,CHEMBL677878,B,CHEMBL169920,Homo sapiens,CHEMBL203,CHEMBL1134003
COc1cccc(-c2cn(C3CCN(CC(N)=O)CC3)c3ncnc(N)c23)c1,6.46,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,350.0,nM,=,CHEMBL677878,B,CHEMBL169064,Homo sapiens,CHEMBL203,CHEMBL1134003
COC(=O)CN1CCC(n2cc(-c3cccc(OC)c3)c3c(N)ncnc32)CC1,5.83,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,1470.0,nM,=,CHEMBL677878,B,CHEMBL169065,Homo sapiens,CHEMBL203,CHEMBL1134003
Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCN(CCO)CC1,5.59,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,2540.0,nM,=,CHEMBL677878,B,CHEMBL169780,Homo sapiens,CHEMBL203,CHEMBL1134003
NC(=O)CN1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)CC1,6.77,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,170.0,nM,=,CHEMBL677878,B,CHEMBL263528,Homo sapiens,CHEMBL203,CHEMBL1134003
COc1cccc(-c2cn(C3CCN(CCO)CC3)c3ncnc(N)c23)c1,6.05,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,900.0,nM,=,CHEMBL677878,B,CHEMBL169200,Homo sapiens,CHEMBL203,CHEMBL1134003
COc1cccc(-c2cn(C3CCN(CC(=O)N(C)C)CC3)c3ncnc(N)c23)c1,6.12,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,750.0,nM,=,CHEMBL677878,B,CHEMBL355269,Homo sapiens,CHEMBL203,CHEMBL1134003
COc1cccc(-c2cn(C3CCNC3)c3ncnc(N)c23)c1,5.95,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,1120.0,nM,=,CHEMBL677878,B,CHEMBL169519,Homo sapiens,CHEMBL203,CHEMBL1134003
COc1cccc(-c2cn(C3CCN(C(=O)OC(C)(C)C)C3)c3ncnc(N)c23)c1,5.68,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,2100.0,nM,=,CHEMBL677878,B,CHEMBL168656,Homo sapiens,CHEMBL203,CHEMBL1134003
Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNC1,5.82,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,1530.0,nM,=,CHEMBL677878,B,CHEMBL171545,Homo sapiens,CHEMBL203,CHEMBL1134003
CC(C)(C)OC(=O)N1CCC(n2cc(-c3cccc(O)c3)c3c(N)ncnc32)C1,5.66,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,IC50,2200.0,nM,=,CHEMBL677878,B,CHEMBL168921,Homo sapiens,CHEMBL203,CHEMBL1134003
CCOc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,4.50,Inhibition of recombinant human EGFR using peptide as substrate by fluorimetric analysis,IC50,31800.0,nM,=,CHEMBL4231196,B,CHEMBL172517,Homo sapiens,CHEMBL203,CHEMBL4229349
Brc1cccc(Nc2ncnc3cc4nccnc4cc23)c1,8.77,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,IC50,1.7,nM,=,CHEMBL683040,B,CHEMBL173498,Homo sapiens,CHEMBL203,CHEMBL1129035
Cc1nc2cc3c(Nc4cccc(Br)c4)ncnc3cc2[nH]1,9.54,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,IC50,0.29,nM,=,CHEMBL683040,B,CHEMBL426580,Homo sapiens,CHEMBL203,CHEMBL1129035
Brc1cccc(Nc2ncnc3cc4c[nH]nc4cc23)c1,9.47,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,IC50,0.34,nM,=,CHEMBL679548,B,CHEMBL366580,Homo sapiens,CHEMBL203,CHEMBL1129035
Brc1cccc(Nc2ncnc3cc4[nH]nnc4cc23)c1,8.39,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,IC50,4.1,nM,=,CHEMBL679548,B,CHEMBL172652,Homo sapiens,CHEMBL203,CHEMBL1129035
CN(C)CCn1cnc2c(Cl)c3c(Nc4cccc(Br)c4)ncnc3cc21,6.69,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,IC50,203.0,nM,=,CHEMBL679548,B,CHEMBL427298,Homo sapiens,CHEMBL203,CHEMBL1129035
CCOC(=O)c1ccc(-c2cn(-c3ccccc3)c3ncnc(N)c23)cc1,5.89,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,1300.0,nM,=,CHEMBL674015,B,CHEMBL369014,Homo sapiens,CHEMBL203,CHEMBL1133080
Nc1ncnc2c1c(-c1ccccc1)cn2-c1cccc(CO)c1,6.22,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,600.0,nM,=,CHEMBL674015,B,CHEMBL173478,Homo sapiens,CHEMBL203,CHEMBL1133080
Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1CO,5.96,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,1100.0,nM,=,CHEMBL674015,B,CHEMBL429057,Homo sapiens,CHEMBL203,CHEMBL1133080
Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,10.60,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,IC50,0.025,nM,=,CHEMBL683040,B,CHEMBL174426,Homo sapiens,CHEMBL203,CHEMBL1129035
Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccc(CO)cc1,6.16,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,700.0,nM,=,CHEMBL674015,B,CHEMBL367442,Homo sapiens,CHEMBL203,CHEMBL1133080
CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCC[C@@H](N)C3)nc21,5.28,Inhibit of epidermal growth factor receptor (EGFR),IC50,5300.0,nM,=,CHEMBL675242,B,CHEMBL368278,Homo sapiens,CHEMBL203,CHEMBL1132163
CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21,5.70,Inhibit of epidermal growth factor receptor (EGFR),IC50,2000.0,nM,=,CHEMBL675242,B,CHEMBL367625,Homo sapiens,CHEMBL203,CHEMBL1132163
COc1cccc(-c2cn(-c3ccc(CNCCO)cc3)c3ncnc(N)c23)c1,6.52,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,300.0,nM,=,CHEMBL674015,B,CHEMBL424375,Homo sapiens,CHEMBL203,CHEMBL1133080
Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccc(CNCCO)cc1,5.85,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,1400.0,nM,=,CHEMBL674015,B,CHEMBL173453,Homo sapiens,CHEMBL203,CHEMBL1133080
Cn1cnc2cc3ncnc(Nc4cccc(Br)c4)c3cc21,11.00,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,IC50,0.01,nM,=,CHEMBL683040,B,CHEMBL176582,Homo sapiens,CHEMBL203,CHEMBL1129035
Brc1cccc(Nc2ncnc3cc4ncsc4cc23)c1,7.36,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,IC50,44.0,nM,=,CHEMBL683040,B,CHEMBL177053,Homo sapiens,CHEMBL203,CHEMBL1129035
Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1CNCCO,5.19,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,6400.0,nM,=,CHEMBL674015,B,CHEMBL176470,Homo sapiens,CHEMBL203,CHEMBL1133080
Nc1ncnc2c1c(-c1cccc(Cl)c1)cn2-c1ccccc1,6.16,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,700.0,nM,=,CHEMBL674015,B,CHEMBL176309,Homo sapiens,CHEMBL203,CHEMBL1133080
COc1cccc(-c2cn(-c3ccccc3)c3ncnc(N)c23)c1,6.30,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,500.0,nM,=,CHEMBL674015,B,CHEMBL172973,Homo sapiens,CHEMBL203,CHEMBL1133080
COc1cccc(-c2cn(-c3cccc(CO)c3)c3ncnc(N)c23)c1,6.10,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,800.0,nM,=,CHEMBL674015,B,CHEMBL176815,Homo sapiens,CHEMBL203,CHEMBL1133080
CN(C)CCn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,7.66,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,IC50,22.0,nM,=,CHEMBL679548,B,CHEMBL175101,Homo sapiens,CHEMBL203,CHEMBL1129035
CN(C)CCn1cnc2cc3ncnc(Nc4cccc(Br)c4)c3cc21,8.88,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,IC50,1.32,nM,=,CHEMBL679548,B,CHEMBL176891,Homo sapiens,CHEMBL203,CHEMBL1129035
Nc1ncnc2c1c(-c1ccccc1)cn2-c1cccc(CNCCO)c1,5.47,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,3400.0,nM,=,CHEMBL674015,B,CHEMBL176702,Homo sapiens,CHEMBL203,CHEMBL1133080
CNc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1,4.51,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,31000.0,nM,=,CHEMBL674015,B,CHEMBL366831,Homo sapiens,CHEMBL203,CHEMBL1133080
Cc1ccccc1-c1cn(-c2ccccc2)c2ncnc(N)c12,5.58,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,2650.0,nM,=,CHEMBL674015,B,CHEMBL174634,Homo sapiens,CHEMBL203,CHEMBL1133080
COc1ccc(-c2cn(-c3ccccc3)c3ncnc(N)c23)cc1,6.46,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,350.0,nM,=,CHEMBL674015,B,CHEMBL176705,Homo sapiens,CHEMBL203,CHEMBL1133080
COc1cccc(-c2cn(-c3ccc(CC(=O)NCCO)cc3)c3ncnc(N)c23)c1,6.10,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,IC50,800.0,nM,=,CHEMBL674015,B,CHEMBL175409,Homo sapiens,CHEMBL203,CHEMBL1133080
OCCCNc1cncc(-c2cncc(Nc3cccc(Cl)c3)n2)c1,5.87,Inhibition of epidermal growth factor receptor,IC50,1360.0,nM,=,CHEMBL832814,B,CHEMBL177688,Homo sapiens,CHEMBL203,CHEMBL1142725
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,9.74,Inhibition of human EGFR in presence of 1 mM ATP,IC50,0.18,nM,=,CHEMBL892954,B,CHEMBL180022,Homo sapiens,CHEMBL203,CHEMBL1147965
Clc1cc(Nc2ncnc3nn4ccccc4c23)ccc1OCc1ccccc1,7.30,Inhibitory concentration against EGFR by using [gamma-33P]-ATP as radioligand in pH 7.5,IC50,50.0,nM,=,CHEMBL832627,B,CHEMBL181742,Homo sapiens,CHEMBL203,CHEMBL1142784
c1ccc(Cc2nc3cc(Nc4ncnc5nn6ccccc6c45)ccc3[nH]2)cc1,5.30,Inhibitory concentration against EGFR by using [gamma-33P]-ATP as radioligand in pH 7.5,IC50,5010.0,nM,=,CHEMBL832627,B,CHEMBL361322,Homo sapiens,CHEMBL203,CHEMBL1142784
Fc1cccc(COc2ccc(Nc3ncnc4nn5ccccc5c34)cc2Cl)c1,7.50,Inhibitory concentration against EGFR by using [gamma-33P]-ATP as radioligand in pH 7.5,IC50,32.0,nM,=,CHEMBL832627,B,CHEMBL182254,Homo sapiens,CHEMBL203,CHEMBL1142784
Nc1ncnc2nn3ccccc3c12,5.00,Inhibition of human recombinant EGFR,IC50,10000.0,nM,=,CHEMBL944276,B,CHEMBL368891,Homo sapiens,CHEMBL203,CHEMBL1140899
Fc1ccc(Nc2ncnc3nn4ccccc4c23)cc1Cl,6.70,Inhibitory concentration against EGFR by using [gamma-33P]-ATP as radioligand in pH 7.5,IC50,200.0,nM,=,CHEMBL832627,B,CHEMBL181275,Homo sapiens,CHEMBL203,CHEMBL1142784
O=C(Nc1ccc(Br)cc1)Nc1ncnc2nn3ccccc3c12,5.00,Inhibition of human recombinant EGFR,IC50,10000.0,nM,=,CHEMBL944276,B,CHEMBL178488,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(Nc1ccc(C(F)(F)F)cc1)Nc1ncnc2nn3ccccc3c12,5.00,Inhibition of human recombinant EGFR,IC50,10000.0,nM,=,CHEMBL944276,B,CHEMBL179224,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(Nc1ccc(F)cc1)Nc1ncnc2nn3ccccc3c12,5.00,Inhibition of human recombinant EGFR,IC50,10000.0,nM,=,CHEMBL944276,B,CHEMBL359830,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(Nc1cccc(C(F)(F)F)c1)Nc1ncnc2nn3ccccc3c12,5.00,Inhibition of human recombinant EGFR,IC50,10000.0,nM,=,CHEMBL944276,B,CHEMBL178306,Homo sapiens,CHEMBL203,CHEMBL1140899
N#Cc1cccc(NC(=O)Nc2ncnc3nn4ccccc4c23)c1,5.00,Inhibition of human recombinant EGFR,IC50,10000.0,nM,=,CHEMBL944276,B,CHEMBL178953,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(Nc1cccc([N+](=O)[O-])c1)Nc1ncnc2nn3ccccc3c12,5.00,Inhibition of human recombinant EGFR,IC50,10000.0,nM,=,CHEMBL944276,B,CHEMBL181029,Homo sapiens,CHEMBL203,CHEMBL1140899
ClCCNc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.00,Inhibition of poly(L-glutamic acid-L-tyrosine) phosphorylation by EGFR tyrosine kinase of A431 carcinoma cells,IC50,10.0,nM,=,CHEMBL828723,B,CHEMBL181617,Homo sapiens,CHEMBL203,CHEMBL1141895
ClCCNc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,7.58,Inhibition of poly(L-glutamic acid-L-tyrosine) phosphorylation by EGFR tyrosine kinase of A431 carcinoma cells,IC50,26.0,nM,=,CHEMBL828723,B,CHEMBL179451,Homo sapiens,CHEMBL203,CHEMBL1141895
COc1cc2ncnc(Nc3cc(NC(=O)c4ccccc4)c(F)cc3F)c2cc1OC,6.31,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,IC50,490.0,nM,=,CHEMBL832673,B,CHEMBL186580,Homo sapiens,CHEMBL203,CHEMBL1138000
COc1cc2ncnc(Nc3cccc(NC(=O)c4ccccc4)c3)c2cc1OC,5.25,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,IC50,5600.0,nM,=,CHEMBL832673,B,CHEMBL186802,Homo sapiens,CHEMBL203,CHEMBL1138000
COc1cc2ncnc(Nc3cccc(NC(=O)c4ccccc4)c3F)c2cc1OC,5.55,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,IC50,2800.0,nM,=,CHEMBL832673,B,CHEMBL182397,Homo sapiens,CHEMBL203,CHEMBL1138000
COc1cc2ncnc(Nc3ccc(C)c(NC(=O)c4ccccc4)c3)c2cc1OC,5.50,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,IC50,3200.0,nM,=,CHEMBL832673,B,CHEMBL186747,Homo sapiens,CHEMBL203,CHEMBL1138000
COc1cc2ncnc(Nc3ccc(Cl)c(NC(=O)c4ccccc4)c3)c2cc1OC,5.66,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,IC50,2200.0,nM,=,CHEMBL832673,B,CHEMBL360209,Homo sapiens,CHEMBL203,CHEMBL1138000
COc1cc2ncnc(Nc3cc(NC(=O)c4ccccc4)ccc3Cl)c2cc1OC,4.96,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,IC50,11000.0,nM,=,CHEMBL832673,B,CHEMBL185327,Homo sapiens,CHEMBL203,CHEMBL1138000
COc1cc2ncnc(Nc3cc(NC(=O)c4cccc(N(C)C)c4)ccc3Cl)c2cc1OC,4.54,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,IC50,29000.0,nM,=,CHEMBL832673,B,CHEMBL187007,Homo sapiens,CHEMBL203,CHEMBL1138000
COc1cc2ncnc(Nc3ccc(Cl)c(NC(=O)c4cccc(N(C)C)c4)c3)c2cc1OC,6.00,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,IC50,1000.0,nM,=,CHEMBL832673,B,CHEMBL184682,Homo sapiens,CHEMBL203,CHEMBL1138000
O=c1c2cccc(O)c2oc2cccc(O)c12,6.05,Inhibition of EGFR tyrosine kinase (unknown origin) preincubated for 5 mins followed by substrate addition and further incubated for 10 mins in presence of ATP by fluorescence based microplate reader analysis,IC50,900.0,nM,=,CHEMBL5133513,B,CHEMBL185686,Homo sapiens,CHEMBL203,CHEMBL5131428
Cc1ccc(Nc2ncnn3cc(C)c(C)c23)cc1O,6.70,In vitro inhibition of Epidermal growth factor receptor,IC50,200.0,nM,=,CHEMBL832893,B,CHEMBL186001,Homo sapiens,CHEMBL203,CHEMBL1138664
Cc1cc2c(Nc3ccc(C)c(O)c3)ncnn2c1,6.19,In vitro inhibition of Epidermal growth factor receptor,IC50,650.0,nM,=,CHEMBL832893,B,CHEMBL184750,Homo sapiens,CHEMBL203,CHEMBL1138664
Cc1ccc(Nc2ncnn3c(C)ccc23)cc1O,4.53,In vitro inhibition of Epidermal growth factor receptor,IC50,29400.0,nM,=,CHEMBL832893,B,CHEMBL187431,Homo sapiens,CHEMBL203,CHEMBL1138664
Fc1ccc(Nc2ncnn3cccc23)cc1Cl,6.96,In vitro inhibition of Epidermal growth factor receptor,IC50,110.0,nM,=,CHEMBL832893,B,CHEMBL185637,Homo sapiens,CHEMBL203,CHEMBL1138664
Cc1ccc2c(Nc3ccc(F)c(Cl)c3)ncnn12,5.49,In vitro inhibition of Epidermal growth factor receptor,IC50,3250.0,nM,=,CHEMBL832893,B,CHEMBL184311,Homo sapiens,CHEMBL203,CHEMBL1138664
Cc1ccn2ncnc(Nc3ccc(F)c(Cl)c3)c12,7.00,In vitro inhibition of Epidermal growth factor receptor,IC50,100.0,nM,=,CHEMBL832893,B,CHEMBL188304,Homo sapiens,CHEMBL203,CHEMBL1138664
O=C1N/C=C/c2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)CCNC(=O)/C(=N/O)Cc2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)C/C1=N\O,5.82,Inhibition of EGFR (unknown origin),IC50,1500.0,nM,=,CHEMBL2344161,B,CHEMBL360190,Homo sapiens,CHEMBL203,CHEMBL2331160
Cc1cc2c(Nc3ccc(F)c(Cl)c3)ncnn2c1,6.82,In vitro inhibition of Epidermal growth factor receptor,IC50,150.0,nM,=,CHEMBL832893,B,CHEMBL186080,Homo sapiens,CHEMBL203,CHEMBL1138664
Cc1ccc(Nc2ncnn3cccc23)cc1O,6.29,In vitro inhibition of Epidermal growth factor receptor,IC50,510.0,nM,=,CHEMBL832893,B,CHEMBL185853,Homo sapiens,CHEMBL203,CHEMBL1138664
Cc1ccc(Nc2ncnn3ccc(C)c23)cc1O,6.47,In vitro inhibition of Epidermal growth factor receptor,IC50,340.0,nM,=,CHEMBL832893,B,CHEMBL188522,Homo sapiens,CHEMBL203,CHEMBL1138664
Cc1cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)nc(C)n1,5.28,Inhibition of Her1,IC50,5200.0,nM,=,CHEMBL912344,B,CHEMBL364623,Homo sapiens,CHEMBL203,CHEMBL1137331
CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.37,Inhibition of EGFR,IC50,0.43,nM,=,CHEMBL978648,B,CHEMBL188762,Homo sapiens,CHEMBL203,CHEMBL1157167
OCCCCNc1cncc(-c2cncc(Nc3cccc(Cl)c3)n2)c1,5.13,Inhibition of epidermal growth factor receptor,IC50,7400.0,nM,=,CHEMBL833554,B,CHEMBL188386,Homo sapiens,CHEMBL203,CHEMBL1140334
Cc1ccsc1C(=O)n1nc(Nc2ccc(S(N)(=O)=O)cc2)nc1N,5.08,Inhibition of Epidermal growth factor receptor,IC50,8400.0,nM,=,CHEMBL829442,B,CHEMBL363130,Homo sapiens,CHEMBL203,CHEMBL1139550
Cc1ccc(F)c(C(=O)n2nc(Nc3ccc(S(N)(=O)=O)cc3)nc2C)c1F,4.34,Inhibition of Epidermal growth factor receptor,IC50,45800.0,nM,=,CHEMBL829442,B,CHEMBL363607,Homo sapiens,CHEMBL203,CHEMBL1139550
O=C(CCl)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.00,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,IC50,10.0,nM,=,CHEMBL833025,B,CHEMBL193159,Homo sapiens,CHEMBL203,CHEMBL1141151
O=C(CCl)Nc1ccc2ncnc(Nc3cccc(I)c3)c2c1,9.92,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,IC50,0.12,nM,=,CHEMBL832761,B,CHEMBL193160,Homo sapiens,CHEMBL203,CHEMBL1141151
C=CC(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cc1N1CCN(C)CC1,6.60,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 50-250 nM,IC50,250.0,nM,=,CHEMBL832921,B,CHEMBL365805,Homo sapiens,CHEMBL203,CHEMBL1141151
COCC(=O)Nc1ccc2ncnc(Nc3cc(Cl)c(Cl)cc3F)c2c1,6.60,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,IC50,252.0,nM,=,CHEMBL832761,B,CHEMBL190651,Homo sapiens,CHEMBL203,CHEMBL1141151
COc1cc2ncnc(Nc3cc(Cl)c(Cl)cc3F)c2cc1OC,9.68,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,IC50,0.208,nM,=,CHEMBL832761,B,CHEMBL437879,Homo sapiens,CHEMBL203,CHEMBL1141151
C=CC(=O)Nc1ccc2ncnc(Nc3cc(Cl)c(Cl)cc3F)c2c1,7.70,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 6.7-20 nM,IC50,20.0,nM,=,CHEMBL832922,B,CHEMBL363815,Homo sapiens,CHEMBL203,CHEMBL1141151
C=CC(=O)Nc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1N1CCN(C)CC1,6.60,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,IC50,250.0,nM,=,CHEMBL831153,B,CHEMBL372246,Homo sapiens,CHEMBL203,CHEMBL1141151
COCC(=O)Nc1ccc2ncnc(Nc3cccc(I)c3)c2c1,6.82,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,IC50,150.0,nM,=,CHEMBL832761,B,CHEMBL190567,Homo sapiens,CHEMBL203,CHEMBL1141151
O=C(CCl)Nc1ccc2ncnc(Nc3cc(Cl)c(Cl)cc3F)c2c1,7.82,Inhibition of HER1 kinase in intact DHER14 cells; Range = 5-15 nM,IC50,15.0,nM,=,CHEMBL828032,B,CHEMBL275762,Homo sapiens,CHEMBL203,CHEMBL1141151
CN(C)C/C=C/C(=O)Nc1ccc2ncnc(Nc3cc(Cl)c(Cl)cc3F)c2c1,9.96,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,IC50,0.11,nM,=,CHEMBL832761,B,CHEMBL190094,Homo sapiens,CHEMBL203,CHEMBL1141151
CN(C)C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(I)c3)c2c1,9.03,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,IC50,0.94,nM,=,CHEMBL832761,B,CHEMBL189779,Homo sapiens,CHEMBL203,CHEMBL1141151
COCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.76,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,IC50,174.0,nM,=,CHEMBL832761,B,CHEMBL192737,Homo sapiens,CHEMBL203,CHEMBL1141151
CONC(=O)c1cc(Nc2ncnn3cc(NC(=O)OCC4CCCO4)c(C(C)C)c23)c(F)cc1F,5.26,Inhibition of human epidermal growth factor receptor (HER-1),IC50,5500.0,nM,=,CHEMBL830273,B,CHEMBL370266,Homo sapiens,CHEMBL203,CHEMBL1144449
CONC(=O)c1cc(Nc2ncnn3cc(NC(=O)OCCCS(C)(=O)=O)c(C(C)C)c23)c(F)cc1F,5.38,Inhibition of human epidermal growth factor receptor (HER-1),IC50,4200.0,nM,=,CHEMBL830273,B,CHEMBL195218,Homo sapiens,CHEMBL203,CHEMBL1144449
CCc1c(C(=O)N(C)C)cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12,6.70,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,200.0,nM,=,CHEMBL881943,B,CHEMBL372293,Homo sapiens,CHEMBL203,CHEMBL1140398
CCc1c(NC(=O)OCc2ccccc2)cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12,6.68,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,210.0,nM,=,CHEMBL881943,B,CHEMBL372523,Homo sapiens,CHEMBL203,CHEMBL1140398
CCc1c(CO)cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12,6.31,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,490.0,nM,=,CHEMBL881943,B,CHEMBL373025,Homo sapiens,CHEMBL203,CHEMBL1140398
CCNCc1cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2c1CC,5.13,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,7400.0,nM,=,CHEMBL881943,B,CHEMBL369967,Homo sapiens,CHEMBL203,CHEMBL1140398
CCOCc1cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2c1CC,6.02,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,950.0,nM,=,CHEMBL881943,B,CHEMBL196548,Homo sapiens,CHEMBL203,CHEMBL1140398
CCc1c(CC(N)=O)cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12,5.96,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,1100.0,nM,=,CHEMBL881943,B,CHEMBL194160,Homo sapiens,CHEMBL203,CHEMBL1140398
CCc1c(CC(=O)O)cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12,5.80,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,1600.0,nM,=,CHEMBL881943,B,CHEMBL372692,Homo sapiens,CHEMBL203,CHEMBL1140398
CCc1c(C(=O)NCCCn2ccnc2)cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12,7.40,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,40.0,nM,=,CHEMBL881943,B,CHEMBL193681,Homo sapiens,CHEMBL203,CHEMBL1140398
CCc1c(C(=O)OCCCn2ccnc2)cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12,6.77,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,170.0,nM,=,CHEMBL881943,B,CHEMBL193368,Homo sapiens,CHEMBL203,CHEMBL1140398
CCc1c(NC(=O)OCCn2ccnc2)cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12,7.40,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,40.0,nM,=,CHEMBL881943,B,CHEMBL412367,Homo sapiens,CHEMBL203,CHEMBL1140398
CCOC(=O)c1cn2ncnc(Nc3ccc(F)c(Cl)c3)c2c1CC,7.05,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,90.0,nM,=,CHEMBL881943,B,CHEMBL196018,Homo sapiens,CHEMBL203,CHEMBL1140398
CCOC(=O)c1cn2ncnc(Nc3cccc(Br)c3)c2c1CC,7.22,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,60.0,nM,=,CHEMBL881943,B,CHEMBL370934,Homo sapiens,CHEMBL203,CHEMBL1140398
CCOC(=O)c1cn2ncnc(Nc3ccc4[nH]ncc4c3)c2c1CC,7.30,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,50.0,nM,=,CHEMBL881943,B,CHEMBL372112,Homo sapiens,CHEMBL203,CHEMBL1140398
CCOC(=O)c1cn2ncnc(NCc3ccccc3)c2c1CC,6.70,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,200.0,nM,=,CHEMBL881943,B,CHEMBL371863,Homo sapiens,CHEMBL203,CHEMBL1140398
CCOC(=O)c1cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2c1CC,6.92,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,120.0,nM,=,CHEMBL881943,B,CHEMBL196925,Homo sapiens,CHEMBL203,CHEMBL1140398
CCOC(=O)c1cn2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2c1CC,6.21,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,610.0,nM,=,CHEMBL881943,B,CHEMBL194349,Homo sapiens,CHEMBL203,CHEMBL1140398
CCOC(=O)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnn2c1,6.92,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,120.0,nM,=,CHEMBL881943,B,CHEMBL425738,Homo sapiens,CHEMBL203,CHEMBL1140398
CCOC(=O)c1cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2c1C,6.70,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,200.0,nM,=,CHEMBL881943,B,CHEMBL196738,Homo sapiens,CHEMBL203,CHEMBL1140398
CCOC(=O)c1cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2c1C(C)C,6.70,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,200.0,nM,=,CHEMBL881943,B,CHEMBL365606,Homo sapiens,CHEMBL203,CHEMBL1140398
CCCc1c(C(=O)OCC)cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12,6.02,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,950.0,nM,=,CHEMBL881943,B,CHEMBL438805,Homo sapiens,CHEMBL203,CHEMBL1140398
CCc1c(C(=O)O)cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12,7.70,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,20.0,nM,=,CHEMBL881943,B,CHEMBL196438,Homo sapiens,CHEMBL203,CHEMBL1140398
CCc1c(C(N)=O)cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12,6.92,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,120.0,nM,=,CHEMBL881943,B,CHEMBL194958,Homo sapiens,CHEMBL203,CHEMBL1140398
CCc1c(C(=O)NC)cn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12,7.16,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,IC50,70.0,nM,=,CHEMBL881943,B,CHEMBL197689,Homo sapiens,CHEMBL203,CHEMBL1140398
COc1cc2ncnc(Nc3ccc(OCc4ccccn4)c(C)c3)c2cc1OC,7.23,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,IC50,59.0,nM,=,CHEMBL881949,B,CHEMBL371888,Homo sapiens,CHEMBL203,CHEMBL1141048
COc1cc(ON2CCC(C)CC2)c2c(Nc3ccc(OCc4ccccn4)c(Cl)c3)ncnc2c1,8.30,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,IC50,5.0,nM,=,CHEMBL881949,B,CHEMBL444619,Homo sapiens,CHEMBL203,CHEMBL1141048
CN1CCC(Oc2cccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c23)CC1,8.30,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,IC50,5.0,nM,=,CHEMBL881949,B,CHEMBL197640,Homo sapiens,CHEMBL203,CHEMBL1141048
COc1ccc(Nc2ncnc3cccc(OC4CCN(C)CC4)c23)cc1Cl,5.75,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,IC50,1800.0,nM,=,CHEMBL881949,B,CHEMBL197525,Homo sapiens,CHEMBL203,CHEMBL1141048
Clc1cc(Nc2ncnc3cccc(OC4CCOCC4)c23)ccc1OCc1ccccn1,5.62,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,IC50,2400.0,nM,=,CHEMBL881949,B,CHEMBL193578,Homo sapiens,CHEMBL203,CHEMBL1141048
CN1CCC(Oc2cccc3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1,6.85,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,IC50,140.0,nM,=,CHEMBL881949,B,CHEMBL193544,Homo sapiens,CHEMBL203,CHEMBL1141048
CN1CCC(Oc2cccc3ncnc(Nc4ccc(OCc5cnccn5)c(Cl)c4)c23)CC1,6.16,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,IC50,690.0,nM,=,CHEMBL881949,B,CHEMBL436511,Homo sapiens,CHEMBL203,CHEMBL1141048
CN1CCC(Oc2cccc3ncnc(Nc4ccc(OCc5cscn5)c(Cl)c4)c23)CC1,6.16,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,IC50,698.0,nM,=,CHEMBL881949,B,CHEMBL195204,Homo sapiens,CHEMBL203,CHEMBL1141048
CN1CCC(Oc2cccc3ncnc(Nc4ccc(OCc5ccccn5)cc4)c23)CC1,5.68,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,IC50,2100.0,nM,=,CHEMBL881949,B,CHEMBL194337,Homo sapiens,CHEMBL203,CHEMBL1141048
COc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12,6.36,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,IC50,440.0,nM,=,CHEMBL881949,B,CHEMBL194389,Homo sapiens,CHEMBL203,CHEMBL1141048
CCCCCCCCc1ccc(O)cc1,4.79,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,16219.0,nM,=,CHEMBL1909203,B,CHEMBL195437,Homo sapiens,CHEMBL203,CHEMBL1909046
COc1cc(Nc2c(C#N)cnc3cc4cc(OCCN5CCOCC5)c(OC)cc4cc23)c(Cl)cc1Cl,5.57,Inhibitory concentration of EGFr,IC50,2700.0,nM,=,CHEMBL857670,B,CHEMBL195029,Homo sapiens,CHEMBL203,CHEMBL1141082
COc1ccc(C#CC(C)(C)N)cc1-c1[nH]nc2nc(Nc3ccc(F)cc3F)ncc12,5.28,Inhibitory activity against HER1,IC50,5200.0,nM,=,CHEMBL863537,B,CHEMBL370808,Homo sapiens,CHEMBL203,CHEMBL1147752
COC(=O)c1c(OC)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O,4.90,Inhibitory activity against EGFR kinase,IC50,12600.0,nM,=,CHEMBL862242,B,CHEMBL201840,Homo sapiens,CHEMBL203,CHEMBL1149378
COC(=O)c1c(OCCN(C)C)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O,4.51,Inhibitory activity against EGFR kinase,IC50,31000.0,nM,=,CHEMBL862242,B,CHEMBL201865,Homo sapiens,CHEMBL203,CHEMBL1149378
CCN(CC)CCOc1c(C(=O)OC)c2c3c(oc2c2ccccc12)C(=O)c1ccccc1C3=O,5.29,Inhibitory activity against EGFR kinase,IC50,5100.0,nM,=,CHEMBL862242,B,CHEMBL202162,Homo sapiens,CHEMBL203,CHEMBL1149378
COC(=O)c1c(OCCCN(C)C)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O,4.87,Inhibitory activity against EGFR kinase,IC50,13600.0,nM,=,CHEMBL862242,B,CHEMBL383030,Homo sapiens,CHEMBL203,CHEMBL1149378
COC(=O)c1c(OCCN2CCCC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O,5.05,Inhibitory activity against EGFR kinase,IC50,9000.0,nM,=,CHEMBL862242,B,CHEMBL202244,Homo sapiens,CHEMBL203,CHEMBL1149378
COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1,6.10,Inhibitory activity against EGFR,IC50,800.0,nM,=,CHEMBL860874,B,CHEMBL201307,Homo sapiens,CHEMBL203,CHEMBL1149372
COC(=O)c1c(OCCN2CCCCC2)c2ccccc2c2oc3c(c12)C(=O)c1ccccc1C3=O,5.55,Inhibitory activity against EGFR kinase,IC50,2800.0,nM,=,CHEMBL862242,B,CHEMBL200976,Homo sapiens,CHEMBL203,CHEMBL1149378
COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC,4.99,Inhibition of EGFR after 80 mins by radiometric protein kinase assay,IC50,10133.0,nM,=,CHEMBL1070746,B,CHEMBL201511,Homo sapiens,CHEMBL203,CHEMBL1158526
C#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.80,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,1.6,nM,=,CHEMBL862512,B,CHEMBL202360,Homo sapiens,CHEMBL203,CHEMBL1138126
O=C(C#CCO)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,8.85,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,1.4,nM,=,CHEMBL862512,B,CHEMBL202411,Homo sapiens,CHEMBL203,CHEMBL1138126
CCN(CC)CC#CC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,8.51,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,3.1,nM,=,CHEMBL862512,B,CHEMBL373207,Homo sapiens,CHEMBL203,CHEMBL1138126
CCCCC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,7.82,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,15.0,nM,=,CHEMBL862512,B,CHEMBL202424,Homo sapiens,CHEMBL203,CHEMBL1138126
CCN(CC)CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,7.82,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,15.0,nM,=,CHEMBL862512,B,CHEMBL202425,Homo sapiens,CHEMBL203,CHEMBL1138126
CCCCN(CC#CC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1)CCCC,7.40,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,40.0,nM,=,CHEMBL862512,B,CHEMBL202398,Homo sapiens,CHEMBL203,CHEMBL1138126
O=C(C#CCN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,7.07,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,86.0,nM,=,CHEMBL862512,B,CHEMBL202621,Homo sapiens,CHEMBL203,CHEMBL1138126
CCN(CC)CCC#CC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,8.74,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,1.8,nM,=,CHEMBL862512,B,CHEMBL382073,Homo sapiens,CHEMBL203,CHEMBL1138126
CCCCN(CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1)CCCC,7.77,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,17.0,nM,=,CHEMBL862512,B,CHEMBL202421,Homo sapiens,CHEMBL203,CHEMBL1138126
O=C(C#CCN1CCOCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,8.51,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,3.1,nM,=,CHEMBL862512,B,CHEMBL202556,Homo sapiens,CHEMBL203,CHEMBL1138126
CC(C)N(CC#CC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1)C(C)C,8.38,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,4.2,nM,=,CHEMBL862512,B,CHEMBL380669,Homo sapiens,CHEMBL203,CHEMBL1138126
O=C(C#CCCN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,8.77,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,1.7,nM,=,CHEMBL862512,B,CHEMBL204085,Homo sapiens,CHEMBL203,CHEMBL1138126
CC(C)N(CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1)C(C)C,7.36,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,44.0,nM,=,CHEMBL862512,B,CHEMBL383499,Homo sapiens,CHEMBL203,CHEMBL1138126
C#CC(=O)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.22,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,0.6,nM,=,CHEMBL862512,B,CHEMBL378144,Homo sapiens,CHEMBL203,CHEMBL1138126
O=C(C#CCCN1CCOCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,8.89,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,1.3,nM,=,CHEMBL862512,B,CHEMBL203661,Homo sapiens,CHEMBL203,CHEMBL1138126
O=C(C#CCCN1CCOCC1)Nc1cc2c(Nc3ccc(F)c(Br)c3)ncnc2cn1,8.82,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,1.5,nM,=,CHEMBL862512,B,CHEMBL204638,Homo sapiens,CHEMBL203,CHEMBL1138126
O=C(C#CCCN1CCCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,9.05,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,0.9,nM,=,CHEMBL862512,B,CHEMBL205059,Homo sapiens,CHEMBL203,CHEMBL1138126
CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,9.52,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,0.3,nM,=,CHEMBL862512,B,CHEMBL203644,Homo sapiens,CHEMBL203,CHEMBL1138126
CCCC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,8.77,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,1.7,nM,=,CHEMBL862512,B,CHEMBL203645,Homo sapiens,CHEMBL203,CHEMBL1138126
CN1CCN(CCC#CC(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cn2)CC1,9.30,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,0.5,nM,=,CHEMBL862512,B,CHEMBL203599,Homo sapiens,CHEMBL203,CHEMBL1138126
CN1CCN(CCC#CC(=O)Nc2cc3c(Nc4ccc(F)c(Br)c4)ncnc3cn2)CC1,8.96,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,IC50,1.1,nM,=,CHEMBL862512,B,CHEMBL437890,Homo sapiens,CHEMBL203,CHEMBL1138126
COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1,6.96,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,IC50,110.0,nM,=,CHEMBL4011794,B,CHEMBL202721,Homo sapiens,CHEMBL203,CHEMBL4011588
Nc1ccc2c(c1)CNc1c(Nc3cccc(Br)c3)ncnc1O2,5.77,Inhibition of EGFR,IC50,1700.0,nM,=,CHEMBL867748,B,CHEMBL203132,Homo sapiens,CHEMBL203,CHEMBL1139019
Nc1ccc2c(c1)CNc1c(Nc3ccc(F)c(Cl)c3)ncnc1O2,5.43,Inhibition of EGFR,IC50,3700.0,nM,=,CHEMBL867748,B,CHEMBL206197,Homo sapiens,CHEMBL203,CHEMBL1139019
Clc1ccc2c(c1)CNc1c(Nc3cccc(Br)c3)ncnc1O2,5.47,Inhibition of EGFR,IC50,3400.0,nM,=,CHEMBL867748,B,CHEMBL378145,Homo sapiens,CHEMBL203,CHEMBL1139019
CS(=O)(=O)Nc1ccc2c(c1)CNc1c(Nc3cccc(Br)c3)ncnc1O2,5.39,Inhibition of EGFR,IC50,4100.0,nM,=,CHEMBL867748,B,CHEMBL382186,Homo sapiens,CHEMBL203,CHEMBL1139019
Brc1cccc(Nc2ncnc3c2NCc2cc(Br)ccc2O3)c1,6.00,Inhibition of EGFR,IC50,1000.0,nM,=,CHEMBL867748,B,CHEMBL383614,Homo sapiens,CHEMBL203,CHEMBL1139019
Fc1ccc2c(c1)CNc1c(Nc3cccc(Br)c3)ncnc1O2,5.82,Inhibition of EGFR,IC50,1500.0,nM,=,CHEMBL867748,B,CHEMBL204965,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1ccc2c(c1)Oc1ncnc(Nc3cccc(Br)c3)c1NC2,5.72,Inhibition of EGFR autophosphorylation in DiFi cells,IC50,1900.0,nM,=,CHEMBL867749,B,CHEMBL204715,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1ccc2c(c1)CNc1c(Nc3cccc(Br)c3)ncnc1O2,6.00,Inhibition of EGFR autophosphorylation in DiFi cells,IC50,1000.0,nM,=,CHEMBL867749,B,CHEMBL383444,Homo sapiens,CHEMBL203,CHEMBL1139019
Fc1ccc(Nc2ncnc3c2NCc2cc(Br)ccc2O3)cc1Cl,5.70,Inhibition of EGFR,IC50,2000.0,nM,=,CHEMBL867748,B,CHEMBL206280,Homo sapiens,CHEMBL203,CHEMBL1139019
Brc1cccc(Nc2ncnc3c2NCc2ccccc2O3)c1,5.47,Inhibition of EGFR,IC50,3400.0,nM,=,CHEMBL867748,B,CHEMBL203219,Homo sapiens,CHEMBL203,CHEMBL1139019
Fc1ccc(Nc2ncnc3c2NCc2ccccc2O3)cc1Cl,5.96,Inhibition of EGFR,IC50,1100.0,nM,=,CHEMBL867748,B,CHEMBL425402,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1cc(OC2CCN(C(C)=O)CC2)c2c(Nc3ccc(F)c(Cl)c3)ncnc2c1,6.06,Inhibitory activity against EGFR,IC50,873.0,nM,=,CHEMBL868329,B,CHEMBL204330,Homo sapiens,CHEMBL203,CHEMBL1146052
COc1cc(OC2CCN(C)CC2)c2c(Nc3ccc(F)c(Cl)c3)ncnc2c1,7.68,Inhibitory activity against EGFR,IC50,21.0,nM,=,CHEMBL868329,B,CHEMBL203295,Homo sapiens,CHEMBL203,CHEMBL1146052
COc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1OC1CCN(C)CC1,6.65,Inhibitory activity against EGFR,IC50,225.0,nM,=,CHEMBL868329,B,CHEMBL203936,Homo sapiens,CHEMBL203,CHEMBL1146052
Fc1ccc(Nc2ncnc3c2NCc2cc(Cl)ccc2O3)cc1Cl,6.00,Inhibition of EGFR,IC50,1000.0,nM,=,CHEMBL867748,B,CHEMBL205676,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1cc(OC2CCN(S(C)(=O)=O)CC2)c2c(Nc3ccc(F)c(Cl)c3)ncnc2c1,5.02,Inhibitory activity against EGFR,IC50,9601.0,nM,=,CHEMBL868329,B,CHEMBL379017,Homo sapiens,CHEMBL203,CHEMBL1146052
COCCOc1cc(OC2CCOCC2)c2c(Nc3ccc(F)c(Cl)c3)ncnc2c1,6.17,Inhibitory activity against EGFR,IC50,671.0,nM,=,CHEMBL868329,B,CHEMBL382041,Homo sapiens,CHEMBL203,CHEMBL1146052
Fc1ccc2c(c1)CNc1c(Nc3ccc(F)c(Cl)c3)ncnc1O2,6.00,Inhibition of EGFR,IC50,1000.0,nM,=,CHEMBL867748,B,CHEMBL424853,Homo sapiens,CHEMBL203,CHEMBL1139019
C=CC(=O)Nc1ccc2c(c1)CNc1c(Nc3cccc(Br)c3)ncnc1O2,5.27,Inhibition of EGFR autophosphorylation in DiFi cells,IC50,5400.0,nM,=,CHEMBL867749,B,CHEMBL381541,Homo sapiens,CHEMBL203,CHEMBL1139019
C=CC(=O)Nc1ccc2c(c1)CNc1c(Nc3ccc(F)c(Cl)c3)ncnc1O2,5.31,Inhibition of EGFR,IC50,4900.0,nM,=,CHEMBL867748,B,CHEMBL204164,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1cc2c(cc1OC)Oc1ncnc(Nc3cccc(Br)c3)c1NC2,6.47,Inhibition of EGFR,IC50,340.0,nM,=,CHEMBL867748,B,CHEMBL380972,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1cc2c(cc1OC)Oc1ncnc(Nc3ccc(F)c(Cl)c3)c1NC2,6.16,Inhibition of EGFR autophosphorylation in DiFi cells,IC50,690.0,nM,=,CHEMBL867749,B,CHEMBL202970,Homo sapiens,CHEMBL203,CHEMBL1139019
CN1CCC(Oc2cccc3ncnc(Nc4ccc(F)c(Cl)c4)c23)CC1,8.52,Inhibitory activity against EGFR,IC50,3.0,nM,=,CHEMBL868329,B,CHEMBL203725,Homo sapiens,CHEMBL203,CHEMBL1146052
CN1CCN(CCCOc2cc(OC3CCOCC3)c3c(Nc4ccc(F)c(Cl)c4)ncnc3c2)CC1,7.18,Inhibitory activity against EGFR,IC50,66.0,nM,=,CHEMBL868329,B,CHEMBL205776,Homo sapiens,CHEMBL203,CHEMBL1146052
Brc1ccc2c(c1)CNc1c(NCc3ccccc3)ncnc1O2,5.22,Inhibition of EGFR,IC50,6000.0,nM,=,CHEMBL867748,B,CHEMBL381306,Homo sapiens,CHEMBL203,CHEMBL1139019
Fc1ccc2c(c1)CNc1c(NCc3ccccc3)ncnc1O2,5.05,Inhibition of EGFR,IC50,8900.0,nM,=,CHEMBL867748,B,CHEMBL379041,Homo sapiens,CHEMBL203,CHEMBL1139019
Fc1ccc2c(c1)CNc1c(Nc3cccc(-c4ccccc4)c3)ncnc1O2,5.70,Inhibition of EGFR,IC50,2000.0,nM,=,CHEMBL867748,B,CHEMBL206320,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1ccc2c(c1)CNc1c(Nc3cccc(-c4ccccc4)c3)ncnc1O2,5.01,Inhibition of EGFR autophosphorylation in DiFi cells,IC50,9800.0,nM,=,CHEMBL867749,B,CHEMBL206370,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1cc(OC)c2c(c1)Oc1ncnc(Nc3cccc(Br)c3)c1NC2,5.20,Inhibition of EGFR,IC50,6300.0,nM,=,CHEMBL867748,B,CHEMBL204223,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1ccc2c(c1)Oc1ncnc(Nc3ccc(F)c(Cl)c3)c1NC2,6.00,Inhibition of EGFR,IC50,1000.0,nM,=,CHEMBL867748,B,CHEMBL206347,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1ccc2c(c1)CNc1c(Nc3ccc(F)c(Cl)c3)ncnc1O2,6.05,Inhibition of EGFR,IC50,900.0,nM,=,CHEMBL867748,B,CHEMBL426124,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1ccc2c(c1)CNc1c(Nc3ccc(Cl)cc3)ncnc1O2,5.24,Inhibition of EGFR,IC50,5800.0,nM,=,CHEMBL867748,B,CHEMBL205454,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1ccc2c(c1)CNc1c(NCc3ccccc3)ncnc1O2,5.70,Inhibition of EGFR,IC50,2000.0,nM,=,CHEMBL867748,B,CHEMBL204335,Homo sapiens,CHEMBL203,CHEMBL1139019
Brc1ccc2c(c1)CNc1c(Nc3ccccc3)ncnc1O2,5.00,Inhibition of EGFR,IC50,10000.0,nM,=,CHEMBL867748,B,CHEMBL382862,Homo sapiens,CHEMBL203,CHEMBL1139019
Fc1ccc2c(c1)CNc1c(Nc3ccccc3)ncnc1O2,5.16,Inhibition of EGFR,IC50,7000.0,nM,=,CHEMBL867748,B,CHEMBL203529,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1ccc2c(c1)CNc1c(Nc3ccccc3)ncnc1O2,5.12,Inhibition of EGFR,IC50,7500.0,nM,=,CHEMBL867748,B,CHEMBL383121,Homo sapiens,CHEMBL203,CHEMBL1139019
O=C(O)c1ccc2c(c1)CNc1c(Nc3cccc(Br)c3)ncnc1O2,6.00,Inhibition of EGFR,IC50,1000.0,nM,=,CHEMBL867748,B,CHEMBL205148,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1cc(OC2CCNCC2)c2c(Nc3ccc(F)c(Cl)c3)ncnc2c1,8.00,Inhibitory activity against EGFR,IC50,10.0,nM,=,CHEMBL868329,B,CHEMBL205149,Homo sapiens,CHEMBL203,CHEMBL1146052
O=C(O)c1ccc2c(c1)CNc1c(Nc3ccc(F)c(Cl)c3)ncnc1O2,5.36,Inhibition of EGFR,IC50,4400.0,nM,=,CHEMBL867748,B,CHEMBL206848,Homo sapiens,CHEMBL203,CHEMBL1139019
COc1cc(OC2CCOCC2)c2c(Nc3ccc(F)c(Cl)c3)ncnc2c1,5.86,Inhibitory activity against EGFR,IC50,1384.0,nM,=,CHEMBL868329,B,CHEMBL205783,Homo sapiens,CHEMBL203,CHEMBL1146052
COc1cc(OC2CCOC2)c2c(Nc3ccc(F)c(Cl)c3)ncnc2c1,6.73,Inhibitory activity against EGFR,IC50,187.0,nM,=,CHEMBL868329,B,CHEMBL204268,Homo sapiens,CHEMBL203,CHEMBL1146052
COc1cc(OC(C)C)c2c(Nc3ccc(F)c(Cl)c3)ncnc2c1,5.09,Inhibitory activity against EGFR,IC50,8068.0,nM,=,CHEMBL868329,B,CHEMBL377277,Homo sapiens,CHEMBL203,CHEMBL1146052
Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,5.58,Binding constant for EGFR(G719S) kinase domain,Kd,2600.0,nM,=,CHEMBL1908696,B,CHEMBL377300,Homo sapiens,CHEMBL203,CHEMBL1908390
Cc1cccc(-n2ncc3c(NCc4ccc5c(c4)OCO5)ncnc32)c1,4.82,Inhibition of EGFR kinase activity,IC50,15000.0,nM,=,CHEMBL863780,B,CHEMBL206483,Homo sapiens,CHEMBL203,CHEMBL1146933
Fc1cccc(COc2ccc(Nc3ccncn3)cc2Cl)c1,6.50,Inhibition of EGFR,IC50,320.0,nM,=,CHEMBL861550,B,CHEMBL205652,Homo sapiens,CHEMBL203,CHEMBL1147004
C#Cc1cncnc1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,7.07,Inhibition of EGFR,IC50,85.0,nM,=,CHEMBL861550,B,CHEMBL205870,Homo sapiens,CHEMBL203,CHEMBL1147004
Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3cccnc3)cc2Cl)c1,7.13,Inhibition of EGFR,IC50,74.0,nM,=,CHEMBL861550,B,CHEMBL438440,Homo sapiens,CHEMBL203,CHEMBL1147004
CS(=O)(=O)CCNC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1,7.82,Inhibition of EGFR,IC50,15.0,nM,=,CHEMBL861550,B,CHEMBL206029,Homo sapiens,CHEMBL203,CHEMBL1147004
OCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1,7.40,Inhibition of EGFR,IC50,40.0,nM,=,CHEMBL861550,B,CHEMBL204570,Homo sapiens,CHEMBL203,CHEMBL1147004
NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1,7.68,Inhibition of EGFR,IC50,21.0,nM,=,CHEMBL861550,B,CHEMBL206003,Homo sapiens,CHEMBL203,CHEMBL1147004
CNC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1,7.64,Inhibition of EGFR,IC50,23.0,nM,=,CHEMBL861550,B,CHEMBL380078,Homo sapiens,CHEMBL203,CHEMBL1147004
Nc1ccccc1C#Cc1cncnc1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,7.20,Inhibition of EGFR,IC50,63.0,nM,=,CHEMBL861550,B,CHEMBL204625,Homo sapiens,CHEMBL203,CHEMBL1147004
Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,7.38,Inhibition of EGFR,IC50,42.0,nM,=,CHEMBL861550,B,CHEMBL205235,Homo sapiens,CHEMBL203,CHEMBL1147004
Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1,7.52,Inhibition of EGFR,IC50,30.0,nM,=,CHEMBL861550,B,CHEMBL205966,Homo sapiens,CHEMBL203,CHEMBL1147004
CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,7.92,Inhibition of EGFR,IC50,12.0,nM,=,CHEMBL861550,B,CHEMBL205798,Homo sapiens,CHEMBL203,CHEMBL1147004
CC(=O)Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1,4.60,Inhibition of EGFR,IC50,25100.0,nM,=,CHEMBL861550,B,CHEMBL438075,Homo sapiens,CHEMBL203,CHEMBL1147004
Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1,7.10,Inhibition of EGFR,IC50,79.0,nM,=,CHEMBL861550,B,CHEMBL379093,Homo sapiens,CHEMBL203,CHEMBL1147004
Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ncccn3)cc2Cl)c1,7.11,Inhibition of EGFR,IC50,77.0,nM,=,CHEMBL861550,B,CHEMBL207869,Homo sapiens,CHEMBL203,CHEMBL1147004
Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccn3)cc2Cl)c1,7.77,Inhibition of EGFR,IC50,17.0,nM,=,CHEMBL861550,B,CHEMBL205045,Homo sapiens,CHEMBL203,CHEMBL1147004
Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3cc[nH]n3)cc2Cl)c1,7.38,Inhibition of EGFR,IC50,42.0,nM,=,CHEMBL861550,B,CHEMBL205284,Homo sapiens,CHEMBL203,CHEMBL1147004
Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1,7.50,Inhibition of EGFR,IC50,32.0,nM,=,CHEMBL861550,B,CHEMBL381604,Homo sapiens,CHEMBL203,CHEMBL1147004
CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1,7.04,Inhibition of EGFR,IC50,91.0,nM,=,CHEMBL861550,B,CHEMBL205765,Homo sapiens,CHEMBL203,CHEMBL1147004
OCc1nc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cs1,7.12,Inhibition of EGFR,IC50,76.0,nM,=,CHEMBL861550,B,CHEMBL205047,Homo sapiens,CHEMBL203,CHEMBL1147004
OCc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)o1,7.48,Inhibition of EGFR,IC50,33.0,nM,=,CHEMBL861550,B,CHEMBL204467,Homo sapiens,CHEMBL203,CHEMBL1147004
CS(=O)(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,6.96,Inhibition of EGFR,IC50,110.0,nM,=,CHEMBL861550,B,CHEMBL208358,Homo sapiens,CHEMBL203,CHEMBL1147004
CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,7.10,Inhibition of EGFR,IC50,79.0,nM,=,CHEMBL861550,B,CHEMBL207410,Homo sapiens,CHEMBL203,CHEMBL1147004
CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,7.22,Inhibition of EGFR,IC50,60.0,nM,=,CHEMBL861550,B,CHEMBL207247,Homo sapiens,CHEMBL203,CHEMBL1147004
CS(=O)(=O)CCC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,7.30,Inhibition of EGFR,IC50,50.0,nM,=,CHEMBL861550,B,CHEMBL381080,Homo sapiens,CHEMBL203,CHEMBL1147004
COC(=O)CCCC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1,7.51,Inhibition of EGFR,IC50,31.0,nM,=,CHEMBL861550,B,CHEMBL206782,Homo sapiens,CHEMBL203,CHEMBL1147004
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCCC[C@@H]1C(N)=O,8.10,Inhibition of EGFR in presence of 2 uM ATP,IC50,8.0,nM,=,CHEMBL853149,B,CHEMBL206783,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCOCC1C(N)=O,7.30,Inhibition of EGFR in presence of 2 uM ATP,IC50,50.0,nM,=,CHEMBL853149,B,CHEMBL207674,Homo sapiens,CHEMBL203,CHEMBL1147701
COC[C@@H](C(N)=O)N(C)Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC,7.52,Inhibition of EGFR in presence of 2 uM ATP,IC50,30.0,nM,=,CHEMBL853149,B,CHEMBL379905,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@H](C)C(=O)N(C)C,7.40,Inhibition of EGFR in presence of 2 uM ATP,IC50,40.0,nM,=,CHEMBL853149,B,CHEMBL380006,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CC(C(N)=O)C1,7.30,Inhibition of EGFR in presence of 2 uM ATP,IC50,50.0,nM,=,CHEMBL853149,B,CHEMBL207037,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN[C@H](C)C(N)=O,6.82,Inhibition of EGFR in presence of 2 uM ATP,IC50,150.0,nM,=,CHEMBL853149,B,CHEMBL380386,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCCC1,6.44,Inhibition of EGFR in presence of 2 uM ATP,IC50,360.0,nM,=,CHEMBL853149,B,CHEMBL437885,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)CC(N)=O,7.70,Inhibition of EGFR in presence of 2 uM ATP,IC50,20.0,nM,=,CHEMBL853149,B,CHEMBL379601,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@H](C)C(N)=O,8.05,Inhibition of EGFR in presence of 2 uM ATP,IC50,9.0,nM,=,CHEMBL853149,B,CHEMBL208118,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@@H](C)C(N)=O,8.10,Inhibition of EGFR in presence of 2 uM ATP,IC50,8.0,nM,=,CHEMBL853149,B,CHEMBL207687,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CN1CCC[C@@H]1C(N)=O,8.22,Inhibition of EGFR in presence of 2 uM ATP,IC50,6.0,nM,=,CHEMBL853149,B,CHEMBL206955,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CN1CCC[C@H]1C(N)=O,7.70,Inhibition of EGFR in presence of 2 uM ATP,IC50,20.0,nM,=,CHEMBL853149,B,CHEMBL382638,Homo sapiens,CHEMBL203,CHEMBL1147701
CNC(=O)[C@@H](C)N(C)Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC,7.52,Inhibition of EGFR in presence of 2 uM ATP,IC50,30.0,nM,=,CHEMBL853149,B,CHEMBL211003,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC[C@H]1C(N)=O,7.52,Inhibition of EGFR in presence of 2 uM ATP,IC50,30.0,nM,=,CHEMBL853149,B,CHEMBL207584,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC1C(N)=O,7.16,Inhibition of EGFR in presence of 2 uM ATP,IC50,70.0,nM,=,CHEMBL853149,B,CHEMBL207246,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC[C@@H]1C(N)=O,8.00,Inhibition of EGFR in presence of 2 uM ATP,IC50,10.0,nM,=,CHEMBL853149,B,CHEMBL208292,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1C[C@H](OC)C[C@@H]1C(N)=O,8.00,Inhibition of EGFR in presence of 2 uM ATP,IC50,10.0,nM,=,CHEMBL853149,B,CHEMBL207235,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1CCNC1=O,7.70,Inhibition of EGFR in presence of 2 uM ATP,IC50,20.0,nM,=,CHEMBL853149,B,CHEMBL378370,Homo sapiens,CHEMBL203,CHEMBL1147701
CNC(=O)[C@H]1CCCN1Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC,7.30,Inhibition of EGFR in presence of 2 uM ATP,IC50,50.0,nM,=,CHEMBL853149,B,CHEMBL383760,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(CCN(C)C)[C@@H](C)C(N)=O,6.92,Inhibition of EGFR in presence of 2 uM ATP,IC50,120.0,nM,=,CHEMBL853149,B,CHEMBL376967,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@@H](CO)C(N)=O,7.70,Inhibition of EGFR in presence of 2 uM ATP,IC50,20.0,nM,=,CHEMBL853149,B,CHEMBL208286,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC[C@@H]1C(=O)N(C)C,6.35,Inhibition of EGFR in presence of 2 uM ATP,IC50,450.0,nM,=,CHEMBL853149,B,CHEMBL382822,Homo sapiens,CHEMBL203,CHEMBL1147701
COCCN(Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC)[C@@H](C)C(N)=O,8.00,Inhibition of EGFR in presence of 2 uM ATP,IC50,10.0,nM,=,CHEMBL853149,B,CHEMBL382823,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC[C@H]1CC(N)=O,6.77,Inhibition of EGFR in presence of 2 uM ATP,IC50,170.0,nM,=,CHEMBL853149,B,CHEMBL377772,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCN(C)CC1C(N)=O,7.52,Inhibition of EGFR in presence of 2 uM ATP,IC50,30.0,nM,=,CHEMBL853149,B,CHEMBL204420,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CC[C@H](C(N)=O)C1,7.10,Inhibition of EGFR in presence of 2 uM ATP,IC50,80.0,nM,=,CHEMBL853149,B,CHEMBL380454,Homo sapiens,CHEMBL203,CHEMBL1147701
COCC[C@@H](C(N)=O)N(C)Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC,8.00,Inhibition of EGFR in presence of 2 uM ATP,IC50,10.0,nM,=,CHEMBL853149,B,CHEMBL207445,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@@H](CN(C)C)C(N)=O,7.30,Inhibition of EGFR in presence of 2 uM ATP,IC50,50.0,nM,=,CHEMBL853149,B,CHEMBL380889,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1(C(N)=O)CCN(C)CC1,8.05,Inhibition of EGFR in presence of 2 uM ATP,IC50,9.0,nM,=,CHEMBL853149,B,CHEMBL207130,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1(C(N)=O)CCN(C(C)C)CC1,7.60,Inhibition of EGFR in presence of 2 uM ATP,IC50,25.0,nM,=,CHEMBL853149,B,CHEMBL383246,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1(C(N)=O)CN(C)C1,7.70,Inhibition of EGFR in presence of 2 uM ATP,IC50,20.0,nM,=,CHEMBL853149,B,CHEMBL207718,Homo sapiens,CHEMBL203,CHEMBL1147701
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1(C(N)=O)CN(C(C)C)C1,8.05,Inhibition of EGFR in presence of 2 uM ATP,IC50,9.0,nM,=,CHEMBL853149,B,CHEMBL425601,Homo sapiens,CHEMBL203,CHEMBL1147701
COCCN1CC(C(N)=O)(N(C)Cc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)C1,8.22,Inhibition of EGFR in presence of 2 uM ATP,IC50,6.0,nM,=,CHEMBL853149,B,CHEMBL207815,Homo sapiens,CHEMBL203,CHEMBL1147701
Cc1cccc(Nc2ncnc3ccc(NC(=O)NCCCl)cc23)c1,6.17,Inhibition of EGFR tyrosine kinase,IC50,676.0,nM,=,CHEMBL870841,B,CHEMBL208240,Homo sapiens,CHEMBL203,CHEMBL1148637
CNc1ccc2ncnc(Nc3cccc(C)c3)c2c1,7.96,Inhibition of EGFR tyrosine kinase,IC50,11.0,nM,=,CHEMBL870841,B,CHEMBL208594,Homo sapiens,CHEMBL203,CHEMBL1148637
CNc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,8.40,Inhibition of EGFR tyrosine kinase,IC50,4.0,nM,=,CHEMBL870841,B,CHEMBL209343,Homo sapiens,CHEMBL203,CHEMBL1148637
O=C(NCCCl)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,7.66,Inhibition of EGFR tyrosine kinase,IC50,22.0,nM,=,CHEMBL870841,B,CHEMBL210444,Homo sapiens,CHEMBL203,CHEMBL1148637
O=C(NCCCl)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.75,Inhibition of EGFR tyrosine kinase,IC50,18.0,nM,=,CHEMBL870841,B,CHEMBL207009,Homo sapiens,CHEMBL203,CHEMBL1148637
Cc1cccc(Nc2ncnc3ccc(NC(=O)N(C)CCCl)cc23)c1,5.77,Inhibition of EGFR tyrosine kinase,IC50,1693.0,nM,=,CHEMBL870841,B,CHEMBL208849,Homo sapiens,CHEMBL203,CHEMBL1148637
CN(CCCl)C(=O)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,7.09,Inhibition of EGFR tyrosine kinase,IC50,81.0,nM,=,CHEMBL870841,B,CHEMBL208144,Homo sapiens,CHEMBL203,CHEMBL1148637
CN(CCCl)C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.81,Inhibition of EGFR tyrosine kinase,IC50,156.0,nM,=,CHEMBL870841,B,CHEMBL379047,Homo sapiens,CHEMBL203,CHEMBL1148637
Cc1cccc(Nc2ncnc3ccc(NC(=O)N(CCCl)N=O)cc23)c1,5.97,Inhibition of EGFR tyrosine kinase,IC50,1061.0,nM,=,CHEMBL870841,B,CHEMBL210502,Homo sapiens,CHEMBL203,CHEMBL1148637
O=NN(CCCl)C(=O)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,7.17,Inhibition of EGFR tyrosine kinase,IC50,67.0,nM,=,CHEMBL870841,B,CHEMBL210659,Homo sapiens,CHEMBL203,CHEMBL1148637
O=NN(CCCl)C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.33,Inhibition of EGFR tyrosine kinase,IC50,47.0,nM,=,CHEMBL870841,B,CHEMBL210660,Homo sapiens,CHEMBL203,CHEMBL1148637
Cc1cccc(Nc2ncnc3ccc(N(C)C(=O)N(CCCl)N=O)cc23)c1,5.94,Inhibition of EGFR tyrosine kinase,IC50,1139.0,nM,=,CHEMBL870841,B,CHEMBL209818,Homo sapiens,CHEMBL203,CHEMBL1148637
CN(C(=O)N(CCCl)N=O)c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,6.69,Inhibition of EGFR tyrosine kinase,IC50,204.0,nM,=,CHEMBL870841,B,CHEMBL210378,Homo sapiens,CHEMBL203,CHEMBL1148637
CN(C(=O)N(CCCl)N=O)c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.53,Inhibition of EGFR tyrosine kinase,IC50,294.0,nM,=,CHEMBL870841,B,CHEMBL210893,Homo sapiens,CHEMBL203,CHEMBL1148637
O=C1NC(=O)N(CCc2ccccc2)/C1=C/c1ccc(O)cc1,6.15,Inhibition of EGFR-mediated polyGAT phosphorylation at 10 uM,IC50,710.0,nM,=,CHEMBL866710,B,CHEMBL213560,Homo sapiens,CHEMBL203,CHEMBL1146012
O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1,7.60,Inhibition of ErbB1,IC50,25.0,nM,=,CHEMBL910357,B,CHEMBL212250,Homo sapiens,CHEMBL203,CHEMBL1149340
O=S(=O)(CCCCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1)c1ccccc1,7.30,Inhibition of ErbB1,IC50,50.0,nM,=,CHEMBL910357,B,CHEMBL212201,Homo sapiens,CHEMBL203,CHEMBL1149340
CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.07,Inhibition of ErbB1,IC50,85.0,nM,=,CHEMBL910357,B,CHEMBL212251,Homo sapiens,CHEMBL203,CHEMBL1149340
CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.57,Inhibition of ErbB1,IC50,27.0,nM,=,CHEMBL910357,B,CHEMBL384407,Homo sapiens,CHEMBL203,CHEMBL1149340
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1,6.80,Inhibition of ErbB1,IC50,160.0,nM,=,CHEMBL910357,B,CHEMBL387207,Homo sapiens,CHEMBL203,CHEMBL1149340
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1,7.10,Inhibition of ErbB1,IC50,80.0,nM,=,CHEMBL910357,B,CHEMBL215814,Homo sapiens,CHEMBL203,CHEMBL1149340
CCCS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.68,Inhibition of ErbB1,IC50,21.0,nM,=,CHEMBL910357,B,CHEMBL383965,Homo sapiens,CHEMBL203,CHEMBL1149340
CC(C)S(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.75,Inhibition of ErbB1,IC50,18.0,nM,=,CHEMBL910357,B,CHEMBL214487,Homo sapiens,CHEMBL203,CHEMBL1149340
[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1,7.55,Inhibition of ErbB1,IC50,28.0,nM,=,CHEMBL910357,B,CHEMBL212954,Homo sapiens,CHEMBL203,CHEMBL1149340
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1,7.57,Inhibition of ErbB1,IC50,27.0,nM,=,CHEMBL910357,B,CHEMBL213342,Homo sapiens,CHEMBL203,CHEMBL1149340
[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1,7.80,Inhibition of ErbB1,IC50,16.0,nM,=,CHEMBL910357,B,CHEMBL215716,Homo sapiens,CHEMBL203,CHEMBL1149340
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)cc4)c3c2)o1,7.62,Inhibition of ErbB1,IC50,24.0,nM,=,CHEMBL910357,B,CHEMBL213818,Homo sapiens,CHEMBL203,CHEMBL1149340
[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1,7.92,Inhibition of ErbB1,IC50,12.0,nM,=,CHEMBL910357,B,CHEMBL212965,Homo sapiens,CHEMBL203,CHEMBL1149340
O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1)c1ccccn1,7.72,Inhibition of ErbB1,IC50,19.0,nM,=,CHEMBL910357,B,CHEMBL214023,Homo sapiens,CHEMBL203,CHEMBL1149340
Cn1ccnc1S(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1,7.77,Inhibition of ErbB1,IC50,17.0,nM,=,CHEMBL910357,B,CHEMBL265367,Homo sapiens,CHEMBL203,CHEMBL1149340
CS(=O)(=O)CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.58,Inhibition of ErbB1,IC50,26.0,nM,=,CHEMBL910357,B,CHEMBL215171,Homo sapiens,CHEMBL203,CHEMBL1149340
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1,7.04,Inhibition of ErbB1,IC50,91.0,nM,=,CHEMBL910357,B,CHEMBL214419,Homo sapiens,CHEMBL203,CHEMBL1149340
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(Br)c5)cc4)c3c2)o1,7.37,Inhibition of ErbB1,IC50,43.0,nM,=,CHEMBL910357,B,CHEMBL384711,Homo sapiens,CHEMBL203,CHEMBL1149340
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1,7.75,Inhibition of ErbB1,IC50,18.0,nM,=,CHEMBL910357,B,CHEMBL380247,Homo sapiens,CHEMBL203,CHEMBL1149340
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1,7.60,Inhibition of ErbB1,IC50,25.0,nM,=,CHEMBL910357,B,CHEMBL214689,Homo sapiens,CHEMBL203,CHEMBL1149340
COc1cc(Nc2ncnc3ccc(-c4ccc(CNCCS(C)(=O)=O)o4)cc23)ccc1OCc1cccc(F)c1,7.00,Inhibition of ErbB1,IC50,100.0,nM,=,CHEMBL910357,B,CHEMBL215033,Homo sapiens,CHEMBL203,CHEMBL1149340
CS(=O)(=O)CCN(Cc1ccccc1)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.05,Inhibition of ErbB1,IC50,90.0,nM,=,CHEMBL910357,B,CHEMBL445572,Homo sapiens,CHEMBL203,CHEMBL1149340
[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(C(F)(F)F)c5)c4c3)o2)CC1,7.05,Inhibition of ErbB1,IC50,89.0,nM,=,CHEMBL910357,B,CHEMBL377250,Homo sapiens,CHEMBL203,CHEMBL1149340
COc1cc2ncnc(Nc3cc(Cl)ccc3F)c2cc1OCCCN1CCOCC1,7.29,Inhibition of EGFR,IC50,51.0,nM,=,CHEMBL856356,B,CHEMBL384699,Homo sapiens,CHEMBL203,CHEMBL1149481
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OCC1CCN(C)CC1,8.70,Inhibition of EGFR,IC50,2.0,nM,=,CHEMBL856356,B,CHEMBL213874,Homo sapiens,CHEMBL203,CHEMBL1149481
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC1CCN(C)CC1,8.70,Inhibition of EGFR,IC50,2.0,nM,=,CHEMBL856356,B,CHEMBL214798,Homo sapiens,CHEMBL203,CHEMBL1149481
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCC1CCN(C)CC1,8.52,Inhibition of EGFR,IC50,3.0,nM,=,CHEMBL856356,B,CHEMBL215786,Homo sapiens,CHEMBL203,CHEMBL1149481
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC1CCN(C)CC1,8.00,Inhibition of EGFR,IC50,10.0,nM,=,CHEMBL856356,B,CHEMBL276154,Homo sapiens,CHEMBL203,CHEMBL1149481
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC1CCN(S(C)(=O)=O)CC1,8.70,Inhibition of EGFR,IC50,2.0,nM,=,CHEMBL856356,B,CHEMBL387265,Homo sapiens,CHEMBL203,CHEMBL1149481
COCCN1CCC(Oc2cc3c(Nc4cc(Cl)ccc4F)ncnc3cc2OC)CC1,6.94,Inhibition of EGFR,IC50,114.0,nM,=,CHEMBL856356,B,CHEMBL215559,Homo sapiens,CHEMBL203,CHEMBL1149481
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OCCCN1CCOCC1,7.75,Inhibition of EGFR,IC50,18.0,nM,=,CHEMBL856356,B,CHEMBL385479,Homo sapiens,CHEMBL203,CHEMBL1149481
COc1cc2ncnc(Nc3cc(Cl)ccc3F)c2cc1OC1CCN(CC(N)=O)CC1,8.05,Inhibition of EGFR,IC50,9.0,nM,=,CHEMBL856356,B,CHEMBL214478,Homo sapiens,CHEMBL203,CHEMBL1149481
COc1cc2ncnc(Nc3cc(Cl)ccc3F)c2cc1OC1CCN(S(C)(=O)=O)CC1,9.00,Inhibition of EGFR,IC50,1.0,nM,=,CHEMBL856356,B,CHEMBL213007,Homo sapiens,CHEMBL203,CHEMBL1149481
CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1,6.75,Binding constant for EGFR(E746-A750del) kinase domain,Kd,180.0,nM,=,CHEMBL1908694,B,CHEMBL386051,Homo sapiens,CHEMBL203,CHEMBL1908390
COc1cc2ncnc(Nc3cc(Cl)ccc3F)c2cc1OCC1CCN(C)CC1,8.05,Inhibition of EGFR,IC50,9.0,nM,=,CHEMBL856356,B,CHEMBL385471,Homo sapiens,CHEMBL203,CHEMBL1149481
COc1cc2ncnc(Nc3cc(Cl)ccc3F)c2cc1OC1CCN(C)CC1,6.97,Inhibition of EGFR,IC50,106.0,nM,=,CHEMBL856356,B,CHEMBL214631,Homo sapiens,CHEMBL203,CHEMBL1149481
COCCN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,8.52,Inhibition of EGFR,IC50,3.0,nM,=,CHEMBL856356,B,CHEMBL214857,Homo sapiens,CHEMBL203,CHEMBL1149481
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC1CCN(CC(N)=O)CC1,8.70,Inhibition of EGFR,IC50,2.0,nM,=,CHEMBL856356,B,CHEMBL218677,Homo sapiens,CHEMBL203,CHEMBL1149481
O=C(Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)C1CCSS1,7.22,Inhibition of EGFR tyrosine kinase activity,IC50,60.0,nM,=,CHEMBL908277,B,CHEMBL217536,Homo sapiens,CHEMBL203,CHEMBL1137325
COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N,5.34,"Binding constant for EGFR(L747-S752del, P753S) kinase domain",Kd,4600.0,nM,=,CHEMBL1908698,B,CHEMBL384304,Homo sapiens,CHEMBL203,CHEMBL1908390
Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2,6.05,Inhibition of recombinant EGFR by ELISA,IC50,900.0,nM,=,CHEMBL854974,B,CHEMBL217090,Homo sapiens,CHEMBL203,CHEMBL1137334
CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1,7.18,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,IC50,66.0,nM,=,CHEMBL4394508,B,CHEMBL217092,Homo sapiens,CHEMBL203,CHEMBL4393671
Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,7.70,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,20.0,nM,=,CHEMBL1243977,B,CHEMBL1421,Homo sapiens,CHEMBL203,CHEMBL1240340
O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1,8.40,Inhibition of EGFR L861Q mutant,IC50,4.0,nM,=,CHEMBL939339,B,CHEMBL387187,Homo sapiens,CHEMBL203,CHEMBL1145498
CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,6.92,Binding constant for EGFR(G719C) kinase domain,Kd,120.0,nM,=,CHEMBL1061068,B,CHEMBL215152,Homo sapiens,CHEMBL203,CHEMBL1150977
CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O,5.76,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Kd,1734.0,nM,=,CHEMBL3991696,B,CHEMBL415049,Homo sapiens,CHEMBL203,CHEMBL3991601
COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN5CCN(C)CC5)c4)c(OC)cc23)c(Cl)cc1Cl,6.64,Inhibitory activity against EGFR,IC50,230.0,nM,=,CHEMBL910453,B,CHEMBL219557,Homo sapiens,CHEMBL203,CHEMBL1138859
CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1,4.60,Inhibition of EGFR,IC50,25000.0,nM,=,CHEMBL908512,B,CHEMBL373882,Homo sapiens,CHEMBL203,CHEMBL1141380
Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1,6.01,Inhibition of EGFR,IC50,965.0,nM,=,CHEMBL908988,B,CHEMBL436137,Homo sapiens,CHEMBL203,CHEMBL1139689
N#Cc1cnc2ccc(NCc3c[nH]cn3)cc2c1Nc1ccc(F)c(Cl)c1,7.52,Inhibition of EGFR kinase autophosphorylation in A431 cells,IC50,30.0,nM,=,CHEMBL898017,B,CHEMBL220037,Homo sapiens,CHEMBL203,CHEMBL1149691
Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,5.19,Binding constant for EGFR(G719C) kinase domain,Kd,6500.0,nM,=,CHEMBL1061068,B,CHEMBL223360,Homo sapiens,CHEMBL203,CHEMBL1150977
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,9.54,Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,0.29,nM,=,CHEMBL4052481,B,CHEMBL388978,Homo sapiens,CHEMBL203,CHEMBL4049460
O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O,4.98,Inhibition of EGFR after 60 mins by radiometric assay,IC50,10500.0,nM,=,CHEMBL1697113,B,CHEMBL1448,Homo sapiens,CHEMBL203,CHEMBL1687697
CN(CCCl)CCN/N=N/c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,8.36,Inhibition of EGFR tyrosine kinase expressed in A431 cells,IC50,4.4,nM,=,CHEMBL904734,B,CHEMBL225928,Homo sapiens,CHEMBL203,CHEMBL1143067
ClCCN(CCN/N=N/c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)Cc1ccccc1,7.15,Inhibition of EGFR tyrosine kinase expressed in A431 cells,IC50,71.0,nM,=,CHEMBL904734,B,CHEMBL225929,Homo sapiens,CHEMBL203,CHEMBL1143067
COc1ccc(N(CCCl)CCN/N=N/c2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)cc1,5.40,Inhibition of EGFR tyrosine kinase expressed in A431 cells,IC50,3960.0,nM,=,CHEMBL904734,B,CHEMBL388286,Homo sapiens,CHEMBL203,CHEMBL1143067
ClCCN(CCN/N=N/c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)c1ccc(Cl)cc1,5.66,Inhibition of EGFR tyrosine kinase expressed in A431 cells,IC50,2200.0,nM,=,CHEMBL904734,B,CHEMBL225930,Homo sapiens,CHEMBL203,CHEMBL1143067
CN(C)CCN/N=N/c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,7.43,Inhibition of EGFR tyrosine kinase expressed in A431 cells,IC50,37.0,nM,=,CHEMBL904734,B,CHEMBL225720,Homo sapiens,CHEMBL203,CHEMBL1143067
COc1ccc(N(CCN/N=N/c2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)CC(C)Cl)cc1,6.01,Inhibition of EGFR tyrosine kinase expressed in A431 cells,IC50,970.0,nM,=,CHEMBL904734,B,CHEMBL225721,Homo sapiens,CHEMBL203,CHEMBL1143067
Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1,6.10,Binding constant for EGFR(S752-I759del) kinase domain,Kd,800.0,nM,=,CHEMBL1908703,B,CHEMBL230011,Homo sapiens,CHEMBL203,CHEMBL1908390
N#Cc1cnc2c(Br)cc(NCc3c[nH]nn3)cc2c1Nc1ccc(F)c(Cl)c1,6.00,Inhibition of EGFR,IC50,1000.0,nM,=,CHEMBL1008385,B,CHEMBL230232,Homo sapiens,CHEMBL203,CHEMBL1136974
O=c1ccc2ccc(O)c(O)c2o1,5.12,Inhibition of EGFR,IC50,7670.0,nM,=,CHEMBL940057,B,CHEMBL244948,Homo sapiens,CHEMBL203,CHEMBL1145498
CCOc1cc2ncnc(NC3=CC(=O)C(OC)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,6.10,Inhibition of human EGFR in presence of 1 uM ATP,IC50,799.3,nM,=,CHEMBL892951,B,CHEMBL428039,Homo sapiens,CHEMBL203,CHEMBL1147965
CCOc1cc2ncnc(NC3=CC(=O)C(OC(CF)CF)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,6.55,Inhibition of human EGFR in presence of 1 uM ATP,IC50,283.3,nM,=,CHEMBL892951,B,CHEMBL243410,Homo sapiens,CHEMBL203,CHEMBL1147965
CCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(F)c4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,8.39,Inhibition of human EGFR in presence of 1 uM ATP,IC50,4.1,nM,=,CHEMBL892951,B,CHEMBL428741,Homo sapiens,CHEMBL203,CHEMBL1147965
CCOc1cc2ncnc(NC3=CC(=O)C(OCc4ccc(F)c(F)c4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,6.78,Inhibition of human EGFR in presence of 1 uM ATP,IC50,166.7,nM,=,CHEMBL892951,B,CHEMBL243628,Homo sapiens,CHEMBL203,CHEMBL1147965
CCOc1cc2ncnc(NC3=CC(=O)C(OCc4ccccc4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,7.73,Inhibition of human EGFR in presence of 1 uM ATP,IC50,18.7,nM,=,CHEMBL892951,B,CHEMBL243629,Homo sapiens,CHEMBL203,CHEMBL1147965
CCOc1cc2ncnc(NC3=CC(=O)C(OCc4ccccn4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,7.04,Inhibition of human EGFR in presence of 1 uM ATP,IC50,90.8,nM,=,CHEMBL892951,B,CHEMBL398154,Homo sapiens,CHEMBL203,CHEMBL1147965
CCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(Cl)c4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,7.91,Inhibition of human EGFR in presence of 1 uM ATP,IC50,12.2,nM,=,CHEMBL892951,B,CHEMBL243837,Homo sapiens,CHEMBL203,CHEMBL1147965
CCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccs4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,7.32,Inhibition of human EGFR in presence of 1 uM ATP,IC50,47.5,nM,=,CHEMBL892951,B,CHEMBL243839,Homo sapiens,CHEMBL203,CHEMBL1147965
CCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(OC)c4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,6.97,Inhibition of human EGFR in presence of 1 uM ATP,IC50,107.3,nM,=,CHEMBL892951,B,CHEMBL241918,Homo sapiens,CHEMBL203,CHEMBL1147965
CCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(C)c4)=CC3=O)c2cc1NC(=O)/C=C/CN(C)C,7.60,Inhibition of human EGFR in presence of 1 uM ATP,IC50,24.9,nM,=,CHEMBL892951,B,CHEMBL241919,Homo sapiens,CHEMBL203,CHEMBL1147965
CN(C)C/C=C/C(=O)Nc1ccc2ncnc(Nc3ccc(Br)cc3F)c2c1,6.15,Inhibition of human EGFR in presence of 1 mM ATP,IC50,704.0,nM,=,CHEMBL892954,B,CHEMBL242131,Homo sapiens,CHEMBL203,CHEMBL1147965
COCCOc1cc2ncnc(NC3=CC(=O)C(OCc4cccc(OC)c4)=CC3=O)c2cc1OC,5.11,Inhibition of human EGFR in presence of 1 uM ATP,IC50,7710.0,nM,=,CHEMBL892951,B,CHEMBL242349,Homo sapiens,CHEMBL203,CHEMBL1147965
COc1c(O)cc2occ(-c3ccc(O)cc3)c(=O)c2c1O,5.48,Inhibition of EGFR,IC50,3300.0,nM,=,CHEMBL970971,B,CHEMBL242740,Homo sapiens,CHEMBL203,CHEMBL1157216
Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,7.54,Inhibition of EGFR after 50 mins by HTRF assay,IC50,29.0,nM,=,CHEMBL1949352,B,CHEMBL242541,Homo sapiens,CHEMBL203,CHEMBL1944591
Cc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,7.09,Inhibition of human EGFR,IC50,81.0,nM,=,CHEMBL893470,B,CHEMBL427671,Homo sapiens,CHEMBL203,CHEMBL1147910
OCCNCc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,7.35,Inhibition of human EGFR,IC50,45.0,nM,=,CHEMBL893470,B,CHEMBL391321,Homo sapiens,CHEMBL203,CHEMBL1147910
CN(CCO)Cc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,6.96,Inhibition of human EGFR,IC50,110.0,nM,=,CHEMBL893470,B,CHEMBL391521,Homo sapiens,CHEMBL203,CHEMBL1147910
Fc1cccc(Cn2ncc3cc(Nc4ncnn5ccc(CN6CCCC6)c45)ccc32)c1,6.30,Inhibition of human EGFR,IC50,500.0,nM,=,CHEMBL893470,B,CHEMBL391675,Homo sapiens,CHEMBL203,CHEMBL1147910
OC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,7.17,Inhibition of human EGFR,IC50,68.0,nM,=,CHEMBL893470,B,CHEMBL401443,Homo sapiens,CHEMBL203,CHEMBL1147910
O=C(O)C1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,6.66,Inhibition of human EGFR,IC50,220.0,nM,=,CHEMBL893470,B,CHEMBL234772,Homo sapiens,CHEMBL203,CHEMBL1147910
COC(=O)C1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,6.00,Inhibition of human EGFR,IC50,1000.0,nM,=,CHEMBL893470,B,CHEMBL231663,Homo sapiens,CHEMBL203,CHEMBL1147910
NC(=O)C1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,6.85,Inhibition of human EGFR,IC50,140.0,nM,=,CHEMBL893470,B,CHEMBL398388,Homo sapiens,CHEMBL203,CHEMBL1147910
Fc1cccc(Cn2ncc3cc(Nc4ncnn5ccc(CN6CCNCC6)c45)ccc32)c1,7.05,Inhibition of human EGFR,IC50,90.0,nM,=,CHEMBL893470,B,CHEMBL231875,Homo sapiens,CHEMBL203,CHEMBL1147910
CN1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,6.77,Inhibition of human EGFR,IC50,170.0,nM,=,CHEMBL893470,B,CHEMBL232082,Homo sapiens,CHEMBL203,CHEMBL1147910
O=C1CN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CCN1,6.46,Inhibition of human EGFR,IC50,350.0,nM,=,CHEMBL893470,B,CHEMBL265629,Homo sapiens,CHEMBL203,CHEMBL1147910
CC(=O)N1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,6.15,Inhibition of human EGFR,IC50,710.0,nM,=,CHEMBL893470,B,CHEMBL231885,Homo sapiens,CHEMBL203,CHEMBL1147910
Fc1cccc(Cn2ncc3cc(Nc4ncnn5ccc(CN6CCCNCC6)c45)ccc32)c1,7.48,Inhibition of human EGFR,IC50,33.0,nM,=,CHEMBL893470,B,CHEMBL392273,Homo sapiens,CHEMBL203,CHEMBL1147910
CN1CCCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,6.89,Inhibition of human EGFR,IC50,130.0,nM,=,CHEMBL893470,B,CHEMBL234577,Homo sapiens,CHEMBL203,CHEMBL1147910
CS(=O)(=O)N1CCCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,6.68,Inhibition of human EGFR,IC50,210.0,nM,=,CHEMBL893470,B,CHEMBL400413,Homo sapiens,CHEMBL203,CHEMBL1147910
O=C1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CCN1,6.62,Inhibition of human EGFR,IC50,240.0,nM,=,CHEMBL893470,B,CHEMBL233324,Homo sapiens,CHEMBL203,CHEMBL1147910
O[C@H]1CNCCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)C1,7.58,Inhibition of human EGFR,IC50,26.0,nM,=,CHEMBL893470,B,CHEMBL233325,Homo sapiens,CHEMBL203,CHEMBL1147910
O[C@@H]1CNCCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)C1,6.70,Inhibition of human EGFR,IC50,200.0,nM,=,CHEMBL893470,B,CHEMBL393787,Homo sapiens,CHEMBL203,CHEMBL1147910
O=C1CNCCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)C1,6.11,Inhibition of human EGFR,IC50,780.0,nM,=,CHEMBL893470,B,CHEMBL234580,Homo sapiens,CHEMBL203,CHEMBL1147910
COC1CNCCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)C1,6.72,Inhibition of human EGFR,IC50,190.0,nM,=,CHEMBL893470,B,CHEMBL392774,Homo sapiens,CHEMBL203,CHEMBL1147910
CC1CNCCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)C1,6.89,Inhibition of human EGFR,IC50,130.0,nM,=,CHEMBL893470,B,CHEMBL398793,Homo sapiens,CHEMBL203,CHEMBL1147910
c1ccc(-c2c(-c3ccc(OCCN4CCCC4)cc3)oc3ncnc(NCCN4CCNCC4)c23)cc1,6.40,Inhibition of EGFR,IC50,397.0,nM,=,CHEMBL902558,B,CHEMBL247468,Homo sapiens,CHEMBL203,CHEMBL1139142
CC(C)Nc1ncnc2oc(-c3ccc(OCCN4CCCC4)cc3)c(-c3ccccc3)c12,5.99,Inhibition of EGFR,IC50,1029.0,nM,=,CHEMBL902558,B,CHEMBL247866,Homo sapiens,CHEMBL203,CHEMBL1139142
COc1cc(Nc2c(C#N)cnc3cc(C#CCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,6.14,Inhibition of EGFR,IC50,720.0,nM,=,CHEMBL885861,B,CHEMBL391738,Homo sapiens,CHEMBL203,CHEMBL1139073
CNc1ncnc(-c2cccnc2Oc2cc(NC(=O)c3cccc(OC(F)(F)C(F)F)c3)ccc2C)n1,4.60,Inhibition of EGFR by radioactive filtration assay,IC50,25000.0,nM,=,CHEMBL887090,B,CHEMBL246356,Homo sapiens,CHEMBL203,CHEMBL1139197
Cc1ccn2ncnc(Nc3ccc4[nH]ncc4c3)c12,6.68,Inhibition of EGFR,IC50,210.0,nM,=,CHEMBL903494,B,CHEMBL247100,Homo sapiens,CHEMBL203,CHEMBL1139130
Cc1ccn2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c12,6.60,Inhibition of EGFR,IC50,250.0,nM,=,CHEMBL903494,B,CHEMBL247101,Homo sapiens,CHEMBL203,CHEMBL1139130
Cc1ccn2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c12,7.07,Inhibition of EGFR,IC50,86.0,nM,=,CHEMBL903494,B,CHEMBL429827,Homo sapiens,CHEMBL203,CHEMBL1139130
Cc1ccn2ncnc(Nc3ccc4c(cnn4Cc4ccccn4)c3)c12,6.70,Inhibition of EGFR,IC50,200.0,nM,=,CHEMBL903494,B,CHEMBL394462,Homo sapiens,CHEMBL203,CHEMBL1139130
Cc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccnc4)c3)c12,5.75,Inhibition of EGFR,IC50,1800.0,nM,=,CHEMBL903494,B,CHEMBL394463,Homo sapiens,CHEMBL203,CHEMBL1139130
OCc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,6.92,Inhibition of EGFR,IC50,120.0,nM,=,CHEMBL903494,B,CHEMBL246276,Homo sapiens,CHEMBL203,CHEMBL1139130
COCc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,6.47,Inhibition of EGFR,IC50,340.0,nM,=,CHEMBL903494,B,CHEMBL394056,Homo sapiens,CHEMBL203,CHEMBL1139130
COCCOCc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,6.31,Inhibition of EGFR,IC50,490.0,nM,=,CHEMBL903494,B,CHEMBL246489,Homo sapiens,CHEMBL203,CHEMBL1139130
O=C(O)COCc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,7.52,Inhibition of EGFR,IC50,30.0,nM,=,CHEMBL903494,B,CHEMBL394057,Homo sapiens,CHEMBL203,CHEMBL1139130
COC(=O)COCc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,6.34,Inhibition of EGFR,IC50,460.0,nM,=,CHEMBL903494,B,CHEMBL246491,Homo sapiens,CHEMBL203,CHEMBL1139130
NC(=O)COCc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,6.85,Inhibition of EGFR,IC50,140.0,nM,=,CHEMBL903494,B,CHEMBL246694,Homo sapiens,CHEMBL203,CHEMBL1139130
NCCOCc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,7.05,Inhibition of EGFR,IC50,90.0,nM,=,CHEMBL903494,B,CHEMBL394333,Homo sapiens,CHEMBL203,CHEMBL1139130
NCCCOCc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,7.19,Inhibition of EGFR,IC50,64.0,nM,=,CHEMBL903494,B,CHEMBL245667,Homo sapiens,CHEMBL203,CHEMBL1139130
NCCCCOCc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,6.80,Inhibition of EGFR,IC50,160.0,nM,=,CHEMBL903494,B,CHEMBL245867,Homo sapiens,CHEMBL203,CHEMBL1139130
CN(C)CCCOCc1ccn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,6.21,Inhibition of EGFR,IC50,620.0,nM,=,CHEMBL903494,B,CHEMBL245868,Homo sapiens,CHEMBL203,CHEMBL1139130
Fc1cccc(Cn2ncc3cc(Nc4ncnn5ccc(COC6CCNCC6)c45)ccc32)c1,7.14,Inhibition of EGFR,IC50,73.0,nM,=,CHEMBL903494,B,CHEMBL245869,Homo sapiens,CHEMBL203,CHEMBL1139130
Fc1cccc(Cn2ncc3cc(Nc4ncnn5ccc(COCC6CCNCC6)c45)ccc32)c1,6.89,Inhibition of EGFR,IC50,130.0,nM,=,CHEMBL903494,B,CHEMBL246072,Homo sapiens,CHEMBL203,CHEMBL1139130
Fc1cccc(Cn2ncc3cc(Nc4ncnn5ccc(COC[C@H]6CCCNC6)c45)ccc32)c1,6.72,Inhibition of EGFR,IC50,190.0,nM,=,CHEMBL903494,B,CHEMBL246073,Homo sapiens,CHEMBL203,CHEMBL1139130
Fc1cccc(Cn2ncc3cc(Nc4ncnn5ccc(COC[C@@H]6CNCCO6)c45)ccc32)c1,7.21,Inhibition of EGFR,IC50,61.0,nM,=,CHEMBL903494,B,CHEMBL246284,Homo sapiens,CHEMBL203,CHEMBL1139130
Fc1cccc(Cn2ncc3cc(Nc4ncnn5ccc(COC[C@H]6CNCCO6)c45)ccc32)c1,7.08,Inhibition of EGFR,IC50,83.0,nM,=,CHEMBL903494,B,CHEMBL428046,Homo sapiens,CHEMBL203,CHEMBL1139130
Fc1cccc(Cn2ncc3cc(Nc4ncnn5ccc(COC[C@@H]6COCCN6)c45)ccc32)c1,6.19,Inhibition of EGFR,IC50,640.0,nM,=,CHEMBL903494,B,CHEMBL246492,Homo sapiens,CHEMBL203,CHEMBL1139130
Fc1cccc(Cn2ncc3cc(Nc4ncnn5ccc(COCC6CNCCOC6)c45)ccc32)c1,6.68,Inhibition of EGFR,IC50,210.0,nM,=,CHEMBL903494,B,CHEMBL395591,Homo sapiens,CHEMBL203,CHEMBL1139130
Fc1cccc(COc2ccc(Nc3ncnn4ccc(COC[C@@H]5CNCCO5)c34)cc2Cl)c1,6.25,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,560.0,nM,=,CHEMBL923201,B,CHEMBL246493,Homo sapiens,CHEMBL203,CHEMBL1140690
c1ccc(Cn2ncc3cc(Nc4ncnn5ccc(COC[C@@H]6CNCCO6)c45)ccc32)nc1,6.30,Inhibition of EGFR,IC50,500.0,nM,=,CHEMBL903494,B,CHEMBL396079,Homo sapiens,CHEMBL203,CHEMBL1139130
c1cncc(Cn2ncc3cc(Nc4ncnn5ccc(COC[C@@H]6CNCCO6)c45)ccc32)c1,6.09,Inhibition of EGFR,IC50,810.0,nM,=,CHEMBL903494,B,CHEMBL247127,Homo sapiens,CHEMBL203,CHEMBL1139130
C[C@H](c1ccccc1)n1ncc2cc(Nc3ncnn4ccc(COC[C@@H]5CNCCO5)c34)ccc21,6.92,Inhibition of EGFR,IC50,120.0,nM,=,CHEMBL903494,B,CHEMBL394495,Homo sapiens,CHEMBL203,CHEMBL1139130
C[C@@H](c1ccccc1)n1ncc2cc(Nc3ncnn4ccc(COC[C@@H]5CNCCO5)c34)ccc21,6.16,Inhibition of EGFR,IC50,690.0,nM,=,CHEMBL903494,B,CHEMBL245277,Homo sapiens,CHEMBL203,CHEMBL1139130
C[C@H](c1cccc(F)c1)n1ncc2cc(Nc3ncnn4ccc(COC[C@@H]5CNCCO5)c34)ccc21,7.17,Inhibition of EGFR,IC50,68.0,nM,=,CHEMBL903494,B,CHEMBL245278,Homo sapiens,CHEMBL203,CHEMBL1139130
C[C@@H](c1cccc(F)c1)n1ncc2cc(Nc3ncnn4ccc(COC[C@@H]5CNCCO5)c34)ccc21,6.40,Inhibition of EGFR,IC50,400.0,nM,=,CHEMBL903494,B,CHEMBL397122,Homo sapiens,CHEMBL203,CHEMBL1139130
COc1cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c2c1COC[C@@H]1CNCCO1,6.37,Inhibition of EGFR,IC50,430.0,nM,=,CHEMBL903494,B,CHEMBL395883,Homo sapiens,CHEMBL203,CHEMBL1139130
NC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,7.46,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,35.0,nM,=,CHEMBL923201,B,CHEMBL248108,Homo sapiens,CHEMBL203,CHEMBL1140690
Fc1cccc(Cn2ncc3cc(Nc4ncnn5ccc(CNC6CCNCC6)c45)ccc32)c1,6.96,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,110.0,nM,=,CHEMBL923201,B,CHEMBL392664,Homo sapiens,CHEMBL203,CHEMBL1140690
N[C@@H]1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)C1,7.22,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,60.0,nM,=,CHEMBL923201,B,CHEMBL393848,Homo sapiens,CHEMBL203,CHEMBL1140690
N[C@H]1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)C1,7.30,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,50.0,nM,=,CHEMBL923201,B,CHEMBL246687,Homo sapiens,CHEMBL203,CHEMBL1140690
NCC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,7.46,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,35.0,nM,=,CHEMBL923201,B,CHEMBL391778,Homo sapiens,CHEMBL203,CHEMBL1140690
CNC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,7.20,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,63.0,nM,=,CHEMBL923201,B,CHEMBL391779,Homo sapiens,CHEMBL203,CHEMBL1140690
OCCNC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,7.32,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,48.0,nM,=,CHEMBL923201,B,CHEMBL247104,Homo sapiens,CHEMBL203,CHEMBL1140690
CS(=O)(=O)CCNC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,6.70,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,200.0,nM,=,CHEMBL923201,B,CHEMBL246898,Homo sapiens,CHEMBL203,CHEMBL1140690
CN(C)C1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,7.00,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,100.0,nM,=,CHEMBL923201,B,CHEMBL247309,Homo sapiens,CHEMBL203,CHEMBL1140690
CC(=O)NC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,6.42,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,380.0,nM,=,CHEMBL923201,B,CHEMBL247512,Homo sapiens,CHEMBL203,CHEMBL1140690
O=C(CO)NC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,6.96,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,110.0,nM,=,CHEMBL923201,B,CHEMBL247513,Homo sapiens,CHEMBL203,CHEMBL1140690
CC1(N)CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)CC1,7.30,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,50.0,nM,=,CHEMBL923201,B,CHEMBL393264,Homo sapiens,CHEMBL203,CHEMBL1140690
Fc1cccc(COc2ccc(Nc3ncnn4ccc(CN5CCCNCC5)c34)cc2Cl)c1,7.32,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,48.0,nM,=,CHEMBL923201,B,CHEMBL247709,Homo sapiens,CHEMBL203,CHEMBL1140690
NC1CCN(Cc2ccn3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c23)CC1,7.42,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,38.0,nM,=,CHEMBL923201,B,CHEMBL247710,Homo sapiens,CHEMBL203,CHEMBL1140690
COc1cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c2c1CN1CCCNCC1,6.72,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,190.0,nM,=,CHEMBL923201,B,CHEMBL247711,Homo sapiens,CHEMBL203,CHEMBL1140690
COc1cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c2c1CN1CCC(N)CC1,7.40,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,40.0,nM,=,CHEMBL923201,B,CHEMBL391181,Homo sapiens,CHEMBL203,CHEMBL1140690
NC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5ccccn5)c4)c23)CC1,7.33,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,47.0,nM,=,CHEMBL923201,B,CHEMBL247914,Homo sapiens,CHEMBL203,CHEMBL1140690
NC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5cccnc5)c4)c23)CC1,6.72,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,190.0,nM,=,CHEMBL923201,B,CHEMBL247915,Homo sapiens,CHEMBL203,CHEMBL1140690
NC1CCN(Cc2ccn3ncnc(Nc4ccc5c(cnn5Cc5ccncc5)c4)c23)CC1,6.28,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,530.0,nM,=,CHEMBL923201,B,CHEMBL247916,Homo sapiens,CHEMBL203,CHEMBL1140690
Cc1cncc(Cn2ncc3cc(Nc4ncnn5ccc(CN6CCC(N)CC6)c45)ccc32)c1,7.72,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,19.0,nM,=,CHEMBL923201,B,CHEMBL248114,Homo sapiens,CHEMBL203,CHEMBL1140690
NC1CCN(Cc2ccn3ncnc(Nc4ccc(OCc5cccnc5)c(Cl)c4)c23)CC1,6.82,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,150.0,nM,=,CHEMBL923201,B,CHEMBL391387,Homo sapiens,CHEMBL203,CHEMBL1140690
Cc1cncc(COc2ccc(Nc3ncnn4ccc(CN5CCC(N)CC5)c34)cc2Cl)c1,7.07,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,85.0,nM,=,CHEMBL923201,B,CHEMBL248115,Homo sapiens,CHEMBL203,CHEMBL1140690
NC1CCN(Cc2ccn3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1,7.44,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,36.0,nM,=,CHEMBL923201,B,CHEMBL248116,Homo sapiens,CHEMBL203,CHEMBL1140690
NC1CCN(Cc2ccn3ncnc(Nc4ccc(OCc5cnccn5)c(Cl)c4)c23)CC1,7.50,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,32.0,nM,=,CHEMBL923201,B,CHEMBL248321,Homo sapiens,CHEMBL203,CHEMBL1140690
NC1CCN(Cc2ccn3ncnc(Nc4ccc(OCc5cccc[n+]5[O-])c(Cl)c4)c23)CC1,7.16,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,IC50,70.0,nM,=,CHEMBL923201,B,CHEMBL248322,Homo sapiens,CHEMBL203,CHEMBL1140690
Nc1ncnc2c1c(-c1ccc3nc(Cc4ccccc4)[nH]c3c1)nn2[C@H]1CC[C@H](N2CCOCC2)CC1,6.57,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,270.0,nM,=,CHEMBL964130,B,CHEMBL249496,Homo sapiens,CHEMBL203,CHEMBL1153290
Nc1ncnc2c1c(-c1ccc3nc(Cc4ccccc4Cl)[nH]c3c1)nn2[C@H]1CC[C@H](N2CCOCC2)CC1,7.19,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,65.0,nM,=,CHEMBL964130,B,CHEMBL251732,Homo sapiens,CHEMBL203,CHEMBL1153290
COc1ccccc1Cc1nc2ccc(-c3nn([C@H]4CC[C@H](N5CCOCC5)CC4)c4ncnc(N)c34)cc2[nH]1,7.24,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,58.0,nM,=,CHEMBL964130,B,CHEMBL437584,Homo sapiens,CHEMBL203,CHEMBL1153290
Nc1ncnc2c1c(-c1ccc3nc(Cc4cccs4)[nH]c3c1)nn2[C@H]1CC[C@H](N2CCOCC2)CC1,6.44,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,361.0,nM,=,CHEMBL964130,B,CHEMBL248877,Homo sapiens,CHEMBL203,CHEMBL1153290
O=C(CO)N1CCC[C@@H]1COc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12,7.01,Inhibition of EGFR,IC50,97.0,nM,=,CHEMBL924156,B,CHEMBL249927,Homo sapiens,CHEMBL203,CHEMBL1140495
O=C(CO)N1CCC[C@H]1COc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12,6.49,Inhibition of EGFR,IC50,327.0,nM,=,CHEMBL924156,B,CHEMBL403569,Homo sapiens,CHEMBL203,CHEMBL1140495
CN(CCOc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12)C(=O)CO,7.46,Inhibition of EGFR,IC50,35.0,nM,=,CHEMBL924156,B,CHEMBL249928,Homo sapiens,CHEMBL203,CHEMBL1140495
C[C@H](COc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12)N(C)C(=O)CO,8.52,Inhibition of EGFR,IC50,3.0,nM,=,CHEMBL924156,B,CHEMBL250130,Homo sapiens,CHEMBL203,CHEMBL1140495
C[C@@H](COc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12)N(C)C(=O)CO,5.59,Inhibition of EGFR,IC50,2580.0,nM,=,CHEMBL924156,B,CHEMBL403785,Homo sapiens,CHEMBL203,CHEMBL1140495
C[C@H](CN(C)C(=O)CO)Oc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12,8.70,Inhibition of EGFR,IC50,2.0,nM,=,CHEMBL924156,B,CHEMBL250132,Homo sapiens,CHEMBL203,CHEMBL1140495
C[C@@H](CN(C)C(=O)CO)Oc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12,6.72,Inhibition of EGFR,IC50,191.0,nM,=,CHEMBL924156,B,CHEMBL413987,Homo sapiens,CHEMBL203,CHEMBL1140495
C#Cc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,6.90,Inhibition of EGFR,IC50,126.9,nM,=,CHEMBL924351,B,CHEMBL249509,Homo sapiens,CHEMBL203,CHEMBL1140520
Fc1ccc(Nc2ncnc3ccc(C#Cc4ccccc4)cc23)cc1Cl,6.48,Inhibition of EGFR,IC50,331.0,nM,=,CHEMBL924351,B,CHEMBL249511,Homo sapiens,CHEMBL203,CHEMBL1140520
Fc1ccc(Nc2ncnc3ccc(C#Cc4cccs4)cc23)cc1Cl,5.79,Inhibition of EGFR,IC50,1640.6,nM,=,CHEMBL924351,B,CHEMBL398963,Homo sapiens,CHEMBL203,CHEMBL1140520
OCC#Cc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,7.85,Inhibition of EGFR,IC50,14.1,nM,=,CHEMBL924351,B,CHEMBL249919,Homo sapiens,CHEMBL203,CHEMBL1140520
OCCC#Cc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,6.73,Inhibition of EGFR,IC50,185.8,nM,=,CHEMBL924351,B,CHEMBL249921,Homo sapiens,CHEMBL203,CHEMBL1140520
OCCCC#Cc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,6.94,Inhibition of EGFR,IC50,114.2,nM,=,CHEMBL924351,B,CHEMBL251291,Homo sapiens,CHEMBL203,CHEMBL1140520
CC(O)C#Cc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,7.03,Inhibition of EGFR,IC50,94.5,nM,=,CHEMBL924351,B,CHEMBL399928,Homo sapiens,CHEMBL203,CHEMBL1140520
CC(C)(O)C#Cc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,6.82,Inhibition of EGFR,IC50,151.5,nM,=,CHEMBL924351,B,CHEMBL251497,Homo sapiens,CHEMBL203,CHEMBL1140520
Fc1ccc(Nc2ncnc3ccc(C#CCN4CCOCC4)cc23)cc1Cl,7.30,Inhibition of EGFR,IC50,50.3,nM,=,CHEMBL924351,B,CHEMBL251498,Homo sapiens,CHEMBL203,CHEMBL1140520
Fc1ccc(Nc2ncnc3ccc(C#CCN4CCCCC4)cc23)cc1Cl,7.05,Inhibition of EGFR,IC50,88.7,nM,=,CHEMBL924351,B,CHEMBL251700,Homo sapiens,CHEMBL203,CHEMBL1140520
COc1cc2ncnc(Nc3cccc(C#Cc4ccccc4)c3)c2cc1OC,6.04,Inhibition of EGFR,IC50,921.0,nM,=,CHEMBL924351,B,CHEMBL399735,Homo sapiens,CHEMBL203,CHEMBL1140520
COc1cc2ncnc(Nc3cccc(C#CCO)c3)c2cc1OC,5.78,Inhibition of EGFR,IC50,1643.6,nM,=,CHEMBL924351,B,CHEMBL399736,Homo sapiens,CHEMBL203,CHEMBL1140520
COc1cc2ncnc(Nc3cccc(C#CCCO)c3)c2cc1OC,6.40,Inhibition of EGFR,IC50,402.1,nM,=,CHEMBL924351,B,CHEMBL248674,Homo sapiens,CHEMBL203,CHEMBL1140520
COc1cc2ncnc(Nc3cccc(C#CCCCO)c3)c2cc1OC,5.87,Inhibition of EGFR,IC50,1362.6,nM,=,CHEMBL924351,B,CHEMBL437197,Homo sapiens,CHEMBL203,CHEMBL1140520
COc1cc2ncnc(Nc3cccc(C#CC(C)(C)O)c3)c2cc1OC,6.69,Inhibition of EGFR,IC50,205.8,nM,=,CHEMBL924351,B,CHEMBL248864,Homo sapiens,CHEMBL203,CHEMBL1140520
COc1cc2ncnc(C#Cc3ccccc3)c2cc1OC,5.25,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,5600.0,nM,=,CHEMBL925198,B,CHEMBL250315,Homo sapiens,CHEMBL203,CHEMBL1140492
COc1cc2ncnc(C#CCCc3ccccc3)c2cc1OC,7.85,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,14.0,nM,=,CHEMBL925198,B,CHEMBL250318,Homo sapiens,CHEMBL203,CHEMBL1140492
COc1cc2ncnc(C#CCOc3ccccc3)c2cc1OC,7.82,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,15.0,nM,=,CHEMBL925198,B,CHEMBL250523,Homo sapiens,CHEMBL203,CHEMBL1140492
COc1cc2ncnc(C#CC(C)(C)Cc3ccccc3)c2cc1OC,7.89,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,13.0,nM,=,CHEMBL925198,B,CHEMBL399953,Homo sapiens,CHEMBL203,CHEMBL1140492
COc1cc2ncnc(C#CC(C)(C)N(C)c3ccccc3)c2cc1OC,7.10,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,80.0,nM,=,CHEMBL925198,B,CHEMBL250524,Homo sapiens,CHEMBL203,CHEMBL1140492
COc1cc2ncnc(/C=C/CCc3ccccc3)c2cc1OC,8.40,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,4.0,nM,=,CHEMBL925198,B,CHEMBL250923,Homo sapiens,CHEMBL203,CHEMBL1140492
COc1cc2ncnc(C#Cc3ccccc3-c3ccccc3)c2cc1OC,7.58,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,26.0,nM,=,CHEMBL925198,B,CHEMBL250924,Homo sapiens,CHEMBL203,CHEMBL1140492
CCOc1cc2ncnc(/C=C/c3ccccc3)c2cc1OCC,7.82,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,15.0,nM,=,CHEMBL925198,B,CHEMBL250925,Homo sapiens,CHEMBL203,CHEMBL1140492
CCOc1cc2ncnc(/C=C/CCc3ccccc3)c2cc1OCC,8.30,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,5.0,nM,=,CHEMBL925198,B,CHEMBL399371,Homo sapiens,CHEMBL203,CHEMBL1140492
CCOc1cc2ncnc(/C=C/CCCc3ccccc3)c2cc1OCC,6.85,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,140.0,nM,=,CHEMBL925198,B,CHEMBL251123,Homo sapiens,CHEMBL203,CHEMBL1140492
CCOc1cc2ncnc(C#Cc3[nH]ccc3-c3ccccc3)c2cc1OCC,8.00,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,10.0,nM,=,CHEMBL925198,B,CHEMBL251124,Homo sapiens,CHEMBL203,CHEMBL1140492
CCOc1cc2ncnc(C#Cc3nccn3-c3ccccc3)c2cc1OCC,7.92,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,12.0,nM,=,CHEMBL925198,B,CHEMBL399372,Homo sapiens,CHEMBL203,CHEMBL1140492
CCOc1cc2ncnc(C#Cc3c[nH]nc3-c3ccc(F)cc3)c2cc1OCC,8.74,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,1.8,nM,=,CHEMBL925198,B,CHEMBL251125,Homo sapiens,CHEMBL203,CHEMBL1140492
CCOc1cc2ncnc(C#CC(C)(Cc3ccccc3)N3CCC(C(=O)O)CC3)c2cc1OCC,7.93,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,11.7,nM,=,CHEMBL925198,B,CHEMBL251314,Homo sapiens,CHEMBL203,CHEMBL1140492
CCOc1cc2ncnc(C#C[C@@](C)(Cc3ccccc3)N3CCC(C(=O)O)CC3)c2cc1OCC,8.38,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,4.2,nM,=,CHEMBL925198,B,CHEMBL399373,Homo sapiens,CHEMBL203,CHEMBL1140492
CCOc1cc2ncnc(C#C[C@](C)(Cc3ccccc3)N3CCC(C(=O)O)CC3)c2cc1OCC,6.18,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,662.0,nM,=,CHEMBL925198,B,CHEMBL251315,Homo sapiens,CHEMBL203,CHEMBL1140492
COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OC,7.62,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,24.0,nM,=,CHEMBL923921,B,CHEMBL248044,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1ccc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2c1,6.75,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,180.0,nM,=,CHEMBL923921,B,CHEMBL248045,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1ccc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2c1,6.44,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,360.0,nM,=,CHEMBL923921,B,CHEMBL401644,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OCc1ccccc1,6.92,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,120.0,nM,=,CHEMBL923921,B,CHEMBL248220,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OCCN1CCOCC1,7.19,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,64.0,nM,=,CHEMBL923921,B,CHEMBL401054,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OCCCN1CCOCC1,7.28,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,52.0,nM,=,CHEMBL923921,B,CHEMBL248221,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OCCCc1cccnc1,7.17,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,68.0,nM,=,CHEMBL923921,B,CHEMBL248222,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1cc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2cc1OCCCc1cccnc1,6.76,Inhibition of human EGFR autophosphorylation in A431 cells,IC50,173.0,nM,=,CHEMBL923922,B,CHEMBL248391,Homo sapiens,CHEMBL203,CHEMBL1140464
COCCOc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OC,7.28,Inhibition of human EGFR autophosphorylation in A431 cells,IC50,52.8,nM,=,CHEMBL923922,B,CHEMBL401251,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1cc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2cc1OCCCN1CCOCC1,8.30,Inhibition of human EGFR autophosphorylation in A431 cells,IC50,5.0,nM,=,CHEMBL923922,B,CHEMBL248392,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1cc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1,8.52,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,3.0,nM,=,CHEMBL923921,B,CHEMBL248393,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1cc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2cc1OC1CCN(C)CC1,6.44,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,360.0,nM,=,CHEMBL923921,B,CHEMBL245798,Homo sapiens,CHEMBL203,CHEMBL1140464
N#Cc1cnc2ccc(-c3cccc(CN4CCOCC4)c3)cc2c1N[C@@H]1C[C@H]1c1ccccc1,6.47,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,340.0,nM,=,CHEMBL923921,B,CHEMBL245799,Homo sapiens,CHEMBL203,CHEMBL1140464
N#Cc1cnc2ccc(-c3ccc(CN)cc3)cc2c1N[C@@H]1C[C@H]1c1ccccc1,7.40,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,40.0,nM,=,CHEMBL923921,B,CHEMBL245800,Homo sapiens,CHEMBL203,CHEMBL1140464
N#Cc1cnc2ccc(-c3ccc(CN4CCOCC4)cc3)cc2c1N[C@@H]1C[C@H]1c1ccccc1,6.40,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,400.0,nM,=,CHEMBL923921,B,CHEMBL247024,Homo sapiens,CHEMBL203,CHEMBL1140464
N#Cc1cnc2cc(-c3ccc(CN4CCOCC4)cc3)ccc2c1N[C@@H]1C[C@H]1c1ccccc1,7.10,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,80.0,nM,=,CHEMBL923921,B,CHEMBL399438,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccc(Cl)cc3)c2cc1OC,7.36,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,44.0,nM,=,CHEMBL923921,B,CHEMBL247196,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccc(Oc4ccccc4)cc3)c2cc1OC,7.10,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,80.0,nM,=,CHEMBL923921,B,CHEMBL245996,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccc(Br)cc3)c2cc1OC,6.66,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,220.0,nM,=,CHEMBL923921,B,CHEMBL400742,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3cccc(Br)c3)c2cc1OC,7.28,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,52.0,nM,=,CHEMBL923921,B,CHEMBL248425,Homo sapiens,CHEMBL203,CHEMBL1140464
COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3F)c2cc1OC,7.44,Inhibition of human recombinant EGFR by fluorescence polarization assay,Ki,36.0,nM,=,CHEMBL923921,B,CHEMBL246419,Homo sapiens,CHEMBL203,CHEMBL1140464
Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12,5.00,Inhibition of human EGFR,IC50,10000.0,nM,=,CHEMBL903566,B,CHEMBL247228,Homo sapiens,CHEMBL203,CHEMBL1139135
CCN(CC)CCOc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1,6.42,Inhibition of EGFR,IC50,380.0,nM,=,CHEMBL929547,B,CHEMBL253292,Homo sapiens,CHEMBL203,CHEMBL1141507
Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)nc12,5.80,In vitro inhibitory concentration EGF receptor with ATP concentration at 1/2Km,IC50,1600.0,nM,=,CHEMBL881766,B,CHEMBL401930,Homo sapiens,CHEMBL203,CHEMBL1143653
NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1,5.23,Inhibition Assay: Inhibition of recombinant EGFR tyrosine kinase using exogenous substrate.,IC50,5853.4,nM,=,CHEMBL3889034,B,CHEMBL253969,Homo sapiens,CHEMBL203,CHEMBL3886928
Cc1ccc(Oc2ccc(Nc3ncnc4cccc(O[C@H](C)C(=O)N(C)C)c34)cc2C)cn1,5.96,Inhibition of EGFR,IC50,1100.0,nM,=,CHEMBL930778,B,CHEMBL256362,Homo sapiens,CHEMBL203,CHEMBL1141561
C[C@@H](Oc1cccc2ncnc(Nc3ccc4c(cnn4Cc4ccccn4)c3)c12)C(=O)N(C)C,6.75,Inhibition of EGFR,IC50,180.0,nM,=,CHEMBL928913,B,CHEMBL402011,Homo sapiens,CHEMBL203,CHEMBL1141539
C[C@@H](Oc1cccc2ncnc(Nc3ccc4c(cnn4Cc4nccs4)c3)c12)C(=O)N1CCOCC1,8.80,Inhibition of EGFR,Ki,1.6,nM,=,CHEMBL928913,B,CHEMBL257411,Homo sapiens,CHEMBL203,CHEMBL1141539
COc1ccccc1CO/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(F)c2)c1,7.33,Inhibition of EGFR,IC50,47.0,nM,=,CHEMBL934832,B,CHEMBL255236,Homo sapiens,CHEMBL203,CHEMBL1145585
COCCO/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(F)c2)c1,7.85,Inhibition of EGFR,IC50,14.0,nM,=,CHEMBL934832,B,CHEMBL255237,Homo sapiens,CHEMBL203,CHEMBL1145585
Nc1ncnc(Nc2ccc3c(cnn3Cc3cccc(F)c3)c2)c1/C=N/OCc1ccccc1,7.64,Inhibition of EGFR,IC50,23.0,nM,=,CHEMBL934832,B,CHEMBL255438,Homo sapiens,CHEMBL203,CHEMBL1145585
CC(C)CO/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(F)c2)c1,7.50,Inhibition of EGFR,IC50,32.0,nM,=,CHEMBL934832,B,CHEMBL430031,Homo sapiens,CHEMBL203,CHEMBL1145585
CC(C)O/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(F)c2)c1,7.85,Inhibition of EGFR,IC50,14.0,nM,=,CHEMBL934832,B,CHEMBL402293,Homo sapiens,CHEMBL203,CHEMBL1145585
CCO/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(F)c2)c1,8.30,Inhibition of EGFR,IC50,5.0,nM,=,CHEMBL934832,B,CHEMBL402294,Homo sapiens,CHEMBL203,CHEMBL1145585
Nc1ncnc(Nc2ccc3c(cnn3Cc3cccc(F)c3)c2)c1/C=N/O,7.92,Inhibition of EGFR,IC50,12.0,nM,=,CHEMBL934832,B,CHEMBL256295,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,7.92,Inhibition of EGFR,IC50,12.0,nM,=,CHEMBL934832,B,CHEMBL256297,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1ccc2c(c1)CCN2Cc1cccc(F)c1,7.24,Inhibition of EGFR,IC50,57.0,nM,=,CHEMBL934832,B,CHEMBL257814,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1ccc(OCc2ccccc2)c(Cl)c1,7.80,Inhibition of EGFR,IC50,16.0,nM,=,CHEMBL934832,B,CHEMBL257815,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1ccc2c(ccn2Cc2cccc(F)c2)c1,7.89,Inhibition of EGFR,IC50,13.0,nM,=,CHEMBL934832,B,CHEMBL257816,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1ccc2[nH]c(Cc3cccc(F)c3)nc2c1,7.32,Inhibition of EGFR,IC50,48.0,nM,=,CHEMBL934832,B,CHEMBL402316,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2ccc(F)cc2)c1,6.98,Inhibition of EGFR,IC50,104.0,nM,=,CHEMBL934832,B,CHEMBL256527,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(OC)c2)c1,6.57,Inhibition of EGFR,IC50,267.0,nM,=,CHEMBL934832,B,CHEMBL403357,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1ccc(OCc2cc(F)cc(F)c2)c(Cl)c1,7.48,Inhibition of EGFR,IC50,33.0,nM,=,CHEMBL934832,B,CHEMBL256529,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(Cl)c2)c1,7.64,Inhibition of EGFR,IC50,23.0,nM,=,CHEMBL934832,B,CHEMBL255656,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(C#N)c2)c1,7.70,Inhibition of EGFR,IC50,20.0,nM,=,CHEMBL934832,B,CHEMBL255865,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1ccc2[nH]ncc2c1,6.51,Inhibition of EGFR,IC50,306.0,nM,=,CHEMBL934832,B,CHEMBL255866,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2ccccc2)c1,7.36,Inhibition of EGFR,IC50,44.0,nM,=,CHEMBL934832,B,CHEMBL402113,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1NCc1ccc(F)c(Cl)c1,5.95,Inhibition of EGFR,IC50,1123.0,nM,=,CHEMBL934832,B,CHEMBL255291,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1ccc(F)c(Cl)c1,7.16,Inhibition of EGFR,IC50,70.0,nM,=,CHEMBL934832,B,CHEMBL255490,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1cccc(Br)c1,7.62,Inhibition of EGFR,IC50,24.0,nM,=,CHEMBL934832,B,CHEMBL402149,Homo sapiens,CHEMBL203,CHEMBL1145585
CO/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(F)c2)c1,8.10,Inhibition of EGFR,IC50,8.0,nM,=,CHEMBL934832,B,CHEMBL255871,Homo sapiens,CHEMBL203,CHEMBL1145585
Cc1nnc(-c2cn3ncnc(Nc4cnc5[nH]ccc5c4)c3c2C(C)C)o1,6.82,Inhibition of EGFR,IC50,150.0,nM,=,CHEMBL929426,B,CHEMBL258694,Homo sapiens,CHEMBL203,CHEMBL1145598
O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,5.50,Binding constant for EGFR(L858R) kinase domain,Kd,3200.0,nM,=,CHEMBL1062839,B,CHEMBL259084,Homo sapiens,CHEMBL203,CHEMBL1150977
CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1ccc(C)cc1)NC(=O)[C@H](CCCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)Cc1ccccc1)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)[C@@H](C)CC)[C@@H](C)CC,9.03,Displacement of radiolabeled EGF from EGF receptor expressed in human MX1 cells,Kd,0.94,nM,=,CHEMBL921756,B,CHEMBL437469,Homo sapiens,CHEMBL203,CHEMBL1147056
O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2,4.88,Inhibition of wild type EGFR,IC50,13300.0,nM,=,CHEMBL937186,B,CHEMBL408565,Homo sapiens,CHEMBL203,CHEMBL1145498
CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1,8.52,Inhibition of ErbB1,IC50,3.0,nM,=,CHEMBL937170,B,CHEMBL258940,Homo sapiens,CHEMBL203,CHEMBL1145498
O=C(O)/C=C/c1cc(CO)ccc1CO,6.11,Inhibition of wild type EGFR,IC50,780.0,nM,=,CHEMBL939337,B,CHEMBL407534,Homo sapiens,CHEMBL203,CHEMBL1145498
Nc1nccn2c1c(-c1ccc3ccc(-c4ccccc4)nc3c1)nc2[C@H]1C[C@@H](CN2CCC2)C1,5.02,Inhibition of EGFR,IC50,9600.0,nM,=,CHEMBL921277,B,CHEMBL410659,Homo sapiens,CHEMBL203,CHEMBL1143953
COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC,5.93,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Kd,1163.0,nM,=,CHEMBL3991696,B,CHEMBL405130,Homo sapiens,CHEMBL203,CHEMBL3991601
COc1cc(Nc2nn3c(N[C@H](CO)Cc4ccccc4)cc(C4CC4)nc3c2C(N)=O)cc(OC)c1,5.62,Inhibition of EGFR,IC50,2400.0,nM,=,CHEMBL921778,B,CHEMBL260861,Homo sapiens,CHEMBL203,CHEMBL1143964
CN1CCN(CCCOc2n[nH]c3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1,7.85,Inhibition of EGFR,IC50,14.0,nM,=,CHEMBL947896,B,CHEMBL272935,Homo sapiens,CHEMBL203,CHEMBL1143160
Clc1cc(Nc2ncnc3[nH]nc(OCCCN4CCOCC4)c23)ccc1OCc1ccccn1,7.80,Inhibition of EGFR,IC50,16.0,nM,=,CHEMBL947896,B,CHEMBL257859,Homo sapiens,CHEMBL203,CHEMBL1143160
OC1CCN(CCCOc2n[nH]c3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1,8.05,Inhibition of EGFR,IC50,9.0,nM,=,CHEMBL947896,B,CHEMBL257860,Homo sapiens,CHEMBL203,CHEMBL1143160
OCCOc1n[nH]c2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12,7.80,Inhibition of EGFR,IC50,16.0,nM,=,CHEMBL947896,B,CHEMBL257861,Homo sapiens,CHEMBL203,CHEMBL1143160
Clc1cc(Nc2ncnc3[nH]nc(OCCN4CCOCC4)c23)ccc1OCc1ccccn1,9.00,Inhibition of EGFR,IC50,1.0,nM,=,CHEMBL947896,B,CHEMBL271705,Homo sapiens,CHEMBL203,CHEMBL1143160
COC1CCN(CCOc2n[nH]c3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1,7.55,Inhibition of EGFR,IC50,28.0,nM,=,CHEMBL947896,B,CHEMBL411897,Homo sapiens,CHEMBL203,CHEMBL1143160
Clc1cc(Nc2ncnc3[nH]nc(OCCN4CCNCC4)c23)ccc1OCc1ccccn1,8.10,Inhibition of EGFR,IC50,8.0,nM,=,CHEMBL947896,B,CHEMBL257430,Homo sapiens,CHEMBL203,CHEMBL1143160
Clc1cc(Nc2ncnc3[nH]nc(OCCN4CCCC4)c23)ccc1OCc1ccccn1,8.10,Inhibition of EGFR,IC50,8.0,nM,=,CHEMBL947896,B,CHEMBL402553,Homo sapiens,CHEMBL203,CHEMBL1143160
CC(=O)N1CCN(CCOc2n[nH]c3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1,8.52,Inhibition of EGFR,IC50,3.0,nM,=,CHEMBL947896,B,CHEMBL258270,Homo sapiens,CHEMBL203,CHEMBL1143160
CN1CCN(CCOc2n[nH]c3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1,8.30,Inhibition of EGFR,IC50,5.0,nM,=,CHEMBL947896,B,CHEMBL258282,Homo sapiens,CHEMBL203,CHEMBL1143160
CNCCOc1n[nH]c2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12,7.77,Inhibition of EGFR,IC50,17.0,nM,=,CHEMBL947896,B,CHEMBL255135,Homo sapiens,CHEMBL203,CHEMBL1143160
COc1cc(Nc2ncnc3[nH]nc(OCCN4CCC(O)CC4)c23)ccc1OCc1ccccn1,6.98,Inhibition of EGFR,IC50,104.0,nM,=,CHEMBL947896,B,CHEMBL401713,Homo sapiens,CHEMBL203,CHEMBL1143160
COc1cc(Nc2ncnc3[nH]nc(OCCN4CCC(O)CC4)c23)ccc1OCc1cccc(F)c1,7.89,Inhibition of EGFR,IC50,13.0,nM,=,CHEMBL947896,B,CHEMBL402339,Homo sapiens,CHEMBL203,CHEMBL1143160
Cc1ccc(Oc2ccc(Nc3ncnc4[nH]nc(OCCN5CCC(O)CC5)c34)cc2C)cn1,6.67,Inhibition of EGFR,IC50,216.0,nM,=,CHEMBL947896,B,CHEMBL257872,Homo sapiens,CHEMBL203,CHEMBL1143160
Cc1ccc(Oc2ccc(Nc3ncnc4[nH]nc(OCCN5CCC(O)CC5)c34)cc2F)cn1,5.84,Inhibition of EGFR,IC50,1430.0,nM,=,CHEMBL947896,B,CHEMBL257873,Homo sapiens,CHEMBL203,CHEMBL1143160
Cc1cc(Nc2ncnc3[nH]nc(OCCN4CCC(O)CC4)c23)ccc1OCc1ccccn1,7.75,Inhibition of EGFR,IC50,18.0,nM,=,CHEMBL947896,B,CHEMBL403435,Homo sapiens,CHEMBL203,CHEMBL1143160
Cc1ccc(Oc2ccc(Nc3ncnc4[nH]nc(OCCN5CCC(O)CC5)c34)cc2Cl)cn1,8.15,Inhibition of EGFR,IC50,7.0,nM,=,CHEMBL947896,B,CHEMBL255170,Homo sapiens,CHEMBL203,CHEMBL1143160
OC1CCN(CCOc2n[nH]c3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)CC1,7.89,Inhibition of EGFR,IC50,13.0,nM,=,CHEMBL947896,B,CHEMBL404405,Homo sapiens,CHEMBL203,CHEMBL1143160
Cc1ccc(Oc2ccc(Nc3ncnc4cccc(O[C@H](C)C(=O)N(C)CCO)c34)cc2C)cn1,5.70,Inhibition of EGFR,IC50,2000.0,nM,=,CHEMBL930778,B,CHEMBL257478,Homo sapiens,CHEMBL203,CHEMBL1141561
C[C@@H](Oc1cccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12)C(=O)N(C)C,7.66,Inhibition of EGFR,IC50,22.0,nM,=,CHEMBL930778,B,CHEMBL428777,Homo sapiens,CHEMBL203,CHEMBL1141561
Brc1cccc(Nc2ncnc3ccncc23)c1NCCN1CCOCC1,8.49,Inhibition of EGFR,IC50,3.236,nM,=,CHEMBL952131,B,CHEMBL405398,Homo sapiens,CHEMBL203,CHEMBL1143196
O=C(O)CNc1c(Br)cccc1Nc1ncnc2ccncc12,8.82,Inhibition of EGFR,IC50,1.514,nM,=,CHEMBL952131,B,CHEMBL405771,Homo sapiens,CHEMBL203,CHEMBL1143196
CN(C)CCN(C)c1c(Br)cccc1Nc1ncnc2ccncc12,7.39,Inhibition of EGFR,IC50,40.74,nM,=,CHEMBL952131,B,CHEMBL270966,Homo sapiens,CHEMBL203,CHEMBL1143196
Nc1cc(C(F)(F)F)ccc1Nc1ncnc2ccncc12,5.32,Inhibition of EGFR,IC50,4786.3,nM,=,CHEMBL952131,B,CHEMBL408351,Homo sapiens,CHEMBL203,CHEMBL1143196
COc1cc2ncnc(Nc3ccccc3N)c2cn1,5.43,Inhibition of EGFR,IC50,3715.35,nM,=,CHEMBL952131,B,CHEMBL408105,Homo sapiens,CHEMBL203,CHEMBL1143196
Brc1cccc(Nc2ncnc3ccncc23)c1NCCc1c[nH]cn1,9.04,Inhibition of EGFR,IC50,0.912,nM,=,CHEMBL952131,B,CHEMBL272187,Homo sapiens,CHEMBL203,CHEMBL1143196
CN(C)CCCCCNc1c(Br)cccc1Nc1ncnc2ccncc12,8.07,Inhibition of EGFR,IC50,8.511,nM,=,CHEMBL952131,B,CHEMBL411243,Homo sapiens,CHEMBL203,CHEMBL1143196
Nc1cc(Br)ccc1Nc1ncnc2ccncc12,7.59,Inhibition of EGFR,IC50,25.7,nM,=,CHEMBL952131,B,CHEMBL271617,Homo sapiens,CHEMBL203,CHEMBL1143196
Brc1cccc(Nc2ncnc3ccncc23)c1NCCCn1ccnc1,9.29,Inhibition of EGFR,IC50,0.5129,nM,=,CHEMBL952131,B,CHEMBL272865,Homo sapiens,CHEMBL203,CHEMBL1143196
Nc1ccccc1Nc1ncnc2cc(Br)ncc12,6.61,Inhibition of EGFR,IC50,245.47,nM,=,CHEMBL952131,B,CHEMBL273116,Homo sapiens,CHEMBL203,CHEMBL1143196
Nc1c(Br)cccc1Nc1ncnc2ccncc12,8.00,Inhibition of EGFR,IC50,10.0,nM,=,CHEMBL952131,B,CHEMBL258598,Homo sapiens,CHEMBL203,CHEMBL1143196
CN(C)CCCCNc1c(Br)cccc1Nc1ncnc2ccncc12,8.13,Inhibition of EGFR,IC50,7.413,nM,=,CHEMBL952131,B,CHEMBL270501,Homo sapiens,CHEMBL203,CHEMBL1143196
Nc1c(Nc2ncnc3ccncc23)cccc1[N+](=O)[O-],7.39,Inhibition of EGFR,IC50,40.74,nM,=,CHEMBL952131,B,CHEMBL441332,Homo sapiens,CHEMBL203,CHEMBL1143196
NNc1c(Br)cccc1Nc1ncnc2ccncc12,8.14,Inhibition of EGFR,IC50,7.244,nM,=,CHEMBL952131,B,CHEMBL272634,Homo sapiens,CHEMBL203,CHEMBL1143196
Nc1ccccc1Nc1ncnc2ccncc12,6.60,Inhibition of EGFR,IC50,251.19,nM,=,CHEMBL952131,B,CHEMBL272258,Homo sapiens,CHEMBL203,CHEMBL1143196
CN(C)CCNc1c(Br)cccc1Nc1ncnc2ccncc12,7.34,Inhibition of EGFR,IC50,45.71,nM,=,CHEMBL952131,B,CHEMBL270713,Homo sapiens,CHEMBL203,CHEMBL1143196
CN(C)CCCNc1c(Br)cccc1Nc1ncnc2ccncc12,8.05,Inhibition of EGFR,IC50,8.913,nM,=,CHEMBL952131,B,CHEMBL408647,Homo sapiens,CHEMBL203,CHEMBL1143196
COc1c(Br)cccc1Nc1ncnc2ccncc12,7.40,Inhibition of EGFR,IC50,39.81,nM,=,CHEMBL952131,B,CHEMBL441333,Homo sapiens,CHEMBL203,CHEMBL1143196
Fc1c(Br)cccc1Nc1ncnc2ccncc12,7.88,Inhibition of EGFR,IC50,13.18,nM,=,CHEMBL952131,B,CHEMBL269889,Homo sapiens,CHEMBL203,CHEMBL1143196
OCCN(CCO)c1c(Br)cccc1Nc1ncnc2ccncc12,7.92,Inhibition of EGFR,IC50,12.02,nM,=,CHEMBL952131,B,CHEMBL406004,Homo sapiens,CHEMBL203,CHEMBL1143196
OCCN(CCO)CCCNc1c(Br)cccc1Nc1ncnc2ccncc12,8.92,Inhibition of EGFR,IC50,1.202,nM,=,CHEMBL952131,B,CHEMBL427832,Homo sapiens,CHEMBL203,CHEMBL1143196
CN(CC(O)CO)c1c(Br)cccc1Nc1ncnc2ccncc12,8.49,Inhibition of EGFR,IC50,3.236,nM,=,CHEMBL952131,B,CHEMBL410635,Homo sapiens,CHEMBL203,CHEMBL1143196
OCN(CO)c1c(Br)cccc1Nc1ncnc2ccncc12,7.85,Inhibition of EGFR,IC50,14.13,nM,=,CHEMBL952131,B,CHEMBL272477,Homo sapiens,CHEMBL203,CHEMBL1143196
OCC(O)CNc1c(Br)cccc1Nc1ncnc2ccncc12,9.03,Inhibition of EGFR,IC50,0.9333,nM,=,CHEMBL952131,B,CHEMBL270695,Homo sapiens,CHEMBL203,CHEMBL1143196
OCCNc1c(Br)cccc1Nc1ncnc2ccncc12,9.61,Inhibition of EGFR,IC50,0.2455,nM,=,CHEMBL952131,B,CHEMBL270696,Homo sapiens,CHEMBL203,CHEMBL1143196
CN(CCO)c1c(Br)cccc1Nc1ncnc2ccncc12,8.58,Inhibition of EGFR,IC50,2.63,nM,=,CHEMBL952131,B,CHEMBL408397,Homo sapiens,CHEMBL203,CHEMBL1143196
CC(=O)Nc1c(Br)cccc1Nc1ncnc2ccncc12,7.53,Inhibition of EGFR,IC50,29.51,nM,=,CHEMBL952131,B,CHEMBL270921,Homo sapiens,CHEMBL203,CHEMBL1143196
OCCN(CCO)CCNc1c(Br)cccc1Nc1ncnc2ccncc12,8.03,Inhibition of EGFR,IC50,9.333,nM,=,CHEMBL952131,B,CHEMBL271623,Homo sapiens,CHEMBL203,CHEMBL1143196
Cc1cccc(Nc2ncnc3ccncc23)c1NCCCn1ccnc1,8.45,Inhibition of EGFR,IC50,3.548,nM,=,CHEMBL952131,B,CHEMBL271408,Homo sapiens,CHEMBL203,CHEMBL1143196
Cc1cccc(Nc2ncnc3ccncc23)c1NCCCN1CCOCC1,8.03,Inhibition of EGFR,IC50,9.333,nM,=,CHEMBL952131,B,CHEMBL271410,Homo sapiens,CHEMBL203,CHEMBL1143196
Cc1cccc(Nc2ncnc3ccncc23)c1NCCCN1CCN(C)CC1,8.25,Inhibition of EGFR,IC50,5.623,nM,=,CHEMBL952131,B,CHEMBL410253,Homo sapiens,CHEMBL203,CHEMBL1143196
Cc1cccc(Nc2ncnc3ccncc23)c1NCCCCN(C)C,8.26,Inhibition of EGFR,IC50,5.495,nM,=,CHEMBL952131,B,CHEMBL271587,Homo sapiens,CHEMBL203,CHEMBL1143196
O=S(=O)(O)CCNc1c(Br)cccc1Nc1ncnc2ccncc12,8.85,Inhibition of EGFR,IC50,1.413,nM,=,CHEMBL952131,B,CHEMBL270895,Homo sapiens,CHEMBL203,CHEMBL1143196
CN(CC(=O)O)c1c(Br)cccc1Nc1ncnc2ccncc12,7.79,Inhibition of EGFR,IC50,16.22,nM,=,CHEMBL952131,B,CHEMBL271113,Homo sapiens,CHEMBL203,CHEMBL1143196
O=C(O)CCCNc1c(Br)cccc1Nc1ncnc2ccncc12,9.55,Inhibition of EGFR,IC50,0.2818,nM,=,CHEMBL952131,B,CHEMBL271122,Homo sapiens,CHEMBL203,CHEMBL1143196
Brc1cccc(Nc2ncnc3cnc(NCCn4ccnc4)nc23)c1,8.63,Inhibition of EGFR,IC50,2.344,nM,=,CHEMBL952131,B,CHEMBL271328,Homo sapiens,CHEMBL203,CHEMBL1143196
CN1CCN(CCCNc2c(Br)cccc2Nc2ncnc3ccncc23)CC1,8.30,Inhibition of EGFR,IC50,5.012,nM,=,CHEMBL952131,B,CHEMBL271532,Homo sapiens,CHEMBL203,CHEMBL1143196
Brc1cccc(Nc2ncnc3ccncc23)c1NCCCCN1CCOCC1,8.26,Inhibition of EGFR,IC50,5.495,nM,=,CHEMBL952131,B,CHEMBL272895,Homo sapiens,CHEMBL203,CHEMBL1143196
Cc1cccc(Nc2ncnc3ccncc23)c1N,7.39,Inhibition of EGFR,IC50,40.74,nM,=,CHEMBL952131,B,CHEMBL405772,Homo sapiens,CHEMBL203,CHEMBL1143196
Nc1c(Cl)cccc1Nc1ncnc2ccncc12,6.92,Inhibition of EGFR,IC50,120.23,nM,=,CHEMBL952131,B,CHEMBL270975,Homo sapiens,CHEMBL203,CHEMBL1143196
Nc1c(O)cccc1Nc1ncnc2ccncc12,7.15,Inhibition of EGFR,IC50,70.79,nM,=,CHEMBL952131,B,CHEMBL402452,Homo sapiens,CHEMBL203,CHEMBL1143196
O=C(O)CCNc1c(Br)cccc1Nc1ncnc2ccncc12,9.21,Inhibition of EGFR,IC50,0.6166,nM,=,CHEMBL952131,B,CHEMBL408399,Homo sapiens,CHEMBL203,CHEMBL1143196
Brc1cccc(Nc2ncnc3ccncc23)c1NCCCN1CCOCC1,8.72,Inhibition of EGFR,IC50,1.905,nM,=,CHEMBL952131,B,CHEMBL271334,Homo sapiens,CHEMBL203,CHEMBL1143196
CN(C)c1ccc(Nc2ncnc3ccncc23)c(N)c1,5.31,Inhibition of EGFR,IC50,4897.79,nM,=,CHEMBL952131,B,CHEMBL271540,Homo sapiens,CHEMBL203,CHEMBL1143196
Nc1c(F)cccc1Nc1ncnc2ccncc12,6.07,Inhibition of EGFR,IC50,851.14,nM,=,CHEMBL952131,B,CHEMBL270924,Homo sapiens,CHEMBL203,CHEMBL1143196
CN(C)c1cccc(Nc2ncnc3ccncc23)c1N,5.74,Inhibition of EGFR,IC50,1819.7,nM,=,CHEMBL952131,B,CHEMBL406236,Homo sapiens,CHEMBL203,CHEMBL1143196
COc1ccc(Nc2ncnc3ccncc23)c(N)c1,6.17,Inhibition of EGFR,IC50,676.08,nM,=,CHEMBL952131,B,CHEMBL407591,Homo sapiens,CHEMBL203,CHEMBL1143196
COc1cccc(Nc2ncnc3ccncc23)c1N,6.88,Inhibition of EGFR,IC50,131.83,nM,=,CHEMBL952131,B,CHEMBL441335,Homo sapiens,CHEMBL203,CHEMBL1143196
Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,5.42,Inhibition of EGFR,IC50,3800.0,nM,=,CHEMBL976899,B,CHEMBL450786,Homo sapiens,CHEMBL203,CHEMBL1149823
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,8.47,"Binding constant for EGFR(L858R,T790M) kinase domain",Kd,3.4,nM,=,CHEMBL1908701,B,CHEMBL509032,Homo sapiens,CHEMBL203,CHEMBL1908390
COc1cc(C2=C(c3c[nH]c4ccccc34)CNC2=O)cc(OC)c1OC,4.64,Inhibition of human recombinant EGFR,IC50,23000.0,nM,=,CHEMBL957972,B,CHEMBL529663,Homo sapiens,CHEMBL203,CHEMBL1157465
COc1cc(C2=C(c3cn(COCC[Si](C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC,4.66,Inhibition of human recombinant EGFR,IC50,22000.0,nM,=,CHEMBL957972,B,CHEMBL486437,Homo sapiens,CHEMBL203,CHEMBL1157465
COc1cc(C2=C(c3cn(COC(C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC,5.05,Inhibition of human recombinant EGFR,IC50,9000.0,nM,=,CHEMBL957972,B,CHEMBL488646,Homo sapiens,CHEMBL203,CHEMBL1157465
COc1cc(C2=C(c3cn(COCc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC,4.85,Inhibition of human recombinant EGFR,IC50,14000.0,nM,=,CHEMBL957972,B,CHEMBL453336,Homo sapiens,CHEMBL203,CHEMBL1157465
Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1,5.65,Inhibition of EGFR,IC50,2240.0,nM,=,CHEMBL980757,B,CHEMBL461571,Homo sapiens,CHEMBL203,CHEMBL1139415
Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C=O,7.12,Inhibition of EGFR,IC50,76.0,nM,=,CHEMBL971642,B,CHEMBL461311,Homo sapiens,CHEMBL203,CHEMBL1156722
Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)O,7.39,Inhibition of EGFR,IC50,41.0,nM,=,CHEMBL971642,B,CHEMBL512391,Homo sapiens,CHEMBL203,CHEMBL1156722
COC(=O)c1c(N)ncnc1Nc1ccc(OCc2ccccc2)c(Cl)c1,7.27,Inhibition of EGFR,IC50,54.0,nM,=,CHEMBL971642,B,CHEMBL516487,Homo sapiens,CHEMBL203,CHEMBL1156722
Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)OCCN1CCOCC1,6.82,Inhibition of EGFR,IC50,150.0,nM,=,CHEMBL971642,B,CHEMBL461113,Homo sapiens,CHEMBL203,CHEMBL1156722
Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)Nc1ccccc1,7.12,Inhibition of EGFR,IC50,76.0,nM,=,CHEMBL971642,B,CHEMBL461114,Homo sapiens,CHEMBL203,CHEMBL1156722
N#Cc1c(N)ncnc1Nc1ccc(OCc2ccccc2)c(Cl)c1,7.57,Inhibition of EGFR,IC50,27.0,nM,=,CHEMBL971642,B,CHEMBL500591,Homo sapiens,CHEMBL203,CHEMBL1156722
NNC(=O)c1c(N)ncnc1Nc1ccc(OCc2ccccc2)c(Cl)c1,6.34,Inhibition of EGFR,IC50,458.0,nM,=,CHEMBL971642,B,CHEMBL511478,Homo sapiens,CHEMBL203,CHEMBL1156722
Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)NNC(=O)CCN1CCOCC1,6.21,Inhibition of EGFR,IC50,620.0,nM,=,CHEMBL971642,B,CHEMBL472544,Homo sapiens,CHEMBL203,CHEMBL1156722
Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1-c1nnc(CCN2CCOCC2)o1,7.52,Inhibition of EGFR,IC50,30.0,nM,=,CHEMBL971642,B,CHEMBL472545,Homo sapiens,CHEMBL203,CHEMBL1156722
CN(C)CCOc1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1,5.48,Inhibition of HER1,IC50,3300.0,nM,=,CHEMBL955786,B,CHEMBL461140,Homo sapiens,CHEMBL203,CHEMBL1152141
N=C(N)SCCCn1c(=O)c2c(c1=O)n1c3ccccc3cc1c1cccc3ccn2c31,5.34,Inhibition of human EGFR,IC50,4600.0,nM,=,CHEMBL962243,B,CHEMBL489083,Homo sapiens,CHEMBL203,CHEMBL1151764
CNC(=N)SCCCn1c(=O)c2c(c1=O)n1c3ccccc3cc1c1cccc3ccn2c31,5.00,Inhibition of human EGFR,IC50,9900.0,nM,=,CHEMBL962243,B,CHEMBL488271,Homo sapiens,CHEMBL203,CHEMBL1151764
N=C(Nc1ccccc1)SCCCN1C(=O)C2=C(C1=O)n1ccc3cccc(c31)C1Cc3ccccc3N21,5.02,Inhibition of human EGFR,IC50,9500.0,nM,=,CHEMBL962243,B,CHEMBL487254,Homo sapiens,CHEMBL203,CHEMBL1151764
COc1cc2ncnc(-c3c[nH]c4cc(F)c(C)cc34)c2cc1OC,6.27,Inhibition of human EGFR tyrosine kinase activity,IC50,533.0,nM,=,CHEMBL945670,B,CHEMBL474323,Homo sapiens,CHEMBL203,CHEMBL1140956
COCCOc1cc2ncnc(-c3c[nH]c4cc(F)c(Cl)cc34)c2cc1OCCOC,6.33,Inhibition of human EGFR tyrosine kinase activity,IC50,472.0,nM,=,CHEMBL945670,B,CHEMBL474324,Homo sapiens,CHEMBL203,CHEMBL1140956
COc1cc2ncnc(-c3c[nH]c4cc(F)c(Cl)cc34)c2cc1OCCCN1CCOCC1,6.48,Inhibition of human EGFR tyrosine kinase activity,IC50,333.0,nM,=,CHEMBL945670,B,CHEMBL474524,Homo sapiens,CHEMBL203,CHEMBL1140956
COc1cc2ncnc(-c3c[nH]c4ccc(Br)cc34)c2cc1OC,6.88,Inhibition of human EGFR tyrosine kinase activity,IC50,131.0,nM,=,CHEMBL945670,B,CHEMBL473320,Homo sapiens,CHEMBL203,CHEMBL1140956
COc1cc2ncnc(-c3c[nH]c4cc(F)c(Cl)cc34)c2cc1OC,6.68,Inhibition of human EGFR tyrosine kinase activity,IC50,209.0,nM,=,CHEMBL945670,B,CHEMBL515401,Homo sapiens,CHEMBL203,CHEMBL1140956
C=CC(=O)Nc1nc2c(Cc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,8.82,Inhibition of human recombinant EGFR,IC50,1.514,nM,=,CHEMBL944276,B,CHEMBL489897,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)N(C)c1nc2c(Cc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,7.70,Inhibition of human recombinant EGFR,IC50,19.95,nM,=,CHEMBL944276,B,CHEMBL490093,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1nc2c(Cc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCC(C)CC1,8.18,Inhibition of human recombinant EGFR,IC50,6.607,nM,=,CHEMBL944276,B,CHEMBL448172,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Cc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.04,Inhibition of human recombinant EGFR,IC50,0.912,nM,=,CHEMBL944276,B,CHEMBL524115,Homo sapiens,CHEMBL203,CHEMBL1140899
CS(=O)(=O)CCNCCCCOc1ccc2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c2c1,7.62,Inhibitory activity against epidermal growth factor receptor,IC50,24.0,nM,=,CHEMBL674106,B,CHEMBL493428,Homo sapiens,CHEMBL203,CHEMBL1146682
C=CC(=O)C(C)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.77,Inhibition of human recombinant EGFR,IC50,0.1698,nM,=,CHEMBL944276,B,CHEMBL491083,Homo sapiens,CHEMBL203,CHEMBL1140899
C=C(C)C(=O)Cc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.80,Inhibition of human recombinant EGFR,IC50,1.585,nM,=,CHEMBL944276,B,CHEMBL508481,Homo sapiens,CHEMBL203,CHEMBL1140899
C=C(C)C(=O)Cc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.92,Inhibition of human recombinant EGFR,IC50,1.202,nM,=,CHEMBL944276,B,CHEMBL524132,Homo sapiens,CHEMBL203,CHEMBL1140899
C/C=C/C(=O)Cc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.30,Inhibition of human recombinant EGFR,IC50,0.5012,nM,=,CHEMBL944276,B,CHEMBL501618,Homo sapiens,CHEMBL203,CHEMBL1140899
C/C=C/C(=O)Cc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.26,Inhibition of human recombinant EGFR,IC50,0.5495,nM,=,CHEMBL944276,B,CHEMBL491085,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(/C=C\Cl)Cc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.16,Inhibition of human recombinant EGFR,IC50,0.6918,nM,=,CHEMBL944276,B,CHEMBL522623,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(/C=C/C(F)(F)F)Cc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.76,Inhibition of human recombinant EGFR,IC50,1.738,nM,=,CHEMBL944276,B,CHEMBL507827,Homo sapiens,CHEMBL203,CHEMBL1140899
C=C/C=C/C(=O)Cc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.96,Inhibition of human recombinant EGFR,IC50,1.096,nM,=,CHEMBL944276,B,CHEMBL454370,Homo sapiens,CHEMBL203,CHEMBL1140899
C=C=CC(=O)Cc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.80,Inhibition of human recombinant EGFR,IC50,1.585,nM,=,CHEMBL944276,B,CHEMBL454371,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(/C=C/c1ccccc1)Cc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.04,Inhibition of human recombinant EGFR,IC50,9.12,nM,=,CHEMBL944276,B,CHEMBL509914,Homo sapiens,CHEMBL203,CHEMBL1140899
CC(=O)/C=C/C(=O)Cc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.92,Inhibition of human recombinant EGFR,IC50,1.202,nM,=,CHEMBL944276,B,CHEMBL455174,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1ccc2ncnc(Cc3cccc(Br)c3)c2c1,9.15,Inhibition of human recombinant EGFR,IC50,0.7079,nM,=,CHEMBL944276,B,CHEMBL454383,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1ccc2ncnc(Cc3ccc(CN(C)C)c(Br)c3)c2c1,7.35,Inhibition of human recombinant EGFR,IC50,44.67,nM,=,CHEMBL944276,B,CHEMBL510155,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1ccc2ncnc(Cc3ccc(OCCN(C)C)c(Br)c3)c2c1,7.57,Inhibition of human recombinant EGFR,IC50,26.92,nM,=,CHEMBL944276,B,CHEMBL510357,Homo sapiens,CHEMBL203,CHEMBL1140899
CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cs1,8.00,Inhibition of human recombinant EGFR,IC50,10.0,nM,=,CHEMBL944276,B,CHEMBL453376,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(O)/C=C/C(=O)Cc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.43,Inhibition of human recombinant EGFR,IC50,0.3715,nM,=,CHEMBL944276,B,CHEMBL510396,Homo sapiens,CHEMBL203,CHEMBL1140899
CCOC(=O)/C=C/C(=O)Cc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.57,Inhibition of human recombinant EGFR,IC50,2.692,nM,=,CHEMBL944276,B,CHEMBL454384,Homo sapiens,CHEMBL203,CHEMBL1140899
CCOC(=O)/C=C/C(=O)Cc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.82,Inhibition of human recombinant EGFR,IC50,1.514,nM,=,CHEMBL944276,B,CHEMBL453378,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)C(CCN(C)C)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.38,Inhibition of human recombinant EGFR,IC50,4.169,nM,=,CHEMBL944276,B,CHEMBL453379,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)C(CCCN1CCOCC1)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.57,Inhibition of human recombinant EGFR,IC50,2.692,nM,=,CHEMBL944276,B,CHEMBL510597,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)C(CCCN1CCOCC1)c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.48,Inhibition of human recombinant EGFR,IC50,3.311,nM,=,CHEMBL944276,B,CHEMBL517127,Homo sapiens,CHEMBL203,CHEMBL1140899
CN(C)CCCOC(=O)/C=C/C(=O)Cc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.62,Inhibition of human recombinant EGFR,IC50,2.399,nM,=,CHEMBL944276,B,CHEMBL461796,Homo sapiens,CHEMBL203,CHEMBL1140899
CN(C)CCCNC(=O)/C=C/C(=O)Cc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.36,Inhibition of human recombinant EGFR,IC50,0.4365,nM,=,CHEMBL944276,B,CHEMBL461797,Homo sapiens,CHEMBL203,CHEMBL1140899
CN(C)CCCNC(=O)/C=C/C(=O)Cc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.96,Inhibition of human recombinant EGFR,IC50,1.096,nM,=,CHEMBL944276,B,CHEMBL460743,Homo sapiens,CHEMBL203,CHEMBL1140899
C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1,7.96,Inhibitory activity against epidermal growth factor receptor,IC50,11.0,nM,=,CHEMBL674106,B,CHEMBL517907,Homo sapiens,CHEMBL203,CHEMBL1146682
CCN(CC)CCCNC(=O)/C=C/C(=O)Cc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.14,Inhibition of human recombinant EGFR,IC50,0.7244,nM,=,CHEMBL944276,B,CHEMBL460721,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(/C=C/C(=O)NCCCN1CCOCC1)Cc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.09,Inhibition of human recombinant EGFR,IC50,0.8128,nM,=,CHEMBL944276,B,CHEMBL460722,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(/C=C/C(=O)NCCCn1ccnc1)Cc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,9.25,Inhibition of human recombinant EGFR,IC50,0.5623,nM,=,CHEMBL944276,B,CHEMBL460723,Homo sapiens,CHEMBL203,CHEMBL1140899
CC(C(=O)/C=C/C(=O)NCCCN(C)C)c1cc2c(Nc3cccc(Br)c3)ncnc2cn1,8.84,Inhibition of human recombinant EGFR,IC50,1.445,nM,=,CHEMBL944276,B,CHEMBL460894,Homo sapiens,CHEMBL203,CHEMBL1140899
CS(=O)(=O)CCNCCCCOc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,7.70,Inhibitory activity against epidermal growth factor receptor,IC50,20.0,nM,=,CHEMBL674106,B,CHEMBL460731,Homo sapiens,CHEMBL203,CHEMBL1146682
CS(=O)(=O)CCNCCCCOc1ccc2ncnc(Nc3ccc(S(=O)(=O)c4ccccc4)cc3)c2c1,7.03,Inhibitory activity against epidermal growth factor receptor,IC50,93.0,nM,=,CHEMBL674106,B,CHEMBL460732,Homo sapiens,CHEMBL203,CHEMBL1146682
CS(=O)(=O)CCNCCCCOc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,7.57,Inhibitory activity against epidermal growth factor receptor,IC50,27.0,nM,=,CHEMBL674106,B,CHEMBL514436,Homo sapiens,CHEMBL203,CHEMBL1146682
O=S(=O)(CO)Nc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,7.03,Inhibition of human recombinant EGFR,IC50,93.33,nM,=,CHEMBL944276,B,CHEMBL503755,Homo sapiens,CHEMBL203,CHEMBL1140899
COC[C@H]1Oc2cc3ncnc(Nc4cccc(Cl)c4)c3cc2O[C@@H]1COC,8.00,Inhibition of human recombinant EGFR,IC50,10.08,nM,=,CHEMBL944276,B,CHEMBL461792,Homo sapiens,CHEMBL203,CHEMBL1140899
COC[C@H]1Oc2cc3ncnc(Nc4cccc(I)c4)c3cc2O[C@@H]1COC,8.78,Inhibition of human recombinant EGFR,IC50,1.66,nM,=,CHEMBL944276,B,CHEMBL516979,Homo sapiens,CHEMBL203,CHEMBL1140899
FC(F)(F)c1ccc(-n2cnnc2SCc2nc(COc3c(Cl)cccc3Cl)no2)cc1,5.20,Inhibition of human recombinant EGFR,IC50,6300.0,nM,=,CHEMBL944276,B,CHEMBL461781,Homo sapiens,CHEMBL203,CHEMBL1140899
CCOC(=O)c1ccc(N2CCOCC2)c(NS(=O)(=O)c2cc(Br)c(Cl)s2)c1,4.96,Inhibition of human recombinant EGFR,IC50,11100.0,nM,=,CHEMBL944276,B,CHEMBL461782,Homo sapiens,CHEMBL203,CHEMBL1140899
C/C=C/C(=O)Nc1ccc2c(Nc3cccc(Br)c3)ncnc2c1,9.17,Inhibition of human recombinant EGFR,IC50,0.6761,nM,=,CHEMBL944276,B,CHEMBL511874,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(/C=C/CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)Nc1ccc2c(Nc3cccc(Br)c3)ncnc2c1,9.35,Inhibition of human recombinant EGFR,IC50,0.4467,nM,=,CHEMBL944276,B,CHEMBL447850,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1cc2ncnc(Nc3cccc(Cl)c3)c2cn1,9.27,Inhibition of human recombinant EGFR,IC50,0.537,nM,=,CHEMBL944276,B,CHEMBL446019,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)NC1=CC=C2N=CN=C(Nc3cccc(Cl)c3)C21,8.80,Inhibition of human recombinant EGFR,IC50,1.585,nM,=,CHEMBL944276,B,CHEMBL460735,Homo sapiens,CHEMBL203,CHEMBL1140899
CN(N)C/C=C/C(=O)Nc1cc2c(Nc3cccc(Br)c3)ccnc2cn1,8.07,Inhibition of human recombinant EGFR,IC50,8.6,nM,=,CHEMBL944276,B,CHEMBL460736,Homo sapiens,CHEMBL203,CHEMBL1140899
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CN1CC[C@@H](C(N)=O)C1,8.22,Inhibition of human recombinant EGFR,IC50,6.0,nM,=,CHEMBL944276,B,CHEMBL461795,Homo sapiens,CHEMBL203,CHEMBL1140899
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CNC(=O)[C@H]1CCCCN1C,8.10,Inhibition of human recombinant EGFR,IC50,8.0,nM,=,CHEMBL944276,B,CHEMBL461967,Homo sapiens,CHEMBL203,CHEMBL1140899
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CN(C)[C@H](C)C(N)=O,8.05,Inhibition of human recombinant EGFR,IC50,9.0,nM,=,CHEMBL944276,B,CHEMBL517130,Homo sapiens,CHEMBL203,CHEMBL1140899
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CN(C)[C@@H](C)C(N)=O,8.10,Inhibition of human recombinant EGFR,IC50,8.0,nM,=,CHEMBL944276,B,CHEMBL461968,Homo sapiens,CHEMBL203,CHEMBL1140899
CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1,7.46,Inhibition of human recombinant EGFR,IC50,34.67,nM,=,CHEMBL944276,B,CHEMBL516375,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)NC1=CC=C2N=CN=C(Nc3cccc(C)c3)C21,9.38,Inhibition of human recombinant EGFR,IC50,0.4169,nM,=,CHEMBL944276,B,CHEMBL474147,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)NC1=CC=C2N=CN=C(Nc3cccc(C(F)(F)F)c3)C21,9.04,Inhibition of human recombinant EGFR,IC50,0.912,nM,=,CHEMBL944276,B,CHEMBL474342,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)NC1=CC=C2N=CN=C(Nc3ccc(Oc4ccccc4)cc3)C21,8.24,Inhibition of human recombinant EGFR,IC50,5.754,nM,=,CHEMBL944276,B,CHEMBL474343,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)NC1=CC=C2N=CN=C(Nc3ccc(OCc4ccccc4)cc3)C21,8.44,Inhibition of human recombinant EGFR,IC50,3.631,nM,=,CHEMBL944276,B,CHEMBL472746,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)NC1=NC=C2N=CN=C(Nc3cccc(C)c3)C21,9.32,Inhibition of human recombinant EGFR,IC50,0.4786,nM,=,CHEMBL944276,B,CHEMBL516022,Homo sapiens,CHEMBL203,CHEMBL1140899
CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)cs1,7.09,Inhibition of human recombinant EGFR,IC50,81.28,nM,=,CHEMBL944276,B,CHEMBL473543,Homo sapiens,CHEMBL203,CHEMBL1140899
CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3c2)cs1,7.15,Inhibition of human recombinant EGFR,IC50,70.79,nM,=,CHEMBL944276,B,CHEMBL472581,Homo sapiens,CHEMBL203,CHEMBL1140899
CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1,6.27,Inhibition of human recombinant EGFR,IC50,537.03,nM,=,CHEMBL944276,B,CHEMBL505970,Homo sapiens,CHEMBL203,CHEMBL1140899
CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)cs1,8.10,Inhibition of human recombinant EGFR,IC50,7.943,nM,=,CHEMBL944276,B,CHEMBL515082,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)NC1=NC=C2N=CN=C(Nc3ccc(F)c(Br)c3)C21,9.14,Inhibition of human recombinant EGFR,IC50,0.7244,nM,=,CHEMBL944276,B,CHEMBL474141,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)NC1=NC=C2N=CN=C(Nc3ccc(F)c(Cl)c3)C21,9.11,Inhibition of human recombinant EGFR,IC50,0.7762,nM,=,CHEMBL944276,B,CHEMBL516373,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1cc2ncnc(Nc3cccc(Br)c3)c2[nH]1,8.96,Inhibition of human recombinant EGFR,IC50,1.096,nM,=,CHEMBL944276,B,CHEMBL474142,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1cc2ncnc(Nc3ccc(F)c(Br)c3)c2[nH]1,8.92,Inhibition of human recombinant EGFR,IC50,1.202,nM,=,CHEMBL944276,B,CHEMBL474143,Homo sapiens,CHEMBL203,CHEMBL1140899
CCOc1cc2nccc(Nc3cccc(Br)c3)c2cc1NC(=O)/C=C/CN1CCOCC1,4.99,Inhibition of human recombinant EGFR,IC50,10320.0,nM,=,CHEMBL944276,B,CHEMBL473141,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1cc2c(Cc3cccc(Br)c3)ncnc2cc1OCCCN1CCC(C)CC1,8.77,Inhibition of human recombinant EGFR,IC50,1.698,nM,=,CHEMBL944276,B,CHEMBL516365,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1cc2c(Cc3cccc(Br)c3)ncnc2cc1OCCCN1CCOCC1,8.44,Inhibition of human recombinant EGFR,IC50,3.631,nM,=,CHEMBL944276,B,CHEMBL473747,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1cc2c(Cc3cccc(Br)c3)ncnc2cc1OCCCCN(C)C,8.41,Inhibition of human recombinant EGFR,IC50,3.89,nM,=,CHEMBL944276,B,CHEMBL473748,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1cc2c(Cc3cccc(Br)c3)ncnc2cc1OCCCn1ccnc1,8.52,Inhibition of human recombinant EGFR,IC50,3.02,nM,=,CHEMBL944276,B,CHEMBL473944,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(CCn1ncc2cc3c(Nc4cccc(Br)c4)ncnc3cc21)N1CCOCC1,8.43,Inhibition of human recombinant EGFR,IC50,3.715,nM,=,CHEMBL944276,B,CHEMBL474341,Homo sapiens,CHEMBL203,CHEMBL1140899
Brc1cccc(Nc2ncnc3cc4c(cc23)CN4)c1,9.36,Inhibition of human recombinant EGFR,IC50,0.4365,nM,=,CHEMBL944276,B,CHEMBL447331,Homo sapiens,CHEMBL203,CHEMBL1140899
COc1cc(NC(=O)/C=C/CN2CCOCC2)cc2c(Nc3cccc(Br)c3)ccnc12,5.27,Inhibition of human recombinant EGFR,IC50,5390.0,nM,=,CHEMBL944276,B,CHEMBL472743,Homo sapiens,CHEMBL203,CHEMBL1140899
COc1cc2nccc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCOCC1,4.87,Inhibition of human recombinant EGFR,IC50,13570.0,nM,=,CHEMBL944276,B,CHEMBL472942,Homo sapiens,CHEMBL203,CHEMBL1140899
COc1cc2nccc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/C(C)N(C)C,5.28,Inhibition of human recombinant EGFR,IC50,5220.0,nM,=,CHEMBL944276,B,CHEMBL472943,Homo sapiens,CHEMBL203,CHEMBL1140899
COc1cc2nccc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/C(C)N1CCOCC1,4.97,Inhibition of human recombinant EGFR,IC50,10590.0,nM,=,CHEMBL944276,B,CHEMBL514771,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1cc2c(Cc3cccc(Br)c3)ncnc2cc1SCCCN(CC)CC,9.11,Inhibition of human recombinant EGFR,IC50,0.7762,nM,=,CHEMBL944276,B,CHEMBL491676,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1ccc2ncnc(Cc3cccc(C)c3)c2c1,9.38,Inhibition of human recombinant EGFR,IC50,0.4169,nM,=,CHEMBL944276,B,CHEMBL522134,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1cc2c(Cc3cccc(C)c3)ncnc2cc1OCCCN1CCC(C)CC1,8.70,Inhibition of human recombinant EGFR,IC50,1.995,nM,=,CHEMBL944276,B,CHEMBL492077,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1cc2c(Cc3cccc(C)c3)ncnc2cc1OCCCN1CCOCC1,8.82,Inhibition of human recombinant EGFR,IC50,1.514,nM,=,CHEMBL944276,B,CHEMBL489111,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1ccc2ncnc(Cc3ccc(F)c(Br)c3)c2c1,9.16,Inhibition of human recombinant EGFR,IC50,0.6918,nM,=,CHEMBL944276,B,CHEMBL521571,Homo sapiens,CHEMBL203,CHEMBL1140899
CN1Cc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,9.10,Inhibition of human recombinant EGFR,IC50,0.7943,nM,=,CHEMBL944276,B,CHEMBL489112,Homo sapiens,CHEMBL203,CHEMBL1140899
OCC(O)CN1Cc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,8.80,Inhibition of human recombinant EGFR,IC50,1.585,nM,=,CHEMBL944276,B,CHEMBL521572,Homo sapiens,CHEMBL203,CHEMBL1140899
CN(C)CCN1Cc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,7.39,Inhibition of human recombinant EGFR,IC50,40.74,nM,=,CHEMBL944276,B,CHEMBL489117,Homo sapiens,CHEMBL203,CHEMBL1140899
CN(C)CCCN1Cc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,7.68,Inhibition of human recombinant EGFR,IC50,20.89,nM,=,CHEMBL944276,B,CHEMBL489312,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(CCN1Cc2cc3c(Nc4cccc(Br)c4)ncnc3cc21)N1CCOCC1,8.43,Inhibition of human recombinant EGFR,IC50,3.715,nM,=,CHEMBL944276,B,CHEMBL489313,Homo sapiens,CHEMBL203,CHEMBL1140899
C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ccnc2cc1CC,5.12,Inhibition of human recombinant EGFR,IC50,7500.0,nM,=,CHEMBL944276,B,CHEMBL490687,Homo sapiens,CHEMBL203,CHEMBL1140899
COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,7.08,Binding constant for EGFR(G719S) kinase domain,Kd,84.0,nM,=,CHEMBL1908696,B,CHEMBL491473,Homo sapiens,CHEMBL203,CHEMBL1908390
C=CC(=O)Nc1cc2c(Cc3ccc(F)c(Br)c3)ncnc2cc1OCCCN1CCOCC1,8.74,Inhibition of human recombinant EGFR,IC50,1.82,nM,=,CHEMBL944276,B,CHEMBL489107,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1ccc2ncnc(Cc3ccc(F)c(Cl)c3)c2c1,9.12,Inhibition of human recombinant EGFR,IC50,0.7586,nM,=,CHEMBL944276,B,CHEMBL447223,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1cc2c(Cc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,8.82,Inhibition of human recombinant EGFR,IC50,1.514,nM,=,CHEMBL944276,B,CHEMBL489306,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1cc2c(Cc3ccc(F)c(Cl)c3)ncnc2cc1OCCOCCCCO,8.77,Inhibition of human recombinant EGFR,IC50,1.698,nM,=,CHEMBL944276,B,CHEMBL522928,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(CCCN1Cc2cc3c(Nc4cccc(Br)c4)ncnc3cc21)N1CCOCC1,8.06,Inhibition of human recombinant EGFR,IC50,8.71,nM,=,CHEMBL944276,B,CHEMBL489307,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(O)CN1Cc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,8.29,Inhibition of human recombinant EGFR,IC50,5.129,nM,=,CHEMBL944276,B,CHEMBL489308,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(Cc1c[nH]c2cc3ncnc(Nc4cccc(Br)c4)c3cc12)N1CCOCC1,8.32,Inhibition of human recombinant EGFR,IC50,4.786,nM,=,CHEMBL944276,B,CHEMBL489501,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1ccc2ncnc(Cc3ccc(F)c(Cl)c3)c2n1,9.12,Inhibition of human recombinant EGFR,IC50,0.7586,nM,=,CHEMBL944276,B,CHEMBL524117,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1nc2c(Cc3ccc(F)c(Cl)c3)ncnc2cc1/C=C/CCN1CCOCC1,9.80,Inhibition of human recombinant EGFR,IC50,0.1585,nM,=,CHEMBL944276,B,CHEMBL490496,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1nc2c(Cc3ccc(F)c(Cl)c3)ncnc2cc1CCCCN1CCOCC1,8.57,Inhibition of human recombinant EGFR,IC50,2.692,nM,=,CHEMBL944276,B,CHEMBL521601,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1nc2c(Cc3ccc(F)c(Cl)c3)ncnc2cc1OC,9.02,Inhibition of human recombinant EGFR,IC50,0.955,nM,=,CHEMBL944276,B,CHEMBL490497,Homo sapiens,CHEMBL203,CHEMBL1140899
C=CC(=O)Nc1nc2c(Cc3ccc(F)c(Cl)c3)ncnc2cc1OCCOC,9.01,Inhibition of human recombinant EGFR,IC50,0.9772,nM,=,CHEMBL944276,B,CHEMBL490498,Homo sapiens,CHEMBL203,CHEMBL1140899
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1,7.19,Inhibition of EGFR by HTRF assay,IC50,65.0,nM,=,CHEMBL1009318,B,CHEMBL507329,Homo sapiens,CHEMBL203,CHEMBL1139297
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c3s2)C1)N1CCOCC1,7.30,Inhibition of EGFR by SPA assay,IC50,50.0,nM,=,CHEMBL964195,B,CHEMBL504117,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cscn5)c(Cl)c4)c3s2)C1)N1CCOCC1,6.92,Inhibition of EGFR by HTRF assay,IC50,120.0,nM,=,CHEMBL964194,B,CHEMBL508760,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)nc4)c3s2)C1)N1CCOCC1,5.58,Inhibition of EGFR by HTRF assay,IC50,2600.0,nM,=,CHEMBL964194,B,CHEMBL449949,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(Oc6ccccn6)cccc5c4)c3s2)C1)N1CCOCC1,5.98,Inhibition of EGFR by HTRF assay,IC50,1050.0,nM,=,CHEMBL964194,B,CHEMBL452716,Homo sapiens,CHEMBL203,CHEMBL1153281
COc1ccccc1Cc1nc2ccc(-c3nn([C@H]4CC[C@H](N5CCNCC5)CC4)c4ncnc(N)c34)cc2[nH]1,7.52,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,30.0,nM,=,CHEMBL964130,B,CHEMBL455208,Homo sapiens,CHEMBL203,CHEMBL1153290
COc1ccccc1Cc1nc2ccc(-c3nn([C@H]4CC[C@H](N5CCN(C(C)=O)CC5)CC4)c4ncnc(N)c34)cc2[nH]1,6.89,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,130.0,nM,=,CHEMBL964130,B,CHEMBL452717,Homo sapiens,CHEMBL203,CHEMBL1153290
CCOC(=O)N1CCN([C@H]2CC[C@H](n3nc(-c4ccc5nc(Cc6ccccc6OC)[nH]c5c4)c4c(N)ncnc43)CC2)CC1,7.52,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,30.0,nM,=,CHEMBL964130,B,CHEMBL503638,Homo sapiens,CHEMBL203,CHEMBL1153290
COc1ccccc1Cc1nc2ccc(-c3nn([C@H]4CC[C@H](N5CCN(C(=O)N(C)C)CC5)CC4)c4ncnc(N)c34)cc2[nH]1,7.60,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,25.0,nM,=,CHEMBL964130,B,CHEMBL448628,Homo sapiens,CHEMBL203,CHEMBL1153290
COCCCN1CCN([C@H]2CC[C@H](n3nc(-c4ccc5nc(Cc6ccccc6OC)[nH]c5c4)c4c(N)ncnc43)CC2)CC1,7.24,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,58.0,nM,=,CHEMBL964130,B,CHEMBL443098,Homo sapiens,CHEMBL203,CHEMBL1153290
COc1ccccc1Cc1nc2ccc(-c3nn([C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)c4ncnc(N)c34)cc2[nH]1,8.52,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,3.0,nM,=,CHEMBL964130,B,CHEMBL446250,Homo sapiens,CHEMBL203,CHEMBL1153290
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Oc5ccccn5)c(Cl)c4)c3s2)C1)N1CCOCC1,6.72,Inhibition of EGFR by SPA assay,IC50,190.0,nM,=,CHEMBL964195,B,CHEMBL453398,Homo sapiens,CHEMBL203,CHEMBL1153281
Cc1cc(Oc2ccc(Nc3ncnc4cc(C#C[C@@H]5C[C@@H](OC(=O)N6CCOCC6)CN5)sc34)cc2Cl)no1,6.40,Inhibition of EGFR by HTRF assay,IC50,400.0,nM,=,CHEMBL964194,B,CHEMBL461811,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Oc5ccnc6ccc(F)cc56)c(Cl)c4)c3s2)C1)N1CCOCC1,6.55,Inhibition of EGFR by HTRF assay,IC50,280.0,nM,=,CHEMBL964194,B,CHEMBL505463,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(NCc4cccc(Oc5ccccc5)c4)c3s2)C1)N1CCOCC1,6.75,Inhibition of EGFR by HTRF assay,IC50,180.0,nM,=,CHEMBL964194,B,CHEMBL455433,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1,6.62,Inhibition of EGFR by HTRF assay,IC50,240.0,nM,=,CHEMBL964194,B,CHEMBL455434,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Sc5ccccn5)cc4)c3s2)C1)N1CCOCC1,5.78,Inhibition of EGFR by HTRF assay,IC50,1650.0,nM,=,CHEMBL964194,B,CHEMBL457250,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Sc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1,6.20,Inhibition of EGFR by HTRF assay,IC50,630.0,nM,=,CHEMBL964194,B,CHEMBL501050,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1,7.10,Inhibition of EGFR by HTRF assay,IC50,80.0,nM,=,CHEMBL964194,B,CHEMBL507821,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c3s2)C1)N1CCOCC1,7.52,Inhibition of EGFR by HTRF assay,IC50,30.0,nM,=,CHEMBL964194,B,CHEMBL510845,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1,7.48,Inhibition of EGFR by HTRF assay,IC50,33.0,nM,=,CHEMBL964194,B,CHEMBL500072,Homo sapiens,CHEMBL203,CHEMBL1153281
CC(c1cccc(F)c1)n1ncc2cc(Nc3ncnc4cc(C#C[C@@H]5C[C@@H](OC(=O)N6CCOCC6)CN5)sc34)ccc21,6.92,Inhibition of EGFR by HTRF assay,IC50,120.0,nM,=,CHEMBL964194,B,CHEMBL503253,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5S(=O)(=O)c5cccc(F)c5)c4)c3s2)C1)N1CCOCC1,6.64,Inhibition of EGFR by HTRF assay,IC50,230.0,nM,=,CHEMBL964194,B,CHEMBL451074,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5S(=O)(=O)c5ccsc5)c4)c3s2)C1)N1CCOCC1,6.82,Inhibition of EGFR by SPA assay,IC50,150.0,nM,=,CHEMBL964195,B,CHEMBL452768,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1,7.05,Inhibition of EGFR by HTRF assay,IC50,90.0,nM,=,CHEMBL964194,B,CHEMBL500217,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5CCc5ccccc5)c4)c3s2)C1)N1CCOCC1,5.50,Inhibition of EGFR by SPA assay,IC50,3160.0,nM,=,CHEMBL964195,B,CHEMBL447720,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cscn5)c4)c3s2)C1)N1CCOCC1,6.17,Inhibition of EGFR by HTRF assay,IC50,680.0,nM,=,CHEMBL964194,B,CHEMBL451347,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(c4)c(F)cn5Cc4ccccc4)c3s2)C1)N1CCOCC1,6.62,Inhibition of EGFR by HTRF assay,IC50,240.0,nM,=,CHEMBL964194,B,CHEMBL452980,Homo sapiens,CHEMBL203,CHEMBL1153281
O=C(NC(=S)Nc1ccc(O)c(-c2nc3ccccc3s2)c1)c1ccc([N+](=O)[O-])cc1,6.55,Inhibition of EGFR by virtual HTS assay,IC50,280.0,nM,=,CHEMBL964945,B,CHEMBL460746,Homo sapiens,CHEMBL203,CHEMBL1153282
CNC(=O)c1cc(Nc2ccc(-c3nc4ccccc4s3)cc2)ccn1,5.70,Inhibition of EGFR by virtual HTS assay,IC50,2000.0,nM,=,CHEMBL964945,B,CHEMBL464210,Homo sapiens,CHEMBL203,CHEMBL1153282
c1ccc2sc(-c3ccc(Nc4ncnc5[nH]ccc45)cc3)nc2c1,5.89,Inhibition of EGFR by virtual HTS assay,IC50,1300.0,nM,=,CHEMBL964945,B,CHEMBL518803,Homo sapiens,CHEMBL203,CHEMBL1153282
COc1cc(Nc2ncnc3[nH]ccc23)ccc1-c1nc2ccccc2s1,6.14,Inhibition of EGFR by virtual HTS assay,IC50,720.0,nM,=,CHEMBL964945,B,CHEMBL462162,Homo sapiens,CHEMBL203,CHEMBL1153282
COc1nc(Nc2ccc(-c3nc4ccccc4s3)cc2)c2cc[nH]c2n1,5.11,Inhibition of EGFR by virtual HTS assay,IC50,7700.0,nM,=,CHEMBL964945,B,CHEMBL462338,Homo sapiens,CHEMBL203,CHEMBL1153282
COc1nc(Nc2ccc(-c3nc4ccccc4s3)c(OC)c2)c2cc[nH]c2n1,5.29,Inhibition of EGFR by virtual HTS assay,IC50,5100.0,nM,=,CHEMBL964945,B,CHEMBL475351,Homo sapiens,CHEMBL203,CHEMBL1153282
c1ccc2sc(-c3ccc(Nc4ncnc5[nH]cnc45)cc3)nc2c1,5.11,Inhibition of EGFR by virtual HTS assay,IC50,7800.0,nM,=,CHEMBL964945,B,CHEMBL515598,Homo sapiens,CHEMBL203,CHEMBL1153282
COc1cc(Nc2ncnc3[nH]cnc23)ccc1-c1nc2ccccc2s1,5.58,Inhibition of EGFR by virtual HTS assay,IC50,2600.0,nM,=,CHEMBL964945,B,CHEMBL475352,Homo sapiens,CHEMBL203,CHEMBL1153282
Clc1ccc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ccnc2c1,5.28,Inhibition of EGFR by virtual HTS assay,IC50,5300.0,nM,=,CHEMBL964945,B,CHEMBL474543,Homo sapiens,CHEMBL203,CHEMBL1153282
Clc1ccc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2c1,6.10,Inhibition of EGFR by virtual HTS assay,IC50,800.0,nM,=,CHEMBL964945,B,CHEMBL514016,Homo sapiens,CHEMBL203,CHEMBL1153282
COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC,5.82,Inhibition of EGFR by virtual HTS assay,IC50,1500.0,nM,=,CHEMBL964945,B,CHEMBL473556,Homo sapiens,CHEMBL203,CHEMBL1153282
COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3C)c2cc1OC,6.62,Inhibition of EGFR by virtual HTS assay,IC50,240.0,nM,=,CHEMBL964945,B,CHEMBL514942,Homo sapiens,CHEMBL203,CHEMBL1153282
COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)c2cc1OC,5.66,Inhibition of EGFR by virtual HTS assay,IC50,2200.0,nM,=,CHEMBL964945,B,CHEMBL473351,Homo sapiens,CHEMBL203,CHEMBL1153282
COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)c2cc1OC,7.20,Inhibition of EGFR by virtual HTS assay,IC50,63.0,nM,=,CHEMBL964945,B,CHEMBL473553,Homo sapiens,CHEMBL203,CHEMBL1153282
Cc1cc(Nc2ccnc(Nc3cccc(-c4nc5ccccc5s4)c3)n2)n[nH]1,5.72,Inhibition of EGFR by virtual HTS assay,IC50,1900.0,nM,=,CHEMBL964945,B,CHEMBL491686,Homo sapiens,CHEMBL203,CHEMBL1153282
COc1cc2nc(Nc3cc(C)[nH]n3)nc(Nc3cccc(-c4nc5ccccc5s4)c3)c2cc1OC,5.48,Inhibition of EGFR by virtual HTS assay,IC50,3300.0,nM,=,CHEMBL964945,B,CHEMBL522785,Homo sapiens,CHEMBL203,CHEMBL1153282
c1cc(Nc2ncnc3[nH]cnc23)cc(-c2nc3ccccc3s2)c1,5.77,Inhibition of EGFR by virtual HTS assay,IC50,1700.0,nM,=,CHEMBL964945,B,CHEMBL443906,Homo sapiens,CHEMBL203,CHEMBL1153282
COc1cc2ncnc(Nc3ccc(N4Cc5ccccc5C4)cc3)c2cc1OC,5.80,Inhibition of EGFR by virtual HTS assay,IC50,1600.0,nM,=,CHEMBL964945,B,CHEMBL491677,Homo sapiens,CHEMBL203,CHEMBL1153282
COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,7.21,"Binding constant for EGFR(L858R,T790M) kinase domain",Kd,61.0,nM,=,CHEMBL1908701,B,CHEMBL475251,Homo sapiens,CHEMBL203,CHEMBL1908390
C[C@H]1[C@H](C)CC[C@]2(C(=O)O)CC[C@]3(COC(=O)/C=C/c4ccc(O)cc4)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@H]12,7.25,Inhibition of EGFR L858R mutant (unknown origin) using polyE4Y1 as substrate measured after 60 mins,IC50,56.48,nM,=,CHEMBL4341613,B,CHEMBL442938,Homo sapiens,CHEMBL203,CHEMBL4340533
CCC(C)/C=C/C(=O)C(=O)/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H]1C[C@@H](O)[C@H](C(=O)O)O1,5.80,Displacement of [125I]-TGFalpha from human EGFR in human A431 cell membrane by SPA,IC50,1600.0,nM,=,CHEMBL1005068,B,CHEMBL464721,Homo sapiens,CHEMBL203,CHEMBL1145687
O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(-c2cc(C/C(=N/O)C(=O)NCCc3ccc(O)c(Br)c3)cc(Br)c2O)c1)=N\O,5.89,Inhibition of EGFR (unknown origin),IC50,1300.0,nM,=,CHEMBL2344161,B,CHEMBL505637,Homo sapiens,CHEMBL203,CHEMBL2331160
O=C1NCCc2cc(Br)c(O)c(c2)Oc2c(Br)cc(cc2Br)CCNC(=O)/C(=N/O)Cc2cc(Br)c(O)c(c2)Oc2c(Br)cc(cc2Br)C/C1=N\O,5.70,Inhibition of EGFR (unknown origin),IC50,2000.0,nM,=,CHEMBL2344161,B,CHEMBL510730,Homo sapiens,CHEMBL203,CHEMBL2331160
Cc1cc(C2CCN(CCCF)CC2)cc2[nH]c(-c3c(NCCn4cc(Cl)cn4)cc[nH]c3=O)nc12,4.68,Inhibition of GST-tagged HER1,IC50,21000.0,nM,=,CHEMBL980904,B,CHEMBL459729,Homo sapiens,CHEMBL203,CHEMBL1140084
COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,5.77,Inhibition of EGFR,IC50,1700.0,nM,=,CHEMBL970655,B,CHEMBL505896,Homo sapiens,CHEMBL203,CHEMBL1140082
COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1,5.77,Inhibition of EGFR,IC50,1700.0,nM,=,CHEMBL970655,B,CHEMBL453737,Homo sapiens,CHEMBL203,CHEMBL1140082
NC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.40,Inhibition of EGFR by HTRF assay,IC50,40.0,nM,=,CHEMBL1009318,B,CHEMBL461426,Homo sapiens,CHEMBL203,CHEMBL1139297
CNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.30,Inhibition of EGFR by HTRF assay,IC50,50.0,nM,=,CHEMBL1009318,B,CHEMBL466586,Homo sapiens,CHEMBL203,CHEMBL1139297
CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.50,Inhibition of EGFR by HTRF assay,IC50,32.0,nM,=,CHEMBL1009318,B,CHEMBL512076,Homo sapiens,CHEMBL203,CHEMBL1139297
CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.55,Inhibition of EGFR by HTRF assay,IC50,28.0,nM,=,CHEMBL1009318,B,CHEMBL517123,Homo sapiens,CHEMBL203,CHEMBL1139297
CCN(CC)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.20,Inhibition of EGFR by scintillation proximity assay,IC50,63.0,nM,=,CHEMBL1009326,B,CHEMBL505626,Homo sapiens,CHEMBL203,CHEMBL1139297
CCN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.30,Inhibition of EGFR by HTRF assay,IC50,50.0,nM,=,CHEMBL1009318,B,CHEMBL517585,Homo sapiens,CHEMBL203,CHEMBL1139297
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCCC1,7.00,Inhibition of EGFR by scintillation proximity assay,IC50,99.0,nM,=,CHEMBL1009326,B,CHEMBL451513,Homo sapiens,CHEMBL203,CHEMBL1139297
O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCNCC1,7.20,Inhibition of EGFR by HTRF assay,IC50,63.0,nM,=,CHEMBL1009318,B,CHEMBL499534,Homo sapiens,CHEMBL203,CHEMBL1139297
CS(=O)(=O)CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.40,Inhibition of EGFR by HTRF assay,IC50,40.0,nM,=,CHEMBL1009318,B,CHEMBL504034,Homo sapiens,CHEMBL203,CHEMBL1139297
CCNC(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.30,Inhibition of EGFR by HTRF assay,IC50,50.0,nM,=,CHEMBL1009318,B,CHEMBL461869,Homo sapiens,CHEMBL203,CHEMBL1139297
CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.40,Inhibition of EGFR by HTRF assay,IC50,40.0,nM,=,CHEMBL1009318,B,CHEMBL466412,Homo sapiens,CHEMBL203,CHEMBL1139297
O=C(O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1,7.40,Inhibition of EGFR by HTRF assay,IC50,40.0,nM,=,CHEMBL1009318,B,CHEMBL450109,Homo sapiens,CHEMBL203,CHEMBL1139297
O=C(O[C@@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1,7.10,Inhibition of EGFR by HTRF assay,IC50,79.0,nM,=,CHEMBL1009318,B,CHEMBL447365,Homo sapiens,CHEMBL203,CHEMBL1139297
CCNC(=O)O[C@@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,6.90,Inhibition of EGFR by HTRF assay,IC50,125.0,nM,=,CHEMBL1009318,B,CHEMBL466614,Homo sapiens,CHEMBL203,CHEMBL1139297
CN(C)C(=O)O[C@@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.10,Inhibition of EGFR by HTRF assay,IC50,79.0,nM,=,CHEMBL1009318,B,CHEMBL466615,Homo sapiens,CHEMBL203,CHEMBL1139297
CCNC(=O)O[C@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.50,Inhibition of EGFR by HTRF assay,IC50,32.0,nM,=,CHEMBL1009318,B,CHEMBL466174,Homo sapiens,CHEMBL203,CHEMBL1139297
CN(C)C(=O)O[C@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.10,Inhibition of EGFR by HTRF assay,IC50,79.0,nM,=,CHEMBL1009318,B,CHEMBL466175,Homo sapiens,CHEMBL203,CHEMBL1139297
O=C(O[C@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1,7.30,Inhibition of EGFR by HTRF assay,IC50,50.0,nM,=,CHEMBL1009318,B,CHEMBL450396,Homo sapiens,CHEMBL203,CHEMBL1139297
COc1ccc2c(c1)SCc1cnc(-c3ccccc3)nc1-2,5.33,Inhibition of EGFR (unknown origin) using omnia tyr peptide 7 substrate by fluorescence assay,IC50,4720.0,nM,=,CHEMBL3630441,B,CHEMBL481789,Homo sapiens,CHEMBL203,CHEMBL3627617
CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1,6.52,Inhibition of EGFR,IC50,304.0,nM,=,CHEMBL1028080,B,CHEMBL475599,Homo sapiens,CHEMBL203,CHEMBL1143296
Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccc[nH]5)cc34)cc2Cl)c1,6.94,Inhibition of EGFR,IC50,115.0,nM,=,CHEMBL1028080,B,CHEMBL475600,Homo sapiens,CHEMBL203,CHEMBL1143296
CN(C)Cc1ccc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)[nH]1,7.17,Inhibition of EGFR,IC50,68.0,nM,=,CHEMBL1028080,B,CHEMBL475767,Homo sapiens,CHEMBL203,CHEMBL1143296
Cc1[nH]c(/C=C2\C(=O)Nc3ccc(C(=O)NNc4ccccc4)cc32)c(C)c1CCC(=O)O,5.46,Inhibition of EGFR,IC50,3480.0,nM,=,CHEMBL1028056,B,CHEMBL480356,Homo sapiens,CHEMBL203,CHEMBL1143293
Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccco5)sc34)cc2Cl)c1,8.00,Inhibition of EGFR,IC50,10.0,nM,=,CHEMBL1028080,B,CHEMBL479800,Homo sapiens,CHEMBL203,CHEMBL1143296
CS(=O)(=O)CCNCc1ccc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)o1,9.00,Inhibition of EGFR,IC50,1.0,nM,=,CHEMBL1028080,B,CHEMBL475768,Homo sapiens,CHEMBL203,CHEMBL1143296
CS(=O)(=O)CCNCc1cc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)co1,8.40,Inhibition of EGFR,IC50,4.0,nM,=,CHEMBL1028080,B,CHEMBL475769,Homo sapiens,CHEMBL203,CHEMBL1143296
Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5cccs5)sc34)cc2Cl)c1,8.10,Inhibition of EGFR,IC50,8.0,nM,=,CHEMBL1028080,B,CHEMBL473427,Homo sapiens,CHEMBL203,CHEMBL1143296
CS(=O)(=O)CCNCc1ccc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)[nH]1,8.15,Inhibition of EGFR,IC50,7.0,nM,=,CHEMBL1028080,B,CHEMBL475446,Homo sapiens,CHEMBL203,CHEMBL1143296
Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1,7.82,Inhibition of EGFR,IC50,15.0,nM,=,CHEMBL1028080,B,CHEMBL514938,Homo sapiens,CHEMBL203,CHEMBL1143296
Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccc(CNCc6ccccc6)o5)cc34)cc2Cl)c1,7.27,Inhibition of EGFR,IC50,54.0,nM,=,CHEMBL1028080,B,CHEMBL519757,Homo sapiens,CHEMBL203,CHEMBL1143296
CCNCc1ccc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)[nH]1,6.92,Inhibition of EGFR,IC50,121.0,nM,=,CHEMBL1028080,B,CHEMBL480348,Homo sapiens,CHEMBL203,CHEMBL1143296
CS(=O)(=O)CCNCc1ccc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)[nH]1,6.86,Inhibition of EGFR,IC50,138.0,nM,=,CHEMBL1028080,B,CHEMBL481331,Homo sapiens,CHEMBL203,CHEMBL1143296
CN(C)Cc1ccc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)o1,8.70,Inhibition of EGFR,IC50,2.0,nM,=,CHEMBL1028080,B,CHEMBL475594,Homo sapiens,CHEMBL203,CHEMBL1143296
CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1,8.30,Inhibition of EGFR,IC50,5.0,nM,=,CHEMBL1028080,B,CHEMBL475761,Homo sapiens,CHEMBL203,CHEMBL1143296
OCc1ccc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)o1,8.52,Inhibition of EGFR,IC50,3.0,nM,=,CHEMBL1028080,B,CHEMBL473428,Homo sapiens,CHEMBL203,CHEMBL1143296
N#CCNCc1ccc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)o1,8.52,Inhibition of EGFR,IC50,3.0,nM,=,CHEMBL1028080,B,CHEMBL473429,Homo sapiens,CHEMBL203,CHEMBL1143296
CS(=O)(=O)CCNCc1cc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)cs1,8.52,Inhibition of EGFR,IC50,3.0,nM,=,CHEMBL1028080,B,CHEMBL474431,Homo sapiens,CHEMBL203,CHEMBL1143296
Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1,7.17,Inhibition of EGFR,IC50,68.0,nM,=,CHEMBL1028080,B,CHEMBL473436,Homo sapiens,CHEMBL203,CHEMBL1143296
CN(C)Cc1ccc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)[nH]1,8.40,Inhibition of EGFR,IC50,4.0,nM,=,CHEMBL1028080,B,CHEMBL473437,Homo sapiens,CHEMBL203,CHEMBL1143296
CCNCc1ccc(-c2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)[nH]1,8.22,Inhibition of EGFR,IC50,6.0,nM,=,CHEMBL1028080,B,CHEMBL473438,Homo sapiens,CHEMBL203,CHEMBL1143296
CS(=O)(=O)CCNCc1ccc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)o1,7.92,Inhibition of EGFR,IC50,12.0,nM,=,CHEMBL1028080,B,CHEMBL480349,Homo sapiens,CHEMBL203,CHEMBL1143296
Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1,8.05,Inhibition of EGFR,IC50,9.0,nM,=,CHEMBL1028080,B,CHEMBL506414,Homo sapiens,CHEMBL203,CHEMBL1143296
CS(=O)(=O)CCNCc1ccc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)s1,7.02,Inhibition of EGFR,IC50,96.0,nM,=,CHEMBL1028080,B,CHEMBL481324,Homo sapiens,CHEMBL203,CHEMBL1143296
COc1cc(N2CCC(N3CCN(S(C)(=O)=O)CC3)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1,7.24,Inhibition of EGFR,IC50,57.0,nM,=,CHEMBL946770,B,CHEMBL507714,Homo sapiens,CHEMBL203,CHEMBL1143280
CCc1cc(Nc2nccc(-c3c(-c4cccc(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1,7.66,Inhibition of EGFR,IC50,22.0,nM,=,CHEMBL946770,B,CHEMBL448929,Homo sapiens,CHEMBL203,CHEMBL1143280
CSc1ccc(N(C)c2nc(C)nc3ccccc23)cc1,8.06,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,IC50,8.7,nM,=,CHEMBL4714413,B,CHEMBL516047,Homo sapiens,CHEMBL203,CHEMBL4706704
COc1ccc(N(C)c2nc(Cl)nc3ccccc23)cc1,8.44,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,IC50,3.6,nM,=,CHEMBL4714413,B,CHEMBL444724,Homo sapiens,CHEMBL203,CHEMBL4706704
COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1,8.55,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,IC50,2.8,nM,=,CHEMBL4714413,B,CHEMBL492399,Homo sapiens,CHEMBL203,CHEMBL4706704
CSCc1cc(/C=C2\C(=O)Nc3ccccc32)cc(CSC)c1O,6.40,Inhibition of EGFR,IC50,400.0,nM,=,CHEMBL941412,B,CHEMBL522116,Homo sapiens,CHEMBL203,CHEMBL1150213
CCOc1cc(/C=C2/CCNC2=O)cc(CSc2ccccc2)c1O,6.05,Inhibition of EGFR,IC50,900.0,nM,=,CHEMBL941412,B,CHEMBL490780,Homo sapiens,CHEMBL203,CHEMBL1150213
CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O,6.40,Inhibition of EGFR,IC50,400.0,nM,=,CHEMBL941412,B,CHEMBL485070,Homo sapiens,CHEMBL203,CHEMBL1150213
CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccc(C)cc2)c1O,4.70,Inhibition of EGFR,IC50,20000.0,nM,=,CHEMBL941412,B,CHEMBL520839,Homo sapiens,CHEMBL203,CHEMBL1150213
CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2cccc(OC)c2)c1O,5.40,Inhibition of EGFR,IC50,4000.0,nM,=,CHEMBL941412,B,CHEMBL483232,Homo sapiens,CHEMBL203,CHEMBL1150213
CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccc(O)cc2)c1O,5.52,Inhibition of EGFR,IC50,3000.0,nM,=,CHEMBL941412,B,CHEMBL483233,Homo sapiens,CHEMBL203,CHEMBL1150213
N#C/C(=C\c1cc(CSc2ccccc2)c(O)c(OCc2ccccc2)c1)C(N)=O,6.10,Inhibition of EGFR,IC50,800.0,nM,=,CHEMBL941412,B,CHEMBL490569,Homo sapiens,CHEMBL203,CHEMBL1150213
N#C/C(=C/c1cc(Cc2ccccc2)c(O)c(Cc2ccccc2)c1)C(N)=O,6.22,Inhibition of EGFR,IC50,600.0,nM,=,CHEMBL941412,B,CHEMBL538909,Homo sapiens,CHEMBL203,CHEMBL1150213
CC(C)(C)c1cc(/C=C(\C#N)C(N)=O)cc(C(C)(C)C)c1O,4.30,Inhibition of EGFR,IC50,50000.0,nM,=,CHEMBL941412,B,CHEMBL490570,Homo sapiens,CHEMBL203,CHEMBL1150213
CC(C)c1cc(/C=C(\C#N)C(N)=O)cc(C(C)C)c1O,6.00,Inhibition of EGFR,IC50,1000.0,nM,=,CHEMBL941412,B,CHEMBL504173,Homo sapiens,CHEMBL203,CHEMBL1150213
N#C/C(=C\c1cc(-c2ccccc2)c(O)c(-c2ccccc2)c1)C(N)=O,6.40,Inhibition of EGFR,IC50,400.0,nM,=,CHEMBL941412,B,CHEMBL490768,Homo sapiens,CHEMBL203,CHEMBL1150213
N#CC(C#N)=C(C#N)c1cc(O)c(O)c(O)c1,5.52,Inhibition of EGFR in human A431 cells,IC50,3000.0,nM,=,CHEMBL941404,B,CHEMBL492199,Homo sapiens,CHEMBL203,CHEMBL1150213
Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2ccc(S(=O)(=O)Oc3ccc(/C=C/[N+](=O)[O-])cc3)cc2)[C@@H](O)[C@H]1O,6.22,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,600.0,nM,=,CHEMBL674640,B,CHEMBL505705,Homo sapiens,CHEMBL203,CHEMBL1125600
COc1cc(/C=C/[N+](=O)[O-])ccc1OS(=O)(=O)c1ccc(C(=O)OC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)cc1,6.30,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,IC50,500.0,nM,=,CHEMBL674640,B,CHEMBL453502,Homo sapiens,CHEMBL203,CHEMBL1125600
COc1cc(C(C#N)=C(C#N)C#N)cc(O)c1O,5.22,Inhibition of EGFR in human A431 cells,IC50,6000.0,nM,=,CHEMBL941404,B,CHEMBL489147,Homo sapiens,CHEMBL203,CHEMBL1150213
N#CC(C#N)=C(C#N)c1ccc(O)c(O)c1,5.00,Inhibition of EGFR in human A431 cells,IC50,10000.0,nM,=,CHEMBL941404,B,CHEMBL474267,Homo sapiens,CHEMBL203,CHEMBL1150213
N#CC(C#N)=C(C#N)c1cc(O)cc(O)c1,5.00,Inhibition of EGFR in human A431 cells,IC50,10000.0,nM,=,CHEMBL941404,B,CHEMBL454002,Homo sapiens,CHEMBL203,CHEMBL1150213
CC(C)NC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1,6.00,Inhibition of EGFR in human A431 cells,IC50,1000.0,nM,=,CHEMBL941404,B,CHEMBL490987,Homo sapiens,CHEMBL203,CHEMBL1150213
Cl.NCCNC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1,5.30,Inhibition of EGFR in human A431 cells,IC50,5000.0,nM,=,CHEMBL941404,B,CHEMBL485065,Homo sapiens,CHEMBL203,CHEMBL1150213
C[C@H](NC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1)C(=O)N[C@@H](C)C(=O)OC(C)(C)C,4.40,Inhibition of EGFR in human A431 cells,IC50,40000.0,nM,=,CHEMBL941404,B,CHEMBL483234,Homo sapiens,CHEMBL203,CHEMBL1150213
N#C/C(=C\c1cc(O)ccc1O)C(=O)O,4.70,Inhibition of EGFR in human A431 cells,IC50,20000.0,nM,=,CHEMBL941404,B,CHEMBL501368,Homo sapiens,CHEMBL203,CHEMBL1150213
N#C/C(=C/c1ccc(O)c(O)c1)C(=O)NCCCCc1ccccc1,7.00,Inhibition of EGFR in human A431 cells,IC50,100.0,nM,=,CHEMBL941404,B,CHEMBL490577,Homo sapiens,CHEMBL203,CHEMBL1150213
N#C/C(=C/c1ccc(O)c(O)c1)C(=O)NC1CCCCC1,5.70,Inhibition of EGFR in human A431 cells,IC50,2000.0,nM,=,CHEMBL941404,B,CHEMBL490774,Homo sapiens,CHEMBL203,CHEMBL1150213
C[C@H](NC(=O)[C@H](C)NC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1)C(=O)O,5.16,Inhibition of EGFR in human A431 cells,IC50,7000.0,nM,=,CHEMBL941404,B,CHEMBL490775,Homo sapiens,CHEMBL203,CHEMBL1150213
C[C@H](NC(=O)c1ccc(S(=O)(=O)Oc2ccc(/C=C/[N+](=O)[O-])cc2)cc1)C(=O)N[C@@H](C)C(=O)NCCN.Cl,4.70,Inhibition of EGFR in human A431 cells,IC50,20000.0,nM,=,CHEMBL941404,B,CHEMBL488101,Homo sapiens,CHEMBL203,CHEMBL1150213
N#C/C(=C/c1ccc(O)c(O)c1)C(=O)Nc1ccccc1Cl,5.00,Inhibition of EGFR in human A431 cells,IC50,10000.0,nM,=,CHEMBL941404,B,CHEMBL520493,Homo sapiens,CHEMBL203,CHEMBL1150213
C=C(CN(C)C)C(=O)c1ccccc1.Cl,5.25,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,5600.0,nM,=,CHEMBL677209,B,CHEMBL468975,Homo sapiens,CHEMBL203,CHEMBL1128740
Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2,5.47,Inhibition of EGFR by ELISA,IC50,3400.0,nM,=,CHEMBL986505,B,CHEMBL477197,Homo sapiens,CHEMBL203,CHEMBL1155833
CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,6.62,"Binding constant for EGFR(L858R,T790M) kinase domain",Kd,240.0,nM,=,CHEMBL1908701,B,CHEMBL513909,Homo sapiens,CHEMBL203,CHEMBL1908390
Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1-c1ccc2ccncc2c1,6.16,Inhibition of EGFR,IC50,700.0,nM,=,CHEMBL998566,B,CHEMBL521887,Homo sapiens,CHEMBL203,CHEMBL1141712
Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@@H]5CCCN5)sc34)cc2Cl)c1,6.96,Inhibition of EGFR kinase,IC50,109.0,nM,=,CHEMBL995846,B,CHEMBL495979,Homo sapiens,CHEMBL203,CHEMBL1143444
Fc1cccc(COc2ccc(Nc3ncnc4cc(C#C[C@H]5CCCN5)sc34)cc2Cl)c1,8.15,Inhibition of EGFR kinase,IC50,7.0,nM,=,CHEMBL995846,B,CHEMBL496174,Homo sapiens,CHEMBL203,CHEMBL1143444
COCCN1CCC[C@@H]1C#Cc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2s1,6.89,Inhibition of EGFR kinase,IC50,130.0,nM,=,CHEMBL995846,B,CHEMBL523573,Homo sapiens,CHEMBL203,CHEMBL1143444
CS(=O)(=O)N1CCC[C@@H]1C#Cc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2s1,6.92,Inhibition of EGFR kinase,IC50,120.0,nM,=,CHEMBL995846,B,CHEMBL495733,Homo sapiens,CHEMBL203,CHEMBL1143444
CC(=O)N1CCC[C@@H]1C#Cc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2s1,7.24,Inhibition of EGFR kinase,IC50,58.0,nM,=,CHEMBL995846,B,CHEMBL495734,Homo sapiens,CHEMBL203,CHEMBL1143444
COC(=O)N1CCC[C@@H]1C#Cc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2s1,6.85,Inhibition of EGFR kinase,IC50,140.0,nM,=,CHEMBL995846,B,CHEMBL497803,Homo sapiens,CHEMBL203,CHEMBL1143444
O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.85,Inhibition of EGFR kinase,IC50,14.0,nM,=,CHEMBL995846,B,CHEMBL497804,Homo sapiens,CHEMBL203,CHEMBL1143444
CCO[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,6.94,Inhibition of EGFR kinase,IC50,115.0,nM,=,CHEMBL995846,B,CHEMBL497184,Homo sapiens,CHEMBL203,CHEMBL1143444
CS(=O)(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.09,Inhibition of EGFR kinase,IC50,81.0,nM,=,CHEMBL995846,B,CHEMBL500115,Homo sapiens,CHEMBL203,CHEMBL1143444
CCC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.20,Inhibition of EGFR kinase,IC50,63.0,nM,=,CHEMBL995846,B,CHEMBL500381,Homo sapiens,CHEMBL203,CHEMBL1143444
CCOC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,6.85,Inhibition of EGFR kinase,IC50,141.0,nM,=,CHEMBL995846,B,CHEMBL500640,Homo sapiens,CHEMBL203,CHEMBL1143444
CCOC(=O)N[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.22,Inhibition of EGFR kinase,IC50,60.0,nM,=,CHEMBL995846,B,CHEMBL525805,Homo sapiens,CHEMBL203,CHEMBL1143444
CCS(=O)(=O)N[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1,7.30,Inhibition of EGFR kinase,IC50,50.0,nM,=,CHEMBL995846,B,CHEMBL501705,Homo sapiens,CHEMBL203,CHEMBL1143444
CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,6.03,"Binding constant for EGFR(L858R,T790M) kinase domain",Kd,940.0,nM,=,CHEMBL1908701,B,CHEMBL522892,Homo sapiens,CHEMBL203,CHEMBL1908390
CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12,7.13,Binding constant for EGFR(T790M) kinase domain,Kd,74.0,nM,=,CHEMBL1908704,B,CHEMBL464552,Homo sapiens,CHEMBL203,CHEMBL1908390
COCCOc1cc2ncnc(Nc3c(Cl)ccc4c3OCO4)c2cc1NC(=O)[C@@H]1CCCN1,5.15,Inhibition of EGFR,IC50,7130.0,nM,=,CHEMBL1022371,B,CHEMBL523122,Homo sapiens,CHEMBL203,CHEMBL1153429
CCN1CCN(Cc2ccc(-c3cc4c(N[C@@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1,7.40,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,40.0,nM,=,CHEMBL2351567,B,CHEMBL484270,Homo sapiens,CHEMBL203,CHEMBL2346524
Nc1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12,4.46,Inhibition of EGFR,IC50,35000.0,nM,=,CHEMBL949877,B,CHEMBL521155,Homo sapiens,CHEMBL203,CHEMBL1137681
Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12,4.09,Inhibition of EGFR,IC50,82000.0,nM,=,CHEMBL949877,B,CHEMBL485246,Homo sapiens,CHEMBL203,CHEMBL1137681
Nc1ncnc2c1ncn2CC(=O)c1ccccc1,4.12,Inhibition of EGFR,IC50,75000.0,nM,=,CHEMBL949877,B,CHEMBL520515,Homo sapiens,CHEMBL203,CHEMBL1137681
Nc1ncnc2c1ncn2CC(=O)c1ccccn1,4.05,Inhibition of EGFR,IC50,89000.0,nM,=,CHEMBL949877,B,CHEMBL504135,Homo sapiens,CHEMBL203,CHEMBL1137681
Nc1ncnc2c1ncn2CC(=O)c1cccnc1,4.03,Inhibition of EGFR,IC50,93000.0,nM,=,CHEMBL949877,B,CHEMBL501256,Homo sapiens,CHEMBL203,CHEMBL1137681
CCN1CCC(n2cc(CNc3cc(Cl)c4ncc(C#N)c(Nc5ccc(F)c(Cl)c5)c4c3)nn2)CC1,4.96,Inhibition of EGFR,IC50,11000.0,nM,=,CHEMBL1008385,B,CHEMBL527026,Homo sapiens,CHEMBL203,CHEMBL1136974
CCCN1CCC(n2cc(CNc3cc(Cl)c4ncc(C#N)c(Nc5ccc(F)c(Cl)c5)c4c3)nn2)CC1,4.52,Inhibition of EGFR,IC50,30000.0,nM,=,CHEMBL1008385,B,CHEMBL495617,Homo sapiens,CHEMBL203,CHEMBL1136974
CC(C)N1CCC(n2cc(CNc3cc(Cl)c4ncc(C#N)c(Nc5ccc(F)c(Cl)c5)c4c3)nn2)CC1,4.66,Inhibition of EGFR,IC50,22000.0,nM,=,CHEMBL1008385,B,CHEMBL523059,Homo sapiens,CHEMBL203,CHEMBL1136974
N#Cc1cnc2c(Cl)cc(NCc3cn(C4CCN(C5CCC5)CC4)nn3)cc2c1Nc1ccc(F)c(Cl)c1,4.66,Inhibition of EGFR,IC50,22000.0,nM,=,CHEMBL1008385,B,CHEMBL501709,Homo sapiens,CHEMBL203,CHEMBL1136974
N#Cc1cnc2c(Cl)cc(NCc3c[nH]nn3)cc2c1Nc1ccc(F)c(Cl)c1,6.00,Inhibition of EGFR,IC50,1000.0,nM,=,CHEMBL1008385,B,CHEMBL496388,Homo sapiens,CHEMBL203,CHEMBL1136974
CCC(C)[C@@H]1[C@@](C)(C(=O)/C=C/OC)[C@H]2[C@H](C)C[C@@](C)(O)C[C@]2(O)C(=O)[C@@]1(C)O,4.98,Inhibition of human recombinant EGFR kinase expressed in Sf9 insect cells,IC50,10500.0,nM,=,CHEMBL974188,B,CHEMBL498247,Homo sapiens,CHEMBL203,CHEMBL1142620
C[C@@H](O)c1c(O)cc2c(c1O)C(=O)c1c(O)cc(O)cc1C2=O,4.43,Inhibition of human recombinant EGFR kinase expressed in Sf9 insect cells,IC50,37500.0,nM,=,CHEMBL974188,B,CHEMBL524820,Homo sapiens,CHEMBL203,CHEMBL1142620
CO[C@H](C)c1c(O)cc2c(c1O)C(=O)c1c(O)cc(O)cc1C2=O,4.56,Inhibition of human recombinant EGFR kinase expressed in Sf9 insect cells,IC50,27500.0,nM,=,CHEMBL974188,B,CHEMBL498248,Homo sapiens,CHEMBL203,CHEMBL1142620
CO[C@H](C)c1c(O)cc2c(c1O)C(=O)c1c(cc(O)c(O)c1O)C2=O,4.39,Inhibition of human recombinant EGFR kinase expressed in Sf9 insect cells,IC50,41000.0,nM,=,CHEMBL974188,B,CHEMBL498249,Homo sapiens,CHEMBL203,CHEMBL1142620
COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,8.00,Binding constant for EGFR(G719C) kinase domain,Kd,10.0,nM,=,CHEMBL1061068,B,CHEMBL483321,Homo sapiens,CHEMBL203,CHEMBL1150977
Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccc3)[nH]c2n1,6.52,Inhibition of EGFR expressed in human tumor cells,IC50,300.0,nM,=,CHEMBL957461,B,CHEMBL485320,Homo sapiens,CHEMBL203,CHEMBL1150356
COc1ccc(CCc2cc3c(Nc4cccc(Br)c4)nc(N)nc3[nH]2)cc1,5.66,Inhibition of EGFR expressed in human tumor cells,IC50,2200.0,nM,=,CHEMBL957461,B,CHEMBL485321,Homo sapiens,CHEMBL203,CHEMBL1150356
Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccc3Cl)[nH]c2n1,5.47,Inhibition of EGFR expressed in human tumor cells,IC50,3400.0,nM,=,CHEMBL957461,B,CHEMBL482489,Homo sapiens,CHEMBL203,CHEMBL1150356
Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3cccc4ccccc34)[nH]c2n1,5.32,Inhibition of EGFR expressed in human tumor cells,IC50,4800.0,nM,=,CHEMBL957461,B,CHEMBL484108,Homo sapiens,CHEMBL203,CHEMBL1150356
Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccc4ccccc4c3)[nH]c2n1,5.33,Inhibition of EGFR expressed in human tumor cells,IC50,4700.0,nM,=,CHEMBL957461,B,CHEMBL484109,Homo sapiens,CHEMBL203,CHEMBL1150356
Nc1nc(Nc2ccc(F)c(Br)c2)c2cc(CCc3ccccc3)[nH]c2n1,4.64,Inhibition of EGFR,IC50,22800.0,nM,=,CHEMBL1115598,B,CHEMBL483108,Homo sapiens,CHEMBL203,CHEMBL1157122
Nc1nc(Nc2ccc(F)c(Cl)c2)c2cc(CCc3ccccc3)[nH]c2n1,4.64,Inhibition of EGFR expressed in human tumor cells,IC50,22800.0,nM,=,CHEMBL957461,B,CHEMBL504416,Homo sapiens,CHEMBL203,CHEMBL1150356
Nc1nc(Nc2ccc(Cl)cc2F)c2cc(CCc3ccccc3)[nH]c2n1,5.88,Inhibition of EGFR expressed in human tumor cells,IC50,1320.0,nM,=,CHEMBL957461,B,CHEMBL483313,Homo sapiens,CHEMBL203,CHEMBL1150356
Nc1nc(Nc2ccc(Cl)cc2)c2cc(CCc3ccccc3)[nH]c2n1,5.50,Inhibition of EGFR expressed in human tumor cells,IC50,3180.0,nM,=,CHEMBL957461,B,CHEMBL519147,Homo sapiens,CHEMBL203,CHEMBL1150356
Nc1nc(Nc2ccc(F)c(C(F)(F)F)c2)c2cc(CCc3ccccc3)[nH]c2n1,3.91,Inhibition of EGFR expressed in human tumor cells,IC50,122000.0,nM,=,CHEMBL957461,B,CHEMBL482715,Homo sapiens,CHEMBL203,CHEMBL1150356
Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccccc3)[nH]c2n1,5.78,Inhibition of EGFR expressed in human tumor cells,IC50,1670.0,nM,=,CHEMBL957461,B,CHEMBL499344,Homo sapiens,CHEMBL203,CHEMBL1150356
Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccccc3Cl)[nH]c2n1,5.37,Inhibition of EGFR expressed in human tumor cells,IC50,4310.0,nM,=,CHEMBL957461,B,CHEMBL499345,Homo sapiens,CHEMBL203,CHEMBL1150356
Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc4ccccc4c3)[nH]c2n1,5.91,Inhibition of EGFR expressed in human tumor cells,IC50,1240.0,nM,=,CHEMBL957461,B,CHEMBL502015,Homo sapiens,CHEMBL203,CHEMBL1150356
COc1cc2nc(Cl)nc(Nc3ccc(S(=O)(=O)Nc4nccs4)cc3)c2cc1OC,5.01,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,IC50,9700.0,nM,=,CHEMBL3101602,B,CHEMBL525527,Homo sapiens,CHEMBL203,CHEMBL3098085
CN/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(F)c2)c1,7.92,Inhibition of human EGFR expressed in SF9 cells,IC50,12.0,nM,=,CHEMBL1007322,B,CHEMBL497697,Homo sapiens,CHEMBL203,CHEMBL1155952
Nc1ncnc(Nc2ccc3c(cnn3Cc3cccc(F)c3)c2)c1/C=N/NCC(F)(F)F,7.28,Inhibition of human EGFR expressed in SF9 cells,IC50,52.0,nM,=,CHEMBL1007322,B,CHEMBL497863,Homo sapiens,CHEMBL203,CHEMBL1155952
COc1ccc(/N=C/c2c(N)ncnc2Nc2ccc3c(cnn3Cc3cccc(F)c3)c2)cc1,7.31,Inhibition of human EGFR expressed in SF9 cells,IC50,49.0,nM,=,CHEMBL1007322,B,CHEMBL525725,Homo sapiens,CHEMBL203,CHEMBL1155952
CN(C)/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(F)c2)c1,8.10,Inhibition of human EGFR expressed in SF9 cells,IC50,8.0,nM,=,CHEMBL1007322,B,CHEMBL497459,Homo sapiens,CHEMBL203,CHEMBL1155952
Nc1ncnc(Nc2ccc3c(cnn3Cc3cccc(F)c3)c2)c1/C=N/N1CCOCC1,7.80,Inhibition of human EGFR expressed in SF9 cells,IC50,16.0,nM,=,CHEMBL1007322,B,CHEMBL498133,Homo sapiens,CHEMBL203,CHEMBL1155952
Nc1ncnc(Nc2ccc3c(cnn3Cc3cccc(F)c3)c2)c1/C=N/N1CCCCC1,7.52,Inhibition of human EGFR expressed in SF9 cells,IC50,30.0,nM,=,CHEMBL1007322,B,CHEMBL524457,Homo sapiens,CHEMBL203,CHEMBL1155952
CN1CCN(/N=C/c2c(N)ncnc2Nc2ccc3c(cnn3Cc3cccc(F)c3)c2)CC1,7.80,Inhibition of human EGFR expressed in SF9 cells,IC50,16.0,nM,=,CHEMBL1007322,B,CHEMBL498134,Homo sapiens,CHEMBL203,CHEMBL1155952
Nc1ncnc(Nc2ccc3c(cnn3Cc3cccc(F)c3)c2)c1/C=N/N1CCN(CCO)CC1,8.05,Inhibition of human EGFR expressed in SF9 cells,IC50,9.0,nM,=,CHEMBL1007322,B,CHEMBL514566,Homo sapiens,CHEMBL203,CHEMBL1155952
COC[C@@H]1CCCN1/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(F)c2)c1,7.58,Inhibition of human EGFR expressed in SF9 cells,IC50,26.0,nM,=,CHEMBL1007322,B,CHEMBL456758,Homo sapiens,CHEMBL203,CHEMBL1155952
COC[C@H]1CCCN1/N=C/c1c(N)ncnc1Nc1ccc2c(cnn2Cc2cccc(F)c2)c1,7.51,Inhibition of human EGFR expressed in SF9 cells,IC50,31.0,nM,=,CHEMBL1007322,B,CHEMBL515664,Homo sapiens,CHEMBL203,CHEMBL1155952
CCN1CCN(CC/C=C/c2ccc3c(Nc4ccc(Sc5nccn5C)c(Cl)c4)c(C#N)cnc3c2)CC1,8.00,Inhibition of EGFR in presence of 100 uM ATP,IC50,10.0,nM,=,CHEMBL991653,B,CHEMBL489058,Homo sapiens,CHEMBL203,CHEMBL1142456
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl,6.26,Inhibition of GST-tagged recombinant HER1 (unknown origin) expressed in baculovirus expression system incubated for 15-45 mins in presence of [gamma32P]-ATP by radiometric assay,IC50,550.0,nM,=,CHEMBL4704542,B,CHEMBL458997,Homo sapiens,CHEMBL203,CHEMBL4699600
Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1,5.20,Inhibition of EGFR,IC50,6300.0,nM,=,CHEMBL1001226,B,CHEMBL485745,Homo sapiens,CHEMBL203,CHEMBL1152233
COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O,5.27,Inhibition of EGFR,IC50,5400.0,nM,=,CHEMBL984177,B,CHEMBL451523,Homo sapiens,CHEMBL203,CHEMBL1138470
NS(=O)(=O)c1ccc(Nc2nc3ncnc(Nc4c(F)cccc4F)c3s2)cc1,6.73,Inhibition of EGFR,IC50,187.0,nM,=,CHEMBL987693,B,CHEMBL513716,Homo sapiens,CHEMBL203,CHEMBL1153982
NS(=O)(=O)c1ccc(Nc2nc3ncnc(Nc4ccccc4)c3s2)cc1,7.09,Inhibition of EGFR,IC50,82.0,nM,=,CHEMBL987693,B,CHEMBL511839,Homo sapiens,CHEMBL203,CHEMBL1153982
NS(=O)(=O)c1ccc(Nc2nc3ncnc(Nc4cccc(Cl)c4)c3s2)cc1,8.15,Inhibition of EGFR,IC50,7.0,nM,=,CHEMBL987693,B,CHEMBL513418,Homo sapiens,CHEMBL203,CHEMBL1153982
NS(=O)(=O)c1ccc(Nc2nc3ncnc(Nc4cccc(Br)c4)c3s2)cc1,8.00,Inhibition of EGFR,IC50,10.0,nM,=,CHEMBL987693,B,CHEMBL469354,Homo sapiens,CHEMBL203,CHEMBL1153982
NS(=O)(=O)c1ccc(Nc2nc3ncnc(Nc4ccc(F)c(Cl)c4)c3s2)cc1,8.05,Inhibition of EGFR,IC50,9.0,nM,=,CHEMBL987693,B,CHEMBL469355,Homo sapiens,CHEMBL203,CHEMBL1153982
Cc1cccc(Nc2ncnc3nc(Nc4ccc(S(N)(=O)=O)cc4)sc23)c1,7.85,Inhibition of EGFR,IC50,14.0,nM,=,CHEMBL987693,B,CHEMBL513362,Homo sapiens,CHEMBL203,CHEMBL1153982
NS(=O)(=O)c1ccc(Nc2nc3ncnc(Nc4ccc(N5CCOCC5)c(Cl)c4)c3s2)cc1,5.48,Inhibition of EGFR,IC50,3300.0,nM,=,CHEMBL987693,B,CHEMBL469996,Homo sapiens,CHEMBL203,CHEMBL1153982
Fc1ccc(Nc2ncnc3nc(Nc4ccccc4)sc23)cc1Cl,7.23,Inhibition of EGFR,IC50,59.0,nM,=,CHEMBL987693,B,CHEMBL469997,Homo sapiens,CHEMBL203,CHEMBL1153982
NS(=O)(=O)c1ccc(Nc2nc3ncnc(Nc4ccc(N5CCOCC5)cc4)c3s2)cc1,4.75,Inhibition of EGFR,IC50,17900.0,nM,=,CHEMBL987693,B,CHEMBL511449,Homo sapiens,CHEMBL203,CHEMBL1153982
Clc1cccc(Nc2ncnc3nc(Nc4ccccc4)sc23)c1,7.57,Inhibition of EGFR,IC50,27.0,nM,=,CHEMBL987693,B,CHEMBL470003,Homo sapiens,CHEMBL203,CHEMBL1153982
COCCN(CCOC)S(=O)(=O)c1ccc(Nc2nc3ncnc(Nc4ccc(F)c(Cl)c4)c3s2)cc1,7.60,Inhibition of EGFR,IC50,25.0,nM,=,CHEMBL987693,B,CHEMBL470010,Homo sapiens,CHEMBL203,CHEMBL1153982
Fc1ccc(Nc2ncnc3nc(NCCN4CCOCC4)sc23)cc1Cl,6.04,Inhibition of EGFR,IC50,918.0,nM,=,CHEMBL987693,B,CHEMBL511623,Homo sapiens,CHEMBL203,CHEMBL1153982
Fc1ccc(Nc2ncnc3nc(Nc4ccc(CN5CCCCC5)cc4)sc23)cc1Cl,8.00,Inhibition of EGFR,IC50,10.0,nM,=,CHEMBL987693,B,CHEMBL470011,Homo sapiens,CHEMBL203,CHEMBL1153982
Fc1ccc(Nc2ncnc3nc(Nc4ccc(CCN5CCOCC5)cc4)sc23)cc1Cl,7.82,Inhibition of EGFR,IC50,15.0,nM,=,CHEMBL987693,B,CHEMBL470012,Homo sapiens,CHEMBL203,CHEMBL1153982
CN(C)Cc1ccc(Nc2nc3ncnc(Nc4ccc(F)c(Cl)c4)c3s2)cc1,7.92,Inhibition of EGFR,IC50,12.0,nM,=,CHEMBL987693,B,CHEMBL513208,Homo sapiens,CHEMBL203,CHEMBL1153982
CN(C)CCc1ccc(Nc2nc3ncnc(Nc4ccc(F)c(Cl)c4)c3s2)cc1,7.89,Inhibition of EGFR,IC50,13.0,nM,=,CHEMBL987693,B,CHEMBL470218,Homo sapiens,CHEMBL203,CHEMBL1153982
Fc1ccc(Nc2ncnc3nc(Nc4ccc(CN5CCCC5)cc4)sc23)cc1Cl,8.40,Inhibition of EGFR,IC50,4.0,nM,=,CHEMBL987693,B,CHEMBL470219,Homo sapiens,CHEMBL203,CHEMBL1153982
Fc1ccc(Nc2ncnc3nc(Nc4ccc(CN5CCOCC5)cc4)sc23)cc1Cl,7.92,Inhibition of EGFR,IC50,12.0,nM,=,CHEMBL987693,B,CHEMBL511637,Homo sapiens,CHEMBL203,CHEMBL1153982
OC[C@@H]1CCCN1Cc1ccc(Nc2nc3ncnc(Nc4ccc(F)c(Cl)c4)c3s2)cc1,7.96,Inhibition of EGFR,IC50,11.0,nM,=,CHEMBL987693,B,CHEMBL511990,Homo sapiens,CHEMBL203,CHEMBL1153982
CCc1nccn1Cc1ccc(Nc2nc3ncnc(Nc4ccc(F)c(Cl)c4)c3s2)cc1,8.22,Inhibition of EGFR,IC50,6.0,nM,=,CHEMBL987693,B,CHEMBL471058,Homo sapiens,CHEMBL203,CHEMBL1153982
C#Cc1cccc(Nc2ncnc3nc(Nc4ccc(CN5CCOCC5)cc4)sc23)c1,7.37,Inhibition of EGFR,IC50,43.0,nM,=,CHEMBL987693,B,CHEMBL470391,Homo sapiens,CHEMBL203,CHEMBL1153982
CN1CCN(Cc2ccc(Nc3nc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)cc2)CC1,8.05,Inhibition of EGFR,IC50,9.0,nM,=,CHEMBL987693,B,CHEMBL503418,Homo sapiens,CHEMBL203,CHEMBL1153982
NC[C@H](Cc1cccc(F)c1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1,5.00,Inhibition of EGFR,IC50,10000.0,nM,=,CHEMBL959256,B,CHEMBL523586,Homo sapiens,CHEMBL203,CHEMBL1153968
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl,6.30,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,500.0,nM,=,CHEMBL677388,B,CHEMBL533849,Homo sapiens,CHEMBL203,CHEMBL1135889
C=C(CN(C)C)C(=O)c1ccc(OCc2ccccc2)c(O)c1.Cl,6.17,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,670.0,nM,=,CHEMBL677209,B,CHEMBL542887,Homo sapiens,CHEMBL203,CHEMBL1128740
C=C(CN(C)C)C(=O)c1ccc(OS(=O)(=O)c2ccc(C(=O)N(C)C)cc2)cc1.Cl,6.16,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,700.0,nM,=,CHEMBL677209,B,CHEMBL552634,Homo sapiens,CHEMBL203,CHEMBL1128740
C=C(CN1CCOCC1)C(=O)c1ccc(OCc2ccccc2)cc1.Cl,5.96,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,1100.0,nM,=,CHEMBL677209,B,CHEMBL544067,Homo sapiens,CHEMBL203,CHEMBL1128740
C=C(CN1CCNCC1)C(=O)c1ccc(OCc2ccccc2)cc1.Cl,5.82,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,1500.0,nM,=,CHEMBL677209,B,CHEMBL544538,Homo sapiens,CHEMBL203,CHEMBL1128740
CN(C)CCC(=O)c1ccc(OCc2ccccc2)cc1.Cl,5.82,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,1500.0,nM,=,CHEMBL677209,B,CHEMBL544770,Homo sapiens,CHEMBL203,CHEMBL1128740
Cl.O=C(CCN1CCCCC1)c1ccc(OCc2ccccc2)cc1,5.75,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,1800.0,nM,=,CHEMBL677209,B,CHEMBL545006,Homo sapiens,CHEMBL203,CHEMBL1128740
CCOC(=O)C1CCN(CCC(=O)c2ccc(OCc3ccccc3)cc2)CC1.Cl,6.52,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,300.0,nM,=,CHEMBL677209,B,CHEMBL542891,Homo sapiens,CHEMBL203,CHEMBL1128740
Cl.O=C(CCN1CCOCC1)c1ccc(OCc2ccccc2)cc1,5.82,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,1500.0,nM,=,CHEMBL677209,B,CHEMBL542893,Homo sapiens,CHEMBL203,CHEMBL1128740
CN(C)CC(CSCCN)C(=O)c1ccc(OCc2ccccc2)cc1.Cl,5.06,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,8800.0,nM,=,CHEMBL677209,B,CHEMBL543361,Homo sapiens,CHEMBL203,CHEMBL1128740
CC(CN(C)C)C(=O)c1ccc(OS(=O)(=O)c2ccc(C(=O)O)cc2)cc1.Cl,4.00,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,100000.0,nM,=,CHEMBL677209,B,CHEMBL543600,Homo sapiens,CHEMBL203,CHEMBL1128740
C=C(CN(C)C)C(=O)c1ccc(OCc2ccccc2)cc1.Cl,6.75,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,180.0,nM,=,CHEMBL677209,B,CHEMBL552859,Homo sapiens,CHEMBL203,CHEMBL1128740
CN(C)CCC(=O)c1ccc(OCc2ccccc2)c(O)c1.Cl,6.44,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,360.0,nM,=,CHEMBL677209,B,CHEMBL552860,Homo sapiens,CHEMBL203,CHEMBL1128740
C=C(CN1CCCCC1)C(=O)c1ccc(OCc2ccccc2)cc1.Cl,5.96,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,1100.0,nM,=,CHEMBL677209,B,CHEMBL544074,Homo sapiens,CHEMBL203,CHEMBL1128740
COc1cc(Nc2ncnc3cc(OC)c(OC)cc23)cc(OC)c1.Cl,5.52,Inhibition of Epidermal growth factor receptor autophosphorylation.,IC50,3000.0,nM,=,CHEMBL676160,B,CHEMBL543661,Homo sapiens,CHEMBL203,CHEMBL1129839
COc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1OC.Cl,6.46,Inhibition of Epidermal growth factor receptor autophosphorylation.,IC50,350.0,nM,=,CHEMBL676160,B,CHEMBL544833,Homo sapiens,CHEMBL203,CHEMBL1129839
COc1cc2ncnc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OC.Cl,6.30,Inhibition of Epidermal growth factor receptor autophosphorylation.,IC50,500.0,nM,=,CHEMBL676160,B,CHEMBL543904,Homo sapiens,CHEMBL203,CHEMBL1129839
COc1cc2ncnc(Nc3ccc4c(c3)CCC4)c2cc1OC.Cl,6.22,Inhibition of Epidermal growth factor receptor autophosphorylation.,IC50,600.0,nM,=,CHEMBL676160,B,CHEMBL555797,Homo sapiens,CHEMBL203,CHEMBL1129839
COc1cc2ncnc(NCc3ccccc3)c2cc1OC.Cl,8.40,Inhibition of Epidermal growth factor receptor autophosphorylation.,IC50,4.0,nM,=,CHEMBL676160,B,CHEMBL545541,Homo sapiens,CHEMBL203,CHEMBL1129839
COc1ccc2ncnc(Nc3cc(OC)c(OC)c(OC)c3)c2c1.Cl,7.00,Inhibition of Epidermal growth factor receptor autophosphorylation.,IC50,100.0,nM,=,CHEMBL676160,B,CHEMBL542729,Homo sapiens,CHEMBL203,CHEMBL1129839
COc1cc2ncnc(N(C)c3ccccc3)c2cc1OC.Cl,5.40,Inhibition of Epidermal growth factor receptor autophosphorylation.,IC50,4000.0,nM,=,CHEMBL676160,B,CHEMBL543669,Homo sapiens,CHEMBL203,CHEMBL1129839
COc1cc2ncnc(Nc3ccccc3)c2cc1OC.Cl,7.30,Inhibition of Epidermal growth factor receptor autophosphorylation.,IC50,50.0,nM,=,CHEMBL676160,B,CHEMBL542484,Homo sapiens,CHEMBL203,CHEMBL1129839
COc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1.Cl,6.60,Inhibition of Epidermal growth factor receptor autophosphorylation.,IC50,250.0,nM,=,CHEMBL676160,B,CHEMBL542733,Homo sapiens,CHEMBL203,CHEMBL1129839
Cl.Clc1cccc(Nc2ncnc3ccccc23)c1,7.30,"Inhibition of Epidermal growth factor receptor autophosphorylation, 0.05-0.10",IC50,50.0,nM,=,CHEMBL676161,B,CHEMBL555321,Homo sapiens,CHEMBL203,CHEMBL1129839
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1.Cl.Cl,8.82,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme (from human A431 carcinoma cell vesicles),IC50,1.5,nM,=,CHEMBL673925,B,CHEMBL545315,Homo sapiens,CHEMBL203,CHEMBL1134843
COc1cccc2sc3c(Nc4cccc(Br)c4)ncnc3c12.Cl,7.70,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,20.0,nM,=,CHEMBL679944,B,CHEMBL542755,Homo sapiens,CHEMBL203,CHEMBL1132555
COc1cc2sc3c(Nc4cccc(Br)c4)ncnc3c2cc1OC.Cl,6.35,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,444.0,nM,=,CHEMBL679944,B,CHEMBL544865,Homo sapiens,CHEMBL203,CHEMBL1132555
Cc1cccc(Nc2ncnc3c2sc2ccc([N+](=O)[O-])cc23)c1.Cl,7.96,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,11.0,nM,=,CHEMBL679944,B,CHEMBL544867,Homo sapiens,CHEMBL203,CHEMBL1132555
Cl.O=[N+]([O-])c1ccc2sc3c(Nc4ccccc4)ncnc3c2c1,7.24,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,58.0,nM,=,CHEMBL679944,B,CHEMBL544868,Homo sapiens,CHEMBL203,CHEMBL1132555
Cl.O=[N+]([O-])c1ccc2sc3c(Nc4cccc(Br)c4)ncnc3c2c1,7.91,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,12.3,nM,=,CHEMBL679944,B,CHEMBL553351,Homo sapiens,CHEMBL203,CHEMBL1132555
Cl.c1ccc(Nc2[nH]cnc3c4ccccc4nc2-3)cc1,5.68,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,2110.0,nM,=,CHEMBL679944,B,CHEMBL544640,Homo sapiens,CHEMBL203,CHEMBL1132555
Cl.Cn1c2ccccc2c2ncnc(Nc3cccc(Br)c3)c21,6.88,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,132.0,nM,=,CHEMBL679944,B,CHEMBL553137,Homo sapiens,CHEMBL203,CHEMBL1132555
Cc1cccc(C)c1Nc1ncc(-c2ccc(OCC3CCCN(C)C3)cc2)n2cncc12.Cl,5.56,Inhibition of EGFR,IC50,2730.0,nM,=,CHEMBL919737,B,CHEMBL534948,Homo sapiens,CHEMBL203,CHEMBL1144561
COC(=O)c1ccccc1SCC(CN(C)C)C(=O)c1ccc(OCc2ccccc2)cc1.Cl,5.06,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,8800.0,nM,=,CHEMBL677209,B,CHEMBL538757,Homo sapiens,CHEMBL203,CHEMBL1128740
CN(C)CC(CSc1ccccc1)C(=O)c1ccc(OCc2ccccc2)cc1.Cl,5.14,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,7300.0,nM,=,CHEMBL677209,B,CHEMBL540292,Homo sapiens,CHEMBL203,CHEMBL1128740
CN(C)CC(CNNC(N)=O)C(=O)c1ccc(OCc2ccccc2)cc1.Cl,5.41,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,3900.0,nM,=,CHEMBL677209,B,CHEMBL541307,Homo sapiens,CHEMBL203,CHEMBL1128740
Cc1ccc(SCC(CN(C)C)C(=O)c2ccc(OCc3ccccc3)cc2)cc1C.Cl,5.68,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,IC50,2100.0,nM,=,CHEMBL677209,B,CHEMBL538507,Homo sapiens,CHEMBL203,CHEMBL1128740
COc1cc2ncnc(Nc3cccc(F)c3)c2cc1OC.Cl,7.60,Inhibition of Epidermal growth factor receptor autophosphorylation.,IC50,25.0,nM,=,CHEMBL676160,B,CHEMBL541586,Homo sapiens,CHEMBL203,CHEMBL1129839
COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC.Cl,7.00,Inhibition of Epidermal growth factor receptor autophosphorylation.,IC50,100.0,nM,=,CHEMBL676160,B,CHEMBL555201,Homo sapiens,CHEMBL203,CHEMBL1129839
COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC.Cl,8.90,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,1.26,nM,=,CHEMBL916319,B,CHEMBL540068,Homo sapiens,CHEMBL203,CHEMBL1140296
Cl.Nc1ccc2c(c1)sc1c(Nc3cccc(Br)c3)ncnc12,9.33,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,0.47,nM,=,CHEMBL679944,B,CHEMBL539822,Homo sapiens,CHEMBL203,CHEMBL1132555
Cl.O=[N+]([O-])c1ccc2c(c1)sc1c(Nc3cccc(Br)c3)ncnc12,7.32,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,48.0,nM,=,CHEMBL679944,B,CHEMBL540590,Homo sapiens,CHEMBL203,CHEMBL1132555
CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1.Cl,5.60,Inhibition of Epidermal growth factor receptor,IC50,2511.89,nM,=,CHEMBL857165,B,CHEMBL538798,Homo sapiens,CHEMBL203,CHEMBL1133428
COc1cccc2c1sc1c(Nc3cccc(Br)c3)ncnc12.Cl,7.90,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,12.6,nM,=,CHEMBL679944,B,CHEMBL555921,Homo sapiens,CHEMBL203,CHEMBL1132555
Cl.O=[N+]([O-])c1cccc2c1sc1c(Nc3cccc(Br)c3)ncnc12,6.80,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,158.0,nM,=,CHEMBL679944,B,CHEMBL540082,Homo sapiens,CHEMBL203,CHEMBL1132555
Cl.O=[N+]([O-])c1ccc2sc3c(Nc4cccc(C(F)(F)F)c4)ncnc3c2c1,6.34,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,460.0,nM,=,CHEMBL679944,B,CHEMBL538814,Homo sapiens,CHEMBL203,CHEMBL1132555
Brc1cccc(Nc2[nH]cnc3c4ccccc4nc2-3)c1.Cl,7.14,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,72.0,nM,=,CHEMBL679944,B,CHEMBL554983,Homo sapiens,CHEMBL203,CHEMBL1132555
COc1ccc2ncnc(Nc3ccccc3)c2c1.Cl,6.92,Inhibition of EGFR,IC50,120.23,nM,=,CHEMBL952131,B,CHEMBL539102,Homo sapiens,CHEMBL203,CHEMBL1143196
CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2,5.51,Inhibition of EGFR,IC50,3069.0,nM,=,CHEMBL1058612,B,CHEMBL564829,Homo sapiens,CHEMBL203,CHEMBL1151962
CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,7.82,Binding constant for EGFR kinase domain,Kd,15.0,nM,=,CHEMBL1060182,B,CHEMBL572881,Homo sapiens,CHEMBL203,CHEMBL1150977
CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,6.66,Binding constant for EGFR(G719C) kinase domain,Kd,220.0,nM,=,CHEMBL1061068,B,CHEMBL574738,Homo sapiens,CHEMBL203,CHEMBL1150977
Cc1cc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)ccc1F,6.41,Inhibition of EGFR,IC50,390.0,nM,=,CHEMBL1060165,B,CHEMBL574058,Homo sapiens,CHEMBL203,CHEMBL1150972
Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(F)cc3)nc21,6.42,Inhibition of EGFR,IC50,380.0,nM,=,CHEMBL1060165,B,CHEMBL574059,Homo sapiens,CHEMBL203,CHEMBL1150972
CCC1=C2C(Nc3ccc4c(cnn4Cc4ccccc4)c3)=NC=NC2N=C1NC(=O)O[C@H]1CC[C@H](N)CC1,7.64,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,IC50,23.0,nM,=,CHEMBL1052827,B,CHEMBL565467,Homo sapiens,CHEMBL203,CHEMBL1154610
CCC1=C2C(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)=NC=NC2N=C1NC(=O)OC[C@@H]1COCCN1,7.64,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,IC50,23.0,nM,=,CHEMBL1052827,B,CHEMBL583403,Homo sapiens,CHEMBL203,CHEMBL1154610
CCC1=C2C(Nc3ccc4c(cnn4Cc4ccccc4)c3)=NC=NC2N=C1NC(=O)O[C@H]1CC[C@@](C)(N)CC1,7.72,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,IC50,19.0,nM,=,CHEMBL1052827,B,CHEMBL567197,Homo sapiens,CHEMBL203,CHEMBL1154610
CCC1=C2C(Nc3ccc4c(cnn4Cc4ccccc4)c3)=NC=NC2N=C1NC(=O)OCCC1CCNCC1,7.36,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,IC50,44.0,nM,=,CHEMBL1052827,B,CHEMBL578044,Homo sapiens,CHEMBL203,CHEMBL1154610
CCC1=C2C(Nc3ccc4c(cnn4Cc4ccccc4)c3)=NC=NC2N=C1NC(=O)OCC1CCNCC1,7.52,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,IC50,30.0,nM,=,CHEMBL1052827,B,CHEMBL583218,Homo sapiens,CHEMBL203,CHEMBL1154610
CCC1=C2C(Nc3ccc4c(cnn4Cc4ccccc4)c3)=NC=NC2N=C1NC(=O)OCC1CCCNC1,7.42,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,IC50,38.0,nM,=,CHEMBL1052827,B,CHEMBL584714,Homo sapiens,CHEMBL203,CHEMBL1154610
CCC1=C2C(Nc3ccc4c(cnn4Cc4ccccc4)c3)=NC=NC2N=C1NC(=O)OCCn1ccnc1,7.40,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,IC50,40.0,nM,=,CHEMBL1052827,B,CHEMBL566337,Homo sapiens,CHEMBL203,CHEMBL1154610
CCC1=C2C(Nc3ccc4c(cnn4Cc4ccccc4)c3)=NC=NC2N=C1NC(=O)OCCN1CCCCC1,7.42,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,IC50,38.0,nM,=,CHEMBL1052827,B,CHEMBL566350,Homo sapiens,CHEMBL203,CHEMBL1154610
CCC1=C2C(Nc3ccc4c(cnn4Cc4ccccc4)c3)=NC=NC2N=C1NC(=O)OCC1CCCCN1,7.35,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,IC50,45.0,nM,=,CHEMBL1052827,B,CHEMBL566559,Homo sapiens,CHEMBL203,CHEMBL1154610
CCC1=C2C(Nc3ccc4c(cnn4Cc4ccccc4)c3)=NC=NC2N=C1NC(=O)OCCN1CCNCC1,7.68,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,IC50,21.0,nM,=,CHEMBL1052827,B,CHEMBL565714,Homo sapiens,CHEMBL203,CHEMBL1154610
CCC1=C2C(Nc3ccc4c(cnn4Cc4ccccc4)c3)=NC=NC2N=C1NC(=O)OC[C@@H]1COCCN1,7.48,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,IC50,33.0,nM,=,CHEMBL1052827,B,CHEMBL567873,Homo sapiens,CHEMBL203,CHEMBL1154610
CCC1=C2C(Nc3ccc4c(cnn4Cc4ccccc4)c3)=NC=NC2N=C1NC(=O)OCCN1CCOCC1,6.96,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,IC50,111.0,nM,=,CHEMBL1052827,B,CHEMBL578255,Homo sapiens,CHEMBL203,CHEMBL1154610
C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC,7.89,Inhibition of Her1 by fluorescence polarization assay,IC50,13.0,nM,=,CHEMBL1044055,B,CHEMBL571040,Homo sapiens,CHEMBL203,CHEMBL1154692
C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCCOC,8.05,Inhibition of Her1 by fluorescence polarization assay,IC50,9.0,nM,=,CHEMBL1044055,B,CHEMBL569880,Homo sapiens,CHEMBL203,CHEMBL1154692
c1csc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1,6.64,Binding affinity to EGFR assessed as dissociation constant,Kd,230.0,nM,=,CHEMBL1039046,B,CHEMBL567331,Homo sapiens,CHEMBL203,CHEMBL1156118
CC(=O)OCN(C)/N=N/c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,6.62,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,IC50,240.0,nM,=,CHEMBL1046364,B,CHEMBL571809,Homo sapiens,CHEMBL203,CHEMBL1155367
C=COC(=O)N(CCN(C)C)/N=N/c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,6.75,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,IC50,180.0,nM,=,CHEMBL1046364,B,CHEMBL572030,Homo sapiens,CHEMBL203,CHEMBL1155367
C=COC(=O)N(C)/N=N/c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,6.14,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,IC50,720.0,nM,=,CHEMBL1046364,B,CHEMBL572031,Homo sapiens,CHEMBL203,CHEMBL1155367
CN(/N=N/c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)C(=O)OCCCl,6.30,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,IC50,500.0,nM,=,CHEMBL1046364,B,CHEMBL570918,Homo sapiens,CHEMBL203,CHEMBL1155367
CC(=O)OCOC(=O)N(C)/N=N/c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,6.20,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,IC50,630.0,nM,=,CHEMBL1046364,B,CHEMBL572028,Homo sapiens,CHEMBL203,CHEMBL1155367
CN(/N=N/c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)C(=O)OCCl,6.41,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,IC50,390.0,nM,=,CHEMBL1046364,B,CHEMBL583683,Homo sapiens,CHEMBL203,CHEMBL1155367
CN(/N=N/c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)C(=O)Oc1ccc([N+](=O)[O-])cc1,6.11,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,IC50,770.0,nM,=,CHEMBL1046364,B,CHEMBL570709,Homo sapiens,CHEMBL203,CHEMBL1155367
CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1,6.10,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,794.4,nM,=,CHEMBL1909203,B,CHEMBL588119,Homo sapiens,CHEMBL203,CHEMBL1909046
CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1,8.70,Inhibition of EGFR by Z-LYTE assay,IC50,2.0,nM,=,CHEMBL1920033,B,CHEMBL587723,Homo sapiens,CHEMBL203,CHEMBL1914342
NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21,6.03,Inhibition of EGFR,IC50,940.0,nM,=,CHEMBL1072676,B,CHEMBL590109,Homo sapiens,CHEMBL203,CHEMBL1153138
COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OC)c(OC)cc12,7.20,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,63.0,nM,=,CHEMBL1073378,B,CHEMBL596059,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3O)ncnc2cc1OCCCN1CCN(C)CC1,6.46,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,350.0,nM,=,CHEMBL1073378,B,CHEMBL595142,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3F)c2cc1OCCCN1CCN(C)CC1,5.35,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,4500.0,nM,=,CHEMBL1073378,B,CHEMBL594661,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1,7.80,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,16.0,nM,=,CHEMBL1073378,B,CHEMBL593274,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1ccc2nc(-c3ccc(Nc4ncnc5cc(OCCCN6CCN(C)CC6)c(OC)cc45)cc3)sc2c1,6.70,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,200.0,nM,=,CHEMBL1073378,B,CHEMBL593306,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,7.34,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,46.0,nM,=,CHEMBL1073378,B,CHEMBL595615,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)c2cc1OCCCN1CCN(C)CC1,5.48,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,3300.0,nM,=,CHEMBL1073378,B,CHEMBL604485,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)c2cc1OCCCN1CCN(C)CC1,5.64,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,2300.0,nM,=,CHEMBL1073378,B,CHEMBL593760,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,6.09,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,805.0,nM,=,CHEMBL1073378,B,CHEMBL594228,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OCCCN1CCN(C)CC1,6.17,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,670.0,nM,=,CHEMBL1073378,B,CHEMBL593292,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(C)c3)ncnc2cc1OCCCN1CCN(C)CC1,7.50,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,32.0,nM,=,CHEMBL1073378,B,CHEMBL596087,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)c2cc1OCCCN1CCN(C)CC1,7.36,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,44.0,nM,=,CHEMBL1073378,B,CHEMBL604893,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2c(Nc3ccc(-c4nc5ccc(F)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,6.14,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,730.0,nM,=,CHEMBL1073378,B,CHEMBL604992,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)ncnc2cc1OCCCN1CCN(C)CC1,6.96,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,110.0,nM,=,CHEMBL1073378,B,CHEMBL606466,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1,8.70,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,2.0,nM,=,CHEMBL1073378,B,CHEMBL593860,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3C)c2cc1OCCCN1CCN(C)CC1,5.85,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,1400.0,nM,=,CHEMBL1073378,B,CHEMBL595374,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)ncnc2cc1OCCCN1CCN(C)CC1,6.37,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,430.0,nM,=,CHEMBL1073378,B,CHEMBL593987,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2c(Nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,6.58,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,260.0,nM,=,CHEMBL1073378,B,CHEMBL593275,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2c(Nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,5.21,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,6200.0,nM,=,CHEMBL1073378,B,CHEMBL593909,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2c(N(C)c3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1,5.85,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,1400.0,nM,=,CHEMBL1073378,B,CHEMBL593770,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3O)c2cc1OC,5.66,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,2200.0,nM,=,CHEMBL1073378,B,CHEMBL593293,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3O)c2cc1OCCCN1CCN(C)CC1,6.64,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,230.0,nM,=,CHEMBL1073378,B,CHEMBL593294,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)c2cc1OCCCN1CCN(C)CC1,7.82,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,15.0,nM,=,CHEMBL1073378,B,CHEMBL593911,Homo sapiens,CHEMBL203,CHEMBL1152560
COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3C)ncnc2cc1OCCCN1CCN(C)CC1,6.60,Inhibition of wild type EGF-R by microplate scintillation counting,IC50,250.0,nM,=,CHEMBL1073378,B,CHEMBL595406,Homo sapiens,CHEMBL203,CHEMBL1152560
CCCCC(Cc1coc2nc(N)nc(N)c12)c1ccccc1OC,4.87,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA,IC50,13400.0,nM,=,CHEMBL1038898,B,CHEMBL594790,Homo sapiens,CHEMBL203,CHEMBL1152608
CCCC(Cc1coc2nc(N)nc(N)c12)c1ccccc1OC,5.66,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA,IC50,2200.0,nM,=,CHEMBL1038898,B,CHEMBL605413,Homo sapiens,CHEMBL203,CHEMBL1152608
COc1ccccc1C(Cc1coc2nc(N)nc(N)c12)C(C)C,4.74,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA,IC50,18200.0,nM,=,CHEMBL1038898,B,CHEMBL595757,Homo sapiens,CHEMBL203,CHEMBL1152608
COc1ccccc1C(Cc1coc2nc(N)nc(N)c12)C1CC1,4.25,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA,IC50,56500.0,nM,=,CHEMBL1038898,B,CHEMBL603198,Homo sapiens,CHEMBL203,CHEMBL1152608
CN(C)c1cccc2c(S(=O)(=O)NCCN/N=N/c3ccc4ncnc(Nc5cccc(Cl)c5)c4c3)cccc12,5.85,Inhibition of EGFR,IC50,1400.0,nM,=,CHEMBL1072146,B,CHEMBL606413,Homo sapiens,CHEMBL203,CHEMBL1157582
CN(CCN/N=N/c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)CCNS(=O)(=O)c1cccc2c(N(C)C)cccc12,6.22,Inhibition of EGFR,IC50,600.0,nM,=,CHEMBL1072146,B,CHEMBL591897,Homo sapiens,CHEMBL203,CHEMBL1157582
O=C(Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)[C@@H]1O[C@H]1CN1CCCCC1,8.91,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,IC50,1.24,nM,=,CHEMBL1072157,B,CHEMBL598007,Homo sapiens,CHEMBL203,CHEMBL1157583
O=C(COc1ccccc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.03,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,IC50,9.25,nM,=,CHEMBL1072157,B,CHEMBL604914,Homo sapiens,CHEMBL203,CHEMBL1157583
O=C(COc1ccc(F)cc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.07,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,IC50,8.43,nM,=,CHEMBL1072157,B,CHEMBL597200,Homo sapiens,CHEMBL203,CHEMBL1157583
O=C(COc1c(F)c(F)c(F)c(F)c1F)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.63,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,IC50,23.6,nM,=,CHEMBL1072157,B,CHEMBL597402,Homo sapiens,CHEMBL203,CHEMBL1157583
O=C(CNC(=O)Oc1ccccc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.43,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,IC50,0.37,nM,=,CHEMBL1072157,B,CHEMBL599863,Homo sapiens,CHEMBL203,CHEMBL1157583
N#CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.77,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,IC50,0.17,nM,=,CHEMBL1072157,B,CHEMBL592617,Homo sapiens,CHEMBL203,CHEMBL1157583
O=C(Cn1sccc1=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.44,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,IC50,0.36,nM,=,CHEMBL1072157,B,CHEMBL603266,Homo sapiens,CHEMBL203,CHEMBL1157583
O=C(Cn1sc2ccccc2c1=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.07,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,IC50,0.85,nM,=,CHEMBL1072157,B,CHEMBL599047,Homo sapiens,CHEMBL203,CHEMBL1157583
CC(C)c1nsc(C(=O)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)n1,6.89,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,IC50,129.0,nM,=,CHEMBL1072157,B,CHEMBL606403,Homo sapiens,CHEMBL203,CHEMBL1157583
C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,8.11,"Binding constant for EGFR(L858R,T790M) kinase domain",Kd,7.8,nM,=,CHEMBL1908701,B,CHEMBL603469,Homo sapiens,CHEMBL203,CHEMBL1908390
O=C(Nc1ccccc1)N(Cc1ccc(F)cc1)Cc1cccc(Cl)c1O,5.70,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,1980.0,nM,=,CHEMBL1064829,B,CHEMBL592426,Homo sapiens,CHEMBL203,CHEMBL1157668
O=C(Nc1ccccc1)N(Cc1ccc(F)cc1)Cc1cccc(Br)c1O,5.65,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,2240.0,nM,=,CHEMBL1064829,B,CHEMBL592427,Homo sapiens,CHEMBL203,CHEMBL1157668
Cc1cccc(CN(Cc2ccc(F)cc2)C(=O)Nc2ccccc2)c1O,4.66,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,21710.0,nM,=,CHEMBL1064829,B,CHEMBL600048,Homo sapiens,CHEMBL203,CHEMBL1157668
O=C(Nc1ccccc1)N(Cc1ccc(F)cc1)Cc1cc(Cl)cc(Cl)c1O,5.38,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,4150.0,nM,=,CHEMBL1064829,B,CHEMBL589809,Homo sapiens,CHEMBL203,CHEMBL1157668
O=C(Nc1ccccc1)N(Cc1ccc(F)cc1)Cc1cc(Br)cc(Br)c1O,5.33,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,4680.0,nM,=,CHEMBL1064829,B,CHEMBL603186,Homo sapiens,CHEMBL203,CHEMBL1157668
Cc1cc(C)c(O)c(CN(Cc2ccc(F)cc2)C(=O)Nc2ccccc2)c1,4.56,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,27350.0,nM,=,CHEMBL1064829,B,CHEMBL592210,Homo sapiens,CHEMBL203,CHEMBL1157668
O=C(Nc1ccccc1)N(Cc1ccc(O)cc1)Cc1cccc(Cl)c1O,6.02,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,960.0,nM,=,CHEMBL1064829,B,CHEMBL592211,Homo sapiens,CHEMBL203,CHEMBL1157668
O=C(Nc1ccccc1)N(Cc1ccc(O)cc1)Cc1cccc(Br)c1O,5.97,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,1070.0,nM,=,CHEMBL1064829,B,CHEMBL590714,Homo sapiens,CHEMBL203,CHEMBL1157668
Cc1cccc(CN(Cc2ccc(O)cc2)C(=O)Nc2ccccc2)c1O,5.12,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,7510.0,nM,=,CHEMBL1064829,B,CHEMBL590525,Homo sapiens,CHEMBL203,CHEMBL1157668
O=C(Nc1ccccc1)N(Cc1ccc(O)cc1)Cc1cc(Cl)cc(Cl)c1O,5.73,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,1860.0,nM,=,CHEMBL1064829,B,CHEMBL590526,Homo sapiens,CHEMBL203,CHEMBL1157668
O=C(Nc1ccccc1)N(Cc1ccc(O)cc1)Cc1cc(Br)cc(Br)c1O,5.95,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,1120.0,nM,=,CHEMBL1064829,B,CHEMBL601828,Homo sapiens,CHEMBL203,CHEMBL1157668
Cc1cc(C)c(O)c(CN(Cc2ccc(O)cc2)C(=O)Nc2ccccc2)c1,5.03,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,9260.0,nM,=,CHEMBL1064829,B,CHEMBL589068,Homo sapiens,CHEMBL203,CHEMBL1157668
CCCCN(Cc1cccc(Cl)c1O)C(=O)Nc1ccccc1,4.49,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,32120.0,nM,=,CHEMBL1064829,B,CHEMBL591706,Homo sapiens,CHEMBL203,CHEMBL1157668
CCCCN(Cc1cccc(Br)c1O)C(=O)Nc1ccccc1,4.43,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,36880.0,nM,=,CHEMBL1064829,B,CHEMBL590962,Homo sapiens,CHEMBL203,CHEMBL1157668
Oc1c(Cl)cccc1CN(Cc1ccc(F)cc1)C(=S)Nc1ccccc1,6.17,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,670.0,nM,=,CHEMBL1064829,B,CHEMBL589560,Homo sapiens,CHEMBL203,CHEMBL1157668
Oc1c(Br)cccc1CN(Cc1ccc(F)cc1)C(=S)Nc1ccccc1,6.01,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,980.0,nM,=,CHEMBL1064829,B,CHEMBL589561,Homo sapiens,CHEMBL203,CHEMBL1157668
Cc1cccc(CN(Cc2ccc(F)cc2)C(=S)Nc2ccccc2)c1O,5.07,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,8540.0,nM,=,CHEMBL1064829,B,CHEMBL589801,Homo sapiens,CHEMBL203,CHEMBL1157668
Oc1c(Cl)cc(Cl)cc1CN(Cc1ccc(F)cc1)C(=S)Nc1ccccc1,5.87,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,1340.0,nM,=,CHEMBL1064829,B,CHEMBL592200,Homo sapiens,CHEMBL203,CHEMBL1157668
Oc1c(Br)cc(Br)cc1CN(Cc1ccc(F)cc1)C(=S)Nc1ccccc1,5.75,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,1760.0,nM,=,CHEMBL1064829,B,CHEMBL592201,Homo sapiens,CHEMBL203,CHEMBL1157668
Cc1cc(C)c(O)c(CN(Cc2ccc(F)cc2)C(=S)Nc2ccccc2)c1,4.71,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,19410.0,nM,=,CHEMBL1064829,B,CHEMBL592224,Homo sapiens,CHEMBL203,CHEMBL1157668
Oc1ccc(CN(Cc2cccc(Cl)c2O)C(=S)Nc2ccccc2)cc1,7.10,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,80.0,nM,=,CHEMBL1064829,B,CHEMBL592466,Homo sapiens,CHEMBL203,CHEMBL1157668
Oc1ccc(CN(Cc2cccc(Br)c2O)C(=S)Nc2ccccc2)cc1,6.92,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,120.0,nM,=,CHEMBL1064829,B,CHEMBL604042,Homo sapiens,CHEMBL203,CHEMBL1157668
Cc1cccc(CN(Cc2ccc(O)cc2)C(=S)Nc2ccccc2)c1O,5.46,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,3460.0,nM,=,CHEMBL1064829,B,CHEMBL604785,Homo sapiens,CHEMBL203,CHEMBL1157668
Oc1ccc(CN(Cc2cc(Cl)cc(Cl)c2O)C(=S)Nc2ccccc2)cc1,6.25,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,560.0,nM,=,CHEMBL1064829,B,CHEMBL591288,Homo sapiens,CHEMBL203,CHEMBL1157668
Oc1ccc(CN(Cc2cc(Br)cc(Br)c2O)C(=S)Nc2ccccc2)cc1,6.06,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,870.0,nM,=,CHEMBL1064829,B,CHEMBL592004,Homo sapiens,CHEMBL203,CHEMBL1157668
Cc1cc(C)c(O)c(CN(Cc2ccc(O)cc2)C(=S)Nc2ccccc2)c1,5.23,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,5830.0,nM,=,CHEMBL1064829,B,CHEMBL592247,Homo sapiens,CHEMBL203,CHEMBL1157668
CCCCN(Cc1cccc(Cl)c1O)C(=S)Nc1ccccc1,4.74,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,18120.0,nM,=,CHEMBL1064829,B,CHEMBL589413,Homo sapiens,CHEMBL203,CHEMBL1157668
CCCCN(Cc1cccc(Br)c1O)C(=S)Nc1ccccc1,4.66,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,22040.0,nM,=,CHEMBL1064829,B,CHEMBL606027,Homo sapiens,CHEMBL203,CHEMBL1157668
CCCCN(Cc1cccc(C)c1O)C(=S)Nc1ccccc1,4.36,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,43210.0,nM,=,CHEMBL1064829,B,CHEMBL591437,Homo sapiens,CHEMBL203,CHEMBL1157668
CCCCN(Cc1cc(Cl)cc(Cl)c1O)C(=S)Nc1ccccc1,4.61,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,24650.0,nM,=,CHEMBL1064829,B,CHEMBL591440,Homo sapiens,CHEMBL203,CHEMBL1157668
CCCCN(Cc1cc(Br)cc(Br)c1O)C(=S)Nc1ccccc1,4.50,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,31940.0,nM,=,CHEMBL1064829,B,CHEMBL589590,Homo sapiens,CHEMBL203,CHEMBL1157668
O=C1CSC(N/N=C/c2ccc(F)cc2)=N1,5.66,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,2180.0,nM,=,CHEMBL1064820,B,CHEMBL589822,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(N/N=C/c2ccc(Cl)cc2)=N1,5.71,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,1940.0,nM,=,CHEMBL1064820,B,CHEMBL589823,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(N/N=C/c2ccc(Br)cc2)=N1,5.76,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,1720.0,nM,=,CHEMBL1064820,B,CHEMBL591910,Homo sapiens,CHEMBL203,CHEMBL1157666
Cc1ccc(/C=N/NC2=NC(=O)CS2)cc1,5.49,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,3260.0,nM,=,CHEMBL1064820,B,CHEMBL592707,Homo sapiens,CHEMBL203,CHEMBL1157666
COc1ccc(/C=N/NC2=NC(=O)CS2)cc1,5.24,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,5780.0,nM,=,CHEMBL1064820,B,CHEMBL592708,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(N/N=C/c2ccc([N+](=O)[O-])cc2)=N1,5.17,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,6820.0,nM,=,CHEMBL1064820,B,CHEMBL604671,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(N/N=C/c2ccc(O)cc2)=N1,5.33,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,4710.0,nM,=,CHEMBL1064820,B,CHEMBL590876,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(N/N=C/c2cc(F)ccc2O)=N1,6.01,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,970.0,nM,=,CHEMBL1064820,B,CHEMBL602328,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(N/N=C/c2cc(Cl)ccc2O)=N1,6.25,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,560.0,nM,=,CHEMBL1064820,B,CHEMBL592480,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(N/N=C/c2cc(Br)ccc2O)=N1,7.05,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,90.0,nM,=,CHEMBL1064820,B,CHEMBL592457,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(N/N=C/c2cc(Cl)cc(Cl)c2O)=N1,5.84,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,1460.0,nM,=,CHEMBL1064820,B,CHEMBL592481,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(N/N=C/c2cc(Br)cc(Br)c2O)=N1,5.91,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,1240.0,nM,=,CHEMBL1064820,B,CHEMBL590875,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(N/N=C/c2cccc(F)c2)=N1,4.87,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,13530.0,nM,=,CHEMBL1064820,B,CHEMBL590877,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(N/N=C/c2cccc(Cl)c2)=N1,4.97,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,10780.0,nM,=,CHEMBL1064820,B,CHEMBL592139,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(N/N=C/c2cccc(Br)c2)=N1,5.13,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,7460.0,nM,=,CHEMBL1064820,B,CHEMBL590524,Homo sapiens,CHEMBL203,CHEMBL1157666
Cc1cccc(/C=N/NC2=NC(=O)CS2)c1,4.63,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,23490.0,nM,=,CHEMBL1064820,B,CHEMBL590568,Homo sapiens,CHEMBL203,CHEMBL1157666
COc1cccc(/C=N/NC2=NC(=O)CS2)c1,4.50,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,31250.0,nM,=,CHEMBL1064820,B,CHEMBL592141,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(N/N=C/c2cccc([N+](=O)[O-])c2)=N1,4.58,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,26610.0,nM,=,CHEMBL1064820,B,CHEMBL591050,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(N/N=C/c2cccc(O)c2)=N1,4.71,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,19320.0,nM,=,CHEMBL1064820,B,CHEMBL591051,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(NN=C2CCCCC2)=N1,4.39,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,41000.0,nM,=,CHEMBL1064820,B,CHEMBL591053,Homo sapiens,CHEMBL203,CHEMBL1157666
O=C1CSC(NN=C2CCCCCC2)=N1,4.44,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,36000.0,nM,=,CHEMBL1064820,B,CHEMBL589165,Homo sapiens,CHEMBL203,CHEMBL1157666
Oc1cc(O)c2cc(O)c(-c3cc(O)c(O)c(O)c3)[o+]c2c1.[Cl-],8.20,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,6.27,nM,=,CHEMBL3870506,B,CHEMBL590878,Homo sapiens,CHEMBL203,CHEMBL3870309
O=C1CSC(NN=C2CCCCCCC2)=N1,4.57,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,IC50,27000.0,nM,=,CHEMBL1064820,B,CHEMBL592240,Homo sapiens,CHEMBL203,CHEMBL1157666
C=C=CCCCOc1cc2c(Nc3cccc(Cl)c3)ncnc2cc1O,7.54,Inhibition of recombinant EGFR by ELISA,IC50,28.5,nM,=,CHEMBL1071045,B,CHEMBL592215,Homo sapiens,CHEMBL203,CHEMBL1157709
C#CCCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,8.60,Inhibition of recombinant EGFR by ELISA,IC50,2.53,nM,=,CHEMBL1071045,B,CHEMBL592216,Homo sapiens,CHEMBL203,CHEMBL1157709
C=C=CCCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O,8.50,Inhibition of recombinant EGFR by ELISA,IC50,3.16,nM,=,CHEMBL1071045,B,CHEMBL591038,Homo sapiens,CHEMBL203,CHEMBL1157709
C#CCCCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,7.06,Inhibition of recombinant EGFR by ELISA,IC50,87.1,nM,=,CHEMBL1071045,B,CHEMBL591039,Homo sapiens,CHEMBL203,CHEMBL1157709
C=C=CCCCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O,7.18,Inhibition of recombinant EGFR by ELISA,IC50,65.5,nM,=,CHEMBL1071045,B,CHEMBL591040,Homo sapiens,CHEMBL203,CHEMBL1157709
Cc1ccc(NC(=O)c2ccc(N(CCCl)CCCl)cc2)cc1,6.24,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,580.0,nM,=,CHEMBL1065784,B,CHEMBL601040,Homo sapiens,CHEMBL203,CHEMBL1157716
COc1ccc(NC(=O)c2ccc(N(CCCl)CCCl)cc2)cc1,7.10,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,80.0,nM,=,CHEMBL1065784,B,CHEMBL589588,Homo sapiens,CHEMBL203,CHEMBL1157716
CC(C)c1ccc(NC(=O)c2ccc(N(CCCl)CCCl)cc2)cc1,6.12,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,750.0,nM,=,CHEMBL1065784,B,CHEMBL589589,Homo sapiens,CHEMBL203,CHEMBL1157716
O=C(Nc1ccccc1F)c1ccc(N(CCCl)CCCl)cc1,4.94,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,11570.0,nM,=,CHEMBL1065784,B,CHEMBL589825,Homo sapiens,CHEMBL203,CHEMBL1157716
C#CCCCCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,7.49,Inhibition of recombinant EGFR by ELISA,IC50,32.7,nM,=,CHEMBL1071045,B,CHEMBL590558,Homo sapiens,CHEMBL203,CHEMBL1157709
C=C=CCCCCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O,8.35,Inhibition of recombinant EGFR by ELISA,IC50,4.45,nM,=,CHEMBL1071045,B,CHEMBL590559,Homo sapiens,CHEMBL203,CHEMBL1157709
C=CCCCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,7.49,Inhibition of recombinant EGFR by ELISA,IC50,32.6,nM,=,CHEMBL1071045,B,CHEMBL589826,Homo sapiens,CHEMBL203,CHEMBL1157709
CCCCCCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,6.97,Inhibition of recombinant EGFR by ELISA,IC50,106.0,nM,=,CHEMBL1071045,B,CHEMBL608860,Homo sapiens,CHEMBL203,CHEMBL1157709
O=C(Nc1ccccc1Cl)c1ccc(N(CCCl)CCCl)cc1,5.02,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,9460.0,nM,=,CHEMBL1065784,B,CHEMBL592710,Homo sapiens,CHEMBL203,CHEMBL1157716
O=C(Nc1ccccc1Br)c1ccc(N(CCCl)CCCl)cc1,5.11,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,7820.0,nM,=,CHEMBL1065784,B,CHEMBL604672,Homo sapiens,CHEMBL203,CHEMBL1157716
O=C(Nc1ccc(F)cc1)c1ccc(N(CCCl)CCCl)cc1,5.76,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,1720.0,nM,=,CHEMBL1065784,B,CHEMBL592711,Homo sapiens,CHEMBL203,CHEMBL1157716
O=C(Nc1ccc(Cl)cc1)c1ccc(N(CCCl)CCCl)cc1,5.83,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,1490.0,nM,=,CHEMBL1065784,B,CHEMBL589830,Homo sapiens,CHEMBL203,CHEMBL1157716
O=C(Nc1ccc(Br)cc1)c1ccc(N(CCCl)CCCl)cc1,6.03,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,940.0,nM,=,CHEMBL1065784,B,CHEMBL589831,Homo sapiens,CHEMBL203,CHEMBL1157716
O=C(Nc1ccc([N+](=O)[O-])cc1)c1ccc(N(CCCl)CCCl)cc1,4.71,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,19260.0,nM,=,CHEMBL1065784,B,CHEMBL589832,Homo sapiens,CHEMBL203,CHEMBL1157716
CCCN(CCC)C(=O)c1ccc(N(CCCl)CCCl)cc1,4.53,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,29830.0,nM,=,CHEMBL1065784,B,CHEMBL602645,Homo sapiens,CHEMBL203,CHEMBL1157716
CCCCN(CCCC)C(=O)c1ccc(N(CCCl)CCCl)cc1,4.51,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,31180.0,nM,=,CHEMBL1065784,B,CHEMBL589119,Homo sapiens,CHEMBL203,CHEMBL1157716
CN(C(=O)c1ccc(N(CCCl)CCCl)cc1)c1ccccc1,4.83,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,14720.0,nM,=,CHEMBL1065784,B,CHEMBL589120,Homo sapiens,CHEMBL203,CHEMBL1157716
CCCCNC(=O)c1ccc(N(CCCl)CCCl)cc1,4.64,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,22810.0,nM,=,CHEMBL1065784,B,CHEMBL590083,Homo sapiens,CHEMBL203,CHEMBL1157716
CC(C)(C)NC(=O)c1ccc(N(CCCl)CCCl)cc1,4.50,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,31430.0,nM,=,CHEMBL1065784,B,CHEMBL589259,Homo sapiens,CHEMBL203,CHEMBL1157716
O=C(NC1CCCC1)c1ccc(N(CCCl)CCCl)cc1,4.45,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,35290.0,nM,=,CHEMBL1065784,B,CHEMBL589503,Homo sapiens,CHEMBL203,CHEMBL1157716
O=C(NCc1ccccc1)c1ccc(N(CCCl)CCCl)cc1,4.76,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,17510.0,nM,=,CHEMBL1065784,B,CHEMBL589847,Homo sapiens,CHEMBL203,CHEMBL1157716
O=C(Nc1cccc2ccccc12)c1ccc(N(CCCl)CCCl)cc1,7.05,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,IC50,90.0,nM,=,CHEMBL1065784,B,CHEMBL602728,Homo sapiens,CHEMBL203,CHEMBL1157716
C#CCOc1cc2c(Nc3cccc(Cl)c3)ncnc2cc1OC,7.59,Inhibition of recombinant EGFR by ELISA,IC50,25.9,nM,=,CHEMBL1071045,B,CHEMBL597948,Homo sapiens,CHEMBL203,CHEMBL1157709
C=C=CCOc1cc2c(Nc3cccc(Cl)c3)ncnc2cc1O,7.77,Inhibition of recombinant EGFR by ELISA,IC50,16.9,nM,=,CHEMBL1071045,B,CHEMBL609321,Homo sapiens,CHEMBL203,CHEMBL1157709
C#CCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,7.83,Inhibition of recombinant EGFR by ELISA,IC50,14.8,nM,=,CHEMBL1071045,B,CHEMBL597949,Homo sapiens,CHEMBL203,CHEMBL1157709
C=C=CCOc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O,7.62,Inhibition of recombinant EGFR by ELISA,IC50,23.8,nM,=,CHEMBL1071045,B,CHEMBL597950,Homo sapiens,CHEMBL203,CHEMBL1157709
C#CCCCOc1cc2c(Nc3cccc(Cl)c3)ncnc2cc1OC,7.75,Inhibition of recombinant EGFR by ELISA,IC50,17.7,nM,=,CHEMBL1071045,B,CHEMBL592713,Homo sapiens,CHEMBL203,CHEMBL1157709
COc1cc(C2=C(c3c[nH]c4ccc(I)cc34)C(=O)NC2=O)cc(OC)c1OC,5.77,Inhibition of EGFR after 80 mins by radiometric protein kinase assay,IC50,1688.0,nM,=,CHEMBL1070746,B,CHEMBL597492,Homo sapiens,CHEMBL203,CHEMBL1158526
COc1cc(C2=C(c3c[nH]c4ccc(Br)cc34)C(=O)NC2=O)cc(OC)c1OC,5.24,Inhibition of EGFR after 80 mins by radiometric protein kinase assay,IC50,5797.0,nM,=,CHEMBL1070746,B,CHEMBL605957,Homo sapiens,CHEMBL203,CHEMBL1158526
CCCCCCOC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.04,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,9120.0,nM,=,CHEMBL1071732,B,CHEMBL591213,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCOC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.14,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,7230.0,nM,=,CHEMBL1071732,B,CHEMBL599524,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCOC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.23,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,5840.0,nM,=,CHEMBL1071732,B,CHEMBL603968,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCCOC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.30,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,4960.0,nM,=,CHEMBL1071732,B,CHEMBL599145,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCCCOC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.51,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,3110.0,nM,=,CHEMBL1071732,B,CHEMBL599728,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCCCCCOC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.76,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,1720.0,nM,=,CHEMBL1071732,B,CHEMBL598305,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCCCCCCCOC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,6.00,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,1010.0,nM,=,CHEMBL1071732,B,CHEMBL598306,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCCCCCCCCCOC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,7.32,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,48.0,nM,=,CHEMBL1071732,B,CHEMBL598307,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCCCCCCCCCCCOC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,6.16,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,692.0,nM,=,CHEMBL1071732,B,CHEMBL597096,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCCCCCCCCCCCCCOC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.80,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,1589.0,nM,=,CHEMBL1071732,B,CHEMBL591495,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCNC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.06,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,8710.0,nM,=,CHEMBL1071732,B,CHEMBL611681,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCNC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.20,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,6280.0,nM,=,CHEMBL1071732,B,CHEMBL597303,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCNC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.27,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,5330.0,nM,=,CHEMBL1071732,B,CHEMBL597304,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCCNC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.45,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,3580.0,nM,=,CHEMBL1071732,B,CHEMBL597708,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCCCNC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.67,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,2140.0,nM,=,CHEMBL1071732,B,CHEMBL605337,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCCCCCNC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.90,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,1270.0,nM,=,CHEMBL1071732,B,CHEMBL597914,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCCCCCCCNC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,6.50,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,316.0,nM,=,CHEMBL1071732,B,CHEMBL598520,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCCCCCCCCCNC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,7.46,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,35.0,nM,=,CHEMBL1071732,B,CHEMBL601625,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCCCCCCCCCCCNC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,6.33,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,464.0,nM,=,CHEMBL1071732,B,CHEMBL600381,Homo sapiens,CHEMBL203,CHEMBL1159111
CCCCCCCCCCCCCCCCCCCCNC(=O)COc1cc(O)c2c(=O)cc(-c3ccccc3)oc2c1,5.87,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,IC50,1350.0,nM,=,CHEMBL1071732,B,CHEMBL592153,Homo sapiens,CHEMBL203,CHEMBL1159111
O=[N+]([O-])c1ccc2c(c1)S(=O)(=O)N=S2c1ccc(Br)cc1,4.66,Inhibition of HER1,IC50,22000.0,nM,=,CHEMBL2208688,B,CHEMBL605161,Homo sapiens,CHEMBL203,CHEMBL2203023
C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,6.17,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay,IC50,681.0,nM,=,CHEMBL4348480,B,CHEMBL601719,Homo sapiens,CHEMBL203,CHEMBL4346688
COc1cc(/C=C2\SC(=N)NC2=O)ccc1OCCCOc1cc(C)cc(C)c1,4.25,Inhibition of EGFR,IC50,56000.0,nM,=,CHEMBL1069630,B,CHEMBL602890,Homo sapiens,CHEMBL203,CHEMBL1156931
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCC(=O)NO,8.15,Inhibition of EGFR,IC50,7.1,nM,=,CHEMBL1064921,B,CHEMBL597551,Homo sapiens,CHEMBL203,CHEMBL1157563
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCC(=O)NO,8.11,Inhibition of EGFR,IC50,7.8,nM,=,CHEMBL1064921,B,CHEMBL597752,Homo sapiens,CHEMBL203,CHEMBL1157563
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCC(=O)NO,8.03,Inhibition of EGFR,IC50,9.4,nM,=,CHEMBL1064921,B,CHEMBL596736,Homo sapiens,CHEMBL203,CHEMBL1157563
C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCC(=O)NO)cc23)c1,7.82,Inhibition of EGFR,IC50,15.0,nM,=,CHEMBL1064921,B,CHEMBL599398,Homo sapiens,CHEMBL203,CHEMBL1157563
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCC(=O)NO,8.47,Inhibition of EGFR,IC50,3.4,nM,=,CHEMBL1064921,B,CHEMBL598163,Homo sapiens,CHEMBL203,CHEMBL1157563
C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCC(=O)NO)cc23)c1,8.34,Inhibition of EGFR,IC50,4.6,nM,=,CHEMBL1064921,B,CHEMBL598164,Homo sapiens,CHEMBL203,CHEMBL1157563
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCCC(=O)NO,8.51,Inhibition of EGFR,IC50,3.1,nM,=,CHEMBL1064921,B,CHEMBL598377,Homo sapiens,CHEMBL203,CHEMBL1157563
C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1,8.62,Inhibition of EGFR,IC50,2.4,nM,=,CHEMBL1064921,B,CHEMBL598797,Homo sapiens,CHEMBL203,CHEMBL1157563
C#Cc1cc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)ccc1F,7.54,Inhibition of EGFR,IC50,28.8,nM,=,CHEMBL1064921,B,CHEMBL598798,Homo sapiens,CHEMBL203,CHEMBL1157563
COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OCCCCCCC(=O)NO,8.04,Inhibition of EGFR,IC50,9.08,nM,=,CHEMBL1064921,B,CHEMBL598799,Homo sapiens,CHEMBL203,CHEMBL1157563
O=C(CCCCCCOc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1)NO,7.08,Inhibition of EGFR,IC50,84.2,nM,=,CHEMBL1064921,B,CHEMBL604094,Homo sapiens,CHEMBL203,CHEMBL1157563
COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCCC(=O)NO,7.98,Inhibition of EGFR,IC50,10.4,nM,=,CHEMBL1064921,B,CHEMBL597569,Homo sapiens,CHEMBL203,CHEMBL1157563
COc1cc(-c2nc(=O)c3c([nH]2)sc2ccc(C)cc23)ccc1OCC(=O)O,5.62,Inhibition of EGFR,IC50,2400.0,nM,=,CHEMBL1069630,B,CHEMBL599388,Homo sapiens,CHEMBL203,CHEMBL1156931
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)CCCCCCC(=O)NO,8.68,Inhibition of EGFR,IC50,2.1,nM,=,CHEMBL1064921,B,CHEMBL597773,Homo sapiens,CHEMBL203,CHEMBL1157563
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1SCCCCCCC(=O)NO,8.70,Inhibition of EGFR,IC50,1.99,nM,=,CHEMBL1064921,B,CHEMBL596754,Homo sapiens,CHEMBL203,CHEMBL1157563
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1S(=O)(=O)CCCCCCC(=O)NO,7.81,Inhibition of EGFR,IC50,15.4,nM,=,CHEMBL1064921,B,CHEMBL596755,Homo sapiens,CHEMBL203,CHEMBL1157563
COc1cc2ncnc(NCc3ccc(Cl)c(F)c3)c2cc1OCCCCCCC(=O)NO,7.14,Inhibition of EGFR,IC50,72.0,nM,=,CHEMBL1064921,B,CHEMBL596957,Homo sapiens,CHEMBL203,CHEMBL1157563
COc1cc2ncnc(NCc3ccccc3)c2cc1OCCCCCCC(=O)NO,7.00,Inhibition of EGFR,IC50,99.4,nM,=,CHEMBL1064921,B,CHEMBL596761,Homo sapiens,CHEMBL203,CHEMBL1157563
COc1cc2ncnc(NCc3ccc(F)cc3)c2cc1OCCCCCCC(=O)NO,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL596964,Homo sapiens,CHEMBL203,CHEMBL3881527
COc1cc2ncnc(N[C@@H](C)c3ccccc3)c2cc1OCCCCCCC(=O)NO,6.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,1000.0,nM,=,CHEMBL3881964,B,CHEMBL599218,Homo sapiens,CHEMBL203,CHEMBL3881527
COc1cc2ncnc(N[C@H](C)c3ccccc3)c2cc1OCCCCCCC(=O)NO,7.89,Inhibition of EGFR,IC50,12.8,nM,=,CHEMBL1064921,B,CHEMBL605976,Homo sapiens,CHEMBL203,CHEMBL1157563
COc1cc2ncnc(N[C@@H](C)c3ccc(F)cc3)c2cc1OCCCCCCC(=O)NO,6.90,Inhibition of EGFR,IC50,125.6,nM,=,CHEMBL1064921,B,CHEMBL598406,Homo sapiens,CHEMBL203,CHEMBL1157563
COc1cc2ncnc(N[C@@H](C)c3ccc(Cl)cc3)c2cc1OCCCCCCC(=O)NO,6.21,Inhibition of EGFR,IC50,614.0,nM,=,CHEMBL1064921,B,CHEMBL598407,Homo sapiens,CHEMBL203,CHEMBL1157563
COc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCCCCC(=O)NO,8.15,Inhibition of EGFR,IC50,7.0,nM,=,CHEMBL1064921,B,CHEMBL598610,Homo sapiens,CHEMBL203,CHEMBL1157563
C#Cc1cccc(Nc2ncnc3cc(OCCCCCCC(=O)NO)c(OC)cc23)c1,8.09,Inhibition of EGFR,IC50,8.2,nM,=,CHEMBL1064921,B,CHEMBL598611,Homo sapiens,CHEMBL203,CHEMBL1157563
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,9.64,"Binding constant for EGFR(L747-T751del,Sins) kinase domain",Kd,0.23,nM,=,CHEMBL1051285,B,CHEMBL607707,Homo sapiens,CHEMBL203,CHEMBL1150977
CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,8.06,"Binding constant for EGFR(L858R,T790M) kinase domain",Kd,8.8,nM,=,CHEMBL1908701,B,CHEMBL608533,Homo sapiens,CHEMBL203,CHEMBL1908390
COc1ccc(N2Cc3cnc(Nc4ccc(F)cc4)nc3N([C@@H]3CC[C@@H](O)C3)C2=O)cc1,6.26,Inhibitory activity against recombinant human EGFR,IC50,545.0,nM,=,CHEMBL861201,B,CHEMBL606964,Homo sapiens,CHEMBL203,CHEMBL1146929
O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1,4.30,Inhibition of EGFR after 1 hr,IC50,50000.0,nM,=,CHEMBL1109425,B,CHEMBL1081198,Homo sapiens,CHEMBL203,CHEMBL1153704
Cc1c(C(=O)NCCN2CCOCC2)[nH]c2cnnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c12,6.06,Inhibition of EGFR in human A431 cells by HTRF assay,IC50,867.0,nM,=,CHEMBL1116652,B,CHEMBL1080812,Homo sapiens,CHEMBL203,CHEMBL1154343
CCOC(=O)c1[nH]c(C)c2cnnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c12,5.92,Inhibition of EGFR in human A431 cells by HTRF assay,IC50,1210.0,nM,=,CHEMBL1116652,B,CHEMBL1080990,Homo sapiens,CHEMBL203,CHEMBL1154343
CCN(CC)CCNC(=O)c1cc2cnnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2[nH]1,4.11,Inhibition of EGFR in human A431 cells by HTRF assay,IC50,77220.0,nM,=,CHEMBL1116652,B,CHEMBL1080271,Homo sapiens,CHEMBL203,CHEMBL1154343
O=C(NCCN1CCCC1)c1cc2cnnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2[nH]1,4.82,Inhibition of EGFR in human A431 cells by HTRF assay,IC50,15140.0,nM,=,CHEMBL1116652,B,CHEMBL1080272,Homo sapiens,CHEMBL203,CHEMBL1154343
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1.Cl,7.82,Inhibition of EGFR by HTRF assay,IC50,15.0,nM,=,CHEMBL1116653,B,CHEMBL1079742,Homo sapiens,CHEMBL203,CHEMBL1154343
Clc1cccc(Nc2ncnc3ccc(Cl)cc23)c1,5.57,Inhibition of EGFR autophosphorylation in human A431 cells,IC50,2700.0,nM,=,CHEMBL1113143,B,CHEMBL1080815,Homo sapiens,CHEMBL203,CHEMBL1154388
CCN(CC)CCNC(=O)c1[nH]c2cnnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1C,5.94,Inhibition of EGFR in human A431 cells by HTRF assay,IC50,1160.0,nM,=,CHEMBL1116652,B,CHEMBL1087368,Homo sapiens,CHEMBL203,CHEMBL1154343
Cc1c(C(=O)NCCCN2CCN(C)CC2)[nH]c2cnnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c12,6.01,Inhibition of EGFR in human A431 cells by HTRF assay,IC50,980.0,nM,=,CHEMBL1116652,B,CHEMBL1081849,Homo sapiens,CHEMBL203,CHEMBL1154343
Cc1c(C(=O)NCCN2CCN(C)CC2)[nH]c2cnnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c12,6.59,Inhibition of EGFR in human A431 cells by HTRF assay,IC50,257.0,nM,=,CHEMBL1116652,B,CHEMBL1082012,Homo sapiens,CHEMBL203,CHEMBL1154343
Cc1c(C(=O)NCCN2CCOCC2)[nH]c2cnnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c12,5.30,Inhibition of EGFR by HTRF assay,IC50,5000.0,nM,=,CHEMBL1116653,B,CHEMBL1080506,Homo sapiens,CHEMBL203,CHEMBL1154343
CC1=C(C(=O)Nc2ccc(C)cc2)C(c2ccc(O)cc2O)NC(SCc2ccccc2)=N1,4.03,Inhibition of EGFR,IC50,93500.0,nM,=,CHEMBL1103281,B,CHEMBL1087054,Homo sapiens,CHEMBL203,CHEMBL1154872
CC1=C(C(=O)Nc2cccc([N+](=O)[O-])c2)C(c2ccc(O)cc2O)NC(SCc2ccccc2)=N1,4.25,Inhibition of EGFR,IC50,55600.0,nM,=,CHEMBL1103281,B,CHEMBL1087055,Homo sapiens,CHEMBL203,CHEMBL1154872
CC1=C(C(=O)Nc2ccc(C)cc2)C(c2ccc(O)cc2O)NC(NCc2ccccc2)=N1,4.63,Inhibition of EGFR,IC50,23500.0,nM,=,CHEMBL1103281,B,CHEMBL1088348,Homo sapiens,CHEMBL203,CHEMBL1154872
CC1=C(C(=O)Nc2ccc(C)cc2)C(c2ccc(O)cc2O)NC(Nc2ccc([N+](=O)[O-])cc2Cl)=N1,4.21,Inhibition of EGFR,IC50,60900.0,nM,=,CHEMBL1103281,B,CHEMBL1084117,Homo sapiens,CHEMBL203,CHEMBL1154872
CC1=C(C(=O)Nc2cccc([N+](=O)[O-])c2)C(c2ccc(O)cc2O)NC(Nc2ccc(S(=O)(=O)Nc3ncccn3)cc2)=N1,4.05,Inhibition of EGFR,IC50,88300.0,nM,=,CHEMBL1103281,B,CHEMBL1077068,Homo sapiens,CHEMBL203,CHEMBL1154872
CC1=C(C(=O)Nc2cccc([N+](=O)[O-])c2)C(c2ccc(O)cc2O)NC(Nc2ccc(S(=O)(=O)Nc3nc(C)cc(C)n3)cc2)=N1,4.10,Inhibition of EGFR,IC50,79800.0,nM,=,CHEMBL1103281,B,CHEMBL1077069,Homo sapiens,CHEMBL203,CHEMBL1154872
CC1=C(C(=O)Nc2cccc([N+](=O)[O-])c2)C(c2ccc(O)cc2O)NC(NN)=N1,4.32,Inhibition of EGFR,IC50,47900.0,nM,=,CHEMBL1103281,B,CHEMBL1077095,Homo sapiens,CHEMBL203,CHEMBL1154872
CC1=C(C(=O)Nc2cccc([N+](=O)[O-])c2)C(c2ccc(O)cc2O)NC(NN2C(=O)/C(=C\c3ccco3)SC2=S)=N1,4.00,Inhibition of EGFR,IC50,99300.0,nM,=,CHEMBL1103281,B,CHEMBL1077107,Homo sapiens,CHEMBL203,CHEMBL1154872
CC1=C(C(=O)Nc2cccc([N+](=O)[O-])c2)C(c2ccc(O)cc2O)NC(NN2C(=O)/C(=C\c3cccs3)SC2=S)=N1,4.09,Inhibition of EGFR,IC50,80600.0,nM,=,CHEMBL1103281,B,CHEMBL1077085,Homo sapiens,CHEMBL203,CHEMBL1154872
Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1,6.58,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,260.0,nM,=,CHEMBL1243977,B,CHEMBL1081312,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1nc(N)c2c(n1)[nH]c1cccc(Sc3ccccc3)c12,4.82,Inhibition of EGFR in human A431 cells by phosphotyrosine cell-based ELISA,IC50,15070.0,nM,=,CHEMBL1115349,B,CHEMBL1093099,Homo sapiens,CHEMBL203,CHEMBL1156263
Cc1ccc(Sc2cccc3[nH]c4nc(N)nc(N)c4c23)cc1,4.98,Inhibition of EGFR in human A431 cells by phosphotyrosine cell-based ELISA,IC50,10410.0,nM,=,CHEMBL1115349,B,CHEMBL1093100,Homo sapiens,CHEMBL203,CHEMBL1156263
CCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1,7.80,Inhibition of wild type EGFR by HTRF assay,IC50,16.0,nM,=,CHEMBL1105216,B,CHEMBL1092382,Homo sapiens,CHEMBL203,CHEMBL1156950
CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1,8.77,Inhibition of wild type EGFR by HTRF assay,IC50,1.7,nM,=,CHEMBL1105216,B,CHEMBL1089524,Homo sapiens,CHEMBL203,CHEMBL1156950
C#Cc1cccc(Nc2ccnc3cc(OCCOC)c(OCCOC)cc23)c1,7.52,Inhibition of wild type EGFR by HTRF assay,IC50,30.0,nM,=,CHEMBL1105216,B,CHEMBL1089203,Homo sapiens,CHEMBL203,CHEMBL1156950
C#Cc1cccc(Nc2ccnc3cc(OC)c(OC)cc23)c1,9.57,Binding affinity to wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by Kinomescan method,Kd,0.27,nM,=,CHEMBL4394506,B,CHEMBL1092250,Homo sapiens,CHEMBL203,CHEMBL4393671
O=C(Nc1cccc(-c2nc3sccn3c2-c2ccncc2)c1)c1ccccc1Cl,6.62,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,240.0,nM,=,CHEMBL1108837,B,CHEMBL1091613,Homo sapiens,CHEMBL203,CHEMBL1156213
O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccccc3)n2)c1)c1ccccc1Cl,7.08,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,83.0,nM,=,CHEMBL1108837,B,CHEMBL1093815,Homo sapiens,CHEMBL203,CHEMBL1156213
O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccccc3)n2)c1)c1ccccc1,7.26,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,55.0,nM,=,CHEMBL1108837,B,CHEMBL1093234,Homo sapiens,CHEMBL203,CHEMBL1156213
O=[N+]([O-])c1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccccc3)n2)c1,6.64,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,230.0,nM,=,CHEMBL1108837,B,CHEMBL1093235,Homo sapiens,CHEMBL203,CHEMBL1156213
O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1)c1ccccc1,8.10,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,7.9,nM,=,CHEMBL1108837,B,CHEMBL1090350,Homo sapiens,CHEMBL203,CHEMBL1156213
O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1)c1c(F)cccc1F,8.72,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,1.9,nM,=,CHEMBL1108837,B,CHEMBL1090351,Homo sapiens,CHEMBL203,CHEMBL1156213
O=C(CC1CCCCC1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1,6.06,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,870.0,nM,=,CHEMBL1108837,B,CHEMBL1090352,Homo sapiens,CHEMBL203,CHEMBL1156213
O=C(CC1CCCC1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1,6.18,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,660.0,nM,=,CHEMBL1108837,B,CHEMBL1090353,Homo sapiens,CHEMBL203,CHEMBL1156213
O=C(Nc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1,7.00,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,100.0,nM,=,CHEMBL1108837,B,CHEMBL1090354,Homo sapiens,CHEMBL203,CHEMBL1156213
O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1)Oc1ccccc1,6.72,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,190.0,nM,=,CHEMBL1108837,B,CHEMBL1090355,Homo sapiens,CHEMBL203,CHEMBL1156213
O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1,7.50,Inhibition of EGFR,Ki,31.62,nM,=,CHEMBL2065348,B,CHEMBL1090356,Homo sapiens,CHEMBL203,CHEMBL2062478
O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1)c1c(F)cccc1F,8.21,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,6.2,nM,=,CHEMBL1108837,B,CHEMBL1088931,Homo sapiens,CHEMBL203,CHEMBL1156213
CN(C)CCc1ccc(Nc2nccc(-c3c(-c4cccc(NC(=O)c5c(F)cccc5F)c4)nc4sccn34)n2)cc1,9.11,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,0.78,nM,=,CHEMBL1108837,B,CHEMBL1090357,Homo sapiens,CHEMBL203,CHEMBL1156213
CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(NC(=O)c6c(F)cccc6F)c5)nc5sccn45)n3)cc2)CC1,9.02,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,0.96,nM,=,CHEMBL1108837,B,CHEMBL1090358,Homo sapiens,CHEMBL203,CHEMBL1156213
O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc4c(c3)CCNC4)n2)c1)c1c(F)cccc1F,8.64,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,2.3,nM,=,CHEMBL1108837,B,CHEMBL1090359,Homo sapiens,CHEMBL203,CHEMBL1156213
O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1,7.25,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,56.0,nM,=,CHEMBL1108837,B,CHEMBL1090360,Homo sapiens,CHEMBL203,CHEMBL1156213
CN1CCc2cc(Nc3nccc(-c4c(-c5cccc(NC(=O)Cc6ccccc6)c5)nc5sccn45)n3)ccc2C1,7.24,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,57.0,nM,=,CHEMBL1108837,B,CHEMBL1090361,Homo sapiens,CHEMBL203,CHEMBL1156213
CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(NC(=O)Cc6ccccc6)c5)nc5sccn45)n3)cc2)CC1,7.80,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,16.0,nM,=,CHEMBL1108837,B,CHEMBL1090362,Homo sapiens,CHEMBL203,CHEMBL1156213
CN(C)CCc1cccc(Nc2nccc(-c3c(-c4cccc(NC(=O)Cc5ccccc5)c4)nc4sccn34)n2)c1,7.62,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,24.0,nM,=,CHEMBL1108837,B,CHEMBL1090363,Homo sapiens,CHEMBL203,CHEMBL1156213
O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc4c(c3)CCNC4)n2)c1,8.19,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,IC50,6.4,nM,=,CHEMBL1108837,B,CHEMBL1090364,Homo sapiens,CHEMBL203,CHEMBL1156213
Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1,6.70,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,IC50,200.0,nM,=,CHEMBL1112818,B,CHEMBL1095761,Homo sapiens,CHEMBL203,CHEMBL1157126
Nc1nc(Nc2ccc(Cl)cc2F)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1,5.60,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,IC50,2500.0,nM,=,CHEMBL1112818,B,CHEMBL1095130,Homo sapiens,CHEMBL203,CHEMBL1157126
Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1,4.57,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,IC50,27200.0,nM,=,CHEMBL1112818,B,CHEMBL1095445,Homo sapiens,CHEMBL203,CHEMBL1157126
C#Cc1cccc(Nc2nc(N)nc3[nH]c(Cc4ccc(Cl)cc4Cl)cc23)c1,4.26,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,IC50,55200.0,nM,=,CHEMBL1112818,B,CHEMBL1094475,Homo sapiens,CHEMBL203,CHEMBL1157126
Nc1nc(Nc2ccc(C(F)(F)F)c(F)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1,4.04,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,IC50,91700.0,nM,=,CHEMBL1112818,B,CHEMBL1094808,Homo sapiens,CHEMBL203,CHEMBL1157126
CC(C)c1ccc(Nc2nc(N)nc3[nH]c(Cc4ccc(Cl)cc4Cl)cc23)cc1,4.34,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,IC50,45600.0,nM,=,CHEMBL1112818,B,CHEMBL1095463,Homo sapiens,CHEMBL203,CHEMBL1157126
CC(C)c1ccccc1Nc1nc(N)nc2[nH]c(Cc3ccc(Cl)cc3Cl)cc12,4.02,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,IC50,96400.0,nM,=,CHEMBL1112818,B,CHEMBL1095776,Homo sapiens,CHEMBL203,CHEMBL1157126
Cc1ccccc1Cc1cc2c(Nc3cccc(Br)c3)nc(N)nc2[nH]1,5.04,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,IC50,9100.0,nM,=,CHEMBL1112818,B,CHEMBL1095464,Homo sapiens,CHEMBL203,CHEMBL1157126
COc1ccc(OC)c(Cc2cc3c(Nc4cccc(Br)c4)nc(N)nc3[nH]2)c1,6.62,Inhibition of EGFR tyrosine kinase activity in EGF-stimulated human A431 cells after 60 mins by ELISA,IC50,240.0,nM,=,CHEMBL1932339,B,CHEMBL1095465,Homo sapiens,CHEMBL203,CHEMBL1926631
FC(F)(F)c1cccc(Nc2ncnc3[nH]c(Cc4ccc(Cl)cc4Cl)cc23)c1,4.48,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,IC50,33100.0,nM,=,CHEMBL1112818,B,CHEMBL1094784,Homo sapiens,CHEMBL203,CHEMBL1157126
c1ccc(CCc2cc3c(Nc4ccc5[nH]ccc5c4)ncnc3[nH]2)cc1,4.25,Inhibition of EGFR,IC50,56100.0,nM,=,CHEMBL1115598,B,CHEMBL1097368,Homo sapiens,CHEMBL203,CHEMBL1157122
Cl.NCCc1cn(CCCCCc2ccccc2)c2ccc(OCCc3ccc(O)cc3)cc12,5.79,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,IC50,1630.0,nM,=,CHEMBL1105615,B,CHEMBL1098119,Homo sapiens,CHEMBL203,CHEMBL1157833
Cl.NC1CCc2c(c3cc(OCCc4ccc(O)cc4)ccc3n2CCCCCc2ccccc2)C1,6.01,Noncompetitive inhibition of EGFR after 30 mins by chemiluminescence ELISA in presence of 50 uM ATP,IC50,980.0,nM,=,CHEMBL1105620,B,CHEMBL1098120,Homo sapiens,CHEMBL203,CHEMBL1157833
COc1ccc(CCCCCn2cc(CCN)c3cc(OCCc4ccc(O)cc4)ccc32)cc1.Cl,5.36,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,IC50,4400.0,nM,=,CHEMBL1105615,B,CHEMBL1098121,Homo sapiens,CHEMBL203,CHEMBL1157833
CSc1ccc(CCCCCn2cc(CCN)c3cc(OCCc4ccc(O)cc4)ccc32)cc1.Cl,5.72,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,IC50,1920.0,nM,=,CHEMBL1105615,B,CHEMBL1094194,Homo sapiens,CHEMBL203,CHEMBL1157833
Cl.NCCc1cn(Cc2ccc(-c3cccc(C(F)(F)F)c3)cc2)c2ccc(OCCc3ccc(O)cc3)cc12,5.97,Noncompetitive inhibition of EGFR after 30 mins by chemiluminescence ELISA in presence of 250 uM ATP,IC50,1060.0,nM,=,CHEMBL1111024,B,CHEMBL1094195,Homo sapiens,CHEMBL203,CHEMBL1157833
COc1ccc(-c2ccc(Cn3cc(CCN)c4cc(OCCc5ccc(O)cc5)ccc43)cc2)cc1.Cl,5.90,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,IC50,1250.0,nM,=,CHEMBL1105615,B,CHEMBL1094196,Homo sapiens,CHEMBL203,CHEMBL1157833
Cl.NCCc1cn(Cc2ccc(-c3ccccc3)cc2)c2ccc(OCCc3ccc(O)cc3)cc12,5.89,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,IC50,1300.0,nM,=,CHEMBL1105615,B,CHEMBL1095154,Homo sapiens,CHEMBL203,CHEMBL1157833
Cl.NCCc1c[nH]c2ccc(OCCc3ccc(O)cc3)cc12,5.68,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,IC50,2070.0,nM,=,CHEMBL1105615,B,CHEMBL1095957,Homo sapiens,CHEMBL203,CHEMBL1157833
COc1ccc(CCOc2ccc3c(c2)c(CCN)cn3CCCCCc2ccc(SC)cc2)cc1.Cl,5.61,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,IC50,2450.0,nM,=,CHEMBL1105615,B,CHEMBL1094835,Homo sapiens,CHEMBL203,CHEMBL1157833
COc1ccc(CCCCCn2c3c(c4cc(OCCc5ccc(O)cc5)ccc42)CC(N)CC3)cc1.Cl,5.86,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,IC50,1370.0,nM,=,CHEMBL1105615,B,CHEMBL1094492,Homo sapiens,CHEMBL203,CHEMBL1157833
Cl.NC1CCc2c(c3cc(OCCc4ccc(O)cc4)ccc3n2CCCCCc2ccc(C(F)(F)F)cc2)C1,5.56,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,IC50,2750.0,nM,=,CHEMBL1105615,B,CHEMBL1094825,Homo sapiens,CHEMBL203,CHEMBL1157833
Cl.NC1CCc2c(c3cc(OCCc4ccc(O)cc4)ccc3n2CCCc2ccccc2)C1,5.60,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,IC50,2500.0,nM,=,CHEMBL1105615,B,CHEMBL1097189,Homo sapiens,CHEMBL203,CHEMBL1157833
Cl.NC1CCc2[nH]c3ccc(OCCc4ccc(O)cc4)cc3c2C1,4.82,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,IC50,15120.0,nM,=,CHEMBL1105615,B,CHEMBL1097190,Homo sapiens,CHEMBL203,CHEMBL1157833
COc1cc(Nc2c(C#N)cnc3cc(/C=C/CCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,5.48,Inhibition of EGFR,IC50,3300.0,nM,=,CHEMBL1117422,B,CHEMBL1088240,Homo sapiens,CHEMBL203,CHEMBL1157919
COc1cc(/C=C(\C#N)C(N)=O)cc(SCCCC(=O)O)c1O,4.32,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,47863.01,nM,=,CHEMBL676067,B,CHEMBL1161234,Homo sapiens,CHEMBL203,CHEMBL1136802
COc1cc(C=C(C#N)C#N)cc(SCC(=O)O)c1O,4.27,Inhibitory activity against epidermal growth factor receptor (EGFR),IC50,53703.18,nM,=,CHEMBL676067,B,CHEMBL1161236,Homo sapiens,CHEMBL203,CHEMBL1136802
Cc1ccc(Br)c2c(C#N)cc(C(=O)C3CC3)n12,7.07,Inhibition of human EGFR autophosphorylation expressed in Sf9 cells DELFIA assay,IC50,85.0,nM,=,CHEMBL1174225,B,CHEMBL1171792,Homo sapiens,CHEMBL203,CHEMBL1177838
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1cccc2ccccc12,5.41,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,3880.0,nM,=,CHEMBL1177207,B,CHEMBL1170278,Homo sapiens,CHEMBL203,CHEMBL1177684
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1ccc2ccccc2c1,5.24,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,5760.0,nM,=,CHEMBL1177207,B,CHEMBL1170459,Homo sapiens,CHEMBL203,CHEMBL1177684
CC(=O)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccccc1Cl,4.62,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,24150.0,nM,=,CHEMBL1177399,B,CHEMBL1172418,Homo sapiens,CHEMBL203,CHEMBL1177661
CC(=O)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccccc1,4.54,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,28690.0,nM,=,CHEMBL1177399,B,CHEMBL1172419,Homo sapiens,CHEMBL203,CHEMBL1177661
COc1cc(OC)cc(C2CC(c3ccc(Cl)c(Cl)c3)=NN2C(C)=O)c1,4.59,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,25470.0,nM,=,CHEMBL1177399,B,CHEMBL1172602,Homo sapiens,CHEMBL203,CHEMBL1177661
CC(=O)N1N=C(c2ccc(C)c(C)c2)CC1c1ccc(F)cc1,4.81,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,15560.0,nM,=,CHEMBL1177399,B,CHEMBL1172603,Homo sapiens,CHEMBL203,CHEMBL1177661
CC(=O)N1N=C(c2ccc(C)c(C)c2)CC1c1ccc(Cl)cc1,4.71,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,19730.0,nM,=,CHEMBL1177399,B,CHEMBL1173022,Homo sapiens,CHEMBL203,CHEMBL1177661
CC(=O)N1N=C(c2ccc(C)c(C)c2)CC1c1ccc(Br)cc1,4.69,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,20610.0,nM,=,CHEMBL1177399,B,CHEMBL1173023,Homo sapiens,CHEMBL203,CHEMBL1177661
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,9.96,Binding constant for EGFR(E746-A750del) kinase domain,Kd,0.11,nM,=,CHEMBL1908694,B,CHEMBL1173655,Homo sapiens,CHEMBL203,CHEMBL1908390
Cc1ccc(C2=NN(C(N)=S)C(c3ccccc3Cl)C2)cc1C,5.41,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,3870.0,nM,=,CHEMBL1177399,B,CHEMBL1173794,Homo sapiens,CHEMBL203,CHEMBL1177661
Cc1ccc(C2=NN(C(N)=S)C(c3ccccc3F)C2)cc1C,5.29,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,5190.0,nM,=,CHEMBL1177399,B,CHEMBL1169856,Homo sapiens,CHEMBL203,CHEMBL1177661
NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1,5.00,Inhibition EGFR,IC50,10000.0,nM,=,CHEMBL1177355,B,CHEMBL1172957,Homo sapiens,CHEMBL203,CHEMBL1177660
Cc1ccc(C2=NN(C(N)=S)C(c3ccc([N+](=O)[O-])cc3)C2)cc1C,5.51,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,3060.0,nM,=,CHEMBL1177399,B,CHEMBL1173454,Homo sapiens,CHEMBL203,CHEMBL1177661
Cc1ccc(C2=NN(C(N)=S)C(c3ccc(F)cc3)C2)cc1C,6.08,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,830.0,nM,=,CHEMBL1177399,B,CHEMBL1173455,Homo sapiens,CHEMBL203,CHEMBL1177661
Cc1ccc(C2=NN(C(N)=S)C(c3ccc(Cl)cc3)C2)cc1C,5.87,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,1360.0,nM,=,CHEMBL1177399,B,CHEMBL1173456,Homo sapiens,CHEMBL203,CHEMBL1177661
Cc1ccc(C2=NN(C(N)=S)C(c3ccc(Br)cc3)C2)cc1C,5.66,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,2170.0,nM,=,CHEMBL1177399,B,CHEMBL1173457,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Br)c(Br)c2)CC1c1ccc(F)cc1,5.05,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,8920.0,nM,=,CHEMBL1177399,B,CHEMBL1172823,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccccc1Br,5.19,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,6430.0,nM,=,CHEMBL1177399,B,CHEMBL1173601,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccccc1Cl,5.14,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,7280.0,nM,=,CHEMBL1177399,B,CHEMBL1173602,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccccc1F,5.18,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,6560.0,nM,=,CHEMBL1177399,B,CHEMBL1173665,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccc([N+](=O)[O-])cc1,5.11,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,7780.0,nM,=,CHEMBL1177399,B,CHEMBL1173666,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccc(O)cc1,5.28,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,5270.0,nM,=,CHEMBL1177399,B,CHEMBL1173667,Homo sapiens,CHEMBL203,CHEMBL1177661
CC(=O)N1N=C(c2ccc(C)c(C)c2)CC1c1ccc(C)cc1,4.76,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,17490.0,nM,=,CHEMBL1177399,B,CHEMBL1173319,Homo sapiens,CHEMBL203,CHEMBL1177661
COc1ccc(C2CC(c3ccc(C)c(C)c3)=NN2C(C)=O)cc1,4.82,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,15240.0,nM,=,CHEMBL1177399,B,CHEMBL1173397,Homo sapiens,CHEMBL203,CHEMBL1177661
CC(=O)N1N=C(c2ccc(C)c(C)c2)CC1c1ccccc1Cl,4.67,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,21480.0,nM,=,CHEMBL1177399,B,CHEMBL1171638,Homo sapiens,CHEMBL203,CHEMBL1177661
CC(=O)N1N=C(c2ccc(C)c(C)c2)CC1c1ccccc1,4.70,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,20040.0,nM,=,CHEMBL1177399,B,CHEMBL1173398,Homo sapiens,CHEMBL203,CHEMBL1177661
COc1cc(OC)cc(C2CC(c3ccc(C)c(C)c3)=NN2C(C)=O)c1,4.76,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,17310.0,nM,=,CHEMBL1177399,B,CHEMBL1173105,Homo sapiens,CHEMBL203,CHEMBL1177661
Cc1ccc(C2CC(c3ccc(C)c(C)c3)=NN2C(N)=S)cc1,6.47,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,340.0,nM,=,CHEMBL1177399,B,CHEMBL1173813,Homo sapiens,CHEMBL203,CHEMBL1177661
COc1ccc(C2CC(c3ccc(C)c(C)c3)=NN2C(N)=S)cc1,7.16,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,70.0,nM,=,CHEMBL1177399,B,CHEMBL1173814,Homo sapiens,CHEMBL203,CHEMBL1177661
Cc1ccc(C2=NN(C(N)=S)C(c3ccc(O)cc3)C2)cc1C,6.89,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,130.0,nM,=,CHEMBL1177399,B,CHEMBL1173815,Homo sapiens,CHEMBL203,CHEMBL1177661
CC(=O)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccc(Br)cc1,4.73,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,18450.0,nM,=,CHEMBL1177399,B,CHEMBL1173816,Homo sapiens,CHEMBL203,CHEMBL1177661
CC(=O)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccc(C)cc1,4.71,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,19320.0,nM,=,CHEMBL1177399,B,CHEMBL1171822,Homo sapiens,CHEMBL203,CHEMBL1177661
CC(=O)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccc(Cl)cc1,4.79,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,16140.0,nM,=,CHEMBL1177399,B,CHEMBL1173248,Homo sapiens,CHEMBL203,CHEMBL1177661
CC(=O)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccc(F)cc1,4.74,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,18350.0,nM,=,CHEMBL1177399,B,CHEMBL1173249,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Br)c(Br)c2)CC1c1ccccc1Br,4.96,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,10970.0,nM,=,CHEMBL1177399,B,CHEMBL1173250,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Br)c(Br)c2)CC1c1ccccc1Cl,4.91,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,12260.0,nM,=,CHEMBL1177399,B,CHEMBL1173251,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Br)c(Br)c2)CC1c1ccccc1F,4.87,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,13370.0,nM,=,CHEMBL1177399,B,CHEMBL1173324,Homo sapiens,CHEMBL203,CHEMBL1177661
COc1ccc(C2CC(c3ccc(Cl)c(Cl)c3)=NN2C(C)=O)cc1,4.76,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,17190.0,nM,=,CHEMBL1177399,B,CHEMBL1173680,Homo sapiens,CHEMBL203,CHEMBL1177661
C=CC(=O)Nc1ccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)cc1,7.09,Inhibition of GST-tagged EGFR expressed in Escherichia coli,IC50,82.0,nM,=,CHEMBL1176122,B,CHEMBL1172773,Homo sapiens,CHEMBL203,CHEMBL1177739
C=CC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,8.15,Inhibition of GST-tagged EGFR expressed in Escherichia coli,IC50,7.0,nM,=,CHEMBL1176122,B,CHEMBL1172843,Homo sapiens,CHEMBL203,CHEMBL1177739
COc1ccc(C2CC(c3ccc(Cl)c(Cl)c3)=NN2C(N)=S)cc1,5.24,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,5740.0,nM,=,CHEMBL1177399,B,CHEMBL1172915,Homo sapiens,CHEMBL203,CHEMBL1177661
Cc1ccc(C2CC(c3ccc(Cl)c(Cl)c3)=NN2C(N)=S)cc1,5.13,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,7380.0,nM,=,CHEMBL1177399,B,CHEMBL1172916,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccc(Br)cc1,5.16,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,6850.0,nM,=,CHEMBL1177399,B,CHEMBL1172917,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccc(Cl)cc1,5.13,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,7320.0,nM,=,CHEMBL1177399,B,CHEMBL1172980,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccc(F)cc1,5.20,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,6270.0,nM,=,CHEMBL1177399,B,CHEMBL1172573,Homo sapiens,CHEMBL203,CHEMBL1177661
Cc1ccc(C2=NN(C(N)=S)C(c3ccccc3Br)C2)cc1C,5.38,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,4210.0,nM,=,CHEMBL1177399,B,CHEMBL1173688,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Br)c(Br)c2)CC1c1ccc([N+](=O)[O-])cc1,4.97,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,10640.0,nM,=,CHEMBL1177399,B,CHEMBL1173191,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Br)c(Br)c2)CC1c1ccc(O)cc1,4.95,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,11270.0,nM,=,CHEMBL1177399,B,CHEMBL1173192,Homo sapiens,CHEMBL203,CHEMBL1177661
COc1ccc(C2CC(c3ccc(Br)c(Br)c3)=NN2C(N)=S)cc1,5.09,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,8090.0,nM,=,CHEMBL1177399,B,CHEMBL1173193,Homo sapiens,CHEMBL203,CHEMBL1177661
Cc1ccc(C2CC(c3ccc(Br)c(Br)c3)=NN2C(N)=S)cc1,5.01,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,9830.0,nM,=,CHEMBL1177399,B,CHEMBL1173262,Homo sapiens,CHEMBL203,CHEMBL1177661
OC[C@@H](Nc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12)c1ccccc1,6.65,Inhibition of GST-tagged EGFR expressed in Escherichia coli,IC50,223.0,nM,=,CHEMBL1176122,B,CHEMBL1172781,Homo sapiens,CHEMBL203,CHEMBL1177739
NC(=S)N1N=C(c2ccc(Br)c(Br)c2)CC1c1ccc(Br)cc1,5.00,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,10060.0,nM,=,CHEMBL1177399,B,CHEMBL1172855,Homo sapiens,CHEMBL203,CHEMBL1177661
NC(=S)N1N=C(c2ccc(Br)c(Br)c2)CC1c1ccc(Cl)cc1,5.09,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,IC50,8150.0,nM,=,CHEMBL1177399,B,CHEMBL1169870,Homo sapiens,CHEMBL203,CHEMBL1177661
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1ccc(Br)cc1,5.49,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,3240.0,nM,=,CHEMBL1177207,B,CHEMBL1173651,Homo sapiens,CHEMBL203,CHEMBL1177684
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1ccccc1,5.11,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,7830.0,nM,=,CHEMBL1177207,B,CHEMBL1173652,Homo sapiens,CHEMBL203,CHEMBL1177684
Cc1ccc(/C=C/C(=O)OCCn2c([N+](=O)[O-])cnc2C)cc1,5.09,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,8110.0,nM,=,CHEMBL1177207,B,CHEMBL1173653,Homo sapiens,CHEMBL203,CHEMBL1177684
COc1ccc(/C=C/C(=O)OCCn2c([N+](=O)[O-])cnc2C)cc1,4.96,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,10850.0,nM,=,CHEMBL1177207,B,CHEMBL1173713,Homo sapiens,CHEMBL203,CHEMBL1177684
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1ccc(C(C)C)cc1,5.17,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,6820.0,nM,=,CHEMBL1177207,B,CHEMBL1173714,Homo sapiens,CHEMBL203,CHEMBL1177684
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1ccc(-c2ccccc2)cc1,6.21,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,620.0,nM,=,CHEMBL1177207,B,CHEMBL1173718,Homo sapiens,CHEMBL203,CHEMBL1177684
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1ccc(OCc2ccccc2)cc1,5.90,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,1270.0,nM,=,CHEMBL1177207,B,CHEMBL1173783,Homo sapiens,CHEMBL203,CHEMBL1177684
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1ccccc1[N+](=O)[O-],4.60,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,25000.0,nM,=,CHEMBL1177207,B,CHEMBL1173789,Homo sapiens,CHEMBL203,CHEMBL1177684
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1ccc(F)cc1,5.38,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,4120.0,nM,=,CHEMBL1177207,B,CHEMBL1172802,Homo sapiens,CHEMBL203,CHEMBL1177684
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1ccc(Cl)cc1,5.44,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,3620.0,nM,=,CHEMBL1177207,B,CHEMBL1172803,Homo sapiens,CHEMBL203,CHEMBL1177684
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1ccccc1F,4.57,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,26740.0,nM,=,CHEMBL1177207,B,CHEMBL1172877,Homo sapiens,CHEMBL203,CHEMBL1177684
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1ccccc1Cl,4.68,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,20810.0,nM,=,CHEMBL1177207,B,CHEMBL1172878,Homo sapiens,CHEMBL203,CHEMBL1177684
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1ccccc1Br,4.61,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,24320.0,nM,=,CHEMBL1177207,B,CHEMBL1172947,Homo sapiens,CHEMBL203,CHEMBL1177684
COc1ccccc1/C=C/C(=O)OCCn1c([N+](=O)[O-])cnc1C,4.50,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,32000.0,nM,=,CHEMBL1177207,B,CHEMBL1171273,Homo sapiens,CHEMBL203,CHEMBL1177684
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1cccc([N+](=O)[O-])c1,4.84,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,14530.0,nM,=,CHEMBL1177207,B,CHEMBL1172950,Homo sapiens,CHEMBL203,CHEMBL1177684
Cc1ncc([N+](=O)[O-])n1CCOC(=O)/C=C/c1cccc(F)c1,4.91,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,12420.0,nM,=,CHEMBL1177207,B,CHEMBL1172951,Homo sapiens,CHEMBL203,CHEMBL1177684
COc1cccc(/C=C/C(=O)OCCn2c([N+](=O)[O-])cnc2C)c1,4.86,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,IC50,13870.0,nM,=,CHEMBL1177207,B,CHEMBL1173014,Homo sapiens,CHEMBL203,CHEMBL1177684
Brc1cccc(Nc2ncnc3cc4c(cc23)OCCCO4)c1,7.07,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,IC50,85.0,nM,=,CHEMBL2090277,B,CHEMBL1198361,Homo sapiens,CHEMBL203,CHEMBL2086389
Brc1cccc(Nc2ncnc3cc4c(cc23)OCCO4)c1,7.87,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,13.6,nM,=,CHEMBL4730561,B,CHEMBL1198370,Homo sapiens,CHEMBL203,CHEMBL4725422
CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1,5.27,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,5377.0,nM,=,CHEMBL1909203,B,CHEMBL1200558,Homo sapiens,CHEMBL203,CHEMBL1909046
[Cl-].[Cl-].[Zn+2],5.66,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,2188.4,nM,=,CHEMBL1909203,B,CHEMBL1200679,Homo sapiens,CHEMBL203,CHEMBL1909046
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1.O,8.30,Inhibition of EGFR by HTRF assay,IC50,5.0,nM,=,CHEMBL1009318,B,CHEMBL1201179,Homo sapiens,CHEMBL203,CHEMBL1139297
CCOC(=O)C(=O)Oc1ccc(-c2c(C(=O)OCC)oc3cc(O)cc(O)c3c2=O)cc1.O=C(O)C(=O)O,6.00,Inhibition of EGFR,IC50,1000.0,nM,=,CHEMBL941412,B,CHEMBL1202061,Homo sapiens,CHEMBL203,CHEMBL1150213
COc1cc2c(Nc3cc(O)c(C)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl,6.52,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,300.0,nM,=,CHEMBL677388,B,CHEMBL1202473,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCCN1CCN(C)CC1.Cl,7.00,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,100.0,nM,=,CHEMBL677388,B,CHEMBL1202477,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC/C=C/CN1CCCC1.Cl,7.00,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,100.0,nM,=,CHEMBL677388,B,CHEMBL1202478,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2ncnc(Nc3ccc(F)cc3)c2cc1OC.Cl,7.29,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,51.0,nM,=,CHEMBL916319,B,CHEMBL1203934,Homo sapiens,CHEMBL203,CHEMBL1140296
CCOc1cc2ncnc(Nc3cc(F)cc(C(F)(F)F)c3)c2cc1OCC.Cl,8.05,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,8.95,nM,=,CHEMBL916319,B,CHEMBL1203935,Homo sapiens,CHEMBL203,CHEMBL1140296
COc1cc2ncnc(Nc3cc(F)cc(C(F)(F)F)c3)c2cc1OC.Cl,7.70,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,20.0,nM,=,CHEMBL916319,B,CHEMBL1203936,Homo sapiens,CHEMBL203,CHEMBL1140296
CCOc1cc2ncnc(NCc3ccc(F)cc3)c2cc1OCC.Cl,7.77,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,17.0,nM,=,CHEMBL916319,B,CHEMBL1203937,Homo sapiens,CHEMBL203,CHEMBL1140296
COc1cc2ncnc(NCc3ccc(F)cc3)c2cc1OC.Cl,7.32,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,47.7,nM,=,CHEMBL916319,B,CHEMBL1203938,Homo sapiens,CHEMBL203,CHEMBL1140296
CCOc1cc2ncnc(Nc3ccccc3F)c2cc1OCC.Cl,8.03,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,9.31,nM,=,CHEMBL916319,B,CHEMBL1203939,Homo sapiens,CHEMBL203,CHEMBL1140296
CCOc1cc2ncnc(Nc3ccc(F)cc3)c2cc1OCC.Cl,7.80,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,16.0,nM,=,CHEMBL916319,B,CHEMBL1203940,Homo sapiens,CHEMBL203,CHEMBL1140296
COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC.Cl,9.18,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,0.66,nM,=,CHEMBL916319,B,CHEMBL1204168,Homo sapiens,CHEMBL203,CHEMBL1140296
CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC.Cl,9.39,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,0.41,nM,=,CHEMBL916319,B,CHEMBL1204199,Homo sapiens,CHEMBL203,CHEMBL1140296
CCOc1cc2ncnc(Nc3cccc(F)c3)c2cc1OCC.Cl,8.09,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,8.17,nM,=,CHEMBL916319,B,CHEMBL1204261,Homo sapiens,CHEMBL203,CHEMBL1140296
CCOc1cc2ncnc(Nc3cccc(I)c3)c2cc1OCC.Cl,9.19,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,0.64,nM,=,CHEMBL916319,B,CHEMBL1204262,Homo sapiens,CHEMBL203,CHEMBL1140296
COc1cc2ncnc(Nc3cccc(I)c3)c2cc1OC.Cl,8.98,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,1.05,nM,=,CHEMBL916319,B,CHEMBL1204305,Homo sapiens,CHEMBL203,CHEMBL1140296
COc1cc2ncnc(Nc3ccccc3F)c2cc1OC.Cl,7.49,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,32.2,nM,=,CHEMBL916319,B,CHEMBL1204360,Homo sapiens,CHEMBL203,CHEMBL1140296
CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS,5.49,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,3216.0,nM,=,CHEMBL1909203,B,CHEMBL1221512,Homo sapiens,CHEMBL203,CHEMBL1909046
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(C(C)(C)C)cc3)c2c1,6.16,Inhibition of human recombinant EGFR expressed in baculovirus-infected Sf9 cells by radioactive phosphotransfer assay,IC50,689.0,nM,=,CHEMBL1226208,B,CHEMBL1221700,Homo sapiens,CHEMBL203,CHEMBL1221199
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1,9.72,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,0.19,nM,=,CHEMBL3430221,B,CHEMBL1229592,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,7.07,Binding constant for EGFR(L861Q) kinase domain,Kd,86.0,nM,=,CHEMBL1908702,B,CHEMBL1230609,Homo sapiens,CHEMBL203,CHEMBL1908390
CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21,6.02,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,954.0,nM,=,CHEMBL1243977,B,CHEMBL1230790,Homo sapiens,CHEMBL203,CHEMBL1240340
C=CC(=O)Nc1ccc2c(Nc3cc[nH]n3)nc(-c3ccccc3)nc2c1,5.72,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,1900.0,nM,=,CHEMBL3606404,B,CHEMBL1232944,Homo sapiens,CHEMBL203,CHEMBL3603765
COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC,5.64,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,2300.0,nM,=,CHEMBL1243977,B,CHEMBL1233881,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21,6.21,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,610.0,nM,=,CHEMBL1243977,B,CHEMBL1233882,Homo sapiens,CHEMBL203,CHEMBL1240340
Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21,6.41,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,388.0,nM,=,CHEMBL1243977,B,CHEMBL1234815,Homo sapiens,CHEMBL203,CHEMBL1240340
Cn1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21,4.82,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,15000.0,nM,=,CHEMBL1243977,B,CHEMBL1240565,Homo sapiens,CHEMBL203,CHEMBL1240340
Cn1nc(-c2ccc3cc[nH]c3c2)c2c(N)ncnc21,5.54,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,2900.0,nM,=,CHEMBL1243977,B,CHEMBL1240566,Homo sapiens,CHEMBL203,CHEMBL1240340
CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O,7.46,"Binding affinity to EGFR L858R,T790M mutant",Kd,35.0,nM,=,CHEMBL1244809,B,CHEMBL1240703,Homo sapiens,CHEMBL203,CHEMBL1240346
CC(C)n1nc(-c2ccc(O)cc2)c2c(N)ncnc21,6.04,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,922.0,nM,=,CHEMBL1243977,B,CHEMBL1241241,Homo sapiens,CHEMBL203,CHEMBL1240340
Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1O,4.91,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,12400.0,nM,=,CHEMBL1243977,B,CHEMBL1241270,Homo sapiens,CHEMBL203,CHEMBL1240340
Cc1ccc(-c2nn(C)c3ncnc(N)c23)cc1O,4.72,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,19000.0,nM,=,CHEMBL1243977,B,CHEMBL1241271,Homo sapiens,CHEMBL203,CHEMBL1240340
Cn1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241299,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1ccc(-c2n[nH]c3ncnc(N)c23)cc1O,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241300,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1ccc(-c2nn(C)c3ncnc(N)c23)cc1O,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241301,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cccnc2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241390,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cncnc2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241391,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cc(C=O)co2)c2c(N)ncnc21,5.22,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,5960.0,nM,=,CHEMBL1243977,B,CHEMBL1241439,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C,6.77,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,170.0,nM,=,CHEMBL1243977,B,CHEMBL1241481,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2Cc1ocnc1-c1ccccc1,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241482,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1F,5.41,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,3860.0,nM,=,CHEMBL1243977,B,CHEMBL1241483,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21,6.80,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,158.0,nM,=,CHEMBL1243977,B,CHEMBL1241484,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1N,5.42,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,3850.0,nM,=,CHEMBL1243977,B,CHEMBL1241485,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1NC(C)CO,5.27,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,5320.0,nM,=,CHEMBL1243977,B,CHEMBL1241486,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O,7.48,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,33.0,nM,=,CHEMBL1243977,B,CHEMBL1241487,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3occc3c2)c2c(N)ncnc21,6.02,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,964.0,nM,=,CHEMBL1243977,B,CHEMBL1241490,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc3occc3c1)nn2C1CCCC1,6.24,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,575.0,nM,=,CHEMBL1243977,B,CHEMBL1241491,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3nonc3c2)c2c(N)ncnc21,5.08,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,8300.0,nM,=,CHEMBL1243977,B,CHEMBL1241492,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21,6.26,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,550.0,nM,=,CHEMBL1243977,B,CHEMBL1241578,Homo sapiens,CHEMBL203,CHEMBL1240340
C[C@H](CN)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21,5.32,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,4800.0,nM,=,CHEMBL1243977,B,CHEMBL1241579,Homo sapiens,CHEMBL203,CHEMBL1240340
C[C@@H](CN)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21,5.04,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,9140.0,nM,=,CHEMBL1243977,B,CHEMBL1240544,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2C1CCC1,5.94,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1150.0,nM,=,CHEMBL1243977,B,CHEMBL1241580,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1cc(-c2nn(C3CCCC3)c3ncnc(N)c23)ccc1N,7.08,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,84.0,nM,=,CHEMBL1243977,B,CHEMBL1241581,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cccc(CO)c2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241582,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cccc(CC#N)c2)c2c(N)ncnc21,4.77,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,17000.0,nM,=,CHEMBL1243977,B,CHEMBL1241583,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3[nH]c(=O)[nH]c3c2)c2c(N)ncnc21,6.03,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,937.0,nM,=,CHEMBL1243977,B,CHEMBL1241586,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3c(c2)CCO3)c2c(N)ncnc21,5.30,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,5000.0,nM,=,CHEMBL1243977,B,CHEMBL1241587,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3c(c2)OCCO3)c2c(N)ncnc21,4.82,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,15000.0,nM,=,CHEMBL1243977,B,CHEMBL1241588,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21,6.66,Binding constant for EGFR(E746-A750del) kinase domain,Kd,220.0,nM,=,CHEMBL1908694,B,CHEMBL1241674,Homo sapiens,CHEMBL203,CHEMBL1908390
Nc1ncnc2c1c(-c1ccn3ccnc3c1)nn2C1CCCC1,4.92,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,12000.0,nM,=,CHEMBL1243977,B,CHEMBL1241675,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2C1CCCC1,7.17,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,67.0,nM,=,CHEMBL1243977,B,CHEMBL1241676,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@@H]1CCNC1,4.91,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,12400.0,nM,=,CHEMBL1243977,B,CHEMBL1241677,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@H]1CCOC1,5.80,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1580.0,nM,=,CHEMBL1243977,B,CHEMBL1241678,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc(CC#N)cc2)c2c(N)ncnc21,4.89,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,13000.0,nM,=,CHEMBL1243977,B,CHEMBL1240545,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cccc(C#N)c2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241679,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc(F)c(C#N)c2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241680,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc3ncccc3c1)nn2C1CCCC1,5.68,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,2100.0,nM,=,CHEMBL1243977,B,CHEMBL1241681,Homo sapiens,CHEMBL203,CHEMBL1240340
Cc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2n1,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241682,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3nc(Cl)ccc3c2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241683,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cc3cc(C=O)ccc3s2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241684,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@@H]1CCOC1,5.85,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1400.0,nM,=,CHEMBL1243977,B,CHEMBL1241768,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCCN1,5.03,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,9380.0,nM,=,CHEMBL1243977,B,CHEMBL1241769,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCNC1,5.70,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,2010.0,nM,=,CHEMBL1243977,B,CHEMBL1241770,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc(C#N)c(F)c2)c2c(N)ncnc21,5.05,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,8900.0,nM,=,CHEMBL1243977,B,CHEMBL1241771,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc(C#N)nc2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241772,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(=O)c1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1,4.92,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,12000.0,nM,=,CHEMBL1243977,B,CHEMBL1241773,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3nccnc3c2)c2c(N)ncnc21,4.75,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,18000.0,nM,=,CHEMBL1243977,B,CHEMBL1241774,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cnc3nccnc3c2)c2c(N)ncnc21,4.16,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,70000.0,nM,=,CHEMBL1243977,B,CHEMBL1241775,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3nc[nH]c(=O)c3c2)c2c(N)ncnc21,5.13,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,7400.0,nM,=,CHEMBL1243977,B,CHEMBL1241776,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCCNC1,5.57,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,2720.0,nM,=,CHEMBL1243977,B,CHEMBL1241858,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCNCC1,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241859,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc(C=O)c(F)c2)c2c(N)ncnc21,5.05,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,9000.0,nM,=,CHEMBL1243977,B,CHEMBL1241860,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cc(F)c(C=O)c(F)c2)c2c(N)ncnc21,5.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,10000.0,nM,=,CHEMBL1243977,B,CHEMBL1241861,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc(C(N)=O)c(Cl)c2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241862,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3[nH]c(=O)ccc3c2)c2c(N)ncnc21,5.17,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,6700.0,nM,=,CHEMBL1243977,B,CHEMBL1241863,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc3[nH]c(=O)ccc3c1)nn2C1CCCC1,5.85,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1400.0,nM,=,CHEMBL1243977,B,CHEMBL1241864,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CCC1CCCNC1,4.69,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,20500.0,nM,=,CHEMBL1243977,B,CHEMBL1241943,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc(C#N)c(O)c2)c2c(N)ncnc21,5.58,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,2600.0,nM,=,CHEMBL1243977,B,CHEMBL1241944,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc(O)c(F)c2)c2c(N)ncnc21,5.98,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1040.0,nM,=,CHEMBL1243977,B,CHEMBL1241945,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(=O)c1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1,5.55,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,2800.0,nM,=,CHEMBL1243977,B,CHEMBL1241946,Homo sapiens,CHEMBL203,CHEMBL1240340
Cc1cc(-c2nn(C(C)C)c3ncnc(N)c23)sc1C=O,5.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,9900.0,nM,=,CHEMBL1243977,B,CHEMBL1241947,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cccc(NS(C)(=O)=O)c2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1241948,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3nc(N)ccc3c2)c2c(N)ncnc21,4.92,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,12000.0,nM,=,CHEMBL1243977,B,CHEMBL1241949,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3nc(NN)ccc3c2)c2c(N)ncnc21,5.16,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,7000.0,nM,=,CHEMBL1243977,B,CHEMBL1241950,Homo sapiens,CHEMBL203,CHEMBL1240340
Cc1cc(O)ccc1-c1nn(C(C)C)c2ncnc(N)c12,6.02,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,954.0,nM,=,CHEMBL1243977,B,CHEMBL1242024,Homo sapiens,CHEMBL203,CHEMBL1240340
Cc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1O,6.18,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,663.0,nM,=,CHEMBL1243977,B,CHEMBL1242026,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1cc(F)c(-c2nn(C(C)C)c3ncnc(N)c23)cc1F,4.99,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,10200.0,nM,=,CHEMBL1243977,B,CHEMBL1242027,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cc(F)c(O)cc2F)c2c(N)ncnc21,5.16,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,6900.0,nM,=,CHEMBL1243977,B,CHEMBL1242028,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1,5.85,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1400.0,nM,=,CHEMBL1243977,B,CHEMBL1242029,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc(NS(C)(=O)=O)cc2)c2c(N)ncnc21,4.89,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,12800.0,nM,=,CHEMBL1243977,B,CHEMBL1242030,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cccc(S(N)(=O)=O)c2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1242031,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc(S(N)(=O)=O)cc2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1242032,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3nccc(NC(=O)OC(C)(C)C)c3c2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1242033,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3nccc(N)c3c2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1242034,Homo sapiens,CHEMBL203,CHEMBL1240340
CCC(C)n1nc(-c2ccc(C)c(O)c2)c2c(N)ncnc21,5.78,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1670.0,nM,=,CHEMBL1243977,B,CHEMBL1242109,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cccc(O)c2F)c2c(N)ncnc21,5.43,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,3720.0,nM,=,CHEMBL1243977,B,CHEMBL1242110,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1cccc(O)c1F)nn2C1CCCC1,5.75,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1770.0,nM,=,CHEMBL1243977,B,CHEMBL1242111,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1O,6.04,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,908.0,nM,=,CHEMBL1243977,B,CHEMBL1242112,Homo sapiens,CHEMBL203,CHEMBL1240340
CCn1nc(-c2ccc(OC)c(O)c2)c2c(N)ncnc21,5.19,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,6450.0,nM,=,CHEMBL1243977,B,CHEMBL1242113,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1O,5.66,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,2190.0,nM,=,CHEMBL1243977,B,CHEMBL1242114,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cccc(C(=O)NC3=NCCS3)c2)c2c(N)ncnc21,6.24,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,579.0,nM,=,CHEMBL1243977,B,CHEMBL1242115,Homo sapiens,CHEMBL203,CHEMBL1240340
Cn1nc(-c2ccc3occc(=O)c3c2)c2c(N)ncnc21,5.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,10000.0,nM,=,CHEMBL1243977,B,CHEMBL1242117,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3occc(=O)c3c2)c2c(N)ncnc21,4.54,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,29000.0,nM,=,CHEMBL1243977,B,CHEMBL1242118,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc3occc(=O)c3c1)nn2C1CCCC1,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1242119,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cc(O)cc(F)c2)c2c(N)ncnc21,6.24,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,576.0,nM,=,CHEMBL1243977,B,CHEMBL1242198,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1cc(O)cc(F)c1)nn2C1CCCC1,6.12,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,751.0,nM,=,CHEMBL1243977,B,CHEMBL1242199,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1cc(Br)cc(-c2nn(C(C)C)c3ncnc(N)c23)c1,4.96,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,11000.0,nM,=,CHEMBL1243977,B,CHEMBL1242200,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O,6.36,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,437.0,nM,=,CHEMBL1243977,B,CHEMBL1242201,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1ccc(-c2nn(C3CCC(C)C3)c3ncnc(N)c23)cc1O,6.57,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,270.0,nM,=,CHEMBL1243977,B,CHEMBL1242202,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1ccc(-c2nn(C3CNC3)c3ncnc(N)c23)cc1O,4.77,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,17000.0,nM,=,CHEMBL1243977,B,CHEMBL1242203,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3cnccc3c2)c2c(N)ncnc21,4.60,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,25000.0,nM,=,CHEMBL1243977,B,CHEMBL1242207,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3ccncc3c2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1242208,Homo sapiens,CHEMBL203,CHEMBL1240340
Cc1ccc2ccc(-c3nn(C(C)C)c4ncnc(N)c34)cc2n1,4.75,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,18000.0,nM,=,CHEMBL1243977,B,CHEMBL1242209,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cc(O)cc(Br)c2)c2c(N)ncnc21,6.60,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,249.0,nM,=,CHEMBL1243977,B,CHEMBL1242285,Homo sapiens,CHEMBL203,CHEMBL1240340
COCOc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1Br,5.37,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,4320.0,nM,=,CHEMBL1243977,B,CHEMBL1242286,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCC1,6.49,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,324.0,nM,=,CHEMBL1243977,B,CHEMBL1242287,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1ccc(-c2nn([C@@H]3CCNC3)c3ncnc(N)c23)cc1O,4.90,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,12600.0,nM,=,CHEMBL1243977,B,CHEMBL1242288,Homo sapiens,CHEMBL203,CHEMBL1240340
CCOc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O,6.12,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,768.0,nM,=,CHEMBL1243977,B,CHEMBL1242289,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1OC,5.52,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,3020.0,nM,=,CHEMBL1243977,B,CHEMBL1242290,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21,6.42,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,380.0,nM,=,CHEMBL1243977,B,CHEMBL1242293,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3[nH]ccc3c2)c2c(N)ncnc21,6.75,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,176.0,nM,=,CHEMBL1243977,B,CHEMBL1242294,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc3[nH]ccc3c1)nn2C1CCCC1,6.13,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,734.0,nM,=,CHEMBL1243977,B,CHEMBL1242295,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCCC1,6.63,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,236.0,nM,=,CHEMBL1243977,B,CHEMBL1242376,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21,5.85,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1400.0,nM,=,CHEMBL1243977,B,CHEMBL1242377,Homo sapiens,CHEMBL203,CHEMBL1240340
C[C@H](CN)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1242378,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1OC,5.20,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,6340.0,nM,=,CHEMBL1243977,B,CHEMBL1242379,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1ccc(-c2nn(C[C@H](C)CO)c3ncnc(N)c23)cc1OC,4.92,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,12000.0,nM,=,CHEMBL1243977,B,CHEMBL1242380,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1ccc(-c2nn(C[C@@H](C)CO)c3ncnc(N)c23)cc1OC,4.75,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,18000.0,nM,=,CHEMBL1243977,B,CHEMBL1242381,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3c(ccn3C)c2)c2c(N)ncnc21,6.02,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,955.0,nM,=,CHEMBL1243977,B,CHEMBL1242384,Homo sapiens,CHEMBL203,CHEMBL1240340
Cn1ccc2cc(-c3nn(C4CCCC4)c4ncnc(N)c34)ccc21,6.27,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,539.0,nM,=,CHEMBL1243977,B,CHEMBL1242385,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3[nH]ncc3c2)c2c(N)ncnc21,5.96,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1100.0,nM,=,CHEMBL1243977,B,CHEMBL1242386,Homo sapiens,CHEMBL203,CHEMBL1240340
C[C@@H](CN)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21,4.58,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,26000.0,nM,=,CHEMBL1243977,B,CHEMBL1242468,Homo sapiens,CHEMBL203,CHEMBL1240340
N#CCCCn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21,4.75,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,18000.0,nM,=,CHEMBL1243977,B,CHEMBL1242469,Homo sapiens,CHEMBL203,CHEMBL1240340
N#CCCCCn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21,4.96,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,11000.0,nM,=,CHEMBL1243977,B,CHEMBL1242470,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1OC,5.48,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,3300.0,nM,=,CHEMBL1243977,B,CHEMBL1240553,Homo sapiens,CHEMBL203,CHEMBL1240340
CCOc1ccc(-c2n[nH]c3ncnc(N)c23)cc1OC,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1242471,Homo sapiens,CHEMBL203,CHEMBL1240340
CCOc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1OC,5.22,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,5950.0,nM,=,CHEMBL1243977,B,CHEMBL1242472,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc3[nH]ncc3c1)nn2C1CCCC1,6.24,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,571.0,nM,=,CHEMBL1243977,B,CHEMBL1242475,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3c(N)n[nH]c3c2)c2c(N)ncnc21,6.68,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,207.0,nM,=,CHEMBL1243977,B,CHEMBL1242476,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3cn[nH]c3c2)c2c(N)ncnc21,5.60,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,2500.0,nM,=,CHEMBL1243977,B,CHEMBL1242477,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCC1,5.54,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,2900.0,nM,=,CHEMBL1243977,B,CHEMBL1242566,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CNC1,5.54,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,2900.0,nM,=,CHEMBL1243977,B,CHEMBL1242567,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCCC1,6.50,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,318.0,nM,=,CHEMBL1243977,B,CHEMBL1242568,Homo sapiens,CHEMBL203,CHEMBL1240340
C=CCn1nc(-c2ccc(OCC)c(OC)c2)c2c(N)ncnc21,5.29,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,5080.0,nM,=,CHEMBL1243977,B,CHEMBL1242569,Homo sapiens,CHEMBL203,CHEMBL1240340
CCOc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1OC,5.85,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1400.0,nM,=,CHEMBL1243977,B,CHEMBL1240554,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc3cn[nH]c3c1)nn2C1CCCC1,6.12,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,760.0,nM,=,CHEMBL1243977,B,CHEMBL1242572,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cc(F)c3cn[nH]c3c2)c2c(N)ncnc21,5.92,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1200.0,nM,=,CHEMBL1243977,B,CHEMBL1242573,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3cc[nH]c3c2)c2c(N)ncnc21,6.66,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,220.0,nM,=,CHEMBL1243977,B,CHEMBL1242574,Homo sapiens,CHEMBL203,CHEMBL1240340
CC1CCC(n2nc(-c3ccc(F)c(O)c3)c3c(N)ncnc32)C1,6.44,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,366.0,nM,=,CHEMBL1243977,B,CHEMBL1242656,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@H]1CCNC1,5.06,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,8700.0,nM,=,CHEMBL1243977,B,CHEMBL1242657,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@@H]1CCNC1,4.81,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,15600.0,nM,=,CHEMBL1243977,B,CHEMBL1242658,Homo sapiens,CHEMBL203,CHEMBL1240340
CCOc1ccc(-c2nn(C3CCCCC3)c3ncnc(N)c23)cc1OC,5.94,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1160.0,nM,=,CHEMBL1243977,B,CHEMBL1242659,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)cc(OC)c1OC,5.29,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,5140.0,nM,=,CHEMBL1243977,B,CHEMBL1242660,Homo sapiens,CHEMBL203,CHEMBL1240340
CCOc1ccc2cc(-c3nn(C)c4ncnc(N)c34)ccc2c1,4.68,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,21000.0,nM,=,CHEMBL1243977,B,CHEMBL1242661,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3cc(O)ccc3c2)c2c(N)ncnc21,7.06,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,88.0,nM,=,CHEMBL1243977,B,CHEMBL1242662,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cc3ccccc3nc2Cl)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1242663,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc3cc[nH]c3c1)nn2C1CCCC1,7.07,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,85.0,nM,=,CHEMBL1243977,B,CHEMBL1242664,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccn3ccnc3c2)c2c(N)ncnc21,4.35,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,45000.0,nM,=,CHEMBL1243977,B,CHEMBL1242665,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3c(C=O)c[nH]c3c2)c2c(N)ncnc21,6.20,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,638.0,nM,=,CHEMBL1243977,B,CHEMBL1242666,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@H]1CCOC1,5.32,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,4800.0,nM,=,CHEMBL1243977,B,CHEMBL1242748,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@@H]1CCOC1,5.58,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,2600.0,nM,=,CHEMBL1243977,B,CHEMBL1242749,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCCCCC1,6.11,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,775.0,nM,=,CHEMBL1243977,B,CHEMBL1242750,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1OC,5.44,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,3660.0,nM,=,CHEMBL1243977,B,CHEMBL1242751,Homo sapiens,CHEMBL203,CHEMBL1240340
CCOc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1OC,4.27,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,54200.0,nM,=,CHEMBL1243977,B,CHEMBL1242752,Homo sapiens,CHEMBL203,CHEMBL1240340
CCOc1cc(-c2nn(CCO)c3ncnc(N)c23)ccc1OC,5.10,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,8010.0,nM,=,CHEMBL1243977,B,CHEMBL1242753,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cnc3ccccc3c2)c2c(N)ncnc21,6.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1000.0,nM,=,CHEMBL1243977,B,CHEMBL1242754,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1cnc3ccccc3c1)nn2C1CCCC1,6.27,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,540.0,nM,=,CHEMBL1243977,B,CHEMBL1242755,Homo sapiens,CHEMBL203,CHEMBL1240340
Cn1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21,4.47,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,34000.0,nM,=,CHEMBL1243977,B,CHEMBL1242756,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2cccc3[nH]ccc23)c2c(N)ncnc21,5.34,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,4600.0,nM,=,CHEMBL1243977,B,CHEMBL1242757,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1cccc3[nH]ccc13)nn2C1CCCC1,5.85,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,1400.0,nM,=,CHEMBL1243977,B,CHEMBL1242758,Homo sapiens,CHEMBL203,CHEMBL1240340
Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2CC1CCNCC1,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1242844,Homo sapiens,CHEMBL203,CHEMBL1240340
Cc1nn(-c2ccccc2)nc1Cn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1242845,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1ncc(-c2nn(C(C)C)c3ncnc(N)c23)c(OC)n1,4.00,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,100000.0,nM,=,CHEMBL1243977,B,CHEMBL1242846,Homo sapiens,CHEMBL203,CHEMBL1240340
COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1,5.37,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,4300.0,nM,=,CHEMBL1243977,B,CHEMBL1242847,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc(N)c(O)c2)c2c(N)ncnc21,5.67,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,2120.0,nM,=,CHEMBL1243977,B,CHEMBL1242848,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)n1nc(-c2ccc3c(ccn3C(=O)OC(C)(C)C)c2)c2c(N)ncnc21,6.75,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,179.0,nM,=,CHEMBL1243977,B,CHEMBL1242852,Homo sapiens,CHEMBL203,CHEMBL1240340
CC(C)(C)OC(=O)n1ccc2cc(-c3nn(C4CCCC4)c4ncnc(N)c34)ccc21,6.41,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,IC50,391.0,nM,=,CHEMBL1243977,B,CHEMBL1242853,Homo sapiens,CHEMBL203,CHEMBL1240340
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)Cc1ccc(F)cc1,9.24,Inhibition of EGFR,IC50,0.57,nM,=,CHEMBL1249168,B,CHEMBL1243254,Homo sapiens,CHEMBL203,CHEMBL1240526
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CNC,9.60,Inhibition of EGFR,IC50,0.25,nM,=,CHEMBL1249168,B,CHEMBL1243255,Homo sapiens,CHEMBL203,CHEMBL1240526
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CNCc1cn(CCF)nn1,8.74,Inhibition of EGFR,IC50,1.81,nM,=,CHEMBL1249168,B,CHEMBL1243283,Homo sapiens,CHEMBL203,CHEMBL1240526
CNC/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cc1OCCF,9.54,Inhibition of EGFR,IC50,0.29,nM,=,CHEMBL1249168,B,CHEMBL1243284,Homo sapiens,CHEMBL203,CHEMBL1240526
C#CCNC/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cc1OCC,7.22,Inhibition of EGFR autophosphorylation in human A431 cells,IC50,60.2,nM,=,CHEMBL1246645,B,CHEMBL1243316,Homo sapiens,CHEMBL203,CHEMBL1240526
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)CCF,9.10,Inhibition of EGFR,IC50,0.8,nM,=,CHEMBL1249168,B,CHEMBL1243345,Homo sapiens,CHEMBL203,CHEMBL1240526
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/c1cn(CCF)nn1,8.39,Inhibition of EGFR,IC50,4.05,nM,=,CHEMBL1249168,B,CHEMBL1243346,Homo sapiens,CHEMBL203,CHEMBL1240526
CN(c1cccc(Br)c1)c1nc(N)nc2[nH]c(Cc3ccccc3)cc12,4.28,Inhibition of EGFR expressed in human A431 cells,IC50,53100.0,nM,=,CHEMBL1252156,B,CHEMBL1254199,Homo sapiens,CHEMBL203,CHEMBL1250424
Cc1ccccc1Cc1cc2c(N(C)c3cccc(Br)c3)nc(N)nc2[nH]1,4.51,Inhibition of EGFR expressed in human A431 cells,IC50,31200.0,nM,=,CHEMBL1252156,B,CHEMBL1254363,Homo sapiens,CHEMBL203,CHEMBL1250424
Cc1ccccc1Cc1cc2c(Nc3cccc(Br)c3)nc(N)nc2n1C,4.89,Inhibition of EGFR expressed in human A431 cells,IC50,12800.0,nM,=,CHEMBL1252156,B,CHEMBL1254364,Homo sapiens,CHEMBL203,CHEMBL1250424
Cc1ccccc1Cc1cc2c(N(C)c3cccc(Br)c3)nc(N)nc2n1C,5.92,Inhibition of EGFR expressed in human A431 cells,IC50,1200.0,nM,=,CHEMBL1252156,B,CHEMBL1254443,Homo sapiens,CHEMBL203,CHEMBL1250424
COc1ccc(OC)c(Cc2cc3c(N(C)c4cccc(Br)c4)nc(N)nc3n2C)c1,6.30,Inhibition of EGFR expressed in human A431 cells,IC50,500.0,nM,=,CHEMBL1252156,B,CHEMBL1254523,Homo sapiens,CHEMBL203,CHEMBL1250424
CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(Nc5nc6cccc(Cl)c6o5)c(F)c4)c4c(N)ncnc43)CC2)CC1,5.54,Inhibition of EGFR phosphorylation in human MIAPaCa cells by ELISA,IC50,2880.0,nM,=,CHEMBL1260610,B,CHEMBL1256432,Homo sapiens,CHEMBL203,CHEMBL1255185
N#Cc1ccc2c(c1)C(c1ccccc1F)=Nc1c[nH]nc1N2,4.96,Inhibition of EGFR,IC50,10900.0,nM,=,CHEMBL1261159,B,CHEMBL1257795,Homo sapiens,CHEMBL203,CHEMBL1255207
Nc1ccc2c(c1)C(c1ccccc1Cl)=Nc1c[nH]nc1N2,6.00,Inhibition of EGFR,IC50,989.0,nM,=,CHEMBL1261159,B,CHEMBL1257911,Homo sapiens,CHEMBL203,CHEMBL1255207
CC(=O)Nc1ccc2c(c1)C(c1ccccc1Cl)=Nc1c[nH]nc1N2,6.14,Inhibition of EGFR,IC50,726.0,nM,=,CHEMBL1261159,B,CHEMBL1257912,Homo sapiens,CHEMBL203,CHEMBL1255207
CN1CCN([C@H]2CC[C@H](n3nc(-c4ccc(Nc5nc6cccc(Cl)c6o5)cc4)c4c(N)ncnc43)CC2)CC1,5.64,Inhibition of EGFR phosphorylation in human MIAPaCa cells by ELISA,IC50,2300.0,nM,=,CHEMBL1260610,B,CHEMBL1257998,Homo sapiens,CHEMBL203,CHEMBL1255185
CSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1,5.30,Inhibition of EGFR,IC50,5048.0,nM,=,CHEMBL1805338,B,CHEMBL1270795,Homo sapiens,CHEMBL203,CHEMBL1799927
CN1CCN(C/C=C/C(=O)N2CCc3c(sc4ncnc(N[C@H](CO)c5ccccc5)c34)C2)CC1,7.05,Inhibition of EGFR,IC50,89.0,nM,=,CHEMBL1273341,B,CHEMBL1271507,Homo sapiens,CHEMBL203,CHEMBL1269003
C[C@@H](Nc1ncnc2sc3c(c12)CCN(C(=O)/C=C/CN(C)C)C3)c1ccccc1,8.34,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,4.6,nM,=,CHEMBL3705330,B,CHEMBL1271561,Homo sapiens,CHEMBL203,CHEMBL3638553
CC[C@@H](Nc1ncnc2sc3c(c12)CCN(C(=O)/C=C/CN(C)C)C3)c1ccccc1,7.92,Inhibition of EGFR,IC50,12.0,nM,=,CHEMBL1273341,B,CHEMBL1271562,Homo sapiens,CHEMBL203,CHEMBL1269003
CN(C)C/C=C/C(=O)N1CCc2c(sc3ncnc(N[C@H](CO)Cc4ccccc4)c23)C1,6.83,Inhibition of EGFR,IC50,149.0,nM,=,CHEMBL1273341,B,CHEMBL1271618,Homo sapiens,CHEMBL203,CHEMBL1269003
CN(C)C/C=C/C(=O)N1CCc2c(sc3ncnc(NCCO)c23)C1,5.31,Inhibition of EGFR,IC50,4884.0,nM,=,CHEMBL1273341,B,CHEMBL1271619,Homo sapiens,CHEMBL203,CHEMBL1269003
OC[C@@H](Nc1ncnc2sc3c(c12)CCCC3)c1ccccc1,6.14,Inhibition of EGFR,IC50,720.0,nM,=,CHEMBL1273341,B,CHEMBL1271950,Homo sapiens,CHEMBL203,CHEMBL1269003
OC[C@@H](Nc1ncnc2sc3c(c12)CCC3)c1ccccc1,5.96,Inhibition of EGFR,IC50,1090.0,nM,=,CHEMBL1273341,B,CHEMBL1272006,Homo sapiens,CHEMBL203,CHEMBL1269003
C=CC(=O)N1CCc2c(sc3ncnc(N[C@H](CO)c4ccccc4)c23)C1,8.10,Inhibition of EGFR,IC50,8.0,nM,=,CHEMBL1273341,B,CHEMBL1272061,Homo sapiens,CHEMBL203,CHEMBL1269003
CC#CC(=O)N1CCc2c(sc3ncnc(N[C@H](CO)c4ccccc4)c23)C1,5.90,Inhibition of EGFR,IC50,1270.0,nM,=,CHEMBL1273341,B,CHEMBL1272113,Homo sapiens,CHEMBL203,CHEMBL1269003
C=CS(=O)(=O)N1CCc2c(sc3ncnc(N[C@H](CO)c4ccccc4)c23)C1,7.04,Inhibition of EGFR,IC50,91.0,nM,=,CHEMBL1273341,B,CHEMBL1272167,Homo sapiens,CHEMBL203,CHEMBL1269003
C=CC(=O)N1CCc2c(sc3ncnc(N[C@@H](CO)c4ccccc4)c23)C1,5.51,Inhibition of EGFR,IC50,3057.0,nM,=,CHEMBL1273341,B,CHEMBL1272168,Homo sapiens,CHEMBL203,CHEMBL1269003
C=CC(=O)N1CCc2c(sc3ncnc(N[C@H](C)c4ccccc4)c23)C1,7.70,Inhibition of EGFR,IC50,20.0,nM,=,CHEMBL1273341,B,CHEMBL1272222,Homo sapiens,CHEMBL203,CHEMBL1269003
C=CC(=O)N1CCc2c(sc3ncnc(N[C@H](CC)c4ccccc4)c23)C1,7.34,Inhibition of EGFR,IC50,46.0,nM,=,CHEMBL1273341,B,CHEMBL1272223,Homo sapiens,CHEMBL203,CHEMBL1269003
O=C(/C=C/c1ccccc1)N1CCc2c(sc3ncnc(N[C@H](CO)c4ccccc4)c23)C1,5.46,Inhibition of EGFR,IC50,3503.0,nM,=,CHEMBL1273341,B,CHEMBL1272275,Homo sapiens,CHEMBL203,CHEMBL1269003
CN(C)C/C=C/C(=O)N1CCc2c(sc3ncnc(N[C@H](CO)c4ccccc4)c23)C1,7.16,Inhibition of EGFR,IC50,70.0,nM,=,CHEMBL1273341,B,CHEMBL1272276,Homo sapiens,CHEMBL203,CHEMBL1269003
CCN(CC)C/C=C/C(=O)N1CCc2c(sc3ncnc(N[C@H](CO)c4ccccc4)c23)C1,8.05,Inhibition of EGFR,IC50,9.0,nM,=,CHEMBL1273341,B,CHEMBL1272324,Homo sapiens,CHEMBL203,CHEMBL1269003
O=C(/C=C/CN1CCOCC1)N1CCc2c(sc3ncnc(N[C@H](CO)c4ccccc4)c23)C1,7.68,Inhibition of EGFR,IC50,21.0,nM,=,CHEMBL1273341,B,CHEMBL1272325,Homo sapiens,CHEMBL203,CHEMBL1269003
CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1,6.76,Inhibition of EGFR,IC50,173.0,nM,=,CHEMBL1285874,B,CHEMBL1276179,Homo sapiens,CHEMBL203,CHEMBL1275379
COc1cc2ncnc(Nc3ccc(Br)cc3F)c2cc1OC,5.24,Inhibition of human EGFR-mediated poly(Glu4Tyr) phosphorylation after 1 hr,IC50,5700.0,nM,=,CHEMBL1763554,B,CHEMBL1277620,Homo sapiens,CHEMBL203,CHEMBL1759979
COc1cc2ncnc(Oc3ccc(Br)c(F)c3)c2cc1OC,5.23,Inhibition of human EGFR-mediated poly(Glu4Tyr) phosphorylation after 1 hr,IC50,5900.0,nM,=,CHEMBL1763554,B,CHEMBL1278149,Homo sapiens,CHEMBL203,CHEMBL1759979
Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,6.24,"Binding constant for EGFR(L858R,T790M) kinase domain",Kd,570.0,nM,=,CHEMBL1908701,B,CHEMBL1287853,Homo sapiens,CHEMBL203,CHEMBL1908390
CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,5.64,Binding constant for EGFR(G719C) kinase domain,Kd,2300.0,nM,=,CHEMBL1908695,B,CHEMBL1289926,Homo sapiens,CHEMBL203,CHEMBL1908390
c1ccc(CNc2ccnc3oc4ccccc4c23)cc1,6.23,Inhibition of EGFR,Ki,590.0,nM,=,CHEMBL1292125,B,CHEMBL1289976,Homo sapiens,CHEMBL203,CHEMBL1287713
c1ccc(CCNc2ccnc3oc4ccccc4c23)cc1,5.46,Inhibition of EGFR,Ki,3450.0,nM,=,CHEMBL1292125,B,CHEMBL1289977,Homo sapiens,CHEMBL203,CHEMBL1287713
c1ccc2c(CNc3ccnc4oc5ccccc5c34)cccc2c1,6.17,Inhibition of EGFR,Ki,680.0,nM,=,CHEMBL1292125,B,CHEMBL1290071,Homo sapiens,CHEMBL203,CHEMBL1287713
COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1,6.40,Inhibition of EGFR,Ki,400.0,nM,=,CHEMBL1292125,B,CHEMBL1290072,Homo sapiens,CHEMBL203,CHEMBL1287713
Clc1ccc(CNc2ccnc3oc4ccccc4c23)cc1,6.30,Inhibition of EGFR,Ki,500.0,nM,=,CHEMBL1292125,B,CHEMBL1290177,Homo sapiens,CHEMBL203,CHEMBL1287713
Oc1ccccc1-c1nc(NCc2cccnc2)c2ccccc2n1,6.83,Inhibition of recombinant human EGFR d746-750/T790M/C797S mutant using poly-Glu-Tyr (4:1) as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding method,IC50,149.0,nM,=,CHEMBL4186285,B,CHEMBL1328065,Homo sapiens,CHEMBL203,CHEMBL4184160
COc1ccc(Nc2nc(Cl)nc(NCc3ccco3)n2)cc1,4.68,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,20900.0,nM,=,CHEMBL1947771,B,CHEMBL1348499,Homo sapiens,CHEMBL203,CHEMBL1944545
CCN(CC)CC1CCN(c2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1,8.52,Inhibition of EGFR (unknown origin),IC50,3.0,nM,=,CHEMBL5131857,B,CHEMBL1358485,Homo sapiens,CHEMBL203,CHEMBL5131375
Cc1ccc2c(C)nc(Nc3nc(O)cc(CSc4nnnn4-c4ccccc4)n3)nc2c1,5.41,Inhibition of human full length HER1 assessed as phosphorylation state by ELISA assay,IC50,3920.0,nM,=,CHEMBL3395991,B,CHEMBL1365395,Homo sapiens,CHEMBL203,CHEMBL3393043
O=C(Nc1cc(N2CCOCC2)ncn1)c1ccc(F)cc1,7.20,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,63.0,nM,=,CHEMBL4267257,B,CHEMBL1379917,Homo sapiens,CHEMBL203,CHEMBL4265907
CCN=C(S)NNc1nncc2ccccc12,7.12,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,76.0,nM,=,CHEMBL3870506,B,CHEMBL1380839,Homo sapiens,CHEMBL203,CHEMBL3870309
Cc1ccccc1-c1nnc(SCc2ccccc2)o1,5.24,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,IC50,5720.0,nM,=,CHEMBL1931161,B,CHEMBL1440725,Homo sapiens,CHEMBL203,CHEMBL1926674
O=C1NN(c2ccc(F)c(Cl)c2)C(=O)/C1=C\c1cccc(OC(=O)c2cccs2)c1,5.46,Inhibition of EGFR after 50 mins by HTRF assay,IC50,3500.0,nM,=,CHEMBL2034705,B,CHEMBL1504817,Homo sapiens,CHEMBL203,CHEMBL2029299
Cc1cc(NC(=O)CCl)no1,6.97,Inhibition of EGFR-TK (unknown origin) relative to control,IC50,106.0,nM,=,CHEMBL4672269,B,CHEMBL1545480,Homo sapiens,CHEMBL203,CHEMBL4665865
Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,5.66,Binding constant for EGFR(T790M) kinase domain,Kd,2200.0,nM,=,CHEMBL1908704,B,CHEMBL1614701,Homo sapiens,CHEMBL203,CHEMBL1908390
Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,5.28,Inhibition of EGFR (unknown origin) in presence of [gamma33P]ATP,IC50,5200.0,nM,=,CHEMBL3789980,B,CHEMBL1614712,Homo sapiens,CHEMBL203,CHEMBL3785066
CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,9.00,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,1.0,nM,=,CHEMBL3636784,B,CHEMBL1614725,Homo sapiens,CHEMBL203,CHEMBL3632549
CCN1CCN(CC(=O)Nc2cc(C)on2)CC1,7.09,Inhibition of EGFR-TK (unknown origin) relative to control,IC50,81.0,nM,=,CHEMBL4672269,B,CHEMBL1619395,Homo sapiens,CHEMBL203,CHEMBL4665865
O=C(/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)NO,8.60,Inhibition of EGFR by flash plate based radioactive enzyme assay,IC50,2.5,nM,=,CHEMBL1640694,B,CHEMBL1630107,Homo sapiens,CHEMBL203,CHEMBL1629443
O=C(/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)s1)NO,8.32,Inhibition of EGFR by flash plate based radioactive enzyme assay,IC50,4.8,nM,=,CHEMBL1640694,B,CHEMBL1630108,Homo sapiens,CHEMBL203,CHEMBL1629443
O=C(/C=C/c1cccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)c1)NO,7.75,Inhibition of EGFR by flash plate based radioactive enzyme assay,IC50,18.0,nM,=,CHEMBL1640694,B,CHEMBL1630109,Homo sapiens,CHEMBL203,CHEMBL1629443
O=C(/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cc1)NO,7.75,Inhibition of EGFR by flash plate based radioactive enzyme assay,IC50,18.0,nM,=,CHEMBL1640694,B,CHEMBL1630110,Homo sapiens,CHEMBL203,CHEMBL1629443
Nc1ccccc1NC(=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,8.54,Inhibition of EGFR by flash plate based radioactive enzyme assay,IC50,2.9,nM,=,CHEMBL1640694,B,CHEMBL1630111,Homo sapiens,CHEMBL203,CHEMBL1629443
Nc1ccccc1NC(=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)s1,8.55,Inhibition of EGFR by flash plate based radioactive enzyme assay,IC50,2.8,nM,=,CHEMBL1640694,B,CHEMBL1630112,Homo sapiens,CHEMBL203,CHEMBL1629443
Nc1ccccc1NC(=O)/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.58,Inhibition of EGFR by flash plate based radioactive enzyme assay,IC50,26.0,nM,=,CHEMBL1640694,B,CHEMBL1630113,Homo sapiens,CHEMBL203,CHEMBL1629443
Nc1ccccc1NC(=O)/C=C/c1cccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)c1,7.31,Inhibition of EGFR by flash plate based radioactive enzyme assay,IC50,49.0,nM,=,CHEMBL1640694,B,CHEMBL1630114,Homo sapiens,CHEMBL203,CHEMBL1629443
Nc1ccccc1NC(=O)/C=C/c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cc1,7.54,Inhibition of EGFR by flash plate based radioactive enzyme assay,IC50,29.0,nM,=,CHEMBL1640694,B,CHEMBL1630115,Homo sapiens,CHEMBL203,CHEMBL1629443
Nc1ccccc1NC(=O)CCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cc1,7.82,Inhibition of EGFR by flash plate based radioactive enzyme assay,IC50,15.0,nM,=,CHEMBL1640694,B,CHEMBL1630116,Homo sapiens,CHEMBL203,CHEMBL1629443
O=C(NO)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,8.41,Inhibition of EGFR by flash plate based radioactive enzyme assay,IC50,3.9,nM,=,CHEMBL1640694,B,CHEMBL1630117,Homo sapiens,CHEMBL203,CHEMBL1629443
O=C(NO)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)s1,8.66,Inhibition of EGFR by flash plate based radioactive enzyme assay,IC50,2.2,nM,=,CHEMBL1640694,B,CHEMBL1630118,Homo sapiens,CHEMBL203,CHEMBL1629443
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1,4.69,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,20397.0,nM,=,CHEMBL1909203,B,CHEMBL1630578,Homo sapiens,CHEMBL203,CHEMBL1909046
CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1,5.39,Inhibition of EGFR by HTRF assay,IC50,4100.0,nM,=,CHEMBL1646349,B,CHEMBL1641989,Homo sapiens,CHEMBL203,CHEMBL1641579
CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1,6.82,Inhibition of EGFR by HTRF assay,IC50,150.0,nM,=,CHEMBL1646349,B,CHEMBL1641990,Homo sapiens,CHEMBL203,CHEMBL1641579
CCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1,4.68,Inhibition of EGFR by HTRF assay,IC50,20800.0,nM,=,CHEMBL1646349,B,CHEMBL1641991,Homo sapiens,CHEMBL203,CHEMBL1641579
CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1,5.89,Inhibition of EGFR by HTRF assay,IC50,1300.0,nM,=,CHEMBL1646349,B,CHEMBL1641992,Homo sapiens,CHEMBL203,CHEMBL1641579
N#Cc1cnc(Nc2cccc(Br)c2)c2cc(NC(=O)CCN3CCOCC3)ccc12,5.16,Inhibition of EGFR by HTRF assay,IC50,6900.0,nM,=,CHEMBL1646349,B,CHEMBL1641993,Homo sapiens,CHEMBL203,CHEMBL1641579
CCOC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1,4.89,Inhibition of EGFR by HTRF assay,IC50,12800.0,nM,=,CHEMBL1646349,B,CHEMBL1641994,Homo sapiens,CHEMBL203,CHEMBL1641579
N#Cc1cnc(Nc2cccc(Br)c2)c2cc(NC(=O)[C@@H]3CCC(=O)N3)ccc12,5.66,Inhibition of EGFR by HTRF assay,IC50,2200.0,nM,=,CHEMBL1646349,B,CHEMBL1641995,Homo sapiens,CHEMBL203,CHEMBL1641579
N#Cc1cnc(Nc2cccc(Br)c2)c2cc(NC(=O)c3ccco3)ccc12,4.25,Inhibition of EGFR by HTRF assay,IC50,55600.0,nM,=,CHEMBL1646349,B,CHEMBL1641996,Homo sapiens,CHEMBL203,CHEMBL1641579
N#Cc1cnc(Nc2cccc(Br)c2)c2cc(NC(=O)c3ccoc3)ccc12,4.34,Inhibition of EGFR by HTRF assay,IC50,45200.0,nM,=,CHEMBL1646349,B,CHEMBL1641997,Homo sapiens,CHEMBL203,CHEMBL1641579
N#Cc1cnc(Nc2cccc(Br)c2)c2cc(NC(=O)CCc3cc4ccccc4[nH]3)ccc12,4.55,Inhibition of EGFR by HTRF assay,IC50,28000.0,nM,=,CHEMBL1646349,B,CHEMBL1641998,Homo sapiens,CHEMBL203,CHEMBL1641579
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3OC)ncc2Cl)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3706050,B,CHEMBL1643971,Homo sapiens,CHEMBL203,CHEMBL3639181
Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12,8.52,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Kd,3.0,nM,=,CHEMBL3991696,B,CHEMBL1645462,Homo sapiens,CHEMBL203,CHEMBL3991601
Cn1ncc2cc(Nc3ncnn4ccc(CN5CCC(N)CC5)c34)ccc21,6.02,Inhibition of EGFR,IC50,950.0,nM,=,CHEMBL1647391,B,CHEMBL1645464,Homo sapiens,CHEMBL203,CHEMBL1641446
C#Cc1cccc(Nc2ncnn3ccc(COC[C@@H]4CNCCO4)c23)c1,6.17,Inhibition of EGFR,IC50,670.0,nM,=,CHEMBL1647391,B,CHEMBL1645465,Homo sapiens,CHEMBL203,CHEMBL1641446
C#Cc1cccc(Nc2ncnn3ccc(CN4CCC(N)CC4)c23)c1,8.00,Inhibition of EGFR,IC50,10.0,nM,=,CHEMBL1647391,B,CHEMBL1645466,Homo sapiens,CHEMBL203,CHEMBL1641446
NC1CCN(Cc2ccn3ncnc(Nc4ccccc4)c23)CC1,7.40,Inhibition of EGFR,IC50,40.0,nM,=,CHEMBL1647391,B,CHEMBL1645467,Homo sapiens,CHEMBL203,CHEMBL1641446
Cc1ccccc1Nc1ncnn2ccc(CN3CCC(N)CC3)c12,6.18,Inhibition of EGFR,IC50,660.0,nM,=,CHEMBL1647391,B,CHEMBL1645469,Homo sapiens,CHEMBL203,CHEMBL1641446
Cc1cccc(Nc2ncnn3ccc(CN4CCC(N)CC4)c23)c1,7.70,Inhibition of EGFR,IC50,20.0,nM,=,CHEMBL1647391,B,CHEMBL1645470,Homo sapiens,CHEMBL203,CHEMBL1641446
Cc1ccc(Nc2ncnn3ccc(CN4CCC(N)CC4)c23)cc1,7.30,Inhibition of EGFR,IC50,50.0,nM,=,CHEMBL1647391,B,CHEMBL1645471,Homo sapiens,CHEMBL203,CHEMBL1641446
NC1CCN(Cc2ccn3ncnc(Nc4cccc(F)c4)c23)CC1,7.50,Inhibition of EGFR,IC50,32.0,nM,=,CHEMBL1647391,B,CHEMBL1645472,Homo sapiens,CHEMBL203,CHEMBL1641446
NC1CCN(Cc2ccn3ncnc(Nc4cccc(Cl)c4)c23)CC1,8.05,Inhibition of EGFR,IC50,9.0,nM,=,CHEMBL1647391,B,CHEMBL1645473,Homo sapiens,CHEMBL203,CHEMBL1641446
NC1CCN(Cc2ccn3ncnc(Nc4cccc(Br)c4)c23)CC1,8.22,Inhibition of EGFR,IC50,6.0,nM,=,CHEMBL1647391,B,CHEMBL1645474,Homo sapiens,CHEMBL203,CHEMBL1641446
NC1CCN(Cc2ccn3ncnc(Nc4cc(Cl)cc(Cl)c4)c23)CC1,6.89,Inhibition of EGFR,IC50,130.0,nM,=,CHEMBL1647391,B,CHEMBL1645475,Homo sapiens,CHEMBL203,CHEMBL1641446
NC1CCN(Cc2ccn3ncnc(Nc4ccc(F)c(Cl)c4)c23)CC1,8.00,Inhibition of EGFR,IC50,10.0,nM,=,CHEMBL1647391,B,CHEMBL1645476,Homo sapiens,CHEMBL203,CHEMBL1641446
COc1ccc(Nc2ncnn3ccc(CN4CCC(N)CC4)c23)cc1Cl,6.68,Inhibition of EGFR,IC50,210.0,nM,=,CHEMBL1647391,B,CHEMBL1645477,Homo sapiens,CHEMBL203,CHEMBL1641446
CN(C)CCn1cnc(-c2ccc(F)cc2)c1-c1ccc2[nH]ncc2c1,7.17,Inhibition of EGFR,Ki,67.0,nM,=,CHEMBL1685430,B,CHEMBL1682557,Homo sapiens,CHEMBL203,CHEMBL1681650
Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1,7.77,Inhibition of EGFR,Ki,17.0,nM,=,CHEMBL1685430,B,CHEMBL1682558,Homo sapiens,CHEMBL203,CHEMBL1681650
Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1,7.57,Inhibition of EGFR,Ki,27.0,nM,=,CHEMBL1685430,B,CHEMBL1682559,Homo sapiens,CHEMBL203,CHEMBL1681650
Fc1ccc(-c2ncn(C3CCN(Cc4ccccc4)C3)c2-c2ccc3[nH]ncc3c2)cc1,8.10,Inhibition of EGFR,Ki,8.0,nM,=,CHEMBL1685430,B,CHEMBL1682560,Homo sapiens,CHEMBL203,CHEMBL1681650
Cc1cc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)ncn1,5.96,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,1100.0,nM,=,CHEMBL1686143,B,CHEMBL1683949,Homo sapiens,CHEMBL203,CHEMBL1681756
Fc1cccc(COc2ccc(Nc3cc(-c4ccccc4)ncn3)cc2Cl)c1,5.92,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,1200.0,nM,=,CHEMBL1686143,B,CHEMBL1683950,Homo sapiens,CHEMBL203,CHEMBL1681756
Fc1cccc(COc2ccc(Nc3cc(-c4cccnc4)ncn3)cc2Cl)c1,4.33,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,47000.0,nM,=,CHEMBL1686143,B,CHEMBL1683951,Homo sapiens,CHEMBL203,CHEMBL1681756
Fc1cccc(COc2ccc(Nc3cc(-c4ccsc4)ncn3)cc2Cl)c1,4.66,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,22000.0,nM,=,CHEMBL1686143,B,CHEMBL1683952,Homo sapiens,CHEMBL203,CHEMBL1681756
Fc1cccc(COc2ccc(Nc3cc(Oc4ccccc4)ncn3)cc2Cl)c1,5.00,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,10000.0,nM,=,CHEMBL1686143,B,CHEMBL1683954,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C,7.77,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,17.0,nM,=,CHEMBL1686143,B,CHEMBL1683955,Homo sapiens,CHEMBL203,CHEMBL1681756
CCc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C,6.19,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,640.0,nM,=,CHEMBL1686143,B,CHEMBL1683956,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1c(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)ncnc1-c1ccccc1,4.70,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,20000.0,nM,=,CHEMBL1686143,B,CHEMBL1683957,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1/C=N/OCCN1CCOCC1,7.17,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,68.0,nM,=,CHEMBL1686143,B,CHEMBL1683958,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1/C=N/OCCCN1CCOCC1,7.19,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,65.0,nM,=,CHEMBL1686143,B,CHEMBL1683959,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1-c1cccc(CN2CCOCC2)c1,6.23,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,590.0,nM,=,CHEMBL1686143,B,CHEMBL1683960,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#CCCCN1CCOCC1,7.47,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,34.0,nM,=,CHEMBL1686143,B,CHEMBL1683961,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1ccc(CN2CCOCC2)cc1,6.62,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,240.0,nM,=,CHEMBL1686143,B,CHEMBL1683962,Homo sapiens,CHEMBL203,CHEMBL1681756
C/C(=C\c1c(C)ncnc1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1)C(=O)NCCN1CCOCC1,7.55,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,28.0,nM,=,CHEMBL1686143,B,CHEMBL1683963,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1/C=C/c1ccc(CN2CCOCC2)cc1,6.92,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,120.0,nM,=,CHEMBL1686143,B,CHEMBL1683964,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1/C=C(\F)C(=O)NCCN1CCOCC1,7.75,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,18.0,nM,=,CHEMBL1686143,B,CHEMBL1683965,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1/C=C/C(=O)NCCN1CCOCC1,6.94,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,114.0,nM,=,CHEMBL1686143,B,CHEMBL1683966,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1/C=C(\F)C(=O)NCCN1CCCC1,8.52,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,3.0,nM,=,CHEMBL1686143,B,CHEMBL1683967,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1/C=C(\F)C(=O)NCCS(C)(=O)=O,7.72,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,19.0,nM,=,CHEMBL1686143,B,CHEMBL1683968,Homo sapiens,CHEMBL203,CHEMBL1681756
CCN1CCN(C(=O)/C(F)=C/c2c(C)ncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)CC1,6.81,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,156.0,nM,=,CHEMBL1686143,B,CHEMBL1683969,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#CCCN1CCOCC1,7.89,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,13.0,nM,=,CHEMBL1686143,B,CHEMBL1683970,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#CCN1CCOCC1,5.38,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,4130.0,nM,=,CHEMBL1686143,B,CHEMBL1683971,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#C/C=N/OCCN1CCOCC1,7.42,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,38.0,nM,=,CHEMBL1686143,B,CHEMBL1683972,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#CCCCN1CCCC1,7.96,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,11.0,nM,=,CHEMBL1686143,B,CHEMBL1683973,Homo sapiens,CHEMBL203,CHEMBL1681756
CCN1CCN(CCCC#Cc2c(C)ncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)CC1,8.05,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,9.0,nM,=,CHEMBL1686143,B,CHEMBL1683974,Homo sapiens,CHEMBL203,CHEMBL1681756
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#CCCNCc1ccccc1,6.57,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,IC50,270.0,nM,=,CHEMBL1686143,B,CHEMBL1683975,Homo sapiens,CHEMBL203,CHEMBL1681756
COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1,6.99,Inhibition of EGFR,IC50,101.4,nM,=,CHEMBL1687360,B,CHEMBL1684800,Homo sapiens,CHEMBL203,CHEMBL1681781
Fc1ccc(Nc2ncnc3ccccc23)cc1Cl,7.52,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,IC50,30.0,nM,=,CHEMBL3631055,B,CHEMBL1688539,Homo sapiens,CHEMBL203,CHEMBL3627661
CN(C)Cc1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1,5.31,Inhibition of EGFR,IC50,4900.0,nM,=,CHEMBL1693590,B,CHEMBL1688860,Homo sapiens,CHEMBL203,CHEMBL1687927
CC(C)(N)c1cc(C(=O)N[C@@H]2CCc3ccc(Oc4ccnc5c4CCC(=O)N5)cc3C2)cc(C(F)(F)F)c1,6.72,Inhibition of EGFR,IC50,190.0,nM,=,CHEMBL1693590,B,CHEMBL1688861,Homo sapiens,CHEMBL203,CHEMBL1687927
COc1cc2ncnc(N[C@H](C)c3ccccc3)c2cc1OC,9.00,Inhibition of EGFR (unknown origin),IC50,1.0,nM,=,CHEMBL5036476,B,CHEMBL1714813,Homo sapiens,CHEMBL203,CHEMBL5036304
Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,5.48,Binding constant for EGFR(T790M) kinase domain,Kd,3300.0,nM,=,CHEMBL1908704,B,CHEMBL1721885,Homo sapiens,CHEMBL203,CHEMBL1908390
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC[C@@H](O)CN1CCOCC1,7.02,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,95.0,nM,=,CHEMBL677210,B,CHEMBL1744086,Homo sapiens,CHEMBL203,CHEMBL1134804
COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCN1CCN(C)CC1.Cl,7.12,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,75.0,nM,=,CHEMBL677388,B,CHEMBL1744347,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OC/C=C/CN1CCCC1.Cl,7.05,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,90.0,nM,=,CHEMBL677388,B,CHEMBL1744349,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc(Nc2nccc(Nc3cnc4ccccc4c3)n2)cc(OC)c1OC,6.07,Inhibition of EGFR,IC50,853.0,nM,=,CHEMBL1764782,B,CHEMBL1760035,Homo sapiens,CHEMBL203,CHEMBL1759866
c1ccc2ncc(Nc3ccnc(Nc4ccc(OCCCN5CCCCC5)cc4)n3)cc2c1,5.64,Inhibition of EGFR,IC50,2290.0,nM,=,CHEMBL1764782,B,CHEMBL1760057,Homo sapiens,CHEMBL203,CHEMBL1759866
COC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1,5.16,Inhibition of human EGFR-mediated poly(Glu4Tyr) phosphorylation after 1 hr,IC50,6900.0,nM,=,CHEMBL1763554,B,CHEMBL1761929,Homo sapiens,CHEMBL203,CHEMBL1759979
CC(=O)NC[C@H]1CC[C@H](c2nc(-c3cc4ccccc4[nH]3)c3c(N)nccn32)CC1,5.45,Inhibition of EGFR,IC50,3580.0,nM,=,CHEMBL1762895,B,CHEMBL1762110,Homo sapiens,CHEMBL203,CHEMBL1759853
NS(=O)(=O)c1ccc(NC(=O)c2ccccc2NC(=O)c2ccco2)cc1,7.51,Inhibition of EGFR (unknown origin) by microplate reader,IC50,31.2,nM,=,CHEMBL5138527,B,CHEMBL1782692,Homo sapiens,CHEMBL203,CHEMBL5137005
CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C,6.64,Inhibition of human EGFR L858R mutant using poly[Glu:Tyr] by Hotspot assay,IC50,231.0,nM,=,CHEMBL1785574,B,CHEMBL1784637,Homo sapiens,CHEMBL203,CHEMBL1781971
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC[C@H](O)CN1CCOCC1,7.17,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,IC50,67.0,nM,=,CHEMBL677210,B,CHEMBL1788321,Homo sapiens,CHEMBL203,CHEMBL1134804
O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1,7.72,Inhibition of ErbB1,IC50,19.0,nM,=,CHEMBL910357,B,CHEMBL1794063,Homo sapiens,CHEMBL203,CHEMBL1149340
Brc1cccc(Nc2ncnc3cc4c(ccn4CCCN4CCOCC4)cc23)c1,7.11,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,77.62,nM,=,CHEMBL1798351,B,CHEMBL1797418,Homo sapiens,CHEMBL203,CHEMBL1795334
N#Cc1cnc2ccc(NC(=O)C#CCN(C3CC3)C3CC3)cc2c1Nc1cccc(Br)c1,6.60,Inhibition autophosphorylation of EGFR in human DiFi cells after 2 hrs by ELISA,IC50,251.19,nM,=,CHEMBL1798351,B,CHEMBL1797541,Homo sapiens,CHEMBL203,CHEMBL1795334
Cc1ccc(-c2nc3cc(NC(=O)CCl)ccc3[nH]2)cc1,5.71,Inhibition of EGFR after 1 hrs by luminescence assay,IC50,1929.0,nM,=,CHEMBL1817212,B,CHEMBL1812374,Homo sapiens,CHEMBL203,CHEMBL1811776
O=C(/C=C/c1ccc(Cl)cc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,5.92,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,1210.0,nM,=,CHEMBL1816084,B,CHEMBL1812431,Homo sapiens,CHEMBL203,CHEMBL1811883
O=C(/C=C/c1ccccc1Br)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,5.37,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,4280.0,nM,=,CHEMBL1816084,B,CHEMBL1812434,Homo sapiens,CHEMBL203,CHEMBL1811883
COc1ccc(/C=C/C(=O)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)cc1,5.14,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,7220.0,nM,=,CHEMBL1816084,B,CHEMBL1812435,Homo sapiens,CHEMBL203,CHEMBL1811883
Cn1cccc1-c1nc2cc(NC(=O)CCl)ccc2[nH]1,4.92,Inhibition of EGFR after 1 hrs by luminescence assay,IC50,12070.0,nM,=,CHEMBL1817212,B,CHEMBL1812491,Homo sapiens,CHEMBL203,CHEMBL1811776
COc1ccccc1/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,5.11,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,7710.0,nM,=,CHEMBL1816084,B,CHEMBL1812555,Homo sapiens,CHEMBL203,CHEMBL1811883
COc1cccc(/C=C/C(=O)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)c1,5.22,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,6020.0,nM,=,CHEMBL1816084,B,CHEMBL1812556,Homo sapiens,CHEMBL203,CHEMBL1811883
O=C(/C=C/c1ccc([N+](=O)[O-])cc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,5.29,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,5160.0,nM,=,CHEMBL1816084,B,CHEMBL1812559,Homo sapiens,CHEMBL203,CHEMBL1811883
O=C(/C=C/c1ccccc1[N+](=O)[O-])Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,5.99,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,1020.0,nM,=,CHEMBL1816084,B,CHEMBL1812560,Homo sapiens,CHEMBL203,CHEMBL1811883
O=C(/C=C/c1ccccc1)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,5.44,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,3610.0,nM,=,CHEMBL1816084,B,CHEMBL1812561,Homo sapiens,CHEMBL203,CHEMBL1811883
O=C(/C=C/c1ccc(Br)cc1)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,5.46,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,3490.0,nM,=,CHEMBL1816084,B,CHEMBL1812564,Homo sapiens,CHEMBL203,CHEMBL1811883
COc1cccc(/C=C/C(=O)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)c1,5.18,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,6630.0,nM,=,CHEMBL1816084,B,CHEMBL1812566,Homo sapiens,CHEMBL203,CHEMBL1811883
O=C(/C=C/c1cccs1)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,5.06,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,IC50,8800.0,nM,=,CHEMBL2427414,B,CHEMBL1812567,Homo sapiens,CHEMBL203,CHEMBL2424555
O=C(/C=C/c1cccc2ccccc12)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,5.55,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,2810.0,nM,=,CHEMBL1816084,B,CHEMBL1812569,Homo sapiens,CHEMBL203,CHEMBL1811883
O=C(/C=C/c1ccc([N+](=O)[O-])cc1)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,5.46,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,3450.0,nM,=,CHEMBL1816084,B,CHEMBL1812570,Homo sapiens,CHEMBL203,CHEMBL1811883
O=C(/C=C/c1ccccc1[N+](=O)[O-])Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,6.03,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,940.0,nM,=,CHEMBL1816084,B,CHEMBL1812571,Homo sapiens,CHEMBL203,CHEMBL1811883
O=C(/C=C/c1cccc([N+](=O)[O-])c1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.92,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,120.0,nM,=,CHEMBL1816084,B,CHEMBL1812572,Homo sapiens,CHEMBL203,CHEMBL1811883
O=C(/C=C/c1cccc([N+](=O)[O-])c1)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,6.72,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,190.0,nM,=,CHEMBL1816084,B,CHEMBL1812573,Homo sapiens,CHEMBL203,CHEMBL1811883
C/C=C(\C)C(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)/C=C(C)/C=C/CC(C)/C=C/c1oc(OC)c(C)c(=O)c1C,7.22,Inhibition of EGFR-induced HIF1alpha activation in human HeLa cells preincubated for 1 hr prior to EGF stimulation by luciferase reporter gene assay,IC50,60.0,nM,=,CHEMBL1820122,B,CHEMBL1817964,Homo sapiens,CHEMBL203,CHEMBL1817613
C/C=C(\C)[C@H](O)[C@H](C)/C=C(C)/C=C/CC(C)/C=C/c1oc(OC)c(C)c(=O)c1C,6.33,Inhibition of EGFR-induced HIF1alpha activation in human HeLa cells preincubated for 1 hr prior to EGF stimulation by luciferase reporter gene assay,IC50,470.0,nM,=,CHEMBL1820122,B,CHEMBL1817965,Homo sapiens,CHEMBL203,CHEMBL1817613
Cc1ccc(C2=NN(c3nc(-c4ccccc4)cs3)C(c3ccc(F)cc3)C2)cc1C,5.76,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,1730.0,nM,=,CHEMBL1827038,B,CHEMBL1821862,Homo sapiens,CHEMBL203,CHEMBL1821709
Cc1ccc(C2=NN(c3nc(-c4ccccc4)cs3)C(c3ccc(Cl)cc3)C2)cc1C,5.63,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,2360.0,nM,=,CHEMBL1827038,B,CHEMBL1821863,Homo sapiens,CHEMBL203,CHEMBL1821709
Cc1ccc(C2=NN(c3nc(-c4ccccc4)cs3)C(c3ccc(Br)cc3)C2)cc1C,5.74,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,1840.0,nM,=,CHEMBL1827038,B,CHEMBL1821864,Homo sapiens,CHEMBL203,CHEMBL1821709
Cc1ccc(C2CC(c3ccc(C)c(C)c3)=NN2c2nc(-c3ccccc3)cs2)cc1,5.57,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,2670.0,nM,=,CHEMBL1827038,B,CHEMBL1821865,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2CC(c3ccc(C)c(C)c3)=NN2c2nc(-c3ccccc3)cs2)cc1,5.51,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,3080.0,nM,=,CHEMBL1827038,B,CHEMBL1821866,Homo sapiens,CHEMBL203,CHEMBL1821709
Cc1ccc(C2=NN(c3nc(-c4ccccc4)cs3)C(c3ccc(O)cc3)C2)cc1C,5.72,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,1920.0,nM,=,CHEMBL1827038,B,CHEMBL1821867,Homo sapiens,CHEMBL203,CHEMBL1821709
Cc1ccc(C2=NN(c3nc(-c4ccccc4)cs3)C(c3ccc([N+](=O)[O-])cc3)C2)cc1C,5.42,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,3850.0,nM,=,CHEMBL1827038,B,CHEMBL1821868,Homo sapiens,CHEMBL203,CHEMBL1821709
Cc1ccc(C2=NN(c3nc(-c4ccc(Cl)cc4)cs3)C(c3ccc(F)cc3)C2)cc1C,7.22,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,60.0,nM,=,CHEMBL1827038,B,CHEMBL1821869,Homo sapiens,CHEMBL203,CHEMBL1821709
Cc1ccc(C2=NN(c3nc(-c4ccc(Cl)cc4)cs3)C(c3ccc(Cl)cc3)C2)cc1C,6.72,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,190.0,nM,=,CHEMBL1827038,B,CHEMBL1821870,Homo sapiens,CHEMBL203,CHEMBL1821709
Cc1ccc(C2=NN(c3nc(-c4ccc(Cl)cc4)cs3)C(c3ccc(Br)cc3)C2)cc1C,6.43,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,370.0,nM,=,CHEMBL1827038,B,CHEMBL1821871,Homo sapiens,CHEMBL203,CHEMBL1821709
Cc1ccc(C2CC(c3ccc(C)c(C)c3)=NN2c2nc(-c3ccc(Cl)cc3)cs2)cc1,5.98,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,1040.0,nM,=,CHEMBL1827038,B,CHEMBL1821872,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2CC(c3ccc(C)c(C)c3)=NN2c2nc(-c3ccc(Cl)cc3)cs2)cc1,6.09,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,820.0,nM,=,CHEMBL1827038,B,CHEMBL1821873,Homo sapiens,CHEMBL203,CHEMBL1821709
Cc1ccc(C2=NN(c3nc(-c4ccc(Cl)cc4)cs3)C(c3ccc(O)cc3)C2)cc1C,6.01,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,970.0,nM,=,CHEMBL1827038,B,CHEMBL1821874,Homo sapiens,CHEMBL203,CHEMBL1821709
Cc1ccc(C2=NN(c3nc(-c4ccc(Cl)cc4)cs3)C(c3ccc([N+](=O)[O-])cc3)C2)cc1C,6.20,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,630.0,nM,=,CHEMBL1827038,B,CHEMBL1821875,Homo sapiens,CHEMBL203,CHEMBL1821709
Fc1ccc(C2CC(c3ccc(Br)cc3)=NN2c2nc(-c3ccccc3)cs2)cc1,4.95,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,11240.0,nM,=,CHEMBL1827038,B,CHEMBL1821876,Homo sapiens,CHEMBL203,CHEMBL1821709
Clc1ccc(C2CC(c3ccc(Br)cc3)=NN2c2nc(-c3ccccc3)cs2)cc1,5.03,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,9370.0,nM,=,CHEMBL1827038,B,CHEMBL1821877,Homo sapiens,CHEMBL203,CHEMBL1821709
Brc1ccc(C2=NN(c3nc(-c4ccccc4)cs3)C(c3ccc(Br)cc3)C2)cc1,5.05,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,8950.0,nM,=,CHEMBL1827038,B,CHEMBL1821878,Homo sapiens,CHEMBL203,CHEMBL1821709
Cc1ccc(C2CC(c3ccc(Br)cc3)=NN2c2nc(-c3ccccc3)cs2)cc1,4.71,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,19640.0,nM,=,CHEMBL1827038,B,CHEMBL1821879,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2CC(c3ccc(Br)cc3)=NN2c2nc(-c3ccccc3)cs2)cc1,4.99,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,10170.0,nM,=,CHEMBL1827038,B,CHEMBL1821880,Homo sapiens,CHEMBL203,CHEMBL1821709
Oc1ccc(C2CC(c3ccc(Br)cc3)=NN2c2nc(-c3ccccc3)cs2)cc1,4.65,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,22360.0,nM,=,CHEMBL1827038,B,CHEMBL1821881,Homo sapiens,CHEMBL203,CHEMBL1821709
O=[N+]([O-])c1ccc(C2CC(c3ccc(Br)cc3)=NN2c2nc(-c3ccccc3)cs2)cc1,4.80,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,15720.0,nM,=,CHEMBL1827038,B,CHEMBL1821882,Homo sapiens,CHEMBL203,CHEMBL1821709
Fc1ccc(C2CC(c3ccc(Br)cc3)=NN2c2nc(-c3ccc(Cl)cc3)cs2)cc1,4.62,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,24160.0,nM,=,CHEMBL1827038,B,CHEMBL1821883,Homo sapiens,CHEMBL203,CHEMBL1821709
Clc1ccc(-c2csc(N3N=C(c4ccc(Br)cc4)CC3c3ccc(Cl)cc3)n2)cc1,4.75,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,17840.0,nM,=,CHEMBL1827038,B,CHEMBL1821884,Homo sapiens,CHEMBL203,CHEMBL1821709
Clc1ccc(-c2csc(N3N=C(c4ccc(Br)cc4)CC3c3ccc(Br)cc3)n2)cc1,4.59,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,25740.0,nM,=,CHEMBL1827038,B,CHEMBL1821885,Homo sapiens,CHEMBL203,CHEMBL1821709
Cc1ccc(C2CC(c3ccc(Br)cc3)=NN2c2nc(-c3ccc(Cl)cc3)cs2)cc1,4.55,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,28170.0,nM,=,CHEMBL1827038,B,CHEMBL1821886,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2CC(c3ccc(Br)cc3)=NN2c2nc(-c3ccc(Cl)cc3)cs2)cc1,4.70,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,19830.0,nM,=,CHEMBL1827038,B,CHEMBL1821887,Homo sapiens,CHEMBL203,CHEMBL1821709
Oc1ccc(C2CC(c3ccc(Br)cc3)=NN2c2nc(-c3ccc(Cl)cc3)cs2)cc1,4.67,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,21520.0,nM,=,CHEMBL1827038,B,CHEMBL1821888,Homo sapiens,CHEMBL203,CHEMBL1821709
O=[N+]([O-])c1ccc(C2CC(c3ccc(Br)cc3)=NN2c2nc(-c3ccc(Cl)cc3)cs2)cc1,4.61,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,24370.0,nM,=,CHEMBL1827038,B,CHEMBL1821889,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2=NN(c3nc(-c4ccccc4)cs3)C(c3ccc(F)cc3)C2)cc1,5.24,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,5710.0,nM,=,CHEMBL1827038,B,CHEMBL1821890,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2=NN(c3nc(-c4ccccc4)cs3)C(c3ccc(Cl)cc3)C2)cc1,5.31,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,4940.0,nM,=,CHEMBL1827038,B,CHEMBL1821891,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2=NN(c3nc(-c4ccccc4)cs3)C(c3ccc(Br)cc3)C2)cc1,5.25,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,5560.0,nM,=,CHEMBL1827038,B,CHEMBL1821892,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2=NN(c3nc(-c4ccccc4)cs3)C(c3ccc(C)cc3)C2)cc1,5.13,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,7480.0,nM,=,CHEMBL1827038,B,CHEMBL1821893,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2=NN(c3nc(-c4ccccc4)cs3)C(c3ccc(OC)cc3)C2)cc1,5.16,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,6920.0,nM,=,CHEMBL1827038,B,CHEMBL1821894,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2=NN(c3nc(-c4ccccc4)cs3)C(c3ccc(O)cc3)C2)cc1,5.27,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,5350.0,nM,=,CHEMBL1827038,B,CHEMBL1821895,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2=NN(c3nc(-c4ccccc4)cs3)C(c3ccc([N+](=O)[O-])cc3)C2)cc1,5.06,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,8630.0,nM,=,CHEMBL1827038,B,CHEMBL1821896,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2=NN(c3nc(-c4ccc(Cl)cc4)cs3)C(c3ccc(F)cc3)C2)cc1,5.29,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,5070.0,nM,=,CHEMBL1827038,B,CHEMBL1821897,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2=NN(c3nc(-c4ccc(Cl)cc4)cs3)C(c3ccc(Cl)cc3)C2)cc1,5.11,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,7780.0,nM,=,CHEMBL1827038,B,CHEMBL1822061,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2=NN(c3nc(-c4ccc(Cl)cc4)cs3)C(c3ccc(Br)cc3)C2)cc1,5.20,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,6310.0,nM,=,CHEMBL1827038,B,CHEMBL1822062,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2=NN(c3nc(-c4ccc(Cl)cc4)cs3)C(c3ccc(C)cc3)C2)cc1,5.33,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,4680.0,nM,=,CHEMBL1827038,B,CHEMBL1822063,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2=NN(c3nc(-c4ccc(Cl)cc4)cs3)C(c3ccc(OC)cc3)C2)cc1,5.20,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,6270.0,nM,=,CHEMBL1827038,B,CHEMBL1822064,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2=NN(c3nc(-c4ccc(Cl)cc4)cs3)C(c3ccc(O)cc3)C2)cc1,5.12,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,7660.0,nM,=,CHEMBL1827038,B,CHEMBL1822065,Homo sapiens,CHEMBL203,CHEMBL1821709
COc1ccc(C2=NN(c3nc(-c4ccc(Cl)cc4)cs3)C(c3ccc([N+](=O)[O-])cc3)C2)cc1,5.07,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,IC50,8430.0,nM,=,CHEMBL1827038,B,CHEMBL1822066,Homo sapiens,CHEMBL203,CHEMBL1821709
Cc1ncc([N+](=O)[O-])n1CC(=O)NS(=O)(=O)c1ccccc1,5.53,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,2940.0,nM,=,CHEMBL1831700,B,CHEMBL1828860,Homo sapiens,CHEMBL203,CHEMBL1828525
Cc1ccc(S(=O)(=O)NC(=O)Cn2c([N+](=O)[O-])cnc2C)cc1,5.46,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,3430.0,nM,=,CHEMBL1831700,B,CHEMBL1828861,Homo sapiens,CHEMBL203,CHEMBL1828525
Cc1ncc([N+](=O)[O-])n1CC(=O)NS(=O)(=O)c1ccc(F)cc1,6.41,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,390.0,nM,=,CHEMBL1831700,B,CHEMBL1828862,Homo sapiens,CHEMBL203,CHEMBL1828525
Cc1ncc([N+](=O)[O-])n1CC(=O)NS(=O)(=O)c1ccc(Cl)cc1,5.82,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,1510.0,nM,=,CHEMBL1831700,B,CHEMBL1828863,Homo sapiens,CHEMBL203,CHEMBL1828525
Cc1ncc([N+](=O)[O-])n1CC(=O)NS(=O)(=O)c1ccc(Br)cc1,5.66,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,2170.0,nM,=,CHEMBL1831700,B,CHEMBL1828864,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1ccc(F)cc1)NS(=O)(=O)c1ccccc1,5.17,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,6740.0,nM,=,CHEMBL1831700,B,CHEMBL1828865,Homo sapiens,CHEMBL203,CHEMBL1828525
Cc1ccc(S(=O)(=O)NC(=O)Cc2ccc(F)cc2)cc1,5.08,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,8280.0,nM,=,CHEMBL1831700,B,CHEMBL1828866,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1ccc(F)cc1)NS(=O)(=O)c1ccc(F)cc1,5.29,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,5170.0,nM,=,CHEMBL1831700,B,CHEMBL1828867,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1ccc(F)cc1)NS(=O)(=O)c1ccc(Cl)cc1,5.23,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,5930.0,nM,=,CHEMBL1831700,B,CHEMBL1828868,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1ccc(F)cc1)NS(=O)(=O)c1ccc(Br)cc1,5.19,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,6410.0,nM,=,CHEMBL1831700,B,CHEMBL1828869,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1ccc(Cl)cc1)NS(=O)(=O)c1ccccc1,4.92,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,11910.0,nM,=,CHEMBL1831700,B,CHEMBL1828870,Homo sapiens,CHEMBL203,CHEMBL1828525
Cc1ccc(S(=O)(=O)NC(=O)Cc2ccc(Cl)cc2)cc1,4.86,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,13730.0,nM,=,CHEMBL1831700,B,CHEMBL1828871,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1ccc(Cl)cc1)NS(=O)(=O)c1ccc(F)cc1,5.02,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,9590.0,nM,=,CHEMBL1831700,B,CHEMBL1828872,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1ccc(Cl)cc1)NS(=O)(=O)c1ccc(Cl)cc1,4.99,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,10340.0,nM,=,CHEMBL1831700,B,CHEMBL1828873,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1ccc(Cl)cc1)NS(=O)(=O)c1ccc(Br)cc1,4.95,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,11290.0,nM,=,CHEMBL1831700,B,CHEMBL1828874,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1ccc(Br)cc1)NS(=O)(=O)c1ccccc1,4.75,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,17810.0,nM,=,CHEMBL1831700,B,CHEMBL1828875,Homo sapiens,CHEMBL203,CHEMBL1828525
Cc1ccc(S(=O)(=O)NC(=O)Cc2ccc(Br)cc2)cc1,4.74,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,18350.0,nM,=,CHEMBL1831700,B,CHEMBL1828876,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1ccc(Br)cc1)NS(=O)(=O)c1ccc(F)cc1,4.84,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,14530.0,nM,=,CHEMBL1831700,B,CHEMBL1828877,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1ccc(Br)cc1)NS(=O)(=O)c1ccc(Cl)cc1,4.80,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,15920.0,nM,=,CHEMBL1831700,B,CHEMBL1828878,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1ccc(Br)cc1)NS(=O)(=O)c1ccc(Br)cc1,4.76,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,17260.0,nM,=,CHEMBL1831700,B,CHEMBL1828879,Homo sapiens,CHEMBL203,CHEMBL1828525
COc1ccc(CC(=O)NS(=O)(=O)c2ccccc2)cc1,4.58,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,26200.0,nM,=,CHEMBL1831700,B,CHEMBL1828880,Homo sapiens,CHEMBL203,CHEMBL1828525
COc1ccc(CC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1,4.41,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,38520.0,nM,=,CHEMBL1831700,B,CHEMBL1828881,Homo sapiens,CHEMBL203,CHEMBL1828525
COc1ccc(CC(=O)NS(=O)(=O)c2ccc(F)cc2)cc1,4.66,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,21840.0,nM,=,CHEMBL1831700,B,CHEMBL1828882,Homo sapiens,CHEMBL203,CHEMBL1828525
COc1ccc(CC(=O)NS(=O)(=O)c2ccc(Cl)cc2)cc1,4.48,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,32850.0,nM,=,CHEMBL1831700,B,CHEMBL1828883,Homo sapiens,CHEMBL203,CHEMBL1828525
COc1ccc(CC(=O)NS(=O)(=O)c2ccc(Br)cc2)cc1,4.62,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,24150.0,nM,=,CHEMBL1831700,B,CHEMBL1828884,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1cccc(Br)c1)NS(=O)(=O)c1ccccc1,4.61,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,24680.0,nM,=,CHEMBL1831700,B,CHEMBL1829271,Homo sapiens,CHEMBL203,CHEMBL1828525
Cc1ccc(S(=O)(=O)NC(=O)Cc2cccc(Br)c2)cc1,4.58,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,26170.0,nM,=,CHEMBL1831700,B,CHEMBL1829272,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1cccc(Br)c1)NS(=O)(=O)c1ccc(F)cc1,4.73,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,18720.0,nM,=,CHEMBL1831700,B,CHEMBL1829273,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1cccc(Br)c1)NS(=O)(=O)c1ccc(Cl)cc1,4.67,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,21280.0,nM,=,CHEMBL1831700,B,CHEMBL1829274,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(Cc1cccc(Br)c1)NS(=O)(=O)c1ccc(Br)cc1,4.61,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,IC50,24330.0,nM,=,CHEMBL1831700,B,CHEMBL1829275,Homo sapiens,CHEMBL203,CHEMBL1828525
O=C(/C=C/c1ccccc1)Nc1ccccc1,4.63,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,23160.0,nM,=,CHEMBL3077166,B,CHEMBL1830129,Homo sapiens,CHEMBL203,CHEMBL3046969
Cc1cccc(NC(=O)/C=C/c2ccccc2)c1,4.71,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,19690.0,nM,=,CHEMBL3077166,B,CHEMBL1830130,Homo sapiens,CHEMBL203,CHEMBL3046969
O=C(/C=C/c1ccccc1)Nc1cccc(Cl)c1,4.84,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,14590.0,nM,=,CHEMBL3077166,B,CHEMBL1830131,Homo sapiens,CHEMBL203,CHEMBL3046969
NC(=S)N/N=C(/C=C/c1ccccc1F)c1ccccc1,4.65,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,22360.0,nM,=,CHEMBL1831627,B,CHEMBL1830257,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1ccccc1Cl)c1ccccc1,4.63,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,23270.0,nM,=,CHEMBL1831627,B,CHEMBL1830258,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1ccccc1Br)c1ccccc1,4.58,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,26000.0,nM,=,CHEMBL1831627,B,CHEMBL1830259,Homo sapiens,CHEMBL203,CHEMBL1828579
COc1ccccc1/C=C/C(=N/NC(N)=S)c1ccccc1,4.48,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,33000.0,nM,=,CHEMBL1831627,B,CHEMBL1830260,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1cccc(F)c1)c1ccccc1,5.68,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,2080.0,nM,=,CHEMBL1831627,B,CHEMBL1830261,Homo sapiens,CHEMBL203,CHEMBL1828579
COc1cccc(/C=C/C(=N/NC(N)=S)c2ccccc2)c1,4.96,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,10950.0,nM,=,CHEMBL1831627,B,CHEMBL1830262,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1cccc([N+](=O)[O-])c1)c1ccccc1,5.43,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,3740.0,nM,=,CHEMBL1831627,B,CHEMBL1830263,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1ccc(F)cc1)c1ccccc1,4.72,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,19120.0,nM,=,CHEMBL1831627,B,CHEMBL1830264,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1ccc(Cl)cc1)c1ccccc1,4.69,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,20480.0,nM,=,CHEMBL1831627,B,CHEMBL1830265,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1ccc(Br)cc1)c1ccccc1,4.58,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,26560.0,nM,=,CHEMBL1831627,B,CHEMBL1830266,Homo sapiens,CHEMBL203,CHEMBL1828579
Cc1ccc(/C=C/C(=N/NC(N)=S)c2ccccc2)cc1,4.76,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,17390.0,nM,=,CHEMBL1831627,B,CHEMBL1830267,Homo sapiens,CHEMBL203,CHEMBL1828579
COc1ccc(/C=C/C(=N/NC(N)=S)c2ccccc2)cc1,4.83,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,14830.0,nM,=,CHEMBL1831627,B,CHEMBL1830268,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1ccc([N+](=O)[O-])cc1)c1ccccc1,5.80,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,1570.0,nM,=,CHEMBL1831627,B,CHEMBL1830269,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1ccc(-c2ccccc2)cc1)c1ccccc1,5.29,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,5110.0,nM,=,CHEMBL1831627,B,CHEMBL1830270,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1ccc(OCc2ccccc2)cc1)c1ccccc1,6.16,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,700.0,nM,=,CHEMBL1831627,B,CHEMBL1830271,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1ccccc1)c1ccccc1,5.62,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,2380.0,nM,=,CHEMBL1831627,B,CHEMBL1830272,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1ccccc1)c1ccc(Br)cc1,4.91,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,12240.0,nM,=,CHEMBL1831627,B,CHEMBL1830273,Homo sapiens,CHEMBL203,CHEMBL1828579
Cc1ccc(C(/C=C/c2ccccc2)=N\NC(N)=S)cc1,6.46,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,350.0,nM,=,CHEMBL1831627,B,CHEMBL1830274,Homo sapiens,CHEMBL203,CHEMBL1828579
COc1ccc(C(/C=C/c2ccccc2)=N\NC(N)=S)cc1,5.06,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,8660.0,nM,=,CHEMBL1831627,B,CHEMBL1830275,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1ccccc1)c1ccc(Cl)cc1,6.23,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,590.0,nM,=,CHEMBL1831627,B,CHEMBL1830276,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1ccccc1)c1ccc(Cl)c(Cl)c1,5.01,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,9780.0,nM,=,CHEMBL1831627,B,CHEMBL1830277,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1ccc(F)cc1)c1ccc(Br)cc1,5.66,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,2170.0,nM,=,CHEMBL1831627,B,CHEMBL1830278,Homo sapiens,CHEMBL203,CHEMBL1828579
COc1ccc(C(/C=C/c2ccccc2Cl)=N\NC(N)=S)cc1,5.11,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,7830.0,nM,=,CHEMBL1831627,B,CHEMBL1830279,Homo sapiens,CHEMBL203,CHEMBL1828579
NC(=S)N/N=C(/C=C/c1cccc2ccccc12)c1ccccc1,6.39,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,IC50,410.0,nM,=,CHEMBL1831627,B,CHEMBL1830280,Homo sapiens,CHEMBL203,CHEMBL1828579
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,9.30,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,0.5,nM,=,CHEMBL3887533,B,CHEMBL1873475,Homo sapiens,CHEMBL203,CHEMBL3886356
COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OC[C@@H]1CCCN(C)C1,7.00,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,100.0,nM,=,CHEMBL677388,B,CHEMBL1907763,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC[C@@H]1CCCN(C)C1,6.70,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,200.0,nM,=,CHEMBL677388,B,CHEMBL1907764,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC[C@H]1CCCN(C)C1,7.00,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,100.0,nM,=,CHEMBL677388,B,CHEMBL1907944,Homo sapiens,CHEMBL203,CHEMBL1135889
Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,6.10,"Binding constant for EGFR(L747-E749del, A750P) kinase domain",Kd,800.0,nM,=,CHEMBL1908697,B,CHEMBL1908391,Homo sapiens,CHEMBL203,CHEMBL1908390
CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl,6.62,"Binding constant for EGFR(L858R,T790M) kinase domain",Kd,240.0,nM,=,CHEMBL1908701,B,CHEMBL1908395,Homo sapiens,CHEMBL203,CHEMBL1908390
COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1,5.70,Binding constant for EGFR(G719S) kinase domain,Kd,2000.0,nM,=,CHEMBL1908696,B,CHEMBL1908396,Homo sapiens,CHEMBL203,CHEMBL1908390
O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1,6.25,Binding constant for EGFR(T790M) kinase domain,Kd,560.0,nM,=,CHEMBL1908704,B,CHEMBL1908397,Homo sapiens,CHEMBL203,CHEMBL1908390
N#Cc1cc2c(N)ncnc2nc1NCCO,4.03,Inhibition of human EGFR,IC50,93300.0,nM,=,CHEMBL1912180,B,CHEMBL1910268,Homo sapiens,CHEMBL203,CHEMBL1909587
Nc1scc2c1c(Nc1ccc(S(N)(=O)=O)cc1)nc1ncnc(N)c12,4.53,Inhibition of human EGFR,IC50,29500.0,nM,=,CHEMBL1912180,B,CHEMBL1910273,Homo sapiens,CHEMBL203,CHEMBL1909587
Cc1c(C#N)c(NCCO)nc2nc(NCCO)nc(N)c12,4.32,Inhibition of human EGFR,IC50,47900.0,nM,=,CHEMBL1912180,B,CHEMBL1910275,Homo sapiens,CHEMBL203,CHEMBL1909587
Nc1scc2c1c(NCCO)nc1nc(NCCO)nc(N)c12,4.18,Inhibition of human EGFR,IC50,66100.0,nM,=,CHEMBL1912180,B,CHEMBL1910278,Homo sapiens,CHEMBL203,CHEMBL1909587
Br.C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1,8.43,Inhibition of EGFR by Z-LYTE assay,IC50,3.7,nM,=,CHEMBL1920033,B,CHEMBL1914653,Homo sapiens,CHEMBL203,CHEMBL1914342
Br.C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccc(F)cc1,8.42,Inhibition of EGFR by Z-LYTE assay,IC50,3.8,nM,=,CHEMBL1920033,B,CHEMBL1914654,Homo sapiens,CHEMBL203,CHEMBL1914342
Br.C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccc(Br)cc1,7.21,Inhibition of EGFR by Z-LYTE assay,IC50,62.0,nM,=,CHEMBL1920033,B,CHEMBL1914655,Homo sapiens,CHEMBL203,CHEMBL1914342
Br.Cc1ccc([C@@H](C)Nc2ncnc3[nH]c(-c4ccc(O)cc4)cc23)cc1,6.35,Inhibition of EGFR by Z-LYTE assay,IC50,450.0,nM,=,CHEMBL1920033,B,CHEMBL1914656,Homo sapiens,CHEMBL203,CHEMBL1914342
Br.CC(Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccc(C(F)(F)F)cc1,5.34,Inhibition of EGFR by Z-LYTE assay,IC50,4608.0,nM,=,CHEMBL1920033,B,CHEMBL1914657,Homo sapiens,CHEMBL203,CHEMBL1914342
Br.C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1F,8.10,Inhibition of EGFR by Z-LYTE assay,IC50,8.0,nM,=,CHEMBL1920033,B,CHEMBL1914658,Homo sapiens,CHEMBL203,CHEMBL1914342
Br.Cc1ccccc1C(C)Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12,7.77,Inhibition of EGFR by Z-LYTE assay,IC50,17.0,nM,=,CHEMBL1920033,B,CHEMBL1914659,Homo sapiens,CHEMBL203,CHEMBL1914342
Br.C[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1cccc(F)c1,8.05,Inhibition of EGFR by Z-LYTE assay,IC50,9.0,nM,=,CHEMBL1920033,B,CHEMBL1914660,Homo sapiens,CHEMBL203,CHEMBL1914342
Br.Cc1cccc(C(C)Nc2ncnc3[nH]c(-c4ccc(O)cc4)cc23)c1,7.02,Inhibition of EGFR by Z-LYTE assay,IC50,95.0,nM,=,CHEMBL1920033,B,CHEMBL1914661,Homo sapiens,CHEMBL203,CHEMBL1914342
Br.Oc1ccc(-c2cc3c(NCc4ccccc4)ncnc3[nH]2)cc1,8.48,Inhibition of EGFR by Z-LYTE assay,IC50,3.3,nM,=,CHEMBL1920033,B,CHEMBL1914461,Homo sapiens,CHEMBL203,CHEMBL1914342
Br.Oc1ccc(-c2cc3c(NCc4ccc(F)cc4)ncnc3[nH]2)cc1,7.58,Inhibition of EGFR by Z-LYTE assay,IC50,26.0,nM,=,CHEMBL1920033,B,CHEMBL1914662,Homo sapiens,CHEMBL203,CHEMBL1914342
Br.Oc1ccc(-c2cc3c(NCc4ccccc4F)ncnc3[nH]2)cc1,7.35,Inhibition of EGFR by Z-LYTE assay,IC50,45.0,nM,=,CHEMBL1920033,B,CHEMBL1914663,Homo sapiens,CHEMBL203,CHEMBL1914342
Br.Oc1ccc(-c2cc3c(NCc4cccc(F)c4)ncnc3[nH]2)cc1,7.28,Inhibition of EGFR by Z-LYTE assay,IC50,52.0,nM,=,CHEMBL1920033,B,CHEMBL1914664,Homo sapiens,CHEMBL203,CHEMBL1914342
Br.CC[C@@H](Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1ccccc1,8.40,Inhibition of EGFR by Z-LYTE assay,IC50,4.0,nM,=,CHEMBL1920033,B,CHEMBL1914665,Homo sapiens,CHEMBL203,CHEMBL1914342
Br.CC(Nc1ncnc2[nH]c(-c3ccc(O)cc3)cc12)c1cccc2ccccc12,6.00,Inhibition of EGFR by Z-LYTE assay,IC50,1008.0,nM,=,CHEMBL1920033,B,CHEMBL1914666,Homo sapiens,CHEMBL203,CHEMBL1914342
COc1ccc(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3[nH]2)cc1,8.33,Inhibition of EGFR by Z-LYTE assay,IC50,4.7,nM,=,CHEMBL1920033,B,CHEMBL1914667,Homo sapiens,CHEMBL203,CHEMBL1914342
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(F)cc3)cc12)c1ccccc1,8.18,Inhibition of EGFR by Z-LYTE assay,IC50,6.6,nM,=,CHEMBL1920033,B,CHEMBL1914668,Homo sapiens,CHEMBL203,CHEMBL1914342
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(Br)cc3)cc12)c1ccccc1,7.20,Inhibition of EGFR by Z-LYTE assay,IC50,63.0,nM,=,CHEMBL1920033,B,CHEMBL1914669,Homo sapiens,CHEMBL203,CHEMBL1914342
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(C#N)cc3)cc12)c1ccccc1,7.92,Inhibition of EGFR by Z-LYTE assay,IC50,12.0,nM,=,CHEMBL1920033,B,CHEMBL1914670,Homo sapiens,CHEMBL203,CHEMBL1914342
C[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccc(F)cc1,7.48,Inhibition of EGFR by Z-LYTE assay,IC50,33.0,nM,=,CHEMBL1920033,B,CHEMBL1914671,Homo sapiens,CHEMBL203,CHEMBL1914342
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(F)cc3)cc12)c1ccc(F)cc1,7.57,Inhibition of EGFR by Z-LYTE assay,IC50,27.0,nM,=,CHEMBL1920033,B,CHEMBL1914672,Homo sapiens,CHEMBL203,CHEMBL1914342
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(Br)cc3)cc12)c1ccc(F)cc1,7.54,Inhibition of EGFR by Z-LYTE assay,IC50,29.0,nM,=,CHEMBL1920033,B,CHEMBL1914673,Homo sapiens,CHEMBL203,CHEMBL1914342
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(C#N)cc3)cc12)c1ccc(F)cc1,7.85,Inhibition of EGFR by Z-LYTE assay,IC50,14.0,nM,=,CHEMBL1920033,B,CHEMBL1914674,Homo sapiens,CHEMBL203,CHEMBL1914342
Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12,8.85,Inhibition of EGFR preincubated for 60 mins measured after 60 mins by TR-FRET Assay,IC50,1.4,nM,=,CHEMBL1919050,B,CHEMBL1916891,Homo sapiens,CHEMBL203,CHEMBL1914368
Cc1ccc(F)cc1Nc1nc2cc(Cl)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12,8.47,Inhibition of EGFR preincubated for 60 mins measured after 60 mins by TR-FRET Assay,IC50,3.35,nM,=,CHEMBL1919050,B,CHEMBL1916897,Homo sapiens,CHEMBL203,CHEMBL1914368
O=C(NS(=O)(=O)c1ccc(Cl)cc1)c1cccnc1,4.60,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,25360.0,nM,=,CHEMBL1949030,B,CHEMBL1916949,Homo sapiens,CHEMBL203,CHEMBL1944626
Cc1ccc(S(=O)(=O)NC(=O)c2cccnc2)cc1,4.61,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,24830.0,nM,=,CHEMBL1949030,B,CHEMBL1916951,Homo sapiens,CHEMBL203,CHEMBL1944626
COC(=O)c1ccc2c(c1)S(=O)(=O)N=S2c1ccc(Br)cc1,6.00,Inhibition of HER1,IC50,1000.0,nM,=,CHEMBL2208688,B,CHEMBL1917092,Homo sapiens,CHEMBL203,CHEMBL2203023
Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,5.31,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Kd,4874.0,nM,=,CHEMBL3991696,B,CHEMBL1922094,Homo sapiens,CHEMBL203,CHEMBL3991601
OCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,7.47,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,34.0,nM,=,CHEMBL2050649,B,CHEMBL1923007,Homo sapiens,CHEMBL203,CHEMBL2046372
O=C(c1cc2ccccc2[nH]1)c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.26,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",IC50,5.54,nM,=,CHEMBL1930721,B,CHEMBL1928291,Homo sapiens,CHEMBL203,CHEMBL1926681
C#Cc1cccc(Nc2ncnc3sc(C(=O)c4cc5ccccc5[nH]4)cc23)c1,7.73,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",IC50,18.7,nM,=,CHEMBL1930721,B,CHEMBL1928293,Homo sapiens,CHEMBL203,CHEMBL1926681
O=C(c1cc2ccccc2[nH]1)c1cc2c(Nc3ccc(OCc4cccc(F)c4)cc3Cl)ncnc2s1,7.73,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",IC50,18.5,nM,=,CHEMBL1930721,B,CHEMBL1928301,Homo sapiens,CHEMBL203,CHEMBL1926681
O=C(c1cc2ccccc2[nH]1)c1cc2c(Nc3cccc(Cl)c3)ncnc2s1,7.78,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",IC50,16.6,nM,=,CHEMBL1930721,B,CHEMBL1928309,Homo sapiens,CHEMBL203,CHEMBL1926681
O=C(c1cc2ccccc2[nH]1)c1cc2c(Nc3ccc(F)cc3)ncnc2s1,7.36,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",IC50,43.7,nM,=,CHEMBL1930721,B,CHEMBL1928310,Homo sapiens,CHEMBL203,CHEMBL1926681
O=C(c1cc2cc(O)ccc2[nH]1)c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,7.62,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",IC50,24.0,nM,=,CHEMBL1930721,B,CHEMBL1928311,Homo sapiens,CHEMBL203,CHEMBL1926681
COc1ccc2[nH]c(C(=O)c3cc4c(Nc5ccc(F)c(Cl)c5)ncnc4s3)cc2c1,8.23,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",IC50,5.93,nM,=,CHEMBL1930721,B,CHEMBL1928312,Homo sapiens,CHEMBL203,CHEMBL1926681
O=C(c1cc2ccccc2s1)c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,7.97,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",IC50,10.8,nM,=,CHEMBL1930721,B,CHEMBL1928315,Homo sapiens,CHEMBL203,CHEMBL1926681
Oc1ccccc1CNc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,5.49,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,IC50,3220.0,nM,=,CHEMBL1930231,B,CHEMBL1928707,Homo sapiens,CHEMBL203,CHEMBL1926595
Oc1ccc(CNc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)cc1,6.06,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,IC50,870.0,nM,=,CHEMBL1930231,B,CHEMBL1928708,Homo sapiens,CHEMBL203,CHEMBL1926595
COc1ccccc1CNc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,4.95,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,IC50,11220.0,nM,=,CHEMBL1930231,B,CHEMBL1928709,Homo sapiens,CHEMBL203,CHEMBL1926595
Clc1ccc(CNc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)cc1,5.79,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,IC50,1640.0,nM,=,CHEMBL1930231,B,CHEMBL1928711,Homo sapiens,CHEMBL203,CHEMBL1926595
Brc1ccc(CNc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)cc1,5.50,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,IC50,3130.0,nM,=,CHEMBL1930231,B,CHEMBL1928712,Homo sapiens,CHEMBL203,CHEMBL1926595
Oc1ccccc1CNc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,5.45,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,IC50,3540.0,nM,=,CHEMBL1930231,B,CHEMBL1928716,Homo sapiens,CHEMBL203,CHEMBL1926595
Oc1ccc(CNc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)cc1,5.73,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,IC50,1870.0,nM,=,CHEMBL1930231,B,CHEMBL1928886,Homo sapiens,CHEMBL203,CHEMBL1926595
COc1ccccc1CNc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,4.86,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,IC50,13880.0,nM,=,CHEMBL1930231,B,CHEMBL1928887,Homo sapiens,CHEMBL203,CHEMBL1926595
Clc1ccc(CNc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)cc1,5.36,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,IC50,4410.0,nM,=,CHEMBL1930231,B,CHEMBL1928889,Homo sapiens,CHEMBL203,CHEMBL1926595
Clc1cccc(Nc2ncnc3ccc(NCc4ccc(Br)cc4)cc23)c1,5.25,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,IC50,5670.0,nM,=,CHEMBL1930231,B,CHEMBL1928890,Homo sapiens,CHEMBL203,CHEMBL1926595
O=[N+]([O-])c1cccc(Oc2cc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncn2)c1,5.92,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,IC50,1204.0,nM,=,CHEMBL1932747,B,CHEMBL1928944,Homo sapiens,CHEMBL203,CHEMBL1926611
Nc1cccc(Oc2cc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncn2)c1,6.33,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,IC50,473.0,nM,=,CHEMBL1932747,B,CHEMBL1928945,Homo sapiens,CHEMBL203,CHEMBL1926611
CC(=O)Nc1cccc(Oc2cc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncn2)c1,6.97,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,IC50,108.0,nM,=,CHEMBL1932747,B,CHEMBL1928946,Homo sapiens,CHEMBL203,CHEMBL1926611
C=CC(=O)Nc1cccc(Oc2cc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncn2)c1,7.43,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,IC50,37.0,nM,=,CHEMBL1932747,B,CHEMBL1928947,Homo sapiens,CHEMBL203,CHEMBL1926611
CCOC(=O)/C=C/C(=O)Nc1cccc(Oc2cc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncn2)c1,6.89,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,IC50,129.0,nM,=,CHEMBL1932747,B,CHEMBL1928948,Homo sapiens,CHEMBL203,CHEMBL1926611
CCOC(=O)CNc1cccc(Oc2cc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncn2)c1,6.43,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,IC50,370.0,nM,=,CHEMBL1932747,B,CHEMBL1928949,Homo sapiens,CHEMBL203,CHEMBL1926611
N#CCC(=O)Nc1cccc(Oc2cc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncn2)c1,7.32,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,IC50,48.0,nM,=,CHEMBL1932747,B,CHEMBL1928950,Homo sapiens,CHEMBL203,CHEMBL1926611
Nc1cc(Nc2cccc(Oc3cc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncn3)c2)ncn1,7.21,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,IC50,61.0,nM,=,CHEMBL1932747,B,CHEMBL1928952,Homo sapiens,CHEMBL203,CHEMBL1926611
O=C(/C=C/c1ccccc1)Nc1cccc(Oc2cc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncn2)c1,5.78,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,IC50,1671.0,nM,=,CHEMBL1932747,B,CHEMBL1928954,Homo sapiens,CHEMBL203,CHEMBL1926611
O=C(COc1ccccc1)Nc1cccc(Oc2cc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncn2)c1,7.19,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,IC50,65.0,nM,=,CHEMBL1932747,B,CHEMBL1928955,Homo sapiens,CHEMBL203,CHEMBL1926611
O=C(Cc1cc(F)c(F)cc1F)Nc1cccc(Oc2cc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncn2)c1,6.20,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,IC50,627.0,nM,=,CHEMBL1932747,B,CHEMBL1928956,Homo sapiens,CHEMBL203,CHEMBL1926611
O=C(/C=C/c1ccc(F)cc1)Nc1cccc(Oc2cc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncn2)c1,6.09,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,IC50,821.0,nM,=,CHEMBL1932747,B,CHEMBL1928957,Homo sapiens,CHEMBL203,CHEMBL1926611
COc1ccc(/C=C/C(=O)Nc2cccc(Oc3cc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncn3)c2)cc1OC,6.28,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,IC50,523.0,nM,=,CHEMBL1932747,B,CHEMBL1928958,Homo sapiens,CHEMBL203,CHEMBL1926611
O=C(COc1cc(F)c(F)c(F)c1)Nc1cccc(Oc2cc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncn2)c1,6.14,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,IC50,721.0,nM,=,CHEMBL1932747,B,CHEMBL1928959,Homo sapiens,CHEMBL203,CHEMBL1926611
c1ccc(CSc2nnc(-c3ccccc3)o2)cc1,4.78,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,IC50,16630.0,nM,=,CHEMBL1931161,B,CHEMBL1929302,Homo sapiens,CHEMBL203,CHEMBL1926674
Fc1ccccc1-c1nnc(SCc2ccccc2)o1,5.29,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,IC50,5110.0,nM,=,CHEMBL1931161,B,CHEMBL1929303,Homo sapiens,CHEMBL203,CHEMBL1926674
O=[N+]([O-])c1ccccc1-c1nnc(SCc2ccccc2)o1,4.42,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,IC50,38320.0,nM,=,CHEMBL1931161,B,CHEMBL1929304,Homo sapiens,CHEMBL203,CHEMBL1926674
Nc1ccccc1-c1nnc(SCc2ccccc2)o1,5.82,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,IC50,1510.0,nM,=,CHEMBL1931161,B,CHEMBL1929305,Homo sapiens,CHEMBL203,CHEMBL1926674
CCOc1ccccc1-c1nnc(SCc2ccccc2)o1,4.42,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,IC50,38430.0,nM,=,CHEMBL1931161,B,CHEMBL1929306,Homo sapiens,CHEMBL203,CHEMBL1926674
COc1ccccc1-c1nnc(SCc2ccccc2)o1,4.91,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,IC50,12320.0,nM,=,CHEMBL1931161,B,CHEMBL1929307,Homo sapiens,CHEMBL203,CHEMBL1926674
CC(C)(C)c1ccc(-c2nnc(SCc3ccccc3)o2)cc1,5.13,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,IC50,7440.0,nM,=,CHEMBL1931161,B,CHEMBL1929308,Homo sapiens,CHEMBL203,CHEMBL1926674
Cc1ccc(-c2nnc(SCc3ccccc3)o2)c(O)c1,4.46,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,IC50,34250.0,nM,=,CHEMBL1931161,B,CHEMBL1929312,Homo sapiens,CHEMBL203,CHEMBL1926674
COc1cc(OC)cc(-c2nnc(SCc3ccccc3)o2)c1,4.58,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,IC50,26060.0,nM,=,CHEMBL1931161,B,CHEMBL1929314,Homo sapiens,CHEMBL203,CHEMBL1926674
Nc1nc(Nc2ccc(Cl)cc2)c2cc(Cc3cccc4ccccc34)[nH]c2n1,4.90,Inhibition of EGFR tyrosine kinase activity in EGF-stimulated human A431 cells after 60 mins by ELISA,IC50,12620.0,nM,=,CHEMBL1932339,B,CHEMBL1929555,Homo sapiens,CHEMBL203,CHEMBL1926631
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1ccccc1,6.19,Inhibition of EGFR by time-resolved fluorescence assay,IC50,650.0,nM,=,CHEMBL1935838,B,CHEMBL1934621,Homo sapiens,CHEMBL203,CHEMBL1933060
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1ccc(CNCCS(C)(=O)=O)cc1,7.66,Inhibition of EGFR by time-resolved fluorescence assay,IC50,22.0,nM,=,CHEMBL1935838,B,CHEMBL1934622,Homo sapiens,CHEMBL203,CHEMBL1933060
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1ccc(CNC(C)C)cc1,8.52,Inhibition of EGFR by time-resolved fluorescence assay,IC50,3.0,nM,=,CHEMBL1935838,B,CHEMBL1934623,Homo sapiens,CHEMBL203,CHEMBL1933060
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1ccc(CN2CCCC2)cc1,8.05,Inhibition of EGFR by time-resolved fluorescence assay,IC50,9.0,nM,=,CHEMBL1935838,B,CHEMBL1934624,Homo sapiens,CHEMBL203,CHEMBL1933060
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1ccc(CN(C)C)cc1,8.15,Inhibition of EGFR by time-resolved fluorescence assay,IC50,7.0,nM,=,CHEMBL1935838,B,CHEMBL1934625,Homo sapiens,CHEMBL203,CHEMBL1933060
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1ccc(CN2CCCC2)c(F)c1,6.72,Inhibition of EGFR by time-resolved fluorescence assay,IC50,190.0,nM,=,CHEMBL1935838,B,CHEMBL1934626,Homo sapiens,CHEMBL203,CHEMBL1933060
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1ccc(CN2CCCC2)o1,7.10,Inhibition of EGFR by time-resolved fluorescence assay,IC50,79.0,nM,=,CHEMBL1935838,B,CHEMBL1934627,Homo sapiens,CHEMBL203,CHEMBL1933060
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1ccc(CN2CCCC2)s1,7.52,Inhibition of EGFR by time-resolved fluorescence assay,IC50,30.0,nM,=,CHEMBL1935838,B,CHEMBL1934628,Homo sapiens,CHEMBL203,CHEMBL1933060
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1ncc(CN2CCCC2)s1,7.13,Inhibition of EGFR by time-resolved fluorescence assay,IC50,74.0,nM,=,CHEMBL1935838,B,CHEMBL1934629,Homo sapiens,CHEMBL203,CHEMBL1933060
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1cccc(CN(C)C)c1,7.26,Inhibition of EGFR by time-resolved fluorescence assay,IC50,55.0,nM,=,CHEMBL1935838,B,CHEMBL1933083,Homo sapiens,CHEMBL203,CHEMBL1933060
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#CCOc1ccc(CNC(C)C)cc1,7.07,Inhibition of EGFR by time-resolved fluorescence assay,IC50,86.0,nM,=,CHEMBL1935838,B,CHEMBL1934630,Homo sapiens,CHEMBL203,CHEMBL1933060
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1/C=C/c1ccc(CNCCS(C)(=O)=O)cc1,7.03,Inhibition of EGFR by time-resolved fluorescence assay,IC50,94.0,nM,=,CHEMBL1935838,B,CHEMBL1934631,Homo sapiens,CHEMBL203,CHEMBL1933060
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1/C=C/c1ccc(CNC(C)C)cc1,7.62,Inhibition of EGFR by time-resolved fluorescence assay,IC50,24.0,nM,=,CHEMBL1935838,B,CHEMBL1934632,Homo sapiens,CHEMBL203,CHEMBL1933060
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1/C=C/c1ccc(CNC2CC2)cc1,7.01,Inhibition of EGFR by time-resolved fluorescence assay,IC50,98.0,nM,=,CHEMBL1935838,B,CHEMBL1934633,Homo sapiens,CHEMBL203,CHEMBL1933060
CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1,4.10,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Kd,79933.0,nM,=,CHEMBL3991696,B,CHEMBL1944698,Homo sapiens,CHEMBL203,CHEMBL3991601
Cn1cc(NC(=O)/C=N/O)c(=O)n1-c1ccccc1,5.05,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,8900.0,nM,=,CHEMBL1947771,B,CHEMBL1944920,Homo sapiens,CHEMBL203,CHEMBL1944545
COc1cccc2c1C(=O)c1c(O)ccc(O)c1C2=O,5.37,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,IC50,4300.0,nM,=,CHEMBL1947770,B,CHEMBL1944921,Homo sapiens,CHEMBL203,CHEMBL1944545
Cn1c2ccccc2n2c(=S)[nH]nc12,4.66,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,22000.0,nM,=,CHEMBL1947771,B,CHEMBL1944922,Homo sapiens,CHEMBL203,CHEMBL1944545
CC(=O)Nc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc(C(=O)O)cc2)cc1,4.63,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,23500.0,nM,=,CHEMBL1947771,B,CHEMBL1944923,Homo sapiens,CHEMBL203,CHEMBL1944545
Cc1c(Cc2ccccc2)sc(NCC(=O)COc2ccc3ccccc3c2)c1C(N)=O,4.61,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,24700.0,nM,=,CHEMBL1947771,B,CHEMBL1944924,Homo sapiens,CHEMBL203,CHEMBL1944545
O=C(NNC(=O)c1ncc(Cc2ccsc2)s1)Nc1ccccc1,4.39,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,40900.0,nM,=,CHEMBL1947771,B,CHEMBL1944925,Homo sapiens,CHEMBL203,CHEMBL1944545
O=C(Nc1cccc(Br)c1)c1c(O)c2ccccc2[nH]c1=O,4.25,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,56800.0,nM,=,CHEMBL1947771,B,CHEMBL1944926,Homo sapiens,CHEMBL203,CHEMBL1944545
CCc1ccc(C(=O)NNc2ccc(Cl)cc2C)cc1,4.18,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,65600.0,nM,=,CHEMBL1947771,B,CHEMBL1944927,Homo sapiens,CHEMBL203,CHEMBL1944545
COc1ccc2c3oc(=O)cc(O)c3c(=O)n(C)c2c1,4.19,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,65100.0,nM,=,CHEMBL1947771,B,CHEMBL1944928,Homo sapiens,CHEMBL203,CHEMBL1944545
C=CCn1c(N)c(C(=O)N/N=C/c2cccs2)sc1=S,4.18,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,66000.0,nM,=,CHEMBL1947771,B,CHEMBL1944929,Homo sapiens,CHEMBL203,CHEMBL1944545
Cc1ccc(-n2c(SCC(=O)Nc3ccccc3Cl)nc3sc(C)c(C)c3c2=O)cc1,4.09,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,IC50,81600.0,nM,=,CHEMBL1947770,B,CHEMBL1944641,Homo sapiens,CHEMBL203,CHEMBL1944545
O=c1c2c(-c3ccccc3)c3c(nc2nc2[nH]nc(S)n12)-c1ccccc1CC3,4.07,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,IC50,85600.0,nM,=,CHEMBL1947770,B,CHEMBL1944930,Homo sapiens,CHEMBL203,CHEMBL1944545
CCOC(=O)c1ccc(NC(=O)CSc2nnc(CNc3ccc(OC)cc3)n2-c2ccccc2)cc1,4.03,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,IC50,92400.0,nM,=,CHEMBL1947770,B,CHEMBL1944931,Homo sapiens,CHEMBL203,CHEMBL1944545
O=C(NS(=O)(=O)c1ccccc1)c1cncc(Br)c1,4.70,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,20190.0,nM,=,CHEMBL1949030,B,CHEMBL1945444,Homo sapiens,CHEMBL203,CHEMBL1944626
Cc1ccc(S(=O)(=O)NC(=O)c2cncc(Br)c2)cc1,4.92,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,12110.0,nM,=,CHEMBL1949030,B,CHEMBL1945445,Homo sapiens,CHEMBL203,CHEMBL1944626
O=C(NS(=O)(=O)c1ccc(F)cc1)c1cncc(Br)c1,5.49,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,3270.0,nM,=,CHEMBL1949030,B,CHEMBL1945446,Homo sapiens,CHEMBL203,CHEMBL1944626
O=C(NS(=O)(=O)c1ccc(Br)cc1)c1cncc(Br)c1,5.68,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,2080.0,nM,=,CHEMBL1949030,B,CHEMBL1945447,Homo sapiens,CHEMBL203,CHEMBL1944626
O=C(NS(=O)(=O)c1ccc(Cl)cc1)c1cncc(Br)c1,7.05,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,90.0,nM,=,CHEMBL1949030,B,CHEMBL1945448,Homo sapiens,CHEMBL203,CHEMBL1944626
Cc1ccc(S(=O)(=O)NC(=O)c2cccnc2Cl)cc1,4.57,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,27050.0,nM,=,CHEMBL1949030,B,CHEMBL1945450,Homo sapiens,CHEMBL203,CHEMBL1944626
O=C(NS(=O)(=O)c1ccc(F)cc1)c1cccnc1Cl,4.54,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,28660.0,nM,=,CHEMBL1949030,B,CHEMBL1945451,Homo sapiens,CHEMBL203,CHEMBL1944626
O=C(NS(=O)(=O)c1ccc(Br)cc1)c1cccnc1Cl,4.80,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,15680.0,nM,=,CHEMBL1949030,B,CHEMBL1945452,Homo sapiens,CHEMBL203,CHEMBL1944626
O=C(NS(=O)(=O)c1ccc(Cl)cc1)c1cccnc1Cl,4.70,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,19830.0,nM,=,CHEMBL1949030,B,CHEMBL1945453,Homo sapiens,CHEMBL203,CHEMBL1944626
O=C(NS(=O)(=O)c1ccc(Br)cc1)c1ccc(Cl)nc1,4.54,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,29070.0,nM,=,CHEMBL1949030,B,CHEMBL1945644,Homo sapiens,CHEMBL203,CHEMBL1944626
O=C(NS(=O)(=O)c1ccc(Cl)cc1)c1ccc(Cl)nc1,4.74,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,18150.0,nM,=,CHEMBL1949030,B,CHEMBL1945645,Homo sapiens,CHEMBL203,CHEMBL1944626
Cc1ccc(C(=O)NS(=O)(=O)c2ccccc2)c(Cl)n1,4.67,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,21560.0,nM,=,CHEMBL1949030,B,CHEMBL1945646,Homo sapiens,CHEMBL203,CHEMBL1944626
Cc1ccc(S(=O)(=O)NC(=O)c2ccc(C)nc2Cl)cc1,4.82,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,15020.0,nM,=,CHEMBL1949030,B,CHEMBL1945647,Homo sapiens,CHEMBL203,CHEMBL1944626
Cc1ccc(C(=O)NS(=O)(=O)c2ccc(Br)cc2)c(Cl)n1,5.58,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,2640.0,nM,=,CHEMBL1949030,B,CHEMBL1945648,Homo sapiens,CHEMBL203,CHEMBL1944626
Cc1ccc(C(=O)NS(=O)(=O)c2ccc(Cl)cc2)c(Cl)n1,5.92,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,IC50,1190.0,nM,=,CHEMBL1949030,B,CHEMBL1945649,Homo sapiens,CHEMBL203,CHEMBL1944626
CN(C)c1nc(N/N=C/c2cc(Br)c(O)c(Br)c2O)nc(Nc2ccc(F)cc2)n1,5.19,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,6500.0,nM,=,CHEMBL1947771,B,CHEMBL1946843,Homo sapiens,CHEMBL203,CHEMBL1944545
O=C(CSc1nc(O)nc(-c2ccc(Cl)cc2)n1)Nc1ccc(Cl)cc1,4.89,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,13000.0,nM,=,CHEMBL1947771,B,CHEMBL1946844,Homo sapiens,CHEMBL203,CHEMBL1944545
CNc1nc(N/N=C\c2ccc(OC)cc2)nc(Nc2ccccc2)n1,4.51,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,31000.0,nM,=,CHEMBL1947771,B,CHEMBL1946845,Homo sapiens,CHEMBL203,CHEMBL1944545
COc1nc(NCCN2CCOCC2)nc(Nc2ccc(Cl)cc2)n1,5.82,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,1500.0,nM,=,CHEMBL1947771,B,CHEMBL1946846,Homo sapiens,CHEMBL203,CHEMBL1944545
CNc1nc(N/N=C/c2ccc(O)cc2)nc(Nc2ccccc2)n1,4.51,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,IC50,30700.0,nM,=,CHEMBL1947771,B,CHEMBL1946847,Homo sapiens,CHEMBL203,CHEMBL1944545
CC1(C)CC(C(=O)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)CC(C)(C)N1[O],7.51,Inhibition of EGFR after 50 mins by HTRF assay,IC50,31.0,nM,=,CHEMBL1949352,B,CHEMBL1946926,Homo sapiens,CHEMBL203,CHEMBL1944591
COc1cccc(Nc2ccnc(Nc3cccc(OC)c3)n2)c1,5.11,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,IC50,7700.0,nM,=,CHEMBL1947770,B,CHEMBL1947045,Homo sapiens,CHEMBL203,CHEMBL1944545
COc1ccccc1Nc1ccnc(Nc2ccccc2OC)n1,4.04,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,IC50,90400.0,nM,=,CHEMBL1947770,B,CHEMBL1947046,Homo sapiens,CHEMBL203,CHEMBL1944545
COc1cc2ncc(C(=O)NC3CC(C)(C)N([O])C(C)(C)C3)c(Nc3ccc(F)c(Cl)c3)c2cc1OC,6.38,Inhibition of EGFR after 50 mins by HTRF assay,IC50,422.0,nM,=,CHEMBL1949352,B,CHEMBL1947121,Homo sapiens,CHEMBL203,CHEMBL1944591
COc1cc2ncc(C(=O)O)c(Nc3cccc(Cl)c3)c2cc1OC,5.04,Inhibition of EGFR after 50 mins by HTRF assay,IC50,9021.0,nM,=,CHEMBL1949352,B,CHEMBL1947122,Homo sapiens,CHEMBL203,CHEMBL1944591
COc1cc2ncc(C(=O)O)c(Nc3ccc(F)c(Cl)c3)c2cc1OC,5.03,Inhibition of EGFR after 50 mins by HTRF assay,IC50,9284.0,nM,=,CHEMBL1949352,B,CHEMBL1947123,Homo sapiens,CHEMBL203,CHEMBL1944591
CC1(C)CC(C(=O)Nc2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)CC(C)(C)N1[O],7.82,Inhibition of EGFR after 50 mins by HTRF assay,IC50,15.0,nM,=,CHEMBL1949352,B,CHEMBL1947124,Homo sapiens,CHEMBL203,CHEMBL1944591
CC1(C)CC(C(=O)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)CC(C)(C)N1[O],7.19,Inhibition of EGFR after 50 mins by HTRF assay,IC50,65.0,nM,=,CHEMBL1949352,B,CHEMBL1947125,Homo sapiens,CHEMBL203,CHEMBL1944591
COc1cc2ncc(C(=O)NC3CC(C)(C)N([O])C(C)(C)C3)c(Nc3cccc(Cl)c3)c2cc1OC,6.21,Inhibition of EGFR after 50 mins by HTRF assay,IC50,623.0,nM,=,CHEMBL1949352,B,CHEMBL1947126,Homo sapiens,CHEMBL203,CHEMBL1944591
COc1cc2ncc(C(=O)NC3CC(C)(C)N([O])C(C)(C)C3)c(Nc3cccc(Br)c3)c2cc1OC,6.47,Inhibition of EGFR after 50 mins by HTRF assay,IC50,342.0,nM,=,CHEMBL1949352,B,CHEMBL1947127,Homo sapiens,CHEMBL203,CHEMBL1944591
O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1,6.42,Inhibition of EGFR,IC50,380.0,nM,=,CHEMBL1955670,B,CHEMBL1950289,Homo sapiens,CHEMBL203,CHEMBL1949521
Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCCCC2)n1,6.82,Inhibition of EGFR,IC50,150.0,nM,=,CHEMBL1954388,B,CHEMBL1951415,Homo sapiens,CHEMBL203,CHEMBL1949673
COc1ccc(N2Cc3cnc(Nc4ccccc4)nc3N([C@@H]3CC[C@@H](O)C3)C2=O)cc1,6.62,Inhibition of human recombinant His-tagged intracellular domain of EGFR using biotin-EEEEYFELV as substrate by HTRF assay,IC50,239.0,nM,=,CHEMBL1952840,B,CHEMBL1952210,Homo sapiens,CHEMBL203,CHEMBL1949512
COc1ccc(N2Cc3cnc(Nc4ccccc4)nc3N([C@H]3CC[C@H](O)C3)C2=O)cc1,6.44,Inhibition of human recombinant His-tagged intracellular domain of EGFR using biotin-EEEEYFELV as substrate by HTRF assay,IC50,365.0,nM,=,CHEMBL1952840,B,CHEMBL1952211,Homo sapiens,CHEMBL203,CHEMBL1949512
Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(Cl)cc3)[nH]c2n1,4.76,Inhibition of EGFR,IC50,17420.0,nM,=,CHEMBL1959298,B,CHEMBL1956885,Homo sapiens,CHEMBL203,CHEMBL1955729
Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(Cl)c(Cl)c3)[nH]c2n1,4.70,Inhibition of EGFR,IC50,19770.0,nM,=,CHEMBL1959298,B,CHEMBL1956886,Homo sapiens,CHEMBL203,CHEMBL1955729
Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(-c4ccccc4)cc3)[nH]c2n1,5.21,Inhibition of EGFR,IC50,6160.0,nM,=,CHEMBL1959298,B,CHEMBL1956887,Homo sapiens,CHEMBL203,CHEMBL1955729
Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccc(Cl)cc3)c2n1,4.00,Inhibition of EGF-induced EGFR autophosphorylation in human A431 cells incubated for 60 mins prior to EGF-induction measured after 10 mins by phosphotyrosine ELISA,IC50,99900.0,nM,=,CHEMBL1959286,B,CHEMBL1956891,Homo sapiens,CHEMBL203,CHEMBL1955729
COc1ccc(OC)c(Cn2ccc3c(Nc4cccc(Br)c4)nc(N)nc32)c1,4.16,Inhibition of EGF-induced EGFR autophosphorylation in human A431 cells incubated for 60 mins prior to EGF-induction measured after 10 mins by phosphotyrosine ELISA,IC50,69200.0,nM,=,CHEMBL1959286,B,CHEMBL1956892,Homo sapiens,CHEMBL203,CHEMBL1955729
O=C1CSC(N2N=C(c3ccccc3)CC2c2ccccc2)=N1,5.47,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,3380.0,nM,=,CHEMBL1958796,B,CHEMBL1958019,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccccc3)CC2c2ccc(F)cc2)=N1,5.31,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,4860.0,nM,=,CHEMBL1958796,B,CHEMBL1958020,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccccc3)CC2c2ccc(Cl)cc2)=N1,5.46,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,3490.0,nM,=,CHEMBL1958796,B,CHEMBL1958021,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccccc3)CC2c2ccc(Br)cc2)=N1,5.87,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,1350.0,nM,=,CHEMBL1958796,B,CHEMBL1958022,Homo sapiens,CHEMBL203,CHEMBL1955848
Cc1ccc(C2CC(c3ccccc3)=NN2C2=NC(=O)CS2)cc1,5.52,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,3030.0,nM,=,CHEMBL1958796,B,CHEMBL1958023,Homo sapiens,CHEMBL203,CHEMBL1955848
COc1ccc(C2CC(c3ccccc3)=NN2C2=NC(=O)CS2)cc1,5.37,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,4270.0,nM,=,CHEMBL1958796,B,CHEMBL1958024,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccc(F)cc3)CC2c2ccccc2)=N1,5.09,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,8140.0,nM,=,CHEMBL1958796,B,CHEMBL1958025,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccc(F)cc3)CC2c2ccc(F)cc2)=N1,4.77,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,16920.0,nM,=,CHEMBL1958796,B,CHEMBL1958026,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccc(F)cc3)CC2c2ccc(Cl)cc2)=N1,4.96,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,10920.0,nM,=,CHEMBL1958796,B,CHEMBL1958027,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccc(F)cc3)CC2c2ccc(Br)cc2)=N1,5.32,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,4790.0,nM,=,CHEMBL1958796,B,CHEMBL1958028,Homo sapiens,CHEMBL203,CHEMBL1955848
Cc1ccc(C2CC(c3ccc(F)cc3)=NN2C2=NC(=O)CS2)cc1,5.08,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,8360.0,nM,=,CHEMBL1958796,B,CHEMBL1958029,Homo sapiens,CHEMBL203,CHEMBL1955848
COc1ccc(C2CC(c3ccc(F)cc3)=NN2C2=NC(=O)CS2)cc1,4.97,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,10690.0,nM,=,CHEMBL1958796,B,CHEMBL1958030,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccc(Cl)cc3)CC2c2ccccc2)=N1,5.27,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,5340.0,nM,=,CHEMBL1958796,B,CHEMBL1958031,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccc(Cl)cc3)CC2c2ccc(F)cc2)=N1,4.85,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,14210.0,nM,=,CHEMBL1958796,B,CHEMBL1958032,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccc(Cl)cc3)CC2c2ccc(Cl)cc2)=N1,5.09,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,8160.0,nM,=,CHEMBL1958796,B,CHEMBL1958033,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccc(Cl)cc3)CC2c2ccc(Br)cc2)=N1,5.64,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,2280.0,nM,=,CHEMBL1958796,B,CHEMBL1958034,Homo sapiens,CHEMBL203,CHEMBL1955848
Cc1ccc(C2CC(c3ccc(Cl)cc3)=NN2C2=NC(=O)CS2)cc1,5.18,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,6670.0,nM,=,CHEMBL1958796,B,CHEMBL1958035,Homo sapiens,CHEMBL203,CHEMBL1955848
COc1ccc(C2CC(c3ccc(Cl)cc3)=NN2C2=NC(=O)CS2)cc1,5.07,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,8580.0,nM,=,CHEMBL1958796,B,CHEMBL1958036,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccc(Br)cc3)CC2c2ccccc2)=N1,5.50,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,3200.0,nM,=,CHEMBL1958796,B,CHEMBL1958037,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccc(Br)cc3)CC2c2ccc(F)cc2)=N1,5.19,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,6480.0,nM,=,CHEMBL1958796,B,CHEMBL1958038,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccc(Br)cc3)CC2c2ccc(Cl)cc2)=N1,5.38,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,4120.0,nM,=,CHEMBL1958796,B,CHEMBL1958039,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C1CSC(N2N=C(c3ccc(Br)cc3)CC2c2ccc(Br)cc2)=N1,5.69,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,2030.0,nM,=,CHEMBL1958796,B,CHEMBL1958209,Homo sapiens,CHEMBL203,CHEMBL1955848
Cc1ccc(C2CC(c3ccc(Br)cc3)=NN2C2=NC(=O)CS2)cc1,5.25,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,5580.0,nM,=,CHEMBL1958796,B,CHEMBL1958210,Homo sapiens,CHEMBL203,CHEMBL1955848
COc1ccc(C2CC(c3ccc(Br)cc3)=NN2C2=NC(=O)CS2)cc1,5.10,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,7960.0,nM,=,CHEMBL1958796,B,CHEMBL1958211,Homo sapiens,CHEMBL203,CHEMBL1955848
Cc1ccc(C2=NN(C3=NC(=O)CS3)C(c3ccccc3)C2)cc1,5.97,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,1080.0,nM,=,CHEMBL1958796,B,CHEMBL1958212,Homo sapiens,CHEMBL203,CHEMBL1955848
Cc1ccc(C2=NN(C3=NC(=O)CS3)C(c3ccc(F)cc3)C2)cc1,5.70,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,2010.0,nM,=,CHEMBL1958796,B,CHEMBL1958213,Homo sapiens,CHEMBL203,CHEMBL1955848
Cc1ccc(C2=NN(C3=NC(=O)CS3)C(c3ccc(Cl)cc3)C2)cc1,5.78,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,1660.0,nM,=,CHEMBL1958796,B,CHEMBL1958214,Homo sapiens,CHEMBL203,CHEMBL1955848
Cc1ccc(C2=NN(C3=NC(=O)CS3)C(c3ccc(Br)cc3)C2)cc1,6.62,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,240.0,nM,=,CHEMBL1958796,B,CHEMBL1958215,Homo sapiens,CHEMBL203,CHEMBL1955848
Cc1ccc(C2=NN(C3=NC(=O)CS3)C(c3ccc(C)cc3)C2)cc1,5.94,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,1160.0,nM,=,CHEMBL1958796,B,CHEMBL1958216,Homo sapiens,CHEMBL203,CHEMBL1955848
COc1ccc(C2CC(c3ccc(C)cc3)=NN2C2=NC(=O)CS2)cc1,5.37,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,4240.0,nM,=,CHEMBL1958796,B,CHEMBL1958217,Homo sapiens,CHEMBL203,CHEMBL1955848
COc1ccc(C2=NN(C3=NC(=O)CS3)C(c3ccccc3)C2)cc1,5.62,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,2370.0,nM,=,CHEMBL1958796,B,CHEMBL1958218,Homo sapiens,CHEMBL203,CHEMBL1955848
COc1ccc(C2=NN(C3=NC(=O)CS3)C(c3ccc(F)cc3)C2)cc1,5.22,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,5950.0,nM,=,CHEMBL1958796,B,CHEMBL1958219,Homo sapiens,CHEMBL203,CHEMBL1955848
COc1ccc(C2=NN(C3=NC(=O)CS3)C(c3ccc(Cl)cc3)C2)cc1,5.27,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,5350.0,nM,=,CHEMBL1958796,B,CHEMBL1958220,Homo sapiens,CHEMBL203,CHEMBL1955848
COc1ccc(C2=NN(C3=NC(=O)CS3)C(c3ccc(Br)cc3)C2)cc1,5.90,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,1260.0,nM,=,CHEMBL1958796,B,CHEMBL1958221,Homo sapiens,CHEMBL203,CHEMBL1955848
COc1ccc(C2=NN(C3=NC(=O)CS3)C(c3ccc(C)cc3)C2)cc1,5.26,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,5460.0,nM,=,CHEMBL1958796,B,CHEMBL1958222,Homo sapiens,CHEMBL203,CHEMBL1955848
COc1ccc(C2=NN(C3=NC(=O)CS3)C(c3ccc(OC)cc3)C2)cc1,5.05,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,8890.0,nM,=,CHEMBL1958796,B,CHEMBL1958223,Homo sapiens,CHEMBL203,CHEMBL1955848
O=C(/C=C/c1ccccc1)Nc1ccccc1Cl,5.01,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,9860.0,nM,=,CHEMBL3077166,B,CHEMBL1981977,Homo sapiens,CHEMBL203,CHEMBL3046969
O=C(CNc1ccc(Cl)cc1)Nn1c(-c2ccccc2)nc2ccccc2c1=O,7.09,Inhibition of EGFR (unknown origin),IC50,81.07,nM,=,CHEMBL4821238,B,CHEMBL1988225,Homo sapiens,CHEMBL203,CHEMBL4819060
Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12,5.68,Inhibition of EGFR in presence of 10 uM ATP,IC50,2090.0,nM,=,CHEMBL2064929,B,CHEMBL1990583,Homo sapiens,CHEMBL203,CHEMBL2062488
O=C(/C=C/c1ccccc1)Nc1ccccc1F,5.13,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,7370.0,nM,=,CHEMBL3077166,B,CHEMBL1998736,Homo sapiens,CHEMBL203,CHEMBL3046969
Nc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1c(Cl)cc(Cl)cc1Cl,7.51,"Inhibition of EGFR L858R mutant using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting",IC50,31.0,nM,=,CHEMBL2015061,B,CHEMBL2011291,Homo sapiens,CHEMBL203,CHEMBL2010688
CCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1,5.15,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,7050.0,nM,=,CHEMBL2020642,B,CHEMBL2018748,Homo sapiens,CHEMBL203,CHEMBL2016491
CCCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1,6.10,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,800.0,nM,=,CHEMBL2020642,B,CHEMBL2018749,Homo sapiens,CHEMBL203,CHEMBL2016491
COc1cc2ncnc(Nc3ccc(NC(=O)OC(C)C)cc3)c2cc1OC,5.32,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,4800.0,nM,=,CHEMBL2020642,B,CHEMBL2018750,Homo sapiens,CHEMBL203,CHEMBL2016491
COC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1Cl,5.21,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,6150.0,nM,=,CHEMBL2020642,B,CHEMBL2018751,Homo sapiens,CHEMBL203,CHEMBL2016491
CCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1Cl,6.00,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,1000.0,nM,=,CHEMBL2020642,B,CHEMBL2018752,Homo sapiens,CHEMBL203,CHEMBL2016491
CCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1Cl,6.00,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,1000.0,nM,=,CHEMBL2020642,B,CHEMBL2018753,Homo sapiens,CHEMBL203,CHEMBL2016491
CCCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1Cl,5.19,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,6400.0,nM,=,CHEMBL2020642,B,CHEMBL2018754,Homo sapiens,CHEMBL203,CHEMBL2016491
COC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1C,5.40,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,4000.0,nM,=,CHEMBL2020642,B,CHEMBL2018755,Homo sapiens,CHEMBL203,CHEMBL2016491
CCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1C,6.05,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,900.0,nM,=,CHEMBL2020642,B,CHEMBL2018756,Homo sapiens,CHEMBL203,CHEMBL2016491
CCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1C,6.05,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,900.0,nM,=,CHEMBL2020642,B,CHEMBL2018757,Homo sapiens,CHEMBL203,CHEMBL2016491
CCCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1C,5.12,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,7600.0,nM,=,CHEMBL2020642,B,CHEMBL2018758,Homo sapiens,CHEMBL203,CHEMBL2016491
COc1cc2ncnc(Nc3ccc(NC(=O)OC(C)C)c(C)c3)c2cc1OC,5.24,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,5800.0,nM,=,CHEMBL2020642,B,CHEMBL2018759,Homo sapiens,CHEMBL203,CHEMBL2016491
CCOC(=O)Nc1cc(Nc2ncnc3cc(OC)c(OC)cc23)ccc1Cl,6.05,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,900.0,nM,=,CHEMBL2020642,B,CHEMBL2018760,Homo sapiens,CHEMBL203,CHEMBL2016491
COC(=O)Nc1cc(Nc2ncnc3cc(OC)c(OC)cc23)ccc1C,5.14,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,7200.0,nM,=,CHEMBL2020642,B,CHEMBL2018761,Homo sapiens,CHEMBL203,CHEMBL2016491
CCOC(=O)Nc1cc(Nc2ncnc3cc(OC)c(OC)cc23)ccc1C,5.30,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,5000.0,nM,=,CHEMBL2020642,B,CHEMBL2018762,Homo sapiens,CHEMBL203,CHEMBL2016491
CCN(CC)CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC,5.00,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,9900.0,nM,=,CHEMBL2020642,B,CHEMBL2018765,Homo sapiens,CHEMBL203,CHEMBL2016491
CCN(CC)CCOc1cc2ncnc(Nc3ccc(C)c(Br)c3)c2cc1OC,5.03,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,9450.0,nM,=,CHEMBL2020642,B,CHEMBL2018767,Homo sapiens,CHEMBL203,CHEMBL2016491
CCN(CC)CCOc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC,5.04,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,9100.0,nM,=,CHEMBL2020642,B,CHEMBL2018773,Homo sapiens,CHEMBL203,CHEMBL2016491
CCCCOc1cc2c(Nc3ccc(NC(=O)OCC)c(Cl)c3)ncnc2cc1OCCN(CC)CC,5.04,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,IC50,9150.0,nM,=,CHEMBL2020642,B,CHEMBL2018777,Homo sapiens,CHEMBL203,CHEMBL2016491
O=C(O)[C@@H]1O[C@H]1C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.30,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,IC50,0.5,nM,=,CHEMBL1072157,B,CHEMBL2021575,Homo sapiens,CHEMBL203,CHEMBL1157583
O=C(O)[C@H]1O[C@@H]1C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.31,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,IC50,0.49,nM,=,CHEMBL1072157,B,CHEMBL2021576,Homo sapiens,CHEMBL203,CHEMBL1157583
C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1,8.62,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,IC50,2.41,nM,=,CHEMBL2033653,B,CHEMBL2029425,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccccc4)nc32)c1,8.16,Inhibition of EGFR after 1.5 hr by FRET assay,IC50,6.95,nM,=,CHEMBL2033651,B,CHEMBL2029426,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(NC)nc32)c1,6.08,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,IC50,837.1,nM,=,CHEMBL2033654,B,CHEMBL2029427,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1,9.37,Inhibition of EGFR after 1.5 hr by FRET assay,IC50,0.43,nM,=,CHEMBL2033651,B,CHEMBL2029428,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(OC)c4)nc32)c1,9.39,Inhibition of EGFR after 1.5 hr by FRET assay,IC50,0.41,nM,=,CHEMBL2033651,B,CHEMBL2029429,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OCC)nc32)c1,8.57,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,IC50,2.68,nM,=,CHEMBL2033653,B,CHEMBL2029430,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC(C)C)nc32)c1,8.05,Inhibition of EGFR after 1.5 hr by FRET assay,IC50,8.81,nM,=,CHEMBL2033651,B,CHEMBL2029431,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4C)nc32)c1,8.92,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,IC50,1.21,nM,=,CHEMBL2033653,B,CHEMBL2029432,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(C(C)C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.42,Inhibition of EGFR after 1.5 hr by FRET assay,IC50,0.38,nM,=,CHEMBL2033651,B,CHEMBL2029434,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(C3CC3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.24,Inhibition of EGFR after 1.5 hr by FRET assay,IC50,0.58,nM,=,CHEMBL2033651,B,CHEMBL2029435,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.52,Inhibition of EGFR after 1.5 hr by FRET assay,IC50,0.3,nM,=,CHEMBL2033651,B,CHEMBL2029436,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(c3ccc4ccccc4c3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.10,Inhibition of EGFR after 1.5 hr by FRET assay,IC50,0.8,nM,=,CHEMBL2033651,B,CHEMBL2029437,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(Cc3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.54,Inhibition of EGFR after 1.5 hr by FRET assay,IC50,0.29,nM,=,CHEMBL2033651,B,CHEMBL2029438,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(c3ccc(-c4ccccc4)cc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.85,Inhibition of EGFR after 1.5 hr by FRET assay,IC50,1.41,nM,=,CHEMBL2033651,B,CHEMBL2029439,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(c3ccc(Oc4ccccc4)cc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.82,Inhibition of EGFR after 1.5 hr by FRET assay,IC50,1.52,nM,=,CHEMBL2033651,B,CHEMBL2029440,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(c3ccc(OCc4ccccc4)cc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.78,Inhibition of EGFR after 1.5 hr by FRET assay,IC50,1.67,nM,=,CHEMBL2033651,B,CHEMBL2029441,Homo sapiens,CHEMBL203,CHEMBL2029259
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(c1cccc(N)c1)C(=O)N(C)C2,6.32,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,IC50,478.0,nM,=,CHEMBL2033653,B,CHEMBL2029442,Homo sapiens,CHEMBL203,CHEMBL2029259
CCC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,6.25,Binding affinity to EGFR T790M mutant,Kd,560.0,nM,=,CHEMBL2033657,B,CHEMBL2029443,Homo sapiens,CHEMBL203,CHEMBL2029259
O=S(=O)(c1ccc(/N=C/c2cc(Br)ccc2O)cc1)N1CCCCC1,5.01,Inhibition of EGFR after 50 mins by HTRF assay,IC50,9700.0,nM,=,CHEMBL2034705,B,CHEMBL2029689,Homo sapiens,CHEMBL203,CHEMBL2029299
Cc1ccc(N2NC(=O)/C(=C\c3ccc(-c4cc([N+](=O)[O-])ccc4O)o3)C2=O)cc1C,4.13,Inhibition of EGFR after 50 mins by HTRF assay,IC50,74300.0,nM,=,CHEMBL2034705,B,CHEMBL2029690,Homo sapiens,CHEMBL203,CHEMBL2029299
O=C(Cc1ccc(F)cc1)Nc1cc(SC[C@@H](O)CO)cc([N+](=O)[O-])c1,4.31,Inhibition of EGFR after 50 mins by HTRF assay,IC50,48600.0,nM,=,CHEMBL2034705,B,CHEMBL2029691,Homo sapiens,CHEMBL203,CHEMBL2029299
O=C(Cn1c(-c2ccccc2)cc(=O)n2ncnc12)NNC(=S)Nc1ccccc1,5.17,Inhibition of EGFR after 50 mins by HTRF assay,IC50,6800.0,nM,=,CHEMBL2034705,B,CHEMBL2029692,Homo sapiens,CHEMBL203,CHEMBL2029299
Cc1cccc(N2NC(=O)/C(=C/c3ccc(-c4ccccc4F)o3)C2=O)c1,4.64,Inhibition of EGFR after 50 mins by HTRF assay,IC50,23100.0,nM,=,CHEMBL2034705,B,CHEMBL2029693,Homo sapiens,CHEMBL203,CHEMBL2029299
CCOc1ccc(-c2cc(C(F)(F)F)c(C#N)c(SCC(=O)NCC(=O)O)n2)cc1,5.08,Inhibition of EGFR after 50 mins by HTRF assay,IC50,8400.0,nM,=,CHEMBL2034705,B,CHEMBL2029694,Homo sapiens,CHEMBL203,CHEMBL2029299
Cn1c(NCc2cccc(C(F)(F)F)c2)cc(=O)n(C)c1=O,4.08,Inhibition of EGFR after 50 mins by HTRF assay,IC50,83900.0,nM,=,CHEMBL2034705,B,CHEMBL2029695,Homo sapiens,CHEMBL203,CHEMBL2029299
O=C1NN(c2ccc(F)cc2)C(=O)/C1=C\c1cccc(OCc2ccccc2F)c1,5.25,Inhibition of EGFR after 50 mins by HTRF assay,IC50,5600.0,nM,=,CHEMBL2034705,B,CHEMBL2029696,Homo sapiens,CHEMBL203,CHEMBL2029299
Cc1nn(C)cc1C(=O)Nc1ccn(Cc2c(F)cccc2Cl)n1,4.14,Inhibition of EGFR after 50 mins by HTRF assay,IC50,72400.0,nM,=,CHEMBL2034705,B,CHEMBL2029697,Homo sapiens,CHEMBL203,CHEMBL2029299
C=C(N/N=C/c1cn[nH]c1-c1ccccc1)[C@H](C)Cc1ccccc1,4.58,Inhibition of EGFR after 50 mins by HTRF assay,IC50,26600.0,nM,=,CHEMBL2034705,B,CHEMBL2029698,Homo sapiens,CHEMBL203,CHEMBL2029299
Cc1ccc(N2NC(=O)/C(=C/c3ccc(OCc4ccccc4)cc3)C2=O)cc1Cl,5.07,Inhibition of EGFR after 50 mins by HTRF assay,IC50,8600.0,nM,=,CHEMBL2034705,B,CHEMBL2029699,Homo sapiens,CHEMBL203,CHEMBL2029299
Nc1nn2c(=O)cc(-c3ccccc3)[nH]c2c1/N=N/c1ccc2c(c1)OCO2,5.28,Inhibition of EGFR after 50 mins by HTRF assay,IC50,5300.0,nM,=,CHEMBL2034705,B,CHEMBL2029700,Homo sapiens,CHEMBL203,CHEMBL2029299
COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC,7.66,Inhibition of EGFR in human HEK293 cells after 1 hr by competition binding assay,Kd,22.0,nM,=,CHEMBL2033409,B,CHEMBL2029988,Homo sapiens,CHEMBL203,CHEMBL2029242
CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.00,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,1.01,nM,=,CHEMBL3815405,B,CHEMBL2031296,Homo sapiens,CHEMBL203,CHEMBL3813636
CN(C)CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.55,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,0.28,nM,=,CHEMBL2033041,B,CHEMBL2031297,Homo sapiens,CHEMBL203,CHEMBL2029270
O=C(CCN1CCCCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.57,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,0.27,nM,=,CHEMBL2033041,B,CHEMBL2031298,Homo sapiens,CHEMBL203,CHEMBL2029270
O=C(CCN1CCOCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.29,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,0.51,nM,=,CHEMBL2033041,B,CHEMBL2031299,Homo sapiens,CHEMBL203,CHEMBL2029270
CN1CCN(CCC(=O)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)CC1,9.64,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,0.23,nM,=,CHEMBL2033041,B,CHEMBL2031300,Homo sapiens,CHEMBL203,CHEMBL2029270
CN(C)CCC(=O)N(C)c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.76,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,17.4,nM,=,CHEMBL2033041,B,CHEMBL2031301,Homo sapiens,CHEMBL203,CHEMBL2029270
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCC,9.74,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,0.18,nM,=,CHEMBL2033041,B,CHEMBL2031302,Homo sapiens,CHEMBL203,CHEMBL2029270
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)CCN(C)C,9.57,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,0.27,nM,=,CHEMBL2033041,B,CHEMBL2031303,Homo sapiens,CHEMBL203,CHEMBL2029270
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)CCN1CCCCC1,9.29,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,0.51,nM,=,CHEMBL2033041,B,CHEMBL2031304,Homo sapiens,CHEMBL203,CHEMBL2029270
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)CCN1CCOCC1,9.54,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,0.29,nM,=,CHEMBL2033041,B,CHEMBL2031305,Homo sapiens,CHEMBL203,CHEMBL2029270
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cc1OCC,8.84,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,1.46,nM,=,CHEMBL2033041,B,CHEMBL2031306,Homo sapiens,CHEMBL203,CHEMBL2029270
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)CCN(C)C,9.17,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,0.68,nM,=,CHEMBL2033041,B,CHEMBL2031307,Homo sapiens,CHEMBL203,CHEMBL2029270
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)CCN1CCCCC1,8.66,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,2.21,nM,=,CHEMBL2033041,B,CHEMBL2031308,Homo sapiens,CHEMBL203,CHEMBL2029270
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)CCN1CCOCC1,8.70,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,2.02,nM,=,CHEMBL2033041,B,CHEMBL2031309,Homo sapiens,CHEMBL203,CHEMBL2029270
C=CC(=O)Nc1cc2c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c(C#N)cnc2cc1OCC,7.29,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,50.7,nM,=,CHEMBL2033041,B,CHEMBL2031310,Homo sapiens,CHEMBL203,CHEMBL2029270
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)CCN(C)C,7.90,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,12.5,nM,=,CHEMBL2033041,B,CHEMBL2031311,Homo sapiens,CHEMBL203,CHEMBL2029270
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)CCN1CCCCC1,7.61,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,24.8,nM,=,CHEMBL2033041,B,CHEMBL2031312,Homo sapiens,CHEMBL203,CHEMBL2029270
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)CCN1CCOCC1,7.43,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,IC50,37.5,nM,=,CHEMBL2033041,B,CHEMBL2031313,Homo sapiens,CHEMBL203,CHEMBL2029270
C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.97,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,IC50,1.08,nM,=,CHEMBL2033653,B,CHEMBL2032376,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N(C)C)cc4OC)nc32)c1,8.30,Inhibition of EGFR after 1.5 hr by FRET assay,IC50,4.99,nM,=,CHEMBL2033651,B,CHEMBL2032377,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCCCC5)cc4OC)nc32)c1,7.98,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,IC50,10.42,nM,=,CHEMBL2033653,B,CHEMBL2032378,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCOCC5)cc4OC)nc32)c1,7.99,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,IC50,10.33,nM,=,CHEMBL2033653,B,CHEMBL2032379,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)Nc1cccc(N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCCN(C)CC5)cc4OC)nc32)c1,8.83,Inhibition of EGFR after 1.5 hr by FRET assay,IC50,1.47,nM,=,CHEMBL2033651,B,CHEMBL2032380,Homo sapiens,CHEMBL203,CHEMBL2029259
C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1,8.49,Inhibition of EGFR T790M mutant preincubated for 10 mins followed by incubation for 30 mins by fluorescence polarization assay,IC50,3.2,nM,=,CHEMBL2038917,B,CHEMBL2035810,Homo sapiens,CHEMBL203,CHEMBL2034880
NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1,6.09,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Kd,808.0,nM,=,CHEMBL3991696,B,CHEMBL2041933,Homo sapiens,CHEMBL203,CHEMBL3991601
O=C(CCCCCC(=O)Nc1ccc(O)c(C(=O)Nc2ccccc2)c1)NO,5.63,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,2340.0,nM,=,CHEMBL2050675,B,CHEMBL2047015,Homo sapiens,CHEMBL203,CHEMBL2046429
O=C(CCCCCC(=O)Nc1ccc(O)c(C(=O)Nc2cccc(F)c2)c1)NO,5.85,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,1410.0,nM,=,CHEMBL2050675,B,CHEMBL2047016,Homo sapiens,CHEMBL203,CHEMBL2046429
O=C(CCCCCC(=O)Nc1ccc(O)c(C(=O)Nc2ccc(F)c(F)c2)c1)NO,5.65,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,2220.0,nM,=,CHEMBL2050675,B,CHEMBL2047017,Homo sapiens,CHEMBL203,CHEMBL2046429
O=C(CCCCCC(=O)Nc1ccc(O)c(C(=O)Nc2ccc(F)c(Cl)c2)c1)NO,5.45,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,3530.0,nM,=,CHEMBL2050675,B,CHEMBL2047018,Homo sapiens,CHEMBL203,CHEMBL2046429
O=C(CCCCCC(=O)Nc1ccc(O)c(C(=O)Nc2cccc(C(F)(F)F)c2)c1)NO,5.38,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,4200.0,nM,=,CHEMBL2050675,B,CHEMBL2047019,Homo sapiens,CHEMBL203,CHEMBL2046429
C#Cc1cccc(NC(=O)c2cc(NC(=O)CCCCCC(=O)NO)ccc2O)c1,5.48,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,3310.0,nM,=,CHEMBL2050675,B,CHEMBL2047020,Homo sapiens,CHEMBL203,CHEMBL2046429
O=C(CCCCCC(=O)Nc1ccc(O)c(C(=O)Nc2ccc(Cl)c(Cl)c2)c1)NO,5.75,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,1800.0,nM,=,CHEMBL2050675,B,CHEMBL2047021,Homo sapiens,CHEMBL203,CHEMBL2046429
O=C(CCCCCC(=O)Nc1ccc(O)c(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)c1)NO,5.85,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,1410.0,nM,=,CHEMBL2050675,B,CHEMBL2047022,Homo sapiens,CHEMBL203,CHEMBL2046429
O=C(CCCCCC(=O)Nc1ccc(O)c(C(=O)Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1)NO,5.96,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,1100.0,nM,=,CHEMBL2050675,B,CHEMBL2047023,Homo sapiens,CHEMBL203,CHEMBL2046429
C#Cc1cccc(NC(=O)c2cc(NC(=O)CCCCCCC(=O)NO)ccc2O)c1,5.65,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,2250.0,nM,=,CHEMBL2050675,B,CHEMBL2047024,Homo sapiens,CHEMBL203,CHEMBL2046429
COc1cc(O)c(C(=O)Nc2ccc(F)c(Cl)c2)cc1NC(=O)CCCCCC(=O)NO,5.81,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,1560.0,nM,=,CHEMBL2050675,B,CHEMBL2047025,Homo sapiens,CHEMBL203,CHEMBL2046429
C#Cc1cccc(NC(=O)c2cc(NC(=O)CCCCCC(=O)NO)c(OC)cc2O)c1,5.95,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,1120.0,nM,=,CHEMBL2050675,B,CHEMBL2047026,Homo sapiens,CHEMBL203,CHEMBL2046429
C#Cc1cccc(NC(=O)c2cccc(NC(=O)CCCCCC(=O)NO)c2)c1,5.21,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,6170.0,nM,=,CHEMBL2050675,B,CHEMBL2047027,Homo sapiens,CHEMBL203,CHEMBL2046429
C#Cc1cccc(NC(=O)c2cc(NC(=O)CCCCCC(=O)NO)ccc2OC)c1,5.29,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,5160.0,nM,=,CHEMBL2050675,B,CHEMBL2047028,Homo sapiens,CHEMBL203,CHEMBL2046429
C#Cc1cccc(NC(=O)c2cc(OCCCCCCC(=O)NO)ccc2O)c1,6.05,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,IC50,900.0,nM,=,CHEMBL2050675,B,CHEMBL2047029,Homo sapiens,CHEMBL203,CHEMBL2046429
Nc1nc2c(c(Nc3cccc(Cl)c3)n1)-c1ccccc1C2,4.71,Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA,IC50,19600.0,nM,=,CHEMBL2050143,B,CHEMBL2047242,Homo sapiens,CHEMBL203,CHEMBL2046359
CC(C)c1ccc(Nc2nc(N)nc3c2-c2ccccc2C3)cc1,4.37,Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA,IC50,42600.0,nM,=,CHEMBL2050143,B,CHEMBL2047245,Homo sapiens,CHEMBL203,CHEMBL2046359
Nc1nc2c(c(Nc3ccc(Cl)cc3)n1)-c1ccccc1C2,4.58,Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA,IC50,26000.0,nM,=,CHEMBL2050143,B,CHEMBL2047247,Homo sapiens,CHEMBL203,CHEMBL2046359
Nc1nc2c(c(Nc3cccc(Br)c3)n1)-c1ccccc1C2,4.62,Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA,IC50,24100.0,nM,=,CHEMBL2050143,B,CHEMBL2047248,Homo sapiens,CHEMBL203,CHEMBL2046359
Nc1nc2c(c(Nc3ccc(Cl)cc3F)n1)-c1ccccc1C2,4.93,Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA,IC50,11700.0,nM,=,CHEMBL2050143,B,CHEMBL2047253,Homo sapiens,CHEMBL203,CHEMBL2046359
CC(C)(C)NC(=O)c1cccc(Oc2ccc(Nc3ncnc4ccn(CCO)c34)cc2Cl)c1,7.48,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,33.0,nM,=,CHEMBL2050649,B,CHEMBL2048788,Homo sapiens,CHEMBL203,CHEMBL2046372
O=C1NCc2ccc(Oc3ccc(Nc4ncnc5ccn(CCO)c45)cc3Cl)cc21,8.11,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,7.8,nM,=,CHEMBL2050649,B,CHEMBL2048789,Homo sapiens,CHEMBL203,CHEMBL2046372
O=C1NCc2cc(Oc3ccc(Nc4ncnc5ccn(CCO)c45)cc3Cl)ccc21,6.29,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,510.0,nM,=,CHEMBL2050649,B,CHEMBL2048790,Homo sapiens,CHEMBL203,CHEMBL2046372
O=C1Cc2cc(Oc3ccc(Nc4ncnc5ccn(CCO)c45)cc3Cl)ccc2N1,6.02,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,960.0,nM,=,CHEMBL2050649,B,CHEMBL2048791,Homo sapiens,CHEMBL203,CHEMBL2046372
O=C1Cc2ccc(Oc3ccc(Nc4ncnc5ccn(CCO)c45)cc3Cl)cc2N1,5.64,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,2300.0,nM,=,CHEMBL2050649,B,CHEMBL2048792,Homo sapiens,CHEMBL203,CHEMBL2046372
O=C1NCc2c(Oc3ccc(Nc4ncnc5ccn(CCO)c45)cc3Cl)cccc21,6.05,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,890.0,nM,=,CHEMBL2050649,B,CHEMBL2048793,Homo sapiens,CHEMBL203,CHEMBL2046372
O=C1NCc2cccc(Oc3ccc(Nc4ncnc5ccn(CCO)c45)cc3Cl)c21,7.68,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,21.0,nM,=,CHEMBL2050649,B,CHEMBL2048794,Homo sapiens,CHEMBL203,CHEMBL2046372
O=C1Cc2cccc(Oc3ccc(Nc4ncnc5ccn(CCO)c45)cc3Cl)c2N1,8.55,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,2.8,nM,=,CHEMBL2050649,B,CHEMBL2048795,Homo sapiens,CHEMBL203,CHEMBL2046372
O=C1Cc2c(cccc2Oc2ccc(Nc3ncnc4ccn(CCO)c34)cc2Cl)N1,8.52,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,3.0,nM,=,CHEMBL2050649,B,CHEMBL2048796,Homo sapiens,CHEMBL203,CHEMBL2046372
OCCn1ccc2ncnc(Nc3ccc(Oc4cccc5[nH]ccc45)c(Cl)c3)c21,8.51,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,3.1,nM,=,CHEMBL2050649,B,CHEMBL2048797,Homo sapiens,CHEMBL203,CHEMBL2046372
OCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sccc45)c(Cl)c3)c21,8.06,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,8.8,nM,=,CHEMBL2050649,B,CHEMBL2048798,Homo sapiens,CHEMBL203,CHEMBL2046372
OCCn1ccc2ncnc(Nc3ccc(Oc4cccc5[nH]ncc45)c(Cl)c3)c21,8.72,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,1.9,nM,=,CHEMBL2050649,B,CHEMBL2048903,Homo sapiens,CHEMBL203,CHEMBL2046372
Cn1ncc2c(Oc3ccc(Nc4ncnc5ccn(CCO)c45)cc3Cl)cccc21,7.44,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,36.0,nM,=,CHEMBL2050649,B,CHEMBL2048904,Homo sapiens,CHEMBL203,CHEMBL2046372
OCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21,8.39,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,4.1,nM,=,CHEMBL2050649,B,CHEMBL2048905,Homo sapiens,CHEMBL203,CHEMBL2046372
CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21,8.54,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,2.9,nM,=,CHEMBL2050649,B,CHEMBL2048906,Homo sapiens,CHEMBL203,CHEMBL2046372
CC(C)(O)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21.CS(=O)(=O)O,8.15,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,7.0,nM,=,CHEMBL2050649,B,CHEMBL2048907,Homo sapiens,CHEMBL203,CHEMBL2046372
CC(C)(CO)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21,8.15,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,7.0,nM,=,CHEMBL2050649,B,CHEMBL2048908,Homo sapiens,CHEMBL203,CHEMBL2046372
CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21)S(C)(=O)=O,8.26,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,5.5,nM,=,CHEMBL2050649,B,CHEMBL2048909,Homo sapiens,CHEMBL203,CHEMBL2046372
CC(C)(C)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21.CS(=O)(=O)O,7.68,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,21.0,nM,=,CHEMBL2050649,B,CHEMBL2048910,Homo sapiens,CHEMBL203,CHEMBL2046372
Cl.O=C(NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21)[C@@H]1CCCN1,8.52,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,3.0,nM,=,CHEMBL2050649,B,CHEMBL2048911,Homo sapiens,CHEMBL203,CHEMBL2046372
CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21,8.59,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,IC50,2.6,nM,=,CHEMBL2050649,B,CHEMBL2048912,Homo sapiens,CHEMBL203,CHEMBL2046372
O=c1oc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc2n1CCCN1CCOCC1,7.11,Inhibition of EGFR,IC50,78.0,nM,=,CHEMBL2066000,B,CHEMBL2064372,Homo sapiens,CHEMBL203,CHEMBL2062376
C#Cc1cccc(Nc2ncnc3cc4oc(=O)n(CCCN5CCOCC5)c4cc23)c1,6.42,Inhibition of EGFR,IC50,380.0,nM,=,CHEMBL2066000,B,CHEMBL2064373,Homo sapiens,CHEMBL203,CHEMBL2062376
CCOC(=O)c1ccc(Nc2ncnc3cc4oc(=O)n(CCCN5CCOCC5)c4cc23)cc1,5.24,Inhibition of EGFR,IC50,5800.0,nM,=,CHEMBL2066000,B,CHEMBL2064374,Homo sapiens,CHEMBL203,CHEMBL2062376
COc1ccc(Nc2ncnc3cc4oc(=O)n(CCCN5CCOCC5)c4cc23)cc1,6.42,Inhibition of EGFR,IC50,380.0,nM,=,CHEMBL2066000,B,CHEMBL2064376,Homo sapiens,CHEMBL203,CHEMBL2062376
Cc1cc(C)cc(Nc2ncnc3cc4oc(=O)n(CCCN5CCOCC5)c4cc23)c1,4.12,Inhibition of EGFR,IC50,75000.0,nM,=,CHEMBL2066000,B,CHEMBL2064379,Homo sapiens,CHEMBL203,CHEMBL2062376
CCOC(=O)c1ccc(O)c(Nc2ncnc3cc4oc(=O)n(CCCN5CCOCC5)c4cc23)c1,6.64,Inhibition of EGFR,IC50,230.0,nM,=,CHEMBL2066000,B,CHEMBL2064380,Homo sapiens,CHEMBL203,CHEMBL2062376
CCOc1ccc(Nc2ncnc3cc4oc(=O)n(CCCN5CCOCC5)c4cc23)cc1,5.85,Inhibition of EGFR,IC50,1400.0,nM,=,CHEMBL2066000,B,CHEMBL2064382,Homo sapiens,CHEMBL203,CHEMBL2062376
Cc1ccc(Nc2ncnc3cc4oc(=O)n(CCCN5CCOCC5)c4cc23)cc1,7.17,Inhibition of EGFR,IC50,67.0,nM,=,CHEMBL2066000,B,CHEMBL2064383,Homo sapiens,CHEMBL203,CHEMBL2062376
O=c1oc2cc3ncnc(Nc4ccc(OCc5ccc(Cl)cc5)cc4)c3cc2n1CCCN1CCOCC1,6.00,Inhibition of EGFR,IC50,990.0,nM,=,CHEMBL2066000,B,CHEMBL2064384,Homo sapiens,CHEMBL203,CHEMBL2062376
O=c1oc2cc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3cc2n1CCCN1CCOCC1,6.85,Inhibition of EGFR,IC50,140.0,nM,=,CHEMBL2066000,B,CHEMBL2064386,Homo sapiens,CHEMBL203,CHEMBL2062376
O=c1oc2cc3ncnc(Nc4ccccc4O)c3cc2n1CCCN1CCOCC1,4.52,Inhibition of EGFR,IC50,30000.0,nM,=,CHEMBL2066000,B,CHEMBL2064388,Homo sapiens,CHEMBL203,CHEMBL2062376
O=c1oc2cc3ncnc(Nc4ccc(F)c(F)c4)c3cc2n1CCCN1CCOCC1,6.24,Inhibition of EGFR,IC50,570.0,nM,=,CHEMBL2066000,B,CHEMBL2064389,Homo sapiens,CHEMBL203,CHEMBL2062376
CC(C)Oc1cccc(Nc2ncnc3cc4oc(=O)n(CCCN5CCOCC5)c4cc23)c1,5.52,Inhibition of EGFR,IC50,3000.0,nM,=,CHEMBL2066000,B,CHEMBL2064390,Homo sapiens,CHEMBL203,CHEMBL2062376
CC(=O)c1cccc(Nc2ncnc3cc4oc(=O)n(CCCN5CCOCC5)c4cc23)c1,5.17,Inhibition of EGFR,IC50,6800.0,nM,=,CHEMBL2066000,B,CHEMBL2064391,Homo sapiens,CHEMBL203,CHEMBL2062376
Cc1c(OCC(F)(F)F)ccnc1COc1ccc(Nc2ncnc3cc4oc(=O)n(CCCN5CCOCC5)c4cc23)cc1,5.11,Inhibition of EGFR,IC50,7800.0,nM,=,CHEMBL2066000,B,CHEMBL2064392,Homo sapiens,CHEMBL203,CHEMBL2062376
Cc1c(OCC(F)(F)F)ccnc1COc1cccc(Nc2ncnc3cc4oc(=O)n(CCCN5CCOCC5)c4cc23)c1,7.00,Inhibition of EGFR,IC50,99.0,nM,=,CHEMBL2066000,B,CHEMBL2064393,Homo sapiens,CHEMBL203,CHEMBL2062376
O=c1oc2cc3ncnc(Nc4ccc(OCc5ccccn5)cc4)c3cc2n1CCCN1CCOCC1,5.77,Inhibition of EGFR,IC50,1700.0,nM,=,CHEMBL2066000,B,CHEMBL2064394,Homo sapiens,CHEMBL203,CHEMBL2062376
O=c1oc2cc3ncnc(Nc4ccc(OCc5ccc(Cl)cc5)c(Cl)c4)c3cc2n1CCCN1CCOCC1,7.21,Inhibition of EGFR,IC50,61.0,nM,=,CHEMBL2066000,B,CHEMBL2064395,Homo sapiens,CHEMBL203,CHEMBL2062376
CC(C)(C)c1ccc(Nc2ncnc3cc4oc(=O)n(CCCN5CCOCC5)c4cc23)cc1,4.10,Inhibition of EGFR,IC50,79000.0,nM,=,CHEMBL2066000,B,CHEMBL2064396,Homo sapiens,CHEMBL203,CHEMBL2062376
CN(c1ccccc1)c1ncnc2cc3oc(=O)n(CCCN4CCOCC4)c3cc12,5.14,Inhibition of EGFR,IC50,7200.0,nM,=,CHEMBL2066000,B,CHEMBL2064397,Homo sapiens,CHEMBL203,CHEMBL2062376
C[C@@H](Nc1ncnc2cc3oc(=O)n(CCCN4CCOCC4)c3cc12)c1ccccc1,5.35,Inhibition of EGFR,IC50,4500.0,nM,=,CHEMBL2066000,B,CHEMBL2064398,Homo sapiens,CHEMBL203,CHEMBL2062376
C[C@H](Nc1ncnc2cc3oc(=O)n(CCCN4CCOCC4)c3cc12)c1ccccc1,5.43,Inhibition of EGFR,IC50,3700.0,nM,=,CHEMBL2066000,B,CHEMBL2064399,Homo sapiens,CHEMBL203,CHEMBL2062376
O=c1oc2cc3ncnc(NCc4ccccc4)c3cc2n1CCCN1CCOCC1,4.19,Inhibition of EGFR,IC50,65000.0,nM,=,CHEMBL2066000,B,CHEMBL2064400,Homo sapiens,CHEMBL203,CHEMBL2062376
O=c1oc2cc3ncnc(Nc4ccc5[nH]ncc5c4)c3cc2n1CCCN1CCOCC1,6.92,Inhibition of EGFR,IC50,120.0,nM,=,CHEMBL2066000,B,CHEMBL2064403,Homo sapiens,CHEMBL203,CHEMBL2062376
COc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl,6.29,Inhibition of human EGFR using poly glu-Tyr as substrate after 30 mins,IC50,510.0,nM,=,CHEMBL2072949,B,CHEMBL2070045,Homo sapiens,CHEMBL203,CHEMBL2069256
CCOc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl,6.16,Inhibition of human EGFR using poly glu-Tyr as substrate after 30 mins,IC50,700.0,nM,=,CHEMBL2072949,B,CHEMBL2070048,Homo sapiens,CHEMBL203,CHEMBL2069256
O=C(Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)c1cccc2c1OCCO2,5.79,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,IC50,1630.0,nM,=,CHEMBL2071758,B,CHEMBL2070190,Homo sapiens,CHEMBL203,CHEMBL2069295
Clc1cccc(Nc2ncnc3ccc(NCc4ccc5c(c4)OCO5)cc23)c1,6.24,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,IC50,570.0,nM,=,CHEMBL2071758,B,CHEMBL2070191,Homo sapiens,CHEMBL203,CHEMBL2069295
Brc1cccc(Nc2ncnc3ccc(NCc4ccc5c(c4)OCCO5)cc23)c1,5.99,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,IC50,1020.0,nM,=,CHEMBL2071758,B,CHEMBL2070192,Homo sapiens,CHEMBL203,CHEMBL2069295
Clc1cccc(Nc2ncnc3ccc(NCc4ccc5c(c4)OCCO5)cc23)c1,6.10,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,IC50,790.0,nM,=,CHEMBL2071758,B,CHEMBL2070193,Homo sapiens,CHEMBL203,CHEMBL2069295
O=C(Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)c1cccc2c1OCCO2,5.89,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,IC50,1290.0,nM,=,CHEMBL2071758,B,CHEMBL2070194,Homo sapiens,CHEMBL203,CHEMBL2069295
O=C(Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)C1COc2ccccc2O1,5.43,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,IC50,3680.0,nM,=,CHEMBL2071758,B,CHEMBL2070195,Homo sapiens,CHEMBL203,CHEMBL2069295
O=C(Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)C1COc2ccccc2O1,5.56,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,IC50,2750.0,nM,=,CHEMBL2071758,B,CHEMBL2070196,Homo sapiens,CHEMBL203,CHEMBL2069295
Brc1cccc(Nc2ncnc3ccc(NCc4ccc5c(c4)OCO5)cc23)c1,6.20,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,IC50,630.0,nM,=,CHEMBL2071758,B,CHEMBL2070197,Homo sapiens,CHEMBL203,CHEMBL2069295
Brc1cccc(Nc2ncnc3ccc(NCc4ccc5c(c4)OCCCO5)cc23)c1,7.01,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,IC50,98.0,nM,=,CHEMBL2071758,B,CHEMBL2070198,Homo sapiens,CHEMBL203,CHEMBL2069295
Clc1cccc(Nc2ncnc3ccc(NCc4ccc5c(c4)OCCCO5)cc23)c1,6.67,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,IC50,216.0,nM,=,CHEMBL2071758,B,CHEMBL2070199,Homo sapiens,CHEMBL203,CHEMBL2069295
Brc1cccc(Nc2ncnc3ccc(NCc4ccc5c(c4)OCCCCO5)cc23)c1,5.94,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,IC50,1140.0,nM,=,CHEMBL2071758,B,CHEMBL2070200,Homo sapiens,CHEMBL203,CHEMBL2069295
Clc1cccc(Nc2ncnc3ccc(NCc4ccc5c(c4)OCCCCO5)cc23)c1,6.04,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,IC50,920.0,nM,=,CHEMBL2071758,B,CHEMBL2070201,Homo sapiens,CHEMBL203,CHEMBL2069295
CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(Cl)cc2)c2ncc[nH]2)C(=O)N3)CC1,6.86,Inhibition of EGFR,IC50,137.0,nM,=,CHEMBL2089890,B,CHEMBL2086760,Homo sapiens,CHEMBL203,CHEMBL2086224
Brc1cccc(Nc2ncnc3cc4c(cc23)Oc2ccccc2O4)c1,6.92,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,IC50,120.0,nM,=,CHEMBL2090277,B,CHEMBL2087352,Homo sapiens,CHEMBL203,CHEMBL2086389
Brc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCO4)c1,7.26,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,IC50,55.0,nM,=,CHEMBL2090277,B,CHEMBL2087353,Homo sapiens,CHEMBL203,CHEMBL2086389
Cc1ccc(S(=O)(=O)N2CCOc3cc4ncnc(Nc5cccc(Br)c5)c4cc3OCC2)cc1,6.82,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,IC50,150.0,nM,=,CHEMBL2090277,B,CHEMBL2087354,Homo sapiens,CHEMBL203,CHEMBL2086389
Brc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,8.30,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,IC50,5.0,nM,=,CHEMBL2090277,B,CHEMBL2087355,Homo sapiens,CHEMBL203,CHEMBL2086389
Brc1cccc(Nc2ncnc3cc4c(cc23)OCCOCOCOCCO4)c1,8.30,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,IC50,5.0,nM,=,CHEMBL2090277,B,CHEMBL2087356,Homo sapiens,CHEMBL203,CHEMBL2086389
Brc1cccc(Nc2ncnc3cc4c(cc23)OCCSCCO4)c1,8.15,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,IC50,7.0,nM,=,CHEMBL2090277,B,CHEMBL2087357,Homo sapiens,CHEMBL203,CHEMBL2086389
Clc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,8.70,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,IC50,2.0,nM,=,CHEMBL2090277,B,CHEMBL2087358,Homo sapiens,CHEMBL203,CHEMBL2086389
Brc1cccc(Nc2ncnc3cc4c(cc23)OCCCSCCCO4)c1,8.10,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,IC50,8.0,nM,=,CHEMBL2090277,B,CHEMBL2087359,Homo sapiens,CHEMBL203,CHEMBL2086389
Fc1ccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)cc1Cl,8.70,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,IC50,2.0,nM,=,CHEMBL2090277,B,CHEMBL2087360,Homo sapiens,CHEMBL203,CHEMBL2086389
C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,8.70,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,IC50,2.0,nM,=,CHEMBL2090277,B,CHEMBL2087361,Homo sapiens,CHEMBL203,CHEMBL2086389
O=C(Cc1cccs1)Nc1cccc(-c2ccc3nnc(-c4cccnc4)n3n2)c1,7.10,Inhibition of EGFR (unknown origin),IC50,79.0,nM,=,CHEMBL5131857,B,CHEMBL2093753,Homo sapiens,CHEMBL203,CHEMBL5131375
C[C@H](Nc1[nH]cnc2c3ccccc3nc1-2)c1ccccc1.Cl,6.38,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,419.0,nM,=,CHEMBL679944,B,CHEMBL2093928,Homo sapiens,CHEMBL203,CHEMBL1132555
C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1,8.30,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Kd,5.0,nM,=,CHEMBL3991696,B,CHEMBL2103842,Homo sapiens,CHEMBL203,CHEMBL3991601
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O,9.52,Affinity Biochemical interaction (Competition binding assay (DiscoverX)) EUB0000596aBDA EGFR,Kd,0.3,nM,=,CHEMBL5210625,B,CHEMBL2105712,Homo sapiens,CHEMBL203,CHEMBL5169023
COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,7.72,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,IC50,19.0,nM,=,CHEMBL4393297,B,CHEMBL2105717,Homo sapiens,CHEMBL203,CHEMBL4392844
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1.O,8.22,Inhibition of GST-tagged EGFR expressed in sf9 cells by ELISA,IC50,6.0,nM,=,CHEMBL2217241,B,CHEMBL2105719,Homo sapiens,CHEMBL203,CHEMBL2216750
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1,8.74,Inhibition of EGFR (unknown origin) by ELISA method,IC50,1.8,nM,=,CHEMBL3625155,B,CHEMBL2110732,Homo sapiens,CHEMBL203,CHEMBL3621102
C[C@H](Nc1cc(-c2sc(C3CCN(C)CC3)nc2-c2ccc(F)cc2)ccn1)c1ccccc1,6.16,Inhibition of human epidermal growth factor receptor,IC50,700.0,nM,=,CHEMBL683039,B,CHEMBL2111784,Homo sapiens,CHEMBL203,CHEMBL1147483
COC[C@@H]1CCCN1C/C=C\C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.71,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,194.0,nM,=,CHEMBL680018,B,CHEMBL2112369,Homo sapiens,CHEMBL203,CHEMBL1134561
COC[C@@H]1CCCN1C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.88,Inhibition of epidermal growth factor receptor using enzyme assay,IC50,131.0,nM,=,CHEMBL680018,B,CHEMBL2112370,Homo sapiens,CHEMBL203,CHEMBL1134561
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1,9.29,Inhibition of human EGFR L858R mutant expressed in mouse Ba/F3 cells,IC50,0.51,nM,=,CHEMBL4271187,B,CHEMBL2138625,Homo sapiens,CHEMBL203,CHEMBL4270496
CS(=O)(=O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,7.82,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,IC50,15.0,nM,=,CHEMBL2150609,B,CHEMBL2148044,Homo sapiens,CHEMBL203,CHEMBL2146394
CCS(=O)(=O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,7.51,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,IC50,31.0,nM,=,CHEMBL2150609,B,CHEMBL2148045,Homo sapiens,CHEMBL203,CHEMBL2146394
CC(C)S(=O)(=O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,7.28,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,IC50,53.0,nM,=,CHEMBL2150609,B,CHEMBL2148046,Homo sapiens,CHEMBL203,CHEMBL2146394
CC(C)(C)S(=O)(=O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,7.25,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,IC50,56.0,nM,=,CHEMBL2150609,B,CHEMBL2148047,Homo sapiens,CHEMBL203,CHEMBL2146394
CC(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21)S(C)(=O)=O,7.75,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,IC50,18.0,nM,=,CHEMBL2150609,B,CHEMBL2148048,Homo sapiens,CHEMBL203,CHEMBL2146394
CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21)S(C)(=O)=O,7.33,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,IC50,47.0,nM,=,CHEMBL2150609,B,CHEMBL2148049,Homo sapiens,CHEMBL203,CHEMBL2146394
CS(=O)(=O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21,8.17,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,IC50,6.7,nM,=,CHEMBL2150609,B,CHEMBL2148050,Homo sapiens,CHEMBL203,CHEMBL2146394
CC(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O,8.01,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,IC50,9.8,nM,=,CHEMBL2150609,B,CHEMBL2148051,Homo sapiens,CHEMBL203,CHEMBL2146394
CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O,7.96,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,IC50,11.0,nM,=,CHEMBL2150609,B,CHEMBL2148052,Homo sapiens,CHEMBL203,CHEMBL2146394
CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1,7.96,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,IC50,11.0,nM,=,CHEMBL2150609,B,CHEMBL2148053,Homo sapiens,CHEMBL203,CHEMBL2146394
CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N,6.13,Inhibition of EGFR,IC50,739.0,nM,=,CHEMBL2156898,B,CHEMBL2152252,Homo sapiens,CHEMBL203,CHEMBL2150966
CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3C)c2)cnc1N,6.39,Inhibition of EGFR,IC50,410.0,nM,=,CHEMBL2156898,B,CHEMBL2152253,Homo sapiens,CHEMBL203,CHEMBL2150966
Cc1ccc(O)cc1-n1c(=O)c2c(c3c(N)ncnc31)CCCC2,5.79,Inhibition of recombinant EGFR catalytic domain in presence of 1 uM radiolabeled ATP,IC50,1620.0,nM,=,CHEMBL2154039,B,CHEMBL2152704,Homo sapiens,CHEMBL203,CHEMBL2150975
COc1ccc(C2=NN(C(=O)c3ccc(Cl)cc3O)C(c3ccc(Cl)cc3)C2)cc1,4.98,Inhibition of EGFR,IC50,10490.0,nM,=,CHEMBL2162537,B,CHEMBL2159053,Homo sapiens,CHEMBL203,CHEMBL2157921
CNC(=O)COc1cccc(Nc2ncc(F)c(Nc3ccc4c(c3)NC(=O)C(F)(F)O4)n2)c1,7.46,Inhibition of EGFR,Ki,35.0,nM,=,CHEMBL2173384,B,CHEMBL2170582,Homo sapiens,CHEMBL203,CHEMBL2169784
CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C)c4n3)cc2)CC1,8.52,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,3.0,nM,=,CHEMBL3887185,B,CHEMBL2178349,Homo sapiens,CHEMBL203,CHEMBL3638579
CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CC5)c4n3)cc2)CC1,8.70,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,2.0,nM,=,CHEMBL3887185,B,CHEMBL2178350,Homo sapiens,CHEMBL203,CHEMBL3638579
CC(C)n1c(Nc2ccccc2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,8.30,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,5.0,nM,=,CHEMBL3706157,B,CHEMBL2178351,Homo sapiens,CHEMBL203,CHEMBL3638579
CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1,9.40,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,0.4,nM,=,CHEMBL3887185,B,CHEMBL2178352,Homo sapiens,CHEMBL203,CHEMBL3638579
CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)[nH]c4n3)cc2)CC1,8.30,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,5.0,nM,=,CHEMBL3887185,B,CHEMBL2178368,Homo sapiens,CHEMBL203,CHEMBL3638579
Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1,7.62,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,24.1,nM,=,CHEMBL4052479,B,CHEMBL2179119,Homo sapiens,CHEMBL203,CHEMBL4049460
Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc3[nH]ccc23)cc1,6.20,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,631.0,nM,=,CHEMBL4052479,B,CHEMBL2179124,Homo sapiens,CHEMBL203,CHEMBL4049460
Fc1ccc(-c2nc(-c3ccccc3)[nH]c2-c2ccnc3[nH]c(-c4ccccc4)cc23)cc1,6.99,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,102.0,nM,=,CHEMBL4052479,B,CHEMBL2179128,Homo sapiens,CHEMBL203,CHEMBL4049460
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(C(F)(F)F)cc3)c3c(N)ncnc32)C1,7.22,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,60.0,nM,=,CHEMBL4041413,B,CHEMBL2180203,Homo sapiens,CHEMBL203,CHEMBL4038351
C=CC(=O)N1CCC[C@@H](n2nc(-c3cccc(C(F)(F)F)c3)c3c(N)ncnc32)C1,7.52,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,30.0,nM,=,CHEMBL4041413,B,CHEMBL2180204,Homo sapiens,CHEMBL203,CHEMBL4038351
O=S1(=O)N=S(c2ccc(Br)cc2)c2ccncc21,5.27,Inhibition of HER1,IC50,5400.0,nM,=,CHEMBL2208688,B,CHEMBL2205030,Homo sapiens,CHEMBL203,CHEMBL2203023
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Oc4ccnc(C(=O)NC)c4)cc3)ncc2F)c1,6.13,"Inhibition of recombinant human N-terminal GST-tagged wild-type EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay",IC50,737.0,nM,=,CHEMBL4024934,B,CHEMBL2216827,Homo sapiens,CHEMBL203,CHEMBL4024706
CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O,5.82,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",IC50,1500.0,nM,=,CHEMBL1909203,B,CHEMBL2221249,Homo sapiens,CHEMBL203,CHEMBL1909046
CC(C)c1ccc(NC(=O)/C=C/c2ccccc2)cc1,4.84,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,14580.0,nM,=,CHEMBL3077166,B,CHEMBL2283245,Homo sapiens,CHEMBL203,CHEMBL3046969
CCOc1ccccc1NC(=O)/C=C/c1ccccc1,5.03,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,9350.0,nM,=,CHEMBL3077166,B,CHEMBL2283248,Homo sapiens,CHEMBL203,CHEMBL3046969
CCOc1ccc(NC(=O)/C=C/c2ccccc2)cc1,4.99,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,10230.0,nM,=,CHEMBL3077166,B,CHEMBL2283249,Homo sapiens,CHEMBL203,CHEMBL3046969
O=C(/C=C/c1ccccc1)Nc1ccc(F)cc1F,4.93,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,11690.0,nM,=,CHEMBL3077166,B,CHEMBL2283251,Homo sapiens,CHEMBL203,CHEMBL3046969
O=C(/C=C/c1ccccc1)Nc1cc(F)cc(F)c1,4.88,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,13230.0,nM,=,CHEMBL3077166,B,CHEMBL2283252,Homo sapiens,CHEMBL203,CHEMBL3046969
O=C(/C=C/c1ccccc1)Nc1cc(F)c(F)c(F)c1,4.89,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,12880.0,nM,=,CHEMBL3077166,B,CHEMBL2283253,Homo sapiens,CHEMBL203,CHEMBL3046969
O=C(/C=C/c1ccccc1)Nc1ccc(Cl)cc1Cl,4.79,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,16170.0,nM,=,CHEMBL3077166,B,CHEMBL2283255,Homo sapiens,CHEMBL203,CHEMBL3046969
O=C(/C=C/c1ccccc1)Nc1cc(Cl)cc(Cl)c1,4.86,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,13930.0,nM,=,CHEMBL3077166,B,CHEMBL2283256,Homo sapiens,CHEMBL203,CHEMBL3046969
O=C(/C=C/c1ccccc1)Nc1ccccc1Br,4.80,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,15740.0,nM,=,CHEMBL3077166,B,CHEMBL2283257,Homo sapiens,CHEMBL203,CHEMBL3046969
CCCCCCCCCCCCNC(=O)/C=C/c1ccccc1,4.42,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,38460.0,nM,=,CHEMBL3077166,B,CHEMBL2283258,Homo sapiens,CHEMBL203,CHEMBL3046969
CC(C)(C)NC(=O)/C=C/c1ccccc1,4.53,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,29850.0,nM,=,CHEMBL3077166,B,CHEMBL2283259,Homo sapiens,CHEMBL203,CHEMBL3046969
COc1cc2ncnc(N[C@H](C)c3ccc(F)cc3)c2cc1OCCCCCCC(=O)NO,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL2309506,Homo sapiens,CHEMBL203,CHEMBL3881527
COc1cc2ncnc(N[C@H](C)c3ccc(Cl)cc3)c2cc1OCCCCCCC(=O)NO,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL2309507,Homo sapiens,CHEMBL203,CHEMBL3881527
C=CC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@@H](CO)c4ccccc4)c23)c1,6.83,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,IC50,147.0,nM,=,CHEMBL4416106,B,CHEMBL2310642,Homo sapiens,CHEMBL203,CHEMBL4414600
O=C(NCCCN1CCCC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1,5.37,Inhibition of EGFR (unknown origin),IC50,4290.0,nM,=,CHEMBL2319132,B,CHEMBL2312303,Homo sapiens,CHEMBL203,CHEMBL2311468
O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1,5.39,Inhibition of EGFR (unknown origin),IC50,4090.0,nM,=,CHEMBL2319132,B,CHEMBL2312304,Homo sapiens,CHEMBL203,CHEMBL2311468
COc1ccccc1CNc1ncc(C(=O)NC2CCN(C)CC2)c(NC2CCCC2)n1,4.52,Inhibition of EGFR (unknown origin) in presence of ATP,IC50,30000.0,nM,=,CHEMBL2317775,B,CHEMBL2312645,Homo sapiens,CHEMBL203,CHEMBL2311250
CN1CCC(NC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC2CCCC2)CC1,4.52,Inhibition of EGFR (unknown origin) in presence of ATP,IC50,30000.0,nM,=,CHEMBL2317775,B,CHEMBL2312646,Homo sapiens,CHEMBL203,CHEMBL2311250
CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)CC1,4.52,Inhibition of EGFR (unknown origin) in presence of ATP,IC50,30000.0,nM,=,CHEMBL2317775,B,CHEMBL2312649,Homo sapiens,CHEMBL203,CHEMBL2311250
CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2N[C@@H]2COC[C@H]2O)CC1,4.52,Inhibition of EGFR (unknown origin) in presence of ATP,IC50,30000.0,nM,=,CHEMBL2317775,B,CHEMBL2312652,Homo sapiens,CHEMBL203,CHEMBL2311250
Cc1cc(-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)on1,6.23,Inhibition of EGFR (unknown origin) in presence of ATP,IC50,590.0,nM,=,CHEMBL2317775,B,CHEMBL2312654,Homo sapiens,CHEMBL203,CHEMBL2311250
COc1cc(/C=C2\CCC/C(=C\c3ccccc3)C2=O)cc(OC)c1,5.80,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,1600.0,nM,=,CHEMBL2318907,B,CHEMBL2316140,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3cccc(Cl)c3)C2=O)cc(OC)c1,5.66,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,2200.0,nM,=,CHEMBL2318907,B,CHEMBL2316141,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3ccccc3Cl)C2=O)cc(OC)c1,5.82,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,1500.0,nM,=,CHEMBL2318907,B,CHEMBL2316142,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3ccccc3F)C2=O)cc(OC)c1,5.68,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,2100.0,nM,=,CHEMBL2318907,B,CHEMBL2316143,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3ccccc3Br)C2=O)cc(OC)c1,5.10,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,8000.0,nM,=,CHEMBL2318907,B,CHEMBL2316144,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3cccc(Br)c3)C2=O)cc(OC)c1,5.17,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,6800.0,nM,=,CHEMBL2318907,B,CHEMBL2316145,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3ccc(Br)cc3)C2=O)cc(OC)c1,5.15,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,7100.0,nM,=,CHEMBL2318907,B,CHEMBL2316146,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3ccc(F)cc3)C2=O)cc(OC)c1,5.25,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,5600.0,nM,=,CHEMBL2318907,B,CHEMBL2316147,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3ccc(Cl)cc3)C2=O)cc(OC)c1,4.82,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,15300.0,nM,=,CHEMBL2318907,B,CHEMBL2316148,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\C3CCCCC3)C2=O)cc(OC)c1,5.12,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,7500.0,nM,=,CHEMBL2318907,B,CHEMBL2316149,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cccc(/C=C2\CCC/C(=C\c3cc(OC)cc(OC)c3)C2=O)c1,5.21,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,6100.0,nM,=,CHEMBL2318907,B,CHEMBL2316150,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3ccc(O)c(O)c3)C2=O)cc(OC)c1,6.40,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,400.0,nM,=,CHEMBL2318907,B,CHEMBL2316151,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3ccccc3OC)C2=O)cc(OC)c1,4.68,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,20800.0,nM,=,CHEMBL2318907,B,CHEMBL2316152,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3ccc(O)cc3)C2=O)cc(OC)c1,5.34,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,4600.0,nM,=,CHEMBL2318907,B,CHEMBL2316153,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3ccc(N(C)C)cc3)C2=O)cc(OC)c1,5.41,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,3900.0,nM,=,CHEMBL2318907,B,CHEMBL2316154,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3ccc(OC)c(O)c3)C2=O)cc(OC)c1,5.28,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,5300.0,nM,=,CHEMBL2318907,B,CHEMBL2316155,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1ccc(/C=C2\CCC/C(=C\c3cc(OC)cc(OC)c3)C2=O)cc1,4.73,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,18600.0,nM,=,CHEMBL2318907,B,CHEMBL2316156,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3cc(OC)cc(OC)c3)C2=O)cc(OC)c1,5.70,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,2000.0,nM,=,CHEMBL2318907,B,CHEMBL2316157,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3ccc(S(C)(=O)=O)cc3)C2=O)cc(OC)c1,5.72,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,1900.0,nM,=,CHEMBL2318907,B,CHEMBL2316158,Homo sapiens,CHEMBL203,CHEMBL2311310
COc1cc(/C=C2\CCC/C(=C\c3cc(C(C)(C)C)c(O)c(C(C)(C)C)c3)C2=O)cc(OC)c1,5.32,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,IC50,4800.0,nM,=,CHEMBL2318907,B,CHEMBL2316159,Homo sapiens,CHEMBL203,CHEMBL2311310
CN(C)C/C=C/C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21,8.34,Inhibition of human wild type EGFR expressed in Sf9 cells using [gamma32P]-ATP after 10 mins by scintillation counting,IC50,4.6,nM,=,CHEMBL2328801,B,CHEMBL2322329,Homo sapiens,CHEMBL203,CHEMBL2321748
O=C(Nc1cccc(Oc2ccc(Nc3ncnc4ccn(CCOCCO)c34)cc2Cl)c1)NC1CCCCC1,8.16,Inhibition of human wild type EGFR expressed in Sf9 cells using [gamma32P]-ATP after 10 mins by scintillation counting,IC50,6.9,nM,=,CHEMBL2328801,B,CHEMBL2322330,Homo sapiens,CHEMBL203,CHEMBL2321748
NC(=S)N1N=C(c2ccc(Cl)cc2)CC1c1ccc2ccccc2c1,6.28,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,530.0,nM,=,CHEMBL2327216,B,CHEMBL2324870,Homo sapiens,CHEMBL203,CHEMBL2321654
NC(=S)N1N=C(c2ccc(Br)cc2)CC1c1ccc2ccccc2c1,6.46,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,350.0,nM,=,CHEMBL2327216,B,CHEMBL2324871,Homo sapiens,CHEMBL203,CHEMBL2321654
COc1ccc(C2=NN(C(N)=S)C(c3ccc4ccccc4c3)C2)cc1,5.98,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,1040.0,nM,=,CHEMBL2327216,B,CHEMBL2324872,Homo sapiens,CHEMBL203,CHEMBL2321654
Cc1ccc(C2=NN(C(N)=S)C(c3ccc4ccccc4c3)C2)cc1,6.28,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,520.0,nM,=,CHEMBL2327216,B,CHEMBL2324873,Homo sapiens,CHEMBL203,CHEMBL2321654
NC(=S)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1ccc2ccccc2c1,6.18,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,660.0,nM,=,CHEMBL2327216,B,CHEMBL2325087,Homo sapiens,CHEMBL203,CHEMBL2321654
c1ccc(C2=NN(c3ccccc3)C(c3cccc4ccccc34)C2)cc1,5.60,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,2520.0,nM,=,CHEMBL2327216,B,CHEMBL2325088,Homo sapiens,CHEMBL203,CHEMBL2321654
Fc1ccc(C2=NN(c3ccccc3)C(c3cccc4ccccc34)C2)cc1,5.97,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,1070.0,nM,=,CHEMBL2327216,B,CHEMBL2325089,Homo sapiens,CHEMBL203,CHEMBL2321654
Clc1ccc(C2=NN(c3ccccc3)C(c3cccc4ccccc34)C2)cc1,6.17,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,680.0,nM,=,CHEMBL2327216,B,CHEMBL2325090,Homo sapiens,CHEMBL203,CHEMBL2321654
Brc1ccc(C2=NN(c3ccccc3)C(c3cccc4ccccc34)C2)cc1,6.31,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,490.0,nM,=,CHEMBL2327216,B,CHEMBL2325091,Homo sapiens,CHEMBL203,CHEMBL2321654
COc1ccc(C2=NN(c3ccccc3)C(c3cccc4ccccc34)C2)cc1,7.00,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,100.0,nM,=,CHEMBL2327216,B,CHEMBL2325092,Homo sapiens,CHEMBL203,CHEMBL2321654
Cc1ccc(C2=NN(c3ccccc3)C(c3cccc4ccccc34)C2)cc1,6.70,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,200.0,nM,=,CHEMBL2327216,B,CHEMBL2325093,Homo sapiens,CHEMBL203,CHEMBL2321654
Clc1ccc(C2=NN(c3ccccc3)C(c3cccc4ccccc34)C2)cc1Cl,6.85,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,140.0,nM,=,CHEMBL2327216,B,CHEMBL2325094,Homo sapiens,CHEMBL203,CHEMBL2321654
c1ccc(C2=NN(c3ccccc3)C(c3ccc4ccccc4c3)C2)cc1,6.62,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,240.0,nM,=,CHEMBL2327216,B,CHEMBL2325095,Homo sapiens,CHEMBL203,CHEMBL2321654
Fc1ccc(C2=NN(c3ccccc3)C(c3ccc4ccccc4c3)C2)cc1,6.52,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,300.0,nM,=,CHEMBL2327216,B,CHEMBL2325096,Homo sapiens,CHEMBL203,CHEMBL2321654
Clc1ccc(C2=NN(c3ccccc3)C(c3ccc4ccccc4c3)C2)cc1,6.96,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,110.0,nM,=,CHEMBL2327216,B,CHEMBL2325097,Homo sapiens,CHEMBL203,CHEMBL2321654
Brc1ccc(C2=NN(c3ccccc3)C(c3ccc4ccccc4c3)C2)cc1,6.15,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,710.0,nM,=,CHEMBL2327216,B,CHEMBL2325098,Homo sapiens,CHEMBL203,CHEMBL2321654
COc1ccc(C2=NN(c3ccccc3)C(c3ccc4ccccc4c3)C2)cc1,6.92,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,120.0,nM,=,CHEMBL2327216,B,CHEMBL2325099,Homo sapiens,CHEMBL203,CHEMBL2321654
Cc1ccc(C2=NN(c3ccccc3)C(c3ccc4ccccc4c3)C2)cc1,7.22,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,60.0,nM,=,CHEMBL2327216,B,CHEMBL2325100,Homo sapiens,CHEMBL203,CHEMBL2321654
Clc1ccc(C2=NN(c3ccccc3)C(c3ccc4ccccc4c3)C2)cc1Cl,7.30,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,50.0,nM,=,CHEMBL2327216,B,CHEMBL2325101,Homo sapiens,CHEMBL203,CHEMBL2321654
NC(=S)N1N=C(c2ccccc2)CC1c1cccc2ccccc12,5.65,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,2230.0,nM,=,CHEMBL2327216,B,CHEMBL2325102,Homo sapiens,CHEMBL203,CHEMBL2321654
NC(=S)N1N=C(c2ccc(F)cc2)CC1c1cccc2ccccc12,5.08,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,8250.0,nM,=,CHEMBL2327216,B,CHEMBL2325103,Homo sapiens,CHEMBL203,CHEMBL2321654
NC(=S)N1N=C(c2ccc(Cl)cc2)CC1c1cccc2ccccc12,6.03,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,940.0,nM,=,CHEMBL2327216,B,CHEMBL2325104,Homo sapiens,CHEMBL203,CHEMBL2321654
NC(=S)N1N=C(c2ccc(Br)cc2)CC1c1cccc2ccccc12,5.25,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,5680.0,nM,=,CHEMBL2327216,B,CHEMBL2325105,Homo sapiens,CHEMBL203,CHEMBL2321654
COc1ccc(C2=NN(C(N)=S)C(c3cccc4ccccc34)C2)cc1,6.80,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,160.0,nM,=,CHEMBL2327216,B,CHEMBL2325106,Homo sapiens,CHEMBL203,CHEMBL2321654
Cc1ccc(C2=NN(C(N)=S)C(c3cccc4ccccc34)C2)cc1,5.69,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,2060.0,nM,=,CHEMBL2327216,B,CHEMBL2325107,Homo sapiens,CHEMBL203,CHEMBL2321654
NC(=S)N1N=C(c2ccc(Cl)c(Cl)c2)CC1c1cccc2ccccc12,6.68,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,210.0,nM,=,CHEMBL2327216,B,CHEMBL2325108,Homo sapiens,CHEMBL203,CHEMBL2321654
NC(=S)N1N=C(c2ccccc2)CC1c1ccc2ccccc2c1,5.52,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,3010.0,nM,=,CHEMBL2327216,B,CHEMBL2325109,Homo sapiens,CHEMBL203,CHEMBL2321654
NC(=S)N1N=C(c2ccc(F)cc2)CC1c1ccc2ccccc2c1,5.48,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,IC50,3280.0,nM,=,CHEMBL2327216,B,CHEMBL2325110,Homo sapiens,CHEMBL203,CHEMBL2321654
NC(=O)C1=C(N)C(=O)C=C(Nc2ccccc2O)C1=O,5.58,Inhibition of EGFR (unknown origin) after 20 mins by scintillation counting,IC50,2600.0,nM,=,CHEMBL2343159,B,CHEMBL2332119,Homo sapiens,CHEMBL203,CHEMBL2331471
O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(Oc2ccc(CCNC(=O)/C(Cc3cc(Br)c(O)c(-c4cc(C/C(=N\O)C(=O)NCCc5ccc(O)c(Br)c5)cc(Br)c4O)c3)=N/O)cc2Br)c1)=N/O,6.22,Inhibition of EGFR (unknown origin),IC50,600.0,nM,=,CHEMBL2344161,B,CHEMBL2333163,Homo sapiens,CHEMBL203,CHEMBL2331160
O=C1NCCc2ccc(O)c(c2)Oc2c(Br)cc(cc2Br)CCNC(=O)/C(=N/O)Cc2cc(Br)c(O)c(c2)Oc2c(Br)cc(cc2Br)C/C1=N\O,5.54,Inhibition of EGFR (unknown origin),IC50,2900.0,nM,=,CHEMBL2344161,B,CHEMBL2333164,Homo sapiens,CHEMBL203,CHEMBL2331160
COc1cc2ncnc(Nc3ccc(C(C)(F)F)cc3)c2cc1OC,5.33,Inhibition of EGFR (unknown origin),IC50,4700.0,nM,=,CHEMBL2341278,B,CHEMBL2333985,Homo sapiens,CHEMBL203,CHEMBL2331141
COc1cc2ncnc(Nc3ccccc3C(F)(F)F)c2cc1OC,5.00,Inhibition of EGFR (unknown origin),IC50,10000.0,nM,=,CHEMBL2341278,B,CHEMBL2333986,Homo sapiens,CHEMBL203,CHEMBL2331141
COc1cc2ncnc(Nc3cccc(-c4ccccc4)c3)c2cc1OC,6.90,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,IC50,126.7,nM,=,CHEMBL2341281,B,CHEMBL2333991,Homo sapiens,CHEMBL203,CHEMBL2331141
COc1cc2ncnc(Nc3cccc(C#N)c3)c2cc1OC,6.38,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,IC50,412.8,nM,=,CHEMBL2341281,B,CHEMBL2333998,Homo sapiens,CHEMBL203,CHEMBL2331141
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCBr,7.74,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,IC50,18.1,nM,=,CHEMBL2341281,B,CHEMBL2333999,Homo sapiens,CHEMBL203,CHEMBL2331141
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCO,7.20,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,IC50,63.4,nM,=,CHEMBL2341281,B,CHEMBL2334001,Homo sapiens,CHEMBL203,CHEMBL2331141
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCNCCN,7.92,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,IC50,12.1,nM,=,CHEMBL2341281,B,CHEMBL2334002,Homo sapiens,CHEMBL203,CHEMBL2331141
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCNCCN,7.87,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,IC50,13.6,nM,=,CHEMBL2341281,B,CHEMBL2334003,Homo sapiens,CHEMBL203,CHEMBL2331141
Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1,4.71,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,IC50,19300.0,nM,=,CHEMBL2343569,B,CHEMBL2335013,Homo sapiens,CHEMBL203,CHEMBL2331499
Nc1nc(Nc2ccc(F)c(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1,4.81,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,IC50,15600.0,nM,=,CHEMBL2343569,B,CHEMBL2335014,Homo sapiens,CHEMBL203,CHEMBL2331499
CC(C)(C)C(=O)Nc1nc(Nc2ccc(F)c(Br)c2)c2cc(CCc3ccccn3)[nH]c2n1,5.27,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,IC50,5400.0,nM,=,CHEMBL2343569,B,CHEMBL2335015,Homo sapiens,CHEMBL203,CHEMBL2331499
CC(C)(C)C(=O)Nc1nc(Nc2ccc(F)c(Cl)c2)c2cc(CCc3ccccn3)[nH]c2n1,4.79,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,IC50,16300.0,nM,=,CHEMBL2343569,B,CHEMBL2335016,Homo sapiens,CHEMBL203,CHEMBL2331499
CC(C)(C)C(=O)Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1,4.89,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,IC50,12800.0,nM,=,CHEMBL2343569,B,CHEMBL2335018,Homo sapiens,CHEMBL203,CHEMBL2331499
CC(C)(C)C(=O)Nc1nc(Nc2ccc(F)c(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1,4.57,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,IC50,26900.0,nM,=,CHEMBL2343569,B,CHEMBL2335019,Homo sapiens,CHEMBL203,CHEMBL2331499
Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccn3)[nH]c2n1,6.52,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,IC50,300.0,nM,=,CHEMBL2343569,B,CHEMBL2335376,Homo sapiens,CHEMBL203,CHEMBL2331499
Nc1nc(Nc2ccc(F)c(Br)c2)c2cc(CCc3ccccn3)[nH]c2n1,4.07,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,IC50,85900.0,nM,=,CHEMBL2343569,B,CHEMBL2335377,Homo sapiens,CHEMBL203,CHEMBL2331499
C#Cc1cccc(Nc2nc(N)nc3[nH]c(CCc4ccccn4)cc23)c1,4.70,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,IC50,19900.0,nM,=,CHEMBL2343569,B,CHEMBL2335379,Homo sapiens,CHEMBL203,CHEMBL2331499
O=C(/C=C/c1ccccc1)Nc1ccc(Cl)cc1,4.86,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,13710.0,nM,=,CHEMBL3077166,B,CHEMBL2336335,Homo sapiens,CHEMBL203,CHEMBL3046969
COc1ccccc1NC(=O)/C=C/c1ccccc1,5.29,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,5160.0,nM,=,CHEMBL3077166,B,CHEMBL2336355,Homo sapiens,CHEMBL203,CHEMBL3046969
COc1ccc(NC(=O)/C=C/c2ccccc2)cc1,5.04,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,9050.0,nM,=,CHEMBL3077166,B,CHEMBL2336357,Homo sapiens,CHEMBL203,CHEMBL3046969
Cc1ccccc1NC(=O)/C=C/c1ccccc1,4.91,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,12290.0,nM,=,CHEMBL3077166,B,CHEMBL2336358,Homo sapiens,CHEMBL203,CHEMBL3046969
Cc1ccc(NC(=O)/C=C/c2ccccc2)cc1,4.90,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,12690.0,nM,=,CHEMBL3077166,B,CHEMBL2336359,Homo sapiens,CHEMBL203,CHEMBL3046969
O=C(/C=C/c1ccccc1)Nc1ccc(F)cc1,5.00,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,IC50,10020.0,nM,=,CHEMBL3077166,B,CHEMBL2336361,Homo sapiens,CHEMBL203,CHEMBL3046969
CC(C)c1ccc(Nc2nc(N)nc3[nH]c4cccc(Cl)c4c23)cc1,4.38,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,IC50,42000.0,nM,=,CHEMBL2344596,B,CHEMBL2337362,Homo sapiens,CHEMBL203,CHEMBL2331095
Nc1nc(Nc2ccc(Cl)cc2)c2c(n1)[nH]c1cccc(Cl)c12,4.20,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,IC50,63600.0,nM,=,CHEMBL2344596,B,CHEMBL2337363,Homo sapiens,CHEMBL203,CHEMBL2331095
Nc1nc(Nc2ccc(Cl)cc2F)c2c(n1)[nH]c1cccc(Cl)c12,4.41,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,IC50,38900.0,nM,=,CHEMBL2344596,B,CHEMBL2337364,Homo sapiens,CHEMBL203,CHEMBL2331095
COc1cccc(Nc2nc(N)nc3[nH]c4cccc(Cl)c4c23)c1,4.08,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,IC50,82900.0,nM,=,CHEMBL2344596,B,CHEMBL2337366,Homo sapiens,CHEMBL203,CHEMBL2331095
CC(C)c1ccc(Nc2nc(NC(=O)C(C)(C)C)nc3[nH]c4cccc(Cl)c4c23)cc1,4.41,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,IC50,39200.0,nM,=,CHEMBL2344596,B,CHEMBL2337368,Homo sapiens,CHEMBL203,CHEMBL2331095
CC(C)(C)C(=O)Nc1nc(Nc2ccc(Cl)cc2)c2c(n1)[nH]c1cccc(Cl)c12,4.23,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,IC50,58700.0,nM,=,CHEMBL2344596,B,CHEMBL2337369,Homo sapiens,CHEMBL203,CHEMBL2331095
CC(C)(C)C(=O)Nc1nc(Nc2cccc(F)c2)c2c(n1)[nH]c1cccc(Cl)c12,4.51,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,IC50,30800.0,nM,=,CHEMBL2344596,B,CHEMBL2337371,Homo sapiens,CHEMBL203,CHEMBL2331095
Nc1nc(Nc2ccccc2)c2c(n1)[nH]c1ccccc12,6.83,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,IC50,147.0,nM,=,CHEMBL2344596,B,CHEMBL2337373,Homo sapiens,CHEMBL203,CHEMBL2331095
NC(=O)Nc1ccc2ncnc(Nc3ccc(Cl)cc3)c2c1,7.21,"Inhibition of EGFR tyrosine kinase (unknown origin) using poly (Glu,Tyr) as substrate after 30 mins by ADP-GloTM assay",IC50,61.0,nM,=,CHEMBL2351374,B,CHEMBL2347231,Homo sapiens,CHEMBL203,CHEMBL2346534
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@@H]1CCOC1,9.40,Inhibition of human EGFR L858R mutant expressed in mouse Ba/F3 cells,IC50,0.4,nM,=,CHEMBL4271187,B,CHEMBL2347958,Homo sapiens,CHEMBL203,CHEMBL4270496
CN(C)CCCC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,7.54,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,29.0,nM,=,CHEMBL2351567,B,CHEMBL2347960,Homo sapiens,CHEMBL203,CHEMBL2346524
CN(C)CCCCC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,7.47,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,34.0,nM,=,CHEMBL2351567,B,CHEMBL2347961,Homo sapiens,CHEMBL203,CHEMBL2346524
CN(C)CCCCCC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,5.36,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,4327.0,nM,=,CHEMBL2351567,B,CHEMBL2347962,Homo sapiens,CHEMBL203,CHEMBL2346524
CN(C)CCC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,8.10,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,8.0,nM,=,CHEMBL2351567,B,CHEMBL2347963,Homo sapiens,CHEMBL203,CHEMBL2346524
CC(=O)Nc1ccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)cc1,6.75,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,179.0,nM,=,CHEMBL2351567,B,CHEMBL2347964,Homo sapiens,CHEMBL203,CHEMBL2346524
CC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,6.66,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,218.0,nM,=,CHEMBL2351567,B,CHEMBL2347965,Homo sapiens,CHEMBL203,CHEMBL2346524
CN(C)CC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,7.32,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,48.0,nM,=,CHEMBL2351567,B,CHEMBL2347966,Homo sapiens,CHEMBL203,CHEMBL2346524
Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,6.69,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,203.0,nM,=,CHEMBL2351567,B,CHEMBL2346678,Homo sapiens,CHEMBL203,CHEMBL2346524
O=[N+]([O-])c1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,6.09,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,820.0,nM,=,CHEMBL2351567,B,CHEMBL2347967,Homo sapiens,CHEMBL203,CHEMBL2346524
OC[C@@H](Nc1ncnc2oc(-c3ccccc3)c(Cl)c12)c1ccccc1,6.23,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,589.0,nM,=,CHEMBL2351567,B,CHEMBL2347968,Homo sapiens,CHEMBL203,CHEMBL2346524
OC[C@@H](Nc1ncnc2oc(-c3ccccc3)c(Br)c12)c1ccccc1,6.34,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,452.0,nM,=,CHEMBL2351567,B,CHEMBL2347969,Homo sapiens,CHEMBL203,CHEMBL2346524
OC[C@@H](Nc1ncnc2oc(-c3ccccc3)c(-c3ccco3)c12)c1ccccc1,6.36,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,434.0,nM,=,CHEMBL2351567,B,CHEMBL2347970,Homo sapiens,CHEMBL203,CHEMBL2346524
OC[C@@H](Nc1ncnc2oc(-c3ccccc3)c(-c3ccoc3)c12)c1ccccc1,6.45,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,352.0,nM,=,CHEMBL2351567,B,CHEMBL2347971,Homo sapiens,CHEMBL203,CHEMBL2346524
OC[C@@H](Nc1ncnc2oc(-c3ccccc3)c(-c3ccc4c(c3)OCO4)c12)c1ccccc1,6.59,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,258.0,nM,=,CHEMBL2351567,B,CHEMBL2347972,Homo sapiens,CHEMBL203,CHEMBL2346524
COC(=O)[C@@H](Nc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12)c1ccccc1,5.10,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,7893.0,nM,=,CHEMBL2351567,B,CHEMBL2347973,Homo sapiens,CHEMBL203,CHEMBL2346524
C[C@@H](Nc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12)c1ccccc1,5.52,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,IC50,2991.0,nM,=,CHEMBL2351567,B,CHEMBL2348194,Homo sapiens,CHEMBL203,CHEMBL2346524
O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc(C(F)(F)F)c3)c(Cl)c2)NCC1,7.42,Inhibition of human N-terminal DYKDDDD-tagged EGFR cytoplasmic domain (669 to 1210) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,IC50,38.0,nM,=,CHEMBL2351562,B,CHEMBL2348414,Homo sapiens,CHEMBL203,CHEMBL2346616
CS(=O)(=O)CCNC(=O)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc(C(F)(F)F)c3)c(Cl)c2)NCC1,7.12,Inhibition of human N-terminal DYKDDDD-tagged EGFR cytoplasmic domain (669 to 1210) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,IC50,75.0,nM,=,CHEMBL2351562,B,CHEMBL2348415,Homo sapiens,CHEMBL203,CHEMBL2346616
COC(=O)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1,7.36,Inhibition of human N-terminal DYKDDDD-tagged EGFR cytoplasmic domain (669 to 1210) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,IC50,44.0,nM,=,CHEMBL2351562,B,CHEMBL2348416,Homo sapiens,CHEMBL203,CHEMBL2346616
O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1,7.44,Inhibition of human N-terminal DYKDDDD-tagged EGFR cytoplasmic domain (669 to 1210) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,IC50,36.0,nM,=,CHEMBL2351562,B,CHEMBL2348417,Homo sapiens,CHEMBL203,CHEMBL2346616
CS(=O)(=O)CCNC(=O)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1,7.33,Inhibition of human N-terminal DYKDDDD-tagged EGFR cytoplasmic domain (669 to 1210) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,IC50,47.0,nM,=,CHEMBL2351562,B,CHEMBL2348418,Homo sapiens,CHEMBL203,CHEMBL2346616
COC(=O)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc(C(F)(F)F)c3)c(Cl)c2)NCC1,6.96,Inhibition of human N-terminal DYKDDDD-tagged EGFR cytoplasmic domain (669 to 1210) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,IC50,110.0,nM,=,CHEMBL2351562,B,CHEMBL2348419,Homo sapiens,CHEMBL203,CHEMBL2346616
CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c(F)c(F)c(O)c(F)c1F)C(=O)NCC(=O)O,5.40,Inhibition of EGFR,Ki,4000.0,nM,=,CHEMBL941412,B,CHEMBL2372245,Homo sapiens,CHEMBL203,CHEMBL1150213
COCCCN1CCC([C@H]2CC[C@H](n3nc(-c4ccc5nc(Cc6ccccc6Cl)[nH]c5c4)c4c(N)ncnc43)CC2)CC1,7.24,Inhibition of EGFR,IC50,58.0,nM,=,CHEMBL1111474,B,CHEMBL2374457,Homo sapiens,CHEMBL203,CHEMBL1155389
COc1ccccc1Cc1nc2ccc(-c3nn([C@H]4CC[C@H](C5CCN(C)CC5)CC4)c4ncnc(N)c34)cc2[nH]1,7.24,Inhibition of EGFR,IC50,58.0,nM,=,CHEMBL1111474,B,CHEMBL2374458,Homo sapiens,CHEMBL203,CHEMBL1155389
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(CC(=O)N5CCC(Oc6no[n+]([O-])c6S(=O)(=O)c6ccccc6)CC5)CC4)cc3OC)ncc2Cl)c1,7.89,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,IC50,13.0,nM,=,CHEMBL2383986,B,CHEMBL2381504,Homo sapiens,CHEMBL203,CHEMBL2380214
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(CC(=O)NCC(C)Oc5no[n+]([O-])c5S(=O)(=O)c5ccccc5)CC4)cc3OC)ncc2Cl)c1,7.70,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,IC50,20.0,nM,=,CHEMBL2383986,B,CHEMBL2381505,Homo sapiens,CHEMBL203,CHEMBL2380214
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(CC(=O)OCCOc5no[n+]([O-])c5S(=O)(=O)c5ccccc5)CC4)cc3OC)ncc2Cl)c1,7.77,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,IC50,17.0,nM,=,CHEMBL2383986,B,CHEMBL2381506,Homo sapiens,CHEMBL203,CHEMBL2380214
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(CC(=O)OCCCOc5no[n+]([O-])c5S(=O)(=O)c5ccccc5)CC4)cc3OC)ncc2Cl)c1,7.64,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,IC50,23.0,nM,=,CHEMBL2383986,B,CHEMBL2381507,Homo sapiens,CHEMBL203,CHEMBL2380214
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(CC(=O)OCCCCOc5no[n+]([O-])c5S(=O)(=O)c5ccccc5)CC4)cc3OC)ncc2Cl)c1,7.42,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,IC50,38.0,nM,=,CHEMBL2383986,B,CHEMBL2381508,Homo sapiens,CHEMBL203,CHEMBL2380214
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(CC(=O)OCC#CCOc5no[n+]([O-])c5S(=O)(=O)c5ccccc5)CC4)cc3OC)ncc2Cl)c1,7.80,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,IC50,16.0,nM,=,CHEMBL2383986,B,CHEMBL2381509,Homo sapiens,CHEMBL203,CHEMBL2380214
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(CC(=O)OCCOCCOc5no[n+]([O-])c5S(=O)(=O)c5ccccc5)CC4)cc3OC)ncc2Cl)c1,7.52,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,IC50,30.0,nM,=,CHEMBL2383986,B,CHEMBL2381510,Homo sapiens,CHEMBL203,CHEMBL2380214
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(CC(=O)OCCCCCCOc5no[n+]([O-])c5S(=O)(=O)c5ccccc5)CC4)cc3OC)ncc2Cl)c1,7.33,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,IC50,47.0,nM,=,CHEMBL2383986,B,CHEMBL2381511,Homo sapiens,CHEMBL203,CHEMBL2380214
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(CC(=O)NCCOc5no[n+]([O-])c5S(=O)(=O)c5ccccc5)CC4)cc3OC)ncc2Cl)c1,7.85,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,IC50,14.0,nM,=,CHEMBL2383986,B,CHEMBL2381514,Homo sapiens,CHEMBL203,CHEMBL2380214
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(CC(=O)NCCCOc5no[n+]([O-])c5S(=O)(=O)c5ccccc5)CC4)cc3OC)ncc2Cl)c1,7.89,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,IC50,13.0,nM,=,CHEMBL2383986,B,CHEMBL2381515,Homo sapiens,CHEMBL203,CHEMBL2380214
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(CC(=O)N5CCN(CCOc6no[n+]([O-])c6S(=O)(=O)c6ccccc6)CC5)CC4)cc3OC)ncc2Cl)c1,8.22,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,IC50,6.0,nM,=,CHEMBL2383986,B,CHEMBL2381516,Homo sapiens,CHEMBL203,CHEMBL2380214
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1/C=C/c1ccc(CNCCS(C)(=O)=O)o1,6.34,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,460.0,nM,=,CHEMBL2390159,B,CHEMBL2385959,Homo sapiens,CHEMBL203,CHEMBL2384937
Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1ccc(CNCCS(C)(=O)=O)o1,7.35,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,45.0,nM,=,CHEMBL2390159,B,CHEMBL2385960,Homo sapiens,CHEMBL203,CHEMBL2384937
Cc1ncc(C#N)c(Nc2ccc(OCc3ccccn3)c(Cl)c2)c1C#Cc1ccc(CNCCS(C)(=O)=O)o1,5.82,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,1500.0,nM,=,CHEMBL2390159,B,CHEMBL2385964,Homo sapiens,CHEMBL203,CHEMBL2384937
CN1CCN(Cc2ccc(C(=O)Nc3ccc(-c4cncc(C#N)c4Nc4ccc(OCc5ccccn5)c(Cl)c4)cc3)cc2)CC1,5.64,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,2300.0,nM,=,CHEMBL2390159,B,CHEMBL2385967,Homo sapiens,CHEMBL203,CHEMBL2384937
CN(C)C/C=C/C(=O)Nc1ccc(-c2cncc(C#N)c2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1,6.18,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,660.0,nM,=,CHEMBL2390159,B,CHEMBL2385968,Homo sapiens,CHEMBL203,CHEMBL2384937
CN1CCN(Cc2ccc(C(=O)Nc3ccc(-c4cncc(C#N)c4Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)cc3)cc2)CC1,5.60,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,2500.0,nM,=,CHEMBL2390159,B,CHEMBL2385969,Homo sapiens,CHEMBL203,CHEMBL2384937
CN(C)C/C=C/C(=O)Nc1ccc(-c2cncc(C#N)c2Nc2ccc(F)c(Cl)c2)cc1,5.46,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,3500.0,nM,=,CHEMBL2390159,B,CHEMBL2385970,Homo sapiens,CHEMBL203,CHEMBL2384937
CN1CCN(Cc2ccc(C(=O)Nc3ccc(-c4cncc(C#N)c4Nc4ccc(F)c(Cl)c4)cc3)cc2)CC1,5.52,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,3000.0,nM,=,CHEMBL2390159,B,CHEMBL2385971,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1cc([N+](=O)[O-])c(C(=O)Nc2ccc(OCc3ccccn3)c(Cl)c2)cc1NC(=O)/C=C/CN(C)C,6.07,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,850.0,nM,=,CHEMBL2390159,B,CHEMBL2385974,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1cc(N)c(C(=O)Nc2ccc(OCc3ccccn3)c(Cl)c2)cc1NC(=O)/C=C/CN(C)C,6.10,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,800.0,nM,=,CHEMBL2390159,B,CHEMBL2385975,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1cc([N+](=O)[O-])c(C(=O)Nc2ccc(OCc3ccccn3)c(Cl)c2)cc1NC(=O)c1ccc(CN2CCN(C)CC2)cc1,6.05,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,900.0,nM,=,CHEMBL2390159,B,CHEMBL2385976,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1cc(N)c(C(=O)Nc2ccc(OCc3ccccn3)c(Cl)c2)cc1NC(=O)c1ccc(CN2CCN(C)CC2)cc1,6.00,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,1000.0,nM,=,CHEMBL2390159,B,CHEMBL2385977,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1cc([N+](=O)[O-])c(C(=O)Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1NC(=O)/C=C/CN(C)C,5.70,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,2000.0,nM,=,CHEMBL2390159,B,CHEMBL2385978,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1cc(N)c(C(=O)Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1NC(=O)/C=C/CN(C)C,5.82,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,1500.0,nM,=,CHEMBL2390159,B,CHEMBL2385979,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1cc([N+](=O)[O-])c(C(=O)Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1NC(=O)c1ccc(CN2CCN(C)CC2)cc1,5.26,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,5500.0,nM,=,CHEMBL2390159,B,CHEMBL2385980,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1cc(N)c(C(=O)Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1NC(=O)c1ccc(CN2CCN(C)CC2)cc1,5.30,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,5000.0,nM,=,CHEMBL2390159,B,CHEMBL2385981,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1cc([N+](=O)[O-])c(C(=O)Nc2ccc(F)c(Cl)c2)cc1NC(=O)/C=C/CN(C)C,5.22,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,6000.0,nM,=,CHEMBL2390159,B,CHEMBL2385982,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1cc(N)c(C(=O)Nc2ccc(F)c(Cl)c2)cc1NC(=O)/C=C/CN(C)C,5.35,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,4500.0,nM,=,CHEMBL2390159,B,CHEMBL2385983,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1cc([N+](=O)[O-])c(C(=O)Nc2ccc(F)c(Cl)c2)cc1NC(=O)c1ccc(CN2CCN(C)CC2)cc1,5.30,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,5000.0,nM,=,CHEMBL2390159,B,CHEMBL2385984,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1cc(N)c(C(=O)Nc2ccc(F)c(Cl)c2)cc1NC(=O)c1ccc(CN2CCN(C)CC2)cc1,6.10,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,800.0,nM,=,CHEMBL2390159,B,CHEMBL2385985,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1ccc(C(=O)Nc2ccc(OCc3ccccn3)c(Cl)c2)cc1NC(=O)/C=C/CN(C)C,5.92,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,1200.0,nM,=,CHEMBL2390159,B,CHEMBL2385986,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1ccc(C(=O)Nc2ccc(OCc3ccccn3)c(Cl)c2)cc1NC(=O)c1ccc(CN2CCN(C)CC2)cc1,5.46,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,3500.0,nM,=,CHEMBL2390159,B,CHEMBL2385987,Homo sapiens,CHEMBL203,CHEMBL2384937
CCOc1ccc(C(=O)Nc2nccc(-c3cccnc3)n2)cc1NC(=O)/C=C/CN(C)C,5.22,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,6000.0,nM,=,CHEMBL2390159,B,CHEMBL2385988,Homo sapiens,CHEMBL203,CHEMBL2384937
Cc1ccc(NC(=O)/C=C/CN(C)C)cc1C(=O)Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,6.35,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,450.0,nM,=,CHEMBL2390159,B,CHEMBL2385990,Homo sapiens,CHEMBL203,CHEMBL2384937
Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1C(=O)Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,6.22,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,600.0,nM,=,CHEMBL2390159,B,CHEMBL2385991,Homo sapiens,CHEMBL203,CHEMBL2384937
Cc1ccc(NC(=O)/C=C/CN(C)C)cc1C(=O)Nc1nccc(-c2cccnc2)n1,5.30,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,5000.0,nM,=,CHEMBL2390159,B,CHEMBL2385992,Homo sapiens,CHEMBL203,CHEMBL2384937
Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1C(=O)Nc1nccc(-c2cccc(F)c2)n1,5.22,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,IC50,6000.0,nM,=,CHEMBL2390159,B,CHEMBL2385993,Homo sapiens,CHEMBL203,CHEMBL2384937
Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1,7.72,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,IC50,19.0,nM,=,CHEMBL4382300,B,CHEMBL2403108,Homo sapiens,CHEMBL203,CHEMBL4382192
CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,9.00,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Kd,1.0,nM,=,CHEMBL3991696,B,CHEMBL2408045,Homo sapiens,CHEMBL203,CHEMBL3991601
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccc(CCCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)cc2)n1,6.11,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,IC50,780.0,nM,=,CHEMBL2412778,B,CHEMBL2408823,Homo sapiens,CHEMBL203,CHEMBL2407010
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccc(CCOc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)cc2)n1,6.02,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,IC50,960.0,nM,=,CHEMBL2412778,B,CHEMBL2408824,Homo sapiens,CHEMBL203,CHEMBL2407010
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccc(COc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)cc2)n1,6.85,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,IC50,140.0,nM,=,CHEMBL2412778,B,CHEMBL2408825,Homo sapiens,CHEMBL203,CHEMBL2407010
COc1cc(N2CCC(O)CC2)ccc1Nc1ncc(Cl)c(Oc2ccc(COc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)cc2)n1,6.60,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,IC50,250.0,nM,=,CHEMBL2412778,B,CHEMBL2408826,Homo sapiens,CHEMBL203,CHEMBL2407010
C=CC(=O)N1CCN(c2ccc(Nc3ncc(Cl)c(Oc4ccc(COc5no[n+]([O-])c5S(=O)(=O)c5ccccc5)cc4)n3)c(OC)c2)CC1,6.39,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,IC50,410.0,nM,=,CHEMBL2412778,B,CHEMBL2408827,Homo sapiens,CHEMBL203,CHEMBL2407010
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(COc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)c2)n1,7.72,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,IC50,19.0,nM,=,CHEMBL2412778,B,CHEMBL2408828,Homo sapiens,CHEMBL203,CHEMBL2407010
COc1cc(N2CCC(O)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(COc3no[n+]([O-])c3S(=O)(=O)c3ccccc3)c2)n1,7.17,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,IC50,68.0,nM,=,CHEMBL2412778,B,CHEMBL2408829,Homo sapiens,CHEMBL203,CHEMBL2407010
C=CC(=O)N1CCN(c2ccc(Nc3ncc(Cl)c(Oc4cccc(COc5no[n+]([O-])c5S(=O)(=O)c5ccccc5)c4)n3)c(OC)c2)CC1,7.35,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,IC50,45.0,nM,=,CHEMBL2412778,B,CHEMBL2408830,Homo sapiens,CHEMBL203,CHEMBL2407010
Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCO5)c2)cc1,8.70,Inhibition of EGFR (unknown origin),IC50,2.0,nM,=,CHEMBL2422326,B,CHEMBL2419760,Homo sapiens,CHEMBL203,CHEMBL2417485
Cl.c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCCO5)c2)cc1,7.57,Inhibition of EGFR (unknown origin),IC50,27.0,nM,=,CHEMBL2422326,B,CHEMBL2419762,Homo sapiens,CHEMBL203,CHEMBL2417485
COc1ccc2c(c1)CCCN2c1nc(C)nc2ccccc12,8.30,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,IC50,5.0,nM,=,CHEMBL4714413,B,CHEMBL2420866,Homo sapiens,CHEMBL203,CHEMBL4706704
COc1ccc2c(c1)CCCN2c1nc(Cl)nc2ccccc12,8.27,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,IC50,5.4,nM,=,CHEMBL4714413,B,CHEMBL2420867,Homo sapiens,CHEMBL203,CHEMBL4706704
O=C(/C=C/c1cccnc1Cl)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,5.44,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,IC50,3600.0,nM,=,CHEMBL2427414,B,CHEMBL2424794,Homo sapiens,CHEMBL203,CHEMBL2424555
Clc1cccc(Nc2ncnc3ccc(NCc4cccs4)cc23)c1,5.47,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,IC50,3400.0,nM,=,CHEMBL2427414,B,CHEMBL2424795,Homo sapiens,CHEMBL203,CHEMBL2424555
Clc1cccc(Nc2ncnc3ccc(NCc4ccc(Br)s4)cc23)c1,5.82,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,IC50,1500.0,nM,=,CHEMBL2427414,B,CHEMBL2424796,Homo sapiens,CHEMBL203,CHEMBL2424555
CSCCCNc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,5.29,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,IC50,5100.0,nM,=,CHEMBL2427414,B,CHEMBL2424799,Homo sapiens,CHEMBL203,CHEMBL2424555
O=C(/C=C/c1cccnc1)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,5.33,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,IC50,4700.0,nM,=,CHEMBL2427414,B,CHEMBL2424801,Homo sapiens,CHEMBL203,CHEMBL2424555
O=C(/C=C/c1ccc(Br)s1)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,5.62,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,IC50,2400.0,nM,=,CHEMBL2427414,B,CHEMBL2424804,Homo sapiens,CHEMBL203,CHEMBL2424555
Clc1cccc(Nc2ncnc3ccc(NCc4cccc(Br)n4)cc23)c1,5.39,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,IC50,4100.0,nM,=,CHEMBL2427414,B,CHEMBL2424807,Homo sapiens,CHEMBL203,CHEMBL2424555
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CC2(C1)CS(=O)(=O)C2,7.62,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,IC50,24.0,nM,=,CHEMBL2429426,B,CHEMBL2425083,Homo sapiens,CHEMBL203,CHEMBL2424588
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CC(O)C1,7.60,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,IC50,25.0,nM,=,CHEMBL2429426,B,CHEMBL2425084,Homo sapiens,CHEMBL203,CHEMBL2424588
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CC(OC)C1,7.47,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,IC50,34.0,nM,=,CHEMBL2429426,B,CHEMBL2425085,Homo sapiens,CHEMBL203,CHEMBL2424588
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCC2(COC2)C1,7.82,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,IC50,15.0,nM,=,CHEMBL2429426,B,CHEMBL2425086,Homo sapiens,CHEMBL203,CHEMBL2424588
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CC2(COC2)C1,7.80,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,IC50,16.0,nM,=,CHEMBL2429426,B,CHEMBL2425087,Homo sapiens,CHEMBL203,CHEMBL2424588
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CC2(CCO2)C1,6.72,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,IC50,190.0,nM,=,CHEMBL2429426,B,CHEMBL2425088,Homo sapiens,CHEMBL203,CHEMBL2424588
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CC2(CSC2)C1,7.28,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,IC50,52.0,nM,=,CHEMBL2429426,B,CHEMBL2425089,Homo sapiens,CHEMBL203,CHEMBL2424588
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CC2(C1)CS(=O)(=O)C2,6.80,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,IC50,158.0,nM,=,CHEMBL2429426,B,CHEMBL2424664,Homo sapiens,CHEMBL203,CHEMBL2424588
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CC(O)C1,7.58,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,IC50,26.0,nM,=,CHEMBL2429426,B,CHEMBL2425090,Homo sapiens,CHEMBL203,CHEMBL2424588
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCN1CC(OC)C1,7.03,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,IC50,94.0,nM,=,CHEMBL2429426,B,CHEMBL2425091,Homo sapiens,CHEMBL203,CHEMBL2424588
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CC2(COC2)C1,7.25,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,IC50,56.0,nM,=,CHEMBL2429426,B,CHEMBL2425092,Homo sapiens,CHEMBL203,CHEMBL2424588
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CC2(CCO2)C1,7.44,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,IC50,36.0,nM,=,CHEMBL2429426,B,CHEMBL2425093,Homo sapiens,CHEMBL203,CHEMBL2424588
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CC2(CSC2)C1,7.32,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,IC50,48.0,nM,=,CHEMBL2429426,B,CHEMBL2425094,Homo sapiens,CHEMBL203,CHEMBL2424588
O=C(CCCN1CCCCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.20,Inhibition of wild type human EGFR tyrosine kinase assessed as Ulight-CAGAGAIETDKEYYTVKD phosphorylation after 15 mins by time-resolved fluorometry,IC50,0.63,nM,=,CHEMBL2428558,B,CHEMBL2425735,Homo sapiens,CHEMBL203,CHEMBL2424521
Brc1cccc(Nc2ncnc3ccc(NCCCN4CCCCC4)cc23)c1,9.39,Inhibition of wild type human EGFR tyrosine kinase assessed as Ulight-CAGAGAIETDKEYYTVKD phosphorylation after 15 mins by time-resolved fluorometry,IC50,0.41,nM,=,CHEMBL2428558,B,CHEMBL2425736,Homo sapiens,CHEMBL203,CHEMBL2424521
O=C(CCOc1ccccc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.72,Inhibition of wild type human EGFR tyrosine kinase assessed as Ulight-CAGAGAIETDKEYYTVKD phosphorylation after 15 mins by time-resolved fluorometry,IC50,19.0,nM,=,CHEMBL2428558,B,CHEMBL2425737,Homo sapiens,CHEMBL203,CHEMBL2424521
COc1ccc(NC(=O)CCCN(C)C)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,5.64,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,2300.0,nM,=,CHEMBL2427158,B,CHEMBL2426248,Homo sapiens,CHEMBL203,CHEMBL2424560
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CCN(C)CC1,7.72,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,19.0,nM,=,CHEMBL2427158,B,CHEMBL2426277,Homo sapiens,CHEMBL203,CHEMBL2424560
C=CC(=O)Nc1cc(Nc2nccc(-c3cnn4ccccc34)n2)c(OC)cc1N1CCN(C)CC1,7.15,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,71.0,nM,=,CHEMBL2427158,B,CHEMBL2424676,Homo sapiens,CHEMBL203,CHEMBL2424560
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)c(OC)cc1N1CCN(C)CC1,8.25,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,5.6,nM,=,CHEMBL2427158,B,CHEMBL2426278,Homo sapiens,CHEMBL203,CHEMBL2424560
C=CC(=O)Nc1cc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)cc1N1CCN(C)CC1,7.20,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,63.0,nM,=,CHEMBL3389020,B,CHEMBL2426279,Homo sapiens,CHEMBL203,CHEMBL3351341
COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(-c2c[nH]c3ccccc23)n1,6.11,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,770.0,nM,=,CHEMBL2427158,B,CHEMBL2426280,Homo sapiens,CHEMBL203,CHEMBL2424560
C=CC(=O)Nc1cccc(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)c1,7.09,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,81.0,nM,=,CHEMBL2427158,B,CHEMBL2426281,Homo sapiens,CHEMBL203,CHEMBL2424560
C=CC(=O)Nc1ccc(OC)c(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)c1,7.66,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,22.0,nM,=,CHEMBL2427158,B,CHEMBL2426282,Homo sapiens,CHEMBL203,CHEMBL2424560
C=CC(=O)Nc1ccc(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)cc1,4.89,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,12900.0,nM,=,CHEMBL2427158,B,CHEMBL2426283,Homo sapiens,CHEMBL203,CHEMBL2424560
C=CC(=O)N1CCc2cc(OC)c(Nc3ncc(Cl)c(-c4c[nH]c5ccccc45)n3)cc21,5.68,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,2100.0,nM,=,CHEMBL2427158,B,CHEMBL2426284,Homo sapiens,CHEMBL203,CHEMBL2424560
COc1ccc(NC(=O)CC#N)cc1Nc1ncc(Cl)c(-c2c[nH]c3ccccc23)n1,5.55,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,2800.0,nM,=,CHEMBL2427158,B,CHEMBL2426285,Homo sapiens,CHEMBL203,CHEMBL2424560
C=CC(=O)Nc1ccc(OC)c(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c1,7.48,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,33.0,nM,=,CHEMBL2427158,B,CHEMBL2426286,Homo sapiens,CHEMBL203,CHEMBL2424560
COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc(Cl)c(-c2c[nH]c3ccccc23)n1,7.28,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,53.0,nM,=,CHEMBL2427158,B,CHEMBL2426287,Homo sapiens,CHEMBL203,CHEMBL2424560
COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1,7.04,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,91.0,nM,=,CHEMBL3389020,B,CHEMBL2426288,Homo sapiens,CHEMBL203,CHEMBL3351341
COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1nccc(-c2cnn3ccccc23)n1,6.60,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,250.0,nM,=,CHEMBL2427158,B,CHEMBL2426289,Homo sapiens,CHEMBL203,CHEMBL2424560
COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc(F)c(-c2cnn3ccccc23)n1,6.66,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,220.0,nM,=,CHEMBL2427158,B,CHEMBL2426290,Homo sapiens,CHEMBL203,CHEMBL2424560
COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc(C)c(-c2cnn3ccccc23)n1,6.54,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,290.0,nM,=,CHEMBL2427158,B,CHEMBL2426377,Homo sapiens,CHEMBL203,CHEMBL2424560
COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc([S+](C)[O-])c(-c2cnn3ccccc23)n1,4.82,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,15200.0,nM,=,CHEMBL2427158,B,CHEMBL2426378,Homo sapiens,CHEMBL203,CHEMBL2424560
COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(C)cc5)ccn4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,7.05,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) (4:1) as substrate after 30 mins by spectrophotometric analysis",IC50,90.05,nM,=,CHEMBL2437777,B,CHEMBL2435999,Homo sapiens,CHEMBL203,CHEMBL2434847
CSCCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1,7.60,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,IC50,25.1,nM,=,CHEMBL2439214,B,CHEMBL2437223,Homo sapiens,CHEMBL203,CHEMBL2434871
C[S+]([O-])CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1,7.89,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,IC50,13.0,nM,=,CHEMBL2439214,B,CHEMBL2437224,Homo sapiens,CHEMBL203,CHEMBL2434871
CS(=O)(=O)NCCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1,7.73,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,IC50,18.7,nM,=,CHEMBL2439214,B,CHEMBL2437225,Homo sapiens,CHEMBL203,CHEMBL2434871
Cc1ccc(S(=O)(=O)O)cc1.NS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.97,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,IC50,10.8,nM,=,CHEMBL2439214,B,CHEMBL2437226,Homo sapiens,CHEMBL203,CHEMBL2434871
Cc1ccc(S(=O)(=O)O)cc1.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)CC(F)(F)F,7.68,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,IC50,21.1,nM,=,CHEMBL2439214,B,CHEMBL2437227,Homo sapiens,CHEMBL203,CHEMBL2434871
Cc1ccc(-c2csc(=N)n2CC(=O)N2CCN(c3ccccc3)CC2)cc1,5.53,Inhibition of human EGFR,Ki,2970.0,nM,=,CHEMBL2439370,B,CHEMBL2437291,Homo sapiens,CHEMBL203,CHEMBL2434944
N=c1scc(-c2ccc(Cl)cc2)n1CC(=O)N1CCN(c2ccccc2)CC1,5.24,Inhibition of human EGFR,Ki,5820.0,nM,=,CHEMBL2439370,B,CHEMBL2437292,Homo sapiens,CHEMBL203,CHEMBL2434944
N=c1scc(-c2ccccc2)n1CC(=O)N1CCN(c2ccccc2)CC1,5.33,Inhibition of human EGFR,Ki,4680.0,nM,=,CHEMBL2439370,B,CHEMBL2437293,Homo sapiens,CHEMBL203,CHEMBL2434944
CC(=O)N1CCN(C(=O)Cn2c(-c3ccc(C)cc3)csc2=N)CC1,5.21,Inhibition of human EGFR,Ki,6090.0,nM,=,CHEMBL2439370,B,CHEMBL2437294,Homo sapiens,CHEMBL203,CHEMBL2434944
CC(=O)N1CCN(C(=O)Cn2c(-c3ccc(Cl)cc3)csc2=N)CC1,5.07,Inhibition of human EGFR,Ki,8580.0,nM,=,CHEMBL2439370,B,CHEMBL2437295,Homo sapiens,CHEMBL203,CHEMBL2434944
Cc1ccc(-c2csc(=N)n2CC(=O)N2CCN(C)CC2)cc1,4.56,Inhibition of human EGFR,Ki,27400.0,nM,=,CHEMBL2439370,B,CHEMBL2437296,Homo sapiens,CHEMBL203,CHEMBL2434944
CC(=O)N1CCN(C(=O)Cn2c(-c3ccccc3)csc2=N)CC1,4.78,Inhibition of human EGFR,Ki,16770.0,nM,=,CHEMBL2439370,B,CHEMBL2437297,Homo sapiens,CHEMBL203,CHEMBL2434944
CN1CCN(C(=O)Cn2c(-c3ccc(Cl)cc3)csc2=N)CC1,4.80,Inhibition of human EGFR,Ki,15650.0,nM,=,CHEMBL2439370,B,CHEMBL2437298,Homo sapiens,CHEMBL203,CHEMBL2434944
Cc1ccc(-c2csc(=N)n2CC(=O)N2CCOCC2)cc1,4.64,Inhibition of human EGFR,Ki,22940.0,nM,=,CHEMBL2439370,B,CHEMBL2437299,Homo sapiens,CHEMBL203,CHEMBL2434944
CN1CCN(C(=O)Cn2c(-c3ccccc3)csc2=N)CC1,4.38,Inhibition of human EGFR,Ki,41580.0,nM,=,CHEMBL2439370,B,CHEMBL2437300,Homo sapiens,CHEMBL203,CHEMBL2434944
N=c1scc(-c2ccccc2)n1CC(=O)N1CCOCC1,4.26,Inhibition of human EGFR,Ki,55290.0,nM,=,CHEMBL2439370,B,CHEMBL2437301,Homo sapiens,CHEMBL203,CHEMBL2434944
N=c1scc(-c2ccc(Cl)cc2)n1CC(=O)N1CCOCC1,5.18,Inhibition of human EGFR,Ki,6640.0,nM,=,CHEMBL2439370,B,CHEMBL2437302,Homo sapiens,CHEMBL203,CHEMBL2434944
C=CC(=O)Nc1ccc(-n2c(=O)cnc3cnc(Nc4ccc(Cl)cc4)nc32)cc1,6.84,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,144.1,nM,=,CHEMBL2439334,B,CHEMBL2437457,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccc(Cl)cc4)nc32)c1,7.75,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,17.6,nM,=,CHEMBL2439334,B,CHEMBL2437458,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1ccc(-n2c(=O)cnc3cnc(Nc4ccc(N5CCOCC5)cc4)nc32)cc1,5.46,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,3456.0,nM,=,CHEMBL2439334,B,CHEMBL2437459,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccc(N5CCOCC5)cc4)nc32)c1,8.54,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,2.86,nM,=,CHEMBL2439334,B,CHEMBL2437460,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1ccc(-n2c(=O)cnc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)cc1,6.16,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,691.0,nM,=,CHEMBL2439334,B,CHEMBL2437461,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1,9.17,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,0.677,nM,=,CHEMBL2439334,B,CHEMBL2437462,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccc(N5CCCCC5)cc4)nc32)c1,8.29,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,5.12,nM,=,CHEMBL2439334,B,CHEMBL2437463,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccc(N5CCCC5)cc4)nc32)c1,8.30,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,4.96,nM,=,CHEMBL2439334,B,CHEMBL2437464,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccc(N(CC)CC)cc4)nc32)c1,8.33,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,4.72,nM,=,CHEMBL2439334,B,CHEMBL2437465,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccc(NC(C)=O)cc4)nc32)c1,8.34,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,4.53,nM,=,CHEMBL2439334,B,CHEMBL2437466,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccc(C(N)=O)cc4)nc32)c1,8.40,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,3.97,nM,=,CHEMBL2439334,B,CHEMBL2437467,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1ccc(-n2c(=O)cnc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)cc1,6.57,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,272.0,nM,=,CHEMBL2439334,B,CHEMBL2437468,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.97,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,1.07,nM,=,CHEMBL2439334,B,CHEMBL2437469,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1ccc(-n2c(=O)c(C)nc3cnc(Nc4ccc(OC)cc4)nc32)cc1,5.14,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,7167.0,nM,=,CHEMBL2439335,B,CHEMBL2437470,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1cccc(-n2c(=O)c(C)nc3cnc(Nc4ccc(OC)cc4)nc32)c1,8.28,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,5.29,nM,=,CHEMBL2439336,B,CHEMBL2437471,Homo sapiens,CHEMBL203,CHEMBL2434822
COc1ccc(Nc2ncc3ncc(=O)n(-c4cccc(N)c4)c3n2)cc1,4.67,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,21280.0,nM,=,CHEMBL2439334,B,CHEMBL2437473,Homo sapiens,CHEMBL203,CHEMBL2434822
COc1ccc(-n2c(=O)cnc3cnc(Nc4cccc(N)c4)nc32)cc1,5.42,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,3836.0,nM,=,CHEMBL2439334,B,CHEMBL2437474,Homo sapiens,CHEMBL203,CHEMBL2434822
COc1ccc(-n2c(=O)cnc3cnc(Nc4ccc(N)cc4)nc32)cc1,5.17,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,6754.0,nM,=,CHEMBL2439334,B,CHEMBL2437475,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1ccc(Nc2ncc3ncc(=O)n(-c4ccc(OC)cc4)c3n2)cc1,4.47,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,33885.0,nM,=,CHEMBL2439336,B,CHEMBL2437477,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1ccc(-n2c(=O)cnc3cnc(Nc4ccc(OC)cc4)nc32)cc1,5.32,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,4802.0,nM,=,CHEMBL2439334,B,CHEMBL2437478,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccc(OC)cc4)nc32)c1,8.25,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,5.6,nM,=,CHEMBL2439334,B,CHEMBL2437479,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Oc1ccc(-n2c(=O)cnc3cnc(Nc4ccc(OC)cc4)nc32)cc1,7.23,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,59.1,nM,=,CHEMBL2439334,B,CHEMBL2437482,Homo sapiens,CHEMBL203,CHEMBL2434822
COc1ccc(Nc2ncc3ncc(=O)n(-c4ccc(NC(=O)/C=C/CN(C)C)cc4)c3n2)cc1,7.50,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,31.3,nM,=,CHEMBL2439334,B,CHEMBL2437483,Homo sapiens,CHEMBL203,CHEMBL2434822
COc1ccc(Nc2ncc3ncc(=O)n(-c4cccc(NC(=O)/C=C/CN(C)C)c4)c3n2)cc1,4.58,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,26283.0,nM,=,CHEMBL2439336,B,CHEMBL2437484,Homo sapiens,CHEMBL203,CHEMBL2434822
CN(C)C/C=C/C(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccccc4)nc32)c1,7.40,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,39.7,nM,=,CHEMBL2439334,B,CHEMBL2437486,Homo sapiens,CHEMBL203,CHEMBL2434822
C=CC(=O)Nc1cccc(-n2c(=O)cnc3cnc(Nc4ccccc4)nc32)c1,8.31,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,IC50,4.94,nM,=,CHEMBL2439334,B,CHEMBL2437488,Homo sapiens,CHEMBL203,CHEMBL2434822
CCc1ccc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2c1,6.20,Inhibition of EGFR (unknown origin),IC50,630.96,nM,=,CHEMBL2446676,B,CHEMBL2441273,Homo sapiens,CHEMBL203,CHEMBL2440060
O=C(/C=C/CN1CCOCC1)N1CCOc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,8.15,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,IC50,7.0,nM,=,CHEMBL4432463,B,CHEMBL2441561,Homo sapiens,CHEMBL203,CHEMBL4431348
O=C(/C=C/CN1CCOCC1)N1CCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21,8.15,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,IC50,7.0,nM,=,CHEMBL4628613,B,CHEMBL2441563,Homo sapiens,CHEMBL203,CHEMBL4627322
CN(C)C/C=C/C(=O)N1CCOc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,8.40,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,IC50,4.0,nM,=,CHEMBL4432463,B,CHEMBL2441565,Homo sapiens,CHEMBL203,CHEMBL4431348
CN(C)C/C=C/C(=O)N1CCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21,6.90,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,IC50,126.0,nM,=,CHEMBL4628612,B,CHEMBL2441567,Homo sapiens,CHEMBL203,CHEMBL4627322
Fc1ccc(Nc2ncnc3cc4c(cc23)NCCO4)cc1Cl,8.89,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins prior to ATP addition measured after 30 mins by HTRF method,IC50,1.29,nM,=,CHEMBL2444969,B,CHEMBL2441568,Homo sapiens,CHEMBL203,CHEMBL2440024
C#Cc1cccc(-n2ccc3cc(OC)cc(OC)c3c2=O)c1,5.46,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,IC50,3510.0,nM,=,CHEMBL2446217,B,CHEMBL2442319,Homo sapiens,CHEMBL203,CHEMBL2440093
COc1cc(OC)c2c(=O)n(-c3ccc(F)c(Cl)c3)ccc2c1,5.26,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,IC50,5490.0,nM,=,CHEMBL2446217,B,CHEMBL2442320,Homo sapiens,CHEMBL203,CHEMBL2440093
COc1cc(OC)c2c(=O)n(-c3cccc(C(=O)N4CCCCC4)c3)ccc2c1,5.67,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,IC50,2120.0,nM,=,CHEMBL2446217,B,CHEMBL2442324,Homo sapiens,CHEMBL203,CHEMBL2440093
C#Cc1cccc(-n2ccc3cc(OC)cc(O)c3c2=O)c1,5.51,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,IC50,3060.0,nM,=,CHEMBL2446217,B,CHEMBL2442327,Homo sapiens,CHEMBL203,CHEMBL2440093
COc1cc(O)c2c(=O)n(-c3cccc(C(=O)N4CCCCC4)c3)ccc2c1,5.86,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,IC50,1380.0,nM,=,CHEMBL2446217,B,CHEMBL2442329,Homo sapiens,CHEMBL203,CHEMBL2440093
COc1cc2c(c(OC)c1)C(=O)N(c1cccc(C(=O)N3CCCCC3)c1)CC2,5.91,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,IC50,1230.0,nM,=,CHEMBL2446217,B,CHEMBL2442332,Homo sapiens,CHEMBL203,CHEMBL2440093
COc1cc(O)c2c(c1)CCN(c1cccc(C(=O)N3CCCCC3)c1)C2=O,5.93,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,IC50,1180.0,nM,=,CHEMBL2446217,B,CHEMBL2442333,Homo sapiens,CHEMBL203,CHEMBL2440093
CCOc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OCC.Cl,9.42,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",IC50,0.38,nM,=,CHEMBL916319,B,CHEMBL2447950,Homo sapiens,CHEMBL203,CHEMBL1140296
COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CCNCC1.Cl,6.52,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,300.0,nM,=,CHEMBL677388,B,CHEMBL2448064,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl,6.52,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,300.0,nM,=,CHEMBL677388,B,CHEMBL2448065,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3cc(O)c(Cl)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl,7.00,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,100.0,nM,=,CHEMBL677388,B,CHEMBL2448066,Homo sapiens,CHEMBL203,CHEMBL1135889
COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCN1CCCC1.Cl,7.00,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,IC50,100.0,nM,=,CHEMBL677388,B,CHEMBL2448067,Homo sapiens,CHEMBL203,CHEMBL1135889
CSCCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.25,"In Vitro Kinase Assay: In vitro kinase analysis was performed by using HTScan EGF Receptor Kinase Assay Kit (#7909) and HTScan HER2/ErbB2 Kinase Assay Kit (#7058) from Cell Signaling Technology Company. Operation steps refer to the specification of the used kits, and the method was used to measure the inhibition effects of the compound to be tested on substrate peptide phosphorylation of EGFR or Her2 receptor tyrosine kinase. At room temperature, ATP and substrate peptide as well as the compound to be tested were incubated in kinase reaction buffer, after a period of incubation, a stop buffer was added to terminate the reaction and the sample was transferred to a streptavidin-coated 96-well plate, the plate was washed and the phosphorylation level of substrate peptide was detected by using HRP-marked antibody against substrate phosphorylation, colorated with TMB, terminated the reaction with 2M sulfuric acid. Absorption at 450 nm wavelength was detected, and IC50 value (μM) was calculated.",IC50,56.24,nM,=,CHEMBL3705522,B,CHEMBL3040455,Homo sapiens,CHEMBL203,CHEMBL3638441
O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)CC(F)(F)F,7.83,"In Vitro Kinase Assay: In vitro kinase analysis was performed by using HTScan EGF Receptor Kinase Assay Kit (#7909) and HTScan HER2/ErbB2 Kinase Assay Kit (#7058) from Cell Signaling Technology Company. Operation steps refer to the specification of the used kits, and the method was used to measure the inhibition effects of the compound to be tested on substrate peptide phosphorylation of EGFR or Her2 receptor tyrosine kinase. At room temperature, ATP and substrate peptide as well as the compound to be tested were incubated in kinase reaction buffer, after a period of incubation, a stop buffer was added to terminate the reaction and the sample was transferred to a streptavidin-coated 96-well plate, the plate was washed and the phosphorylation level of substrate peptide was detected by using HRP-marked antibody against substrate phosphorylation, colorated with TMB, terminated the reaction with 2M sulfuric acid. Absorption at 450 nm wavelength was detected, and IC50 value (μM) was calculated.",IC50,14.61,nM,=,CHEMBL3705522,B,CHEMBL3040543,Homo sapiens,CHEMBL203,CHEMBL3638441
C[S+]([O-])CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.28,"In Vitro Kinase Assay: In vitro kinase analysis was performed by using HTScan EGF Receptor Kinase Assay Kit (#7909) and HTScan HER2/ErbB2 Kinase Assay Kit (#7058) from Cell Signaling Technology Company. Operation steps refer to the specification of the used kits, and the method was used to measure the inhibition effects of the compound to be tested on substrate peptide phosphorylation of EGFR or Her2 receptor tyrosine kinase. At room temperature, ATP and substrate peptide as well as the compound to be tested were incubated in kinase reaction buffer, after a period of incubation, a stop buffer was added to terminate the reaction and the sample was transferred to a streptavidin-coated 96-well plate, the plate was washed and the phosphorylation level of substrate peptide was detected by using HRP-marked antibody against substrate phosphorylation, colorated with TMB, terminated the reaction with 2M sulfuric acid. Absorption at 450 nm wavelength was detected, and IC50 value (μM) was calculated.",IC50,52.67,nM,=,CHEMBL3705522,B,CHEMBL3040548,Homo sapiens,CHEMBL203,CHEMBL3638441
NS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,8.57,"In Vitro Kinase Assay: In vitro kinase analysis was performed by using HTScan EGF Receptor Kinase Assay Kit (#7909) and HTScan HER2/ErbB2 Kinase Assay Kit (#7058) from Cell Signaling Technology Company. Operation steps refer to the specification of the used kits, and the method was used to measure the inhibition effects of the compound to be tested on substrate peptide phosphorylation of EGFR or Her2 receptor tyrosine kinase. At room temperature, ATP and substrate peptide as well as the compound to be tested were incubated in kinase reaction buffer, after a period of incubation, a stop buffer was added to terminate the reaction and the sample was transferred to a streptavidin-coated 96-well plate, the plate was washed and the phosphorylation level of substrate peptide was detected by using HRP-marked antibody against substrate phosphorylation, colorated with TMB, terminated the reaction with 2M sulfuric acid. Absorption at 450 nm wavelength was detected, and IC50 value (μM) was calculated.",IC50,2.71,nM,=,CHEMBL3705522,B,CHEMBL3040566,Homo sapiens,CHEMBL203,CHEMBL3638441
CS(=O)(=O)NCCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.81,"In Vitro Kinase Assay: In vitro kinase analysis was performed by using HTScan EGF Receptor Kinase Assay Kit (#7909) and HTScan HER2/ErbB2 Kinase Assay Kit (#7058) from Cell Signaling Technology Company. Operation steps refer to the specification of the used kits, and the method was used to measure the inhibition effects of the compound to be tested on substrate peptide phosphorylation of EGFR or Her2 receptor tyrosine kinase. At room temperature, ATP and substrate peptide as well as the compound to be tested were incubated in kinase reaction buffer, after a period of incubation, a stop buffer was added to terminate the reaction and the sample was transferred to a streptavidin-coated 96-well plate, the plate was washed and the phosphorylation level of substrate peptide was detected by using HRP-marked antibody against substrate phosphorylation, colorated with TMB, terminated the reaction with 2M sulfuric acid. Absorption at 450 nm wavelength was detected, and IC50 value (μM) was calculated.",IC50,15.54,nM,=,CHEMBL3705522,B,CHEMBL3040597,Homo sapiens,CHEMBL203,CHEMBL3638441
c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCO5)c2)cc1,7.38,Inhibition of EGFR (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis,IC50,42.0,nM,=,CHEMBL3300694,B,CHEMBL3040806,Homo sapiens,CHEMBL203,CHEMBL3297684
c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCO5)c2)cc1,8.70,Inhibition of EGFR (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis,IC50,2.0,nM,=,CHEMBL3300694,B,CHEMBL3040861,Homo sapiens,CHEMBL203,CHEMBL3297684
c1ccc(-c2cccc(Nc3ncnc4cc5c(cc34)OCCCO5)c2)cc1,7.57,Inhibition of EGFR (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis,IC50,27.0,nM,=,CHEMBL3300694,B,CHEMBL3040910,Homo sapiens,CHEMBL203,CHEMBL3297684
C[C@H](Nc1ncnc2c1sc1ccccc12)c1ccccc1,6.27,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),IC50,538.0,nM,=,CHEMBL679944,B,CHEMBL3085277,Homo sapiens,CHEMBL203,CHEMBL1132555
COc1cc2ncnc(C#C[C@](C)(O)Cc3ccccc3)c2cc1OC,8.05,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,9.0,nM,=,CHEMBL925198,B,CHEMBL3085374,Homo sapiens,CHEMBL203,CHEMBL1140492
COc1cc2ncnc(C#C[C@@](C)(Cc3ccccc3)N3CCC(C(=O)O)CC3)c2cc1OC,7.48,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,33.0,nM,=,CHEMBL925198,B,CHEMBL3085375,Homo sapiens,CHEMBL203,CHEMBL1140492
CCN(CC)[C@@](C)(C#Cc1ncnc2cc(OC)c(OC)cc12)Cc1ccccc1,8.52,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,3.0,nM,=,CHEMBL925198,B,CHEMBL3085376,Homo sapiens,CHEMBL203,CHEMBL1140492
CCN(CC)[C@@](C)(C#Cc1ncnc2cc(OC)c(OC)cc12)c1ccccc1,5.14,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,7300.0,nM,=,CHEMBL925198,B,CHEMBL3085377,Homo sapiens,CHEMBL203,CHEMBL1140492
CCN(CC)[C@@](C)(C#Cc1ncnc2cc(OC)c(OC)cc12)CCc1ccccc1,5.92,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,1200.0,nM,=,CHEMBL925198,B,CHEMBL3085378,Homo sapiens,CHEMBL203,CHEMBL1140492
CCN(CC)[C@@](C)(C#Cc1ncnc2cc(OC)c(OC)cc12)Cc1ccncc1,6.70,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,200.0,nM,=,CHEMBL925198,B,CHEMBL3085379,Homo sapiens,CHEMBL203,CHEMBL1140492
CCN(CC)[C@@](C)(C#Cc1ncnc2cc(OC)c(OC)cc12)CC1CCCCC1,5.96,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,1100.0,nM,=,CHEMBL925198,B,CHEMBL3085380,Homo sapiens,CHEMBL203,CHEMBL1140492
CCN(CC)[C@@](C)(CCc1ncnc2cc(OC)c(OC)cc12)Cc1ccccc1,6.89,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,IC50,130.0,nM,=,CHEMBL925198,B,CHEMBL3085381,Homo sapiens,CHEMBL203,CHEMBL1140492
C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,8.85,Binding affinity to EGFR L858R/T790M double mutant (unknown origin),Kd,1.4,nM,=,CHEMBL3088497,B,CHEMBL3086102,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C(F)(F)F)c4)nc32)C1,7.26,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,55.5,nM,=,CHEMBL3088813,B,CHEMBL3086103,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(Cl)c4)nc32)C1,7.45,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,35.6,nM,=,CHEMBL3088813,B,CHEMBL3086104,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(F)c4)nc32)C1,7.77,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,17.1,nM,=,CHEMBL3088813,B,CHEMBL3086105,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(OC)c4)nc32)C1,8.14,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,7.2,nM,=,CHEMBL3088813,B,CHEMBL3086106,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(C5CCN(C)CC5)cc4)nc32)C1,7.79,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,16.2,nM,=,CHEMBL3088813,B,CHEMBL3087193,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(CCN5CCN(C)CC5)cc4)nc32)C1,7.38,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,41.3,nM,=,CHEMBL3088813,B,CHEMBL3087194,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4cccc(N5CCN(C)CC5)c4)nc32)C1,7.01,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,97.9,nM,=,CHEMBL3088813,B,CHEMBL3087195,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)C1,7.54,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,29.1,nM,=,CHEMBL3088813,B,CHEMBL3087196,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccccc4)nc32)C1,6.63,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,235.4,nM,=,CHEMBL3088813,B,CHEMBL3087197,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)C1,7.82,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,15.2,nM,=,CHEMBL3088813,B,CHEMBL3087198,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(C3CCCC3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)C1,7.23,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,58.7,nM,=,CHEMBL3088813,B,CHEMBL3087199,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(C3CCCCC3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)C1,7.37,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,42.9,nM,=,CHEMBL3088813,B,CHEMBL3087200,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(C(C)C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)C1,6.06,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,864.0,nM,=,CHEMBL3088813,B,CHEMBL3087201,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)C1,6.28,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,525.0,nM,=,CHEMBL3088813,B,CHEMBL3087202,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@@H](N2C(=O)N(Cc3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)C1,6.97,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,107.1,nM,=,CHEMBL3088813,B,CHEMBL3087204,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CC[C@H](N2C(=O)N(Cc3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)C1,8.06,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,8.8,nM,=,CHEMBL3088813,B,CHEMBL3087205,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CCC[C@@H](N2C(=O)N(Cc3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)C1,7.39,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,40.3,nM,=,CHEMBL3088813,B,CHEMBL3087206,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CCC[C@H](N2C(=O)N(Cc3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)C1,6.69,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,204.1,nM,=,CHEMBL3088813,B,CHEMBL3087207,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)N1CCC(N2C(=O)N(Cc3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)CC1,6.84,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,143.6,nM,=,CHEMBL3088813,B,CHEMBL3087208,Homo sapiens,CHEMBL203,CHEMBL3085739
C=CC(=O)NC1CCC(N2C(=O)N(Cc3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)CC1,6.15,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,708.5,nM,=,CHEMBL3088813,B,CHEMBL3087209,Homo sapiens,CHEMBL203,CHEMBL3085739
Cc1ncc([N+](=O)[O-])n1C/C(=N/NC(=O)c1ccncc1)c1ccc(Br)cc1,5.09,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,IC50,8190.0,nM,=,CHEMBL3091175,B,CHEMBL3088218,Homo sapiens,CHEMBL203,CHEMBL3085672
Cc1ncc([N+](=O)[O-])n1C/C(=N/NC(=O)c1ccc(N)cc1)c1ccc(Br)cc1,6.37,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,IC50,430.0,nM,=,CHEMBL3091175,B,CHEMBL3088219,Homo sapiens,CHEMBL203,CHEMBL3085672
Cc1ncc([N+](=O)[O-])n1C/C(=N/NC(=O)c1ccc(O)cc1)c1ccc(Br)cc1,6.68,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,IC50,210.0,nM,=,CHEMBL3091175,B,CHEMBL3088220,Homo sapiens,CHEMBL203,CHEMBL3085672
Cc1ncc([N+](=O)[O-])n1C/C(=N/NC(=O)c1ccccc1N)c1ccc(Br)cc1,5.72,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,IC50,1890.0,nM,=,CHEMBL3091175,B,CHEMBL3088221,Homo sapiens,CHEMBL203,CHEMBL3085672
Cc1ncc([N+](=O)[O-])n1C/C(=N/NC(=O)c1ccccc1O)c1ccc(Br)cc1,5.59,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,IC50,2580.0,nM,=,CHEMBL3091175,B,CHEMBL3088222,Homo sapiens,CHEMBL203,CHEMBL3085672
Cc1ncc([N+](=O)[O-])n1C/C(=N/NC(=O)c1ccc(Cl)cc1)c1ccc(Br)cc1,4.91,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,IC50,12450.0,nM,=,CHEMBL3091175,B,CHEMBL3088223,Homo sapiens,CHEMBL203,CHEMBL3085672
Cc1ccc(C(=O)N/N=C(/Cn2c([N+](=O)[O-])cnc2C)c2ccc(Br)cc2)cc1,5.21,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,IC50,6130.0,nM,=,CHEMBL3091175,B,CHEMBL3088224,Homo sapiens,CHEMBL203,CHEMBL3085672
Cc1ncc([N+](=O)[O-])n1C/C(=N/NC(=O)c1ccccc1)c1ccc(Br)cc1,5.00,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,IC50,10020.0,nM,=,CHEMBL3091175,B,CHEMBL3088225,Homo sapiens,CHEMBL203,CHEMBL3085672
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)N1CCC(F)CC1,6.16,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,699.0,nM,=,CHEMBL3095060,B,CHEMBL3092297,Homo sapiens,CHEMBL203,CHEMBL3091333
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)N1CCC(F)(F)CC1,6.07,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,859.0,nM,=,CHEMBL3095060,B,CHEMBL3092298,Homo sapiens,CHEMBL203,CHEMBL3091333
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)N1CCCC(F)(F)C1,6.05,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,884.0,nM,=,CHEMBL3095060,B,CHEMBL3092299,Homo sapiens,CHEMBL203,CHEMBL3091333
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)N1CCC2(CC1)OCCO2,5.77,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,1715.0,nM,=,CHEMBL3095060,B,CHEMBL3092300,Homo sapiens,CHEMBL203,CHEMBL3091333
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)N1CCC(N2CCCC2)CC1,6.58,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,265.0,nM,=,CHEMBL3095060,B,CHEMBL3092301,Homo sapiens,CHEMBL203,CHEMBL3091333
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)N1CCC(CCO)CC1,6.52,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,304.0,nM,=,CHEMBL3095060,B,CHEMBL3092302,Homo sapiens,CHEMBL203,CHEMBL3091333
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)N1CCN(CCO)CC1,6.48,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,331.0,nM,=,CHEMBL3095060,B,CHEMBL3092303,Homo sapiens,CHEMBL203,CHEMBL3091333
C#CCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,6.63,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,232.0,nM,=,CHEMBL3095060,B,CHEMBL3092304,Homo sapiens,CHEMBL203,CHEMBL3091333
COC(=O)/C=C/CNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,6.39,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,404.0,nM,=,CHEMBL3095060,B,CHEMBL3092305,Homo sapiens,CHEMBL203,CHEMBL3091333
CN(C)CCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,6.20,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,635.0,nM,=,CHEMBL3095060,B,CHEMBL3092306,Homo sapiens,CHEMBL203,CHEMBL3091333
CCN(CC)CCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,6.44,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,365.0,nM,=,CHEMBL3095060,B,CHEMBL3092307,Homo sapiens,CHEMBL203,CHEMBL3091333
O=C(NCCN1CCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,7.17,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,68.0,nM,=,CHEMBL3095060,B,CHEMBL3092308,Homo sapiens,CHEMBL203,CHEMBL3091333
O=C(NCCN1CCCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,6.78,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,165.0,nM,=,CHEMBL3095060,B,CHEMBL3092309,Homo sapiens,CHEMBL203,CHEMBL3091333
O=C(NCCN1CCOCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,7.09,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,82.0,nM,=,CHEMBL3095060,B,CHEMBL3092310,Homo sapiens,CHEMBL203,CHEMBL3091333
COCCCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,6.71,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,197.0,nM,=,CHEMBL3095060,B,CHEMBL3092311,Homo sapiens,CHEMBL203,CHEMBL3091333
COC(CCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)OC,6.26,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,544.0,nM,=,CHEMBL3095060,B,CHEMBL3092312,Homo sapiens,CHEMBL203,CHEMBL3091333
CN(C)CCCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,7.62,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,24.0,nM,=,CHEMBL3095060,B,CHEMBL3092313,Homo sapiens,CHEMBL203,CHEMBL3091333
CCN(CC)CCCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,7.50,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,32.0,nM,=,CHEMBL3095060,B,CHEMBL3092314,Homo sapiens,CHEMBL203,CHEMBL3091333
CN(C)CCN(C)C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,6.55,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,281.0,nM,=,CHEMBL3095060,B,CHEMBL3092315,Homo sapiens,CHEMBL203,CHEMBL3091333
CCN(CC)CCN(C)C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,6.30,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,505.0,nM,=,CHEMBL3095060,B,CHEMBL3092316,Homo sapiens,CHEMBL203,CHEMBL3091333
CN(C)CCCN(C)C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,6.33,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,464.0,nM,=,CHEMBL3095060,B,CHEMBL3092317,Homo sapiens,CHEMBL203,CHEMBL3091333
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)N1CC(O)C1,6.26,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,543.0,nM,=,CHEMBL3095060,B,CHEMBL3092318,Homo sapiens,CHEMBL203,CHEMBL3091333
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)N1CC(F)C1,6.01,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,967.0,nM,=,CHEMBL3095060,B,CHEMBL3092319,Homo sapiens,CHEMBL203,CHEMBL3091333
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)N1CCC(F)(F)C1,5.80,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,1581.0,nM,=,CHEMBL3095060,B,CHEMBL3092320,Homo sapiens,CHEMBL203,CHEMBL3091333
CN1CCN(C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2O[C@H]2CCOC2)CC1,6.33,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,464.0,nM,=,CHEMBL3095060,B,CHEMBL3092321,Homo sapiens,CHEMBL203,CHEMBL3091333
O=C(NCCO)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,7.57,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,27.0,nM,=,CHEMBL3095060,B,CHEMBL3092322,Homo sapiens,CHEMBL203,CHEMBL3091333
COCCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,6.32,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,479.0,nM,=,CHEMBL3095060,B,CHEMBL3092323,Homo sapiens,CHEMBL203,CHEMBL3091333
CS(=O)(=O)CCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,7.39,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,41.0,nM,=,CHEMBL3095060,B,CHEMBL3092324,Homo sapiens,CHEMBL203,CHEMBL3091333
COc1cc2nc(Cl)nc(Nc3ccc(S(=O)(=O)N(C)C)cc3)c2cc1OC,4.17,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,IC50,67200.0,nM,=,CHEMBL3101602,B,CHEMBL3098312,Homo sapiens,CHEMBL203,CHEMBL3098085
CN(C)S(=O)(=O)c1ccc(Nc2nc(Cl)nc3cc4c(cc23)OCO4)cc1,4.74,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,IC50,18300.0,nM,=,CHEMBL3101602,B,CHEMBL3098313,Homo sapiens,CHEMBL203,CHEMBL3098085
COc1cc2nc(Cl)nc(Nc3ccc(S(C)(=O)=O)cc3)c2cc1OC,4.21,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,IC50,61500.0,nM,=,CHEMBL3101602,B,CHEMBL3098315,Homo sapiens,CHEMBL203,CHEMBL3098085
COc1cc2nc(Cl)nc(Nc3ccc(S(N)(=O)=O)cc3)c2cc1OC,5.62,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,IC50,2370.0,nM,=,CHEMBL3101602,B,CHEMBL3098317,Homo sapiens,CHEMBL203,CHEMBL3098085
NS(=O)(=O)c1ccc(Nc2nc(Cl)nc3cc4c(cc23)OCO4)cc1,4.46,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,IC50,34600.0,nM,=,CHEMBL3101602,B,CHEMBL3098318,Homo sapiens,CHEMBL203,CHEMBL3098085
COc1cc2nc(Cl)nc(Nc3ccc(N(C)C)cc3)c2cc1OC,4.44,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,IC50,36000.0,nM,=,CHEMBL3101602,B,CHEMBL3098319,Homo sapiens,CHEMBL203,CHEMBL3098085
CNS(=O)(=O)c1ccc(Nc2nc(Cl)nc3cc(OC)c(OC)cc23)cc1,5.79,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,IC50,1630.0,nM,=,CHEMBL3101602,B,CHEMBL3098321,Homo sapiens,CHEMBL203,CHEMBL3098085
COc1cc2nc(Cl)nc(Nc3ccc(O)cc3)c2cc1OC,5.37,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,IC50,4300.0,nM,=,CHEMBL3101602,B,CHEMBL3098322,Homo sapiens,CHEMBL203,CHEMBL3098085
COc1cc2nc(Cl)nc(Nc3ccc(C(N)=O)cc3)c2cc1OC,6.05,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,IC50,900.0,nM,=,CHEMBL3101602,B,CHEMBL3098325,Homo sapiens,CHEMBL203,CHEMBL3098085
COc1cc2nc(Cl)nc(Nc3ccc(NC(C)=O)cc3)c2cc1OC,4.42,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,IC50,37600.0,nM,=,CHEMBL3101602,B,CHEMBL3098326,Homo sapiens,CHEMBL203,CHEMBL3098085
COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3,6.22,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Kd,602.0,nM,=,CHEMBL3991696,B,CHEMBL3109738,Homo sapiens,CHEMBL203,CHEMBL3991601
C#Cc1cccc(Nc2ncnc3cc4c(cc23)N(C(=O)/C=C/CN2CCCCC2C)CCO4)c1,8.30,Inhibition of EGFR (unknown origin) after 10 mins,IC50,5.0,nM,=,CHEMBL3118714,B,CHEMBL3114686,Homo sapiens,CHEMBL203,CHEMBL3112407
C#Cc1cccc(Nc2ncnc3cc4c(cc23)N(C(=O)/C=C/CN(CC)CC)CCO4)c1,8.30,Inhibition of EGFR (unknown origin) after 10 mins,IC50,5.0,nM,=,CHEMBL3118714,B,CHEMBL3114687,Homo sapiens,CHEMBL203,CHEMBL3112407
C#Cc1cccc(Nc2ncnc3cc4c(cc23)N(C(=O)/C=C/CN2CCCCC2)CCO4)c1,8.40,Inhibition of EGFR (unknown origin) after 10 mins,IC50,4.0,nM,=,CHEMBL3118714,B,CHEMBL3114688,Homo sapiens,CHEMBL203,CHEMBL3112407
C#Cc1cccc(Nc2ncnc3cc4c(cc23)N(C(=O)/C=C/CN2CCN(C)CC2)CCO4)c1,7.80,Inhibition of EGFR (unknown origin) after 10 mins,IC50,16.0,nM,=,CHEMBL3118714,B,CHEMBL3114689,Homo sapiens,CHEMBL203,CHEMBL3112407
C#Cc1cccc(Nc2ncnc3cc4c(cc23)N(C(=O)/C=C/CN(C)C)CCO4)c1,8.52,Inhibition of EGFR (unknown origin) after 10 mins,IC50,3.0,nM,=,CHEMBL3118714,B,CHEMBL3114690,Homo sapiens,CHEMBL203,CHEMBL3112407
C#Cc1cccc(Nc2ncnc3cc4c(cc23)N(C(=O)/C=C/CN2CCOCC2)CCO4)c1,7.92,Inhibition of EGFR (unknown origin) after 10 mins,IC50,12.0,nM,=,CHEMBL3118714,B,CHEMBL3114699,Homo sapiens,CHEMBL203,CHEMBL3112407
C#Cc1cccc(Nc2ncnc3cc4c(cc23)N(C(=O)/C=C/CN2CCCC2)CCO4)c1,8.52,Inhibition of EGFR (unknown origin) after 10 mins,IC50,3.0,nM,=,CHEMBL3118714,B,CHEMBL3114700,Homo sapiens,CHEMBL203,CHEMBL3112407
C#Cc1cccc(Nc2ncnc3cc4c(cc23)N(C(=O)/C=C/CN2CCC(C)CC2)CCO4)c1,8.30,Inhibition of EGFR (unknown origin) after 10 mins,IC50,5.0,nM,=,CHEMBL3118714,B,CHEMBL3114701,Homo sapiens,CHEMBL203,CHEMBL3112407
COc1cc2ncnc(Nc3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c2cc1OCCCN1CCOCC1,6.54,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,IC50,285.0,nM,=,CHEMBL3136336,B,CHEMBL3133751,Homo sapiens,CHEMBL203,CHEMBL3132845
COc1cc2ncnc(Nc3cccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)c3)c2cc1OCCCN1CCOCC1,7.09,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,IC50,82.0,nM,=,CHEMBL3136336,B,CHEMBL3133752,Homo sapiens,CHEMBL203,CHEMBL3132845
COc1cc2ncnc(Nc3cccc(NC(=O)Nc4cccc(C)c4)c3)c2cc1OCCCN1CCOCC1,5.63,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,IC50,2350.0,nM,=,CHEMBL3136336,B,CHEMBL3133754,Homo sapiens,CHEMBL203,CHEMBL3132845
O=C(Nc1cccc(Nc2ncnc3cc(OCCCN4CCOCC4)ccc23)c1)Nc1ccc(F)c(Cl)c1,5.48,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,IC50,3315.0,nM,=,CHEMBL3136336,B,CHEMBL3133755,Homo sapiens,CHEMBL203,CHEMBL3132845
O=C(Nc1cccc(Nc2ncnc3cc(OCCCN4CCN(CCO)CC4)ccc23)c1)Nc1ccc(Cl)c(C(F)(F)F)c1,7.00,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,IC50,99.0,nM,=,CHEMBL3136336,B,CHEMBL3133756,Homo sapiens,CHEMBL203,CHEMBL3132845
CCN(CCO)CCCOc1ccc2c(Nc3cccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)c3)ncnc2c1,6.73,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,IC50,188.0,nM,=,CHEMBL3136336,B,CHEMBL3133757,Homo sapiens,CHEMBL203,CHEMBL3132845
CCN(CCO)CCCOc1ccc2c(Nc3cccc(NC(=O)Nc4ccc(F)c(Cl)c4)c3)ncnc2c1,6.78,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,IC50,165.0,nM,=,CHEMBL3136336,B,CHEMBL3133758,Homo sapiens,CHEMBL203,CHEMBL3132845
Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1,6.57,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting",IC50,270.0,nM,=,CHEMBL3134653,B,CHEMBL3133821,Homo sapiens,CHEMBL203,CHEMBL3132748
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(S(=O)(=O)Nc4ccccn4)cc3)c2c1,5.36,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,IC50,4390.0,nM,=,CHEMBL3137113,B,CHEMBL3133893,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)Nc1ccc2ncnc(NC3CCCCC3)c2c1,5.55,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,IC50,2800.0,nM,=,CHEMBL3137113,B,CHEMBL3133894,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)N1CCc2c(sc3ncnc(Nc4cccc(C)c4F)c23)C1,6.55,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,IC50,280.0,nM,=,CHEMBL3137113,B,CHEMBL3133895,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)N1CCc2c(sc3ncnc(Nc4ccc(Br)cc4F)c23)C1,5.43,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,IC50,3710.0,nM,=,CHEMBL3134707,B,CHEMBL3133896,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)N1CCc2c(sc3ncnc(Nc4ccc(Br)c(C)c4)c23)C1,5.36,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,IC50,4400.0,nM,=,CHEMBL3134707,B,CHEMBL3133897,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)N1CCc2c(sc3ncnc(Nc4cccc(CC)c4)c23)C1,5.06,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,IC50,8730.0,nM,=,CHEMBL3134707,B,CHEMBL3133898,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)N1CCc2c(sc3ncnc(Nc4ccc(CC)cc4)c23)C1,6.89,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,IC50,130.0,nM,=,CHEMBL3137113,B,CHEMBL3133899,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)Nc1ccc2ncnc(Nc3c(F)cccc3Br)c2c1,5.66,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,IC50,2200.0,nM,=,CHEMBL3134707,B,CHEMBL3133901,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(Br)cc3F)c2c1,8.68,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,2.1,nM,=,CHEMBL4011053,B,CHEMBL3132872,Homo sapiens,CHEMBL203,CHEMBL4007489
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(Br)cc3C)c2c1,5.66,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,IC50,2200.0,nM,=,CHEMBL3134707,B,CHEMBL3133902,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(Br)c(C)c3)c2c1,5.64,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,IC50,2300.0,nM,=,CHEMBL3134707,B,CHEMBL3133903,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)Nc1ccc2ncnc(Nc3cccc(C)c3F)c2c1,8.82,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,1.5,nM,=,CHEMBL4011053,B,CHEMBL3133904,Homo sapiens,CHEMBL203,CHEMBL4007489
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(Br)c(OC)c3)c2c1,5.60,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,IC50,2500.0,nM,=,CHEMBL3134707,B,CHEMBL3133905,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(OC)cc3OC)c2c1,6.03,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,IC50,931.0,nM,=,CHEMBL3137113,B,CHEMBL3133906,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)Nc1ccc2ncnc(Nc3ccccc3CC)c2c1,5.70,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,IC50,2000.0,nM,=,CHEMBL3137113,B,CHEMBL3133907,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)Nc1ccc2ncnc(Nc3cccc(CC)c3)c2c1,6.56,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,IC50,275.0,nM,=,CHEMBL3137113,B,CHEMBL3133908,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(CC)cc3)c2c1,5.50,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,IC50,3200.0,nM,=,CHEMBL3134707,B,CHEMBL3133909,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(S(N)(=O)=O)cc3)c2c1,4.12,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,IC50,76500.0,nM,=,CHEMBL3134707,B,CHEMBL3133910,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(S(=O)(=O)NC(=N)N)cc3)c2c1,4.27,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,IC50,53300.0,nM,=,CHEMBL3134707,B,CHEMBL3133911,Homo sapiens,CHEMBL203,CHEMBL3132827
C=CC(=O)Nc1ccc2ncnc(Nc3ccc(S(=O)(=O)Nc4nccs4)cc3)c2c1,4.36,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,IC50,43700.0,nM,=,CHEMBL3134707,B,CHEMBL3133912,Homo sapiens,CHEMBL203,CHEMBL3132827
COc1cc(Nc2nccc(-c3ccc(Cl)cc3)n2)cc(OC)c1OC,5.67,Inhibition of EGFR (unknown origin),IC50,2145.0,nM,=,CHEMBL3136749,B,CHEMBL3134612,Homo sapiens,CHEMBL203,CHEMBL3132747
CN(C)c1ccc(CCCCCn2c3c(c4cc(OCCc5ccc(O)cc5)ccc42)CC(N)CC3)cc1.Cl.Cl,5.72,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,IC50,1910.0,nM,=,CHEMBL1105615,B,CHEMBL3216254,Homo sapiens,CHEMBL203,CHEMBL1157833
Cl.Cl.NC1CCc2c(c3cc(OCCc4ccc(O)cc4)ccc3n2CCCCCc2ccccn2)C1,5.64,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,IC50,2280.0,nM,=,CHEMBL1105615,B,CHEMBL3216699,Homo sapiens,CHEMBL203,CHEMBL1157833
Nc1ccccc1NC(=O)c1ccc(COc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)cc1,7.48,Inhibition of recombinant EGFR (unknown origin) using poly-Glu-Tyr peptide as substrate,IC50,33.0,nM,=,CHEMBL3226013,B,CHEMBL3217993,Homo sapiens,CHEMBL203,CHEMBL3217617
C#Cc1cccc(Nc2ncnc3ccc(OCc4ccc(C(=O)Nc5ccccc5N)cc4)cc23)c1,7.11,Inhibition of recombinant EGFR (unknown origin) using poly-Glu-Tyr peptide as substrate,IC50,78.0,nM,=,CHEMBL3226013,B,CHEMBL3218000,Homo sapiens,CHEMBL203,CHEMBL3217617
C#Cc1cccc(Nc2ncnc3ccc(S(=O)(=O)n4ccc(/C=C/C(=O)Nc5ccccc5N)c4)cc23)c1,7.11,Inhibition of EGFR (unknown origin),IC50,78.0,nM,=,CHEMBL5215094,B,CHEMBL3218001,Homo sapiens,CHEMBL203,CHEMBL5214883
C#Cc1cccc(Nc2ncnc3ccc(S(=O)(=O)n4ccc(/C=C/C(=O)NO)c4)cc23)c1,5.92,Inhibition of recombinant EGFR (unknown origin) using poly-Glu-Tyr peptide as substrate,IC50,1200.0,nM,=,CHEMBL3226013,B,CHEMBL3218002,Homo sapiens,CHEMBL203,CHEMBL3217617
C=CC(=O)Nc1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1,8.27,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Y12-Sox peptide as substrate preincubated for 30 mins by fluorescence assay,IC50,5.4,nM,=,CHEMBL3223204,B,CHEMBL3218346,Homo sapiens,CHEMBL203,CHEMBL3217690
CCC(=O)Nc1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1,6.87,Inhibition of EGF-induced EGFR-mediated Akt phosphorylation in human A431 cells after 1 hr by immunoblotting method,IC50,136.0,nM,=,CHEMBL3223209,B,CHEMBL3218347,Homo sapiens,CHEMBL203,CHEMBL3217690
OB(O)c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,6.19,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,IC50,650.0,nM,=,CHEMBL3223148,B,CHEMBL3218424,Homo sapiens,CHEMBL203,CHEMBL3217494
C=CC(=O)Nc1cccc(N2C(=O)CN(C)C(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.04,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,9.14,nM,=,CHEMBL3223691,B,CHEMBL3219125,Homo sapiens,CHEMBL203,CHEMBL3217539
C=CC(=O)Nc1cccc(N2C(=O)C3CCCCN3C(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.61,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,2.45,nM,=,CHEMBL3223691,B,CHEMBL3219127,Homo sapiens,CHEMBL203,CHEMBL3217539
C=CC(=O)Nc1cccc(N2C(=O)C(C)N(C)C(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.22,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,6.02,nM,=,CHEMBL3223694,B,CHEMBL3219128,Homo sapiens,CHEMBL203,CHEMBL3217539
C=CC(=O)Nc1cccc(N2C(=O)C(C(C)C)N(C)C(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,7.62,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,24.11,nM,=,CHEMBL3223694,B,CHEMBL3219129,Homo sapiens,CHEMBL203,CHEMBL3217539
C=CC(=O)Nc1cccc(N2C(=O)C(C(C)CC)N(C)C(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.14,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,7.25,nM,=,CHEMBL3223694,B,CHEMBL3219130,Homo sapiens,CHEMBL203,CHEMBL3217539
C=CC(=O)Nc1cccc(N2C(=O)C(c3ccccc3)N(C)C(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,7.11,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,77.19,nM,=,CHEMBL3223691,B,CHEMBL3219131,Homo sapiens,CHEMBL203,CHEMBL3217539
C=CC(=O)Nc1cccc(N2C(=O)CN(c3ccccc3)C(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.16,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,6.99,nM,=,CHEMBL3223691,B,CHEMBL3219132,Homo sapiens,CHEMBL203,CHEMBL3217539
C=CC(=O)Nc1cccc(N2C(=O)C(Cc3ccccc3)N(C)C(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.33,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,4.68,nM,=,CHEMBL3223691,B,CHEMBL3219133,Homo sapiens,CHEMBL203,CHEMBL3217539
C=CC(=O)Nc1cccc(N2C(=O)C(Cc3ccc(OC)cc3)N(C)C(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,7.47,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,33.95,nM,=,CHEMBL3223691,B,CHEMBL3219134,Homo sapiens,CHEMBL203,CHEMBL3217539
C=CC(=O)Nc1cccc(N2C(=O)C(Cc3ccc(Cl)cc3)N(C)C(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,7.46,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,34.67,nM,=,CHEMBL3223694,B,CHEMBL3219135,Homo sapiens,CHEMBL203,CHEMBL3217539
C=CC(=O)Nc1cccc(N2C(=O)C(Cc3ccc(F)cc3)N(C)C(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.24,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,5.78,nM,=,CHEMBL3223691,B,CHEMBL3219347,Homo sapiens,CHEMBL203,CHEMBL3217539
C=CC(=O)Nc1cccc(N2C(=O)CN(Cc3ccccc3)C(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.20,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,IC50,6.26,nM,=,CHEMBL3223691,B,CHEMBL3219348,Homo sapiens,CHEMBL203,CHEMBL3217539
COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1B1OC(C)(C)C(C)(C)O1,6.31,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,IC50,490.0,nM,=,CHEMBL3223148,B,CHEMBL3219502,Homo sapiens,CHEMBL203,CHEMBL3217494
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1B1OC(C)(C)C(C)(C)O1,6.28,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,IC50,520.0,nM,=,CHEMBL3223148,B,CHEMBL3219503,Homo sapiens,CHEMBL203,CHEMBL3217494
CC1(C)OB(c2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)OC1(C)C,6.23,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,IC50,590.0,nM,=,CHEMBL3223148,B,CHEMBL3219504,Homo sapiens,CHEMBL203,CHEMBL3217494
CC1(C)OB(c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)OC1(C)C,6.24,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,IC50,570.0,nM,=,CHEMBL3223148,B,CHEMBL3219505,Homo sapiens,CHEMBL203,CHEMBL3217494
OB(O)c1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,6.10,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,IC50,800.0,nM,=,CHEMBL3223148,B,CHEMBL3219506,Homo sapiens,CHEMBL203,CHEMBL3217494
COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1B(O)O,6.34,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,IC50,460.0,nM,=,CHEMBL3223148,B,CHEMBL3219507,Homo sapiens,CHEMBL203,CHEMBL3217494
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1B(O)O,6.29,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,IC50,510.0,nM,=,CHEMBL3223148,B,CHEMBL3219508,Homo sapiens,CHEMBL203,CHEMBL3217494
CCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1Cl.Cl,6.00,Inhibition of EGFR (unknown origin),IC50,1000.0,nM,=,CHEMBL3226103,B,CHEMBL3221258,Homo sapiens,CHEMBL203,CHEMBL3217416
CCCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1Cl.Cl,5.19,Inhibition of EGFR (unknown origin),IC50,6400.0,nM,=,CHEMBL3226103,B,CHEMBL3221259,Homo sapiens,CHEMBL203,CHEMBL3217416
CCOC(=O)Nc1ccc(Nc2ncnc3cc(OCCN4CCOCC4)c(OC)cc23)cc1C.Cl,5.10,Inhibition of EGFR (unknown origin),IC50,8000.0,nM,=,CHEMBL3226103,B,CHEMBL3221541,Homo sapiens,CHEMBL203,CHEMBL3217416
CCCOc1cc2ncnc(Nc3ccc(NC(=O)OCC)c(C)c3)c2cc1OC.Cl,5.41,Inhibition of EGFR (unknown origin),IC50,3900.0,nM,=,CHEMBL3226103,B,CHEMBL3221542,Homo sapiens,CHEMBL203,CHEMBL3217416
CCOC(=O)Nc1ccc(Nc2ncnc3cc(OCCN4CCOCC4)c(OC)cc23)cc1Cl.Cl,5.07,Inhibition of EGFR (unknown origin),IC50,8500.0,nM,=,CHEMBL3226103,B,CHEMBL3221546,Homo sapiens,CHEMBL203,CHEMBL3217416
CCCOc1cc2ncnc(Nc3ccc(NC(=O)OCC)c(Cl)c3)c2cc1OC.Cl,5.26,Inhibition of EGFR (unknown origin),IC50,5500.0,nM,=,CHEMBL3226103,B,CHEMBL3221547,Homo sapiens,CHEMBL203,CHEMBL3217416
CCCCOc1cc2c(Nc3ccc(NC(=O)OCC)c(Cl)c3)ncnc2cc1OCCN(CC)CC.Cl,5.01,Inhibition of EGFR (unknown origin),IC50,9800.0,nM,=,CHEMBL3226103,B,CHEMBL3221548,Homo sapiens,CHEMBL203,CHEMBL3217416
CCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1.Cl,5.15,Inhibition of EGFR (unknown origin),IC50,7050.0,nM,=,CHEMBL3226103,B,CHEMBL3221550,Homo sapiens,CHEMBL203,CHEMBL3217416
CCCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1.Cl,6.10,Inhibition of EGFR (unknown origin),IC50,800.0,nM,=,CHEMBL3226103,B,CHEMBL3221551,Homo sapiens,CHEMBL203,CHEMBL3217416
COC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1C.Cl,5.40,Inhibition of EGFR (unknown origin),IC50,4000.0,nM,=,CHEMBL3226103,B,CHEMBL3221552,Homo sapiens,CHEMBL203,CHEMBL3217416
COC(=O)Nc1cc(Nc2ncnc3cc(OC)c(OC)cc23)ccc1C.Cl,5.14,Inhibition of EGFR (unknown origin),IC50,7200.0,nM,=,CHEMBL3226103,B,CHEMBL3221553,Homo sapiens,CHEMBL203,CHEMBL3217416
CCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1C.Cl,6.05,Inhibition of EGFR (unknown origin),IC50,900.0,nM,=,CHEMBL3226103,B,CHEMBL3221554,Homo sapiens,CHEMBL203,CHEMBL3217416
CCOC(=O)Nc1cc(Nc2ncnc3cc(OC)c(OC)cc23)ccc1C.Cl,5.30,Inhibition of EGFR (unknown origin),IC50,5000.0,nM,=,CHEMBL3226103,B,CHEMBL3221555,Homo sapiens,CHEMBL203,CHEMBL3217416
CCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1C.Cl,6.05,Inhibition of EGFR (unknown origin),IC50,900.0,nM,=,CHEMBL3226103,B,CHEMBL3221556,Homo sapiens,CHEMBL203,CHEMBL3217416
CCCCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1C.Cl,5.12,Inhibition of EGFR (unknown origin),IC50,7600.0,nM,=,CHEMBL3226103,B,CHEMBL3221557,Homo sapiens,CHEMBL203,CHEMBL3217416
COC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1Cl.Cl,5.21,Inhibition of EGFR (unknown origin),IC50,6150.0,nM,=,CHEMBL3226103,B,CHEMBL3221558,Homo sapiens,CHEMBL203,CHEMBL3217416
CCOC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1Cl.Cl,6.00,Inhibition of EGFR (unknown origin),IC50,1000.0,nM,=,CHEMBL3226103,B,CHEMBL3221560,Homo sapiens,CHEMBL203,CHEMBL3217416
CCOC(=O)Nc1cc(Nc2ncnc3cc(OC)c(OC)cc23)ccc1Cl.Cl,6.05,Inhibition of EGFR (unknown origin),IC50,900.0,nM,=,CHEMBL3226103,B,CHEMBL3221561,Homo sapiens,CHEMBL203,CHEMBL3217416
COC(=O)CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,5.30,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,4997.0,nM,=,CHEMBL3238947,B,CHEMBL3233759,Homo sapiens,CHEMBL203,CHEMBL3233010
CN(C)CCCC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,6.10,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,799.0,nM,=,CHEMBL3238947,B,CHEMBL3233761,Homo sapiens,CHEMBL203,CHEMBL3233010
CN(C)CCN(C)CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,5.37,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,4286.0,nM,=,CHEMBL3238947,B,CHEMBL3233762,Homo sapiens,CHEMBL203,CHEMBL3233010
CN(C)CCCN(C)CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,5.77,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,1699.0,nM,=,CHEMBL3238948,B,CHEMBL3233763,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(CN1CCC(CCO)CC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,6.27,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,542.0,nM,=,CHEMBL3238947,B,CHEMBL3233764,Homo sapiens,CHEMBL203,CHEMBL3233010
CN1CCN(CC(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3s2)CC1,5.47,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,3399.0,nM,=,CHEMBL3238947,B,CHEMBL3233765,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(CN1CCN(CCO)CC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,6.11,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,770.0,nM,=,CHEMBL3238947,B,CHEMBL3233766,Homo sapiens,CHEMBL203,CHEMBL3233010
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,7.80,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,16.0,nM,=,CHEMBL3238947,B,CHEMBL3233767,Homo sapiens,CHEMBL203,CHEMBL3233010
C/C=C(\C)C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,5.19,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,6414.0,nM,=,CHEMBL3238947,B,CHEMBL3233768,Homo sapiens,CHEMBL203,CHEMBL3233010
C=CCOC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,5.75,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,1792.0,nM,=,CHEMBL3238947,B,CHEMBL3233769,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(CCl)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,7.40,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,40.0,nM,=,CHEMBL3238947,B,CHEMBL3233770,Homo sapiens,CHEMBL203,CHEMBL3233010
COCCNC/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.30,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,5.0,nM,=,CHEMBL3238948,B,CHEMBL3233771,Homo sapiens,CHEMBL203,CHEMBL3233010
CN(C)CCCNC/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,9.15,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,0.7,nM,=,CHEMBL3238948,B,CHEMBL3233772,Homo sapiens,CHEMBL203,CHEMBL3233010
CS(=O)(=O)CCNC/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.52,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,3.0,nM,=,CHEMBL3238947,B,CHEMBL3233773,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(/C=C/CNCC1COC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.00,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,10.0,nM,=,CHEMBL3238947,B,CHEMBL3233774,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(/C=C/CNC1CCOCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,7.70,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,20.0,nM,=,CHEMBL3238947,B,CHEMBL3233775,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(/C=C/CNCc1ncccn1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.10,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,8.0,nM,=,CHEMBL3238947,B,CHEMBL3233776,Homo sapiens,CHEMBL203,CHEMBL3233010
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,7.62,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,24.0,nM,=,CHEMBL3238947,B,CHEMBL3233777,Homo sapiens,CHEMBL203,CHEMBL3233010
CCN(CC)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.10,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,8.0,nM,=,CHEMBL3238947,B,CHEMBL3233778,Homo sapiens,CHEMBL203,CHEMBL3233010
COC(CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1)OC,8.70,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,2.0,nM,=,CHEMBL3238947,B,CHEMBL3233779,Homo sapiens,CHEMBL203,CHEMBL3233010
CCN(CC)CCN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,6.86,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,139.0,nM,=,CHEMBL3238947,B,CHEMBL3233780,Homo sapiens,CHEMBL203,CHEMBL3233010
CN(C)CCCN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,7.03,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,93.0,nM,=,CHEMBL3238947,B,CHEMBL3233781,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(/C=C/CN1CC(O)C1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,7.42,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,38.0,nM,=,CHEMBL3238947,B,CHEMBL3233782,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(/C=C/CN1CCC(F)(F)C1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,7.55,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,28.0,nM,=,CHEMBL3238947,B,CHEMBL3233783,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(/C=C/CN1CCCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.70,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,2.0,nM,=,CHEMBL3238948,B,CHEMBL3233784,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(/C=C/CN1CC2CCC1C(=O)C2)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,9.05,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,0.9,nM,=,CHEMBL3238947,B,CHEMBL3233785,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(/C=C/CN1CCC(F)CC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.40,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,4.0,nM,=,CHEMBL3238947,B,CHEMBL3233786,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(/C=C/CN1CCC(F)(F)CC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.40,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,4.0,nM,=,CHEMBL3238948,B,CHEMBL3233787,Homo sapiens,CHEMBL203,CHEMBL3233010
CSC1CCN(C/C=C/C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3s2)CC1,7.75,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,18.0,nM,=,CHEMBL3238947,B,CHEMBL3233788,Homo sapiens,CHEMBL203,CHEMBL3233010
CN1CCN(C/C=C/C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3s2)CC1,8.52,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,3.0,nM,=,CHEMBL3238948,B,CHEMBL3233789,Homo sapiens,CHEMBL203,CHEMBL3233010
CCN1CCN(C/C=C/C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3s2)CC1,8.40,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,4.0,nM,=,CHEMBL3238948,B,CHEMBL3233790,Homo sapiens,CHEMBL203,CHEMBL3233010
CC(C)N1CCN(C/C=C/C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3s2)CC1,8.70,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,2.0,nM,=,CHEMBL3238948,B,CHEMBL3233791,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(/C=C/CN1CCOCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.52,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,3.0,nM,=,CHEMBL3238947,B,CHEMBL3233792,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(/C=C/CN1CCS(=O)(=O)CC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.15,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,7.0,nM,=,CHEMBL3238948,B,CHEMBL3233793,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(/C=C/CN1CC2(COC2)C1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.15,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,7.0,nM,=,CHEMBL3238947,B,CHEMBL3233020,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(/C=C/CN1CC2(CCOCC2)C1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,5.67,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,2159.0,nM,=,CHEMBL3238947,B,CHEMBL3233794,Homo sapiens,CHEMBL203,CHEMBL3233010
O=C(/C=C/CN1CCC2(CC1)OCCO2)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.70,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,IC50,2.0,nM,=,CHEMBL3238947,B,CHEMBL3233795,Homo sapiens,CHEMBL203,CHEMBL3233010
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cccnc1,6.26,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,550.0,nM,=,CHEMBL3240253,B,CHEMBL3234736,Homo sapiens,CHEMBL203,CHEMBL3233006
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1ccccn1,6.24,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,575.0,nM,=,CHEMBL3240253,B,CHEMBL3234737,Homo sapiens,CHEMBL203,CHEMBL3233006
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnccn1,5.41,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,3900.0,nM,=,CHEMBL3240253,B,CHEMBL3234740,Homo sapiens,CHEMBL203,CHEMBL3233006
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cncnc1,5.72,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,1920.0,nM,=,CHEMBL3240253,B,CHEMBL3234741,Homo sapiens,CHEMBL203,CHEMBL3233006
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc(N)nc1,7.37,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,43.0,nM,=,CHEMBL3240253,B,CHEMBL3234742,Homo sapiens,CHEMBL203,CHEMBL3233006
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1ccc(O)nc1,5.88,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,1330.0,nM,=,CHEMBL3240253,B,CHEMBL3234743,Homo sapiens,CHEMBL203,CHEMBL3233006
CNc1ncc(C(=O)Nc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)cn1,6.92,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,120.0,nM,=,CHEMBL3240253,B,CHEMBL3234744,Homo sapiens,CHEMBL203,CHEMBL3233006
CCNc1ncc(C(=O)Nc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)cn1,6.89,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,130.0,nM,=,CHEMBL3240253,B,CHEMBL3234745,Homo sapiens,CHEMBL203,CHEMBL3233006
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc(NC(C)C)nc1,7.37,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,43.0,nM,=,CHEMBL3240253,B,CHEMBL3234746,Homo sapiens,CHEMBL203,CHEMBL3233006
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc(NC2CC2)nc1,7.36,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,44.0,nM,=,CHEMBL3240253,B,CHEMBL3234747,Homo sapiens,CHEMBL203,CHEMBL3233006
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc(NC2CCCC2)nc1,7.48,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,33.0,nM,=,CHEMBL3240253,B,CHEMBL3234748,Homo sapiens,CHEMBL203,CHEMBL3233006
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc(NC2CCCCC2)nc1,7.33,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,47.0,nM,=,CHEMBL3240253,B,CHEMBL3234749,Homo sapiens,CHEMBL203,CHEMBL3233006
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc(Nc2ccccc2)nc1,8.22,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,6.0,nM,=,CHEMBL3240253,B,CHEMBL3234750,Homo sapiens,CHEMBL203,CHEMBL3233006
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc(N(C)C)nc1,5.26,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,5540.0,nM,=,CHEMBL3240253,B,CHEMBL3234751,Homo sapiens,CHEMBL203,CHEMBL3233006
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc2[nH]ccc2c1,8.10,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,8.0,nM,=,CHEMBL3240253,B,CHEMBL3234752,Homo sapiens,CHEMBL203,CHEMBL3233006
Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc2[nH]ncc2c1,7.52,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,30.0,nM,=,CHEMBL3240253,B,CHEMBL3234753,Homo sapiens,CHEMBL203,CHEMBL3233006
CN1CCN(Cc2ccc(NC(=O)c3cccc(NC(=O)c4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1,6.17,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,680.0,nM,=,CHEMBL3240253,B,CHEMBL3234755,Homo sapiens,CHEMBL203,CHEMBL3233006
CCc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc2[nH]ccc2c1,7.00,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,99.0,nM,=,CHEMBL3240253,B,CHEMBL3234756,Homo sapiens,CHEMBL203,CHEMBL3233006
CC(C)c1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NC(=O)c1cnc2[nH]ccc2c1,6.80,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,IC50,160.0,nM,=,CHEMBL3240253,B,CHEMBL3234757,Homo sapiens,CHEMBL203,CHEMBL3233006
Cc1ncc([N+](=O)[O-])n1CC(=O)N/N=C/c1cc2ccccc2nc1Oc1ccccc1,4.99,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,IC50,10350.0,nM,=,CHEMBL3240620,B,CHEMBL3234864,Homo sapiens,CHEMBL203,CHEMBL3232917
Cc1ccc(Oc2nc3ccccc3cc2/C=N/NC(=O)Cn2c([N+](=O)[O-])cnc2C)cc1,5.12,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,IC50,7670.0,nM,=,CHEMBL3240621,B,CHEMBL3234865,Homo sapiens,CHEMBL203,CHEMBL3232917
COc1ccc(Oc2nc3ccccc3cc2/C=N/NC(=O)Cn2c([N+](=O)[O-])cnc2C)cc1,6.57,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,IC50,270.0,nM,=,CHEMBL3240620,B,CHEMBL3234866,Homo sapiens,CHEMBL203,CHEMBL3232917
Cc1ncc([N+](=O)[O-])n1CC(=O)N/N=C/c1cc2ccccc2nc1Oc1ccc(F)cc1,6.43,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,IC50,370.0,nM,=,CHEMBL3240621,B,CHEMBL3234867,Homo sapiens,CHEMBL203,CHEMBL3232917
Cc1ncc([N+](=O)[O-])n1CC(=O)N/N=C/c1cc2ccccc2nc1Oc1ccc(Cl)cc1,5.39,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,IC50,4100.0,nM,=,CHEMBL3240621,B,CHEMBL3235199,Homo sapiens,CHEMBL203,CHEMBL3232917
Cc1ccc2nc(Oc3ccccc3)c(/C=N/NC(=O)Cn3c([N+](=O)[O-])cnc3C)cc2c1,5.80,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,IC50,1580.0,nM,=,CHEMBL3240621,B,CHEMBL3235200,Homo sapiens,CHEMBL203,CHEMBL3232917
Cc1ccc(Oc2nc3ccc(C)cc3cc2/C=N/NC(=O)Cn2c([N+](=O)[O-])cnc2C)cc1,6.75,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,IC50,180.0,nM,=,CHEMBL3240620,B,CHEMBL3235201,Homo sapiens,CHEMBL203,CHEMBL3232917
COc1ccc(Oc2nc3ccc(C)cc3cc2/C=N/NC(=O)Cn2c([N+](=O)[O-])cnc2C)cc1,6.92,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,IC50,120.0,nM,=,CHEMBL3240620,B,CHEMBL3235202,Homo sapiens,CHEMBL203,CHEMBL3232917
Cc1ccc2nc(Oc3ccc(F)cc3)c(/C=N/NC(=O)Cn3c([N+](=O)[O-])cnc3C)cc2c1,6.38,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,IC50,420.0,nM,=,CHEMBL3240620,B,CHEMBL3235203,Homo sapiens,CHEMBL203,CHEMBL3232917
Cc1ccc2nc(Oc3ccc(Cl)cc3)c(/C=N/NC(=O)Cn3c([N+](=O)[O-])cnc3C)cc2c1,5.06,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,IC50,8660.0,nM,=,CHEMBL3240620,B,CHEMBL3235204,Homo sapiens,CHEMBL203,CHEMBL3232917
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)CCN(C)C)c2)n1,6.74,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,IC50,184.0,nM,=,CHEMBL3241597,B,CHEMBL3237929,Homo sapiens,CHEMBL203,CHEMBL3232794
CCN(CC)CCC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1,6.74,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,IC50,181.0,nM,=,CHEMBL3241597,B,CHEMBL3237930,Homo sapiens,CHEMBL203,CHEMBL3232794
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)CCN3CCCC3)c2)n1,7.06,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,IC50,88.0,nM,=,CHEMBL3241597,B,CHEMBL3237931,Homo sapiens,CHEMBL203,CHEMBL3232794
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)CCN3CCCCC3)c2)n1,5.66,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,IC50,2177.0,nM,=,CHEMBL3241597,B,CHEMBL3237932,Homo sapiens,CHEMBL203,CHEMBL3232794
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)CCN3CCN(C)CC3)c2)n1,5.33,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,IC50,4706.0,nM,=,CHEMBL3241597,B,CHEMBL3237934,Homo sapiens,CHEMBL203,CHEMBL3232794
CCOC(=O)N1CCN(CCC(=O)Nc2cccc(Oc3nc(Nc4ccc(N5CCN(C)CC5)cc4OC)ncc3Cl)c2)CC1,6.27,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,IC50,537.0,nM,=,CHEMBL3241597,B,CHEMBL3237935,Homo sapiens,CHEMBL203,CHEMBL3232794
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)CCN3CCN(CCO)CC3)c2)n1,5.62,Inhibition of EGFR (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,IC50,2388.0,nM,=,CHEMBL3241595,B,CHEMBL3237936,Homo sapiens,CHEMBL203,CHEMBL3232794
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)CCN3CCN(CCOc4no[n+]([O-])c4S(=O)(=O)c4ccccc4)CC3)c2)n1,6.70,Inhibition of EGFR (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,IC50,201.0,nM,=,CHEMBL3241595,B,CHEMBL3237937,Homo sapiens,CHEMBL203,CHEMBL3232794
Cc1nn(-c2ccccc2)c(Cl)c1C1C(C#N)=C(N)N(c2cccnc2)C2=C1C(=O)CCC2,4.74,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,18020.0,nM,=,CHEMBL3240469,B,CHEMBL3237938,Homo sapiens,CHEMBL203,CHEMBL3232751
Cc1ccc(-n2nc(C)c(C3C(C#N)=C(N)N(c4cccnc4)C4=C3C(=O)CCC4)c2Cl)cc1,5.00,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,10120.0,nM,=,CHEMBL3240469,B,CHEMBL3237939,Homo sapiens,CHEMBL203,CHEMBL3232751
Cc1nn(-c2ccc(Cl)cc2)c(Cl)c1C1C(C#N)=C(N)N(c2cccnc2)C2=C1C(=O)CCC2,5.38,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,4150.0,nM,=,CHEMBL3240469,B,CHEMBL3237940,Homo sapiens,CHEMBL203,CHEMBL3232751
Cc1nn(-c2ccccc2)c(Cl)c1C1C(C#N)=C(N)N(c2cccnc2)C2=C1C(=O)CC(C)(C)C2,4.49,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,32130.0,nM,=,CHEMBL3240469,B,CHEMBL3237941,Homo sapiens,CHEMBL203,CHEMBL3232751
Cc1ccc(-n2nc(C)c(C3C(C#N)=C(N)N(c4cccnc4)C4=C3C(=O)CC(C)(C)C4)c2Cl)cc1,4.83,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,14700.0,nM,=,CHEMBL3240469,B,CHEMBL3237942,Homo sapiens,CHEMBL203,CHEMBL3232751
Cc1nn(-c2ccc(Cl)cc2)c(Cl)c1C1C(C#N)=C(N)N(c2cccnc2)C2=C1C(=O)CC(C)(C)C2,4.62,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,24050.0,nM,=,CHEMBL3240469,B,CHEMBL3237943,Homo sapiens,CHEMBL203,CHEMBL3232751
CCOC(=O)C1=C(N)N(c2cccnc2)C2=C(C(=O)CCC2)C1c1c(C)nn(-c2ccccc2)c1Cl,5.68,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,2090.0,nM,=,CHEMBL3240469,B,CHEMBL3237944,Homo sapiens,CHEMBL203,CHEMBL3232751
CCOC(=O)C1=C(N)N(c2cccnc2)C2=C(C(=O)CCC2)C1c1c(C)nn(-c2ccc(C)cc2)c1Cl,6.04,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,910.0,nM,=,CHEMBL3240469,B,CHEMBL3237945,Homo sapiens,CHEMBL203,CHEMBL3232751
CCOC(=O)C1=C(N)N(c2cccnc2)C2=C(C(=O)CCC2)C1c1c(C)nn(-c2ccc(Cl)cc2)c1Cl,5.21,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,6150.0,nM,=,CHEMBL3240469,B,CHEMBL3237946,Homo sapiens,CHEMBL203,CHEMBL3232751
CCOC(=O)C1=C(N)N(c2cccnc2)C2=C(C(=O)CC(C)(C)C2)C1c1c(C)nn(-c2ccccc2)c1Cl,4.95,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,11180.0,nM,=,CHEMBL3240469,B,CHEMBL3237947,Homo sapiens,CHEMBL203,CHEMBL3232751
CCOC(=O)C1=C(N)N(c2cccnc2)C2=C(C(=O)CC(C)(C)C2)C1c1c(C)nn(-c2ccc(C)cc2)c1Cl,6.29,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,510.0,nM,=,CHEMBL3240469,B,CHEMBL3237948,Homo sapiens,CHEMBL203,CHEMBL3232751
CCOC(=O)C1=C(N)N(c2cccnc2)C2=C(C(=O)CC(C)(C)C2)C1c1c(C)nn(-c2ccc(Cl)cc2)c1Cl,5.99,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,1030.0,nM,=,CHEMBL3240469,B,CHEMBL3237949,Homo sapiens,CHEMBL203,CHEMBL3232751
Cc1ccc(C2=NN(C3=NC(c4ccccc4)CS3)C(c3cccc4ccccc34)C2)cc1C,5.40,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,IC50,3960.0,nM,=,CHEMBL3267504,B,CHEMBL3263359,Homo sapiens,CHEMBL203,CHEMBL3259814
COc1ccc(C2=NN(C3=NC(=O)CS3)C(c3cccc4ccccc34)C2)cc1,5.26,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,IC50,5530.0,nM,=,CHEMBL3267504,B,CHEMBL3263364,Homo sapiens,CHEMBL203,CHEMBL3259814
Cc1ccc(C2=NN(C3=NC(=O)CS3)C(c3cccc4ccccc34)C2)cc1C,5.88,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,IC50,1320.0,nM,=,CHEMBL3267504,B,CHEMBL3263366,Homo sapiens,CHEMBL203,CHEMBL3259814
Cc1ccc(C2=NN(C3=NC(c4ccccc4)CS3)C(c3ccc4ccccc4c3)C2)cc1,5.28,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,IC50,5260.0,nM,=,CHEMBL3267504,B,CHEMBL3263372,Homo sapiens,CHEMBL203,CHEMBL3259814
Cc1ccc(C2=NN(C3=NC(c4ccccc4)CS3)C(c3ccc4ccccc4c3)C2)cc1C,6.19,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,IC50,650.0,nM,=,CHEMBL3267504,B,CHEMBL3263373,Homo sapiens,CHEMBL203,CHEMBL3259814
O=C1CSC(N2N=C(c3ccccc3)CC2c2ccc3ccccc3c2)=N1,5.20,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,IC50,6310.0,nM,=,CHEMBL3267504,B,CHEMBL3263374,Homo sapiens,CHEMBL203,CHEMBL3259814
COc1ccc(C2=NN(C3=NC(=O)CS3)C(c3ccc4ccccc4c3)C2)cc1,5.55,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,IC50,2800.0,nM,=,CHEMBL3267504,B,CHEMBL3263378,Homo sapiens,CHEMBL203,CHEMBL3259814
Cc1ccc(C2=NN(C3=NC(=O)CS3)C(c3ccc4ccccc4c3)C2)cc1,5.49,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,IC50,3250.0,nM,=,CHEMBL3267504,B,CHEMBL3263379,Homo sapiens,CHEMBL203,CHEMBL3259814
Cc1ccc(C2=NN(C3=NC(=O)CS3)C(c3ccc4ccccc4c3)C2)cc1C,6.92,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,IC50,120.0,nM,=,CHEMBL3267504,B,CHEMBL3263380,Homo sapiens,CHEMBL203,CHEMBL3259814
COc1cc2c(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,5.12,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,IC50,7670.0,nM,=,CHEMBL3266279,B,CHEMBL3263959,Homo sapiens,CHEMBL203,CHEMBL3259680
COc1cc2c(Oc3ccc(NS(=O)(=O)c4cccc(-c5ccoc5)c4)cc3F)ccnc2cc1OCCCN1CCOCC1,5.54,Inhibition of recombinant EGFR L858R mutant (unknown origin) using poly-GT peptide as substrate after 1 hr by Transcreener assay,IC50,2895.0,nM,=,CHEMBL3266280,B,CHEMBL3263960,Homo sapiens,CHEMBL203,CHEMBL3259680
COc1cc2c(Oc3ccc(NS(=O)(=O)c4cccc(-c5cnn(C)c5)c4)cc3F)ccnc2cc1OCCCN1CCOCC1,5.86,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,IC50,1370.0,nM,=,CHEMBL3266279,B,CHEMBL3263961,Homo sapiens,CHEMBL203,CHEMBL3259680
COc1cc2c(Oc3ccc(NS(=O)(=O)c4cccc(-c5cnn(C)c5)c4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,7.08,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,IC50,84.0,nM,=,CHEMBL3266279,B,CHEMBL3263962,Homo sapiens,CHEMBL203,CHEMBL3259680
COc1cc2c(Oc3ccc(NS(=O)(=O)c4cccc(-c5ccoc5)c4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,6.78,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,IC50,168.0,nM,=,CHEMBL3266279,B,CHEMBL3263963,Homo sapiens,CHEMBL203,CHEMBL3259680
COc1cc2c(Oc3ccc(NS(=O)(=O)c4cccc(-c5ccsc5)c4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,7.03,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,IC50,94.0,nM,=,CHEMBL3266279,B,CHEMBL3263964,Homo sapiens,CHEMBL203,CHEMBL3259680
COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(-c5ccsc5)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,6.24,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,IC50,572.0,nM,=,CHEMBL3266279,B,CHEMBL3263965,Homo sapiens,CHEMBL203,CHEMBL3259680
COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccc(-c5cnn(C)c5)cc4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,5.36,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,IC50,4354.0,nM,=,CHEMBL3266279,B,CHEMBL3263966,Homo sapiens,CHEMBL203,CHEMBL3259680
COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccc(-c5ccsc5)cc4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,5.92,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,IC50,1201.0,nM,=,CHEMBL3266279,B,CHEMBL3263967,Homo sapiens,CHEMBL203,CHEMBL3259680
COc1cc2c(Oc3ccc(NS(=O)(=O)c4cccc(-c5cccs5)c4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,5.98,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,IC50,1052.0,nM,=,CHEMBL3266279,B,CHEMBL3263968,Homo sapiens,CHEMBL203,CHEMBL3259680
COc1cc2c(Oc3ccc(NS(=O)(=O)c4cccc(-c5ccco5)c4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,5.72,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,IC50,1907.0,nM,=,CHEMBL3266279,B,CHEMBL3263969,Homo sapiens,CHEMBL203,CHEMBL3259680
C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21,7.25,Selectivity interaction (Z’-LYTE assay (SelectScreen Invitrogen)) EUB0000690a EGFR,Ki,56.0,nM,=,CHEMBL5213166,B,CHEMBL3286830,Homo sapiens,CHEMBL203,CHEMBL5169023
CCc1ccccc1NC(=O)N1C[C@@H](C)Oc2cc(-c3ccc([C@H]4CC[C@H](CC(=O)O)CC4)cc3)ccc21,5.12,Inhibition of EGF receptor (unknown origin),IC50,7500.0,nM,=,CHEMBL3294216,B,CHEMBL3287898,Homo sapiens,CHEMBL203,CHEMBL3286266
C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1,7.96,Inhibition of EGFR (unknown origin) after 1 hr by HTRF assay,IC50,11.0,nM,=,CHEMBL3292439,B,CHEMBL3290142,Homo sapiens,CHEMBL203,CHEMBL3286193
C=CC(=O)NCC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1,8.15,Inhibition of EGFR (unknown origin) after 1 hr by HTRF assay,IC50,7.0,nM,=,CHEMBL3292439,B,CHEMBL3290148,Homo sapiens,CHEMBL203,CHEMBL3286193
Cc1nc(Nc2ccccc2)c2cc(C)oc2n1,6.95,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,IC50,113.2,nM,=,CHEMBL3299340,B,CHEMBL3297816,Homo sapiens,CHEMBL203,CHEMBL3297731
Cc1nc(Nc2cccc3ccccc23)c2cc(C)oc2n1,6.84,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,IC50,145.2,nM,=,CHEMBL3299340,B,CHEMBL3297891,Homo sapiens,CHEMBL203,CHEMBL3297731
C#Cc1cccc(Nc2nc(C)nc3oc(C)cc23)c1,7.52,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,IC50,30.0,nM,=,CHEMBL3299340,B,CHEMBL3297892,Homo sapiens,CHEMBL203,CHEMBL3297731
Cc1nc(Nc2ccc(C(F)(F)F)cc2)c2cc(C)oc2n1,6.91,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,IC50,122.1,nM,=,CHEMBL3299340,B,CHEMBL3297893,Homo sapiens,CHEMBL203,CHEMBL3297731
Cc1nc(Nc2ccc(F)c(Cl)c2)c2cc(C)oc2n1,7.52,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,IC50,30.2,nM,=,CHEMBL3299340,B,CHEMBL3297894,Homo sapiens,CHEMBL203,CHEMBL3297731
Cc1nc(Nc2ccc(Cl)cc2)c2cc(C)oc2n1,6.99,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,IC50,102.3,nM,=,CHEMBL3299340,B,CHEMBL3297895,Homo sapiens,CHEMBL203,CHEMBL3297731
Cc1nc(Nc2cccc3[nH]ccc23)c2cc(C)oc2n1,7.04,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,IC50,90.2,nM,=,CHEMBL3299340,B,CHEMBL3297896,Homo sapiens,CHEMBL203,CHEMBL3297731
COc1ccc(Nc2nc(C)nc3oc(C)cc23)cc1,7.38,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,IC50,42.2,nM,=,CHEMBL3299340,B,CHEMBL3297897,Homo sapiens,CHEMBL203,CHEMBL3297731
COc1ccc(N(C)c2nc(C)nc3oc(C)cc23)cc1,7.17,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,IC50,68.2,nM,=,CHEMBL3299340,B,CHEMBL3297898,Homo sapiens,CHEMBL203,CHEMBL3297731
CCN(c1ccc(OC)cc1)c1nc(C)nc2oc(C)cc12,7.15,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,IC50,70.7,nM,=,CHEMBL3299340,B,CHEMBL3297899,Homo sapiens,CHEMBL203,CHEMBL3297731
CCCN(c1ccc(OC)cc1)c1nc(C)nc2oc(C)cc12,7.13,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,IC50,73.3,nM,=,CHEMBL3299340,B,CHEMBL3297900,Homo sapiens,CHEMBL203,CHEMBL3297731
CCCCN(c1ccc(OC)cc1)c1nc(C)nc2oc(C)cc12,6.47,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,IC50,340.1,nM,=,CHEMBL3299340,B,CHEMBL3297998,Homo sapiens,CHEMBL203,CHEMBL3297731
COc1ccc(N(c2nc(C)nc3oc(C)cc23)C(C)C)cc1,7.07,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,IC50,84.4,nM,=,CHEMBL3299340,B,CHEMBL3297999,Homo sapiens,CHEMBL203,CHEMBL3297731
COc1ccc(N(C)c2nc(C)nc3oc(C)cc23)cc1.Cl,7.08,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,IC50,82.3,nM,=,CHEMBL3299340,B,CHEMBL3298000,Homo sapiens,CHEMBL203,CHEMBL3297731
CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1,5.46,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Kd,3502.0,nM,=,CHEMBL3991696,B,CHEMBL3301622,Homo sapiens,CHEMBL203,CHEMBL3991601
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1,6.36,"Inhibition of recombinant human N-terminal GST-tagged wild-type EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay",IC50,442.0,nM,=,CHEMBL4024934,B,CHEMBL3301625,Homo sapiens,CHEMBL203,CHEMBL4024706
Cc1ccc2c(c1)cc(C1C(C#N)=C(N)N(c3cccnc3)C3=C1C(=O)CCC3)c1nnnn12,4.98,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,IC50,10400.0,nM,=,CHEMBL3375023,B,CHEMBL3325470,Homo sapiens,CHEMBL203,CHEMBL3352252
COc1ccc2c(c1)cc(C1C(C#N)=C(N)N(c3cccnc3)C3=C1C(=O)CCC3)c1nnnn12,5.27,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,IC50,5400.0,nM,=,CHEMBL3375023,B,CHEMBL3325471,Homo sapiens,CHEMBL203,CHEMBL3352252
N#CC1=C(N)N(c2cccnc2)C2=C(C(=O)CCC2)C1c1cc2cc(Cl)ccc2n2nnnc12,4.74,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,IC50,18300.0,nM,=,CHEMBL3375023,B,CHEMBL3325472,Homo sapiens,CHEMBL203,CHEMBL3352252
COC(=O)C1=C(N)N(c2cccnc2)C2=C(C(=O)CCC2)C1c1cc2ccccc2n2nnnc12,5.96,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,IC50,1100.0,nM,=,CHEMBL3375023,B,CHEMBL3325473,Homo sapiens,CHEMBL203,CHEMBL3352252
COC(=O)C1=C(N)N(c2cccnc2)C2=C(C(=O)CCC2)C1c1cc2cc(C)ccc2n2nnnc12,5.37,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,IC50,4300.0,nM,=,CHEMBL3375023,B,CHEMBL3325474,Homo sapiens,CHEMBL203,CHEMBL3352252
COC(=O)C1=C(N)N(c2cccnc2)C2=C(C(=O)CCC2)C1c1cc2cc(OC)ccc2n2nnnc12,5.89,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,IC50,1300.0,nM,=,CHEMBL3375023,B,CHEMBL3325475,Homo sapiens,CHEMBL203,CHEMBL3352252
COC(=O)C1=C(N)N(c2cccnc2)C2=C(C(=O)CCC2)C1c1cc2cc(Cl)ccc2n2nnnc12,5.09,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,IC50,8100.0,nM,=,CHEMBL3375023,B,CHEMBL3325476,Homo sapiens,CHEMBL203,CHEMBL3352252
CCOC(=O)C1=C(N)N(c2cccnc2)C2=C(C(=O)CCC2)C1c1cc2ccccc2n2nnnc12,7.05,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,IC50,90.0,nM,=,CHEMBL3375023,B,CHEMBL3325477,Homo sapiens,CHEMBL203,CHEMBL3352252
CCOC(=O)C1=C(N)N(c2cccnc2)C2=C(C(=O)CCC2)C1c1cc2cc(C)ccc2n2nnnc12,5.16,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,IC50,7000.0,nM,=,CHEMBL3375023,B,CHEMBL3325478,Homo sapiens,CHEMBL203,CHEMBL3352252
CCOC(=O)C1=C(N)N(c2cccnc2)C2=C(C(=O)CCC2)C1c1cc2cc(OC)ccc2n2nnnc12,6.70,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,IC50,200.0,nM,=,CHEMBL3375023,B,CHEMBL3325479,Homo sapiens,CHEMBL203,CHEMBL3352252
CCOC(=O)C1=C(N)N(c2cccnc2)C2=C(C(=O)CCC2)C1c1cc2cc(Cl)ccc2n2nnnc12,4.78,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,IC50,16700.0,nM,=,CHEMBL3375023,B,CHEMBL3325480,Homo sapiens,CHEMBL203,CHEMBL3352252
N#CC1=C(N)N(c2cccnc2)C2=C(C(=O)CCC2)C1c1cc2ccccc2n2nnnc12,5.32,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,IC50,4800.0,nM,=,CHEMBL3375023,B,CHEMBL3327179,Homo sapiens,CHEMBL203,CHEMBL3352252
COc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O,4.05,Inhibition of EGFR (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay,IC50,88670.0,nM,=,CHEMBL3382433,B,CHEMBL3335244,Homo sapiens,CHEMBL203,CHEMBL3352553
CCOc1cc(Br)c(Br)c(/C=N/c2ccc3[nH]c(=O)[nH]c3c2)c1O,4.12,Inhibition of EGFR (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay,IC50,76700.0,nM,=,CHEMBL3382433,B,CHEMBL3335245,Homo sapiens,CHEMBL203,CHEMBL3352553
CN(C)C(CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,8.17,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,IC50,6.8,nM,=,CHEMBL3385740,B,CHEMBL3344208,Homo sapiens,CHEMBL203,CHEMBL3352165
CS(=O)(=O)CC(N)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.75,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,IC50,17.6,nM,=,CHEMBL3385740,B,CHEMBL3344209,Homo sapiens,CHEMBL203,CHEMBL3352165
CNC(CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.46,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,IC50,34.8,nM,=,CHEMBL3385740,B,CHEMBL3344210,Homo sapiens,CHEMBL203,CHEMBL3352165
CCNC(CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.83,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,IC50,14.7,nM,=,CHEMBL3385740,B,CHEMBL3344211,Homo sapiens,CHEMBL203,CHEMBL3352165
CS(=O)(=O)CC(NC1CCCCC1)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.11,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,IC50,77.2,nM,=,CHEMBL3385740,B,CHEMBL3344212,Homo sapiens,CHEMBL203,CHEMBL3352165
CC(C)NC(CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.41,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,IC50,39.2,nM,=,CHEMBL3385740,B,CHEMBL3344213,Homo sapiens,CHEMBL203,CHEMBL3352165
CS(=O)(=O)CCNC(CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.54,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,IC50,28.7,nM,=,CHEMBL3385740,B,CHEMBL3344214,Homo sapiens,CHEMBL203,CHEMBL3352165
CS(=O)(=O)C[C@@H](N)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.97,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,IC50,10.8,nM,=,CHEMBL3385740,B,CHEMBL3344215,Homo sapiens,CHEMBL203,CHEMBL3352165
CN(C)[C@H](CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,8.39,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,IC50,4.1,nM,=,CHEMBL3385740,B,CHEMBL3344216,Homo sapiens,CHEMBL203,CHEMBL3352165
CCC(=O)ON[C@H](CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.05,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,IC50,89.6,nM,=,CHEMBL3385740,B,CHEMBL3344217,Homo sapiens,CHEMBL203,CHEMBL3352165
CCCCC(=O)ON[C@H](CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.03,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,IC50,92.8,nM,=,CHEMBL3385740,B,CHEMBL3344218,Homo sapiens,CHEMBL203,CHEMBL3352165
CCCCCCC(=O)ON[C@H](CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,6.96,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,IC50,110.2,nM,=,CHEMBL3385740,B,CHEMBL3344219,Homo sapiens,CHEMBL203,CHEMBL3352165
CS(=O)(=O)C[C@H](N)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.87,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,IC50,13.5,nM,=,CHEMBL3385740,B,CHEMBL3344220,Homo sapiens,CHEMBL203,CHEMBL3352165
CN(C)[C@@H](CS(C)(=O)=O)c1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,7.52,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,IC50,30.4,nM,=,CHEMBL3385740,B,CHEMBL3344221,Homo sapiens,CHEMBL203,CHEMBL3352165
CC1(C)[C@H]2CC3OB(COc4ccc5ncnc(Nc6cccc(Cl)c6)c5c4)O[C@@]3(C)[C@@H]1C2,6.70,Inhibition of EGFR kinase (unknown origin) using poly(Glu:Tyr) as substrate,IC50,200.0,nM,=,CHEMBL3391161,B,CHEMBL3347487,Homo sapiens,CHEMBL203,CHEMBL3390847
OB(O)/C=C/COc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,6.57,Inhibition of EGFR kinase (unknown origin) using poly(Glu:Tyr) as substrate,IC50,270.0,nM,=,CHEMBL3391161,B,CHEMBL3347488,Homo sapiens,CHEMBL203,CHEMBL3390847
OB(O)c1ccc(COc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)cc1,6.07,Inhibition of EGFR kinase (unknown origin) using poly(Glu:Tyr) as substrate,IC50,850.0,nM,=,CHEMBL3391161,B,CHEMBL3347498,Homo sapiens,CHEMBL203,CHEMBL3390847
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CCN(C(=O)CN(C)C)CC1,4.80,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,16000.0,nM,=,CHEMBL3389020,B,CHEMBL3353395,Homo sapiens,CHEMBL203,CHEMBL3351341
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CCN(C(=O)[C@H](C)N)CC1,4.72,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,19000.0,nM,=,CHEMBL3389020,B,CHEMBL3353396,Homo sapiens,CHEMBL203,CHEMBL3351341
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CCN(C(=O)[C@@H]2CCCCN2)CC1,4.51,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,31000.0,nM,=,CHEMBL3389020,B,CHEMBL3353397,Homo sapiens,CHEMBL203,CHEMBL3351341
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CCN(C(=O)[C@H]2CCCCN2)CC1,4.24,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,57000.0,nM,=,CHEMBL3389020,B,CHEMBL3353398,Homo sapiens,CHEMBL203,CHEMBL3351341
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CCN(C(=O)CNC)CC1,4.18,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,66000.0,nM,=,CHEMBL3389020,B,CHEMBL3353399,Homo sapiens,CHEMBL203,CHEMBL3351341
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CCN(C(=O)[C@H](C)O)CC1,4.12,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,75000.0,nM,=,CHEMBL3389020,B,CHEMBL3353400,Homo sapiens,CHEMBL203,CHEMBL3351341
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CC[C@@H](N(C)C)C1,5.70,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,2000.0,nM,=,CHEMBL3389020,B,CHEMBL3353403,Homo sapiens,CHEMBL203,CHEMBL3351341
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,6.22,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,600.0,nM,=,CHEMBL3389020,B,CHEMBL3353404,Homo sapiens,CHEMBL203,CHEMBL3351341
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cnn4ccccc34)n2)c(OC)cc1N1CC(N(C)C)C1,5.40,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,4000.0,nM,=,CHEMBL3389020,B,CHEMBL3353405,Homo sapiens,CHEMBL203,CHEMBL3351341
C=CC(=O)Nc1cc(Nc2ncc(C#N)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.60,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,25.0,nM,=,CHEMBL4411959,B,CHEMBL3353406,Homo sapiens,CHEMBL203,CHEMBL4411272
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,5.70,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,2000.0,nM,=,CHEMBL3389020,B,CHEMBL3353407,Homo sapiens,CHEMBL203,CHEMBL3351341
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,6.70,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,200.0,nM,=,CHEMBL3389020,B,CHEMBL3353408,Homo sapiens,CHEMBL203,CHEMBL3351341
C=CC(=O)Nc1cc(Nc2ncc(C)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,6.00,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,IC50,1000.0,nM,=,CHEMBL3389020,B,CHEMBL3353409,Homo sapiens,CHEMBL203,CHEMBL3351341
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,9.70,Inhibition of human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 25 mins by HTRF assay,IC50,0.2,nM,=,CHEMBL4670931,B,CHEMBL3353410,Homo sapiens,CHEMBL203,CHEMBL4665812
C=CC(=O)Nc1cc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,8.70,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs by ELISA,IC50,2.0,nM,=,CHEMBL3789494,B,CHEMBL3353411,Homo sapiens,CHEMBL203,CHEMBL3785051
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCNC,7.35,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs by ELISA,IC50,45.0,nM,=,CHEMBL3789494,B,CHEMBL3353412,Homo sapiens,CHEMBL203,CHEMBL3785051
Cc1cc(Nc2cc(NC(=O)c3c(Cl)cccc3Cl)ccn2)nc(N[C@@H](C)CO)n1,8.05,Inhibition of EGFR T790M/del746 to 750 mutant (unknown origin) by high-throughput biochemical screening,Ki,9.0,nM,=,CHEMBL3375800,B,CHEMBL3354183,Homo sapiens,CHEMBL203,CHEMBL3351701
O=C(Nc1ccnc(Nc2ccnc(N3CCC(O)CC3)n2)c1)c1c(Cl)cccc1Cl,7.55,Inhibition of EGFR T790M/L858R mutant (unknown origin) by high-throughput biochemical screening,Ki,28.0,nM,=,CHEMBL3375799,B,CHEMBL3354184,Homo sapiens,CHEMBL203,CHEMBL3351701
COC1CCN(c2nccc(Nc3cc(NC(=O)c4c(Cl)cccc4Cl)ccn3)n2)CC1,7.85,Inhibition of EGFR T790M/L858R mutant (unknown origin) by high-throughput biochemical screening,Ki,14.0,nM,=,CHEMBL3375799,B,CHEMBL3352835,Homo sapiens,CHEMBL203,CHEMBL3351701
COC1CCN(c2nccc(Nc3cc4[nH]c(-c5cn[nH]c5)nc4cn3)n2)CC1,7.29,Inhibition of EGFR T790M/del746 to 750 mutant (unknown origin) by high-throughput biochemical screening,Ki,51.0,nM,=,CHEMBL3375800,B,CHEMBL3354185,Homo sapiens,CHEMBL203,CHEMBL3351701
COC1CCN(c2nccc(Nc3cc4[nH]c(-c5cn[nH]c5)cc4cn3)n2)CC1,7.18,Inhibition of EGFR T790M/L858R mutant (unknown origin) by high-throughput biochemical screening,Ki,66.0,nM,=,CHEMBL3375799,B,CHEMBL3354186,Homo sapiens,CHEMBL203,CHEMBL3351701
COC1CCN(c2nccc(Nc3cc4c(cn3)cc(-c3cn[nH]c3)n4C(C)C)n2)CC1,7.80,Inhibition of EGFR T790M/L858R mutant (unknown origin) by high-throughput biochemical screening,Ki,16.0,nM,=,CHEMBL3375799,B,CHEMBL3354187,Homo sapiens,CHEMBL203,CHEMBL3351701
COC1CCN(c2nccc(Nc3cc4c(ccn4C(C)C)cn3)n2)CC1,7.48,Inhibition of EGFR T790M/L858R mutant (unknown origin) by high-throughput biochemical screening,Ki,33.0,nM,=,CHEMBL3375799,B,CHEMBL3354188,Homo sapiens,CHEMBL203,CHEMBL3351701
COC1CCN(c2nccc(Nc3cc4c(ccn4C4CCCC4)cn3)n2)CC1,7.77,Inhibition of EGFR T790M/L858R mutant (unknown origin) by high-throughput biochemical screening,Ki,17.0,nM,=,CHEMBL3375799,B,CHEMBL3354189,Homo sapiens,CHEMBL203,CHEMBL3351701
COC1CCN(c2nccc(Nc3cc4c(cn3)ncn4C(C)C)n2)CC1,7.40,Inhibition of EGFR T790M/L858R mutant (unknown origin) by high-throughput biochemical screening,Ki,40.0,nM,=,CHEMBL3375799,B,CHEMBL3354190,Homo sapiens,CHEMBL203,CHEMBL3351701
COC1CCN(c2nccc(Nc3cc4c(cn3)c(N)nn4C(C)C)n2)CC1,7.92,Inhibition of EGFR T790M/L858R mutant (unknown origin) by high-throughput biochemical screening,Ki,12.0,nM,=,CHEMBL3375799,B,CHEMBL3354191,Homo sapiens,CHEMBL203,CHEMBL3351701
COC1CCN(c2nccc(Nc3cc4c(C(C)C)n[nH]c4cn3)n2)CC1,7.75,Inhibition of EGFR T790M/L858R mutant (unknown origin) by high-throughput biochemical screening,Ki,18.0,nM,=,CHEMBL3375799,B,CHEMBL3354192,Homo sapiens,CHEMBL203,CHEMBL3351701
COC1CCN(c2nccc(Nc3cc4c(cn3)[nH]c(=O)n4C(C)C)n2)CC1,6.94,Inhibition of EGFR T790M/L858R mutant (unknown origin) by high-throughput biochemical screening,Ki,114.0,nM,=,CHEMBL3375799,B,CHEMBL3354193,Homo sapiens,CHEMBL203,CHEMBL3351701
COC1CCN(c2nccc(Nc3cc4c(cn3)CCN4C(C)C)n2)CC1,6.37,Inhibition of EGFR T790M/L858R mutant (unknown origin) by high-throughput biochemical screening,Ki,423.0,nM,=,CHEMBL3375799,B,CHEMBL3354194,Homo sapiens,CHEMBL203,CHEMBL3351701
COC1CCN(c2nccc(Nc3cc4c(ccc(=O)n4C(C)C)cn3)n2)CC1,7.09,Inhibition of EGFR T790M/L858R mutant (unknown origin) by high-throughput biochemical screening,Ki,82.0,nM,=,CHEMBL3375799,B,CHEMBL3354195,Homo sapiens,CHEMBL203,CHEMBL3351701
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCn1ccnc1[N+](=O)[O-],8.52,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,3.05,nM,=,CHEMBL3372999,B,CHEMBL3355873,Homo sapiens,CHEMBL203,CHEMBL3351739
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCn1ccnc1[N+](=O)[O-],9.05,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.89,nM,=,CHEMBL3372999,B,CHEMBL3355874,Homo sapiens,CHEMBL203,CHEMBL3351739
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCn1ccnc1[N+](=O)[O-],9.33,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.47,nM,=,CHEMBL3372999,B,CHEMBL3355875,Homo sapiens,CHEMBL203,CHEMBL3351739
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCn1ccnc1[N+](=O)[O-],9.29,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.51,nM,=,CHEMBL3372999,B,CHEMBL3355876,Homo sapiens,CHEMBL203,CHEMBL3351739
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCCn1ccnc1[N+](=O)[O-],9.49,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.32,nM,=,CHEMBL3372999,B,CHEMBL3355877,Homo sapiens,CHEMBL203,CHEMBL3351739
COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCCCn1ccnc1[N+](=O)[O-],9.18,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.66,nM,=,CHEMBL3372999,B,CHEMBL3355878,Homo sapiens,CHEMBL203,CHEMBL3351739
C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCn4ccnc4[N+](=O)[O-])cc23)c1,8.97,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,1.08,nM,=,CHEMBL3372999,B,CHEMBL3355879,Homo sapiens,CHEMBL203,CHEMBL3351739
C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCn4ccnc4[N+](=O)[O-])cc23)c1,9.25,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.56,nM,=,CHEMBL3372999,B,CHEMBL3355880,Homo sapiens,CHEMBL203,CHEMBL3351739
C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCn4ccnc4[N+](=O)[O-])cc23)c1,9.31,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.49,nM,=,CHEMBL3372999,B,CHEMBL3355881,Homo sapiens,CHEMBL203,CHEMBL3351739
C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCn4ccnc4[N+](=O)[O-])cc23)c1,9.30,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.5,nM,=,CHEMBL3372999,B,CHEMBL3355882,Homo sapiens,CHEMBL203,CHEMBL3351739
COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OCCCn1ccnc1[N+](=O)[O-],7.42,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,38.3,nM,=,CHEMBL3372999,B,CHEMBL3355883,Homo sapiens,CHEMBL203,CHEMBL3351739
COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OCCCCn1ccnc1[N+](=O)[O-],7.54,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,28.5,nM,=,CHEMBL3372999,B,CHEMBL3355884,Homo sapiens,CHEMBL203,CHEMBL3351739
COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OCCCCCn1ccnc1[N+](=O)[O-],7.29,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,51.2,nM,=,CHEMBL3372999,B,CHEMBL3355885,Homo sapiens,CHEMBL203,CHEMBL3351739
COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OCCCCCCn1ccnc1[N+](=O)[O-],7.82,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,15.1,nM,=,CHEMBL3372999,B,CHEMBL3355886,Homo sapiens,CHEMBL203,CHEMBL3351739
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCn1c([N+](=O)[O-])cnc1C,8.31,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,4.9,nM,=,CHEMBL3372999,B,CHEMBL3355887,Homo sapiens,CHEMBL203,CHEMBL3351739
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCn1c([N+](=O)[O-])cnc1C,8.46,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,3.43,nM,=,CHEMBL3372999,B,CHEMBL3355888,Homo sapiens,CHEMBL203,CHEMBL3351739
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCn1c([N+](=O)[O-])cnc1C,9.28,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.53,nM,=,CHEMBL3372999,B,CHEMBL3355889,Homo sapiens,CHEMBL203,CHEMBL3351739
COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCCCn1c([N+](=O)[O-])cnc1C,8.93,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,1.18,nM,=,CHEMBL3372999,B,CHEMBL3355890,Homo sapiens,CHEMBL203,CHEMBL3351739
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C(F)=C/CN(C)C,9.70,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,0.2,nM,=,CHEMBL3385194,B,CHEMBL3357634,Homo sapiens,CHEMBL203,CHEMBL3351667
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C(F)=C/CN1CCCCC1,9.57,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,0.27,nM,=,CHEMBL3385194,B,CHEMBL3357635,Homo sapiens,CHEMBL203,CHEMBL3351667
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C(F)=C\CN1CCCCC1,9.17,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,0.67,nM,=,CHEMBL3385194,B,CHEMBL3357636,Homo sapiens,CHEMBL203,CHEMBL3351667
CCOc1cc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C(F)=C/CN(C)C,9.74,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,0.18,nM,=,CHEMBL3385194,B,CHEMBL3357637,Homo sapiens,CHEMBL203,CHEMBL3351667
CCOc1cc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C(F)=C\CN(C)C,9.05,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,0.89,nM,=,CHEMBL3385194,B,CHEMBL3357638,Homo sapiens,CHEMBL203,CHEMBL3351667
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)/C(F)=C/CN1CCOCC1,9.59,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,0.26,nM,=,CHEMBL3385194,B,CHEMBL3357639,Homo sapiens,CHEMBL203,CHEMBL3351667
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)/C(F)=C\CN1CCOCC1,9.00,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,1.0,nM,=,CHEMBL3385194,B,CHEMBL3357640,Homo sapiens,CHEMBL203,CHEMBL3351667
CN(C)C/C=C(\F)C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,9.80,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,0.16,nM,=,CHEMBL3385194,B,CHEMBL3357641,Homo sapiens,CHEMBL203,CHEMBL3351667
CN(C)C/C=C(/F)C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,9.51,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,0.31,nM,=,CHEMBL3385194,B,CHEMBL3357642,Homo sapiens,CHEMBL203,CHEMBL3351667
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C(F)=C/CN1CCOCC1,9.28,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,0.53,nM,=,CHEMBL3385194,B,CHEMBL3357643,Homo sapiens,CHEMBL203,CHEMBL3351667
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C(F)=C\CN1CCOCC1,9.52,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,0.3,nM,=,CHEMBL3385194,B,CHEMBL3357644,Homo sapiens,CHEMBL203,CHEMBL3351667
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)/C(F)=C/CN1CCCCC1,8.59,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,2.6,nM,=,CHEMBL3385194,B,CHEMBL3357645,Homo sapiens,CHEMBL203,CHEMBL3351667
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1)/C(F)=C\CN1CCCCC1,8.59,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,2.55,nM,=,CHEMBL3385194,B,CHEMBL3357646,Homo sapiens,CHEMBL203,CHEMBL3351667
CCOc1cc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(Cl)c3)c2cc1NC(=O)/C(F)=C/CN1CCCCC1,7.89,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,12.9,nM,=,CHEMBL3385194,B,CHEMBL3357647,Homo sapiens,CHEMBL203,CHEMBL3351667
CCOc1cc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(Cl)c3)c2cc1NC(=O)/C(F)=C\CN1CCCCC1,7.41,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,39.2,nM,=,CHEMBL3385194,B,CHEMBL3357648,Homo sapiens,CHEMBL203,CHEMBL3351667
COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)/C(F)=C/CN(C)C,8.81,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,1.56,nM,=,CHEMBL3385194,B,CHEMBL3357649,Homo sapiens,CHEMBL203,CHEMBL3351667
COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)/C(F)=C\CN(C)C,8.89,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,1.3,nM,=,CHEMBL3385194,B,CHEMBL3352869,Homo sapiens,CHEMBL203,CHEMBL3351667
CCOc1cc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(Cl)c3)c2cc1NC(=O)/C(F)=C/CN(C)C,8.35,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,4.5,nM,=,CHEMBL3385194,B,CHEMBL3357650,Homo sapiens,CHEMBL203,CHEMBL3351667
CCOc1cc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(Cl)c3)c2cc1NC(=O)/C(F)=C\CN(C)C,8.02,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,9.5,nM,=,CHEMBL3385194,B,CHEMBL3357651,Homo sapiens,CHEMBL203,CHEMBL3351667
CCOc1cc2ncnc(Nc3ccc(OCC4CC4)c(Cl)c3)c2cc1NC(=O)/C(F)=C/CN(C)C,8.46,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,IC50,3.5,nM,=,CHEMBL3385195,B,CHEMBL3357652,Homo sapiens,CHEMBL203,CHEMBL3351667
CCOc1cc2ncnc(Nc3ccc(OCC4CC4)c(Cl)c3)c2cc1NC(=O)/C(F)=C\CN(C)C,7.95,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,11.2,nM,=,CHEMBL3385194,B,CHEMBL3357653,Homo sapiens,CHEMBL203,CHEMBL3351667
COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1NC(=O)/C(F)=C/CN(C)C,8.59,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,2.6,nM,=,CHEMBL3385194,B,CHEMBL3357654,Homo sapiens,CHEMBL203,CHEMBL3351667
COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1NC(=O)/C(F)=C\CN(C)C,8.30,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,IC50,5.0,nM,=,CHEMBL3385194,B,CHEMBL3357655,Homo sapiens,CHEMBL203,CHEMBL3351667
C[C@@H]1CN(c2nc(C(F)(F)F)no2)CCN1c1ncc(OCc2ccc(CS(C)(=O)=O)cc2F)cn1,5.68,Inhibition of EGFR (unknown origin),IC50,2100.0,nM,=,CHEMBL3384643,B,CHEMBL3358006,Homo sapiens,CHEMBL203,CHEMBL3351317
COc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCn1ccnc1[N+](=O)[O-],9.11,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.77,nM,=,CHEMBL3375345,B,CHEMBL3360602,Homo sapiens,CHEMBL203,CHEMBL3352011
COc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCCn1ccnc1[N+](=O)[O-],9.51,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.31,nM,=,CHEMBL3375345,B,CHEMBL3360603,Homo sapiens,CHEMBL203,CHEMBL3352011
COc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCCCn1ccnc1[N+](=O)[O-],9.28,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.52,nM,=,CHEMBL3375345,B,CHEMBL3360604,Homo sapiens,CHEMBL203,CHEMBL3352011
COc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCCCCn1ccnc1[N+](=O)[O-],8.84,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,1.44,nM,=,CHEMBL3375345,B,CHEMBL3360605,Homo sapiens,CHEMBL203,CHEMBL3352011
COc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCOCCn1ccnc1[N+](=O)[O-],9.49,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.32,nM,=,CHEMBL3375345,B,CHEMBL3360606,Homo sapiens,CHEMBL203,CHEMBL3352011
C#Cc1cccc(Nc2ncnc3cc(OCCCn4ccnc4[N+](=O)[O-])c(OC)cc23)c1,9.19,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.65,nM,=,CHEMBL3375345,B,CHEMBL3360607,Homo sapiens,CHEMBL203,CHEMBL3352011
C#Cc1cccc(Nc2ncnc3cc(OCCCCn4ccnc4[N+](=O)[O-])c(OC)cc23)c1,9.59,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.26,nM,=,CHEMBL3375345,B,CHEMBL3360608,Homo sapiens,CHEMBL203,CHEMBL3352011
C#Cc1cccc(Nc2ncnc3cc(OCCCCCn4ccnc4[N+](=O)[O-])c(OC)cc23)c1,9.33,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.47,nM,=,CHEMBL3375345,B,CHEMBL3360609,Homo sapiens,CHEMBL203,CHEMBL3352011
C#Cc1cccc(Nc2ncnc3cc(OCCCCCCn4ccnc4[N+](=O)[O-])c(OC)cc23)c1,9.24,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.57,nM,=,CHEMBL3375345,B,CHEMBL3360610,Homo sapiens,CHEMBL203,CHEMBL3352011
C#Cc1cccc(Nc2ncnc3cc(OCCOCCn4ccnc4[N+](=O)[O-])c(OC)cc23)c1,9.27,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.54,nM,=,CHEMBL3375345,B,CHEMBL3360611,Homo sapiens,CHEMBL203,CHEMBL3352011
COc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1OCCCn1ccnc1[N+](=O)[O-],7.52,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,30.5,nM,=,CHEMBL3375345,B,CHEMBL3360612,Homo sapiens,CHEMBL203,CHEMBL3352011
COc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1OCCCCn1ccnc1[N+](=O)[O-],7.92,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,11.9,nM,=,CHEMBL3375345,B,CHEMBL3360613,Homo sapiens,CHEMBL203,CHEMBL3352011
COc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1OCCCCCn1ccnc1[N+](=O)[O-],7.78,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,16.6,nM,=,CHEMBL3375345,B,CHEMBL3360614,Homo sapiens,CHEMBL203,CHEMBL3352011
COc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1OCCCCCCn1ccnc1[N+](=O)[O-],7.45,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,35.5,nM,=,CHEMBL3375345,B,CHEMBL3360615,Homo sapiens,CHEMBL203,CHEMBL3352011
COc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1OCCOCCn1ccnc1[N+](=O)[O-],7.70,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,20.1,nM,=,CHEMBL3375345,B,CHEMBL3360616,Homo sapiens,CHEMBL203,CHEMBL3352011
COc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCCCn1ccnc1[N+](=O)[O-],9.31,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.49,nM,=,CHEMBL3375345,B,CHEMBL3360617,Homo sapiens,CHEMBL203,CHEMBL3352011
COc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCCCCn1ccnc1[N+](=O)[O-],9.43,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.37,nM,=,CHEMBL3375345,B,CHEMBL3360618,Homo sapiens,CHEMBL203,CHEMBL3352011
COc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCCCCCn1ccnc1[N+](=O)[O-],9.48,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.33,nM,=,CHEMBL3375345,B,CHEMBL3360619,Homo sapiens,CHEMBL203,CHEMBL3352011
COc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCCCCCCn1ccnc1[N+](=O)[O-],9.11,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.78,nM,=,CHEMBL3375345,B,CHEMBL3352899,Homo sapiens,CHEMBL203,CHEMBL3352011
COc1cc2c(Nc3cccc(Br)c3)ncnc2cc1OCCOCCn1ccnc1[N+](=O)[O-],9.09,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,IC50,0.82,nM,=,CHEMBL3375345,B,CHEMBL3360620,Homo sapiens,CHEMBL203,CHEMBL3352011
O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21,4.00,Inhibition of recombinant EGFR (unknown origin) after 60 mins by z'-lyte kinase assay,IC50,100000.0,nM,=,CHEMBL3372237,B,CHEMBL3361128,Homo sapiens,CHEMBL203,CHEMBL3351909
O=C(Cc1c[nH]c2ccccc12)NNC(=S)Nc1ncccc1Br,5.07,Inhibition of human full length HER1 assessed as phosphorylation state by ELISA assay,IC50,8490.0,nM,=,CHEMBL3395991,B,CHEMBL3393072,Homo sapiens,CHEMBL203,CHEMBL3393043
Clc1cc(Nc2ncnc3ccc(NC4=NC[C@H](COc5ccccc5)O4)cc23)ccc1OCc1nccs1,5.92,Inhibition of EGFR (unknown origin),IC50,1210.0,nM,=,CHEMBL3399407,B,CHEMBL3397275,Homo sapiens,CHEMBL203,CHEMBL3396974
Clc1cc(Nc2ncnc3ccc(NC4=NC[C@@H](COc5ccccc5)O4)cc23)ccc1OCc1nccs1,6.02,Inhibition of EGFR (unknown origin),IC50,950.0,nM,=,CHEMBL3399407,B,CHEMBL3397276,Homo sapiens,CHEMBL203,CHEMBL3396974
COc1ccc(N(C)c2nc(C)nc3oc(C)cc23)c(OC)c1,6.79,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,IC50,162.3,nM,=,CHEMBL3404061,B,CHEMBL3403509,Homo sapiens,CHEMBL203,CHEMBL3400114
COc1ccc(N(C)c2nc(C)nc3oc(C)cc23)cc1OC,7.04,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,IC50,90.3,nM,=,CHEMBL3404061,B,CHEMBL3403510,Homo sapiens,CHEMBL203,CHEMBL3400114
Cc1nc(N(C)c2ccc3c(c2)OCO3)c2cc(C)oc2n1,6.53,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,IC50,298.2,nM,=,CHEMBL3404061,B,CHEMBL3403512,Homo sapiens,CHEMBL203,CHEMBL3400114
Cc1nc(N(C)c2ccc3c(c2)CCO3)c2cc(C)oc2n1,6.64,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,IC50,226.4,nM,=,CHEMBL3404061,B,CHEMBL3403513,Homo sapiens,CHEMBL203,CHEMBL3400114
Cc1nc(N(C)c2ccc3occc3c2)c2cc(C)oc2n1,6.51,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,IC50,306.6,nM,=,CHEMBL3404061,B,CHEMBL3403514,Homo sapiens,CHEMBL203,CHEMBL3400114
COc1ccc2c(c1)CCN2c1nc(C)nc2oc(C)cc12,6.99,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,IC50,103.2,nM,=,CHEMBL3404061,B,CHEMBL3403515,Homo sapiens,CHEMBL203,CHEMBL3400114
COc1ccc2c(c1)CCCN2c1nc(C)nc2oc(C)cc12,8.47,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,IC50,3.4,nM,=,CHEMBL3404061,B,CHEMBL3403517,Homo sapiens,CHEMBL203,CHEMBL3400114
Cc1nc(N(C)c2ccc(OC(C)C)cc2)c2cc(C)oc2n1,6.99,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,IC50,102.2,nM,=,CHEMBL3404061,B,CHEMBL3403518,Homo sapiens,CHEMBL203,CHEMBL3400114
CN(CCO)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1,7.44,Inhibition of EGFR intracellular domain (unknown origin) purified from a baculovirus expression system using Biotin-(amino hexonoic acid)-EEEEYFELVAKKK-CONH2 as substrate after 10 mins by scintillation counting in presence of [gamma-33P]ATP,IC50,36.0,nM,=,CHEMBL3412565,B,CHEMBL3409482,Homo sapiens,CHEMBL203,CHEMBL3407467
[O-][S+]1CCN(Cc2ccc(-c3cc4c(Nc5ccc(OCc6cccc(F)c6)cc5)ncnc4cn3)o2)CC1,7.64,Inhibition of EGFR intracellular domain (unknown origin) purified from a baculovirus expression system using Biotin-(amino hexonoic acid)-EEEEYFELVAKKK-CONH2 as substrate after 10 mins by scintillation counting in presence of [gamma-33P]ATP,IC50,23.0,nM,=,CHEMBL3412565,B,CHEMBL3409483,Homo sapiens,CHEMBL203,CHEMBL3407467
CS(=O)(=O)CCNCc1ccc(-c2cc3c(Nc4ccc(OCc5ccccc5)cc4)ncnc3cn2)o1,7.60,Inhibition of EGFR intracellular domain (unknown origin) purified from a baculovirus expression system using Biotin-(amino hexonoic acid)-EEEEYFELVAKKK-CONH2 as substrate after 10 mins by scintillation counting in presence of [gamma-33P]ATP,IC50,25.0,nM,=,CHEMBL3412565,B,CHEMBL3409484,Homo sapiens,CHEMBL203,CHEMBL3407467
COc1ccccc1-c1cc2c(N[C@H](C)c3ccccn3)ncnc2s1,6.82,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,153.0,nM,=,CHEMBL3418211,B,CHEMBL3416437,Homo sapiens,CHEMBL203,CHEMBL3414443
Fc1ccc(Nc2ncnc3sc(Br)cc23)cc1Cl,7.28,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,53.0,nM,=,CHEMBL3418211,B,CHEMBL3416438,Homo sapiens,CHEMBL203,CHEMBL3414443
C#Cc1cccc(Nc2ncnc3sc(Br)cc23)c1,7.64,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,23.0,nM,=,CHEMBL3418211,B,CHEMBL3416439,Homo sapiens,CHEMBL203,CHEMBL3414443
Fc1cccc(COc2ccc(Nc3ncnc4sc(Br)cc34)cc2Cl)c1,6.59,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,257.0,nM,=,CHEMBL3418211,B,CHEMBL3416441,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(NCc3ccccc3)ncnc2s1,7.77,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,17.0,nM,=,CHEMBL3418211,B,CHEMBL3416446,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,8.05,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,9.0,nM,=,CHEMBL3418211,B,CHEMBL3416447,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(N[C@@H](C)c3ccccc3)ncnc2s1,5.73,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,1860.0,nM,=,CHEMBL3418211,B,CHEMBL3416590,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(NC(C)c3ccccc3)ncnc2s1,7.72,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,19.0,nM,=,CHEMBL3418211,B,CHEMBL3416591,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1,9.00,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,1.0,nM,=,CHEMBL3418211,B,CHEMBL3416592,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(N[C@@H](CO)c3ccccc3)ncnc2s1,6.20,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,629.0,nM,=,CHEMBL3418211,B,CHEMBL3416593,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(NC(CO)c3ccccc3)ncnc2s1,8.10,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,8.0,nM,=,CHEMBL3418211,B,CHEMBL3416594,Homo sapiens,CHEMBL203,CHEMBL3414443
COC[C@@H](Nc1ncnc2sc(-c3ccccc3OC)cc12)c1ccccc1,7.64,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,23.0,nM,=,CHEMBL3418211,B,CHEMBL3416595,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(N[C@H](C)c3ccc(F)cc3)ncnc2s1,7.57,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,27.0,nM,=,CHEMBL3418211,B,CHEMBL3416596,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(NCc3ccncc3)ncnc2s1,6.97,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,108.0,nM,=,CHEMBL3418211,B,CHEMBL3416597,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(NCc3cccnc3)ncnc2s1,6.56,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,275.0,nM,=,CHEMBL3418211,B,CHEMBL3416598,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(NCc3ccccn3)ncnc2s1,6.74,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,183.0,nM,=,CHEMBL3418211,B,CHEMBL3414594,Homo sapiens,CHEMBL203,CHEMBL3414443
Brc1cc2c(NCc3ccccc3)ncnc2s1,6.62,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,241.0,nM,=,CHEMBL3418211,B,CHEMBL3416599,Homo sapiens,CHEMBL203,CHEMBL3414443
C[C@@H](Nc1ncnc2sc(Br)cc12)c1ccccc1,7.42,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,38.0,nM,=,CHEMBL3418211,B,CHEMBL3416600,Homo sapiens,CHEMBL203,CHEMBL3414443
CC(Nc1ncnc2sc(Br)cc12)c1ccccc1,6.81,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,156.0,nM,=,CHEMBL3418211,B,CHEMBL3416602,Homo sapiens,CHEMBL203,CHEMBL3414443
OC[C@@H](Nc1ncnc2sc(Br)cc12)c1ccccc1,7.44,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,36.0,nM,=,CHEMBL3418211,B,CHEMBL3416603,Homo sapiens,CHEMBL203,CHEMBL3414443
OCC(Nc1ncnc2sc(Br)cc12)c1ccccc1,7.08,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,83.0,nM,=,CHEMBL3418211,B,CHEMBL3416605,Homo sapiens,CHEMBL203,CHEMBL3414443
COC[C@@H](Nc1ncnc2sc(Br)cc12)c1ccccc1,6.58,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,262.0,nM,=,CHEMBL3418211,B,CHEMBL3416606,Homo sapiens,CHEMBL203,CHEMBL3414443
CC[C@@H](Nc1ncnc2sc(Br)cc12)c1ccccc1,6.74,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,183.0,nM,=,CHEMBL3418211,B,CHEMBL3416608,Homo sapiens,CHEMBL203,CHEMBL3414443
C[C@@H](Nc1ncnc2sc(Br)cc12)c1ccc(F)cc1,6.82,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,150.0,nM,=,CHEMBL3418211,B,CHEMBL3416612,Homo sapiens,CHEMBL203,CHEMBL3414443
Brc1cc2c(NCc3ccncc3)ncnc2s1,5.41,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,3883.0,nM,=,CHEMBL3418211,B,CHEMBL3416614,Homo sapiens,CHEMBL203,CHEMBL3414443
Brc1cc2c(NCc3ccccn3)ncnc2s1,5.10,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,7904.0,nM,=,CHEMBL3418211,B,CHEMBL3416616,Homo sapiens,CHEMBL203,CHEMBL3414443
C[C@@H](Nc1ncnc2sc(Br)cc12)c1ccccn1,5.68,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,2079.0,nM,=,CHEMBL3418211,B,CHEMBL3416617,Homo sapiens,CHEMBL203,CHEMBL3414443
Brc1cc2c(NCc3cccs3)ncnc2s1,5.86,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,1374.0,nM,=,CHEMBL3418211,B,CHEMBL3416619,Homo sapiens,CHEMBL203,CHEMBL3414443
C[C@@H](Nc1ncnc2sc(Br)cc12)c1cccs1,6.38,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,415.0,nM,=,CHEMBL3418211,B,CHEMBL3416620,Homo sapiens,CHEMBL203,CHEMBL3414443
Brc1cc2c(Nc3ccccc3)ncnc2s1,7.10,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,80.0,nM,=,CHEMBL3418211,B,CHEMBL3416621,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(NCc3cccs3)ncnc2s1,6.77,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,170.0,nM,=,CHEMBL3418211,B,CHEMBL3416622,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(N[C@H](C)c3cccs3)ncnc2s1,7.26,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,55.0,nM,=,CHEMBL3418211,B,CHEMBL3416623,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(Nc3ccccc3)ncnc2s1,6.76,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,173.0,nM,=,CHEMBL3418211,B,CHEMBL3416624,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.30,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,5.0,nM,=,CHEMBL3418211,B,CHEMBL3416625,Homo sapiens,CHEMBL203,CHEMBL3414443
C#Cc1cccc(Nc2ncnc3sc(-c4ccccc4OC)cc23)c1,7.75,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,18.0,nM,=,CHEMBL3418211,B,CHEMBL3416626,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1ccccc1-c1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2s1,6.66,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,IC50,220.0,nM,=,CHEMBL3418211,B,CHEMBL3416627,Homo sapiens,CHEMBL203,CHEMBL3414443
O=C(Nc1ccc(CN2CCCC2)cc1)c1sc2ncnc3c2c1NC(=O)N3c1ccc(F)c(Cl)c1,8.15,Inhibition of human GST-tagged EGFR expressed in baculovirus-infected insect Sf9 cells using biotinylating polyGluTyr as substrate after 1 hr by scintillation counting analysis in presence of [gamma-33P]-ATP,IC50,7.0,nM,=,CHEMBL3418212,B,CHEMBL3416628,Homo sapiens,CHEMBL203,CHEMBL3414443
C#Cc1cccc(N2C(=O)Nc3c(C(=O)Nc4ccc(CN5CCCC5)cc4)sc4ncnc2c34)c1,7.58,Inhibition of human GST-tagged EGFR expressed in baculovirus-infected insect Sf9 cells using biotinylating polyGluTyr as substrate after 1 hr by scintillation counting analysis in presence of [gamma-33P]-ATP,IC50,26.0,nM,=,CHEMBL3418212,B,CHEMBL3416629,Homo sapiens,CHEMBL203,CHEMBL3414443
OC[C@@H](Nc1ncnc2sc(-c3ccc(CN4CCNCC4)cc3)cc12)c1ccccc1,6.22,Inhibition of EGFR (unknown origin) using Poly(Glu:Tyr) 4:1 as substrate after 12 to 16 hrs,IC50,600.0,nM,=,CHEMBL3418213,B,CHEMBL3416630,Homo sapiens,CHEMBL203,CHEMBL3414443
OCCN1CCN(Cc2ccc(-c3cc4c(N[C@H](CO)c5ccccc5)ncnc4s3)cc2)CC1,6.22,Inhibition of EGFR (unknown origin) using Poly(Glu:Tyr) 4:1 as substrate after 12 to 16 hrs,IC50,600.0,nM,=,CHEMBL3418213,B,CHEMBL3416631,Homo sapiens,CHEMBL203,CHEMBL3414443
C[C@H](N)C#Cc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2s1,7.16,Inhibition of EGFR (unknown origin) after 40 mins by scintillation proximity assay,IC50,69.0,nM,=,CHEMBL3418214,B,CHEMBL3416633,Homo sapiens,CHEMBL203,CHEMBL3414443
C#Cc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2s1,7.15,Inhibition of EGFR (unknown origin) after 40 mins by scintillation proximity assay,IC50,71.0,nM,=,CHEMBL3418214,B,CHEMBL3416634,Homo sapiens,CHEMBL203,CHEMBL3414443
Fc1cccc(COc2ccc(Nc3ncnc4sc(C#CC5CCCN5)cc34)cc2Cl)c1,6.96,Inhibition of EGFR (unknown origin) after 40 mins by scintillation proximity assay,IC50,109.0,nM,=,CHEMBL3418214,B,CHEMBL3416635,Homo sapiens,CHEMBL203,CHEMBL3414443
Nc1cnc(C#Cc2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cn1,6.43,Inhibition of EGFR (unknown origin) after 40 mins by scintillation proximity assay,IC50,372.0,nM,=,CHEMBL3418214,B,CHEMBL3416636,Homo sapiens,CHEMBL203,CHEMBL3414443
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/c3ccc(F)cc3)c2)n1,6.92,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,120.0,nM,=,CHEMBL3430221,B,CHEMBL3425655,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/c3ccc(SC)cc3)c2)n1,6.29,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,510.0,nM,=,CHEMBL3430221,B,CHEMBL3425656,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/c3ccc([N+](=O)[O-])cc3)c2)n1,5.92,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,1200.0,nM,=,CHEMBL3430221,B,CHEMBL3425657,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/c3cccc([N+](=O)[O-])c3)c2)n1,6.14,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,720.0,nM,=,CHEMBL3430221,B,CHEMBL3425658,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/c3ccc(C#N)cc3)c2)n1,6.03,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,940.0,nM,=,CHEMBL3430221,B,CHEMBL3425660,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/c3ccncc3)c2)n1,7.43,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,37.0,nM,=,CHEMBL3430221,B,CHEMBL3425661,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/c3ccco3)c2)n1,6.48,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,330.0,nM,=,CHEMBL3430221,B,CHEMBL3425662,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/c3cnc[nH]3)c2)n1,7.09,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,81.0,nM,=,CHEMBL3430221,B,CHEMBL3425663,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/C3CC3)c2)n1,7.08,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,83.0,nM,=,CHEMBL3430221,B,CHEMBL3425664,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/C(C)C)c2)n1,6.10,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,800.0,nM,=,CHEMBL3430221,B,CHEMBL3425665,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/C(C)(C)C)c2)n1,6.40,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,400.0,nM,=,CHEMBL3430221,B,CHEMBL3425666,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(C#N)=C/C3CCCC3)c2)n1,5.92,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,1200.0,nM,=,CHEMBL3430221,B,CHEMBL3425667,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(=C/c3ccc(F)cc3)C(F)(F)F)c2)n1,5.20,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,6300.0,nM,=,CHEMBL3430221,B,CHEMBL3425668,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C(=C/c3ccc(N(C)C)cc3)C(F)(F)F)c2)n1,5.66,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,2200.0,nM,=,CHEMBL3430221,B,CHEMBL3425669,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1ccc(/C=C(/C(=O)Nc2cccc(Oc3nc(Nc4ccc(N5CCN(C)CC5)cc4OC)ncc3Cl)c2)C(F)(F)F)cc1,5.05,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,8900.0,nM,=,CHEMBL3430221,B,CHEMBL3425670,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(C)=O)c2)n1,6.75,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,180.0,nM,=,CHEMBL3430221,B,CHEMBL3425671,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C=C/C3CC3)c2)n1,6.08,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,830.0,nM,=,CHEMBL3430221,B,CHEMBL3425672,Homo sapiens,CHEMBL203,CHEMBL3425413
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)CCC3CC3)c2)n1,6.11,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,IC50,770.0,nM,=,CHEMBL3430221,B,CHEMBL3425673,Homo sapiens,CHEMBL203,CHEMBL3425413
CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21,5.45,Inhibition of human EGFR,IC50,3518.0,nM,=,CHEMBL3429887,B,CHEMBL3426225,Homo sapiens,CHEMBL203,CHEMBL3425429
Cc1ccc(S(=O)(=O)O)cc1.Fc1cccc(COc2ccc(Nc3ncnc4ccc(-c5ccc(CN6CCOCC6)o5)cc34)cc2Cl)c1,7.58,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,IC50,26.0,nM,=,CHEMBL2439214,B,CHEMBL3436354,Homo sapiens,CHEMBL203,CHEMBL2434871
CN1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1.Cc1ccc(S(=O)(=O)O)cc1,7.90,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,IC50,12.5,nM,=,CHEMBL2439214,B,CHEMBL3436355,Homo sapiens,CHEMBL203,CHEMBL2434871
Cc1ccc(S(=O)(=O)O)cc1.Fc1cccc(COc2ccc(Nc3ncnc4ccc(-c5ccc(CN6CCNCC6)o5)cc34)cc2Cl)c1,7.97,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,IC50,10.8,nM,=,CHEMBL2439214,B,CHEMBL3436356,Homo sapiens,CHEMBL203,CHEMBL2434871
CCOC(=O)N1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1.Cc1ccc(S(=O)(=O)O)cc1,7.55,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,IC50,28.0,nM,=,CHEMBL2439214,B,CHEMBL3436357,Homo sapiens,CHEMBL203,CHEMBL2434871
CS(=O)(=O)N1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1.Cc1ccc(S(=O)(=O)O)cc1,7.22,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,IC50,59.9,nM,=,CHEMBL2439214,B,CHEMBL3436358,Homo sapiens,CHEMBL203,CHEMBL2434871
CC(=O)N1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1.Cc1ccc(S(=O)(=O)O)cc1,7.94,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,IC50,11.4,nM,=,CHEMBL2439214,B,CHEMBL3436359,Homo sapiens,CHEMBL203,CHEMBL2434871
CN1CCN(C(=O)c2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1.Cc1ccc(S(=O)(=O)O)cc1,6.63,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,IC50,232.4,nM,=,CHEMBL2439214,B,CHEMBL3436360,Homo sapiens,CHEMBL203,CHEMBL2434871
OCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,8.30,"Inhibition of wild type recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,5.06,nM,=,CHEMBL4007059,B,CHEMBL3542268,Homo sapiens,CHEMBL203,CHEMBL4004868
CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1,5.83,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Kd,1468.0,nM,=,CHEMBL3991696,B,CHEMBL3544932,Homo sapiens,CHEMBL203,CHEMBL3991601
COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1,9.52,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,IC50,0.3,nM,=,CHEMBL4394508,B,CHEMBL3544983,Homo sapiens,CHEMBL203,CHEMBL4393671
Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1,5.76,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Kd,1722.0,nM,=,CHEMBL3991696,B,CHEMBL3545137,Homo sapiens,CHEMBL203,CHEMBL3991601
C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1,9.66,"Inhibition of GST-tagged human EGFR D770_N771insNPG mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",IC50,0.218,nM,=,CHEMBL4416111,B,CHEMBL3545154,Homo sapiens,CHEMBL203,CHEMBL4414600
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O,9.09,Displacement of radiolabeled EGF from EGF receptor expressed in human MX1 cells,Kd,0.82,nM,=,CHEMBL921756,B,CHEMBL3545252,Homo sapiens,CHEMBL203,CHEMBL1147056
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1,8.80,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,IC50,1.6,nM,=,CHEMBL4009507,B,CHEMBL3545308,Homo sapiens,CHEMBL203,CHEMBL4007434
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,9.15,Inhibition of EGFR del19/T790M mutant (unknown origin),IC50,0.7,nM,=,CHEMBL5114502,B,CHEMBL3545311,Homo sapiens,CHEMBL203,CHEMBL5113388
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1,4.68,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Kd,20827.0,nM,=,CHEMBL3991696,B,CHEMBL3545360,Homo sapiens,CHEMBL203,CHEMBL3991601
COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1,6.66,Binding affinity to wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by Kinomescan method,Kd,220.0,nM,=,CHEMBL4394506,B,CHEMBL3545396,Homo sapiens,CHEMBL203,CHEMBL4393671
O=C1N=C(N2CCC[C@H]2C(=O)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)S/C1=C/c1cccs1,5.09,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,IC50,8100.0,nM,=,CHEMBL3588418,B,CHEMBL3586174,Homo sapiens,CHEMBL203,CHEMBL3585298
O=C1N=C(N2CCC[C@H]2C(=O)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)S/C1=C/c1ccc(Br)s1,4.50,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,IC50,31400.0,nM,=,CHEMBL3588418,B,CHEMBL3586175,Homo sapiens,CHEMBL203,CHEMBL3585298
Cc1cccc(/C=C2/SC(N3CCC[C@H]3C(=O)Nc3ccc4ncnc(Nc5cccc(Cl)c5)c4c3)=NC2=O)n1,5.19,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,IC50,6500.0,nM,=,CHEMBL3588418,B,CHEMBL3586176,Homo sapiens,CHEMBL203,CHEMBL3585298
O=C1N=C(N2CCC[C@H]2C(=O)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)S/C1=C/c1cccc(Br)n1,5.51,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,IC50,3100.0,nM,=,CHEMBL3588418,B,CHEMBL3586177,Homo sapiens,CHEMBL203,CHEMBL3585298
O=C1N=C(N2CCC[C@H]2C(=O)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)S/C1=C/c1cccnc1Cl,5.13,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,IC50,7400.0,nM,=,CHEMBL3588418,B,CHEMBL3586178,Homo sapiens,CHEMBL203,CHEMBL3585298
O=C1N=C(N2CCC[C@H]2C(=O)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)S/C1=C/c1cccnc1,5.01,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,IC50,9800.0,nM,=,CHEMBL3588418,B,CHEMBL3586179,Homo sapiens,CHEMBL203,CHEMBL3585298
O=C1N=C(N2CCC[C@H]2C(=O)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)S/C1=C/c1ccc(Cl)cc1,5.12,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,IC50,7600.0,nM,=,CHEMBL3588418,B,CHEMBL3586185,Homo sapiens,CHEMBL203,CHEMBL3585298
O=C1N=C(N2CCC[C@H]2C(=O)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)S/C1=C/c1ccc(-c2ccccc2)cc1,4.88,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,IC50,13200.0,nM,=,CHEMBL3588418,B,CHEMBL3586189,Homo sapiens,CHEMBL203,CHEMBL3585298
C=CC(=O)Nc1cccc(CNc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1,6.39,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte assay,IC50,409.0,nM,=,CHEMBL3603321,B,CHEMBL3601223,Homo sapiens,CHEMBL203,CHEMBL3600288
COc1ccc2c(c1)CCCN2c1ncnc2ccccc12,7.31,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,IC50,48.9,nM,=,CHEMBL4714413,B,CHEMBL3604205,Homo sapiens,CHEMBL203,CHEMBL4706704
CCC(=O)Nc1ccc2c(Nc3cc[nH]n3)nc(-c3ccccc3)nc2c1,5.68,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,2100.0,nM,=,CHEMBL3606404,B,CHEMBL3604910,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)Nc1ccccc1-c1nc(Nc2cc[nH]n2)c2ccccc2n1,5.96,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,1100.0,nM,=,CHEMBL3606405,B,CHEMBL3604911,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)Nc1cccc(-c2nc(Nc3cc[nH]n3)c3ccccc3n2)c1,7.00,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,100.0,nM,=,CHEMBL3606405,B,CHEMBL3604912,Homo sapiens,CHEMBL203,CHEMBL3603765
CCC(=O)Nc1cccc(-c2nc(Nc3cc[nH]n3)c3ccccc3n2)c1,6.40,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,400.0,nM,=,CHEMBL3606405,B,CHEMBL3604915,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)Nc1cc(Nc2cc[nH]n2)nc(-c2ccccc2)n1,6.52,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,300.0,nM,=,CHEMBL3606405,B,CHEMBL3604917,Homo sapiens,CHEMBL203,CHEMBL3603765
CCC(=O)Nc1cc(Nc2cc[nH]n2)nc(-c2ccccc2)n1,5.47,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,3400.0,nM,=,CHEMBL3606404,B,CHEMBL3604918,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)Nc1cccc(-c2nccc(Nc3cc(C)[nH]n3)n2)c1,5.60,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,2500.0,nM,=,CHEMBL3606405,B,CHEMBL3604919,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)Nc1ccccc1Oc1nc(Nc2cc(C)[nH]n2)cc(N2CCN(C)CC2)n1,6.22,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,600.0,nM,=,CHEMBL3606404,B,CHEMBL3604920,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)Nc1cccc(Oc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)c1,9.19,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells by enzyme kinetics assay,Ki,0.64,nM,=,CHEMBL3606413,B,CHEMBL3604921,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)Nc1ccc(Oc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1,5.75,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,1800.0,nM,=,CHEMBL3606404,B,CHEMBL3604922,Homo sapiens,CHEMBL203,CHEMBL3603765
CCC(=O)Nc1cccc(Oc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)c1,5.72,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,1900.0,nM,=,CHEMBL3606404,B,CHEMBL3604924,Homo sapiens,CHEMBL203,CHEMBL3603765
CCC(=O)Nc1ccc(Oc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1,6.16,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,700.0,nM,=,CHEMBL3606405,B,CHEMBL3604925,Homo sapiens,CHEMBL203,CHEMBL3603765
Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Oc3ccccc3[N+](=O)[O-])n2)n[nH]1,5.80,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,1600.0,nM,=,CHEMBL3606405,B,CHEMBL3604926,Homo sapiens,CHEMBL203,CHEMBL3603765
Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Oc3cccc([N+](=O)[O-])c3)n2)n[nH]1,6.22,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,600.0,nM,=,CHEMBL3606405,B,CHEMBL3604927,Homo sapiens,CHEMBL203,CHEMBL3603765
Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Oc3ccc([N+](=O)[O-])cc3)n2)n[nH]1,6.05,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,900.0,nM,=,CHEMBL3606405,B,CHEMBL3604928,Homo sapiens,CHEMBL203,CHEMBL3603765
Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Oc3cccc(N)c3)n2)n[nH]1,5.31,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,4900.0,nM,=,CHEMBL3606405,B,CHEMBL3604929,Homo sapiens,CHEMBL203,CHEMBL3603765
Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Oc3ccc(N)cc3)n2)n[nH]1,5.85,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,1400.0,nM,=,CHEMBL3606405,B,CHEMBL3604930,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)Nc1cccc(Oc2nccc(Nc3cc(C)[nH]n3)n2)c1,6.05,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,900.0,nM,=,CHEMBL3606405,B,CHEMBL3604931,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)Nc1cccc(Oc2nc(Nc3cc[nH]n3)cc(N3CCN(C)CC3)n2)c1,5.72,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,1900.0,nM,=,CHEMBL3606405,B,CHEMBL3604933,Homo sapiens,CHEMBL203,CHEMBL3603765
Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Oc3ccc(NC(=O)/C=C/CN(C)C)cc3)n2)n[nH]1,5.77,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,1700.0,nM,=,CHEMBL3606403,B,CHEMBL3604935,Homo sapiens,CHEMBL203,CHEMBL3603765
Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Oc3ccc(NC(=O)/C=C/C(F)(F)F)cc3)n2)n[nH]1,5.82,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,1500.0,nM,=,CHEMBL3606405,B,CHEMBL3604936,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)Nc1cccc(Oc2nc(Nc3n[nH]c4ccccc34)cc(N3CCN(C)CC3)n2)c1,9.49,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells by enzyme kinetics assay,Ki,0.32,nM,=,CHEMBL3606413,B,CHEMBL3604937,Homo sapiens,CHEMBL203,CHEMBL3603765
CCC(=O)Nc1cccc(Oc2nc(Nc3n[nH]c4ccccc34)cc(N3CCN(C)CC3)n2)c1,5.07,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,8600.0,nM,=,CHEMBL3606405,B,CHEMBL3604938,Homo sapiens,CHEMBL203,CHEMBL3603765
CN(C)C/C=C/C(=O)Nc1cccc(Oc2nc(Nc3n[nH]c4ccccc34)cc(N3CCN(C)CC3)n2)c1,6.16,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,700.0,nM,=,CHEMBL3606405,B,CHEMBL3604939,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)Nc1cccc(Oc2nc(Nc3n[nH]c4ccc(Br)cc34)cc(N3CCN(C)CC3)n2)c1,6.52,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,300.0,nM,=,CHEMBL3606405,B,CHEMBL3604940,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)Nc1cccc(Oc2nc(Nc3n[nH]c4ccccc34)cc(N3CCN(C(C)=O)CC3)n2)c1,6.70,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,200.0,nM,=,CHEMBL3606405,B,CHEMBL3604941,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)Nc1cccc(-c2nc(Nc3n[nH]c4ccccc34)cc(N3CCN(C)CC3)n2)c1,5.31,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,4900.0,nM,=,CHEMBL3606405,B,CHEMBL3604942,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N1CCN(C)CC1,9.00,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,IC50,1.0,nM,=,CHEMBL3606404,B,CHEMBL3604943,Homo sapiens,CHEMBL203,CHEMBL3603765
C=CC(=O)N[C@@H]1CN(c2nc(Nc3cnn(C)c3)c3ncn(C(C)C)c3n2)C[C@H]1F,8.70,Inhibition of EGFR L858R mutant in human H3255 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,IC50,2.0,nM,=,CHEMBL3609989,B,CHEMBL3608429,Homo sapiens,CHEMBL203,CHEMBL3608213
C=CC(=O)N1C[C@@H]2CN(c3nc(Nc4ccc(N5CCN(C)CC5)cc4)c4ncn(C(C)C)c4n3)C[C@@H]2C1,8.10,Inhibition of EGFR L858R mutant in human H3255 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,IC50,8.0,nM,=,CHEMBL3609989,B,CHEMBL3608430,Homo sapiens,CHEMBL203,CHEMBL3608213
C=CC(=O)N[C@H]1CCN(c2nc(Nc3ccc(N4CCN(C)CC4)cc3)c3ncn(CCO)c3n2)C1,8.15,Inhibition of EGFR L858R mutant in human H3255 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,IC50,7.0,nM,=,CHEMBL3609989,B,CHEMBL3608431,Homo sapiens,CHEMBL203,CHEMBL3608213
C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3C)c3ncn(C(C)C)c3n2)C[C@H]1F,8.40,Inhibition of EGFR T790M/exon 19 deletion mutant phosphorylation in human PC9-DRH cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,IC50,4.0,nM,=,CHEMBL4178360,B,CHEMBL3608432,Homo sapiens,CHEMBL203,CHEMBL4177539
C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C4CCN(C)C4)nc3OC)c3ncn(C(C)C)c3n2)C[C@H]1F,8.52,Inhibition of EGFR deletion/T790M mutant in human PC9-DRH cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,IC50,3.0,nM,=,CHEMBL3609990,B,CHEMBL3608433,Homo sapiens,CHEMBL203,CHEMBL3608213
C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(CC)nc3OC)c3ncn(C)c3n2)C[C@H]1F,9.00,Inhibition of EGFR deletion/T790M mutant in human PC9-DRH cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,IC50,1.0,nM,=,CHEMBL3609990,B,CHEMBL3608434,Homo sapiens,CHEMBL203,CHEMBL3608213
COCCn1c(=O)oc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,6.33,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,470.0,nM,=,CHEMBL3614855,B,CHEMBL3612561,Homo sapiens,CHEMBL203,CHEMBL3611993
C#Cc1cccc(Nc2ncnc3cc4oc(=O)n(CCOC)c4cc23)c1,6.72,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,190.0,nM,=,CHEMBL3614855,B,CHEMBL3612562,Homo sapiens,CHEMBL203,CHEMBL3611993
COCCn1c(=O)oc2cc3ncnc(Nc4ccc(F)c(F)c4)c3cc21,7.58,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,26.0,nM,=,CHEMBL3614855,B,CHEMBL3612563,Homo sapiens,CHEMBL203,CHEMBL3611993
COCCn1c(=O)oc2cc3ncnc(Nc4ccc(OC)cc4)c3cc21,5.29,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,5100.0,nM,=,CHEMBL3614855,B,CHEMBL3612564,Homo sapiens,CHEMBL203,CHEMBL3611993
COCCn1c(=O)oc2cc3ncnc(Nc4ccc(OCc5nccc(OCC(F)(F)F)c5C)cc4)c3cc21,6.47,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,340.0,nM,=,CHEMBL3614855,B,CHEMBL3612567,Homo sapiens,CHEMBL203,CHEMBL3611993
COCCn1c(=O)oc2cc3ncnc(Nc4cccc(C(C)=O)c4)c3cc21,6.25,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,560.0,nM,=,CHEMBL3614855,B,CHEMBL3612570,Homo sapiens,CHEMBL203,CHEMBL3611993
COCCn1c(=O)oc2cc3ncnc(Nc4ccc(OCc5ccc(Cl)cc5)c(Cl)c4)c3cc21,5.89,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,1300.0,nM,=,CHEMBL3614855,B,CHEMBL3612571,Homo sapiens,CHEMBL203,CHEMBL3611993
COCCn1c(=O)oc2cc3ncnc(Nc4ccc(OC)c(OC)c4)c3cc21,5.26,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,5500.0,nM,=,CHEMBL3614855,B,CHEMBL3612572,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)c1ccc(O)c(Nc2ncnc3cc4oc(=O)n(CCOC)c4cc23)c1,6.36,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,440.0,nM,=,CHEMBL3614855,B,CHEMBL3612573,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,5.11,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,7800.0,nM,=,CHEMBL3614855,B,CHEMBL3612574,Homo sapiens,CHEMBL203,CHEMBL3611993
C#Cc1cccc(Nc2ncnc3cc4oc(=O)n(CCCC(=O)OCC)c4cc23)c1,5.24,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,5700.0,nM,=,CHEMBL3614855,B,CHEMBL3612575,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4ccc(Cl)cc4)c3cc21,5.92,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,1200.0,nM,=,CHEMBL3614855,B,CHEMBL3612578,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4ccc(OC)cc4)c3cc21,5.12,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,7500.0,nM,=,CHEMBL3614855,B,CHEMBL3612580,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4ccc(OCc5nccc(OCC(F)(F)F)c5C)cc4)c3cc21,6.11,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,780.0,nM,=,CHEMBL3614855,B,CHEMBL3612585,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4cc(C(=O)OCC)ccc4O)c3cc21,8.14,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,7.3,nM,=,CHEMBL3614855,B,CHEMBL3612587,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4ccc5[nH]ncc5c4)c3cc21,6.89,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,130.0,nM,=,CHEMBL3614855,B,CHEMBL3612590,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4ccc(OCc5ccccn5)cc4)c3cc21,5.64,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,2300.0,nM,=,CHEMBL3614855,B,CHEMBL3612591,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4ccc(F)c(F)c4)c3cc21,6.85,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,140.0,nM,=,CHEMBL3614855,B,CHEMBL3612592,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4ccc(OCc5ccc(Cl)cc5)c(Cl)c4)c3cc21,7.28,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,53.0,nM,=,CHEMBL3614855,B,CHEMBL3612593,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4ccc(O)cc4)c3cc21,7.70,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,20.0,nM,=,CHEMBL3614855,B,CHEMBL3612594,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4cccc(O)c4)c3cc21,8.06,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,8.7,nM,=,CHEMBL3614855,B,CHEMBL3612595,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4ccc(OC(C)C)cc4)c3cc21,6.80,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,160.0,nM,=,CHEMBL3614855,B,CHEMBL3612596,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4ccc(C(=O)OCc5ccc(Cl)cc5)cc4)c3cc21,6.18,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,660.0,nM,=,CHEMBL3614855,B,CHEMBL3612598,Homo sapiens,CHEMBL203,CHEMBL3611993
CCOC(=O)CCCn1c(=O)oc2cc3ncnc(Nc4cc(C)cc(C)c4)c3cc21,5.82,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,IC50,1500.0,nM,=,CHEMBL3614855,B,CHEMBL3612599,Homo sapiens,CHEMBL203,CHEMBL3611993
CN(C)c1ccc(/C=C/C(=O)c2ccc3ncc(C(N)=O)c(Nc4ccc(Cl)cc4)c3c2)cc1,5.28,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,IC50,5283.0,nM,=,CHEMBL3616083,B,CHEMBL3613691,Homo sapiens,CHEMBL203,CHEMBL3611967
NC(=O)c1cnc2ccc(C(=O)/C=C/c3ccc(Cl)cc3)cc2c1Nc1ccc(Br)cc1,5.32,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,IC50,4824.0,nM,=,CHEMBL3616083,B,CHEMBL3613695,Homo sapiens,CHEMBL203,CHEMBL3611967
C=CC(=O)Nc1ccc2ncnc(Nc3cc(F)c(Cl)c(Cl)c3)c2c1,10.43,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,IC50,0.037,nM,=,CHEMBL3616083,B,CHEMBL3613702,Homo sapiens,CHEMBL203,CHEMBL3611967
C=CC(=O)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1OCCOC,6.99,Inhibition of EGFR (unknown origin) by ELISA method,IC50,102.2,nM,=,CHEMBL3625155,B,CHEMBL3621220,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(NC(=O)C=C)cc23)c1,8.74,Inhibition of EGFR (unknown origin) by ELISA method,IC50,1.8,nM,=,CHEMBL3625155,B,CHEMBL3622617,Homo sapiens,CHEMBL203,CHEMBL3621102
C=CC(=O)Nc1cc2c(Nc3ccc(NC(=O)C=C)c(C(F)(F)F)c3)ncnc2cc1OCCOC,6.94,Inhibition of EGFR (unknown origin) by ELISA method,IC50,115.1,nM,=,CHEMBL3625155,B,CHEMBL3622619,Homo sapiens,CHEMBL203,CHEMBL3621102
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(C#N)c3)ncnc2cc1OCCOC,6.71,Inhibition of EGFR (unknown origin) by ELISA method,IC50,195.8,nM,=,CHEMBL3625155,B,CHEMBL3622620,Homo sapiens,CHEMBL203,CHEMBL3621102
C=CC(=O)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,6.25,Inhibition of EGFR (unknown origin) by ELISA method,IC50,560.4,nM,=,CHEMBL3625155,B,CHEMBL3622621,Homo sapiens,CHEMBL203,CHEMBL3621102
C=CC(=O)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)cc3)ncnc2cc1O[C@H]1CCOC1,7.14,Inhibition of EGFR (unknown origin) by ELISA method,IC50,72.2,nM,=,CHEMBL3625155,B,CHEMBL3622622,Homo sapiens,CHEMBL203,CHEMBL3621102
C=CC(=O)Nc1cc2c(Nc3ccc(OCc4ccccn4)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,6.87,Inhibition of EGFR (unknown origin) by ELISA method,IC50,134.9,nM,=,CHEMBL3625155,B,CHEMBL3622623,Homo sapiens,CHEMBL203,CHEMBL3621102
C=CC(=O)Nc1cc2c(Nc3ccc(OCc4ccccn4)cc3)ncnc2cc1O[C@H]1CCOC1,7.00,Inhibition of EGFR (unknown origin) by ELISA method,IC50,100.1,nM,=,CHEMBL3625155,B,CHEMBL3622624,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(O[C@H]4CCOC4)c(NC(=O)C=C)cc23)c1,7.49,Inhibition of EGFR (unknown origin) by ELISA method,IC50,32.2,nM,=,CHEMBL3625155,B,CHEMBL3622625,Homo sapiens,CHEMBL203,CHEMBL3621102
C=CC(=O)Nc1cc2c(Nc3ccc(Cl)c(C(F)(F)F)c3)ncnc2cc1O[C@H]1CCOC1,6.98,Inhibition of EGFR (unknown origin) by ELISA method,IC50,104.7,nM,=,CHEMBL3625155,B,CHEMBL3622626,Homo sapiens,CHEMBL203,CHEMBL3621102
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(C#N)c3)ncnc2cc1O[C@H]1CCOC1,6.78,Inhibition of EGFR (unknown origin) by ELISA method,IC50,167.3,nM,=,CHEMBL3625155,B,CHEMBL3622628,Homo sapiens,CHEMBL203,CHEMBL3621102
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,8.24,Inhibition of EGFR (unknown origin) by ELISA method,IC50,5.8,nM,=,CHEMBL3625155,B,CHEMBL3622629,Homo sapiens,CHEMBL203,CHEMBL3621102
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1O[C@H]1CCOC1,6.92,Inhibition of EGFR (unknown origin) by ELISA method,IC50,121.1,nM,=,CHEMBL3625155,B,CHEMBL3622630,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(NC(=O)/C=C/CN(C)C)cc23)c1,8.92,Inhibition of EGFR (unknown origin) by ELISA method,IC50,1.2,nM,=,CHEMBL3625155,B,CHEMBL3622632,Homo sapiens,CHEMBL203,CHEMBL3621102
COCCOc1cc2ncnc(Nc3ccc(Cl)c(C(F)(F)F)c3)c2cc1NC(=O)/C=C/CN(C)C,6.24,Inhibition of EGFR (unknown origin) by ELISA method,IC50,573.6,nM,=,CHEMBL3625155,B,CHEMBL3622633,Homo sapiens,CHEMBL203,CHEMBL3621102
COCCOc1cc2ncnc(Nc3ccc(NC(=O)/C=C/CN(C)C)c(C(F)(F)F)c3)c2cc1NC(=O)/C=C/CN(C)C,6.99,Inhibition of EGFR (unknown origin) by ELISA method,IC50,102.3,nM,=,CHEMBL3625155,B,CHEMBL3622634,Homo sapiens,CHEMBL203,CHEMBL3621102
COCCOc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)cc3)c2cc1NC(=O)/C=C/CN(C)C,7.04,Inhibition of EGFR (unknown origin) by ELISA method,IC50,91.0,nM,=,CHEMBL3625155,B,CHEMBL3622636,Homo sapiens,CHEMBL203,CHEMBL3621102
COCCOc1cc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,8.27,Inhibition of EGFR (unknown origin) by ELISA method,IC50,5.4,nM,=,CHEMBL3625155,B,CHEMBL3622637,Homo sapiens,CHEMBL203,CHEMBL3621102
COCCOc1cc2ncnc(Nc3ccc(OCc4ccccn4)cc3)c2cc1NC(=O)/C=C/CN(C)C,8.00,Inhibition of EGFR (unknown origin) by ELISA method,IC50,10.0,nM,=,CHEMBL3625155,B,CHEMBL3622638,Homo sapiens,CHEMBL203,CHEMBL3621102
COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,8.92,Inhibition of EGFR (unknown origin) by ELISA method,IC50,1.2,nM,=,CHEMBL3625155,B,CHEMBL3622639,Homo sapiens,CHEMBL203,CHEMBL3621102
COCCOc1cc2ncnc(Nc3ccc(Br)cc3F)c2cc1NC(=O)/C=C/CN(C)C,8.52,Inhibition of EGFR (unknown origin) by ELISA method,IC50,3.0,nM,=,CHEMBL3625155,B,CHEMBL3622640,Homo sapiens,CHEMBL203,CHEMBL3621102
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,6.29,Inhibition of EGFR (unknown origin) by ELISA method,IC50,510.2,nM,=,CHEMBL3625155,B,CHEMBL3622641,Homo sapiens,CHEMBL203,CHEMBL3621102
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)cc3)ncnc2cc1O[C@H]1CCOC1,6.87,Inhibition of EGFR (unknown origin) by ELISA method,IC50,133.9,nM,=,CHEMBL3625155,B,CHEMBL3622642,Homo sapiens,CHEMBL203,CHEMBL3621102
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(OCc4ccccn4)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,8.09,Inhibition of EGFR (unknown origin) by ELISA method,IC50,8.1,nM,=,CHEMBL3625155,B,CHEMBL3622643,Homo sapiens,CHEMBL203,CHEMBL3621102
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(OCc4ccccn4)cc3)ncnc2cc1O[C@H]1CCOC1,8.05,Inhibition of EGFR (unknown origin) by ELISA method,IC50,9.0,nM,=,CHEMBL3625155,B,CHEMBL3622644,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(O[C@H]4CCOC4)c(NC(=O)/C=C/CN(C)C)cc23)c1,8.92,Inhibition of EGFR (unknown origin) by ELISA method,IC50,1.2,nM,=,CHEMBL3625155,B,CHEMBL3622645,Homo sapiens,CHEMBL203,CHEMBL3621102
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(C#N)c3)ncnc2cc1O[C@H]1CCOC1,6.83,Inhibition of EGFR (unknown origin) by ELISA method,IC50,147.4,nM,=,CHEMBL3625155,B,CHEMBL3622647,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(OC4CCOCC4)c(NC(=O)/C=C/CN(C)C)cc23)c1,8.22,Inhibition of EGFR (unknown origin) by ELISA method,IC50,6.0,nM,=,CHEMBL3625155,B,CHEMBL3622648,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(OC4CCN(C)CC4)c(NC(=O)/C=C/CN(C)C)cc23)c1,8.09,Inhibition of EGFR (unknown origin) by ELISA method,IC50,8.1,nM,=,CHEMBL3625155,B,CHEMBL3622649,Homo sapiens,CHEMBL203,CHEMBL3621102
O=C(/C=C/CN1CCCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,8.28,Inhibition of EGFR (unknown origin) by ELISA method,IC50,5.3,nM,=,CHEMBL3625155,B,CHEMBL3622650,Homo sapiens,CHEMBL203,CHEMBL3621102
COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1,8.68,Inhibition of EGFR (unknown origin) by ELISA method,IC50,2.1,nM,=,CHEMBL3625155,B,CHEMBL3622651,Homo sapiens,CHEMBL203,CHEMBL3621102
O=C1CCN(C/C=C/C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2O[C@H]2CCOC2)CC1,6.28,Inhibition of EGFR (unknown origin) by ELISA method,IC50,520.2,nM,=,CHEMBL3625155,B,CHEMBL3622652,Homo sapiens,CHEMBL203,CHEMBL3621102
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C1CC1,7.57,Inhibition of EGFR (unknown origin) by ELISA method,IC50,26.9,nM,=,CHEMBL3625155,B,CHEMBL3622653,Homo sapiens,CHEMBL203,CHEMBL3621102
COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C1CC1,8.05,Inhibition of EGFR (unknown origin) by ELISA method,IC50,8.9,nM,=,CHEMBL3625155,B,CHEMBL3622654,Homo sapiens,CHEMBL203,CHEMBL3621102
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C1CC1,8.26,Inhibition of EGFR (unknown origin) by ELISA method,IC50,5.5,nM,=,CHEMBL3625155,B,CHEMBL3622655,Homo sapiens,CHEMBL203,CHEMBL3621102
O=C(/C=C/CN1CC[S+]([O-])CC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,6.96,Inhibition of EGFR (unknown origin) by ELISA method,IC50,109.4,nM,=,CHEMBL3625155,B,CHEMBL3622658,Homo sapiens,CHEMBL203,CHEMBL3621102
COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CC[S+]([O-])CC1,6.45,Inhibition of EGFR (unknown origin) by ELISA method,IC50,356.6,nM,=,CHEMBL3625155,B,CHEMBL3622659,Homo sapiens,CHEMBL203,CHEMBL3621102
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CNC1CC1,9.05,Inhibition of EGFR (unknown origin) by ELISA method,IC50,0.9,nM,=,CHEMBL3625155,B,CHEMBL3622664,Homo sapiens,CHEMBL203,CHEMBL3621102
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CNC1CC1,8.68,Inhibition of EGFR (unknown origin) by ELISA method,IC50,2.1,nM,=,CHEMBL3625155,B,CHEMBL3622665,Homo sapiens,CHEMBL203,CHEMBL3621102
O=C(/C=C/CNC1CC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,8.19,Inhibition of EGFR (unknown origin) by ELISA method,IC50,6.5,nM,=,CHEMBL3625155,B,CHEMBL3622666,Homo sapiens,CHEMBL203,CHEMBL3621102
O=C(/C=C/CNC1CC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC(F)F,8.02,Inhibition of EGFR (unknown origin) by ELISA method,IC50,9.6,nM,=,CHEMBL3625155,B,CHEMBL3622667,Homo sapiens,CHEMBL203,CHEMBL3621102
O=C(/C=C/CNC1CC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCC(F)(F)F,8.16,Inhibition of EGFR (unknown origin) by ELISA method,IC50,6.9,nM,=,CHEMBL3625155,B,CHEMBL3622668,Homo sapiens,CHEMBL203,CHEMBL3621102
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CNC1CC(F)(F)C1,6.85,Inhibition of EGFR (unknown origin) by ELISA method,IC50,141.0,nM,=,CHEMBL3625155,B,CHEMBL3622669,Homo sapiens,CHEMBL203,CHEMBL3621102
CC(C)NC/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,8.15,Inhibition of EGFR (unknown origin) by ELISA method,IC50,7.0,nM,=,CHEMBL3625155,B,CHEMBL3622670,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(O[C@H]4CCOC4)c(NC(=O)/C=C/CN4CCCCC4)cc23)c1,8.28,Inhibition of EGFR (unknown origin) by ELISA method,IC50,5.3,nM,=,CHEMBL3625155,B,CHEMBL3622671,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(OC)c(NC(=O)/C=C/CN4CCCCC4)cc23)c1,8.57,Inhibition of EGFR (unknown origin) by ELISA method,IC50,2.7,nM,=,CHEMBL3625155,B,CHEMBL3622672,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(OCC)c(NC(=O)/C=C/CN4CCCCC4)cc23)c1,8.21,Inhibition of EGFR (unknown origin) by ELISA method,IC50,6.1,nM,=,CHEMBL3625155,B,CHEMBL3622673,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(OC)c(NC(=O)/C=C/CN(C)C4CC4)cc23)c1,8.48,Inhibition of EGFR (unknown origin) by ELISA method,IC50,3.3,nM,=,CHEMBL3625155,B,CHEMBL3622674,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(OCC)c(NC(=O)/C=C/CN(C)C4CC4)cc23)c1,8.62,Inhibition of EGFR (unknown origin) by ELISA method,IC50,2.4,nM,=,CHEMBL3625155,B,CHEMBL3622675,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(O[C@H]4CCOC4)c(NC(=O)/C=C/CNC4CC4)cc23)c1,8.25,Inhibition of EGFR (unknown origin) by ELISA method,IC50,5.6,nM,=,CHEMBL3625155,B,CHEMBL3622676,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(OC)c(NC(=O)/C=C/CNC4CC4)cc23)c1,8.10,Inhibition of EGFR (unknown origin) by ELISA method,IC50,7.9,nM,=,CHEMBL3625155,B,CHEMBL3622677,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(OCC)c(NC(=O)/C=C/CNC4CC4)cc23)c1,8.38,Inhibition of EGFR (unknown origin) by ELISA method,IC50,4.2,nM,=,CHEMBL3625155,B,CHEMBL3622678,Homo sapiens,CHEMBL203,CHEMBL3621102
C#Cc1cccc(Nc2ncnc3cc(O[C@H]4CCOC4)c(NC(=O)/C=C/CNC(C)C)cc23)c1,8.19,Inhibition of EGFR (unknown origin) by ELISA method,IC50,6.4,nM,=,CHEMBL3625155,B,CHEMBL3622679,Homo sapiens,CHEMBL203,CHEMBL3621102
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCOCC1,8.18,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,IC50,6.6,nM,=,CHEMBL3624312,B,CHEMBL3623278,Homo sapiens,CHEMBL203,CHEMBL3621142
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1N1CCOCC1,8.82,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,IC50,1.5,nM,=,CHEMBL3624312,B,CHEMBL3623279,Homo sapiens,CHEMBL203,CHEMBL3621142
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1C(=O)N1CCOCC1,6.78,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,IC50,166.0,nM,=,CHEMBL3624312,B,CHEMBL3623280,Homo sapiens,CHEMBL203,CHEMBL3621142
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCOCC1,8.39,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,IC50,4.1,nM,=,CHEMBL3624312,B,CHEMBL3623281,Homo sapiens,CHEMBL203,CHEMBL3621142
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)CC1,8.30,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,IC50,5.0,nM,=,CHEMBL3624312,B,CHEMBL3623282,Homo sapiens,CHEMBL203,CHEMBL3621142
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1N1CCOCC1,8.82,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,IC50,1.5,nM,=,CHEMBL3624312,B,CHEMBL3623283,Homo sapiens,CHEMBL203,CHEMBL3621142
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CC[C@@H](N(C)C)C1,8.96,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,IC50,1.1,nM,=,CHEMBL3624312,B,CHEMBL3623284,Homo sapiens,CHEMBL203,CHEMBL3621142
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CC[C@H](N(C)C)C1,8.57,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,IC50,2.7,nM,=,CHEMBL3624312,B,CHEMBL3623285,Homo sapiens,CHEMBL203,CHEMBL3621142
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1C[C@@H]2C[C@H]1CN2C,8.64,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,IC50,2.3,nM,=,CHEMBL3624312,B,CHEMBL3623286,Homo sapiens,CHEMBL203,CHEMBL3621142
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C2CC21,8.36,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,IC50,4.4,nM,=,CHEMBL3624312,B,CHEMBL3623287,Homo sapiens,CHEMBL203,CHEMBL3621142
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)[C@@H](C)C1,7.77,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,IC50,16.9,nM,=,CHEMBL3624312,B,CHEMBL3623288,Homo sapiens,CHEMBL203,CHEMBL3621142
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)[C@H](C)C1,7.67,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,IC50,21.5,nM,=,CHEMBL3624312,B,CHEMBL3623289,Homo sapiens,CHEMBL203,CHEMBL3621142
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C,9.70,Inhibition of EGFR L858R mutant (unknown origin) by HTRF assay in presence of Km of ATP,IC50,0.2,nM,=,CHEMBL3624467,B,CHEMBL3623290,Homo sapiens,CHEMBL203,CHEMBL3621142
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@@H]1C,8.16,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,IC50,6.9,nM,=,CHEMBL3624312,B,CHEMBL3623291,Homo sapiens,CHEMBL203,CHEMBL3621142
Fc1ccc(Nc2ncnc3sccc23)cc1Cl,5.53,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,IC50,2980.0,nM,=,CHEMBL3631055,B,CHEMBL3628791,Homo sapiens,CHEMBL203,CHEMBL3627661
Fc1ccc(Nc2ncnc3sc4c(c23)CCCC4)cc1Cl,5.88,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,IC50,1330.0,nM,=,CHEMBL3631055,B,CHEMBL3628792,Homo sapiens,CHEMBL203,CHEMBL3627661
COc1cc2ncnc(Nc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c2cc1OC,5.11,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,IC50,7710.0,nM,=,CHEMBL3631055,B,CHEMBL3628796,Homo sapiens,CHEMBL203,CHEMBL3627661
O=C(Nc1ccc(Nc2ncnc3sc4c(c23)CCCC4)cc1)Nc1cccc(Br)c1,5.40,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,IC50,3950.0,nM,=,CHEMBL3631055,B,CHEMBL3628799,Homo sapiens,CHEMBL203,CHEMBL3627661
Fc1ccc(Oc2ncnc3ccccc23)cc1Cl,6.23,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,IC50,590.0,nM,=,CHEMBL3631055,B,CHEMBL3628800,Homo sapiens,CHEMBL203,CHEMBL3627661
Clc1ccc2c(c1)SCc1cnc(Nc3ccccc3)nc1-2,4.67,Inhibition of EGFR (unknown origin) using omnia tyr peptide 7 substrate by fluorescence assay,IC50,21180.0,nM,=,CHEMBL3630441,B,CHEMBL3628816,Homo sapiens,CHEMBL203,CHEMBL3627617
COc1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2SC3)cc1,4.67,Inhibition of EGFR (unknown origin) using omnia tyr peptide 7 substrate by fluorescence assay,IC50,21560.0,nM,=,CHEMBL3630441,B,CHEMBL3628817,Homo sapiens,CHEMBL203,CHEMBL3627617
Clc1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2SC3)cc1,4.34,Inhibition of EGFR (unknown origin) using omnia tyr peptide 7 substrate by fluorescence assay,IC50,45700.0,nM,=,CHEMBL3630441,B,CHEMBL3628818,Homo sapiens,CHEMBL203,CHEMBL3627617
Cc1cc(Oc2ncnc3sc4c(c23)CCCC4)ccc1NC(=O)Nc1cccc(Br)c1,5.48,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,IC50,3290.0,nM,=,CHEMBL3631055,B,CHEMBL3628906,Homo sapiens,CHEMBL203,CHEMBL3627661
O=C(Nc1cccc(Br)c1)Nc1ccc(Oc2ncnc3sc4c(c23)CCCC4)cc1Cl,5.90,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,IC50,1260.0,nM,=,CHEMBL3631055,B,CHEMBL3628907,Homo sapiens,CHEMBL203,CHEMBL3627661
C=CC(=O)Nc1cc(Nc2cncc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.82,Inhibition of EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells after 60 mins by mesoscale multiplex assay,IC50,15.0,nM,=,CHEMBL3635658,B,CHEMBL3633141,Homo sapiens,CHEMBL203,CHEMBL3632511
C=CC(=O)Nc1cccc(-n2c(=O)ccc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.37,Binding affinity to human EGFR L858R/T790M mutant expressed in Escherichia coli BL21 incubated for 1 hr,Kd,0.43,nM,=,CHEMBL3755962,B,CHEMBL3633142,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.59,Binding affinity to human EGFR L858R/T790M mutant expressed in Escherichia coli BL21 incubated for 1 hr,Kd,0.26,nM,=,CHEMBL3755962,B,CHEMBL3633143,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)c(Cc3ccccc3)cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.30,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",IC50,0.5,nM,=,CHEMBL3755797,B,CHEMBL3633145,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1,9.80,Binding affinity to human EGFR L858R/T790M mutant expressed in Escherichia coli BL21 incubated for 1 hr,Kd,0.16,nM,=,CHEMBL3755962,B,CHEMBL3633146,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N(C)CCN(C)C)cc4OC)nc32)c1,8.22,Inhibition of EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells after 60 mins by mesoscale multiplex assay,IC50,6.0,nM,=,CHEMBL3635658,B,CHEMBL3633151,Homo sapiens,CHEMBL203,CHEMBL3632511
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(OCCN(C)C)cc4OC)nc32)c1,9.02,Competitive binding affinity to human EGFR T790M mutant in presence of immobilized ligand,Kd,0.96,nM,=,CHEMBL3635826,B,CHEMBL3633152,Homo sapiens,CHEMBL203,CHEMBL3632511
C=CC(=O)Nc1cccc(-n2c3nc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)ncc3c(=O)n3ccnc23)c1,8.59,Binding affinity to EGFR T790M/L858R double mutant (unknown origin),Kd,2.6,nM,=,CHEMBL3635843,B,CHEMBL3633349,Homo sapiens,CHEMBL203,CHEMBL3632511
NC(=O)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c2c1,8.40,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,4.0,nM,=,CHEMBL3636784,B,CHEMBL3633774,Homo sapiens,CHEMBL203,CHEMBL3632549
NC(=O)Nc1ccc2ncnc(Nc3ccc(Oc4ccc(Cl)c(Cl)c4)c(Cl)c3)c2c1,6.26,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,543.0,nM,=,CHEMBL3636784,B,CHEMBL3633775,Homo sapiens,CHEMBL203,CHEMBL3632549
NC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,8.69,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,2.03,nM,=,CHEMBL3815405,B,CHEMBL3633928,Homo sapiens,CHEMBL203,CHEMBL3813636
CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2c1,8.52,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,3.0,nM,=,CHEMBL3636784,B,CHEMBL3633929,Homo sapiens,CHEMBL203,CHEMBL3632549
CCNC(=O)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c2c1,7.54,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,29.0,nM,=,CHEMBL3636784,B,CHEMBL3633930,Homo sapiens,CHEMBL203,CHEMBL3632549
CCNC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,7.46,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,35.0,nM,=,CHEMBL3636784,B,CHEMBL3633932,Homo sapiens,CHEMBL203,CHEMBL3632549
CCNC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2c1,6.64,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,227.0,nM,=,CHEMBL3636784,B,CHEMBL3633933,Homo sapiens,CHEMBL203,CHEMBL3632549
CCOC(=O)C(=CNc1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c2c1)C(=O)OCC,7.64,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,23.0,nM,=,CHEMBL3636784,B,CHEMBL3633934,Homo sapiens,CHEMBL203,CHEMBL3632549
CCOC(=O)C(=CNc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1)C(=O)OCC,6.09,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,812.0,nM,=,CHEMBL3636784,B,CHEMBL3633936,Homo sapiens,CHEMBL203,CHEMBL3632549
CCOC(=O)C(=CNc1ccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2c1)C(=O)OCC,5.99,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,1020.0,nM,=,CHEMBL3636784,B,CHEMBL3632637,Homo sapiens,CHEMBL203,CHEMBL3632549
N#CC(C#N)=CNc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,6.35,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,445.0,nM,=,CHEMBL3636784,B,CHEMBL3633938,Homo sapiens,CHEMBL203,CHEMBL3632549
N#CC(C#N)=CNc1ccc2ncnc(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2c1,5.52,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,3050.0,nM,=,CHEMBL3636784,B,CHEMBL3633939,Homo sapiens,CHEMBL203,CHEMBL3632549
NC(=O)Nc1ccc(C(=O)Nc2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cc1,8.05,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,9.0,nM,=,CHEMBL3636784,B,CHEMBL3633940,Homo sapiens,CHEMBL203,CHEMBL3632549
CCNC(=O)Nc1ccc(C(=O)Nc2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cc1,7.51,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,31.0,nM,=,CHEMBL3636784,B,CHEMBL3633941,Homo sapiens,CHEMBL203,CHEMBL3632549
CCOC(=O)C(=CNC(=O)Nc1ccc(C(=O)Nc2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cc1)C(=O)OCC,5.84,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,IC50,1460.0,nM,=,CHEMBL3636784,B,CHEMBL3633942,Homo sapiens,CHEMBL203,CHEMBL3632549
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@@H]1CCCN1C,7.89,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 μM Na3VO4, 1.25 M DTT (1000×) and 20 μM ATP at 25° C., for 45 minutes.",IC50,13.0,nM,=,CHEMBL3705672,B,CHEMBL3647417,Homo sapiens,CHEMBL203,CHEMBL3639095
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@@H]1CCCN1,8.52,"Cell Proliferation Inhibition Assay: The following in vitro assay is to determine the activity of the tested compounds for inhibiting the proliferation of cancer cells, which has high expression of EGFR. The activity is represented by the IC50 value. The general procedures of the assay are given as follows: The cancer cells A431 that highly expressing EGFR (Institute of biochemistry and cell biology) were chosen and seeded to 96-well cell culture plate at a suitable concentration (e.g., 5000 cells/mL medium). The cells then were incubated in carbon dioxide (CO2) incubator until they reached 85% confluency. Then, the cell culture medium was replaced by fresh one with tested compounds added in it at serial concentrations (general 6 to 7 concentrations). Then the cells were put back to the incubator and cultured continuously. 72 hours later, the activity of the tested compounds for inhibiting the cell proliferation was determined by using Sulforhodamine B (SRB) method.",IC50,3.0,nM,=,CHEMBL3888516,B,CHEMBL3647418,Homo sapiens,CHEMBL203,CHEMBL3886744
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@@H]1C[C@@H](O)CN1C,7.44,"Cell Proliferation Inhibition Assay: The following in vitro assay is to determine the activity of the tested compounds for inhibiting the proliferation of cancer cells, which has high expression of EGFR. The activity is represented by the IC50 value. The general procedures of the assay are given as follows: The cancer cells A431 that highly expressing EGFR (Institute of biochemistry and cell biology) were chosen and seeded to 96-well cell culture plate at a suitable concentration (e.g., 5000 cells/mL medium). The cells then were incubated in carbon dioxide (CO2) incubator until they reached 85% confluency. Then, the cell culture medium was replaced by fresh one with tested compounds added in it at serial concentrations (general 6 to 7 concentrations). Then the cells were put back to the incubator and cultured continuously. 72 hours later, the activity of the tested compounds for inhibiting the cell proliferation was determined by using Sulforhodamine B (SRB) method.",IC50,36.0,nM,=,CHEMBL3888516,B,CHEMBL3647419,Homo sapiens,CHEMBL203,CHEMBL3886744
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C,9.32,Inhibition of EGFR (unknown origin),IC50,0.48,nM,=,CHEMBL5162370,B,CHEMBL3647420,Homo sapiens,CHEMBL203,CHEMBL5154811
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/[C@@H]1CCCN1C,8.70,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 μM Na3VO4, 1.25 M DTT (1000×) and 20 μM ATP at 25° C., for 45 minutes.",IC50,2.0,nM,=,CHEMBL3705672,B,CHEMBL3647421,Homo sapiens,CHEMBL203,CHEMBL3639095
COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C,8.70,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 μM Na3VO4, 1.25 M DTT (1000×) and 20 μM ATP at 25° C., for 45 minutes. The EGFR kinase activity was determined by using a Time-Resolved fluorescence method.",IC50,2.0,nM,=,CHEMBL3888517,B,CHEMBL3647422,Homo sapiens,CHEMBL203,CHEMBL3886744
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C,8.70,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 μM Na3VO4, 1.25 M DTT (1000×) and 20 μM ATP at 25° C., for 45 minutes. The EGFR kinase activity was determined by using a Time-Resolved fluorescence method.",IC50,2.0,nM,=,CHEMBL3888517,B,CHEMBL3647423,Homo sapiens,CHEMBL203,CHEMBL3886744
C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,8.92,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,1.2,nM,=,CHEMBL4843876,B,CHEMBL3647964,Homo sapiens,CHEMBL203,CHEMBL4842353
C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1,7.69,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,20.6,nM,=,CHEMBL3887533,B,CHEMBL3647967,Homo sapiens,CHEMBL203,CHEMBL3886356
CN(C)C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,7.31,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,48.8,nM,=,CHEMBL3887533,B,CHEMBL3647970,Homo sapiens,CHEMBL203,CHEMBL3886356
C=CC(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1,7.21,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,60.9,nM,=,CHEMBL3887533,B,CHEMBL3647973,Homo sapiens,CHEMBL203,CHEMBL3886356
Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C)CC1,6.02,Inhibition of HER1 (unknown origin),IC50,960.0,nM,=,CHEMBL4716851,B,CHEMBL3651854,Homo sapiens,CHEMBL203,CHEMBL4715698
O=C(/C=C/CN1CCCOCC1)N1CCc2c(sc3ncnc(Nc4ccc(F)c(Cl)c4)c23)C1,9.00,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,1.0,nM,=,CHEMBL3705330,B,CHEMBL3655336,Homo sapiens,CHEMBL203,CHEMBL3638553
O=C(/C=C/CN1C2CCC1CC2)N1CCc2c(sc3ncnc(Nc4ccc(F)c(Cl)c4)c23)C1,8.96,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,1.1,nM,=,CHEMBL3705330,B,CHEMBL3655337,Homo sapiens,CHEMBL203,CHEMBL3638553
CC(C)(CN1CCOCC1)NC/C=C/C(=O)N1CCc2c(sc3ncnc(Nc4ccc(F)c(Cl)c4)c23)C1,9.00,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,1.0,nM,=,CHEMBL3705330,B,CHEMBL3655338,Homo sapiens,CHEMBL203,CHEMBL3638553
O=C(/C=C/[C@@H]1CCCN1)N1CCc2c(sc3ncnc(Nc4ccc(F)c(Cl)c4)c23)C1,8.70,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,2.0,nM,=,CHEMBL3705330,B,CHEMBL3655339,Homo sapiens,CHEMBL203,CHEMBL3638553
CN1CCC[C@H]1/C=C/C(=O)N1CCc2c(sc3ncnc(Nc4ccc(F)c(Cl)c4)c23)C1,9.00,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,1.0,nM,=,CHEMBL3705330,B,CHEMBL3655340,Homo sapiens,CHEMBL203,CHEMBL3638553
COCCN(C/C=C/C(=O)N1CCc2c(sc3ncnc(Nc4ccc(F)c(Cl)c4)c23)C1)CCOC,9.00,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,1.0,nM,=,CHEMBL3705330,B,CHEMBL3655341,Homo sapiens,CHEMBL203,CHEMBL3638553
CN(C)C(=O)N1CCN(C/C=C/C(=O)N2CCc3c(sc4ncnc(Nc5ccc(F)c(Cl)c5)c34)C2)CC1,9.00,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,1.0,nM,=,CHEMBL3705330,B,CHEMBL3655342,Homo sapiens,CHEMBL203,CHEMBL3638553
CN(C)C/C=C/C(=O)N1Cc2sc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2C1,7.92,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,12.0,nM,=,CHEMBL3705330,B,CHEMBL3655343,Homo sapiens,CHEMBL203,CHEMBL3638553
CC(C)N(C)C/C=C/C(=O)N1Cc2sc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3c2C1,8.85,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,1.4,nM,=,CHEMBL3705330,B,CHEMBL3655344,Homo sapiens,CHEMBL203,CHEMBL3638553
CN(C)C/C=C/C(=O)N1Cc2sc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2C1,8.30,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,5.0,nM,=,CHEMBL3705330,B,CHEMBL3655345,Homo sapiens,CHEMBL203,CHEMBL3638553
CN(C)C/C=C/C(=O)N1Cc2sc3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c3c2C1,7.72,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,19.0,nM,=,CHEMBL3705330,B,CHEMBL3655346,Homo sapiens,CHEMBL203,CHEMBL3638553
CC(C)N(C)C/C=C/C(=O)N1CCc2c(oc3ncnc(Nc4ccc(F)c(Cl)c4)c23)C1,9.00,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,1.0,nM,=,CHEMBL3705330,B,CHEMBL3655347,Homo sapiens,CHEMBL203,CHEMBL3638553
CN(C)C/C=C/C(=O)N1CCc2c(sc3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c23)C1,8.00,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,10.0,nM,=,CHEMBL3705330,B,CHEMBL3655348,Homo sapiens,CHEMBL203,CHEMBL3638553
O=C(/C=C/CNC12CC3CC(CC(C3)C1)C2)N1CCc2c(sc3ncnc(Nc4ccc(Cl)c(Cl)c4)c23)C1,9.00,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,1.0,nM,=,CHEMBL3705330,B,CHEMBL3655349,Homo sapiens,CHEMBL203,CHEMBL3638553
CC(C)C(C)C/C=C/C(=O)N1CCc2c(sc3ncnc(Nc4cc(O)cc(Cl)c4)c23)C1,9.00,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,1.0,nM,=,CHEMBL3705330,B,CHEMBL3655350,Homo sapiens,CHEMBL203,CHEMBL3638553
CN(C/C=C/C(=O)N1CCc2c(sc3ncnc(Nc4cc(O)c(Cl)c(Cl)c4)c23)C1)C(C)(C)C,9.00,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,1.0,nM,=,CHEMBL3705330,B,CHEMBL3655351,Homo sapiens,CHEMBL203,CHEMBL3638553
CC(C)N(C)C/C=C/C(=O)N1CCc2sc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3c2C1,8.04,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,9.2,nM,=,CHEMBL3705330,B,CHEMBL3639542,Homo sapiens,CHEMBL203,CHEMBL3638553
O=C(/C=C/CN1CCCOCC1)N1CCCc2c(sc3ncnc(Nc4ccc(Cl)c(Cl)c4)c23)C1,9.00,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,1.0,nM,=,CHEMBL3705330,B,CHEMBL3655352,Homo sapiens,CHEMBL203,CHEMBL3638553
N#Cc1cnc2sc3c(c2c1Nc1ccc(Cl)c(Cl)c1)CCN(C(=O)/C=C/CN1CCCOCC1)C3,8.37,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,4.3,nM,=,CHEMBL3705330,B,CHEMBL3655353,Homo sapiens,CHEMBL203,CHEMBL3638553
CC(C)N(C)C/C=C/C(=O)N1CCc2c(sc3ncc(C#N)c(Nc4ccc5c(cnn5Cc5cccc(F)c5)c4)c23)C1,8.19,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,IC50,6.4,nM,=,CHEMBL3705330,B,CHEMBL3655354,Homo sapiens,CHEMBL203,CHEMBL3638553
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)c(C(N)=O)nc2CC)c1,8.89,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,1.3,nM,=,CHEMBL3705896,B,CHEMBL3663921,Homo sapiens,CHEMBL203,CHEMBL3638445
CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1Oc1cccc(NC(=O)/C=C/CN(C)C)c1,8.85,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,1.4,nM,=,CHEMBL3705896,B,CHEMBL3663922,Homo sapiens,CHEMBL203,CHEMBL3638445
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)c(C(N)=O)nc2CC)c1C,8.96,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,1.1,nM,=,CHEMBL3705896,B,CHEMBL3663923,Homo sapiens,CHEMBL203,CHEMBL3638445
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)c(C(N)=O)nc2C(C)C)c1,8.82,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,1.5,nM,=,CHEMBL3705896,B,CHEMBL3663924,Homo sapiens,CHEMBL203,CHEMBL3638445
C=CC(=O)N1CCC(c2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)c(C)c3)c(C(N)=O)nc2CC)CC1,8.96,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,1.1,nM,=,CHEMBL3705896,B,CHEMBL3663925,Homo sapiens,CHEMBL203,CHEMBL3638445
C=CC(=O)Nc1cccc(Oc2cnc(C(N)=O)c(Nc3ccc(N4CCN(C)CC4)cc3)n2)c1,9.04,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,0.92,nM,=,CHEMBL3705896,B,CHEMBL3663926,Homo sapiens,CHEMBL203,CHEMBL3638445
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OC)c(N4CCN(C)CC4)c3)c(C(N)=O)nc2CC)c1,8.92,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,1.2,nM,=,CHEMBL3705896,B,CHEMBL3663927,Homo sapiens,CHEMBL203,CHEMBL3638445
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(CC)CC4)cc3)c(C(N)=O)nc2CC)c1,9.18,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,0.66,nM,=,CHEMBL3705896,B,CHEMBL3663928,Homo sapiens,CHEMBL203,CHEMBL3638445
C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1,8.77,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,1.7,nM,=,CHEMBL3705896,B,CHEMBL3663929,Homo sapiens,CHEMBL203,CHEMBL3638445
C=CC(=O)Nc1cccc(Oc2nc(Nc3cnn(C4CCN(C)CC4)c3)c(C(N)=O)nc2C(C)C)c1,8.89,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,1.3,nM,=,CHEMBL3705896,B,CHEMBL3663930,Homo sapiens,CHEMBL203,CHEMBL3638445
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)[C@@H](C)C4)cc3)c(C(N)=O)nc2CC)c1,8.92,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,1.2,nM,=,CHEMBL3705896,B,CHEMBL3663931,Homo sapiens,CHEMBL203,CHEMBL3638445
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)[C@H](C)C4)cc3)c(C(N)=O)nc2CC)c1,9.25,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,0.56,nM,=,CHEMBL3705896,B,CHEMBL3663932,Homo sapiens,CHEMBL203,CHEMBL3638445
C=CC(=O)N1CCC(c2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)CC1,8.89,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,1.3,nM,=,CHEMBL3705896,B,CHEMBL3663933,Homo sapiens,CHEMBL203,CHEMBL3638445
CCC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)c(C(N)=O)nc2CC)C1,8.92,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,1.2,nM,=,CHEMBL3705896,B,CHEMBL3663934,Homo sapiens,CHEMBL203,CHEMBL3638445
C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1,8.89,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,1.3,nM,=,CHEMBL3705896,B,CHEMBL3663935,Homo sapiens,CHEMBL203,CHEMBL3638445
C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)c(C)c3)c(C(N)=O)nc2CC)C1,8.92,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,1.2,nM,=,CHEMBL3705896,B,CHEMBL3663936,Homo sapiens,CHEMBL203,CHEMBL3638445
C=CC(=O)Nc1ccc(F)c(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)c(C(N)=O)nc2CC)c1,8.82,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",IC50,1.5,nM,=,CHEMBL3705896,B,CHEMBL3663937,Homo sapiens,CHEMBL203,CHEMBL3638445
O=S(=O)(NCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)C(F)(F)F,7.49,"In Vitro Kinase Assay: In vitro kinase analysis was performed by using HTScan EGF Receptor Kinase Assay Kit (#7909) and HTScan HER2/ErbB2 Kinase Assay Kit (#7058) from Cell Signaling Technology Company. Operation steps refer to the specification of the used kits, and the method was used to measure the inhibition effects of the compound to be tested on substrate peptide phosphorylation of EGFR or Her2 receptor tyrosine kinase. At room temperature, ATP and substrate peptide as well as the compound to be tested were incubated in kinase reaction buffer, after a period of incubation, a stop buffer was added to terminate the reaction and the sample was transferred to a streptavidin-coated 96-well plate, the plate was washed and the phosphorylation level of substrate peptide was detected by using HRP-marked antibody against substrate phosphorylation, colorated with TMB, terminated the reaction with 2M sulfuric acid. Absorption at 450 nm wavelength was detected, and IC50 value (μM) was calculated.",IC50,32.4,nM,=,CHEMBL3705522,B,CHEMBL3666714,Homo sapiens,CHEMBL203,CHEMBL3638441
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(C)=O)CC1,8.52,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,3.0,nM,=,CHEMBL3705421,B,CHEMBL3671475,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(=O)C(F)(F)F)CC1,7.33,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,47.0,nM,=,CHEMBL3705421,B,CHEMBL3671476,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(=O)CS(C)(=O)=O)CC1,7.58,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,26.0,nM,=,CHEMBL3705421,B,CHEMBL3671477,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(N)=O)CC1,7.82,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,15.0,nM,=,CHEMBL3705421,B,CHEMBL3671478,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(=O)C=C)CC1,8.52,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,3.0,nM,=,CHEMBL3705421,B,CHEMBL3671479,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCc1ccncc1,7.25,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,56.0,nM,=,CHEMBL3705421,B,CHEMBL3671480,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(F)c3F)ncnc2cc1OCC1CCN(C(C)=O)CC1,7.58,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,26.0,nM,=,CHEMBL3705421,B,CHEMBL3671481,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3c(F)cc(Br)cc3F)ncnc2cc1OCC1CCN(C(C)=O)CC1,7.89,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,13.0,nM,=,CHEMBL3705421,B,CHEMBL3671482,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(=O)NCCC)CC1,7.44,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,36.0,nM,=,CHEMBL3705421,B,CHEMBL3671483,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(=O)CN(C)C)CC1,8.22,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,6.0,nM,=,CHEMBL3705421,B,CHEMBL3671484,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(=O)NC(C)(C)C)CC1,7.85,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,14.0,nM,=,CHEMBL3705421,B,CHEMBL3671485,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCCNC(=O)CN(C)C,8.70,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,2.0,nM,=,CHEMBL3705421,B,CHEMBL3671486,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCCNC(C)=O,8.40,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,4.0,nM,=,CHEMBL3705421,B,CHEMBL3671487,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCCNC(=O)C(F)(F)F,7.23,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,59.0,nM,=,CHEMBL3705421,B,CHEMBL3671488,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCCNC(=O)CS(C)(=O)=O,7.17,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,68.0,nM,=,CHEMBL3705421,B,CHEMBL3639703,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCCNC(=O)NCC,7.96,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,11.0,nM,=,CHEMBL3705421,B,CHEMBL3671489,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCCNC,8.52,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,3.0,nM,=,CHEMBL3705421,B,CHEMBL3671490,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(C)=O,8.70,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,2.0,nM,=,CHEMBL3705421,B,CHEMBL3671491,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCN(C)C,8.05,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,9.0,nM,=,CHEMBL3705421,B,CHEMBL3671492,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCCCNC(C)=O,8.00,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,10.0,nM,=,CHEMBL3705421,B,CHEMBL3671493,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C1CC1,8.10,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,8.0,nM,=,CHEMBL3705421,B,CHEMBL3671494,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(F)F,8.30,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,5.0,nM,=,CHEMBL3705421,B,CHEMBL3671495,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)NCC,8.70,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,2.0,nM,=,CHEMBL3705421,B,CHEMBL3671496,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(N)=O,8.40,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,4.0,nM,=,CHEMBL3705421,B,CHEMBL3671497,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CN(C)C,8.70,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,2.0,nM,=,CHEMBL3705421,B,CHEMBL3671498,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)NCCOc1cc2ncnc(Nc3ccc(Br)cc3F)c2cc1NC(=O)C=C,8.30,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,5.0,nM,=,CHEMBL3705421,B,CHEMBL3671499,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNCC(C)=O,8.52,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,3.0,nM,=,CHEMBL3705421,B,CHEMBL3671500,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(F)(F)F,7.64,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,23.0,nM,=,CHEMBL3705421,B,CHEMBL3671501,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCN,8.40,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,4.0,nM,=,CHEMBL3705421,B,CHEMBL3671502,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC,7.02,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,96.0,nM,=,CHEMBL3705421,B,CHEMBL3671503,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CCCOc1cc2ncnc(Nc3ccc(Br)cc3F)c2cc1NC(=O)C=C,7.05,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,90.0,nM,=,CHEMBL3705421,B,CHEMBL3671504,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCOC,7.60,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,25.0,nM,=,CHEMBL3705421,B,CHEMBL3671505,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNS(C)(=O)=O,7.60,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,25.0,nM,=,CHEMBL3705421,B,CHEMBL3671506,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)NCCC,7.58,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,26.0,nM,=,CHEMBL3705421,B,CHEMBL3671507,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=S)NC,7.01,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,98.0,nM,=,CHEMBL3705421,B,CHEMBL3671508,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=S)NCC,7.04,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,91.0,nM,=,CHEMBL3705421,B,CHEMBL3671509,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)NC(C)C,7.44,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,36.0,nM,=,CHEMBL3705421,B,CHEMBL3671510,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)NC(C)CC,7.70,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,20.0,nM,=,CHEMBL3705421,B,CHEMBL3671511,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CNC(=O)NCCOc1cc2ncnc(Nc3ccc(Br)cc3F)c2cc1NC(=O)C=C,7.54,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,29.0,nM,=,CHEMBL3705421,B,CHEMBL3671512,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CCNC(=O)NCCOc1cc2ncnc(Nc3ccc(Br)cc3F)c2cc1NC(=O)C=C,7.72,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,19.0,nM,=,CHEMBL3705421,B,CHEMBL3671513,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)N1CCOCC1,7.46,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,35.0,nM,=,CHEMBL3705421,B,CHEMBL3671514,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCN(C)C(C)=O,7.23,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,59.0,nM,=,CHEMBL3705421,B,CHEMBL3671515,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1SCCNC(C)=O,6.96,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,109.0,nM,=,CHEMBL3705421,B,CHEMBL3671516,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)COC,7.85,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,14.0,nM,=,CHEMBL3705421,B,CHEMBL3671517,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CO,7.50,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,32.0,nM,=,CHEMBL3705421,B,CHEMBL3671518,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CSC,7.41,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,39.0,nM,=,CHEMBL3705421,B,CHEMBL3671519,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CS(C)(=O)=O,7.62,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,24.0,nM,=,CHEMBL3705421,B,CHEMBL3671520,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(C)C,6.89,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,128.0,nM,=,CHEMBL3705421,B,CHEMBL3671521,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(=C)C,7.16,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,69.0,nM,=,CHEMBL3705421,B,CHEMBL3671522,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)/C=C/C,7.72,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,19.0,nM,=,CHEMBL3705421,B,CHEMBL3671523,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CCC,7.50,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,32.0,nM,=,CHEMBL3705421,B,CHEMBL3671524,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)/C=C/CC,7.44,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,36.0,nM,=,CHEMBL3705421,B,CHEMBL3671525,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)/C=C/CN(C)C,7.80,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,16.0,nM,=,CHEMBL3705421,B,CHEMBL3671526,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)NC(C)(C)C,7.35,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,45.0,nM,=,CHEMBL3705421,B,CHEMBL3671527,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CN(C)CC,6.70,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,198.0,nM,=,CHEMBL3705421,B,CHEMBL3671528,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CN,7.05,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,89.0,nM,=,CHEMBL3705421,B,CHEMBL3671529,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(C)N(C)C,6.90,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,125.0,nM,=,CHEMBL3705421,B,CHEMBL3671530,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CCN(CC)CC,7.36,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,44.0,nM,=,CHEMBL3705421,B,CHEMBL3671531,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CNC,6.87,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,136.0,nM,=,CHEMBL3705421,B,CHEMBL3671532,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CCN(C)C,8.05,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,9.0,nM,=,CHEMBL3705421,B,CHEMBL3671533,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CCN,6.59,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,258.0,nM,=,CHEMBL3705421,B,CHEMBL3671534,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)OC,6.80,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,158.0,nM,=,CHEMBL3705421,B,CHEMBL3671535,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CCOC,7.16,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,70.0,nM,=,CHEMBL3705421,B,CHEMBL3671536,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC(=O)NCCN(CC)CC,6.19,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,652.0,nM,=,CHEMBL3705421,B,CHEMBL3671537,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CCCN(C)C,7.68,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,21.0,nM,=,CHEMBL3705421,B,CHEMBL3671538,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CCO,7.05,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,89.0,nM,=,CHEMBL3705421,B,CHEMBL3671539,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(F)cc3F)ncnc2cc1OCCNC(=O)CN(C)C,6.81,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,156.0,nM,=,CHEMBL3705421,B,CHEMBL3671540,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(=O)OCC,7.01,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,98.0,nM,=,CHEMBL3705421,B,CHEMBL3671541,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(=O)O,6.99,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,102.0,nM,=,CHEMBL3705421,B,CHEMBL3671542,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)/C=N/OC,6.59,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,256.0,nM,=,CHEMBL3705421,B,CHEMBL3671543,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(C)CN(C)C,6.60,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,251.0,nM,=,CHEMBL3705421,B,CHEMBL3671544,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CC(C)N(C)C,6.49,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,325.0,nM,=,CHEMBL3705421,B,CHEMBL3671545,Homo sapiens,CHEMBL203,CHEMBL3638799
C=C(C)C(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(C)=O,5.99,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,1020.0,nM,=,CHEMBL3705421,B,CHEMBL3671546,Homo sapiens,CHEMBL203,CHEMBL3638799
CCC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(C)=O,6.06,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,866.0,nM,=,CHEMBL3705421,B,CHEMBL3671547,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)N(C)c1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(C)=O,6.41,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,389.0,nM,=,CHEMBL3705421,B,CHEMBL3671548,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(F)c3)ncnc2cc1OCCNC(=O)CN(C)C,7.11,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,78.0,nM,=,CHEMBL3705421,B,CHEMBL3671549,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC(C)CNC(C)=O,7.44,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,36.0,nM,=,CHEMBL3705421,B,CHEMBL3671550,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC(C)NC(C)=O,6.81,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,154.0,nM,=,CHEMBL3705421,B,CHEMBL3671551,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC[C@@H](C)NC(C)=O,7.54,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,29.0,nM,=,CHEMBL3705421,B,CHEMBL3671552,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC[C@H](C)NC(C)=O,7.01,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,98.0,nM,=,CHEMBL3705421,B,CHEMBL3671553,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCCNCC(C)=O,7.58,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,26.0,nM,=,CHEMBL3705421,B,CHEMBL3671554,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC(C)NC(=O)NCCC,7.54,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,29.0,nM,=,CHEMBL3705421,B,CHEMBL3671555,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC(CC)NC(C)=O,7.16,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,69.0,nM,=,CHEMBL3705421,B,CHEMBL3671556,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCCNCCC=O,7.40,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,40.0,nM,=,CHEMBL3705421,B,CHEMBL3671557,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC1CCN(C(C)=O)C1,7.03,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,94.0,nM,=,CHEMBL3705421,B,CHEMBL3671558,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC1CCCN(C(C)=O)C1,6.89,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,128.0,nM,=,CHEMBL3705421,B,CHEMBL3671559,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNc1nccs1,6.53,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,295.0,nM,=,CHEMBL3705421,B,CHEMBL3671560,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CNC(=O)O1,7.77,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,17.0,nM,=,CHEMBL3705421,B,CHEMBL3671561,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)c1cccs1,7.33,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,47.0,nM,=,CHEMBL3705421,B,CHEMBL3671562,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)N1CCOCC1,7.44,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,36.0,nM,=,CHEMBL3705421,B,CHEMBL3671563,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)N1CCNCC1,6.16,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,698.0,nM,=,CHEMBL3705421,B,CHEMBL3671564,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)N1CCN(C(C)=O)CC1,7.12,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,76.0,nM,=,CHEMBL3705421,B,CHEMBL3671565,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)N1CCN(C)CC1,7.89,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,13.0,nM,=,CHEMBL3705421,B,CHEMBL3671566,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C1CCCN1,5.71,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,1954.0,nM,=,CHEMBL3705421,B,CHEMBL3671567,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C1CCCN1C,7.62,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,24.0,nM,=,CHEMBL3705421,B,CHEMBL3671568,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)c1ccc[nH]1,6.43,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,368.0,nM,=,CHEMBL3705421,B,CHEMBL3671569,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CN1CCCCC1,8.15,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,7.0,nM,=,CHEMBL3705421,B,CHEMBL3671570,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CN1CCN(C)CC1,7.92,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,12.0,nM,=,CHEMBL3705421,B,CHEMBL3671571,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CN1CCOCC1,7.50,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,32.0,nM,=,CHEMBL3705421,B,CHEMBL3671572,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CCN1CCCCC1,7.85,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,14.0,nM,=,CHEMBL3705421,B,CHEMBL3671573,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C1CCCN1C(C)=O,7.60,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,25.0,nM,=,CHEMBL3705421,B,CHEMBL3671574,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C1CCCN1C(=O)CC,6.71,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,196.0,nM,=,CHEMBL3705421,B,CHEMBL3671575,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CN1CCCC1,7.35,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,45.0,nM,=,CHEMBL3705421,B,CHEMBL3671576,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CN1CC=CC1,7.50,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,32.0,nM,=,CHEMBL3705421,B,CHEMBL3671577,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1=NCCO1,6.90,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,125.0,nM,=,CHEMBL3705421,B,CHEMBL3671578,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CN1CCC1,6.01,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,987.0,nM,=,CHEMBL3705421,B,CHEMBL3671579,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCNC(C)=O,7.92,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,12.0,nM,=,CHEMBL3705421,B,CHEMBL3671580,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCNC(C)=O,7.75,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,18.0,nM,=,CHEMBL3705421,B,CHEMBL3671581,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Cl)cc3Cl)ncnc2cc1OCCNC(C)=O,7.31,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,49.0,nM,=,CHEMBL3705421,B,CHEMBL3671582,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3C(F)(F)F)ncnc2cc1OCCNC(C)=O,6.34,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,456.0,nM,=,CHEMBL3705421,B,CHEMBL3671583,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3Cl)ncnc2cc1OCCNC(C)=O,7.38,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,42.0,nM,=,CHEMBL3705421,B,CHEMBL3671584,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCNC(=O)CN(C)C,6.38,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,419.0,nM,=,CHEMBL3705421,B,CHEMBL3671585,Homo sapiens,CHEMBL203,CHEMBL3638799
CC(C)n1c(Nc2ccc(F)c(Cl)c2)nc2cnc(Nc3ccc(C(=O)NN4CCN(C)CC4)cc3)nc21,9.00,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,1.0,nM,=,CHEMBL3887185,B,CHEMBL3674148,Homo sapiens,CHEMBL203,CHEMBL3638579
CC(C)n1c(Nc2ccccc2)nc2cnc(Nc3ccc(C(=O)NN4CCN(C)CC4)cc3F)nc21,9.40,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,0.4,nM,=,CHEMBL3887185,B,CHEMBL3674150,Homo sapiens,CHEMBL203,CHEMBL3638579
CC(C)n1c(Nc2ccc(F)c(Cl)c2)nc2cnc(Nc3ccc(C(=O)NN4CCN(C)CC4)cc3F)nc21,8.40,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,4.0,nM,=,CHEMBL3706157,B,CHEMBL3674151,Homo sapiens,CHEMBL203,CHEMBL3638579
COc1cc(C(=O)NN2CCN(C)CC2)ccc1Nc1ncc2nc(Nc3ccccc3)n(C(C)C)c2n1,9.00,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,1.0,nM,=,CHEMBL3887185,B,CHEMBL3674152,Homo sapiens,CHEMBL203,CHEMBL3638579
C=CC(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCNC(=O)CN(C)C,6.03,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,924.0,nM,=,CHEMBL3705421,B,CHEMBL3676338,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(F)c3F)ncnc2cc1OCCNC(C)=O,7.85,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,14.0,nM,=,CHEMBL3705421,B,CHEMBL3676339,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(F)c(Br)cc3F)ncnc2cc1OCCNC(C)=O,7.92,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,12.0,nM,=,CHEMBL3705421,B,CHEMBL3639752,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3c(F)cc(Br)cc3F)ncnc2cc1OCCNC(C)=O,7.66,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,22.0,nM,=,CHEMBL3705421,B,CHEMBL3676340,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OCCNC(C)=O,8.30,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,5.0,nM,=,CHEMBL3705421,B,CHEMBL3676341,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(Cl)c(Cl)cc3Cl)ncnc2cc1OCCNC(C)=O,6.06,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,876.0,nM,=,CHEMBL3705421,B,CHEMBL3676342,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3c(F)cc(Br)cc3F)ncnc2cc1OCCNC(=O)CN(C)C,6.76,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,175.0,nM,=,CHEMBL3705421,B,CHEMBL3676343,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(F)c3F)ncnc2cc1OCCNC(=O)CN(C)C,7.75,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,18.0,nM,=,CHEMBL3705421,B,CHEMBL3676344,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(F)c3F)ncnc2cc1OCCNC(=O)CCN(CC)CC,7.72,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,19.0,nM,=,CHEMBL3705421,B,CHEMBL3676345,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(F)c3F)ncnc2cc1OCCNC(=O)CCN1CCCCC1,6.05,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,894.0,nM,=,CHEMBL3705421,B,CHEMBL3676346,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(F)c3F)ncnc2cc1OCCNC(=O)CCCN(C)C,6.25,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,568.0,nM,=,CHEMBL3705421,B,CHEMBL3676347,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Cl)nc3)ncnc2cc1OCCNC(C)=O,7.19,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,65.0,nM,=,CHEMBL3705421,B,CHEMBL3676348,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(OC)c(Cl)cc3F)ncnc2cc1OCCNC(C)=O,7.10,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,80.0,nM,=,CHEMBL3705421,B,CHEMBL3676349,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(OCc4cccnc4)c(Cl)c3)ncnc2cc1OCCNC(C)=O,6.10,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,796.0,nM,=,CHEMBL3705421,B,CHEMBL3676350,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(C(=O)NOC)c(Br)cc3F)ncnc2cc1OCCNC(C)=O,5.00,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,10000.0,nM,=,CHEMBL3705421,B,CHEMBL3676351,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(OC)c(Cl)cc3Cl)ncnc2cc1OCCNC(C)=O,7.38,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,42.0,nM,=,CHEMBL3705421,B,CHEMBL3676352,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OCCNC(C)=O,7.82,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,15.0,nM,=,CHEMBL3705421,B,CHEMBL3676353,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OCCNCC(C)=O,7.89,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,13.0,nM,=,CHEMBL3705421,B,CHEMBL3676354,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OCCNC(=O)CN(C)C,8.05,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,9.0,nM,=,CHEMBL3705421,B,CHEMBL3676355,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OCCN(C)C,6.49,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,321.0,nM,=,CHEMBL3705421,B,CHEMBL3676356,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OCCNCC(C)=O,8.40,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,4.0,nM,=,CHEMBL3705421,B,CHEMBL3676357,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OCCNC(=O)COC,7.70,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,20.0,nM,=,CHEMBL3705421,B,CHEMBL3676358,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OCCNC(=O)CS(C)(=O)=O,7.40,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,40.0,nM,=,CHEMBL3705421,B,CHEMBL3676359,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OCCNC(=O)CN(C)C,8.05,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,9.0,nM,=,CHEMBL3705421,B,CHEMBL3676360,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(C)=O,7.89,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,13.0,nM,=,CHEMBL3705421,B,CHEMBL3676361,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNCC(C)=O,7.85,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,14.0,nM,=,CHEMBL3705421,B,CHEMBL3676362,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)CN(C)C,7.72,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,19.0,nM,=,CHEMBL3705421,B,CHEMBL3676363,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)CCN(CC)CC,8.15,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,7.0,nM,=,CHEMBL3705421,B,CHEMBL3676364,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)CCO,7.39,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,41.0,nM,=,CHEMBL3705421,B,CHEMBL3676365,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)COC,6.67,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,213.0,nM,=,CHEMBL3705421,B,CHEMBL3676366,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)CCN1CCCCC1,7.92,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,12.0,nM,=,CHEMBL3705421,B,CHEMBL3676367,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)CCCN(C)C,7.55,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,28.0,nM,=,CHEMBL3705421,B,CHEMBL3676368,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)CO,7.80,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,16.0,nM,=,CHEMBL3705421,B,CHEMBL3676369,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)CCOC,7.68,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,21.0,nM,=,CHEMBL3705421,B,CHEMBL3676370,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)CN(CC)CC,7.24,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,58.0,nM,=,CHEMBL3705421,B,CHEMBL3676371,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1OCCNC(=O)CN(C)C,7.12,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,75.0,nM,=,CHEMBL3705421,B,CHEMBL3676372,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC(C)(C)NC(=O)CN(C)C,6.65,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,222.0,nM,=,CHEMBL3705421,B,CHEMBL3676373,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC(C)NC(=O)CCN(CC)CC,7.62,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,24.0,nM,=,CHEMBL3705421,B,CHEMBL3676374,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCC(C)NC(=O)CN(C)C,7.06,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,88.0,nM,=,CHEMBL3705421,B,CHEMBL3676375,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@H](C)NC(=O)CN(C)C,7.92,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,12.0,nM,=,CHEMBL3705421,B,CHEMBL3676376,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@@H](C)NC(=O)CN(C)C,7.85,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,14.0,nM,=,CHEMBL3705421,B,CHEMBL3676377,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC(CC)NC(=O)CN(C)C,7.64,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,23.0,nM,=,CHEMBL3705421,B,CHEMBL3676378,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(COC)N(C)C,7.24,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,57.0,nM,=,CHEMBL3705421,B,CHEMBL3676379,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(CO)N(C)C,6.90,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,126.0,nM,=,CHEMBL3705421,B,CHEMBL3676380,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)OC,7.01,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,98.0,nM,=,CHEMBL3705421,B,CHEMBL3676381,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(OC)c(Cl)cc3OC)ncnc2cc1OCCNC(=O)CN(C)C,7.85,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,14.0,nM,=,CHEMBL3705421,B,CHEMBL3676382,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CN(CC)CC,7.58,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,26.0,nM,=,CHEMBL3705421,B,CHEMBL3676383,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)NCC,8.10,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,8.0,nM,=,CHEMBL3705421,B,CHEMBL3676384,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=O)NCCC,7.58,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,26.0,nM,=,CHEMBL3705421,B,CHEMBL3676385,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCCNC(=S)NCC,7.17,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,68.0,nM,=,CHEMBL3705421,B,CHEMBL3676386,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(=O)NCC)CC1,7.70,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,20.0,nM,=,CHEMBL3705421,B,CHEMBL3676387,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3cc(OC)c(Cl)cc3OC)ncnc2cc1OCCNC(C)=O,7.06,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,87.0,nM,=,CHEMBL3705421,B,CHEMBL3676388,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)C(C)N,7.75,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,18.0,nM,=,CHEMBL3705421,B,CHEMBL3676389,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)CC,6.23,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,589.0,nM,=,CHEMBL3705421,B,CHEMBL3676390,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCOCCOC(=O)CC(=O)OCC,6.61,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,246.0,nM,=,CHEMBL3705421,B,CHEMBL3676391,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCOCCOC(=O)CC(=O)O,6.02,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,956.0,nM,=,CHEMBL3705421,B,CHEMBL3676392,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC(C)NC(=O)CN(C)C,6.76,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,172.0,nM,=,CHEMBL3705421,B,CHEMBL3676393,Homo sapiens,CHEMBL203,CHEMBL3638799
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC(NC(=O)CN(C)C)C(C)C,6.83,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",IC50,149.0,nM,=,CHEMBL3705421,B,CHEMBL3676394,Homo sapiens,CHEMBL203,CHEMBL3638799
CC(C)n1c(Nc2ccccc2)nc2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3)nc21,9.40,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,0.4,nM,=,CHEMBL3887185,B,CHEMBL3678946,Homo sapiens,CHEMBL203,CHEMBL3638579
CC(C)n1c(Nc2cccc(Br)c2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,8.40,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,4.0,nM,=,CHEMBL3887185,B,CHEMBL3678947,Homo sapiens,CHEMBL203,CHEMBL3638579
C#Cc1cccc(Nc2nc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3n2C(C)C)c1,8.52,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,3.0,nM,=,CHEMBL3887185,B,CHEMBL3678948,Homo sapiens,CHEMBL203,CHEMBL3638579
CC(C)n1c(Nc2ccc(F)c(Cl)c2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,8.52,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,3.0,nM,=,CHEMBL3887185,B,CHEMBL3678949,Homo sapiens,CHEMBL203,CHEMBL3638579
CC(C)n1c(Nc2ccc(Br)cc2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,9.00,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,1.0,nM,=,CHEMBL3887185,B,CHEMBL3678950,Homo sapiens,CHEMBL203,CHEMBL3638579
CC(C)n1c(Nc2cccc(C(F)(F)F)c2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,9.00,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,1.0,nM,=,CHEMBL3887185,B,CHEMBL3678951,Homo sapiens,CHEMBL203,CHEMBL3638579
COc1cccc(Nc2nc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3n2C(C)C)c1,9.00,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,1.0,nM,=,CHEMBL3887185,B,CHEMBL3678952,Homo sapiens,CHEMBL203,CHEMBL3638579
COc1ccc(Nc2nc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc3n2C(C)C)cc1,8.30,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,5.0,nM,=,CHEMBL3887185,B,CHEMBL3678953,Homo sapiens,CHEMBL203,CHEMBL3638579
CC(C)n1c(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,8.40,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,4.0,nM,=,CHEMBL3887185,B,CHEMBL3678954,Homo sapiens,CHEMBL203,CHEMBL3638579
CC(C)n1c(Nc2ccc(NC(=O)Nc3ccc(F)c(Cl)c3)cc2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,8.30,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,5.0,nM,=,CHEMBL3887185,B,CHEMBL3678955,Homo sapiens,CHEMBL203,CHEMBL3638579
CC(C)n1c(Nc2ccc(C(=O)Nc3cccc(F)c3)cc2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,8.00,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,10.0,nM,=,CHEMBL3887185,B,CHEMBL3678956,Homo sapiens,CHEMBL203,CHEMBL3638579
CC(C)n1c(Nc2ccc(C(F)(F)F)cc2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,8.30,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,5.0,nM,=,CHEMBL3887185,B,CHEMBL3678957,Homo sapiens,CHEMBL203,CHEMBL3638579
CC(C)n1c(Nc2cccnc2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,8.40,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,4.0,nM,=,CHEMBL3887185,B,CHEMBL3678958,Homo sapiens,CHEMBL203,CHEMBL3638579
CC(C)n1c(NC2CCCCC2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21,8.30,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,5.0,nM,=,CHEMBL3887185,B,CHEMBL3678959,Homo sapiens,CHEMBL203,CHEMBL3638579
C=CC(=O)Nc1cccc(Nc2ncc3nc(Nc4ccccc4)n(C(C)C)c3n2)c1,9.22,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,0.6,nM,=,CHEMBL3887185,B,CHEMBL3678960,Homo sapiens,CHEMBL203,CHEMBL3638579
O=C(/C=C/CN1CCCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCF,8.19,"ELISA-Based Kinase Assay: Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl2, 100 μM sodium orthovanadate, 2 mM dithiothreitol, 20 uM ATP, test compound or vehicle control and 1-5 nM GST-erbB per 50 uL reaction) were run in 96-well plates coated with 0.25 mg/ml poly-Glu-Tyr (Sigma). The reactions were incubated for 6 minutes at room temperature while shaking. Kinase reactions were stopped by removal of reaction mixture, then wells were washed with wash buffer comprising 3% Bovine Serum Albumin and 0.1% Tween 20 in Phosphate Buffered Saline (PBS). Phosphorylated tyrosine residues were detected by adding 0.2 μg/ml anti-phosphotyrosine antibody (Oncogene Ab-4; 50 μL/well) coupled to Horse Radish Peroxidase (HRP) for 25 minutes while shaking at room temperature.",IC50,6.44,nM,=,CHEMBL3705968,B,CHEMBL3680373,Homo sapiens,CHEMBL203,CHEMBL3639119
O=C(/C=C/CN1CCCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCC(F)F,8.01,"ELISA-Based Kinase Assay: Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl2, 100 μM sodium orthovanadate, 2 mM dithiothreitol, 20 uM ATP, test compound or vehicle control and 1-5 nM GST-erbB per 50 uL reaction) were run in 96-well plates coated with 0.25 mg/ml poly-Glu-Tyr (Sigma). The reactions were incubated for 6 minutes at room temperature while shaking. Kinase reactions were stopped by removal of reaction mixture, then wells were washed with wash buffer comprising 3% Bovine Serum Albumin and 0.1% Tween 20 in Phosphate Buffered Saline (PBS). Phosphorylated tyrosine residues were detected by adding 0.2 μg/ml anti-phosphotyrosine antibody (Oncogene Ab-4; 50 μL/well) coupled to Horse Radish Peroxidase (HRP) for 25 minutes while shaking at room temperature.",IC50,9.87,nM,=,CHEMBL3705968,B,CHEMBL3680374,Homo sapiens,CHEMBL203,CHEMBL3639119
O=C(/C=C/CN1CCCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,7.95,"ELISA-Based Kinase Assay: Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl2, 100 μM sodium orthovanadate, 2 mM dithiothreitol, 20 uM ATP, test compound or vehicle control and 1-5 nM GST-erbB per 50 uL reaction) were run in 96-well plates coated with 0.25 mg/ml poly-Glu-Tyr (Sigma). The reactions were incubated for 6 minutes at room temperature while shaking. Kinase reactions were stopped by removal of reaction mixture, then wells were washed with wash buffer comprising 3% Bovine Serum Albumin and 0.1% Tween 20 in Phosphate Buffered Saline (PBS). Phosphorylated tyrosine residues were detected by adding 0.2 μg/ml anti-phosphotyrosine antibody (Oncogene Ab-4; 50 μL/well) coupled to Horse Radish Peroxidase (HRP) for 25 minutes while shaking at room temperature.",IC50,11.35,nM,=,CHEMBL3705968,B,CHEMBL3680375,Homo sapiens,CHEMBL203,CHEMBL3639119
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCC(F)C1,7.34,"ELISA-Based Kinase Assay: Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl2, 100 μM sodium orthovanadate, 2 mM dithiothreitol, 20 uM ATP, test compound or vehicle control and 1-5 nM GST-erbB per 50 uL reaction) were run in 96-well plates coated with 0.25 mg/ml poly-Glu-Tyr (Sigma). The reactions were incubated for 6 minutes at room temperature while shaking. Kinase reactions were stopped by removal of reaction mixture, then wells were washed with wash buffer comprising 3% Bovine Serum Albumin and 0.1% Tween 20 in Phosphate Buffered Saline (PBS). Phosphorylated tyrosine residues were detected by adding 0.2 μg/ml anti-phosphotyrosine antibody (Oncogene Ab-4; 50 μL/well) coupled to Horse Radish Peroxidase (HRP) for 25 minutes while shaking at room temperature.",IC50,45.34,nM,=,CHEMBL3705968,B,CHEMBL3680376,Homo sapiens,CHEMBL203,CHEMBL3639119
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCC(F)CC1,7.74,"ELISA-Based Kinase Assay: Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl2, 100 μM sodium orthovanadate, 2 mM dithiothreitol, 20 uM ATP, test compound or vehicle control and 1-5 nM GST-erbB per 50 uL reaction) were run in 96-well plates coated with 0.25 mg/ml poly-Glu-Tyr (Sigma). The reactions were incubated for 6 minutes at room temperature while shaking. Kinase reactions were stopped by removal of reaction mixture, then wells were washed with wash buffer comprising 3% Bovine Serum Albumin and 0.1% Tween 20 in Phosphate Buffered Saline (PBS). Phosphorylated tyrosine residues were detected by adding 0.2 μg/ml anti-phosphotyrosine antibody (Oncogene Ab-4; 50 μL/well) coupled to Horse Radish Peroxidase (HRP) for 25 minutes while shaking at room temperature.",IC50,18.08,nM,=,CHEMBL3705968,B,CHEMBL3680377,Homo sapiens,CHEMBL203,CHEMBL3639119
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCCC1,7.92,"ELISA-Based Kinase Assay: Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl2, 100 μM sodium orthovanadate, 2 mM dithiothreitol, 20 uM ATP, test compound or vehicle control and 1-5 nM GST-erbB per 50 uL reaction) were run in 96-well plates coated with 0.25 mg/ml poly-Glu-Tyr (Sigma). The reactions were incubated for 6 minutes at room temperature while shaking. Kinase reactions were stopped by removal of reaction mixture, then wells were washed with wash buffer comprising 3% Bovine Serum Albumin and 0.1% Tween 20 in Phosphate Buffered Saline (PBS). Phosphorylated tyrosine residues were detected by adding 0.2 μg/ml anti-phosphotyrosine antibody (Oncogene Ab-4; 50 μL/well) coupled to Horse Radish Peroxidase (HRP) for 25 minutes while shaking at room temperature.",IC50,12.13,nM,=,CHEMBL3705968,B,CHEMBL3680378,Homo sapiens,CHEMBL203,CHEMBL3639119
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3706050,B,CHEMBL3699581,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCOCC4)cc3OC)ncc2C(F)(F)F)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,20.0,nM,=,CHEMBL3707998,B,CHEMBL3699582,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)CO)CC4)cc3OC)ncc2Cl)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3707998,B,CHEMBL3699583,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(=O)CO)CC4)cc3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3707998,B,CHEMBL3699584,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,20.0,nM,=,CHEMBL3707998,B,CHEMBL3699585,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2Cl)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3706050,B,CHEMBL3699586,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2Cl)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3707998,B,CHEMBL3699587,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3707998,B,CHEMBL3699588,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)CO)CC4)cc3OC)ncc2C(F)(F)F)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,20.0,nM,=,CHEMBL3707998,B,CHEMBL3699589,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(=O)CO)CC4)cc3OC)ncc2Cl)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,20.0,nM,=,CHEMBL3707998,B,CHEMBL3699590,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3OC(F)F)ncc2C(F)(F)F)c1,7.19,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,65.0,nM,=,CHEMBL3707998,B,CHEMBL3699591,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCOCC4)cc3OC(F)F)ncc2C(F)(F)F)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,20.0,nM,=,CHEMBL3707998,B,CHEMBL3699592,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(S(C)(=O)=O)CC4)cc3OC)ncc2C(F)(F)F)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,20.0,nM,=,CHEMBL3707998,B,CHEMBL3699593,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)OC(C)(C)C)CC4)cc3OCC)ncc2Cl)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,20.0,nM,=,CHEMBL3706050,B,CHEMBL3699594,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCCN(C(=O)C(F)(F)F)CC4)cc3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3706050,B,CHEMBL3699595,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)OC)CC4)cc3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3706050,B,CHEMBL3699596,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)NC)CC4)cc3OC)ncc2C(F)(F)F)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,20.0,nM,=,CHEMBL3707998,B,CHEMBL3699597,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(S(C)(=O)=O)CC4)cc3OC)ncc2C(F)(F)F)c1,7.19,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,65.0,nM,=,CHEMBL3707998,B,CHEMBL3699598,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)CC(C)(C)C)CC4)cc3OC)ncc2Cl)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3706050,B,CHEMBL3699599,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)C(F)(F)F)CC4)cc3OC)ncc2Cl)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3706050,B,CHEMBL3699600,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(S(C)(=O)=O)CC4)cc3OC)ncc2Cl)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,20.0,nM,=,CHEMBL3707998,B,CHEMBL3699601,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(S(N)(=O)=O)CC4)cc3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3707998,B,CHEMBL3699602,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(=O)NC)CC4)cc3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3707998,B,CHEMBL3699603,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(=O)OC)CC4)cc3OC)ncc2C(F)(F)F)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,20.0,nM,=,CHEMBL3707998,B,CHEMBL3699604,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(=O)CO)CC4)cc3OC(F)(F)F)ncc2C(F)(F)F)c1,7.19,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,65.0,nM,=,CHEMBL3707998,B,CHEMBL3639984,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC(F)(F)F)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3707998,B,CHEMBL3699607,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(=O)C(C)(C)C)CC4)cc3OC)ncc2C(F)(F)F)c1,7.19,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,65.0,nM,=,CHEMBL3707998,B,CHEMBL3699608,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(=O)CC)CC4)cc3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3707998,B,CHEMBL3699609,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3OC(F)F)ncc2Cl)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,20.0,nM,=,CHEMBL3707998,B,CHEMBL3699610,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCCOCC4)cc3OC)ncc2Cl)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3706050,B,CHEMBL3699611,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCCOCC4)cc3OC)ncc2C(F)(F)F)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,20.0,nM,=,CHEMBL3707998,B,CHEMBL3699612,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCCN(C(=O)OC(C)(C)C)CC4)cc3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3706050,B,CHEMBL3699613,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2Br)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3706050,B,CHEMBL3699614,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(S(C)(=O)=O)CC4)cc3OC)ncc2Cl)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3706050,B,CHEMBL3699615,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)CC(C)(C)C)CC4)cc3OC)ncc2C(F)(F)F)c1,6.19,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,650.0,nM,=,CHEMBL3706050,B,CHEMBL3699616,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCCN(C(=O)OC(C)(C)C)CC4)cc3OC)ncc2Cl)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3706050,B,CHEMBL3699617,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(=O)CC(C)(C)C)CC4)cc3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3706050,B,CHEMBL3699618,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)OC(C)(C)C)CC4)cc3OC)ncc2Cl)c1,6.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,200.0,nM,=,CHEMBL3707998,B,CHEMBL3699619,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)OC(C)(C)C)CC4)cc3OC(F)(F)F)ncc2Cl)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,20.0,nM,=,CHEMBL3706050,B,CHEMBL3699620,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)[C@H](C(=O)OC)C4)cc3OC)ncc2C(F)(F)F)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,20.0,nM,=,CHEMBL3707998,B,CHEMBL3699621,Homo sapiens,CHEMBL203,CHEMBL3639181
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCS(=O)(=O)CC4)cc3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 Î¼L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",IC50,5.5,nM,=,CHEMBL3707998,B,CHEMBL3699622,Homo sapiens,CHEMBL203,CHEMBL3639181
CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12,6.77,Binding affinity to EGFR (unknown origin) assessed as dissociation constant by KINOMEscan analysis,Kd,170.0,nM,=,CHEMBL5133814,B,CHEMBL3707348,Homo sapiens,CHEMBL203,CHEMBL5131445
Nc1nc(NCc2ccccc2)c2c(n1)[nH]c1ccc(O)cc12,6.16,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,700.0,nM,=,CHEMBL4021780,B,CHEMBL3715932,Homo sapiens,CHEMBL203,CHEMBL4020756
COC1CCN(c2nccc(Nc3cc4c(cn3)ncn4C3CCCC3)n2)CC1,7.70,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,20.0,nM,=,CHEMBL3737823,B,CHEMBL3734825,Homo sapiens,CHEMBL203,CHEMBL3734664
COC1CCN(c2nccc(Nc3cc4[nH]cnc4cn3)n2)CC1,6.48,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,329.0,nM,=,CHEMBL3737823,B,CHEMBL3735952,Homo sapiens,CHEMBL203,CHEMBL3734664
CCn1cnc2cnc(Nc3ccnc(N4CCC(OC)CC4)n3)cc21,6.70,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,201.0,nM,=,CHEMBL3737823,B,CHEMBL3736094,Homo sapiens,CHEMBL203,CHEMBL3734664
COC1CCN(c2nccc(Nc3cc4c(cn3)ncn4C3CC3)n2)CC1,7.06,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,87.0,nM,=,CHEMBL3737823,B,CHEMBL3736178,Homo sapiens,CHEMBL203,CHEMBL3734664
COC1CCN(c2nccc(Nc3cc4c(cn3)ncn4C3CCC3)n2)CC1,7.32,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,48.0,nM,=,CHEMBL3737823,B,CHEMBL3736409,Homo sapiens,CHEMBL203,CHEMBL3734664
CCC(C)n1cnc2cnc(Nc3ccnc(N4CCC(OC)CC4)n3)cc21,7.85,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,14.0,nM,=,CHEMBL3737823,B,CHEMBL3735250,Homo sapiens,CHEMBL203,CHEMBL3734664
COC1CCN(c2nccc(Nc3cc4c(cn3)ncn4C3CCOC3)n2)CC1,6.83,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,149.0,nM,=,CHEMBL3737823,B,CHEMBL3734928,Homo sapiens,CHEMBL203,CHEMBL3734664
COC1CCN(c2nccc(Nc3cc4c(cn3)ncn4CC(F)(F)F)n2)CC1,7.15,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,71.0,nM,=,CHEMBL3737823,B,CHEMBL3736254,Homo sapiens,CHEMBL203,CHEMBL3734664
COC1CCN(c2nccc(Nc3cc4c(cn3)ncn4C3CCCCC3)n2)CC1,7.75,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,18.0,nM,=,CHEMBL3737823,B,CHEMBL3735335,Homo sapiens,CHEMBL203,CHEMBL3734664
COC1CCN(c2nccc(Nc3cc4c(cn3)ncn4C3CCOCC3)n2)CC1,7.12,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,76.0,nM,=,CHEMBL3737823,B,CHEMBL3735725,Homo sapiens,CHEMBL203,CHEMBL3734664
COC1CCN(c2nccc(Nc3cc4c(cn3)ncn4C(C)C(F)(F)F)n2)CC1,7.57,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,27.0,nM,=,CHEMBL3737823,B,CHEMBL3736365,Homo sapiens,CHEMBL203,CHEMBL3734664
COC1CCN(c2nccc(Nc3cc4c(cn3)nc(C)n4C(C)C)n2)CC1,7.72,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,19.0,nM,=,CHEMBL3737823,B,CHEMBL3736508,Homo sapiens,CHEMBL203,CHEMBL3734664
Cc1nc2cnc(Nc3ccnc(N4CCC(O)CC4)n3)cc2n1C(C)C,7.47,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,34.0,nM,=,CHEMBL3737823,B,CHEMBL3735533,Homo sapiens,CHEMBL203,CHEMBL3734664
Cc1nc2cnc(Nc3ccnc(N4CCC(S(C)(=O)=O)CC4)n3)cc2n1C(C)C,7.19,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,64.0,nM,=,CHEMBL3737823,B,CHEMBL3735045,Homo sapiens,CHEMBL203,CHEMBL3734664
CC(C)n1cnc2cnc(Nc3ccnc(N4CCC(C(N)=O)CC4)n3)cc21,6.82,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,151.0,nM,=,CHEMBL3737823,B,CHEMBL3735410,Homo sapiens,CHEMBL203,CHEMBL3734664
COC1(CN(C)C)CCN(c2nccc(Nc3cc4c(cn3)nc(C)n4C(C)C)n2)CC1,6.31,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,492.0,nM,=,CHEMBL3737823,B,CHEMBL3735927,Homo sapiens,CHEMBL203,CHEMBL3734664
COCC1(OC)CCN(c2nccc(Nc3cc4c(cn3)nc(C)n4C(C)C)n2)CC1,7.11,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,77.0,nM,=,CHEMBL3737823,B,CHEMBL3735848,Homo sapiens,CHEMBL203,CHEMBL3734664
COC1(CO)CCN(c2nccc(Nc3cc4c(cn3)nc(C)n4C(C)C)n2)CC1,7.62,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,24.0,nM,=,CHEMBL3737823,B,CHEMBL3736395,Homo sapiens,CHEMBL203,CHEMBL3734664
COC1(CCO)CCN(c2nccc(Nc3cc4c(cn3)nc(C)n4C(C)C)n2)CC1,7.30,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,50.0,nM,=,CHEMBL3737823,B,CHEMBL3736191,Homo sapiens,CHEMBL203,CHEMBL3734664
COC1(CCN)CCN(c2nccc(Nc3cc4c(cn3)nc(C)n4C(C)C)n2)CC1,7.55,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,28.0,nM,=,CHEMBL3737823,B,CHEMBL3736430,Homo sapiens,CHEMBL203,CHEMBL3734664
Cc1nc2cnc(Nc3ccnc(NCC(C)(C)C(N)=O)n3)cc2n1C(C)C,7.66,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,22.0,nM,=,CHEMBL3737823,B,CHEMBL3735689,Homo sapiens,CHEMBL203,CHEMBL3734664
Cc1nc2cnc(Nc3ccnc(SCC(C)(C)C(N)=O)n3)cc2n1C(C)C,6.18,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,658.0,nM,=,CHEMBL3737823,B,CHEMBL3736480,Homo sapiens,CHEMBL203,CHEMBL3734664
Cc1nc2cnc(Nc3ccnc(OCC(C)(C)C(N)=O)n3)cc2n1C(C)C,6.71,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,196.0,nM,=,CHEMBL3737823,B,CHEMBL3735892,Homo sapiens,CHEMBL203,CHEMBL3734664
Cc1nc2cnc(Nc3ccnc(N4CCC(C)(C(N)=O)C4)n3)cc2n1C(C)C,6.91,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,124.0,nM,=,CHEMBL3737823,B,CHEMBL3735638,Homo sapiens,CHEMBL203,CHEMBL3734664
Cc1nc2cnc(Nc3ccnc(/C=C/C(C)(C)C(N)=O)n3)cc2n1C(C)C,6.71,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,196.0,nM,=,CHEMBL3737823,B,CHEMBL3735559,Homo sapiens,CHEMBL203,CHEMBL3734664
Cc1nc2cnc(Nc3ccnc(NCC(C)(C)S(C)(=O)=O)n3)cc2n1C(C)C,7.42,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,38.0,nM,=,CHEMBL3737823,B,CHEMBL3735782,Homo sapiens,CHEMBL203,CHEMBL3734664
Cc1nc2cnc(Nc3ccnc(OCC(C)(C)S(C)(=O)=O)n3)cc2n1C(C)C,7.28,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,52.0,nM,=,CHEMBL3737823,B,CHEMBL3736210,Homo sapiens,CHEMBL203,CHEMBL3734664
Cc1nc2cnc(Nc3ccnc(/C=C/C(C)(C)O)n3)cc2n1C(C)C,6.49,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,323.0,nM,=,CHEMBL3737823,B,CHEMBL3735157,Homo sapiens,CHEMBL203,CHEMBL3734664
COC1CCN(c2nccc(Nc3cc4c(cn3)nc(CO)n4C(C)C)n2)CC1,7.72,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,19.0,nM,=,CHEMBL3737823,B,CHEMBL3734877,Homo sapiens,CHEMBL203,CHEMBL3734664
CO[C@H]1CCN(c2nccc(Nc3cc4c(cn3)nc(C)n4C(C)C)n2)C[C@H]1F,8.57,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,2.7,nM,=,CHEMBL3737823,B,CHEMBL3736183,Homo sapiens,CHEMBL203,CHEMBL3734664
CO[C@H]1CCN(c2nccc(Nc3cc4c(cn3)nc(CO)n4C(C)C)n2)C[C@H]1F,8.37,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,4.3,nM,=,CHEMBL3737823,B,CHEMBL3734933,Homo sapiens,CHEMBL203,CHEMBL3734664
Cc1nc2cnc(Nc3ccnc(N4CC[C@H](O)[C@H](F)C4)n3)cc2n1C(C)C,7.89,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,13.0,nM,=,CHEMBL3737823,B,CHEMBL3735958,Homo sapiens,CHEMBL203,CHEMBL3734664
CC(C)n1c(CO)nc2cnc(Nc3ccnc(N4CC[C@H](O)[C@H](F)C4)n3)cc21,7.80,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,16.0,nM,=,CHEMBL3737823,B,CHEMBL3734934,Homo sapiens,CHEMBL203,CHEMBL3734664
CO[C@H]1CCN(c2nccc(Nc3cc4c(cn3)nc(CO)n4C(C)C)n2)CC1(F)F,8.13,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,7.4,nM,=,CHEMBL3737823,B,CHEMBL3735474,Homo sapiens,CHEMBL203,CHEMBL3734664
Cc1nc2cnc(Nc3ccnc(N4CC[C@H](O)C(F)(F)C4)n3)cc2n1C(C)C,8.02,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,9.5,nM,=,CHEMBL3737823,B,CHEMBL3734786,Homo sapiens,CHEMBL203,CHEMBL3734664
CO[C@H]1CCN(c2nccc(Nc3cc4c(cn3)nc(C)n4C(C)C)n2)C[C@@H]1F,7.36,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,44.0,nM,=,CHEMBL3737823,B,CHEMBL3735740,Homo sapiens,CHEMBL203,CHEMBL3734664
CO[C@H]1CCN(c2nccc(Nc3cc4c(cn3)nc(CO)n4C(C)C)n2)C[C@@H]1F,7.24,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,57.0,nM,=,CHEMBL3737823,B,CHEMBL3736181,Homo sapiens,CHEMBL203,CHEMBL3734664
CO[C@H]1CCN(c2nccc(Nc3cc4c(cn3)nc([C@@H](C)O)n4[C@H](C)C(F)(F)F)n2)C[C@H]1F,8.96,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,1.1,nM,=,CHEMBL3737823,B,CHEMBL3736121,Homo sapiens,CHEMBL203,CHEMBL3734664
C[C@@H](O)c1nc2cnc(Nc3ccnc(N4CC[C@H](O)[C@H](F)C4)n3)cc2n1[C@H](C)C(F)(F)F,8.60,Inhibition of human EGFR T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 as substrate preincubated for 30 mins followed by addition of substrate measured after 30 mins by Morrison plot analysis,Ki,2.5,nM,=,CHEMBL3737823,B,CHEMBL3734988,Homo sapiens,CHEMBL203,CHEMBL3734664
CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21,6.46,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M/L858R double mutant (696 residues) expressed in insect Sf21 cells using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA",IC50,350.0,nM,=,CHEMBL3830418,B,CHEMBL3735648,Homo sapiens,CHEMBL203,CHEMBL3826932
C=CC(=O)Nc1cccc(Nc2nc(N/N=C/c3ccc(F)cc3)ncc2Cl)c1,6.24,Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,IC50,570.0,nM,=,CHEMBL3743365,B,CHEMBL3740577,Homo sapiens,CHEMBL203,CHEMBL3739350
C=CC(=O)Nc1cccc(Nc2nc(N/N=C/c3ccccc3F)ncc2Cl)c1,5.82,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,IC50,1510.0,nM,=,CHEMBL3743364,B,CHEMBL3739812,Homo sapiens,CHEMBL203,CHEMBL3739350
C=CC(=O)Nc1cccc(Nc2nc(N/N=C/c3ccc(F)cc3F)ncc2Cl)c1,4.94,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,IC50,11570.0,nM,=,CHEMBL3743364,B,CHEMBL3740614,Homo sapiens,CHEMBL203,CHEMBL3739350
C=CC(=O)Nc1cccc(Nc2nc(N/N=C(\C)c3ccc(F)cc3)ncc2Cl)c1,5.89,Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,IC50,1290.0,nM,=,CHEMBL3743365,B,CHEMBL3741245,Homo sapiens,CHEMBL203,CHEMBL3739350
C=CC(=O)Nc1cccc(Nc2nc(N/N=C(\C)c3ccc(F)cc3F)ncc2Cl)c1,5.64,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,IC50,2270.0,nM,=,CHEMBL3743364,B,CHEMBL3740257,Homo sapiens,CHEMBL203,CHEMBL3739350
C=CC(=O)Nc1cccc(Nc2nc(N/N=C(\C)c3ccc(C)cc3)ncc2Cl)c1,5.25,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,IC50,5670.0,nM,=,CHEMBL3743364,B,CHEMBL3741796,Homo sapiens,CHEMBL203,CHEMBL3739350
CN(C)C/C=C/C(=O)Nc1cccc(Nc2nc(N/N=C/c3ccccc3F)ncc2Cl)c1,6.10,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,IC50,790.0,nM,=,CHEMBL3743364,B,CHEMBL3741436,Homo sapiens,CHEMBL203,CHEMBL3739350
CN(C)C/C=C/C(=O)Nc1cccc(Nc2nc(N/N=C/c3ccc(F)cc3)ncc2Cl)c1,6.17,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,IC50,680.0,nM,=,CHEMBL3743364,B,CHEMBL3741762,Homo sapiens,CHEMBL203,CHEMBL3739350
CN(C)C/C=C/C(=O)Nc1cccc(Nc2nc(N/N=C/c3ccc(F)cc3F)ncc2Cl)c1,5.60,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,IC50,2520.0,nM,=,CHEMBL3743364,B,CHEMBL3742128,Homo sapiens,CHEMBL203,CHEMBL3739350
CN(C)C/C=C/C(=O)Nc1cccc(Nc2nc(N/N=C/c3cn(Cc4ccccc4)c4ccccc34)ncc2Cl)c1,6.12,Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,IC50,760.0,nM,=,CHEMBL3743365,B,CHEMBL3741219,Homo sapiens,CHEMBL203,CHEMBL3739350
C/C(=N\Nc1ncc(Cl)c(Nc2cccc(NC(=O)/C=C/CN(C)C)c2)n1)c1ccc(F)cc1,5.63,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,IC50,2350.0,nM,=,CHEMBL3743364,B,CHEMBL3740102,Homo sapiens,CHEMBL203,CHEMBL3739350
C/C(=N\Nc1ncc(Cl)c(Nc2cccc(NC(=O)/C=C/CN(C)C)c2)n1)c1ccc(F)cc1F,6.14,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,IC50,720.0,nM,=,CHEMBL3743364,B,CHEMBL3740907,Homo sapiens,CHEMBL203,CHEMBL3739350
C/C(=N\Nc1ncc(Cl)c(Nc2cccc(NC(=O)/C=C/CN(C)C)c2)n1)c1ccccn1,5.62,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,IC50,2380.0,nM,=,CHEMBL3743364,B,CHEMBL3741324,Homo sapiens,CHEMBL203,CHEMBL3739350
C/C(=N\Nc1ncc(Cl)c(Nc2cccc(NC(=O)/C=C/CN(C)C)c2)n1)c1cccnc1,5.37,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,IC50,4320.0,nM,=,CHEMBL3743364,B,CHEMBL3742146,Homo sapiens,CHEMBL203,CHEMBL3739350
C#Cc1cccc(Nc2ncnc3cc(OCCOC(=O)c4ccccc4OC(C)=O)c(OCCOC)cc23)c1,8.30,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,IC50,5.0,nM,=,CHEMBL3745491,B,CHEMBL3741424,Homo sapiens,CHEMBL203,CHEMBL3739340
C#Cc1cccc(Nc2ncnc3cc(OCCOC(=O)C(C)c4ccc(CC(C)C)cc4)c(OCCOC)cc23)c1,8.05,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,IC50,9.0,nM,=,CHEMBL3745491,B,CHEMBL3741026,Homo sapiens,CHEMBL203,CHEMBL3739340
C#Cc1cccc(Nc2ncnc3cc(OCCOC(=O)CC4=C(C)/C(=C\c5ccc([S+](C)[O-])cc5)c5ccc(F)cc54)c(OCCOC)cc23)c1,7.51,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,IC50,31.0,nM,=,CHEMBL3745491,B,CHEMBL3742059,Homo sapiens,CHEMBL203,CHEMBL3739340
C#Cc1cccc(Nc2ncnc3cc(OCCOC(=O)C(C)c4ccc5cc(OC)ccc5c4)c(OCCOC)cc23)c1,7.14,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,IC50,72.0,nM,=,CHEMBL3745491,B,CHEMBL3740850,Homo sapiens,CHEMBL203,CHEMBL3739340
C#Cc1cccc(Nc2ncnc3cc(OCCOC(=O)Cc4c(C)n(C(=O)c5ccc(Cl)cc5)c5ccc(OC)cc45)c(OCCOC)cc23)c1,7.57,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,IC50,27.0,nM,=,CHEMBL3745491,B,CHEMBL3740595,Homo sapiens,CHEMBL203,CHEMBL3739340
C#Cc1cccc(Nc2ncnc3cc(OCCOC(=O)c4ccc(C(=O)Nc5ccc6c(c5)C(C)(C)CCC6(C)C)cc4)c(OCCOC)cc23)c1,7.50,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,IC50,32.0,nM,=,CHEMBL3745491,B,CHEMBL3741304,Homo sapiens,CHEMBL203,CHEMBL3739340
C#Cc1cccc(Nc2ncnc3cc(OCCOC(=O)c4ccccc4OC(C)=O)c(OCCOC(=O)c4ccccc4OC(C)=O)cc23)c1,7.47,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,IC50,34.0,nM,=,CHEMBL3745491,B,CHEMBL3741399,Homo sapiens,CHEMBL203,CHEMBL3739340
C#Cc1cccc(Nc2ncnc3cc(OCCOC(=O)CC4=C(C)/C(=C/c5ccc([S+](C)[O-])cc5)c5ccc(F)cc54)c(OCCOC(=O)CC4=C(C)/C(=C/c5ccc([S+](C)[O-])cc5)c5ccc(F)cc54)cc23)c1,7.57,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,IC50,27.0,nM,=,CHEMBL3745491,B,CHEMBL3739527,Homo sapiens,CHEMBL203,CHEMBL3739340
C#Cc1cccc(Nc2ncnc3cc(OCCOC(=O)C(C)c4ccc5cc(OC)ccc5c4)c(OCCOC(=O)C(C)c4ccc5cc(OC)ccc5c4)cc23)c1,6.41,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,IC50,390.0,nM,=,CHEMBL3745491,B,CHEMBL3741768,Homo sapiens,CHEMBL203,CHEMBL3739340
C#Cc1cccc(Nc2ncnc3cc(OCCOC(=O)Cc4c(C)n(C(=O)c5ccc(Cl)cc5)c5ccc(OC)cc45)c(OCCOC(=O)Cc4c(C)n(C(=O)c5ccc(Cl)cc5)c5ccc(OC)cc45)cc23)c1,7.48,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,IC50,33.0,nM,=,CHEMBL3745491,B,CHEMBL3739771,Homo sapiens,CHEMBL203,CHEMBL3739340
C#Cc1cccc(Nc2ncnc3cc(OCCOC(=O)c4ccc(C(=O)Nc5ccc6c(c5)C(C)(C)CCC6(C)C)cc4)c(OCCOC(=O)c4ccc(C(=O)Nc5ccc6c(c5)C(C)(C)CCC6(C)C)cc4)cc23)c1,6.06,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,IC50,880.0,nM,=,CHEMBL3745491,B,CHEMBL3740105,Homo sapiens,CHEMBL203,CHEMBL3739340
C#Cc1cccc(Nc2ncnc3cc(OCCO)c(OCCOC)cc23)c1,9.00,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,IC50,1.0,nM,=,CHEMBL3745491,B,CHEMBL3741490,Homo sapiens,CHEMBL203,CHEMBL3739340
CN1CCN(Cc2ccc(NC(=O)Nc3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)cc2)CC1,8.08,Inhibition of wild-type EGFR tyrosine kinase (unknown origin) assessed as ATP level by luminescence analysis,IC50,8.4,nM,=,CHEMBL3745460,B,CHEMBL3740144,Homo sapiens,CHEMBL203,CHEMBL3739356
O=C(Nc1ccc(CN2CCCCC2)cc1)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1,8.30,Inhibition of wild-type EGFR tyrosine kinase (unknown origin) assessed as ATP level by luminescence analysis,IC50,5.0,nM,=,CHEMBL3745460,B,CHEMBL3741473,Homo sapiens,CHEMBL203,CHEMBL3739356
O=C(Nc1ccc(CN2CCCC2)cc1)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1,8.39,Inhibition of wild-type EGFR tyrosine kinase (unknown origin) assessed as ATP level by luminescence analysis,IC50,4.1,nM,=,CHEMBL3745460,B,CHEMBL3740910,Homo sapiens,CHEMBL203,CHEMBL3739356
CC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1,5.33,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,4670.0,nM,=,CHEMBL3744325,B,CHEMBL3739750,Homo sapiens,CHEMBL203,CHEMBL3739348
CC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1,5.04,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,9190.0,nM,=,CHEMBL3744325,B,CHEMBL3740247,Homo sapiens,CHEMBL203,CHEMBL3739348
CC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1,5.35,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,4480.0,nM,=,CHEMBL3744325,B,CHEMBL3739587,Homo sapiens,CHEMBL203,CHEMBL3739348
CCOC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1,5.49,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,3220.0,nM,=,CHEMBL3744325,B,CHEMBL3740131,Homo sapiens,CHEMBL203,CHEMBL3739348
CCOC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1,5.10,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,7880.0,nM,=,CHEMBL3744325,B,CHEMBL3742349,Homo sapiens,CHEMBL203,CHEMBL3739348
CCOC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1,5.50,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,3200.0,nM,=,CHEMBL3744325,B,CHEMBL3741526,Homo sapiens,CHEMBL203,CHEMBL3739348
Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1C(=O)Nc1ccccc1,5.45,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,3560.0,nM,=,CHEMBL3744325,B,CHEMBL3740930,Homo sapiens,CHEMBL203,CHEMBL3739348
Cc1ccc(-n2cc(C(=O)c3c(C)[nH]c(-c4ccccc4)c3-c3ccccc3)c(C(=O)Nc3ccccc3)n2)cc1,5.35,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,4490.0,nM,=,CHEMBL3744325,B,CHEMBL3740713,Homo sapiens,CHEMBL203,CHEMBL3739348
Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccc(Cl)cc2)nc1C(=O)Nc1ccccc1,5.42,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,3780.0,nM,=,CHEMBL3744325,B,CHEMBL3740385,Homo sapiens,CHEMBL203,CHEMBL3739348
Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1-c1ccccc1,5.59,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,2560.0,nM,=,CHEMBL3744325,B,CHEMBL3741069,Homo sapiens,CHEMBL203,CHEMBL3739348
Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccccc3)cc12,5.41,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,3890.0,nM,=,CHEMBL3744325,B,CHEMBL3740582,Homo sapiens,CHEMBL203,CHEMBL3739348
Cc1ccc(-n2cc3c(-c4c(C)[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(C)c3n2)cc1,5.26,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,5430.0,nM,=,CHEMBL3744325,B,CHEMBL3742060,Homo sapiens,CHEMBL203,CHEMBL3739348
Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccc(Cl)cc3)cc12,5.59,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,2550.0,nM,=,CHEMBL3744325,B,CHEMBL3741655,Homo sapiens,CHEMBL203,CHEMBL3739348
Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccccc3)nc12,5.44,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,3600.0,nM,=,CHEMBL3744325,B,CHEMBL3740923,Homo sapiens,CHEMBL203,CHEMBL3739348
Cc1ccc(-n2cc3c(-c4c[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(O)c3n2)cc1,5.46,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,3450.0,nM,=,CHEMBL3744325,B,CHEMBL3739586,Homo sapiens,CHEMBL203,CHEMBL3739348
Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12,5.36,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,4390.0,nM,=,CHEMBL3744325,B,CHEMBL3742200,Homo sapiens,CHEMBL203,CHEMBL3739348
Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccc(NC(=O)c2ccccc2)c(=O)o1,5.54,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,2890.0,nM,=,CHEMBL3744325,B,CHEMBL3740003,Homo sapiens,CHEMBL203,CHEMBL3739348
Cc1c(C(=O)c2coc3ccc(O)cc23)[nH]c(-c2ccccc2)c1-c1ccccc1,5.43,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,3670.0,nM,=,CHEMBL3744325,B,CHEMBL3741960,Homo sapiens,CHEMBL203,CHEMBL3739348
Cc1c(C(=O)c2coc3c2cc(O)c2ccccc23)[nH]c(-c2ccccc2)c1-c1ccccc1,5.29,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,IC50,5100.0,nM,=,CHEMBL3744325,B,CHEMBL3740492,Homo sapiens,CHEMBL203,CHEMBL3739348
CC(=O)N1N=C(c2ccccc2)CC1c1ccc(C(=O)OC(C)Cn2c([N+](=O)[O-])cnc2C)cc1,4.91,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,12240.0,nM,=,CHEMBL3750872,B,CHEMBL3747570,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccc(Br)cc2)CC1c1ccc(C(=O)OCCn2c([N+](=O)[O-])cnc2C)cc1,5.38,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,4130.0,nM,=,CHEMBL3750872,B,CHEMBL3746212,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccc(Br)cc2)CC1c1ccc(C(=O)OC(C)Cn2c([N+](=O)[O-])cnc2C)cc1,5.22,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,5960.0,nM,=,CHEMBL3750872,B,CHEMBL3747776,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccc(C(F)(F)F)cc2)CC1c1ccc(C(=O)OCCn2c([N+](=O)[O-])cnc2C)cc1,6.58,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,260.0,nM,=,CHEMBL3750872,B,CHEMBL3746557,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccc(C(F)(F)F)cc2)CC1c1ccc(C(=O)OC(C)Cn2c([N+](=O)[O-])cnc2C)cc1,5.18,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,6670.0,nM,=,CHEMBL3750872,B,CHEMBL3746421,Homo sapiens,CHEMBL203,CHEMBL3745647
COc1ccc(C2=NN(C(C)=O)C(c3ccc(C(=O)OCCn4c([N+](=O)[O-])cnc4C)cc3)C2)cc1,5.07,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,8540.0,nM,=,CHEMBL3750872,B,CHEMBL3747055,Homo sapiens,CHEMBL203,CHEMBL3745647
COc1ccc(C2=NN(C(C)=O)C(c3ccc(C(=O)OC(C)Cn4c([N+](=O)[O-])cnc4C)cc3)C2)cc1,4.67,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,21310.0,nM,=,CHEMBL3750872,B,CHEMBL3746387,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccccc2)CC1c1ccc(C(=O)OCCn2c([N+](=O)[O-])cnc2C)cc1,5.02,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,9580.0,nM,=,CHEMBL3750872,B,CHEMBL3747079,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccc([N+](=O)[O-])cc2)CC1c1ccc(C(=O)OCCn2c([N+](=O)[O-])cnc2C)cc1,6.22,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,600.0,nM,=,CHEMBL3750872,B,CHEMBL3746473,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccc([N+](=O)[O-])cc2)CC1c1ccc(C(=O)OC(C)Cn2c([N+](=O)[O-])cnc2C)cc1,5.84,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,1450.0,nM,=,CHEMBL3750872,B,CHEMBL3746642,Homo sapiens,CHEMBL203,CHEMBL3745647
CCOc1ccc(C2=NN(C(C)=O)C(c3ccc(C(=O)OCCn4c([N+](=O)[O-])cnc4C)cc3)C2)cc1,4.82,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,15160.0,nM,=,CHEMBL3750872,B,CHEMBL3747407,Homo sapiens,CHEMBL203,CHEMBL3745647
CCOc1ccc(C2=NN(C(C)=O)C(c3ccc(C(=O)OC(C)Cn4c([N+](=O)[O-])cnc4C)cc3)C2)cc1,4.57,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,26920.0,nM,=,CHEMBL3750872,B,CHEMBL3745929,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccc(Cl)cc2)CC1c1ccc(C(=O)OCCn2c([N+](=O)[O-])cnc2C)cc1,5.13,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,7370.0,nM,=,CHEMBL3750872,B,CHEMBL3747277,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccc(Cl)cc2)CC1c1ccc(C(=O)OC(C)Cn2c([N+](=O)[O-])cnc2C)cc1,5.03,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,9260.0,nM,=,CHEMBL3750872,B,CHEMBL3746168,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccc(F)cc2)CC1c1ccc(C(=O)OCCn2c([N+](=O)[O-])cnc2C)cc1,5.30,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,5020.0,nM,=,CHEMBL3750872,B,CHEMBL3747281,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccc(F)cc2)CC1c1ccc(C(=O)OC(C)Cn2c([N+](=O)[O-])cnc2C)cc1,5.18,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,6580.0,nM,=,CHEMBL3750872,B,CHEMBL3747152,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccc(I)cc2)CC1c1ccc(C(=O)OCCn2c([N+](=O)[O-])cnc2C)cc1,5.90,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,1260.0,nM,=,CHEMBL3750872,B,CHEMBL3746711,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccc(I)cc2)CC1c1ccc(C(=O)OC(C)Cn2c([N+](=O)[O-])cnc2C)cc1,4.97,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,10690.0,nM,=,CHEMBL3750872,B,CHEMBL3746564,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccc(C)cc2)CC1c1ccc(C(=O)OCCn2c([N+](=O)[O-])cnc2C)cc1,4.96,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,10920.0,nM,=,CHEMBL3750872,B,CHEMBL3746268,Homo sapiens,CHEMBL203,CHEMBL3745647
CC(=O)N1N=C(c2ccc(C)cc2)CC1c1ccc(C(=O)OC(C)Cn2c([N+](=O)[O-])cnc2C)cc1,4.59,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,IC50,25580.0,nM,=,CHEMBL3750872,B,CHEMBL3746980,Homo sapiens,CHEMBL203,CHEMBL3745647
COc1cc(NC(=O)Nc2ccccn2)cc(-c2cccnc2)c1OC,7.31,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,48.81,nM,=,CHEMBL3756968,B,CHEMBL3752074,Homo sapiens,CHEMBL203,CHEMBL3751776
COc1ccc(-c2cc(NC(=O)Nc3ccccn3)cc(OC)c2OC)cn1,7.18,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,66.59,nM,=,CHEMBL3756968,B,CHEMBL3754785,Homo sapiens,CHEMBL203,CHEMBL3751776
O=C(Nc1ccccn1)Nc1cc(-c2cccnc2)ccc1OC(F)(F)F,7.04,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,90.57,nM,=,CHEMBL3756968,B,CHEMBL3753208,Homo sapiens,CHEMBL203,CHEMBL3751776
O=C(Nc1ccccn1)Nc1cc(-c2cncnc2)ccc1OC(F)(F)F,7.58,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,26.56,nM,=,CHEMBL3756968,B,CHEMBL3754057,Homo sapiens,CHEMBL203,CHEMBL3751776
COc1cc(NC(=O)Nc2ccncc2)cc(-c2cccnc2)c1OC,6.88,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,131.09,nM,=,CHEMBL3756968,B,CHEMBL3753836,Homo sapiens,CHEMBL203,CHEMBL3751776
COc1ccc(-c2cc(NC(=O)Nc3ccncc3)cc(OC)c2OC)cn1,6.34,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,455.17,nM,=,CHEMBL3756968,B,CHEMBL3753444,Homo sapiens,CHEMBL203,CHEMBL3751776
COc1cc(NC(=O)Nc2ccncc2)cc(-c2cncnc2)c1OC,6.54,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,290.46,nM,=,CHEMBL3756968,B,CHEMBL3754722,Homo sapiens,CHEMBL203,CHEMBL3751776
O=C(Nc1ccncc1)Nc1cc(-c2cccnc2)cc(C(F)(F)F)c1,6.72,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,189.49,nM,=,CHEMBL3756968,B,CHEMBL3752404,Homo sapiens,CHEMBL203,CHEMBL3751776
O=C(Nc1ccncc1)Nc1cc(-c2cncnc2)cc(C(F)(F)F)c1,7.83,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,14.83,nM,=,CHEMBL3756968,B,CHEMBL3752008,Homo sapiens,CHEMBL203,CHEMBL3751776
O=C(Nc1ccncc1)Nc1cc(-c2cccnc2)ccc1OC(F)(F)F,7.01,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,97.22,nM,=,CHEMBL3756968,B,CHEMBL3753886,Homo sapiens,CHEMBL203,CHEMBL3751776
COc1ccc(-c2ccc(OC(F)(F)F)c(NC(=O)Nc3ccncc3)c2)cn1,6.99,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,102.93,nM,=,CHEMBL3756968,B,CHEMBL3753623,Homo sapiens,CHEMBL203,CHEMBL3751776
O=C(Nc1ccncc1)Nc1cc(-c2cncnc2)ccc1OC(F)(F)F,7.74,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,18.04,nM,=,CHEMBL3756968,B,CHEMBL3752370,Homo sapiens,CHEMBL203,CHEMBL3751776
COc1cc(NC(=O)Nc2nccs2)cc(-c2cccnc2)c1OC,6.50,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,317.12,nM,=,CHEMBL3756968,B,CHEMBL3754709,Homo sapiens,CHEMBL203,CHEMBL3751776
O=C(Nc1cc(-c2cccnc2)cc(C(F)(F)F)c1)Nc1nccs1,7.11,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,78.17,nM,=,CHEMBL3756968,B,CHEMBL3753142,Homo sapiens,CHEMBL203,CHEMBL3751776
COc1ccc(-c2cc(NC(=O)Nc3nccs3)cc(C(F)(F)F)c2)cn1,6.32,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,476.66,nM,=,CHEMBL3756968,B,CHEMBL3751967,Homo sapiens,CHEMBL203,CHEMBL3751776
O=C(Nc1cc(-c2cncnc2)cc(C(F)(F)F)c1)Nc1nccs1,7.14,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,71.82,nM,=,CHEMBL3756968,B,CHEMBL3754556,Homo sapiens,CHEMBL203,CHEMBL3751776
O=C(Nc1nccs1)Nc1cc(-c2cccnc2)ccc1OC(F)(F)F,6.92,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,121.09,nM,=,CHEMBL3756968,B,CHEMBL3753811,Homo sapiens,CHEMBL203,CHEMBL3751776
COc1ccc(-c2ccc(OC(F)(F)F)c(NC(=O)Nc3nccs3)c2)cn1,6.30,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,495.3,nM,=,CHEMBL3756968,B,CHEMBL3753157,Homo sapiens,CHEMBL203,CHEMBL3751776
O=C(Nc1nccs1)Nc1cc(-c2cncnc2)ccc1OC(F)(F)F,7.14,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,71.71,nM,=,CHEMBL3756968,B,CHEMBL3752248,Homo sapiens,CHEMBL203,CHEMBL3751776
COc1cc(NC(=O)Nc2ccccn2)cc(-c2c[nH]cn2)c1OC,7.61,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,24.81,nM,=,CHEMBL3756968,B,CHEMBL3753532,Homo sapiens,CHEMBL203,CHEMBL3751776
Cn1cnc(-c2cc(NC(=O)Nc3ccncc3)cc(C(F)(F)F)c2)c1,6.78,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,165.6,nM,=,CHEMBL3756968,B,CHEMBL3754301,Homo sapiens,CHEMBL203,CHEMBL3751776
Cn1cnc(-c2ccc(OC(F)(F)F)c(NC(=O)Nc3ccncc3)c2)c1,7.02,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,94.82,nM,=,CHEMBL3756968,B,CHEMBL3752825,Homo sapiens,CHEMBL203,CHEMBL3751776
COc1cc(NC(=O)Nc2nccs2)cc(-c2cn(C)cn2)c1OC,6.44,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,362.0,nM,=,CHEMBL3756968,B,CHEMBL3752129,Homo sapiens,CHEMBL203,CHEMBL3751776
Cn1cnc(-c2cc(NC(=O)Nc3nccs3)cc(C(F)(F)F)c2)c1,6.51,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,IC50,310.76,nM,=,CHEMBL3756968,B,CHEMBL3752916,Homo sapiens,CHEMBL203,CHEMBL3751776
C=CC(=O)Nc1cccc(-n2c(=O)c(C)cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.06,Binding affinity to human EGFR L858R/T790M mutant expressed in Escherichia coli BL21 incubated for 1 hr,Kd,0.88,nM,=,CHEMBL3755962,B,CHEMBL3752363,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)c(-c3ccccc3)cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.70,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",IC50,0.2,nM,=,CHEMBL3755797,B,CHEMBL3753235,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)c(-c3ccccc3)c(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.04,Binding affinity to human EGFR L858R/T790M mutant expressed in Escherichia coli BL21 incubated for 1 hr,Kd,0.91,nM,=,CHEMBL3755962,B,CHEMBL3753011,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(CC)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.74,Binding affinity to human EGFR L858R/T790M mutant expressed in Escherichia coli BL21 incubated for 1 hr,Kd,1.8,nM,=,CHEMBL3755962,B,CHEMBL3751976,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(CCC)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,7.75,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",IC50,17.8,nM,=,CHEMBL3755797,B,CHEMBL3753874,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(C3CC3)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.66,Binding affinity to human EGFR L858R/T790M mutant expressed in Escherichia coli BL21 incubated for 1 hr,Kd,2.2,nM,=,CHEMBL3755962,B,CHEMBL3752448,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(C(C)C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,7.03,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",IC50,94.0,nM,=,CHEMBL3755797,B,CHEMBL3754040,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(C(F)(F)F)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,7.41,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",IC50,39.0,nM,=,CHEMBL3755797,B,CHEMBL3753228,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(N(C)C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,7.02,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",IC50,95.0,nM,=,CHEMBL3755797,B,CHEMBL3752139,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(-c3ccccc3)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,7.68,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",IC50,21.0,nM,=,CHEMBL3755797,B,CHEMBL3753305,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3c(C)nc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,6.55,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",IC50,280.0,nM,=,CHEMBL3755797,B,CHEMBL3753461,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4C)nc32)c1,9.57,Binding affinity to human EGFR L858R/T790M mutant expressed in Escherichia coli BL21 incubated for 1 hr,Kd,0.27,nM,=,CHEMBL3755962,B,CHEMBL3754803,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OCC)nc32)c1,8.92,Binding affinity to human EGFR L858R/T790M mutant expressed in Escherichia coli BL21 incubated for 1 hr,Kd,1.2,nM,=,CHEMBL3755962,B,CHEMBL3754564,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OCCC)nc32)c1,7.72,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",IC50,19.0,nM,=,CHEMBL3755797,B,CHEMBL3754213,Homo sapiens,CHEMBL203,CHEMBL3751728
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC(C)C)nc32)c1,7.11,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",IC50,78.0,nM,=,CHEMBL3755797,B,CHEMBL3752365,Homo sapiens,CHEMBL203,CHEMBL3751728
CN(C)/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,8.96,Binding affinity to human EGFR L858R/T790M mutant expressed in Escherichia coli BL21 incubated for 1 hr,Kd,1.1,nM,=,CHEMBL3755962,B,CHEMBL3752204,Homo sapiens,CHEMBL203,CHEMBL3751728
OCc1ccc(-c2cc3c(NCc4ccccc4)ncnc3s2)cc1,7.32,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,48.0,nM,=,CHEMBL3761557,B,CHEMBL3758946,Homo sapiens,CHEMBL203,CHEMBL3758163
OCc1ccc(-c2cc3c(Nc4ccccc4)ncnc3s2)cc1,7.68,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,21.0,nM,=,CHEMBL3761557,B,CHEMBL3759257,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cc(CO)ccc1-c1cc2c(NCc3ccccc3)ncnc2s1,8.30,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,5.0,nM,=,CHEMBL3761557,B,CHEMBL3759022,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1,7.85,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,14.0,nM,=,CHEMBL3761557,B,CHEMBL3758768,Homo sapiens,CHEMBL203,CHEMBL3758163
C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1,8.30,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,5.0,nM,=,CHEMBL3761557,B,CHEMBL3758802,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.70,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,2.0,nM,=,CHEMBL3761557,B,CHEMBL3758351,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cc(C=O)ccc1-c1cc2c(NCc3ccccc3)ncnc2s1,8.22,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,6.0,nM,=,CHEMBL3761557,B,CHEMBL3759900,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cc(C=O)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1,7.70,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,20.0,nM,=,CHEMBL3761557,B,CHEMBL3759733,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cc(C=O)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1,8.30,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,5.0,nM,=,CHEMBL3761557,B,CHEMBL3759280,Homo sapiens,CHEMBL203,CHEMBL3758163
C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)O)cc3)cc12)c1ccccc1,7.72,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,19.0,nM,=,CHEMBL3761557,B,CHEMBL3759980,Homo sapiens,CHEMBL203,CHEMBL3758163
C[C@@H](Nc1ncnc2sc(-c3ccc(C(N)=O)cc3)cc12)c1ccccc1,8.15,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,7.0,nM,=,CHEMBL3761557,B,CHEMBL3758762,Homo sapiens,CHEMBL203,CHEMBL3758163
C[C@@H](Nc1ncnc2sc(-c3ccc(S(C)(=O)=O)cc3)cc12)c1ccccc1,7.39,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,41.0,nM,=,CHEMBL3761557,B,CHEMBL3758889,Homo sapiens,CHEMBL203,CHEMBL3758163
C[C@@H](Nc1ncnc2sc(-c3ccc(CO)cc3F)cc12)c1ccccc1,7.89,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,13.0,nM,=,CHEMBL3761557,B,CHEMBL3759815,Homo sapiens,CHEMBL203,CHEMBL3758163
C[C@@H](Nc1ncnc2sc(-c3ccc(C=O)cc3F)cc12)c1ccccc1,7.23,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,59.0,nM,=,CHEMBL3761557,B,CHEMBL3759649,Homo sapiens,CHEMBL203,CHEMBL3758163
C[C@@H](Nc1ncnc2sc(-c3cccc(C(=O)O)c3)cc12)c1ccccc1,8.10,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,8.0,nM,=,CHEMBL3761557,B,CHEMBL3759356,Homo sapiens,CHEMBL203,CHEMBL3758163
C[C@@H](Nc1ncnc2sc(-c3cccc(C(N)=O)c3)cc12)c1ccccc1,8.30,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,5.0,nM,=,CHEMBL3761557,B,CHEMBL3758939,Homo sapiens,CHEMBL203,CHEMBL3758163
C[C@@H](Nc1ncnc2sc(-c3cccc(S(C)(=O)=O)c3)cc12)c1ccccc1,7.58,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,26.0,nM,=,CHEMBL3761557,B,CHEMBL3760023,Homo sapiens,CHEMBL203,CHEMBL3758163
C[C@@H](Nc1ncnc2sc(-c3cccc(C=O)c3)cc12)c1ccccc1,8.22,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,6.0,nM,=,CHEMBL3761557,B,CHEMBL3758471,Homo sapiens,CHEMBL203,CHEMBL3758163
C[C@@H](Nc1ncnc2sc(-c3ccc(F)c(C=O)c3)cc12)c1ccccc1,8.10,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,8.0,nM,=,CHEMBL3761557,B,CHEMBL3758951,Homo sapiens,CHEMBL203,CHEMBL3758163
C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1,6.56,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,276.0,nM,=,CHEMBL3761557,B,CHEMBL3759085,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cccc(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3s2)c1OC,7.89,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,13.0,nM,=,CHEMBL3761557,B,CHEMBL3759963,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cc(F)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,8.22,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,6.0,nM,=,CHEMBL3761557,B,CHEMBL3759780,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1ccc(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3s2)c(OC)c1,8.30,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,5.0,nM,=,CHEMBL3761557,B,CHEMBL3758868,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cccc(OC)c1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,8.70,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,2.0,nM,=,CHEMBL3761557,B,CHEMBL3759961,Homo sapiens,CHEMBL203,CHEMBL3758163
C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1,8.70,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,2.0,nM,=,CHEMBL3761557,B,CHEMBL3758800,Homo sapiens,CHEMBL203,CHEMBL3758163
C[C@@H](Nc1ncnc2sc(-c3cccc(C(=O)NCCN(C)C)c3)cc12)c1ccccc1,9.05,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,0.9,nM,=,CHEMBL3761557,B,CHEMBL3759369,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,8.70,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,2.0,nM,=,CHEMBL3761557,B,CHEMBL3758278,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1c(C=O)cccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,7.68,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,21.0,nM,=,CHEMBL3761557,B,CHEMBL3758761,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1c(CO)cccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,8.82,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,1.5,nM,=,CHEMBL3761557,B,CHEMBL3759359,Homo sapiens,CHEMBL203,CHEMBL3758163
COC(=O)c1cccc(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3s2)c1OC,8.05,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,9.0,nM,=,CHEMBL3761557,B,CHEMBL3758990,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1c(C(=O)NCCN(C)C)cccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,8.52,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,3.0,nM,=,CHEMBL3761557,B,CHEMBL3759725,Homo sapiens,CHEMBL203,CHEMBL3758163
COC(=O)c1ccc(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3s2)c(OC)c1,7.70,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,20.0,nM,=,CHEMBL3761557,B,CHEMBL3759459,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cc(C(=O)NCCN(C)C)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,9.30,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,0.5,nM,=,CHEMBL3761557,B,CHEMBL3758770,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1ccc(C=O)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,8.52,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,3.0,nM,=,CHEMBL3761557,B,CHEMBL3760082,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1ccc(CO)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,8.30,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,5.0,nM,=,CHEMBL3761557,B,CHEMBL3759929,Homo sapiens,CHEMBL203,CHEMBL3758163
COC(=O)c1ccc(OC)c(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3s2)c1,8.15,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,7.0,nM,=,CHEMBL3761557,B,CHEMBL3758758,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,9.30,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,0.5,nM,=,CHEMBL3761557,B,CHEMBL3758582,Homo sapiens,CHEMBL203,CHEMBL3758163
COC(=O)c1cc(OC)c(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3s2)c(OC)c1,8.40,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,4.0,nM,=,CHEMBL3761557,B,CHEMBL3760071,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cc(C(=O)NCCN(C)C)cc(OC)c1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1,9.40,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,0.4,nM,=,CHEMBL3761557,B,CHEMBL3759317,Homo sapiens,CHEMBL203,CHEMBL3758163
OCc1cccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)c1,8.52,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,3.0,nM,=,CHEMBL3761557,B,CHEMBL3759986,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cccc(OC)c1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1,9.05,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,0.9,nM,=,CHEMBL3761557,B,CHEMBL3759199,Homo sapiens,CHEMBL203,CHEMBL3758163
CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1,8.70,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,2.0,nM,=,CHEMBL3761557,B,CHEMBL3758376,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1,8.82,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,1.5,nM,=,CHEMBL3761557,B,CHEMBL3759480,Homo sapiens,CHEMBL203,CHEMBL3758163
OC[C@@H](Nc1ncnc2sc(-c3ccccc3)cc12)c1ccccc1,8.05,Inhibition of EGFR (unknown origin) by Z -LYTE assay,IC50,9.0,nM,=,CHEMBL3761557,B,CHEMBL3759478,Homo sapiens,CHEMBL203,CHEMBL3758163
COc1cc2c(Nc3ccc(NC(=O)c4ccccc4Cl)cc3)ncnc2cc1OCc1ccccc1,6.14,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,IC50,730.0,nM,=,CHEMBL3760417,B,CHEMBL3759203,Homo sapiens,CHEMBL203,CHEMBL3758083
COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,6.89,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,IC50,130.0,nM,=,CHEMBL3760417,B,CHEMBL3759127,Homo sapiens,CHEMBL203,CHEMBL3758083
COc1cc2c(Nc3ccc(NC(=O)c4cccc(Cl)c4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,6.82,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,IC50,150.0,nM,=,CHEMBL3760417,B,CHEMBL3758749,Homo sapiens,CHEMBL203,CHEMBL3758083
COc1cc2c(Nc3ccc(NC(=O)c4ccccc4Cl)cc3)ncnc2cc1OCCCN1CCN(C)CC1,7.70,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,IC50,20.0,nM,=,CHEMBL3760417,B,CHEMBL3759190,Homo sapiens,CHEMBL203,CHEMBL3758083
COc1cc2c(Nc3ccc(NC(=O)c4ccc(Cl)cc4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,5.88,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,IC50,1330.0,nM,=,CHEMBL3760417,B,CHEMBL3760090,Homo sapiens,CHEMBL203,CHEMBL3758083
COc1cc2c(Nc3ccc(NC(=O)c4ccc(C)cc4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,6.16,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,IC50,690.0,nM,=,CHEMBL3760417,B,CHEMBL3758585,Homo sapiens,CHEMBL203,CHEMBL3758083
COc1ccc(C(=O)Nc2ccc(Nc3ncnc4cc(OCCCN5CCN(C)CC5)c(OC)cc34)cc2)cc1,5.96,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,IC50,1110.0,nM,=,CHEMBL3760417,B,CHEMBL3759830,Homo sapiens,CHEMBL203,CHEMBL3758083
COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCN1CCCCC1,5.34,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,IC50,4610.0,nM,=,CHEMBL3760417,B,CHEMBL3759155,Homo sapiens,CHEMBL203,CHEMBL3758083
COc1cc2c(Nc3ccc(NC(=O)c4ccc(Cl)cc4)cc3)ncnc2cc1OCCCN1CCOCC1,5.87,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,IC50,1350.0,nM,=,CHEMBL3760417,B,CHEMBL3759754,Homo sapiens,CHEMBL203,CHEMBL3758083
COc1cc2c(Nc3ccc(NC(=O)c4ccc(C)cc4)cc3)ncnc2cc1OCCCN1CCOCC1,6.12,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,IC50,760.0,nM,=,CHEMBL3760417,B,CHEMBL3758875,Homo sapiens,CHEMBL203,CHEMBL3758083
COc1cc2c(Nc3ccc(NC(=O)c4cccc(Cl)c4)cc3)ncnc2cc1OCCCN1CCOCC1,6.64,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,IC50,230.0,nM,=,CHEMBL3760417,B,CHEMBL3759015,Homo sapiens,CHEMBL203,CHEMBL3758083
COc1cc2c(Nc3ccc(NC(=O)c4cccc(Cl)c4)cc3)ncnc2cc1OCCN1CCCCC1,6.52,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,IC50,300.0,nM,=,CHEMBL3760417,B,CHEMBL3759848,Homo sapiens,CHEMBL203,CHEMBL3758083
CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21,9.22,Inhibition of wild type EGFR (unknown origin),Ki,0.6,nM,=,CHEMBL3762136,B,CHEMBL3758502,Homo sapiens,CHEMBL203,CHEMBL3758169
Cc1cc(Nc2nc(-c3cn[nH]c3)nc3c2COC3(C)C)n[nH]1,6.07,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,844.0,nM,=,CHEMBL3762127,B,CHEMBL3759002,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c(Cl)c3Cl)nc(-c3cn[nH]c3)nc21,6.41,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,389.0,nM,=,CHEMBL3762127,B,CHEMBL3758646,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3c[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21,7.77,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,17.0,nM,=,CHEMBL3762127,B,CHEMBL3758958,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3nsc4ccccc34)nc(-c3cn[nH]c3)nc21,6.13,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,747.0,nM,=,CHEMBL3762127,B,CHEMBL3758954,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c4c(F)cccc34)nc(-c3cn[nH]c3)nc21,8.52,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,3.0,nM,=,CHEMBL3762127,B,CHEMBL3759615,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c4cc(F)ccc34)nc(-c3cn[nH]c3)nc21,8.70,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,2.0,nM,=,CHEMBL3762127,B,CHEMBL3759499,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c4ccc(F)cc34)nc(-c3cn[nH]c3)nc21,8.10,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,8.0,nM,=,CHEMBL3762127,B,CHEMBL3758283,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c4cccc(F)c34)nc(-c3cn[nH]c3)nc21,7.77,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,17.0,nM,=,CHEMBL3762127,B,CHEMBL3759935,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c4c(C(F)(F)F)cccc34)nc(-c3cn[nH]c3)nc21,6.87,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,134.0,nM,=,CHEMBL3762127,B,CHEMBL3758948,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21,8.89,Inhibition of EGFR T790M/deletion (746 to 750 residues) mutant (unknown origin),Ki,1.3,nM,=,CHEMBL3762139,B,CHEMBL3758602,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c4cc(Cl)ccc34)nc(-c3cn[nH]c3)nc21,7.65,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,22.4,nM,=,CHEMBL3762127,B,CHEMBL3758773,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c4c(F)cc(F)cc34)nc(-c3cn[nH]c3)nc21,7.98,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,10.4,nM,=,CHEMBL3762127,B,CHEMBL3760072,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c4c(Cl)c(F)ccc34)nc(-c3cn[nH]c3)nc21,8.40,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,4.0,nM,=,CHEMBL3762127,B,CHEMBL3758700,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cc(F)cc34)nc(-c3cn[nH]c3)nc21,7.80,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,16.0,nM,=,CHEMBL3762127,B,CHEMBL3758862,Homo sapiens,CHEMBL203,CHEMBL3758169
Cn1nc(Nc2nc(-c3cn[nH]c3)nc3c2COC3(C)C)c2cccc(F)c21,7.24,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,57.0,nM,=,CHEMBL3762127,B,CHEMBL3758830,Homo sapiens,CHEMBL203,CHEMBL3758169
CN(c1nc(-c2cn[nH]c2)nc2c1COC2(C)C)c1n[nH]c2ccccc12,6.29,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,519.0,nM,=,CHEMBL3762127,B,CHEMBL3758981,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Oc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21,7.07,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,85.0,nM,=,CHEMBL3762127,B,CHEMBL3759442,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(C(=O)c3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21,6.98,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,104.0,nM,=,CHEMBL3762127,B,CHEMBL3759761,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3c[nH]nn3)nc21,6.13,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,732.0,nM,=,CHEMBL3762127,B,CHEMBL3759696,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cscn3)nc21,8.25,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,5.6,nM,=,CHEMBL3762127,B,CHEMBL3759135,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cc[nH]n3)nc21,6.76,Inhibition of EGFR T790M/L858R mutant (unknown origin),Ki,175.0,nM,=,CHEMBL3762127,B,CHEMBL3760058,Homo sapiens,CHEMBL203,CHEMBL3758169
Cn1nccc1-c1nc(Nc2n[nH]c3ccccc23)c2c(n1)C(C)(C)OC2,8.96,Inhibition of wild type EGFR (unknown origin),Ki,1.1,nM,=,CHEMBL3762136,B,CHEMBL3759096,Homo sapiens,CHEMBL203,CHEMBL3758169
CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3C(F)F)nc21,8.60,Inhibition of EGFR T790M/deletion (746 to 750 residues) mutant (unknown origin),Ki,2.5,nM,=,CHEMBL3762139,B,CHEMBL3758739,Homo sapiens,CHEMBL203,CHEMBL3758169
COc1cc2ncnc(Nc3cccc(C(=O)NC45CC6CC(CC(C6)C4)C5)c3)c2cc1OCCCN1CCOCC1,8.95,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,IC50,1.12,nM,=,CHEMBL3767531,B,CHEMBL3765263,Homo sapiens,CHEMBL203,CHEMBL3763063
COc1cc2ncnc(Nc3cc(C(=O)NC45CC6CC(CC(C6)C4)C5)ccc3C)c2cc1OCCCN1CCOCC1,7.81,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,IC50,15.4,nM,=,CHEMBL3767531,B,CHEMBL3763701,Homo sapiens,CHEMBL203,CHEMBL3763063
COc1cc2ncnc(Nc3ccc(C(=O)NC45CC6CC(CC(C6)C4)C5)cc3)c2cc1OCCCN1CCOCC1,8.70,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,IC50,2.01,nM,=,CHEMBL3767531,B,CHEMBL3763627,Homo sapiens,CHEMBL203,CHEMBL3763063
COc1cc2ncnc(Nc3ccc(C(=O)NC45CC6CC(CC(C6)C4)C5)c(Cl)c3)c2cc1OCCCN1CCOCC1,8.34,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,IC50,4.62,nM,=,CHEMBL3767532,B,CHEMBL3763405,Homo sapiens,CHEMBL203,CHEMBL3763063
COc1cc2ncnc(Nc3ccc(C(=O)NC45CC6CC(CC(C6)C4)C5)c(C#N)c3)c2cc1OCCCN1CCOCC1,8.33,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,IC50,4.71,nM,=,CHEMBL3767531,B,CHEMBL3765425,Homo sapiens,CHEMBL203,CHEMBL3763063
COCCOc1cc2ncnc(Nc3ccc(C(=O)NC45CC6CC(CC(C6)C4)C5)cc3)c2cc1OCCOC,8.22,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,IC50,6.02,nM,=,CHEMBL3767532,B,CHEMBL3765815,Homo sapiens,CHEMBL203,CHEMBL3763063
COCCOc1cc2ncnc(Nc3cccc(NC(=O)C45CC6CC(CC(C6)C4)C5)c3)c2cc1OCCOC,8.79,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,IC50,1.63,nM,=,CHEMBL3767531,B,CHEMBL3764603,Homo sapiens,CHEMBL203,CHEMBL3763063
COc1cc2ncnc(Nc3cccc(NC(=O)C45CC6CC(CC(C6)C4)C5)c3)c2cc1OCCCN1CCOCC1,8.51,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,IC50,3.11,nM,=,CHEMBL3767531,B,CHEMBL3765789,Homo sapiens,CHEMBL203,CHEMBL3763063
COCCOc1cc2ncnc(Nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)cc3C)c2cc1OCCOC,8.35,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,IC50,4.52,nM,=,CHEMBL3767531,B,CHEMBL3764312,Homo sapiens,CHEMBL203,CHEMBL3763063
COCCOc1cc2ncnc(Nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)c(C)c3)c2cc1OCCOC,8.54,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,IC50,2.92,nM,=,CHEMBL3767531,B,CHEMBL3764589,Homo sapiens,CHEMBL203,CHEMBL3763063
COCCOc1cc2ncnc(Nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)c(OC)c3)c2cc1OCCOC,8.23,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,IC50,5.94,nM,=,CHEMBL3767531,B,CHEMBL3763757,Homo sapiens,CHEMBL203,CHEMBL3763063
COCCOc1cc2ncnc(Nc3ccc(NC(=O)C45CC6CC(CC(C6)C4)C5)c(C#N)c3)c2cc1OCCOC,8.30,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,IC50,5.01,nM,=,CHEMBL3767531,B,CHEMBL3763796,Homo sapiens,CHEMBL203,CHEMBL3763063
COc1ccc(/C=C/C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2O[C@H]2CCOC2)cc1,8.04,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by addition of substrate by mobility shift assay,IC50,9.1,nM,=,CHEMBL3766407,B,CHEMBL3763360,Homo sapiens,CHEMBL203,CHEMBL3763091
COc1ccc(/C=C/C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2O[C@H]2CCOC2)c(OC)c1OC,8.44,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by addition of substrate by mobility shift assay,IC50,3.6,nM,=,CHEMBL3766407,B,CHEMBL3763790,Homo sapiens,CHEMBL203,CHEMBL3763091
O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1nnn(-c2ccc(F)cc2)c1C(F)(F)F,6.24,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay",IC50,582.17,nM,=,CHEMBL3779159,B,CHEMBL3774451,Homo sapiens,CHEMBL203,CHEMBL3774303
O=C1COc2cc3ncnc(Nc4cccc(F)c4)c3cc2N1CCCN1CCOCC1,6.61,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,245.1,nM,=,CHEMBL3776094,B,CHEMBL3775285,Homo sapiens,CHEMBL203,CHEMBL3774304
O=C1COc2cc3ncnc(Nc4cccc(Cl)c4)c3cc2N1CCCN1CCOCC1,7.20,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,63.1,nM,=,CHEMBL3776094,B,CHEMBL3774947,Homo sapiens,CHEMBL203,CHEMBL3774304
O=C1COc2cc3ncnc(Nc4cccc(Br)c4)c3cc2N1CCCN1CCOCC1,7.05,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,89.6,nM,=,CHEMBL3776094,B,CHEMBL3774906,Homo sapiens,CHEMBL203,CHEMBL3774304
Cc1cccc(Nc2ncnc3cc4c(cc23)N(CCCN2CCOCC2)C(=O)CO4)c1,6.73,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,186.9,nM,=,CHEMBL3776094,B,CHEMBL3775459,Homo sapiens,CHEMBL203,CHEMBL3774304
O=C1COc2cc3ncnc(Nc4cccc(C(F)(F)F)c4)c3cc2N1CCCN1CCOCC1,6.08,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,829.2,nM,=,CHEMBL3776094,B,CHEMBL3774982,Homo sapiens,CHEMBL203,CHEMBL3774304
C#Cc1cccc(Nc2ncnc3cc4c(cc23)N(CCCN2CCOCC2)C(=O)CO4)c1,6.86,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,139.0,nM,=,CHEMBL3776094,B,CHEMBL3774926,Homo sapiens,CHEMBL203,CHEMBL3774304
O=C1COc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc2N1CCCN1CCOCC1,7.28,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,53.1,nM,=,CHEMBL3776094,B,CHEMBL3775664,Homo sapiens,CHEMBL203,CHEMBL3774304
O=C1COc2cc3ncnc(Nc4ccc(F)cc4)c3cc2N1CCCN1CCOCC1,6.36,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,434.1,nM,=,CHEMBL3776094,B,CHEMBL3774471,Homo sapiens,CHEMBL203,CHEMBL3774304
O=C1COc2cc3ncnc(Nc4ccc(Cl)cc4)c3cc2N1CCCN1CCOCC1,6.45,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,353.7,nM,=,CHEMBL3776094,B,CHEMBL3775911,Homo sapiens,CHEMBL203,CHEMBL3774304
O=C1COc2cc3ncnc(Nc4ccc(Br)cc4)c3cc2N1CCCN1CCOCC1,6.08,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,823.9,nM,=,CHEMBL3776094,B,CHEMBL3774609,Homo sapiens,CHEMBL203,CHEMBL3774304
Cc1ccc(Nc2ncnc3cc4c(cc23)N(CCCN2CCOCC2)C(=O)CO4)cc1,6.23,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,594.5,nM,=,CHEMBL3776094,B,CHEMBL3774712,Homo sapiens,CHEMBL203,CHEMBL3774304
O=C1COc2cc3ncnc(Nc4ccccc4)c3cc2N1CCCN1CCOCC1,6.29,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,518.6,nM,=,CHEMBL3776094,B,CHEMBL3775148,Homo sapiens,CHEMBL203,CHEMBL3774304
Cc1ccc(Nc2ncnc3cc4c(cc23)N(CCCN2CCOCC2)C(=O)CO4)cc1Cl,6.79,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,162.7,nM,=,CHEMBL3776094,B,CHEMBL3774578,Homo sapiens,CHEMBL203,CHEMBL3774304
O=C1COc2cc3ncnc(Nc4cccc(F)c4)c3cc2N1CCCN1CCCCC1,6.34,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,460.0,nM,=,CHEMBL3776094,B,CHEMBL3774808,Homo sapiens,CHEMBL203,CHEMBL3774304
O=C1COc2cc3ncnc(Nc4cccc(Cl)c4)c3cc2N1CCCN1CCCCC1,6.94,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,115.9,nM,=,CHEMBL3776094,B,CHEMBL3775536,Homo sapiens,CHEMBL203,CHEMBL3774304
O=C1COc2cc3ncnc(Nc4cccc(Br)c4)c3cc2N1CCCN1CCCCC1,7.00,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,99.0,nM,=,CHEMBL3776094,B,CHEMBL3775112,Homo sapiens,CHEMBL203,CHEMBL3774304
Cc1cccc(Nc2ncnc3cc4c(cc23)N(CCCN2CCCCC2)C(=O)CO4)c1,6.34,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,456.2,nM,=,CHEMBL3776094,B,CHEMBL3775897,Homo sapiens,CHEMBL203,CHEMBL3774304
C#Cc1cccc(Nc2ncnc3cc4c(cc23)N(CCCN2CCCCC2)C(=O)CO4)c1,6.67,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,211.4,nM,=,CHEMBL3776094,B,CHEMBL3774396,Homo sapiens,CHEMBL203,CHEMBL3774304
O=C1COc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc2N1CCCN1CCCCC1,6.86,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,IC50,137.9,nM,=,CHEMBL3776094,B,CHEMBL3775046,Homo sapiens,CHEMBL203,CHEMBL3774304
COc1ccccc1Nc1cc[nH]c(=O)c1C(=O)Nc1ccc(CN2CCN(C)CC2)cc1,7.29,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,51.0,nM,=,CHEMBL3784893,B,CHEMBL3780563,Homo sapiens,CHEMBL203,CHEMBL3779874
COc1ccccc1Nc1cc[nH]c(=O)c1C(=O)Nc1ccc(C2CCN(C)CC2)cc1,7.82,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,15.0,nM,=,CHEMBL3784893,B,CHEMBL3781897,Homo sapiens,CHEMBL203,CHEMBL3779874
COc1ccccc1Nc1cc[nH]c(=O)c1C(=O)Nc1ccc(N2CCCN(C)CC2)cc1,7.92,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,12.0,nM,=,CHEMBL3784893,B,CHEMBL3779957,Homo sapiens,CHEMBL203,CHEMBL3779874
COc1ccccc1Nc1cc[nH]c(=O)c1C(=O)Nc1ccc(N2CCC(C)CC2)cc1,6.20,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,625.0,nM,=,CHEMBL3784893,B,CHEMBL3781805,Homo sapiens,CHEMBL203,CHEMBL3779874
COc1ccccc1Nc1cc[nH]c(=O)c1C(=O)Nc1ccc(N2CCS(=O)(=O)CC2)cc1,7.43,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,37.0,nM,=,CHEMBL3784893,B,CHEMBL3780175,Homo sapiens,CHEMBL203,CHEMBL3779874
COc1ccccc1Nc1cc[nH]c(=O)c1C(=O)Nc1ccc(N2CCN(C)CC2)nc1,7.11,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,78.0,nM,=,CHEMBL3784893,B,CHEMBL3781462,Homo sapiens,CHEMBL203,CHEMBL3779874
COc1ccccc1Nc1cc[nH]c(=O)c1C(=O)Nc1ccc(N2CCN(C)CC2)c(C)c1,7.58,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,26.0,nM,=,CHEMBL3784893,B,CHEMBL3780320,Homo sapiens,CHEMBL203,CHEMBL3779874
CCc1cc(NC(=O)c2c(Nc3ccccc3OC)cc[nH]c2=O)ccc1N1CCN(C)CC1,7.51,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,31.0,nM,=,CHEMBL3784893,B,CHEMBL3780509,Homo sapiens,CHEMBL203,CHEMBL3779874
COc1ccccc1Nc1cc[nH]c(=O)c1-c1nc2c(C(C)C)ccc(C)c2[nH]1,7.06,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,88.0,nM,=,CHEMBL3784893,B,CHEMBL3780404,Homo sapiens,CHEMBL203,CHEMBL3779874
CN1CCN(c2ccc(NC(=O)c3c(NC[C@@H](O)c4cccc(Cl)c4)cc[nH]c3=O)cc2)CC1,7.75,Inhibition of human N-terminal GST-tagged EGFR catalytic domain (669 to 1210 residues) expressed in baculovirus expression system using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,18.0,nM,=,CHEMBL3784892,B,CHEMBL3781433,Homo sapiens,CHEMBL203,CHEMBL3779874
CN1CCN(c2ccc(NC(=O)c3c(NCCc4ccc(Cl)cc4)cc[nH]c3=O)cc2)CC1,7.43,Inhibition of human N-terminal GST-tagged EGFR catalytic domain (669 to 1210 residues) expressed in baculovirus expression system using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,37.0,nM,=,CHEMBL3784892,B,CHEMBL3780553,Homo sapiens,CHEMBL203,CHEMBL3779874
CN1CCN(c2ccc(NC(=O)c3c(NCCc4ccccc4)cc[nH]c3=O)cc2)CC1,7.31,Inhibition of human N-terminal GST-tagged EGFR catalytic domain (669 to 1210 residues) expressed in baculovirus expression system using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,49.0,nM,=,CHEMBL3784892,B,CHEMBL3780109,Homo sapiens,CHEMBL203,CHEMBL3779874
CN1CCN(c2ccc(NC(=O)c3c(NCc4ccccc4)cc[nH]c3=O)cc2)CC1,6.46,Inhibition of human N-terminal GST-tagged EGFR catalytic domain (669 to 1210 residues) expressed in baculovirus expression system using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,349.0,nM,=,CHEMBL3784892,B,CHEMBL3780709,Homo sapiens,CHEMBL203,CHEMBL3779874
CN1CCN(c2ccc(NC(=O)c3c(Nc4ccccc4)cc[nH]c3=O)cc2)CC1,6.84,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,144.0,nM,=,CHEMBL3784893,B,CHEMBL3780484,Homo sapiens,CHEMBL203,CHEMBL3779874
CN1CCN(c2ccc(NC(=O)c3c(N)cc[nH]c3=O)cc2)CC1,6.46,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,346.0,nM,=,CHEMBL3784893,B,CHEMBL3780635,Homo sapiens,CHEMBL203,CHEMBL3779874
CN1CCN(c2ccc(NC(=O)c3c(Nc4ccccc4Cl)cc[nH]c3=O)cc2)CC1,7.09,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,82.0,nM,=,CHEMBL3784893,B,CHEMBL3780955,Homo sapiens,CHEMBL203,CHEMBL3779874
CN1CCN(c2ccc(NC(=O)c3c(Nc4cccc(Cl)c4)cc[nH]c3=O)cc2)CC1,6.81,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,155.0,nM,=,CHEMBL3784893,B,CHEMBL3781439,Homo sapiens,CHEMBL203,CHEMBL3779874
CN1CCN(c2ccc(NC(=O)c3c(Nc4ccc(Cl)cc4)cc[nH]c3=O)cc2)CC1,6.20,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,629.0,nM,=,CHEMBL3784893,B,CHEMBL3781338,Homo sapiens,CHEMBL203,CHEMBL3779874
Cc1ccccc1Nc1cc[nH]c(=O)c1C(=O)Nc1ccc(N2CCN(C)CC2)cc1,7.21,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,61.0,nM,=,CHEMBL3784893,B,CHEMBL3780073,Homo sapiens,CHEMBL203,CHEMBL3779874
COc1ccccc1Nc1cc[nH]c(=O)c1C(=O)Nc1ccc(N2CCN(C)CC2)cc1,7.72,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,19.0,nM,=,CHEMBL3784893,B,CHEMBL3780090,Homo sapiens,CHEMBL203,CHEMBL3779874
CN1CCN(c2ccc(NC(=O)c3c(Nc4ccccn4)cc[nH]c3=O)cc2)CC1,6.97,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,108.0,nM,=,CHEMBL3784893,B,CHEMBL3781988,Homo sapiens,CHEMBL203,CHEMBL3779874
CN1CCN(c2ccc(NC(=O)c3c(Nc4ccncn4)cc[nH]c3=O)cc2)CC1,7.02,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,95.0,nM,=,CHEMBL3784893,B,CHEMBL3781344,Homo sapiens,CHEMBL203,CHEMBL3779874
CN1CCN(c2ccc(NC(=O)c3c(Nc4ccnc(N)n4)cc[nH]c3=O)cc2)CC1,8.40,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,4.0,nM,=,CHEMBL3784893,B,CHEMBL3781993,Homo sapiens,CHEMBL203,CHEMBL3779874
CN1CCN(c2ccc(NC(=O)c3c(Nc4ccncc4N)cc[nH]c3=O)cc2)CC1,6.84,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,145.0,nM,=,CHEMBL3784893,B,CHEMBL3781676,Homo sapiens,CHEMBL203,CHEMBL3779874
CN1CCN(c2ccc(NC(=O)c3c(NCCc4cccc(Cl)c4)cc[nH]c3=O)cc2)CC1,7.37,Inhibition of human N-terminal GST-tagged EGFR catalytic domain (669 to 1210 residues) expressed in baculovirus expression system using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,43.0,nM,=,CHEMBL3784892,B,CHEMBL3780037,Homo sapiens,CHEMBL203,CHEMBL3779874
O=C(Nc1ccccc1)c1c(NCCc2cccc(Cl)c2)cc[nH]c1=O,6.48,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,330.0,nM,=,CHEMBL3784893,B,CHEMBL3780006,Homo sapiens,CHEMBL203,CHEMBL3779874
CN(C)c1ccc(NC(=O)c2c(NCCc3cccc(Cl)c3)cc[nH]c2=O)cc1,6.54,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,290.0,nM,=,CHEMBL3784893,B,CHEMBL3781817,Homo sapiens,CHEMBL203,CHEMBL3779874
COc1ccccc1Nc1cc[nH]c(=O)c1-c1nc2c(C(C)C)cccc2[nH]1,7.24,Inhibition of human EGFR catalytic domain (668 to 1210 residues) T790M/L858R double mutant using Fl-EEPLYWSFPAKKK-CONH2 peptide substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by Caliper Mobility Shift Assay,Ki,58.0,nM,=,CHEMBL3784893,B,CHEMBL3780841,Homo sapiens,CHEMBL203,CHEMBL3779874
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccn(C)n3)nc3[nH]ccc23)c1,7.85,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,14.0,nM,=,CHEMBL3790712,B,CHEMBL3786453,Homo sapiens,CHEMBL203,CHEMBL3785081
C=CC(=O)Nc1cccc(Oc2nc(Nc3cnn(C)c3)nc3[nH]ccc23)c1,8.52,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,3.0,nM,=,CHEMBL3790712,B,CHEMBL3786962,Homo sapiens,CHEMBL203,CHEMBL3785081
C=CC(=O)N1CC[C@@H](COc2nc(Nc3cnn(C)c3)nc3[nH]ccc23)C1,6.23,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,590.0,nM,=,CHEMBL3790712,B,CHEMBL3787327,Homo sapiens,CHEMBL203,CHEMBL3785081
C=CC(=O)N1C[C@H](COc2nc(Nc3cnn(C)c3)nc3[nH]ccc23)[C@@H](C(F)(F)F)C1,7.46,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,35.0,nM,=,CHEMBL3790712,B,CHEMBL3785393,Homo sapiens,CHEMBL203,CHEMBL3785081
C=CC(=O)N1CC[C@@H](COc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)C1,8.10,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,8.0,nM,=,CHEMBL3790712,B,CHEMBL3786858,Homo sapiens,CHEMBL203,CHEMBL3785081
C=CC(=O)N1C[C@H](COc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)[C@@H](C(F)(F)F)C1,8.52,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,3.0,nM,=,CHEMBL3790712,B,CHEMBL3786802,Homo sapiens,CHEMBL203,CHEMBL3785081
C=CC(=O)N1C[C@H](COc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)[C@@H](F)C1,8.52,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,3.0,nM,=,CHEMBL3790712,B,CHEMBL3787220,Homo sapiens,CHEMBL203,CHEMBL3785081
C=CC(=O)N1C[C@H](COc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)[C@@H](O)C1,8.10,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,8.0,nM,=,CHEMBL3790712,B,CHEMBL3786220,Homo sapiens,CHEMBL203,CHEMBL3785081
C=CC(=O)N1C[C@H](CO)[C@@H](COc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)C1,7.82,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,15.0,nM,=,CHEMBL3790712,B,CHEMBL3786647,Homo sapiens,CHEMBL203,CHEMBL3785081
C=CC(=O)N1C[C@H](COC)[C@@H](COc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)C1,8.40,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,4.0,nM,=,CHEMBL3790712,B,CHEMBL3786523,Homo sapiens,CHEMBL203,CHEMBL3785081
C=CC(=O)N1C[C@@H](COc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)[C@H](OC)C1,7.50,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,32.0,nM,=,CHEMBL3790712,B,CHEMBL3787132,Homo sapiens,CHEMBL203,CHEMBL3785081
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3[nH]ccc23)c1,8.70,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,2.0,nM,=,CHEMBL3790712,B,CHEMBL3787662,Homo sapiens,CHEMBL203,CHEMBL3785081
C#CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=C,8.70,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,2.0,nM,=,CHEMBL3790712,B,CHEMBL3787386,Homo sapiens,CHEMBL203,CHEMBL3785081
C#CCCn1cc(Nc2nc(OC[C@H]3CN(C(=O)C=C)C[C@@H]3OC)c3c(Cl)c[nH]c3n2)cn1,8.00,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,10.0,nM,=,CHEMBL3790712,B,CHEMBL3786812,Homo sapiens,CHEMBL203,CHEMBL3785081
C=CC(=O)N1C[C@H](COc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)[C@@H](OC)C1,8.40,Reversible binding affinity to human EGFR L858R/ T790M double mutant expressed in baculovirus by fluorometric analysis,Ki,4.0,nM,=,CHEMBL3790712,B,CHEMBL3786098,Homo sapiens,CHEMBL203,CHEMBL3785081
Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1,5.64,Inhibition of Her1 (unknown origin),IC50,2300.0,nM,=,CHEMBL3789407,B,CHEMBL3787112,Homo sapiens,CHEMBL203,CHEMBL3784924
Cc1cc(C(=O)Nc2nc3cccc(Cl)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1,8.38,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,IC50,4.18,nM,=,CHEMBL3860368,B,CHEMBL3787344,Homo sapiens,CHEMBL203,CHEMBL3860038
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1,9.05,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,IC50,0.9,nM,=,CHEMBL4770070,B,CHEMBL3786343,Homo sapiens,CHEMBL203,CHEMBL4765321
CC(=O)c1cccc(NC(=O)c2cc3ccccc3[nH]2)c1,4.24,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,IC50,57000.0,nM,=,CHEMBL3804124,B,CHEMBL3800262,Homo sapiens,CHEMBL203,CHEMBL3797044
CC(=O)c1ccc(NC(=O)c2cc3ccccc3[nH]2)cc1,4.30,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,IC50,50000.0,nM,=,CHEMBL3804124,B,CHEMBL3797839,Homo sapiens,CHEMBL203,CHEMBL3797044
O=C(c1ccccc1)c1cccc(NC(=O)c2cc3ccccc3[nH]2)c1,4.35,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,IC50,45000.0,nM,=,CHEMBL3804124,B,CHEMBL3799956,Homo sapiens,CHEMBL203,CHEMBL3797044
O=C(c1ccccc1)c1ccc(NC(=O)c2cc3ccccc3[nH]2)cc1,4.31,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,IC50,49000.0,nM,=,CHEMBL3804124,B,CHEMBL3799345,Homo sapiens,CHEMBL203,CHEMBL3797044
CC(O)c1cccc(NC(=O)c2cc3ccccc3[nH]2)c1,4.47,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,IC50,34000.0,nM,=,CHEMBL3804124,B,CHEMBL3800448,Homo sapiens,CHEMBL203,CHEMBL3797044
CC(O)c1ccc(NC(=O)c2cc3ccccc3[nH]2)cc1,4.46,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,IC50,35000.0,nM,=,CHEMBL3804124,B,CHEMBL3798556,Homo sapiens,CHEMBL203,CHEMBL3797044
O=C(Nc1cccc(C(O)c2ccccc2)c1)c1cc2ccccc2[nH]1,4.82,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,IC50,15000.0,nM,=,CHEMBL3804124,B,CHEMBL3798658,Homo sapiens,CHEMBL203,CHEMBL3797044
O=C(Nc1ccc(C(O)c2ccccc2)cc1)c1cc2ccccc2[nH]1,4.42,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,IC50,38000.0,nM,=,CHEMBL3804124,B,CHEMBL3799332,Homo sapiens,CHEMBL203,CHEMBL3797044
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2SC)c1,9.40,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,IC50,0.4,nM,=,CHEMBL3804025,B,CHEMBL3797606,Homo sapiens,CHEMBL203,CHEMBL3797107
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2SC)c1,9.15,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,IC50,0.7,nM,=,CHEMBL3804025,B,CHEMBL3798501,Homo sapiens,CHEMBL203,CHEMBL3797107
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(S(C)(=O)=O)CC4)cc3OC)ncc2SC)c1,8.14,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,IC50,7.3,nM,=,CHEMBL3804025,B,CHEMBL3797963,Homo sapiens,CHEMBL203,CHEMBL3797107
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCCN(C(C)=O)CC4)cc3OC)ncc2SC)c1,8.74,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,IC50,1.8,nM,=,CHEMBL3804025,B,CHEMBL3799864,Homo sapiens,CHEMBL203,CHEMBL3797107
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)C(C)C)CC4)cc3OC)ncc2SC)c1,8.44,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,IC50,3.6,nM,=,CHEMBL3804025,B,CHEMBL3798887,Homo sapiens,CHEMBL203,CHEMBL3797107
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)CC)CC4)cc3OC)ncc2SC)c1,8.24,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,IC50,5.8,nM,=,CHEMBL3804025,B,CHEMBL3800597,Homo sapiens,CHEMBL203,CHEMBL3797107
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)C(C)(C)C)CC4)cc3OC)ncc2SC)c1,8.02,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,IC50,9.6,nM,=,CHEMBL3804025,B,CHEMBL3799138,Homo sapiens,CHEMBL203,CHEMBL3797107
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)C(F)(F)F)CC4)cc3OC)ncc2SC)c1,8.36,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,IC50,4.4,nM,=,CHEMBL3804025,B,CHEMBL3799255,Homo sapiens,CHEMBL203,CHEMBL3797107
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC(F)F)ncc2SC)c1,8.55,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,IC50,2.8,nM,=,CHEMBL3804025,B,CHEMBL3798128,Homo sapiens,CHEMBL203,CHEMBL3797107
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(=O)CC)CC4)cc3OC(F)F)ncc2SC)c1,8.43,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,IC50,3.7,nM,=,CHEMBL3804025,B,CHEMBL3799428,Homo sapiens,CHEMBL203,CHEMBL3797107
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2c2c1OCCO2,7.65,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,22.5,nM,=,CHEMBL3807186,B,CHEMBL3806292,Homo sapiens,CHEMBL203,CHEMBL3804755
C#Cc1cccc(Nc2ncnc3cc(OC)c4c(c23)OCCO4)c1,7.96,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,10.9,nM,=,CHEMBL3807186,B,CHEMBL3805236,Homo sapiens,CHEMBL203,CHEMBL3804755
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2c2c1OCCO2,8.70,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,2.0,nM,=,CHEMBL3807186,B,CHEMBL3806248,Homo sapiens,CHEMBL203,CHEMBL3804755
C#Cc1cccc(Nc2ncnc3cc(OCC)c4c(c23)OCCO4)c1,8.04,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,9.2,nM,=,CHEMBL3807186,B,CHEMBL3805039,Homo sapiens,CHEMBL203,CHEMBL3804755
CCOc1cc2ncnc(Nc3cccc(OC)c3)c2c2c1OCCO2,8.36,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,4.4,nM,=,CHEMBL3807186,B,CHEMBL3805774,Homo sapiens,CHEMBL203,CHEMBL3804755
CCOc1cc2ncnc(Nc3ccc(C)c(Cl)c3)c2c2c1OCCO2,8.17,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,6.7,nM,=,CHEMBL3807186,B,CHEMBL3804868,Homo sapiens,CHEMBL203,CHEMBL3804755
CCOc1cc2ncnc(Nc3cccc([N+](=O)[O-])c3)c2c2c1OCCO2,8.01,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,9.7,nM,=,CHEMBL3807186,B,CHEMBL3805238,Homo sapiens,CHEMBL203,CHEMBL3804755
CCOc1cc2ncnc(Nc3ccc(C)cc3)c2c2c1OCCO2,8.44,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,3.6,nM,=,CHEMBL3807186,B,CHEMBL3805859,Homo sapiens,CHEMBL203,CHEMBL3804755
COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2c2c1OCCO2,7.98,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,10.5,nM,=,CHEMBL3807187,B,CHEMBL3806110,Homo sapiens,CHEMBL203,CHEMBL3804755
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c4c(c23)OCCO4)c1,8.09,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,8.1,nM,=,CHEMBL3807187,B,CHEMBL3805461,Homo sapiens,CHEMBL203,CHEMBL3804755
COCCOc1cc2ncnc(Nc3ccc(F)cc3)c2c2c1OCCO2,6.70,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,200.3,nM,=,CHEMBL3807186,B,CHEMBL3806005,Homo sapiens,CHEMBL203,CHEMBL3804755
COCCOc1cc2ncnc(Nc3cccc(OC)c3)c2c2c1OCCO2,6.96,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,109.1,nM,=,CHEMBL3807187,B,CHEMBL3806066,Homo sapiens,CHEMBL203,CHEMBL3804755
COCCOc1cc2ncnc(Nc3ccc(F)c([N+](=O)[O-])c3)c2c2c1OCCO2,7.36,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,43.8,nM,=,CHEMBL3807186,B,CHEMBL3805333,Homo sapiens,CHEMBL203,CHEMBL3804755
COCCOc1cc2ncnc(Nc3ccc(C)c([N+](=O)[O-])c3)c2c2c1OCCO2,7.13,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,74.6,nM,=,CHEMBL3807186,B,CHEMBL3805299,Homo sapiens,CHEMBL203,CHEMBL3804755
COCCOc1cc2ncnc(Nc3ccc(Cl)c([N+](=O)[O-])c3)c2c2c1OCCO2,7.44,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,36.2,nM,=,CHEMBL3807186,B,CHEMBL3806200,Homo sapiens,CHEMBL203,CHEMBL3804755
COCCOc1cc2ncnc(Nc3ccc(F)c(C#N)c3)c2c2c1OCCO2,6.41,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,387.8,nM,=,CHEMBL3807186,B,CHEMBL3805280,Homo sapiens,CHEMBL203,CHEMBL3804755
Fc1ccc(Nc2ncnc3cc(OCC4CCCO4)c4c(c23)OCCO4)cc1Cl,7.62,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,24.1,nM,=,CHEMBL3807186,B,CHEMBL3806213,Homo sapiens,CHEMBL203,CHEMBL3804755
C#Cc1cccc(Nc2ncnc3cc(OCC4CCCO4)c4c(c23)OCCO4)c1,7.56,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,27.3,nM,=,CHEMBL3807186,B,CHEMBL3805325,Homo sapiens,CHEMBL203,CHEMBL3804755
CC(C)Oc1cc2ncnc(Nc3ccc(F)c([N+](=O)[O-])c3)c2c2c1OCCO2,7.08,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,82.5,nM,=,CHEMBL3807186,B,CHEMBL3805383,Homo sapiens,CHEMBL203,CHEMBL3804755
Cc1ccc(Nc2ncnc3cc(OC(C)C)c4c(c23)OCCO4)cc1[N+](=O)[O-],6.73,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,184.5,nM,=,CHEMBL3807186,B,CHEMBL3805089,Homo sapiens,CHEMBL203,CHEMBL3804755
CC(C)Oc1cc2ncnc(Nc3ccc(Cl)c([N+](=O)[O-])c3)c2c2c1OCCO2,6.99,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,102.6,nM,=,CHEMBL3807186,B,CHEMBL3805177,Homo sapiens,CHEMBL203,CHEMBL3804755
CC(C)Oc1cc2ncnc(Nc3ccc(F)c(C#N)c3)c2c2c1OCCO2,6.50,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,313.6,nM,=,CHEMBL3807186,B,CHEMBL3805949,Homo sapiens,CHEMBL203,CHEMBL3804755
Cc1ccc(Nc2ncnc3cc(OC(C)C)c4c(c23)OCCO4)cc1C#N,6.38,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,416.1,nM,=,CHEMBL3807186,B,CHEMBL3806321,Homo sapiens,CHEMBL203,CHEMBL3804755
CC(C)Oc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2c2c1OCCO2,7.54,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,29.1,nM,=,CHEMBL3807186,B,CHEMBL3805283,Homo sapiens,CHEMBL203,CHEMBL3804755
C#Cc1cccc(Nc2ncnc3cc(OC(C)C)c4c(c23)OCCO4)c1,7.62,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,23.7,nM,=,CHEMBL3807186,B,CHEMBL3805509,Homo sapiens,CHEMBL203,CHEMBL3804755
CCOC(C)Oc1cc2ncnc(Nc3ccc(F)c([N+](=O)[O-])c3)c2c2c1OCCO2,6.63,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,232.3,nM,=,CHEMBL3807186,B,CHEMBL3806172,Homo sapiens,CHEMBL203,CHEMBL3804755
CCOC(C)Oc1cc2ncnc(Nc3ccc(C)c([N+](=O)[O-])c3)c2c2c1OCCO2,6.44,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,363.3,nM,=,CHEMBL3807186,B,CHEMBL3805260,Homo sapiens,CHEMBL203,CHEMBL3804755
CCOC(C)Oc1cc2ncnc(Nc3ccc(F)c(C#N)c3)c2c2c1OCCO2,6.45,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,351.8,nM,=,CHEMBL3807186,B,CHEMBL3805654,Homo sapiens,CHEMBL203,CHEMBL3804755
COCC(C)Oc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2c2c1OCCO2,7.05,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,89.2,nM,=,CHEMBL3807187,B,CHEMBL3805775,Homo sapiens,CHEMBL203,CHEMBL3804755
C#Cc1cccc(Nc2ncnc3cc(OC(C)COC)c4c(c23)OCCO4)c1,7.12,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,76.1,nM,=,CHEMBL3807187,B,CHEMBL3805584,Homo sapiens,CHEMBL203,CHEMBL3804755
Fc1ccc(Nc2ncnc3cc(OC4CCOC4)c4c(c23)OCCO4)cc1Cl,7.69,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,20.5,nM,=,CHEMBL3807186,B,CHEMBL3805782,Homo sapiens,CHEMBL203,CHEMBL3804755
C#Cc1cccc(Nc2ncnc3cc(OC4CCOC4)c4c(c23)OCCO4)c1,7.78,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,16.7,nM,=,CHEMBL3807186,B,CHEMBL3806170,Homo sapiens,CHEMBL203,CHEMBL3804755
Fc1ccc(Nc2ncnc3cc(OC4CCOCC4)c4c(c23)OCCO4)cc1Cl,7.23,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,58.8,nM,=,CHEMBL3807186,B,CHEMBL3806222,Homo sapiens,CHEMBL203,CHEMBL3804755
C#Cc1cccc(Nc2ncnc3cc(OC4CCOCC4)c4c(c23)OCCO4)c1,7.24,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,57.8,nM,=,CHEMBL3807186,B,CHEMBL3806145,Homo sapiens,CHEMBL203,CHEMBL3804755
Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c4c(c23)OCCO4)cc1Cl,7.59,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,25.86,nM,=,CHEMBL3807186,B,CHEMBL3805218,Homo sapiens,CHEMBL203,CHEMBL3804755
Brc1cccc(Nc2ncnc3cc(OCCCN4CCOCC4)c4c(c23)OCCO4)c1,7.73,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,18.48,nM,=,CHEMBL3807186,B,CHEMBL3806143,Homo sapiens,CHEMBL203,CHEMBL3804755
Clc1cccc(Nc2ncnc3cc(OCCCN4CCOCC4)c4c(c23)OCCO4)c1,7.66,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,21.95,nM,=,CHEMBL3807186,B,CHEMBL3805681,Homo sapiens,CHEMBL203,CHEMBL3804755
Fc1cccc(Nc2ncnc3cc(OCCCN4CCOCC4)c4c(c23)OCCO4)c1,7.08,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,83.88,nM,=,CHEMBL3807186,B,CHEMBL3804886,Homo sapiens,CHEMBL203,CHEMBL3804755
FC(F)(F)c1cccc(Nc2ncnc3cc(OCCCN4CCOCC4)c4c(c23)OCCO4)c1,7.01,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,IC50,97.18,nM,=,CHEMBL3807186,B,CHEMBL3805588,Homo sapiens,CHEMBL203,CHEMBL3804755
c1ccc(COc2cccc(C3CC(c4ccc5c(c4)OCCO5)=NN3c3ccccc3)c2)cc1,5.10,Inhibition of recombinant His6-tagged EGFR (unknown origin) cytoplasmic domain (645 to 1186 residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometric analysis,IC50,7920.0,nM,=,CHEMBL3807568,B,CHEMBL3805508,Homo sapiens,CHEMBL203,CHEMBL3804763
Clc1cccc(C2CC(c3ccc4c(c3)OCCO4)=NN2c2ccccc2)c1,4.09,Inhibition of recombinant His6-tagged EGFR (unknown origin) cytoplasmic domain (645 to 1186 residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometric analysis,IC50,81200.0,nM,=,CHEMBL3807568,B,CHEMBL3805409,Homo sapiens,CHEMBL203,CHEMBL3804763
c1ccc(COc2ccc(C3CC(c4ccc5c(c4)OCCO5)=NN3c3ccccc3)cc2)cc1,5.04,Inhibition of recombinant His6-tagged EGFR (unknown origin) cytoplasmic domain (645 to 1186 residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometric analysis,IC50,9040.0,nM,=,CHEMBL3807568,B,CHEMBL3805893,Homo sapiens,CHEMBL203,CHEMBL3804763
Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2,5.41,"Inhibition of wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",IC50,3900.0,nM,=,CHEMBL4188985,B,CHEMBL3809489,Homo sapiens,CHEMBL203,CHEMBL4184298
S=C=Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.06,Inhibition of EGFR-TK in human A431 cell lysate assessed as reduction in EGF stimulated kinase activity after 60 mins using biotinylated peptide substrate by ELISA,IC50,880.0,nM,=,CHEMBL3813356,B,CHEMBL3809045,Homo sapiens,CHEMBL203,CHEMBL3808338
COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1,7.82,Inhibition of GST-tagged human recombinant EGFR (668 to1210 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate,IC50,15.0,nM,=,CHEMBL3811753,B,CHEMBL3808884,Homo sapiens,CHEMBL203,CHEMBL3808348
C=CC(=O)NCCn1c(-c2nc(-c3cnn(C4CCN(C)CC4)c3)cnc2N)nc2ccccc21,5.66,Inhibition of recombinant N-terminal GST-tagged human EGFR T790M/L858R double mutant using biotinylated TK substrate incubated for 50 mins by HTRF assay,IC50,2200.0,nM,=,CHEMBL3817134,B,CHEMBL3813746,Homo sapiens,CHEMBL203,CHEMBL3813644
C=CC(=O)NCCCn1c(-c2nc(-c3cnn(C4CCN(C)CC4)c3)cnc2N)nc2ccccc21,6.70,Inhibition of recombinant N-terminal GST-tagged human EGFR T790M/L858R double mutant using biotinylated TK substrate incubated for 50 mins by HTRF assay,IC50,200.0,nM,=,CHEMBL3817134,B,CHEMBL3814878,Homo sapiens,CHEMBL203,CHEMBL3813644
CN1CCC(n2cc(-c3cnc(N)c(-c4nc5ccccc5[nH]4)n3)cn2)CC1,6.54,Inhibition of recombinant N-terminal GST-tagged human EGFR T790M/L858R double mutant using biotinylated TK substrate incubated for 50 mins by HTRF assay,IC50,290.0,nM,=,CHEMBL3817134,B,CHEMBL3813979,Homo sapiens,CHEMBL203,CHEMBL3813644
CCn1c(-c2nc(-c3cnn(C4CCN(C)CC4)c3)cnc2N)nc2ccccc21,7.30,Inhibition of recombinant N-terminal GST-tagged human EGFR T790M/L858R double mutant using biotinylated TK substrate incubated for 50 mins by HTRF assay,IC50,50.0,nM,=,CHEMBL3817134,B,CHEMBL3815045,Homo sapiens,CHEMBL203,CHEMBL3813644
NC(=O)Nc1ccc2ncnc(Nc3ccc(Br)cc3)c2c1,9.10,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,0.803,nM,=,CHEMBL3815405,B,CHEMBL3814959,Homo sapiens,CHEMBL203,CHEMBL3813636
C#Cc1cccc(Nc2ncnc3ccc(NC(N)=O)cc23)c1,8.65,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,2.22,nM,=,CHEMBL3815405,B,CHEMBL3814447,Homo sapiens,CHEMBL203,CHEMBL3813636
C#Cc1cccc(Nc2ncnc3ccc(NC(C)=O)cc23)c1,8.69,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,2.04,nM,=,CHEMBL3815405,B,CHEMBL3815074,Homo sapiens,CHEMBL203,CHEMBL3813636
NC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,9.07,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,0.854,nM,=,CHEMBL3815405,B,CHEMBL3814211,Homo sapiens,CHEMBL203,CHEMBL3813636
CC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,9.18,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,0.662,nM,=,CHEMBL3815405,B,CHEMBL3814257,Homo sapiens,CHEMBL203,CHEMBL3813636
CC(=O)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,8.40,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,3.96,nM,=,CHEMBL3815405,B,CHEMBL3814846,Homo sapiens,CHEMBL203,CHEMBL3813636
O=C(NCCN1CCOCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.85,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,1.43,nM,=,CHEMBL3815405,B,CHEMBL3814320,Homo sapiens,CHEMBL203,CHEMBL3813636
O=C(NCCN1CCCCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,9.11,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,0.772,nM,=,CHEMBL3815405,B,CHEMBL3814882,Homo sapiens,CHEMBL203,CHEMBL3813636
O=C(NCCN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,8.54,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,2.92,nM,=,CHEMBL3815405,B,CHEMBL3815161,Homo sapiens,CHEMBL203,CHEMBL3813636
O=C(NCCN1CCCCC1)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,8.97,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,1.06,nM,=,CHEMBL3815405,B,CHEMBL3814956,Homo sapiens,CHEMBL203,CHEMBL3813636
O=C(NCCN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,6.59,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,IC50,259.0,nM,=,CHEMBL3815441,B,CHEMBL3814460,Homo sapiens,CHEMBL203,CHEMBL3813636
O=C(NCCN1CCCCC1)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,5.69,Inhibition of EGFR L858R/T790M double mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,IC50,2030.0,nM,=,CHEMBL3815445,B,CHEMBL3814021,Homo sapiens,CHEMBL203,CHEMBL3813636
Fc1ccc(Nc2ncnc3ccc(NC(=S)NCCN4CCOCC4)cc23)cc1Cl,8.65,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,2.25,nM,=,CHEMBL3815405,B,CHEMBL3814445,Homo sapiens,CHEMBL203,CHEMBL3813636
Fc1ccc(Nc2ncnc3ccc(NC(=S)NCCN4CCCCC4)cc23)cc1Cl,8.43,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,3.7,nM,=,CHEMBL3815405,B,CHEMBL3814694,Homo sapiens,CHEMBL203,CHEMBL3813636
S=C(NCCN1CCOCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.74,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,1.81,nM,=,CHEMBL3815405,B,CHEMBL3815163,Homo sapiens,CHEMBL203,CHEMBL3813636
Fc1cccc(COc2ccc(Nc3ncnc4ccc(NC(=S)NCCN5CCOCC5)cc34)cc2Cl)c1,8.65,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,2.26,nM,=,CHEMBL3815405,B,CHEMBL3813728,Homo sapiens,CHEMBL203,CHEMBL3813636
Fc1cccc(COc2ccc(Nc3ncnc4ccc(NC(=S)NCCN5CCCCC5)cc34)cc2Cl)c1,6.53,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,IC50,296.0,nM,=,CHEMBL3815441,B,CHEMBL3814940,Homo sapiens,CHEMBL203,CHEMBL3813636
S=C(NCCN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Cl)c(Cl)c3)c2c1,8.04,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,9.05,nM,=,CHEMBL3815405,B,CHEMBL3814182,Homo sapiens,CHEMBL203,CHEMBL3813636
S=C(NCCN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Cl)cc3)c2c1,8.30,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,5.06,nM,=,CHEMBL3815405,B,CHEMBL3814816,Homo sapiens,CHEMBL203,CHEMBL3813636
S=C(NCCCN1CCOCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.61,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,IC50,247.0,nM,=,CHEMBL3815441,B,CHEMBL3815115,Homo sapiens,CHEMBL203,CHEMBL3813636
Fc1ccc(Nc2ncnc3ccc(NC(=S)NCCCN4CCOCC4)cc23)cc1Cl,6.41,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,IC50,390.0,nM,=,CHEMBL3815441,B,CHEMBL3813876,Homo sapiens,CHEMBL203,CHEMBL3813636
Fc1cccc(COc2ccc(Nc3ncnc4ccc(NC(=S)NCCCN5CCOCC5)cc34)cc2Cl)c1,8.82,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,IC50,1.5,nM,=,CHEMBL3815405,B,CHEMBL3814812,Homo sapiens,CHEMBL203,CHEMBL3813636
Cc1cc(=O)n2nc(SCc3ccc(Cl)cc3)nc2[nH]1,7.27,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,IC50,54.0,nM,=,CHEMBL4341976,B,CHEMBL3818535,Homo sapiens,CHEMBL203,CHEMBL4340550
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)[C@@H]1COC(=O)N1,8.97,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,IC50,1.06,nM,=,CHEMBL3820192,B,CHEMBL3818547,Homo sapiens,CHEMBL203,CHEMBL3817746
CCOc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)[C@@H]1COC(=O)N1,8.87,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,IC50,1.34,nM,=,CHEMBL3820192,B,CHEMBL3818115,Homo sapiens,CHEMBL203,CHEMBL3817746
COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1NC(=O)[C@@H]1COC(=O)N1,9.33,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,IC50,0.47,nM,=,CHEMBL3820192,B,CHEMBL3818015,Homo sapiens,CHEMBL203,CHEMBL3817746
CCOc1cc2ncnc(N[C@@H](C)c3ccccc3)c2cc1NC(=O)[C@@H]1COC(=O)N1,8.26,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,IC50,5.52,nM,=,CHEMBL3820192,B,CHEMBL3818563,Homo sapiens,CHEMBL203,CHEMBL3817746
CCOc1cc2ncnc(Nc3ccc(OCC4CC4)c(Cl)c3)c2cc1NC(=O)[C@@H]1COC(=O)N1,7.42,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,IC50,37.81,nM,=,CHEMBL3820192,B,CHEMBL3818970,Homo sapiens,CHEMBL203,CHEMBL3817746
O=C1N[C@H](C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2OCCN2CCCCC2)CO1,7.59,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,IC50,25.53,nM,=,CHEMBL3820192,B,CHEMBL3819120,Homo sapiens,CHEMBL203,CHEMBL3817746
O=C1N[C@H](C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2OCCCN2CCOCC2)CO1,8.34,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,IC50,4.54,nM,=,CHEMBL3820192,B,CHEMBL3818289,Homo sapiens,CHEMBL203,CHEMBL3817746
CCOc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)[C@H]1COC(=O)N1,8.92,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,IC50,1.19,nM,=,CHEMBL3820192,B,CHEMBL3818364,Homo sapiens,CHEMBL203,CHEMBL3817746
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)[C@H]1NC(=O)O[C@@H]1C,8.70,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,IC50,1.98,nM,=,CHEMBL3820192,B,CHEMBL3818062,Homo sapiens,CHEMBL203,CHEMBL3817746
CCOc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)[C@H]1NC(=O)O[C@@H]1C,8.59,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,IC50,2.57,nM,=,CHEMBL3820192,B,CHEMBL3819553,Homo sapiens,CHEMBL203,CHEMBL3817746
COc1cc2c(Oc3ccc(NC(=O)c4cn(-c5ccccc5Cl)nn4)cc3F)ccnc2cc1OCCCN1CCCCC1,6.28,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate incubated for 30 mins by HTRF assay",IC50,529.4,nM,=,CHEMBL3826532,B,CHEMBL3823520,Homo sapiens,CHEMBL203,CHEMBL3822439
Cn1cc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cn1,8.53,Inhibition of cytoplasmic GST-tagged human recombinant EGFR expressed in baculovirus system by z-lyte assay,IC50,2.97,nM,=,CHEMBL3829377,B,CHEMBL3828269,Homo sapiens,CHEMBL203,CHEMBL3826970
Cn1cc(-c2ccc3ncnc(Nc4ccc5ncccc5c4)c3c2)cn1,7.36,Inhibition of cytoplasmic GST-tagged human recombinant EGFR expressed in baculovirus system by z-lyte assay,IC50,44.1,nM,=,CHEMBL3829377,B,CHEMBL3828079,Homo sapiens,CHEMBL203,CHEMBL3826970
C#Cc1cccc(Nc2ncnc3ccc(-c4cnn(C)c4)cc23)c1,8.45,Inhibition of cytoplasmic GST-tagged human recombinant EGFR expressed in baculovirus system by z-lyte assay,IC50,3.58,nM,=,CHEMBL3829377,B,CHEMBL3828021,Homo sapiens,CHEMBL203,CHEMBL3826970
Fc1ccc(Nc2ncnc3ccc(-c4cnn(C5CCNCC5)c4)cc23)cc1Cl,7.50,Inhibition of cytoplasmic GST-tagged human recombinant EGFR expressed in baculovirus system by z-lyte assay,IC50,31.9,nM,=,CHEMBL3829377,B,CHEMBL3828092,Homo sapiens,CHEMBL203,CHEMBL3826970
c1cnc2ccc(Nc3ncnc4ccc(-c5cnn(C6CCNCC6)c5)cc34)cc2c1,7.55,Inhibition of cytoplasmic GST-tagged human recombinant EGFR expressed in baculovirus system by z-lyte assay,IC50,28.2,nM,=,CHEMBL3829377,B,CHEMBL3827349,Homo sapiens,CHEMBL203,CHEMBL3826970
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC,9.85,Inhibition of PF-06422899 binding to EGFR in human A431 cells after 1 hr by gel-based ABPP assay,Ki,0.14,nM,=,CHEMBL3877213,B,CHEMBL3883534,Homo sapiens,CHEMBL203,CHEMBL3875233
Cc1cccc(Nc2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c1,4.96,Inhibition of human EGFR using poly (Glu:Tyr) as substrate measured for 1.5 hrs by oregon green 488 dye-based fluorescence assay,IC50,11000.0,nM,=,CHEMBL3875840,B,CHEMBL3883652,Homo sapiens,CHEMBL203,CHEMBL3875172
CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21,5.00,Inhibition of human recombinant GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system,IC50,10000.0,nM,=,CHEMBL3876067,B,CHEMBL3884319,Homo sapiens,CHEMBL203,CHEMBL3875183
CN(C)C/C=C/C(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1,7.08,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,83.4,nM,=,CHEMBL3887533,B,CHEMBL3889694,Homo sapiens,CHEMBL203,CHEMBL3886356
COc1cc(Nc2ncnc3ccc(-c4ccc(CN5C[C@@H]6[C@@H](CO)[C@@H]6C5)cc4)cc23)ccc1Oc1ccccc1,6.17,"Inhibition of recombinant human GST-fused EGFR (668 to 1211 residues) assessed as phosphotyrosine formation using poly(Glu:Tyr, 4:1) as substrate and ATP measured after 6 mins",IC50,670.0,nM,=,CHEMBL3870719,B,CHEMBL3890526,Homo sapiens,CHEMBL203,CHEMBL3870325
C=CC(=O)Nc1cccc(Nc2nc(Nc3cccc(OC)c3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,5.5,nM,=,CHEMBL3887858,B,CHEMBL3891187,Homo sapiens,CHEMBL203,CHEMBL3886183
O=C(Nc1ccc(Nc2ncnc3cc4oc(=O)n(CCOC(=O)CBr)c4cc23)cc1)NC1CCCCC1,5.07,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,8500.0,nM,=,CHEMBL3854309,B,CHEMBL3891774,Homo sapiens,CHEMBL203,CHEMBL3853296
C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1,9.22,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,0.6,nM,=,CHEMBL3857034,B,CHEMBL3891846,Homo sapiens,CHEMBL203,CHEMBL3856204
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCC1C2COCC21,9.89,"Time-Resolved Fret (TR-FRET) Assay: 1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dilutions of 10 fold from 100 micoM are used. Kinase activity was determined with time-resolved Fret (TR-FRET) assay (LanthaScreen® kinase activity assay, from InVitrogen).2) The assay is performed in a Black 384-well plate (from Corning). The kinase and the compound was incubated for 30 mM at room temperature. ATP (1 mM) and fluorescein-poly GT were added, and the reaction was incubated for 15 mM. Detection agent SA-XL665 (from Cisbio Assay) and TK Ab-Cryptate detection antibody (from InVitrogen) were added to stop the reaction.3) The 384-well plate was sealed and incubated for 1 hour. The fluorescence was then measured at 620 nM (Cryptate) and 665 nM (XL655) wavelength.4) Each concentration of compound was done in triplicate, and vehicle (without compound) and a positive control were used.",IC50,0.13,nM,=,CHEMBL3887593,B,CHEMBL3892310,Homo sapiens,CHEMBL203,CHEMBL3886368
OC[C@@H](Nc1ncnc2oc(-c3ccccc3)cc12)c1ccccc1,8.41,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,3.9,nM,=,CHEMBL3857034,B,CHEMBL3892567,Homo sapiens,CHEMBL203,CHEMBL3856204
C=CC(=O)NC1CCC(n2c(NC(=O)c3cccc(C(F)(F)F)c3)nc3cc(C)ccc32)C1,5.17,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,IC50,6810.0,nM,=,CHEMBL3860367,B,CHEMBL3892960,Homo sapiens,CHEMBL203,CHEMBL3860038
CN(C)C/C=C/C(=O)N[C@H]1CC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1,7.65,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,22.53,nM,=,CHEMBL3887533,B,CHEMBL3893004,Homo sapiens,CHEMBL203,CHEMBL3886356
COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1c(-c2c(Cl)cccc2Cl)noc1C,7.30,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,IC50,50.0,nM,=,CHEMBL3883067,B,CHEMBL3893128,Homo sapiens,CHEMBL203,CHEMBL3882729
CCN1C(=O)CS/C1=N/Nc1nncc2ccccc12,7.33,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,47.0,nM,=,CHEMBL3870506,B,CHEMBL3893698,Homo sapiens,CHEMBL203,CHEMBL3870309
CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2ccc(C(F)(F)F)cc2)ncc1Cl,6.23,Inhibition of EGFR (unknown origin) using peptide as substrate after 60 mins by HTRF assay,IC50,593.0,nM,=,CHEMBL3870418,B,CHEMBL3893810,Homo sapiens,CHEMBL203,CHEMBL3870304
Cc1ccc(Oc2ccc(Nc3ncnc4ccc(-c5cn(CCCCCCC(=O)NO)nn5)cc34)cc2C)cn1,8.00,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,IC50,10.0,nM,=,CHEMBL3870704,B,CHEMBL3893822,Homo sapiens,CHEMBL203,CHEMBL3870325
C=CC(=O)Nc1cccc(Oc2nc(Nc3cccc(OC)c3OC)ncc2Br)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,5.5,nM,=,CHEMBL3887858,B,CHEMBL3894076,Homo sapiens,CHEMBL203,CHEMBL3886183
Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@H]1CC[C@@H](NC(=O)/C=C/CN2CCOCC2)CC1,6.56,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,272.9,nM,=,CHEMBL3887533,B,CHEMBL3894102,Homo sapiens,CHEMBL203,CHEMBL3886356
COc1cc2c(Nc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)ncnc2cc1OCc1ccccc1,5.33,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,4649.0,nM,=,CHEMBL3877875,B,CHEMBL3894623,Homo sapiens,CHEMBL203,CHEMBL3877259
COc1ccc(/C=N/Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1,6.23,Inhibition of EGFR (unknown origin) using peptide as substrate after 60 mins by HTRF assay,IC50,587.0,nM,=,CHEMBL3870418,B,CHEMBL3894726,Homo sapiens,CHEMBL203,CHEMBL3870304
C=CC(=O)NCCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,7.15,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,70.49,nM,=,CHEMBL3887533,B,CHEMBL3894938,Homo sapiens,CHEMBL203,CHEMBL3886356
C=C(CN1CCOCC1)C(=O)N1CC(Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)C1,8.40,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,4.0,nM,=,CHEMBL3882126,B,CHEMBL3895411,Homo sapiens,CHEMBL203,CHEMBL3881529
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCC12COCC1C2,9.43,"Time-Resolved Fret (TR-FRET) Assay: 1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dilutions of 10 fold from 100 micoM are used. Kinase activity was determined with time-resolved Fret (TR-FRET) assay (LanthaScreen® kinase activity assay, from InVitrogen).2) The assay is performed in a Black 384-well plate (from Corning). The kinase and the compound was incubated for 30 mM at room temperature. ATP (1 mM) and fluorescein-poly GT were added, and the reaction was incubated for 15 mM. Detection agent SA-XL665 (from Cisbio Assay) and TK Ab-Cryptate detection antibody (from InVitrogen) were added to stop the reaction.3) The 384-well plate was sealed and incubated for 1 hour. The fluorescence was then measured at 620 nM (Cryptate) and 665 nM (XL655) wavelength.4) Each concentration of compound was done in triplicate, and vehicle (without compound) and a positive control were used.",IC50,0.37,nM,=,CHEMBL3887593,B,CHEMBL3895468,Homo sapiens,CHEMBL203,CHEMBL3886368
S=C(NNc1nncc2ccccc12)Nc1ccc(Cl)cc1,7.19,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,64.0,nM,=,CHEMBL3870506,B,CHEMBL3896476,Homo sapiens,CHEMBL203,CHEMBL3870309
COc1cc2c(Nc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,6.30,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,500.0,nM,=,CHEMBL3877875,B,CHEMBL3896615,Homo sapiens,CHEMBL203,CHEMBL3877259
Cc1cc(OC2CCN(CCS(C)(=O)=O)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3897153,Homo sapiens,CHEMBL203,CHEMBL3882727
CN1CCN(c2ccc(Nc3ncnc4cc5oc(=O)n(CCOC(=O)CBr)c5cc34)cc2Cl)CC1,8.10,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,8.0,nM,=,CHEMBL3854309,B,CHEMBL3897363,Homo sapiens,CHEMBL203,CHEMBL3853296
COc1ccc(/C=C/C(=N/Nc2nncc3ccccc23)c2ccc(Cl)cc2)cc1,8.27,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,5.4,nM,=,CHEMBL3870506,B,CHEMBL3897723,Homo sapiens,CHEMBL203,CHEMBL3870309
C=C(CN(C)C)C(=O)N1CC(Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)C1,8.70,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,2.0,nM,=,CHEMBL3882126,B,CHEMBL3898077,Homo sapiens,CHEMBL203,CHEMBL3881529
C=CC(=O)N1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,8.30,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,5.0,nM,=,CHEMBL3882126,B,CHEMBL3898447,Homo sapiens,CHEMBL203,CHEMBL3881529
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(CNCCCCCCCC(=O)NO)cc3)cc12)c1ccccc1,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3898480,Homo sapiens,CHEMBL203,CHEMBL3881527
C=CC(=O)N1CC(Oc2cc3c(Nc4cccc(Cl)c4)ncnc3cc2OC)C1,8.80,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,1.6,nM,=,CHEMBL3882125,B,CHEMBL3898690,Homo sapiens,CHEMBL203,CHEMBL3881529
Cc1cc(NS(=O)(=O)c2ccc(Nc3nncc4ccccc34)cc2)no1,6.89,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,130.0,nM,=,CHEMBL3870506,B,CHEMBL3899216,Homo sapiens,CHEMBL203,CHEMBL3870309
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC1CCN(C(=O)CO)CC1,6.69,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,204.0,nM,=,CHEMBL3882125,B,CHEMBL3900054,Homo sapiens,CHEMBL203,CHEMBL3881529
Clc1ccc(/C=C/C(=N/Nc2nncc3ccccc23)c2ccccc2)cc1,8.34,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,4.6,nM,=,CHEMBL3870506,B,CHEMBL3900264,Homo sapiens,CHEMBL203,CHEMBL3870309
CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC[C@@]12COC[C@@H]1C2,9.29,"Time-Resolved Fret (TR-FRET) Assay: 1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dilutions of 10 fold from 100 micoM are used. Kinase activity was determined with time-resolved Fret (TR-FRET) assay (LanthaScreen® kinase activity assay, from InVitrogen).2) The assay is performed in a Black 384-well plate (from Corning). The kinase and the compound was incubated for 30 mM at room temperature. ATP (1 mM) and fluorescein-poly GT were added, and the reaction was incubated for 15 mM. Detection agent SA-XL665 (from Cisbio Assay) and TK Ab-Cryptate detection antibody (from InVitrogen) were added to stop the reaction.3) The 384-well plate was sealed and incubated for 1 hour. The fluorescence was then measured at 620 nM (Cryptate) and 665 nM (XL655) wavelength.4) Each concentration of compound was done in triplicate, and vehicle (without compound) and a positive control were used.",IC50,0.51,nM,=,CHEMBL3887593,B,CHEMBL3901296,Homo sapiens,CHEMBL203,CHEMBL3886368
C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1,9.40,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,0.4,nM,=,CHEMBL3857034,B,CHEMBL3901622,Homo sapiens,CHEMBL203,CHEMBL3856204
C=CC(=O)N1CCCCC(n2c(NC(=O)c3cccc(C(F)(F)F)c3)nc3cc(C)ccc32)C1,8.21,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,IC50,6.1,nM,=,CHEMBL3860368,B,CHEMBL3901943,Homo sapiens,CHEMBL203,CHEMBL3860038
Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCN(C(=O)/C=C/CN2CCOCC2)C1,6.49,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,326.0,nM,=,CHEMBL3887533,B,CHEMBL3902180,Homo sapiens,CHEMBL203,CHEMBL3886356
O=C(CCl)OCCn1c(=O)oc2cc3ncnc(Nc4ccc(F)c(F)c4)c3cc21,5.33,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,4700.0,nM,=,CHEMBL3854309,B,CHEMBL3902295,Homo sapiens,CHEMBL203,CHEMBL3853296
Nc1nc(Nc2cccc(Br)c2)c2c(n1)-c1ccccc1C2,4.00,Inhibition Assay: Inhibition of various kinase enzyme.,IC50,98800.0,nM,=,CHEMBL3888922,B,CHEMBL3902576,Homo sapiens,CHEMBL203,CHEMBL3886207
O=C(CCCCCCn1cc(-c2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)nn1)NO,8.44,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,IC50,3.6,nM,=,CHEMBL3870704,B,CHEMBL3902778,Homo sapiens,CHEMBL203,CHEMBL3870325
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC(=O)Cn4ccnc4)cc3)ncc2[N+](=O)[O-])c1,6.93,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,IC50,118.7,nM,=,CHEMBL3861200,B,CHEMBL3903063,Homo sapiens,CHEMBL203,CHEMBL3860065
CN(C)C/C=C/C(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,6.16,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,698.3,nM,=,CHEMBL3887533,B,CHEMBL3903249,Homo sapiens,CHEMBL203,CHEMBL3886356
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccccc3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,5.5,nM,=,CHEMBL3887858,B,CHEMBL3903641,Homo sapiens,CHEMBL203,CHEMBL3886183
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccccc3OC)ncc2Cl)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,20.0,nM,=,CHEMBL3887858,B,CHEMBL3903707,Homo sapiens,CHEMBL203,CHEMBL3886183
C(=C/c1ccccc1)\C(=N\Nc1nncc2ccccc12)c1ccccc1,8.25,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,5.6,nM,=,CHEMBL3870506,B,CHEMBL3903713,Homo sapiens,CHEMBL203,CHEMBL3870309
CN(C)C/C=C/C(=O)N1CCCC1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,7.72,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,18.85,nM,=,CHEMBL3887533,B,CHEMBL3903870,Homo sapiens,CHEMBL203,CHEMBL3886356
COc1cc(N2CCN(S(C)(=O)=O)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3904450,Homo sapiens,CHEMBL203,CHEMBL3882727
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OC)cc3OC)ncc2Br)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,5.5,nM,=,CHEMBL3887858,B,CHEMBL3904778,Homo sapiens,CHEMBL203,CHEMBL3886183
COC(=O)CNC(=O)c1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(OC)cc23)cc1,6.12,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,763.0,nM,=,CHEMBL3877875,B,CHEMBL3904787,Homo sapiens,CHEMBL203,CHEMBL3877259
C=CC(=O)N1CC[C@H](Oc2cc3c(Nc4ccc(Br)c(Cl)c4F)ncnc3cc2OC)C1,8.10,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,8.0,nM,=,CHEMBL3882126,B,CHEMBL3904966,Homo sapiens,CHEMBL203,CHEMBL3881529
COc1cc2c(Nc3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,6.63,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,235.0,nM,=,CHEMBL3877875,B,CHEMBL3905242,Homo sapiens,CHEMBL203,CHEMBL3877259
COc1cccc(/C=N/Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c1,6.22,Inhibition of EGFR (unknown origin) using peptide as substrate after 60 mins by HTRF assay,IC50,601.0,nM,=,CHEMBL3870418,B,CHEMBL3905284,Homo sapiens,CHEMBL203,CHEMBL3870304
CCCCNC(=S)NNc1nncc2ccccc12,7.28,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,52.0,nM,=,CHEMBL3870506,B,CHEMBL3905411,Homo sapiens,CHEMBL203,CHEMBL3870309
CC#CC(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,6.54,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,289.4,nM,=,CHEMBL3888240,B,CHEMBL3905432,Homo sapiens,CHEMBL203,CHEMBL3886627
COc1cc2c(Nc3ccc(NC(=O)Nc4ccc(C)c(C)c4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,6.17,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,668.0,nM,=,CHEMBL3877875,B,CHEMBL3905552,Homo sapiens,CHEMBL203,CHEMBL3877259
COc1cc(N2CCC(N3CCCCC3)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4ccc(F)cc4Cl)c3)nc3ccccn23)n1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3905921,Homo sapiens,CHEMBL203,CHEMBL3882727
COc1cc2ncnc(NCc3cccc(Br)c3)c2cc1OCCCCCCC(=O)NO,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3906200,Homo sapiens,CHEMBL203,CHEMBL3881527
O=C(CBr)OCCn1c(=O)oc2cc3ncnc(Nc4ccc(F)c(F)c4)c3cc21,6.52,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,300.0,nM,=,CHEMBL3854309,B,CHEMBL3906330,Homo sapiens,CHEMBL203,CHEMBL3853296
COc1cc(N2CCC(O)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3906473,Homo sapiens,CHEMBL203,CHEMBL3882727
CCOC(=O)c1ccc(Nc2nncc3ccccc23)cc1,8.36,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,4.4,nM,=,CHEMBL3870506,B,CHEMBL3906533,Homo sapiens,CHEMBL203,CHEMBL3870309
COc1cc(N2CCC(N3CCCCC3)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4ccc(Cl)cc4F)c3)nc3ccccn23)n1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3907756,Homo sapiens,CHEMBL203,CHEMBL3882727
O=S(=O)(Nc1ncccn1)c1ccc(Nc2nncc3ccccc23)cc1,7.07,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,86.0,nM,=,CHEMBL3870506,B,CHEMBL3908272,Homo sapiens,CHEMBL203,CHEMBL3870309
C[C@@H](Nc1ncnc2oc(-c3ccccc3)cc12)c1ccccc1,7.96,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,11.0,nM,=,CHEMBL3857034,B,CHEMBL3908303,Homo sapiens,CHEMBL203,CHEMBL3856204
O=C(CBr)OCCn1c(=O)oc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,6.34,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,460.0,nM,=,CHEMBL3854309,B,CHEMBL3908711,Homo sapiens,CHEMBL203,CHEMBL3853296
C=CC(=O)N1CC(Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)C1,9.15,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,0.7,nM,=,CHEMBL3882125,B,CHEMBL3909201,Homo sapiens,CHEMBL203,CHEMBL3881529
O=C(CCCOc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1)NO,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3909214,Homo sapiens,CHEMBL203,CHEMBL3881527
Cc1ccc2nc(NC(=O)c3cccc(C(F)(F)F)c3)n([C@H]3CC[C@H](O)CC3)c2c1,6.55,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,IC50,280.0,nM,=,CHEMBL3860363,B,CHEMBL3909438,Homo sapiens,CHEMBL203,CHEMBL3860038
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(CNCC(=O)NO)cc3)cc12)c1ccccc1,6.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,1000.0,nM,=,CHEMBL3881964,B,CHEMBL3910297,Homo sapiens,CHEMBL203,CHEMBL3881527
C#Cc1cccc(Nc2ncnc3cc4oc(=O)n(CCOC(=O)CBr)c4cc23)c1,5.28,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,5200.0,nM,=,CHEMBL3854309,B,CHEMBL3910361,Homo sapiens,CHEMBL203,CHEMBL3853296
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OC)cc3OC)ncc2Br)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,5.5,nM,=,CHEMBL3887858,B,CHEMBL3910422,Homo sapiens,CHEMBL203,CHEMBL3886183
C=CC(=O)N1CCC[C@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,8.64,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,2.298,nM,=,CHEMBL3887533,B,CHEMBL3910496,Homo sapiens,CHEMBL203,CHEMBL3886356
C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Br)c(C)c4)ncnc3cc2OC)CC1,8.12,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,7.6,nM,=,CHEMBL3882126,B,CHEMBL3910915,Homo sapiens,CHEMBL203,CHEMBL3881529
O=C(CCCCCCn1cc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)nn1)NO,8.38,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,IC50,4.2,nM,=,CHEMBL3870704,B,CHEMBL3911796,Homo sapiens,CHEMBL203,CHEMBL3870325
C=CC(=O)N[C@H]1CC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1,7.35,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,44.5,nM,=,CHEMBL3887533,B,CHEMBL3912266,Homo sapiens,CHEMBL203,CHEMBL3886356
O=C(CCl)OCCn1c(=O)oc2cc3ncnc(Nc4ccc(N5CCCCC5)c(Cl)c4)c3cc21,6.62,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,240.0,nM,=,CHEMBL3854309,B,CHEMBL3912361,Homo sapiens,CHEMBL203,CHEMBL3853296
C#Cc1cccc(Nc2ncnc3ccc(OCCCCCC(=O)NO)cc23)c1,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3912598,Homo sapiens,CHEMBL203,CHEMBL3881527
O=C1CS/C(=N/Nc2nncc3ccccc23)N1c1ccc(Cl)cc1,7.38,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,42.0,nM,=,CHEMBL3870506,B,CHEMBL3912723,Homo sapiens,CHEMBL203,CHEMBL3870309
CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2ccc(OC(F)(F)F)cc2)ncc1Cl,6.05,Inhibition of EGFR (unknown origin) using peptide as substrate after 60 mins by HTRF assay,IC50,898.0,nM,=,CHEMBL3870418,B,CHEMBL3913728,Homo sapiens,CHEMBL203,CHEMBL3870304
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OC)cc3OC)ncc2Cl)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,5.5,nM,=,CHEMBL3887858,B,CHEMBL3913778,Homo sapiens,CHEMBL203,CHEMBL3886183
C=CC(=O)N1CC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)C1,8.35,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,4.5,nM,=,CHEMBL3882126,B,CHEMBL3914159,Homo sapiens,CHEMBL203,CHEMBL3881529
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(OCCCCCCC(=O)NO)cc3)cc12)c1ccc(F)cc1,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3914322,Homo sapiens,CHEMBL203,CHEMBL3881527
CCCN1CCCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1,7.30,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,IC50,50.0,nM,=,CHEMBL3883067,B,CHEMBL3914599,Homo sapiens,CHEMBL203,CHEMBL3882729
COc1cc2ncnc(NCc3ccc(F)c(F)c3)c2cc1OCCCCCCC(=O)NO,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3914607,Homo sapiens,CHEMBL203,CHEMBL3881527
COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nccc(-c2c(-c3ccc(OC)c(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3915202,Homo sapiens,CHEMBL203,CHEMBL3882727
O=C(CBr)OCCn1c(=O)oc2cc3ncnc(Nc4ccc(OCc5ccc(Cl)cc5)cc4)c3cc21,5.19,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,6400.0,nM,=,CHEMBL3854309,B,CHEMBL3915306,Homo sapiens,CHEMBL203,CHEMBL3853296
N#Cc1ccc(Nc2nncc3ccccc23)cc1,8.39,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,4.1,nM,=,CHEMBL3870506,B,CHEMBL3915508,Homo sapiens,CHEMBL203,CHEMBL3870309
Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C[C@@H]1CCCN1C(=O)/C=C/CN1CCOCC1,5.21,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,6238.0,nM,=,CHEMBL3887533,B,CHEMBL3915538,Homo sapiens,CHEMBL203,CHEMBL3886356
C=CC(=O)N1CC(Oc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2OC)C1,8.89,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,1.3,nM,=,CHEMBL3882126,B,CHEMBL3916927,Homo sapiens,CHEMBL203,CHEMBL3881529
O=C(CCCCCN1CCN(Cc2ccc(-c3cc4c(NCc5ccccc5)ncnc4[nH]3)cc2)CC1)NO,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3917105,Homo sapiens,CHEMBL203,CHEMBL3881527
CC(C)(C)c1ccc(Nc2ncnc3cc4oc(=O)n(CCOC(=O)CBr)c4cc23)cc1,6.06,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,870.0,nM,=,CHEMBL3854309,B,CHEMBL3917657,Homo sapiens,CHEMBL203,CHEMBL3853296
CN(C)C/C=C/C(=O)N1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1,6.57,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,268.7,nM,=,CHEMBL3887533,B,CHEMBL3917698,Homo sapiens,CHEMBL203,CHEMBL3886356
COC(=O)CNC(=O)c1ccc(Nc2ncnc3cc(OCCN4CCCCC4)c(OC)cc23)cc1,5.00,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,9941.0,nM,=,CHEMBL3877875,B,CHEMBL3917723,Homo sapiens,CHEMBL203,CHEMBL3877259
COc1cc2ncnc(NCCc3ccccc3)c2cc1OCCCCCCC(=O)NO,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3917951,Homo sapiens,CHEMBL203,CHEMBL3881527
Cc1cccc2c1nc(NC(=O)c1cccc(C(F)(F)F)c1)n2[C@H]1CC[C@H](O)CC1,5.86,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,IC50,1370.0,nM,=,CHEMBL3860363,B,CHEMBL3918367,Homo sapiens,CHEMBL203,CHEMBL3860038
C=CC(=O)Nc1cccc(Nc2nc(Nc3cccc(OC)c3OC)ncc2Cl)c1,7.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,55.0,nM,=,CHEMBL3887858,B,CHEMBL3919271,Homo sapiens,CHEMBL203,CHEMBL3886183
C=CC(=O)N1CC[C@H](Oc2cc3c(N[C@H](C)c4ccccc4)ncnc3cc2OC)C1,7.92,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,12.0,nM,=,CHEMBL3882125,B,CHEMBL3919447,Homo sapiens,CHEMBL203,CHEMBL3881529
C[C@@H](Nc1ncnc2oc(-c3ccc(O)cc3)cc12)c1ccccc1,8.82,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,1.5,nM,=,CHEMBL3857034,B,CHEMBL3919609,Homo sapiens,CHEMBL203,CHEMBL3856204
COc1cc2c(Nc3ccc(NC(=O)Nc4ccc(C)c(C)c4)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,7.29,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,51.0,nM,=,CHEMBL3877875,B,CHEMBL3920551,Homo sapiens,CHEMBL203,CHEMBL3877259
O=C(CCCCCn1cc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)nn1)NO,9.19,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,IC50,0.65,nM,=,CHEMBL3870704,B,CHEMBL3920583,Homo sapiens,CHEMBL203,CHEMBL3870325
C=CC(=O)N(C)CCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,7.55,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,28.22,nM,=,CHEMBL3887533,B,CHEMBL3921017,Homo sapiens,CHEMBL203,CHEMBL3886356
CN1CCN(c2ccc(Nc3ncnc4cc5oc(=O)n(CCOC(=O)CCl)c5cc34)cc2Cl)CC1,7.70,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,20.0,nM,=,CHEMBL3854309,B,CHEMBL3921302,Homo sapiens,CHEMBL203,CHEMBL3853296
CC#CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1,6.81,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,156.3,nM,=,CHEMBL3887533,B,CHEMBL3921655,Homo sapiens,CHEMBL203,CHEMBL3886356
CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2ccc(F)cc2)ncc1Cl,6.24,Inhibition of EGFR (unknown origin) using peptide as substrate after 60 mins by HTRF assay,IC50,570.0,nM,=,CHEMBL3870418,B,CHEMBL3921664,Homo sapiens,CHEMBL203,CHEMBL3870304
CCCCN1C(=O)CS/C1=N/Nc1nncc2ccccc12,7.64,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,23.0,nM,=,CHEMBL3870506,B,CHEMBL3921710,Homo sapiens,CHEMBL203,CHEMBL3870309
COc1cc(Nc2ncnc3ccc(-c4cn(CCCCCC(=O)NO)nn4)cc23)ccc1Oc1ccccc1,8.24,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,IC50,5.8,nM,=,CHEMBL3870704,B,CHEMBL3921816,Homo sapiens,CHEMBL203,CHEMBL3870325
Nc1cc(Br)ccc1NC(=O)COc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3922068,Homo sapiens,CHEMBL203,CHEMBL3881527
C=CC(=O)N1CC[C@H](Oc2cc3c(Nc4ccc(OCc5ccccn5)c(Cl)c4)ncnc3cc2OC)C1,8.30,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,5.0,nM,=,CHEMBL3882125,B,CHEMBL3922182,Homo sapiens,CHEMBL203,CHEMBL3881529
Cc1ccc(OCCN(C)C)cc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3923275,Homo sapiens,CHEMBL203,CHEMBL3882727
COc1cc2c(Nc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,6.71,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,194.0,nM,=,CHEMBL3877875,B,CHEMBL3923551,Homo sapiens,CHEMBL203,CHEMBL3877259
S=C(NNc1nncc2ccccc12)Nc1ccccc1,7.19,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,65.0,nM,=,CHEMBL3870506,B,CHEMBL3924500,Homo sapiens,CHEMBL203,CHEMBL3870309
C[C@@H](Nc1ncnc2ccc(OCCCCCC(=O)NO)cc12)c1ccccc1,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3924787,Homo sapiens,CHEMBL203,CHEMBL3881527
COc1ccc(-c2cc3c(N[C@H](C)c4ccccc4F)ncnc3o2)cc1,7.62,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,24.0,nM,=,CHEMBL3857034,B,CHEMBL3925584,Homo sapiens,CHEMBL203,CHEMBL3856204
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCn4cnnn4)cc3)ncc2[N+](=O)[O-])c1,7.00,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,IC50,100.6,nM,=,CHEMBL3861200,B,CHEMBL3925959,Homo sapiens,CHEMBL203,CHEMBL3860065
NS(=O)(=O)c1ccc(Nc2nncc3ccccc23)cc1,6.85,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,140.0,nM,=,CHEMBL3870506,B,CHEMBL3926223,Homo sapiens,CHEMBL203,CHEMBL3870309
C=CC(=O)N1CC(Oc2cc3c(N[C@H](C)c4ccccc4)ncnc3cc2OC)C1,8.22,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,6.0,nM,=,CHEMBL3882125,B,CHEMBL3926558,Homo sapiens,CHEMBL203,CHEMBL3881529
Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCCN(C(=O)/C=C/c2c[nH]cn2)C1,6.31,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,487.6,nM,=,CHEMBL3887533,B,CHEMBL3926657,Homo sapiens,CHEMBL203,CHEMBL3886356
COc1ccc(NC(=S)NNc2nncc3ccccc23)cc1,7.28,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,53.0,nM,=,CHEMBL3870506,B,CHEMBL3927914,Homo sapiens,CHEMBL203,CHEMBL3870309
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccccc3OC)ncc2F)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,20.0,nM,=,CHEMBL3887858,B,CHEMBL3928176,Homo sapiens,CHEMBL203,CHEMBL3886183
C[C@@H](Nc1ncnc2oc(-c3ccccc3O)cc12)c1ccccc1,8.70,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,2.0,nM,=,CHEMBL3857034,B,CHEMBL3928512,Homo sapiens,CHEMBL203,CHEMBL3856204
COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc2ccc(Cl)cc12,7.30,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,IC50,50.0,nM,=,CHEMBL3883067,B,CHEMBL3929002,Homo sapiens,CHEMBL203,CHEMBL3882729
C=CC(=O)N1CC[C@H](Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)C[C@H]1C(N)=O,9.15,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,0.7,nM,=,CHEMBL3882126,B,CHEMBL3929060,Homo sapiens,CHEMBL203,CHEMBL3881529
COc1cc2c(Nc3ccc(NC(=O)Nc4ccc(F)c(Cl)c4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1,7.11,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,78.0,nM,=,CHEMBL3877875,B,CHEMBL3929448,Homo sapiens,CHEMBL203,CHEMBL3877259
O=C(CCCCCn1cc(-c2ccc3ncnc(Nc4cccc(Cl)c4F)c3c2)nn1)NO,9.57,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,IC50,0.27,nM,=,CHEMBL3870704,B,CHEMBL3929484,Homo sapiens,CHEMBL203,CHEMBL3870325
C=Cc1ccc(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3o2)cc1,7.54,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,29.0,nM,=,CHEMBL3857034,B,CHEMBL3929584,Homo sapiens,CHEMBL203,CHEMBL3856204
CC#CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,6.36,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,435.3,nM,=,CHEMBL3888240,B,CHEMBL3929922,Homo sapiens,CHEMBL203,CHEMBL3886627
O=C(CCl)OCCn1c(=O)oc2cc3ncnc(Nc4ccc(Oc5cccc(C(F)(F)F)c5)c(Cl)c4)c3cc21,6.29,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,510.0,nM,=,CHEMBL3854309,B,CHEMBL3930270,Homo sapiens,CHEMBL203,CHEMBL3853296
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Cn4ccnc4)cc3)ncc2F)c1,8.05,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,IC50,9.0,nM,=,CHEMBL3861200,B,CHEMBL3930539,Homo sapiens,CHEMBL203,CHEMBL3860065
O=C(CCCCCCn1cc(-c2ccc3ncnc(Nc4cccc(Cl)c4F)c3c2)nn1)NO,9.92,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,IC50,0.12,nM,=,CHEMBL3870704,B,CHEMBL3930620,Homo sapiens,CHEMBL203,CHEMBL3870325
Cc1ccc(Oc2ccc(Nc3ncnc4ccc(-c5cn(CCCCCC(=O)NO)nn5)cc34)cc2C)cn1,8.19,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,IC50,6.4,nM,=,CHEMBL3870704,B,CHEMBL3930762,Homo sapiens,CHEMBL203,CHEMBL3870325
C=CC(=O)Nc1cccc(Oc2nc(Nc3cccc(OC)c3OC)ncc2C(F)(F)F)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,20.0,nM,=,CHEMBL3887858,B,CHEMBL3930810,Homo sapiens,CHEMBL203,CHEMBL3886183
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(-n4ccnc4)cc3)ncc2[N+](=O)[O-])c1,7.01,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,IC50,98.2,nM,=,CHEMBL3861200,B,CHEMBL3931038,Homo sapiens,CHEMBL203,CHEMBL3860065
COc1cc2c(Oc3ccc(NC(=O)c4cn(-c5ccccc5OC)cn4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,6.16,Inhibition of EGFR (unknown origin),IC50,690.0,nM,=,CHEMBL3874958,B,CHEMBL3931223,Homo sapiens,CHEMBL203,CHEMBL3872279
CN(C/C=C/C(=O)N1CCCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1)CCO,7.13,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,74.5,nM,=,CHEMBL3887533,B,CHEMBL3931858,Homo sapiens,CHEMBL203,CHEMBL3886356
C=CC(=O)N1CCC(Oc2cc3c(Nc4cccc(Cl)c4)ncnc3cc2OC)CC1,8.38,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,4.2,nM,=,CHEMBL3882125,B,CHEMBL3932286,Homo sapiens,CHEMBL203,CHEMBL3881529
C=CC(=O)N1CC[C@H](Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)C[C@H]1C(=O)NCCSC,8.85,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,1.4,nM,=,CHEMBL3882126,B,CHEMBL3932784,Homo sapiens,CHEMBL203,CHEMBL3881529
COc1ccc(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3o2)cc1,8.28,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,5.3,nM,=,CHEMBL3857034,B,CHEMBL3933539,Homo sapiens,CHEMBL203,CHEMBL3856204
COc1cc2c(Nc3ccc(NC(=O)Nc4ccccc4C)cc3)ncnc2cc1OCCCN1CCN(C)CC1,6.30,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,502.0,nM,=,CHEMBL3877875,B,CHEMBL3933568,Homo sapiens,CHEMBL203,CHEMBL3877259
COc1ccc(-c2cc3c(NC(CC(N)=O)c4ccccc4)ncnc3o2)cc1,7.66,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,22.0,nM,=,CHEMBL3857034,B,CHEMBL3934461,Homo sapiens,CHEMBL203,CHEMBL3856204
CCOc1cc(N2CCC(N3CCN(S(C)(=O)=O)CC3)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3934556,Homo sapiens,CHEMBL203,CHEMBL3882727
CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2cccc(C(F)(F)F)c2)ncc1Cl,6.34,Inhibition of EGFR (unknown origin) using peptide as substrate after 60 mins by HTRF assay,IC50,460.0,nM,=,CHEMBL3870418,B,CHEMBL3934594,Homo sapiens,CHEMBL203,CHEMBL3870304
C=CC(=O)N1CCC(Oc2cc3c(Nc4cccc(Br)c4)ncnc3cc2OC)CC1,8.15,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,7.1,nM,=,CHEMBL3882126,B,CHEMBL3935007,Homo sapiens,CHEMBL203,CHEMBL3881529
C=CC(=O)N1CC[C@H](Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)C[C@H]1C(=O)NCCS(C)(=O)=O,8.52,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,3.0,nM,=,CHEMBL3882126,B,CHEMBL3935492,Homo sapiens,CHEMBL203,CHEMBL3881529
O=C(CBr)OCCn1c(=O)oc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21,7.11,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,77.0,nM,=,CHEMBL3854309,B,CHEMBL3936642,Homo sapiens,CHEMBL203,CHEMBL3853296
C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1,8.62,Inhibition of EGFR (unknown origin),IC50,2.4,nM,=,CHEMBL5135834,B,CHEMBL3936761,Homo sapiens,CHEMBL203,CHEMBL5131516
CCCN1CCC(c2cc(OC)c(Nc3nccc(-c4c(-c5ccc(OC)c(C(=O)Nc6c(F)cccc6F)c5)nc5ccccn45)n3)cc2C)CC1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3937303,Homo sapiens,CHEMBL203,CHEMBL3882727
Cc1cccc2nc(NC(=O)c3cccc(C(F)(F)F)c3)n([C@H]3CC[C@H](O)CC3)c12,7.05,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,IC50,90.0,nM,=,CHEMBL3860363,B,CHEMBL3937373,Homo sapiens,CHEMBL203,CHEMBL3860038
CCOc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nccc(-c2c(-c3ccc(OC)c(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3937417,Homo sapiens,CHEMBL203,CHEMBL3882727
C[C@@H](Nc1ncnc2oc(-c3ccc(Br)cc3)cc12)c1ccccc1,7.25,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,56.0,nM,=,CHEMBL3857034,B,CHEMBL3937527,Homo sapiens,CHEMBL203,CHEMBL3856204
O=C(O)c1ccc(Nc2nncc3ccccc23)cc1,8.21,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,6.2,nM,=,CHEMBL3870506,B,CHEMBL3937949,Homo sapiens,CHEMBL203,CHEMBL3870309
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OC)cc3OC)ncc2Cl)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,5.5,nM,=,CHEMBL3887858,B,CHEMBL3938358,Homo sapiens,CHEMBL203,CHEMBL3886183
COc1cc2c(Nc3ccc(NC(=O)Nc4ccccc4C)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1,7.82,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,15.0,nM,=,CHEMBL3877875,B,CHEMBL3938494,Homo sapiens,CHEMBL203,CHEMBL3877259
O=C1CS/C(=N/Nc2nncc3ccccc23)N1,7.29,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,51.0,nM,=,CHEMBL3870506,B,CHEMBL3938794,Homo sapiens,CHEMBL203,CHEMBL3870309
COc1ccc(-c2cc3c(NCc4ccccc4)ncnc3o2)cc1,7.13,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,74.0,nM,=,CHEMBL3857034,B,CHEMBL3939429,Homo sapiens,CHEMBL203,CHEMBL3856204
COc1cc2c(Nc3ccc(NC(=O)Nc4ccc(C)c(C)c4)c(Cl)c3)ncnc2cc1OCCN1CCCCC1,6.09,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,817.0,nM,=,CHEMBL3877875,B,CHEMBL3939588,Homo sapiens,CHEMBL203,CHEMBL3877259
O=C(CCCCCn1cc(-c2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)nn1)NO,8.16,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,IC50,6.9,nM,=,CHEMBL3870704,B,CHEMBL3939771,Homo sapiens,CHEMBL203,CHEMBL3870325
Cc1cccc2nc(NC(=O)c3ccnc(C(F)(F)F)c3)n([C@@H]3CCCCN(C(=O)/C=C/CN(C)C)C3)c12,8.82,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,IC50,1.51,nM,=,CHEMBL3860368,B,CHEMBL3939913,Homo sapiens,CHEMBL203,CHEMBL3860038
O=C(CCl)OCCn1c(=O)oc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,6.48,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,330.0,nM,=,CHEMBL3854309,B,CHEMBL3940060,Homo sapiens,CHEMBL203,CHEMBL3853296
C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OCCC)CC1,9.15,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,0.7,nM,=,CHEMBL3882125,B,CHEMBL3940089,Homo sapiens,CHEMBL203,CHEMBL3881529
COc1ccn2c(-c3ccnc(Nc4ccc(N5CCC(N6CCCCC6)CC5)cc4OC)n3)c(-c3ccc(OC)c(C(=O)Nc4c(F)cccc4F)c3)nc2c1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3940401,Homo sapiens,CHEMBL203,CHEMBL3882727
C=CC(=O)N1CC[C@H](Oc2ccc3ncnc(Nc4ccc(F)c(Cl)c4F)c3c2)C1,8.05,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,9.0,nM,=,CHEMBL3882125,B,CHEMBL3940909,Homo sapiens,CHEMBL203,CHEMBL3881529
CCOc1cc2[nH]cc(C#N)c(=Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/[C@H]1C[C@H](O)CN1C,7.23,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 μM Na3VO4, 1.25 M DTT (1000×) and 20 μM ATP at 25° C., for 45 minutes.",IC50,59.0,nM,=,CHEMBL3705672,B,CHEMBL3941626,Homo sapiens,CHEMBL203,CHEMBL3639095
COC[C@@H](Nc1ncnc2oc(-c3ccc(OC)cc3)cc12)c1ccccc1,7.85,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,14.0,nM,=,CHEMBL3857034,B,CHEMBL3943438,Homo sapiens,CHEMBL203,CHEMBL3856204
CCOc1cc(N2CCC(CCS(C)(=O)=O)CC2)c(C)cc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3943489,Homo sapiens,CHEMBL203,CHEMBL3882727
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OC)c(OC)c3OC)ncc2Cl)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,5.5,nM,=,CHEMBL3887858,B,CHEMBL3944027,Homo sapiens,CHEMBL203,CHEMBL3886183
COc1cc(Nc2ncnc3cc(OCC4CN(C)CCO4)c(OC)cc23)c(OC)cc1Cl,7.30,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,IC50,50.0,nM,=,CHEMBL3883067,B,CHEMBL3944702,Homo sapiens,CHEMBL203,CHEMBL3882729
O=C(CBr)OCCn1c(=O)oc2cc3ncnc(Nc4ccc(Oc5cccc(C(F)(F)F)c5)c(Cl)c4)c3cc21,6.80,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,160.0,nM,=,CHEMBL3854309,B,CHEMBL3945555,Homo sapiens,CHEMBL203,CHEMBL3853296
C=CC(=O)N1CC[C@@H](Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)C[C@@H]1C(=O)NC,9.05,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,0.9,nM,=,CHEMBL3882126,B,CHEMBL3946096,Homo sapiens,CHEMBL203,CHEMBL3881529
Cc1ccc2c(c1)nc(NC(=O)c1cccc(C(F)(F)F)c1)n2[C@H]1CC[C@H](O)CC1,6.85,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,IC50,140.0,nM,=,CHEMBL3860363,B,CHEMBL3946259,Homo sapiens,CHEMBL203,CHEMBL3860038
COc1cccc(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3o2)c1,8.15,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,7.0,nM,=,CHEMBL3857034,B,CHEMBL3946396,Homo sapiens,CHEMBL203,CHEMBL3856204
COc1ccccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2o1,8.40,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,4.0,nM,=,CHEMBL3857034,B,CHEMBL3947406,Homo sapiens,CHEMBL203,CHEMBL3856204
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCn4ccnc4)cc3)ncc2Cl)c1,6.97,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,IC50,106.0,nM,=,CHEMBL3861200,B,CHEMBL3947759,Homo sapiens,CHEMBL203,CHEMBL3860065
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OC)cc3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,5.5,nM,=,CHEMBL3887858,B,CHEMBL3947802,Homo sapiens,CHEMBL203,CHEMBL3886183
COc1cc2c(Nc3ccc(NC(=O)Nc4ccccc4)c(Cl)c3)ncnc2cc1OCCN1CCCCC1,6.67,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,212.0,nM,=,CHEMBL3877875,B,CHEMBL3948354,Homo sapiens,CHEMBL203,CHEMBL3877259
CC(C)c1ccccc1Nc1nc(N)nc2c1Cc1ccccc1-2,4.64,Inhibition Assay: Inhibition of various kinase enzyme.,IC50,23000.0,nM,=,CHEMBL3888922,B,CHEMBL3948546,Homo sapiens,CHEMBL203,CHEMBL3886207
COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1ccc2nc(C(F)(F)F)cc(Cl)c2c1,7.30,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,IC50,50.0,nM,=,CHEMBL3883067,B,CHEMBL3948661,Homo sapiens,CHEMBL203,CHEMBL3882729
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(NC(=O)CCNCC(=O)NO)cc3)cc12)c1ccccc1,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3950023,Homo sapiens,CHEMBL203,CHEMBL3881527
COc1cc(N2CCC(N3CCN(CCF)CC3)CC2)ccc1Nc1nccc(-c2c(-c3ccc(OC)c(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3950296,Homo sapiens,CHEMBL203,CHEMBL3882727
Cc1cc(C)nc(NS(=O)(=O)c2ccc(Nc3nncc4ccccc34)cc2)n1,8.17,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,6.7,nM,=,CHEMBL3870506,B,CHEMBL3950630,Homo sapiens,CHEMBL203,CHEMBL3870309
COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(-c2ccc(C(C)(C)C)cc2)no1,7.30,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,IC50,50.0,nM,=,CHEMBL3883067,B,CHEMBL3951099,Homo sapiens,CHEMBL203,CHEMBL3882729
Cc1cccc2nc(NC(=O)c3cccc(C(F)(F)F)c3)n([C@@H]3CCCCN(C(=O)/C=C/CN(C)C)C3)c12,8.66,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,IC50,2.18,nM,=,CHEMBL3860368,B,CHEMBL3951434,Homo sapiens,CHEMBL203,CHEMBL3860038
COc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3o2)cc1,8.57,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,2.7,nM,=,CHEMBL3857034,B,CHEMBL3952157,Homo sapiens,CHEMBL203,CHEMBL3856204
COC[C@@H](Nc1ncnc2oc(-c3ccccc3)cc12)c1ccccc1,7.55,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,28.0,nM,=,CHEMBL3857034,B,CHEMBL3952877,Homo sapiens,CHEMBL203,CHEMBL3856204
COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/[C@@H]1CCCN1C,8.70,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 μM Na3VO4, 1.25 M DTT (1000×) and 20 μM ATP at 25° C., for 45 minutes.",IC50,2.0,nM,=,CHEMBL3705672,B,CHEMBL3952953,Homo sapiens,CHEMBL203,CHEMBL3639095
COc1ccc(-c2cc3c(N[C@H](C)c4cccc(F)c4)ncnc3o2)cc1,7.62,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,24.0,nM,=,CHEMBL3857034,B,CHEMBL3953210,Homo sapiens,CHEMBL203,CHEMBL3856204
C=CC(=O)N[C@H]1CCC[C@@H](n2c(NC(=O)c3cccc(C(F)(F)F)c3)nc3cc(C)ccc32)C1,8.40,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,IC50,4.0,nM,=,CHEMBL3860367,B,CHEMBL3953221,Homo sapiens,CHEMBL203,CHEMBL3860038
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCCn4ccnc4)cc3)ncc2[N+](=O)[O-])c1,7.39,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,IC50,40.6,nM,=,CHEMBL3861200,B,CHEMBL3953593,Homo sapiens,CHEMBL203,CHEMBL3860065
C=CC(=O)N1CCCC(n2c(NC(=O)c3cccc(C(F)(F)F)c3)nc3cc(C)ccc32)C1,7.70,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,IC50,20.0,nM,=,CHEMBL3860367,B,CHEMBL3953921,Homo sapiens,CHEMBL203,CHEMBL3860038
O=C(Nc1nc2ccccc2n1[C@H]1CC[C@H](O)CC1)c1cccc(C(F)(F)F)c1,6.58,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,IC50,260.0,nM,=,CHEMBL3860363,B,CHEMBL3954370,Homo sapiens,CHEMBL203,CHEMBL3860038
COc1ccc(N2CCC(N3CCCCC3)CC2)cc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3954571,Homo sapiens,CHEMBL203,CHEMBL3882727
C=CC(=O)N1CC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)C1,8.40,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,4.0,nM,=,CHEMBL3882126,B,CHEMBL3954587,Homo sapiens,CHEMBL203,CHEMBL3881529
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OC)cc3OC)ncc2C(F)(F)F)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,20.0,nM,=,CHEMBL3887857,B,CHEMBL3954684,Homo sapiens,CHEMBL203,CHEMBL3886183
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccccc3OC)ncc2Br)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,5.5,nM,=,CHEMBL3887858,B,CHEMBL3954906,Homo sapiens,CHEMBL203,CHEMBL3886183
COc1cc(N2CCC(N3CCCCC3)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4ccc(F)cc4F)c3)nc3ccccn23)n1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3955829,Homo sapiens,CHEMBL203,CHEMBL3882727
C[C@@H](Nc1ncnc2oc(-c3cccc(O)c3)cc12)c1ccccc1,8.34,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,4.6,nM,=,CHEMBL3857034,B,CHEMBL3956112,Homo sapiens,CHEMBL203,CHEMBL3856204
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCn4ccnc4)cc3)ncc2F)c1,8.04,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,IC50,9.1,nM,=,CHEMBL3861200,B,CHEMBL3956430,Homo sapiens,CHEMBL203,CHEMBL3860065
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OC)c(OC)c3OC)ncc2C(F)(F)F)c1,7.70,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,20.0,nM,=,CHEMBL3887857,B,CHEMBL3956465,Homo sapiens,CHEMBL203,CHEMBL3886183
COc1cc2c(Nc3ccc(NC(=O)Nc4ccc(Cl)cc4)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,7.77,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,17.0,nM,=,CHEMBL3877875,B,CHEMBL3957025,Homo sapiens,CHEMBL203,CHEMBL3877259
O=C(CCCCCCn1cc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)nn1)NO,9.16,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,IC50,0.69,nM,=,CHEMBL3870704,B,CHEMBL3957055,Homo sapiens,CHEMBL203,CHEMBL3870325
C=CC(=O)N1CC[C@@H](Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)C[C@@H]1C(N)=O,9.15,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,0.7,nM,=,CHEMBL3882126,B,CHEMBL3958624,Homo sapiens,CHEMBL203,CHEMBL3881529
C=CC(=O)Nc1cccc(-n2c(NC(=O)c3cccc(C(F)(F)F)c3)nc3cc(C)ccc32)c1,8.40,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,IC50,4.0,nM,=,CHEMBL3860367,B,CHEMBL3959632,Homo sapiens,CHEMBL203,CHEMBL3860038
Cc1cc(C(=O)Nc2nc3cccc(C)c3n2[C@@H]2CCCCN(C(=O)/C=C/CN(C)C)C2)ccn1,8.68,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,IC50,2.11,nM,=,CHEMBL3860368,B,CHEMBL3960167,Homo sapiens,CHEMBL203,CHEMBL3860038
C#Cc1cccc(Nc2ncnc3cc(O[C@H]4CCOC4)c(NC(=O)/C=C/CN(CC)CC)cc23)c1,8.17,"Enzyme Assay: BT474 Cell Line: 1. 5×103 cells per well in 100 μl of medium were seeded in 96-well plate, here the medium contained 5% FBS2. 24 hours later, 100 μl fresh medium was added with various concentrations of compounds into each well, while the medium here was free of FBS.3. After the cells were treated with compounds for 72 hours, 20 μl MTT (5 mg/ml) was added into each well, and then the assay plate was incubated at 37° C. for 4 more hours.4. The assay plate was centrifuged at 800 g for 10 min. The medium was aspirated, 150 μl DMSO was added into each well. The plate was gently shaken for 10 min.5. The absorbance at 570 nm was measured on the plate reader.6. IR %=(WC−WT)/WC×100%.",IC50,6.8,nM,=,CHEMBL3888588,B,CHEMBL3960332,Homo sapiens,CHEMBL203,CHEMBL3886202
O=C(CBr)OCCn1c(=O)oc2cc3ncnc(Nc4ccc(NC(=O)N5CCCCC5)cc4)c3cc21,5.03,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,9300.0,nM,=,CHEMBL3854309,B,CHEMBL3960786,Homo sapiens,CHEMBL203,CHEMBL3853296
C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCOCC4)cc3)cc12)c1ccccc1,8.96,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,1.1,nM,=,CHEMBL3857034,B,CHEMBL3960853,Homo sapiens,CHEMBL203,CHEMBL3856204
C=CC(=O)N(C)c1cccc(-n2c(NC(=O)c3cccc(C(F)(F)F)c3)nc3cc(C)ccc32)c1,8.00,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,IC50,10.0,nM,=,CHEMBL3860367,B,CHEMBL3961202,Homo sapiens,CHEMBL203,CHEMBL3860038
OC[C@@H](Nc1ncnc2oc(-c3ccc(O)cc3)cc12)c1ccccc1,8.70,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,2.0,nM,=,CHEMBL3857034,B,CHEMBL3961553,Homo sapiens,CHEMBL203,CHEMBL3856204
C=CC(=O)N1CCC(Oc2cc3c(Nc4cccc(C=C)c4)ncnc3cc2OC)CC1,8.52,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,3.0,nM,=,CHEMBL3882126,B,CHEMBL3961848,Homo sapiens,CHEMBL203,CHEMBL3881529
COc1ccc(-c2cc3c(N[C@H](CCO)c4ccccc4)ncnc3o2)cc1,8.40,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,4.0,nM,=,CHEMBL3857034,B,CHEMBL3961961,Homo sapiens,CHEMBL203,CHEMBL3856204
COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1cc(Br)cc(Br)c1,7.30,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,IC50,50.0,nM,=,CHEMBL3883067,B,CHEMBL3961982,Homo sapiens,CHEMBL203,CHEMBL3882729
COc1cc2c(Nc3ccc(NC(=O)Nc4ccc(Cl)cc4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1,9.00,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,1.0,nM,=,CHEMBL3877875,B,CHEMBL3962233,Homo sapiens,CHEMBL203,CHEMBL3877259
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC(C)C)cc3OC)ncc2Cl)c1,8.30,"Omnia Assay: Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1× kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10× stock, KB002A) and 0.2 mM DTT (DS001A). 5 μL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25°ree; C. with a 0.5 μL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 μL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.).",IC50,5.0,nM,=,CHEMBL3888772,B,CHEMBL3962343,Homo sapiens,CHEMBL203,CHEMBL3886832
Fc1ccc(/C=C/C(=N/Nc2nncc3ccccc23)c2ccccc2)cc1,8.16,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,6.9,nM,=,CHEMBL3870506,B,CHEMBL3963403,Homo sapiens,CHEMBL203,CHEMBL3870309
COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(-c2ccc(Cl)cc2)n1,7.30,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,IC50,50.0,nM,=,CHEMBL3883067,B,CHEMBL3963620,Homo sapiens,CHEMBL203,CHEMBL3882729
O=C(CCCCCn1cc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)nn1)NO,8.72,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,IC50,1.9,nM,=,CHEMBL3870704,B,CHEMBL3964033,Homo sapiens,CHEMBL203,CHEMBL3870325
CCOCc1ccc2c(c1)nc(NC(=O)c1cccc(C(F)(F)F)c1)n2[C@H]1CC[C@H](O)CC1,6.33,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,IC50,470.0,nM,=,CHEMBL3860363,B,CHEMBL3965075,Homo sapiens,CHEMBL203,CHEMBL3860038
C=CC(=O)N1CC[C@H](Oc2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)C1,8.10,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,8.0,nM,=,CHEMBL3882125,B,CHEMBL3965087,Homo sapiens,CHEMBL203,CHEMBL3881529
C=CC(=O)N1CC[C@H](Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)C1,8.89,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,1.3,nM,=,CHEMBL3882126,B,CHEMBL3965391,Homo sapiens,CHEMBL203,CHEMBL3881529
O=C(CBr)OCCn1c(=O)oc2cc3ncnc(Nc4ccc(N5CCOCC5)c(Cl)c4)c3cc21,8.00,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,10.0,nM,=,CHEMBL3854309,B,CHEMBL3965948,Homo sapiens,CHEMBL203,CHEMBL3853296
C=CC(=O)NCCCn1c(NC(=O)c2cccc(C(F)(F)F)c2)nc2cc(C)ccc21,7.30,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,IC50,50.0,nM,=,CHEMBL3860367,B,CHEMBL3966111,Homo sapiens,CHEMBL203,CHEMBL3860038
Clc1ccc(C(/C=C/c2ccccc2)=N\Nc2nncc3ccccc23)cc1,8.20,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,6.3,nM,=,CHEMBL3870506,B,CHEMBL3966129,Homo sapiens,CHEMBL203,CHEMBL3870309
C[C@@H](Nc1ncnc2oc(-c3ccc(F)cc3)cc12)c1ccccc1,7.89,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,13.0,nM,=,CHEMBL3857034,B,CHEMBL3967219,Homo sapiens,CHEMBL203,CHEMBL3856204
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Cn4ccnc4)cc3)ncc2Cl)c1,8.48,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,IC50,3.3,nM,=,CHEMBL3861200,B,CHEMBL3967512,Homo sapiens,CHEMBL203,CHEMBL3860065
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(NC4CN(C(=O)OC(C)(C)C)C4)cc3OC)ncc2C(F)(F)F)c1,8.30,"Omnia Assay: Briefly, 10× stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13×ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1× kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10× stock, KB002A) and 0.2 mM DTT (DS001A). 5 μL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25°ree; C. with a 0.5 μL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 μL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.).",IC50,5.0,nM,=,CHEMBL3888772,B,CHEMBL3967836,Homo sapiens,CHEMBL203,CHEMBL3886832
COc1cc2c(Nc3ccc(NC(=O)Nc4ccc(C)c(C)c4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1,9.00,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,1.0,nM,=,CHEMBL3877875,B,CHEMBL3968039,Homo sapiens,CHEMBL203,CHEMBL3877259
Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@H]1CCCN(C(=O)/C=C/CN2CCOCC2)C1,6.42,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,383.7,nM,=,CHEMBL3888240,B,CHEMBL3968716,Homo sapiens,CHEMBL203,CHEMBL3886627
C=CC(=O)N1CC[C@H](Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)C1,8.89,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,1.3,nM,=,CHEMBL3882126,B,CHEMBL3968784,Homo sapiens,CHEMBL203,CHEMBL3881529
COc1cc(N2CCC(CCS(C)(=O)=O)CC2)c(C)cc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3969511,Homo sapiens,CHEMBL203,CHEMBL3882727
O=C(CBr)OCCn1c(=O)oc2cc3ncnc(Nc4ccc(N5CCCCC5)c(Cl)c4)c3cc21,6.74,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,184.0,nM,=,CHEMBL3854309,B,CHEMBL3969628,Homo sapiens,CHEMBL203,CHEMBL3853296
Nc1nc(Nc2cccc(Cl)c2)c2c(n1)-c1ccccc1C2,4.35,Inhibition Assay: Inhibition of various kinase enzyme.,IC50,45100.0,nM,=,CHEMBL3888922,B,CHEMBL3970063,Homo sapiens,CHEMBL203,CHEMBL3886207
C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)CC1,8.96,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,1.1,nM,=,CHEMBL3882125,B,CHEMBL3970231,Homo sapiens,CHEMBL203,CHEMBL3881529
O=S(=O)(Nc1nccs1)c1ccc(Nc2nncc3ccccc23)cc1,7.06,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,88.0,nM,=,CHEMBL3870506,B,CHEMBL3970399,Homo sapiens,CHEMBL203,CHEMBL3870309
C=CC(=O)N1CCC(Oc2cc3c(Nc4cccc(C)c4)ncnc3cc2OC)CC1,8.03,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,9.3,nM,=,CHEMBL3882126,B,CHEMBL3971939,Homo sapiens,CHEMBL203,CHEMBL3881529
C=CC(=O)N1CC[C@@H](Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)C[C@@H]1C(=O)OC,8.77,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,1.7,nM,=,CHEMBL3882126,B,CHEMBL3972168,Homo sapiens,CHEMBL203,CHEMBL3881529
C=CC(=O)N1CCCC[C@@H](n2c(NC(=O)c3cccc(C(F)(F)F)c3)nc3cccc(C)c32)C1,8.86,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,IC50,1.39,nM,=,CHEMBL3860368,B,CHEMBL3972316,Homo sapiens,CHEMBL203,CHEMBL3860038
CC[C@@H](Nc1ncnc2oc(-c3ccc(OC)cc3)cc12)c1ccccc1,7.66,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,22.0,nM,=,CHEMBL3857034,B,CHEMBL3972981,Homo sapiens,CHEMBL203,CHEMBL3856204
COc1ccc(-c2cc3c(N[C@H](C)c4ccc(F)cc4)ncnc3o2)cc1,7.57,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,27.0,nM,=,CHEMBL3857034,B,CHEMBL3973601,Homo sapiens,CHEMBL203,CHEMBL3856204
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OC)c(OC)c3OC)ncc2Br)c1,7.19,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,65.0,nM,=,CHEMBL3887857,B,CHEMBL3973862,Homo sapiens,CHEMBL203,CHEMBL3886183
C=CC(=O)N[C@@H]1CCC[C@@H](n2c(NC(=O)c3cccc(C(F)(F)F)c3)nc3cc(C)ccc32)C1,7.22,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,IC50,60.0,nM,=,CHEMBL3860367,B,CHEMBL3973973,Homo sapiens,CHEMBL203,CHEMBL3860038
COc1ccc(N2C(=O)CS/C2=N/Nc2nncc3ccccc23)cc1,7.44,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,36.0,nM,=,CHEMBL3870506,B,CHEMBL3974626,Homo sapiens,CHEMBL203,CHEMBL3870309
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccccc3OC)ncc2Cl)c1,6.19,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,650.0,nM,=,CHEMBL3887857,B,CHEMBL3975588,Homo sapiens,CHEMBL203,CHEMBL3886183
COC(=O)CNC(=O)c1ccc(Nc2ncnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)cc1,6.21,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,611.0,nM,=,CHEMBL3877875,B,CHEMBL3975598,Homo sapiens,CHEMBL203,CHEMBL3877259
C[C@@H](Nc1ncnc2oc(-c3ccc(C#N)cc3)cc12)c1ccccc1,7.36,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,44.0,nM,=,CHEMBL3857034,B,CHEMBL3975699,Homo sapiens,CHEMBL203,CHEMBL3856204
O=C(/C=C/c1ccc(OCCOc2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cc1)NO,6.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,1000.0,nM,=,CHEMBL3881964,B,CHEMBL3975710,Homo sapiens,CHEMBL203,CHEMBL3881527
C#Cc1cccc(Nc2ncnc3ccc(OCCCCCCC(=O)NO)cc23)c1,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3975990,Homo sapiens,CHEMBL203,CHEMBL3881527
CCCN1CCN(c2ccc(Nc3nccc(-c4c(-c5ccc(OC)c(C(=O)Nc6c(F)cccc6F)c5)nc5ccccn45)n3)c(OC)c2)CC1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3976571,Homo sapiens,CHEMBL203,CHEMBL3882727
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCn4cncn4)cc3)ncc2Cl)c1,6.99,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,IC50,103.4,nM,=,CHEMBL3861200,B,CHEMBL3977022,Homo sapiens,CHEMBL203,CHEMBL3860065
NC(=S)NNc1nncc2ccccc12,7.11,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,77.0,nM,=,CHEMBL3870506,B,CHEMBL3977192,Homo sapiens,CHEMBL203,CHEMBL3870309
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccccc3OC)ncc2C(F)(F)F)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,5.5,nM,=,CHEMBL3887858,B,CHEMBL3978161,Homo sapiens,CHEMBL203,CHEMBL3886183
O=S(=O)(Nc1ccccn1)c1ccc(Nc2nncc3ccccc23)cc1,7.08,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,84.0,nM,=,CHEMBL3870506,B,CHEMBL3978686,Homo sapiens,CHEMBL203,CHEMBL3870309
C=CC(=O)N1CCC(Oc2cc3c(Nc4cccc(C(F)(F)F)c4)ncnc3cc2OC)CC1,7.79,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,16.2,nM,=,CHEMBL3882126,B,CHEMBL3978740,Homo sapiens,CHEMBL203,CHEMBL3881529
COc1cc2c(Nc3ccc(NC(=O)Nc4ccccc4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1,7.85,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,14.0,nM,=,CHEMBL3877875,B,CHEMBL3979264,Homo sapiens,CHEMBL203,CHEMBL3877259
C=CC(=O)N1CC[C@H](Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)C[C@H]1C(=O)NCCN(C)C,8.18,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,6.6,nM,=,CHEMBL3882126,B,CHEMBL3979366,Homo sapiens,CHEMBL203,CHEMBL3881529
C#Cc1cccc(Nc2ncnc3ccc(OCCCC(=O)NO)cc23)c1,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3979482,Homo sapiens,CHEMBL203,CHEMBL3881527
Fc1ccc(Nc2nncc3ccccc23)cc1,8.22,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,6.0,nM,=,CHEMBL3870506,B,CHEMBL3979610,Homo sapiens,CHEMBL203,CHEMBL3870309
CN(C)C/C=C/C(=O)NC1CCC(n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1,7.65,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,22.53,nM,=,CHEMBL3888240,B,CHEMBL3980550,Homo sapiens,CHEMBL203,CHEMBL3886627
C=CC(=O)N1CC[C@H](Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)C[C@H]1C(=O)NCCOC,8.42,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,3.8,nM,=,CHEMBL3882126,B,CHEMBL3980793,Homo sapiens,CHEMBL203,CHEMBL3881529
c1ccc(CNc2ncnc3oc(-c4ccccc4)cc23)cc1,7.03,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,93.0,nM,=,CHEMBL3857034,B,CHEMBL3981621,Homo sapiens,CHEMBL203,CHEMBL3856204
Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C1CCN(C(=O)/C=C/CN2CCOCC2)CC1,6.52,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,303.6,nM,=,CHEMBL3887533,B,CHEMBL3982014,Homo sapiens,CHEMBL203,CHEMBL3886356
O=C(CCl)OCCn1c(=O)oc2cc3ncnc(Nc4ccc(N5CCOCC5)c(Cl)c4)c3cc21,7.72,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,IC50,19.0,nM,=,CHEMBL3854309,B,CHEMBL3982289,Homo sapiens,CHEMBL203,CHEMBL3853296
COc1cc(/C=C2\CCCCC2=O)cc(OC)c1,4.73,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 μL of the test compounds and 10 μL solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 μL solution containing 20 mM HEPES, 2 mM MnCl2, 100 μM Na3VO4, 1 mM DTT buffer, and 20 μL of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 μL anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%−[(negative control)/(positive control−negative control)].",IC50,18670.0,nM,=,CHEMBL3888815,B,CHEMBL3982407,Homo sapiens,CHEMBL203,CHEMBL3886845
C=CC(=O)N1CCC(n2c(NC(=O)c3cccc(C(F)(F)F)c3)nc3cc(C)ccc32)CC1,4.78,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,IC50,16460.0,nM,=,CHEMBL3860367,B,CHEMBL3982602,Homo sapiens,CHEMBL203,CHEMBL3860038
O=C1CS/C(=N/Nc2nncc3ccccc23)N1c1ccccc1,7.35,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,45.0,nM,=,CHEMBL3870506,B,CHEMBL3982619,Homo sapiens,CHEMBL203,CHEMBL3870309
COc1cc(Nc2ncnc3ccc(-c4cn(CCCCCCC(=O)NO)nn4)cc23)ccc1Oc1ccccc1,7.94,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,IC50,11.6,nM,=,CHEMBL3870704,B,CHEMBL3982710,Homo sapiens,CHEMBL203,CHEMBL3870325
COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(-c2ccc(C(F)(F)F)cc2)n1,7.30,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,IC50,50.0,nM,=,CHEMBL3883067,B,CHEMBL3983201,Homo sapiens,CHEMBL203,CHEMBL3882729
COc1cc2c(Nc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2cc1OCc1ccccc1,5.53,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,IC50,2933.0,nM,=,CHEMBL3877875,B,CHEMBL3983460,Homo sapiens,CHEMBL203,CHEMBL3877259
Cc1ccc(C(/C=C/c2ccc(F)cc2)=N\Nc2nncc3ccccc23)cc1,8.19,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,6.5,nM,=,CHEMBL3870506,B,CHEMBL3983586,Homo sapiens,CHEMBL203,CHEMBL3870309
C[C@@H](Nc1ncnc2ccc(OCCCCCCC(=O)NO)cc12)c1ccccc1,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3984008,Homo sapiens,CHEMBL203,CHEMBL3881527
O=C(CCCCCCOc1ccc(-c2cc3c(NCc4ccccc4)ncnc3[nH]2)cc1)NO,7.00,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,IC50,100.0,nM,=,CHEMBL3881964,B,CHEMBL3985004,Homo sapiens,CHEMBL203,CHEMBL3881527
CN(C)CCOc1cccc(Nc2nccc(-c3c(-c4cccc(C(=O)Nc5cc(C(F)(F)F)ccc5F)c4)nc4ccccn34)n2)c1,6.00,Inhibition of recombinant human full length EGFR expressed in baculovirus expression system assessed as decrease in transfer of gamma-phosphate from ATP onto tyrosine residue of biotinylated peptide substrate preincubated for 1 hr followed by substrate addition measured after 90 mins by HTRF method,IC50,1000.0,nM,=,CHEMBL3882759,B,CHEMBL3985011,Homo sapiens,CHEMBL203,CHEMBL3882727
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(Cn4ccnc4)cc3OC)ncc2Cl)c1,6.96,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,IC50,109.0,nM,=,CHEMBL3861200,B,CHEMBL3985086,Homo sapiens,CHEMBL203,CHEMBL3860065
C=CC(=O)N1CC[C@H](Oc2cc3c(Nc4ccc(F)c(Cl)c4F)ncnc3cc2OC)C[C@H]1C(=O)NCCO,8.74,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",IC50,1.8,nM,=,CHEMBL3882126,B,CHEMBL3985465,Homo sapiens,CHEMBL203,CHEMBL3881529
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OC)c(OC)c3OC)ncc2Cl)c1,8.26,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM β-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25° C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at λex360/λem485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",IC50,5.5,nM,=,CHEMBL3887858,B,CHEMBL3986363,Homo sapiens,CHEMBL203,CHEMBL3886183
Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1,6.35,Inhibition of N-terminal GST fused EGFR (668 to 1091 residues) (unknown origin) using poly (Glu-Tyr) E4Y1 peptide as substrate incubated for 2 hrs by ADP-Glo reagent method,IC50,449.0,nM,=,CHEMBL5143814,B,CHEMBL3989868,Homo sapiens,CHEMBL203,CHEMBL5143507
C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C)c3n2)C[C@H]1F,8.52,Inhibition of EGFR T790M/exon 19 deletion mutant phosphorylation in human PC9-DRH cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,IC50,3.0,nM,=,CHEMBL4178360,B,CHEMBL3989970,Homo sapiens,CHEMBL203,CHEMBL4177539
C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,7.72,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Kd,19.0,nM,=,CHEMBL3991696,B,CHEMBL3991931,Homo sapiens,CHEMBL203,CHEMBL3991601
Oc1ccc(-c2nnc(Cc3nc4ccccc4[nH]3)o2)cc1,4.00,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,100000.0,nM,=,CHEMBL3995335,B,CHEMBL4059610,Homo sapiens,CHEMBL203,CHEMBL3994595
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(/C=C/c4cc(Cl)cc(Cl)c4)cc3)ncc2F)c1,7.85,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",IC50,14.2,nM,=,CHEMBL4025984,B,CHEMBL4059772,Homo sapiens,CHEMBL203,CHEMBL4024721
C=CC(=O)Nc1cc(Nc2n[nH]c3cc(-c4cccc5ccccc45)ccc23)c(OC)cc1N(C)CCN(C)C,8.37,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,IC50,4.3,nM,=,CHEMBL4009508,B,CHEMBL4060039,Homo sapiens,CHEMBL203,CHEMBL4007434
C=CC(=O)Nc1cc(Nc2n[nH]c3cc(-c4ccc(F)cc4)ccc23)c(OC)cc1N(C)CCN(C)C,8.07,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,IC50,8.5,nM,=,CHEMBL4009507,B,CHEMBL4060103,Homo sapiens,CHEMBL203,CHEMBL4007434
CCC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3F)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.75,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,17.6,nM,=,CHEMBL4038017,B,CHEMBL4060198,Homo sapiens,CHEMBL203,CHEMBL4033795
NP(=O)(OCCCCCOc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)N(CCCl)CCCl,8.64,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,2.3,nM,=,CHEMBL3993803,B,CHEMBL4060320,Homo sapiens,CHEMBL203,CHEMBL3992535
Nc1nc(N)c2c(n1)[nH]c1cccc(Sc3ccc4ccccc4c3)c12,4.70,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells preincubated for 60 mins followed by EGF induction measured after 10 mins by ELISA,IC50,20000.0,nM,=,CHEMBL4007193,B,CHEMBL4060383,Homo sapiens,CHEMBL203,CHEMBL4004880
Nc1nc(NCCc2ccccc2)c2c(n1)[nH]c1ccc(O)cc12,6.19,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,640.0,nM,=,CHEMBL4021780,B,CHEMBL4060727,Homo sapiens,CHEMBL203,CHEMBL4020756
O=c1c2ccc(Cl)cc2nc(-c2ccccc2)n1-c1nnc(-c2ccccc2)s1,5.95,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,IC50,1120.0,nM,=,CHEMBL4025907,B,CHEMBL4060821,Homo sapiens,CHEMBL203,CHEMBL4024718
C=CC(=O)N1CCC[C@@H](n2nc(Cc3ccccc3)c3c(N)ncnc32)C1,8.52,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,3.0,nM,=,CHEMBL4041413,B,CHEMBL4060919,Homo sapiens,CHEMBL203,CHEMBL4038351
COc1ccc(N(C)c2nc(C)nc3c(Cc4ccccc4)cn(C)c23)cc1.Cl,8.64,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,IC50,2.3,nM,=,CHEMBL3998244,B,CHEMBL4060996,Homo sapiens,CHEMBL203,CHEMBL3997769
C=CC(=O)Nc1cc(Nc2n[nH]c3cc(-c4ccc5ccccc5c4)ccc23)c(OC)cc1N(C)CCN(C)C,7.60,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,IC50,25.0,nM,=,CHEMBL4009507,B,CHEMBL4061043,Homo sapiens,CHEMBL203,CHEMBL4007434
CC[C@H](C)[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.26,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,IC50,55.5,nM,=,CHEMBL4011794,B,CHEMBL4061283,Homo sapiens,CHEMBL203,CHEMBL4011588
Nc1nc(NCc2ccc(Cl)cc2)c2c(n1)[nH]c1ccc(O)cc12,7.10,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,80.0,nM,=,CHEMBL4021780,B,CHEMBL4061297,Homo sapiens,CHEMBL203,CHEMBL4020756
NP(=O)(OCCCC(=O)Oc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1)N(CCCl)CCCl,7.58,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,26.0,nM,=,CHEMBL3993803,B,CHEMBL4061382,Homo sapiens,CHEMBL203,CHEMBL3992535
C=CC(=O)N1CCC[C@@H]1CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,8.51,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,3.1,nM,=,CHEMBL4013155,B,CHEMBL4061473,Homo sapiens,CHEMBL203,CHEMBL4011631
COc1ccc(CNc2nc(N)nc3[nH]c4ccc(O)cc4c23)cc1OC,5.43,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,3680.0,nM,=,CHEMBL4021780,B,CHEMBL4061797,Homo sapiens,CHEMBL203,CHEMBL4020756
OCCc1nc(-c2ccc(F)cc2)c(-c2ccnc3[nH]c(-c4ccccc4)cc23)[nH]1,8.12,Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,7.64,nM,=,CHEMBL4052481,B,CHEMBL4061829,Homo sapiens,CHEMBL203,CHEMBL4049460
c1coc(-c2nnc(Cc3nc4ccccc4[nH]3)o2)c1,4.00,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,100000.0,nM,=,CHEMBL3995335,B,CHEMBL4061912,Homo sapiens,CHEMBL203,CHEMBL3994595
Cc1cc(Nc2ncc3c(n2)N([C@H]2CCN(C(=O)CO)C2)C(=O)N(c2ccccc2Cl)C3)ccc1N1CCN(C)CC1,8.15,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,7.0,nM,=,CHEMBL4038017,B,CHEMBL4062178,Homo sapiens,CHEMBL203,CHEMBL4033795
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCCCC5)c(C)c4)nc32)C1,6.33,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,467.0,nM,=,CHEMBL4038017,B,CHEMBL4062192,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(F)cc3)c3c(N)ncnc32)C1,7.52,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,30.0,nM,=,CHEMBL4041413,B,CHEMBL4062509,Homo sapiens,CHEMBL203,CHEMBL4038351
S=C(Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)N1CCOCC1,7.57,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,26.9,nM,=,CHEMBL4011053,B,CHEMBL4062528,Homo sapiens,CHEMBL203,CHEMBL4007489
C=CC(=O)NCCSc1nc(-c2ccccc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,8.77,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,1.7,nM,=,CHEMBL4013155,B,CHEMBL4062543,Homo sapiens,CHEMBL203,CHEMBL4011631
C=CC(=O)NCc1cccc(-c2nc(C3CC3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)c1,5.41,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,3920.0,nM,=,CHEMBL4052479,B,CHEMBL4062617,Homo sapiens,CHEMBL203,CHEMBL4049460
CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3cc(F)cc([N+](=O)[O-])c3)c2)[nH]1,7.26,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,55.0,nM,=,CHEMBL4013155,B,CHEMBL4062722,Homo sapiens,CHEMBL203,CHEMBL4011631
CCCN1CC[C@H](N2C(=O)N(c3ccccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.28,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,52.8,nM,=,CHEMBL4038017,B,CHEMBL4062830,Homo sapiens,CHEMBL203,CHEMBL4033795
Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12,9.40,Inhibition of EGFR exon 19 deletion mutant in human HCC827 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay,IC50,0.4,nM,=,CHEMBL4018689,B,CHEMBL4062877,Homo sapiens,CHEMBL203,CHEMBL4017490
CCC(=O)N1CC[C@H](N2C(=O)N(c3cccc(OC)c3Cl)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,6.38,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,413.0,nM,=,CHEMBL4038017,B,CHEMBL4063067,Homo sapiens,CHEMBL203,CHEMBL4033795
O=C(Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)C1CCCCC1,8.21,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,IC50,6.13,nM,=,CHEMBL3999845,B,CHEMBL4063301,Homo sapiens,CHEMBL203,CHEMBL3997839
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4nc5c(s4)CN(C)CC5)nc32)c1,8.60,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,2.5,nM,=,CHEMBL4001768,B,CHEMBL4063421,Homo sapiens,CHEMBL203,CHEMBL4000215
Clc1ccc2nc(Cc3nnc(-c4ccccc4)o3)[nH]c2c1,4.00,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,100000.0,nM,=,CHEMBL3995335,B,CHEMBL4063427,Homo sapiens,CHEMBL203,CHEMBL3994595
CCC(=O)N1CCC[C@@H](n2nc(-c3ccc(C(F)(F)F)cc3)c3c(N)ncnc32)C1,5.23,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,5900.0,nM,=,CHEMBL4041413,B,CHEMBL4063701,Homo sapiens,CHEMBL203,CHEMBL4038351
COc1cc(Br)c(/C=C2\CN(C)C/C(=C\c3nc(C)c(C)nc3C)C2=O)cc1OC,7.22,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,IC50,60.0,nM,=,CHEMBL4034792,B,CHEMBL4063890,Homo sapiens,CHEMBL203,CHEMBL4033650
C=CC(=O)Nc1cccc(-c2c[nH]c3nccc(Cl)c23)c1,7.17,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,67.9,nM,=,CHEMBL4052480,B,CHEMBL4064224,Homo sapiens,CHEMBL203,CHEMBL4049460
COc1cc(Br)c(/C=C2\CN(C)CC(=C\c3nc(C)c(C)nc3C)/C2=N\O)cc1OC,7.70,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,IC50,20.0,nM,=,CHEMBL4034792,B,CHEMBL4064361,Homo sapiens,CHEMBL203,CHEMBL4033650
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4cnn(C5CCN(C)CC5)c4)nc32)c1,8.74,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,1.8,nM,=,CHEMBL4001768,B,CHEMBL4064475,Homo sapiens,CHEMBL203,CHEMBL4000215
O=C(N/N=C/c1ccc(O)cc1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,7.25,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate measured after 10 mins by mobility shift assay,IC50,56.0,nM,=,CHEMBL4034720,B,CHEMBL4064776,Homo sapiens,CHEMBL203,CHEMBL4033645
Cc1cc(Nc2ncc3c(n2)N([C@H]2CCN(C(=O)C4CC4)C2)C(=O)N(c2ccccc2Cl)C3)ccc1N1CCN(C)CC1,7.54,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,28.7,nM,=,CHEMBL4038017,B,CHEMBL4064937,Homo sapiens,CHEMBL203,CHEMBL4033795
CN(C)C(=O)CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,9.00,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,1.0,nM,=,CHEMBL4013155,B,CHEMBL4064942,Homo sapiens,CHEMBL203,CHEMBL4011631
S=C(Nc1cccnc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.99,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,10.2,nM,=,CHEMBL4011053,B,CHEMBL4065288,Homo sapiens,CHEMBL203,CHEMBL4007489
Fc1cc(F)cc(NC(=S)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)c1,7.22,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,60.1,nM,=,CHEMBL4011053,B,CHEMBL4065300,Homo sapiens,CHEMBL203,CHEMBL4007489
COc1cccc(-c2nnc(Cc3nc4ccccc4[nH]3)o2)c1OC,4.21,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,61000.0,nM,=,CHEMBL3995335,B,CHEMBL4065301,Homo sapiens,CHEMBL203,CHEMBL3994595
Cc1nnc(NC(=S)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)s1,6.92,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,120.0,nM,=,CHEMBL4011053,B,CHEMBL4065503,Homo sapiens,CHEMBL203,CHEMBL4007489
CCCC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.54,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,28.9,nM,=,CHEMBL4038017,B,CHEMBL4065970,Homo sapiens,CHEMBL203,CHEMBL4033795
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(OC)c4)nc32)C1,6.22,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,600.0,nM,=,CHEMBL4038017,B,CHEMBL4065984,Homo sapiens,CHEMBL203,CHEMBL4033795
c1ccc2c(Cc3nnc(Cc4nc5ccccc5[nH]4)o3)cccc2c1,5.24,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,5700.0,nM,=,CHEMBL3995335,B,CHEMBL4066118,Homo sapiens,CHEMBL203,CHEMBL3994595
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C6COC6)CC5)c(C)c4)nc32)C1,6.44,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,360.0,nM,=,CHEMBL4038017,B,CHEMBL4066141,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccc(F)cc34)n2)c(OC)cc1N(C)CC[N+](C)(C)[O-],7.99,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate in presence of ATP by Z-LYTE kinase assay,IC50,10.2,nM,=,CHEMBL4044503,B,CHEMBL4066170,Homo sapiens,CHEMBL203,CHEMBL4043110
C[C@@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1,4.52,Binding affinity to EGFR (unknown origin) assessed as dissociation constant by KINOMEscan analysis,Kd,30000.0,nM,=,CHEMBL5133814,B,CHEMBL4066176,Homo sapiens,CHEMBL203,CHEMBL5131445
Fc1ccc(NC(=S)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)cc1Cl,7.60,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,25.3,nM,=,CHEMBL4011053,B,CHEMBL4066504,Homo sapiens,CHEMBL203,CHEMBL4007489
C=CC(=O)Nc1cc(Nc2cc(-c3cn(C)c4ccccc34)nc(C)n2)c(OC)cc1N(C)CCN(C)C,7.33,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,46.5,nM,=,CHEMBL4053811,B,CHEMBL4066569,Homo sapiens,CHEMBL203,CHEMBL4052618
Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1,6.14,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay",IC50,725.3,nM,=,CHEMBL4034169,B,CHEMBL4066684,Homo sapiens,CHEMBL203,CHEMBL4033630
CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)o1,7.62,"Inhibition of wild type recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,23.99,nM,=,CHEMBL4007059,B,CHEMBL4066845,Homo sapiens,CHEMBL203,CHEMBL4004868
Nc1cccc(-c2cc3c(-c4[nH]c(-c5ccccc5)nc4-c4ccc(F)cc4)ccnc3[nH]2)c1,7.81,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,15.4,nM,=,CHEMBL4052479,B,CHEMBL4066951,Homo sapiens,CHEMBL203,CHEMBL4049460
C=CC(=O)Nc1cc(Nc2nccc(-n3cc(C)c4ccccc43)n2)c(OC)cc1N(C)CCN(C)C,6.73,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,185.6,nM,=,CHEMBL4053811,B,CHEMBL4067014,Homo sapiens,CHEMBL203,CHEMBL4052618
Fc1ccc(-c2nc(SCCN3CCOCC3)[nH]c2-c2ccnc(Nc3ccccc3)c2)cc1,7.12,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,75.0,nM,=,CHEMBL4013155,B,CHEMBL4067255,Homo sapiens,CHEMBL203,CHEMBL4011631
O=C(Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)C1CCC2(CC1)OOC1(OO2)C2CC3CC(C2)CC1C3,6.43,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain (695-end residues) expressed in insect cells by Z'-Lyte assay,IC50,373.7,nM,=,CHEMBL3999846,B,CHEMBL4067373,Homo sapiens,CHEMBL203,CHEMBL3997839
S=C(Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)Nc1ccc(Cl)cc1Cl,7.31,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,48.9,nM,=,CHEMBL4011053,B,CHEMBL4067514,Homo sapiens,CHEMBL203,CHEMBL4007489
N#CCc1nnc(Cc2nc3ccccc3[nH]2)o1,4.00,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,100000.0,nM,=,CHEMBL3995335,B,CHEMBL4067556,Homo sapiens,CHEMBL203,CHEMBL3994595
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(/C=C/c4cc(Cl)cc(Cl)c4)cc3)ncc2Cl)c1,7.95,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",IC50,11.3,nM,=,CHEMBL4025984,B,CHEMBL4067855,Homo sapiens,CHEMBL203,CHEMBL4024721
OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1,8.72,"Inhibition of recombinant EGFR T790M/L858R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,1.9,nM,=,CHEMBL4018632,B,CHEMBL4067871,Homo sapiens,CHEMBL203,CHEMBL4017490
CCC(=O)N1CC[C@H](N2C(=O)N(c3cccc(OC(F)F)c3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,6.59,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,257.0,nM,=,CHEMBL4038017,B,CHEMBL4067916,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1cc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)cc(C(F)(F)F)c1,8.70,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,2.0,nM,=,CHEMBL4001768,B,CHEMBL4068047,Homo sapiens,CHEMBL203,CHEMBL4000215
C=CC(=O)NCc1cn(Cc2cccc(Nc3cc(-c4[nH]c(SC)nc4-c4ccc(F)cc4)ccn3)c2)nn1,7.34,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,46.0,nM,=,CHEMBL4013155,B,CHEMBL4068092,Homo sapiens,CHEMBL203,CHEMBL4011631
c1ccc(-c2nnc(Cc3nc4ccccc4[nH]3)o2)cc1,4.50,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,31800.0,nM,=,CHEMBL3995335,B,CHEMBL4068254,Homo sapiens,CHEMBL203,CHEMBL3994595
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C(F)(F)F)c4)nc32)C1,5.47,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,3400.0,nM,=,CHEMBL4038017,B,CHEMBL4068695,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1cc(Nc2n[nH]c3cc(Nc4cccc(F)c4)ccc23)c(OC)cc1N(C)CCN(C)C,8.41,Reversible inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated for 2 to 90 mins followed by 6-fold dilution,Ki,3.9,nM,=,CHEMBL4009534,B,CHEMBL4068763,Homo sapiens,CHEMBL203,CHEMBL4007434
CC(=O)c1ccccc1-c1nnc(Cc2nc3ccccc3[nH]2)o1,4.18,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,65400.0,nM,=,CHEMBL3995335,B,CHEMBL4068814,Homo sapiens,CHEMBL203,CHEMBL3994595
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(OCc4ccccn4)c(Cl)c3)c3c(N)ncnc32)C1,8.28,Inhibition of recombinant human GST-tagged EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,IC50,5.3,nM,=,CHEMBL4050456,B,CHEMBL4068839,Homo sapiens,CHEMBL203,CHEMBL4049404
NP(=O)(OCCCOc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)N(CCCl)CCCl,8.52,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,3.0,nM,=,CHEMBL3993803,B,CHEMBL4069003,Homo sapiens,CHEMBL203,CHEMBL3992535
COc1ccc(OC)c(Sc2cccc3[nH]c4nc(N)nc(N)c4c23)c1,5.37,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells preincubated for 60 mins followed by EGF induction measured after 10 mins by ELISA,IC50,4300.0,nM,=,CHEMBL4007193,B,CHEMBL4069070,Homo sapiens,CHEMBL203,CHEMBL4004880
C=CC(=O)Nc1cccc(-c2c[nH]c3nccc(-c4[nH]c(CCCO)nc4C(F)(F)F)c23)c1,6.53,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,297.0,nM,=,CHEMBL4052479,B,CHEMBL4069229,Homo sapiens,CHEMBL203,CHEMBL4049460
C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C(C)=O,6.72,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,188.2,nM,=,CHEMBL4053812,B,CHEMBL4069277,Homo sapiens,CHEMBL203,CHEMBL4052618
CCC(=O)Nc1cc(Nc2n[nH]c3ccccc23)ccc1N(C)CCN(C)C,5.07,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,IC50,8470.0,nM,=,CHEMBL4009507,B,CHEMBL4069284,Homo sapiens,CHEMBL203,CHEMBL4007434
C=CC(=O)N1CCC[C@@H](n2nc(C#CCC3CCCC3)c3c(N)ncnc32)C1,6.92,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,120.0,nM,=,CHEMBL4041413,B,CHEMBL4069586,Homo sapiens,CHEMBL203,CHEMBL4038351
COc1ccc2c(c1)CCCN2c1nc(C)nc2c(Cc3ccccc3)c[nH]c12.Cl,7.47,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,IC50,33.6,nM,=,CHEMBL3998244,B,CHEMBL4069672,Homo sapiens,CHEMBL203,CHEMBL3997769
Nc1nc(NCc2ccccc2)c2c(n1)[nH]c1cc(Br)c(O)cc12,6.43,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,370.0,nM,=,CHEMBL4021780,B,CHEMBL4069965,Homo sapiens,CHEMBL203,CHEMBL4020756
NP(=O)(OCCCC(=O)Oc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)N(CCCl)CCCl,8.48,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,3.3,nM,=,CHEMBL3993803,B,CHEMBL4070053,Homo sapiens,CHEMBL203,CHEMBL3992535
CCC(=O)N1CC[C@H](N2C(=O)N(c3cccc(F)c3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.45,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,35.8,nM,=,CHEMBL4038017,B,CHEMBL4070404,Homo sapiens,CHEMBL203,CHEMBL4033795
Nc1nc(NCc2cccc(Cl)c2)c2c(n1)[nH]c1ccc(O)cc12,6.54,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,290.0,nM,=,CHEMBL4021780,B,CHEMBL4070420,Homo sapiens,CHEMBL203,CHEMBL4020756
Oc1ccc(-c2nc(-c3ccccc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1,7.95,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,11.2,nM,=,CHEMBL4052479,B,CHEMBL4070454,Homo sapiens,CHEMBL203,CHEMBL4049460
CCC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3OC)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.56,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,27.4,nM,=,CHEMBL4038017,B,CHEMBL4070640,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)N1CCC[C@H]1CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,8.72,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,1.9,nM,=,CHEMBL4013155,B,CHEMBL4070707,Homo sapiens,CHEMBL203,CHEMBL4011631
C=CC(=O)NCCSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,9.42,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin incubated for 2 to 90 mins by HTFR assay,Ki,0.38,nM,=,CHEMBL4013167,B,CHEMBL4071012,Homo sapiens,CHEMBL203,CHEMBL4011631
CC(C)(C)OC(=O)NCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.49,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,IC50,3.2,nM,=,CHEMBL4011794,B,CHEMBL4071058,Homo sapiens,CHEMBL203,CHEMBL4011588
C#Cc1nn([C@@H]2CCCN(C(=O)C=C)C2)c2ncnc(N)c12,6.16,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,IC50,690.0,nM,=,CHEMBL4041414,B,CHEMBL4071151,Homo sapiens,CHEMBL203,CHEMBL4038351
S=C(NCc1ccc(Cl)cc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.55,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,28.3,nM,=,CHEMBL4011053,B,CHEMBL4071170,Homo sapiens,CHEMBL203,CHEMBL4007489
CN(C)C/C=C/C(=O)NCCSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,8.72,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,1.9,nM,=,CHEMBL4013155,B,CHEMBL4071180,Homo sapiens,CHEMBL203,CHEMBL4011631
C=CC(=O)Nc1cc(Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)cc(N2CCN(C)CC2)c1,7.96,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,11.0,nM,=,CHEMBL5143769,B,CHEMBL4071368,Homo sapiens,CHEMBL203,CHEMBL5143505
C=CC(=O)Nc1cc(Nc2n[nH]c3cc(-c4cccc(F)c4)ccc23)c(OC)cc1N(C)CCN(C)C,8.80,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,IC50,1.6,nM,=,CHEMBL4009507,B,CHEMBL4071463,Homo sapiens,CHEMBL203,CHEMBL4007434
C=CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,9.30,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,0.5,nM,=,CHEMBL4038017,B,CHEMBL4071474,Homo sapiens,CHEMBL203,CHEMBL4033795
Oc1ccc(-c2nc(-c3ccco3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1,5.89,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,1300.0,nM,=,CHEMBL4052479,B,CHEMBL4071494,Homo sapiens,CHEMBL203,CHEMBL4049460
C=CC(=O)Nc1cccc(-c2c[nH]c3nccc(-c4[nH]c(CCCO)nc4-c4ccc(F)cc4)c23)c1,9.03,Binding affinity to human EGFR L858R mutant (669 to 1011 residues) expressed in bacterial system incubated for 1 hr,Kd,0.93,nM,=,CHEMBL4052492,B,CHEMBL4071827,Homo sapiens,CHEMBL203,CHEMBL4049460
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CC(C)N(C)C(C)C5)cc4OC)nc32)c1,8.48,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,3.3,nM,=,CHEMBL4001768,B,CHEMBL4072048,Homo sapiens,CHEMBL203,CHEMBL4000215
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(O)cc3)c3c(N)ncnc32)C1,8.52,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,3.0,nM,=,CHEMBL4041413,B,CHEMBL4072299,Homo sapiens,CHEMBL203,CHEMBL4038351
COc1ccc2c(c1)CCCN2c1nc(N)nc2c(Cc3ccccc3)c[nH]c12,7.33,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,IC50,47.1,nM,=,CHEMBL3998244,B,CHEMBL4072383,Homo sapiens,CHEMBL203,CHEMBL3997769
CC(=O)c1ccccc1-n1c(-c2ccccc2)nc2cc(Cl)ccc2c1=O,6.14,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,IC50,720.0,nM,=,CHEMBL4025907,B,CHEMBL4072392,Homo sapiens,CHEMBL203,CHEMBL4024718
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4c(F)cccc34)n2)c(OC)cc1N(C)CC[N+](C)(C)[O-],7.75,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate in presence of ATP by Z-LYTE kinase assay,IC50,17.8,nM,=,CHEMBL4044503,B,CHEMBL4072620,Homo sapiens,CHEMBL203,CHEMBL4043110
COc1ccc(CNc2nc(N)nc3[nH]c4cc(C)c(O)cc4c23)cc1,5.22,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,5950.0,nM,=,CHEMBL4021780,B,CHEMBL4072687,Homo sapiens,CHEMBL203,CHEMBL4020756
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCN(C6COC6)CC5)c(C)c4)nc32)C1,6.52,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,302.0,nM,=,CHEMBL4038017,B,CHEMBL4072688,Homo sapiens,CHEMBL203,CHEMBL4033795
Cc1cccc(Nc2ncnc3ccc(NC(=S)NCc4ccccc4)cc23)c1,7.43,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,36.8,nM,=,CHEMBL4011053,B,CHEMBL4072769,Homo sapiens,CHEMBL203,CHEMBL4007489
C=CC(=O)Nc1cccc(-c2c[nH]c3nccc(-c4[nH]c(-c5ccccc5)nc4-c4ccc(F)cc4)c23)c1,8.11,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,7.8,nM,=,CHEMBL4052479,B,CHEMBL4072874,Homo sapiens,CHEMBL203,CHEMBL4049460
S=C(Nc1ccc(Cl)c(Cl)c1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.88,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,133.1,nM,=,CHEMBL4011053,B,CHEMBL4072928,Homo sapiens,CHEMBL203,CHEMBL4007489
S=C(Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)Nc1ncc(Cl)s1,6.92,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,120.0,nM,=,CHEMBL4011053,B,CHEMBL4072986,Homo sapiens,CHEMBL203,CHEMBL4007489
C=CC(=O)N1CC[C@@H](n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)C1,6.36,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,436.3,nM,=,CHEMBL4001768,B,CHEMBL4073062,Homo sapiens,CHEMBL203,CHEMBL4000215
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(/C=C/c4cc(C)cc(C)c4)cc3)ncc2Cl)c1,7.58,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",IC50,26.5,nM,=,CHEMBL4025984,B,CHEMBL4073278,Homo sapiens,CHEMBL203,CHEMBL4024721
O=C(O)c1ccccc1-c1nnc(Cc2nc3ccccc3[nH]2)o1,4.00,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,100000.0,nM,=,CHEMBL3995335,B,CHEMBL4073285,Homo sapiens,CHEMBL203,CHEMBL3994595
COc1cc2[nH]c3nc(N)nc(NCc4ccccc4)c3c2cc1O,6.21,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,610.0,nM,=,CHEMBL4021780,B,CHEMBL4073523,Homo sapiens,CHEMBL203,CHEMBL4020756
COc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1OCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,8.34,Inhibition of wild type recombinant EGFR (unknown origin) by ELISA,IC50,4.53,nM,=,CHEMBL4046770,B,CHEMBL4073595,Homo sapiens,CHEMBL203,CHEMBL4043197
CN(C)C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3ccccc3)c3c(N)ncnc32)C1,6.66,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,220.0,nM,=,CHEMBL4041413,B,CHEMBL4073874,Homo sapiens,CHEMBL203,CHEMBL4038351
FC(F)(F)c1csc(NC(=S)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)n1,6.86,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,137.0,nM,=,CHEMBL4011053,B,CHEMBL4073912,Homo sapiens,CHEMBL203,CHEMBL4007489
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(F)c4ccccc34)c3c(N)ncnc32)C1,7.70,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,20.0,nM,=,CHEMBL4041413,B,CHEMBL4073960,Homo sapiens,CHEMBL203,CHEMBL4038351
NCCn1c(-c2ccccc2)nc2cc(Cl)ccc2c1=O,6.54,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,IC50,287.0,nM,=,CHEMBL4025907,B,CHEMBL4074248,Homo sapiens,CHEMBL203,CHEMBL4024718
CC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.92,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,12.1,nM,=,CHEMBL4038017,B,CHEMBL4074601,Homo sapiens,CHEMBL203,CHEMBL4033795
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4C)nc32)C1,5.60,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,2500.0,nM,=,CHEMBL4038017,B,CHEMBL4074615,Homo sapiens,CHEMBL203,CHEMBL4033795
c1ccc(-c2nnc(Cc3nc4ccccc4[nH]3)o2)nc1,4.13,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,73500.0,nM,=,CHEMBL3995335,B,CHEMBL4074726,Homo sapiens,CHEMBL203,CHEMBL3994595
C=CC(=O)Nc1cc(Nc2n[nH]c3ccccc23)c(OC)cc1N(C)CCN(C)C,6.33,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,IC50,462.0,nM,=,CHEMBL4009508,B,CHEMBL4074766,Homo sapiens,CHEMBL203,CHEMBL4007434
Cc1ccccc1-c1nnc(Cc2nc3ccccc3[nH]2)o1,4.40,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,39700.0,nM,=,CHEMBL3995335,B,CHEMBL4074782,Homo sapiens,CHEMBL203,CHEMBL3994595
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(N(C)C)c4ccccc34)c3c(N)ncnc32)C1,6.68,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,IC50,210.0,nM,=,CHEMBL4041414,B,CHEMBL4075015,Homo sapiens,CHEMBL203,CHEMBL4038351
NS(=O)(=O)c1ccc(NC(=S)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)cc1,8.02,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,9.5,nM,=,CHEMBL4011053,B,CHEMBL4075103,Homo sapiens,CHEMBL203,CHEMBL4007489
COc1cc(Cl)c(/C=C2\CN(C(C)C)C/C(=C\c3nc(C)c(C)nc3C)C2=O)cc1OC,5.51,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,IC50,3100.0,nM,=,CHEMBL4034792,B,CHEMBL4075241,Homo sapiens,CHEMBL203,CHEMBL4033650
Oc1ccc(NC(=S)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)cc1,8.05,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,8.9,nM,=,CHEMBL4011053,B,CHEMBL4075530,Homo sapiens,CHEMBL203,CHEMBL4007489
c1csc(-c2nnc(Cc3nc4ccccc4[nH]3)o2)c1,4.00,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,100000.0,nM,=,CHEMBL3995335,B,CHEMBL4075892,Homo sapiens,CHEMBL203,CHEMBL3994595
Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12,8.89,"Inhibition of recombinant EGFR T790M/L858R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,1.3,nM,=,CHEMBL4018632,B,CHEMBL4075917,Homo sapiens,CHEMBL203,CHEMBL4017490
NCCCSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,7.92,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,12.0,nM,=,CHEMBL4013155,B,CHEMBL4076363,Homo sapiens,CHEMBL203,CHEMBL4011631
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCC(N(C)C)CC5)c(C)c4)nc32)C1,6.54,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,286.0,nM,=,CHEMBL4038017,B,CHEMBL4076405,Homo sapiens,CHEMBL203,CHEMBL4033795
S=C(Nc1ccccc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.80,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,15.8,nM,=,CHEMBL4011053,B,CHEMBL4076434,Homo sapiens,CHEMBL203,CHEMBL4007489
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N(C)CCN(C)C)c(C)c4)nc32)C1,5.89,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,1300.0,nM,=,CHEMBL4038017,B,CHEMBL4076515,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3cnc(SC)[nH]3)ccn2)c1,8.25,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,5.6,nM,=,CHEMBL4013155,B,CHEMBL4076854,Homo sapiens,CHEMBL203,CHEMBL4011631
C=CC(=O)N1CCc2ccc(-n3c(=O)ccc4cnc5ccc(-c6cnn(C)c6)cc5c43)cc21,6.06,"Inhibition of recombinant human N-terminal GST-tagged wild-type EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay",IC50,874.0,nM,=,CHEMBL4024934,B,CHEMBL4077064,Homo sapiens,CHEMBL203,CHEMBL4024706
CCC(=O)Nc1cccc(-c2c[nH]c3nccc(-c4[nH]c(CCCO)nc4-c4ccc(F)cc4)c23)c1,6.55,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,279.0,nM,=,CHEMBL4052479,B,CHEMBL4077228,Homo sapiens,CHEMBL203,CHEMBL4049460
O=C(Nn1c(-c2ccccc2)nc2ccccc2c1=O)c1ccc(Br)cc1,6.11,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,IC50,780.0,nM,=,CHEMBL4025907,B,CHEMBL4077349,Homo sapiens,CHEMBL203,CHEMBL4024718
S=C(Nc1cc(Cl)cc(Cl)c1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.83,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,146.3,nM,=,CHEMBL4011053,B,CHEMBL4077419,Homo sapiens,CHEMBL203,CHEMBL4007489
FC(F)(F)c1nnc(NC(=S)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)s1,6.89,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,130.0,nM,=,CHEMBL4011053,B,CHEMBL4077608,Homo sapiens,CHEMBL203,CHEMBL4007489
CCC(=O)Nc1cccc(-c2cc3c(-c4[nH]c(-c5ccccc5)nc4-c4ccc(F)cc4)ccnc3[nH]2)c1,7.73,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,18.7,nM,=,CHEMBL4052479,B,CHEMBL4077917,Homo sapiens,CHEMBL203,CHEMBL4049460
COc1cc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c4ccccc34)c2cc1OC,4.08,Inhibition of EGFR (unknown origin) using biotin as substrate incubated for 2 hrs by HTRF assay,IC50,83900.0,nM,=,CHEMBL5138512,B,CHEMBL4077930,Homo sapiens,CHEMBL203,CHEMBL5137005
NP(=O)(Oc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)N(CCCl)CCCl,8.04,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,9.2,nM,=,CHEMBL3993803,B,CHEMBL4077956,Homo sapiens,CHEMBL203,CHEMBL3992535
C=CC(=O)Nc1cc(Nc2cc(-c3cn4c5c(cccc35)CCC4)nc(OC)n2)c(OC)cc1N(C)CCN(C)C,7.66,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,22.0,nM,=,CHEMBL4053812,B,CHEMBL4077973,Homo sapiens,CHEMBL203,CHEMBL4052618
Cc1nc(C)c(/C=C2\CN(C)C/C(=C\c3nc(C)c(C)nc3C)C2=NO)nc1C,7.70,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,IC50,20.0,nM,=,CHEMBL4034792,B,CHEMBL4078023,Homo sapiens,CHEMBL203,CHEMBL4033650
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCN(C(C)=O)CC5)c(C)c4)nc32)C1,6.83,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,148.0,nM,=,CHEMBL4038017,B,CHEMBL4078026,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1cc(C)cc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.74,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,1.8,nM,=,CHEMBL4001768,B,CHEMBL4078120,Homo sapiens,CHEMBL203,CHEMBL4000215
S=C(Nc1cccc(Cl)c1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.69,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,20.6,nM,=,CHEMBL4011053,B,CHEMBL4078182,Homo sapiens,CHEMBL203,CHEMBL4007489
COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCCCOP(N)(=O)N(CCCl)CCCl,9.52,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,0.3,nM,=,CHEMBL3993803,B,CHEMBL4078431,Homo sapiens,CHEMBL203,CHEMBL3992535
CCC(=O)N1CC[C@H](N2C(=O)N(c3cccc(OC)c3F)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,6.38,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,421.0,nM,=,CHEMBL4038017,B,CHEMBL4078801,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1cc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CC(C)N(C)C(C)C5)cc4OC)nc32)cc(C(F)(F)F)c1,8.48,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,3.3,nM,=,CHEMBL4001768,B,CHEMBL4078914,Homo sapiens,CHEMBL203,CHEMBL4000215
C=CC(=O)Nc1cccc(-c2c[nH]c3nccc(-c4[nH]c(CCCO)nc4C4CC4)c23)c1,6.59,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,258.0,nM,=,CHEMBL4052479,B,CHEMBL4078920,Homo sapiens,CHEMBL203,CHEMBL4049460
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CC6(CCN(C)CC6)C5)c(C)c4)nc32)C1,6.66,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,218.0,nM,=,CHEMBL4038017,B,CHEMBL4078973,Homo sapiens,CHEMBL203,CHEMBL4033795
Clc1ccc(-c2nnc(Cc3nc4ccccc4[nH]3)o2)c(Cl)c1,5.43,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,3700.0,nM,=,CHEMBL3995335,B,CHEMBL4079125,Homo sapiens,CHEMBL203,CHEMBL3994595
O=c1c2ccc(Cl)cc2nc(-c2ccccc2)n1-c1nnc(C2CC2)s1,6.99,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,IC50,102.0,nM,=,CHEMBL4025907,B,CHEMBL4079183,Homo sapiens,CHEMBL203,CHEMBL4024718
C=CC(=O)Nc1cccc(Nc2cc(-c3[nH]c(SCCNC(=O)CC)nc3-c3ccccc3)ccn2)c1,8.60,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,IC50,2.5,nM,=,CHEMBL4013157,B,CHEMBL4079393,Homo sapiens,CHEMBL203,CHEMBL4011631
C=CC(=O)Nc1cc(Nc2n[nH]c3cc(-c4ccncc4)ccc23)c(OC)cc1N(C)CCN(C)C,8.30,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,IC50,5.0,nM,=,CHEMBL4009508,B,CHEMBL4079501,Homo sapiens,CHEMBL203,CHEMBL4007434
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(F)c4)nc32)C1,5.89,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,1300.0,nM,=,CHEMBL4038017,B,CHEMBL4079506,Homo sapiens,CHEMBL203,CHEMBL4033795
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,7.97,Inhibition of wild type recombinant EGFR (unknown origin) by ELISA,IC50,10.71,nM,=,CHEMBL4046770,B,CHEMBL4079553,Homo sapiens,CHEMBL203,CHEMBL4043197
C=CC(=O)Nc1cc(Nc2n[nH]c3ccc(-c4cccc5ccccc45)cc23)c(OC)cc1N(C)CCN(C)C,8.57,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,IC50,2.7,nM,=,CHEMBL4009508,B,CHEMBL4079566,Homo sapiens,CHEMBL203,CHEMBL4007434
CCC(=O)N1CC[C@H](N2C(=O)N(c3cccc(Cl)c3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,6.84,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,144.0,nM,=,CHEMBL4038017,B,CHEMBL4079649,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CC[N+](C)(C)[O-],8.19,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate in presence of ATP by Z-LYTE kinase assay,IC50,6.4,nM,=,CHEMBL4044503,B,CHEMBL4079658,Homo sapiens,CHEMBL203,CHEMBL4043110
C#Cc1cccc(Nc2ncnc3ccc(OCCCOP(N)(=O)N(CCCl)CCCl)cc23)c1,8.14,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,7.2,nM,=,CHEMBL3993803,B,CHEMBL4079768,Homo sapiens,CHEMBL203,CHEMBL3992535
Nc1nc(N)c2c(n1)[nH]c1cccc(Sc3ccc(Cl)cc3)c12,5.08,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells preincubated for 60 mins followed by EGF induction measured after 10 mins by ELISA,IC50,8300.0,nM,=,CHEMBL4007193,B,CHEMBL4079829,Homo sapiens,CHEMBL203,CHEMBL4004880
C=CC(=O)Nc1cc(C(C)C)cc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.62,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,2.4,nM,=,CHEMBL4001768,B,CHEMBL4079861,Homo sapiens,CHEMBL203,CHEMBL4000215
C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N1CC(CN(C)C)C1,8.17,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,6.7,nM,=,CHEMBL4053812,B,CHEMBL4080008,Homo sapiens,CHEMBL203,CHEMBL4052618
C=CC(=O)Nc1cc(Nc2n[nH]c3cc(-c4cccnc4)ccc23)c(OC)cc1N(C)CCN(C)C,7.82,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,IC50,15.0,nM,=,CHEMBL4009508,B,CHEMBL4080424,Homo sapiens,CHEMBL203,CHEMBL4007434
Cc1ccc(CNc2nc(N)nc3[nH]c4ccc(O)cc4c23)cc1,7.05,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,90.0,nM,=,CHEMBL4021780,B,CHEMBL4080640,Homo sapiens,CHEMBL203,CHEMBL4020756
Oc1cccc(Nc2ncnc3ccc(NC(=S)NCc4ccccc4)cc23)c1,7.20,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,63.6,nM,=,CHEMBL4011053,B,CHEMBL4080711,Homo sapiens,CHEMBL203,CHEMBL4007489
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCOP(N)(=O)N(CCCl)CCCl,9.30,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,0.5,nM,=,CHEMBL3993803,B,CHEMBL4080720,Homo sapiens,CHEMBL203,CHEMBL3992535
C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N1CC(CCN(C)C)C1,7.93,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,11.8,nM,=,CHEMBL4053812,B,CHEMBL4080934,Homo sapiens,CHEMBL203,CHEMBL4052618
CCC(=O)N1CC[C@H](N2C(=O)N(c3ccc(OC)cc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,6.82,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,153.0,nM,=,CHEMBL4038017,B,CHEMBL4081252,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N1CCNC(=O)C1,6.37,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,427.7,nM,=,CHEMBL4053811,B,CHEMBL4081429,Homo sapiens,CHEMBL203,CHEMBL4052618
CCC(=O)N1CCC[C@@H](n2nc(-c3ccccc3)c3c(N)ncnc32)C1,5.33,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,4700.0,nM,=,CHEMBL4041413,B,CHEMBL4081698,Homo sapiens,CHEMBL203,CHEMBL4038351
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(/C=C/c4cc(C)cc(C)c4)cc3)ncc2Cl)c1,7.65,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",IC50,22.4,nM,=,CHEMBL4025984,B,CHEMBL4081703,Homo sapiens,CHEMBL203,CHEMBL4024721
COc1cc(Br)c(/C=C2\CC(C)C/C(=C\c3nc(C)c(C)nc3C)C2=O)cc1OC,5.72,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,IC50,1900.0,nM,=,CHEMBL4034792,B,CHEMBL4081727,Homo sapiens,CHEMBL203,CHEMBL4033650
N#CCCSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,7.40,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,40.0,nM,=,CHEMBL4013155,B,CHEMBL4081732,Homo sapiens,CHEMBL203,CHEMBL4011631
NCCSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,8.59,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,2.6,nM,=,CHEMBL4013155,B,CHEMBL4081860,Homo sapiens,CHEMBL203,CHEMBL4011631
C=CC(=O)Nc1cc(Nc2n[nH]c3cc(-c4cccc(C(F)(F)F)c4)ccc23)c(OC)cc1N(C)CCN(C)C,8.35,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,IC50,4.5,nM,=,CHEMBL4009507,B,CHEMBL4082000,Homo sapiens,CHEMBL203,CHEMBL4007434
C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3[nH]c(SC)nc3C3CCCC3)ccn2)c1,8.35,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,IC50,4.5,nM,=,CHEMBL4013157,B,CHEMBL4082362,Homo sapiens,CHEMBL203,CHEMBL4011631
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4cnn(CCN(C)C)c4)nc32)c1,8.38,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,4.2,nM,=,CHEMBL4001768,B,CHEMBL4082515,Homo sapiens,CHEMBL203,CHEMBL4000215
COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,6.01,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay",IC50,980.83,nM,=,CHEMBL4057894,B,CHEMBL4082724,Homo sapiens,CHEMBL203,CHEMBL4052772
C=CC(=O)Nc1cc(Nc2cc(-c3cn(C)c4ccccc34)nc(OC)n2)c(OC)cc1N(C)CCN(C)C,7.96,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,10.9,nM,=,CHEMBL4053812,B,CHEMBL4082763,Homo sapiens,CHEMBL203,CHEMBL4052618
NCc1cccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)c1,6.80,Inhibition of EGFR L858R/T790M double mutant (unknown origin),IC50,160.0,nM,=,CHEMBL4052484,B,CHEMBL4082764,Homo sapiens,CHEMBL203,CHEMBL4049460
C=CC(=O)N1CCC[C@@H](n2nc(C#CC3CCCC3)c3c(N)ncnc32)C1,7.22,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,60.0,nM,=,CHEMBL4041413,B,CHEMBL4082783,Homo sapiens,CHEMBL203,CHEMBL4038351
O=C(Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)C1CCC2(CC1)OCC1(OO2)C2CC3CC(C2)CC1C3,7.02,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,IC50,94.72,nM,=,CHEMBL3999845,B,CHEMBL4082840,Homo sapiens,CHEMBL203,CHEMBL3997839
C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3[nH]c(SC)nc3C(C)(C)C)ccn2)c1,7.80,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,16.0,nM,=,CHEMBL4013155,B,CHEMBL4082884,Homo sapiens,CHEMBL203,CHEMBL4011631
Cc1cc2[nH]c3nc(N)nc(NCc4ccc(Cl)cc4)c3c2cc1O,6.96,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,110.0,nM,=,CHEMBL4021780,B,CHEMBL4083162,Homo sapiens,CHEMBL203,CHEMBL4020756
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCCN(C)CC5)c(C)c4)nc32)C1,6.68,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,209.0,nM,=,CHEMBL4038017,B,CHEMBL4083224,Homo sapiens,CHEMBL203,CHEMBL4033795
c1cncc(-c2nnc(Cc3nc4ccccc4[nH]3)o2)c1,4.00,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,100000.0,nM,=,CHEMBL3995335,B,CHEMBL4083305,Homo sapiens,CHEMBL203,CHEMBL3994595
Cc1nnc(-n2c(-c3ccccc3)nc3cc(Cl)ccc3c2=O)s1,4.92,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,IC50,12120.0,nM,=,CHEMBL4025907,B,CHEMBL4083467,Homo sapiens,CHEMBL203,CHEMBL4024718
C=CC(=O)Nc1cc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)ccc1C,8.64,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,2.3,nM,=,CHEMBL4001768,B,CHEMBL4083486,Homo sapiens,CHEMBL203,CHEMBL4000215
Clc1ccc2nc(Cc3nnc(-c4ccccc4Cl)o3)[nH]c2c1,4.48,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,33200.0,nM,=,CHEMBL3995335,B,CHEMBL4083493,Homo sapiens,CHEMBL203,CHEMBL3994595
Cc1cc2[nH]c3nc(N)nc(NCc4cccc(Cl)c4)c3c2cc1O,6.05,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,900.0,nM,=,CHEMBL4021780,B,CHEMBL4083567,Homo sapiens,CHEMBL203,CHEMBL4020756
Cc1nc(C)c(/C=C2\CN(C)C/C(=C\c3nc(C)c(C)nc3C)C2=O)nc1C,7.40,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,IC50,40.0,nM,=,CHEMBL4034792,B,CHEMBL4083642,Homo sapiens,CHEMBL203,CHEMBL4033650
O=c1c2ccccc2nc(-c2ccccc2)n1-c1nnc(-c2ccccc2Cl)s1,5.14,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,IC50,7230.0,nM,=,CHEMBL4025907,B,CHEMBL4083815,Homo sapiens,CHEMBL203,CHEMBL4024718
Cc1cc(Nc2ncc3c(n2)N([C@H]2CCN(C(=O)CN(C)C)C2)C(=O)N(c2ccccc2Cl)C3)ccc1N1CCN(C)CC1,7.58,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,26.6,nM,=,CHEMBL4038017,B,CHEMBL4083904,Homo sapiens,CHEMBL203,CHEMBL4033795
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C(C)C)c4)nc32)C1,6.44,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,365.0,nM,=,CHEMBL4038017,B,CHEMBL4083916,Homo sapiens,CHEMBL203,CHEMBL4033795
COc1cccc(CNc2nc(N)nc3[nH]c4ccc(O)cc4c23)c1,5.90,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,1260.0,nM,=,CHEMBL4021780,B,CHEMBL4084090,Homo sapiens,CHEMBL203,CHEMBL4020756
CCC(=O)N1CCC[C@@H](n2nc(-c3cccc(F)c3)c3c(N)ncnc32)C1,5.47,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,3400.0,nM,=,CHEMBL4041413,B,CHEMBL4084214,Homo sapiens,CHEMBL203,CHEMBL4038351
C=CC(=O)NCCSc1nc(-c2ccc(F)c(C(F)(F)F)c2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,6.84,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,144.0,nM,=,CHEMBL4013155,B,CHEMBL4084248,Homo sapiens,CHEMBL203,CHEMBL4011631
COc1ccc(-c2nnc(Cc3nc4ccccc4[nH]3)o2)cc1,7.01,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,98.0,nM,=,CHEMBL3995335,B,CHEMBL4084249,Homo sapiens,CHEMBL203,CHEMBL3994595
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,6.43,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,373.0,nM,=,CHEMBL4038017,B,CHEMBL4084726,Homo sapiens,CHEMBL203,CHEMBL4033795
NP(=O)(OCCOc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)N(CCCl)CCCl,8.37,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,4.3,nM,=,CHEMBL3993803,B,CHEMBL4084847,Homo sapiens,CHEMBL203,CHEMBL3992535
Cc1cc(Nc2ncc3c(n2)N([C@H]2CCN(C(=O)C4CCCC4)C2)C(=O)N(c2ccccc2Cl)C3)ccc1N1CCN(C)CC1,7.59,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,25.5,nM,=,CHEMBL4038017,B,CHEMBL4084868,Homo sapiens,CHEMBL203,CHEMBL4033795
Clc1ccc(-c2nnc(Cc3nc4ccc(Cl)cc4[nH]3)o2)cc1,6.01,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,980.0,nM,=,CHEMBL3995335,B,CHEMBL4084996,Homo sapiens,CHEMBL203,CHEMBL3994595
FC(F)(F)c1cccc(NC(=S)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)c1,7.22,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,60.7,nM,=,CHEMBL4011053,B,CHEMBL4085352,Homo sapiens,CHEMBL203,CHEMBL4007489
C=CC(=O)Nc1cc(Nc2cc(-c3cn(C)c4ccccc34)ncn2)c(OC)cc1N(C)CCN(C)C,8.80,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,1.6,nM,=,CHEMBL4053812,B,CHEMBL4085842,Homo sapiens,CHEMBL203,CHEMBL4052618
C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(N(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1,5.23,"Inhibition of recombinant human N-terminal GST-tagged wild-type EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay",IC50,5882.0,nM,=,CHEMBL4024934,B,CHEMBL4085868,Homo sapiens,CHEMBL203,CHEMBL4024706
COc1cc(Br)c(/C=C2\CC(C)CC(=C\c3nc(C)c(C)nc3C)/C2=N/O)cc1OC,5.54,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,IC50,2900.0,nM,=,CHEMBL4034792,B,CHEMBL4085902,Homo sapiens,CHEMBL203,CHEMBL4033650
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)nc4)nc32)c1,8.85,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,1.4,nM,=,CHEMBL4001768,B,CHEMBL4086000,Homo sapiens,CHEMBL203,CHEMBL4000215
COc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,8.75,Inhibition of wild type recombinant EGFR (unknown origin) by ELISA,IC50,1.79,nM,=,CHEMBL4046770,B,CHEMBL4086056,Homo sapiens,CHEMBL203,CHEMBL4043197
C=CC(=O)N1CCC(Sc2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccccc4)c3)[nH]2)C1,7.60,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,25.0,nM,=,CHEMBL4013155,B,CHEMBL4086078,Homo sapiens,CHEMBL203,CHEMBL4011631
C=CC(=O)Nc1cc(Nc2ncnc(-c3cn(C)c4ccccc34)c2OC)c(OC)cc1N(C)CCN(C)C,7.26,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,55.5,nM,=,CHEMBL4053811,B,CHEMBL4086559,Homo sapiens,CHEMBL203,CHEMBL4052618
Cc1ccc(-c2nnc(Cc3nc4ccccc4[nH]3)o2)cc1,4.00,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,100000.0,nM,=,CHEMBL3995335,B,CHEMBL4086731,Homo sapiens,CHEMBL203,CHEMBL3994595
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCC6(CCN(C)C6)C5)c(C)c4)nc32)C1,6.53,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,295.7,nM,=,CHEMBL4038017,B,CHEMBL4086821,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3[nH]c(SC)nc3C)ccn2)c1,8.00,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,10.0,nM,=,CHEMBL4013155,B,CHEMBL4086878,Homo sapiens,CHEMBL203,CHEMBL4011631
CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,6.85,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,IC50,140.0,nM,=,CHEMBL4011794,B,CHEMBL4087241,Homo sapiens,CHEMBL203,CHEMBL4011588
C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCO,7.46,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,34.8,nM,=,CHEMBL4053812,B,CHEMBL4087243,Homo sapiens,CHEMBL203,CHEMBL4052618
C=CC(=O)Nc1cccc(Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c1,8.48,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,IC50,3.3,nM,=,CHEMBL4013157,B,CHEMBL4087268,Homo sapiens,CHEMBL203,CHEMBL4011631
Cc1cc(Nc2ncc3c(n2)N([C@H]2CCN(C(=O)CC(C)C)C2)C(=O)N(c2ccccc2Cl)C3)ccc1N1CCN(C)CC1,7.65,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,22.2,nM,=,CHEMBL4038017,B,CHEMBL4087375,Homo sapiens,CHEMBL203,CHEMBL4033795
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)C1,5.80,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,1600.0,nM,=,CHEMBL4038017,B,CHEMBL4087383,Homo sapiens,CHEMBL203,CHEMBL4033795
C1=CC2=C(Cc3nnc(Cc4nc5ccccc5[nH]4)o3)CNC2C=C1,4.06,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,86200.0,nM,=,CHEMBL3995335,B,CHEMBL4087489,Homo sapiens,CHEMBL203,CHEMBL3994595
CCC(=O)N1CC[C@H](N2C(=O)N(c3cccc(C)c3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,6.44,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,365.0,nM,=,CHEMBL4038017,B,CHEMBL4087525,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4c(F)cccc34)n2)c(OC)cc1N(C)CCN(C)C,8.22,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate in presence of ATP by Z-LYTE kinase assay,IC50,6.0,nM,=,CHEMBL4044503,B,CHEMBL4087538,Homo sapiens,CHEMBL203,CHEMBL4043110
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(/C=C/c4cc(C)cc(C)c4)cc3)ncc2F)c1,7.96,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",IC50,11.0,nM,=,CHEMBL4025984,B,CHEMBL4087570,Homo sapiens,CHEMBL203,CHEMBL4024721
NP(=O)(OCCCCOc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1)N(CCCl)CCCl,8.22,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,6.0,nM,=,CHEMBL3993803,B,CHEMBL4087646,Homo sapiens,CHEMBL203,CHEMBL3992535
COc1cc2cnnc(Nc3ccc(Cl)cc3F)c2cc1OC,6.70,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells preincubated for 60 mins followed by EGF induction measured after 10 mins by ELISA,IC50,200.0,nM,=,CHEMBL4007193,B,CHEMBL4087709,Homo sapiens,CHEMBL203,CHEMBL4004880
C=CC(=O)Nc1cc(F)cc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.10,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,0.8,nM,=,CHEMBL4001768,B,CHEMBL4087740,Homo sapiens,CHEMBL203,CHEMBL4000215
c1ccc(OCc2nnc(Cc3nc4ccccc4[nH]3)o2)cc1,4.33,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,46300.0,nM,=,CHEMBL3995335,B,CHEMBL4087921,Homo sapiens,CHEMBL203,CHEMBL3994595
C#Cc1cccc(Nc2ncnc3ccc(-c4ccc(CNCCS(C)(=O)=O)o4)cc23)c1,7.47,"Inhibition of wild type recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,34.16,nM,=,CHEMBL4007059,B,CHEMBL4088135,Homo sapiens,CHEMBL203,CHEMBL4004868
O=C(Nc1ccc2nccc(Nc3cccc(Cl)c3)c2c1)C1CCC2(CC1)OOC1(O2)C2CC3CC(C2)CC1C3,6.89,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,IC50,127.8,nM,=,CHEMBL3999845,B,CHEMBL4088200,Homo sapiens,CHEMBL203,CHEMBL3997839
C=CC(=O)Nc1cc(Nc2n[nH]c3cc(-c4cncc5ccccc45)ccc23)c(OC)cc1N(C)CCN(C)C,8.96,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,IC50,1.1,nM,=,CHEMBL4009507,B,CHEMBL4088277,Homo sapiens,CHEMBL203,CHEMBL4007434
S=C(NCc1ccccc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.76,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,17.2,nM,=,CHEMBL4011053,B,CHEMBL4088718,Homo sapiens,CHEMBL203,CHEMBL4007489
S=C(Nc1ccc(Br)cc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.45,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,35.4,nM,=,CHEMBL4011053,B,CHEMBL4088760,Homo sapiens,CHEMBL203,CHEMBL4007489
C[C@@H](Nc1nc(N)nc2[nH]c3ccc(O)cc3c12)c1ccccc1,6.04,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,910.0,nM,=,CHEMBL4021780,B,CHEMBL4088941,Homo sapiens,CHEMBL203,CHEMBL4020756
OCCCc1nc(-c2ccc(F)cc2)c(-c2ccnc3[nH]ccc23)[nH]1,7.61,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,24.4,nM,=,CHEMBL4052479,B,CHEMBL4088971,Homo sapiens,CHEMBL203,CHEMBL4049460
CCC(=O)N1CC[C@H](N2C(=O)N(c3cccc(OC(F)(F)F)c3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,6.05,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,889.0,nM,=,CHEMBL4038017,B,CHEMBL4089120,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)NCc1cccc(Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c1,8.31,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,4.9,nM,=,CHEMBL4013155,B,CHEMBL4089279,Homo sapiens,CHEMBL203,CHEMBL4011631
C#Cc1cccc(Nc2ncnc3ccc(-c4ccc(CO)o4)cc23)c1,7.80,"Inhibition of wild type recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,15.69,nM,=,CHEMBL4007059,B,CHEMBL4089347,Homo sapiens,CHEMBL203,CHEMBL4004868
O=C(Nc1ccc(Cl)cc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.71,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,19.3,nM,=,CHEMBL4011053,B,CHEMBL4089588,Homo sapiens,CHEMBL203,CHEMBL4007489
C=CC(=O)NCCCSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,7.66,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,22.0,nM,=,CHEMBL4013155,B,CHEMBL4089601,Homo sapiens,CHEMBL203,CHEMBL4011631
C=CC(=O)Nc1cc(Nc2n[nH]c3ccc(-c4ccc5ccccc5c4)cc23)c(OC)cc1N(C)CCN(C)C,8.96,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,IC50,1.1,nM,=,CHEMBL4009508,B,CHEMBL4089863,Homo sapiens,CHEMBL203,CHEMBL4007434
OCCCCc1nc(-c2ccc(F)cc2)c(-c2ccnc3[nH]c(-c4ccccc4)cc23)[nH]1,8.08,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,8.39,nM,=,CHEMBL4052480,B,CHEMBL4089892,Homo sapiens,CHEMBL203,CHEMBL4049460
CCC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3C)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,8.12,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,7.6,nM,=,CHEMBL4038017,B,CHEMBL4089951,Homo sapiens,CHEMBL203,CHEMBL4033795
NP(=O)(OCCCCOc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)N(CCCl)CCCl,8.13,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,7.4,nM,=,CHEMBL3993803,B,CHEMBL4090083,Homo sapiens,CHEMBL203,CHEMBL3992535
Fc1ccc(-c2nnc(Cc3nc4ccccc4[nH]3)o2)cc1,4.00,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,100000.0,nM,=,CHEMBL3995335,B,CHEMBL4090323,Homo sapiens,CHEMBL203,CHEMBL3994595
C=CC(=O)Nc1cc(Nc2n[nH]c3ccccc23)ccc1N(C)CCN(C)C,5.58,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,IC50,2626.0,nM,=,CHEMBL4009508,B,CHEMBL4090330,Homo sapiens,CHEMBL203,CHEMBL4007434
CN(C)C/C=C/C(=O)NCc1cccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)c1,8.13,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,7.41,nM,=,CHEMBL4052479,B,CHEMBL4090582,Homo sapiens,CHEMBL203,CHEMBL4049460
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc4ccccc4c3)c3c(N)ncnc32)C1,9.00,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,1.0,nM,=,CHEMBL4041413,B,CHEMBL4090601,Homo sapiens,CHEMBL203,CHEMBL4038351
CCC(=O)Nc1ccc(OC)c(Nc2cc(-c3[nH]c(CCCO)nc3-c3ccc(F)cc3)ccn2)c1,8.15,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,7.0,nM,=,CHEMBL5143769,B,CHEMBL4090686,Homo sapiens,CHEMBL203,CHEMBL5143505
Nc1nc(NCc2ccccc2)c2c(n1)[nH]c1cc(Cl)c(O)cc12,6.57,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,270.0,nM,=,CHEMBL4021780,B,CHEMBL4090945,Homo sapiens,CHEMBL203,CHEMBL4020756
CC(C)C[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.84,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,IC50,145.0,nM,=,CHEMBL4011794,B,CHEMBL4091010,Homo sapiens,CHEMBL203,CHEMBL4011588
O=C(Nc1ccc2nccc(Nc3cccc(Cl)c3)c2c1)C1CCC2(CC1)OCC1(OO2)C2CC3CC(C2)CC1C3,6.88,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain (695-end residues) expressed in insect cells by Z'-Lyte assay,IC50,132.1,nM,=,CHEMBL3999846,B,CHEMBL4091166,Homo sapiens,CHEMBL203,CHEMBL3997839
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)C(C)C5)cc4OC)nc32)c1,8.92,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,1.2,nM,=,CHEMBL4001768,B,CHEMBL4091276,Homo sapiens,CHEMBL203,CHEMBL4000215
Clc1ccc2nc(Cc3nnc(Cc4ccccc4)o3)[nH]c2c1,4.00,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,100000.0,nM,=,CHEMBL3995335,B,CHEMBL4091284,Homo sapiens,CHEMBL203,CHEMBL3994595
COc1ccccc1CNc1nc(N)nc2[nH]c3cc(C)c(O)cc3c12,5.39,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,4030.0,nM,=,CHEMBL4021780,B,CHEMBL4091355,Homo sapiens,CHEMBL203,CHEMBL4020756
OCCSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,8.96,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,1.1,nM,=,CHEMBL4013155,B,CHEMBL4091569,Homo sapiens,CHEMBL203,CHEMBL4011631
C#Cc1cccc(Nc2ncnc3ccc(OCCCCOP(N)(=O)N(CCCl)CCCl)cc23)c1,7.96,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,11.0,nM,=,CHEMBL3993803,B,CHEMBL4091626,Homo sapiens,CHEMBL203,CHEMBL3992535
S=C(NCc1ccccc1)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,7.94,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,11.4,nM,=,CHEMBL4011053,B,CHEMBL4091921,Homo sapiens,CHEMBL203,CHEMBL4007489
C=CC(=O)N1CCC[C@@H](n2nc(I)c3c(N)ncnc32)C1,7.70,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,20.0,nM,=,CHEMBL4041413,B,CHEMBL4091966,Homo sapiens,CHEMBL203,CHEMBL4038351
CC(=O)CCCSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,7.12,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,76.0,nM,=,CHEMBL4013155,B,CHEMBL4092003,Homo sapiens,CHEMBL203,CHEMBL4011631
CC(C)[C@@H](NC(=O)OC(C)(C)C)C(=O)Nc1ccc2ncnc(Nc3cccc(C(F)(F)F)c3)c2c1,5.99,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,IC50,1021.0,nM,=,CHEMBL4011794,B,CHEMBL4092491,Homo sapiens,CHEMBL203,CHEMBL4011588
Cc1cc(Nc2ncc3c(n2)N([C@H]2CCN(C(=O)C(C)(C)C)C2)C(=O)N(c2ccccc2Cl)C3)ccc1N1CCN(C)CC1,7.53,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,29.4,nM,=,CHEMBL4038017,B,CHEMBL4092632,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CC(=O)N(C)C,6.56,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,278.2,nM,=,CHEMBL4053812,B,CHEMBL4092788,Homo sapiens,CHEMBL203,CHEMBL4052618
CNC(=S)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.04,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,9.1,nM,=,CHEMBL4011053,B,CHEMBL4092951,Homo sapiens,CHEMBL203,CHEMBL4007489
S=C(Nc1cncc(Cl)c1)Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,7.26,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,55.5,nM,=,CHEMBL4011053,B,CHEMBL4092966,Homo sapiens,CHEMBL203,CHEMBL4007489
C=CC(=O)Nc1ccc(CN(C(=O)Nc2c(Cl)c(OC)cc(OC)c2Cl)c2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)cc1,7.78,Inhibition of EGFR L858R mutant (unknown origin),IC50,16.8,nM,=,CHEMBL3998355,B,CHEMBL4092990,Homo sapiens,CHEMBL203,CHEMBL3997770
Fc1c(NC(=S)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)cccc1C(F)(F)F,6.95,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,112.4,nM,=,CHEMBL4011053,B,CHEMBL4093114,Homo sapiens,CHEMBL203,CHEMBL4007489
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCN(C)C(C)C5)c(C)c4)nc32)C1,6.15,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,715.0,nM,=,CHEMBL4038017,B,CHEMBL4093535,Homo sapiens,CHEMBL203,CHEMBL4033795
COc1cc(Br)c(/C=C2\CN(C(C)C)CC(=C\c3nc(C)c(C)nc3C)/C2=N/O)cc1OC,5.31,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,IC50,4900.0,nM,=,CHEMBL4034792,B,CHEMBL4093642,Homo sapiens,CHEMBL203,CHEMBL4033650
C=CC(=O)N1CC[C@H](n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)C1,7.04,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,91.8,nM,=,CHEMBL4001768,B,CHEMBL4093766,Homo sapiens,CHEMBL203,CHEMBL4000215
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(/C=C/c4cc(OC)cc(OC)c4)cc3)ncc2Cl)c1,7.80,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",IC50,15.7,nM,=,CHEMBL4025984,B,CHEMBL4093954,Homo sapiens,CHEMBL203,CHEMBL4024721
C=CC(=O)Nc1cc(Nc2nc(OC)cc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.89,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,13.0,nM,=,CHEMBL4053812,B,CHEMBL4094086,Homo sapiens,CHEMBL203,CHEMBL4052618
Cc1cc2[nH]c3nc(N)nc(NCc4ccccc4)c3c2cc1O,6.19,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,640.0,nM,=,CHEMBL4021780,B,CHEMBL4094157,Homo sapiens,CHEMBL203,CHEMBL4020756
O=C(Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)C1CCC2(CC1)OOC1(CCCCC1)OO2,7.08,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,IC50,83.82,nM,=,CHEMBL3999845,B,CHEMBL4094174,Homo sapiens,CHEMBL203,CHEMBL3997839
C=CC(=O)Nc1cccc(-c2cc3c(-c4[nH]c(-c5ccccc5)nc4-c4ccc(F)cc4)ccnc3[nH]2)c1,7.49,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,32.1,nM,=,CHEMBL4052479,B,CHEMBL4094438,Homo sapiens,CHEMBL203,CHEMBL4049460
Clc1ccccc1-c1nnc(Cc2nc3ccccc3[nH]2)o1,5.35,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,4500.0,nM,=,CHEMBL3995335,B,CHEMBL4094471,Homo sapiens,CHEMBL203,CHEMBL3994595
C=CC(=O)N1CCC[C@@H](n2ncc3c(N)ncnc32)C1,5.80,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,IC50,1600.0,nM,=,CHEMBL4041414,B,CHEMBL4094527,Homo sapiens,CHEMBL203,CHEMBL4038351
Cc1nc(C)c(/C=C2\CC(C)C/C(=C\c3nc(C)c(C)nc3C)C2=NO)nc1C,5.62,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,IC50,2400.0,nM,=,CHEMBL4034792,B,CHEMBL4094546,Homo sapiens,CHEMBL203,CHEMBL4033650
Nc1ccc(O)c(-c2nnc(Cc3nc4ccccc4[nH]3)o2)c1,4.16,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,70000.0,nM,=,CHEMBL3995335,B,CHEMBL4094647,Homo sapiens,CHEMBL203,CHEMBL3994595
O=C(Nc1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)C1CCC2(CC1)OOC1(O2)C2CC3CC(C2)CC1C3,7.49,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,IC50,32.35,nM,=,CHEMBL3999845,B,CHEMBL4094823,Homo sapiens,CHEMBL203,CHEMBL3997839
CCC(=O)Nc1ccc(OC)c(Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c1,8.30,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,IC50,5.0,nM,=,CHEMBL4013157,B,CHEMBL4094927,Homo sapiens,CHEMBL203,CHEMBL4011631
C=CC(=O)N1CCC[C@@H](n2nc(-c3cn(C)c4ccccc34)c3c(N)ncnc32)C1,8.70,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,2.0,nM,=,CHEMBL4041413,B,CHEMBL4094959,Homo sapiens,CHEMBL203,CHEMBL4038351
Cc1cc(Nc2ncc3c(n2)N([C@H]2CCN(C(=O)C(C)C)C2)C(=O)N(c2ccccc2Cl)C3)ccc1N1CCN(C)CC1,8.07,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,8.5,nM,=,CHEMBL4038017,B,CHEMBL4095063,Homo sapiens,CHEMBL203,CHEMBL4033795
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)C1,5.96,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,1100.0,nM,=,CHEMBL4038017,B,CHEMBL4095071,Homo sapiens,CHEMBL203,CHEMBL4033795
Cc1ccccc1Cc1nnc(Cc2nc3ccccc3[nH]2)o1,4.30,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,50000.0,nM,=,CHEMBL3995335,B,CHEMBL4095195,Homo sapiens,CHEMBL203,CHEMBL3994595
C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21,6.19,Inhibition of recombinant human N-terminal GST-tagged EGFR (696 to end residues) expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay,IC50,642.7,nM,=,CHEMBL4058124,B,CHEMBL4095253,Homo sapiens,CHEMBL203,CHEMBL4052785
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(/C=C/c4ccc(C)cc4C)cc3)ncc2F)c1,8.09,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",IC50,8.1,nM,=,CHEMBL4025984,B,CHEMBL4095271,Homo sapiens,CHEMBL203,CHEMBL4024721
C=CC(=O)Nc1cc(Br)cc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.74,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,1.8,nM,=,CHEMBL4001768,B,CHEMBL4095439,Homo sapiens,CHEMBL203,CHEMBL4000215
C=CC(=O)N1CCC[C@@H](n2nc(-c3cccc4ccccc34)c3c(N)ncnc32)C1,9.00,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,1.0,nM,=,CHEMBL4041413,B,CHEMBL4095447,Homo sapiens,CHEMBL203,CHEMBL4038351
c1ccc(Cc2nnc(Cc3nc4ccccc4[nH]3)o2)cc1,4.60,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,25000.0,nM,=,CHEMBL3995335,B,CHEMBL4095623,Homo sapiens,CHEMBL203,CHEMBL3994595
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(CC)c4)nc32)C1,6.29,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,518.0,nM,=,CHEMBL4038017,B,CHEMBL4096014,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1cc(Nc2cc(-c3cn4c5c(cccc35)CCC4)ncn2)c(OC)cc1N(C)CCN(C)C,8.92,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,1.2,nM,=,CHEMBL4053811,B,CHEMBL4096021,Homo sapiens,CHEMBL203,CHEMBL4052618
C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4cc5c(s4)CCCC5)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1,5.16,"Inhibition of recombinant human N-terminal GST-tagged wild-type EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay",IC50,6863.0,nM,=,CHEMBL4024934,B,CHEMBL4096207,Homo sapiens,CHEMBL203,CHEMBL4024706
COc1ccc(Sc2cccc3[nH]c4nc(N)nc(N)c4c23)cc1,4.68,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells preincubated for 60 mins followed by EGF induction measured after 10 mins by ELISA,IC50,20800.0,nM,=,CHEMBL4007193,B,CHEMBL4096329,Homo sapiens,CHEMBL203,CHEMBL4004880
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,6.44,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,362.0,nM,=,CHEMBL4038017,B,CHEMBL4096822,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3[nH]c(SC)nc3-c3ccc4ccccc4c3)ccn2)c1,8.96,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,IC50,1.1,nM,=,CHEMBL4013157,B,CHEMBL4096980,Homo sapiens,CHEMBL203,CHEMBL4011631
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5C[C@H]6CN(C)C[C@H]6C5)c(C)c4)nc32)C1,6.67,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,216.0,nM,=,CHEMBL4038017,B,CHEMBL4096988,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N1CC(N(C)C)C1,8.31,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,4.9,nM,=,CHEMBL4053812,B,CHEMBL4097141,Homo sapiens,CHEMBL203,CHEMBL4052618
NP(=O)(OCCCOc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1)N(CCCl)CCCl,7.12,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,75.0,nM,=,CHEMBL3993803,B,CHEMBL4097216,Homo sapiens,CHEMBL203,CHEMBL3992535
NP(=O)(OCCCC(=O)Oc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1)N(CCCl)CCCl,8.06,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,8.7,nM,=,CHEMBL3993803,B,CHEMBL4097245,Homo sapiens,CHEMBL203,CHEMBL3992535
O=C(Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)c1ccco1,8.08,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,8.4,nM,=,CHEMBL4011053,B,CHEMBL4097369,Homo sapiens,CHEMBL203,CHEMBL4007489
C=CC(=O)Nc1cc(Nc2n[nH]c3ccc(-c4ccc(F)cc4)cc23)c(OC)cc1N(C)CCN(C)C,8.70,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,IC50,2.0,nM,=,CHEMBL4009507,B,CHEMBL4097594,Homo sapiens,CHEMBL203,CHEMBL4007434
Oc1cccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)c1,7.63,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,23.6,nM,=,CHEMBL4052479,B,CHEMBL4097627,Homo sapiens,CHEMBL203,CHEMBL4049460
CCC(=O)N1CC[C@H](N2C(=O)N(c3ccc(F)cc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.14,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,71.6,nM,=,CHEMBL4038017,B,CHEMBL4097682,Homo sapiens,CHEMBL203,CHEMBL4033795
CCC(=O)N1CC[C@H](N2C(=O)N(c3ccc(C)cc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,6.42,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,377.0,nM,=,CHEMBL4038017,B,CHEMBL4097770,Homo sapiens,CHEMBL203,CHEMBL4033795
NP(=O)(OCCCOc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1)N(CCCl)CCCl,8.24,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,5.7,nM,=,CHEMBL3993803,B,CHEMBL4097795,Homo sapiens,CHEMBL203,CHEMBL3992535
S=C(Nc1ccc(Cl)cc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.71,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,19.5,nM,=,CHEMBL4011053,B,CHEMBL4097862,Homo sapiens,CHEMBL203,CHEMBL4007489
C=CC(=O)Nc1cc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)cc(C(C)(C)C)c1,7.75,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,17.7,nM,=,CHEMBL4001768,B,CHEMBL4097883,Homo sapiens,CHEMBL203,CHEMBL4000215
C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c1,9.59,Inhibition of human EGFR L858R mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,IC50,0.26,nM,=,CHEMBL5155237,B,CHEMBL4098072,Homo sapiens,CHEMBL203,CHEMBL5154643
COc1ccc2c(c1)CCN2c1nc(C)nc2c(Cc3ccccc3)c[nH]c12.Cl,6.78,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,IC50,167.1,nM,=,CHEMBL3998244,B,CHEMBL4098409,Homo sapiens,CHEMBL203,CHEMBL3997769
CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3cc(N4CCN(C)CC4)cc([N+](=O)[O-])c3)c2)[nH]1,7.92,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,IC50,12.0,nM,=,CHEMBL4013157,B,CHEMBL4098412,Homo sapiens,CHEMBL203,CHEMBL4011631
C=CC(=O)Nc1cc(Nc2n[nH]c3cc(-c4cn(C)c5ccccc45)ccc23)c(OC)cc1N(C)CCN(C)C,8.82,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,IC50,1.5,nM,=,CHEMBL4009507,B,CHEMBL4098444,Homo sapiens,CHEMBL203,CHEMBL4007434
C=CC(=O)Nc1cc(Nc2n[nH]c3cc(-c4ccc(N(C)C)cc4)ccc23)c(OC)cc1N(C)CCN(C)C,7.14,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,IC50,72.0,nM,=,CHEMBL4009508,B,CHEMBL4098500,Homo sapiens,CHEMBL203,CHEMBL4007434
CCC(=O)N1CC[C@H](N2C(=O)N(c3ccccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.80,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,15.7,nM,=,CHEMBL4038017,B,CHEMBL4098507,Homo sapiens,CHEMBL203,CHEMBL4033795
CC(C)(C)OC(=O)NCC(=O)Nc1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1,7.77,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,IC50,17.0,nM,=,CHEMBL4011794,B,CHEMBL4098587,Homo sapiens,CHEMBL203,CHEMBL4011588
CCC(=O)N1CC[C@@H](N2C(=O)N(c3ccccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.63,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,23.4,nM,=,CHEMBL4038017,B,CHEMBL4098591,Homo sapiens,CHEMBL203,CHEMBL4033795
Cc1ccc(CNc2nc(N)nc3[nH]c4cc(C)c(O)cc4c23)cc1,5.25,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,5670.0,nM,=,CHEMBL4021780,B,CHEMBL4098682,Homo sapiens,CHEMBL203,CHEMBL4020756
C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N1CCC(CN(C)C)C1,8.72,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,1.9,nM,=,CHEMBL4053812,B,CHEMBL4098967,Homo sapiens,CHEMBL203,CHEMBL4052618
C=CC(=O)N1CCC(Cn2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)C1,7.20,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,63.8,nM,=,CHEMBL4001768,B,CHEMBL4099008,Homo sapiens,CHEMBL203,CHEMBL4000215
C[C@H](Nc1nc(N)nc2[nH]c3ccc(O)cc3c12)c1ccccc1,6.28,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,520.0,nM,=,CHEMBL4021780,B,CHEMBL4099089,Homo sapiens,CHEMBL203,CHEMBL4020756
C=CC(=O)N1CCC[C@@H](n2nc(C3CC3)c3c(N)ncnc32)C1,6.96,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,110.0,nM,=,CHEMBL4041413,B,CHEMBL4099254,Homo sapiens,CHEMBL203,CHEMBL4038351
COc1ccc(N(C)c2nc(N)nc3c(Cc4ccccc4)c[nH]c23)cc1,8.96,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,IC50,1.1,nM,=,CHEMBL3998244,B,CHEMBL4099329,Homo sapiens,CHEMBL203,CHEMBL3997769
C=CC(=O)Nc1cc(Nc2ncnc(-c3cn(C)c4ccccc34)c2F)c(OC)cc1N(C)CCN(C)C,8.00,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,9.9,nM,=,CHEMBL4053811,B,CHEMBL4099377,Homo sapiens,CHEMBL203,CHEMBL4052618
C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N1CCN(C)CC1,7.26,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,55.5,nM,=,CHEMBL4053812,B,CHEMBL4099445,Homo sapiens,CHEMBL203,CHEMBL4052618
COc1ccc(CNc2nc(N)nc3[nH]c4ccc(O)cc4c23)cc1,6.92,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,120.0,nM,=,CHEMBL4021780,B,CHEMBL4099589,Homo sapiens,CHEMBL203,CHEMBL4020756
COc1ccc(Nc2nc(C)nc3c(Cc4ccccc4)cn(C)c23)cc1.Cl,8.59,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,IC50,2.6,nM,=,CHEMBL3998244,B,CHEMBL4099682,Homo sapiens,CHEMBL203,CHEMBL3997769
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccccc3)c3c(N)ncnc32)C1,8.00,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,10.0,nM,=,CHEMBL4041413,B,CHEMBL4099713,Homo sapiens,CHEMBL203,CHEMBL4038351
Cc1nc(C)c(/C=C2\CC(C)C/C(=C\c3nc(C)c(C)nc3C)C2=O)nc1C,5.96,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,IC50,1100.0,nM,=,CHEMBL4034792,B,CHEMBL4100075,Homo sapiens,CHEMBL203,CHEMBL4033650
C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3[nH]c(SC)nc3C3CCC3)ccn2)c1,8.17,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,IC50,6.8,nM,=,CHEMBL4013157,B,CHEMBL4100377,Homo sapiens,CHEMBL203,CHEMBL4011631
CC1(C)OOC2(CCC(C(=O)Nc3ccc4ncnc(Nc5cccc(Cl)c5)c4c3)CC2)OO1,7.94,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,IC50,11.42,nM,=,CHEMBL3999845,B,CHEMBL4100647,Homo sapiens,CHEMBL203,CHEMBL3997839
C=CC(=O)N1CCC[C@@H](n2nc(-c3cccc(F)c3)c3c(N)ncnc32)C1,8.00,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,10.0,nM,=,CHEMBL4041413,B,CHEMBL4100655,Homo sapiens,CHEMBL203,CHEMBL4038351
C=CC(=O)NCc1cccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)c1,7.89,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,13.0,nM,=,CHEMBL4052479,B,CHEMBL4100759,Homo sapiens,CHEMBL203,CHEMBL4049460
C=CC(=O)Nc1cccc(Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)n1,8.51,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,IC50,3.1,nM,=,CHEMBL4013157,B,CHEMBL4100777,Homo sapiens,CHEMBL203,CHEMBL4011631
C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3[nH]c(CCCO)nc3-c3ccc(F)cc3)ccn2)c1,8.10,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,8.0,nM,=,CHEMBL5143769,B,CHEMBL4100860,Homo sapiens,CHEMBL203,CHEMBL5143505
CCC(=O)Nc1ccc(OC)c(Nc2cc(-c3cnc(SC)[nH]3)ccn2)c1,6.44,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,360.0,nM,=,CHEMBL4013155,B,CHEMBL4101193,Homo sapiens,CHEMBL203,CHEMBL4011631
OCCCc1nc(-c2ccc(F)cc2)c(-c2ccnc3[nH]c(-c4ccccc4)cc23)[nH]1,8.19,Inhibition of EGFR L858R/T790M double mutant (unknown origin),IC50,6.47,nM,=,CHEMBL4052484,B,CHEMBL4101719,Homo sapiens,CHEMBL203,CHEMBL4049460
CN(C)C/C=C/C(=O)N1CCC[C@@H](n2nc(-c3cccc(C(F)(F)F)c3)c3c(N)ncnc32)C1,6.00,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,1000.0,nM,=,CHEMBL4041413,B,CHEMBL4101735,Homo sapiens,CHEMBL203,CHEMBL4038351
O=S(=O)(Nc1nccs1)c1ccc(NC(=S)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)cc1,7.66,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,22.0,nM,=,CHEMBL4011053,B,CHEMBL4101774,Homo sapiens,CHEMBL203,CHEMBL4007489
COc1ccccc1CNc1nc(N)nc2[nH]c3ccc(O)cc3c12,5.73,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr)4:1 as substrate in presence of [gamma-33P]-ATP after 60 mins by scintillation counting analysis",Ki,1870.0,nM,=,CHEMBL4021780,B,CHEMBL4102074,Homo sapiens,CHEMBL203,CHEMBL4020756
C=CC(=O)NCc1cccc(-c2cc3c(-c4[nH]c(-c5ccccc5)nc4-c4ccc(F)cc4)ccnc3[nH]2)c1,7.47,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,IC50,34.2,nM,=,CHEMBL4052479,B,CHEMBL4102179,Homo sapiens,CHEMBL203,CHEMBL4049460
c1ccc(C(c2ccccc2)c2nnc(Cc3nc4ccccc4[nH]3)o2)cc1,4.35,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,45000.0,nM,=,CHEMBL3995335,B,CHEMBL4102214,Homo sapiens,CHEMBL203,CHEMBL3994595
CCC(=O)NCCSc1nc(-c2ccc(F)cc2)c(-c2ccnc(Nc3ccccc3)c2)[nH]1,8.49,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,3.2,nM,=,CHEMBL4013155,B,CHEMBL4102224,Homo sapiens,CHEMBL203,CHEMBL4011631
Cc1nc(C)c(/C=C2\CN(C(C)C)C/C(=C\c3nc(C)c(C)nc3C)C2=NO)nc1C,5.41,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,IC50,3900.0,nM,=,CHEMBL4034792,B,CHEMBL4102284,Homo sapiens,CHEMBL203,CHEMBL4033650
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCOCC5)c(C)c4)nc32)C1,6.20,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,626.0,nM,=,CHEMBL4038017,B,CHEMBL4102288,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1cc(CC)cc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.47,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,3.4,nM,=,CHEMBL4001768,B,CHEMBL4102389,Homo sapiens,CHEMBL203,CHEMBL4000215
S=C(Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)Nc1ccccc1Cl,7.80,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,15.8,nM,=,CHEMBL4011053,B,CHEMBL4102455,Homo sapiens,CHEMBL203,CHEMBL4007489
CCC(=O)Nc1cccc(Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c1,8.17,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,IC50,6.8,nM,=,CHEMBL4013155,B,CHEMBL4102577,Homo sapiens,CHEMBL203,CHEMBL4011631
Cc1cc(Nc2ncc3c(n2)N([C@H]2CCN(C(=O)C4CCCCC4)C2)C(=O)N(c2ccccc2Cl)C3)ccc1N1CCN(C)CC1,7.60,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,24.9,nM,=,CHEMBL4038017,B,CHEMBL4102822,Homo sapiens,CHEMBL203,CHEMBL4033795
C#Cc1cccc(Nc2ncnc3cc(OCCCN4C[C@H](O)[C@@H](O)[C@H](O)[C@H]4CO)c(OC)cc23)c1,8.31,Inhibition of wild type recombinant EGFR (unknown origin) by ELISA,IC50,4.87,nM,=,CHEMBL4046770,B,CHEMBL4102886,Homo sapiens,CHEMBL203,CHEMBL4043197
Clc1ccc(-c2nnc(Cc3nc4ccc(Cl)cc4[nH]3)o2)c(Cl)c1,4.35,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,45100.0,nM,=,CHEMBL3995335,B,CHEMBL4102942,Homo sapiens,CHEMBL203,CHEMBL3994595
CCC(=O)N1CCC[C@@H](n2nc(-c3ccc(F)cc3)c3c(N)ncnc32)C1,5.30,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,5000.0,nM,=,CHEMBL4041413,B,CHEMBL4103121,Homo sapiens,CHEMBL203,CHEMBL4038351
C=CC(=O)Nc1cc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)C(C)C5)cc4OC)nc32)cc(C(F)(F)F)c1,8.80,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,1.6,nM,=,CHEMBL4001768,B,CHEMBL4103194,Homo sapiens,CHEMBL203,CHEMBL4000215
C=CC(=O)N1CCC[C@@H](n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)C1,8.70,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,IC50,2.0,nM,=,CHEMBL4041413,B,CHEMBL4103201,Homo sapiens,CHEMBL203,CHEMBL4038351
Clc1ccc(-c2nnc(Cc3nc4ccccc4[nH]3)o2)cc1,7.09,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,IC50,81.0,nM,=,CHEMBL3995335,B,CHEMBL4103370,Homo sapiens,CHEMBL203,CHEMBL3994595
COc1ccc(-c2nnc(-n3c(-c4ccccc4)nc4cc(Cl)ccc4c3=O)s2)cc1,7.68,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,IC50,21.0,nM,=,CHEMBL4025907,B,CHEMBL4103440,Homo sapiens,CHEMBL203,CHEMBL4024718
O=C(NCc1ccccc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,8.05,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,IC50,8.9,nM,=,CHEMBL4011053,B,CHEMBL4103464,Homo sapiens,CHEMBL203,CHEMBL4007489
C=CC(=O)Nc1cc(Nc2n[nH]c3cc(-c4cccc(N(C)C)c4)ccc23)c(OC)cc1N(C)CCN(C)C,8.00,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,IC50,10.0,nM,=,CHEMBL4009507,B,CHEMBL4103757,Homo sapiens,CHEMBL203,CHEMBL4007434
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(Cl)c4)nc32)C1,5.92,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,1200.0,nM,=,CHEMBL4038017,B,CHEMBL4103761,Homo sapiens,CHEMBL203,CHEMBL4033795
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5C[C@@H](C)N(C)[C@@H](C)C5)c(C)c4)nc32)C1,6.05,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,888.2,nM,=,CHEMBL4038017,B,CHEMBL4103893,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccc(F)cc34)n2)c(OC)cc1N(C)CCN(C)C,8.31,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate in presence of ATP by Z-LYTE kinase assay,IC50,4.9,nM,=,CHEMBL4044503,B,CHEMBL4103912,Homo sapiens,CHEMBL203,CHEMBL4043110
Cc1nc(C)c(/C=C2\CN(C(C)C)C/C(=C\c3nc(C)c(C)nc3C)C2=O)nc1C,5.60,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,IC50,2500.0,nM,=,CHEMBL4034792,B,CHEMBL4104427,Homo sapiens,CHEMBL203,CHEMBL4033650
COc1ccc2c(c1)CCCN2c1nc(C)nc2c(Cc3ccccc3)cn(C)c12.Cl,8.31,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,IC50,4.9,nM,=,CHEMBL3998244,B,CHEMBL4104515,Homo sapiens,CHEMBL203,CHEMBL3997769
C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C,8.59,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,IC50,2.6,nM,=,CHEMBL4053812,B,CHEMBL4104658,Homo sapiens,CHEMBL203,CHEMBL4052618
CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3F)Cc3cnc(Nc4ccc(N5CCC6(CCN(C)CC6)CC5)c(C)c4)nc32)C1,6.65,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,224.5,nM,=,CHEMBL4038017,B,CHEMBL4104717,Homo sapiens,CHEMBL203,CHEMBL4033795
COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OCCCOP(N)(=O)N(CCCl)CCCl,7.66,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,22.0,nM,=,CHEMBL3993803,B,CHEMBL4104950,Homo sapiens,CHEMBL203,CHEMBL3992535
Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12,8.51,"Inhibition of recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,3.1,nM,=,CHEMBL4018631,B,CHEMBL4105329,Homo sapiens,CHEMBL203,CHEMBL4017490
CCC(=O)N1CC[C@H](N2C(=O)N(c3ccc(Cl)cc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,6.42,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,383.0,nM,=,CHEMBL4038017,B,CHEMBL4105392,Homo sapiens,CHEMBL203,CHEMBL4033795
CCCCOC(=O)c1c(-c2ccccc2)nn2ccccc12,4.62,"Inhibition of recombinant EGFR (unknown origin) using poly (Glu4, Tyr) as substrate after 60 mins by ADP-glo kinase assay",IC50,23700.0,nM,=,CHEMBL4002953,B,CHEMBL4105434,Homo sapiens,CHEMBL203,CHEMBL4002564
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(/C=C/c4ccc(C)cc4C)cc3)ncc2Cl)c1,8.17,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",IC50,6.8,nM,=,CHEMBL4025984,B,CHEMBL4105442,Homo sapiens,CHEMBL203,CHEMBL4024721
CCC(=O)N1CC[C@H](N2C(=O)N(c3cccc(OC)c3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,6.38,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,IC50,417.0,nM,=,CHEMBL4038017,B,CHEMBL4105503,Homo sapiens,CHEMBL203,CHEMBL4033795
C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3[nH]c(SC)nc3C3CC3)ccn2)c1,8.13,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,IC50,7.4,nM,=,CHEMBL4013157,B,CHEMBL4105526,Homo sapiens,CHEMBL203,CHEMBL4011631
NP(=O)(OCCCCOc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1)N(CCCl)CCCl,7.57,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",IC50,27.0,nM,=,CHEMBL3993803,B,CHEMBL4105530,Homo sapiens,CHEMBL203,CHEMBL3992535
C=CC(=O)Nc1cc(Cl)cc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.22,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,0.6,nM,=,CHEMBL4001768,B,CHEMBL4105621,Homo sapiens,CHEMBL203,CHEMBL4000215
Cc1[nH]c2ncnc(NC3CCCCC3)c2c1C,5.16,In vitro inhibitory activity against epidermal growth factor receptor,IC50,6920.0,nM,=,CHEMBL677880,B,CHEMBL4106341,Homo sapiens,CHEMBL203,CHEMBL1129072
CC#CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,6.36,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,435.3,nM,=,CHEMBL3887533,B,CHEMBL4106607,Homo sapiens,CHEMBL203,CHEMBL3886356
Cc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2C[C@H]1CCCN1C(=O)/C=C/CN(C)C,7.72,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,18.85,nM,=,CHEMBL3888240,B,CHEMBL4107818,Homo sapiens,CHEMBL203,CHEMBL3886627
CC#CC(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,6.54,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,289.4,nM,=,CHEMBL3887533,B,CHEMBL4107879,Homo sapiens,CHEMBL203,CHEMBL3886356
C=CC(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21,7.73,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,18.75,nM,=,CHEMBL3887533,B,CHEMBL4109796,Homo sapiens,CHEMBL203,CHEMBL3886356
CN(C)CC/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC[C@]12COC[C@H]1C2,9.27,"Time-Resolved Fret (TR-FRET) Assay: 1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dilutions of 10 fold from 100 micoM are used. Kinase activity was determined with time-resolved Fret (TR-FRET) assay (LanthaScreen® kinase activity assay, from InVitrogen).2) The assay is performed in a Black 384-well plate (from Corning). The kinase and the compound was incubated for 30 mM at room temperature. ATP (1 mM) and fluorescein-poly GT were added, and the reaction was incubated for 15 mM. Detection agent SA-XL665 (from Cisbio Assay) and TK Ab-Cryptate detection antibody (from InVitrogen) were added to stop the reaction.3) The 384-well plate was sealed and incubated for 1 hour. The fluorescence was then measured at 620 nM (Cryptate) and 665 nM (XL655) wavelength.4) Each concentration of compound was done in triplicate, and vehicle (without compound) and a positive control were used.",IC50,0.54,nM,=,CHEMBL3887593,B,CHEMBL4110258,Homo sapiens,CHEMBL203,CHEMBL3886368
Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)nn2[C@@H]1CCCN(C(=O)/C=C/CN2CCOCC2)C1,6.42,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",IC50,383.7,nM,=,CHEMBL3887533,B,CHEMBL4110614,Homo sapiens,CHEMBL203,CHEMBL3886356
CC(=O)Nc1cccc(Nc2nc3cnc(Nc4ccc(C(=O)N[N+]5=CCN(C)CC5)cc4F)nc3n2C(C)C)c1,7.60,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,25.0,nM,=,CHEMBL3706157,B,CHEMBL4111809,Homo sapiens,CHEMBL203,CHEMBL3638579
CO[C@@H]1COC2C1OC[C@H]2Oc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,9.40,"Time-Resolved Fret (TR-FRET) Assay: 1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dilutions of 10 fold from 100 micoM are used. Kinase activity was determined with time-resolved Fret (TR-FRET) assay (LanthaScreen® kinase activity assay, from InVitrogen).2) The assay is performed in a Black 384-well plate (from Corning). The kinase and the compound was incubated for 30 mM at room temperature. ATP (1 mM) and fluorescein-poly GT were added, and the reaction was incubated for 15 mM. Detection agent SA-XL665 (from Cisbio Assay) and TK Ab-Cryptate detection antibody (from InVitrogen) were added to stop the reaction.3) The 384-well plate was sealed and incubated for 1 hour. The fluorescence was then measured at 620 nM (Cryptate) and 665 nM (XL655) wavelength.4) Each concentration of compound was done in triplicate, and vehicle (without compound) and a positive control were used.",IC50,0.4,nM,=,CHEMBL3887593,B,CHEMBL4112924,Homo sapiens,CHEMBL203,CHEMBL3886368
CC(C)n1c(Nc2ccccc2)nc2cnc(Nc3ccc(C(=O)N[N+]4=CCN(C)CC4)cc3)nc21,8.52,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",IC50,3.0,nM,=,CHEMBL3706157,B,CHEMBL4113919,Homo sapiens,CHEMBL203,CHEMBL3638579
CC(C)(C)/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1,6.43,Inhibition of EGFR (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method,IC50,368.0,nM,=,CHEMBL5104912,B,CHEMBL4114766,Homo sapiens,CHEMBL203,CHEMBL5104103
COc1ccc(N(C)c2nc(C)nc3c(Cc4ccccc4)cn(C)c23)cc1,8.64,Inhibition of EGFR (unknown origin),IC50,2.3,nM,=,CHEMBL5138507,B,CHEMBL4116552,Homo sapiens,CHEMBL203,CHEMBL5137005
COc1ccc2c(c1)CCCN2c1nc(C)nc2c(Cc3ccccc3)cn(C)c12,8.31,Inhibition of EGFR (unknown origin),IC50,4.9,nM,=,CHEMBL5138507,B,CHEMBL4117373,Homo sapiens,CHEMBL203,CHEMBL5137005
C=CC(=O)N[C@@H]1CCN(c2nc(Nc3ccccc3)nc3cnc(Nc4ccc(N5CCN(C)CC5)cn4)cc23)C1,8.33,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",IC50,4.7,nM,=,CHEMBL4124414,B,CHEMBL4125764,Homo sapiens,CHEMBL203,CHEMBL4118234
C=CC(=O)Nc1cccc(-n2c(=O)n(C)c(=O)c3cnc(Nc4ccc(N5CCSCC5)cc4OC)nc32)c1,7.04,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,91.0,nM,=,CHEMBL4125335,B,CHEMBL4125772,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)N1CC[C@H](Nc2nc(Nc3ccccc3)nc3cnc(Nc4ccc(N5CCN(C)CC5)cn4)cc23)C1,7.97,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",IC50,10.8,nM,=,CHEMBL4124414,B,CHEMBL4125840,Homo sapiens,CHEMBL203,CHEMBL4118234
C=CC(=O)Nc1cccc(-n2c(=O)n(C(C)C)c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)c(OC)c4)nc32)c1,8.17,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,6.8,nM,=,CHEMBL4125335,B,CHEMBL4125940,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)Nc1cccc(-n2c(=O)n(CC)c(=O)c3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1,8.60,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,2.5,nM,=,CHEMBL4125335,B,CHEMBL4126358,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)Nc1cccc(-n2c(=O)n(C(C)C)c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)c1,9.00,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,1.0,nM,=,CHEMBL4125335,B,CHEMBL4126630,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)Nc1cccc(-n2c(=O)n(C)c(=O)c3cnc(Nc4ccc(N5CCOCC5)cc4OC)nc32)c1,7.16,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,70.0,nM,=,CHEMBL4125335,B,CHEMBL4126654,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)Nc1cccc(-n2c(=O)n(C)c(=O)c3cnc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)nc32)c1,7.34,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,46.0,nM,=,CHEMBL4125335,B,CHEMBL4126797,Homo sapiens,CHEMBL203,CHEMBL4118273
CN1CCN(c2ccc(Nc3cc4c(N[C@H]5CCCN(C)C5)nc(Nc5ccccc5)nc4cn3)nc2)CC1,8.77,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",IC50,1.7,nM,=,CHEMBL4124414,B,CHEMBL4126810,Homo sapiens,CHEMBL203,CHEMBL4118234
C=CC(=O)Nc1cccc(-n2c(=O)n(C(C)C)c(=O)c3cnc(Nc4ccc(OCCN(C)C)cc4OC)nc32)c1,6.94,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,115.0,nM,=,CHEMBL4125335,B,CHEMBL4126986,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)Nc1cccc(-n2c(=O)n(C(C)C)c(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.52,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,0.3,nM,=,CHEMBL4125335,B,CHEMBL4127317,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)N[C@H]1CCN(c2nc(Nc3ccccc3)nc3cnc(Nc4ccc(N5CCN(C)CC5)cn4)cc23)C1,8.49,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",IC50,3.2,nM,=,CHEMBL4124414,B,CHEMBL4127809,Homo sapiens,CHEMBL203,CHEMBL4118234
C=CC(=O)N1CC[C@@H](Nc2nc(Nc3ccccc3)nc3cnc(Nc4ccc(N5CCN(C)CC5)cn4)cc23)C1,8.34,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",IC50,4.6,nM,=,CHEMBL4124414,B,CHEMBL4127897,Homo sapiens,CHEMBL203,CHEMBL4118234
C=CC(=O)Nc1cccc(-n2c(=O)n(Cc3ccccc3)c(=O)c3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1,8.72,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,1.9,nM,=,CHEMBL4125335,B,CHEMBL4128415,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)Nc1cccc(-n2c(=O)n(CCc3ccccc3)c(=O)c3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1,9.00,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,1.0,nM,=,CHEMBL4125335,B,CHEMBL4128567,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)Nc1cccc(-n2c(=O)n(C)c(=O)c3cnc(Nc4ccccc4)nc32)c1,7.17,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,68.0,nM,=,CHEMBL4125335,B,CHEMBL4128726,Homo sapiens,CHEMBL203,CHEMBL4118273
CN1CCN(c2ccc(Nc3cc4c(N[C@@H]5CCCN(C)C5)nc(Nc5ccccc5)nc4cn3)nc2)CC1,8.35,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",IC50,4.5,nM,=,CHEMBL4124414,B,CHEMBL4129138,Homo sapiens,CHEMBL203,CHEMBL4118234
C=CC(=O)N[C@@H]1CCCN(c2nc(Nc3ccccc3)nc3cnc(Nc4ccc(N5CCN(C)CC5)cn4)cc23)C1,8.19,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",IC50,6.5,nM,=,CHEMBL4124414,B,CHEMBL4129209,Homo sapiens,CHEMBL203,CHEMBL4118234
C=CC(=O)N[C@H]1CCCN(c2nc(Nc3ccccc3)nc3cnc(Nc4ccc(N5CCN(C)CC5)cn4)cc23)C1,7.85,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",IC50,14.2,nM,=,CHEMBL4124414,B,CHEMBL4129287,Homo sapiens,CHEMBL203,CHEMBL4118234
C=CC(=O)Nc1cccc(-n2c(=O)n(C)c(=O)c3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1,7.52,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,30.0,nM,=,CHEMBL4125335,B,CHEMBL4129387,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)Nc1cccc(-n2c(=O)n(C(C)C)c(=O)c3cnc(Nc4ccc(N5CCC(N6CCN(C)CC6)CC5)cc4OC)nc32)c1,7.85,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,14.0,nM,=,CHEMBL4125335,B,CHEMBL4129607,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)Nc1cccc(-n2c(=O)n(CCC)c(=O)c3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1,9.40,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,0.4,nM,=,CHEMBL4125335,B,CHEMBL4129646,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)Nc1cccc(-n2c(=O)n(C(C)C)c(=O)c3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1,9.10,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,0.8,nM,=,CHEMBL4125335,B,CHEMBL4129781,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)Nc1cccc(-n2c(=O)n(C(C)C)c(=O)c3cnc(Nc4ccc(N(C)CCN(C)C)cc4OC)nc32)c1,7.80,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,16.0,nM,=,CHEMBL4125335,B,CHEMBL4129902,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)Nc1cccc(-n2c(=O)n(CCCc3ccccc3)c(=O)c3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cc4OC)nc32)c1,8.85,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",IC50,1.4,nM,=,CHEMBL4125335,B,CHEMBL4130016,Homo sapiens,CHEMBL203,CHEMBL4118273
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3-c3ccn(C)n3)n2)c(OC)cc1N1CCC(N(C)C)CC1,7.42,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,38.5,nM,=,CHEMBL4154496,B,CHEMBL4159404,Homo sapiens,CHEMBL203,CHEMBL4152247
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1,8.44,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant expressed in Baculovirus expression system using Tyr 4 peptide as substrate after 1 hr in presence of ATP by Z-LYTE assay,IC50,3.6,nM,=,CHEMBL4145703,B,CHEMBL4159909,Homo sapiens,CHEMBL203,CHEMBL4145441
COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)cc4F)cc3)ccnc2cc1OCCCN1CCOCC1,5.47,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,IC50,3350.0,nM,=,CHEMBL4393297,B,CHEMBL4160329,Homo sapiens,CHEMBL203,CHEMBL4392844
Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4cc(Br)ccc4OC(F)(F)F)cc3)c12,5.27,Inhibition of EGFR (unknown origin),IC50,5400.0,nM,=,CHEMBL4140585,B,CHEMBL4160854,Homo sapiens,CHEMBL203,CHEMBL4138129
COc1cc2ncnc(N3CCc4ccccc43)c2cc1NC(=O)/C=C/CN1CCCCC1,7.34,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,IC50,45.4,nM,=,CHEMBL4155049,B,CHEMBL4161396,Homo sapiens,CHEMBL203,CHEMBL4152264
Fc1cccc(COc2ccc(Nc3ncnc4cc(OCCCN5CCOCC5)c(OCCCN5CCOCC5)cc34)cc2Cl)c1,8.15,Inhibition of recombinant human N-terminal His-tagged EGFR (1 to 645 residues) expressed in HEK293 cells by ELISA,IC50,7.0,nM,=,CHEMBL4148356,B,CHEMBL4161938,Homo sapiens,CHEMBL203,CHEMBL4145533
CCC/C=C/C(=O)Nc1cc2c(N3CCCc4ccccc43)ncnc2cc1OC,7.48,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,IC50,33.0,nM,=,CHEMBL4155049,B,CHEMBL4162530,Homo sapiens,CHEMBL203,CHEMBL4152264
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3-n3nccn3)n2)c(OC)cc1N(C)CCN(C)C,7.48,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,33.1,nM,=,CHEMBL4154496,B,CHEMBL4162767,Homo sapiens,CHEMBL203,CHEMBL4152247
CC/C=C/C(=O)Nc1cc2c(N3CCc4ccccc43)ncnc2cc1OC,7.77,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,IC50,17.0,nM,=,CHEMBL4155049,B,CHEMBL4162882,Homo sapiens,CHEMBL203,CHEMBL4152264
CN(CCN(C)Cc1ccc(C(=O)Nc2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)cc1)CCn1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21,6.50,Inhibition of human A431 cells derived EGFR by ELISA,IC50,320.0,nM,=,CHEMBL4139114,B,CHEMBL4163321,Homo sapiens,CHEMBL203,CHEMBL4138087
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3-c3ccn(C)n3)n2)c(OC)cc1OCCN(C)C,7.79,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,16.4,nM,=,CHEMBL4154496,B,CHEMBL4164396,Homo sapiens,CHEMBL203,CHEMBL4152247
COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,9.70,Inhibition of EGFR (unknown origin) using Tyr 04 peptide as substrate incubated for 1 hr by Z'-LYTE assay,IC50,0.2,nM,=,CHEMBL4718840,B,CHEMBL4164805,Homo sapiens,CHEMBL203,CHEMBL4715760
NS(=O)(=O)c1ccc(-n2c(SCC(=O)Nc3cc(Cl)c(Cl)cc3Cl)nc3cc4ccccc4cc3c2=O)cc1,6.62,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus virus expression system after 1 hr by ELISA,IC50,240.0,nM,=,CHEMBL4135134,B,CHEMBL4164936,Homo sapiens,CHEMBL203,CHEMBL4130490
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3-n3nccn3)n2)c(OC)cc1N1CCOCC1,6.08,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,838.5,nM,=,CHEMBL4154496,B,CHEMBL4165126,Homo sapiens,CHEMBL203,CHEMBL4152247
C/C=C/C(=O)Nc1cc2c(N3CCc4ccccc43)ncnc2cc1O[C@@H]1CCOC1,7.54,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,IC50,29.0,nM,=,CHEMBL4155049,B,CHEMBL4165267,Homo sapiens,CHEMBL203,CHEMBL4152264
COc1cc2ncnc(N3CCc4ccccc43)c2cc1NC(=O)/C=C/CN1CCCC1,8.52,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,IC50,3.0,nM,=,CHEMBL4155049,B,CHEMBL4165894,Homo sapiens,CHEMBL203,CHEMBL4152264
COc1cc(-n2cc(CN3CCNCC3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,6.05,Inhibition of recombinant human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay,IC50,890.0,nM,=,CHEMBL4136451,B,CHEMBL4166038,Homo sapiens,CHEMBL203,CHEMBL4130574
O=C(CN1CCCCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.43,Inhibition of EGFR in human MCF7 cell lysates after 24 to 48 hrs by ELISA,IC50,37.0,nM,=,CHEMBL4156805,B,CHEMBL4166069,Homo sapiens,CHEMBL203,CHEMBL4152342
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3-n3cccn3)n2)c(OC)cc1N1CCN(C)CC1,6.85,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,142.7,nM,=,CHEMBL4154496,B,CHEMBL4166210,Homo sapiens,CHEMBL203,CHEMBL4152247
NS(=O)(=O)c1ccc(-n2c(SCC(=O)Nc3cnc4ccccc4c3)nc3cc4ccccc4cc3c2=O)cc1,6.96,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus virus expression system after 1 hr by ELISA,IC50,110.0,nM,=,CHEMBL4135134,B,CHEMBL4166412,Homo sapiens,CHEMBL203,CHEMBL4130490
COc1cc(-n2cc(CN3C[C@@H](C)N[C@@H](C)C3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,6.06,Inhibition of recombinant human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay,IC50,865.0,nM,=,CHEMBL4136451,B,CHEMBL4166436,Homo sapiens,CHEMBL203,CHEMBL4130574
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3-n3cccn3)n2)c(OC)cc1N(C)CCN(C)C,8.39,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,4.1,nM,=,CHEMBL4154496,B,CHEMBL4166609,Homo sapiens,CHEMBL203,CHEMBL4152247
O=C(CN1CCCC1)Nc1ccc2ncnc(Nc3ccc(Cl)cc3)c2c1,7.50,Inhibition of EGFR in human MCF7 cell lysates after 24 to 48 hrs by ELISA,IC50,32.0,nM,=,CHEMBL4156805,B,CHEMBL4167162,Homo sapiens,CHEMBL203,CHEMBL4152342
COc1cc2c(Nc3ccc(C#N)cc3)ncnc2cc1OCCCN1CCC(c2ccccc2)CC1,8.44,Inhibition of recombinant human His-tagged EGFR (1 to 645 residues) expressed in HEK293 cells using Tyr66-biotinylated PTP1B peptide as substrate preincubated for 5 mins followed by substrate addition measured after 1 hr by ELISA,IC50,3.62,nM,=,CHEMBL4131304,B,CHEMBL4168235,Homo sapiens,CHEMBL203,CHEMBL4130355
CN(C)C/C=C/C(=O)Nc1cc2c(N3CCc4ccccc43)ncnc2cc1O[C@@H]1CCOC1,8.30,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,IC50,5.0,nM,=,CHEMBL4155049,B,CHEMBL4168254,Homo sapiens,CHEMBL203,CHEMBL4152264
CN1CCN(CC(=O)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)CC1,7.50,Inhibition of EGFR in human MCF7 cell lysates after 24 to 48 hrs by ELISA,IC50,32.0,nM,=,CHEMBL4156805,B,CHEMBL4169489,Homo sapiens,CHEMBL203,CHEMBL4152342
COc1cccc(OC)c1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2[nH]1,9.22,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.6,nM,=,CHEMBL4718820,B,CHEMBL4170121,Homo sapiens,CHEMBL203,CHEMBL4715760
O=C(CN1CCCC1)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)cc3)c2c1,7.15,Inhibition of EGFR in human MCF7 cell lysates after 24 to 48 hrs by ELISA,IC50,71.0,nM,=,CHEMBL4156805,B,CHEMBL4170916,Homo sapiens,CHEMBL203,CHEMBL4152342
COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccccc4F)cc3)ccnc2cc1OCCCN1CCOCC1,5.39,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,IC50,4100.0,nM,=,CHEMBL4393297,B,CHEMBL4170935,Homo sapiens,CHEMBL203,CHEMBL4392844
COc1cc2c(Oc3ccc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)c(F)c3)ccnc2cc1OCCCN1CCCC1,6.09,"Inhibition of EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,812.0,nM,=,CHEMBL4147642,B,CHEMBL4171115,Homo sapiens,CHEMBL203,CHEMBL4145515
C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)cn1,8.06,Inhibition of EGFR (unknown origin),IC50,8.7,nM,=,CHEMBL4135864,B,CHEMBL4171543,Homo sapiens,CHEMBL203,CHEMBL4130538
Brc1cccc(Nc2ncnc3sc4c(c23)CCCC4)c1,8.58,Inhibition of EGFR1 (unknown origin) after 1 hr in presence of adenosine 5'[gamma-33P]triphosphate by microbeta microplate counting method,IC50,2.61,nM,=,CHEMBL4132129,B,CHEMBL4171764,Homo sapiens,CHEMBL203,CHEMBL4130368
COc1cc2ncnc(N3CCc4ccccc43)c2cc1NC(=O)/C=C/CN1CCC(CO)CC1,8.40,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,IC50,4.0,nM,=,CHEMBL4155049,B,CHEMBL4172718,Homo sapiens,CHEMBL203,CHEMBL4152264
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3-n3nccn3)n2)c(OC)cc1N1CCN(C)CC1,6.76,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,174.5,nM,=,CHEMBL4154496,B,CHEMBL4173032,Homo sapiens,CHEMBL203,CHEMBL4152247
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3-n3nccn3)n2)c(OC)cc1N1CCC(N(C)C)CC1,6.69,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,202.3,nM,=,CHEMBL4154496,B,CHEMBL4173470,Homo sapiens,CHEMBL203,CHEMBL4152247
C/C=C/c1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(OCCCN4CCOCC4)cc23)cc1,7.68,Inhibition of recombinant human N-terminal His-tagged EGFR (1 to 645 residues) expressed in HEK293 cells by ELISA,IC50,20.7,nM,=,CHEMBL4148356,B,CHEMBL4173696,Homo sapiens,CHEMBL203,CHEMBL4145533
OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1,9.70,Inhibition of EGFR (unknown origin) using Tyr 04 peptide as substrate incubated for 1 hr by Z'-LYTE assay,IC50,0.2,nM,=,CHEMBL4718840,B,CHEMBL4175024,Homo sapiens,CHEMBL203,CHEMBL4715760
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3-c3ccn(C)n3)n2)c(OC)cc1N(C)CCN(C)C,8.39,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,4.1,nM,=,CHEMBL4154496,B,CHEMBL4175045,Homo sapiens,CHEMBL203,CHEMBL4152247
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3-c3ncn(C)n3)n2)c(OC)cc1N(C)CCN(C)C,8.11,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,7.7,nM,=,CHEMBL4154496,B,CHEMBL4175782,Homo sapiens,CHEMBL203,CHEMBL4152247
NS(=O)(=O)c1ccc(-n2c(SCC(=O)Nc3ccc([N+](=O)[O-])cc3[N+](=O)[O-])nc3cc4ccccc4cc3c2=O)cc1,7.22,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus virus expression system after 1 hr by ELISA,IC50,60.0,nM,=,CHEMBL4135134,B,CHEMBL4176629,Homo sapiens,CHEMBL203,CHEMBL4130490
COc1cc2ncnc(N3CCCc4ccccc43)c2cc1NC(=O)/C=C/CN(C)C,7.14,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,IC50,72.0,nM,=,CHEMBL4155049,B,CHEMBL4176787,Homo sapiens,CHEMBL203,CHEMBL4152264
O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,7.01,Inhibition of EGFR in human MCF7 cell lysates after 24 to 48 hrs by ELISA,IC50,98.0,nM,=,CHEMBL4156805,B,CHEMBL4177348,Homo sapiens,CHEMBL203,CHEMBL4152342
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)COCc3ccccc3)c2)n1,5.97,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,1070.0,nM,=,CHEMBL4179475,B,CHEMBL4202413,Homo sapiens,CHEMBL203,CHEMBL4177590
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccccc2NC(=O)/C=C/CN(C)C)n1,5.22,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,6070.0,nM,=,CHEMBL4179474,B,CHEMBL4202780,Homo sapiens,CHEMBL203,CHEMBL4177590
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)/C=C/CN(C)C)c2)n1,5.42,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,3800.0,nM,=,CHEMBL4179475,B,CHEMBL4202955,Homo sapiens,CHEMBL203,CHEMBL4177590
CN(CCO)c1nc(Nc2ccccc2)nc2cnc(Nc3ccc(N4CCC(N(C)C)CC4)cn3)cc12,7.29,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",IC50,51.3,nM,=,CHEMBL4197225,B,CHEMBL4203001,Homo sapiens,CHEMBL203,CHEMBL4196024
CN(C)C1CCN(c2ccc(Nc3cc4c(N5CCCCC5)nc(Nc5ccccc5)nc4cn3)nc2)CC1,8.31,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",IC50,4.9,nM,=,CHEMBL4197223,B,CHEMBL4203016,Homo sapiens,CHEMBL203,CHEMBL4196024
C=CC(=O)N[C@@H]1CCN(c2nc(Nc3cnn(C)c3)c3ncn(C(C)C)c3n2)C1,6.74,Inhibition of EGFR T790M/L858R double mutant (unknown origin),Ki,183.0,nM,=,CHEMBL4178356,B,CHEMBL4203072,Homo sapiens,CHEMBL203,CHEMBL4177539
O=[N+]([O-])c1ccc2oc3nccc(NCc4ccc(Cl)cc4)c3c2c1,5.60,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,2520.0,nM,=,CHEMBL4190463,B,CHEMBL4203084,Homo sapiens,CHEMBL203,CHEMBL4190164
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccccc2N=[N+]=[N-])n1,6.64,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,230.0,nM,=,CHEMBL4179474,B,CHEMBL4203110,Homo sapiens,CHEMBL203,CHEMBL4177590
Nc1ccc2oc3nccc(NCc4cccc(Cl)c4)c3c2c1,6.40,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,400.0,nM,=,CHEMBL4190463,B,CHEMBL4203339,Homo sapiens,CHEMBL203,CHEMBL4190164
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccc(NC(C)=O)cc2)n1,5.51,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,3080.0,nM,=,CHEMBL4179474,B,CHEMBL4203804,Homo sapiens,CHEMBL203,CHEMBL4177590
CN(CCCO)c1nc(Nc2ccc(F)cc2)nc2cnc(Nc3ccc(N4CCC(N(C)C)CC4)cn3)cc12,7.29,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",IC50,51.9,nM,=,CHEMBL4197225,B,CHEMBL4204139,Homo sapiens,CHEMBL203,CHEMBL4196024
Nc1cccc(CNc2ccnc3oc4ccc([N+](=O)[O-])cc4c23)c1,5.45,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,3590.0,nM,=,CHEMBL4190463,B,CHEMBL4204320,Homo sapiens,CHEMBL203,CHEMBL4190164
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccc(N=C=S)cc2)n1,5.04,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,9040.0,nM,=,CHEMBL4179474,B,CHEMBL4204354,Homo sapiens,CHEMBL203,CHEMBL4177590
C=CC(=O)N1C[C@H](Nc2nc(Nc3cnn(C)c3)c3ncn(C(C)C)c3n2)[C@@H](F)C1,7.25,Inhibition of EGFR T790M/L858R double mutant (unknown origin),Ki,56.0,nM,=,CHEMBL4178356,B,CHEMBL4204498,Homo sapiens,CHEMBL203,CHEMBL4177539
C=CC(=O)N[C@H]1CN(c2nc(Nc3cnn(C)c3)c3ncn(C(C)C)c3n2)C[C@@H]1F,6.82,Inhibition of EGFR T790M/L858R double mutant (unknown origin),Ki,152.0,nM,=,CHEMBL4178356,B,CHEMBL4204566,Homo sapiens,CHEMBL203,CHEMBL4177539
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccccc2N=C=S)n1,5.74,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,1820.0,nM,=,CHEMBL4179474,B,CHEMBL4204596,Homo sapiens,CHEMBL203,CHEMBL4177590
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)CCOCc3ccccc3)c2)n1,5.85,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,1410.0,nM,=,CHEMBL4179474,B,CHEMBL4204937,Homo sapiens,CHEMBL203,CHEMBL4177590
CN(C)CCN(C)c1nc(Nc2ccc(F)cc2)nc2cnc(Nc3ccc(N4CCC(N(C)C)CC4)cn3)cc12,7.61,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",IC50,24.7,nM,=,CHEMBL4197225,B,CHEMBL4204983,Homo sapiens,CHEMBL203,CHEMBL4196024
C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(CC)c3n2)C[C@H]1F,8.22,Inhibition of EGFR T790M/L858R double mutant (unknown origin),Ki,6.0,nM,=,CHEMBL4178356,B,CHEMBL4205392,Homo sapiens,CHEMBL203,CHEMBL4177539
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccc(N)cc2)n1,5.13,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,7370.0,nM,=,CHEMBL4179474,B,CHEMBL4205469,Homo sapiens,CHEMBL203,CHEMBL4177590
COc1ccc(-c2c3c4cc(OCCN(C)C)c(OCCN(C)C)cc4oc(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,6.63,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,IC50,232.9,nM,=,CHEMBL4181934,B,CHEMBL4205688,Homo sapiens,CHEMBL203,CHEMBL4177688
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc([N+](=O)[O-])c2)n1,5.24,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,5700.0,nM,=,CHEMBL4179475,B,CHEMBL4205869,Homo sapiens,CHEMBL203,CHEMBL4177590
Nc1cccc(CNc2ccnc3oc4ccc(N)cc4c23)c1,6.03,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,940.0,nM,=,CHEMBL4190463,B,CHEMBL4206140,Homo sapiens,CHEMBL203,CHEMBL4190164
CN(C)C1CCN(c2ccc(Nc3cc4c(N5CCC(CO)CC5)nc(Nc5ccccc5)nc4cn3)nc2)CC1,8.49,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",IC50,3.2,nM,=,CHEMBL4197223,B,CHEMBL4206166,Homo sapiens,CHEMBL203,CHEMBL4196024
COc1ccc(-c2c3c4cc(OC)c(OCCCN(C)C)cc4oc(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O.O=C(O)C(F)(F)F,6.72,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,IC50,188.3,nM,=,CHEMBL4181934,B,CHEMBL4206193,Homo sapiens,CHEMBL203,CHEMBL4177688
CN1CCN(c2ccc(Nc3cc4c(N5CCOCC5)nc(Nc5ccccc5)nc4cn3)nc2)CC1,8.68,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",IC50,2.1,nM,=,CHEMBL4197223,B,CHEMBL4206288,Homo sapiens,CHEMBL203,CHEMBL4196024
C=CC(=O)N1CC[C@@H](Nc2nc(Nc3ccc(N4CCN(C)CC4)cc3)c3ncn(C(C)C)c3n2)C1,7.54,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,IC50,29.0,nM,=,CHEMBL4178351,B,CHEMBL4206312,Homo sapiens,CHEMBL203,CHEMBL4177539
C=CC(=O)N1CC[C@@H](Nc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)C1,8.40,Inhibition of EGFR T790M/L858R double mutant (unknown origin),Ki,4.0,nM,=,CHEMBL4178356,B,CHEMBL4206481,Homo sapiens,CHEMBL203,CHEMBL4177539
C=CC(=O)Nc1cc(Nc2ccnc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.89,Inhibition of EGFR T790M/exon 19 deletion mutant phosphorylation in human PC9-DRH cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,IC50,13.0,nM,=,CHEMBL4178360,B,CHEMBL4206501,Homo sapiens,CHEMBL203,CHEMBL4177539
CCS(=O)(=O)Nc1cc(-c2ccc3ncnc(Nc4cccc(C(=O)OC)c4)c3c2)cnc1OC,6.39,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by mobility shift assay,IC50,409.0,nM,=,CHEMBL4196434,B,CHEMBL4206585,Homo sapiens,CHEMBL203,CHEMBL4196007
CC(=O)N1CC[C@H](Nc2nc(Nc3ccc(N4CCN(C)CC4)cc3)c3ncn(C(C)C)c3n2)C1,6.79,Inhibition of EGFR T790M/L858R double mutant (unknown origin),Ki,161.0,nM,=,CHEMBL4178356,B,CHEMBL4206604,Homo sapiens,CHEMBL203,CHEMBL4177539
CN1CCN(c2ccc(Nc3cc4c(N5CCCCC5)nc(Nc5ccccc5)nc4cn3)nc2)CC1,8.96,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",IC50,1.1,nM,=,CHEMBL4197223,B,CHEMBL4206716,Homo sapiens,CHEMBL203,CHEMBL4196024
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)CO)c2)n1,5.91,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,1230.0,nM,=,CHEMBL4179475,B,CHEMBL4207305,Homo sapiens,CHEMBL203,CHEMBL4177590
CCc1c(C(=O)NC(CO)Cc2ccccc2)[nH]c2ccc(C(F)(F)F)cc12,6.05,Inhibition of His6-tagged EGFR (unknown origin) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells after 10 mins followed by addition of ATP-MgCl2 and measured after 1 hr by time-resolved fluorometric analysis,IC50,900.0,nM,=,CHEMBL4196285,B,CHEMBL4207316,Homo sapiens,CHEMBL203,CHEMBL4196002
O=[N+]([O-])c1ccc2[nH]c3nccc(NCc4cccc(Cl)c4)c3c2c1,7.10,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,80.0,nM,=,CHEMBL4190463,B,CHEMBL4207398,Homo sapiens,CHEMBL203,CHEMBL4190164
C=CC(=O)N[C@@H]1CCN(c2nc(Nc3ccc(N4CCN(C)CC4)cc3)c3ncn(C(C)C)c3n2)C1,6.79,Inhibition of EGFR T790M/L858R double mutant (unknown origin),Ki,161.0,nM,=,CHEMBL4178356,B,CHEMBL4207425,Homo sapiens,CHEMBL203,CHEMBL4177539
CCS(=O)(=O)Nc1cc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cnc1OC,8.62,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by mobility shift assay,IC50,2.4,nM,=,CHEMBL4196434,B,CHEMBL4207750,Homo sapiens,CHEMBL203,CHEMBL4196007
C=CC(=O)N1C[C@@H]2CN(c3nc(Nc4cnn(C)c4)c4ncn(C(C)C)c4n3)C[C@@H]2C1,7.31,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,IC50,49.0,nM,=,CHEMBL4178351,B,CHEMBL4207951,Homo sapiens,CHEMBL203,CHEMBL4177539
N#Cc1ccc(O)c(-c2nc(NCc3cccnc3)c3ccccc3n2)c1,7.75,Inhibition of human EGFR del19/T790M/C797S mutant assessed as enzyme remaining activity using poly-Glu-Tyr peptide substrate incubated for 2 hrs in presence of [gamma-33P]ATP by radiometric kinase assay,IC50,17.9,nM,=,CHEMBL5215212,B,CHEMBL4207984,Homo sapiens,CHEMBL203,CHEMBL5214888
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccc([N+](=O)[O-])cc2)n1,5.03,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,9360.0,nM,=,CHEMBL4179474,B,CHEMBL4208167,Homo sapiens,CHEMBL203,CHEMBL4177590
Cc1c2cc(Cl)ccc2n2cc(Cc3ccccc3)[nH]c(=O)c12,5.77,Inhibition of His6-tagged EGFR (unknown origin) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells after 10 mins followed by addition of ATP-MgCl2 and measured after 1 hr by time-resolved fluorometric analysis,IC50,1700.0,nM,=,CHEMBL4196285,B,CHEMBL4208224,Homo sapiens,CHEMBL203,CHEMBL4196002
O=[N+]([O-])c1ccc2oc3nccc(NCc4cccc(Br)c4)c3c2c1,6.17,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,680.0,nM,=,CHEMBL4190463,B,CHEMBL4208649,Homo sapiens,CHEMBL203,CHEMBL4190164
CN1CCN(c2nc(Nc3ccc(F)cc3)nc3cnc(Nc4ccc(N5CCC(N(C)C)CC5)cn4)cc23)CC1,7.46,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",IC50,34.8,nM,=,CHEMBL4197225,B,CHEMBL4208673,Homo sapiens,CHEMBL203,CHEMBL4196024
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccccc2NC(=O)CCO)n1,6.19,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,650.0,nM,=,CHEMBL4179474,B,CHEMBL4208712,Homo sapiens,CHEMBL203,CHEMBL4177590
O=c1[nH]c(Cc2ccccc2)cn2c1cc1cc(Cl)ccc12,5.62,Inhibition of His6-tagged EGFR (unknown origin) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells after 10 mins followed by addition of ATP-MgCl2 and measured after 1 hr by time-resolved fluorometric analysis,IC50,2400.0,nM,=,CHEMBL4196285,B,CHEMBL4208745,Homo sapiens,CHEMBL203,CHEMBL4196002
C=CC(=O)N[C@H]1CCN(c2nc(Nc3ccc(N4CCN(C)CC4)cc3)c3ncn(C(C)C)c3n2)C1,8.05,Inhibition of EGFR T790M/L858R double mutant (unknown origin),Ki,9.0,nM,=,CHEMBL4178356,B,CHEMBL4208811,Homo sapiens,CHEMBL203,CHEMBL4177539
C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C(C)(C)C)c3n2)C[C@H]1F,7.77,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,IC50,17.0,nM,=,CHEMBL4178351,B,CHEMBL4208829,Homo sapiens,CHEMBL203,CHEMBL4177539
CN(C)C1CCN(c2ccc(Nc3cc4c(N5CCC(CO)CC5)nc(Nc5ccc(F)cc5)nc4cn3)nc2)CC1,8.96,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",IC50,1.1,nM,=,CHEMBL4197223,B,CHEMBL4209019,Homo sapiens,CHEMBL203,CHEMBL4196024
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccc(NC(=O)CCOCc3ccccc3)cc2)n1,5.96,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,1090.0,nM,=,CHEMBL4179474,B,CHEMBL4209119,Homo sapiens,CHEMBL203,CHEMBL4177590
O=[N+]([O-])c1ccc2oc3nccc(NCc4ccc(Br)cc4)c3c2c1,6.09,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,810.0,nM,=,CHEMBL4190463,B,CHEMBL4209187,Homo sapiens,CHEMBL203,CHEMBL4190164
C=CC(=O)N1CC[C@@H](Nc2nc(Nc3cnn(C)c3)c3ncn(C(C)C)c3n2)C1,6.98,Inhibition of EGFR T790M/L858R double mutant (unknown origin),Ki,105.0,nM,=,CHEMBL4178356,B,CHEMBL4209368,Homo sapiens,CHEMBL203,CHEMBL4177539
Nc1ccc2[nH]c3nccc(NCc4cccc(Cl)c4)c3c2c1,6.85,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,140.0,nM,=,CHEMBL4190463,B,CHEMBL4209480,Homo sapiens,CHEMBL203,CHEMBL4190164
Cc1c(C(=O)NC(CO)Cc2ccccc2)[nH]c2ccc(Cl)cc12,6.30,Inhibition of His6-tagged EGFR (unknown origin) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells after 10 mins followed by addition of ATP-MgCl2 and measured after 1 hr by time-resolved fluorometric analysis,IC50,500.0,nM,=,CHEMBL4196285,B,CHEMBL4209588,Homo sapiens,CHEMBL203,CHEMBL4196002
CN1CCN(c2ccc(Nc3cc4c(N5CCCC5)nc(Nc5ccccc5)nc4cn3)nc2)CC1,8.64,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",IC50,2.3,nM,=,CHEMBL4197223,B,CHEMBL4209801,Homo sapiens,CHEMBL203,CHEMBL4196024
COc1cc2c(cc1OC)Nc1ncnc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c1NC2,6.57,Inhibition of EGFR (unknown origin),IC50,267.6,nM,=,CHEMBL4194205,B,CHEMBL4210100,Homo sapiens,CHEMBL203,CHEMBL4190351
COc1cccc(CNc2ccnc3oc4ccc(N)cc4c23)c1,6.77,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,170.0,nM,=,CHEMBL4190463,B,CHEMBL4210187,Homo sapiens,CHEMBL203,CHEMBL4190164
C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2OC)ncc1Cl,5.16,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,6980.0,nM,=,CHEMBL4179476,B,CHEMBL4210237,Homo sapiens,CHEMBL203,CHEMBL4177590
COc1ccc(-c2c3c4cc(O)c(OCCCN(C)C)cc4oc(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O.O=C(O)C(F)(F)F,7.08,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,IC50,82.6,nM,=,CHEMBL4181934,B,CHEMBL4210550,Homo sapiens,CHEMBL203,CHEMBL4177688
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(N)c2)n1,5.50,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,3150.0,nM,=,CHEMBL4179475,B,CHEMBL4210744,Homo sapiens,CHEMBL203,CHEMBL4177590
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccccc2[N+](=O)[O-])n1,5.12,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,7590.0,nM,=,CHEMBL4179474,B,CHEMBL4211322,Homo sapiens,CHEMBL203,CHEMBL4177590
O=[N+]([O-])c1cccc(CNc2ccnc3oc4ccc([N+](=O)[O-])cc4c23)c1,6.03,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,930.0,nM,=,CHEMBL4190463,B,CHEMBL4211341,Homo sapiens,CHEMBL203,CHEMBL4190164
C=CC(=O)N1C[C@H](Nc2nc(Nc3cnn(C)c3)nc3[nH]cc(Cl)c23)[C@@H](F)C1,8.52,Inhibition of EGFR T790M/L858R double mutant (unknown origin),Ki,3.0,nM,=,CHEMBL4178356,B,CHEMBL4211367,Homo sapiens,CHEMBL203,CHEMBL4177539
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccc(NC(=O)COCc3ccccc3)cc2)n1,6.03,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,940.0,nM,=,CHEMBL4179475,B,CHEMBL4211573,Homo sapiens,CHEMBL203,CHEMBL4177590
C=CC(=O)Nc1cccc(Oc2nc(Nc3cnn(CCN(C)C)c3)nc3[nH]ccc23)c1,8.52,Inhibition of EGFR T790M/L858R double mutant (unknown origin),Ki,3.0,nM,=,CHEMBL4178356,B,CHEMBL4211782,Homo sapiens,CHEMBL203,CHEMBL4177539
COc1ccc(-c2c3c4cc(OCCCN(C)C)c(OCCCN(C)C)cc4oc(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,8.05,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,IC50,8.9,nM,=,CHEMBL4181934,B,CHEMBL4211835,Homo sapiens,CHEMBL203,CHEMBL4177688
C=CC(=O)N[C@H]1CCN(c2nc(Nc3cnn(C)c3)c3ncn(C(C)C)c3n2)C1,7.44,Inhibition of EGFR T790M/L858R double mutant (unknown origin),Ki,36.0,nM,=,CHEMBL4178356,B,CHEMBL4212326,Homo sapiens,CHEMBL203,CHEMBL4177539
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccccc2NC(=O)CO)n1,7.00,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,100.0,nM,=,CHEMBL4179475,B,CHEMBL4212450,Homo sapiens,CHEMBL203,CHEMBL4177590
CN(C)C1CCN(c2ccc(Nc3cc4c(N5CCCC5)nc(Nc5ccccc5)nc4cn3)nc2)CC1,8.80,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",IC50,1.6,nM,=,CHEMBL4197223,B,CHEMBL4212884,Homo sapiens,CHEMBL203,CHEMBL4196024
Nc1ccc2oc3nccc(NCc4cccc(Br)c4)c3c2c1,6.64,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,230.0,nM,=,CHEMBL4190463,B,CHEMBL4213021,Homo sapiens,CHEMBL203,CHEMBL4190164
O=[N+]([O-])c1ccc2oc3nccc(NCc4cccc(Cl)c4)c3c2c1,5.87,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,1360.0,nM,=,CHEMBL4190463,B,CHEMBL4213049,Homo sapiens,CHEMBL203,CHEMBL4190164
C=CC(=O)Nc1ccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)cc1,5.61,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,2480.0,nM,=,CHEMBL4179476,B,CHEMBL4213082,Homo sapiens,CHEMBL203,CHEMBL4177590
CCc1c2cc(C(F)(F)F)ccc2n2cc(Cc3ccccc3)[nH]c(=O)c12,5.41,Inhibition of His6-tagged EGFR (unknown origin) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells after 10 mins followed by addition of ATP-MgCl2 and measured after 1 hr by time-resolved fluorometric analysis,IC50,3900.0,nM,=,CHEMBL4196285,B,CHEMBL4213146,Homo sapiens,CHEMBL203,CHEMBL4196002
CC(C)C(CO)Nc1nc(Nc2ccc(N3CCNCC3)cc2)c2ncn(C(C)C)c2n1,7.11,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,IC50,78.0,nM,=,CHEMBL4178351,B,CHEMBL4213400,Homo sapiens,CHEMBL203,CHEMBL4177539
COc1ccc(-c2c3c4cc(OC)c(OCCN(C)C)cc4oc(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O.O=C(O)C(F)(F)F,6.25,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,IC50,559.8,nM,=,CHEMBL4181934,B,CHEMBL4213519,Homo sapiens,CHEMBL203,CHEMBL4177688
C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3nc[nH]c3n2)C[C@H]1F,6.17,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,IC50,675.0,nM,=,CHEMBL4178351,B,CHEMBL4213609,Homo sapiens,CHEMBL203,CHEMBL4177539
C=CC(=O)N1CC[C@H](Nc2nc(Nc3ccc(N4CCN(C)CC4)cc3)c3ncn(C(C)C)c3n2)C1,6.79,Inhibition of EGFR T790M/L858R double mutant (unknown origin),Ki,164.0,nM,=,CHEMBL4178356,B,CHEMBL4213741,Homo sapiens,CHEMBL203,CHEMBL4177539
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccc(NC(=O)CO)cc2)n1,6.07,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,860.0,nM,=,CHEMBL4179475,B,CHEMBL4214040,Homo sapiens,CHEMBL203,CHEMBL4177590
O=[N+]([O-])c1ccc2[nH]c3nccc(NCc4cccc(Br)c4)c3c2c1,6.96,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,110.0,nM,=,CHEMBL4190463,B,CHEMBL4214266,Homo sapiens,CHEMBL203,CHEMBL4190164
Nc1ccc2[nH]c3nccc(NCc4cccc(Br)c4)c3c2c1,6.96,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,110.0,nM,=,CHEMBL4190463,B,CHEMBL4214387,Homo sapiens,CHEMBL203,CHEMBL4190164
O=C(NC(CO)Cc1ccccc1)c1cc2cc(Cl)ccc2[nH]1,6.10,Inhibition of His6-tagged EGFR (unknown origin) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells after 10 mins followed by addition of ATP-MgCl2 and measured after 1 hr by time-resolved fluorometric analysis,IC50,800.0,nM,=,CHEMBL4196285,B,CHEMBL4214496,Homo sapiens,CHEMBL203,CHEMBL4196002
O=C(Nc1nccs1)C(c1cc(F)ccc1O)N1Cc2ccccc2C1=O,8.52,Inhibition of EGFR L858R/T790M mutant (unknown origin),IC50,3.0,nM,=,CHEMBL4186277,B,CHEMBL4214567,Homo sapiens,CHEMBL203,CHEMBL4184160
COC(=O)c1ccc(O)c(-c2nc(NCc3cccnc3)c3ccccc3n2)c1,7.34,Inhibition of recombinant human EGFR d746-750/T790M/C797S mutant using poly-Glu-Tyr (4:1) as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding method,IC50,46.0,nM,=,CHEMBL4186285,B,CHEMBL4214588,Homo sapiens,CHEMBL203,CHEMBL4184160
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(N=[N+]=[N-])c2)n1,5.22,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,6020.0,nM,=,CHEMBL4179476,B,CHEMBL4214620,Homo sapiens,CHEMBL203,CHEMBL4177590
CN(C)C1CCN(c2ccc(Nc3cc4c(N5CCOCC5)nc(Nc5ccc(F)cc5)nc4cn3)nc2)CC1,8.60,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",IC50,2.5,nM,=,CHEMBL4197223,B,CHEMBL4215076,Homo sapiens,CHEMBL203,CHEMBL4196024
CN(C)C1CCN(c2ccc(Nc3cc4c(N5CCOCC5)nc(Nc5ccc(F)cc5F)nc4cn3)nc2)CC1,8.68,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",IC50,2.1,nM,=,CHEMBL4197223,B,CHEMBL4215080,Homo sapiens,CHEMBL203,CHEMBL4196024
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)CCO)c2)n1,5.93,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,1180.0,nM,=,CHEMBL4179475,B,CHEMBL4215164,Homo sapiens,CHEMBL203,CHEMBL4177590
COc1ccc(-c2c3c4cc(OC)c(OCCCNC(=N)N)cc4oc(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O.O=C(O)C(F)(F)F,7.41,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,IC50,39.0,nM,=,CHEMBL4181934,B,CHEMBL4215397,Homo sapiens,CHEMBL203,CHEMBL4177688
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccccc2NC(=O)COCc2ccccc2)n1,6.58,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,260.0,nM,=,CHEMBL4179475,B,CHEMBL4215496,Homo sapiens,CHEMBL203,CHEMBL4177590
Cc1cc(=O)n(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ncnc3ccsc23)c(F)c1,5.16,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,IC50,6900.0,nM,=,CHEMBL4186567,B,CHEMBL4215703,Homo sapiens,CHEMBL203,CHEMBL4184177
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccc(N=[N+]=[N-])cc2)n1,5.01,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,9760.0,nM,=,CHEMBL4179474,B,CHEMBL4216025,Homo sapiens,CHEMBL203,CHEMBL4177590
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccccc2NC(C)=O)n1,5.38,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,4210.0,nM,=,CHEMBL4179474,B,CHEMBL4216265,Homo sapiens,CHEMBL203,CHEMBL4177590
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccc(NC(=O)/C=C/CN(C)C)cc2)n1,5.30,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,5020.0,nM,=,CHEMBL4179476,B,CHEMBL4216551,Homo sapiens,CHEMBL203,CHEMBL4177590
C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C(C)C)c3n2)C[C@H]1F,9.00,Inhibition of EGFR T790M/exon 19 deletion mutant phosphorylation in human PC9-DRH cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,IC50,1.0,nM,=,CHEMBL4178360,B,CHEMBL4216679,Homo sapiens,CHEMBL203,CHEMBL4177539
C=CC(=O)Nc1cccc(Oc2nc(Nc3cnn(CCN(C)C)c3)nc3[nH]ccc23)c1F,8.70,Inhibition of EGFR T790M/L858R double mutant (unknown origin),Ki,2.0,nM,=,CHEMBL4178356,B,CHEMBL4216749,Homo sapiens,CHEMBL203,CHEMBL4177539
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccccc2N)n1,5.94,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,1160.0,nM,=,CHEMBL4179475,B,CHEMBL4216784,Homo sapiens,CHEMBL203,CHEMBL4177590
COc1cccc(CNc2ccnc3[nH]c4ccc([N+](=O)[O-])cc4c23)c1,6.48,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,330.0,nM,=,CHEMBL4190463,B,CHEMBL4217440,Homo sapiens,CHEMBL203,CHEMBL4190164
COc1cccc(CNc2ccnc3oc4ccc([N+](=O)[O-])cc4c23)c1,5.56,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,2740.0,nM,=,CHEMBL4190463,B,CHEMBL4217461,Homo sapiens,CHEMBL203,CHEMBL4190164
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccc(NC(=O)CCO)cc2)n1,5.49,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,3250.0,nM,=,CHEMBL4179475,B,CHEMBL4217686,Homo sapiens,CHEMBL203,CHEMBL4177590
COc1cccc(CNc2ccnc3[nH]c4ccc(N)cc4c23)c1,6.50,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,320.0,nM,=,CHEMBL4190463,B,CHEMBL4217693,Homo sapiens,CHEMBL203,CHEMBL4190164
COc1ccc(CNc2ccnc3oc4ccc([N+](=O)[O-])cc4c23)cc1,5.69,"Inhibition of recombinant human GST-tagged wild-type EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method",Ki,2050.0,nM,=,CHEMBL4190463,B,CHEMBL4217976,Homo sapiens,CHEMBL203,CHEMBL4190164
CN(C)C1CCN(c2ccc(Nc3cc4c(N5CCOCC5)nc(Nc5ccccc5)nc4cn3)nc2)CC1,8.41,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",IC50,3.9,nM,=,CHEMBL4197223,B,CHEMBL4217992,Homo sapiens,CHEMBL203,CHEMBL4196024
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2cccc(N=C=S)c2)n1,5.32,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,4780.0,nM,=,CHEMBL4179475,B,CHEMBL4218052,Homo sapiens,CHEMBL203,CHEMBL4177590
C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3CC)c3ncn(C(C)C)c3n2)C[C@H]1F,8.52,Inhibition of EGFR T790M/exon 19 deletion mutant phosphorylation in human PC9-DRH cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,IC50,3.0,nM,=,CHEMBL4178360,B,CHEMBL4218154,Homo sapiens,CHEMBL203,CHEMBL4177539
COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Oc2ccccc2NC(=O)CCOCc2ccccc2)n1,5.70,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,IC50,1980.0,nM,=,CHEMBL4179474,B,CHEMBL4218320,Homo sapiens,CHEMBL203,CHEMBL4177590
N#Cc1ccc(O)c(-c2nc(NCc3cnccn3)c3ccccc3n2)c1,7.77,Inhibition of recombinant human EGFR d746-750/T790M/C797S mutant using poly-Glu-Tyr (4:1) as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding method,IC50,17.0,nM,=,CHEMBL4186285,B,CHEMBL4218431,Homo sapiens,CHEMBL203,CHEMBL4184160
COc1ccc(-c2c3c4cc(O)c(OC)cc4oc(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O,6.40,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,IC50,396.7,nM,=,CHEMBL4181934,B,CHEMBL4218447,Homo sapiens,CHEMBL203,CHEMBL4177688
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3OC)n2)c1,8.30,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,5.0,nM,=,CHEMBL4222199,B,CHEMBL4224932,Homo sapiens,CHEMBL203,CHEMBL4219138
C=CC(=O)Nc1cc(Nc2ncc3ncn(-c4ccc(F)c(Br)c4)c3n2)c(OC)cc1N(C)CCN(C)C,8.64,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,IC50,2.3,nM,=,CHEMBL4221420,B,CHEMBL4225166,Homo sapiens,CHEMBL203,CHEMBL4219100
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N(C)C)CC4)cc3OC)n2)c1,8.70,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,2.0,nM,=,CHEMBL4222199,B,CHEMBL4225191,Homo sapiens,CHEMBL203,CHEMBL4219138
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N(C)CCN(C)C)cc3OC)n2)c1,7.72,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,19.0,nM,=,CHEMBL4222199,B,CHEMBL4225255,Homo sapiens,CHEMBL203,CHEMBL4219138
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N(C)C)cc3)n2)c1,6.77,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,170.0,nM,=,CHEMBL4222199,B,CHEMBL4225517,Homo sapiens,CHEMBL203,CHEMBL4219138
CN1CCN(c2ccc(Nc3ncc4nc(Sc5ccccc5)n([C@H]5CC[C@H](O)CC5)c4n3)cc2)CC1,6.28,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",IC50,529.0,nM,=,CHEMBL4222847,B,CHEMBL4225565,Homo sapiens,CHEMBL203,CHEMBL4219174
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(C4CCN(C)CC4)cc3)n2)c1,6.29,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,510.0,nM,=,CHEMBL4222199,B,CHEMBL4225571,Homo sapiens,CHEMBL203,CHEMBL4219138
CN(C)CCOc1ccc(Nc2ncc3nc(Sc4ccccc4)n(C4CCOCC4)c3n2)cc1,6.25,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",IC50,556.0,nM,=,CHEMBL4222847,B,CHEMBL4225777,Homo sapiens,CHEMBL203,CHEMBL4219174
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)n2)c1,8.40,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,4.0,nM,=,CHEMBL4222199,B,CHEMBL4225781,Homo sapiens,CHEMBL203,CHEMBL4219138
CNC(=O)c1ccc(Sc2cccc(NC(=S)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)nc1,6.22,Inhibition of EGFR (unknown origin),IC50,596.0,nM,=,CHEMBL4223404,B,CHEMBL4225828,Homo sapiens,CHEMBL203,CHEMBL4219211
C=CC(=O)Nc1cc(Nc2ncc3ncn(-c4ccc(F)cc4)c3n2)c(OC)cc1N(C)CCN(C)C,8.49,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,IC50,3.2,nM,=,CHEMBL4221420,B,CHEMBL4225863,Homo sapiens,CHEMBL203,CHEMBL4219100
CN1CCN(c2ccc(Nc3ncc4nc(Sc5ccccc5)n(C5CCOCC5)c4n3)cc2)CC1,6.05,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",IC50,892.0,nM,=,CHEMBL4222847,B,CHEMBL4226151,Homo sapiens,CHEMBL203,CHEMBL4219174
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3OC)n2)c1,6.67,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,215.0,nM,=,CHEMBL4222199,B,CHEMBL4226177,Homo sapiens,CHEMBL203,CHEMBL4219138
C=CC(=O)Nc1cccc(NC(=O)Nc2nc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)ncc2C(F)(F)F)c1,6.57,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,270.0,nM,=,CHEMBL4222199,B,CHEMBL4226254,Homo sapiens,CHEMBL203,CHEMBL4219138
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(C4CCN(C)CC4)cc3OC)n2)c1,7.55,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,28.0,nM,=,CHEMBL4222199,B,CHEMBL4226436,Homo sapiens,CHEMBL203,CHEMBL4219138
C=CC(=O)Nc1cccc(NC(=O)Nc2nc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)ncc2Cl)c1,7.43,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,37.0,nM,=,CHEMBL4222199,B,CHEMBL4226562,Homo sapiens,CHEMBL203,CHEMBL4219138
CN(C)C1CCN(c2ccc(Nc3ncc4nc(Sc5ccccc5)n(C5CCOCC5)c4n3)cc2)CC1,8.80,"Inhibition of wild type EGFR (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",IC50,1.6,nM,=,CHEMBL4222844,B,CHEMBL4226676,Homo sapiens,CHEMBL203,CHEMBL4219174
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCOCC4)cc3OC)n2)c1,7.82,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,15.0,nM,=,CHEMBL4222199,B,CHEMBL4226702,Homo sapiens,CHEMBL203,CHEMBL4219138
O=C(N/N=C/c1ccc(F)cc1Cl)N1CCc2ncnc(Nc3cccc(Br)c3)c2C1,7.75,Inhibition of EGFR (unknown origin) using peptide substrate after 60 mins by HTRF assay,IC50,18.0,nM,=,CHEMBL4221532,B,CHEMBL4226907,Homo sapiens,CHEMBL203,CHEMBL4219106
CN(C)CCOc1ccc(Nc2ncc3nc(Sc4cccc(F)c4)n(C4CCOCC4)c3n2)cc1,6.09,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",IC50,805.0,nM,=,CHEMBL4222847,B,CHEMBL4226937,Homo sapiens,CHEMBL203,CHEMBL4219174
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCN(C)CC4)cc3)n2)c1,7.32,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,48.0,nM,=,CHEMBL4222199,B,CHEMBL4226965,Homo sapiens,CHEMBL203,CHEMBL4219138
C=CC(=O)Nc1cc(Nc2ncc3ncn(-c4ccc(I)cc4)c3n2)c(OC)cc1N(C)CCN(C)C,8.46,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,IC50,3.5,nM,=,CHEMBL4221420,B,CHEMBL4227091,Homo sapiens,CHEMBL203,CHEMBL4219100
C=CC(=O)Nc1cc(Nc2ncc3nc(Nc4ccccc4)n(C)c3n2)c(OC)cc1N(C)CCN(C)C,8.57,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,IC50,2.7,nM,=,CHEMBL4221420,B,CHEMBL4227201,Homo sapiens,CHEMBL203,CHEMBL4219100
C=CC(=O)Nc1cc(Nc2ncc3ncn(-c4ccc(C(C)C)cc4)c3n2)c(OC)cc1N(C)CCN(C)C,8.38,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,IC50,4.2,nM,=,CHEMBL4221420,B,CHEMBL4227210,Homo sapiens,CHEMBL203,CHEMBL4219100
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1,7.06,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,87.0,nM,=,CHEMBL4222199,B,CHEMBL4227278,Homo sapiens,CHEMBL203,CHEMBL4219138
Cc1ccc(/C=N/NC(=O)N2CCc3ncnc(Nc4cccc(C(F)(F)F)c4)c3C2)cc1,7.62,Inhibition of EGFR (unknown origin) using peptide substrate after 60 mins by HTRF assay,IC50,24.2,nM,=,CHEMBL4221532,B,CHEMBL4227281,Homo sapiens,CHEMBL203,CHEMBL4219106
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccccc3OC)n2)c1,6.72,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,192.0,nM,=,CHEMBL4222199,B,CHEMBL4227490,Homo sapiens,CHEMBL203,CHEMBL4219138
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCN(CCF)CC4)cc3OC)n2)c1,7.66,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,22.0,nM,=,CHEMBL4222199,B,CHEMBL4227552,Homo sapiens,CHEMBL203,CHEMBL4219138
C=CC(=O)Nc1cc(Nc2ncc3nc(Nc4ccccc4)n(C(C)C)c3n2)c(OC)cc1N(C)CCN(C)C,8.29,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,IC50,5.1,nM,=,CHEMBL4221420,B,CHEMBL4227701,Homo sapiens,CHEMBL203,CHEMBL4219100
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(OC)cc3OC)n2)c1,7.24,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,58.0,nM,=,CHEMBL4222199,B,CHEMBL4227812,Homo sapiens,CHEMBL203,CHEMBL4219138
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(OCCOC)cc3)n2)c1,6.58,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,266.0,nM,=,CHEMBL4222199,B,CHEMBL4228018,Homo sapiens,CHEMBL203,CHEMBL4219138
O=C(N/N=C/c1cc(F)c(F)cc1Cl)N1CCc2ncnc(Nc3ccc(F)c(Cl)c3)c2C1,7.37,Inhibition of EGFR (unknown origin) using peptide substrate after 60 mins by HTRF assay,IC50,42.3,nM,=,CHEMBL4221532,B,CHEMBL4228120,Homo sapiens,CHEMBL203,CHEMBL4219106
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N(CC)CC)CC4)cc3OC)n2)c1,8.70,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,2.0,nM,=,CHEMBL4222199,B,CHEMBL4228176,Homo sapiens,CHEMBL203,CHEMBL4219138
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCN(C)CC4)cc3OC)n2)c1,7.77,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,17.0,nM,=,CHEMBL4222198,B,CHEMBL4228473,Homo sapiens,CHEMBL203,CHEMBL4219138
CN(C)CCOc1ccc(Nc2ncc3nc(Sc4ccc(F)cc4)n(C4CCOCC4)c3n2)cc1,8.92,Inhibition of EGFR L858R mutant (unknown origin),IC50,1.2,nM,=,CHEMBL5143777,B,CHEMBL4228518,Homo sapiens,CHEMBL203,CHEMBL5143505
C=CC(=O)Nc1cc(Nc2ncc3ncn(-c4ccc(Cl)cc4)c3n2)c(OC)cc1N(C)CCN(C)C,8.41,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,IC50,3.9,nM,=,CHEMBL4221420,B,CHEMBL4228672,Homo sapiens,CHEMBL203,CHEMBL4219100
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(C(=O)N4CCOCC4)cc3OC)n2)c1,6.89,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,128.0,nM,=,CHEMBL4222199,B,CHEMBL4228848,Homo sapiens,CHEMBL203,CHEMBL4219138
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N(CC)CC)cc3OC)n2)c1,7.92,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,12.0,nM,=,CHEMBL4222199,B,CHEMBL4229010,Homo sapiens,CHEMBL203,CHEMBL4219138
O=C(N/N=C/c1cccs1)N1CCc2ncnc(Nc3ccc(F)c(Cl)c3)c2C1,7.20,Inhibition of EGFR (unknown origin) using peptide substrate after 60 mins by HTRF assay,IC50,62.5,nM,=,CHEMBL4221532,B,CHEMBL4229213,Homo sapiens,CHEMBL203,CHEMBL4219106
C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(C(=O)N(CC)CC)cc3OC)n2)c1,7.00,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,IC50,101.0,nM,=,CHEMBL4222199,B,CHEMBL4229266,Homo sapiens,CHEMBL203,CHEMBL4219138
CCCN(c1ccc(OC)cc1)c1ncnc2occ(C)c12,8.15,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,IC50,7.1,nM,=,CHEMBL4235834,B,CHEMBL4237916,Homo sapiens,CHEMBL203,CHEMBL4229524
Clc1ccc(SCc2n[nH]c(-c3ccc(Cl)cc3)n2)cc1,4.34,Inhibition of recombinant human EGFR using peptide as substrate by fluorimetric analysis,IC50,45500.0,nM,=,CHEMBL4231196,B,CHEMBL4238771,Homo sapiens,CHEMBL203,CHEMBL4229349
CSc1ccc(N(C)c2ncnc3occ(C)c23)cc1,8.14,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,IC50,7.2,nM,=,CHEMBL4235834,B,CHEMBL4239716,Homo sapiens,CHEMBL203,CHEMBL4229524
O=C(N/N=C1\CC2(CCCCC2)Oc2c1ccc1ccccc21)C1C2CC3CC(C2)CC1C3,5.92,Inhibition of His-6 tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in Baculovirus infected Sf9 cells by dissociation-enhanced lanthanide fluorescence immunoassay/time-resolved fluorometric analysis,IC50,1200.0,nM,=,CHEMBL4231282,B,CHEMBL4241486,Homo sapiens,CHEMBL203,CHEMBL4229351
CCN(c1ccc(OC)cc1)c1ncnc2occ(C)c12,7.03,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,IC50,92.5,nM,=,CHEMBL4235834,B,CHEMBL4241638,Homo sapiens,CHEMBL203,CHEMBL4229524
O=C(N/N=C1\CC2(CCCC2)Oc2ccccc21)Nc1ccc(Cl)cc1,5.72,Inhibition of His-6 tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in Baculovirus infected Sf9 cells by dissociation-enhanced lanthanide fluorescence immunoassay/time-resolved fluorometric analysis,IC50,1900.0,nM,=,CHEMBL4231282,B,CHEMBL4241867,Homo sapiens,CHEMBL203,CHEMBL4229351
CCc1ccc(N(C)c2ncnc3occ(C)c23)cc1,8.40,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,IC50,4.0,nM,=,CHEMBL4235834,B,CHEMBL4242522,Homo sapiens,CHEMBL203,CHEMBL4229524
NCCCCCCC(=S)N/N=C1\CC2(CCCCC2)Oc2c1ccc1ccccc21,5.85,Inhibition of His-6 tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in Baculovirus infected Sf9 cells by dissociation-enhanced lanthanide fluorescence immunoassay/time-resolved fluorometric analysis,IC50,1400.0,nM,=,CHEMBL4231282,B,CHEMBL4244030,Homo sapiens,CHEMBL203,CHEMBL4229351
Cc1coc2ncnc(N(C)c3ccc(N(C)C)cc3)c12,8.51,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,IC50,3.1,nM,=,CHEMBL4235834,B,CHEMBL4245415,Homo sapiens,CHEMBL203,CHEMBL4229524
COc1ccc(Nc2ncnc3occ(C)c23)cc1,6.55,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,IC50,283.1,nM,=,CHEMBL4235834,B,CHEMBL4245874,Homo sapiens,CHEMBL203,CHEMBL4229524
Oc1cccc(Nc2nnnc3sc4c(c23)CCC4)c1,4.28,Inhibition of EGFR (unknown origin),IC50,52110.0,nM,=,CHEMBL4229651,B,CHEMBL4246256,Homo sapiens,CHEMBL203,CHEMBL4229324
COc1ccc(N(C)c2ncnc3occ(C)c23)cc1,7.81,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,IC50,15.5,nM,=,CHEMBL4235834,B,CHEMBL4250191,Homo sapiens,CHEMBL203,CHEMBL4229524
CNc1ccc(N(C)c2ncnc3occ(C)c23)cc1,8.19,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,IC50,6.4,nM,=,CHEMBL4235834,B,CHEMBL4250210,Homo sapiens,CHEMBL203,CHEMBL4229524
COc1ccc(N(c2ncnc3occ(C)c23)C(C)C)cc1,8.00,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,IC50,10.1,nM,=,CHEMBL4235834,B,CHEMBL4250273,Homo sapiens,CHEMBL203,CHEMBL4229524
Oc1ccc(Nc2nnnc3sc4c(c23)CCC4)cc1,4.41,Inhibition of EGFR (unknown origin),IC50,38730.0,nM,=,CHEMBL4229651,B,CHEMBL4251297,Homo sapiens,CHEMBL203,CHEMBL4229324
C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(OCCCN3CCOCC3)cc2)ncc1Cl,7.67,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",IC50,21.5,nM,=,CHEMBL4271007,B,CHEMBL4276744,Homo sapiens,CHEMBL203,CHEMBL4270490
C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.33,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",IC50,4.7,nM,=,CHEMBL4427028,B,CHEMBL4276842,Homo sapiens,CHEMBL203,CHEMBL4425144
COc1ccc(OC)c(Nc2cc(Nc3ccc(S(N)(=O)=O)cc3)ncn2)c1,6.33,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,467.0,nM,=,CHEMBL4267257,B,CHEMBL4276965,Homo sapiens,CHEMBL203,CHEMBL4265907
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(CC(=O)N4CCOCC4)cc3)ncc2Cl)c1,7.00,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",IC50,100.5,nM,=,CHEMBL4271007,B,CHEMBL4277822,Homo sapiens,CHEMBL203,CHEMBL4270490
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(CC)CCN(C)C,9.10,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,0.8,nM,=,CHEMBL4258550,B,CHEMBL4277911,Homo sapiens,CHEMBL203,CHEMBL4257480
C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(OC)c4)nc32)c1,8.89,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",IC50,1.3,nM,=,CHEMBL4427028,B,CHEMBL4277912,Homo sapiens,CHEMBL203,CHEMBL4425144
COc1cccc(Nc2cc(Nc3cccc(Cl)c3)ncn2)c1,6.01,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,974.0,nM,=,CHEMBL4267257,B,CHEMBL4278031,Homo sapiens,CHEMBL203,CHEMBL4265907
C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(NC(=O)CN3CCOCC3)cc2)ncc1Cl,7.66,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",IC50,21.7,nM,=,CHEMBL4271007,B,CHEMBL4278226,Homo sapiens,CHEMBL203,CHEMBL4270490
C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N(C)CCN(C)C)cc4OC)nc32)c1,7.77,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",IC50,17.0,nM,=,CHEMBL4427028,B,CHEMBL4278325,Homo sapiens,CHEMBL203,CHEMBL4425144
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cnn4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,8.89,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,1.3,nM,=,CHEMBL4258550,B,CHEMBL4278815,Homo sapiens,CHEMBL203,CHEMBL4257480
Nc1ccc(-c2cc3c(Nc4ccc(Oc5cccc(C(F)(F)F)c5)c(Cl)c4)ncnc3s2)cc1,7.67,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay",IC50,21.4,nM,=,CHEMBL4272061,B,CHEMBL4278886,Homo sapiens,CHEMBL203,CHEMBL4270530
O=C(O)CCCC(=O)Nc1cc(Nc2ccccc2)ncn1,6.98,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,105.0,nM,=,CHEMBL4267257,B,CHEMBL4278997,Homo sapiens,CHEMBL203,CHEMBL4265907
COc1ccc(-c2nc3sc(-c4ccc(Cl)cc4)cn3n2)cc1,5.82,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,1500.0,nM,=,CHEMBL4273762,B,CHEMBL4279008,Homo sapiens,CHEMBL203,CHEMBL4270577
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N1CCC(N2CCN(C)CC2)CC1,9.15,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,0.7,nM,=,CHEMBL4258550,B,CHEMBL4279016,Homo sapiens,CHEMBL203,CHEMBL4257480
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N1CCC(N(C)C)C1,9.15,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,0.7,nM,=,CHEMBL4258550,B,CHEMBL4279057,Homo sapiens,CHEMBL203,CHEMBL4257480
C=C=CC(=O)Nc1cc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,9.30,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,0.5,nM,=,CHEMBL4258550,B,CHEMBL4279227,Homo sapiens,CHEMBL203,CHEMBL4257480
O=C(N/N=C/c1cccn1CCCN1CCCC1)Nc1ccc(Oc2ccnc3[nH]ccc23)cc1,4.35,Inhibition of EGFR (unknown origin),IC50,45000.0,nM,=,CHEMBL4254926,B,CHEMBL4279863,Homo sapiens,CHEMBL203,CHEMBL4251648
C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(CN3CCOCC3)cc2)ncc1Cl,7.82,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",IC50,15.3,nM,=,CHEMBL4271007,B,CHEMBL4280174,Homo sapiens,CHEMBL203,CHEMBL4270490
COc1ccc(OC)c(Nc2cc(Nc3ccc(F)cc3)ncn2)c1,6.68,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,208.0,nM,=,CHEMBL4267257,B,CHEMBL4280395,Homo sapiens,CHEMBL203,CHEMBL4265907
O=C1Nc2ccc(S(=O)(=O)N3CCOCC3)cc2/C1=N/c1ccc(/N=C2\C(=O)Nc3ccc(S(=O)(=O)N4CCOCC4)cc32)cc1,5.93,Inhibition of EGFR in human HepG2 cells,IC50,1182.0,nM,=,CHEMBL4274200,B,CHEMBL4280749,Homo sapiens,CHEMBL203,CHEMBL4270595
O=C1CSC(N2N=C(c3ccncc3)CC2c2ccc(Br)cc2)=N1,8.05,Inhibition of 6x-His-tagged human EGFR cytoplasmic domain (645 to 1186 amino acids) assessed as reduction in autophosphorylation pre-incubated for 10 mins and measured after 1 hr by DELFIA/time-resolved fluorometry,IC50,9.0,nM,=,CHEMBL4271213,B,CHEMBL4280817,Homo sapiens,CHEMBL203,CHEMBL4270497
CS(=O)(=O)Nc1ccc(-c2cc3c(Nc4ccc(Oc5cccc(C(F)(F)F)c5)c(Cl)c4)ncnc3s2)cc1,7.33,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay",IC50,47.1,nM,=,CHEMBL4272061,B,CHEMBL4280835,Homo sapiens,CHEMBL203,CHEMBL4270530
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(C)cc1N(C)CCN(C)C,8.57,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,2.7,nM,=,CHEMBL4258550,B,CHEMBL4280993,Homo sapiens,CHEMBL203,CHEMBL4257480
C=CC(=O)Nc1cccc(-n2c(=O)c(=O)[nH]c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.60,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",IC50,2.5,nM,=,CHEMBL4427028,B,CHEMBL4281367,Homo sapiens,CHEMBL203,CHEMBL4425144
O=C(Nc1cc(Nc2ccc(Cl)cc2)ncn1)c1ccc(F)cc1,5.85,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,1409.0,nM,=,CHEMBL4267257,B,CHEMBL4281413,Homo sapiens,CHEMBL203,CHEMBL4265907
O=C1Nc2ccc(S(=O)(=O)N3CCOCC3)cc2/C1=N/Nc1ccccc1,7.34,Inhibition of EGFR in human HepG2 cells,IC50,46.0,nM,=,CHEMBL4274200,B,CHEMBL4281426,Homo sapiens,CHEMBL203,CHEMBL4270595
O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1,8.15,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,7.0,nM,=,CHEMBL4267257,B,CHEMBL4282460,Homo sapiens,CHEMBL203,CHEMBL4265907
Clc1ccc(-c2cn3nc(-c4ccccc4)nc3s2)cc1,5.14,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,7200.0,nM,=,CHEMBL4273762,B,CHEMBL4282482,Homo sapiens,CHEMBL203,CHEMBL4270577
N#CCC(=O)N/N=C1\C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc21,7.64,Inhibition of EGFR in human HepG2 cells,IC50,23.0,nM,=,CHEMBL4274200,B,CHEMBL4282506,Homo sapiens,CHEMBL203,CHEMBL4270595
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)ccc1N(C)CCN(C)C,8.82,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,1.5,nM,=,CHEMBL4258550,B,CHEMBL4282523,Homo sapiens,CHEMBL203,CHEMBL4257480
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1OCCN1CCN(C)CC1,9.40,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,0.4,nM,=,CHEMBL4258550,B,CHEMBL4282543,Homo sapiens,CHEMBL203,CHEMBL4257480
C=C=CC(=O)Nc1cc(Nc2ncc(OC)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,9.15,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,0.7,nM,=,CHEMBL4258550,B,CHEMBL4282688,Homo sapiens,CHEMBL203,CHEMBL4257480
COc1ccc(OC)c(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1,7.17,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,68.0,nM,=,CHEMBL4267255,B,CHEMBL4282879,Homo sapiens,CHEMBL203,CHEMBL4265907
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N1CCOCC1,9.22,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,0.6,nM,=,CHEMBL4258550,B,CHEMBL4282954,Homo sapiens,CHEMBL203,CHEMBL4257480
CCOC(=O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1,7.57,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,27.0,nM,=,CHEMBL4267255,B,CHEMBL4283061,Homo sapiens,CHEMBL203,CHEMBL4265907
COc1ccc(OC)c(Nc2cc(NCCc3cccs3)ncn2)c1,6.99,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,102.0,nM,=,CHEMBL4267257,B,CHEMBL4283097,Homo sapiens,CHEMBL203,CHEMBL4265907
COc1cc(Nc2cc(Nc3ccc(Cl)cc3)ncn2)cc(OC)c1OC,6.04,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,901.0,nM,=,CHEMBL4267255,B,CHEMBL4283517,Homo sapiens,CHEMBL203,CHEMBL4265907
COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1,7.58,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,26.0,nM,=,CHEMBL4267257,B,CHEMBL4283823,Homo sapiens,CHEMBL203,CHEMBL4265907
O=C(O)CCCC(=O)Nc1cc(N2CCOCC2)ncn1,7.96,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,11.0,nM,=,CHEMBL4267257,B,CHEMBL4283970,Homo sapiens,CHEMBL203,CHEMBL4265907
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(CN4CCOCC4)cc3)ncc2Cl)c1,9.15,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",IC50,0.71,nM,=,CHEMBL4271007,B,CHEMBL4284071,Homo sapiens,CHEMBL203,CHEMBL4270490
O=C(Nc1nccs1)C(c1ccccc1)N1Cc2ccccc2C1=O,7.62,Inhibition of human EGFR L858R mutant expressed in Sf9 cells in presence of 1 mM ATP by HTRF assay,IC50,24.0,nM,=,CHEMBL4271076,B,CHEMBL4284413,Homo sapiens,CHEMBL203,CHEMBL4270493
C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(OCC(=O)N3CCOCC3)cc2)ncc1Cl,7.61,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",IC50,24.8,nM,=,CHEMBL4271007,B,CHEMBL4284684,Homo sapiens,CHEMBL203,CHEMBL4270490
C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(CC)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,8.92,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",IC50,1.2,nM,=,CHEMBL4427028,B,CHEMBL4284780,Homo sapiens,CHEMBL203,CHEMBL4425144
COc1ccc(C2=C(C#N)C3=NC4=Nc5ccc(S(=O)(=O)N6CCOCC6)cc5C4=NC3C(O)=C2C#N)cc1,6.97,Inhibition of EGFR in human HepG2 cells,IC50,108.0,nM,=,CHEMBL4274200,B,CHEMBL4284841,Homo sapiens,CHEMBL203,CHEMBL4270595
COc1cccc(Nc2cc(Nc3ccc(S(N)(=O)=O)cc3)ncn2)c1,5.91,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,1229.0,nM,=,CHEMBL4267257,B,CHEMBL4284911,Homo sapiens,CHEMBL203,CHEMBL4265907
C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(CCC)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.22,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",IC50,0.6,nM,=,CHEMBL4427028,B,CHEMBL4285217,Homo sapiens,CHEMBL203,CHEMBL4425144
Cc1oc2ncnc(Nc3cccc(Br)c3)c2c1C(=O)O,6.12,Inhibition of recombinant human C-terminal His/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using biotin-labeled poly[Glu:Tyr] (4:1) as substrate after 30 mins by Kinase-Glo plus luminescence assay,IC50,752.0,nM,=,CHEMBL4253971,B,CHEMBL4285894,Homo sapiens,CHEMBL203,CHEMBL4251615
Fc1cc(F)cc(NC(=S)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)c1,7.22,Inhibition of C-terminal His-tagged and N-terminal GST tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using KHKKLAEGSAYEEV substrate peptide and gamma-[32P]ATP,IC50,60.0,nM,=,CHEMBL4252972,B,CHEMBL4286031,Homo sapiens,CHEMBL203,CHEMBL4251580
C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(OCCN(C)C)cc4OC)nc32)c1,7.17,"Inhibition of wild type EGFR kinase domain (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",IC50,68.0,nM,=,CHEMBL4427027,B,CHEMBL4286241,Homo sapiens,CHEMBL203,CHEMBL4425144
O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Br)c2)ncn1,7.16,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,70.0,nM,=,CHEMBL4267255,B,CHEMBL4286263,Homo sapiens,CHEMBL203,CHEMBL4265907
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,8.85,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,1.4,nM,=,CHEMBL4258550,B,CHEMBL4286318,Homo sapiens,CHEMBL203,CHEMBL4257480
O=C(Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)c1ccc(C(F)(F)F)cc1O,6.92,Inhibition of EGFR (unknown origin),IC50,120.0,nM,=,CHEMBL4271176,B,CHEMBL4286374,Homo sapiens,CHEMBL203,CHEMBL4270496
O=C(Nc1ccc(-c2cc3c(Nc4ccc(Oc5cccc(C(F)(F)F)c5)c(Cl)c4)ncnc3s2)cc1)NC1CC1,6.95,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay",IC50,112.0,nM,=,CHEMBL4272061,B,CHEMBL4286733,Homo sapiens,CHEMBL203,CHEMBL4270530
CCNc1cc(Nc2cccc(Cl)c2)ncn1,6.77,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,170.0,nM,=,CHEMBL4267255,B,CHEMBL4286871,Homo sapiens,CHEMBL203,CHEMBL4265907
COc1cc(-c2nc3sc(-c4ccccc4)cn3n2)cc(OC)c1OC,5.55,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,2800.0,nM,=,CHEMBL4273762,B,CHEMBL4286943,Homo sapiens,CHEMBL203,CHEMBL4270577
c1ccc(-c2nc3sc(-c4ccccc4)cn3n2)cc1,5.01,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,9800.0,nM,=,CHEMBL4273762,B,CHEMBL4286998,Homo sapiens,CHEMBL203,CHEMBL4270577
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4cc(F)ccc34)n2)c(OC)cc1N(C)CCN(C)C,9.00,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,1.0,nM,=,CHEMBL4258550,B,CHEMBL4287141,Homo sapiens,CHEMBL203,CHEMBL4257480
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1OCCN1CCOCC1,9.15,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,0.7,nM,=,CHEMBL4258550,B,CHEMBL4287401,Homo sapiens,CHEMBL203,CHEMBL4257480
O=C(O)CCC(=O)Nc1cc(Nc2ccc(Cl)cc2)ncn1,6.10,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,792.0,nM,=,CHEMBL4267257,B,CHEMBL4287629,Homo sapiens,CHEMBL203,CHEMBL4265907
C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(OCCN3CCOCC3)cc2)ncc1Cl,7.87,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",IC50,13.4,nM,=,CHEMBL4271007,B,CHEMBL4288080,Homo sapiens,CHEMBL203,CHEMBL4270490
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN1CCOCC1,8.92,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,1.2,nM,=,CHEMBL4258550,B,CHEMBL4288246,Homo sapiens,CHEMBL203,CHEMBL4257480
Clc1ccc(Nc2cc(Nc3cccc(Cl)n3)ncn2)cc1,6.64,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,229.0,nM,=,CHEMBL4267257,B,CHEMBL4288262,Homo sapiens,CHEMBL203,CHEMBL4265907
COc1cccc(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1,8.11,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,7.7,nM,=,CHEMBL4267257,B,CHEMBL4288300,Homo sapiens,CHEMBL203,CHEMBL4265907
O=C(NCCN1CCOCC1)Nc1ccc(-c2cc3c(Nc4ccc(Oc5cccc(C(F)(F)F)c5)c(Cl)c4)ncnc3s2)cc1,7.04,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay",IC50,91.7,nM,=,CHEMBL4272061,B,CHEMBL4288374,Homo sapiens,CHEMBL203,CHEMBL4270530
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(CC(=O)N4CCOCC4)cc3)ncc2Cl)c1,7.01,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",IC50,96.6,nM,=,CHEMBL4271007,B,CHEMBL4288482,Homo sapiens,CHEMBL203,CHEMBL4270490
C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)c1,8.85,"Inhibition of wild type EGFR kinase domain (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",IC50,1.4,nM,=,CHEMBL4427027,B,CHEMBL4288562,Homo sapiens,CHEMBL203,CHEMBL4425144
O=C1Nc2ccc(S(=O)(=O)N3CCOCC3)cc2/C1=N/c1ccc(O)cc1,6.12,Inhibition of EGFR in human HepG2 cells,IC50,751.0,nM,=,CHEMBL4274200,B,CHEMBL4288648,Homo sapiens,CHEMBL203,CHEMBL4270595
CCOC(=O)CCC(=O)Nc1cc(Nc2cccc(Br)c2)ncn1,6.03,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,933.0,nM,=,CHEMBL4267257,B,CHEMBL4288761,Homo sapiens,CHEMBL203,CHEMBL4265907
COc1ccc(-c2c(C#N)c(N)n(/N=C3\C(=O)Nc4ccc(S(=O)(=O)N5CCOCC5)cc43)c(=O)c2C#N)cc1,5.71,Inhibition of EGFR in human HepG2 cells,IC50,1931.0,nM,=,CHEMBL4274200,B,CHEMBL4289083,Homo sapiens,CHEMBL203,CHEMBL4270595
COc1cc(-c2nc3sc(-c4ccc(Cl)cc4)cn3n2)cc(OC)c1OC,5.77,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,1700.0,nM,=,CHEMBL4273762,B,CHEMBL4289274,Homo sapiens,CHEMBL203,CHEMBL4270577
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4cc(Cl)ccc34)n2)c(OC)cc1N(C)CCN(C)C,8.59,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,2.6,nM,=,CHEMBL4258550,B,CHEMBL4289490,Homo sapiens,CHEMBL203,CHEMBL4257480
O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cc2cccnc2n(-c2ccc(F)cc2)c1=O,6.20,"Inhibition of EGFR (unknown origin) using poly(Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay",IC50,632.8,nM,=,CHEMBL4252893,B,CHEMBL4289577,Homo sapiens,CHEMBL203,CHEMBL4251577
O=C(O)CCCC(=O)Nc1cc(Nc2ccc(Cl)cc2)ncn1,6.03,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,944.0,nM,=,CHEMBL4267257,B,CHEMBL4289682,Homo sapiens,CHEMBL203,CHEMBL4265907
N=c1oc2ccccc2cc1C(=O)N/N=C1\C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc21,6.69,Inhibition of EGFR in human HepG2 cells,IC50,205.0,nM,=,CHEMBL4274200,B,CHEMBL4289728,Homo sapiens,CHEMBL203,CHEMBL4270595
COc1ccc(-c2nc3sc(-c4ccccc4)cn3n2)cc1,5.25,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,5600.0,nM,=,CHEMBL4273762,B,CHEMBL4290355,Homo sapiens,CHEMBL203,CHEMBL4270577
Cc1oc2ncnc(Nc3cccc(Cl)c3)c2c1C(=O)O,6.04,Inhibition of recombinant human C-terminal His/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using biotin-labeled poly[Glu:Tyr] (4:1) as substrate after 30 mins by Kinase-Glo plus luminescence assay,IC50,901.0,nM,=,CHEMBL4253971,B,CHEMBL4290375,Homo sapiens,CHEMBL203,CHEMBL4251615
C=C=CC(=O)Nc1cc(Nc2ncc(C)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,9.00,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,1.0,nM,=,CHEMBL4258550,B,CHEMBL4290568,Homo sapiens,CHEMBL203,CHEMBL4257480
CCOC(=O)c1ccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)cc1,7.68,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,21.0,nM,=,CHEMBL4267257,B,CHEMBL4290750,Homo sapiens,CHEMBL203,CHEMBL4265907
C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N5CCC(N6CCN(C)CC6)CC5)cc4OC)nc32)c1,8.11,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",IC50,7.8,nM,=,CHEMBL4427028,B,CHEMBL4290785,Homo sapiens,CHEMBL203,CHEMBL4425144
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N1CCN(C)CC1,9.52,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,0.3,nM,=,CHEMBL4258550,B,CHEMBL4290812,Homo sapiens,CHEMBL203,CHEMBL4257480
CC(C)(O)CC(=O)NCCc1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c2c1,8.01,Inhibition of EGFR (unknown origin),IC50,9.8,nM,=,CHEMBL4271176,B,CHEMBL4290869,Homo sapiens,CHEMBL203,CHEMBL4270496
CC(=O)Nc1ccc(-c2cc3c(Nc4ccc(Oc5cccc(C(F)(F)F)c5)c(Cl)c4)ncnc3s2)cc1,7.32,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay",IC50,47.7,nM,=,CHEMBL4272061,B,CHEMBL4291471,Homo sapiens,CHEMBL203,CHEMBL4270530
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCN4CCOCC4)cc3)ncc2Cl)c1,7.02,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",IC50,94.7,nM,=,CHEMBL4271007,B,CHEMBL4291900,Homo sapiens,CHEMBL203,CHEMBL4270490
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(CN4CCOCC4)cc3)ncc2F)c1,7.09,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",IC50,80.8,nM,=,CHEMBL4271007,B,CHEMBL4291935,Homo sapiens,CHEMBL203,CHEMBL4270490
CCOC(=O)c1ccc(Nc2cc(Nc3cccc(OC)c3)ncn2)cc1,5.92,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,1188.0,nM,=,CHEMBL4267257,B,CHEMBL4292110,Homo sapiens,CHEMBL203,CHEMBL4265907
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(CN4CCOCC4)cc3OC)ncc2Cl)c1,7.77,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",IC50,17.0,nM,=,CHEMBL4271007,B,CHEMBL4292351,Homo sapiens,CHEMBL203,CHEMBL4270490
Cc1oc2ncnc(Nc3cccc(Cl)c3)c2c1C(=O)NCCO,5.57,Inhibition of recombinant human C-terminal His/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using biotin-labeled poly[Glu:Tyr] (4:1) as substrate after 30 mins by Kinase-Glo plus luminescence assay,IC50,2700.0,nM,=,CHEMBL4253971,B,CHEMBL4292715,Homo sapiens,CHEMBL203,CHEMBL4251615
C=CC(=O)Nc1cccc(-n2c(=O)c(=O)n(C(C)C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.52,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",IC50,0.3,nM,=,CHEMBL4427028,B,CHEMBL4293051,Homo sapiens,CHEMBL203,CHEMBL4425144
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OCC)cc1N(C)CCN(C)C,9.10,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,0.8,nM,=,CHEMBL4258550,B,CHEMBL4293126,Homo sapiens,CHEMBL203,CHEMBL4257480
CCOc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1,6.12,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,754.0,nM,=,CHEMBL4267257,B,CHEMBL4293134,Homo sapiens,CHEMBL203,CHEMBL4265907
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1O[C@H]1CCOC1,9.15,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,0.7,nM,=,CHEMBL4258550,B,CHEMBL4293145,Homo sapiens,CHEMBL203,CHEMBL4257480
Cc1oc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1C(=O)O,6.02,Inhibition of recombinant human C-terminal His/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using biotin-labeled poly[Glu:Tyr] (4:1) as substrate after 30 mins by Kinase-Glo plus luminescence assay,IC50,951.0,nM,=,CHEMBL4253971,B,CHEMBL4293326,Homo sapiens,CHEMBL203,CHEMBL4251615
COc1ccc(OC)c(Nc2cc(Nc3ccc(N4CCN(C)CC4)cc3)ncn2)c1,6.54,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,288.0,nM,=,CHEMBL4267255,B,CHEMBL4293690,Homo sapiens,CHEMBL203,CHEMBL4265907
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N1CCC(N(C)C)CC1,9.00,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,1.0,nM,=,CHEMBL4258550,B,CHEMBL4293734,Homo sapiens,CHEMBL203,CHEMBL4257480
COc1cccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1,7.92,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,IC50,12.0,nM,=,CHEMBL4267257,B,CHEMBL4294156,Homo sapiens,CHEMBL203,CHEMBL4265907
C=C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N1CCC(N2CCOCC2)CC1,9.15,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",IC50,0.7,nM,=,CHEMBL4258550,B,CHEMBL4294211,Homo sapiens,CHEMBL203,CHEMBL4257480
COc1cc2ncnc(Nc3ccc(-c4cc(-c5ccc(Br)cc5)c(C#N)c(=N)[nH]4)cc3)c2cc1OC,5.71,Inhibition of EGFR (unknown origin),IC50,1935.0,nM,=,CHEMBL4271176,B,CHEMBL4294264,Homo sapiens,CHEMBL203,CHEMBL4270496
CCC(=O)N[C@H]1CC[C@H](N2C(=O)N(c3ccccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)CC1,8.24,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",IC50,5.8,nM,=,CHEMBL4270447,B,CHEMBL4294743,Homo sapiens,CHEMBL203,CHEMBL4266062
CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1,5.70,Inhibition of HER1 (unknown origin),IC50,2000.0,nM,=,CHEMBL4616782,B,CHEMBL4297674,Homo sapiens,CHEMBL203,CHEMBL4616583
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1,9.77,Inhibition of wild type EGFR L858R mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,IC50,0.17,nM,=,CHEMBL4829486,B,CHEMBL4297865,Homo sapiens,CHEMBL203,CHEMBL4828722
CC(C)(O)Cn1/c(=N/C(=O)c2ccnc(-c3ccccc3)c2)[nH]c2ccccc21,6.57,Inhibition of GST-fusion tagged EGFR L858R/T790M/C797S triple mutant (unknown origin) (696 to 1022 residues) expressed in insect cells assessed as decrease in phosphorylation of ULight-poly-GT using poly-GT as substrate in presence of ATP,IC50,267.0,nM,=,CHEMBL4324121,B,CHEMBL4434788,Homo sapiens,CHEMBL203,CHEMBL4321840
COc1cc(N(C)CCN(C)C)c(NC(=O)/C=C\C(C)C)cc1Nc1nc(C)cc(-c2cn(C)c3ccccc23)n1,7.42,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,38.0,nM,=,CHEMBL4411959,B,CHEMBL4434924,Homo sapiens,CHEMBL203,CHEMBL4411272
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCOCCOCCNC(=O)Cn1cnc([N+](=O)[O-])n1,8.30,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,4.95,nM,=,CHEMBL4362208,B,CHEMBL4435233,Homo sapiens,CHEMBL203,CHEMBL4359867
O=C(/C=C/CN1CCCC1)N1CCCOc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,6.05,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,IC50,890.0,nM,=,CHEMBL4432452,B,CHEMBL4435619,Homo sapiens,CHEMBL203,CHEMBL4431348
Cc1cc(=O)n2nc(SCc3cccc(C(F)(F)F)c3)nc2[nH]1,7.09,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,IC50,81.0,nM,=,CHEMBL4341976,B,CHEMBL4435632,Homo sapiens,CHEMBL203,CHEMBL4340550
C=CC(=O)Oc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCC,7.82,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,IC50,15.0,nM,=,CHEMBL4384426,B,CHEMBL4435699,Homo sapiens,CHEMBL203,CHEMBL4382245
COc1cc2ncnc(Nc3ccc(Br)cc3F)c2cc1OCCCN1CCNCCNCC1,7.55,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,IC50,28.2,nM,=,CHEMBL4329616,B,CHEMBL4435885,Homo sapiens,CHEMBL203,CHEMBL4325914
C=CC(=O)Nc1cccc(Nc2ncnc3cc(OC)c(OCCN4CCOCC4)cc23)c1,8.37,Inhibition of EGFR T790M mutant (unknown origin) incubated for 60 mins by ADP-Glo kinase assay,IC50,4.3,nM,=,CHEMBL4342766,B,CHEMBL4436337,Homo sapiens,CHEMBL203,CHEMBL4342406
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(Cc2ccc(OC)cc2)nn1,8.30,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",IC50,5.0,nM,=,CHEMBL4373060,B,CHEMBL4436695,Homo sapiens,CHEMBL203,CHEMBL4371069
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)COC(=O)c1ccccc1,7.60,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,IC50,25.0,nM,=,CHEMBL4384426,B,CHEMBL4437599,Homo sapiens,CHEMBL203,CHEMBL4382245
O=C(Nc1cccc(NC(=O)c2ccccn2)c1)NC1CCCCC1,6.83,Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end) expressed in baculovirus infected Sf9 cells using ATP as substrate after 40 mins by Kinase-Glo MAX luminescence assay,IC50,147.0,nM,=,CHEMBL4433480,B,CHEMBL4437803,Homo sapiens,CHEMBL203,CHEMBL4433204
CC1(C)CC[C@]2(C(=O)OCCO[N+](=O)[O-])CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1,7.52,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M/C797S mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,IC50,30.0,nM,=,CHEMBL4417018,B,CHEMBL4437863,Homo sapiens,CHEMBL203,CHEMBL4414650
O=C(CCSC(=S)N1CCN(c2ccccc2)CC1)Nc1cccc(NC(=O)c2ccccn2)c1,7.16,Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end) expressed in baculovirus infected Sf9 cells using ATP as substrate after 40 mins by Kinase-Glo MAX luminescence assay,IC50,70.0,nM,=,CHEMBL4433480,B,CHEMBL4437943,Homo sapiens,CHEMBL203,CHEMBL4433204
C=CC(=O)Nc1cccc(-n2c3nc(Nc4ccc(N5CCN(NC)CC5)cc4OC)ncc3c(=O)n3ccnc23)c1,8.59,Binding affinity to partial length human EGFR L858R/T790M double mutant expressed in mammalian system by KINOMEscan assay,Kd,2.6,nM,=,CHEMBL4425262,B,CHEMBL4438135,Homo sapiens,CHEMBL203,CHEMBL4425085
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3ccc(C(F)(F)F)cc3)n2)c(OC)cc1N(C)CCN(C)C,7.33,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,46.52,nM,=,CHEMBL4384381,B,CHEMBL4438856,Homo sapiens,CHEMBL203,CHEMBL4382243
COc1cc(N(C)CCN(C)C)c(NC(=O)/C=C\C(C)C)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,6.40,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,397.0,nM,=,CHEMBL4411959,B,CHEMBL4438905,Homo sapiens,CHEMBL203,CHEMBL4411272
O=C(Nc1cnn(-c2ccccc2)c1)c1cccc(NS(=O)(=O)c2ccc(Cl)cc2)c1,4.98,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,10580.0,nM,=,CHEMBL4387504,B,CHEMBL4439053,Homo sapiens,CHEMBL203,CHEMBL4385653
C=CC(=O)N(c1cc(F)c(F)cc1F)c1ncnc2cc(OC)c(OCCCN3CCOCC3)cc12,6.30,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,IC50,500.0,nM,=,CHEMBL4385373,B,CHEMBL4439066,Homo sapiens,CHEMBL203,CHEMBL4382284
COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OCCCN1CCNCCNCC1,9.52,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,IC50,0.3,nM,=,CHEMBL4329616,B,CHEMBL4439338,Homo sapiens,CHEMBL203,CHEMBL4325914
C=C(Cl)C(=O)Nc1cc(Nc2nc(C)cc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,8.00,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,10.0,nM,=,CHEMBL4411959,B,CHEMBL4439632,Homo sapiens,CHEMBL203,CHEMBL4411272
COc1ccc(/C=C/C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2O[C@@H]2CCOC2)cc1,8.05,Inhibition of EGFR (unknown origin),IC50,9.0,nM,=,CHEMBL4362047,B,CHEMBL4439680,Homo sapiens,CHEMBL203,CHEMBL4359862
Cn1c(=O)c2[nH]c(SC/C(=N/O)c3ccc(Br)cc3)nc2n(C)c1=O,6.35,Inhibition of human EGFR measured after 3 hrs by ELISA,IC50,450.0,nM,=,CHEMBL4396109,B,CHEMBL4439837,Homo sapiens,CHEMBL203,CHEMBL4393713
COc1cc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc(OC)c1,6.50,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669-1210 AA) expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,IC50,315.0,nM,=,CHEMBL4417509,B,CHEMBL4439933,Homo sapiens,CHEMBL203,CHEMBL4414679
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)COC(C)=O,9.28,Inhibition of recombinant human wild type GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus expression system after 1 hr by kinase tracer 199 based TR-FRET assay,IC50,0.52,nM,=,CHEMBL4384432,B,CHEMBL4439974,Homo sapiens,CHEMBL203,CHEMBL4382245
C[N+](C)(C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)Cc1ccc([N+](=O)[O-])cc1.[Br-],9.66,Inhibition of erbB1 (unknown origin) using FRET-capable peptide substrate by FRET assay,IC50,0.22,nM,=,CHEMBL4316716,B,CHEMBL4439982,Homo sapiens,CHEMBL203,CHEMBL4316582
COc1ccc(/C(CSc2nc3c([nH]2)c(=O)n(C)c(=O)n3C)=N\O)cc1,6.50,Inhibition of human EGFR measured after 3 hrs by ELISA,IC50,320.0,nM,=,CHEMBL4396109,B,CHEMBL4440012,Homo sapiens,CHEMBL203,CHEMBL4393713
C#Cc1cccc(Nc2c(C#N)cnc3cc(OC)c(OC)cc23)c1,8.74,Binding affinity to wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by Kinomescan method,Kd,1.8,nM,=,CHEMBL4394506,B,CHEMBL4440586,Homo sapiens,CHEMBL203,CHEMBL4393671
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC(=O)CCl,9.06,Inhibition of recombinant human wild type GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus expression system after 1 hr by kinase tracer 199 based TR-FRET assay,IC50,0.87,nM,=,CHEMBL4384432,B,CHEMBL4440618,Homo sapiens,CHEMBL203,CHEMBL4382245
C=CC(=O)N(c1cccc(Cl)c1F)c1ncnc2cc(OC)c(OCCCN3CCOCC3)cc12,7.28,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,IC50,52.6,nM,=,CHEMBL4385373,B,CHEMBL4441029,Homo sapiens,CHEMBL203,CHEMBL4382284
C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3c(-c4ccc(F)cc4)nc(SC)n3C)ccn2)c1,6.96,Inhibition of human EGFR L858R/T790M mutant using poly[Glu:Tyr] (4:1) as substrate measured in presence of [gamma-33P]ATP by radiometric assay,IC50,111.0,nM,=,CHEMBL4359338,B,CHEMBL4441037,Homo sapiens,CHEMBL203,CHEMBL4354875
N#Cc1cnc2ccc(NC(=O)C3CSSC3)cc2c1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,6.70,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,IC50,199.0,nM,=,CHEMBL4388527,B,CHEMBL4441244,Homo sapiens,CHEMBL203,CHEMBL4387720
Cc1cc(=O)n2nc(SCc3ccc(F)cc3)nc2[nH]1,7.28,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,IC50,52.0,nM,=,CHEMBL4341976,B,CHEMBL4441392,Homo sapiens,CHEMBL203,CHEMBL4340550
COc1ccc(/C(CSc2nc3[nH]c(=O)n(C)c(=O)c3[nH]2)=N\O)cc1,6.15,Inhibition of human EGFR measured after 3 hrs by ELISA,IC50,710.0,nM,=,CHEMBL4396109,B,CHEMBL4441404,Homo sapiens,CHEMBL203,CHEMBL4393713
C=CC(=O)Nc1cccc(-c2coc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,6.80,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,159.0,nM,=,CHEMBL4416105,B,CHEMBL4441440,Homo sapiens,CHEMBL203,CHEMBL4414600
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1[S+]([O-])CCN(C)C,8.40,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,IC50,4.0,nM,=,CHEMBL4378482,B,CHEMBL4441606,Homo sapiens,CHEMBL203,CHEMBL4376823
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3ccc(OC)c(OC)c3)n2)c(OC)cc1N1CCC(C(N)=O)CC1,7.26,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,54.69,nM,=,CHEMBL4384381,B,CHEMBL4441745,Homo sapiens,CHEMBL203,CHEMBL4382243
C=CC(=O)N(c1cccc(C(F)(F)F)c1)c1ncnc2cc(OC)c(OCCCN3CCOCC3)cc12,6.07,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,IC50,844.0,nM,=,CHEMBL4385373,B,CHEMBL4441921,Homo sapiens,CHEMBL203,CHEMBL4382284
C=C(Cl)C(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.48,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,33.0,nM,=,CHEMBL4411959,B,CHEMBL4441933,Homo sapiens,CHEMBL203,CHEMBL4411272
COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccccc4)cc3)ccnc2cc1OCCCN1CCOCC1,5.34,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,IC50,4520.0,nM,=,CHEMBL4393297,B,CHEMBL4442035,Homo sapiens,CHEMBL203,CHEMBL4392844
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCN(CCC(=O)NCCCCCCCCOc2cccc3c2C(=O)N(C2CCC(=O)N(C)C2=O)C3=O)CC1,8.52,Binding affinity to human wild-type partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by kinomescan assay,Kd,3.0,nM,=,CHEMBL4380725,B,CHEMBL4442491,Homo sapiens,CHEMBL203,CHEMBL4376874
COc1cccc(-n2cc(NC(=O)c3ccc(NS(=O)(=O)c4ccccc4)cc3)cn2)c1,4.62,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,24130.0,nM,=,CHEMBL4387504,B,CHEMBL4442932,Homo sapiens,CHEMBL203,CHEMBL4385653
O=C(Nc1nccs1)C(c1cc(F)ccc1O)N1Cc2ccc(-c3ccc(N4CCNCC4)cc3)cc2C1=O,9.59,Inhibition of EGFR L858R/T790M double mutant (unknown origin),IC50,0.26,nM,=,CHEMBL5143776,B,CHEMBL4443062,Homo sapiens,CHEMBL203,CHEMBL5143505
COC[C@H](C)Oc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,8.56,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,IC50,2.73,nM,=,CHEMBL4332363,B,CHEMBL4443188,Homo sapiens,CHEMBL203,CHEMBL4330113
CCC(=O)N1CC[C@@H](n2c(=O)c(-c3ccccc3Cl)c(C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.09,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,81.7,nM,=,CHEMBL4375049,B,CHEMBL4443413,Homo sapiens,CHEMBL203,CHEMBL4373695
COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1,8.66,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant expressed in baculovirus expression system using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",IC50,2.2,nM,=,CHEMBL4398796,B,CHEMBL4443483,Homo sapiens,CHEMBL203,CHEMBL4396901
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1,5.90,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,IC50,1257.0,nM,=,CHEMBL4349142,B,CHEMBL4443805,Homo sapiens,CHEMBL203,CHEMBL4346710
COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,6.91,Binding affinity to EGFR in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay,Kd,122.0,nM,=,CHEMBL4371415,B,CHEMBL4443828,Homo sapiens,CHEMBL203,CHEMBL4371006
CC(C)(O)Cn1/c(=N/C(=O)c2cccc(-c3cccnc3)c2)[nH]c2ccccc21,5.57,Inhibition of GST-fusion tagged EGFR L858R/T790M/C797S triple mutant (unknown origin) (696 to 1022 residues) expressed in insect cells assessed as decrease in phosphorylation of ULight-poly-GT using poly-GT as substrate in presence of ATP,IC50,2700.0,nM,=,CHEMBL4324121,B,CHEMBL4444231,Homo sapiens,CHEMBL203,CHEMBL4321840
CCC/C=C\C(=O)Nc1cc(Nc2nc3c(c(-c4cn(C)c5ccccc45)n2)CS(=O)(=O)CC3)c(OC)cc1N(C)CCN(C)C,7.80,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,IC50,16.0,nM,=,CHEMBL4315819,B,CHEMBL4444312,Homo sapiens,CHEMBL203,CHEMBL4312015
COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4cc(F)cc(F)c4)cc3)ccnc2cc1OCCCN1CCOCC1,5.32,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,IC50,4750.0,nM,=,CHEMBL4393297,B,CHEMBL4445015,Homo sapiens,CHEMBL203,CHEMBL4392844
O=C(/C=C/CN1CCCCC1)N1CCOc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,8.40,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,IC50,4.0,nM,=,CHEMBL4432463,B,CHEMBL4445017,Homo sapiens,CHEMBL203,CHEMBL4431348
Cc1cc(=O)n2nc(SCc3ccc([N+](=O)[O-])cc3)nc2[nH]1,7.12,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,IC50,76.0,nM,=,CHEMBL4341977,B,CHEMBL4445265,Homo sapiens,CHEMBL203,CHEMBL4340550
CC/C=C\C(=O)Nc1cc(Nc2nc(C)cc(-c3cn(C)c4ccc(F)cc34)n2)c(OC)cc1N(C)CCN(C)C,6.00,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,998.0,nM,=,CHEMBL4411959,B,CHEMBL4445761,Homo sapiens,CHEMBL203,CHEMBL4411272
CC/C=C\C(=O)Nc1cc(Nc2ncc(C#N)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.80,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,16.0,nM,=,CHEMBL4411959,B,CHEMBL4445797,Homo sapiens,CHEMBL203,CHEMBL4411272
O=C(Nc1cnn(-c2ccccc2)c1)c1ccc(NS(=O)(=O)c2ccccc2)cc1,4.59,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,25410.0,nM,=,CHEMBL4387504,B,CHEMBL4445843,Homo sapiens,CHEMBL203,CHEMBL4385653
N#Cc1cnc2ccc(NC(=O)CC3CCSS3)cc2c1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,7.44,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,IC50,36.0,nM,=,CHEMBL4388527,B,CHEMBL4446124,Homo sapiens,CHEMBL203,CHEMBL4387720
CCC(=O)N1CCC[C@@H](n2c(=O)c(-c3ccccc3Cl)c(C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.19,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,65.1,nM,=,CHEMBL4375049,B,CHEMBL4446258,Homo sapiens,CHEMBL203,CHEMBL4373695
C=CC(=O)Nc1cccc(-n2c3nc(Nc4ccc(N5CCN(C)CC5)cc4OCC)ncc3c(=O)n3ccnc23)c1,8.51,Binding affinity to partial length human EGFR L858R/T790M double mutant expressed in mammalian system by KINOMEscan assay,Kd,3.1,nM,=,CHEMBL4425262,B,CHEMBL4446485,Homo sapiens,CHEMBL203,CHEMBL4425085
CC/C=C\C(=O)Nc1cc(Nc2nc3c(c(-c4cn(C)c5ccccc45)n2)CSCC3)c(OC)cc1N(C)CCN(C)C,5.90,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,IC50,1248.0,nM,=,CHEMBL4315819,B,CHEMBL4446546,Homo sapiens,CHEMBL203,CHEMBL4312015
COc1cc(Nc2ncnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC,5.21,Binding affinity to wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by Kinomescan method,Kd,6100.0,nM,=,CHEMBL4394506,B,CHEMBL4446630,Homo sapiens,CHEMBL203,CHEMBL4393671
CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12,5.00,Inhibition of recombinant human wild-type N-terminal GST-His6-fused EGFR C-terminal domain (H672 to A1210) expressed in Sf9 insect cells using Poly(Glu:Tyr)4:1 as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method,IC50,10000.0,nM,=,CHEMBL4340725,B,CHEMBL4446681,Homo sapiens,CHEMBL203,CHEMBL4340507
CCOC(=O)/C=C/C(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,7.10,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,79.0,nM,=,CHEMBL4416105,B,CHEMBL4446953,Homo sapiens,CHEMBL203,CHEMBL4414600
COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)cc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,6.40,Inhibition of EGFR (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,IC50,400.0,nM,=,CHEMBL4393296,B,CHEMBL4446992,Homo sapiens,CHEMBL203,CHEMBL4392844
C=CS(=O)(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,5.61,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,IC50,2459.0,nM,=,CHEMBL4416106,B,CHEMBL4447036,Homo sapiens,CHEMBL203,CHEMBL4414600
COc1ccc(/C=C/C(=O)c2ccc(NC(=O)c3cc4cc5cc(C)ccc5nc4s3)cc2)cc1OC,6.30,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,IC50,500.0,nM,=,CHEMBL4370781,B,CHEMBL4447196,Homo sapiens,CHEMBL203,CHEMBL4368931
COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,6.23,Inhibition of wild type EGFR (unknown origin),IC50,592.0,nM,=,CHEMBL4371479,B,CHEMBL4447225,Homo sapiens,CHEMBL203,CHEMBL4371006
C=CC(=O)Nc1cccc(-c2noc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,6.38,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,416.0,nM,=,CHEMBL4416105,B,CHEMBL4447289,Homo sapiens,CHEMBL203,CHEMBL4414600
COc1cc2nccc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OC,7.50,Binding affinity to wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by Kinomescan method,Kd,32.0,nM,=,CHEMBL4394506,B,CHEMBL4447797,Homo sapiens,CHEMBL203,CHEMBL4393671
C=CC(=O)Nc1cccc(-c2c(C)sc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,6.97,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,107.0,nM,=,CHEMBL4416105,B,CHEMBL4447962,Homo sapiens,CHEMBL203,CHEMBL4414600
CCOCCOc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,6.81,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,IC50,153.5,nM,=,CHEMBL4332363,B,CHEMBL4447976,Homo sapiens,CHEMBL203,CHEMBL4330113
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CC[S+](C)[O-],6.98,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,IC50,105.0,nM,=,CHEMBL4378482,B,CHEMBL4447982,Homo sapiens,CHEMBL203,CHEMBL4376823
C=CC(=O)Nc1cc(Nc2ncc(F)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C,8.70,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,IC50,2.0,nM,=,CHEMBL4382300,B,CHEMBL4448107,Homo sapiens,CHEMBL203,CHEMBL4382192
C/C=C/C(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,6.62,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,239.0,nM,=,CHEMBL4416105,B,CHEMBL4448148,Homo sapiens,CHEMBL203,CHEMBL4414600
COc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3)c2cc1OCCCN1CCOCC1,9.00,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,IC50,1.0,nM,=,CHEMBL4385373,B,CHEMBL4448162,Homo sapiens,CHEMBL203,CHEMBL4382284
COc1ccc(-n2cc(NC(=O)c3ccc(NS(=O)(=O)c4ccccc4)cc3)cn2)cc1,4.58,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,26150.0,nM,=,CHEMBL4387504,B,CHEMBL4448424,Homo sapiens,CHEMBL203,CHEMBL4385653
CC(C)=CC[C@@H](OC(=O)/C=C\C(=O)c1ccc(Cl)cc1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,7.49,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,IC50,32.5,nM,=,CHEMBL4410222,B,CHEMBL4448428,Homo sapiens,CHEMBL203,CHEMBL4406881
Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C,5.71,Inhibition of EGFR (unknown origin),IC50,1970.0,nM,=,CHEMBL4305817,B,CHEMBL4448494,Homo sapiens,CHEMBL203,CHEMBL4304763
C=CC(=O)Nc1cccc(-c2c(C)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,7.21,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,62.0,nM,=,CHEMBL4416105,B,CHEMBL4448691,Homo sapiens,CHEMBL203,CHEMBL4414600
C=CC(=O)N(c1ccc(F)c(C)c1)c1ncnc2cc(OC)c(OCCCN3CCOCC3)cc12,6.30,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,IC50,499.0,nM,=,CHEMBL4385373,B,CHEMBL4448712,Homo sapiens,CHEMBL203,CHEMBL4382284
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)N(C)C)n2)c(OC)cc1N(C)CCN(C)C,8.70,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,IC50,2.0,nM,=,CHEMBL4382299,B,CHEMBL4449391,Homo sapiens,CHEMBL203,CHEMBL4382192
CC(C)(O)Cn1/c(=N/C(=O)c2ccnc(-c3cccnc3)c2)[nH]c2ccccc21,6.45,Inhibition of GST-fusion tagged EGFR L858R/T790M/C797S triple mutant (unknown origin) (696 to 1022 residues) expressed in insect cells assessed as decrease in phosphorylation of ULight-poly-GT using poly-GT as substrate in presence of ATP,IC50,353.0,nM,=,CHEMBL4324121,B,CHEMBL4449589,Homo sapiens,CHEMBL203,CHEMBL4321840
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)CO,9.47,Inhibition of recombinant human wild type GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus expression system after 1 hr by kinase tracer 199 based TR-FRET assay,IC50,0.34,nM,=,CHEMBL4384432,B,CHEMBL4449681,Homo sapiens,CHEMBL203,CHEMBL4382245
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3ccc(C(F)(F)F)cc3)n2)c(OC)cc1N1CCC(C(N)=O)CC1,7.18,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,65.34,nM,=,CHEMBL4384381,B,CHEMBL4449898,Homo sapiens,CHEMBL203,CHEMBL4382243
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3ccc(OC)c(OC)c3)n2)c(OC)cc1N(C)CCN(C)C,6.91,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,123.2,nM,=,CHEMBL4384381,B,CHEMBL4450061,Homo sapiens,CHEMBL203,CHEMBL4382243
CC(C)OCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,8.81,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,IC50,1.54,nM,=,CHEMBL4332363,B,CHEMBL4450824,Homo sapiens,CHEMBL203,CHEMBL4330113
CN(C)C/C=C/C(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@@H](CO)c4ccccc4)c23)c1,6.25,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,562.0,nM,=,CHEMBL4416105,B,CHEMBL4450843,Homo sapiens,CHEMBL203,CHEMBL4414600
CCC(=O)N1CCC[C@@H](n2c(=O)c(-c3ccc(F)cc3Cl)c(C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.05,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,88.6,nM,=,CHEMBL4375049,B,CHEMBL4450934,Homo sapiens,CHEMBL203,CHEMBL4373695
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)CC1CCSS1,6.52,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,IC50,300.0,nM,=,CHEMBL4388527,B,CHEMBL4451538,Homo sapiens,CHEMBL203,CHEMBL4387720
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3cccc(OC)c3)n2)c(OC)cc1N1CCN(C)CC1,7.26,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,54.99,nM,=,CHEMBL4384381,B,CHEMBL4451619,Homo sapiens,CHEMBL203,CHEMBL4382243
C/C=C\C(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.28,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,52.0,nM,=,CHEMBL4411959,B,CHEMBL4451986,Homo sapiens,CHEMBL203,CHEMBL4411272
O=C(Nc1nccs1)[C@@H](c1cc(F)ccc1O)N1Cc2ccccc2C1=O,8.70,Inhibition of human N-terminal GST-tagged EGFR double T790M/L858R mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,IC50,2.0,nM,=,CHEMBL4410887,B,CHEMBL4452106,Homo sapiens,CHEMBL203,CHEMBL4406912
COc1cc(N(C)CCN(C)C)c(NC(=O)/C=C\C(C)C)cc1Nc1ncc(C#N)c(-c2cn(C)c3ccccc23)n1,6.66,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,219.0,nM,=,CHEMBL4411959,B,CHEMBL4452628,Homo sapiens,CHEMBL203,CHEMBL4411272
CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@H]5CC(C)(C)CC[C@]5(C(=O)OCCCCO[N+](=O)[O-])CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C,7.70,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M/C797S mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,IC50,20.0,nM,=,CHEMBL4417018,B,CHEMBL4452906,Homo sapiens,CHEMBL203,CHEMBL4414650
CC(C)=CC[C@@H](OC(=O)/C=C\C(=O)c1cc(F)ccc1C)C1=CC(=O)c2c(O)ccc(O)c2C1=O,7.63,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,IC50,23.4,nM,=,CHEMBL4410222,B,CHEMBL4452957,Homo sapiens,CHEMBL203,CHEMBL4406881
C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCO4)c1,7.31,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,48.7,nM,=,CHEMBL4730561,B,CHEMBL4453068,Homo sapiens,CHEMBL203,CHEMBL4725422
CCC(=O)N1CCC[C@@H](n2c(=O)c(-c3ccccc3C)c(C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,6.64,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,227.9,nM,=,CHEMBL4375049,B,CHEMBL4453276,Homo sapiens,CHEMBL203,CHEMBL4373695
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCNC(=O)Cn1cnc([N+](=O)[O-])n1,7.36,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,43.56,nM,=,CHEMBL4362208,B,CHEMBL4453429,Homo sapiens,CHEMBL203,CHEMBL4359867
C=CC(=O)N(c1ccc(F)c(Cl)c1)c1ncnc2cc(OC)c(OCCCN3CCOCC3)cc12,7.19,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,IC50,65.2,nM,=,CHEMBL4385373,B,CHEMBL4453748,Homo sapiens,CHEMBL203,CHEMBL4382284
C=CC(=O)Nc1cccc(N2C3=NCCCCN3C(=O)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,9.06,Binding affinity to partial length human EGFR L858R/T790M double mutant expressed in mammalian system by KINOMEscan assay,Kd,0.88,nM,=,CHEMBL4425262,B,CHEMBL4454373,Homo sapiens,CHEMBL203,CHEMBL4425085
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3ccccc3)n2)c(OC)cc1N1CCC(C(N)=O)CC1,9.23,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,0.5872,nM,=,CHEMBL4384381,B,CHEMBL4454516,Homo sapiens,CHEMBL203,CHEMBL4382243
COc1cc(N(C)CCN(C)C)c(NC(=O)/C=C\C(C)C)cc1Nc1nc2c(c(-c3cn(C)c4ccc(F)cc34)n1)CSCC2,5.77,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,IC50,1689.0,nM,=,CHEMBL4315819,B,CHEMBL4454709,Homo sapiens,CHEMBL203,CHEMBL4312015
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCCl,6.91,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,IC50,122.0,nM,=,CHEMBL4378482,B,CHEMBL4454745,Homo sapiens,CHEMBL203,CHEMBL4376823
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N1CCS(=O)(=O)CC1,7.42,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,IC50,38.0,nM,=,CHEMBL4378482,B,CHEMBL4454929,Homo sapiens,CHEMBL203,CHEMBL4376823
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(Cc2cccc(F)c2)nn1,8.40,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",IC50,4.0,nM,=,CHEMBL4373060,B,CHEMBL4454948,Homo sapiens,CHEMBL203,CHEMBL4371069
Cn1cc(NC(=O)c2cccc(NS(=O)(=O)c3ccc(Cl)cc3)c2)cn1,4.52,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,30450.0,nM,=,CHEMBL4387504,B,CHEMBL4455321,Homo sapiens,CHEMBL203,CHEMBL4385653
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3ccccc3)n2)c(OC)cc1N1CCN(C)CC1,6.92,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,120.7,nM,=,CHEMBL4384381,B,CHEMBL4456234,Homo sapiens,CHEMBL203,CHEMBL4382243
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)C1CSSC1,7.75,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,IC50,18.0,nM,=,CHEMBL4388527,B,CHEMBL4456266,Homo sapiens,CHEMBL203,CHEMBL4387720
CC#CC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,7.19,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,64.0,nM,=,CHEMBL4416105,B,CHEMBL4456359,Homo sapiens,CHEMBL203,CHEMBL4414600
OC(c1cccs1)c1cc2ccccc2nc1Cl,5.20,Inhibition of EGFR-TK in human HeLa cells overexpressing EGFR incubated for 18 to 24 hrs by kinase assay,IC50,6300.0,nM,=,CHEMBL4399533,B,CHEMBL4456370,Homo sapiens,CHEMBL203,CHEMBL4396926
COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)cc4)cc3)ccnc2cc1OCCCN1CCOCC1,5.37,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,IC50,4300.0,nM,=,CHEMBL4393297,B,CHEMBL4456494,Homo sapiens,CHEMBL203,CHEMBL4392844
COc1cc2c(Oc3ccc(C4SCC(=O)N4NC(=O)Nc4ccc(F)c(F)c4F)cc3)ccnc2cc1OCCCN1CCOCC1,5.37,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,IC50,4240.0,nM,=,CHEMBL4393297,B,CHEMBL4456688,Homo sapiens,CHEMBL203,CHEMBL4392844
Cc1cc(=O)n2nc(SCc3ccc(C(C)C)cc3)nc2[nH]1,7.21,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,IC50,62.0,nM,=,CHEMBL4341977,B,CHEMBL4456976,Homo sapiens,CHEMBL203,CHEMBL4340550
C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3ccc(N4CCN(CC)CC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)C1,8.06,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,IC50,8.7,nM,=,CHEMBL4349142,B,CHEMBL4457018,Homo sapiens,CHEMBL203,CHEMBL4346710
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)CC1CCSS1,8.32,Binding affinity to human partial length EGFR L861Q mutant (R669 to V1011 residues) expressed in bacterial expression system by KinomeScan assay,Kd,4.8,nM,=,CHEMBL4388554,B,CHEMBL4457447,Homo sapiens,CHEMBL203,CHEMBL4387720
COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1,5.95,Inhibition of wild type EGFR (unknown origin),IC50,1128.0,nM,=,CHEMBL4371479,B,CHEMBL4457733,Homo sapiens,CHEMBL203,CHEMBL4371006
COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)C1CSSC1,8.19,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,IC50,6.5,nM,=,CHEMBL4388527,B,CHEMBL4457885,Homo sapiens,CHEMBL203,CHEMBL4387720
C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)C1,6.86,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,IC50,138.0,nM,=,CHEMBL4349142,B,CHEMBL4458344,Homo sapiens,CHEMBL203,CHEMBL4346710
CCN(C/C=C/C(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1)CCO,7.89,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,13.0,nM,=,CHEMBL4416105,B,CHEMBL4458437,Homo sapiens,CHEMBL203,CHEMBL4414600
CC1CCCCN1C/C=C/C(=O)N1CCOc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,8.52,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,IC50,3.0,nM,=,CHEMBL4432463,B,CHEMBL4458843,Homo sapiens,CHEMBL203,CHEMBL4431348
O=C(Nc1cnn(-c2ccccc2)c1)c1cccc(NS(=O)(=O)c2ccccc2)c1,4.81,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,15360.0,nM,=,CHEMBL4387504,B,CHEMBL4459052,Homo sapiens,CHEMBL203,CHEMBL4385653
C=CC(=O)Nc1cccc(-n2c3nc(Nc4ccc(N5CCN(C)CC5)cc4OC)ncc3c(=O)n3ccnc23)c1,8.74,Binding affinity to partial length human EGFR L858R/T790M double mutant expressed in mammalian system by KINOMEscan assay,Kd,1.8,nM,=,CHEMBL4425262,B,CHEMBL4459080,Homo sapiens,CHEMBL203,CHEMBL4425085
O=C(Nc1cnn(-c2ccccc2)c1)c1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1,4.73,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,18690.0,nM,=,CHEMBL4387504,B,CHEMBL4459564,Homo sapiens,CHEMBL203,CHEMBL4385653
CCC(=O)N[C@H]1CC[C@@H](n2c(=O)c(-c3ccccc3Cl)c(C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)CC1,7.56,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,27.7,nM,=,CHEMBL4375049,B,CHEMBL4459978,Homo sapiens,CHEMBL203,CHEMBL4373695
COc1cc2c(Nc3ccc(F)cc3)ncnc2cc1OCCOCCNC(=O)Cn1cnc([N+](=O)[O-])n1,7.78,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,16.43,nM,=,CHEMBL4362208,B,CHEMBL4460151,Homo sapiens,CHEMBL203,CHEMBL4359867
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N1CC[S+]([O-])CC1,7.19,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,IC50,65.0,nM,=,CHEMBL4378483,B,CHEMBL4460261,Homo sapiens,CHEMBL203,CHEMBL4376823
CC/C=C\C(=O)Nc1cc(Nc2nc(C)cc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.75,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,18.0,nM,=,CHEMBL4411959,B,CHEMBL4460320,Homo sapiens,CHEMBL203,CHEMBL4411272
COc1cc(Nc2ncnc3cc(-c4cccs4)sc23)cc(OC)c1OC,8.60,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,IC50,2.5,nM,=,CHEMBL4370290,B,CHEMBL4460381,Homo sapiens,CHEMBL203,CHEMBL4368913
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(Cc2ccc(Cl)cc2)nn1,7.92,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",IC50,12.0,nM,=,CHEMBL4373060,B,CHEMBL4460706,Homo sapiens,CHEMBL203,CHEMBL4371069
Cc1ccc(-n2cc(NC(=O)c3cccc(NS(=O)(=O)c4ccc(Cl)cc4)c3)cn2)cc1,5.06,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,8770.0,nM,=,CHEMBL4387504,B,CHEMBL4460897,Homo sapiens,CHEMBL203,CHEMBL4385653
COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,7.80,Binding affinity to EGFR in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay,Kd,16.0,nM,=,CHEMBL4371415,B,CHEMBL4462318,Homo sapiens,CHEMBL203,CHEMBL4371006
COc1cc(N(C)c2ccnc3ccc(C(F)(F)F)cc23)cc(OC)c1OC,5.66,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,IC50,2200.0,nM,=,CHEMBL4394508,B,CHEMBL4462395,Homo sapiens,CHEMBL203,CHEMBL4393671
COc1cc(NC(=O)C2CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1,6.21,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) cytoplasmic domain expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay,IC50,617.0,nM,=,CHEMBL4400322,B,CHEMBL4462528,Homo sapiens,CHEMBL203,CHEMBL4396963
CCC(=O)N1CCC[C@@H](n2c(=O)c(-c3cc(F)ccc3Cl)c(C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.43,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,37.1,nM,=,CHEMBL4375049,B,CHEMBL4462965,Homo sapiens,CHEMBL203,CHEMBL4373695
COc1ccc2nc3sc(C(=O)Nc4ccc(C(=O)/C=C/c5ccc(OC)c(OC)c5)cc4)cc3cc2c1,6.16,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,IC50,700.0,nM,=,CHEMBL4370781,B,CHEMBL4462971,Homo sapiens,CHEMBL203,CHEMBL4368931
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)CCCCC1CCSS1,6.38,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,IC50,420.0,nM,=,CHEMBL4388527,B,CHEMBL4463005,Homo sapiens,CHEMBL203,CHEMBL4387720
CCN(CC)C/C=C/C(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,7.85,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,14.0,nM,=,CHEMBL4416105,B,CHEMBL4463012,Homo sapiens,CHEMBL203,CHEMBL4414600
CC(C)=CC[C@@H](OC(=O)/C=C\C(=O)c1ccc(F)cc1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,7.64,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,IC50,22.7,nM,=,CHEMBL4410222,B,CHEMBL4463094,Homo sapiens,CHEMBL203,CHEMBL4406881
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1,6.04,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,IC50,903.0,nM,=,CHEMBL4349142,B,CHEMBL4463563,Homo sapiens,CHEMBL203,CHEMBL4346710
C=C(Cl)C(=O)Nc1cc(Nc2ncc(C#N)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.70,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,20.0,nM,=,CHEMBL4411959,B,CHEMBL4463634,Homo sapiens,CHEMBL203,CHEMBL4411272
COc1cc2c(Nc3ccc(C)c(Br)c3)ncnc2cc1OCCNC(=O)Cn1cnc([N+](=O)[O-])n1,7.73,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,18.54,nM,=,CHEMBL4362208,B,CHEMBL4463765,Homo sapiens,CHEMBL203,CHEMBL4359867
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N1CCSCC1,7.19,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,IC50,64.0,nM,=,CHEMBL4378482,B,CHEMBL4463766,Homo sapiens,CHEMBL203,CHEMBL4376823
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C(=O)Cn2cncc2[N+](=O)[O-])CC1,8.49,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,3.23,nM,=,CHEMBL4362208,B,CHEMBL4463898,Homo sapiens,CHEMBL203,CHEMBL4359867
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4ccncc4)c23)c1,8.64,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,IC50,2.3,nM,=,CHEMBL4349142,B,CHEMBL4464404,Homo sapiens,CHEMBL203,CHEMBL4346710
CCC/C=C\C(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccc(F)cc34)n2)c(OC)cc1N(C)CCN(C)C,8.12,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,7.5,nM,=,CHEMBL4411959,B,CHEMBL4464589,Homo sapiens,CHEMBL203,CHEMBL4411272
C=CC(=O)Nc1cccc(-n2c3nc(Nc4ccc(N5CCN(C)CC5)cc4OC)ncc3c(=O)n3c4ccccc4nc23)c1,8.96,Binding affinity to partial length human EGFR L858R/T790M double mutant expressed in mammalian system by KINOMEscan assay,Kd,1.1,nM,=,CHEMBL4425262,B,CHEMBL4464614,Homo sapiens,CHEMBL203,CHEMBL4425085
COc1ccc(/C=C/C(=O)c2ccc(NC(=O)c3cc4cc5ccccc5nc4s3)cc2)cc1OC,5.80,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,IC50,1600.0,nM,=,CHEMBL4370781,B,CHEMBL4464785,Homo sapiens,CHEMBL203,CHEMBL4368931
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCO,7.00,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,IC50,101.0,nM,=,CHEMBL4378482,B,CHEMBL4464879,Homo sapiens,CHEMBL203,CHEMBL4376823
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3P(C)(C)=O)n2)c(OC)cc1N(C)CCN(C)C,8.30,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,IC50,5.0,nM,=,CHEMBL4382299,B,CHEMBL4465103,Homo sapiens,CHEMBL203,CHEMBL4382192
CNc1cncc(-c2c[nH]c3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4)nc(Oc4ccccc4)c23)n1,5.98,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,IC50,1048.0,nM,=,CHEMBL4349142,B,CHEMBL4465231,Homo sapiens,CHEMBL203,CHEMBL4346710
COc1cc2c(Nc3ccc(NC(=O)[C@H](c4ccccc4)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1,8.10,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant expressed in baculovirus expression system using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",IC50,7.9,nM,=,CHEMBL4398796,B,CHEMBL4465497,Homo sapiens,CHEMBL203,CHEMBL4396901
COc1cc(N2CCNC2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,6.12,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay,IC50,765.0,nM,=,CHEMBL4348480,B,CHEMBL4465558,Homo sapiens,CHEMBL203,CHEMBL4346688
O=C(/C=C/Cn1ccnc1)N1CCOc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,6.26,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,IC50,550.0,nM,=,CHEMBL4432452,B,CHEMBL4465727,Homo sapiens,CHEMBL203,CHEMBL4431348
COc1cc(/C=C/C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2O[C@@H]2CCOC2)cc(OC)c1OC,8.05,Inhibition of EGFR (unknown origin),IC50,9.0,nM,=,CHEMBL4362047,B,CHEMBL4466350,Homo sapiens,CHEMBL203,CHEMBL4359862
COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OC,8.89,Binding affinity to wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by Kinomescan method,Kd,1.3,nM,=,CHEMBL4394506,B,CHEMBL4467033,Homo sapiens,CHEMBL203,CHEMBL4393671
C=CC(=O)Nc1cc(Nc2ncc(I)c(Nc3ccccc3S(=O)(=O)N(C)C)n2)c(OC)cc1N(C)CCN(C)C,8.52,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,IC50,3.0,nM,=,CHEMBL4382299,B,CHEMBL4467561,Homo sapiens,CHEMBL203,CHEMBL4382192
CC/C=C\C(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,6.75,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,177.0,nM,=,CHEMBL4411959,B,CHEMBL4468034,Homo sapiens,CHEMBL203,CHEMBL4411272
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(Cc2ccccc2F)nn1,7.92,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",IC50,12.0,nM,=,CHEMBL4373060,B,CHEMBL4468464,Homo sapiens,CHEMBL203,CHEMBL4371069
COCCOc1cc2ncnc(Nc3cc(OC)c(OC)c(OC)c3)c2cc1OCCOC,7.28,Binding affinity to wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by Kinomescan method,Kd,53.0,nM,=,CHEMBL4394506,B,CHEMBL4468521,Homo sapiens,CHEMBL203,CHEMBL4393671
COc1cc2c(Nc3ccc(F)c(F)c3)ncnc2cc1OCCOCCOCCNC(=O)Cn1cnc([N+](=O)[O-])n1,7.70,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,19.97,nM,=,CHEMBL4362208,B,CHEMBL4468893,Homo sapiens,CHEMBL203,CHEMBL4359867
CC1CCN(C/C=C/C(=O)N2CCOc3cc4ncnc(Nc5ccc(F)c(Cl)c5)c4cc32)CC1,8.30,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,IC50,5.0,nM,=,CHEMBL4432463,B,CHEMBL4468924,Homo sapiens,CHEMBL203,CHEMBL4431348
Fc1ccc(COC(c2cccs2)c2cc3ccccc3nc2Cl)cc1,5.56,Inhibition of EGFR-TK in human MCF7 cells overexpressing EGFR incubated for 18 to 24 hrs by kinase assay,IC50,2750.0,nM,=,CHEMBL4399534,B,CHEMBL4469453,Homo sapiens,CHEMBL203,CHEMBL4396926
C=CC(=O)N(c1cccc(Cl)c1F)c1ncnc2cc(OC)c(OC(=O)N3CCN(C)C[C@H]3C)cc12,8.06,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,IC50,8.7,nM,=,CHEMBL4385373,B,CHEMBL4469866,Homo sapiens,CHEMBL203,CHEMBL4382284
C=CC(=O)N1CCC[C@@H](Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)C1,6.30,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,IC50,499.0,nM,=,CHEMBL4349142,B,CHEMBL4469900,Homo sapiens,CHEMBL203,CHEMBL4346710
CCC/C=C\C(=O)Nc1cc(Nc2ncc(C#N)c(-c3cn(C)c4ccc(F)cc34)n2)c(OC)cc1N(C)CCN(C)C,6.70,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,201.0,nM,=,CHEMBL4411959,B,CHEMBL4470120,Homo sapiens,CHEMBL203,CHEMBL4411272
Cc1ccc(-n2cc(NC(=O)c3ccc(NS(=O)(=O)c4ccccc4)cc3)cn2)cc1,4.74,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,18260.0,nM,=,CHEMBL4387504,B,CHEMBL4470214,Homo sapiens,CHEMBL203,CHEMBL4385653
COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4OC(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,5.51,Inhibition of wild type EGFR (unknown origin),IC50,3081.0,nM,=,CHEMBL4371479,B,CHEMBL4470236,Homo sapiens,CHEMBL203,CHEMBL4371006
Clc1ccc(COC(c2cccs2)c2cc3ccccc3nc2Cl)cc1,5.44,Inhibition of EGFR-TK in human MCF7 cells overexpressing EGFR incubated for 18 to 24 hrs by kinase assay,IC50,3660.0,nM,=,CHEMBL4399534,B,CHEMBL4470431,Homo sapiens,CHEMBL203,CHEMBL4396926
C=CC(=O)N(c1ccc(Cl)c(Cl)c1)c1ncnc2cc(OC)c(OCCCN3CCOCC3)cc12,7.50,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,IC50,31.7,nM,=,CHEMBL4385373,B,CHEMBL4471155,Homo sapiens,CHEMBL203,CHEMBL4382284
COc1cc2c(Nc3cc(NC(=O)C(c4ccccc4)N4Cc5ccccc5C4=O)ccc3F)ncnc2cc1OCC1CCN(C)CC1,7.43,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant expressed in baculovirus expression system using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",IC50,37.1,nM,=,CHEMBL4398796,B,CHEMBL4471235,Homo sapiens,CHEMBL203,CHEMBL4396901
COc1ccc(-n2cc(NC(=O)c3cccc(NS(=O)(=O)c4ccc(Cl)cc4)c3)cn2)cc1,4.81,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,15330.0,nM,=,CHEMBL4387504,B,CHEMBL4471464,Homo sapiens,CHEMBL203,CHEMBL4385653
COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OCCOCCNC(=O)Cn1cnc([N+](=O)[O-])n1,9.16,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,0.69,nM,=,CHEMBL4362208,B,CHEMBL4471491,Homo sapiens,CHEMBL203,CHEMBL4359867
C=C(Cl)C(=O)Nc1cc(Nc2nc3c(c(-c4cn(C)c5ccccc45)n2)CSCC3)c(OC)cc1N(C)CCN(C)C,7.51,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,IC50,31.0,nM,=,CHEMBL4315819,B,CHEMBL4471845,Homo sapiens,CHEMBL203,CHEMBL4312015
COc1cc(N(C)CCN(C)C)c(NC(=O)/C=C\C(C)C)cc1Nc1nc2c(c(-c3cn(C)c4ccccc34)n1)CS(=O)(=O)CC2,5.76,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,IC50,1753.0,nM,=,CHEMBL4315819,B,CHEMBL4472571,Homo sapiens,CHEMBL203,CHEMBL4312015
CC/C=C\C(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccc(F)cc34)n2)c(OC)cc1N(C)CCN(C)C,6.41,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,388.0,nM,=,CHEMBL4411959,B,CHEMBL4472983,Homo sapiens,CHEMBL203,CHEMBL4411272
Cn1cc([N+](=O)[O-])nc1C[N+](C)(C)C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1.[Br-],9.66,Inhibition of erbB1 (unknown origin) using FRET-capable peptide substrate by FRET assay,IC50,0.22,nM,=,CHEMBL4316716,B,CHEMBL4473277,Homo sapiens,CHEMBL203,CHEMBL4316582
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C,8.70,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,IC50,2.0,nM,=,CHEMBL4382299,B,CHEMBL4473365,Homo sapiens,CHEMBL203,CHEMBL4382192
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC(=O)CSc1nc2ccccc2s1,7.08,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,IC50,83.0,nM,=,CHEMBL4384426,B,CHEMBL4473375,Homo sapiens,CHEMBL203,CHEMBL4382245
COc1cc(Nc2ncnc3cc(-c4ccc(I)cc4)sc23)cc(OC)c1OC,8.00,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,IC50,10.0,nM,=,CHEMBL4370290,B,CHEMBL4473768,Homo sapiens,CHEMBL203,CHEMBL4368913
CCOCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,9.16,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,IC50,0.69,nM,=,CHEMBL4332363,B,CHEMBL4473875,Homo sapiens,CHEMBL203,CHEMBL4330113
COCCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,9.12,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,IC50,0.76,nM,=,CHEMBL4332363,B,CHEMBL4474073,Homo sapiens,CHEMBL203,CHEMBL4330113
CCC(=O)N1CCC[C@@H](n2c(=O)c(-c3cccc(F)c3Cl)c(C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.56,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,27.5,nM,=,CHEMBL4375049,B,CHEMBL4474196,Homo sapiens,CHEMBL203,CHEMBL4373695
COc1cccc(/C=C/C(=O)c2ccc(NC(=O)c3cc4cc5cc(OC)ccc5nc4s3)cc2)c1,5.55,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,IC50,2800.0,nM,=,CHEMBL4370781,B,CHEMBL4474429,Homo sapiens,CHEMBL203,CHEMBL4368931
C=CC(=O)Nc1cccc(-n2c3nc(Nc4ccc(N5CCOCC5)cc4OC)ncc3c(=O)n3ccnc23)c1,8.21,Binding affinity to partial length human EGFR L858R/T790M double mutant expressed in mammalian system by KINOMEscan assay,Kd,6.1,nM,=,CHEMBL4425262,B,CHEMBL4474541,Homo sapiens,CHEMBL203,CHEMBL4425085
C=CC(=O)Nc1cccc(-c2c(Cl)sc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,7.09,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,81.0,nM,=,CHEMBL4416105,B,CHEMBL4475546,Homo sapiens,CHEMBL203,CHEMBL4414600
COc1cc(N(C)CCN(C)C)c(NC(=O)C=C(C)C)cc1Nc1nc2c(c(-c3cn(C)c4ccc(F)cc34)n1)CS(=O)(=O)CC2,6.70,Inhibition of wildtype EGFR (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,IC50,201.0,nM,=,CHEMBL4315818,B,CHEMBL4475770,Homo sapiens,CHEMBL203,CHEMBL4312015
C=CC(=O)N(c1ccc(Cl)cc1F)c1ncnc2cc(OC)c(OCCCN3CCOCC3)cc12,6.63,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,IC50,234.0,nM,=,CHEMBL4385373,B,CHEMBL4475780,Homo sapiens,CHEMBL203,CHEMBL4382284
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(CCCO)nn1,8.40,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",IC50,4.0,nM,=,CHEMBL4373060,B,CHEMBL4476544,Homo sapiens,CHEMBL203,CHEMBL4371069
CC/C=C\C(=O)Nc1cc(Nc2nc3c(c(-c4cn(C)c5ccc(F)cc45)n2)CSCC3)c(OC)cc1N(C)CCN(C)C,5.95,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,IC50,1128.0,nM,=,CHEMBL4315819,B,CHEMBL4476689,Homo sapiens,CHEMBL203,CHEMBL4312015
CCN(CC)C/C=C/C(=O)N1CCOc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,7.57,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,IC50,27.0,nM,=,CHEMBL4432452,B,CHEMBL4476772,Homo sapiens,CHEMBL203,CHEMBL4431348
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3ccccc3)n2)c(OC)cc1N(C)C,8.65,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,2.213,nM,=,CHEMBL4384381,B,CHEMBL4476791,Homo sapiens,CHEMBL203,CHEMBL4382243
C=CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C,4.52,Binding affinity to EGFR (unknown origin) assessed as dissociation constant by KINOMEscan analysis,Kd,30000.0,nM,=,CHEMBL5133814,B,CHEMBL4483575,Homo sapiens,CHEMBL203,CHEMBL5131445
CC(=O)SCC(CSC(C)=O)C(=O)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c(C#N)cnc2cc1OC[C@H](O)CO,8.68,Binding affinity to human partial length EGFR L858R mutant (R669 to V1011 residues) expressed in bacterial expression system under full equilibrating condition by scanKINETIC assay,Kd,2.1,nM,=,CHEMBL4388560,B,CHEMBL4513286,Homo sapiens,CHEMBL203,CHEMBL4387720
CC(C)=CC[C@@H](OC(=O)/C=C\C(=O)c1ccc(C)cc1Cl)C1=CC(=O)c2c(O)ccc(O)c2C1=O,6.98,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,IC50,105.3,nM,=,CHEMBL4410222,B,CHEMBL4514393,Homo sapiens,CHEMBL203,CHEMBL4406881
C=CC(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](C)c4ccccc4)c23)c1,9.67,"Inhibition of GST-tagged human EGFR A763_Y764insFHEA mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",IC50,0.214,nM,=,CHEMBL4416109,B,CHEMBL4514452,Homo sapiens,CHEMBL203,CHEMBL4414600
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(Cc2ccc(F)cc2)nn1,8.22,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",IC50,6.0,nM,=,CHEMBL4373060,B,CHEMBL4515526,Homo sapiens,CHEMBL203,CHEMBL4371069
COc1cc2c(Nc3ccc(F)cc3Cl)ncnc2cc1OCCOCCNC(=O)Cn1cnc([N+](=O)[O-])n1,7.68,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,20.83,nM,=,CHEMBL4362208,B,CHEMBL4515673,Homo sapiens,CHEMBL203,CHEMBL4359867
Cn1ncc([N+](=O)[O-])c1C[N+](C)(C)C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1.[Br-],9.66,Inhibition of erbB1 (unknown origin) using FRET-capable peptide substrate by FRET assay,IC50,0.22,nM,=,CHEMBL4316716,B,CHEMBL4516232,Homo sapiens,CHEMBL203,CHEMBL4316582
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C,7.58,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,IC50,26.0,nM,=,CHEMBL4382299,B,CHEMBL4516287,Homo sapiens,CHEMBL203,CHEMBL4382192
C=CC(=O)Nc1ccc(Nc2ncnc3cc(OC)c(OCCN4CCOCC4)cc23)cc1,8.37,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant (catalytic domain 695 to end) expressed in baculovirus-infected Sf9 cells assessed as reduction in phosphorylation of polyglutamic acid/tyrosine incubated for 60 mins by ADP-Glo assay,IC50,4.3,nM,=,CHEMBL4342874,B,CHEMBL4516586,Homo sapiens,CHEMBL203,CHEMBL4342409
COc1cc2c(Nc3ccc(NC(=O)C(c4ccccc4)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1,8.03,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant expressed in baculovirus expression system using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",IC50,9.3,nM,=,CHEMBL4398796,B,CHEMBL4516635,Homo sapiens,CHEMBL203,CHEMBL4396901
N#Cc1ccc(-c2csc(N3N=C(c4ccc(N5CCOCC5)cc4)CC3c3ccc(Cl)cc3)n2)cc1,5.36,"Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay",IC50,4340.0,nM,=,CHEMBL4408847,B,CHEMBL4516736,Homo sapiens,CHEMBL203,CHEMBL4406839
Fc1ccc(-c2csc(N3N=C(c4ccc(N5CCOCC5)cc4)CC3c3ccc(Cl)cc3)n2)cc1,4.63,"Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay",IC50,23340.0,nM,=,CHEMBL4408847,B,CHEMBL4516916,Homo sapiens,CHEMBL203,CHEMBL4406839
N#Cc1cnc2cc(OC[C@@H](O)CO)c(NC(=O)C3CSSC3)cc2c1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,9.15,Binding affinity to human partial length EGFR L858R mutant (R669 to V1011 residues) expressed in bacterial expression system under full equilibrating condition by scanKINETIC assay,Kd,0.7,nM,=,CHEMBL4388560,B,CHEMBL4517633,Homo sapiens,CHEMBL203,CHEMBL4387720
N#Cc1cnc2cc(OC[C@H](O)CO)c(NC(=O)C3CSSC3)cc2c1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,7.70,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,IC50,20.0,nM,=,CHEMBL4388527,B,CHEMBL4519305,Homo sapiens,CHEMBL203,CHEMBL4387720
COc1cc(N2CCN(CC(=O)N(C)C)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,6.22,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay,IC50,598.0,nM,=,CHEMBL4348480,B,CHEMBL4519408,Homo sapiens,CHEMBL203,CHEMBL4346688
COc1cc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2cc1NC(=O)CC1CCSS1,7.32,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,IC50,48.0,nM,=,CHEMBL4388527,B,CHEMBL4519470,Homo sapiens,CHEMBL203,CHEMBL4387720
CC(C)=CC[C@@H](OC(=O)/C=C\C(=O)c1ccc(Br)cc1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,6.92,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,IC50,119.7,nM,=,CHEMBL4410222,B,CHEMBL4519860,Homo sapiens,CHEMBL203,CHEMBL4406881
FC(F)(F)c1ccc(COc2ccc(Nc3ncnc4cc5c(cc34)OCCOCCOCCOCCO5)cc2)cc1,6.42,Inhibition of EGFR (unknown origin) using TK substrate incubated for 60 mins by FRET assay,IC50,384.8,nM,=,CHEMBL4307556,B,CHEMBL4520064,Homo sapiens,CHEMBL203,CHEMBL4304802
COc1cccc(-n2cc(NC(=O)c3cccc(NS(=O)(=O)c4ccccc4)c3)cn2)c1,4.64,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,22850.0,nM,=,CHEMBL4387504,B,CHEMBL4520103,Homo sapiens,CHEMBL203,CHEMBL4385653
CNc1cncc(-c2c[nH]c3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4)nc(OC4CCCCC4)c23)n1,6.18,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,IC50,654.0,nM,=,CHEMBL4349142,B,CHEMBL4520286,Homo sapiens,CHEMBL203,CHEMBL4346710
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n2)c(OC)cc1N(C)CCN(C)C,8.70,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,IC50,2.0,nM,=,CHEMBL4382299,B,CHEMBL4520341,Homo sapiens,CHEMBL203,CHEMBL4382192
O=C1c2ccccc2Nc2ccc(F)cc2N1Cc1ccccc1,7.41,Inhibition of human N-terminal GST-tagged EGFR double T790M/L858R mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,IC50,39.0,nM,=,CHEMBL4410887,B,CHEMBL4520903,Homo sapiens,CHEMBL203,CHEMBL4406912
COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCOCCNC(=O)Cn1cnc([N+](=O)[O-])n1,8.23,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,5.9,nM,=,CHEMBL4362208,B,CHEMBL4521028,Homo sapiens,CHEMBL203,CHEMBL4359867
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC(=O)CSc1ccccn1,7.16,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,IC50,70.0,nM,=,CHEMBL4384426,B,CHEMBL4521214,Homo sapiens,CHEMBL203,CHEMBL4382245
CN(C)C/C=C/C(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,9.88,"Inhibition of GST-tagged human EGFR D770_N771insNPG mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",IC50,0.133,nM,=,CHEMBL4416111,B,CHEMBL4521381,Homo sapiens,CHEMBL203,CHEMBL4414600
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(CCCN2CCOCC2)nn1,8.40,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",IC50,4.0,nM,=,CHEMBL4373060,B,CHEMBL4521506,Homo sapiens,CHEMBL203,CHEMBL4371069
COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OCCCN1CCNCCNCCNCC1,8.85,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,IC50,1.4,nM,=,CHEMBL4329616,B,CHEMBL4522240,Homo sapiens,CHEMBL203,CHEMBL4325914
Cn1cc(NC(=O)c2ccc(NS(=O)(=O)c3ccccc3)cc2)cn1,4.43,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,36840.0,nM,=,CHEMBL4387504,B,CHEMBL4522594,Homo sapiens,CHEMBL203,CHEMBL4385653
COc1cc(N(C)CCN(C)C)c(NC(=O)/C=C\C(C)C)cc1Nc1nc2c(c(-c3cn(C)c4ccccc34)n1)CSCC2,5.79,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,IC50,1621.0,nM,=,CHEMBL4315819,B,CHEMBL4522613,Homo sapiens,CHEMBL203,CHEMBL4312015
Cn1c(=O)c2[nH]c(SC/C(=N/O)c3ccc(Cl)cc3)nc2n(C)c1=O,6.40,Inhibition of human EGFR measured after 3 hrs by ELISA,IC50,400.0,nM,=,CHEMBL4396109,B,CHEMBL4525168,Homo sapiens,CHEMBL203,CHEMBL4393713
Cn1cc(-c2cc(C(=O)/N=c3\[nH]c4ccccc4n3CC(C)(C)O)ccn2)cn1,6.29,Inhibition of GST-fusion tagged EGFR L858R/T790M/C797S triple mutant (unknown origin) (696 to 1022 residues) expressed in insect cells assessed as decrease in phosphorylation of ULight-poly-GT using poly-GT as substrate in presence of ATP,IC50,519.0,nM,=,CHEMBL4324121,B,CHEMBL4525935,Homo sapiens,CHEMBL203,CHEMBL4321840
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC(=O)CSc1ncc[nH]1,9.21,Inhibition of recombinant human wild type GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus expression system after 1 hr by kinase tracer 199 based TR-FRET assay,IC50,0.62,nM,=,CHEMBL4384432,B,CHEMBL4526992,Homo sapiens,CHEMBL203,CHEMBL4382245
C[N+](C)(C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1)Cc1ccccc1[N+](=O)[O-].[Br-],9.66,Inhibition of erbB1 (unknown origin) using FRET-capable peptide substrate by FRET assay,IC50,0.22,nM,=,CHEMBL4316716,B,CHEMBL4527121,Homo sapiens,CHEMBL203,CHEMBL4316582
O=C(/C=C/c1ccccc1)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,5.30,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,5004.0,nM,=,CHEMBL4416105,B,CHEMBL4527132,Homo sapiens,CHEMBL203,CHEMBL4414600
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)c(OC)c3)ncc2C(F)(F)F)c1,7.70,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",IC50,20.0,nM,=,CHEMBL4427028,B,CHEMBL4527443,Homo sapiens,CHEMBL203,CHEMBL4425144
CCN(CC)C/C=C/C(=O)N1CCCOc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,6.00,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,IC50,1010.0,nM,=,CHEMBL4432452,B,CHEMBL4527630,Homo sapiens,CHEMBL203,CHEMBL4431348
COc1cc(N(C)CCN(C)C)c(NC(=O)C=C(C)C)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,6.68,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,209.0,nM,=,CHEMBL4411959,B,CHEMBL4527702,Homo sapiens,CHEMBL203,CHEMBL4411272
C=CC(=O)N(c1cc(Cl)ccc1F)c1ncnc2cc(OC)c(OCCCN3CCOCC3)cc12,6.88,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,IC50,133.0,nM,=,CHEMBL4385373,B,CHEMBL4527715,Homo sapiens,CHEMBL203,CHEMBL4382284
Cn1c(=O)[nH]c2nc(SC/C(=N/O)c3ccc(Cl)cc3)[nH]c2c1=O,6.09,Inhibition of human EGFR measured after 3 hrs by ELISA,IC50,820.0,nM,=,CHEMBL4396109,B,CHEMBL4529183,Homo sapiens,CHEMBL203,CHEMBL4393713
CCC(=O)N1CCC[C@@H](n2c(=O)c(-c3ccccc3Br)c(C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.25,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",IC50,56.1,nM,=,CHEMBL4375049,B,CHEMBL4529308,Homo sapiens,CHEMBL203,CHEMBL4373695
CCc1ccc(C(=O)/C=C\C(=O)O[C@H](CC=C(C)C)C2=CC(=O)c3c(O)ccc(O)c3C2=O)cc1,7.29,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,IC50,50.8,nM,=,CHEMBL4410222,B,CHEMBL4529521,Homo sapiens,CHEMBL203,CHEMBL4406881
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCN(C(=O)CCCCCCCCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)CC1,7.96,Binding affinity to human wild-type partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by kinomescan assay,Kd,11.0,nM,=,CHEMBL4380725,B,CHEMBL4529558,Homo sapiens,CHEMBL203,CHEMBL4376874
COc1ccc(-n2cc(NC(=O)c3cccc(NS(=O)(=O)c4ccccc4)c3)cn2)cc1,4.57,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,26970.0,nM,=,CHEMBL4387504,B,CHEMBL4530048,Homo sapiens,CHEMBL203,CHEMBL4385653
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC(=O)CSc1nnnn1C,9.28,Inhibition of recombinant human wild type GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus expression system after 1 hr by kinase tracer 199 based TR-FRET assay,IC50,0.53,nM,=,CHEMBL4384432,B,CHEMBL4530170,Homo sapiens,CHEMBL203,CHEMBL4382245
O=C1c2cc(Oc3ccc(N4CCNCC4)cc3)ccc2Nc2ccc(F)cc2N1Cc1ccccc1,7.92,Inhibition of human N-terminal GST-tagged EGFR double T790M/L858R mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,IC50,12.0,nM,=,CHEMBL4410887,B,CHEMBL4530686,Homo sapiens,CHEMBL203,CHEMBL4406912
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC(=O)CCc1cccnc1,7.85,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,IC50,14.0,nM,=,CHEMBL4384426,B,CHEMBL4530987,Homo sapiens,CHEMBL203,CHEMBL4382245
O=C1Nc2ccccc2N/C1=C\C(=O)c1cccc2ccccc12,6.43,Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting analysis,IC50,370.0,nM,=,CHEMBL4361552,B,CHEMBL4531109,Homo sapiens,CHEMBL203,CHEMBL4359842
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)C(CSC(C)=O)CSC(C)=O,7.80,Binding affinity to human partial length EGFR L858R mutant (R669 to V1011 residues) expressed in bacterial expression system by kinomescan assay,Kd,16.0,nM,=,CHEMBL4388544,B,CHEMBL4531250,Homo sapiens,CHEMBL203,CHEMBL4387720
C=CC(=O)Nc1cc(Nc2ncc(I)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C,8.05,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,IC50,9.0,nM,=,CHEMBL4382299,B,CHEMBL4531697,Homo sapiens,CHEMBL203,CHEMBL4382192
COc1cc2c(Nc3ccc(F)cc3Cl)ncnc2cc1OCCOCCOCCNC(=O)Cn1cnc([N+](=O)[O-])n1,7.89,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,12.93,nM,=,CHEMBL4362208,B,CHEMBL4531912,Homo sapiens,CHEMBL203,CHEMBL4359867
COc1ccncc1-c1cc(C(=O)/N=c2\[nH]c3ccccc3n2CC(C)(C)O)ccn1,7.92,Inhibition of GST-fusion tagged EGFR L858R/T790M/C797S triple mutant (unknown origin) (696 to 1022 residues) expressed in insect cells assessed as decrease in phosphorylation of ULight-poly-GT using poly-GT as substrate in presence of ATP,IC50,12.0,nM,=,CHEMBL4324121,B,CHEMBL4532034,Homo sapiens,CHEMBL203,CHEMBL4321840
COc1cc2c(Nc3ccc(C)c(Br)c3)ncnc2cc1OCCOCCOCCNC(=O)Cn1cnc([N+](=O)[O-])n1,8.21,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,6.24,nM,=,CHEMBL4362208,B,CHEMBL4532084,Homo sapiens,CHEMBL203,CHEMBL4359867
O=C1c2cc(-c3ccc(N4CCNCC4)cc3)ccc2Nc2ccc(F)cc2N1Cc1ccccc1,7.72,Inhibition of human N-terminal GST-tagged EGFR triple T790M/L858R/C797S mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,IC50,19.0,nM,=,CHEMBL4410888,B,CHEMBL4533337,Homo sapiens,CHEMBL203,CHEMBL4406912
C=CC(=O)N1CCC[C@@H](n2nc(-c3cn(-c4cc(C(F)(F)F)cnc4C#N)nn3)c3c(N)ncnc32)C1,8.22,Inhibition of wild type EGFR (unknown origin) by HTRF assay,IC50,6.0,nM,=,CHEMBL4481537,B,CHEMBL4534592,Homo sapiens,CHEMBL203,CHEMBL4480410
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCNCCNCCNCC1,8.18,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,IC50,6.6,nM,=,CHEMBL4329616,B,CHEMBL4534611,Homo sapiens,CHEMBL203,CHEMBL4325914
C=CC(=O)Nc1cccc(-c2c(-c3ccccc3)sc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,8.94,"Inhibition of GST-tagged human EGFR A763_Y764insFHEA mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",IC50,1.15,nM,=,CHEMBL4416109,B,CHEMBL4534719,Homo sapiens,CHEMBL203,CHEMBL4414600
COc1cc(N(C)CCN(C)C)c(NC(=O)/C=C\C(C)C)cc1Nc1ncc(C#N)c(-c2cn(C)c3ccc(F)cc23)n1,6.44,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,360.0,nM,=,CHEMBL4411959,B,CHEMBL4535047,Homo sapiens,CHEMBL203,CHEMBL4411272
O=C(Nc1ccccc1)Nc1nnc(-c2cccnc2)o1,6.56,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,IC50,275.7,nM,=,CHEMBL4313654,B,CHEMBL4535881,Homo sapiens,CHEMBL203,CHEMBL4311968
COc1cc2c(Nc3ccc(F)cc3Cl)ncnc2cc1OCCNC(=O)Cn1cnc([N+](=O)[O-])n1,7.32,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,48.07,nM,=,CHEMBL4362208,B,CHEMBL4535949,Homo sapiens,CHEMBL203,CHEMBL4359867
COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1,6.19,Inhibition of wild type EGFR (unknown origin),IC50,650.0,nM,=,CHEMBL4371479,B,CHEMBL4536115,Homo sapiens,CHEMBL203,CHEMBL4371006
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4cccnc34)n2)c(OC)cc1N(C)CCNC,5.18,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant (696-end residues) by fluorescence assay,IC50,6600.0,nM,=,CHEMBL4383758,B,CHEMBL4536146,Homo sapiens,CHEMBL203,CHEMBL4382217
Cc1cc(F)cc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1,6.76,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,IC50,174.0,nM,=,CHEMBL4417511,B,CHEMBL4537004,Homo sapiens,CHEMBL203,CHEMBL4414679
CC1(C)CC[C@]2(C(=O)OCCCCO[N+](=O)[O-])CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1,7.40,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M/C797S mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,IC50,40.0,nM,=,CHEMBL4417018,B,CHEMBL4537422,Homo sapiens,CHEMBL203,CHEMBL4414650
Cc1cc2cc(n1)-c1cnn(C)c1OCCC[C@@H](C)CN1/C(=N/C2=O)Nc2ccc(CN3CCN(C)CC3)cc21,9.52,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,0.3,nM,=,CHEMBL5153035,B,CHEMBL4537790,Homo sapiens,CHEMBL203,CHEMBL5150044
COc1cc2c(Nc3ccc(NC(=O)C(C4CCCCC4)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1,6.75,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant expressed in baculovirus expression system using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",IC50,179.6,nM,=,CHEMBL4398796,B,CHEMBL4538066,Homo sapiens,CHEMBL203,CHEMBL4396901
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)COC(=O)c1c(C)cccc1C,7.36,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,IC50,44.0,nM,=,CHEMBL4384426,B,CHEMBL4538707,Homo sapiens,CHEMBL203,CHEMBL4382245
Cc1ccc(CSc2nc3[nH]c(C)cc(=O)n3n2)cc1,6.78,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,IC50,168.0,nM,=,CHEMBL4341977,B,CHEMBL4539566,Homo sapiens,CHEMBL203,CHEMBL4340550
COc1cccc(/C=C/C(=O)c2ccc(NC(=O)c3cc4cc5cc(C)ccc5nc4s3)cc2)c1,5.54,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,IC50,2900.0,nM,=,CHEMBL4370781,B,CHEMBL4540070,Homo sapiens,CHEMBL203,CHEMBL4368931
Cn1c(C[N+](C)(C)C/C=C/C(=O)Nc2ccc3ncnc(Nc4cccc(Br)c4)c3c2)ccc1[N+](=O)[O-].[Br-],9.66,Inhibition of erbB1 (unknown origin) using FRET-capable peptide substrate by FRET assay,IC50,0.22,nM,=,CHEMBL4316716,B,CHEMBL4540138,Homo sapiens,CHEMBL203,CHEMBL4316582
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3ccc(C(F)(F)F)cc3)n2)c(OC)cc1N1CCN(C)CC1,7.55,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,27.92,nM,=,CHEMBL4384381,B,CHEMBL4540295,Homo sapiens,CHEMBL203,CHEMBL4382243
COc1cc2c(Nc3ccc(C)c(Br)c3)ncnc2cc1OCCOCCNC(=O)Cn1cnc([N+](=O)[O-])n1,9.43,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,0.37,nM,=,CHEMBL4362208,B,CHEMBL4540303,Homo sapiens,CHEMBL203,CHEMBL4359867
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3S(=O)(=O)N(C)C)n2)c(OC)cc1N(C)CCN(C)C,8.40,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,IC50,4.0,nM,=,CHEMBL4382299,B,CHEMBL4540442,Homo sapiens,CHEMBL203,CHEMBL4382192
COc1cc(Nc2ncnc3cc(-c4ccccc4)sc23)cc(OC)c1OC,7.64,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,IC50,23.0,nM,=,CHEMBL4370290,B,CHEMBL4541014,Homo sapiens,CHEMBL203,CHEMBL4368913
CN(C)C/C=C/C(=O)N1CCCOc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,6.44,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,IC50,360.0,nM,=,CHEMBL4432452,B,CHEMBL4541573,Homo sapiens,CHEMBL203,CHEMBL4431348
C=CC(=O)N1CCC[C@H]1COc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)nc2[nH]cc(-c3cncc(NC)n3)c12,5.70,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,IC50,1975.0,nM,=,CHEMBL4349142,B,CHEMBL4543893,Homo sapiens,CHEMBL203,CHEMBL4346710
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCN(CCC(=O)NCCCCCCCCOc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,8.74,Binding affinity to human wild-type partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by kinomescan assay,Kd,1.8,nM,=,CHEMBL4380725,B,CHEMBL4544574,Homo sapiens,CHEMBL203,CHEMBL4376874
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4cccnc34)n2)c(OC)cc1N(C)CCN(C)C,5.68,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant (696-end residues) by fluorescence assay,IC50,2100.0,nM,=,CHEMBL4383758,B,CHEMBL4545086,Homo sapiens,CHEMBL203,CHEMBL4382217
COc1ccc(-c2cc3ncnc(Nc4cc(OC)c(OC)c(OC)c4)c3s2)cc1,7.28,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,IC50,52.0,nM,=,CHEMBL4370290,B,CHEMBL4546122,Homo sapiens,CHEMBL203,CHEMBL4368913
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C(CSC(C)=O)CSC(C)=O,6.31,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,IC50,494.0,nM,=,CHEMBL4388527,B,CHEMBL4546553,Homo sapiens,CHEMBL203,CHEMBL4387720
C=CC(=O)Nc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCCC(=O)CN(C)C,8.70,Inhibition of EGFR (unknown origin),IC50,2.0,nM,=,CHEMBL4342859,B,CHEMBL4547332,Homo sapiens,CHEMBL203,CHEMBL4342409
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)CCCCC1CCSS1,7.50,Binding affinity to human partial length EGFR L858R mutant (R669 to V1011 residues) expressed in bacterial expression system by kinomescan assay,Kd,32.0,nM,=,CHEMBL4388544,B,CHEMBL4547475,Homo sapiens,CHEMBL203,CHEMBL4387720
COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1,7.41,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,IC50,39.0,nM,=,CHEMBL4417511,B,CHEMBL4548481,Homo sapiens,CHEMBL203,CHEMBL4414679
CCC/C=C\C(=O)Nc1cc(Nc2nc(C)cc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,8.10,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,8.0,nM,=,CHEMBL4411959,B,CHEMBL4548960,Homo sapiens,CHEMBL203,CHEMBL4411272
Cc1ccc(-n2cc(NC(=O)c3ccc(NS(=O)(=O)c4ccc(Cl)cc4)cc3)cn2)cc1,4.91,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,12450.0,nM,=,CHEMBL4387504,B,CHEMBL4549295,Homo sapiens,CHEMBL203,CHEMBL4385653
CN1CCN(C/C=C/C(=O)N2CCOc3cc4ncnc(Nc5ccc(F)c(Cl)c5)c4cc32)CC1,8.05,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,IC50,9.0,nM,=,CHEMBL4432463,B,CHEMBL4549542,Homo sapiens,CHEMBL203,CHEMBL4431348
Cc1ccc(-n2cc(NC(=O)c3cccc(NS(=O)(=O)c4ccccc4)c3)cn2)cc1,5.02,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,9570.0,nM,=,CHEMBL4387504,B,CHEMBL4549604,Homo sapiens,CHEMBL203,CHEMBL4385653
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4ccnc(NC)c4)c23)CC1,7.42,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,IC50,38.0,nM,=,CHEMBL4349142,B,CHEMBL4549626,Homo sapiens,CHEMBL203,CHEMBL4346710
Cc1cc(=O)n2nc(SCc3cccc(Cl)c3)nc2[nH]1,7.23,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,IC50,59.0,nM,=,CHEMBL4341977,B,CHEMBL4550473,Homo sapiens,CHEMBL203,CHEMBL4340550
Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1,4.55,Inhibition of recombinant human His-tagged EGFR expressed in mammalian expression system by Z'-LYTE assay,IC50,28000.0,nM,=,CHEMBL4479715,B,CHEMBL4550702,Homo sapiens,CHEMBL203,CHEMBL4477252
C=CC(=O)Nc1cc(Nc2nc(C)cc(-c3cn(C)c4ccc(F)cc34)n2)c(OC)cc1N(C)CCN(C)C,6.23,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,591.0,nM,=,CHEMBL4411959,B,CHEMBL4551557,Homo sapiens,CHEMBL203,CHEMBL4411272
Cn1cc(NC(=O)c2cccc(NS(=O)(=O)c3ccccc3)c2)cn1,4.46,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,34280.0,nM,=,CHEMBL4387504,B,CHEMBL4552065,Homo sapiens,CHEMBL203,CHEMBL4385653
C=CC(=O)Nc1cc(Nc2nc3c(c(-c4cn(C)c5ccccc45)n2)CSCC3)c(OC)cc1N(C)CCN(C)C,7.46,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,IC50,35.0,nM,=,CHEMBL4315819,B,CHEMBL4552429,Homo sapiens,CHEMBL203,CHEMBL4312015
COc1cc(Nc2ncnc3cc(-c4ccc(Cl)cc4)sc23)cc(OC)c1OC,6.56,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,IC50,273.0,nM,=,CHEMBL4370290,B,CHEMBL4552482,Homo sapiens,CHEMBL203,CHEMBL4368913
COc1cc(N(C)CCN(C)C)c(NC(=O)/C=C\C(C)C)cc1Nc1nc(C)cc(-c2cn(C)c3ccc(F)cc23)n1,6.05,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,892.0,nM,=,CHEMBL4411959,B,CHEMBL4553484,Homo sapiens,CHEMBL203,CHEMBL4411272
CC(C)=CC[C@@H](OC(=O)/C=C\C(=O)c1ccc(C)cc1F)C1=CC(=O)c2c(O)ccc(O)c2C1=O,6.92,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,IC50,120.2,nM,=,CHEMBL4410222,B,CHEMBL4553504,Homo sapiens,CHEMBL203,CHEMBL4406881
CCC/C=C\C(=O)Nc1cc(Nc2ncc(C#N)c(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.43,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,37.0,nM,=,CHEMBL4411959,B,CHEMBL4553685,Homo sapiens,CHEMBL203,CHEMBL4411272
OCCNc1nc(Nc2cccc(F)c2)c2cn[nH]c2n1,4.18,Inhibition of human EGFR C-terminal domain,IC50,66100.0,nM,=,CHEMBL4346783,B,CHEMBL4553708,Homo sapiens,CHEMBL203,CHEMBL4346652
COc1cccc(-n2cc(NC(=O)c3cccc(NS(=O)(=O)c4ccc(Cl)cc4)c3)cn2)c1,4.81,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,15630.0,nM,=,CHEMBL4387504,B,CHEMBL4554486,Homo sapiens,CHEMBL203,CHEMBL4385653
C=CC(=O)N(c1ccc(F)c(F)c1)c1ncnc2cc(OC)c(OCCCN3CCOCC3)cc12,6.43,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,IC50,368.0,nM,=,CHEMBL4385373,B,CHEMBL4555488,Homo sapiens,CHEMBL203,CHEMBL4382284
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3cccc(OC)c3)n2)c(OC)cc1N1CCC(C(N)=O)CC1,7.49,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,32.61,nM,=,CHEMBL4384381,B,CHEMBL4555707,Homo sapiens,CHEMBL203,CHEMBL4382243
C=CC(=O)Nc1cccc(-c2csc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,7.09,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,82.0,nM,=,CHEMBL4416105,B,CHEMBL4556670,Homo sapiens,CHEMBL203,CHEMBL4414600
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC(=O)CSc1nc2ccccc2n1C,7.92,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,IC50,12.0,nM,=,CHEMBL4384426,B,CHEMBL4556799,Homo sapiens,CHEMBL203,CHEMBL4382245
C=CC(=O)Nc1cc(Nc2nc(C)cc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.03,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,93.0,nM,=,CHEMBL4411959,B,CHEMBL4557005,Homo sapiens,CHEMBL203,CHEMBL4411272
N#Cc1ccc(-c2csc(N3N=C(c4ccc(N5CCCCC5)cc4)CC3c3ccc(Cl)cc3)n2)cc1,5.33,"Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay",IC50,4710.0,nM,=,CHEMBL4408847,B,CHEMBL4557318,Homo sapiens,CHEMBL203,CHEMBL4406839
C=C(F)C(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,8.22,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,6.0,nM,=,CHEMBL4411959,B,CHEMBL4557772,Homo sapiens,CHEMBL203,CHEMBL4411272
CC(C)=CC[C@@H](OC(=O)/C=C\C(=O)c1ccc(C)cc1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,7.34,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,IC50,45.2,nM,=,CHEMBL4410222,B,CHEMBL4557993,Homo sapiens,CHEMBL203,CHEMBL4406881
C=CC(=O)Nc1cc(Nc2ncc(F)c(Nc3ccccc3P(C)(C)=O)n2)c(OC)cc1N(C)CCN(C)C,8.70,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,IC50,2.0,nM,=,CHEMBL4382299,B,CHEMBL4558227,Homo sapiens,CHEMBL203,CHEMBL4382192
C=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1,8.57,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,IC50,2.7,nM,=,CHEMBL4707740,B,CHEMBL4558324,Homo sapiens,CHEMBL203,CHEMBL4706488
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC(=O)CSc1ncccn1,7.57,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,IC50,27.0,nM,=,CHEMBL4384426,B,CHEMBL4558356,Homo sapiens,CHEMBL203,CHEMBL4382245
CN1CCN(c2ccc(Oc3ccc4c(c3)C(=O)N(Cc3ccccc3)c3cc(F)ccc3N4)cc2)CC1,7.96,Inhibition of human N-terminal GST-tagged EGFR double T790M/L858R mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,IC50,11.0,nM,=,CHEMBL4410887,B,CHEMBL4558528,Homo sapiens,CHEMBL203,CHEMBL4406912
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC(=O)CSc1nc2cc(OC)ccc2s1,6.71,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,IC50,197.0,nM,=,CHEMBL4384426,B,CHEMBL4559217,Homo sapiens,CHEMBL203,CHEMBL4382245
C=CC(=O)Nc1cccc(-c2c(-c3ccccc3OC)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,9.84,"Inhibition of GST-tagged human EGFR A763_Y764insFHEA mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",IC50,0.145,nM,=,CHEMBL4416109,B,CHEMBL4559807,Homo sapiens,CHEMBL203,CHEMBL4414600
COc1cc2c(Nc3cccc(F)c3)ncnc2cc1OCCOCCNC(=O)Cn1cnc([N+](=O)[O-])n1,8.51,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,3.11,nM,=,CHEMBL4362208,B,CHEMBL4560187,Homo sapiens,CHEMBL203,CHEMBL4359867
Cn1cnc([N+](=O)[O-])c1C[N+](C)(C)C/C=C/C(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1.[Br-],9.66,Inhibition of erbB1 (unknown origin) using FRET-capable peptide substrate by FRET assay,IC50,0.22,nM,=,CHEMBL4316716,B,CHEMBL4560430,Homo sapiens,CHEMBL203,CHEMBL4316582
O=[N+]([O-])c1ccc(/C=N/Nc2nnc(-c3ccncc3)o2)cc1,6.38,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,IC50,412.3,nM,=,CHEMBL4313654,B,CHEMBL4561572,Homo sapiens,CHEMBL203,CHEMBL4311968
O=C(/C=C/CN1CCCC1)N1CCOc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc21,8.52,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,IC50,3.0,nM,=,CHEMBL4432463,B,CHEMBL4561606,Homo sapiens,CHEMBL203,CHEMBL4431348
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC(=O)CSc1cccnc1,9.22,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,IC50,0.6,nM,=,CHEMBL4384426,B,CHEMBL4562352,Homo sapiens,CHEMBL203,CHEMBL4382245
CNc1cncc(-c2c[nH]c3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4)nc(OC4CCOCC4)c23)n1,6.03,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,IC50,937.0,nM,=,CHEMBL4349142,B,CHEMBL4562744,Homo sapiens,CHEMBL203,CHEMBL4346710
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(Cc2ccc(C)cc2)nn1,7.82,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",IC50,15.0,nM,=,CHEMBL4373060,B,CHEMBL4563683,Homo sapiens,CHEMBL203,CHEMBL4371069
COc1cc2ncnc(Nc3ccc(F)c(Br)c3)c2cc1OCCCN1CCNCCNCC1,8.25,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,IC50,5.6,nM,=,CHEMBL4329616,B,CHEMBL4563873,Homo sapiens,CHEMBL203,CHEMBL4325914
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3cccc(OC)c3)n2)c(OC)cc1N(C)CCN(C)C,7.23,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,59.0,nM,=,CHEMBL4384381,B,CHEMBL4563980,Homo sapiens,CHEMBL203,CHEMBL4382243
Cc1cc(=O)n2nc(SCc3cccc([N+](=O)[O-])c3)nc2[nH]1,7.11,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,IC50,77.0,nM,=,CHEMBL4341977,B,CHEMBL4565086,Homo sapiens,CHEMBL203,CHEMBL4340550
O=C(O)/C=C/C(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,5.51,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,3059.0,nM,=,CHEMBL4416105,B,CHEMBL4565374,Homo sapiens,CHEMBL203,CHEMBL4414600
C=CC(=O)Nc1cc(Nc2ncc(F)c(Nc3ccccc3S(=O)(=O)N(C)C)n2)c(OC)cc1N(C)CCN(C)C,8.70,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,IC50,2.0,nM,=,CHEMBL4382299,B,CHEMBL4565984,Homo sapiens,CHEMBL203,CHEMBL4382192
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCSC,6.67,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,IC50,215.0,nM,=,CHEMBL4378482,B,CHEMBL4566583,Homo sapiens,CHEMBL203,CHEMBL4376823
Cc1cc(=O)n2nc(SCc3ccc(C(C)(C)C)cc3)nc2[nH]1,7.07,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,IC50,86.0,nM,=,CHEMBL4341976,B,CHEMBL4567599,Homo sapiens,CHEMBL203,CHEMBL4340550
Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1,6.47,Inhibition of recombinant human His-tagged EGFR expressed in mammalian expression system by Z'-LYTE assay,IC50,340.0,nM,=,CHEMBL4479715,B,CHEMBL4568087,Homo sapiens,CHEMBL203,CHEMBL4477252
COc1cc(/C=C/C(=O)c2ccc(NC(=O)c3cc4cc5cc(C)ccc5nc4s3)cc2)cc(OC)c1OC,5.50,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,IC50,3200.0,nM,=,CHEMBL4370781,B,CHEMBL4568408,Homo sapiens,CHEMBL203,CHEMBL4368931
O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1,5.96,Inhibition of recombinant human His-tagged EGFR expressed in mammalian expression system by Z'-LYTE assay,IC50,1100.0,nM,=,CHEMBL4479715,B,CHEMBL4569508,Homo sapiens,CHEMBL203,CHEMBL4477252
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3ccc(OC)c(OC)c3)n2)c(OC)cc1N(C)C,7.40,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,40.19,nM,=,CHEMBL4384381,B,CHEMBL4569552,Homo sapiens,CHEMBL203,CHEMBL4382243
Clc1ccc(/C=N/c2nnc(-c3cccnc3)o2)cc1,5.95,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,IC50,1128.9,nM,=,CHEMBL4313654,B,CHEMBL4569755,Homo sapiens,CHEMBL203,CHEMBL4311968
COc1cc(Nc2ncnc3cc(-c4ccc(C)cc4)sc23)cc(OC)c1OC,7.52,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,IC50,30.0,nM,=,CHEMBL4370290,B,CHEMBL4569885,Homo sapiens,CHEMBL203,CHEMBL4368913
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3cccc4ccccc34)n2)c(OC)cc1N1CCN(C)CC1,7.48,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,33.31,nM,=,CHEMBL4384381,B,CHEMBL4570293,Homo sapiens,CHEMBL203,CHEMBL4382243
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1SCCN(C)C,7.96,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,IC50,11.0,nM,=,CHEMBL4378482,B,CHEMBL4570333,Homo sapiens,CHEMBL203,CHEMBL4376823
Cc1cc(=O)n2nc(SCc3ccc(Cl)cc3Cl)nc2[nH]1,6.85,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,IC50,141.0,nM,=,CHEMBL4341977,B,CHEMBL4570484,Homo sapiens,CHEMBL203,CHEMBL4340550
CC(C)=CC[C@@H](OC(=O)/C=C\C(=O)c1ccc(C)c(F)c1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,6.97,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,IC50,107.2,nM,=,CHEMBL4410222,B,CHEMBL4571687,Homo sapiens,CHEMBL203,CHEMBL4406881
CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC(=O)CSc1nccn1C,7.96,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,IC50,11.0,nM,=,CHEMBL4384426,B,CHEMBL4572315,Homo sapiens,CHEMBL203,CHEMBL4382245
COc1cc(Nc2ncnc3cc(-c4ccc(Br)cc4)sc23)cc(OC)c1OC,6.49,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,IC50,326.0,nM,=,CHEMBL4370290,B,CHEMBL4572443,Homo sapiens,CHEMBL203,CHEMBL4368913
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(-c2ccccc2)nn1,7.58,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",IC50,26.0,nM,=,CHEMBL4373060,B,CHEMBL4575267,Homo sapiens,CHEMBL203,CHEMBL4371069
CC(C)=CC[C@@H](OC(=O)/C=C\C(=O)c1ccc(C)c(C)c1)C1=CC(=O)c2c(O)ccc(O)c2C1=O,6.93,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,IC50,118.6,nM,=,CHEMBL4410222,B,CHEMBL4575374,Homo sapiens,CHEMBL203,CHEMBL4406881
C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3nc(SC)n(C)c3-c3ccc(F)cc3)ccn2)c1,9.00,Inhibition of human EGFR L858R/T790M mutant using poly[Glu:Tyr] (4:1) as substrate measured in presence of [gamma-33P]ATP by radiometric assay,IC50,1.0,nM,=,CHEMBL4359338,B,CHEMBL4575583,Homo sapiens,CHEMBL203,CHEMBL4354875
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4cccnc34)n2)c(OC)cc1NCCN(C)C,4.92,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system by fluorescence assay,IC50,12000.0,nM,=,CHEMBL4383759,B,CHEMBL4575647,Homo sapiens,CHEMBL203,CHEMBL4382217
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3ccccc3)n2)c(OC)cc1N(C)CCN(C)C,6.85,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,142.7,nM,=,CHEMBL4384381,B,CHEMBL4575697,Homo sapiens,CHEMBL203,CHEMBL4382243
COc1cc2c(Nc3ccc(F)c(F)c3)ncnc2cc1OCCOCCNC(=O)Cn1cnc([N+](=O)[O-])n1,8.43,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,IC50,3.7,nM,=,CHEMBL4362208,B,CHEMBL4576032,Homo sapiens,CHEMBL203,CHEMBL4359867
COc1ccc(-n2cc(NC(=O)c3ccc(NS(=O)(=O)c4ccc(Cl)cc4)cc3)cn2)cc1,4.79,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,IC50,16180.0,nM,=,CHEMBL4387504,B,CHEMBL4576626,Homo sapiens,CHEMBL203,CHEMBL4385653
CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C1CSSC1,6.66,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,IC50,219.0,nM,=,CHEMBL4388527,B,CHEMBL4576802,Homo sapiens,CHEMBL203,CHEMBL4387720
COC[C@@H](C)Oc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,9.03,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,IC50,0.94,nM,=,CHEMBL4332363,B,CHEMBL4577883,Homo sapiens,CHEMBL203,CHEMBL4330113
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCN(C(=O)CCCCCCCCCC(=O)N[C@H](C(=O)N2C[C@@H](O)C[C@@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)CC1,8.07,Binding affinity to human wild-type partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system by kinomescan assay,Kd,8.6,nM,=,CHEMBL4380725,B,CHEMBL4578319,Homo sapiens,CHEMBL203,CHEMBL4376874
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(F)c3)c2cc1NC(=O)/C=C/CN(C)C,7.04,Inhibition of EGFR (unknown origin),IC50,92.0,nM,=,CHEMBL4332301,B,CHEMBL4578466,Homo sapiens,CHEMBL203,CHEMBL4330108
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(Cc2ccccc2)nn1,8.10,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",IC50,8.0,nM,=,CHEMBL4373060,B,CHEMBL4578487,Homo sapiens,CHEMBL203,CHEMBL4371069
CCOc1cc2ncc(C#N)c(Nc3ccc(Cl)c(F)c3)c2cc1NC(=O)/C=C/CN(C)C,7.42,Inhibition of recombinant human His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in autophosphorylation preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,IC50,38.5,nM,=,CHEMBL4332286,B,CHEMBL4578561,Homo sapiens,CHEMBL203,CHEMBL4330108
Cc1ccc(C2=NN(c3ccccc3)C(c3ccc(OC4CCCC4)cc3)C2)cc1,5.67,Inhibition of human EGFR by ELISA,IC50,2160.0,nM,=,CHEMBL4307064,B,CHEMBL4578764,Homo sapiens,CHEMBL203,CHEMBL4304778
C=CC(=O)N(c1ccc(F)cc1F)c1ncnc2cc(OC)c(OCCCN3CCOCC3)cc12,6.52,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,IC50,302.0,nM,=,CHEMBL4385373,B,CHEMBL4579429,Homo sapiens,CHEMBL203,CHEMBL4382284
CCC/C=C\C(=O)Nc1cc(Nc2nc(C)cc(-c3cn(C)c4ccc(F)cc34)n2)c(OC)cc1N(C)CCN(C)C,6.04,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,923.0,nM,=,CHEMBL4411959,B,CHEMBL4579805,Homo sapiens,CHEMBL203,CHEMBL4411272
C=CC(=O)N1CCC[C@@H](n2nc(-c3cn(-c4ccc(C(C)=O)cc4)nn3)c3c(N)ncnc32)C1,5.10,Inhibition of wild type EGFR (unknown origin) by HTRF assay,IC50,8006.0,nM,=,CHEMBL4481537,B,CHEMBL4581088,Homo sapiens,CHEMBL203,CHEMBL4480410
C=CC(=O)Nc1cc(Nc2ncc(I)c(Nc3ccccc3P(C)(C)=O)n2)c(OC)cc1N(C)CCN(C)C,8.70,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,IC50,2.0,nM,=,CHEMBL4382299,B,CHEMBL4581316,Homo sapiens,CHEMBL203,CHEMBL4382192
O=C(CSC(=S)N1CCCCC1)Nc1cccc(NC(=O)c2ccccn2)c1,7.08,Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end) expressed in baculovirus infected Sf9 cells using ATP as substrate after 40 mins by Kinase-Glo MAX luminescence assay,IC50,84.0,nM,=,CHEMBL4433480,B,CHEMBL4582195,Homo sapiens,CHEMBL203,CHEMBL4433204
COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)CC1CCSS1,8.24,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,IC50,5.8,nM,=,CHEMBL4388527,B,CHEMBL4582933,Homo sapiens,CHEMBL203,CHEMBL4387720
O=C(/C=C/CN1CCOCC1)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1,7.72,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",IC50,19.0,nM,=,CHEMBL4416105,B,CHEMBL4583178,Homo sapiens,CHEMBL203,CHEMBL4414600
C=C(Cl)C(=O)Nc1cc(Nc2nc3c(c(-c4cn(C)c5ccccc45)n2)CS(=O)(=O)CC3)c(OC)cc1N(C)CCN(C)C,6.98,Inhibition of wildtype EGFR (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,IC50,104.0,nM,=,CHEMBL4315818,B,CHEMBL4583545,Homo sapiens,CHEMBL203,CHEMBL4312015
CCC/C=C\C(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,6.69,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,IC50,203.0,nM,=,CHEMBL4411959,B,CHEMBL4583858,Homo sapiens,CHEMBL203,CHEMBL4411272
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(CCc2ccccc2)nn1,7.92,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",IC50,12.0,nM,=,CHEMBL4373060,B,CHEMBL4584413,Homo sapiens,CHEMBL203,CHEMBL4371069
C=CC(=O)N1CCC[C@@H](n2nc(-c3cn(Cc4nc5ccc(Cl)cn5c4Br)nn3)c3c(N)ncnc32)C1,7.07,Inhibition of wild type EGFR (unknown origin) by HTRF assay,IC50,85.0,nM,=,CHEMBL4481537,B,CHEMBL4584630,Homo sapiens,CHEMBL203,CHEMBL4480410
CC(C)=CC[C@@H](OC(=O)/C=C\C(=O)c1cc(Cl)ccc1C)C1=CC(=O)c2c(O)ccc(O)c2C1=O,6.83,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,IC50,146.2,nM,=,CHEMBL4410222,B,CHEMBL4584651,Homo sapiens,CHEMBL203,CHEMBL4406881
COc1cc(/C=C/C(=O)c2ccc(NC(=O)c3cc4cc5ccccc5nc4s3)cc2)cc(OC)c1OC,5.92,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,IC50,1200.0,nM,=,CHEMBL4370781,B,CHEMBL4585048,Homo sapiens,CHEMBL203,CHEMBL4368931
Cn1c(=O)[nH]c2nc(SC/C(=N/O)c3ccc(Br)cc3)[nH]c2c1=O,5.54,Inhibition of human EGFR measured after 3 hrs by ELISA,IC50,2880.0,nM,=,CHEMBL4396109,B,CHEMBL4586164,Homo sapiens,CHEMBL203,CHEMBL4393713
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCNCCNCC1,8.08,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,IC50,8.3,nM,=,CHEMBL4329616,B,CHEMBL4586581,Homo sapiens,CHEMBL203,CHEMBL4325914
CCN1CCN(CCCOc2cc3nccc(Oc4c(F)cc(NC(=O)NN5C(=O)CSC5c5c(F)cccc5F)cc4F)c3cc2OC)CC1,6.28,Inhibition of EGFR (unknown origin) using FAM-labelled peptide and ATP incubated for 10 mins by mobility shift assay,IC50,520.0,nM,=,CHEMBL4330453,B,CHEMBL4587222,Homo sapiens,CHEMBL203,CHEMBL4330059
COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1,6.55,Inhibition of wild type EGFR (unknown origin),IC50,281.0,nM,=,CHEMBL4371479,B,CHEMBL4587811,Homo sapiens,CHEMBL203,CHEMBL4371006
C=CC(=O)Nc1cc(Nc2nccc(NC(=O)c3ccc(OC)c(OC)c3)n2)c(OC)cc1N1CCN(C)CC1,7.90,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",IC50,12.57,nM,=,CHEMBL4384381,B,CHEMBL4587847,Homo sapiens,CHEMBL203,CHEMBL4382243
CCC(=O)N1CCC[C@@H](n2nc(-c3cn(-c4ccc(C(C)=O)cc4)nn3)c3c(N)ncnc32)C1,6.19,Inhibition of wild type EGFR (unknown origin) by HTRF assay,IC50,649.0,nM,=,CHEMBL4481537,B,CHEMBL4588202,Homo sapiens,CHEMBL203,CHEMBL4480410
COc1ccc2nc3sc(C(=O)Nc4ccc(C(=O)/C=C/c5cc(OC)c(OC)c(OC)c5)cc4)cc3cc2c1,5.85,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,IC50,1400.0,nM,=,CHEMBL4370781,B,CHEMBL4588486,Homo sapiens,CHEMBL203,CHEMBL4368931
CC(=O)OC[C@@]1(C)[C@@H]2CC[C@]3(C)[C@H](CC=C4[C@@H]5CC(C)(C)CC[C@]5(C(=O)OCCCCO[N+](=O)[O-])CC[C@]43C)[C@@]2(C)CC[C@@H]1OC(C)=O,8.00,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M/C797S mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,IC50,10.0,nM,=,CHEMBL4417018,B,CHEMBL4588786,Homo sapiens,CHEMBL203,CHEMBL4414650
CC(C)(O)Cn1/c(=N/C(=O)c2cc(F)cc(-c3cccnc3)c2)[nH]c2ccccc21,5.68,Inhibition of GST-fusion tagged EGFR L858R/T790M/C797S triple mutant (unknown origin) (696 to 1022 residues) expressed in insect cells assessed as decrease in phosphorylation of ULight-poly-GT using poly-GT as substrate in presence of ATP,IC50,2100.0,nM,=,CHEMBL4324121,B,CHEMBL4591327,Homo sapiens,CHEMBL203,CHEMBL4321840
CCOCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(CC)CC,8.83,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,IC50,1.48,nM,=,CHEMBL4332363,B,CHEMBL4591886,Homo sapiens,CHEMBL203,CHEMBL4330113
CCCOCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,8.55,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,IC50,2.84,nM,=,CHEMBL4332363,B,CHEMBL4592101,Homo sapiens,CHEMBL203,CHEMBL4330113
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1S(=O)(=O)CCN(C)C,6.97,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,IC50,108.0,nM,=,CHEMBL4378483,B,CHEMBL4592472,Homo sapiens,CHEMBL203,CHEMBL4376823
COc1cc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2cc1NC(=O)C1CSSC1,6.38,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,IC50,413.0,nM,=,CHEMBL4388527,B,CHEMBL4593016,Homo sapiens,CHEMBL203,CHEMBL4387720
C=CC(=O)N1CCC[C@@H]1COc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)nc2[nH]cc(-c3cncc(NC)n3)c12,6.82,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,IC50,150.0,nM,=,CHEMBL4349142,B,CHEMBL4593230,Homo sapiens,CHEMBL203,CHEMBL4346710
COc1cc2c(Nc3ccc(NC(=O)[C@@H](c4ccccc4)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1,7.72,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant expressed in baculovirus expression system using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",IC50,19.2,nM,=,CHEMBL4398796,B,CHEMBL4593609,Homo sapiens,CHEMBL203,CHEMBL4396901
CC1CCN(C/C=C/C(=O)N2CCOc3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4cc32)CC1,6.25,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,IC50,569.0,nM,=,CHEMBL4628612,B,CHEMBL4634127,Homo sapiens,CHEMBL203,CHEMBL4627322
C=C1CC(CI)(c2ccc(F)cc2)OC1=O,4.82,Inhibition of EGFR L858R/T790M (unknown origin),IC50,15000.0,nM,=,CHEMBL4617240,B,CHEMBL4634317,Homo sapiens,CHEMBL203,CHEMBL4616600
O=C(/C=C/Cn1ccnc1)N1CCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21,6.92,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,IC50,120.0,nM,=,CHEMBL4628612,B,CHEMBL4634499,Homo sapiens,CHEMBL203,CHEMBL4627322
CN(C)C/C=C/C(=O)N1CCCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21,6.35,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,IC50,446.0,nM,=,CHEMBL4628612,B,CHEMBL4634817,Homo sapiens,CHEMBL203,CHEMBL4627322
O=C(/C=C/CN1CCCC1)N1CCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21,8.15,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,IC50,7.0,nM,=,CHEMBL4628613,B,CHEMBL4635100,Homo sapiens,CHEMBL203,CHEMBL4627322
C[C@@H]1[C@@H]2CN(c3nc(Nc4cnn(C)c4)ncc3F)C[C@]12NC(=O)[C@@H]1CC1(F)F,5.39,Inhibition of human recombinant EGFR in presence of substrate Ulight-CAGAGAIETDKEYYTVKD and Km ATP,IC50,4110.0,nM,=,CHEMBL4620454,B,CHEMBL4635625,Homo sapiens,CHEMBL203,CHEMBL4619733
CCN(CC)C/C=C/C(=O)N1CCCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21,7.10,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,IC50,80.0,nM,=,CHEMBL4628612,B,CHEMBL4636996,Homo sapiens,CHEMBL203,CHEMBL4627322
C#Cc1cccc(Nc2cccc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1,8.62,Inhibition of EGFR (unknown origin),IC50,2.4,nM,=,CHEMBL4612446,B,CHEMBL4637274,Homo sapiens,CHEMBL203,CHEMBL4610108
CCN1CCN(CC(=O)Nc2nnc3c4ccccc4nc(Sc4ccc(Br)cc4)n23)CC1,5.41,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,IC50,3910.0,nM,=,CHEMBL4619916,B,CHEMBL4637355,Homo sapiens,CHEMBL203,CHEMBL4619706
O=C(/C=C/CN1CCCCC1)N1CCCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21,6.07,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,IC50,844.0,nM,=,CHEMBL4628612,B,CHEMBL4638194,Homo sapiens,CHEMBL203,CHEMBL4627322
Clc1nc2ccccc2c2nnc(/N=C/C=C/c3ccccc3)n12,5.12,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,IC50,7560.0,nM,=,CHEMBL4619916,B,CHEMBL4638857,Homo sapiens,CHEMBL203,CHEMBL4619706
CCC(=O)Nc1cc(Nc2nccc(-c3cn(CCCO)c4ccccc34)n2)c(OC)cc1F,7.14,Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) by ELISA,IC50,72.5,nM,=,CHEMBL4625258,B,CHEMBL4639459,Homo sapiens,CHEMBL203,CHEMBL4622942
CN1CCN(C/C=C/C(=O)N2CCCOc3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4cc32)CC1,5.31,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,IC50,4870.0,nM,=,CHEMBL4628612,B,CHEMBL4639556,Homo sapiens,CHEMBL203,CHEMBL4627322
C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(-c5cn[nH]c5)ccc34)cc12,5.35,Inhibition of EGFR (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay,IC50,4500.0,nM,=,CHEMBL4603816,B,CHEMBL4639739,Homo sapiens,CHEMBL203,CHEMBL4602634
C=C1CC(CBr)(c2ccc(F)cc2)OC1=O,4.52,Inhibition of EGFR L858R/T790M (unknown origin),IC50,30000.0,nM,=,CHEMBL4617240,B,CHEMBL4640482,Homo sapiens,CHEMBL203,CHEMBL4616600
CCC(=O)Nc1cc(Nc2nccc(-c3cn(CCO)c4ccccc34)n2)c(OC)cc1F,7.09,Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) by ELISA,IC50,80.5,nM,=,CHEMBL4625258,B,CHEMBL4640686,Homo sapiens,CHEMBL203,CHEMBL4622942
CCC(=O)Nc1cc(Nc2nccc(-c3cn(CCCO)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.14,Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) by ELISA,IC50,73.0,nM,=,CHEMBL4625258,B,CHEMBL4641096,Homo sapiens,CHEMBL203,CHEMBL4622942
CC1CCN(C/C=C/C(=O)N2CCCOc3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4cc32)CC1,5.31,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,IC50,4870.0,nM,=,CHEMBL4628612,B,CHEMBL4641942,Homo sapiens,CHEMBL203,CHEMBL4627322
O=C(/C=C/CN1CCCCC1)N1CCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21,6.94,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,IC50,116.0,nM,=,CHEMBL4628612,B,CHEMBL4642158,Homo sapiens,CHEMBL203,CHEMBL4627322
CCC(=O)Nc1cc(Nc2nccc(-c3c[nH]c4c(CCO)cccc34)n2)c(OC)cc1F,6.68,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,IC50,208.0,nM,=,CHEMBL4625256,B,CHEMBL4642177,Homo sapiens,CHEMBL203,CHEMBL4622942
N#Cc1cnc2cc(OC[C@H](O)CO)c(NC(=O)CC3CSSC3)cc2c1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,8.70,Inhibition of wild type EGFR (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,IC50,2.0,nM,=,CHEMBL4625049,B,CHEMBL4642574,Homo sapiens,CHEMBL203,CHEMBL4622931
C=C1CC(CI)(c2ccccc2)OC1=O,4.58,Inhibition of EGFR L858R/T790M (unknown origin),IC50,26000.0,nM,=,CHEMBL4617240,B,CHEMBL4642842,Homo sapiens,CHEMBL203,CHEMBL4616600
CN1CCN(C/C=C/C(=O)N2CCOc3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4cc32)CC1,8.22,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,IC50,6.0,nM,=,CHEMBL4628613,B,CHEMBL4643111,Homo sapiens,CHEMBL203,CHEMBL4627322
O=C(/C=C/CN1CCCC1)N1CCCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21,6.24,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,IC50,578.0,nM,=,CHEMBL4628612,B,CHEMBL4643903,Homo sapiens,CHEMBL203,CHEMBL4627322
C=C1CC(c2ccccc2)(C(Br)c2ccccc2)OC1=O,4.85,Inhibition of EGFR L858R/T790M (unknown origin),IC50,14000.0,nM,=,CHEMBL4617240,B,CHEMBL4644209,Homo sapiens,CHEMBL203,CHEMBL4616600
O=C1CSCC(=O)N1c1nnc2c3ccccc3nc(Sc3ccc(Br)cc3)n12,5.39,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,IC50,4100.0,nM,=,CHEMBL4619916,B,CHEMBL4644480,Homo sapiens,CHEMBL203,CHEMBL4619706
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(CCCO)c4ccccc34)n2)c(OC)cc1F,8.66,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,IC50,2.2,nM,=,CHEMBL4625256,B,CHEMBL4645434,Homo sapiens,CHEMBL203,CHEMBL4622942
N#CC1=C(N)N(c2nnc3c4ccccc4nc(Sc4ccc(Br)cc4)n23)C(=O)C1,5.75,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,IC50,1800.0,nM,=,CHEMBL4619916,B,CHEMBL4645726,Homo sapiens,CHEMBL203,CHEMBL4619706
N#Cc1cnc2cc(OC[C@@H](O)CO)c(NC(=O)CC3CSSC3)cc2c1Nc1ccc(OCc2cccc(F)c2)c(Cl)c1,8.62,Inhibition of wild type EGFR (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,IC50,2.4,nM,=,CHEMBL4625049,B,CHEMBL4646030,Homo sapiens,CHEMBL203,CHEMBL4622931
C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12,5.63,Inhibition of EGFR (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay,IC50,2360.0,nM,=,CHEMBL4603816,B,CHEMBL4646281,Homo sapiens,CHEMBL203,CHEMBL4602634
CN(CCO)c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.84,Inhibition of recombinant human N-terminal GST-tagged EGFR (668 to end residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 2 hrs followed by EGF stimulation and measured after 30 mins by TMB peroxidase substrate based assay,IC50,145.0,nM,=,CHEMBL4606713,B,CHEMBL4646415,Homo sapiens,CHEMBL203,CHEMBL4602739
CC1CCCCN1C/C=C/C(=O)N1CCCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21,5.23,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,IC50,5830.0,nM,=,CHEMBL4628612,B,CHEMBL4646638,Homo sapiens,CHEMBL203,CHEMBL4627322
COc1ccc(/C=N/c2nnc3c4ccccc4nc(Nc4ccc(C)cc4N)n23)cc1O,5.37,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,IC50,4280.0,nM,=,CHEMBL4619916,B,CHEMBL4646644,Homo sapiens,CHEMBL203,CHEMBL4619706
CCC(=O)Nc1cc(Nc2nccc(-c3cn(CCCO)c4ccc(F)cc34)n2)c(OC)cc1F,7.39,Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) by ELISA,IC50,40.4,nM,=,CHEMBL4625258,B,CHEMBL4647073,Homo sapiens,CHEMBL203,CHEMBL4622942
CN(CCOS(=O)(=O)CCc1cn(CCCC(=O)N2CCN(C(=O)c3cc(Cc4n[nH]c(=O)c5ccccc45)ccc3F)CC2)nn1)c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.49,Inhibition of recombinant human N-terminal GST-tagged EGFR (668 to end residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 2 hrs followed by EGF stimulation and measured after 30 mins by TMB peroxidase substrate based assay,IC50,326.2,nM,=,CHEMBL4606713,B,CHEMBL4647257,Homo sapiens,CHEMBL203,CHEMBL4602739
Nc1nc(Nc2nnc3c4ccccc4nc(Sc4ccc(Br)cc4)n23)cs1,6.16,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,IC50,690.0,nM,=,CHEMBL4619916,B,CHEMBL4647325,Homo sapiens,CHEMBL203,CHEMBL4619706
CCN(CC)C/C=C/C(=O)N1CCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21,8.10,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,IC50,8.0,nM,=,CHEMBL4628613,B,CHEMBL4648271,Homo sapiens,CHEMBL203,CHEMBL4627322
CC1CCCCN1C/C=C/C(=O)N1CCOc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3cc21,6.75,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,IC50,179.0,nM,=,CHEMBL4628612,B,CHEMBL4648924,Homo sapiens,CHEMBL203,CHEMBL4627322
Clc1nc2ccccc2c2nnc(/N=C/c3ccco3)n12,6.13,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,IC50,740.0,nM,=,CHEMBL4619916,B,CHEMBL4649213,Homo sapiens,CHEMBL203,CHEMBL4619706
COc1cc(N(C)CCN(C)C)ccc1Nc1nccc(-c2cn(CCCO)c3ccccc23)n1,8.07,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,8.5,nM,=,CHEMBL5143769,B,CHEMBL4649261,Homo sapiens,CHEMBL203,CHEMBL5143505
CCN1CCN(CCCNc2ccc(Oc3nc4ccccc4c4nncn34)cc2)CC1,5.02,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,IC50,9510.0,nM,=,CHEMBL4619916,B,CHEMBL4649833,Homo sapiens,CHEMBL203,CHEMBL4619706
Clc1cccc(Nc2ncnc3cc4c(cc23)OCCO4)c1,8.19,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,6.41,nM,=,CHEMBL4730561,B,CHEMBL4740063,Homo sapiens,CHEMBL203,CHEMBL4725422
Cc1cc(NC(=O)CN2CCN(c3ccccc3)CC2)no1,7.19,Inhibition of EGFR-TK (unknown origin) relative to control,IC50,64.0,nM,=,CHEMBL4672269,B,CHEMBL4740108,Homo sapiens,CHEMBL203,CHEMBL4665865
C=C(Cl)C(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)nc3)ncc2Cl)c1,8.12,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,IC50,7.5,nM,=,CHEMBL4730145,B,CHEMBL4740234,Homo sapiens,CHEMBL203,CHEMBL4725398
CS(=O)(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1,9.10,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.8,nM,=,CHEMBL4718820,B,CHEMBL4740295,Homo sapiens,CHEMBL203,CHEMBL4715760
COc1cc(NS(C)(=O)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,9.52,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.3,nM,=,CHEMBL4718820,B,CHEMBL4740573,Homo sapiens,CHEMBL203,CHEMBL4715760
COc1ccc(/C=N\Nc2nc(-c3nc4ccccc4n3C)cs2)cc1OC,6.68,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,208.09,nM,=,CHEMBL4729710,B,CHEMBL4740646,Homo sapiens,CHEMBL203,CHEMBL4725379
[2H]C([2H])=CC(=O)Nc1cc(Nc2nccc(-c3cn(C([2H])([2H])[2H])c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,8.77,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system using poly (Glu-Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA,IC50,1.7,nM,=,CHEMBL4736380,B,CHEMBL4741340,Homo sapiens,CHEMBL203,CHEMBL4732150
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cccc(F)c1F,7.54,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,29.0,nM,=,CHEMBL4721180,B,CHEMBL4741678,Homo sapiens,CHEMBL203,CHEMBL4715818
C[C@@H](Nc1ncnc2[nH]c(-c3ccncc3)cc12)c1ccccc1,9.22,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.6,nM,=,CHEMBL4718820,B,CHEMBL4741922,Homo sapiens,CHEMBL203,CHEMBL4715760
COc1ccc(-c2c3c4cc(OC)c(O)cc4[nH]c(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O,6.87,Inhibition of recombinant wild type EGFR T790M/L858R mutant (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,IC50,134.8,nM,=,CHEMBL4724943,B,CHEMBL4741925,Homo sapiens,CHEMBL203,CHEMBL4715917
COc1cc(CNCCN2CCNCC2)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,10.00,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.1,nM,=,CHEMBL4718820,B,CHEMBL4742081,Homo sapiens,CHEMBL203,CHEMBL4715760
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)c1cc([N+](=O)[O-])ccc1F,7.17,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,68.0,nM,=,CHEMBL4721180,B,CHEMBL4743173,Homo sapiens,CHEMBL203,CHEMBL4715818
Fc1c(Br)cccc1Nc1ncnc2cc3c(cc12)OCCO3,8.60,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,2.49,nM,=,CHEMBL4730561,B,CHEMBL4743220,Homo sapiens,CHEMBL203,CHEMBL4725422
N#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCO4)c1F,7.66,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,22.0,nM,=,CHEMBL4730561,B,CHEMBL4743464,Homo sapiens,CHEMBL203,CHEMBL4725422
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cccc([N+](=O)[O-])c1Cl,7.85,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,14.0,nM,=,CHEMBL4721180,B,CHEMBL4743566,Homo sapiens,CHEMBL203,CHEMBL4715818
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(NS(C)(=O)=O)cc3)cc12)c1ccccc1,9.52,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.3,nM,=,CHEMBL4718820,B,CHEMBL4743998,Homo sapiens,CHEMBL203,CHEMBL4715760
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C(C)=O)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,8.68,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,IC50,2.09,nM,=,CHEMBL4714437,B,CHEMBL4744138,Homo sapiens,CHEMBL203,CHEMBL4706705
Fc1c(Nc2ncnc3cc4c(cc23)OCCO4)ccc(Cl)c1Cl,7.60,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,25.0,nM,=,CHEMBL4730561,B,CHEMBL4744207,Homo sapiens,CHEMBL203,CHEMBL4725422
Fc1c(Cl)cccc1Nc1ncnc2cc3c(cc12)OCCO3,8.41,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,3.91,nM,=,CHEMBL4730561,B,CHEMBL4744655,Homo sapiens,CHEMBL203,CHEMBL4725422
CC(=O)Nc1ccc(-c2cc3c(N[C@H](C)c4ccccc4)ncnc3[nH]2)cc1,9.15,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.7,nM,=,CHEMBL4718820,B,CHEMBL4744798,Homo sapiens,CHEMBL203,CHEMBL4715760
CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccc(F)cc5)n([C@H]5CCN(S(=O)(=O)C6CC6)C5)c4n3)cc2)CC1,7.66,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,22.0,nM,=,CHEMBL5143769,B,CHEMBL4744973,Homo sapiens,CHEMBL203,CHEMBL5143505
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(CCCCC(=O)NO)nn1,9.46,Inhibition of EGFR (unknown origin) by mobility shift assay,IC50,0.35,nM,=,CHEMBL4736787,B,CHEMBL4744985,Homo sapiens,CHEMBL203,CHEMBL4732162
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(CCO)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,9.07,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,IC50,0.86,nM,=,CHEMBL4714437,B,CHEMBL4745195,Homo sapiens,CHEMBL203,CHEMBL4706705
CN(C)CCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)c1cc([N+](=O)[O-])ccc1F,8.42,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,3.8,nM,=,CHEMBL4721175,B,CHEMBL4745521,Homo sapiens,CHEMBL203,CHEMBL4715818
C=C(Cl)C(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)c(C)c3)ncc2Cl)c1,8.59,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,IC50,2.6,nM,=,CHEMBL4730145,B,CHEMBL4745868,Homo sapiens,CHEMBL203,CHEMBL4725398
COc1ncc(-c2ccc3ncnc(Nc4cnn(CCO)c4)c3c2)cc1NS(C)(=O)=O,5.60,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins followed by substrate addition and measured after 1 hr by mobility shift assay,IC50,2520.0,nM,=,CHEMBL4667354,B,CHEMBL4745877,Homo sapiens,CHEMBL203,CHEMBL4665651
Cc1ccc(/C=N\Nc2nc(-c3nc4ccccc4n3C)cs2)o1,6.67,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,212.82,nM,=,CHEMBL4729710,B,CHEMBL4746023,Homo sapiens,CHEMBL203,CHEMBL4725379
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC(=O)CCCCC[N+]4=C(/C=C/C=C/C=C/C=C5/N(CCCC)c6ccccc6C5(C)C)C(C)(C)c5cc(C(F)(F)F)ccc54)cc23)c1.[Br-],6.69,Inhibition of EGFR in human A549 cells measured after 30 hrs by ELISA,IC50,205.0,nM,=,CHEMBL4671284,B,CHEMBL4746030,Homo sapiens,CHEMBL203,CHEMBL4665826
Cn1c(-c2csc(N/N=C\c3ccc(Br)cc3)n2)nc2ccccc21,6.39,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,406.09,nM,=,CHEMBL4729710,B,CHEMBL4746321,Homo sapiens,CHEMBL203,CHEMBL4725379
C=C(Cl)C(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1,7.80,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,IC50,16.0,nM,=,CHEMBL4730145,B,CHEMBL4746377,Homo sapiens,CHEMBL203,CHEMBL4725398
COc1cccc2cc(N(C)c3nc(C)nc4ccccc34)ccc12,7.97,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,IC50,10.6,nM,=,CHEMBL4714413,B,CHEMBL4746488,Homo sapiens,CHEMBL203,CHEMBL4706704
C[C@@H](Nc1ncnc2[nH]c(-c3ccccc3OC(F)F)cc12)c1ccccc1,9.10,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.8,nM,=,CHEMBL4718820,B,CHEMBL4746697,Homo sapiens,CHEMBL203,CHEMBL4715760
CC(C)Oc1ccccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2[nH]1,9.22,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.6,nM,=,CHEMBL4718820,B,CHEMBL4746770,Homo sapiens,CHEMBL203,CHEMBL4715760
COc1ccc(-c2c3c4cc(OC)c(OCCCN(C)C)cc4[nH]c(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O.O=C(O)C(F)(F)F,8.24,Inhibition of recombinant wild type EGFR T790M/L858R mutant (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,IC50,5.7,nM,=,CHEMBL4724943,B,CHEMBL4746895,Homo sapiens,CHEMBL203,CHEMBL4715917
Cn1cc(-c2ccnc(Nc3ccc(C(=O)NCCCCCCC(=O)NO)cc3)n2)c2ccccc21,5.92,Inhibition of EGFR T790M mutant (unknown origin) incubated for 40 mins by luminescence based assay,IC50,1200.0,nM,=,CHEMBL5138521,B,CHEMBL4746995,Homo sapiens,CHEMBL203,CHEMBL5137005
C=CC(=O)Nc1cc(Nc2ncc(C(F)(F)F)c(-c3cn(C4CC4)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,7.92,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,IC50,12.08,nM,=,CHEMBL4714437,B,CHEMBL4747078,Homo sapiens,CHEMBL203,CHEMBL4706705
Cn1c(-c2csc(NN=C3CCCCC3)n2)nc2ccccc21,6.55,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,278.88,nM,=,CHEMBL4729710,B,CHEMBL4747759,Homo sapiens,CHEMBL203,CHEMBL4725379
O=C(Nc1cc2c(Nc3ccc(OCc4ccccn4)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F,7.41,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,39.0,nM,=,CHEMBL4721180,B,CHEMBL4747893,Homo sapiens,CHEMBL203,CHEMBL4715818
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(S(=O)(=O)N(C)C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,9.70,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,IC50,0.2,nM,=,CHEMBL4714437,B,CHEMBL4747958,Homo sapiens,CHEMBL203,CHEMBL4706705
OCc1cc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)ccc1F,8.80,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,1.6,nM,=,CHEMBL4718820,B,CHEMBL4748149,Homo sapiens,CHEMBL203,CHEMBL4715760
CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1,9.52,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.3,nM,=,CHEMBL4718820,B,CHEMBL4748320,Homo sapiens,CHEMBL203,CHEMBL4715760
CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F,10.00,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.1,nM,=,CHEMBL4718820,B,CHEMBL4748367,Homo sapiens,CHEMBL203,CHEMBL4715760
CN(C)CCNCc1cc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)ccc1F,8.92,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,1.2,nM,=,CHEMBL4718820,B,CHEMBL4749064,Homo sapiens,CHEMBL203,CHEMBL4715760
Cn1c(-c2csc(N/N=C\c3ccccc3)n2)nc2ccccc21,5.91,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,1235.34,nM,=,CHEMBL4729710,B,CHEMBL4749342,Homo sapiens,CHEMBL203,CHEMBL4725379
Fc1cccc(Nc2ncnc3cc4c(cc23)OCCO4)c1F,7.72,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,18.9,nM,=,CHEMBL4730561,B,CHEMBL4749501,Homo sapiens,CHEMBL203,CHEMBL4725422
Cn1c(-c2csc(N/N=C\C3CCCN3)n2)nc2ccccc21,6.47,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,342.06,nM,=,CHEMBL4729710,B,CHEMBL4749518,Homo sapiens,CHEMBL203,CHEMBL4725379
O=C(Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F,7.55,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,28.0,nM,=,CHEMBL4721180,B,CHEMBL4749765,Homo sapiens,CHEMBL203,CHEMBL4715818
COc1cnccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,9.22,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.6,nM,=,CHEMBL4718820,B,CHEMBL4749862,Homo sapiens,CHEMBL203,CHEMBL4715760
COc1ccc(-c2c3c4cc(OCCCN(C)C)c(O)cc4[nH]c(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O.O=C(O)C(F)(F)F,7.78,Inhibition of recombinant wild type EGFR T790M/L858R mutant (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,IC50,16.6,nM,=,CHEMBL4724943,B,CHEMBL4750158,Homo sapiens,CHEMBL203,CHEMBL4715917
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F,8.57,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,2.7,nM,=,CHEMBL4721175,B,CHEMBL4750196,Homo sapiens,CHEMBL203,CHEMBL4715818
COc1ccc(C2N=C(C(N)=O)c3ncn(-c4ccc(N5CCN(C)CC5)c([N+](=O)[O-])c4)c3N2)cc1OC,6.63,Inhibition of EGFR (unknown origin) using Tyrosine 4 peptide and ATP as substrate incubated for 1 hr by Z'-lyte kinase assay based UV-VIS spectrophotometric method,IC50,236.38,nM,=,CHEMBL4700377,B,CHEMBL4750343,Homo sapiens,CHEMBL203,CHEMBL4699428
CNc1nc(C)c(C(=O)/C=C/c2ccc(O)cc2)s1,7.47,Inhibition of human EGFR TK domain expressed in Escherichia coli BL21 (DE3) pLysS using poly-Glu-Tyr (51 to 68 residues) as substrate incubated for 1 hr by ADP-Glo assay,IC50,33.66,nM,=,CHEMBL4732644,B,CHEMBL4750368,Homo sapiens,CHEMBL203,CHEMBL4732032
C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCO4)c1F,7.71,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,19.7,nM,=,CHEMBL4730561,B,CHEMBL4750375,Homo sapiens,CHEMBL203,CHEMBL4725422
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc(F)ccc1[N+](=O)[O-],7.37,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,43.0,nM,=,CHEMBL4721180,B,CHEMBL4750608,Homo sapiens,CHEMBL203,CHEMBL4715818
Cn1c(-c2csc(N/N=C\c3ccc([N+](=O)[O-])o3)n2)nc2ccccc21,7.14,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,71.67,nM,=,CHEMBL4729710,B,CHEMBL4750734,Homo sapiens,CHEMBL203,CHEMBL4725379
CC(C)(C)c1cc(NC2=NC(=O)CS2)no1,6.82,Inhibition of EGFR-TK (unknown origin) relative to control,IC50,150.0,nM,=,CHEMBL4672269,B,CHEMBL4751085,Homo sapiens,CHEMBL203,CHEMBL4665865
Cc1cc(NC2=NC(=O)/C(=C\c3c4ccccc4cc4ccccc34)S2)no1,7.27,Inhibition of EGFR-TK (unknown origin) relative to control,IC50,54.0,nM,=,CHEMBL4672269,B,CHEMBL4751362,Homo sapiens,CHEMBL203,CHEMBL4665865
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(S(N)(=O)=O)cc3)cc12)c1ccccc1,9.15,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.7,nM,=,CHEMBL4718820,B,CHEMBL4751641,Homo sapiens,CHEMBL203,CHEMBL4715760
O=[N+]([O-])c1ccc(F)c(CNc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2OCCCN2CCOCC2)c1,6.62,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,242.4,nM,=,CHEMBL4721180,B,CHEMBL4751768,Homo sapiens,CHEMBL203,CHEMBL4715818
CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccc(F)cc5)n([C@@H]5CCN(S(=O)(=O)C6CC6)C5)c4n3)cc2)CC1,7.66,"Inhibition of EGFR L858R/T790M/C797S (unknown origin) using Poly (Glu, Tyr) as substrate measured after 40 mins by kinase-glo assay",IC50,22.0,nM,=,CHEMBL4722830,B,CHEMBL4752022,Homo sapiens,CHEMBL203,CHEMBL4715846
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC(=O)CCCCC[N+]4=C(/C=C/C=C/C=C/C=C5/N(CCCC)c6ccc(OC)cc6C5(C)C)C(C)(C)c5cc(C(F)(F)F)ccc54)cc23)c1.[Br-],6.91,Inhibition of EGFR in human A549 cells measured after 30 hrs by ELISA,IC50,124.0,nM,=,CHEMBL4671284,B,CHEMBL4752492,Homo sapiens,CHEMBL203,CHEMBL4665826
Cn1c(-c2csc(N/N=C\c3ccc(F)cc3)n2)nc2ccccc21,6.60,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,253.74,nM,=,CHEMBL4729710,B,CHEMBL4752843,Homo sapiens,CHEMBL203,CHEMBL4725379
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cccnc1F,8.37,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,4.3,nM,=,CHEMBL4721180,B,CHEMBL4752951,Homo sapiens,CHEMBL203,CHEMBL4715818
Cn1c(-c2ccccc2)cc2c(N[C@H](CO)c3ccccc3)ncnc21,6.05,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,900.0,nM,=,CHEMBL4718820,B,CHEMBL4753008,Homo sapiens,CHEMBL203,CHEMBL4715760
CN1CCN(CCOc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc2NC(=O)c2cc([N+](=O)[O-])ccc2F)CC1,7.92,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,12.0,nM,=,CHEMBL4721175,B,CHEMBL4753193,Homo sapiens,CHEMBL203,CHEMBL4715818
C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N1CCC(N2CCOCC2)CC1,6.95,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,IC50,111.6,nM,=,CHEMBL4707740,B,CHEMBL4753387,Homo sapiens,CHEMBL203,CHEMBL4706488
C=CC(=O)Nc1cccc(-c2c(-c3ccc(N4CCN(C)CC4)cc3)[nH]c3ncnc(OCC(C)C)c23)c1,8.07,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,8.5,nM,=,CHEMBL5143769,B,CHEMBL4753389,Homo sapiens,CHEMBL203,CHEMBL5143505
Cn1c(-c2csc(N/N=C\c3ccc([N+](=O)[O-])cc3)n2)nc2ccccc21,7.07,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,85.03,nM,=,CHEMBL4729710,B,CHEMBL4753631,Homo sapiens,CHEMBL203,CHEMBL4725379
C=CC(=O)Nc1cccc(-n2c(=O)cc(C)c3cnc(Nc4ccc(N5CCN(CCCCCC(=O)N[C@H](C(=O)N6C[C@H](O)C[C@H]6C(=O)NCc6ccc(-c7scnc7C)cc6)C(C)(C)C)CC5)cc4OC)nc32)c1,7.71,"Inhibition of EGFR L858R/T790M (unknown origin) using Poly (Glu, Tyr) 4:1 as substrate measured after 1 hr by ELISA",IC50,19.3,nM,=,CHEMBL4686127,B,CHEMBL4753700,Homo sapiens,CHEMBL203,CHEMBL4680227
COc1ccc(/C=C2/N=C(c3ccc(Cl)cc3)N(C(=O)Cc3nc4c(c(C)nn4-c4ccccc4)c(=O)[nH]3)NC2=O)cc1,6.64,Inhibition of EGFR T790M mutant (unknown origin),IC50,226.7,nM,=,CHEMBL4737325,B,CHEMBL4753913,Homo sapiens,CHEMBL203,CHEMBL4732181
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cccc([N+](=O)[O-])c1F,7.89,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,13.0,nM,=,CHEMBL4721180,B,CHEMBL4754811,Homo sapiens,CHEMBL203,CHEMBL4715818
CN(C)CCOc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)c4cc([N+](=O)[O-])ccc4F)cc23)cc1Cl,6.57,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,270.0,nM,=,CHEMBL4721175,B,CHEMBL4755444,Homo sapiens,CHEMBL203,CHEMBL4715818
CC(C)(C)c1cc(NC(=O)CN2CCN(c3ccccc3)CC2)no1,7.18,Inhibition of EGFR-TK (unknown origin) relative to control,IC50,66.0,nM,=,CHEMBL4672269,B,CHEMBL4755651,Homo sapiens,CHEMBL203,CHEMBL4665865
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1ccccc1,7.57,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,27.0,nM,=,CHEMBL4721180,B,CHEMBL4755832,Homo sapiens,CHEMBL203,CHEMBL4715818
Cc1cc(NC2=NC(=O)CS2)no1,7.09,Inhibition of EGFR-TK (unknown origin) relative to control,IC50,81.0,nM,=,CHEMBL4672269,B,CHEMBL4755988,Homo sapiens,CHEMBL203,CHEMBL4665865
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C4COC4)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,9.02,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,IC50,0.95,nM,=,CHEMBL4714437,B,CHEMBL4756020,Homo sapiens,CHEMBL203,CHEMBL4706705
Cc1ccc(Oc2ccc(Nc3ncnc4cc(OCCCN5CCOCC5)c(NC(=O)c5cc([N+](=O)[O-])ccc5F)cc34)cc2Cl)cn1,6.41,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,390.0,nM,=,CHEMBL4721180,B,CHEMBL4756049,Homo sapiens,CHEMBL203,CHEMBL4715818
C=CC(=O)Nc1cc(-c2c[nH]c3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c23)ccc1OCCO,8.22,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 20 mins by HTRF assay,IC50,6.0,nM,=,CHEMBL4670929,B,CHEMBL4756368,Homo sapiens,CHEMBL203,CHEMBL4665812
ClCCN(CCCl)c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,5.90,"Inhibition of EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 8 mins in presence of ATP by colorimetric analysis",IC50,1257.0,nM,=,CHEMBL4685759,B,CHEMBL4757104,Homo sapiens,CHEMBL203,CHEMBL4680216
C=CC(=O)Nc1cc(-c2c[nH]c3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)ccc1OCCN(C)C,8.70,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 20 mins by HTRF assay,IC50,2.0,nM,=,CHEMBL4670929,B,CHEMBL4757145,Homo sapiens,CHEMBL203,CHEMBL4665812
N#Cc1cccc(Oc2ccc(Nc3ncnc4cc(OCCCN5CCOCC5)c(NC(=O)c5cc([N+](=O)[O-])ccc5F)cc34)cc2Cl)c1,6.77,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,169.0,nM,=,CHEMBL4721180,B,CHEMBL4757531,Homo sapiens,CHEMBL203,CHEMBL4715818
CN1CCN(CCCOc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc2NC(=O)c2cc([N+](=O)[O-])ccc2F)CC1,8.42,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,3.8,nM,=,CHEMBL4721175,B,CHEMBL4757724,Homo sapiens,CHEMBL203,CHEMBL4715818
COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2[nH]1,9.40,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.4,nM,=,CHEMBL4718820,B,CHEMBL4757806,Homo sapiens,CHEMBL203,CHEMBL4715760
CNC(=O)CN1CC[C@H](n2c(Nc3ccc(F)cc3)nc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)C1,6.25,"Inhibition of EGFR L858R/T790M/C797S (unknown origin) using Poly (Glu, Tyr) as substrate measured after 40 mins by kinase-glo assay",IC50,561.0,nM,=,CHEMBL4722830,B,CHEMBL4758107,Homo sapiens,CHEMBL203,CHEMBL4715846
COc1cc(/C=N\Nc2nc(-c3nc4ccccc4n3C)cs2)cc(OC)c1OC,6.21,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,622.64,nM,=,CHEMBL4729710,B,CHEMBL4758204,Homo sapiens,CHEMBL203,CHEMBL4725379
C=CC(=O)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1OCc1cn(CCCCC(=O)NO)nn1,8.82,Inhibition of EGFR (unknown origin) by mobility shift assay,IC50,1.5,nM,=,CHEMBL4736787,B,CHEMBL4758761,Homo sapiens,CHEMBL203,CHEMBL4732162
C=CC(=O)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1OCc1cn(CCC(=O)NO)nn1,8.96,Inhibition of EGFR (unknown origin) by mobility shift assay,IC50,1.1,nM,=,CHEMBL4736787,B,CHEMBL4758842,Homo sapiens,CHEMBL203,CHEMBL4732162
COc1cc(CNCCN(C)C)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2[nH]1,10.00,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.1,nM,=,CHEMBL4718820,B,CHEMBL4759003,Homo sapiens,CHEMBL203,CHEMBL4715760
Fc1c(I)cccc1Nc1ncnc2cc3c(cc12)OCCO3,7.98,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,10.4,nM,=,CHEMBL4730561,B,CHEMBL4759031,Homo sapiens,CHEMBL203,CHEMBL4725422
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(CCCC(=O)NO)nn1,9.46,Inhibition of EGFR (unknown origin) by mobility shift assay,IC50,0.35,nM,=,CHEMBL4736787,B,CHEMBL4759072,Homo sapiens,CHEMBL203,CHEMBL4732162
CN(C)C/C=C/C(=O)Nc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1O[C@@H]1CCOC1,9.49,Inhibition of EGFR (unknown origin) by mobility shift assay,IC50,0.32,nM,=,CHEMBL4736787,B,CHEMBL4759112,Homo sapiens,CHEMBL203,CHEMBL4732162
NC(=O)Cc1cccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)c1,9.15,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.7,nM,=,CHEMBL4718820,B,CHEMBL4759127,Homo sapiens,CHEMBL203,CHEMBL4715760
Cc1ccc(C2=N/C(=C/c3ccc(Cl)cc3)C(=O)NN2C(=O)Cc2nc3c(c(C)nn3-c3ccccc3)c(=O)[nH]2)cc1,6.37,Inhibition of EGFR T790M mutant (unknown origin),IC50,422.25,nM,=,CHEMBL4737325,B,CHEMBL4759405,Homo sapiens,CHEMBL203,CHEMBL4732181
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cccc([N+](=O)[O-])c1,7.29,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,50.9,nM,=,CHEMBL4721180,B,CHEMBL4759414,Homo sapiens,CHEMBL203,CHEMBL4715818
Fc1c(Nc2ncnc3cc4c(cc23)OCCO4)cccc1C(F)(F)F,7.38,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,41.4,nM,=,CHEMBL4730561,B,CHEMBL4759650,Homo sapiens,CHEMBL203,CHEMBL4725422
C=CC(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCc1cn(CCC(=O)NO)nn1,9.47,Inhibition of EGFR (unknown origin) by mobility shift assay,IC50,0.34,nM,=,CHEMBL4736787,B,CHEMBL4759697,Homo sapiens,CHEMBL203,CHEMBL4732162
CCOc1ccccc1-c1cc2c(N[C@H](CCO)c3ccccc3)ncnc2[nH]1,10.00,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.1,nM,=,CHEMBL4718820,B,CHEMBL4760328,Homo sapiens,CHEMBL203,CHEMBL4715760
CS(=O)(=O)c1ccc(F)c(C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2OCCCN2CCOCC2)c1,7.24,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,57.0,nM,=,CHEMBL4721180,B,CHEMBL4760606,Homo sapiens,CHEMBL203,CHEMBL4715818
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cccc(C(F)(F)F)c1F,7.52,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,30.0,nM,=,CHEMBL4721180,B,CHEMBL4760864,Homo sapiens,CHEMBL203,CHEMBL4715818
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C4CC4)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,9.74,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,IC50,0.18,nM,=,CHEMBL4714437,B,CHEMBL4761468,Homo sapiens,CHEMBL203,CHEMBL4706705
Fc1c(Nc2ncnc3cc4c(cc23)OCCO4)ccc(Cl)c1Br,7.79,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,16.2,nM,=,CHEMBL4730561,B,CHEMBL4762453,Homo sapiens,CHEMBL203,CHEMBL4725422
Cn1c(-c2csc(N/N=C\c3ccc(Cl)cc3Cl)n2)nc2ccccc21,6.29,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,513.63,nM,=,CHEMBL4729710,B,CHEMBL4762604,Homo sapiens,CHEMBL203,CHEMBL4725379
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc(F)cc(F)c1F,6.44,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,365.0,nM,=,CHEMBL4721180,B,CHEMBL4762998,Homo sapiens,CHEMBL203,CHEMBL4715818
CS(=O)(=O)Nc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1,9.30,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.5,nM,=,CHEMBL4718820,B,CHEMBL4763315,Homo sapiens,CHEMBL203,CHEMBL4715760
O=C(Nc1cc2c(Nc3ccc(F)cc3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F,6.37,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,427.0,nM,=,CHEMBL4721175,B,CHEMBL4763697,Homo sapiens,CHEMBL203,CHEMBL4715818
Cn1c(-c2csc(N/N=C\c3cccs3)n2)nc2ccccc21,6.11,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,773.24,nM,=,CHEMBL4729710,B,CHEMBL4763960,Homo sapiens,CHEMBL203,CHEMBL4725379
O=C(Nc1cc2c(Nc3ccc(F)c(F)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F,7.50,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,32.0,nM,=,CHEMBL4721175,B,CHEMBL4763967,Homo sapiens,CHEMBL203,CHEMBL4715818
COc1cc(NC(C)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,9.10,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.8,nM,=,CHEMBL4718820,B,CHEMBL4764993,Homo sapiens,CHEMBL203,CHEMBL4715760
CN(CCCl)c1ccc2ncnc(Nc3cccc(Br)c3)c2c1,6.30,"Inhibition of EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 8 mins in presence of ATP by colorimetric analysis",IC50,504.0,nM,=,CHEMBL4685759,B,CHEMBL4765122,Homo sapiens,CHEMBL203,CHEMBL4680216
C=C(Cl)C(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)c(Cl)c3)ncc2Cl)c1,8.49,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,IC50,3.2,nM,=,CHEMBL4730145,B,CHEMBL4776012,Homo sapiens,CHEMBL203,CHEMBL4725398
C[C@@H](Nc1ncnc2[nH]c(-c3cccc(C(N)=O)c3)cc12)c1ccccc1,8.85,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,1.4,nM,=,CHEMBL4718820,B,CHEMBL4776056,Homo sapiens,CHEMBL203,CHEMBL4715760
CS(=O)(=O)c1cccc(C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2OCCCN2CCOCC2)c1F,7.62,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,24.0,nM,=,CHEMBL4721180,B,CHEMBL4776057,Homo sapiens,CHEMBL203,CHEMBL4715818
C=C(Cl)C(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3Cl)ncc2Cl)c1,7.33,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,IC50,47.0,nM,=,CHEMBL4730145,B,CHEMBL4776073,Homo sapiens,CHEMBL203,CHEMBL4725398
CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,9.70,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.2,nM,=,CHEMBL4718820,B,CHEMBL4776396,Homo sapiens,CHEMBL203,CHEMBL4715760
CC(C)(C)c1cc(NC(=O)CCl)no1,6.91,Inhibition of EGFR-TK (unknown origin) relative to control,IC50,124.0,nM,=,CHEMBL4672269,B,CHEMBL4776730,Homo sapiens,CHEMBL203,CHEMBL4665865
COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,9.30,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.5,nM,=,CHEMBL4718820,B,CHEMBL4776751,Homo sapiens,CHEMBL203,CHEMBL4715760
C=CC(=O)Nc1cccc(Oc2nc(Nc3cccc(OC)c3)nc3c2CSCC3)c1,6.20,Inhibition of EGFR T790M/L858R mutant (unknown origin) using FAM-labelled peptide as substrate incubated for 10 mins in presence of ATP by Kinase Glo luminescence assay,IC50,638.4,nM,=,CHEMBL4730214,B,CHEMBL4776833,Homo sapiens,CHEMBL203,CHEMBL4725402
S=C(NNc1ccccc1)Nc1ccc2c(c1)OCO2,5.08,Inhibition of EGFR (unknown origin) by FRET assay,IC50,8264.0,nM,=,CHEMBL4769431,B,CHEMBL4776925,Homo sapiens,CHEMBL203,CHEMBL4765304
CN(C)CCCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)c1cc([N+](=O)[O-])ccc1F,8.42,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,3.8,nM,=,CHEMBL4721175,B,CHEMBL4777353,Homo sapiens,CHEMBL203,CHEMBL4715818
O=C(Nc1cc2c(Nc3ccc(OCC4CC4)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F,6.76,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,172.0,nM,=,CHEMBL4721180,B,CHEMBL4777554,Homo sapiens,CHEMBL203,CHEMBL4715818
N#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCO4)c1,7.62,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,24.0,nM,=,CHEMBL4730561,B,CHEMBL4778159,Homo sapiens,CHEMBL203,CHEMBL4725422
COc1cc(CNCCN2CCCCC2)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,10.00,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.1,nM,=,CHEMBL4718820,B,CHEMBL4778248,Homo sapiens,CHEMBL203,CHEMBL4715760
C=CC(=O)Nc1ccc(OC)c(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c1,6.83,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,IC50,146.9,nM,=,CHEMBL4707740,B,CHEMBL4778502,Homo sapiens,CHEMBL203,CHEMBL4706488
O=S(=O)(Nc1ccccn1)c1ccc(NC(=S)Nc2ccc3c(c2)OCO3)cc1,5.72,Inhibition of EGFR (unknown origin) by FRET assay,IC50,1885.0,nM,=,CHEMBL4769431,B,CHEMBL4778717,Homo sapiens,CHEMBL203,CHEMBL4765304
COc1ccc(/C=C/C(=O)c2nnn(-c3ccc(Cl)cc3)c2C)cc1OC,7.44,Inhibition of EGFR in human RPMI-8226 cells incubated for 2 hrs by ELISA,IC50,36.0,nM,=,CHEMBL4684707,B,CHEMBL4778826,Homo sapiens,CHEMBL203,CHEMBL4680183
COc1cc(NS(C)(=O)=O)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2[nH]1,9.15,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.7,nM,=,CHEMBL4718820,B,CHEMBL4778894,Homo sapiens,CHEMBL203,CHEMBL4715760
C=CCSSCCC(=O)OCCCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC,5.17,Inhibition of wild type EGFR in human A-431 cells assessed as cell growth inhibition measured after 72 hrs by Celltiter-Glo luminescent cell viability assay,IC50,6703.0,nM,=,CHEMBL4771547,B,CHEMBL4779194,Homo sapiens,CHEMBL203,CHEMBL4765363
O=c1ccc2ccc(Oc3nc(Nc4ccc(N5CCC(N6CCCCC6)CC5)c(F)c4)nc4ccsc34)cc2[nH]1,6.96,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,IC50,110.0,nM,=,CHEMBL4770070,B,CHEMBL4779681,Homo sapiens,CHEMBL203,CHEMBL4765321
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(C(=O)O)cc3)cc12)c1ccccc1,8.96,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,1.1,nM,=,CHEMBL4718820,B,CHEMBL4779711,Homo sapiens,CHEMBL203,CHEMBL4715760
Cc1c(NC(=S)Nc2ccc3c(c2)OCO3)c(=O)n(-c2ccccc2)n1C,6.45,Inhibition of EGFR (unknown origin) by FRET assay,IC50,358.0,nM,=,CHEMBL4769431,B,CHEMBL4779958,Homo sapiens,CHEMBL203,CHEMBL4765304
Cn1c(-c2csc(NN=C3CCCC3)n2)nc2ccccc21,6.96,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,109.71,nM,=,CHEMBL4729710,B,CHEMBL4780058,Homo sapiens,CHEMBL203,CHEMBL4725379
Cc1ccc(C2=N/C(=C\c3ccc(Cl)cc3)C(=O)NN2C(=O)c2nc3c(c(C)nn3-c3ccccc3)c(=O)[nH]2)cc1,5.72,Inhibition of EGFR T790M mutant (unknown origin),IC50,1887.2,nM,=,CHEMBL4737325,B,CHEMBL4780210,Homo sapiens,CHEMBL203,CHEMBL4732181
OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1,9.40,Inhibition of EGFR (unknown origin) using Tyr 04 peptide as substrate incubated for 1 hr by Z'-LYTE assay,IC50,0.4,nM,=,CHEMBL4718840,B,CHEMBL4780286,Homo sapiens,CHEMBL203,CHEMBL4715760
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(OC)cc3)nc3c2CSCC3)c1,7.55,Inhibition of recombinant EGFR (unknown origin) using TMB as substrate incubated for 3 hrs in presence of ATP by ELISA,IC50,28.0,nM,=,CHEMBL5097758,B,CHEMBL4780534,Homo sapiens,CHEMBL203,CHEMBL5096180
CN(C)CCNc1ccc(Nc2nc(Oc3ccc4ccc(=O)[nH]c4c3)c3sccc3n2)cc1F,6.64,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,IC50,230.0,nM,=,CHEMBL4770070,B,CHEMBL4780855,Homo sapiens,CHEMBL203,CHEMBL4765321
CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccc(F)cc5)n([C@H]5CCN(C(=O)OC(C)(C)C)C5)c4n3)cc2)CC1,6.91,"Inhibition of EGFR L858R/T790M/C797S (unknown origin) using Poly (Glu, Tyr) as substrate measured after 40 mins by kinase-glo assay",IC50,122.0,nM,=,CHEMBL4722830,B,CHEMBL4780903,Homo sapiens,CHEMBL203,CHEMBL4715846
OC[C@@H](Nc1ncnc2[nH]c(-c3ccncc3)cc12)c1ccccc1,8.70,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,2.0,nM,=,CHEMBL4718820,B,CHEMBL4780965,Homo sapiens,CHEMBL203,CHEMBL4715760
CN1CCN(c2ccc(Nc3nc(Oc4ccc5ccc(=O)[nH]c5c4)c4sccc4n3)cc2)CC1,6.60,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,IC50,250.0,nM,=,CHEMBL4770070,B,CHEMBL4781497,Homo sapiens,CHEMBL203,CHEMBL4765321
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1Cl,8.08,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,8.3,nM,=,CHEMBL4721180,B,CHEMBL4782025,Homo sapiens,CHEMBL203,CHEMBL4715818
S=C(Nc1ccc2c(c1)OCO2)Nc1c2ccccc2nc2ccccc12,6.31,Inhibition of EGFR (unknown origin) by FRET assay,IC50,493.0,nM,=,CHEMBL4769431,B,CHEMBL4782320,Homo sapiens,CHEMBL203,CHEMBL4765304
COc1ccc(-c2c3c4cc(O)c(OCCCN(C)C)cc4[nH]c(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O.O=C(O)C(F)(F)F,7.99,Inhibition of recombinant wild type EGFR T790M/L858R mutant (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,IC50,10.2,nM,=,CHEMBL4724943,B,CHEMBL4782900,Homo sapiens,CHEMBL203,CHEMBL4715917
Fc1cc(Br)c(F)c(Nc2ncnc3cc4c(cc23)OCCO4)c1,8.21,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,6.16,nM,=,CHEMBL4730561,B,CHEMBL4783428,Homo sapiens,CHEMBL203,CHEMBL4725422
COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,9.40,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.4,nM,=,CHEMBL4718820,B,CHEMBL4783569,Homo sapiens,CHEMBL203,CHEMBL4715760
C=CC(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCc1cn(CCCCC(=O)NO)nn1,9.36,Inhibition of EGFR (unknown origin) by mobility shift assay,IC50,0.44,nM,=,CHEMBL4736787,B,CHEMBL4783641,Homo sapiens,CHEMBL203,CHEMBL4732162
Cc1ccc(/C=N\Nc2nc(-c3nc4ccccc4n3C)cs2)cc1,6.82,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,150.36,nM,=,CHEMBL4729710,B,CHEMBL4783948,Homo sapiens,CHEMBL203,CHEMBL4725379
N#Cc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)c4cc([N+](=O)[O-])ccc4F)cc23)cc1Cl,5.65,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,2245.0,nM,=,CHEMBL4721175,B,CHEMBL4784185,Homo sapiens,CHEMBL203,CHEMBL4715818
COc1cc(CN(C)CCN(C)C)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,10.00,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.1,nM,=,CHEMBL4718820,B,CHEMBL4784258,Homo sapiens,CHEMBL203,CHEMBL4715760
COc1cc(CNCCS(C)(=O)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,9.40,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.4,nM,=,CHEMBL4718820,B,CHEMBL4784777,Homo sapiens,CHEMBL203,CHEMBL4715760
CCN1CCN(Cc2ccc(Nc3nc(Oc4ccc5ccc(=O)[nH]c5c4)c4sccc4n3)cc2)CC1,6.62,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,IC50,240.0,nM,=,CHEMBL4770070,B,CHEMBL4785528,Homo sapiens,CHEMBL203,CHEMBL4765321
CCOc1ccccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2[nH]1,9.52,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.3,nM,=,CHEMBL4718820,B,CHEMBL4785569,Homo sapiens,CHEMBL203,CHEMBL4715760
C=C(Cl)C(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)ncc2Cl)c1,7.89,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,IC50,13.0,nM,=,CHEMBL4730145,B,CHEMBL4785849,Homo sapiens,CHEMBL203,CHEMBL4725398
COc1cc(/C=N/NC(=O)COc2nc(C)nc3c2c(C)nn3-c2ccccc2)cc(OC)c1OC,5.38,Inhibition of EGFR (unknown origin) by Kinase-Glo luminescence assay,IC50,4180.0,nM,=,CHEMBL4673685,B,CHEMBL4786003,Homo sapiens,CHEMBL203,CHEMBL4673190
CN(C)c1ccc(/C=N\Nc2nc(-c3nc4ccccc4n3C)cs2)cc1,6.98,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,103.71,nM,=,CHEMBL4729710,B,CHEMBL4786168,Homo sapiens,CHEMBL203,CHEMBL4725379
C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N1CCCN(C)CC1,6.81,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,IC50,155.7,nM,=,CHEMBL4707740,B,CHEMBL4786701,Homo sapiens,CHEMBL203,CHEMBL4706488
OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1,9.30,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.5,nM,=,CHEMBL4718820,B,CHEMBL4786776,Homo sapiens,CHEMBL203,CHEMBL4715760
CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n([C@@H]5CCN(S(=O)(=O)C6CC6)C5)c4n3)cc2)CC1,7.75,"Inhibition of EGFR L858R/T790M/C797S (unknown origin) using Poly (Glu, Tyr) as substrate measured after 40 mins by kinase-glo assay",IC50,18.0,nM,=,CHEMBL4722830,B,CHEMBL4786787,Homo sapiens,CHEMBL203,CHEMBL4715846
Oc1c(Br)cccc1Nc1ncnc2cc3c(cc12)OCCO3,6.30,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,505.1,nM,=,CHEMBL4730561,B,CHEMBL4786797,Homo sapiens,CHEMBL203,CHEMBL4725422
Fc1ccc(Br)c(F)c1Nc1ncnc2cc3c(cc12)OCCO3,8.00,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,10.0,nM,=,CHEMBL4730561,B,CHEMBL4786961,Homo sapiens,CHEMBL203,CHEMBL4725422
C=CC(=O)Nc1cccc(-c2c[nH]c3ncnc(Nc4ccc(OCc5ccccn5)c(Cl)c4)c23)c1,8.41,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 20 mins by HTRF assay,IC50,3.9,nM,=,CHEMBL4670929,B,CHEMBL4787483,Homo sapiens,CHEMBL203,CHEMBL4665812
C=CC(=O)Nc1cccc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c1,6.63,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,IC50,234.4,nM,=,CHEMBL4707740,B,CHEMBL4787536,Homo sapiens,CHEMBL203,CHEMBL4706488
CC(C)(C)c1cc(NC(=O)CN2CCOCC2)no1,6.84,Inhibition of EGFR-TK (unknown origin) relative to control,IC50,144.0,nM,=,CHEMBL4672269,B,CHEMBL4787698,Homo sapiens,CHEMBL203,CHEMBL4665865
COc1cc(CNCCN(C)C)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,9.52,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.3,nM,=,CHEMBL4718820,B,CHEMBL4787816,Homo sapiens,CHEMBL203,CHEMBL4715760
COc1cc(CNCCN2CCOCC2)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,10.00,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.1,nM,=,CHEMBL4718820,B,CHEMBL4787951,Homo sapiens,CHEMBL203,CHEMBL4715760
C=CC(=O)Nc1cccc(Nc2cc(-n3c(CCCO)nnc3-c3ccc(F)cc3)ccn2)c1,6.84,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,IC50,143.4,nM,=,CHEMBL4707740,B,CHEMBL4788364,Homo sapiens,CHEMBL203,CHEMBL4706488
OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F,9.22,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.6,nM,=,CHEMBL4718820,B,CHEMBL4789027,Homo sapiens,CHEMBL203,CHEMBL4715760
OC[C@@H](Nc1ncnc2[nH]c(-c3cccnc3)cc12)c1ccccc1,8.66,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,2.2,nM,=,CHEMBL4718820,B,CHEMBL4789312,Homo sapiens,CHEMBL203,CHEMBL4715760
C=C(F)C(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)c(C)c3)ncc2Cl)c1,6.76,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,IC50,174.0,nM,=,CHEMBL4730145,B,CHEMBL4789716,Homo sapiens,CHEMBL203,CHEMBL4725398
S=C(NN=C(c1ccccc1)c1ccccc1)Nc1ccc2c(c1)OCO2,6.00,Inhibition of EGFR (unknown origin) by FRET assay,IC50,993.0,nM,=,CHEMBL4769431,B,CHEMBL4789796,Homo sapiens,CHEMBL203,CHEMBL4765304
N#Cc1ccc(F)c(C(=O)Nc2cc3c(Nc4ccc(F)c(Cl)c4)ncnc3cc2OCCCN2CCOCC2)c1,8.89,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,1.3,nM,=,CHEMBL4721180,B,CHEMBL4789811,Homo sapiens,CHEMBL203,CHEMBL4715818
COCCOc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)c4cc([N+](=O)[O-])ccc4F)cc23)cc1Cl,6.33,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,463.0,nM,=,CHEMBL4721175,B,CHEMBL4790485,Homo sapiens,CHEMBL203,CHEMBL4715818
Cc1nn(-c2ccccc2)c2nc(CC(=O)N3NC(=O)/C(=C\c4ccccc4)N=C3c3ccccc3)[nH]c(=O)c12,6.18,Inhibition of EGFR T790M mutant (unknown origin),IC50,655.6,nM,=,CHEMBL4737325,B,CHEMBL4790553,Homo sapiens,CHEMBL203,CHEMBL4732181
C#CCn1cc(-c2ccnc(Nc3cc(NC(=O)C=C)c(N(C)CCN(C)C)cc3OC)n2)c2ccccc21,9.00,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,IC50,1.01,nM,=,CHEMBL4714437,B,CHEMBL4790568,Homo sapiens,CHEMBL203,CHEMBL4706705
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1F)c1cc([N+](=O)[O-])ccc1F,7.77,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,17.0,nM,=,CHEMBL4721175,B,CHEMBL4790583,Homo sapiens,CHEMBL203,CHEMBL4715818
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1ccccc1F,8.52,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,3.0,nM,=,CHEMBL4721180,B,CHEMBL4790655,Homo sapiens,CHEMBL203,CHEMBL4715818
CCN1CCN(c2ccc(Nc3nc(Oc4ccc5ccc(=O)[nH]c5c4)c4sccc4n3)c(OC)c2)CC1,6.48,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,IC50,330.0,nM,=,CHEMBL4770070,B,CHEMBL4791108,Homo sapiens,CHEMBL203,CHEMBL4765321
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(C(N)=O)cc3)cc12)c1ccccc1,9.10,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.8,nM,=,CHEMBL4718820,B,CHEMBL4791195,Homo sapiens,CHEMBL203,CHEMBL4715760
COc1ccc(-c2c3c4cc(OCCCN(C)C)c(OCCCN(C)C)cc4[nH]c(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F,8.77,Inhibition of recombinant wild type EGFR T790M/L858R mutant (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,IC50,1.7,nM,=,CHEMBL4724943,B,CHEMBL4791596,Homo sapiens,CHEMBL203,CHEMBL4715917
Fc1ccc(Br)cc1Nc1ncnc2cc3c(cc12)OCCO3,8.12,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,7.63,nM,=,CHEMBL4730561,B,CHEMBL4791756,Homo sapiens,CHEMBL203,CHEMBL4725422
CN1CCN(Cc2ccc(Nc3nc(Oc4ccc5ccc(=O)[nH]c5c4)c4sccc4n3)cc2)CC1,6.70,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,IC50,200.0,nM,=,CHEMBL4770070,B,CHEMBL4791953,Homo sapiens,CHEMBL203,CHEMBL4765321
CC(C)(C)c1cc(NC(=O)Cc2ccc(Nc3ncnc4[nH]c(-c5ccc(S(C)(=O)=O)cc5)cc34)cc2)no1,4.25,Inhibition of EGFR (unknown origin),IC50,56780.0,nM,=,CHEMBL4774183,B,CHEMBL4791960,Homo sapiens,CHEMBL203,CHEMBL4765434
Cc1nn(-c2ccc(F)cc2)c2ncnc(Nc3ccc(F)c(Cl)c3)c12,6.73,Inhibition of EGFR (unknown origin),IC50,186.0,nM,=,CHEMBL4673696,B,CHEMBL4792279,Homo sapiens,CHEMBL203,CHEMBL4673190
O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCNCC1)c1cc([N+](=O)[O-])ccc1F,8.72,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,1.9,nM,=,CHEMBL4721175,B,CHEMBL4792426,Homo sapiens,CHEMBL203,CHEMBL4715818
COC[C@@H](Nc1ncnc2[nH]c(-c3ccc(CO)cc3OC)cc12)c1ccccc1,9.30,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.5,nM,=,CHEMBL4718820,B,CHEMBL4792577,Homo sapiens,CHEMBL203,CHEMBL4715760
COc1ccc(-c2c3c4cc(OC)c(OC)cc4[nH]c(=O)c3n3ccc4cc(O)c(OC)cc4c23)cc1O,7.18,Inhibition of recombinant wild type EGFR T790M/L858R mutant (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,IC50,65.3,nM,=,CHEMBL4724943,B,CHEMBL4792673,Homo sapiens,CHEMBL203,CHEMBL4715917
C=CC(=O)Nc1cc(Nc2ncc(C(F)(F)F)c(-c3cn(C4COC4)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C,9.77,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,IC50,0.17,nM,=,CHEMBL4714437,B,CHEMBL4792967,Homo sapiens,CHEMBL203,CHEMBL4706705
[2H]C([2H])([2H])Oc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1,9.40,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.4,nM,=,CHEMBL4718820,B,CHEMBL4793053,Homo sapiens,CHEMBL203,CHEMBL4715760
C=C(Cl)C(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)ncc2Cl)c1,8.41,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,IC50,3.9,nM,=,CHEMBL4730145,B,CHEMBL4793105,Homo sapiens,CHEMBL203,CHEMBL4725398
C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCc1cn(CCC(=O)NO)nn1,9.48,Inhibition of EGFR (unknown origin) by mobility shift assay,IC50,0.33,nM,=,CHEMBL4736787,B,CHEMBL4793338,Homo sapiens,CHEMBL203,CHEMBL4732162
Fc1ccc(Nc2ncnc3cc4c(cc23)OCCO4)c(F)c1Br,7.81,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,15.6,nM,=,CHEMBL4730561,B,CHEMBL4793453,Homo sapiens,CHEMBL203,CHEMBL4725422
COc1ccc(C2N=C(C(N)=O)c3ncn(-c4ccc(F)cc4)c3N2)cc1OC,6.21,Inhibition of EGFR (unknown origin) using Tyrosine 4 peptide and ATP as substrate incubated for 1 hr by Z'-lyte kinase assay based UV-VIS spectrophotometric method,IC50,617.33,nM,=,CHEMBL4700377,B,CHEMBL4793639,Homo sapiens,CHEMBL203,CHEMBL4699428
CC(=O)N1CCN(CCCOc2cc3ncnc(Nc4ccc(F)c(Cl)c4)c3cc2NC(=O)c2cc([N+](=O)[O-])ccc2F)CC1,7.85,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,14.0,nM,=,CHEMBL4721175,B,CHEMBL4793852,Homo sapiens,CHEMBL203,CHEMBL4715818
Fc1c(Br)cc(Cl)cc1Nc1ncnc2cc3c(cc12)OCCO3,6.11,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,782.8,nM,=,CHEMBL4730561,B,CHEMBL4793944,Homo sapiens,CHEMBL203,CHEMBL4725422
COC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3OC(F)F)cc12)c1ccccc1,8.89,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,1.3,nM,=,CHEMBL4718820,B,CHEMBL4794073,Homo sapiens,CHEMBL203,CHEMBL4715760
COc1ccc(/C=N\Nc2nc(-c3nc4ccccc4n3C)cs2)cc1,6.51,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,311.75,nM,=,CHEMBL4729710,B,CHEMBL4794131,Homo sapiens,CHEMBL203,CHEMBL4725379
Fc1c(Nc2ncnc3cc4c(cc23)OCCO4)ccc(Br)c1Br,7.68,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",IC50,21.0,nM,=,CHEMBL4730561,B,CHEMBL4794223,Homo sapiens,CHEMBL203,CHEMBL4725422
C=CC(=O)Nc1cc2c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)ncnc2cc1OCc1cn(CCCC(=O)NO)nn1,8.74,Inhibition of EGFR (unknown origin) by mobility shift assay,IC50,1.8,nM,=,CHEMBL4736787,B,CHEMBL4794670,Homo sapiens,CHEMBL203,CHEMBL4732162
C=C(F)C(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)ncc2Cl)c1,6.67,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,IC50,213.0,nM,=,CHEMBL4730145,B,CHEMBL4794857,Homo sapiens,CHEMBL203,CHEMBL4725398
C=CC(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCc1cn(CCCC(=O)NO)nn1,9.44,Inhibition of EGFR (unknown origin) by mobility shift assay,IC50,0.36,nM,=,CHEMBL4736787,B,CHEMBL4794998,Homo sapiens,CHEMBL203,CHEMBL4732162
C=CC(=O)Nc1cccc(-c2c[nH]c3ncnc(Nc4ccc(CN5C(=O)c6ccccc6C5=O)cc4)c23)c1,9.70,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 15 mins by HTRF assay,IC50,0.2,nM,=,CHEMBL4670930,B,CHEMBL4795165,Homo sapiens,CHEMBL203,CHEMBL4665812
C[C@@H](Nc1ncnc2[nH]c(-c3ccc(S(C)(=O)=O)cc3)cc12)c1ccccc1,9.40,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,0.4,nM,=,CHEMBL4718820,B,CHEMBL4795296,Homo sapiens,CHEMBL203,CHEMBL4715760
CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n([C@H]5CCN(S(=O)(=O)C6CC6)C5)c4n3)cc2)CC1,7.75,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,18.0,nM,=,CHEMBL5143769,B,CHEMBL4795878,Homo sapiens,CHEMBL203,CHEMBL5143505
CC(C)c1ccc(C2N=C(C(N)=O)c3ncn(-c4ccc(F)cc4)c3N2)cc1,6.15,Inhibition of EGFR (unknown origin) using Tyrosine 4 peptide and ATP as substrate incubated for 1 hr by Z'-lyte kinase assay based UV-VIS spectrophotometric method,IC50,710.0,nM,=,CHEMBL4700377,B,CHEMBL4795888,Homo sapiens,CHEMBL203,CHEMBL4699428
C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C4CC4)c4ccccc34)n2)c(OC)cc1[S+]([O-])CCN(C)C,9.59,Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus expression system using Tyr 4 as substrate incubated for 60 mins by Z'-Lyte assay,IC50,0.26,nM,=,CHEMBL4713360,B,CHEMBL4796010,Homo sapiens,CHEMBL203,CHEMBL4706659
CN(C)CCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)c1cc([N+](=O)[O-])ccc1F,7.75,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,18.0,nM,=,CHEMBL4721175,B,CHEMBL4796407,Homo sapiens,CHEMBL203,CHEMBL4715818
Cn1c(-c2csc(N/N=C\c3ccncc3)n2)nc2ccccc21,6.25,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,IC50,569.41,nM,=,CHEMBL4729710,B,CHEMBL4796408,Homo sapiens,CHEMBL203,CHEMBL4725379
CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccc(F)cc5)n([C@H]5CCCN(C(=O)CO)C5)c4n3)cc2)CC1,7.39,"Inhibition of EGFR L858R/T790M/C797S (unknown origin) using Poly (Glu, Tyr) as substrate measured after 40 mins by kinase-glo assay",IC50,41.0,nM,=,CHEMBL4722830,B,CHEMBL4797395,Homo sapiens,CHEMBL203,CHEMBL4715846
CNc1nc(C)c(C(=O)/C=C/c2ccsc2)s1,6.84,Inhibition of human EGFR TK domain expressed in Escherichia coli BL21 (DE3) pLysS using poly-Glu-Tyr (51 to 68 residues) as substrate incubated for 1 hr by ADP-Glo assay,IC50,143.63,nM,=,CHEMBL4732644,B,CHEMBL4797515,Homo sapiens,CHEMBL203,CHEMBL4732032
C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N(C)CCN(C)C,7.37,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,IC50,43.1,nM,=,CHEMBL4707740,B,CHEMBL4798177,Homo sapiens,CHEMBL203,CHEMBL4706488
CNc1nc(C)c(C(=O)/C=C/c2nccs2)s1,6.59,Inhibition of human EGFR TK domain expressed in Escherichia coli BL21 (DE3) pLysS using poly-Glu-Tyr (51 to 68 residues) as substrate incubated for 1 hr by ADP-Glo assay,IC50,255.6,nM,=,CHEMBL4732644,B,CHEMBL4798434,Homo sapiens,CHEMBL203,CHEMBL4732032
C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)ccc1N(C)CCN(C)C,6.81,Inhibition of wild type N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 20 mins by HTRF assay,IC50,156.4,nM,=,CHEMBL4707739,B,CHEMBL4798480,Homo sapiens,CHEMBL203,CHEMBL4706488
Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12,7.72,Inhibition of human recombinant EGFR T790M mutant (696 to end residues) using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis,IC50,19.0,nM,=,CHEMBL4766169,B,CHEMBL4798527,Homo sapiens,CHEMBL203,CHEMBL4765233
O=C(Cc1csc2nc3ccccc3n12)Nc1ccccc1O,7.26,Inhibition of EGFR (unknown origin) incubated for 40 mins by intrinsic ATPase activity luminescence assay,IC50,55.0,nM,=,CHEMBL5096403,B,CHEMBL4798627,Homo sapiens,CHEMBL203,CHEMBL5096145
C=CC(=O)Nc1cccc(-c2c(-c3ccc(N4CCN(C)CC4)cc3)[nH]c3ncnc(OC(C)C)c23)c1,8.07,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,8.6,nM,=,CHEMBL5143769,B,CHEMBL4799276,Homo sapiens,CHEMBL203,CHEMBL5143505
O=S(=O)(Nc1nccs1)c1ccc(NC(=S)Nc2ccc3c(c2)OCO3)cc1,5.79,Inhibition of EGFR (unknown origin) by FRET assay,IC50,1623.0,nM,=,CHEMBL4769431,B,CHEMBL4799700,Homo sapiens,CHEMBL203,CHEMBL4765304
C=CCn1cc(-c2ccnc(Nc3cc(NC(=O)C=C)c(N(C)CCN(C)C)cc3OC)n2)c2ccccc21,8.82,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,IC50,1.51,nM,=,CHEMBL4714437,B,CHEMBL4800367,Homo sapiens,CHEMBL203,CHEMBL4706705
COc1cc(N2CCN(C)CC2)ccc1Nc1nc(Oc2ccc3ccc(=O)[nH]c3c2)c2sccc2n1,6.48,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,IC50,330.0,nM,=,CHEMBL4770070,B,CHEMBL4800533,Homo sapiens,CHEMBL203,CHEMBL4765321
C[C@@H](Nc1ncnc2[nH]c(-c3ccccc3OC(F)(F)F)cc12)c1ccccc1,8.37,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,4.3,nM,=,CHEMBL4718820,B,CHEMBL4800697,Homo sapiens,CHEMBL203,CHEMBL4715760
CCS(=O)(=O)NNC(=O)CSc1nc2ccccc2c(=O)n1Cc1ccc2c(c1)OCO2,6.83,Inhibition of EGFR (unknown origin),IC50,146.9,nM,=,CHEMBL4810720,B,CHEMBL4845732,Homo sapiens,CHEMBL203,CHEMBL4808227
NS(=O)(=O)c1ccc(NC(=S)Nc2ccc3ncnc(Nc4cccc(C(F)(F)F)c4)c3c2)cc1,7.29,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,51.2,nM,=,CHEMBL4815790,B,CHEMBL4846607,Homo sapiens,CHEMBL203,CHEMBL4813962
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(N)c3)nc3[nH]ccc23)c1,9.68,Inhibition of wild type EGFR L858R mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,IC50,0.21,nM,=,CHEMBL4829486,B,CHEMBL4847264,Homo sapiens,CHEMBL203,CHEMBL4828722
CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c(C(N)=O)n1N,4.93,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,11802.0,nM,=,CHEMBL4841672,B,CHEMBL4847730,Homo sapiens,CHEMBL203,CHEMBL4840351
NS(=O)(=O)c1ccc(CCNC(=S)Nc2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)cc1,7.55,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,28.4,nM,=,CHEMBL4815790,B,CHEMBL4848093,Homo sapiens,CHEMBL203,CHEMBL4813962
O=C(NO)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1Cl,6.93,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,116.5,nM,=,CHEMBL4832125,B,CHEMBL4848234,Homo sapiens,CHEMBL203,CHEMBL4831496
CC#CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(-c4ccccc4)ccn3)cc2)c(C(N)=O)n1N,4.78,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,16807.0,nM,=,CHEMBL4841672,B,CHEMBL4849268,Homo sapiens,CHEMBL203,CHEMBL4840351
O=C(CN1CCOCC1)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3C(=O)NO)n2)cc1,6.95,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,113.5,nM,=,CHEMBL4832125,B,CHEMBL4849337,Homo sapiens,CHEMBL203,CHEMBL4831496
COc1cc2cccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC,5.51,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,IC50,3110.0,nM,=,CHEMBL4836401,B,CHEMBL4849721,Homo sapiens,CHEMBL203,CHEMBL4834452
COc1ccc(/C=C2/SC(NN3Cc4ccccc4N=C3c3ccccc3)=NC2=O)cc1,6.87,Inhibition of EGFR (unknown origin),IC50,136.0,nM,=,CHEMBL4821238,B,CHEMBL4849859,Homo sapiens,CHEMBL203,CHEMBL4819060
C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c([N+](=O)[O-])c3)nc3[nH]ccc23)c1,9.41,Inhibition of wild type EGFR L858R mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,IC50,0.39,nM,=,CHEMBL4829486,B,CHEMBL4850239,Homo sapiens,CHEMBL203,CHEMBL4828722
O=C(CSc1nc2ccccc2c(=O)n1Cc1ccc2c(c1)OCO2)Nc1ccccc1F,6.68,Inhibition of EGFR (unknown origin),IC50,207.1,nM,=,CHEMBL4810720,B,CHEMBL4850856,Homo sapiens,CHEMBL203,CHEMBL4808227
C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCN/C(=N\C#N)Nc4ccncc4)cc23)c1,9.64,Inhibition of N-terminal GST-tagged human recombinant EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,IC50,0.23,nM,=,CHEMBL4819610,B,CHEMBL4851176,Homo sapiens,CHEMBL203,CHEMBL4818995
O=C(CSc1nc2ccccc2c(=O)n1Cc1ccc2c(c1)OCO2)Nc1ccc(Br)cc1Br,5.99,Inhibition of EGFR (unknown origin),IC50,1032.7,nM,=,CHEMBL4810720,B,CHEMBL4851555,Homo sapiens,CHEMBL203,CHEMBL4808227
O=C(COc1ccc(Nc2ncc(Cl)c(Nc3ccccc3C(=O)NO)n2)cc1)NO,7.18,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,65.41,nM,=,CHEMBL4832125,B,CHEMBL4851795,Homo sapiens,CHEMBL203,CHEMBL4831496
C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5)cc4)[nH]c23)C1,7.41,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,38.6,nM,=,CHEMBL4843876,B,CHEMBL4852264,Homo sapiens,CHEMBL203,CHEMBL4842353
C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCN/C(=N\C#N)Nc4cccnc4)cc23)c1,9.39,Inhibition of N-terminal GST-tagged human recombinant EGFR L858R mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,IC50,0.41,nM,=,CHEMBL4819613,B,CHEMBL4852664,Homo sapiens,CHEMBL203,CHEMBL4818995
COc1cc2ncnc(Nc3cccc(C(F)(F)F)c3)c2cc1OCCCCC(=O)Nc1ccc(S(N)(=O)=O)cc1,8.04,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,9.2,nM,=,CHEMBL4815791,B,CHEMBL4853833,Homo sapiens,CHEMBL203,CHEMBL4813962
C=CS(=O)(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2Cl)c1,6.17,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate incubated for 1 hr by TR-FRET assay,IC50,675.0,nM,=,CHEMBL4830966,B,CHEMBL4854693,Homo sapiens,CHEMBL203,CHEMBL4828755
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OCCCCC(=O)Nc1ccc(S(N)(=O)=O)cc1,7.75,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,18.0,nM,=,CHEMBL4815791,B,CHEMBL4855080,Homo sapiens,CHEMBL203,CHEMBL4813962
O=C(CSc1nc2ccccc2c(=O)n1Cc1ccc2c(c1)OCO2)Nc1ccc(I)cc1,6.12,Inhibition of EGFR (unknown origin),IC50,754.3,nM,=,CHEMBL4810720,B,CHEMBL4855312,Homo sapiens,CHEMBL203,CHEMBL4808227
C#CCNC(=O)c1cc(Nc2cc(C3CC3)[nH]n2)nc(N2CCN(Cc3ccc(S(=O)(=O)F)cc3)CC2)n1,8.22,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate preincubated with enzyme for 3 hrs followed by substrate and ATP addition by TR-FRET assay,IC50,6.0,nM,=,CHEMBL4830967,B,CHEMBL4855850,Homo sapiens,CHEMBL203,CHEMBL4828755
COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2cccc(NC(C)=O)c2)n1,5.96,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate incubated for 1 hr by TR-FRET assay,IC50,1105.0,nM,=,CHEMBL4830966,B,CHEMBL4856343,Homo sapiens,CHEMBL203,CHEMBL4828755
COc1ccc(-c2coc3cc(OCC(=O)N/C=C\c4ccc(O)cc4)ccc3c2=O)cc1,7.48,Inhibition of EGFR (unknown origin),IC50,33.1,nM,=,CHEMBL4821238,B,CHEMBL4856453,Homo sapiens,CHEMBL203,CHEMBL4819060
C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(OC)cc5)cc4)[nH]c23)CC1,7.29,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,50.8,nM,=,CHEMBL4843876,B,CHEMBL4856592,Homo sapiens,CHEMBL203,CHEMBL4842353
C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(F)cc5F)cc4)[nH]c23)CC1,7.48,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,32.8,nM,=,CHEMBL4843876,B,CHEMBL4857353,Homo sapiens,CHEMBL203,CHEMBL4842353
CN(C(=O)NCCCl)c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1,7.09,Inhibition of EGFR (unknown origin),IC50,81.0,nM,=,CHEMBL4821238,B,CHEMBL4857477,Homo sapiens,CHEMBL203,CHEMBL4819060
NS(=O)(=O)c1ccc(CCNC(=S)Nc2ccc3ncnc(Nc4cccc(C(F)(F)F)c4)c3c2)cc1,7.37,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,42.6,nM,=,CHEMBL4815790,B,CHEMBL4857605,Homo sapiens,CHEMBL203,CHEMBL4813962
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CC[Se]CC1,4.60,Inhibition of EGFR (unknown origin) by ADP-Glo kinase assay,IC50,25300.0,nM,=,CHEMBL4827337,B,CHEMBL4858176,Homo sapiens,CHEMBL203,CHEMBL4825706
O=C(NO)c1ccccc1Nc1nc(Nc2ccc(OCC(=O)N3CCOCC3)cc2)ncc1Cl,7.79,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,16.04,nM,=,CHEMBL4832125,B,CHEMBL4858409,Homo sapiens,CHEMBL203,CHEMBL4831496
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(OCCCN3CCC(C(=O)NO)CC3)cc2)ncc1Cl,7.35,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,44.96,nM,=,CHEMBL4832125,B,CHEMBL4858535,Homo sapiens,CHEMBL203,CHEMBL4831496
CN(/N=N\c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1)C(=O)OCCl,9.41,Inhibition of EGFR (unknown origin),IC50,0.39,nM,=,CHEMBL4821238,B,CHEMBL4858583,Homo sapiens,CHEMBL203,CHEMBL4819060
O=C(NO)c1ccccc1Nc1nc(Nc2ccc(CN3CCOCC3)cc2)ncc1Cl,7.00,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,98.78,nM,=,CHEMBL4832125,B,CHEMBL4858714,Homo sapiens,CHEMBL203,CHEMBL4831496
C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCCN/C(=N\C#N)Nc4cccnc4)cc23)c1,9.32,Inhibition of N-terminal GST-tagged human recombinant EGFR L858R mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,IC50,0.48,nM,=,CHEMBL4819613,B,CHEMBL4859375,Homo sapiens,CHEMBL203,CHEMBL4818995
CCc1ccc(NCC(=O)Nn2c(-c3ccccc3)nc3ccccc3c2=O)cc1,6.84,Inhibition of EGFR (unknown origin),IC50,143.4,nM,=,CHEMBL4821238,B,CHEMBL4859473,Homo sapiens,CHEMBL203,CHEMBL4819060
C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCC(=O)Nc4ccc(S(N)(=O)=O)cc4)cc23)c1,7.31,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,49.2,nM,=,CHEMBL4815790,B,CHEMBL4859542,Homo sapiens,CHEMBL203,CHEMBL4813962
CS(=O)(=O)c1nccc(-c2c(-c3cccc(OCc4ccccc4)c3)nc3sccn23)n1,5.00,Inhibition of EGFR (unknown origin) incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method,IC50,9920.0,nM,=,CHEMBL4832290,B,CHEMBL4860202,Homo sapiens,CHEMBL203,CHEMBL4831500
C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCN/C(=N\C#N)Nc4ccncc4)cc23)c1,9.49,Inhibition of N-terminal GST-tagged human recombinant EGFR L858R mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,IC50,0.32,nM,=,CHEMBL4819613,B,CHEMBL4860398,Homo sapiens,CHEMBL203,CHEMBL4818995
C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(Cl)ccn3)cc2)c(C(N)=O)n1N,6.75,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,176.0,nM,=,CHEMBL4841672,B,CHEMBL4860527,Homo sapiens,CHEMBL203,CHEMBL4840351
COc1cc2ncnc(Nc3ccc(Cl)c(C(F)(F)F)c3)c2cc1OCCCCC(=O)Nc1ccc(S(N)(=O)=O)cc1,7.86,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,13.7,nM,=,CHEMBL4815790,B,CHEMBL4861346,Homo sapiens,CHEMBL203,CHEMBL4813962
COc1ccc(C(Nc2ccc(Cl)cc2)n2c(=O)ccc3cc(O)ccc32)cc1,5.95,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,IC50,1130.0,nM,=,CHEMBL4836401,B,CHEMBL4861493,Homo sapiens,CHEMBL203,CHEMBL4834452
CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NO)n3)cc2)CC1,7.16,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,68.81,nM,=,CHEMBL4832125,B,CHEMBL4861707,Homo sapiens,CHEMBL203,CHEMBL4831496
COc1ccc(C(Nc2ccc(Br)cc2)n2c(=O)ccc3cc(O)ccc32)cc1,6.02,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,IC50,960.0,nM,=,CHEMBL4836401,B,CHEMBL4861796,Homo sapiens,CHEMBL203,CHEMBL4834452
CCOC(=O)c1ccccc1Nc1nc(Nc2ccc(OCC(=O)N3CCOCC3)cc2)ncc1Cl,9.61,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,0.2446,nM,=,CHEMBL4832125,B,CHEMBL4862351,Homo sapiens,CHEMBL203,CHEMBL4831496
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CN3CCOCC3)c(C)c2)ncc1Cl,8.41,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,3.89,nM,=,CHEMBL4832125,B,CHEMBL4862976,Homo sapiens,CHEMBL203,CHEMBL4831496
C=CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)CC1,6.96,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,109.0,nM,=,CHEMBL4843876,B,CHEMBL4863078,Homo sapiens,CHEMBL203,CHEMBL4842353
C#CC(=O)N1CC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)C1,7.47,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,33.8,nM,=,CHEMBL4843876,B,CHEMBL4863088,Homo sapiens,CHEMBL203,CHEMBL4842353
COc1ccc(NC(c2ccc(OC)cc2)n2c(=O)ccc3cc(O)ccc32)cc1,5.28,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,IC50,5290.0,nM,=,CHEMBL4836401,B,CHEMBL4863109,Homo sapiens,CHEMBL203,CHEMBL4834452
O=C(CCCCCCn1cc(-c2ccc3ncnc(Nc4ccc(Br)cc4F)c3c2)nn1)NO,7.99,Inhibition of EGFR (unknown origin),IC50,10.3,nM,=,CHEMBL4819289,B,CHEMBL4863294,Homo sapiens,CHEMBL203,CHEMBL4818986
C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(-c4ccccc4)ccn3)cc2)c(C(N)=O)n1N,7.10,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,79.4,nM,=,CHEMBL4841672,B,CHEMBL4863836,Homo sapiens,CHEMBL203,CHEMBL4840351
C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(-c4ccc(F)cc4)ccn3)cc2)c(C(N)=O)n1N,6.95,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,113.0,nM,=,CHEMBL4841672,B,CHEMBL4863913,Homo sapiens,CHEMBL203,CHEMBL4840351
C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c(C(N)=O)n1N,6.36,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,433.0,nM,=,CHEMBL4841672,B,CHEMBL4864983,Homo sapiens,CHEMBL203,CHEMBL4840351
COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2cccc(NC(=O)CCl)c2)n1,6.02,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate incubated for 1 hr by TR-FRET assay,IC50,946.0,nM,=,CHEMBL4830966,B,CHEMBL4865792,Homo sapiens,CHEMBL203,CHEMBL4828755
c1ccc(COc2cccc(-c3nc4sccn4c3-c3ccncn3)c2)cc1,6.42,Inhibition of EGFR- T790M mutant (unknown origin) incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method,IC50,380.0,nM,=,CHEMBL4832302,B,CHEMBL4866102,Homo sapiens,CHEMBL203,CHEMBL4831500
COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(NCc3ccc(S(=O)(=O)F)cc3)cc2)n1,8.82,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate preincubated with enzyme for 3 hrs followed by substrate and ATP addition by TR-FRET assay,IC50,1.5,nM,=,CHEMBL4830967,B,CHEMBL4866162,Homo sapiens,CHEMBL203,CHEMBL4828755
O=C1N=C(NN2Cc3ccccc3N=C2c2ccccc2)S/C1=C/c1ccccc1,7.18,Inhibition of EGFR (unknown origin),IC50,65.63,nM,=,CHEMBL4821238,B,CHEMBL4866476,Homo sapiens,CHEMBL203,CHEMBL4819060
C#CC(=O)N1CC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccc(OC)cc5)cc4)[nH]c23)C1,7.05,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,88.3,nM,=,CHEMBL4843876,B,CHEMBL4867893,Homo sapiens,CHEMBL203,CHEMBL4842353
COCCOc1cc2ncnc(Sc3nc[nH]n3)c2cc1OCCOC,5.28,Inhibition of EGFR (unknown origin),IC50,5210.0,nM,=,CHEMBL4832760,B,CHEMBL4868123,Homo sapiens,CHEMBL203,CHEMBL4831513
C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCCN/C(=N\C#N)Nc4ccncc4)cc23)c1,9.34,Inhibition of N-terminal GST-tagged human recombinant EGFR L858R mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,IC50,0.46,nM,=,CHEMBL4819613,B,CHEMBL4868614,Homo sapiens,CHEMBL203,CHEMBL4818995
COc1cccc(-c2cc(-c3c(O)c4ccccc4oc3=O)nc(N)c2C#N)c1,7.48,Inhibition of EGFR (unknown origin),IC50,33.0,nM,=,CHEMBL4810017,B,CHEMBL4868909,Homo sapiens,CHEMBL203,CHEMBL4808203
COc1ccc(C(Nc2ccc([N+](=O)[O-])cc2)n2c(=O)ccc3cc(O)ccc32)cc1,5.87,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,IC50,1350.0,nM,=,CHEMBL4836401,B,CHEMBL4868965,Homo sapiens,CHEMBL203,CHEMBL4834452
CN1CCN(CCOc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NO)n3)cc2)CC1,8.17,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,6.82,nM,=,CHEMBL4832125,B,CHEMBL4869024,Homo sapiens,CHEMBL203,CHEMBL4831496
C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5F)cc4)[nH]c23)CC1,7.79,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,16.3,nM,=,CHEMBL4843876,B,CHEMBL4869409,Homo sapiens,CHEMBL203,CHEMBL4842353
CC(C)Oc1cc(F)ccc1Nc1ncnc2ccc(-c3ccc(C(=O)N4CCNCC4)cc3)nc12,5.71,"Inhibition of recombinant human EGFR (696 to end residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis",IC50,1970.0,nM,=,CHEMBL4828267,B,CHEMBL4869634,Homo sapiens,CHEMBL203,CHEMBL4825757
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CN3CCC(C(=O)NO)CC3)cc2)ncc1Cl,6.93,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,117.5,nM,=,CHEMBL4832125,B,CHEMBL4870265,Homo sapiens,CHEMBL203,CHEMBL4831496
O=C(NO)c1ccccc1Nc1nc(Nc2ccc(OCCCN3CCOCC3)cc2)ncc1Cl,7.19,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,64.79,nM,=,CHEMBL4832125,B,CHEMBL4870560,Homo sapiens,CHEMBL203,CHEMBL4831496
COc1cc(NC(=O)CCCCCCCCCCC(=O)NO)ccc1Nc1nccc(-c2cn(C)c3ccccc23)n1,5.24,Inhibition of EGFR (unknown origin) incubated for 40 mins by kinase-glo plus luminescence assay,IC50,5700.0,nM,=,CHEMBL4819292,B,CHEMBL4870955,Homo sapiens,CHEMBL203,CHEMBL4818986
C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)CC1,7.51,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,30.8,nM,=,CHEMBL4843876,B,CHEMBL4871192,Homo sapiens,CHEMBL203,CHEMBL4842353
Cc1nc2c(Br)cc(Br)cc2c(=O)n1N,7.14,Inhibition of autophosphorylation of EGFR (unknown origin) by Cell free assay,IC50,72.0,nM,=,CHEMBL4824512,B,CHEMBL4871569,Homo sapiens,CHEMBL203,CHEMBL4823273
C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1ccc2c(n1)C(O)(CC)CC2,7.22,Inhibition of EGFR d747-749/A750P mutant (unknown origin),IC50,60.0,nM,=,CHEMBL4844330,B,CHEMBL4871593,Homo sapiens,CHEMBL203,CHEMBL4842364
CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCC(C(=O)NO)CC3)cc2)ncc1Cl,7.30,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,49.94,nM,=,CHEMBL4832125,B,CHEMBL4871985,Homo sapiens,CHEMBL203,CHEMBL4831496
COc1ccc(C(Nc2ccccc2)n2c(=O)ccc3cc(O)ccc32)cc1,4.85,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,IC50,14260.0,nM,=,CHEMBL4836401,B,CHEMBL4872030,Homo sapiens,CHEMBL203,CHEMBL4834452
COc1cc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1OCCCCC(=O)Nc1ccc(S(N)(=O)=O)cc1,7.78,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,16.5,nM,=,CHEMBL4815790,B,CHEMBL4873098,Homo sapiens,CHEMBL203,CHEMBL4813962
Oc1ccc(/C=N/Nc2nc3ccccc3c3nncn23)cc1,6.16,Inhibition of EGFR (unknown origin),IC50,690.0,nM,=,CHEMBL4836513,B,CHEMBL4873202,Homo sapiens,CHEMBL203,CHEMBL4834460
COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2cccc(NCCS(=O)(=O)F)c2)n1,6.34,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate incubated for 1 hr by TR-FRET assay,IC50,458.0,nM,=,CHEMBL4830966,B,CHEMBL4873392,Homo sapiens,CHEMBL203,CHEMBL4828755
C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCN/C(=N\C#N)Nc4cccnc4)cc23)c1,9.49,Inhibition of N-terminal GST-tagged human recombinant EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,IC50,0.32,nM,=,CHEMBL4819610,B,CHEMBL4873506,Homo sapiens,CHEMBL203,CHEMBL4818995
COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2cccc(NC(=O)c3cccc(S(=O)(=O)F)c3)c2)n1,6.32,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate incubated for 1 hr by TR-FRET assay,IC50,476.0,nM,=,CHEMBL4830966,B,CHEMBL4873600,Homo sapiens,CHEMBL203,CHEMBL4828755
Oc1cc(Nc2ccnc3cc(-c4ccccc4)ccc23)ccc1Cl,7.00,Inhibition of EGFR (unknown origin),IC50,100.0,nM,=,CHEMBL4829094,B,CHEMBL4873767,Homo sapiens,CHEMBL203,CHEMBL4828713
O=C(O)c1ccccc1Nc1nc(Nc2ccc(OCC(=O)N3CCOCC3)cc2)ncc1Cl,6.70,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,198.5,nM,=,CHEMBL4832125,B,CHEMBL4873830,Homo sapiens,CHEMBL203,CHEMBL4831496
C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5OC)cc4)[nH]c23)C1,6.98,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,104.0,nM,=,CHEMBL4843876,B,CHEMBL4873984,Homo sapiens,CHEMBL203,CHEMBL4842353
C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(OC)ccn3)cc2)c(C(N)=O)n1N,6.35,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,450.0,nM,=,CHEMBL4841672,B,CHEMBL4874550,Homo sapiens,CHEMBL203,CHEMBL4840351
C#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)C1,7.53,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,29.7,nM,=,CHEMBL4843876,B,CHEMBL4875332,Homo sapiens,CHEMBL203,CHEMBL4842353
O=C(NO)c1ccccc1Nc1nc(Nc2ccc(OCCN3CCOCC3)cc2)ncc1Cl,8.96,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,IC50,1.097,nM,=,CHEMBL4832125,B,CHEMBL4875985,Homo sapiens,CHEMBL203,CHEMBL4831496
c1ccc(-c2ccc3c(Nc4ccc5scnc5c4)ccnc3c2)cc1,5.60,Inhibition of EGFR (unknown origin),IC50,2500.0,nM,=,CHEMBL4829094,B,CHEMBL4876135,Homo sapiens,CHEMBL203,CHEMBL4828713
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCC(=O)Nc1ccc(S(N)(=O)=O)cc1,7.74,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,IC50,18.3,nM,=,CHEMBL4815790,B,CHEMBL4877054,Homo sapiens,CHEMBL203,CHEMBL4813962
O=C1N=C(NN2Cc3ccccc3N=C2c2ccccc2)S/C1=C/c1ccc(O)cc1O,6.75,Inhibition of EGFR (unknown origin),IC50,178.1,nM,=,CHEMBL4821238,B,CHEMBL4877452,Homo sapiens,CHEMBL203,CHEMBL4819060
CCn1c(-c2ccccc2)c(-c2ncnc3cc(OC)c(OCCCN4CCOCC4)cc23)c2ccccc21,8.89,Inhibition of EGFR L858R mutant (unknown origin),IC50,1.3,nM,=,CHEMBL4844824,B,CHEMBL4877510,Homo sapiens,CHEMBL203,CHEMBL4842379
CC#CC(=O)N1CCC(c2cnn3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)[nH]c23)CC1,4.85,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,14010.0,nM,=,CHEMBL4843876,B,CHEMBL4878090,Homo sapiens,CHEMBL203,CHEMBL4842353
C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(Br)ccn3)cc2)c(C(N)=O)n1N,6.24,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,578.0,nM,=,CHEMBL4841672,B,CHEMBL4878421,Homo sapiens,CHEMBL203,CHEMBL4840351
C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(-c4ccc(Cl)cc4)ccn3)cc2)c(C(N)=O)n1N,7.90,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,IC50,12.6,nM,=,CHEMBL4841672,B,CHEMBL4878626,Homo sapiens,CHEMBL203,CHEMBL4840351
O=C(Nc1cncnc1Oc1cccc(C(F)(F)F)c1)c1ccc(F)cc1,5.53,Inhibition of human EGFR using poly(Glu:Tyr)(4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,IC50,2980.0,nM,=,CHEMBL4844361,B,CHEMBL4878790,Homo sapiens,CHEMBL203,CHEMBL4842366
C=CC(=O)Nc1cccc(-n2c(=O)c(-c3ccccc3F)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1,8.96,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,IC50,1.1,nM,=,CHEMBL5045467,B,CHEMBL5069609,Homo sapiens,CHEMBL203,CHEMBL5042540
C=CC(=O)Nc1cccc(-n2c(=O)c(-c3ccccc3)nc3cnc(Nc4ccc(OC)cc4)nc32)c1,7.74,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,IC50,18.1,nM,=,CHEMBL5045467,B,CHEMBL5069689,Homo sapiens,CHEMBL203,CHEMBL5042540
CC(C)C[C@H]1CN(C(=O)Cc2ccc3c(c2)OCO3)CC(=O)N[C@@H](Cc2ccccc2)CN(C(=O)CCC2CCCCC2)CC(=O)N[C@@H](Cc2ccccc2)CN(C(=O)Cc2ccc3c(c2)OCO3)CC(=O)N[C@@H](CC(C)C)C(=O)N(CC(N)=O)C(=O)CCSCc2ccc(cc2)C(=O)N1,6.26,Binding affinity to EGFR (unknown origin) assessed as dissociation constant by fluorescence polarization assay,Kd,550.0,nM,=,CHEMBL5031334,B,CHEMBL5069698,Homo sapiens,CHEMBL203,CHEMBL5030524
C#CCN(C)CCN(C)c1cc(OC)c(Nc2nccc(Nc3ccn(C)n3)n2)cc1NC(=O)C=C,8.07,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,8.58,nM,=,CHEMBL5046854,B,CHEMBL5070579,Homo sapiens,CHEMBL203,CHEMBL5046228
C=CC(=O)Nc1cc(Nc2nccc(Nc3cnn(C)c3)n2)c(OC)cc1N(C)CCN(C)C,7.67,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,21.43,nM,=,CHEMBL5046854,B,CHEMBL5071181,Homo sapiens,CHEMBL203,CHEMBL5046228
C#CCN(C)CCN(C)c1cc(OC)c(Nc2nccc(Nc3cn(C)c4ccccc34)n2)cc1NC(=O)C=C,8.40,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,4.014,nM,=,CHEMBL5046854,B,CHEMBL5072451,Homo sapiens,CHEMBL203,CHEMBL5046228
C/C=C/C(=O)Nc1cc(Nc2ncc(Cl)c(N3CCc4sccc4C3)n2)c(OC)cc1N(C)CCN(C)C,6.45,Inhibition of wild type EGFR (unknown origin) measured by ELISA,IC50,352.8,nM,=,CHEMBL5037732,B,CHEMBL5075204,Homo sapiens,CHEMBL203,CHEMBL5036341
C=CC(=O)Nc1cccc(-n2c(=O)c(-c3ccccc3Cl)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1,7.96,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,IC50,11.0,nM,=,CHEMBL5045467,B,CHEMBL5075594,Homo sapiens,CHEMBL203,CHEMBL5042540
C=CC(=O)N1CCC2(CC1)CNC(=O)c1cc(-c3nc(Nc4ccccc4OC)ncc3Cl)[nH]c12,9.10,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,IC50,0.8,nM,=,CHEMBL5029924,B,CHEMBL5076067,Homo sapiens,CHEMBL203,CHEMBL5029169
C=CC(=O)Nc1cccc(-n2c(=O)c(-c3ccccc3)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1,8.29,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,IC50,5.1,nM,=,CHEMBL5045467,B,CHEMBL5076283,Homo sapiens,CHEMBL203,CHEMBL5042540
C=CC(=O)Nc1cc(Nc2nccc(Nc3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C(=O)C#CC,7.24,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,57.97,nM,=,CHEMBL5046854,B,CHEMBL5076881,Homo sapiens,CHEMBL203,CHEMBL5046228
CN1CCN(C2CCN(c3ccc(Nc4ncc(Cl)c(Nc5ccccc5P(C)(C)=O)n4)cc3Cl)CC2)CC1,9.22,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,IC50,0.6,nM,=,CHEMBL5038289,B,CHEMBL5076986,Homo sapiens,CHEMBL203,CHEMBL5036369
COc1cc(N2CCC(N3CCN(C)CC3)CC2)c(-c2cn[nH]c2)cc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,8.89,Inhibition of Wild type EGFR (unknown origin),IC50,1.3,nM,=,CHEMBL5031761,B,CHEMBL5077378,Homo sapiens,CHEMBL203,CHEMBL5030539
C=CC(=O)Nc1cccc(-n2c(=O)c(CC)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1,6.55,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,IC50,279.2,nM,=,CHEMBL5045467,B,CHEMBL5077665,Homo sapiens,CHEMBL203,CHEMBL5042540
C=CC(=O)N1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(Nc4ccccc4OC)n3)[nH]c12,9.40,Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,IC50,0.4,nM,=,CHEMBL5029925,B,CHEMBL5077776,Homo sapiens,CHEMBL203,CHEMBL5029169
CN1CCN(C2CCN(c3ccc(Nc4ncc(Cl)c(Nc5ccccc5P(C)(C)=O)n4)cc3OC(F)(F)F)CC2)CC1,7.89,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,IC50,12.9,nM,=,CHEMBL5038289,B,CHEMBL5077866,Homo sapiens,CHEMBL203,CHEMBL5036369
C=CC(=O)Nc1cccc(-n2c(=O)c(C(C)C)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1,6.42,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,IC50,379.0,nM,=,CHEMBL5045467,B,CHEMBL5077901,Homo sapiens,CHEMBL203,CHEMBL5042540
CCP(=O)(CC)c1ccccc1Nc1nc(Nc2cc(-c3cnn(C)c3)c(N3CCOCC3)cc2OC)ncc1Cl,8.62,Inhibition of Wild type EGFR (unknown origin),IC50,2.4,nM,=,CHEMBL5031761,B,CHEMBL5078413,Homo sapiens,CHEMBL203,CHEMBL5030539
CN1CCN(C2CCN(c3ccc(Nc4ncc(Cl)c(Nc5ccccc5P(C)(C)=O)n4)cc3C(F)F)CC2)CC1,7.64,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,IC50,23.1,nM,=,CHEMBL5038289,B,CHEMBL5078816,Homo sapiens,CHEMBL203,CHEMBL5036369
C=C(Cl)C(=O)Nc1cc(Nc2ncc(Cl)c(N3CCc4sccc4C3)n2)c(OC)cc1N(C)CCN(C)C,7.02,Inhibition of wild type EGFR (unknown origin) measured by ELISA,IC50,96.3,nM,=,CHEMBL5037732,B,CHEMBL5079081,Homo sapiens,CHEMBL203,CHEMBL5036341
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCC(=O)NC(Cc1ccc(OCc2cn(CCOCCNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)nn2)cc1)C(=O)N1CCN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)CC1,5.56,Binding affinity to recombinant human His/GST tagged EFGR (668 to 1220 residues) expressed in baculovirus infected cells assessed as dissociation constant incubated for 30 mins by microscale thermophoresis analysis,Kd,2740.0,nM,=,CHEMBL5039985,B,CHEMBL5079358,Homo sapiens,CHEMBL203,CHEMBL5038593
C=CC(=O)N1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(Nc4ccccc4OC(C)C)n3)[nH]c12,8.92,Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,IC50,1.2,nM,=,CHEMBL5029925,B,CHEMBL5079430,Homo sapiens,CHEMBL203,CHEMBL5029169
CC(OC(=O)CCCC(=O)N(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1cc2c(o1)C(=O)c1ccccc1C2=O,8.13,Inhibition of exogenous EGFR (unknown origin),IC50,7.36,nM,=,CHEMBL5031645,B,CHEMBL5079998,Homo sapiens,CHEMBL203,CHEMBL5030535
C=CC(=O)Nc1cccc(-n2c(=O)c(C3CCCCC3)nc3cnc(Nc4cccc(OCC(C)=O)c4)nc32)c1,7.47,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,IC50,33.8,nM,=,CHEMBL5045467,B,CHEMBL5080260,Homo sapiens,CHEMBL203,CHEMBL5042540
C=CC(=O)Nc1cc(Nc2nccc(Nc3cn(C)nc3C)n2)c(OC)cc1N(C)CCN(C)C,8.25,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,5.654,nM,=,CHEMBL5046854,B,CHEMBL5080676,Homo sapiens,CHEMBL203,CHEMBL5046228
CN1CCN(C2CCN(c3cc(Cl)c(Nc4ncc(Cl)c(Nc5ccccc5P(C)(C)=O)n4)cc3Cl)CC2)CC1,9.15,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,IC50,0.7,nM,=,CHEMBL5038289,B,CHEMBL5081174,Homo sapiens,CHEMBL203,CHEMBL5036369
COc1cc(N2CCOCC2)c(-c2cn[nH]c2)cc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,8.25,Inhibition of Wild type EGFR (unknown origin),IC50,5.6,nM,=,CHEMBL5031761,B,CHEMBL5081299,Homo sapiens,CHEMBL203,CHEMBL5030539
C=CC(=O)Nc1cccc(-n2c(=O)c(C3CCCCC3)nc3cnc(Nc4cccc(OCC(N)=O)c4)nc32)c1,7.08,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,IC50,83.2,nM,=,CHEMBL5045467,B,CHEMBL5081433,Homo sapiens,CHEMBL203,CHEMBL5042540
CN1CCN(C2CCN(c3c(Cl)cc(Nc4ncc(Cl)c(Nc5ccccc5P(C)(C)=O)n4)cc3Cl)CC2)CC1,7.47,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,IC50,33.5,nM,=,CHEMBL5038289,B,CHEMBL5081817,Homo sapiens,CHEMBL203,CHEMBL5036369
C=CC(=O)Nc1cc(Nc2nccc(Nc3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)Cc1ccc(Br)cc1,8.09,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,8.131,nM,=,CHEMBL5046854,B,CHEMBL5082074,Homo sapiens,CHEMBL203,CHEMBL5046228
COc1cc(CC(=O)N2CC(=O)N[C@@H](Cc3ccccc3)C(=O)N(CC(N)=O)C(=O)CCSCc3ccc(cc3)C(=O)N[C@@H](CCCCN)CN(C(=O)CCC3CCCCC3)CC(=O)N[C@@H](Cc3ccccc3)CN(C(=O)CCc3ccccc3)CC(=O)N[C@@H](Cc3ccccc3)C2)cc(OC)c1,6.37,Binding affinity to EGFR (unknown origin) assessed as dissociation constant by fluorescence polarization assay,Kd,430.0,nM,=,CHEMBL5031334,B,CHEMBL5082149,Homo sapiens,CHEMBL203,CHEMBL5030524
CCC(=O)Nc1cc(Nc2ncc(Cl)c(N3CCc4sccc4C3)n2)c(OC)cc1N(C)CCN(C)C,6.77,Inhibition of wild type EGFR (unknown origin) measured by ELISA,IC50,170.0,nM,=,CHEMBL5037732,B,CHEMBL5082394,Homo sapiens,CHEMBL203,CHEMBL5036341
CC#CC(=O)Nc1cccc(-c2nccc(-c3cc4c([nH]3)C3(CCNCC3)CNC4=O)n2)c1,6.30,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,IC50,499.0,nM,=,CHEMBL5029924,B,CHEMBL5082422,Homo sapiens,CHEMBL203,CHEMBL5029169
C=CC(=O)Nc1cc(Nc2nccc(Nc3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)CC(=O)OC,8.24,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,5.751,nM,=,CHEMBL5046854,B,CHEMBL5083034,Homo sapiens,CHEMBL203,CHEMBL5046228
C=CC(=O)Nc1cccc(-n2c(=O)c(Oc3ccccc3)nc3cnc(Nc4ccc(OC)cc4)nc32)c1,8.04,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,IC50,9.1,nM,=,CHEMBL5045467,B,CHEMBL5083645,Homo sapiens,CHEMBL203,CHEMBL5042540
C=CC(=O)N1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(-c4cccc(OC)c4)n3)[nH]c12,8.02,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,IC50,9.6,nM,=,CHEMBL5029924,B,CHEMBL5083976,Homo sapiens,CHEMBL203,CHEMBL5029169
Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n2)ccc1N1CCC(N2CCN(C)CC2)CC1,9.15,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,IC50,0.7,nM,=,CHEMBL5038289,B,CHEMBL5084760,Homo sapiens,CHEMBL203,CHEMBL5036369
C=CC(=O)Nc1cc(Nc2nccc(Nc3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C(=O)OC,7.91,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,12.34,nM,=,CHEMBL5046854,B,CHEMBL5084983,Homo sapiens,CHEMBL203,CHEMBL5046228
C=CC(=O)N1CCC2(CC1)CNC(=O)c1cc(-c3nc(Nc4ccccc4OC)ncc3C)[nH]c12,8.92,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,IC50,1.2,nM,=,CHEMBL5029924,B,CHEMBL5085118,Homo sapiens,CHEMBL203,CHEMBL5029169
C=CC(=O)N1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(-c4ccc5c(c4)OCO5)n3)[nH]c12,8.19,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,IC50,6.5,nM,=,CHEMBL5029924,B,CHEMBL5085136,Homo sapiens,CHEMBL203,CHEMBL5029169
C=CC(=O)Nc1cc(Nc2ncc(Cl)c(N3CCc4sccc4C3)n2)c(OC)cc1N(C)CCN(C)C,8.19,Inhibition of wild type EGFR (unknown origin) measured by ELISA,IC50,6.4,nM,=,CHEMBL5037732,B,CHEMBL5085143,Homo sapiens,CHEMBL203,CHEMBL5036341
C=CC(=O)Nc1cccc(-n2c(=O)c(C3CCCCC3)nc3cnc(Nc4cccc(OCCOC)c4)nc32)c1,6.93,Inhibition of EGFR phosphorylation in human A549 cells incubated for 4 hrs by Western blot assay,IC50,117.6,nM,=,CHEMBL5045472,B,CHEMBL5085807,Homo sapiens,CHEMBL203,CHEMBL5042540
C=CC(=O)Nc1cc(Nc2nccc(Nc3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)CC(=C)C,8.24,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,5.751,nM,=,CHEMBL5046854,B,CHEMBL5085816,Homo sapiens,CHEMBL203,CHEMBL5046228
C=CC(=O)Nc1cccc(-n2c(=O)c(C3CC3)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1,6.33,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,IC50,462.9,nM,=,CHEMBL5045467,B,CHEMBL5086054,Homo sapiens,CHEMBL203,CHEMBL5042540
COc1cc(N2CCC(N(C)C)CC2)c(-c2cnn(C)c2)cc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,8.77,Inhibition of Wild type EGFR (unknown origin),IC50,1.7,nM,=,CHEMBL5031761,B,CHEMBL5086066,Homo sapiens,CHEMBL203,CHEMBL5030539
COc1cc(Nc2ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n2)ccc1N1CCC(N2CCN(C)CC2)CC1,8.62,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,IC50,2.4,nM,=,CHEMBL5038289,B,CHEMBL5086894,Homo sapiens,CHEMBL203,CHEMBL5036369
C=CC(=O)Nc1cc(Nc2nccc(Nc3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C(=O)c1ccc(Br)cc1,7.90,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,12.54,nM,=,CHEMBL5046854,B,CHEMBL5087139,Homo sapiens,CHEMBL203,CHEMBL5046228
C=CC(=O)Nc1cccc(-n2c(=O)c(Cc3ccccc3)nc3cnc(Nc4ccc(OC)cc4)nc32)c1,6.88,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,IC50,130.3,nM,=,CHEMBL5045467,B,CHEMBL5087214,Homo sapiens,CHEMBL203,CHEMBL5042540
COc1cc(N2CCOCC2)c(-c2cnn(C)c2)cc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,8.36,Inhibition of Wild type EGFR (unknown origin),IC50,4.4,nM,=,CHEMBL5031761,B,CHEMBL5087264,Homo sapiens,CHEMBL203,CHEMBL5030539
COc1cc(N2CCN(C)CC2)c(-c2cnn(C)c2)cc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,8.48,Inhibition of Wild type EGFR (unknown origin),IC50,3.3,nM,=,CHEMBL5031761,B,CHEMBL5087610,Homo sapiens,CHEMBL203,CHEMBL5030539
C=CC(=O)Nc1cccc(-n2c(=O)c(C)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1,6.47,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,IC50,335.5,nM,=,CHEMBL5045467,B,CHEMBL5087785,Homo sapiens,CHEMBL203,CHEMBL5042540
C=CC(=O)Nc1cccc(-n2c(=O)c(C3CCCC3)nc3cnc(Nc4ccc(OCCOC)cc4)nc32)c1,6.86,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,IC50,136.9,nM,=,CHEMBL5045467,B,CHEMBL5087793,Homo sapiens,CHEMBL203,CHEMBL5042540
COc1cc(N2CCC(N3CCN(C)CC3)CC2)c(-c2cnn(C)c2)cc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,9.04,Inhibition of Wild type EGFR (unknown origin),IC50,0.92,nM,=,CHEMBL5031761,B,CHEMBL5087815,Homo sapiens,CHEMBL203,CHEMBL5030539
Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n2)cnc1N1CCC(N2CCN(C)CC2)CC1,8.68,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,IC50,2.1,nM,=,CHEMBL5038289,B,CHEMBL5087931,Homo sapiens,CHEMBL203,CHEMBL5036369
COc1cc2nc(C)nc(N[C@H](C)c3ccccc3)c2cc1OC,5.55,Inhibition of EGFR (unknown origin),IC50,2800.0,nM,=,CHEMBL5036476,B,CHEMBL5087955,Homo sapiens,CHEMBL203,CHEMBL5036304
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccn(C)n3)n2)c(OC)cc1N(C)CCN(C)CC(=C)C,6.40,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,397.0,nM,=,CHEMBL5046854,B,CHEMBL5087994,Homo sapiens,CHEMBL203,CHEMBL5046228
COc1ccccc1Nc1nccc(-c2cc3c([nH]2)C2(CCN(C(=O)C#CN(C)C)CC2)CNC3=O)n1,8.55,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,IC50,2.8,nM,=,CHEMBL5029924,B,CHEMBL5088102,Homo sapiens,CHEMBL203,CHEMBL5029169
CN1CCN(C2CCN(c3ccc(Nc4ncc(Cl)c(Nc5ccccc5P(C)(C)=O)n4)cc3C(F)(F)F)CC2)CC1,8.46,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,IC50,3.5,nM,=,CHEMBL5038289,B,CHEMBL5088423,Homo sapiens,CHEMBL203,CHEMBL5036369
C=CC(=O)Nc1cccc(-n2c(=O)c(C3CCCCC3)nc3cnc(Nc4cccc(N5CCN(C)CC5)c4)nc32)c1,6.47,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,IC50,341.6,nM,=,CHEMBL5045467,B,CHEMBL5088574,Homo sapiens,CHEMBL203,CHEMBL5042540
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccn(C)n3)n2)c(OC)cc1N(C)CCN(C)C,8.21,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,6.198,nM,=,CHEMBL5046854,B,CHEMBL5088907,Homo sapiens,CHEMBL203,CHEMBL5046228
C=CC(=O)N1CCC2(CC1)CNC(=O)c1cc(-c3ccnc(Nc4ccccc4OC)c3)[nH]c12,7.43,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,IC50,37.0,nM,=,CHEMBL5029924,B,CHEMBL5089073,Homo sapiens,CHEMBL203,CHEMBL5029169
C=CC(=O)Nc1cc(Nc2nccc(Nc3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)Cc1ccccc1,8.36,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,4.363,nM,=,CHEMBL5046854,B,CHEMBL5089161,Homo sapiens,CHEMBL203,CHEMBL5046228
C=CC(=O)Nc1cc(Nc2nccc(Nc3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C(=O)C=C,7.44,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,36.61,nM,=,CHEMBL5046854,B,CHEMBL5089336,Homo sapiens,CHEMBL203,CHEMBL5046228
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccn(C)n3)n2)c(OC)cc1N(C)CCN(C)CC(=O)OC,7.37,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,42.38,nM,=,CHEMBL5046854,B,CHEMBL5089912,Homo sapiens,CHEMBL203,CHEMBL5046228
C=CCCN(C)CCN(C)c1cc(OC)c(Nc2nccc(Nc3ccn(C)n3)n2)cc1NC(=O)C=C,5.12,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,7513.0,nM,=,CHEMBL5046855,B,CHEMBL5090133,Homo sapiens,CHEMBL203,CHEMBL5046228
CN1CCN(C2CCN(c3ccc(Nc4ncc(Br)c(Nc5ccccc5P(C)(C)=O)n4)cc3Cl)CC2)CC1,8.48,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,IC50,3.3,nM,=,CHEMBL5038289,B,CHEMBL5091683,Homo sapiens,CHEMBL203,CHEMBL5036369
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCCCC(=O)NC(COCc1cn(CCCC(=O)N[C@H](C(=O)N2C[C@H](O)C[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)C(C)(C)C)nn1)C(=O)NCCCCCC(=O)N1CCN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)CC1,5.26,Binding affinity to recombinant human His/GST tagged EFGR (668 to 1220 residues) expressed in baculovirus infected cells assessed as dissociation constant incubated for 30 mins by microscale thermophoresis analysis,Kd,5470.0,nM,=,CHEMBL5039985,B,CHEMBL5091890,Homo sapiens,CHEMBL203,CHEMBL5038593
CN(C)C(=O)c1ccc(Nc2ncc(C(F)(F)F)c(N[C@H]3CC[C@@H](N)CC3)n2)cc1,5.15,Inhibition of human recombinant EGFR incubated for 1 hrs by HTRF KinEASE TK assay,IC50,7137.0,nM,=,CHEMBL5045723,B,CHEMBL5092606,Homo sapiens,CHEMBL203,CHEMBL5042545
C=CCCN(C)CCN(C)c1cc(OC)c(Nc2nccc(Nc3cn(C)c4ccccc34)n2)cc1NC(=O)C=C,8.70,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,2.003,nM,=,CHEMBL5046854,B,CHEMBL5093402,Homo sapiens,CHEMBL203,CHEMBL5046228
C=CCC(=O)N(C)CCN(C)c1cc(OC)c(Nc2nccc(Nc3cn(C)c4ccccc34)n2)cc1NC(=O)C=C,7.40,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,39.62,nM,=,CHEMBL5046854,B,CHEMBL5093625,Homo sapiens,CHEMBL203,CHEMBL5046228
C=CC(=O)Nc1cc(Nc2nccc(Nc3ccn(C)n3)n2)c(OC)cc1N(C)CCN(C)C(=O)OC,6.54,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,287.7,nM,=,CHEMBL5046853,B,CHEMBL5093794,Homo sapiens,CHEMBL203,CHEMBL5046228
C=CC(=O)Nc1cc(Nc2nccc(Nc3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C(=O)/C=C/C,7.56,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,27.34,nM,=,CHEMBL5046854,B,CHEMBL5094237,Homo sapiens,CHEMBL203,CHEMBL5046228
CS(=O)(=O)CCN(Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)C(=O)CCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,7.98,Inhibition of exogenous EGFR (unknown origin),IC50,10.52,nM,=,CHEMBL5031645,B,CHEMBL5094282,Homo sapiens,CHEMBL203,CHEMBL5030535
C#CCN1CCN(c2ccc(Nc3ncc4c(C)cc(=O)n(-c5cccc(NC(=O)C=C)c5)c4n3)c(OC)c2)CC1,8.10,"Inhibition of EGFR T790M mutant (unknown origin) using Poly (Glu, Tyr)4:1 as substrate by spectrophotometry",IC50,8.04,nM,=,CHEMBL5036279,B,CHEMBL5094288,Homo sapiens,CHEMBL203,CHEMBL5034051
C=CC(=O)Nc1cc(Nc2nccc(Nc3cnn(CC)c3)n2)c(OC)cc1N(C)CCN(C)C,8.10,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,IC50,8.023,nM,=,CHEMBL5046854,B,CHEMBL5094406,Homo sapiens,CHEMBL203,CHEMBL5046228
COc1cc(N2CCC(N(C)C)CC2)c(-c2cn[nH]c2)cc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,9.05,Inhibition of Wild type EGFR (unknown origin),IC50,0.9,nM,=,CHEMBL5031761,B,CHEMBL5094480,Homo sapiens,CHEMBL203,CHEMBL5030539
COc1cc(N2CCC3(CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1,7.46,Inhibition of wild type EGFR (unknown origin),IC50,35.0,nM,=,CHEMBL5147517,B,CHEMBL5095068,Homo sapiens,CHEMBL203,CHEMBL5143665
CO[C@@H]1CCN(c2nccc(Nc3cc4c(C(C)C)ccc(N5C[C@H](CS(C)(=O)=O)[C@H]5C)c4cn3)n2)C[C@@H]1F,9.40,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,0.4,nM,=,CHEMBL5141214,B,CHEMBL5095169,Homo sapiens,CHEMBL203,CHEMBL5137066
C=CCn1ccc2cc(Nc3ncnc4ccc(N)cc34)ccc21,6.45,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,351.9,nM,=,CHEMBL5161051,B,CHEMBL5169328,Homo sapiens,CHEMBL203,CHEMBL5154786
COc1cc2ncnc3c2cc1OCCOCCOCCOc1cc(Cl)ccc1N3,7.79,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,16.2,nM,=,CHEMBL5153035,B,CHEMBL5169346,Homo sapiens,CHEMBL203,CHEMBL5150044
CC(C)c1cnc(N2CC(C#N)C2)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,7.77,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,IC50,17.0,nM,=,CHEMBL5141217,B,CHEMBL5169349,Homo sapiens,CHEMBL203,CHEMBL5137066
COc1cc(N2CCC(N3CCN(C)CC3)CC2)c(C)cc1Nc1ncc(Br)c(Nc2ccc3nccnc3c2P(C)(C)=O)n1,9.80,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,0.16,nM,=,CHEMBL5143769,B,CHEMBL5169450,Homo sapiens,CHEMBL203,CHEMBL5143505
C=CC(=O)Nc1ccc2ncnc(Nc3ccc4[nH]ccc4c3)c2c1,7.86,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,13.7,nM,=,CHEMBL5161051,B,CHEMBL5169547,Homo sapiens,CHEMBL203,CHEMBL5154786
COc1ccc(CCOc2ccc(C(=O)/C=C/c3ccc(O)c(O)c3)cc2OC)cc1OC,4.95,Inhibition of EGFR (unknown origin) by ADP-Glo kinase assay,IC50,11120.0,nM,=,CHEMBL5127091,B,CHEMBL5169900,Homo sapiens,CHEMBL203,CHEMBL5126509
CCS(=O)(=O)n1cc2c3ccc(cc31)OCCCCCCOc1cc(c(C3CCCC3)cc1N1CCOCC1)Nc1ncc(Cl)c-2n1,6.78,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,164.9,nM,=,CHEMBL5165817,B,CHEMBL5169943,Homo sapiens,CHEMBL203,CHEMBL5154883
Nc1ccc(C#Cc2cc(F)c3c(c2)C(=O)N(C(C(=O)Nc2nccs2)c2ncn4c2CCC4)C3)cn1,6.94,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,116.0,nM,=,CHEMBL5120428,B,CHEMBL5170278,Homo sapiens,CHEMBL203,CHEMBL5113538
CC(C)c1cnc(N2CC(C(=O)N(C)C)C2)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,9.05,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,0.9,nM,=,CHEMBL5141214,B,CHEMBL5170376,Homo sapiens,CHEMBL203,CHEMBL5137066
Cc1c(-c2ccc(N3CCOCC3)cc2)cc(C(F)F)c2cn(C(C(=O)Nc3nccs3)c3ncn4c3CCC43CC3)nc12,8.00,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,10.0,nM,=,CHEMBL5120428,B,CHEMBL5170519,Homo sapiens,CHEMBL203,CHEMBL5113538
CCS(=O)(=O)n1cc2c3ccc(cc31)OCCCCCCOc1cc(c(Cl)cc1N1CCOCC1)Nc1ncc(Cl)c-2n1,7.24,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,57.8,nM,=,CHEMBL5165817,B,CHEMBL5170653,Homo sapiens,CHEMBL203,CHEMBL5154883
Cc1ccc(-c2c(CN3CCOCC3)nc3scc(C(=O)NN)n23)cc1,6.61,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,IC50,246.0,nM,=,CHEMBL5110647,B,CHEMBL5170804,Homo sapiens,CHEMBL203,CHEMBL5108025
CCOc1cc2ncnc(Nc3ccc(Oc4cc5nncn5cn4)c(C)c3)c2cc1NC(=O)/C(F)=C\[C@H]1CCCN1C,7.06,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,86.33,nM,=,CHEMBL5162303,B,CHEMBL5170965,Homo sapiens,CHEMBL203,CHEMBL5154811
O=C(Nc1nccs1)C(c1ncn2c1CCC2)N1Cc2ccc(C#Cc3cccnc3)cc2C1=O,6.34,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,460.0,nM,=,CHEMBL5120428,B,CHEMBL5171139,Homo sapiens,CHEMBL203,CHEMBL5113538
C=CC(=O)N1CCC(Oc2nc(Nc3cnn(C)c3)nc3ccsc23)CC1,6.87,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,135.0,nM,=,CHEMBL5099547,B,CHEMBL5171318,Homo sapiens,CHEMBL203,CHEMBL5096223
COc1cc(-c2nc3ccccc3s2)ccc1OCC(=O)NNC(=O)CN[C@@H](Cc1c[nH]c2ccccc12)C(=O)O,6.68,Inhibition of EGFR (unknown origin),IC50,209.0,nM,=,CHEMBL5133605,B,CHEMBL5171983,Homo sapiens,CHEMBL203,CHEMBL5131433
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3ccsc23)CC1,8.19,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,6.532,nM,=,CHEMBL5099547,B,CHEMBL5172236,Homo sapiens,CHEMBL203,CHEMBL5096223
O=C(CCCCl)Nc1ccc2ncnc(Nc3ccc4c(ccn4Cc4cccc(F)c4)c3)c2c1,8.22,Inhibition of recombinant human EGFR L858R/T790M double mutant using GGMEDIYFEFMGG as substrate in presence of ATP by radiometric assay,IC50,6.0,nM,=,CHEMBL5161054,B,CHEMBL5172245,Homo sapiens,CHEMBL203,CHEMBL5154786
CCc1cc(Nc2ncc(Cl)c(-c3cn(S(=O)(=O)CC)c4ccccc34)n2)c(OC)cc1N1CCC(N2CCN(C)CC2)CC1,8.20,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,IC50,6.3,nM,=,CHEMBL5165818,B,CHEMBL5172251,Homo sapiens,CHEMBL203,CHEMBL5154883
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(-c2c[nH]c3ccccc23)n1,7.81,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,IC50,15.6,nM,=,CHEMBL5165818,B,CHEMBL5172338,Homo sapiens,CHEMBL203,CHEMBL5154883
CN1CCN(c2ccc(-c3ccc4ncn(C(C(=O)Nc5nccs5)c5ccccc5)c(=O)c4c3)cc2)CC1,9.05,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,0.9,nM,=,CHEMBL5147203,B,CHEMBL5172573,Homo sapiens,CHEMBL203,CHEMBL5143652
CC(C)c1ncc(N2C[C@H](O)[C@H]2C)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,8.74,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,1.8,nM,=,CHEMBL5141214,B,CHEMBL5172587,Homo sapiens,CHEMBL203,CHEMBL5137066
O=C(Nc1nccs1)C(c1ncn2c1CCC2)N1Cc2c(F)cc(C#Cc3ccc(CN4CCCCC4)cc3)cc2C1=O,8.15,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,7.0,nM,=,CHEMBL5120428,B,CHEMBL5172668,Homo sapiens,CHEMBL203,CHEMBL5113538
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1,9.70,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),IC50,0.2,nM,=,CHEMBL5143771,B,CHEMBL5172794,Homo sapiens,CHEMBL203,CHEMBL5143505
CN1CCN(c2ccc(Nc3ncc(Br)c(Nc4ccc5cn[nH]c5c4)n3)cc2)CC1,7.37,Inhibition of N-terminal GST-tagged recombinant human EGFR (669 to 1210 residues) L858R/T790M double mutant expressed in baculovirus infected Sf21 cells incubated for 1 hr in presence of ATP by caliper mobility shift assay,IC50,43.1,nM,=,CHEMBL5127053,B,CHEMBL5173070,Homo sapiens,CHEMBL203,CHEMBL5126509
c1ccc(CNc2ncnc3c2[nH]c2ccccc23)cc1,6.34,Inhibition of EGFR in human A-431 cell membrane vesicles using phospholipase C-gamma-1 as substrate incubated for 10 mins by scintillation counter method,IC50,460.0,nM,=,CHEMBL5138014,B,CHEMBL5173075,Homo sapiens,CHEMBL203,CHEMBL5136983
O=C(Cc1csc2nc3ccccc3n12)Nc1cccc2ccccc12,7.05,Inhibition of EGFR (unknown origin) incubated for 40 mins by intrinsic ATPase activity luminescence assay,IC50,88.3,nM,=,CHEMBL5096403,B,CHEMBL5173408,Homo sapiens,CHEMBL203,CHEMBL5096145
COc1ccc(-c2c(CN3CCOCC3)nc3scc(C(=O)NN)n23)cc1,6.91,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,IC50,122.0,nM,=,CHEMBL5110647,B,CHEMBL5173449,Homo sapiens,CHEMBL203,CHEMBL5108025
CC(C)c1cnc(N2CC(CS(C)(=O)=O)C2)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,8.32,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,IC50,4.8,nM,=,CHEMBL5141217,B,CHEMBL5173517,Homo sapiens,CHEMBL203,CHEMBL5137066
COc1cc(N(C)CCN(C)C)c(NC(=O)c2ccnc(Cl)c2)cc1Nc1nccc(-c2cn(CCCO)c3ccccc23)n1,7.38,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,IC50,42.0,nM,=,CHEMBL5140665,B,CHEMBL5173534,Homo sapiens,CHEMBL203,CHEMBL5137051
COc1cc2ncnc3c2cc1OCCOCCOc1ccc(Cl)c(c1)N3,4.70,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,19880.0,nM,=,CHEMBL5153036,B,CHEMBL5173596,Homo sapiens,CHEMBL203,CHEMBL5150044
CN1CCC(c2ccc(-c3ccc4ccn(C(C(=O)Nc5nccs5)c5ccccc5)c(=O)c4c3)cc2)CC1,8.74,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,1.8,nM,=,CHEMBL5147203,B,CHEMBL5173701,Homo sapiens,CHEMBL203,CHEMBL5143652
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCN(C(=O)CCOCCOCCOCCOCCOCCNc2ccc3c(c2)C(=O)N(C2CCC(=O)N(C)C2=O)C3=O)CC1,8.54,Binding affinity to human partial length EGFR (R669 to V1011 residues) L858R mutant expressed in bacterial expression system assessed as immobilized ligand binding by competitive binding assay,Kd,2.9,nM,=,CHEMBL5136285,B,CHEMBL5173715,Homo sapiens,CHEMBL203,CHEMBL5131542
N#CC1=C(c2ccccc2)Nc2c(c(-c3cccs3)nn2-c2ccccc2)C12C(=O)Nc1ccc(Cl)cc12,6.92,Inhibition of EGFR (unknown origin) by colorimetric assay,IC50,120.0,nM,=,CHEMBL5150886,B,CHEMBL5173862,Homo sapiens,CHEMBL203,CHEMBL5149978
O=C(Nc1nccs1)C(c1ncn2c1CCC2)N1Cc2c(Cl)cccc2C1=O,8.40,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,4.0,nM,=,CHEMBL5120428,B,CHEMBL5173979,Homo sapiens,CHEMBL203,CHEMBL5113538
O=C(Nc1nccs1)C(c1ncn2c1CCC2)N1Cc2ccc(C#Cc3ccccc3)cc2C1=O,7.70,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,20.0,nM,=,CHEMBL5120428,B,CHEMBL5173986,Homo sapiens,CHEMBL203,CHEMBL5113538
CN(C)CCN(C)c1ccc(Nc2ncc3cc(CNc4ccccc4)n(C4CCCC4)c3n2)cc1,6.52,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),IC50,304.0,nM,=,CHEMBL5122790,B,CHEMBL5174109,Homo sapiens,CHEMBL203,CHEMBL5120829
COc1cc(N(C)CCN(C)C)c(NC(=O)c2ccncc2)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,6.41,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,IC50,391.0,nM,=,CHEMBL5140665,B,CHEMBL5174232,Homo sapiens,CHEMBL203,CHEMBL5137051
Cn1ccc2cc(Nc3ncnc4ccc(N)cc34)ccc21,5.40,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,4020.0,nM,=,CHEMBL5161051,B,CHEMBL5174372,Homo sapiens,CHEMBL203,CHEMBL5154786
CCc1cc(Nc2ncc(Br)c(Nc3ccc4nccnc4c3P(C)(C)=O)n2)c(OC)cc1N1CCC(N2CCN(C)CC2)CC1,9.67,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),IC50,0.212,nM,=,CHEMBL5143771,B,CHEMBL5174418,Homo sapiens,CHEMBL203,CHEMBL5143505
CC(C)c1cnc(N2CC[C@@H]2C)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,6.97,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,106.0,nM,=,CHEMBL5141214,B,CHEMBL5174629,Homo sapiens,CHEMBL203,CHEMBL5137066
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)nc3ccsc23)CC1,7.69,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,20.23,nM,=,CHEMBL5099547,B,CHEMBL5174995,Homo sapiens,CHEMBL203,CHEMBL5096223
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCN(C(=O)CCCCCCCCCCNC(=O)C[C@H](NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](c2cc(C)no2)C(C)C)c2ccc(-c3scnc3C)cc2)CC1,8.00,Binding affinity to human partial length EGFR (R669 to V1011 residues) L858R mutant expressed in bacterial expression system assessed as immobilized ligand binding by competitive binding assay,Kd,10.0,nM,=,CHEMBL5136285,B,CHEMBL5175033,Homo sapiens,CHEMBL203,CHEMBL5131542
COc1ccc(C(=O)Nc2cc(Nc3nccc(-c4cn(C)c5ccccc45)n3)c(OC)cc2N(C)CCN(C)C)nc1,7.06,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,IC50,87.0,nM,=,CHEMBL5140665,B,CHEMBL5175316,Homo sapiens,CHEMBL203,CHEMBL5137051
C=CC(=O)Nc1cc2c(Nc3ccc(Oc4cc5nncn5cn4)c(C)c3)ncnc2cc1OCC,8.83,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,1.47,nM,=,CHEMBL5162303,B,CHEMBL5175489,Homo sapiens,CHEMBL203,CHEMBL5154811
Cc1cc(Nc2ncnc3ccc(NC(=O)/C=C/CN(C)C)cc23)ccc1Oc1cc2nncn2cn1,8.67,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,2.13,nM,=,CHEMBL5162303,B,CHEMBL5175873,Homo sapiens,CHEMBL203,CHEMBL5154811
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(CC(=O)NCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)cc3OC)ncc2C(F)(F)F)c1,7.37,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,IC50,43.12,nM,=,CHEMBL5115840,B,CHEMBL5175891,Homo sapiens,CHEMBL203,CHEMBL5113409
CC#CC(=O)Nc1ccc(Nc2nccc(-c3cn(C)c4ccccc34)n2)cc1,6.66,Inhibition of EGFR T790M mutant (unknown origin),IC50,220.0,nM,=,CHEMBL5097717,B,CHEMBL5175924,Homo sapiens,CHEMBL203,CHEMBL5096180
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(N)(=O)=O)n1,9.70,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),IC50,0.2,nM,=,CHEMBL5143771,B,CHEMBL5176129,Homo sapiens,CHEMBL203,CHEMBL5143505
COc1cc2ncnc3c2cc1OCCCCCCOc1ccccc1N3,6.31,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,490.6,nM,=,CHEMBL5153035,B,CHEMBL5176295,Homo sapiens,CHEMBL203,CHEMBL5150044
CN1CCN(c2ccc(-c3ccc4c(c3)C(=O)N(C(C(=O)Nc3nccs3)c3cccc(F)c3)C4)cc2)CC1,8.74,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,1.8,nM,=,CHEMBL5147203,B,CHEMBL5176460,Homo sapiens,CHEMBL203,CHEMBL5143652
CCC(=O)NNC(=O)c1csc2ncc(-c3ccc(C)cc3)n12,6.35,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,IC50,450.0,nM,=,CHEMBL5110647,B,CHEMBL5176561,Homo sapiens,CHEMBL203,CHEMBL5108025
Cc1cc2cc(Nc3ncnc4ccc(N)cc34)ccc2[nH]1,6.59,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,255.0,nM,=,CHEMBL5161051,B,CHEMBL5176588,Homo sapiens,CHEMBL203,CHEMBL5154786
CCOc1cc2ncnc(Nc3ccc(Oc4cc5nncn5cn4)c(C)c3)c2cc1NC(=O)/C(F)=C/[C@@H]1CCCN1C,7.49,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,32.14,nM,=,CHEMBL5162303,B,CHEMBL5176854,Homo sapiens,CHEMBL203,CHEMBL5154811
CCS(=O)(=O)n1cc(-c2nc(Nc3cc(Cl)c(N4CCC(N5CCN(C)CC5)CC4)cc3OC)ncc2Cl)c2ccccc21,8.37,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,4.3,nM,=,CHEMBL5165817,B,CHEMBL5176897,Homo sapiens,CHEMBL203,CHEMBL5154883
Cc1cc(Nc2ncnc3cc(O)c(NC(=O)/C=C/[C@H]4CCCN4C)cc23)ccc1Oc1cc2nccn2cn1,8.96,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,1.11,nM,=,CHEMBL5162303,B,CHEMBL5176920,Homo sapiens,CHEMBL203,CHEMBL5154811
Cc1c(C#Cc2ccc(CN3CCC(CO)CC3)cc2)cc(C(F)F)c2cn(C(C(=O)Nc3nccs3)c3ncn4c3CCC43CC3)nc12,8.70,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,2.0,nM,=,CHEMBL5120428,B,CHEMBL5177023,Homo sapiens,CHEMBL203,CHEMBL5113538
CNC(=O)c1cnc(Nc2ccnc(N3CC[C@@H](O)[C@@H](F)C3)n2)cc1NC(C)C,7.00,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,99.0,nM,=,CHEMBL5141214,B,CHEMBL5177090,Homo sapiens,CHEMBL203,CHEMBL5137066
CN1CCC(c2ccc(-c3cc(F)c4ncn(C(C(=O)Nc5nccs5)c5ccccc5)c(=O)c4c3)cc2)CC1,9.22,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,0.6,nM,=,CHEMBL5147203,B,CHEMBL5177272,Homo sapiens,CHEMBL203,CHEMBL5143652
CN1CCN(c2ccc(-c3ccc4c(c3)C(=O)N(C(C(=O)Nc3nccs3)c3ccccc3)C4)cc2)CC1,9.05,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,0.9,nM,=,CHEMBL5147203,B,CHEMBL5177306,Homo sapiens,CHEMBL203,CHEMBL5143652
O=C(CCCCl)Nc1ccc2ncnc(Nc3ccc4[nH]ccc4c3)c2c1,8.24,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,5.8,nM,=,CHEMBL5161051,B,CHEMBL5177378,Homo sapiens,CHEMBL203,CHEMBL5154786
C=CC(=O)N1CCN(C(=O)Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)[C@H](C)C1,9.47,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells using kinase substrate 22 incubated for 30 mins in presence of ATP,IC50,0.34,nM,=,CHEMBL5147184,B,CHEMBL5178180,Homo sapiens,CHEMBL203,CHEMBL5143650
CN1CCC(c2ccc(-c3cc4c(=O)n(C(C(=O)Nc5nccs5)c5ccccc5)cnc4cc3F)cc2)CC1,8.85,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,1.4,nM,=,CHEMBL5147203,B,CHEMBL5178571,Homo sapiens,CHEMBL203,CHEMBL5143652
CCOc1cc2ncnc(Nc3ccc(Oc4cc5nncn5cn4)c(C)c3)c2cc1NC(=O)/C(F)=C/[C@H]1CCCN1C,8.09,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,8.13,nM,=,CHEMBL5162303,B,CHEMBL5178703,Homo sapiens,CHEMBL203,CHEMBL5154811
Nc1ccc2ncnc(Nc3ccc4[nH]ncc4c3)c2c1,8.53,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,2.98,nM,=,CHEMBL5161051,B,CHEMBL5178707,Homo sapiens,CHEMBL203,CHEMBL5154786
CN1CCC(c2ccc(-c3ccc4cnn(C(C(=O)Nc5nccs5)c5ccccc5)c(=O)c4c3)cc2)CC1,8.40,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,4.0,nM,=,CHEMBL5147203,B,CHEMBL5178754,Homo sapiens,CHEMBL203,CHEMBL5143652
CN1CCN(c2ccc(-c3ccc4c(=O)n(C(C(=O)Nc5nccs5)c5ccccc5)ccc4c3)cc2)CC1,8.47,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,3.4,nM,=,CHEMBL5147203,B,CHEMBL5178865,Homo sapiens,CHEMBL203,CHEMBL5143652
C=C(C(=O)N1CCN(C(=O)Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)[C@H](C)C1)C(F)(F)F,9.42,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells using kinase substrate 22 incubated for 30 mins in presence of ATP,IC50,0.38,nM,=,CHEMBL5147184,B,CHEMBL5178898,Homo sapiens,CHEMBL203,CHEMBL5143650
O=C(CCCCCCN1CC(c2ccc3ncnc(Nc4ccc(Br)cc4F)c3c2)N=N1)NO,7.99,Inhibition of EGFR (unknown origin),IC50,10.3,nM,=,CHEMBL5113705,B,CHEMBL5178922,Homo sapiens,CHEMBL203,CHEMBL5113372
CCN(C)C1CN(C2CCN(c3cc(OC)c(Nc4ncc(Br)c(Nc5ccc6c(c5P(C)(C)=O)OCCO6)n4)cc3C)CC2)C1,9.55,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.28,nM,=,CHEMBL5117930,B,CHEMBL5178971,Homo sapiens,CHEMBL203,CHEMBL5113487
COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc2cc(CNc3ccccc3)n(C3CCCC3)c2n1,8.00,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),IC50,10.0,nM,=,CHEMBL5122790,B,CHEMBL5179023,Homo sapiens,CHEMBL203,CHEMBL5120829
CCS(=O)(=O)n1cc2c3ccc(cc31)OCCCCCCOc1cc(c(C3CC3)cc1N1CCOCC1)Nc1ncc(Cl)c-2n1,7.25,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,56.4,nM,=,CHEMBL5165817,B,CHEMBL5179214,Homo sapiens,CHEMBL203,CHEMBL5154883
N#Cc1ccc(O)c(-c2nc(NCc3ncccn3)c3ccccc3n2)c1,6.20,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) by HTRF method,IC50,630.0,nM,=,CHEMBL5143783,B,CHEMBL5179288,Homo sapiens,CHEMBL203,CHEMBL5143505
CCOC1CN(C2CCN(c3cc(OC)c(Nc4ncc(Br)c(Nc5ccc6nccnc6c5P(C)(C)=O)n4)cc3C)CC2)C1,9.37,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.43,nM,=,CHEMBL5117930,B,CHEMBL5179357,Homo sapiens,CHEMBL203,CHEMBL5113487
CCS(=O)(=O)n1cc(-c2nc(Nc3cc(C(C)C)c(N4CCC(N5CCN(C)CC5)CC4)cc3OC)ncc2Cl)c2ccccc21,7.13,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,IC50,74.3,nM,=,CHEMBL5165818,B,CHEMBL5179495,Homo sapiens,CHEMBL203,CHEMBL5154883
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(CC(=O)NCCNc5cccc6c5CN(C5CCC(=O)NC5=O)C6=O)CC4)cc3OC)ncc2C(F)(F)F)c1,6.01,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,IC50,965.3,nM,=,CHEMBL5115840,B,CHEMBL5179538,Homo sapiens,CHEMBL203,CHEMBL5113409
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)CC1,8.31,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,4.902,nM,=,CHEMBL5099547,B,CHEMBL5179952,Homo sapiens,CHEMBL203,CHEMBL5096223
Cc1cc(Nc2ncnc3ccc(NC(=O)/C=C/[C@H]4CCCN4C)cc23)ccc1Oc1cc2nncn2cn1,8.92,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,1.19,nM,=,CHEMBL5162303,B,CHEMBL5179954,Homo sapiens,CHEMBL203,CHEMBL5154811
COc1cc2ncnc3c2cc1OCCCCCCOc1c(Cl)cccc1N3,5.52,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,3034.0,nM,=,CHEMBL5153035,B,CHEMBL5180070,Homo sapiens,CHEMBL203,CHEMBL5150044
Nc1ccc2ncnc(Nc3ccc4[nH]ccc4c3)c2c1,9.19,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,0.65,nM,=,CHEMBL5161051,B,CHEMBL5180251,Homo sapiens,CHEMBL203,CHEMBL5154786
CCN1CCN(c2ccc(-c3cc(F)c4cn(C(C(=O)Nc5nccs5)c5ncn6c5CCC6)nc4c3)cc2)CC1,8.15,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,7.0,nM,=,CHEMBL5120428,B,CHEMBL5180289,Homo sapiens,CHEMBL203,CHEMBL5113538
Nc1ccc2ncnc(Nc3cccc4cc[nH]c34)c2c1,7.60,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,25.17,nM,=,CHEMBL5161051,B,CHEMBL5180325,Homo sapiens,CHEMBL203,CHEMBL5154786
CCc1cc(Nc2ncc(Br)c(Nc3ccc4nccnc4c3P(C)(C)=O)n2)c(OC)cc1N1CCC(N2CC(N(C)C)C2)CC1,9.96,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.11,nM,=,CHEMBL5117929,B,CHEMBL5180388,Homo sapiens,CHEMBL203,CHEMBL5113487
Cc1cc(Nc2c(C#N)cnc3ccc(NC(=O)/C=C/CN(C)C)cc23)ccc1Oc1cc2nncn2cn1,7.68,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,20.72,nM,=,CHEMBL5162303,B,CHEMBL5180725,Homo sapiens,CHEMBL203,CHEMBL5154811
CCS(=O)(=O)n1cc(-c2nc(Nc3cc(Cl)c(N4CCC(N5CCN(C)CC5)CC4)cc3C)ncc2Cl)c2ccccc21,8.80,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,1.6,nM,=,CHEMBL5165817,B,CHEMBL5180778,Homo sapiens,CHEMBL203,CHEMBL5154883
O=C1c2cc(F)ccc2Nc2ccccc2N1Cc1ccccc1,7.28,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,52.0,nM,=,CHEMBL5143769,B,CHEMBL5180830,Homo sapiens,CHEMBL203,CHEMBL5143505
O=C(Nc1nccs1)C(c1ncn2c1CCC2)N1Cc2c(F)cc(C#Cc3ccc(CN4CCC(CO)CC4)cc3)cc2C1=O,8.30,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,5.0,nM,=,CHEMBL5120428,B,CHEMBL5180839,Homo sapiens,CHEMBL203,CHEMBL5113538
CCc1cc(Nc2ncc(Br)c(Nc3ccc4nccnc4c3P(C)(C)=O)n2)c(OC)cc1N1CCC(N2CCCN(C)CC2)CC1,9.57,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.27,nM,=,CHEMBL5117930,B,CHEMBL5180894,Homo sapiens,CHEMBL203,CHEMBL5113487
COc1cc2ncnc3c2cc1OCCOCCOCCOc1cc(F)c(Cl)cc1N3,8.89,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,1.3,nM,=,CHEMBL5153035,B,CHEMBL5180914,Homo sapiens,CHEMBL203,CHEMBL5150044
Cc1cc(Nc2ncnc3cc(O)c(NC(=O)/C=C/[C@H]4CCCN4C)cc23)ccc1Oc1ccn2cnnc2c1,7.64,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,22.75,nM,=,CHEMBL5162303,B,CHEMBL5180965,Homo sapiens,CHEMBL203,CHEMBL5154811
COc1cccc2c1C(=O)C1=C(C2=O)c2c(O)cc(CO)cc2[C@@H](O)[C@@H]1O,8.18,Inhibition of EGFR tyrosine kinase (unknown origin),IC50,6.54,nM,=,CHEMBL5133518,B,CHEMBL5181037,Homo sapiens,CHEMBL203,CHEMBL5131428
CCOC(=O)[C@H](Cc1c[nH]cn1)NCC(=O)NNC(=O)COc1ccc(-c2nc3ccccc3s2)cc1OC,6.80,Inhibition of EGFR (unknown origin),IC50,157.0,nM,=,CHEMBL5133605,B,CHEMBL5181045,Homo sapiens,CHEMBL203,CHEMBL5131433
Brc1cccc(Nc2ncnc3[nH]ccc23)c1,8.43,Inhibition of EGFR (unknown origin) by ADP-Glo kinase assay,IC50,3.76,nM,=,CHEMBL5097726,B,CHEMBL5181237,Homo sapiens,CHEMBL203,CHEMBL5096180
CCS(=O)(=O)n1cc2c3ccc(cc31)OCCCCCCCCOc1cc(ccc1N1CCOCC1)Nc1ncc(Cl)c-2n1,6.85,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,141.9,nM,=,CHEMBL5165817,B,CHEMBL5181437,Homo sapiens,CHEMBL203,CHEMBL5154883
C=CC(=O)Oc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC,9.27,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells using kinase substrate 22 incubated for 30 mins in presence of ATP,IC50,0.54,nM,=,CHEMBL5147184,B,CHEMBL5181469,Homo sapiens,CHEMBL203,CHEMBL5143650
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc2cc(CNc3ccccc3)n(C3CCCC3)c2n1,7.26,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),IC50,55.0,nM,=,CHEMBL5122790,B,CHEMBL5181487,Homo sapiens,CHEMBL203,CHEMBL5120829
CCc1cc(N2CCOCC2)c2cc1Nc1ncc(Cl)c(n1)-c1cn(S(=O)(=O)CC)c3cc(ccc13)OCCCCCCO2,7.49,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,32.1,nM,=,CHEMBL5165817,B,CHEMBL5181684,Homo sapiens,CHEMBL203,CHEMBL5154883
CCOc1cc2ncnc(Nc3ccc(Oc4cc5nncn5cn4)c(C)c3)c2cc1NC(=O)/C(F)=C\[C@@H]1CCCN1C,7.59,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,25.92,nM,=,CHEMBL5162303,B,CHEMBL5181694,Homo sapiens,CHEMBL203,CHEMBL5154811
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3OC)nc3ccsc23)CC1,8.02,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,9.664,nM,=,CHEMBL5099547,B,CHEMBL5181848,Homo sapiens,CHEMBL203,CHEMBL5096223
O=C(Cc1ccccc1)Nc1cccc(-c2nc3n(c2-c2ccnc(Nc4ccc(N5CCOCC5)cc4)n2)CCS3)c1,7.45,Inhibition of human EGFR expressed in baculovirus expression system using CAGAGAIETDKEYYTVKD as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 1 hr by TR-FRET assay,IC50,35.5,nM,=,CHEMBL5127060,B,CHEMBL5182231,Homo sapiens,CHEMBL203,CHEMBL5126509
COc1cc2ncnc3c2cc1OCCOCCOc1cc(F)c(Cl)cc1N3,6.92,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,119.1,nM,=,CHEMBL5153035,B,CHEMBL5182465,Homo sapiens,CHEMBL203,CHEMBL5150044
CN1CCC(c2ccc(-c3ccc4c(c3)C(=O)N(C(C(=O)Nc3nccs3)c3cccc(F)c3)C4)cc2)CC1,9.70,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,0.2,nM,=,CHEMBL5147203,B,CHEMBL5182553,Homo sapiens,CHEMBL203,CHEMBL5143652
C=CC(=O)Nc1ccc2ncnc(Nc3ccc4[nH]cc(Br)c4c3)c2c1,9.42,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,0.38,nM,=,CHEMBL5161051,B,CHEMBL5182567,Homo sapiens,CHEMBL203,CHEMBL5154786
CC(C)c1ncc(N2CC[C@H]2C)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,8.66,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,2.2,nM,=,CHEMBL5141214,B,CHEMBL5182741,Homo sapiens,CHEMBL203,CHEMBL5137066
CSc1nc(-c2cccc(NC(=O)c3c(F)ccc(O)c3CN3C(=O)c4ccccc4C3=O)c2)c(-c2ccnc(NC(C)=O)c2)[nH]1,8.92,Inhibition of human EGFR L858R mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,IC50,1.2,nM,=,CHEMBL5155237,B,CHEMBL5183286,Homo sapiens,CHEMBL203,CHEMBL5154643
CC1(C)CCc2c(C(C(=O)Nc3nccs3)N3Cc4c(cc(C#Cc5ccc(CN6CCC(CO)CC6)cc5)cc4C(F)F)C3=O)ncn21,8.40,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,4.0,nM,=,CHEMBL5120428,B,CHEMBL5183324,Homo sapiens,CHEMBL203,CHEMBL5113538
Nc1ccc2ncnc(Nc3cccc4c3CCCC4)c2c1,6.78,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,164.8,nM,=,CHEMBL5161051,B,CHEMBL5183327,Homo sapiens,CHEMBL203,CHEMBL5154786
COc1cc2ncnc3c2cc1OCCOCCOc1cccc(c1)N3,4.47,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,33860.0,nM,=,CHEMBL5153035,B,CHEMBL5183329,Homo sapiens,CHEMBL203,CHEMBL5150044
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc2Cl)CC1,7.70,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,20.1,nM,=,CHEMBL5099547,B,CHEMBL5183664,Homo sapiens,CHEMBL203,CHEMBL5096223
CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccc(F)cc5)n(C5CCN(C(=O)CO)CC5)c4n3)cc2)CC1,7.39,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,41.0,nM,=,CHEMBL5143769,B,CHEMBL5183865,Homo sapiens,CHEMBL203,CHEMBL5143505
C=C(F)C(=O)Nc1cc2c(Nc3ccc(Oc4cc5nncn5cn4)c(C)c3)ncnc2cc1OCC,8.02,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,9.6,nM,=,CHEMBL5162303,B,CHEMBL5183924,Homo sapiens,CHEMBL203,CHEMBL5154811
C=CC(=O)N1CCC(Oc2nc(Nc3ccn(C)n3)nc3ccsc23)CC1,6.90,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,126.0,nM,=,CHEMBL5099547,B,CHEMBL5184048,Homo sapiens,CHEMBL203,CHEMBL5096223
CC(C)(/C=C(/C#N)C(=O)N1CCC[C@@H]1Cn1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc21)N1CCOCC1,5.52,Inhibition of EGFR (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method,IC50,3000.0,nM,=,CHEMBL5104912,B,CHEMBL5184084,Homo sapiens,CHEMBL203,CHEMBL5104103
COc1cc2ncnc3c2cc1OCCCCCCOc1cccc(Cl)c1N3,7.25,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,56.8,nM,=,CHEMBL5153035,B,CHEMBL5184313,Homo sapiens,CHEMBL203,CHEMBL5150044
O=C(Nc1nccs1)C(c1ncn2c1CCC2)N1Cc2c(cc(C#Cc3ccc(CN4CCC(CO)CC4)cc3)cc2C(F)F)C1=O,8.40,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,4.0,nM,=,CHEMBL5120428,B,CHEMBL5184539,Homo sapiens,CHEMBL203,CHEMBL5113538
CCOc1cc2ncnc(Nc3ccc(Oc4cc5nncn5cn4)c(C)c3)c2cc1NC(=O)/C=C/[C@H]1CCCN1C,8.87,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,1.36,nM,=,CHEMBL5162303,B,CHEMBL5184610,Homo sapiens,CHEMBL203,CHEMBL5154811
Cc1c(C#Cc2ccc(CN3CCC(CO)CC3)cc2)cc(C(F)F)c2cn(C(C(=O)Nc3nccs3)c3ncn4c3CCC4)nc12,8.52,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,3.0,nM,=,CHEMBL5120428,B,CHEMBL5184760,Homo sapiens,CHEMBL203,CHEMBL5113538
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(CN4CCC(CO)CC4)cc3)ncc2Cl)CC1,7.91,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,12.3,nM,=,CHEMBL5099547,B,CHEMBL5184813,Homo sapiens,CHEMBL203,CHEMBL5096223
CC(C)c1nnc(N2CC[C@H]2C)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,7.80,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,16.0,nM,=,CHEMBL5141214,B,CHEMBL5184941,Homo sapiens,CHEMBL203,CHEMBL5137066
CCc1ccc(C2=C(O)C(=O)C(c3ccc(CC)cc3)=C(O)C2=O)cc1,7.52,Inhibition of EGFR tyrosine kinase (unknown origin),IC50,30.18,nM,=,CHEMBL5133518,B,CHEMBL5185036,Homo sapiens,CHEMBL203,CHEMBL5131428
CC(C)c1ccc(N2C[C@H](O)[C@H]2C)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,9.30,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,0.5,nM,=,CHEMBL5141214,B,CHEMBL5185207,Homo sapiens,CHEMBL203,CHEMBL5137066
CNc1ncc(C(C)C)c2cc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)ncc12,8.09,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,8.1,nM,=,CHEMBL5141214,B,CHEMBL5185287,Homo sapiens,CHEMBL203,CHEMBL5137066
COc1cc2ncnc3c2cc1OCCOCCOc1ccccc1N3,6.81,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,154.6,nM,=,CHEMBL5153035,B,CHEMBL5185330,Homo sapiens,CHEMBL203,CHEMBL5150044
COc1cc(N(C)CCN(C)C)c(NC(=O)c2nccn2C)cc1Nc1nc(-c2cn(C)c3ccccc23)c2cccnc2n1,6.38,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,IC50,420.0,nM,=,CHEMBL5140665,B,CHEMBL5185772,Homo sapiens,CHEMBL203,CHEMBL5137051
CCS(=O)(=O)n1cc(-c2nc(Nc3cc(C)c(N4CCC(N5CCN(C)CC5)CC4)cc3OC)ncc2Cl)c2ccccc21,8.82,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,1.5,nM,=,CHEMBL5165817,B,CHEMBL5185864,Homo sapiens,CHEMBL203,CHEMBL5154883
CCS(=O)(=O)n1cc(-c2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)c(Cl)c3)ncc2Cl)c2ccccc21,8.66,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,IC50,2.2,nM,=,CHEMBL5165818,B,CHEMBL5185922,Homo sapiens,CHEMBL203,CHEMBL5154883
O=C(Cc1csc2nc3ccccc3n12)Nc1cccc(O)c1,4.26,Inhibition of EGFR (unknown origin) assessed as kinase activity by measuring ATP remaining for 40 mins in presence of ATP by Kinase-Glo Plus luminescence kinase assay,IC50,55000.0,nM,=,CHEMBL5129114,B,CHEMBL5185952,Homo sapiens,CHEMBL203,CHEMBL5126578
C=CC(=O)N1C[C@@H]2C[C@H]1CN2C(=O)Oc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC,9.52,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells using kinase substrate 22 incubated for 30 mins in presence of ATP,IC50,0.3,nM,=,CHEMBL5147184,B,CHEMBL5186362,Homo sapiens,CHEMBL203,CHEMBL5143650
CCc1nnc2c(Nc3ccc(C(=O)/C=C/c4cc(OC)c(OC)c(OC)c4)cc3)nc3ccccc3n12,7.41,Inhibition of GST-tagged EGFR (unknown origin) assessed as phosphorylation level using biotinylated peptide as substrate in presence of ATP by HTScan EGFR kinase assay,IC50,39.0,nM,=,CHEMBL5127063,B,CHEMBL5186583,Homo sapiens,CHEMBL203,CHEMBL5126509
COc1cc(N2CCC(N3CC(N(C)C)C3)CC2)c(C)cc1Nc1ncc(Br)c(Nc2ccc3nccnc3c2P(C)(C)=O)n1,10.22,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.06,nM,=,CHEMBL5117929,B,CHEMBL5186680,Homo sapiens,CHEMBL203,CHEMBL5113487
COc1cc2ncnc3c2cc1OCCOCCOc1ccc(Cl)cc1N3,7.60,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,24.9,nM,=,CHEMBL5153035,B,CHEMBL5186794,Homo sapiens,CHEMBL203,CHEMBL5150044
Nc1ccc2ncnc(Nc3ccc4c(c3)CCC4)c2c1,6.60,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,251.3,nM,=,CHEMBL5161051,B,CHEMBL5186969,Homo sapiens,CHEMBL203,CHEMBL5154786
CNC(=O)C1CN(c2ncc(C(C)C)c3cc(Nc4ccnc(N5CC[C@@H](O)[C@@](C)(F)C5)n4)ncc23)C1,9.00,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,1.0,nM,=,CHEMBL5141214,B,CHEMBL5187021,Homo sapiens,CHEMBL203,CHEMBL5137066
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(SCC(=O)N4CCOCC4)cc3)ncc2Cl)c1,8.04,Inhibition of EGFR L858R/T790M double mutant (unknown origin) in presence of ATP by ADP-Glo assay,IC50,9.1,nM,=,CHEMBL5097724,B,CHEMBL5187169,Homo sapiens,CHEMBL203,CHEMBL5096180
O=C(Nc1nccs1)C(c1ncn2c1CCC2)N1Cc2ccc(C#Cc3ccc(CN4CCC(O)CC4)cc3)cc2C1=O,8.15,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,7.0,nM,=,CHEMBL5120428,B,CHEMBL5187250,Homo sapiens,CHEMBL203,CHEMBL5113538
Cc1nn(-c2ccc(F)cc2)c2c(Nc3ccc(F)c(Cl)c3)ncnc12,6.75,Inhibition of EGFR (unknown origin) incubated for 30 min in presence of ATP by fluorescence based assay,IC50,180.0,nM,=,CHEMBL5097732,B,CHEMBL5187375,Homo sapiens,CHEMBL203,CHEMBL5096180
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCN(C(=O)CCOCCOCCOCCOCCOCCNc2ccc3c(c2)C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1,8.37,Binding affinity to human partial length EGFR (R669 to V1011 residues) L858R mutant expressed in bacterial expression system assessed as immobilized ligand binding by competitive binding assay,Kd,4.3,nM,=,CHEMBL5136285,B,CHEMBL5187547,Homo sapiens,CHEMBL203,CHEMBL5131542
CN1CCN(c2ccc(-c3ccc4c(c3)C(=O)N(C(C(=O)Nc3nccs3)c3cccc(F)c3)CC4)cc2)CC1,8.17,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,6.8,nM,=,CHEMBL5147203,B,CHEMBL5187605,Homo sapiens,CHEMBL203,CHEMBL5143652
C#CC(=O)N1CCN(C(=O)Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)[C@H](C)C1,9.49,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells using kinase substrate 22 incubated for 30 mins in presence of ATP,IC50,0.32,nM,=,CHEMBL5147184,B,CHEMBL5187762,Homo sapiens,CHEMBL203,CHEMBL5143650
COc1cc(N2CCC(N3CCN(CCO)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1,9.10,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),IC50,0.8,nM,=,CHEMBL5143771,B,CHEMBL5187838,Homo sapiens,CHEMBL203,CHEMBL5143505
CSc1nc(-c2cccc(NC(=O)c3cc(O)ccc3F)c2)c(-c2ccnc(NC(C)=O)c2)[nH]1,8.26,Inhibition of human EGFR L858R mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,IC50,5.5,nM,=,CHEMBL5155237,B,CHEMBL5188250,Homo sapiens,CHEMBL203,CHEMBL5154643
CCS(=O)(=O)n1cc2c3ccc(cc31)OCCCCCOc1cc(ccc1N1CCOCC1)Nc1ncc(Cl)c-2n1,7.72,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,19.0,nM,=,CHEMBL5165817,B,CHEMBL5188272,Homo sapiens,CHEMBL203,CHEMBL5154883
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(-c2cn(S(=O)(=O)C(C)C)c3ccccc23)n1,7.75,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,IC50,18.0,nM,=,CHEMBL5165818,B,CHEMBL5188281,Homo sapiens,CHEMBL203,CHEMBL5154883
COCC1CN(C2CCN(c3cc(OC)c(Nc4ncc(Br)c(Nc5ccc6c(c5P(C)(C)=O)OCCO6)n4)cc3C)CC2)C1,9.51,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.31,nM,=,CHEMBL5117929,B,CHEMBL5188373,Homo sapiens,CHEMBL203,CHEMBL5113487
C=CC(=O)Nc1ccc(OC)c(Nc2cc(-c3[nH]c(SC)nc3-c3cccc(NC(=O)c4c(F)ccc(O)c4CN4C(=O)c5ccccc5C4=O)c3)ccn2)c1,8.70,Inhibition of human EGFR L858R mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,IC50,2.0,nM,=,CHEMBL5155237,B,CHEMBL5188399,Homo sapiens,CHEMBL203,CHEMBL5154643
C=CC(=O)N1CCC(N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,8.04,Inhibition of EGFR L858R/T790M double mutant (unknown origin),IC50,9.2,nM,=,CHEMBL5121366,B,CHEMBL5188568,Homo sapiens,CHEMBL203,CHEMBL5120754
COc1cc(N(C)CCN(C)C)c(NC(=O)c2cnccn2)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,7.77,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,IC50,17.0,nM,=,CHEMBL5140665,B,CHEMBL5188618,Homo sapiens,CHEMBL203,CHEMBL5137051
Nc1ccc2ncnc(Nc3ccc4ncccc4c3)c2c1,6.67,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,215.1,nM,=,CHEMBL5161051,B,CHEMBL5188730,Homo sapiens,CHEMBL203,CHEMBL5154786
C=CC(=O)N(C)CCOc1c(N)ncnc1-c1ccc(CN2CCN(CC(C)C)CC2=O)c(C)c1,4.52,Binding affinity to EGFR (unknown origin) assessed as dissociation constant by KINOMEscan analysis,Kd,30000.0,nM,=,CHEMBL5133814,B,CHEMBL5188786,Homo sapiens,CHEMBL203,CHEMBL5131445
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccc4)cc3)c2cc1NC(=O)/C=C/c1cccnc1,6.22,Inhibition of EGFR (unknown origin),IC50,597.0,nM,=,CHEMBL5127078,B,CHEMBL5188857,Homo sapiens,CHEMBL203,CHEMBL5126509
CCc1cc(Nc2ncc(Br)c(Nc3ccc4c(c3P(C)(C)=O)OCCO4)n2)c(OC)cc1N1CCC(N2CC(N(C)C)C2)CC1,10.10,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.08,nM,=,CHEMBL5117929,B,CHEMBL5188940,Homo sapiens,CHEMBL203,CHEMBL5113487
CN1CCN(c2ccc(Nc3ncc4cc(CNc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1,7.77,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),IC50,17.0,nM,=,CHEMBL5122790,B,CHEMBL5188948,Homo sapiens,CHEMBL203,CHEMBL5120829
CNc1ncc(C(C)C)c2cc(Nc3ccnc(N4CC[C@@H](O)[C@@H](F)C4)n3)ncc12,7.30,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,50.0,nM,=,CHEMBL5141214,B,CHEMBL5188960,Homo sapiens,CHEMBL203,CHEMBL5137066
O=C(Nc1nccs1)C(c1ncn2c1CCC2)N1Cc2c(F)cc(C#Cc3cccnc3)cc2C1=O,8.15,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,7.0,nM,=,CHEMBL5120428,B,CHEMBL5189114,Homo sapiens,CHEMBL203,CHEMBL5113538
COc1cc(N(C)CCN(C)C)c(NC(=O)c2ccncn2)cc1Nc1nc(-c2cn(C)c3ccccc23)c2cccnc2n1,6.44,Inhibition of wild type EGFR (unknown origin) by mobility shift assay,IC50,360.0,nM,=,CHEMBL5140664,B,CHEMBL5189183,Homo sapiens,CHEMBL203,CHEMBL5137051
CN(C)c1ccc(/C=N/NC(=O)Cn2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)cc1,9.35,Inhibition of EGFR (unknown origin),IC50,0.45,nM,=,CHEMBL5104377,B,CHEMBL5189340,Homo sapiens,CHEMBL203,CHEMBL5104091
CN1CCN(C(C)(C)/C=C(\C#N)C(=O)N2CCC[C@@H](n3nc(-c4ccc(Oc5ccccc5)cc4F)c4c(N)ncnc43)C2)CC1,6.01,Inhibition of EGFR (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method,IC50,980.0,nM,=,CHEMBL5104912,B,CHEMBL5189379,Homo sapiens,CHEMBL203,CHEMBL5104103
O=C(Nc1nccs1)C(c1ncn2c1CCC2)N1Cc2c(cc(C#Cc3ccc(CN4CCC(CO)CC4)cc3)cc2C(F)(F)F)C1=O,8.52,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,3.0,nM,=,CHEMBL5120428,B,CHEMBL5189574,Homo sapiens,CHEMBL203,CHEMBL5113538
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)nc3[nH]ccc23)CC1,7.50,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,31.35,nM,=,CHEMBL5099547,B,CHEMBL5189711,Homo sapiens,CHEMBL203,CHEMBL5096223
CC(C)c1cnc(N2CCCC2)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,7.28,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,IC50,52.0,nM,=,CHEMBL5141217,B,CHEMBL5189778,Homo sapiens,CHEMBL203,CHEMBL5137066
CCOCCSc1nc(-c2ccccc2Cl)nn1CCOCC,7.06,Inhibition of EGFR (unknown origin) by microplate reader,IC50,86.7,nM,=,CHEMBL5138527,B,CHEMBL5190121,Homo sapiens,CHEMBL203,CHEMBL5137005
Cc1cc(Nc2ncnc3cc(O)c(NC(=O)/C=C/[C@H]4CCCN4C)cc23)ccc1Oc1cnc2ccnn2c1,8.99,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,1.03,nM,=,CHEMBL5162303,B,CHEMBL5190132,Homo sapiens,CHEMBL203,CHEMBL5154811
CCC1CCN(c2ccc(-c3cc(F)c4c(c3)C(=O)N(C(C(=O)Nc3nccs3)c3ncn5c3CCC5)C4)cc2)CC1,8.40,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,4.0,nM,=,CHEMBL5143769,B,CHEMBL5190204,Homo sapiens,CHEMBL203,CHEMBL5143505
COc1cc2ncnc3c2cc1OCCOCCOc1cc(Cl)cc(c1)N3,5.20,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,6302.0,nM,=,CHEMBL5153035,B,CHEMBL5190227,Homo sapiens,CHEMBL203,CHEMBL5150044
CCC(=O)N[C@H]1CC[C@@H](N2C(=O)N(c3ccccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)CC1,6.54,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,290.0,nM,=,CHEMBL5143769,B,CHEMBL5190294,Homo sapiens,CHEMBL203,CHEMBL5143505
Fc1cc2c(cc1Cl)Nc1ncnc3ccc(cc13)OCCOCCO2,6.17,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,676.7,nM,=,CHEMBL5153037,B,CHEMBL5190513,Homo sapiens,CHEMBL203,CHEMBL5150044
COc1cc(N(C)CCN(C)C)c(NC(=O)c2ccncc2OC)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,7.00,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,IC50,100.0,nM,=,CHEMBL5140665,B,CHEMBL5191292,Homo sapiens,CHEMBL203,CHEMBL5137051
CN1CCN(c2ccc(-c3ccc4c(c3)C(=O)N(C(C(=O)Nc3nccs3)c3cc(F)ccc3O)C4)cc2)CC1,9.52,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,0.3,nM,=,CHEMBL5147203,B,CHEMBL5191510,Homo sapiens,CHEMBL203,CHEMBL5143652
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3ccsc23)CC1,7.99,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,10.32,nM,=,CHEMBL5099547,B,CHEMBL5191556,Homo sapiens,CHEMBL203,CHEMBL5096223
CN1CCC(c2ccc(-c3ccc4ncn(C(C(=O)Nc5nccs5)c5ccccc5)c(=O)c4n3)cc2)CC1,9.22,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,0.6,nM,=,CHEMBL5147203,B,CHEMBL5191674,Homo sapiens,CHEMBL203,CHEMBL5143652
COc1cc(NC(=O)CCCCCCC(=O)NO)ccc1Nc1nccc(-c2cn(C)c3ccccc23)n1,5.30,Inhibition of EGFR T790M mutant (unknown origin) incubated for 40 mins by Kinase-Glo Plus luminescence kinase assay,IC50,5000.0,nM,=,CHEMBL5127067,B,CHEMBL5191956,Homo sapiens,CHEMBL203,CHEMBL5126509
COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCN(C(=O)CCCCCCCCCCNC(=O)C[C@H](NC(=O)[C@@H]2C[C@H](O)CN2C(=O)[C@@H](c2cc(C)no2)C(C)C)c2ccc(-c3scnc3C)cc2)CC1,7.89,Binding affinity to human partial length EGFR (R669 to V1011 residues) L858R mutant expressed in bacterial expression system assessed as immobilized ligand binding by competitive binding assay,Kd,13.0,nM,=,CHEMBL5136285,B,CHEMBL5191970,Homo sapiens,CHEMBL203,CHEMBL5131542
COc1cc2ncnc3c2cc1OCCOCCOCCOc1c(Cl)cccc1N3,6.94,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,114.0,nM,=,CHEMBL5153035,B,CHEMBL5192038,Homo sapiens,CHEMBL203,CHEMBL5150044
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)CC1,7.87,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,13.42,nM,=,CHEMBL5099547,B,CHEMBL5192155,Homo sapiens,CHEMBL203,CHEMBL5096223
COc1cc(-c2nc3ccccc3s2)ccc1OCC(=O)NNC(=O)CN1CCC[C@H]1C(=O)O,6.47,Inhibition of EGFR (unknown origin),IC50,342.0,nM,=,CHEMBL5133605,B,CHEMBL5192184,Homo sapiens,CHEMBL203,CHEMBL5131433
C#Cc1cccc(Oc2ncnc3ccc(OCc4ccc(S(=O)(=O)N(C)C#C)cc4)cc23)c1,5.25,Inhibition of EGFR L858R mutant (unknown origin) using peptide substrate by FRET assay,IC50,5670.0,nM,=,CHEMBL5125953,B,CHEMBL5192185,Homo sapiens,CHEMBL203,CHEMBL5120948
COc1cc(N2CCC(N3CCCOCC3)CC2)c(C)cc1Nc1ncc(Br)c(Nc2ccc3c(c2P(C)(C)=O)OCCO3)n1,9.89,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.13,nM,=,CHEMBL5117929,B,CHEMBL5192223,Homo sapiens,CHEMBL203,CHEMBL5113487
NNC(=O)/C=C1/Nc2ccc(Br)cc2NC1=O,7.06,Inhibition of EGFR L858R mutant (unknown origin),IC50,87.34,nM,=,CHEMBL5114136,B,CHEMBL5192318,Homo sapiens,CHEMBL203,CHEMBL5113380
COc1cc2c(cc1OC)C(Sc1cccc(NC(=S)Nc3ccc(Br)c(C(F)(F)F)c3)c1)=NCN2,8.00,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins in presence of ATP by caliper mobility shift assay,IC50,10.0,nM,=,CHEMBL5127082,B,CHEMBL5192572,Homo sapiens,CHEMBL203,CHEMBL5126509
Cc1cc(Nc2ncnc3cc(O)c(NC(=O)/C=C/[C@H]4CCCN4C)cc23)ccc1Oc1ccn2ccnc2c1,8.64,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,2.31,nM,=,CHEMBL5162303,B,CHEMBL5192750,Homo sapiens,CHEMBL203,CHEMBL5154811
COc1ccc(-c2cc(=O)cc(-c3ccc(OC)cc3)o2)cc1,9.82,Inhibition of EGFR tyrosine kinase (unknown origin),IC50,0.15,nM,=,CHEMBL5133518,B,CHEMBL5192793,Homo sapiens,CHEMBL203,CHEMBL5131428
CO[C@@H]1[C@H](O)CN(c2nccc(Nc3cc4c(C(C)C)ccc(N5C[C@H](CS(C)(=O)=O)[C@H]5C)c4cn3)n2)CC1(F)F,9.15,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,0.7,nM,=,CHEMBL5141214,B,CHEMBL5193016,Homo sapiens,CHEMBL203,CHEMBL5137066
O=C(Nc1nccs1)C(c1ccccc1)N1Cc2ccc(-c3ccc4[nH]ccc4c3)cc2C1=O,7.82,Inhibition of EGFR L858R/T790M double mutant (unknown origin),IC50,15.0,nM,=,CHEMBL5143776,B,CHEMBL5193027,Homo sapiens,CHEMBL203,CHEMBL5143505
COc1cc(N2CCC(N3CCCN(C)CC3)CC2)c(C)cc1Nc1ncc(Br)c(Nc2ccc3c(c2P(C)(C)=O)OCCO3)n1,10.30,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.05,nM,=,CHEMBL5117929,B,CHEMBL5193123,Homo sapiens,CHEMBL203,CHEMBL5113487
C=CC(=O)N1CCC([C@@H]2CCNC3C(C(N)=O)C(c4ccc(Oc5ccccc5)cc4)=NN32)CC1,7.68,Inhibition of EGFR (unknown origin),IC50,21.0,nM,=,CHEMBL5127259,B,CHEMBL5193128,Homo sapiens,CHEMBL203,CHEMBL5126513
COc1cc(N2CCC(N3CC[C@H](N(C)C)C3)CC2)c(C)cc1Nc1ncc(Br)c(Nc2ccc3c(c2P(C)(C)=O)OCCO3)n1,9.92,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.12,nM,=,CHEMBL5117929,B,CHEMBL5193149,Homo sapiens,CHEMBL203,CHEMBL5113487
CC(C)c1ccc(Cn2cc(-c3cc(-c4ccc(Br)cc4)nc(N)n3)c3ccccc32)cc1,7.03,Inhibition of EGFR T790M mutant (unknown origin) incubated for 1 hr by Z-lyte kinase assay,IC50,94.0,nM,=,CHEMBL5127076,B,CHEMBL5193175,Homo sapiens,CHEMBL203,CHEMBL5126509
C=CC(=O)Nc1cc2c(cc1OCCNC(=O)CN(C)C)NCN=C2Nc1ccc(Br)cc1F,8.70,Inhibition of EGFR (unknown origin),IC50,2.0,nM,=,CHEMBL5127078,B,CHEMBL5193247,Homo sapiens,CHEMBL203,CHEMBL5126509
Cc1cc(Nc2ncnc3cc(O)c(NC(=O)/C=C/[C@H]4CCCN4C)cc23)ccc1Oc1ccn2ncnc2c1,8.55,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,2.8,nM,=,CHEMBL5162303,B,CHEMBL5193451,Homo sapiens,CHEMBL203,CHEMBL5154811
Cc1c(-c2ccc(N3CCOCC3)cc2)cc(C(F)F)c2cn(C(C(=O)Nc3nccs3)c3ncn4c3C[C@@H](F)C4)nc12,8.15,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,7.0,nM,=,CHEMBL5120428,B,CHEMBL5193594,Homo sapiens,CHEMBL203,CHEMBL5113538
CCS(=O)(=O)n1cc2c3ccc(cc31)OCCCCCCOc1cc(c(C)cc1N1CCOCC1)Nc1ncc(Cl)c-2n1,7.63,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,23.6,nM,=,CHEMBL5165817,B,CHEMBL5193609,Homo sapiens,CHEMBL203,CHEMBL5154883
O=C(Nc1nccs1)C(c1ncn2c1CCC2)n1cc2c(F)cc(C#Cc3ccc(CN4CCC(O)CC4)cc3)cc2n1,8.22,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,6.0,nM,=,CHEMBL5120428,B,CHEMBL5193772,Homo sapiens,CHEMBL203,CHEMBL5113538
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(-c2cn(S(C)(=O)=O)c3ccccc23)n1,8.72,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,IC50,1.9,nM,=,CHEMBL5165816,B,CHEMBL5194174,Homo sapiens,CHEMBL203,CHEMBL5154883
CCC(=O)N[C@H]1CC[C@H](n2c(=O)c(-c3ccccc3Cl)cc3ccc(Nc4ccc(N5CCN(C)CC5)c(C)c4)cc32)CC1,7.42,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,38.1,nM,=,CHEMBL5143769,B,CHEMBL5194245,Homo sapiens,CHEMBL203,CHEMBL5143505
COc1cc2ncnc3c2cc1OCCOCCOCCOc1cccc(Cl)c1N3,7.49,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,32.6,nM,=,CHEMBL5153036,B,CHEMBL5194285,Homo sapiens,CHEMBL203,CHEMBL5150044
C=CC(=O)Nc1cccc(Cn2c(=O)ccc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1,6.67,Inhibition of EGFR T790M mutant (unknown origin) incubated for 1 hr in the presence of ATP by FRET based Z'-LYTE assay,IC50,216.3,nM,=,CHEMBL5146950,B,CHEMBL5194482,Homo sapiens,CHEMBL203,CHEMBL5143636
Cc1ccc(-c2c(CN3CCCCC3)nc3scc(C(=O)O)n23)cc1,6.75,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,IC50,180.0,nM,=,CHEMBL5110647,B,CHEMBL5194543,Homo sapiens,CHEMBL203,CHEMBL5108025
COc1ccc(/C=C\C(=O)c2ccc(Br)c3cc(-c4ccc(F)cc4)oc23)cc1,7.05,Inhibition of EGFR (unknown origin),IC50,90.0,nM,=,CHEMBL5138507,B,CHEMBL5194719,Homo sapiens,CHEMBL203,CHEMBL5137005
CC[C@]1(F)CN(c2nccc(Nc3cc4c(C(C)C)ccc(N5C[C@H](CS(C)(=O)=O)[C@H]5C)c4cn3)n2)CC[C@H]1O,9.30,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,0.5,nM,=,CHEMBL5141214,B,CHEMBL5194722,Homo sapiens,CHEMBL203,CHEMBL5137066
Nc1nc(Nc2ccc(COc3cccc(F)c3)cc2)c2c(n1)[nH]c1ccc(O)cc12,6.77,"Binding affinity to GST-tagged human recombinant EGFR expressed in baculovirus infected Sf9 insect cells assessed as inhibition constant using poly(Glu,Tyr) 4:1 as substrate incubated for 60 mins in presence of [gamma33P]ATP by microplate scintillation counter analysis",Ki,170.0,nM,=,CHEMBL5127074,B,CHEMBL5194946,Homo sapiens,CHEMBL203,CHEMBL5126509
Nc1ccc2ncnc(Nc3ccc4c(ccn4Cc4cccc(Cl)c4)c3)c2c1,8.08,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,8.38,nM,=,CHEMBL5161051,B,CHEMBL5194966,Homo sapiens,CHEMBL203,CHEMBL5154786
CCc1cc(Nc2ncc(Br)c(Nc3ccn4ncnc4c3P(C)(C)=O)n2)c(OC)cc1N1CCC(N2CCOCC2)CC1,9.74,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.18,nM,=,CHEMBL5117929,B,CHEMBL5195137,Homo sapiens,CHEMBL203,CHEMBL5113487
CC(C)c1cnc(N2CC[C@H]2C)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,9.52,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,0.3,nM,=,CHEMBL5141214,B,CHEMBL5195164,Homo sapiens,CHEMBL203,CHEMBL5137066
Cn1cc(-c2cc(C(=O)/N=c3\[nH]c4ccccc4n3[C@H]3CC[C@H](O)CC3)ccn2)cn1,7.92,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),IC50,12.0,nM,=,CHEMBL5143771,B,CHEMBL5195167,Homo sapiens,CHEMBL203,CHEMBL5143505
CC(C)(C)n1cc(-c2cncc3ccccc23)c2c(N)ncnc21,7.28,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,53.0,nM,=,CHEMBL5143769,B,CHEMBL5195321,Homo sapiens,CHEMBL203,CHEMBL5143505
COc1cc2ncnc3c2cc1OCCCCCCOc1ccc(Cl)cc1N3,7.71,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,19.6,nM,=,CHEMBL5153035,B,CHEMBL5195531,Homo sapiens,CHEMBL203,CHEMBL5150044
Cc1ccc(/C=N/NC(=O)CNc2nc(-c3ccccc3)c(-c3ccccc3)s2)cc1,6.70,Inhibition of recombinant EGFR (unknown origin) expressed in baculovirus incubated for 10 mins by europium-labeled antiphosphotyrosine/enhancement solution based assay,IC50,200.0,nM,=,CHEMBL5097849,B,CHEMBL5195593,Homo sapiens,CHEMBL203,CHEMBL5096183
O=C(Nc1nccs1)C(c1n[nH]c2c1CCC2)N1Cc2ccccc2C1=O,7.64,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,23.0,nM,=,CHEMBL5120428,B,CHEMBL5195669,Homo sapiens,CHEMBL203,CHEMBL5113538
CCOC1CN(C2CCN(c3cc(OC)c(Nc4ncc(Br)c(Nc5ccc6c(c5P(C)(C)=O)OCCO6)n4)cc3C)CC2)C1,9.37,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.43,nM,=,CHEMBL5117929,B,CHEMBL5195904,Homo sapiens,CHEMBL203,CHEMBL5113487
CN1CCC(c2ccc(-c3ccc4c(c3)C(=O)N(C(C(=O)Nc3nccs3)c3cccc(F)c3)CC4)cc2)CC1,8.49,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,3.2,nM,=,CHEMBL5147203,B,CHEMBL5195912,Homo sapiens,CHEMBL203,CHEMBL5143652
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(SCCCN4CCOCC4)cc3)ncc2Cl)c1,7.56,Inhibition of EGFR L858R/T790M double mutant (unknown origin) in presence of ATP by ADP-Glo assay,IC50,27.5,nM,=,CHEMBL5097724,B,CHEMBL5196024,Homo sapiens,CHEMBL203,CHEMBL5096180
COc1cc2ncnc3c2cc1OCCCCCCOc1cc(Cl)ccc1N3,4.20,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,63506.7,nM,=,CHEMBL5153035,B,CHEMBL5196064,Homo sapiens,CHEMBL203,CHEMBL5150044
Cc1n[nH]c2c1C(c1ccccc1Br)c1c(ncn(N)c1=N)O2,7.22,"Inhibition of recombinant EGFR (unknown origin) using Poly-(Glu,Tyr 4:1) peptide as a substrate in presence of ATP by luminescence based assay",IC50,60.0,nM,=,CHEMBL5097734,B,CHEMBL5196209,Homo sapiens,CHEMBL203,CHEMBL5096180
COc1cc(N(C)CCN(C)C)c(NC(=O)c2nccn2C)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,6.96,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,IC50,110.0,nM,=,CHEMBL5140665,B,CHEMBL5196254,Homo sapiens,CHEMBL203,CHEMBL5137051
CN1CCC(c2ccc(-c3ccc4ncn(C(C(=O)Nc5nccs5)c5ccccc5)c(=O)c4c3F)cc2)CC1,10.00,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,0.1,nM,=,CHEMBL5147203,B,CHEMBL5196360,Homo sapiens,CHEMBL203,CHEMBL5143652
CC(C)c1ccc(N2C[C@H](CS(C)(=O)=O)[C@H]2C)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,9.52,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,0.3,nM,=,CHEMBL5141214,B,CHEMBL5196495,Homo sapiens,CHEMBL203,CHEMBL5137066
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(=O)CCCC(=O)Nc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)cc3OC)ncc2C(F)(F)F)c1,7.48,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,IC50,33.03,nM,=,CHEMBL5115840,B,CHEMBL5196498,Homo sapiens,CHEMBL203,CHEMBL5113409
CN1CCC(c2ccc(-c3ccc4c(=O)n(C(C(=O)Nc5nccs5)c5ccccc5)ccc4c3)cc2)CC1,8.92,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,1.2,nM,=,CHEMBL5147203,B,CHEMBL5197154,Homo sapiens,CHEMBL203,CHEMBL5143652
CCc1cc(Nc2ncc(Br)c(Nc3ccc4c(c3P(C)(C)=O)OCCO4)n2)c(OC)cc1N1CCC(N2CC(COC)C2)CC1,9.92,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.12,nM,=,CHEMBL5117930,B,CHEMBL5197545,Homo sapiens,CHEMBL203,CHEMBL5113487
CCS(=O)(=O)n1cc2c3ccc(cc31)OCCCCCCOc1cc(c(F)cc1N1CCOCC1)Nc1ncc(Cl)c-2n1,7.55,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,28.0,nM,=,CHEMBL5165817,B,CHEMBL5197952,Homo sapiens,CHEMBL203,CHEMBL5154883
CCS(=O)(=O)n1cc(-c2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3OC)ncc2Cl)c2ccccc21,8.25,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,IC50,5.6,nM,=,CHEMBL5165816,B,CHEMBL5198314,Homo sapiens,CHEMBL203,CHEMBL5154883
CC1=NNC2=NC(=O)NC(c3ccccc3Br)C12,7.05,"Inhibition of recombinant EGFR (unknown origin) using Poly-(Glu,Tyr 4:1) peptide as a substrate in presence of ATP by luminescence based assay",IC50,90.0,nM,=,CHEMBL5097734,B,CHEMBL5198368,Homo sapiens,CHEMBL203,CHEMBL5096180
Nc1ccc2ncnc(Nc3ccc4c(ccn4Cc4cccc(F)c4)c3)c2c1,8.52,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,3.01,nM,=,CHEMBL5161051,B,CHEMBL5198424,Homo sapiens,CHEMBL203,CHEMBL5154786
O=C(Nc1nccs1)C(c1ncn2c1CCC2)N1Cc2ccc(C#Cc3ccc(CN4CCCCC4)cc3)cc2C1=O,7.80,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,16.0,nM,=,CHEMBL5120428,B,CHEMBL5198433,Homo sapiens,CHEMBL203,CHEMBL5113538
Brc1cccc(Nc2ncnc3c2[nH]c2ccccc23)c1,7.14,Inhibition of EGFR in human A-431 cell membrane vesicles using phospholipase C-gamma-1 as substrate incubated for 10 mins by scintillation counter method,IC50,72.0,nM,=,CHEMBL5138014,B,CHEMBL5198809,Homo sapiens,CHEMBL203,CHEMBL5136983
CN1CCC(c2ccc(-c3ccc4c(c3)C(=O)N(C(C(=O)Nc3nccs3)c3ccccc3)C4)cc2)CC1,9.05,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,0.9,nM,=,CHEMBL5147203,B,CHEMBL5198812,Homo sapiens,CHEMBL203,CHEMBL5143652
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N(C)CCN(C)C)cc3OC)nc3[nH]ccc23)CC1,8.11,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,7.696,nM,=,CHEMBL5099547,B,CHEMBL5198920,Homo sapiens,CHEMBL203,CHEMBL5096223
COCC1CN(c2ncc(C(C)C)c3cc(Nc4ccnc(N5CC[C@@H](O)[C@@](C)(F)C5)n4)ncc23)C1,7.96,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,11.0,nM,=,CHEMBL5141214,B,CHEMBL5198992,Homo sapiens,CHEMBL203,CHEMBL5137066
COc1cc2ncnc3c2cc1OCCOCCOc1cc(ccc1Cl)N3,6.31,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,492.9,nM,=,CHEMBL5153035,B,CHEMBL5199106,Homo sapiens,CHEMBL203,CHEMBL5150044
CSc1nc(-c2cccc(NC(=O)c3c(F)ccc(O)c3CN3Cc4ccccc4C3=O)c2)c(-c2ccnc(NC(C)=O)c2)[nH]1,6.55,Inhibition of human EGFR L858R mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,IC50,280.0,nM,=,CHEMBL5155237,B,CHEMBL5199122,Homo sapiens,CHEMBL203,CHEMBL5154643
COc1cc(N(C)CCN(C)C)c(NC(=O)c2ncccn2)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,7.52,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,IC50,30.0,nM,=,CHEMBL5140665,B,CHEMBL5199169,Homo sapiens,CHEMBL203,CHEMBL5137051
Nc1ccc2ncnc(Nc3cccc4ccccc34)c2c1,8.80,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,1.6,nM,=,CHEMBL5161051,B,CHEMBL5199341,Homo sapiens,CHEMBL203,CHEMBL5154786
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(CCO)CC4)cc3)ncc2Cl)CC1,7.38,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,42.06,nM,=,CHEMBL5099547,B,CHEMBL5199354,Homo sapiens,CHEMBL203,CHEMBL5096223
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc3ccsc23)CC1,7.85,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,14.2,nM,=,CHEMBL5099547,B,CHEMBL5199399,Homo sapiens,CHEMBL203,CHEMBL5096223
Nc1ccc2ncnc(Nc3ccc4cc[nH]c4c3)c2c1,6.74,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,183.7,nM,=,CHEMBL5161051,B,CHEMBL5199612,Homo sapiens,CHEMBL203,CHEMBL5154786
CCc1cc(Nc2ncc(Br)c(Nc3ccc4ncnn4c3P(C)(C)=O)n2)c(OC)cc1N1CCC(N2CC(COC)C2)CC1,9.08,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.84,nM,=,CHEMBL5117930,B,CHEMBL5199678,Homo sapiens,CHEMBL203,CHEMBL5113487
C=CC(=O)Nc1cccc(N2C(=O)OC(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,7.32,Inhibition EGFR (unknown origin) expressed in baculovirus expression system by ELISA,IC50,47.4,nM,=,CHEMBL5150940,B,CHEMBL5200275,Homo sapiens,CHEMBL203,CHEMBL5149979
CC(=O)N[C@H]1CC[C@H](n2c(=O)c(-c3ccccc3Cl)cc3ccc(Nc4ccc(N5CCN(C)CC5)c(C)c4)cc32)CC1,7.32,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,47.8,nM,=,CHEMBL5143769,B,CHEMBL5200385,Homo sapiens,CHEMBL203,CHEMBL5143505
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(=O)CCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)cc3OC)ncc2C(F)(F)F)c1,6.92,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,IC50,121.3,nM,=,CHEMBL5115840,B,CHEMBL5200495,Homo sapiens,CHEMBL203,CHEMBL5113409
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(-c2cn(S(=O)(=O)C3CC3)c3ccccc23)n1,7.49,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,IC50,32.6,nM,=,CHEMBL5165818,B,CHEMBL5200598,Homo sapiens,CHEMBL203,CHEMBL5154883
CN1CCC(c2ccc(-c3ccc4c(c3)CCN(C(C(=O)Nc3nccs3)c3cccc(F)c3)C4=O)cc2)CC1,8.66,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,2.2,nM,=,CHEMBL5147203,B,CHEMBL5200637,Homo sapiens,CHEMBL203,CHEMBL5143652
CCCn1ccc2cc(Nc3ncnc4ccc(N)cc34)ccc21,6.45,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,358.3,nM,=,CHEMBL5161051,B,CHEMBL5200760,Homo sapiens,CHEMBL203,CHEMBL5154786
COCC(=O)NC/C=C/c1ccc2ncc(C#N)c(Nc3ccc(Oc4cc5nncn5cn4)c(C)c3)c2c1,5.74,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,1833.8,nM,=,CHEMBL5162303,B,CHEMBL5200783,Homo sapiens,CHEMBL203,CHEMBL5154811
CN1CCC(c2ccc(-c3ccc4c(=O)n(C(C(=O)Nc5nccs5)c5ccccc5)ncc4c3)cc2)CC1,8.01,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,9.7,nM,=,CHEMBL5147203,B,CHEMBL5200988,Homo sapiens,CHEMBL203,CHEMBL5143652
CC(C)c1cnc(N2C[C@H](CS(C)(=O)=O)[C@H]2C)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,9.70,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,0.2,nM,=,CHEMBL5141214,B,CHEMBL5200991,Homo sapiens,CHEMBL203,CHEMBL5137066
O=C(CCCCn1cc(-c2ccc3ncnc(Nc4ccccc4F)c3c2)nn1)NO,7.99,Inhibition of EGFR (unknown origin),IC50,10.3,nM,=,CHEMBL5138507,B,CHEMBL5201054,Homo sapiens,CHEMBL203,CHEMBL5137005
CCOC(=O)[C@@H]1CCCN1CC(=O)NNC(=O)COc1ccc(-c2nc3ccccc3s2)cc1OC,6.96,Inhibition of EGFR (unknown origin),IC50,109.0,nM,=,CHEMBL5133605,B,CHEMBL5201110,Homo sapiens,CHEMBL203,CHEMBL5131433
COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)NC5CC5)CC4)c(Cl)c3)c2cc1C(N)=O,5.19,Inhibition of EGFR (unknown origin) by ELISA method,IC50,6500.0,nM,=,CHEMBL5151935,B,CHEMBL5201128,Homo sapiens,CHEMBL203,CHEMBL5150004
CCS(=O)(=O)n1cc2c3ccc(cc31)OCCCCCCCOc1cc(ccc1N1CCOCC1)Nc1ncc(Cl)c-2n1,7.05,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,89.9,nM,=,CHEMBL5165817,B,CHEMBL5201250,Homo sapiens,CHEMBL203,CHEMBL5154883
C=CC(=O)Nc1ccc(Nc2nccc(-c3cn(C)c4ccccc34)n2)cc1,6.75,Inhibition of EGFR T790M mutant (unknown origin),IC50,180.0,nM,=,CHEMBL5097717,B,CHEMBL5201387,Homo sapiens,CHEMBL203,CHEMBL5096180
COc1cc(/C=C/S(=O)(=O)c2ccccc2)cc(OC)c1OC,8.11,Inhibition of EGFR (unknown origin) using poly (glu-tyr) as substrate incubated for 1 hr in presence of ATP measured by ADP-Glo kinase assay,IC50,7.85,nM,=,CHEMBL5128251,B,CHEMBL5201532,Homo sapiens,CHEMBL203,CHEMBL5126541
CN1CCC(c2ccc(-c3ccc4c(c3)C(=O)N(C(C(=O)Nc3nccs3)c3cc(F)ccc3O)C4)cc2)CC1,10.00,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,0.1,nM,=,CHEMBL5147203,B,CHEMBL5201543,Homo sapiens,CHEMBL203,CHEMBL5143652
O=C(Nc1nccs1)C(c1ncn2c1CCC2)n1cc2c(Cl)cc(-c3ccc(N4CCOCC4)cc3)c(Cl)c2n1,7.66,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,22.0,nM,=,CHEMBL5120428,B,CHEMBL5201725,Homo sapiens,CHEMBL203,CHEMBL5113538
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(=O)CCCCCC(=O)Nc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)cc3OC)ncc2C(F)(F)F)c1,7.69,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,IC50,20.33,nM,=,CHEMBL5115840,B,CHEMBL5201794,Homo sapiens,CHEMBL203,CHEMBL5113409
COc1cc(N(C)CCN(C)C)c(NC(=O)c2ccncn2)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,8.00,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,IC50,10.0,nM,=,CHEMBL5140665,B,CHEMBL5201846,Homo sapiens,CHEMBL203,CHEMBL5137051
Cc1cc(Nc2ncnc3cc(O)c(NC(=O)/C=C/[C@H]4CCCN4C)cc23)ccc1Oc1ccc2nccn2c1,8.63,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,2.32,nM,=,CHEMBL5162303,B,CHEMBL5201973,Homo sapiens,CHEMBL203,CHEMBL5154811
CCc1ccc(Cn2cc(-c3cc(-c4ccc(Br)cc4)nc(N)n3)c3ccccc32)cc1,7.01,Inhibition of EGFR T790M mutant (unknown origin) incubated for 1 hr by Z-lyte kinase assay,IC50,97.0,nM,=,CHEMBL5127076,B,CHEMBL5202119,Homo sapiens,CHEMBL203,CHEMBL5126509
CN1CCN(c2ccc(-c3ccc4c(c3)CCN(C(C(=O)Nc3nccs3)c3cccc(F)c3)C4=O)cc2)CC1,8.96,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,1.1,nM,=,CHEMBL5147203,B,CHEMBL5202129,Homo sapiens,CHEMBL203,CHEMBL5143652
CSc1nc(-c2ccc(F)cc2)c(-c2ccnc3[nH]c(-c4ccccc4)cc23)[nH]1,6.54,Inhibition of wild type EGFR (unknown origin),IC50,287.0,nM,=,CHEMBL5143770,B,CHEMBL5202381,Homo sapiens,CHEMBL203,CHEMBL5143505
Cc1cc(Nc2ncnc3cc(O)c(NC(=O)/C=C/[C@H]4CCCN4C)cc23)ccc1Oc1cnn2cnnc2c1,7.93,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,11.82,nM,=,CHEMBL5162303,B,CHEMBL5202846,Homo sapiens,CHEMBL203,CHEMBL5154811
CCN1CCN(c2ccc(-c3cc(Cl)c4cn(C(C(=O)Nc5nccs5)c5ncn6c5C[C@@H](F)C6)nc4c3Cl)cc2)CC1,8.40,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,4.0,nM,=,CHEMBL5120428,B,CHEMBL5202945,Homo sapiens,CHEMBL203,CHEMBL5113538
CCOC1CN(C2CCN(c3cc(OC)c(Nc4ncc(Br)c(Nc5ccc6ncnn6c5P(C)(C)=O)n4)cc3CC)CC2)C1,9.17,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.67,nM,=,CHEMBL5117930,B,CHEMBL5203041,Homo sapiens,CHEMBL203,CHEMBL5113487
C=CC(=O)Nc1cccc(N2C(=O)OCc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1,7.54,Inhibition EGFR (unknown origin) expressed in baculovirus expression system by ELISA,IC50,28.8,nM,=,CHEMBL5150940,B,CHEMBL5203118,Homo sapiens,CHEMBL203,CHEMBL5149979
CCC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)CC1,6.45,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,356.26,nM,=,CHEMBL5099547,B,CHEMBL5203176,Homo sapiens,CHEMBL203,CHEMBL5096223
COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4cc5nncn5cn4)c(C)c3)c2c1,6.96,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,110.32,nM,=,CHEMBL5162303,B,CHEMBL5203179,Homo sapiens,CHEMBL203,CHEMBL5154811
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)ncc2Cl)CC1,8.02,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,9.6,nM,=,CHEMBL5099547,B,CHEMBL5203195,Homo sapiens,CHEMBL203,CHEMBL5096223
CCc1cc(Nc2ncc(Br)c(Nc3ccc4c(c3P(C)(C)=O)OCO4)n2)c(OC)cc1N1CCC(N2CC(N(C)C)C2)CC1,9.82,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.15,nM,=,CHEMBL5117930,B,CHEMBL5203220,Homo sapiens,CHEMBL203,CHEMBL5113487
CC(C)c1cnc(N2CC(O)C2)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,8.44,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,3.6,nM,=,CHEMBL5141214,B,CHEMBL5203267,Homo sapiens,CHEMBL203,CHEMBL5137066
CCc1cc(Nc2ncc(Br)c(Nc3ccc4c(c3P(C)(C)=O)OCCO4)n2)c(OC)cc1N1CCC(N2CC(CC#N)C2)CC1,9.39,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.41,nM,=,CHEMBL5117930,B,CHEMBL5203385,Homo sapiens,CHEMBL203,CHEMBL5113487
O=C(Nc1nccs1)C(c1ncn2c1CCC2)N1Cc2ccccc2C1=O,7.80,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,16.0,nM,=,CHEMBL5120428,B,CHEMBL5203388,Homo sapiens,CHEMBL203,CHEMBL5113538
CCN1CCN(c2ccc(-c3cc(Cl)c4cn(C(C(=O)Nc5nccs5)c5ncn6c5CCC6)nc4c3Cl)cc2)CC1,7.96,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,11.0,nM,=,CHEMBL5120428,B,CHEMBL5203543,Homo sapiens,CHEMBL203,CHEMBL5113538
C=CC(=O)N1CCCC(n2nc(-c3ccc4ccccc4c3)c3c(N)ncnc32)C1,7.06,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,88.0,nM,=,CHEMBL5097728,B,CHEMBL5203640,Homo sapiens,CHEMBL203,CHEMBL5096180
O=C(/C=C\c1ccc(OC(F)(F)F)cc1)c1ccc(Br)c2cc(-c3ccc(F)cc3)oc12,6.92,Inhibition of EGFR (unknown origin),IC50,120.0,nM,=,CHEMBL5138507,B,CHEMBL5203711,Homo sapiens,CHEMBL203,CHEMBL5137005
Nc1nc(-c2ccc(Br)cc2)cc(-c2cn(Cc3cccc(Cl)c3)c3ccccc23)n1,6.71,Inhibition of EGFR T790M mutant (unknown origin) incubated for 1 hr by Z-lyte kinase assay,IC50,195.0,nM,=,CHEMBL5127076,B,CHEMBL5203758,Homo sapiens,CHEMBL203,CHEMBL5126509
COc1cc(-c2nc3ccccc3s2)ccc1OCC(=O)NNC(=O)CN[C@@H](Cc1c[nH]cn1)C(=O)O,6.52,Inhibition of EGFR (unknown origin),IC50,305.0,nM,=,CHEMBL5133605,B,CHEMBL5203784,Homo sapiens,CHEMBL203,CHEMBL5131433
COc1cc(N(C)CCN(C)C)c(NC(=O)c2cccnc2)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,6.44,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,IC50,360.0,nM,=,CHEMBL5140665,B,CHEMBL5203821,Homo sapiens,CHEMBL203,CHEMBL5137051
CN1CCC(c2ccc(-c3ccc4c(=O)n(C(C(=O)Nc5nccs5)c5ccccc5)cnc4c3)cc2)CC1,8.24,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,5.8,nM,=,CHEMBL5147203,B,CHEMBL5204270,Homo sapiens,CHEMBL203,CHEMBL5143652
CC(=O)NNC(=O)c1csc2ncc(-c3ccc(Br)cc3)n12,6.82,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,IC50,153.0,nM,=,CHEMBL5110647,B,CHEMBL5204417,Homo sapiens,CHEMBL203,CHEMBL5108025
COc1cc2ncnc3c2cc1OCCOCCOCCOc1ccccc1N3,7.06,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,87.6,nM,=,CHEMBL5153036,B,CHEMBL5204446,Homo sapiens,CHEMBL203,CHEMBL5150044
C=CC(=O)Nc1ccc2ncnc(Nc3ccc4c(ccn4Cc4cccc(F)c4)c3)c2c1,8.96,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,1.1,nM,=,CHEMBL5161051,B,CHEMBL5204535,Homo sapiens,CHEMBL203,CHEMBL5154786
NNC(=O)c1csc2nc(CN3CCOCC3)c(-c3ccc(Br)cc3)n12,6.38,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,IC50,419.0,nM,=,CHEMBL5110647,B,CHEMBL5204650,Homo sapiens,CHEMBL203,CHEMBL5108025
CCO[C@@H]1CCN(C2CCN(c3cc(OC)c(Nc4ncc(Br)c(Nc5ccc6c(c5P(C)(C)=O)OCCO6)n4)cc3C)CC2)C1,9.55,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.28,nM,=,CHEMBL5117929,B,CHEMBL5204749,Homo sapiens,CHEMBL203,CHEMBL5113487
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(CC(=O)NCCNc5cccc6c5C(=O)N(C5CCC(=O)N(C)C5=O)C6=O)CC4)cc3OC)ncc2C(F)(F)F)c1,6.87,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,IC50,133.7,nM,=,CHEMBL5115840,B,CHEMBL5204954,Homo sapiens,CHEMBL203,CHEMBL5113409
CN1CCN(c2ccc(-c3ccc4c(=O)n(C(C(=O)Nc5nccs5)c5ccccc5)cnc4c3)cc2)CC1,8.51,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,3.1,nM,=,CHEMBL5147203,B,CHEMBL5204970,Homo sapiens,CHEMBL203,CHEMBL5143652
C=CC(=O)Nc1cccc(-c2c(-c3ccc(N4CCN(C)CC4)cc3)[nH]c3ncnc(OCCCC)c23)c1,8.03,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,9.4,nM,=,CHEMBL5143769,B,CHEMBL5205022,Homo sapiens,CHEMBL203,CHEMBL5143505
COc1cc2ncnc3c2cc1OCCOCCOc1c(Cl)cccc1N3,6.29,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,509.3,nM,=,CHEMBL5153035,B,CHEMBL5205073,Homo sapiens,CHEMBL203,CHEMBL5150044
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc3[nH]ccc23)CC1,7.91,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,12.32,nM,=,CHEMBL5099547,B,CHEMBL5205097,Homo sapiens,CHEMBL203,CHEMBL5096223
CCS(=O)(=O)n1cc2c3ccc(cc31)OCCCCCCOc1cc(ccc1N1CCOCC1)Nc1ncc(Cl)c-2n1,8.21,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,6.2,nM,=,CHEMBL5165817,B,CHEMBL5205581,Homo sapiens,CHEMBL203,CHEMBL5154883
COC1CN(c2ncc(C(C)C)c3cc(Nc4ccnc(N5CC[C@@H](O)[C@@](C)(F)C5)n4)ncc23)C1,8.47,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,3.4,nM,=,CHEMBL5141214,B,CHEMBL5205583,Homo sapiens,CHEMBL203,CHEMBL5137066
COc1cc2ncnc3c2cc1OCCOCCOCCOc1ccc(Cl)cc1N3,9.52,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,0.3,nM,=,CHEMBL5153035,B,CHEMBL5206110,Homo sapiens,CHEMBL203,CHEMBL5150044
COc1cc(N2CCC(N3CC(N(C)C)C3)CC2)c(C)cc1Nc1ncc(Br)c(Nc2ccc3c(c2P(C)(C)=O)OCCO3)n1,9.66,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.22,nM,=,CHEMBL5117930,B,CHEMBL5206164,Homo sapiens,CHEMBL203,CHEMBL5113487
O=C(Nc1ccccc1C(=O)N/N=C/c1ccc(O)cc1O)c1ccco1,7.07,Inhibition of EGFR (unknown origin) by microplate reader,IC50,85.4,nM,=,CHEMBL5138527,B,CHEMBL5206193,Homo sapiens,CHEMBL203,CHEMBL5137005
COc1cc(N(C)CCN(C)C)c(NC(=O)c2ccncn2)cc1Nc1nccc(-c2cn(CCCO)c3ccccc23)n1,7.39,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,IC50,41.0,nM,=,CHEMBL5140665,B,CHEMBL5206298,Homo sapiens,CHEMBL203,CHEMBL5137051
COC(=O)CCc1nc2ccc(Cl)cc2[nH]c1=O,7.08,Inhibition of EGFR L858R mutant (unknown origin),IC50,82.76,nM,=,CHEMBL5114136,B,CHEMBL5206400,Homo sapiens,CHEMBL203,CHEMBL5113380
CN1CCN(c2ccc(-c3ccc4cnn(C(C(=O)Nc5nccs5)c5ccccc5)c(=O)c4c3)cc2)CC1,7.99,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,10.3,nM,=,CHEMBL5147203,B,CHEMBL5206436,Homo sapiens,CHEMBL203,CHEMBL5143652
CC(C)c1ccc(N2CC(CS(C)(=O)=O)C2)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,9.70,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,0.2,nM,=,CHEMBL5141214,B,CHEMBL5206444,Homo sapiens,CHEMBL203,CHEMBL5137066
O=C1c2ccccc2CN1C(c1nc(=O)c2ccccc2[nH]1)c1cc(F)ccc1O,5.28,Inhibition of EGFR L858R/T790M double mutant (unknown origin),IC50,5300.0,nM,=,CHEMBL5143776,B,CHEMBL5206476,Homo sapiens,CHEMBL203,CHEMBL5143505
CCC(=O)N1CCC[C@@H](N2CC(c3cccc(F)c3Cl)=C(C)c3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)C1,7.56,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,27.5,nM,=,CHEMBL5143769,B,CHEMBL5206600,Homo sapiens,CHEMBL203,CHEMBL5143505
CCOc1cc(N2CCC(N3CCN(C)CC3)CC2)c(Cl)cc1Nc1ncc(Cl)c(-c2cn(S(=O)(=O)CC)c3ccccc23)n1,8.38,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,4.2,nM,=,CHEMBL5165817,B,CHEMBL5206683,Homo sapiens,CHEMBL203,CHEMBL5154883
COc1cc2ncnc(Nc3cc(Cl)c(F)cc3O)c2cc1O,7.94,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,11.5,nM,=,CHEMBL5153035,B,CHEMBL5206697,Homo sapiens,CHEMBL203,CHEMBL5150044
CCc1cc(Nc2ncc(Br)c(Nc3ccc4nccnc4c3P(C)(C)=O)n2)c(OC)cc1N1CCC(N2CCN(CCS(C)(=O)=O)CC2)CC1,9.70,Inhibition of EGFR L858R/T790M mutant (unknown origin),IC50,0.2,nM,=,CHEMBL5114503,B,CHEMBL5206715,Homo sapiens,CHEMBL203,CHEMBL5113388
C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(CCOCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)cc3OC)ncc2C(F)(F)F)c1,7.62,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,IC50,24.12,nM,=,CHEMBL5115840,B,CHEMBL5206775,Homo sapiens,CHEMBL203,CHEMBL5113409
Fc1cccc(COc2ccc(Nc3ncnc4sc5c(c34)CCCC5)cc2Cl)c1,6.70,"Inhibition of recombinant C-terminal His-tagged/N-terminal GST-tagged human EGFR expressed in sf9 insect cells using poly(Glu, Tyr) sodium salt (4:1, Glu:Tyr) as a substrate measured after 40 mins by Kinase-Glo reagent based luminescence analysis",IC50,200.0,nM,=,CHEMBL5097745,B,CHEMBL5206805,Homo sapiens,CHEMBL203,CHEMBL5096180
C=CC(=O)Nc1cccc(-c2c(-c3ccc(N4CCN(C)CC4)cc3)[nH]c3ncnc(OC4CCCC4)c23)c1,7.72,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),IC50,19.0,nM,=,CHEMBL5143769,B,CHEMBL5206817,Homo sapiens,CHEMBL203,CHEMBL5143505
CN1CCC(c2ccc(-c3ccc4ncn(C(C(=O)Nc5nccs5)c5ccccc5)c(=O)c4c3)cc2)CC1,9.70,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,0.2,nM,=,CHEMBL5147203,B,CHEMBL5206902,Homo sapiens,CHEMBL203,CHEMBL5143652
COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(-c2cn(C(C)=O)c3ccccc23)n1,8.07,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,IC50,8.5,nM,=,CHEMBL5165816,B,CHEMBL5207083,Homo sapiens,CHEMBL203,CHEMBL5154883
CN1CCC(c2ccc(-c3cnc4ncn(C(C(=O)Nc5nccs5)c5ccccc5)c(=O)c4c3)cc2)CC1,8.72,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,1.9,nM,=,CHEMBL5147203,B,CHEMBL5207108,Homo sapiens,CHEMBL203,CHEMBL5143652
O=C(Nc1nccs1)C(c1ncn2c1C[C@@H](F)C2)n1cc2c(Cl)cc(-c3ccc(N4CCN(C5CC5)CC4)cc3)c(Cl)c2n1,7.77,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,17.0,nM,=,CHEMBL5120428,B,CHEMBL5207152,Homo sapiens,CHEMBL203,CHEMBL5113538
COc1cc2c(cc1OC)C(Oc1cccc(NC(=S)Nc3ccc(Cl)c(C(F)(F)F)c3)c1)=NCN2,7.70,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins in presence of ATP by caliper mobility shift assay,IC50,20.0,nM,=,CHEMBL5127082,B,CHEMBL5207327,Homo sapiens,CHEMBL203,CHEMBL5126509
CC(C)c1cnc(N2C[C@H](O)[C@H]2C)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,9.52,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,0.3,nM,=,CHEMBL5141214,B,CHEMBL5207390,Homo sapiens,CHEMBL203,CHEMBL5137066
CN1CCN(c2ccc(-c3ccc4c(=O)n(C(C(=O)Nc5nccs5)c5ccccc5)ncc4c3)cc2)CC1,7.75,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,17.8,nM,=,CHEMBL5147203,B,CHEMBL5207462,Homo sapiens,CHEMBL203,CHEMBL5143652
O=C(Nc1nccs1)C(c1ncn2c1CCC2)N1Cc2c(F)cc(C#Cc3ccc(CN4CCC(O)CC4)cc3)cc2C1=O,8.30,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,5.0,nM,=,CHEMBL5120428,B,CHEMBL5207479,Homo sapiens,CHEMBL203,CHEMBL5113538
Clc1ccc(Nc2ncnc3[nH]ccc23)cc1Br,8.44,Inhibition of EGFR (unknown origin) by ADP-Glo kinase assay,IC50,3.63,nM,=,CHEMBL5097726,B,CHEMBL5207949,Homo sapiens,CHEMBL203,CHEMBL5096180
O=C(Nc1nccs1)C(c1ncn2c1C[C@@H](F)C2)n1cc2c(Cl)cc(-c3ccc(N4CCOCC4)cc3)c(Cl)c2n1,8.22,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,6.0,nM,=,CHEMBL5120428,B,CHEMBL5208056,Homo sapiens,CHEMBL203,CHEMBL5113538
CN1CCN(c2ccc(-c3ccc4ccn(C(C(=O)Nc5nccs5)c5ccccc5)c(=O)c4c3)cc2)CC1,8.30,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,IC50,5.0,nM,=,CHEMBL5147203,B,CHEMBL5208065,Homo sapiens,CHEMBL203,CHEMBL5143652
COc1cc2ncnc3c2cc1OCCCCCCOc1cc(F)c(Cl)cc1N3,6.63,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,IC50,235.5,nM,=,CHEMBL5153035,B,CHEMBL5208312,Homo sapiens,CHEMBL203,CHEMBL5150044
CCC/C=C/C(=O)Nc1cc(Nc2ncc(-c3cc4ccccc4n3C)c(C)n2)c(OC)cc1N(C)CCN(C)C,5.10,Inhibition of EGFR L858R/T790M double mutant (unknown origin),IC50,8000.0,nM,=,CHEMBL5097720,B,CHEMBL5208349,Homo sapiens,CHEMBL203,CHEMBL5096180
O=C(Nc1nccs1)C(c1cc[nH]n1)N1Cc2ccccc2C1=O,6.03,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,IC50,938.0,nM,=,CHEMBL5120428,B,CHEMBL5208369,Homo sapiens,CHEMBL203,CHEMBL5113538
CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NCC(=O)NNC(=O)COc1ccc(-c2nc3ccccc3s2)cc1OC,6.94,Inhibition of EGFR (unknown origin),IC50,114.0,nM,=,CHEMBL5133605,B,CHEMBL5208397,Homo sapiens,CHEMBL203,CHEMBL5131433
C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3[nH]ccc23)CC1,8.25,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,5.681,nM,=,CHEMBL5099547,B,CHEMBL5208416,Homo sapiens,CHEMBL203,CHEMBL5096223
O=C(CCCl)Nc1ccc2ncnc(Nc3ccc4[nH]cc(Br)c4c3)c2c1,9.14,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,0.72,nM,=,CHEMBL5161051,B,CHEMBL5208454,Homo sapiens,CHEMBL203,CHEMBL5154786
C=CC(=O)N1CCC(Oc2nc(Nc3cnn(C)c3)nc3[nH]ccc23)CC1,6.69,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",IC50,203.8,nM,=,CHEMBL5099547,B,CHEMBL5208549,Homo sapiens,CHEMBL203,CHEMBL5096223
CC(C)c1cnc(N2CCC2)c2cnc(Nc3ccnc(N4CC[C@@H](O)[C@@](C)(F)C4)n3)cc12,8.68,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,2.1,nM,=,CHEMBL5141214,B,CHEMBL5208679,Homo sapiens,CHEMBL203,CHEMBL5137066
CC(C)c1ccc(N2C[C@H](CS(C)(=O)=O)[C@H]2C)c2cnc(Nc3ccnc(N4CC[C@@](C)(O)[C@@H](F)C4)n3)cc12,9.40,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,0.4,nM,=,CHEMBL5141214,B,CHEMBL5208737,Homo sapiens,CHEMBL203,CHEMBL5137066
COC(=O)CCc1nc2ccc(Br)cc2[nH]c1=O,7.12,Inhibition of EGFR L858R mutant (unknown origin),IC50,75.42,nM,=,CHEMBL5114136,B,CHEMBL5208825,Homo sapiens,CHEMBL203,CHEMBL5113380
Nc1ccc2ncnc(Nc3ccc4[nH]cc(Br)c4c3)c2c1,9.13,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,IC50,0.74,nM,=,CHEMBL5161051,B,CHEMBL5208907,Homo sapiens,CHEMBL203,CHEMBL5154786
Cc1cc(Nc2c(C#N)cnc3ccc(NC(=O)/C=C/[C@H]4CCCN4C)cc23)ccc1Oc1cc2nncn2cn1,8.50,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,IC50,3.13,nM,=,CHEMBL5162303,B,CHEMBL5209046,Homo sapiens,CHEMBL203,CHEMBL5154811
COc1cc(N(C)CCN(C)C)c(NC(=O)c2ccnc(Cl)c2)cc1Nc1nccc(-c2cn(C)c3ccccc23)n1,6.38,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by mobility shift assay,IC50,420.0,nM,=,CHEMBL5140666,B,CHEMBL5209075,Homo sapiens,CHEMBL203,CHEMBL5137051
CCc1cc(Nc2ncc(Br)c(Nc3ccn4ncnc4c3P(C)(C)=O)n2)c(OC)cc1N1CCC(N2CCN(CC)CC2)CC1,9.17,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,IC50,0.67,nM,=,CHEMBL5117930,B,CHEMBL5209094,Homo sapiens,CHEMBL203,CHEMBL5113487
N#CC1=C(c2ccccc2)Nc2c(c(-c3cccs3)nn2-c2ccccc2)C12C(=O)Nc1ccc(Br)cc12,6.82,Inhibition of EGFR (unknown origin) by colorimetric assay,IC50,150.0,nM,=,CHEMBL5150886,B,CHEMBL5209100,Homo sapiens,CHEMBL203,CHEMBL5149978
CNC(=O)c1cnc(Nc2ccnc(N3CCC(O)CC3)n2)cc1NC(C)C,6.54,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,IC50,290.0,nM,=,CHEMBL5141214,B,CHEMBL5209276,Homo sapiens,CHEMBL203,CHEMBL5137066
CCS(=O)(=O)n1cc(-c2nc(Nc3cc(Cl)c(N4CCC(N5CCN(C)CC5)CC4)cc3OC(C)C)ncc2Cl)c2ccccc21,8.68,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,IC50,2.1,nM,=,CHEMBL5165818,B,CHEMBL5209545,Homo sapiens,CHEMBL203,CHEMBL5154883
COc1cc2ncnc(Oc3cccc(NC(=S)Nc4ccc(Cl)c(C(F)(F)F)c4)c3)c2cc1OC,7.70,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins in presence of ATP by caliper mobility shift assay,IC50,20.0,nM,=,CHEMBL5215241,B,CHEMBL5218459,Homo sapiens,CHEMBL203,CHEMBL5214889
CCCCOc1ncnc2[nH]c(-c3ccc(N4CCN(C)CC4)cc3)c(-c3cccc(NC(=O)CC)c3)c12,8.03,Inhibition of human GST-tagged EGFR L858R/T790M/C797S mutant expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 10 mins by HTRF assay,IC50,9.4,nM,=,CHEMBL5215215,B,CHEMBL5218754,Homo sapiens,CHEMBL203,CHEMBL5214888
Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4c3CC(c3ccccc3)N4)[nH]2)cc1,7.31,Inhibition of wild type EGFR (unknown origin),IC50,49.2,nM,=,CHEMBL5215211,B,CHEMBL5218780,Homo sapiens,CHEMBL203,CHEMBL5214888
CCC(=O)Nc1cccc(-c2c(-c3ccc(N4CCN(C)CC4)cc3)[nH]c3ncn(C4CCCCC4)c(=O)c23)c1,9.40,Inhibition of human wild type GST-tagged EGFR expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 25 mins by HTRF assay,IC50,0.4,nM,=,CHEMBL5215199,B,CHEMBL5218797,Homo sapiens,CHEMBL203,CHEMBL5214888
CCC(=O)Nc1cccc(-c2c(-c3ccccc3)[nH]c3ncnc(OC)c23)c1,6.75,Inhibition of human GST-tagged EGFR L858R/T790M mutant expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 20 mins by HTRF assay,IC50,176.0,nM,=,CHEMBL5215214,B,CHEMBL5218821,Homo sapiens,CHEMBL203,CHEMBL5214888
OCCCCc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4c3CC(c3ccccc3)N4)[nH]2)cc1,8.08,Inhibition of EGFR L858R/T790M mutant (unknown origin),IC50,8.39,nM,=,CHEMBL5215210,B,CHEMBL5218879,Homo sapiens,CHEMBL203,CHEMBL5214888
COc1cc2ncnc(Sc3cccc(NC(=S)Nc4ccc(Br)c(C(F)(F)F)c4)c3)c2cc1OC,8.00,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins in presence of ATP by caliper mobility shift assay,IC50,10.0,nM,=,CHEMBL5215241,B,CHEMBL5218990,Homo sapiens,CHEMBL203,CHEMBL5214889
Cn1cc(-c2ccnc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)n2)c2ccccc21,5.92,Inhibition of EGFR T790M (unknown origin) incubated for 40 mins in presence of ATP,IC50,1200.0,nM,=,CHEMBL5215098,B,CHEMBL5218998,Homo sapiens,CHEMBL203,CHEMBL5214883
CC(=O)N[C@H]1CC[C@@H](N2C(=O)N(c3ccccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C)CC5)c(C)c4)nc32)CC1,8.51,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,IC50,3.1,nM,=,CHEMBL5215216,B,CHEMBL5219777,Homo sapiens,CHEMBL203,CHEMBL5214888
OCCc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4c3CC(c3ccccc3)N4)[nH]2)cc1,8.12,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),IC50,7.64,nM,=,CHEMBL5215207,B,CHEMBL5220061,Homo sapiens,CHEMBL203,CHEMBL5214888
CCC(=O)Nc1cccc(-c2c(-c3ccc(N4CCN(C)CC4)cc3)[nH]c3ncnc(OCC(C)C)c23)c1,9.70,Inhibition of human wild type GST-tagged EGFR expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 25 mins by HTRF assay,IC50,0.2,nM,=,CHEMBL5215199,B,CHEMBL5220529,Homo sapiens,CHEMBL203,CHEMBL5214888
CCC(=O)Nc1cccc(-c2c(-c3ccc(N4CCN(C)CC4)cc3)[nH]c3ncnc(OC(C)C)c23)c1,8.07,Inhibition of human GST-tagged EGFR L858R/T790M/C797S mutant expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 10 mins by HTRF assay,IC50,8.6,nM,=,CHEMBL5215215,B,CHEMBL5220645,Homo sapiens,CHEMBL203,CHEMBL5214888
N#Cc1c(NC(=O)CNc2n[nH]c3ncccc23)sc2c1CCCC2,9.33,Inhibition of EGFR (unknown origin) incubated for 1 hr in presence of ATP by Kinase-Glo Plus luminescence kinase assay,IC50,0.47,nM,=,CHEMBL5216306,B,CHEMBL5221067,Homo sapiens,CHEMBL203,CHEMBL5214926
